data_2jz4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jz4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 C--O 1.237 0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -148.56 102.35 3.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.049 0.94 . . . . 0.0 108.889 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.5 t -77.0 146.47 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 123.803 0.841 . . . . 0.0 109.209 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.96 148.85 25.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.621 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.535 ' HB3' ' HD1' ' A' ' 129' ' ' HIS . . . -78.93 76.22 5.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.278 1.831 . . . . 0.0 109.66 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.84 113.52 4.81 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.9 35.39 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 118.215 1.007 . . . . 0.0 111.389 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.04 178.79 36.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.889 0.756 . . . . 0.0 113.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.6 87.19 2.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.921 1.289 . . . . 0.0 109.751 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.36 21.31 3.47 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.722 1.153 . . . . 0.0 112.386 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.22 -169.14 20.04 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 118.879 1.34 . . . . 0.0 113.446 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.52 105.02 3.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.221 1.809 . . . . 0.0 108.687 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 m -171.7 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.615 1.966 . . . . 0.0 113.926 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -65.35 -173.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.542 1.937 . . . . 0.0 110.494 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.68 109.19 0.2 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.103 1.361 . . . . 0.0 114.634 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.53 172.3 13.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.343 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.982 -179.115 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.88 158.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.354 1.862 . . . . 0.0 109.979 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -140.07 -42.94 0.42 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.251 1.42 . . . . 0.0 113.674 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -142.5 150.32 40.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 120.528 1.513 . . . . 0.0 109.884 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.6 t -126.24 137.1 58.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.39 139.52 52.33 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.44 ' H ' ' HB2' ' A' ' 63' ' ' GLU . 42.8 t -140.6 94.01 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.08 108.44 3.44 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -71.49 110.78 6.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.9 2.08 . . . . 0.0 108.036 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.65 -173.98 38.37 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.28 -31.3 61.47 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.21 6.63 7.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 158.62 -175.79 35.63 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.531 1.514 . . . . 0.0 111.279 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.33 96.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.115 1.957 . . . . 0.0 108.755 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -97.86 -6.62 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.948 -1.501 . . . . 0.0 114.209 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.8 p -140.91 146.45 37.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 122.173 2.26 . . . . 0.0 112.609 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.0 171.4 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.718 1.607 . . . . 0.0 109.767 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -151.87 141.24 21.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -130.13 113.95 27.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 119.515 1.052 . . . . 0.0 109.409 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.25 154.24 13.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.525 0.73 . . . . 0.0 109.593 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -132.92 155.86 48.31 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.39 122.01 40.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 108.473 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 46' ' ' SER . 0.4 OUTLIER -109.6 167.72 9.93 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.399 1.079 . . . . 0.0 108.314 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.12 5.29 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.852 5.661 . . . . 0.0 116.424 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 44' ' ' LYS . 34.4 t -151.0 -67.96 0.18 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.874 2.07 . . . . 0.0 108.891 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -139.71 166.18 25.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.847 1.259 . . . . 0.0 111.558 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -78.01 162.95 26.36 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.73 2.012 . . . . 0.0 109.406 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.37 136.59 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -121.6 162.28 20.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.595 1.558 . . . . 0.0 109.036 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.439 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 144.46 21.49 0.16 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 128.695 3.045 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.46 20.3 45.03 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.08 121.62 19.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.473 1.637 . . . . 0.0 109.142 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.79 171.56 12.57 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 110.094 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.03 -153.49 41.81 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 98.7 5.25 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 120.421 -1.635 . . . . 0.0 113.169 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.47 149.95 49.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.3 t -144.57 158.74 43.63 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.2 -19.33 65.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.996 0.918 . . . . 0.0 112.155 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.39 15.34 26.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.765 1.226 . . . . 0.0 110.487 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.07 90.88 0.11 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.305 0.957 . . . . 0.0 112.813 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -164.0 153.16 13.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.188 2.195 . . . . 0.0 107.62 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 28' ' ' VAL . 5.4 mm-40 -144.22 164.7 29.97 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.55 1.54 . . . . 0.0 110.208 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -143.01 128.85 19.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -137.16 109.69 7.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.82 117.14 27.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.68 110.67 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.92 157.74 20.88 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.277 1.431 . . . . 0.0 111.627 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -16.02 63.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.201 1.4 . . . . 0.0 110.008 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.56 6.44 15.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.687 2.395 . . . . 0.0 110.71 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.84 141.81 31.99 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.684 -1.26 . . . . 0.0 108.969 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.434 ' CD1' ' HE2' ' A' ' 124' ' ' LYS . 54.3 m-85 -134.27 114.57 13.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -85.5 106.93 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -92.54 -21.47 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.376 1.07 . . . . 0.0 113.777 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.93 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.232 0.924 . . . . 0.0 110.472 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.44 144.67 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.36 119.75 40.21 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.95 128.19 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.681 1.128 . . . . 0.0 109.012 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 111' ' ' THR . 70.3 m -121.86 152.1 39.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.637 1.975 . . . . 0.0 109.42 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.63 168.38 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.042 1.737 . . . . 0.0 109.181 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -156.59 164.71 37.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -144.41 137.86 27.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.818 2.047 . . . . 0.0 108.337 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.8 m -132.87 161.05 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.0 104.26 0.23 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.945 1.298 . . . . 0.0 112.021 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.36 -21.76 8.06 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 124.694 1.14 . . . . 0.0 113.342 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -80.68 85.9 5.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.4 -5.01 29.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.49 1.116 . . . . 0.0 111.161 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -131.88 95.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.041 2.136 . . . . 0.0 105.575 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -54.58 147.48 14.22 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 pt -133.41 169.51 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.223 1.011 . . . . 0.0 112.657 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.6 mt -85.33 148.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.678 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -69.06 0.89 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.1 p -123.04 147.98 46.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 mm -131.4 148.53 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 m -151.06 104.19 3.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.02 144.77 31.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.13 113.3 13.72 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 p -92.01 165.82 13.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -76.55 -27.41 55.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -69.29 -7.21 34.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 111.75 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.37 5.5 57.97 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 125.945 1.736 . . . . 0.0 113.251 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -87.49 137.98 31.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.512 1.156 . . . . 0.0 108.869 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 110.75 9.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.66 155.26 89.26 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.32 169.59 18.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.396 2.064 . . . . 0.0 110.619 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 108' ' ' GLY . 73.2 Cg_endo -68.42 111.13 2.44 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 107.921 -1.607 . . . . 0.0 107.921 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -67.7 14.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.8 2.04 . . . . 0.0 113.917 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 106' ' ' PRO . . . 177.17 -175.95 47.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 126.242 1.877 . . . . 0.0 109.92 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.8 tp -72.73 108.1 5.54 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.707 1.603 . . . . 0.0 114.027 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.38 128.17 34.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 79' ' ' THR . 34.3 m -130.57 165.06 23.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.814 1.646 . . . . 0.0 108.815 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -57.05 -52.3 65.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.51 1.524 . . . . 0.0 111.446 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -61.94 102.88 0.31 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 109.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.47 170.19 21.47 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.187 0.518 . . . . 0.0 110.465 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -142.12 164.79 29.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.87 135.56 42.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.576 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.39 123.93 18.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.701 0.801 . . . . 0.0 110.991 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.93 39.23 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.293 1.437 . . . . 0.0 107.89 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.85 122.28 43.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.304 0.642 . . . . 0.0 110.734 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -119.7 -22.1 7.01 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.603 1.561 . . . . 0.0 110.414 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -67.62 -22.04 65.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.365 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.96 -10.4 6.65 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.984 -1.454 . . . . 0.0 114.62 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.75 162.81 33.81 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 120.083 1.942 . . . . 0.0 112.167 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HE2' ' CD1' ' A' ' 72' ' ' TYR . 35.4 ttmt -126.66 143.03 51.36 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.59 146.71 39.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 -28.88 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.31 -151.91 9.53 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.31 171.17 14.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.903 0.859 . . . . 0.0 112.528 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.535 ' HD1' ' HB3' ' A' ' 6' ' ' ALA . 20.6 p80 -144.31 159.7 42.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.484 1.914 . . . . 0.0 106.579 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.03 110.09 2.08 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.304 0.954 . . . . 0.0 115.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -53.27 131.38 37.24 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.601 1.96 . . . . 0.0 107.071 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.43 164.98 37.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.462 1.505 . . . . 0.0 108.397 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.91 -101.67 0.16 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.4 -40.08 77.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.192 0.996 . . . . 0.0 110.238 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -125.41 153.31 43.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.22 98.52 10.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -74.2 -46.51 41.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.372 0.669 . . . . 0.0 110.994 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.51 165.4 31.33 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 110.46 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.3 tp -147.89 159.11 44.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.402 1.481 . . . . 0.0 107.691 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.85 21.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.76 133.78 24.15 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -82.22 168.34 17.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -130.31 163.56 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.524 -0.735 . . . . 0.0 110.508 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.362 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.78 134.73 35.11 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.339 1.056 . . . . 0.0 110.388 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -87.02 146.59 26.06 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.9 mt -113.65 -166.66 1.11 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.2 m -146.32 125.89 13.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.84 -159.47 0.69 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.694 2.398 . . . . 0.0 108.67 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.9 tt -149.04 151.57 12.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.95 -38.77 0.42 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.842 0.746 . . . . 0.0 114.442 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.56 162.01 25.41 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.113 1.457 . . . . 0.0 112.85 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 49.2 p30 -112.73 0.88 15.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.076 1.75 . . . . 0.0 112.851 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -131.71 135.43 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.637 1.108 . . . . 0.0 109.86 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 132.6 159.13 9.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 127.713 2.577 . . . . 0.0 109.125 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.5 m -67.9 134.37 50.72 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 112.267 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.74 135.22 36.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -127.68 33.46 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.093 1.357 . . . . 0.0 110.475 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -58.03 107.63 0.49 Allowed 'General case' 0 C--N 1.334 -0.095 0 O-C-N 120.775 -1.203 . . . . 0.0 112.48 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.72 -16.73 60.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.986 0.914 . . . . 0.0 110.274 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 -75.14 1.53 Allowed Glycine 0 C--N 1.337 0.612 0 CA-C-O 118.522 -1.155 . . . . 0.0 110.53 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.89 146.81 2.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.426 2.291 . . . . 0.0 109.02 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -124.86 167.19 14.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.893 2.077 . . . . 0.0 106.831 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -24.36 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.92 -174.73 42.25 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.63 116.59 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.63 -39.03 8.08 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.642 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -145.42 150.63 36.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.46 150.36 33.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.925 0.89 . . . . 0.0 109.084 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -142.48 155.63 45.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.823 1.249 . . . . 0.0 108.677 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.59 130.49 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.84 93.43 0.54 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -70.67 155.66 40.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.117 0.961 . . . . 0.0 110.076 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.35 -167.82 14.89 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 126.674 2.083 . . . . 0.0 109.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.16 -9.05 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.326 -1.102 . . . . 0.0 110.9 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -117.25 -31.85 5.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.507 3.123 . . . . 0.0 113.686 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.07 -158.3 30.59 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.62 110.61 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 62.6 m -116.39 -12.71 11.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.017 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.21 130.75 29.25 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.91 1.232 . . . . 0.0 110.143 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.97 135.82 50.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -148.44 139.81 23.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -132.92 163.25 29.57 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.74 1.616 . . . . 0.0 109.13 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -123.03 150.99 42.35 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -161.29 167.95 24.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.252 1.021 . . . . 0.0 111.726 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -120.28 113.01 19.76 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 199' ' ' GLU . 21.7 pttp -107.19 122.52 46.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.31 -84.19 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.73 -4.95 1.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.912 2.085 . . . . 0.0 110.799 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.431 ' CD ' ' HZ1' ' A' ' 196' ' ' LYS . 33.5 mt-10 -75.4 168.28 20.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.57 1.548 . . . . 0.0 110.455 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -131.92 101.93 5.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.445 2.698 . . . . 0.0 105.94 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.78 118.18 36.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.264 1.026 . . . . 0.0 109.35 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.19 128.53 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 128.3 -140.13 11.56 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 110.06 9.86 23.47 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.433 1.117 . . . . 0.0 115.851 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -68.58 108.53 3.37 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.739 1.77 . . . . 0.0 109.499 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -129.2 27.14 5.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.084 2.153 . . . . 0.0 109.774 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -145.06 -178.74 20.88 Favored Glycine 0 N--CA 1.451 -0.322 0 O-C-N 120.444 -1.41 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -85.36 94.64 0.33 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.809 1.244 . . . . 0.0 111.024 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.4 162.51 38.51 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.571 1.597 . . . . 0.0 108.047 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.9 m -137.48 166.32 24.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -2.59 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.0 -7.16 47.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.405 1.082 . . . . 0.0 109.202 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.56 -148.92 32.84 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -141.65 157.28 45.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 108.436 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.57 154.7 28.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 128.523 2.729 . . . . 0.0 104.052 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.05 140.12 23.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.02 132.24 23.24 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.312 1.045 . . . . 0.0 108.491 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -105.61 97.02 6.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.45 141.24 15.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.98 88.76 4.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -49.02 -55.6 19.81 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 113.876 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.25 -9.62 21.93 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.51 1.575 . . . . 0.0 114.578 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.42 -38.05 6.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.63 1.105 . . . . 0.0 113.88 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 172.62 10.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.0 112.678 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -150.15 149.03 29.67 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.65 -0.656 . . . . 0.0 112.543 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.04 100.16 7.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.5 t -73.17 -29.13 62.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.525 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.04 170.63 16.29 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.71 1.604 . . . . 0.0 108.646 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.72 150.65 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.655 1.182 . . . . 0.0 108.366 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -133.77 166.76 21.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.786 2.035 . . . . 0.0 109.245 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.45 166.93 28.35 Favored Glycine 0 N--CA 1.452 -0.265 0 O-C-N 120.968 -1.083 . . . . 0.0 110.823 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 79.1 p -137.1 133.95 35.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -117.31 138.22 51.91 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 109.77 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -119.14 146.85 44.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.098 0.952 . . . . 0.0 108.586 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -69.68 129.11 38.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 112.948 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.8 155.42 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -93.33 173.63 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 77.41 -25.69 1.97 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.301 1.429 . . . . 0.0 114.62 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 11.9 p -141.56 168.85 18.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.542 1.671 . . . . 0.0 109.715 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -84.4 11.73 8.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 110.648 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.46 -175.78 27.4 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.788 1.185 . . . . 0.0 112.939 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.5 mt -149.23 166.67 28.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.662 1.985 . . . . 0.0 109.335 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.15 172.78 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.12 112.97 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.12 1.368 . . . . 0.0 108.994 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.55 -4.42 19.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.569 0.748 . . . . 0.0 112.742 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.3 tmm? -147.7 110.98 4.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 17.7 mt -125.75 132.72 52.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.14 1.376 . . . . 0.0 108.363 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -129.04 166.15 19.78 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.647 1.213 . . . . 0.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.01 134.83 44.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -73.11 130.71 40.89 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.3 m -139.0 130.64 27.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.492 HD21 ' HD3' ' A' ' 253' ' ' LYS . 3.4 p-10 -100.94 156.22 17.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.207 1.803 . . . . 0.0 107.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.492 ' HD3' HD21 ' A' ' 252' ' ' ASN . 1.0 OUTLIER 59.8 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.82 2.448 . . . . 0.0 115.268 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' A' ' 252' ' ' ASN . 49.6 mt-30 -131.63 174.78 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 129.124 2.97 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 97.3 m -130.08 108.96 10.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.319 1.447 . . . . 0.0 108.81 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -81.27 136.03 35.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.0 154.27 69.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.46 88.86 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.185 2.59 . . . . 0.0 107.363 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -69.89 105.29 2.76 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.15 -172.38 23.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.712 0.687 . . . . 0.0 113.43 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.65 113.33 21.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.799 1.64 . . . . 0.0 110.09 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.16 131.19 50.04 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.113 1.365 . . . . 0.0 110.183 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.07 1.95 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 129.272 3.029 . . . . 0.0 105.873 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.26 -166.2 45.8 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 83.4 m -84.87 144.99 28.04 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.412 1.485 . . . . 0.0 108.143 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -100.48 150.76 22.32 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -143.92 164.17 31.34 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 111.456 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.79 154.45 37.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.631 1.572 . . . . 0.0 109.657 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.3 mt -131.89 105.61 7.55 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -139.81 143.99 37.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.921 0.889 . . . . 0.0 112.686 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -144.46 153.51 41.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.696 1.998 . . . . 0.0 106.371 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -86.83 145.83 26.45 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.494 -1.379 . . . . 0.0 112.206 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.94 -43.33 0.79 Allowed Glycine 0 C--N 1.341 0.853 0 C-N-CA 127.035 2.255 . . . . 0.0 115.431 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -74.28 159.47 32.4 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.321 1.049 . . . . 0.0 111.935 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 297' ' ' LEU . 1.2 mppt? -125.59 174.31 8.35 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.943 2.097 . . . . 0.0 105.555 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.8 140.34 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.492 0.663 . . . . 0.0 109.661 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.13 -3.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 128.337 2.655 . . . . 0.0 111.717 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.11 156.89 28.38 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 120.526 1.512 . . . . 0.0 114.6 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -114.83 162.7 16.53 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 112.161 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -150.75 137.44 18.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 169.07 -160.45 33.87 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.404 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -145.6 143.66 30.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.255 0.55 . . . . 0.0 111.967 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.61 148.54 12.57 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 126.938 2.095 . . . . 0.0 107.171 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.2 m -131.41 -34.08 1.42 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 127.288 2.235 . . . . 0.0 107.003 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -144.21 -56.74 0.37 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.48 148.65 26.23 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.55 1.94 . . . . 0.0 110.076 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 86.51 4.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.554 0.616 . . . . 0.0 110.595 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -67.01 -58.73 4.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.618 0.367 . . . . 0.0 111.737 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -126.1 136.34 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.481 0.582 . . . . 0.0 110.954 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -132.32 123.1 26.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.715 1.606 . . . . 0.0 108.883 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -137.34 170.48 23.58 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.316 1.436 . . . . 0.0 109.911 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.02 171.95 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.238 0.615 . . . . 0.0 111.44 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -121.37 166.09 14.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.94 2.096 . . . . 0.0 106.131 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.58 136.7 56.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 75.1 mtp -137.03 140.62 31.95 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 108.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.2 104.83 1.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.1 3.2 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.41 ' HB2' ' HE2' ' A' ' 275' ' ' LYS . 74.9 mt . . . . . 0 N--CA 1.462 0.171 0 C-N-CA 124.56 1.144 . . . . 0.0 109.263 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.402 1.096 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -148.72 138.35 21.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 130.688 3.595 . . . . 0.0 105.202 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.73 145.86 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -89.5 161.96 15.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.562 1.172 . . . . 0.0 111.255 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.96 90.05 8.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.23 103.96 1.26 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.99 -177.29 44.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.33 1.919 . . . . 0.0 108.976 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.92 161.75 46.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 118.452 1.126 . . . . 0.0 112.85 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.44 0.37 55.35 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.67 166.28 43.16 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.61 174.35 23.09 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 123.98 0.8 . . . . 0.0 112.915 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.32 131.77 34.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.4 p -71.55 128.33 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.015 0.825 . . . . 0.0 110.341 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -121.54 4.8 10.13 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -64.36 136.1 56.8 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 71.58 12.0 6.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.892 2.477 . . . . 0.0 110.468 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.868 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.178 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.56 153.6 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.024 0.912 . . . . 0.0 108.592 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -131.18 -52.27 1.03 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.862 1.665 . . . . 0.0 111.2 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -126.08 160.74 29.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.69 129.14 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.56 119.88 26.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 92.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.09 143.87 16.87 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.93 175.02 3.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.063 0.945 . . . . 0.0 110.863 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.94 175.71 43.31 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.41 -36.96 84.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.88 2.79 28.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 130.863 3.665 . . . . 0.0 110.711 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -166.89 24.81 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.45 122.76 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -136.47 -19.85 1.4 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.426 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -99.17 112.95 24.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.52 144.26 36.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 121.97 -0.456 . . . . 0.0 110.35 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -148.44 151.01 34.48 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.937 1.695 . . . . 0.0 107.837 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.78 158.53 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.918 1.287 . . . . 0.0 108.206 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.39 115.2 39.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -88.99 105.54 17.85 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.178 1.391 . . . . 0.0 109.068 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.37 126.15 28.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.088 -0.383 . . . . 0.0 110.509 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -113.78 146.27 40.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.7 -36.12 75.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.593 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -64.36 -63.66 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -156.13 141.56 17.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.048 0.939 . . . . 0.0 108.873 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.27 111.72 10.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.28 136.74 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.804 0.812 . . . . 0.0 112.395 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -78.28 162.47 26.5 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.622 1.969 . . . . 0.0 109.682 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.58 6.75 8.48 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.131 1.824 . . . . 0.0 111.238 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.26 161.04 26.16 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 125.953 1.74 . . . . 0.0 113.75 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.3 137.68 56.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.907 0.883 . . . . 0.0 109.573 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -122.88 51.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.24 -177.34 27.54 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.861 1.696 . . . . 0.0 111.3 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.61 84.89 3.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.919 1.288 . . . . 0.0 110.404 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -56.56 132.56 51.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.428 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -129.49 147.61 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -75.18 -36.73 61.45 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.856 -0.528 . . . . 0.0 111.628 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mp -102.11 23.12 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.25 91.93 0.15 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 121.761 -0.587 . . . . 0.0 112.1 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -161.64 154.79 20.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 105.01 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -150.57 164.85 35.01 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.12 1.768 . . . . 0.0 108.847 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.6 m -145.07 122.12 11.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.93 0.492 . . . . 0.0 110.541 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -131.61 131.53 43.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -107.92 141.34 39.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.213 1.005 . . . . 0.0 108.687 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.48 112.9 42.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.88 176.56 4.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.765 2.026 . . . . 0.0 111.533 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -46.38 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -101.9 -5.04 25.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.008 2.123 . . . . 0.0 113.388 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -94.53 137.13 34.03 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -123.94 162.41 23.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.342 0.973 . . . . 0.0 110.573 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.4 mt -86.92 118.27 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.16 -45.88 20.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.266 1.426 . . . . 0.0 109.823 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.38 166.15 28.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.621 1.169 . . . . 0.0 109.651 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.06 103.35 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -82.37 135.37 35.19 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -133.66 127.75 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.9 p -114.64 149.1 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -151.85 168.15 26.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.889 0.768 . . . . 0.0 110.571 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -153.78 151.96 30.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -128.46 127.88 43.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.544 2.338 . . . . 0.0 105.918 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.64 166.21 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.887 1.275 . . . . 0.0 111.086 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.83 156.9 31.89 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.42 -14.65 6.49 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.071 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -129.03 107.23 9.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.184 1.492 . . . . 0.0 108.177 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.36 -14.25 62.86 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 111.041 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.4 p -72.01 176.44 5.06 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.547 1.539 . . . . 0.0 110.011 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.68 135.65 30.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.53 154.11 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.776 0.716 . . . . 0.0 110.647 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.73 112.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.857 1.263 . . . . 0.0 107.989 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -77.24 -36.78 54.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.566 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.6 t -158.98 158.72 33.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.843 2.057 . . . . 0.0 109.243 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.06 151.49 27.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.775 2.03 . . . . 0.0 107.11 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 m -150.67 108.45 3.69 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.18 158.71 31.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -135.49 122.04 20.73 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.1 p -108.53 160.68 15.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 119.276 0.944 . . . . 0.0 112.287 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -68.76 -37.88 79.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.315 0.646 . . . . 0.0 109.746 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -15.28 63.51 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 116.772 -1.585 . . . . 0.0 113.431 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.61 3.5 49.8 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 120.188 1.358 . . . . 0.0 112.589 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -82.7 95.07 7.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.5 m -104.35 122.31 45.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.8 p -70.13 159.7 83.46 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 111.561 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.33 170.26 20.34 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.073 1.849 . . . . 0.0 107.435 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.58 109.75 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 N-CA-C 106.519 -2.147 . . . . 0.0 106.519 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -81.03 77.06 7.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.65 -149.97 20.36 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.772 1.653 . . . . 0.0 110.234 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.3 tp -105.27 125.77 51.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.113 1.365 . . . . 0.0 110.591 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.46 139.48 53.97 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.9 m -134.78 157.14 47.51 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.439 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -61.76 -45.56 93.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.217 0.607 . . . . 0.0 109.492 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -65.2 110.32 2.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 107.229 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -163.86 166.8 21.48 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.409 -0.807 . . . . 0.0 112.226 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -150.87 167.67 26.8 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.24 1.816 . . . . 0.0 108.921 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.24 142.62 38.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 129.84 55.48 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.985 0.914 . . . . 0.0 111.129 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 147.2 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.144 1.377 . . . . 0.0 108.229 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 123' ' ' GLY . 27.9 t0 -76.49 174.51 10.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -50.05 -53.73 25.02 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.928 1.691 . . . . 0.0 109.425 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -114.32 -23.81 9.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 117.835 -1.078 . . . . 0.0 113.607 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.22 55.83 0.13 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.939 1.245 . . . . 0.0 113.919 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 119' ' ' ASP . . . -71.74 138.5 27.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -65.75 144.47 56.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -62.12 97.05 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.143 1.777 . . . . 0.0 107.866 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.72 -51.99 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -174.07 141.12 5.8 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -87.55 177.76 6.98 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.642 1.177 . . . . 0.0 111.328 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -147.2 169.37 19.48 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 107.319 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.91 -177.99 47.49 Favored Glycine 0 CA--C 1.523 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.258 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -142.45 50.71 1.48 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.67 2.388 . . . . 0.0 108.629 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.43 163.53 17.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 119.902 -1.748 . . . . 0.0 109.164 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.86 -104.45 0.19 Allowed Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.09 -15.99 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.409 0.711 . . . . 0.0 111.144 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.83 174.61 12.03 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.874 2.47 . . . . 0.0 107.343 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.6 tp -98.91 88.54 4.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -79.58 -52.64 7.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.694 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.77 158.53 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 111.982 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -148.6 147.09 28.59 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.447 3.499 . . . . 0.0 106.576 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -144.18 -173.21 15.4 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.83 156.18 35.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.758 1.279 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -128.68 109.84 11.68 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.65 99.14 8.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -74.74 131.09 40.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -111.92 147.9 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.633 1.973 . . . . 0.0 106.855 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.32 167.76 10.17 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.166 1.386 . . . . 0.0 107.84 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -73.51 107.33 5.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.8 171.56 10.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.667 0.787 . . . . 0.0 109.339 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.49 148.05 30.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 159.8 -112.44 0.52 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 125.006 1.289 . . . . 0.0 110.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -115.67 163.51 12.29 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.882 1.706 . . . . 0.0 110.453 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.13 -5.61 40.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.13 1.372 . . . . 0.0 112.474 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.49 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 44.7 tt0 -112.98 144.0 43.32 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.417 1.487 . . . . 0.0 109.752 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.56 171.52 12.87 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 123.795 0.712 . . . . 0.0 113.167 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.4 m -82.07 116.96 21.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.847 0.859 . . . . 0.0 108.901 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.06 126.27 29.19 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -134.13 127.07 31.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.011 0.924 . . . . 0.0 111.746 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.18 155.63 17.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.985 1.714 . . . . 0.0 108.681 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -150.81 100.19 2.79 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.55 160.36 5.02 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.54 143.71 51.53 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -104.77 178.33 4.59 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 111.317 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -53.05 -45.1 67.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.078 1.751 . . . . 0.0 112.361 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.74 -176.33 46.97 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 128.874 3.13 . . . . 0.0 106.157 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.67 141.26 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -121.86 -19.8 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.453 ' HZ3' ' CD ' ' A' ' 216' ' ' GLU . 49.2 mtpt -144.28 158.54 43.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.95 145.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -128.94 156.05 44.36 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 t -136.29 123.35 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.87 57.67 0.58 Allowed Glycine 0 C--N 1.341 0.833 0 C-N-CA 124.394 0.997 . . . . 0.0 114.834 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.412 ' H ' ' CD ' ' A' ' 182' ' ' GLN . 3.2 pm0 -68.21 159.93 30.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.964 0.905 . . . . 0.0 110.024 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.28 -140.07 3.83 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.542 1.544 . . . . 0.0 110.477 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -82.15 -37.13 26.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.192 0.997 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.55 -31.45 11.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.725 2.01 . . . . 0.0 113.759 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.16 -158.48 29.52 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 119.749 1.158 . . . . 0.0 110.975 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 105.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 m -95.13 -23.46 17.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 0.0 111.472 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.35 157.69 38.97 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.808 1.643 . . . . 0.0 109.3 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.57 156.53 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.592 1.957 . . . . 0.0 106.545 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 214' ' ' PHE . 59.8 pttt -174.13 134.0 0.43 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 128.78 2.832 . . . . 0.0 105.842 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -125.95 162.22 25.73 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.092 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -103.09 152.35 21.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.778 1.231 . . . . 0.0 109.585 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.03 163.9 23.2 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.532 1.133 . . . . 0.0 109.682 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.24 145.72 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.071 1.748 . . . . 0.0 106.978 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -140.56 97.19 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 65.34 -143.57 46.16 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.65 5.7 10.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.844 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.94 168.5 9.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.738 1.215 . . . . 0.0 110.709 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.75 142.79 49.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.821 1.648 . . . . 0.0 107.186 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.4 mm -131.81 102.41 5.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.26 105.23 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 139.31 170.5 11.9 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 121.751 0.64 . . . . 0.0 114.516 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.43 45.23 0.02 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.684 2.087 . . . . 0.0 109.28 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.62 100.61 3.38 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.665 1.186 . . . . 0.0 109.87 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -116.84 -24.45 7.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.639 1.176 . . . . 0.0 112.122 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -91.8 -179.24 41.93 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.96 91.55 0.97 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.248 1.024 . . . . 0.0 109.161 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.36 156.63 58.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 121.367 1.524 . . . . 0.0 109.324 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 71.2 p -98.91 173.48 6.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.62 -10.55 59.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.086 -1.009 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.0 tt -53.37 -39.35 64.13 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.59 175.28 29.73 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.665 1.603 . . . . 0.0 111.149 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.41 ' CG ' ' HE2' ' A' ' 191' ' ' LYS . 53.4 m-85 -102.34 138.41 39.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.355 1.062 . . . . 0.0 109.628 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.88 164.17 13.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.977 2.511 . . . . 0.0 106.326 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 177' ' ' LYS . 6.9 pt-20 -143.13 157.37 44.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 121.542 1.974 . . . . 0.0 115.684 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.55 143.63 32.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.633 1.173 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 124.2 43.75 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 108.762 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.96 117.5 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 C-N-CA 126.604 1.962 . . . . 0.0 106.304 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -93.98 106.36 18.34 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.574 1.079 . . . . 0.0 109.999 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -38.66 -61.42 0.89 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.6 -19.31 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.192 1.819 . . . . 0.0 116.301 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.5 t -106.93 -12.92 15.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.576 1.989 . . . . 0.0 114.769 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.33 160.18 15.81 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 107.229 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -152.48 106.87 3.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 119.935 -1.728 . . . . 0.0 109.894 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.93 70.48 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 t -68.12 -16.95 64.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.546 -1.346 . . . . 0.0 112.739 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -157.94 167.51 29.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.862 1.665 . . . . 0.0 107.914 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.55 159.54 37.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.413 ' OE2' ' HE3' ' A' ' 250' ' ' LYS . 31.4 mt-10 -131.51 172.92 11.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.41 1.484 . . . . 0.0 108.388 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.52 179.8 42.8 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.3 m -157.19 150.52 23.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 155.47 48.61 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -153.02 164.4 38.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.892 0.853 . . . . 0.0 108.964 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -70.07 148.36 48.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.053 2.141 . . . . 0.0 112.907 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.7 mt -90.16 151.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -108.8 76.8 1.03 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 149.22 -15.85 1.14 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-O 117.944 -1.476 . . . . 0.0 115.483 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 m -132.44 148.49 52.41 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.734 1.267 . . . . 0.0 108.293 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.62 86.23 7.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.844 1.258 . . . . 0.0 109.235 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 178.28 -169.92 41.84 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 0.0 110.065 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.65 156.44 39.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.99 2.116 . . . . 0.0 105.393 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.8 tt -134.52 167.46 25.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.958 1.303 . . . . 0.0 107.761 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.9 mm -99.05 93.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 111.708 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -87.31 -21.77 25.54 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.267 -0.896 . . . . 0.0 113.323 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -137.72 144.63 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 109.632 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.31 149.89 38.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.245 0.93 . . . . 0.0 109.624 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -148.33 159.67 43.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.917 1.687 . . . . 0.0 109.226 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -138.7 116.0 11.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.413 ' HE3' ' OE2' ' A' ' 230' ' ' GLU . 85.2 mttt -73.77 149.79 41.51 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.0 p -145.37 165.39 28.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.255 0.48 . . . . 0.0 110.493 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 254' ' ' GLN . 5.7 t30 -99.99 133.78 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.32 2.248 . . . . 0.0 105.362 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 58.2 -19.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.946 2.098 . . . . 0.0 115.498 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 252' ' ' ASN . 0.6 OUTLIER -89.98 171.61 9.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.4 2.28 . . . . 0.0 108.797 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.3 p -141.52 99.88 3.66 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.0 p -82.92 172.46 12.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.031 1.332 . . . . 0.0 111.197 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -120.62 157.82 53.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.015 1.326 . . . . 0.0 111.067 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.214 2.61 . . . . 0.0 107.521 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -81.35 92.21 6.37 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.1 174.19 17.5 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.572 1.558 . . . . 0.0 111.224 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 92.2 mt -95.95 146.57 24.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 109.087 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -71.72 146.72 47.99 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.9 -179.99 7.17 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.134 1.374 . . . . 0.0 109.986 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 37.73 -96.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.968 2.223 . . . . 0.0 116.082 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 96.2 m -146.29 129.1 16.28 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.873 0.869 . . . . 0.0 110.407 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.98 35.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -142.01 161.19 38.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.88 154.74 38.84 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.982 -1.074 . . . . 0.0 109.86 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.99 151.97 47.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -158.91 173.96 15.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.991 2.516 . . . . 0.0 107.064 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -144.93 164.09 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 107.146 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.34 -18.16 57.67 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 175.84 63.97 0.06 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -152.24 175.49 12.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.218 1.807 . . . . 0.0 106.753 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -115.46 152.24 33.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.396 1.478 . . . . 0.0 107.29 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.2 mt -86.61 119.87 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.4 m -147.22 69.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.467 0.707 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.73 -178.79 18.4 Favored Glycine 0 N--CA 1.467 0.722 0 O-C-N 120.198 -1.564 . . . . 0.0 114.316 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.89 160.97 40.44 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.69 1.196 . . . . 0.0 110.758 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -157.69 132.61 8.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -175.43 -152.74 9.62 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.49 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 16.1 ptmt -143.8 147.46 34.17 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.2 156.18 21.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 108.195 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 20.3 t -127.35 -90.66 0.52 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -79.2 -58.17 3.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 20.2 mt -110.75 165.89 11.46 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.999 1.719 . . . . 0.0 111.832 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.01 106.39 4.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 109.545 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -96.12 -45.94 6.67 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.2 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -122.05 137.68 54.72 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.068 0.849 . . . . 0.0 112.151 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -138.1 149.8 46.27 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.511 1.124 . . . . 0.0 109.945 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -169.16 154.98 24.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.32 151.47 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 118.343 1.072 . . . . 0.0 112.504 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.85 154.02 20.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 141.24 47.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.516 0.726 . . . . 0.0 111.371 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 83.2 mmm -144.73 144.45 24.58 Favored Pre-proline 0 N--CA 1.465 0.278 0 C-N-CA 126.924 2.09 . . . . 0.0 107.399 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.96 159.39 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.627 1.26 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--O 1.238 0.482 0 C-N-CA 124.088 0.955 . . . . 0.0 110.362 179.538 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 121.79 0.805 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -129.95 139.12 51.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.904 1.682 . . . . 0.0 107.602 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -124.83 110.07 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 103.981 -2.599 . . . . 0.0 103.981 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 165.63 17.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.983 0.897 . . . . 0.0 110.843 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 163.41 12.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.307 1.443 . . . . 0.0 107.542 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.07 154.46 25.33 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.99 -153.04 24.75 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.83 -2.508 . . . . 0.0 106.83 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.11 121.71 14.84 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 122.477 1.043 . . . . 0.0 115.087 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.85 -8.36 57.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.812 0.845 . . . . 0.0 111.859 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.96 -19.12 60.83 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.636 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.95 20.72 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.386 1.593 . . . . 0.0 113.345 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.68 157.37 27.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 108.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -69.9 119.46 14.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -86.48 -70.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 17.52 2.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.643 1.177 . . . . 0.0 113.709 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.45 134.91 55.45 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.04 -1.038 . . . . 0.0 109.686 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 106.534 -2.626 . . . . 0.0 106.534 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 N-CA-C 118.011 1.964 . . . . 0.0 118.011 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.0 124.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 120.839 2.319 . . . . 0.0 110.793 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -104.26 -71.18 0.74 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.839 1.256 . . . . 0.0 110.569 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -111.13 151.63 27.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.485 1.114 . . . . 0.0 109.251 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.47 141.92 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.423 ' CD2' ' HG1' ' A' ' 64' ' ' THR . 11.6 m80 -123.7 120.42 32.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.33 102.79 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.42 129.46 9.82 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.3 168.03 20.45 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.118 0.961 . . . . 0.0 109.139 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.37 163.92 31.77 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -57.42 -40.78 79.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.291 1.436 . . . . 0.0 111.034 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.3 3.22 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.074 2.949 . . . . 0.0 113.613 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.35 -171.23 13.67 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.491 1.041 . . . . 0.0 112.208 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.73 106.13 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.27 -22.23 5.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.184 0.994 . . . . 0.0 113.501 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.4 p -117.96 131.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.201 1.0 . . . . 0.0 109.784 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.88 154.45 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 121.271 -0.893 . . . . 0.0 111.159 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -146.47 150.82 36.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.9 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.68 117.68 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.14 171.61 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.289 . . . . 0.0 108.498 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.12 109.3 5.28 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.753 -1.217 . . . . 0.0 109.03 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -116.3 165.51 13.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.306 1.442 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 44.5 5.58 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.027 1.394 . . . . 0.0 110.79 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m 49.37 33.04 4.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.982 2.913 . . . . 0.0 114.448 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.79 165.26 27.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.425 1.89 . . . . 0.0 109.975 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.41 127.04 31.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.923 2.089 . . . . 0.0 109.48 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.44 116.75 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.359 1.064 . . . . 0.0 108.79 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.03 159.36 30.95 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.91 0.884 . . . . 0.0 112.205 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.23 -17.72 4.38 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-O 117.352 -1.804 . . . . 0.0 115.805 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.59 154.19 2.96 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-N 120.428 2.114 . . . . 0.0 114.033 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.66 105.5 5.78 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.392 -1.064 . . . . 0.0 113.485 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -93.1 176.48 6.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.784 2.834 . . . . 0.0 109.613 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -163.14 54.69 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.49 100.36 11.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -61.75 150.03 38.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.435 -178.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.9 p -123.53 157.76 32.89 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.324 1.049 . . . . 0.0 108.837 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 tp -90.74 -38.83 12.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.778 0.831 . . . . 0.0 112.009 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mp -101.46 32.73 3.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 112.687 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.6 108.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -162.82 146.06 10.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.828 1.651 . . . . 0.0 107.294 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.1 162.04 41.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.322 2.649 . . . . 0.0 108.249 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.423 ' HG1' ' CD2' ' A' ' 27' ' ' HIS . 95.0 m -144.7 96.04 2.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.39 116.23 24.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.32 133.64 34.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.469 1.107 . . . . 0.0 108.814 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.62 107.25 22.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.81 160.58 5.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 111.135 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.66 -40.38 76.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.764 -0.585 . . . . 0.0 111.84 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.38 -19.32 20.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.469 0.577 . . . . 0.0 112.32 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -81.03 140.22 35.28 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -135.58 154.55 51.31 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.479 0.712 . . . . 0.0 110.803 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.69 133.64 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.52 -24.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 123.791 0.836 . . . . 0.0 111.1 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.19 156.72 42.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.87 146.26 25.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.95 115.26 15.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.33 123.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.3 m -99.42 138.04 37.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.182 1.793 . . . . 0.0 107.22 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -152.79 155.69 37.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.44 169.32 23.29 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -128.21 160.09 33.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.396 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -123.85 152.1 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.814 0.846 . . . . 0.0 108.753 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.33 113.34 1.91 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.997 0.919 . . . . 0.0 108.615 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.85 3.9 42.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.468 -1.184 . . . . 0.0 113.113 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -134.17 84.58 2.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.41 24.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 130.548 3.539 . . . . 0.0 113.19 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.3 t -149.8 108.47 3.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.181 -1.575 . . . . 0.0 108.533 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.56 157.27 7.14 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.023 1.729 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -139.39 147.11 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.702 1.601 . . . . 0.0 108.524 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.8 mm -70.37 113.19 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.2 p -80.47 -34.19 36.05 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.736 -0.602 . . . . 0.0 109.745 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 p -165.45 164.32 19.55 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.881 1.672 . . . . 0.0 109.712 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.8 tt -141.45 154.41 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 142.9 29.24 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -115.3 156.7 24.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -137.25 114.06 10.47 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -104.42 164.99 11.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.311 0.577 . . . . 0.0 110.632 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.44 -36.26 75.59 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -28.85 66.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.983 0.81 . . . . 0.0 111.816 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.69 5.67 47.76 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -72.85 88.49 1.34 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -84.76 109.22 17.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 p -71.26 161.76 76.52 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 125.174 1.389 . . . . 0.0 110.18 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.84 165.34 19.92 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.034 2.49 . . . . 0.0 110.285 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.44 119.27 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.087 2.525 . . . . 0.0 108.486 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -81.75 77.55 8.58 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.72 -155.8 25.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.563 1.078 . . . . 0.0 111.188 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.0 tp -88.15 119.17 28.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.372 1.469 . . . . 0.0 109.636 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.35 152.14 45.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.59 168.98 24.37 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.966 -1.084 . . . . 0.0 109.928 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -73.22 -47.48 43.05 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 120.96 -1.087 . . . . 0.0 109.496 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.97 109.15 1.69 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.355 1.074 . . . . 0.0 109.249 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.09 166.49 21.29 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.182 1.393 . . . . 0.0 108.685 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -144.78 164.97 29.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.34 149.14 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.5 141.13 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.947 1.299 . . . . 0.0 108.807 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -157.56 164.47 37.28 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.047 1.339 . . . . 0.0 110.978 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.91 170.87 15.72 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 108.168 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.19 -56.24 12.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.048 -1.032 . . . . 0.0 109.893 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -117.95 -14.08 10.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.26 -63.96 0.29 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.47 -143.01 18.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -163.38 137.2 5.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.42 137.51 52.77 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.35 -34.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.269 0.941 . . . . 0.0 111.976 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.71 172.95 42.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.39 153.46 43.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.582 1.153 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 159.82 42.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.469 1.108 . . . . 0.0 108.055 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.08 137.96 2.89 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -61.46 135.73 57.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 110.145 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -153.23 164.93 37.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.191 1.396 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.72 -107.42 0.2 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.95 -26.59 66.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.026 0.913 . . . . 0.0 111.328 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.62 172.03 13.25 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.3 1.84 . . . . 0.0 107.615 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 38.7 tp -84.89 100.15 11.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -81.61 -39.89 23.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.87 146.25 31.04 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 124.478 1.111 . . . . 0.0 108.81 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.7 tp -155.76 100.11 2.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.335 0.516 . . . . 0.0 112.317 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.99 178.55 16.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.801 2.143 . . . . 0.0 109.293 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.4 163.55 39.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.565 1.682 . . . . 0.0 110.201 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -127.82 143.27 51.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.686 1.232 . . . . 0.0 109.534 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -110.42 105.09 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.702 2.001 . . . . 0.0 106.202 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 119.301 0.955 . . . . 0.0 110.848 -179.157 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.245 0.545 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 133.59 52.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -114.31 121.53 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.391 0.677 . . . . 0.0 111.575 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.49 -169.65 1.52 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.7 t -136.33 115.05 12.03 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 120.463 -1.398 . . . . 0.0 108.19 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.41 -171.18 2.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.968 0.907 . . . . 0.0 109.861 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.19 152.46 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.82 -72.78 0.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 123.963 0.792 . . . . 0.0 111.295 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.46 143.07 6.0 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.444 ' HA ' ' HE3' ' A' ' 282' ' ' LYS . 10.0 p-10 -90.19 48.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.811 1.644 . . . . 0.0 111.739 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.64 152.12 26.76 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.45 1.5 . . . . 0.0 107.819 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.04 166.88 12.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.52 1.534 . . . . 0.0 114.264 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 m -65.56 129.32 39.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.355 1.062 . . . . 0.0 109.225 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.6 109.46 11.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -95.05 7.15 47.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.474 1.11 . . . . 0.0 112.443 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.99 132.34 51.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.816 -0.552 . . . . 0.0 112.331 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.82 -9.59 17.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.863 1.665 . . . . 0.0 111.601 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.45 -156.44 51.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.905 -1.122 . . . . 0.0 111.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -109.48 164.41 12.53 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.588 1.555 . . . . 0.0 110.606 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -147.79 -170.29 3.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.822 2.049 . . . . 0.0 110.45 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.04 -45.92 89.52 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.644 -0.66 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.05 40.63 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 9.3 t -123.6 156.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.024 1.33 . . . . 0.0 108.964 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -116.49 -55.69 2.36 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -150.93 165.11 34.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.61 1.096 . . . . 0.0 111.301 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.6 t -125.65 149.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.095 2.158 . . . . 0.0 108.128 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -137.93 120.92 16.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.14 138.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -118.75 83.47 0.35 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -74.08 -171.44 1.13 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.311 1.053 . . . . 0.0 111.583 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.99 45.41 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -62.31 -37.31 85.06 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.81 0.844 . . . . 0.0 111.283 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 -15.58 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.544 3.137 . . . . 0.0 113.166 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 122.42 -175.66 16.43 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.483 1.992 . . . . 0.0 108.405 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.5 mt -69.39 106.14 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 120.941 -1.329 . . . . 0.0 109.381 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 m -98.35 -24.66 15.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.636 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.39 47.78 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 122.395 1.093 . . . . 0.0 113.21 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.1 m -147.45 144.55 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.37 1.868 . . . . 0.0 106.605 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.484 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 56.0 pttt -161.61 170.01 20.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.713 1.205 . . . . 0.0 110.435 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -153.94 175.22 13.63 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.787 0.803 . . . . 0.0 113.087 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.8 114.28 17.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.319 -2.845 . . . . 0.0 103.319 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.98 148.37 51.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.765 1.626 . . . . 0.0 108.562 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -112.07 155.55 23.66 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.741 0.781 . . . . 0.0 110.244 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.21 86.25 2.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.01 1.324 . . . . 0.0 109.161 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.05 -79.39 0.88 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -123.49 -35.39 2.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.103 1.361 . . . . 0.0 110.246 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.95 148.61 48.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 122.195 0.997 . . . . 0.0 109.439 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.22 135.64 54.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.8 mm -120.07 116.27 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.03 109.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 127.847 2.459 . . . . 0.0 104.827 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.22 1.29 2.28 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 117.644 -1.642 . . . . 0.0 116.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.83 82.75 0.72 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 119.687 1.744 . . . . 0.0 108.942 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -112.66 135.02 53.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.586 2.755 . . . . 0.0 106.778 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -128.97 -43.55 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.76 153.1 39.87 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.98 112.51 8.3 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.29 1.836 . . . . 0.0 112.222 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.6 171.2 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.919 1.746 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 p -129.66 177.26 7.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.348 1.059 . . . . 0.0 108.413 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.1 mt -66.52 -10.43 44.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.308 -0.87 . . . . 0.0 111.321 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 -22.31 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.71 1.204 . . . . 0.0 109.988 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 86.32 -139.94 17.11 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.484 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 46.3 m-85 -143.58 158.79 43.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.667 1.187 . . . . 0.0 109.193 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -110.28 164.63 12.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.995 2.918 . . . . 0.0 106.422 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.61 139.89 44.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.961 0.8 . . . . 0.0 110.906 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -142.55 123.89 14.73 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.65 0.38 . . . . 0.0 111.035 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.07 130.78 34.55 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.442 1.097 . . . . 0.0 109.392 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.6 mt -127.69 124.58 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -80.23 88.57 5.48 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -52.97 -53.51 54.32 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.631 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.3 -0.71 10.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.2 1.933 . . . . 0.0 115.074 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 m -125.68 -29.45 3.15 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.504 1.956 . . . . 0.0 116.22 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.74 159.91 24.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.568 1.076 . . . . 0.0 109.504 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.55 124.76 36.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.85 101.31 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -69.09 -36.73 77.89 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -157.13 170.45 22.48 Favored 'General case' 0 C--N 1.343 0.294 0 O-C-N 120.703 -1.248 . . . . 0.0 112.132 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.53 151.06 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -132.44 171.59 13.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.402 1.881 . . . . 0.0 106.119 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 143.4 -175.79 23.22 Favored Glycine 0 N--CA 1.465 0.628 0 O-C-N 119.906 -1.746 . . . . 0.0 112.761 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -140.0 146.42 39.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.155 0.982 . . . . 0.0 110.598 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -128.2 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -156.08 170.82 21.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.793 0.837 . . . . 0.0 110.165 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.442 ' HZ1' ' CG ' ' A' ' 240' ' ' ASP . 62.1 mmtt -75.8 148.18 38.63 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 127.073 2.149 . . . . 0.0 110.886 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.0 pt -102.48 157.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 109.325 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -79.01 169.78 17.68 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.27 -41.41 1.57 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.863 -1.148 . . . . 0.0 114.873 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.3 m -141.28 160.37 40.26 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.597 1.698 . . . . 0.0 108.198 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.442 ' CG ' ' HZ1' ' A' ' 235' ' ' LYS . 14.8 t70 -78.79 18.44 0.6 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.91 41.4 Favored Glycine 0 C--N 1.338 0.674 0 O-C-N 120.758 -1.213 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.92 157.08 30.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.371 1.469 . . . . 0.0 108.238 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.54 168.52 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 40.4 mm -105.74 103.41 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 101.219 -3.622 . . . . 0.0 101.219 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -82.16 -17.43 46.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.595 1.089 . . . . 0.0 112.048 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -150.74 136.02 17.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.19 141.34 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -135.99 158.4 44.51 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.169 0.987 . . . . 0.0 108.576 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.92 119.1 18.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -68.13 135.55 52.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.5 p -128.11 165.4 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.602 1.161 . . . . 0.0 109.941 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -129.87 145.38 51.6 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.6 tptp 72.95 -26.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.301 1.44 . . . . 0.0 111.589 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -124.06 173.48 8.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 109.729 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.3 m -117.64 144.17 45.45 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 107.419 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.5 p -121.67 153.87 37.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.418 1.087 . . . . 0.0 109.639 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -97.84 159.07 31.79 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 111.418 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.67 115.44 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.366 2.71 . . . . 0.0 107.9 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.78 93.07 7.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.35 -179.13 16.98 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.252 0.929 . . . . 0.0 112.582 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.93 111.18 22.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.206 1.002 . . . . 0.0 108.369 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.79 107.93 0.92 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.809 0.844 . . . . 0.0 108.853 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.62 156.72 18.57 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.708 2.003 . . . . 0.0 107.345 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.06 -177.54 50.81 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.87 111.04 1.15 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.651 1.18 . . . . 0.0 111.773 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.4 146.03 28.68 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.802 0.441 . . . . 0.0 110.49 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.32 160.01 41.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.284 1.434 . . . . 0.0 110.872 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -146.88 127.53 14.23 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.94 101.32 11.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.69 1.132 . . . . 0.0 110.825 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -123.07 153.39 39.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.452 1.101 . . . . 0.0 110.648 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.73 150.26 36.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.54 1.536 . . . . 0.0 108.143 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -99.02 142.39 30.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.816 1.246 . . . . 0.0 109.894 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.73 55.8 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.847 0.736 . . . . 0.0 114.792 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -134.22 175.38 9.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.19 1.396 . . . . 0.0 110.467 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 162.21 33.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.757 1.623 . . . . 0.0 108.417 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 52.6 mt -95.12 140.91 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.63 -0.35 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.43 -167.68 38.35 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.75 166.84 19.05 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.461 1.105 . . . . 0.0 110.983 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -159.08 163.69 36.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.195 1.398 . . . . 0.0 107.964 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.06 -161.99 29.06 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 30.4 mtmm -126.97 136.82 52.78 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -158.13 96.84 1.48 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.424 1.489 . . . . 0.0 107.474 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.9 m -69.04 -23.85 64.11 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -165.46 -60.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.8 mt -84.24 147.91 27.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.18 2.592 . . . . 0.0 106.066 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.44 80.22 1.42 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.032 . . . . 0.0 112.089 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -64.53 -40.47 95.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -141.55 129.92 22.43 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.67 1.123 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -119.6 106.95 12.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.252 1.421 . . . . 0.0 107.772 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -132.2 -179.73 16.48 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.2 170.27 10.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.582 -0.952 . . . . 0.0 111.158 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.11 156.3 25.48 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.37 160.74 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.524 0.73 . . . . 0.0 109.048 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.46 144.49 42.79 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.64 149.27 79.17 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.867 1.711 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.466 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 112.083 179.568 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.207 0.527 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -147.26 139.71 24.7 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.427 1.891 . . . . 0.0 107.057 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -132.28 118.43 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -64.48 137.91 58.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.365 0.666 . . . . 0.0 109.893 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.56 -58.46 8.38 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.708 1.603 . . . . 0.0 109.649 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.93 -23.22 24.1 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.302 1.43 . . . . 0.0 113.12 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.38 173.84 24.0 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.126 0.963 . . . . 0.0 111.581 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.68 174.27 54.81 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 122.56 1.089 . . . . 0.0 113.837 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.74 9.03 15.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.58 1.552 . . . . 0.0 113.126 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.41 174.73 44.35 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.32 -124.36 31.63 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 158.91 43.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.728 1.611 . . . . 0.0 109.489 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.9 p -101.69 102.86 13.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 116.58 22.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 103.968 -2.605 . . . . 0.0 103.968 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.08 118.61 12.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -133.87 -64.55 0.7 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.703 0.801 . . . . 0.0 110.85 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.015 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 107.376 -2.289 . . . . 0.0 107.376 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.2 157.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.476 1.91 . . . . 0.0 112.442 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -131.59 -23.33 2.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 112.908 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -153.19 155.56 36.9 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.99 148.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -132.96 144.82 50.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.98 148.81 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.847 2.059 . . . . 0.0 106.431 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.39 -112.16 1.1 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.19 148.28 32.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.372 1.086 . . . . 0.0 108.688 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 -20.79 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 127.189 2.328 . . . . 0.0 112.912 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -56.13 -40.28 73.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.348 2.259 . . . . 0.0 110.237 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.47 7.63 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.128 3.371 . . . . 0.0 109.514 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.71 159.77 23.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 126.371 1.939 . . . . 0.0 109.655 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.58 96.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.3 m -89.78 -21.7 22.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.1 p -127.37 127.19 43.79 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 120.489 1.495 . . . . 0.0 110.83 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.76 137.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 122.891 1.329 . . . . 0.0 109.561 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -148.38 138.72 22.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.652 0.781 . . . . 0.0 109.368 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 t -95.51 123.42 47.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -115.99 165.72 12.8 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.83 0.852 . . . . 0.0 108.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.24 108.69 3.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.263 54.9 pttt -117.15 116.18 26.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.457 1.503 . . . . 0.0 110.129 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 47.5 27.28 0.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.594 1.958 . . . . 0.0 113.548 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -162.76 -159.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.309 -1.494 . . . . 0.0 108.829 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.46 165.24 19.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 116.48 17.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.19 109.03 12.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.38 162.16 29.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.971 0.908 . . . . 0.0 109.699 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 2.36 9.35 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.611 1.577 . . . . 0.0 112.21 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.37 163.95 27.41 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.237 1.518 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -70.94 147.64 48.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.906 2.082 . . . . 0.0 110.805 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -130.4 104.35 7.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.956 2.103 . . . . 0.0 106.011 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.18 -156.26 26.72 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.18 102.76 7.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.866 1.266 . . . . 0.0 108.457 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -103.29 162.7 12.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.9 m -155.6 150.59 26.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.12 -8.42 54.58 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.69 -4.94 7.17 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.25 15.12 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.625 1.102 . . . . 0.0 114.049 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -75.37 128.58 35.71 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.931 1.366 . . . . 0.0 110.145 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -132.49 164.12 27.29 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.226 2.61 . . . . 0.0 111.072 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 m -132.97 138.79 46.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.696 1.599 . . . . 0.0 108.046 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -121.2 109.6 15.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.159 1.783 . . . . 0.0 106.364 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -89.75 165.1 14.38 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.699 1.2 . . . . 0.0 109.042 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 p -111.04 152.86 12.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.202 0.525 . . . . 0.0 110.366 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.18 164.9 12.13 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.822 1.249 . . . . 0.0 110.512 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.78 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.579 0.752 . . . . 0.0 110.986 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -105.59 0.71 26.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.16 140.1 52.45 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -134.2 151.9 51.55 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.94 1.296 . . . . 0.0 108.95 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.0 mm -82.67 142.82 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.906 1.282 . . . . 0.0 108.075 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 m -136.81 -19.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.18 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 146.46 28.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -145.59 96.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -65.26 138.3 58.13 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.19 150.13 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.435 ' CG2' ' H ' ' A' ' 111' ' ' THR . 18.4 m -126.06 140.27 52.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.593 1.957 . . . . 0.0 106.754 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -151.8 149.62 29.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -158.82 168.55 26.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.829 1.195 . . . . 0.0 111.362 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -103.14 154.9 18.82 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.551 1.54 . . . . 0.0 110.581 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.93 146.46 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -75.68 76.4 2.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.06 14.89 0.1 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 127.583 2.516 . . . . 0.0 111.919 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -123.98 111.42 15.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.143 1.377 . . . . 0.0 109.078 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.54 -3.28 8.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.473 1.509 . . . . 0.0 111.42 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -153.37 137.39 16.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.716 1.606 . . . . 0.0 109.353 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.71 152.35 45.63 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.06 154.72 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.19 0.996 . . . . 0.0 109.209 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.16 119.99 22.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.8 p -95.63 -31.1 13.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.159 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.443 ' HG ' ' HG3' ' A' ' 110' ' ' GLU . 17.5 p -157.43 164.05 37.89 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.823 1.647 . . . . 0.0 110.613 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.91 147.57 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.778 1.631 . . . . 0.0 107.525 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 105.82 4.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.994 0.918 . . . . 0.0 109.387 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.42 148.61 48.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.588 -0.695 . . . . 0.0 109.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.48 114.32 11.25 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.0 p -84.97 158.75 20.42 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -30.41 70.69 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.53 -46.84 83.37 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.409 1.083 . . . . 0.0 109.087 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.01 -14.62 3.79 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.847 1.213 . . . . 0.0 112.06 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -68.24 145.07 54.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 107.97 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.1 p -133.77 148.05 51.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 108.979 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.2 p -85.43 162.46 48.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.34 165.3 32.9 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 107.285 -1.852 . . . . 0.0 107.285 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.98 105.49 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 105.738 -2.447 . . . . 0.0 105.738 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.04 81.2 5.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.18 -177.51 18.89 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.301 1.429 . . . . 0.0 111.716 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -84.0 111.5 19.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.697 1.199 . . . . 0.0 112.75 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.443 ' HG3' ' HG ' ' A' ' 93' ' ' SER . 14.6 mt-10 -65.84 140.54 58.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.435 ' H ' ' CG2' ' A' ' 79' ' ' THR . 0.6 OUTLIER -128.39 177.14 7.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.775 1.63 . . . . 0.0 109.543 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.91 -48.86 77.15 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -72.91 122.62 21.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 110' ' ' GLU . 12.9 ptmm? 176.34 163.64 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.454 1.902 . . . . 0.0 108.586 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -157.99 167.9 28.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.484 0.713 . . . . 0.0 110.56 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.59 149.54 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.856 1.662 . . . . 0.0 107.044 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.82 136.09 17.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.577 1.951 . . . . 0.0 107.116 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 162.93 34.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.098 0.559 . . . . 0.0 110.064 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -76.69 74.03 3.36 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.693 1.997 . . . . 0.0 109.055 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -54.72 -24.3 21.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.452 -2.03 . . . . 0.0 115.147 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -93.66 -7.44 43.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.506 1.122 . . . . 0.0 113.103 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.92 -5.0 75.85 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.501 1.524 . . . . 0.0 115.982 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.14 124.12 9.92 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.029 1.914 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.56 161.83 7.16 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.15 0.58 . . . . 0.0 110.398 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 148.06 43.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.343 0.657 . . . . 0.0 109.646 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.82 -35.46 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.054 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.39 -147.46 7.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.61 161.04 43.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.148 1.379 . . . . 0.0 108.722 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -122.07 149.55 43.38 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.487 1.115 . . . . 0.0 108.555 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.51 129.74 5.04 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.28 1.895 . . . . 0.0 109.047 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -93.73 -178.17 4.6 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 122.905 1.336 . . . . 0.0 107.916 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.26 164.4 27.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.469 1.907 . . . . 0.0 107.026 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.64 -103.16 0.3 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 104.313 -3.515 . . . . 0.0 104.313 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -72.83 -25.75 61.24 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.524 0.662 . . . . 0.0 110.426 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.36 -175.14 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.997 3.319 . . . . 0.0 107.684 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.9 tp -95.51 129.51 42.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 126.54 1.936 . . . . 0.0 108.47 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.24 -46.37 4.84 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.947 0.499 . . . . 0.0 111.68 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -137.76 153.09 49.75 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.359 1.063 . . . . 0.0 109.028 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.4 tp -161.83 91.51 0.82 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 172.76 14.54 Favored Glycine 0 C--O 1.229 -0.214 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.33 156.59 48.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -124.48 160.38 28.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -141.98 131.58 23.97 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 103.541 -2.762 . . . . 0.0 103.541 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.275 0 CA-C-N 119.636 1.107 . . . . 0.0 112.993 -178.466 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 131.06 39.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -93.59 114.4 26.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.62 -172.33 3.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.216 1.008 . . . . 0.0 109.751 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.6 m -77.59 155.44 31.5 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.825 -1.172 . . . . 0.0 109.544 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.54 157.3 36.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.708 1.603 . . . . 0.0 109.941 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -127.66 167.3 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.251 1.82 . . . . 0.0 107.472 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.8 -113.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.67 164.46 20.23 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.604 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 9.1 p30 -105.92 6.65 31.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.641 1.577 . . . . 0.0 111.031 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.48 122.92 43.99 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 135.23 177.04 14.67 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.729 2.585 . . . . 0.0 111.894 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.0 m -102.82 153.58 20.04 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.028 1.414 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -72.49 154.67 40.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.643 1.177 . . . . 0.0 112.422 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -142.55 38.63 1.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.248 1.419 . . . . 0.0 109.089 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.3 104.63 0.08 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.082 2.553 . . . . 0.0 112.945 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.43 -40.82 16.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.863 2.865 . . . . 0.0 114.11 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.63 -95.83 1.37 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.28 169.69 10.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.37 1.468 . . . . 0.0 109.334 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -135.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.422 2.289 . . . . 0.0 106.271 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.01 -33.14 71.59 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 221' ' ' TYR . . . -179.59 -151.07 9.51 Favored Glycine 0 CA--C 1.534 1.266 1 C-N-CA 131.501 4.381 . . . . 0.0 107.935 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.8 m -135.07 155.54 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.516 1.926 . . . . 0.0 106.146 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -124.55 -53.78 1.68 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.259 0.936 . . . . 0.0 113.229 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.454 ' HE3' ' CZ ' ' A' ' 179' ' ' TYR . 29.5 ttpt -146.35 136.38 23.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.132 -1.605 . . . . 0.0 109.342 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 51.9 t -90.28 146.57 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 177' ' ' LYS . 45.2 m-85 -141.09 109.81 6.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.134 1.374 . . . . 0.0 108.333 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.76 138.58 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.86 92.29 0.56 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.76 160.88 29.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.251 1.024 . . . . 0.0 109.251 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.4 -170.41 12.04 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 125.414 1.483 . . . . 0.0 109.664 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -46.4 23.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.92 1.288 . . . . 0.0 112.182 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 -4.13 54.69 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.715 1.606 . . . . 0.0 114.236 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.12 -154.05 25.73 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.5 mm -75.08 133.78 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 119.171 1.485 . . . . 0.0 108.225 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 73.6 m -115.39 -22.41 9.36 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.461 1.104 . . . . 0.0 113.683 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.3 169.15 20.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.732 1.254 . . . . 0.0 110.31 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.53 149.48 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -160.16 175.72 12.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.824 1.649 . . . . 0.0 107.09 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -162.69 174.77 12.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.23 149.31 42.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -153.8 167.87 28.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.033 1.333 . . . . 0.0 108.293 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.87 164.89 13.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 119.962 -1.711 . . . . 0.0 108.622 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -140.24 93.33 2.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 64.03 -118.98 14.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.366 -2.694 . . . . 0.0 106.366 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.17 1.93 55.89 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.861 1.265 . . . . 0.0 113.5 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.59 157.33 17.01 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.906 1.23 . . . . 0.0 111.187 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -113.68 125.57 54.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.5 mm -120.64 143.82 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.187 1.395 . . . . 0.0 110.773 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.9 t -116.89 136.76 52.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.78 158.21 42.61 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -96.58 107.04 3.45 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -39.0 113.4 0.31 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.968 2.107 . . . . 0.0 112.252 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -93.39 29.42 1.96 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.693 0.797 . . . . 0.0 111.049 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.88 21.14 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 121.207 -0.933 . . . . 0.0 112.842 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -91.2 111.22 47.53 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.02 -0.99 . . . . 0.0 108.767 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.74 157.55 51.84 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.983 1.788 . . . . 0.0 109.462 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.6 p -133.95 166.36 22.88 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 25.6 tp -67.52 -12.83 61.26 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 112.169 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.68 -32.5 72.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.157 0.983 . . . . 0.0 109.771 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.64 -154.2 16.79 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -139.93 142.53 36.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.701 1.601 . . . . 0.0 107.887 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -97.32 110.77 23.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.69 134.39 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.541 0.736 . . . . 0.0 109.531 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.37 111.85 6.97 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.177 0.591 . . . . 0.0 110.527 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.32 131.12 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 110.414 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.0 mt -128.21 126.37 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 130.65 43.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.862 -0.524 . . . . 0.0 109.81 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' A' ' 174' ' ' GLY . 15.2 t80 -65.06 -63.54 3.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.25 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -85.96 -29.76 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.249 1.482 . . . . 0.0 114.277 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.6 t -77.32 -26.36 52.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.102 1.319 . . . . 0.0 112.829 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -126.09 172.98 9.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.304 1.041 . . . . 0.0 108.464 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -157.2 117.3 3.48 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.92 -1.113 . . . . 0.0 111.489 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.7 mt -68.22 113.44 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -26.71 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.386 0.674 . . . . 0.0 111.933 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -162.34 169.61 20.27 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.756 1.222 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.8 145.82 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.485 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 55.4 mt-10 -132.61 178.42 6.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.607 2.363 . . . . 0.0 109.141 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 166.72 -178.57 41.03 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.6 p -139.98 136.1 33.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.731 0.765 . . . . 0.0 109.241 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -131.12 156.24 45.6 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 113.157 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.02 162.03 40.75 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.657 -0.652 . . . . 0.0 110.545 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 235' ' ' LYS . 0.1 OUTLIER -76.48 136.12 39.37 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.173 1.389 . . . . 0.0 110.486 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.4 mt -72.85 109.71 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -48.3 121.37 4.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 110.647 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.94 22.0 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.492 1.52 . . . . 0.0 110.484 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.2 p -141.38 165.27 27.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.696 1.598 . . . . 0.0 109.501 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.7 -14.32 37.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.404 0.681 . . . . 0.0 110.306 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -68.47 146.32 45.43 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.16 159.45 24.86 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.418 1.487 . . . . 0.0 113.21 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 16.9 tt -136.96 152.2 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 127.207 2.203 . . . . 0.0 107.972 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 2.8 mt -97.68 134.15 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t -121.31 -8.25 9.21 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -146.6 141.16 26.65 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.347 0.659 . . . . 0.0 109.383 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.75 155.56 43.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.238 1.815 . . . . 0.0 108.697 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -144.89 154.62 42.82 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.877 1.671 . . . . 0.0 107.518 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.71 153.61 46.3 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.485 ' HZ3' ' CD ' ' A' ' 230' ' ' GLU . 18.1 mmmt -120.67 114.66 22.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.7 p -133.68 165.9 23.86 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.065 2.946 . . . . 0.0 107.209 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 254' ' ' GLN . 1.6 p30 -112.79 160.26 18.15 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 66.15 -16.49 0.12 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.877 1.671 . . . . 0.0 112.996 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 252' ' ' ASN . 0.2 OUTLIER -145.67 174.2 11.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.772 2.429 . . . . 0.0 108.788 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.3 p -143.65 107.99 4.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -10.72 3.85 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 70.12 165.88 0.13 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.29 1.836 . . . . 0.0 112.187 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.14 137.9 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.932 2.422 . . . . 0.0 109.69 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.32 93.13 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.566 1.947 . . . . 0.0 105.763 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.58 177.7 16.85 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.057 0.837 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.67 113.69 20.52 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.343 1.057 . . . . 0.0 110.243 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.21 108.49 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.354 1.061 . . . . 0.0 109.289 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.15 149.3 19.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.301 1.441 . . . . 0.0 109.056 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.56 -175.0 48.95 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.649 0.583 . . . . 0.0 112.905 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.0 m -66.7 127.53 32.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.508 1.523 . . . . 0.0 108.584 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -86.04 147.56 26.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.778 0.431 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.55 163.7 29.92 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.499 1.12 . . . . 0.0 110.749 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -145.58 147.6 32.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.764 2.425 . . . . 0.0 107.281 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.3 mt -142.01 141.77 32.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.524 1.129 . . . . 0.0 108.528 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -164.65 179.32 6.69 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.303 1.841 . . . . 0.0 110.163 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -144.05 152.95 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 104.892 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.52 71.45 10.42 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 120.398 -1.439 . . . . 0.0 112.636 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.56 -59.28 0.67 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 123.556 0.598 . . . . 0.0 113.65 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -55.49 155.68 5.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.81 0.844 . . . . 0.0 111.681 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 164.07 12.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 108.89 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.78 129.93 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.1 8.4 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.271 1.029 . . . . 0.0 111.617 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 175.11 -179.97 46.05 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -113.73 -179.07 3.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -165.68 158.98 15.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.376 0.989 . . . . 0.0 111.745 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.49 -107.48 0.44 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.604 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -160.74 165.37 30.54 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.481 1.112 . . . . 0.0 110.23 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.23 147.05 37.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.686 1.594 . . . . 0.0 107.12 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 286' ' ' LEU . 19.5 t -174.26 70.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 59.73 -7.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 129.481 3.112 . . . . 0.0 114.651 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 284' ' ' SER . 72.1 mt -136.43 167.73 20.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.603 2.361 . . . . 0.0 110.232 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.1 76.19 0.99 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.793 1.637 . . . . 0.0 109.479 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -76.54 -59.56 2.72 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 110.584 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -110.15 152.81 25.58 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.616 1.167 . . . . 0.0 111.596 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -159.33 145.93 16.66 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.027 0.531 . . . . 0.0 110.057 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -162.8 -175.91 34.32 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.902 2.191 . . . . 0.0 108.33 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.17 130.44 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.633 1.216 . . . . 0.0 113.718 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -73.98 155.59 38.46 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.9 m -130.75 149.64 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 58.2 mmm -151.29 153.65 32.81 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 127.656 2.383 . . . . 0.0 106.354 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.65 165.92 30.38 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.841 1.694 . . . . 0.0 111.556 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.237 0.404 0 C-N-CA 127.251 2.22 . . . . 0.0 107.781 178.45 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -149.56 132.48 16.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.012 1.325 . . . . 0.0 107.855 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.05 145.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.91 143.52 44.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.8 1.64 . . . . 0.0 108.977 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.38 174.89 4.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 109.331 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.6 44.78 0.54 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.376 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.72 -178.72 26.89 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.03 0.915 . . . . 0.0 111.222 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 161.69 2.19 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.779 1.657 . . . . 0.0 115.042 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.16 3.21 40.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.723 1.609 . . . . 0.0 113.549 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.26 -4.87 45.95 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.413 1.006 . . . . 0.0 115.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.14 158.19 18.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.46 157.52 28.92 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.235 0.517 . . . . 0.0 110.212 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -47.27 130.11 12.97 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.446 1.099 . . . . 0.0 110.67 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -130.59 121.5 25.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -161.38 141.83 10.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.32 -20.85 2.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.204 0.911 . . . . 0.0 113.406 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.045 0 C-N-CA 125.361 1.457 . . . . 0.0 114.465 179.459 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.392 0 CA-C-O 119.339 -0.701 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.77 90.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.902 1.681 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.51 94.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.743 1.617 . . . . 0.0 112.127 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' ' CG2' ' A' ' 41' ' ' VAL . 36.8 mtmt -145.18 162.23 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.63 1.172 . . . . 0.0 108.15 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.49 115.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -113.13 132.9 55.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.52 144.36 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.45 140.09 7.46 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.73 143.62 26.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.322 1.849 . . . . 0.0 108.777 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.33 178.8 16.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 127.584 2.516 . . . . 0.0 108.58 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.81 -26.64 68.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -6.41 59.42 Favored 'General case' 0 CA--C 1.543 0.691 1 C-N-CA 131.8 4.04 . . . . 0.0 111.78 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.54 -160.35 15.02 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.04 110.45 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.6 m -140.0 0.37 1.75 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -123.45 118.41 27.38 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -144.72 155.3 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.891 0.877 . . . . 0.0 110.424 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.21 147.11 20.66 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.596 0.758 . . . . 0.0 109.567 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.26 158.56 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.424 1.49 . . . . 0.0 108.968 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.465 ' CG2' ' HE3' ' A' ' 25' ' ' LYS . 4.8 t -112.79 135.39 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.92 104.65 13.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.67 110.85 22.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -78.06 166.0 23.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.0 -9.69 23.66 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.414 -1.429 . . . . 0.0 113.82 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -119.75 -17.85 8.46 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.92 149.66 26.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.709 1.595 . . . . 0.0 109.299 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -115.75 135.97 53.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.165 1.386 . . . . 0.0 110.705 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.9 t -142.64 123.07 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 0.0 110.014 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -81.85 124.28 29.55 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.79 -3.27 87.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.64 174.05 49.77 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.956 1.378 . . . . 0.0 110.296 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -82.09 152.73 26.43 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.006 -0.702 . . . . 0.0 110.488 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -134.24 154.15 51.44 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 108.338 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.77 -160.48 31.32 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -96.95 105.52 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -53.9 121.5 8.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.438 0.695 . . . . 0.0 110.772 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -138.98 95.92 3.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.776 1.274 . . . . 0.0 108.326 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.26 3.12 13.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.593 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -16.85 7.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.489 2.316 . . . . 0.0 112.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.54 80.37 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -119.37 159.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 164.01 28.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.496 2.319 . . . . 0.0 112.763 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -132.96 95.46 3.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.54 124.87 41.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.45 135.48 44.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.434 0.694 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.2 t -81.51 109.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.46 130.35 42.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.79 67.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.221 1.373 . . . . 0.0 111.427 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.3 -8.23 59.47 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.723 1.609 . . . . 0.0 111.265 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.34 151.85 24.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.322 -0.861 . . . . 0.0 110.135 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -134.79 139.96 45.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mt -78.49 118.35 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.36 -26.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.362 0.665 . . . . 0.0 111.524 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.78 152.92 38.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.898 0.879 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.11 152.89 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -135.17 127.57 30.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.383 2.673 . . . . 0.0 106.691 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.61 116.33 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.368 0.985 . . . . 0.0 109.816 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.8 p -87.44 152.0 22.59 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.999 1.272 . . . . 0.0 107.612 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -150.34 142.64 24.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.53 160.27 28.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.42 131.8 35.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.9 m -102.55 175.11 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 122.062 0.934 . . . . 0.0 113.0 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -60.44 119.55 8.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 109.082 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 3.44 65.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.239 -1.311 . . . . 0.0 113.794 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -122.31 158.49 29.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.722 1.261 . . . . 0.0 110.979 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -107.31 -48.96 3.35 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -78.94 145.17 34.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.59 0.709 . . . . 0.0 110.57 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.99 155.83 39.9 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -139.72 159.86 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 mt -65.49 125.5 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.6 p -100.79 -28.27 12.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.402 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -157.83 165.53 35.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.302 1.41 . . . . 0.0 109.401 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.6 mt -143.69 145.96 21.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.607 1.963 . . . . 0.0 106.623 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.8 m -150.61 118.5 6.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.36 157.0 16.47 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -133.17 129.95 38.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 72.2 p -101.17 154.75 18.48 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.323 0.249 . . . . 0.0 110.838 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -73.2 -28.98 62.49 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -49.26 -44.56 43.88 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 125.095 1.358 . . . . 0.0 109.354 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.5 -6.18 3.87 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.847 -0.974 . . . . 0.0 114.402 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.256 0.3 OUTLIER -103.2 157.07 17.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.911 1.355 . . . . 0.0 111.559 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.6 p -133.11 147.9 52.14 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.043 1.737 . . . . 0.0 107.916 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.74 158.73 56.27 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.31 167.7 26.2 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 121.652 1.568 . . . . 0.0 108.096 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.4 109.91 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.847 2.364 . . . . 0.0 110.247 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -79.09 62.03 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.51 1.524 . . . . 0.0 108.442 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.54 177.77 15.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.891 1.71 . . . . 0.0 110.561 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.9 110.03 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 113.631 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.28 126.56 27.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.6 m -122.79 171.6 9.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.539 0.735 . . . . 0.0 110.916 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -61.85 -58.72 6.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.66 1.184 . . . . 0.0 109.628 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -67.01 129.57 40.34 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -160.79 169.95 21.69 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.029 0.532 . . . . 0.0 111.097 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -122.15 138.8 54.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.637 2.775 . . . . 0.0 106.431 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.65 132.59 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.06 151.99 30.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.857 0.863 . . . . 0.0 108.906 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 156.33 20.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.195 0.998 . . . . 0.0 109.559 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.02 165.22 12.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.002 0.921 . . . . 0.0 108.57 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -138.22 -75.46 0.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -127.85 13.51 6.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.574 1.15 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.25 -17.13 38.04 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 117.331 -1.816 . . . . 0.0 116.569 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.83 27.39 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.953 1.876 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -137.01 166.34 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.88 128.86 37.84 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.65 -59.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.304 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.7 176.57 17.61 Favored Glycine 0 N--CA 1.465 0.617 0 CA-C-N 119.429 1.013 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -125.3 163.58 22.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.955 1.702 . . . . 0.0 112.321 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -167.79 171.07 10.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.548 1.539 . . . . 0.0 109.466 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.64 -119.66 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -154.73 110.92 3.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.641 3.176 . . . . 0.0 103.821 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.84 18.55 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.558 1.143 . . . . 0.0 108.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.79 -131.13 1.97 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.96 -17.47 25.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.886 1.675 . . . . 0.0 114.484 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.87 19.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.324 1.05 . . . . 0.0 110.433 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 tp -86.83 87.01 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -86.57 -32.56 20.6 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.5 162.45 40.11 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.336 -0.852 . . . . 0.0 112.999 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 tp -161.93 106.08 1.22 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.317 -0.239 . . . . 0.0 110.987 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.01 166.22 13.55 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.316 2.389 . . . . 0.0 107.135 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.24 161.75 36.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.133 0.967 . . . . 0.0 109.165 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -101.04 146.13 27.83 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.82 99.82 4.28 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 C-N-CA 124.033 0.933 . . . . 0.0 109.413 179.902 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -74.97 138.34 42.21 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -106.27 110.93 23.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.17 1.388 . . . . 0.0 111.848 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 mt -69.0 173.78 5.12 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.258 1.423 . . . . 0.0 108.535 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.6 t -98.23 103.9 15.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.77 170.88 14.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 tt -164.07 160.23 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 106.82 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.68 -20.46 1.3 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.81 -23.6 0.41 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 118.56 1.18 . . . . 0.0 114.004 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.473 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 3.7 m-20 60.14 10.96 2.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.301 1.44 . . . . 0.0 114.027 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -96.2 150.64 20.31 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.821 -1.174 . . . . 0.0 109.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 -179.19 18.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.025 1.298 . . . . 0.0 110.699 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 65.7 m -75.26 124.22 26.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -86.09 131.53 34.24 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.777 0.831 . . . . 0.0 110.322 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -158.89 130.35 6.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.925 0.89 . . . . 0.0 110.028 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.18 135.18 39.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -123.44 60.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.718 2.007 . . . . 0.0 107.269 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -24.68 -82.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.646 0 C-N-CA 129.666 3.507 . . . . 0.0 115.071 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.86 162.94 7.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.682 0.793 . . . . 0.0 112.915 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.07 -165.86 1.57 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.648 2.379 . . . . 0.0 108.684 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.83 -45.16 79.12 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.895 -1.128 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.21 164.26 32.88 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.785 0.707 . . . . 0.0 112.207 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -74.83 157.5 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.08 1.352 . . . . 0.0 111.3 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -133.49 -65.17 0.69 Allowed 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.411 1.084 . . . . 0.0 109.479 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -140.64 156.2 46.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.493 0.588 . . . . 0.0 110.197 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.66 147.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.315 1.846 . . . . 0.0 107.315 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -138.99 163.46 32.33 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.826 1.251 . . . . 0.0 108.515 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.1 t -141.88 123.63 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -100.97 77.09 0.4 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.5 -175.78 0.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.805 0.812 . . . . 0.0 112.151 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.83 -172.53 38.57 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.47 -28.67 69.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 128.632 2.773 . . . . 0.0 114.901 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.76 -31.67 5.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.6 2.76 . . . . 0.0 112.398 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.8 -167.88 36.01 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.21 114.37 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.2 m -103.79 -25.24 13.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.883 1.673 . . . . 0.0 112.005 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -134.21 154.51 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.024 0.93 . . . . 0.0 109.02 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.74 155.34 27.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.418 1.087 . . . . 0.0 109.002 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -175.43 152.56 1.38 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 111.061 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.99 162.32 35.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.541 1.536 . . . . 0.0 108.217 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.37 151.22 37.45 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.517 1.127 . . . . 0.0 108.516 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -163.83 154.22 15.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.646 0.736 . . . . 0.0 111.052 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -110.27 123.75 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -139.78 145.15 37.85 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.34 35.86 61.73 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.68 0.38 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.243 3.417 . . . . 0.0 114.421 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.52 154.75 19.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.756 1.622 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.78 130.69 39.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.781 0.832 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.1 mt -119.25 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 37.2 t -122.54 121.45 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 176.96 -110.97 0.32 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 67.03 -4.63 3.16 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 127.143 2.306 . . . . 0.0 116.469 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.58 124.92 25.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.163 1.982 . . . . 0.0 108.678 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.22 16.9 1.36 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.435 1.894 . . . . 0.0 111.803 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.45 151.34 23.61 Favored Glycine 0 C--N 1.335 0.501 0 O-C-N 119.099 -2.251 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 285' ' ' GLU . 45.8 pttt -35.43 98.94 0.16 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.682 1.593 . . . . 0.0 114.009 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.37 114.26 2.79 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.243 1.962 . . . . 0.0 107.977 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.0 p -78.32 145.33 35.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.059 0.944 . . . . 0.0 110.329 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.46 -7.1 34.96 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.429 -0.795 . . . . 0.0 110.202 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.86 2.064 . . . . 0.0 108.622 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.93 -161.95 13.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -141.99 129.06 20.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -79.41 161.93 25.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -144.19 157.21 44.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 111.964 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.52 115.75 8.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.38 116.17 31.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.9 mm -127.55 107.57 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.71 103.79 1.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 123.92 0.762 . . . . 0.0 110.909 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -36.5 -56.07 1.36 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.211 2.204 . . . . 0.0 115.957 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.7 -16.96 11.35 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 115.017 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.9 m -101.24 -10.59 20.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.484 1.493 . . . . 0.0 113.288 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 225' ' ' TYR . 23.8 tt0 -139.99 -168.82 2.6 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.534 ' H ' ' HG2' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -168.27 140.7 2.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.35 115.45 49.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.372 2.269 . . . . 0.0 106.208 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 32.5 m -94.14 -72.02 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.281 0.491 . . . . 0.0 111.658 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -107.82 170.5 7.95 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.551 1.14 . . . . 0.0 113.981 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.3 p -132.68 144.97 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.81 1.644 . . . . 0.0 107.91 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -133.07 169.82 16.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.711 1.604 . . . . 0.0 107.428 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.87 -175.26 45.77 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 120.248 -1.532 . . . . 0.0 109.599 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.32 136.27 22.23 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.47 38.99 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.348 1.059 . . . . 0.0 109.339 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -136.97 166.13 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.688 0.756 . . . . 0.0 112.172 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -72.87 141.22 47.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.926 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.1 157.93 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.763 2.025 . . . . 0.0 109.1 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -107.43 106.34 16.7 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 160.25 -49.13 0.38 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.441 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 49.9 m -135.46 173.92 11.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.196 0.998 . . . . 0.0 111.965 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.86 -12.2 58.58 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.159 0.584 . . . . 0.0 112.314 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.54 120.22 5.95 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.39 172.52 9.3 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.532 1.933 . . . . 0.0 107.061 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.7 tt -125.82 134.49 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.734 1.152 . . . . 0.0 111.441 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.4 mt -79.43 122.88 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 -6.67 10.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.983 0.513 . . . . 0.0 111.828 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -143.37 147.29 34.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.95 149.13 44.41 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.033 1.733 . . . . 0.0 110.255 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -149.4 153.83 37.96 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.05 1.74 . . . . 0.0 106.613 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.43 138.47 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -89.27 114.31 25.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.27 0.941 . . . . 0.0 109.492 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.8 p -97.85 165.42 11.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.7 2.0 . . . . 0.0 110.659 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.28 134.75 55.04 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? 75.79 -50.92 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.749 2.42 . . . . 0.0 107.659 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -82.67 155.91 24.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.853 2.061 . . . . 0.0 108.262 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 59.4 m -118.83 114.52 22.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.3 p -68.88 168.22 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 111.802 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.45 154.17 42.42 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.021 1.328 . . . . 0.0 109.442 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.45 109.17 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.874 2.383 . . . . 0.0 108.234 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.54 92.34 5.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.42 -172.01 14.41 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.495 1.045 . . . . 0.0 111.495 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.98 133.94 52.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.42 -1.047 . . . . 0.0 110.516 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.2 108.33 3.12 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -147.56 125.91 12.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 97.81 -157.77 20.73 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.41 0.45 . . . . 0.0 112.095 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.3 m -77.21 117.52 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.722 1.209 . . . . 0.0 110.474 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.92 129.58 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -136.52 151.24 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.46 155.42 50.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.355 1.062 . . . . 0.0 108.58 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp -141.37 130.79 23.76 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.803 0.841 . . . . 0.0 109.017 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.47 166.29 10.26 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.069 1.348 . . . . 0.0 109.369 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -134.78 134.0 40.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.74 128.27 35.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.864 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.21 26.62 70.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -135.96 162.62 32.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.505 1.653 . . . . 0.0 111.097 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -121.62 162.49 20.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.211 1.404 . . . . 0.0 110.165 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 25.4 mt -79.63 145.64 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.1 m -145.49 -12.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.25 34.34 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 120.674 1.579 . . . . 0.0 111.136 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -144.85 157.06 44.29 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.112 1.765 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -149.64 149.29 30.42 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 128.489 2.716 . . . . 0.0 104.783 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.55 -135.99 6.45 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 11.5 mptt -140.63 157.54 45.3 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.87 149.37 51.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.3 p -159.75 -178.01 6.77 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.212 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.456 ' O ' ' HE2' ' A' ' 208' ' ' LYS . 5.7 mm-40 -67.83 -0.19 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.785 1.234 . . . . 0.0 111.671 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 22.6 mt -140.77 135.81 31.88 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 129.316 3.047 . . . . 0.0 103.148 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -85.74 95.62 9.45 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -88.89 -70.41 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.277 0.361 . . . . 0.0 111.722 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -106.13 111.68 24.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.563 1.145 . . . . 0.0 111.995 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -116.98 160.74 20.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.52 40.24 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.73 141.01 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 117.818 0.809 . . . . 0.0 108.943 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -84.24 155.63 22.39 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.1 m -125.12 158.49 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.861 0.864 . . . . 0.0 109.816 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 28.2 mtt -157.44 145.71 14.27 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.871 2.468 . . . . 0.0 105.491 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.54 155.91 62.39 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.182 -1.507 . . . . 0.0 108.182 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.624 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.251 0.548 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -148.53 140.6 23.97 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.3 93.35 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.823 0.738 . . . . 0.0 109.03 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.34 146.46 19.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.477 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 150.98 47.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.093 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.12 9.67 69.99 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.7 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.28 179.88 43.78 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.305 1.552 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.37 -31.34 63.53 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.63 12.85 9.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.47 2.308 . . . . 0.0 113.448 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.04 -28.22 12.16 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.749 2.119 . . . . 0.0 116.352 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.71 -81.33 0.58 Allowed Glycine 0 C--N 1.342 0.863 0 CA-C-N 120.15 1.975 . . . . 0.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.67 158.89 43.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.986 0.915 . . . . 0.0 109.885 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.29 97.88 6.0 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.894 1.278 . . . . 0.0 111.414 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.453 ' CD1' ' HG3' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -67.38 0.6 2.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.538 1.535 . . . . 0.0 113.001 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.65 109.79 2.13 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.12 -0.987 . . . . 0.0 111.103 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.05 165.36 17.62 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 109.434 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 118.376 -1.235 . . . . 0.0 113.443 179.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.379 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -143.11 96.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.62 1.568 . . . . 0.0 107.42 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -85.59 -50.56 7.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.805 1.242 . . . . 0.0 110.836 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -141.19 164.48 30.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.37 96.97 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.1 126.1 34.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.89 136.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.38 162.71 30.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -106.86 141.19 38.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.239 2.216 . . . . 0.0 111.259 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.39 -156.68 9.72 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 106.039 -2.824 . . . . 0.0 106.039 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -96.06 -9.4 30.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.705 -1.467 . . . . 0.0 109.629 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.82 2.71 38.59 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 134.132 4.973 . . . . 0.0 112.707 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.71 -139.4 14.49 Favored Glycine 0 C--N 1.339 0.736 0 O-C-N 121.146 -0.971 . . . . 0.0 111.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -77.42 96.45 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -105.43 2.74 28.91 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.47 124.91 23.43 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 122.138 2.245 . . . . 0.0 107.919 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 169.37 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -159.14 152.83 22.97 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.745 -1.222 . . . . 0.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.58 107.6 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.037 1.335 . . . . 0.0 109.585 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.42 114.88 35.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -101.93 122.97 45.05 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.781 0.719 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.81 125.64 29.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -113.98 145.32 41.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.16 -35.58 59.93 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 t -80.71 -65.08 1.06 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.207 0.458 . . . . 0.0 110.203 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -150.96 140.91 21.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.341 1.056 . . . . 0.0 108.359 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.63 135.58 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.202 1.801 . . . . 0.0 109.665 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.74 146.56 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 106.984 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 156.89 21.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.711 1.204 . . . . 0.0 109.657 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.62 35.36 3.33 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.234 1.873 . . . . 0.0 111.384 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.07 -154.36 47.09 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.012 0.906 . . . . 0.0 111.628 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.3 152.8 47.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -128.81 166.11 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.1 0.96 . . . . 0.0 109.002 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' O ' ' HE3' ' A' ' 56' ' ' LYS . . . 85.71 -157.96 31.73 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -126.66 105.56 8.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 113.358 -178.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 1.5 ttmp? -62.41 128.73 37.43 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -131.14 155.17 47.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.56 -9.88 58.96 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -0.19 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.604 1.562 . . . . 0.0 113.089 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.08 130.87 2.39 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 125.888 1.709 . . . . 0.0 108.903 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.518 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 63.7 t80 -163.58 132.32 3.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.321 2.648 . . . . 0.0 105.781 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 163.67 32.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.79 1.636 . . . . 0.0 111.817 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -134.2 96.85 3.7 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.681 1.193 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.61 138.43 31.69 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.94 119.21 32.81 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.243 1.017 . . . . 0.0 109.602 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.24 123.67 25.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.046 0.938 . . . . 0.0 109.403 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.42 159.88 31.73 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.51 1.524 . . . . 0.0 110.742 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.51 25.99 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.5 1.57 55.71 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.469 2.308 . . . . 0.0 114.254 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -127.21 155.98 42.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.721 1.146 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -135.08 137.12 42.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.49 1.116 . . . . 0.0 108.884 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mt -73.96 102.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.24 -34.77 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 113.965 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.06 43.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.827 0.739 . . . . 0.0 109.482 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.29 146.29 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -131.49 137.69 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.49 139.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 p -115.8 154.49 29.55 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -154.3 168.63 25.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.86 1.264 . . . . 0.0 108.9 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -161.07 168.51 24.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -115.88 159.02 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.848 2.059 . . . . 0.0 109.063 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.1 m -127.25 135.62 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.29 107.82 0.61 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.24 3.66 7.99 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.041 -1.421 . . . . 0.0 113.35 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.23 142.17 47.26 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 119.817 1.808 . . . . 0.0 108.203 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.71 16.2 12.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.879 2.071 . . . . 0.0 111.517 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -136.35 172.72 12.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.348 1.459 . . . . 0.0 111.469 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.84 158.4 30.36 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.811 1.644 . . . . 0.0 106.897 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 pt -131.68 150.51 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.736 1.614 . . . . 0.0 107.397 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.89 122.76 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.292 1.037 . . . . 0.0 110.348 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 p -88.8 -29.67 19.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.71 0.804 . . . . 0.0 112.274 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -164.55 161.61 21.23 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.94 1.296 . . . . 0.0 109.793 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 mt -136.35 136.71 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 m -135.81 132.66 36.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -114.74 158.88 21.23 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.522 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -140.75 144.72 35.67 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.522 2.329 . . . . 0.0 105.227 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -134.2 166.39 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.0 -41.04 95.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 10.3 mmpt? -58.33 -12.09 3.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.455 1.102 . . . . 0.0 112.275 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.0 18.61 62.76 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.194 1.378 . . . . 0.0 111.954 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -89.15 97.01 10.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 p -85.46 105.81 16.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.24 157.11 83.35 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.53 164.17 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 0.0 111.331 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 111.82 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.063 2.509 . . . . 0.0 107.02 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -75.52 74.79 2.56 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.365 0.666 . . . . 0.0 109.566 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 142.36 -141.17 10.54 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.228 1.395 . . . . 0.0 110.519 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.9 tp -108.5 132.5 53.75 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 125.544 1.538 . . . . 0.0 109.619 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 116.86 18.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 m -114.67 164.6 13.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -61.26 -51.9 66.98 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.814 1.246 . . . . 0.0 110.174 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.29 115.77 11.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.9 168.27 27.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.358 -0.839 . . . . 0.0 110.872 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.37 167.18 22.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.607 1.563 . . . . 0.0 107.887 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.65 149.8 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -142.95 157.32 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.344 0.52 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.42 160.04 15.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.719 1.608 . . . . 0.0 111.51 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -81.28 177.12 9.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.796 1.639 . . . . 0.0 107.898 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.08 -46.31 2.32 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.111 -0.993 . . . . 0.0 112.519 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -109.52 19.25 19.48 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.41 -4.93 85.23 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.001 1.286 . . . . 0.0 114.244 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 118.32 13.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.53 164.18 0.54 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.243 1.817 . . . . 0.0 113.752 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.28 111.27 1.68 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.9 t -61.75 -50.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.78 48.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.08 -2.408 . . . . 0.0 107.08 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -102.49 172.32 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 169.14 20.89 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.48 126.69 1.73 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.453 ' HG3' ' CD1' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -99.74 179.3 4.58 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 123.208 1.48 . . . . 0.0 109.075 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.23 152.85 39.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 129.663 3.185 . . . . 0.0 105.519 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.52 -87.09 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 104.214 -3.555 . . . . 0.0 104.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -95.12 -27.48 15.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.186 0.493 . . . . 0.0 111.142 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.59 160.73 37.17 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 tp -77.45 93.67 4.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.597 0.713 . . . . 0.0 110.284 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -81.76 -37.12 27.71 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.306 1.042 . . . . 0.0 112.681 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.58 152.02 39.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.813 1.188 . . . . 0.0 109.853 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.4 tp -161.77 141.89 10.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.256 1.422 . . . . 0.0 108.296 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.89 -179.73 46.85 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.55 167.43 28.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.654 1.182 . . . . 0.0 109.069 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -136.39 168.44 19.45 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.815 1.293 . . . . 0.0 111.169 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -133.04 97.37 3.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 103.151 -2.907 . . . . 0.0 103.151 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -178.744 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.92 0.867 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 126.52 31.13 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.149 -0.969 . . . . 0.0 112.816 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.82 147.88 24.94 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.992 2.117 . . . . 0.0 109.882 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.66 162.47 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.5 t -72.63 135.49 45.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -135.37 169.43 17.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.387 1.875 . . . . 0.0 109.976 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.6 154.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.25 1.82 . . . . 0.0 108.883 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.8 -85.2 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.68 47.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.668 2.08 . . . . 0.0 108.271 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.425 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 2.9 p30 -111.19 10.15 21.84 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -83.45 150.06 26.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.35 -179.56 22.94 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.721 1.146 . . . . 0.0 115.805 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.4 m -96.3 119.39 34.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.197 1.799 . . . . 0.0 109.136 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.6 153.65 40.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.438 0.563 . . . . 0.0 110.295 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -142.46 131.2 22.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.33 1.062 . . . . 0.0 111.0 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.32 139.91 32.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.806 1.643 . . . . 0.0 108.512 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.16 124.66 19.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.78 177.68 41.99 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.386 1.47 . . . . 0.0 111.05 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.36 149.69 27.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -131.96 -175.31 3.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.216 1.007 . . . . 0.0 110.896 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.07 -32.21 54.01 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.934 1.694 . . . . 0.0 113.327 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.32 -158.64 31.36 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.512 2.006 . . . . 0.0 108.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.39 139.47 50.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.688 1.195 . . . . 0.0 108.622 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.89 -68.89 0.9 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 110.233 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -119.03 157.65 27.37 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.399 0.545 . . . . 0.0 110.749 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.83 143.73 38.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 127.303 2.241 . . . . 0.0 107.775 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -143.39 145.41 32.63 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.722 1.209 . . . . 0.0 108.041 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 t -139.39 151.3 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.381 1.072 . . . . 0.0 109.605 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.74 144.37 16.24 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -123.36 -170.05 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.359 1.464 . . . . 0.0 110.571 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.85 -175.83 45.78 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 126.002 1.763 . . . . 0.0 110.127 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.26 -17.92 2.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.428 3.091 . . . . 0.0 118.219 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -117.78 -9.91 10.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.912 0.778 . . . . 0.0 112.259 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.7 -146.69 18.58 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 mm -63.86 153.4 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.588 1.194 . . . . 0.0 108.393 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.3 p -134.81 -23.84 1.54 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.76 151.93 34.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.692 1.133 . . . . 0.0 111.718 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 m -149.51 124.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 123.543 0.737 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -149.81 161.28 42.57 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -151.3 172.91 15.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.013 0.925 . . . . 0.0 108.511 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -130.88 147.03 52.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.837 0.827 . . . . 0.0 109.767 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.47 168.42 21.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.811 2.044 . . . . 0.0 109.979 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -112.3 161.83 16.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.0 1.72 . . . . 0.0 108.764 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -134.35 83.77 2.06 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.692 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.63 -66.58 1.34 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.398 1.475 . . . . 0.0 111.477 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -135.07 -45.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.365 1.866 . . . . 0.0 108.555 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -60.9 164.43 4.88 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.872 1.32 . . . . 0.0 111.333 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.34 149.78 44.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.625 1.57 . . . . 0.0 107.414 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -140.43 143.9 28.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.53 147.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -71.79 146.49 40.17 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.46 10.66 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.334 -3.106 . . . . 0.0 105.334 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 133.57 49.31 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 118.616 1.208 . . . . 0.0 108.863 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -106.41 -15.25 14.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.559 0.744 . . . . 0.0 110.486 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -102.48 -177.62 27.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.827 1.68 . . . . 0.0 113.232 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -107.93 83.52 1.76 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 128.531 2.733 . . . . 0.0 106.323 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.4 148.97 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.75 . . . . 0.0 111.553 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 66.7 p -87.06 -179.26 6.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.45 -1.06 25.23 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.151 -1.593 . . . . 0.0 112.771 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -32.27 32.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.23 0.923 . . . . 0.0 113.239 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.56 -157.11 18.81 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -147.42 119.94 8.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -66.94 154.76 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -139.75 142.74 36.77 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -143.04 142.98 31.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.495 1.518 . . . . 0.0 107.486 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -133.14 95.85 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.76 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.97 1.308 . . . . 0.0 111.395 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.78 89.79 2.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.403 1.081 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -45.46 -47.74 35.99 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.598 1.959 . . . . 0.0 112.626 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.89 -7.03 15.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 122.048 1.767 . . . . 0.0 114.682 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.7 t -109.93 -13.15 14.48 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 120.814 1.643 . . . . 0.0 113.402 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 171.66 13.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.344 0.975 . . . . 0.0 111.328 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -145.66 90.63 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.62 101.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.3 p -87.19 -26.47 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.441 1.097 . . . . 0.0 112.46 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.52 171.02 20.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.156 0.889 . . . . 0.0 112.24 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.86 159.26 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.16 176.35 5.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.717 2.407 . . . . 0.0 107.543 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.97 41.86 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -153.18 141.3 20.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.11 153.79 48.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.761 0.825 . . . . 0.0 110.432 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . 0.326 0.3 OUTLIER -156.17 172.01 19.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -74.78 139.94 43.66 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.409 1.483 . . . . 0.0 110.953 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.25 157.54 34.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 127.221 2.208 . . . . 0.0 110.041 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -84.93 178.37 7.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.32 -69.7 1.52 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.1 p -95.48 -178.21 4.34 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.715 0.769 . . . . 0.0 111.427 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.58 14.19 24.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.613 1.565 . . . . 0.0 111.435 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -128.27 163.49 21.81 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.249 1.404 . . . . 0.0 113.099 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.82 173.28 11.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.978 1.711 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.75 146.07 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.403 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.3 mm -76.12 133.78 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 t -112.36 -21.82 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -152.27 152.7 32.48 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 140.42 34.23 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.821 2.048 . . . . 0.0 109.013 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -145.23 153.42 41.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 106.339 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.45 128.69 56.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.408 ' HE3' ' OE2' ' A' ' 268' ' ' GLU . 1.3 mtpm? -80.47 114.39 19.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -119.66 165.16 14.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.365 1.079 . . . . 0.0 109.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.93 133.51 47.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 65.95 -46.39 0.4 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.501 2.32 . . . . 0.0 111.188 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -92.11 165.5 13.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 129.283 3.033 . . . . 0.0 109.408 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 73.7 m -150.76 118.83 6.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 83.9 p -66.85 165.03 16.08 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.095 0.474 . . . . 0.0 110.613 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -67.84 153.96 94.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.84 97.77 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.439 2.093 . . . . 0.0 106.731 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -76.14 92.47 3.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 111.28 178.24 20.33 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.952 1.263 . . . . 0.0 111.534 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.75 123.44 49.0 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.09 0.956 . . . . 0.0 110.035 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.11 107.23 5.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -157.05 45.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.219 1.008 . . . . 0.0 109.357 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -167.87 -164.92 24.39 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 121.405 -0.81 . . . . 0.0 111.115 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.2 m -66.7 104.6 1.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.27 146.98 36.54 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.578 -0.701 . . . . 0.0 110.788 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -141.4 170.42 15.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.924 0.868 . . . . 0.0 112.763 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.408 ' OE2' ' HE3' ' A' ' 250' ' ' LYS . 39.7 tt0 -140.99 152.83 45.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.542 2.337 . . . . 0.0 106.891 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.6 mt -138.64 104.22 5.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -140.05 150.82 44.83 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.255 0.622 . . . . 0.0 110.461 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -144.8 130.75 19.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -67.71 138.72 56.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.63 -11.23 3.38 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.483 1.516 . . . . 0.0 115.818 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -99.21 159.75 14.76 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 120.111 1.956 . . . . 0.0 112.197 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -119.95 147.6 44.55 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.823 1.649 . . . . 0.0 107.543 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 87.9 mt -80.69 141.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.16 -29.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.46 -178.07 35.08 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.001 1.286 . . . . 0.0 110.559 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -113.37 -179.04 3.53 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.878 1.671 . . . . 0.0 111.22 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -153.35 179.36 8.84 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.822 2.049 . . . . 0.0 105.549 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 126.98 -151.73 18.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -151.54 149.53 29.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -108.11 154.6 21.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.936 1.295 . . . . 0.0 108.513 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 t -151.92 -63.03 0.17 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -149.18 -31.36 0.23 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.387 1.075 . . . . 0.0 112.542 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 79.6 mt -134.4 -112.81 0.21 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.948 1.249 . . . . 0.0 109.259 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.78 77.43 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.175 1.352 . . . . 0.0 108.628 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -60.58 -62.24 2.0 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 0.0 113.322 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -132.38 140.76 48.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.866 0.757 . . . . 0.0 109.702 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -140.99 151.32 44.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.566 1.547 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.88 165.83 37.76 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.0 m -113.52 157.02 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.788 1.294 . . . . 0.0 113.719 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.97 136.44 38.95 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.59 141.95 38.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.21 129.41 20.84 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 125.044 1.338 . . . . 0.0 108.425 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.95 86.53 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.857 3.038 . . . . 0.0 110.059 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 20.7 mt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.455 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.391 0.615 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -140.99 140.66 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 130.442 3.497 . . . . 0.0 107.1 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 82.5 t -127.94 130.9 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.61 169.89 5.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.333 1.053 . . . . 0.0 113.836 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.37 106.55 6.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.44 134.08 13.29 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 105.67 -2.972 . . . . 0.0 105.67 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.25 -151.42 20.08 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.77 168.89 42.89 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 122.779 1.21 . . . . 0.0 114.444 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.74 -18.39 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.457 1.103 . . . . 0.0 111.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.53 169.33 41.23 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.577 0.608 . . . . 0.0 113.005 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.91 168.49 44.46 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.134 1.35 . . . . 0.0 112.462 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.74 156.06 21.59 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 84.0 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.199 1.4 . . . . 0.0 110.264 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -90.04 135.58 33.56 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.38 151.95 28.49 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 128.295 2.638 . . . . 0.0 105.41 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.78 153.0 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.842 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -178.952 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.11 142.71 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 119.397 1.598 . . . . 0.0 109.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.29 -33.33 1.3 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.265 0.626 . . . . 0.0 112.29 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -135.89 160.67 37.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.453 0.569 . . . . 0.0 110.735 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.29 90.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.63 110.45 20.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -132.92 147.58 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 172.37 22.45 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -135.12 157.27 47.35 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.835 0.854 . . . . 0.0 112.568 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.83 -153.28 8.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.389 -2.684 . . . . 0.0 106.389 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -95.86 -7.34 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.96 -1.318 . . . . 0.0 110.373 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.38 -7.23 26.48 Favored 'General case' 0 N--CA 1.446 -0.645 1 C-N-CA 133.705 4.802 . . . . 0.0 112.427 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.77 -151.91 18.07 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.78 131.69 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -148.09 13.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.758 -1.214 . . . . 0.0 113.297 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 p -131.7 125.42 32.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.5 mt -140.52 119.39 11.19 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -128.03 145.36 51.01 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 107.714 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.2 t -129.08 131.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.313 1.045 . . . . 0.0 110.407 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.59 132.51 44.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 102.184 -3.265 . . . . 0.0 102.184 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -103.07 152.63 21.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 109.834 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.26 115.87 30.92 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.16 166.73 11.33 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.357 1.075 . . . . 0.0 111.16 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.53 -5.65 25.64 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.406 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.2 m -104.91 -67.01 0.93 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 119.583 -1.948 . . . . 0.0 110.803 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -156.35 165.6 35.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.664 1.185 . . . . 0.0 107.831 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.52 141.88 42.94 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -145.79 138.44 20.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.61 136.45 57.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.152 0.981 . . . . 0.0 108.438 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.73 -65.88 1.84 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.15 171.81 20.17 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.09 146.3 23.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.483 0.659 . . . . 0.0 111.02 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -123.92 83.73 2.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.28 26.29 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -126.61 112.44 15.5 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -52.98 111.96 0.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 110.082 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -81.61 108.36 15.11 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 127.756 2.422 . . . . 0.0 109.842 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.77 -24.02 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.569 -0.707 . . . . 0.0 112.672 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.28 8.77 43.89 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.271 1.029 . . . . 0.0 113.548 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.44 121.9 0.84 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.951 1.25 . . . . 0.0 110.658 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.85 121.38 2.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.623 2.369 . . . . 0.0 105.026 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -128.4 164.45 22.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.4 m -121.87 131.22 53.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.865 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -137.47 110.27 7.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -95.52 124.66 39.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.98 1.312 . . . . 0.0 108.922 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.84 116.25 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.56 143.57 56.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -41.63 75.41 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.626 -0.671 . . . . 0.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.34 -7.4 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.677 1.191 . . . . 0.0 112.638 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.11 151.33 21.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.969 1.708 . . . . 0.0 108.23 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -130.89 143.15 50.52 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.9 mt -68.57 137.64 24.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.2 m -107.18 -46.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 123.144 0.578 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 165.32 31.07 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.215 1.406 . . . . 0.0 108.635 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.07 108.82 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -91.91 137.68 32.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.5 t -136.36 144.16 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.6 m -118.61 140.46 49.88 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.69 167.17 30.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.218 1.807 . . . . 0.0 106.308 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.18 168.54 24.03 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.53 0.605 . . . . 0.0 109.842 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -108.5 148.72 29.84 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.375 1.07 . . . . 0.0 111.313 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.48 131.13 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -60.24 -0.25 0.22 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.817 1.647 . . . . 0.0 115.201 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.36 7.66 34.77 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.18 1.847 . . . . 0.0 113.35 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -138.42 144.07 40.02 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 120.365 2.083 . . . . 0.0 109.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.59 -2.29 28.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.281 1.832 . . . . 0.0 111.664 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 t -155.02 150.38 27.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.83 -1.169 . . . . 0.0 110.137 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.52 163.87 27.24 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 pt -139.39 151.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.973 1.309 . . . . 0.0 109.246 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.16 118.92 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.4 p -89.53 -32.76 17.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.584 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -162.84 166.22 24.36 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.557 1.071 . . . . 0.0 112.863 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.6 mt -135.72 151.58 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.066 1.347 . . . . 0.0 107.681 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.3 m -141.25 101.74 4.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.392 1.877 . . . . 0.0 107.009 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -81.82 121.8 26.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.752 1.221 . . . . 0.0 108.914 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -106.13 128.24 53.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.414 1.486 . . . . 0.0 109.067 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.9 p -99.9 169.06 9.48 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.642 1.177 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -76.92 -39.93 49.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -68.75 -26.2 65.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 116.432 -1.747 . . . . 0.0 115.348 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.52 -12.58 7.01 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 121.068 1.758 . . . . 0.0 114.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -70.49 137.4 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -135.06 128.66 32.69 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.5 p -74.31 158.66 85.11 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 117.914 0.325 . . . . 0.0 110.917 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.93 164.53 35.37 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 107.128 -1.912 . . . . 0.0 107.128 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.81 83.5 1.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.783 2.322 . . . . 0.0 108.663 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -57.16 115.52 2.71 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.05 -126.45 6.89 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -139.4 131.73 28.39 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.87 1.268 . . . . 0.0 107.916 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -68.19 154.26 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.34 175.56 12.11 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.432 -1.417 . . . . 0.0 111.784 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -58.38 -64.52 0.89 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.915 1.686 . . . . 0.0 111.527 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.95 163.52 27.8 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.948 0.88 . . . . 0.0 110.927 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER 176.11 168.82 0.43 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.156 1.783 . . . . 0.0 109.047 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.48 160.96 42.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.663 1.585 . . . . 0.0 107.565 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.06 137.17 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.22 137.09 50.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.14 138.03 0.72 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.379 2.672 . . . . 0.0 107.865 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -64.31 140.28 58.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.75 -28.06 63.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.383 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.99 2.96 55.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.081 1.309 . . . . 0.0 111.641 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.7 87.24 0.75 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.526 1.057 . . . . 0.0 111.153 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.57 144.35 15.92 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.42 145.69 28.84 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.3 tt -75.86 107.66 8.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 m -86.62 -23.57 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.531 0.605 . . . . 0.0 110.135 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.24 -179.68 43.27 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -144.47 175.71 9.92 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.333 1.053 . . . . 0.0 110.265 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.53 167.95 28.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.373 2.269 . . . . 0.0 106.565 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 118.48 0.52 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.309 1.413 . . . . 0.0 114.398 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -60.1 120.87 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.13 164.88 31.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.601 1.56 . . . . 0.0 109.131 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.77 -112.59 0.26 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.97 -21.89 66.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.971 0.385 . . . . 0.0 111.004 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.65 173.31 13.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.025 2.13 . . . . 0.0 108.998 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 50.5 tp -89.94 98.64 11.89 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -82.55 -42.91 17.74 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.68 34.0 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.245 0.929 . . . . 0.0 112.53 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.45 153.64 36.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.068 0.947 . . . . 0.0 111.086 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.15 29.41 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.309 1.433 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.4 40.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.351 1.06 . . . . 0.0 110.505 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -109.66 114.52 28.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -107.94 131.75 54.21 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.671 0.788 . . . . 0.0 111.055 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.795 0.838 . . . . 0.0 112.264 179.425 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -75.85 127.25 32.61 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -95.21 135.38 36.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.9 mt -89.87 178.43 6.23 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.3 m -100.1 101.71 12.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.41 173.55 7.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.575 0.702 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.5 tt -144.4 172.03 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.346 1.858 . . . . 0.0 106.76 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.36 -111.75 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -146.74 -1.61 0.6 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 125.325 1.25 . . . . 0.0 114.68 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.503 ' HA ' ' CE ' ' A' ' 282' ' ' LYS 0.388 55.0 m-20 46.68 15.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.66 -29.3 59.03 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.29 -168.2 38.74 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.0 t -82.14 112.33 19.07 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.34 1.456 . . . . 0.0 109.462 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.95 35.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -135.82 107.31 6.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 110.177 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -97.9 104.68 16.73 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.84 -1.85 15.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.01 -83.96 1.15 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.174 1.369 . . . . 0.0 113.108 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.59 170.43 8.14 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.583 2.353 . . . . 0.0 110.65 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -138.6 144.64 39.86 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.151 0.98 . . . . 0.0 109.738 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.65 -10.71 59.34 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.238 1.015 . . . . 0.0 112.665 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.05 153.36 22.04 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.287 1.422 . . . . 0.0 109.964 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.06 156.46 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.899 1.68 . . . . 0.0 108.062 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -124.71 -58.31 1.5 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.616 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -158.76 162.03 37.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.277 1.398 . . . . 0.0 112.602 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.59 144.4 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.404 1.882 . . . . 0.0 107.077 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -139.23 144.67 38.57 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.88 1.272 . . . . 0.0 107.88 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 8.9 t -132.27 126.85 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -121.3 83.01 0.35 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -86.15 172.95 10.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.396 1.093 . . . . 0.0 111.286 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.26 -168.6 11.8 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 128.573 2.987 . . . . 0.0 106.981 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -66.49 -36.64 83.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.07 -32.24 61.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.53 0.732 . . . . 0.0 112.169 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.0 -154.21 25.35 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.6 mm -64.82 124.51 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.8 m -108.96 -25.48 10.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.683 1.128 . . . . 0.0 112.485 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -140.99 141.53 34.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.174 0.989 . . . . 0.0 110.774 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.47 130.41 72.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -152.47 144.68 23.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -144.19 168.76 19.27 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.283 1.033 . . . . 0.0 109.821 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -133.53 129.39 37.04 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -131.28 168.97 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.763 1.625 . . . . 0.0 110.22 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -124.47 99.25 6.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -117.28 138.7 51.57 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.983 2.113 . . . . 0.0 105.768 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.31 29.27 45.64 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.222 -0.765 . . . . 0.0 112.174 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.78 -7.72 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.475 2.71 . . . . 0.0 114.593 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.02 158.66 18.56 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 123.554 1.645 . . . . 0.0 114.752 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -86.6 99.95 12.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.177 1.791 . . . . 0.0 106.937 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.5 143.92 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.27 129.93 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.162 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.54 -34.3 28.88 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.51 174.49 35.67 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.911 1.72 . . . . 0.0 111.113 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -62.84 100.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.005 1.322 . . . . 0.0 108.184 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -73.99 -50.4 20.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -93.19 165.27 27.7 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.529 1.061 . . . . 0.0 112.297 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -62.81 108.2 1.58 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 126.176 1.791 . . . . 0.0 110.876 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.79 178.55 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 N-CA-C 107.713 -1.687 . . . . 0.0 107.713 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 t -147.56 176.15 10.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -14.54 11.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.8 tt -65.61 -28.86 69.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.883 0.873 . . . . 0.0 110.329 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.89 -137.65 13.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.28 156.21 38.0 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.306 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.52 154.1 28.85 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.62 148.69 47.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.474 0.579 . . . . 0.0 111.676 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.06 112.54 6.82 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -83.36 109.91 17.69 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.5 mt -110.51 102.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.6 99.26 5.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -45.04 -41.55 13.61 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.46 -26.42 29.02 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 CA-C-N 123.592 2.319 . . . . 0.0 112.887 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 98.6 p -107.79 -16.12 14.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.97 1.714 . . . . 0.0 114.278 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 117.72 29.15 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.301 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.52 92.9 4.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.14 1.776 . . . . 0.0 111.374 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.46 106.17 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 22.4 m -77.86 -38.89 45.04 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.139 0.576 . . . . 0.0 110.436 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.67 36.69 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.952 0.901 . . . . 0.0 110.652 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.2 143.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.416 ' CG ' ' HE3' ' A' ' 250' ' ' LYS . 9.5 mm-40 -128.72 166.49 18.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.603 1.961 . . . . 0.0 109.094 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.08 166.84 31.34 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.7 p -128.81 132.66 47.86 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.24 147.62 43.89 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.77 171.3 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.951 0.901 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 148.1 42.52 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.63 1.572 . . . . 0.0 110.747 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.22 135.59 29.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.75 85.63 2.75 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 139.63 -6.04 2.92 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.109 1.338 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 t -123.76 170.55 10.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.61 1.705 . . . . 0.0 108.905 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -116.92 52.62 0.94 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.972 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -167.72 -174.91 37.12 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.07 1.319 . . . . 0.0 110.299 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.59 157.92 23.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.381 1.072 . . . . 0.0 109.666 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.7 tt -130.87 135.93 59.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 124.985 1.314 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.05 104.34 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.066 -2.939 . . . . 0.0 103.066 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.284 5.5 t -86.22 -19.17 30.39 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -147.24 149.73 33.46 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.269 -0.895 . . . . 0.0 110.129 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.78 143.61 43.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.307 2.243 . . . . 0.0 108.565 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -147.42 161.81 40.29 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.046 1.738 . . . . 0.0 107.645 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -131.42 118.79 20.73 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.538 ' HZ1' ' CD ' ' A' ' 268' ' ' GLU . 73.6 mttt -69.79 113.14 6.75 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 100.325 -3.954 . . . . 0.0 100.325 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 152.31 23.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.162 2.185 . . . . 0.0 107.942 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 154.9 23.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 57.29 -7.72 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -157.55 174.66 15.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 131.208 3.803 . . . . 0.0 106.875 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.8 m -138.24 124.31 20.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.1 175.96 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.669 1.223 . . . . 0.0 111.84 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -79.31 158.34 74.27 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.734 2.014 . . . . 0.0 111.94 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.66 90.35 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.924 2.416 . . . . 0.0 106.859 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -73.69 91.97 1.94 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 115.24 -179.91 18.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.623 1.106 . . . . 0.0 113.784 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.17 111.02 22.03 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.63 1.172 . . . . 0.0 109.889 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.57 107.73 1.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -168.36 141.49 3.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.303 2.241 . . . . 0.0 107.284 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 103.74 -177.13 24.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 55.3 m -72.15 122.61 21.29 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.216 -0.579 . . . . 0.0 109.79 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.68 122.08 22.67 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.95 120.28 31.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.45 0.568 . . . . 0.0 111.465 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . 0.538 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 67.4 tt0 -100.47 144.02 29.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.873 0.869 . . . . 0.0 109.408 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 82.6 mt -122.47 103.53 8.78 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -133.95 171.35 14.31 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.681 1.992 . . . . 0.0 108.999 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -143.5 167.87 21.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.748 0.819 . . . . 0.0 110.741 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.98 7.48 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.113 1.765 . . . . 0.0 114.102 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 142.36 65.18 0.03 OUTLIER Glycine 0 C--N 1.335 0.472 0 O-C-N 121.298 -0.876 . . . . 0.0 111.583 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -147.74 153.83 39.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.231 1.412 . . . . 0.0 107.84 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.68 154.72 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.348 1.459 . . . . 0.0 107.34 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.24 153.36 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 49.8 t -132.01 -80.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.15 -151.83 11.0 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 118.913 0.778 . . . . 0.0 111.743 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.43 ' CE1' ' HA3' ' A' ' 281' ' ' GLY . 4.7 t80 -138.77 147.78 43.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.808 1.243 . . . . 0.0 110.086 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -133.73 92.19 2.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 279' ' ' PHE . . . -155.21 -138.88 2.66 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.503 ' CE ' ' HA ' ' A' ' 162' ' ' ASP 0.289 0.3 OUTLIER -156.4 162.37 40.04 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.082 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.95 50.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.519 0.676 . . . . 0.0 111.382 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 12.3 t -156.66 -167.4 2.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.696 1.998 . . . . 0.0 107.395 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -62.57 -19.43 63.68 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.076 2.15 . . . . 0.0 112.342 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 24.3 mt -139.23 150.05 45.07 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 128.987 2.915 . . . . 0.0 105.294 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 24.8 tp -85.12 86.62 7.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.007 0.821 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -78.72 -40.15 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.637 1.175 . . . . 0.0 110.895 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -128.43 130.62 47.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 120.079 1.308 . . . . 0.0 110.037 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.53 148.53 29.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.39 -164.67 27.43 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.13 137.47 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.461 0.704 . . . . 0.0 112.478 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 155.56 28.32 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 147.63 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.542 0.61 . . . . 0.0 111.641 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 80.2 mtp -139.72 149.09 58.25 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.74 118.05 5.45 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.686 2.257 . . . . 0.0 108.889 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.234 0.263 0 C-N-CA 123.322 0.649 . . . . 0.0 111.042 179.481 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--O 1.235 0.29 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 80.6 t -133.96 124.16 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.79 164.7 20.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.117 0.96 . . . . 0.0 110.185 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.09 105.61 2.51 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.329 1.452 . . . . 0.0 109.651 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.65 47.53 2.47 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.13 1.824 . . . . 0.0 114.571 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.18 -156.91 9.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.466 1.507 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' HA3' ' H ' ' A' ' 89' ' ' ASP . . . -80.98 160.06 42.35 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.233 1.016 . . . . 0.0 114.053 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.14 5.42 41.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.333 1.453 . . . . 0.0 112.61 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.34 59.94 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.18 14.03 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 119.906 1.853 . . . . 0.0 111.771 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.73 156.69 28.77 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.735 0.814 . . . . 0.0 110.895 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 m -66.19 127.68 33.12 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.683 0.793 . . . . 0.0 111.583 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -134.36 161.4 35.09 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 160.09 149.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.599 3.16 . . . . 0.0 107.544 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -142.3 119.71 11.62 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.591 0.756 . . . . 0.0 109.346 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 C-N-CA 127.62 2.533 . . . . 0.0 117.829 -178.411 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.332 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -145.38 139.84 22.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.5 mmt-85 -114.88 -60.97 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.086 1.754 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -126.36 162.85 24.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.761 1.225 . . . . 0.0 110.216 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.94 131.95 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.11 123.16 39.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.18 117.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 119.19 6.18 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.534 0.519 . . . . 0.0 112.268 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -69.98 172.58 7.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.05 1.74 . . . . 0.0 109.53 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.17 175.95 34.49 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 129.463 3.411 . . . . 0.0 104.821 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -68.06 -31.24 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -26.65 50.08 Favored 'General case' 0 N--CA 1.45 -0.447 1 C-N-CA 132.731 4.413 . . . . 0.0 113.327 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.97 -164.6 24.44 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -62.77 106.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.612 1.206 . . . . 0.0 108.217 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -97.16 -34.67 11.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.415 1.486 . . . . 0.0 114.455 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -119.34 153.26 35.39 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.534 1.133 . . . . 0.0 110.46 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.62 142.2 28.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.789 1.636 . . . . 0.0 109.088 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.44 151.62 22.8 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.59 1.956 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.85 158.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.134 1.374 . . . . 0.0 108.93 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.48 124.89 73.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -91.56 167.81 11.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.477 1.111 . . . . 0.0 110.01 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.14 111.39 19.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.731 1.212 . . . . 0.0 108.202 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -113.67 109.18 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 126.494 1.918 . . . . 0.0 108.066 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 64.0 1.01 1.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.143 1.777 . . . . 0.0 114.128 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.5 m 118.6 -11.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 1 C-N-CA 133.252 4.621 . . . . 0.0 110.498 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.3 144.72 28.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.119 0.967 . . . . 0.0 109.077 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.7 137.04 36.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.04 121.86 55.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.806 0.73 . . . . 0.0 110.074 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.98 161.84 20.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.623 2.369 . . . . 0.0 106.83 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.54 25.25 0.05 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.175 2.321 . . . . 0.0 112.384 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.33 91.91 0.1 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 121.838 2.819 . . . . 0.0 116.995 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -111.04 114.67 28.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -118.49 175.7 5.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.707 1.603 . . . . 0.0 112.061 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.4 -169.91 22.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 98.66 6.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -57.21 133.66 55.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.77 1.228 . . . . 0.0 110.856 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -129.06 124.07 33.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.384 . . . . 0.0 109.231 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.32 -21.52 66.72 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.13 -0.981 . . . . 0.0 112.851 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.54 38.3 3.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.508 1.523 . . . . 0.0 108.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.54 100.46 0.27 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.044 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.94 151.24 12.19 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.625 1.57 . . . . 0.0 109.673 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -151.14 160.58 43.78 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 130.164 3.386 . . . . 0.0 106.342 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 m -135.87 98.56 3.93 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.364 0.666 . . . . 0.0 111.465 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -95.73 108.92 21.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.56 101.79 13.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.683 1.593 . . . . 0.0 108.208 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.96 141.39 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -95.12 150.79 19.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.247 -0.908 . . . . 0.0 112.157 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.27 13.85 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.266 1.426 . . . . 0.0 111.949 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.53 -5.96 14.48 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.647 2.379 . . . . 0.0 111.345 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.08 150.99 36.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.855 1.262 . . . . 0.0 113.622 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 62.1 m-85 -135.56 132.94 37.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -71.65 113.2 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -93.9 -21.3 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.449 -0.782 . . . . 0.0 112.742 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.56 156.5 42.51 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.86 140.84 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.54 127.63 25.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.9 147.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.63 138.24 46.28 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 129.674 3.19 . . . . 0.0 108.613 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -154.57 166.14 34.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.68 0.792 . . . . 0.0 110.543 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' OD1' ' HE3' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -161.65 169.23 21.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.666 0.786 . . . . 0.0 110.968 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 158.44 20.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.512 2.325 . . . . 0.0 109.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.47 154.73 40.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.421 1.089 . . . . 0.0 108.634 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -63.89 144.08 57.35 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.37 11.96 71.03 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.839 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -142.74 142.75 32.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.891 1.276 . . . . 0.0 108.925 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.37 16.5 23.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.414 2.286 . . . . 0.0 107.701 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -115.6 179.34 4.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.681 2.392 . . . . 0.0 109.802 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.422 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 4.6 m-20 -135.15 149.34 49.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 102.896 -3.001 . . . . 0.0 102.896 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.48 143.32 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.653 1.181 . . . . 0.0 108.764 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.99 129.2 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.0 p -100.23 -38.96 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.599 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.3 169.46 18.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.91 1.284 . . . . 0.0 110.368 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.3 mm -132.24 144.83 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.171 1.388 . . . . 0.0 108.613 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 87.6 m -150.27 139.71 21.45 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.124 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -123.39 158.12 31.84 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.72 121.89 34.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.1 p -80.1 159.25 26.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.65 -33.39 73.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -21.27 66.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.301 1.44 . . . . 0.0 112.84 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.34 -10.0 30.96 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.245 1.402 . . . . 0.0 113.658 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -78.51 159.31 28.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.039 2.135 . . . . 0.0 108.259 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.8 p -134.79 156.42 48.9 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.995 1.318 . . . . 0.0 111.648 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.45 157.37 35.55 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.01 165.64 31.57 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 121.854 1.703 . . . . 0.0 109.52 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.87 83.76 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.81 3.006 . . . . 0.0 107.701 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.92 101.66 0.07 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.984 1.314 . . . . 0.0 107.698 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.41 -143.65 14.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 tp -108.63 121.73 45.62 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.74 153.55 43.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 112' ' ' GLN . 1.4 m -150.75 -179.59 7.39 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.073 -1.642 . . . . 0.0 111.074 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.404 ' H ' HG21 ' A' ' 111' ' ' THR . 41.1 tt0 -73.7 -58.68 3.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.036 -1.04 . . . . 0.0 111.246 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HE3' ' OD1' ' A' ' 81' ' ' ASP . 22.6 mttt -70.19 166.48 19.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.923 1.238 . . . . 0.0 110.223 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 175.69 167.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.237 2.215 . . . . 0.0 108.915 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.9 164.25 33.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.587 1.555 . . . . 0.0 107.83 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.04 142.39 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.57 135.33 34.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.984 1.313 . . . . 0.0 108.608 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -143.84 163.73 32.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.276 1.83 . . . . 0.0 108.784 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -118.5 175.45 5.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.679 1.992 . . . . 0.0 105.921 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -63.41 166.87 5.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.68 -9.06 40.19 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.585 -1.322 . . . . 0.0 113.795 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.78 -9.51 71.37 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.325 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.69 159.03 20.93 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.806 1.803 . . . . 0.0 113.764 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HE3' ' CG ' ' A' ' 72' ' ' TYR . 14.3 mmtm -128.23 166.94 17.59 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.317 2.647 . . . . 0.0 107.441 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.16 -61.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.625 1.57 . . . . 0.0 107.588 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.67 31.07 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -133.25 157.43 45.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.932 1.293 . . . . 0.0 108.277 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -128.07 158.45 37.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.66 100.09 0.18 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -65.19 91.74 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.0 165.8 12.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 128.069 2.548 . . . . 0.0 113.663 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -157.3 -121.17 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 106.07 -2.812 . . . . 0.0 106.07 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -66.25 -18.23 65.23 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.16 169.76 19.32 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 125.557 1.543 . . . . 0.0 108.164 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.74 84.26 7.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -69.39 -45.68 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 110.738 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.41 144.28 29.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.099 0.959 . . . . 0.0 111.872 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.8 tp -140.72 144.91 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.38 -178.63 28.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.12 38.41 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.227 1.014 . . . . 0.0 108.281 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.68 113.85 24.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.829 0.852 . . . . 0.0 108.927 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.35 100.96 10.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.769 0.828 . . . . 0.0 111.801 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.582 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.598 0.714 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 119.24 37.74 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.537 ' HE2' ' CE1' ' A' ' 293' ' ' HIS . 10.4 ptpt -88.19 123.66 33.05 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.0 mt -75.56 -166.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.312 1.045 . . . . 0.0 109.86 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 128.48 56.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.58 165.31 11.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.484 1.514 . . . . 0.0 107.653 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.05 -176.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.207 1.003 . . . . 0.0 110.883 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.21 -108.58 3.7 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.754 1.169 . . . . 0.0 111.559 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -176.0 136.9 3.46 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.06 53.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.808 2.443 . . . . 0.0 110.186 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.451 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 81.3 mm-40 -117.4 92.91 3.98 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.663 1.185 . . . . 0.0 110.692 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.79 -177.35 31.33 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.494 1.045 . . . . 0.0 112.278 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.41 113.56 3.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.786 1.634 . . . . 0.0 110.127 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.17 145.2 56.08 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.114 0.966 . . . . 0.0 110.825 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -138.51 61.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.04 104.66 6.67 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.68 99.4 10.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.263 2.625 . . . . 0.0 108.627 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.32 177.9 2.29 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.762 2.601 . . . . 0.0 112.441 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.23 25.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -118.44 -178.8 3.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.552 1.141 . . . . 0.0 109.257 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.07 -13.2 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.044 1.738 . . . . 0.0 114.198 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.32 -167.85 24.3 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 119.312 0.96 . . . . 0.0 112.291 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.44 156.8 40.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 127.824 2.45 . . . . 0.0 108.504 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -127.35 -52.08 1.39 Allowed 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.918 0.887 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.51 149.69 50.7 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.682 1.193 . . . . 0.0 108.306 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.1 139.73 50.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -127.05 112.74 15.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.594 1.157 . . . . 0.0 111.062 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.72 124.96 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.78 1.632 . . . . 0.0 107.623 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -115.78 139.59 15.51 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -138.29 -177.12 4.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.266 1.031 . . . . 0.0 112.019 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.64 -174.07 25.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 128.69 3.043 . . . . 0.0 106.846 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.97 -29.27 70.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.855 0.328 . . . . 0.0 110.854 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.36 -31.91 66.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.033 2.533 . . . . 0.0 113.01 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.88 -152.83 21.47 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.98 107.32 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.974 1.31 . . . . 0.0 109.007 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.0 p -101.79 -20.24 15.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.777 0.831 . . . . 0.0 112.564 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.06 160.72 42.11 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.084 1.311 . . . . 0.0 112.185 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 m -156.13 148.3 11.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.07 170.16 10.59 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.803 2.041 . . . . 0.0 107.011 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -160.29 164.49 32.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 109.894 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -102.53 123.21 45.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 148.19 23.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.647 1.979 . . . . 0.0 106.185 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.74 130.93 46.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -105.01 104.95 14.78 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.9 1.28 . . . . 0.0 108.019 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 71.31 -84.58 0.42 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.62 -18.29 2.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.257 . . . . 0.0 111.072 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.84 162.04 29.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.941 1.297 . . . . 0.0 109.572 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.21 145.5 39.79 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.679 0.792 . . . . 0.0 109.972 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.7 101.59 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.4 t -67.45 133.07 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.3 -169.8 42.6 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.1 -153.99 27.41 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.09 141.41 51.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -115.03 -80.22 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.44 1.018 . . . . 0.0 110.54 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.37 -179.11 50.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -99.81 103.69 23.5 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 120.931 2.365 . . . . 0.0 111.333 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.06 160.71 48.8 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 120.928 1.086 . . . . 0.0 109.367 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -102.81 178.11 4.66 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 27.2 tp -65.73 -13.57 59.58 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.795 -0.566 . . . . 0.0 111.509 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.65 -33.87 56.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.692 1.597 . . . . 0.0 110.645 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 110.83 -157.74 14.79 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.237 0.446 . . . . 0.0 112.387 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -133.93 170.74 15.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.159 2.184 . . . . 0.0 109.069 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.61 149.69 52.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 129.153 2.981 . . . . 0.0 104.765 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -133.49 149.12 51.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.954 0.797 . . . . 0.0 112.542 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -142.0 124.46 15.74 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -78.66 121.05 24.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.03 1.332 . . . . 0.0 109.682 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.76 124.71 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 128.127 2.571 . . . . 0.0 105.721 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.22 94.3 5.29 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.36 -33.6 15.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.525 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.76 13.94 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 CA-C-N 123.762 2.379 . . . . 0.0 111.198 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.31 -53.82 1.03 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.089 1.356 . . . . 0.0 109.878 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.86 177.75 4.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.461 1.504 . . . . 0.0 110.27 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.83 115.3 4.8 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.814 -0.553 . . . . 0.0 111.208 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.75 101.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -86.32 -19.5 29.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.995 1.318 . . . . 0.0 110.266 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.33 156.05 34.77 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.529 1.059 . . . . 0.0 110.833 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.7 144.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -132.08 173.27 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.647 1.979 . . . . 0.0 106.843 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.82 177.47 41.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.6 p -136.92 145.1 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -126.09 131.37 52.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.477 0.711 . . . . 0.0 111.554 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.41 170.77 15.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.136 1.375 . . . . 0.0 110.851 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -76.01 142.99 41.73 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.875 1.27 . . . . 0.0 111.882 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 20.2 pt -80.43 135.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.2 88.53 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.127 0.571 . . . . 0.0 110.808 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 151.95 -17.76 0.83 Allowed Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.296 -1.28 . . . . 0.0 112.76 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.2 m -140.27 179.16 6.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.554 1.177 . . . . 0.0 110.783 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.22 -30.09 24.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.177 2.591 . . . . 0.0 109.517 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -55.4 152.7 14.73 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 127.349 2.404 . . . . 0.0 112.976 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 66.3 mt -111.43 152.95 26.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.607 1.963 . . . . 0.0 109.222 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -143.73 160.38 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.246 1.418 . . . . 0.0 107.482 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.63 105.89 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -41.96 80.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.64 1.176 . . . . 0.0 111.582 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -147.89 159.48 43.81 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.912 0.485 . . . . 0.0 111.769 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 62.7 mt -135.13 147.11 49.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.287 1.835 . . . . 0.0 110.802 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -137.85 128.41 26.61 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.456 2.303 . . . . 0.0 107.749 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -111.38 113.61 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.71 113.83 19.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.2 p -109.99 165.84 11.41 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 126.623 1.969 . . . . 0.0 110.316 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -112.37 155.1 24.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 62.94 -16.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -135.18 172.27 13.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.619 1.568 . . . . 0.0 108.398 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.04 155.36 31.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.618 1.167 . . . . 0.0 108.005 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.6 p -123.01 178.27 5.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.421 1.889 . . . . 0.0 110.046 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -133.0 159.25 73.45 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.064 1.346 . . . . 0.0 109.73 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 108.24 2.65 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 109.01 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.24 92.94 5.17 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.01 179.78 17.2 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.687 1.137 . . . . 0.0 110.655 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 tp -82.96 111.97 19.31 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -68.47 106.95 2.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -171.23 146.51 2.37 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.838 2.455 . . . . 0.0 107.393 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 105.58 -176.69 22.46 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.1 m -67.77 122.97 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 144.2 43.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.138 -0.351 . . . . 0.0 110.317 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -138.65 144.34 39.64 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.5 1.12 . . . . 0.0 109.139 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.64 155.91 47.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.74 121.14 17.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -169.66 133.32 1.27 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.425 1.89 . . . . 0.0 109.829 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -146.0 129.21 16.67 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.0 1.32 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 30.33 52.61 0.12 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.115 2.966 . . . . 0.0 112.721 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 53.25 13.04 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 117.264 -1.853 . . . . 0.0 115.706 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.41 151.71 3.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.239 1.816 . . . . 0.0 111.228 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.28 132.61 40.1 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.15 1.78 . . . . 0.0 109.294 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.19 121.68 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.71 34.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.882 0.873 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.86 174.25 35.93 Favored Glycine 0 C--N 1.334 0.436 0 O-C-N 120.663 -1.273 . . . . 0.0 111.918 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -129.98 158.81 38.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.235 1.814 . . . . 0.0 108.509 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . 0.4 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 7.8 p-80 -149.26 165.74 31.01 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 112.23 -160.05 13.38 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.451 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -129.23 164.58 23.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.928 0.87 . . . . 0.0 110.743 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.96 149.52 50.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 m -152.37 -155.14 0.58 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 101.668 -3.456 . . . . 0.0 101.668 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -55.31 -36.45 66.21 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.008 -1.058 . . . . 0.0 110.285 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.14 164.44 21.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.128 1.371 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.72 77.4 9.79 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.92 -39.39 89.2 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -128.16 144.88 51.15 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -156.23 110.64 2.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . 0.4 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -137.26 174.45 21.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.9 m -128.45 174.93 11.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.03 0.932 . . . . 0.0 112.578 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . 0.537 ' CE1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER -118.16 128.13 54.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.9 2.48 . . . . 0.0 106.458 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.83 147.52 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.75 1.22 . . . . 0.0 109.996 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 81.2 mtp -141.97 144.15 31.07 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 126.331 1.852 . . . . 0.0 107.652 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.89 153.64 53.11 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.049 2.499 . . . . 0.0 112.433 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.237 0.396 0 C-N-CA 124.579 1.152 . . . . 0.0 110.261 179.36 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 . . . . . 0 C--O 1.235 0.333 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 130.43 34.62 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.35 128.11 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -72.7 155.54 39.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.693 0.679 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.44 101.62 13.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.366 1.466 . . . . 0.0 110.042 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.32 153.5 52.94 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.81 177.85 38.32 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 89' ' ' ASP . . . -72.53 -50.44 15.35 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.527 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 125.64 0.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 129.639 3.176 . . . . 0.0 118.312 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.67 -4.05 1.88 Allowed Glycine 0 CA--C 1.539 1.535 0 N-CA-C 120.706 3.042 . . . . 0.0 120.706 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.5 -174.01 22.37 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 121.336 2.568 . . . . 0.0 113.899 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.81 159.83 15.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.147 2.579 . . . . 0.0 112.991 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -3.66 109.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 1 C-N-CA 132.862 4.465 . . . . 0.0 117.531 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.404 ' HB3' ' H ' ' A' ' 130' ' ' GLY . 2.6 m0 -56.93 144.0 35.49 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 128.91 2.884 . . . . 0.0 108.353 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p30 59.1 9.38 1.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -50.67 129.32 22.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.385 0.993 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.169 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.484 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 CA-C-O 118.842 -0.976 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.27 146.48 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.712 1.756 . . . . 0.0 111.735 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.06 -28.81 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -146.15 159.03 43.86 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -142.68 115.29 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -88.28 144.52 26.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -141.56 148.08 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.496 1.119 . . . . 0.0 108.377 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.63 119.95 1.57 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.94 126.09 30.57 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.504 1.122 . . . . 0.0 108.72 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.03 -175.82 20.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -64.5 -36.8 85.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.11 17.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 131.126 3.77 . . . . 0.0 112.476 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.67 -136.79 18.45 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.48 95.68 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 p -109.41 -10.54 14.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.02 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -138.21 128.08 25.39 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.619 1.1 . . . . 0.0 109.015 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.98 154.24 23.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.114 1.366 . . . . 0.0 109.078 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.424 HD22 ' CD ' ' A' ' 50' ' ' GLU . 54.2 t30 -155.63 99.18 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.859 0.463 . . . . 0.0 110.747 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -77.97 145.04 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -127.73 134.57 65.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -115.77 169.95 8.83 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.459 1.123 . . . . 0.0 111.508 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.14 134.63 50.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.916 2.486 . . . . 0.0 106.61 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -115.88 150.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.55 -39.45 87.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.204 0.202 . . . . 0.0 110.555 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -70.89 0.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -149.45 139.91 22.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.37 141.05 48.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.473 1.509 . . . . 0.0 108.351 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.5 147.32 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 108.33 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' CD ' HD22 ' A' ' 39' ' ' ASN . 36.3 tt0 -101.1 138.05 38.64 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.06 -68.06 1.64 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.72 144.09 3.93 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 121.595 -0.944 . . . . 0.0 112.465 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.95 133.71 43.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.757 1.623 . . . . 0.0 107.687 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -119.65 169.7 9.85 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.913 1.285 . . . . 0.0 110.252 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 -151.73 20.81 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -121.36 106.1 11.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -63.41 163.16 11.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.195 0.522 . . . . 0.0 111.392 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -138.79 162.7 34.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.044 0.938 . . . . 0.0 108.579 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.9 tp -89.34 -33.22 16.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.841 1.256 . . . . 0.0 112.174 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.9 mt -100.77 12.14 38.12 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.74 106.21 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -160.63 126.27 3.92 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.255 1.422 . . . . 0.0 108.239 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -148.77 163.59 36.92 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.866 1.666 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.2 m -141.14 133.4 28.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -128.25 131.24 48.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -113.55 146.67 39.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.153 0.981 . . . . 0.0 108.515 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.3 t -109.8 117.35 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.42 156.4 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.27 -12.11 59.65 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.499 -0.75 . . . . 0.0 111.812 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -104.79 -7.79 19.22 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.465 1.506 . . . . 0.0 111.394 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -119.64 136.58 54.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.87 147.51 50.45 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.288 0.566 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.6 mt -78.23 131.2 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.96 -21.41 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 122.691 0.396 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.59 152.62 38.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.935 1.294 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.5 t -146.42 142.38 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -110.23 115.23 29.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -108.18 125.34 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.2 p -116.43 139.54 50.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -154.78 163.65 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.382 1.073 . . . . 0.0 108.6 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.03 168.89 23.59 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.44 0.564 . . . . 0.0 110.113 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -99.55 155.55 17.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.321 1.848 . . . . 0.0 112.008 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.7 137.5 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -78.56 72.26 5.08 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.49 18.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.494 1.521 . . . . 0.0 113.008 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.98 149.68 52.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.7 -16.02 61.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.037 0.935 . . . . 0.0 112.554 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 p -161.28 172.0 17.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.521 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -76.47 151.91 36.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.0 pt -134.64 152.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.594 1.158 . . . . 0.0 109.453 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.2 mm -68.35 112.05 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.422 1.089 . . . . 0.0 108.163 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -81.31 -40.61 23.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.866 1.266 . . . . 0.0 111.217 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 t -157.84 173.92 16.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.57 1.948 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.54 155.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 109.63 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.1 m -148.92 122.38 9.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.301 1.44 . . . . 0.0 108.761 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -92.74 138.22 31.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 108.73 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -123.12 115.56 22.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.006 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.6 p -91.34 168.06 11.84 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 121.546 -0.721 . . . . 0.0 110.409 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -70.88 -30.1 66.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.29 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -69.79 -6.25 30.91 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.21 66.46 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -82.08 126.6 32.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.5 m -127.66 149.8 50.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 p -99.1 161.58 24.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.006 0.923 . . . . 0.0 110.465 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.49 166.25 27.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.729 1.619 . . . . 0.0 109.778 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.6 108.53 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.067 2.511 . . . . 0.0 109.089 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.31 73.82 7.16 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 135.73 -176.15 20.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.05 112.86 15.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 110.62 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 154.01 19.88 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.414 HG21 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -144.24 176.4 9.37 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 119.916 -1.74 . . . . 0.0 112.719 -177.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.414 ' H ' HG21 ' A' ' 111' ' ' THR . 12.3 tt0 -70.36 -56.93 5.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -66.07 150.6 48.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 pttt 172.73 173.42 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 126.461 1.904 . . . . 0.0 109.321 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.91 164.82 31.67 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.617 1.967 . . . . 0.0 107.338 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.48 139.06 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -136.36 122.67 20.58 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 160.77 42.19 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.389 1.475 . . . . 0.0 109.456 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.27 176.77 8.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.068 0.849 . . . . 0.0 109.34 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -128.03 -49.48 1.34 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.315 1.446 . . . . 0.0 109.207 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -68.52 -3.05 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.072 1.749 . . . . 0.0 113.97 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.28 47.55 5.43 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 120.617 1.553 . . . . 0.0 111.275 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.73 -165.14 40.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.23 1.395 . . . . 0.0 111.657 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -131.24 151.71 51.22 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.436 1.895 . . . . 0.0 107.281 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -71.34 154.06 41.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.53 -47.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 118.762 0.71 . . . . 0.0 112.548 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -167.29 168.39 40.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 120.091 1.314 . . . . 0.0 111.022 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -114.49 169.94 8.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.967 1.307 . . . . 0.0 110.216 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -164.84 170.88 14.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.241 2.616 . . . . 0.0 106.678 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 15' ' ' TRP . . . 128.65 129.4 3.18 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 126.145 1.831 . . . . 0.0 110.027 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.61 122.36 1.94 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.179 0.99 . . . . 0.0 112.651 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.0 166.06 25.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.847 2.459 . . . . 0.0 109.628 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.29 -119.14 0.82 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -68.5 -6.3 24.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.08 175.1 13.36 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 128.782 2.833 . . . . 0.0 106.656 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.67 95.06 5.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -83.22 -30.44 27.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.845 1.658 . . . . 0.0 113.112 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.16 42.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 108.772 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 65.3 tp -154.66 134.56 12.96 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.43 179.12 37.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 125.67 1.605 . . . . 0.0 109.127 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.05 171.89 17.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.478 0.639 . . . . 0.0 111.395 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -115.7 150.67 36.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.592 1.157 . . . . 0.0 108.522 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -125.01 111.53 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.75 0.786 . . . . 0.0 109.587 179.839 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 CA-C-O 121.927 0.87 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -74.09 129.72 38.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HE3' ' ND1' ' A' ' 280' ' ' HIS . 77.9 tttt -98.95 106.47 18.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.002 1.321 . . . . 0.0 108.045 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mt -74.88 173.9 9.99 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.0 t -76.08 163.66 26.9 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.838 -1.164 . . . . 0.0 109.062 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -144.41 138.19 27.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 tp -118.47 138.35 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.227 2.211 . . . . 0.0 107.321 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.57 -31.2 0.57 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 154.54 -169.55 32.84 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -136.19 6.69 3.09 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.082 1.753 . . . . 0.0 109.3 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -113.97 146.99 39.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.157 1.383 . . . . 0.0 109.82 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.56 175.36 14.04 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.955 1.264 . . . . 0.0 110.43 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.9 m -65.35 123.34 19.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 115.58 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.165 0.986 . . . . 0.0 110.038 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.501 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 7.8 m0 -78.22 125.08 28.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.41 114.45 26.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.288 1.835 . . . . 0.0 108.142 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.53 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.523 2.729 . . . . 0.0 115.012 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 64.28 -162.08 37.05 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.79 143.17 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.304 1.842 . . . . 0.0 107.866 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.28 -178.74 4.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.28 -34.0 66.03 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.423 1.011 . . . . 0.0 110.328 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.0 -163.7 33.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 124.563 1.078 . . . . 0.0 110.418 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.56 157.18 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.403 2.281 . . . . 0.0 108.22 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -120.37 -46.41 2.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.786 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.403 ' HE2' ' OE1' ' A' ' 193' ' ' GLU . 26.1 ttpt -137.19 145.24 43.46 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 145.73 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.68 157.72 38.3 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.619 1.168 . . . . 0.0 109.582 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.6 t -138.88 129.5 33.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.65 111.84 2.03 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.22 177.45 4.68 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.478 0.711 . . . . 0.0 110.794 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -160.08 -168.06 21.52 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 127.486 2.47 . . . . 0.0 107.994 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.17 -20.0 59.56 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 122.142 -0.622 . . . . 0.0 111.259 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.92 -31.57 35.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.869 3.668 . . . . 0.0 112.691 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 139.36 -132.48 5.67 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mm -88.03 105.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.87 -23.46 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 113.18 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.02 32.29 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.285 0.948 . . . . 0.0 111.717 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.32 133.6 46.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.947 0.899 . . . . 0.0 108.596 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.582 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 15.0 pttp -156.42 170.99 21.05 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 107.308 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -167.73 174.77 7.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.333 1.453 . . . . 0.0 108.367 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.403 ' OE1' ' HE2' ' A' ' 177' ' ' LYS . 21.7 mt-10 -100.65 137.06 39.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -97.79 167.82 10.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.148 0.499 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -121.01 116.78 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.021 1.728 . . . . 0.0 108.138 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -140.54 114.11 8.75 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 40.51 57.86 2.64 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.289 0.947 . . . . 0.0 113.974 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.79 -3.35 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.008 2.523 . . . . 0.0 117.165 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.66 170.2 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.349 0.977 . . . . 0.0 108.532 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -136.51 104.44 5.57 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.78 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.172 0.896 . . . . 0.0 113.018 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.01 129.33 36.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 124.831 1.252 . . . . 0.0 108.743 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -66.15 -179.36 9.64 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.718 1.627 . . . . 0.0 111.353 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.71 151.7 21.96 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.71 0.617 . . . . 0.0 113.294 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -77.39 102.8 6.98 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.219 1.408 . . . . 0.0 107.617 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -78.85 -64.35 1.2 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.65 1.18 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.74 170.86 53.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.659 1.124 . . . . 0.0 111.622 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -80.66 113.32 38.93 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.581 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.82 169.86 20.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.33 1.353 . . . . 0.0 110.748 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.4 p -126.79 173.93 9.17 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.488 1.115 . . . . 0.0 108.49 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.39 -6.33 42.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.512 -0.742 . . . . 0.0 112.494 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.7 -1.44 6.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.332 1.053 . . . . 0.0 111.069 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.48 -160.91 54.15 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.582 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 35.8 m-85 -135.8 163.08 31.02 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.98 1.312 . . . . 0.0 108.5 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -124.47 157.44 35.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.42 148.88 52.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.494 1.118 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -141.51 116.33 9.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.14 138.42 34.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.412 1.085 . . . . 0.0 109.049 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.6 mm -128.2 130.24 69.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.18 90.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -39.1 -50.99 4.31 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.19 -19.11 8.24 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 121.365 1.523 . . . . 0.0 114.388 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.0 m -106.52 -10.87 16.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.88 147.3 31.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.909 1.284 . . . . 0.0 107.643 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.37 126.3 11.21 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.09 112.75 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.248 1.819 . . . . 0.0 108.056 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.6 p -84.8 -24.74 28.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 0.0 111.142 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -172.29 171.13 4.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.942 2.097 . . . . 0.0 109.207 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.5 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -83.75 171.03 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.886 -1.134 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 170.18 177.03 40.16 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 p -142.16 147.08 36.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.53 162.39 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.852 0.861 . . . . 0.0 109.415 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -146.9 156.46 43.1 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.474 ' HZ3' ' CG ' ' A' ' 240' ' ' ASP . 26.7 mmtp -71.78 138.83 48.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.963 1.705 . . . . 0.0 113.175 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -81.24 97.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -47.26 147.04 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.569 1.548 . . . . 0.0 112.089 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.6 52.46 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 62.9 p -141.13 -174.15 3.93 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.654 1.981 . . . . 0.0 107.68 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . 0.474 ' CG ' ' HZ3' ' A' ' 235' ' ' LYS . 8.8 t0 -133.69 91.65 2.87 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -158.91 173.44 35.82 Favored Glycine 0 CA--C 1.53 0.994 1 C-N-CA 131.185 4.231 . . . . 0.0 104.154 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.18 166.01 31.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 119.602 1.701 . . . . 0.0 111.781 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 7.6 tt -141.65 144.58 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.176 1.39 . . . . 0.0 109.239 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 37.4 mt -75.45 132.82 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.255 5.4 t -116.78 -12.16 10.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.615 0.766 . . . . 0.0 112.027 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -146.63 144.01 29.21 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.602 1.161 . . . . 0.0 108.775 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.95 127.15 13.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.735 0.698 . . . . 0.0 111.206 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -130.55 154.61 47.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.451 1.5 . . . . 0.0 109.408 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -118.54 126.62 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -71.97 114.87 10.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -109.69 165.76 11.43 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.476 2.31 . . . . 0.0 109.231 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -119.83 134.13 55.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.33 7.17 0.87 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -144.23 152.07 40.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.994 2.118 . . . . 0.0 106.074 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 61.3 m -143.95 118.48 9.73 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.7 p -78.16 177.83 8.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.92 1.688 . . . . 0.0 111.793 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -73.51 154.36 89.75 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.875 . . . . 0.0 110.015 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.15 96.96 1.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 109.207 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -78.5 114.26 17.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.74 -163.03 22.38 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.9 pp -127.63 122.69 33.74 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.74 108.35 2.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.738 1.615 . . . . 0.0 109.964 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.9 9.19 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.188 0.995 . . . . 0.0 111.633 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 72.58 -98.74 0.86 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 126.311 1.91 . . . . 0.0 112.425 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 95.9 m -145.36 122.01 11.14 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.214 1.405 . . . . 0.0 107.612 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.64 145.07 33.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.101 0.56 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -132.43 158.59 41.62 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.534 1.159 . . . . 0.0 110.519 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.92 146.24 26.15 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 53.5 mt -141.87 108.77 5.42 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.861 1.664 . . . . 0.0 108.478 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -157.8 163.92 37.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.679 1.581 . . . . 0.0 111.496 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.87 157.46 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 107.85 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -75.1 140.88 43.75 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 110.013 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 63.38 5.36 11.26 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 117.389 -1.784 . . . . 0.0 116.741 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -112.1 153.7 26.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.197 1.998 . . . . 0.0 112.003 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -115.52 164.19 14.67 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.272 2.229 . . . . 0.0 107.692 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.08 134.18 31.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.89 -0.38 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.167 0.987 . . . . 0.0 113.554 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.98 157.19 27.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -131.33 124.29 30.1 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.495 1.918 . . . . 0.0 109.92 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . 0.414 ' ND1' ' HE3' ' A' ' 155' ' ' LYS . 15.0 p80 -127.27 179.51 5.41 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.03 1.332 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 120.2 -127.37 7.05 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -161.25 151.35 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.906 1.282 . . . . 0.0 111.818 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.501 ' HB2' ' HE1' ' A' ' 167' ' ' TRP . . . -113.06 146.8 38.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.397 1.479 . . . . 0.0 108.113 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -155.75 -160.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.431 1.892 . . . . 0.0 106.064 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -38.06 88.43 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.36 162.95 20.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.41 1.484 . . . . 0.0 108.884 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.33 95.68 1.76 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 109.855 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -83.56 -84.01 0.14 Allowed 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -88.55 165.6 14.73 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -167.85 99.89 0.47 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.43 1.892 . . . . 0.0 107.435 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -129.35 169.73 20.54 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 121.694 -0.629 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.06 173.36 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 122.118 0.961 . . . . 0.0 112.776 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.15 124.97 42.94 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.998 -2.594 . . . . 0.0 103.998 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.93 137.63 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.492 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.24 139.47 34.6 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 123.978 0.911 . . . . 0.0 109.606 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.43 137.09 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.493 2.795 . . . . 0.0 110.738 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.202 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -137.81 139.77 40.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 128.339 2.656 . . . . 0.0 107.62 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.481 ' CG1' ' H ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -121.4 148.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.073 0.949 . . . . 0.0 111.267 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.11 131.3 46.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.4 87.87 1.56 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.09 116.16 5.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.39 -170.5 30.99 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.35 177.73 33.74 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 122.834 1.241 . . . . 0.0 115.87 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.5 55.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.844 1.658 . . . . 0.0 114.49 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 175.04 54.85 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.254 0.933 . . . . 0.0 110.817 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -175.06 50.51 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.57 1.081 . . . . 0.0 114.696 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.56 157.2 27.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.155 1.382 . . . . 0.0 110.36 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -77.1 88.17 3.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.023 2.529 . . . . 0.0 114.942 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -106.17 92.46 4.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.82 149.65 23.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.795 1.638 . . . . 0.0 108.797 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 31.21 58.55 0.27 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 127.753 2.421 . . . . 0.0 110.873 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 C-N-CA 126.535 2.017 . . . . 0.0 116.091 -177.544 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 118.654 -1.081 . . . . 0.0 115.553 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.96 154.08 7.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 119.793 1.796 . . . . 0.0 110.629 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -128.77 -41.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.532 1.133 . . . . 0.0 110.696 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -133.48 171.72 13.69 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.449 1.5 . . . . 0.0 108.174 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -140.25 130.22 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -131.11 144.03 51.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.3 t -148.31 147.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 127.862 2.465 . . . . 0.0 105.69 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.13 133.15 3.47 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 107.119 -2.392 . . . . 0.0 107.119 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -75.85 176.8 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.066 0.936 . . . . 0.0 108.934 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -160.42 10.5 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -77.06 -31.53 56.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.836 0.35 . . . . 0.0 110.227 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -91.4 -27.34 18.38 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.653 3.181 . . . . 0.0 115.182 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.75 -140.7 11.46 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -75.63 96.34 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.28 -7.29 21.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.449 1.1 . . . . 0.0 113.647 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -129.86 143.72 50.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.96 1.255 . . . . 0.0 112.377 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -159.02 130.53 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.039 0.936 . . . . 0.0 109.705 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -117.85 151.43 37.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.819 1.648 . . . . 0.0 109.809 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.12 140.96 45.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.062 1.345 . . . . 0.0 110.263 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -127.47 98.77 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -81.3 105.68 12.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.99 120.44 27.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -115.16 157.39 23.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.749 -0.594 . . . . 0.0 110.879 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 6.56 4.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.59 1.956 . . . . 0.0 108.609 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -121.58 -69.55 0.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.432 2.293 . . . . 0.0 108.742 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -154.96 135.05 13.05 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.84 150.27 39.31 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.906 1.282 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 122.9 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.992 0.917 . . . . 0.0 111.37 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.21 99.66 11.24 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.91 -21.63 45.46 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.936 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.01 142.29 12.06 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.021 1.296 . . . . 0.0 111.766 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -74.08 130.23 39.4 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.612 1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -116.4 175.7 5.44 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.236 0.541 . . . . 0.0 109.949 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -134.78 12.41 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 105.653 -2.979 . . . . 0.0 105.653 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -126.77 99.24 5.68 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.24 144.97 56.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.06 142.87 30.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.776 1.274 . . . . 0.0 110.516 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.23 -4.65 58.12 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.592 -1.317 . . . . 0.0 110.447 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.49 -16.71 62.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.499 1.12 . . . . 0.0 111.455 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.3 117.83 0.42 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -163.14 135.44 5.29 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.997 2.919 . . . . 0.0 105.734 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -132.18 160.12 37.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 m -116.3 118.61 33.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.566 1.946 . . . . 0.0 108.905 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.13 109.13 13.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.8 160.91 20.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 109.747 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.72 106.12 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 156.92 23.07 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.509 -0.744 . . . . 0.0 109.617 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.68 -26.69 27.58 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.62 -34.98 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.108 1.763 . . . . 0.0 112.393 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.86 164.51 13.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.986 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.67 -178.72 5.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.127 1.771 . . . . 0.0 109.812 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.9 139.11 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.62 -36.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.074 0.95 . . . . 0.0 112.864 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.72 165.76 29.52 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.975 0.91 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.7 101.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.65 94.28 9.04 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.2 153.55 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.686 1.994 . . . . 0.0 108.134 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -139.02 148.47 43.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.357 1.063 . . . . 0.0 109.069 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.05 155.42 36.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.121 1.368 . . . . 0.0 108.515 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.84 168.49 22.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.109 0.963 . . . . 0.0 110.144 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -109.51 119.38 39.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.35 1.06 . . . . 0.0 109.213 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.7 m -90.08 151.29 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -60.89 -6.61 1.89 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 113.32 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.29 -0.65 58.24 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 117.54 -1.7 . . . . 0.0 112.703 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -133.43 158.59 42.67 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.89 1.845 . . . . 0.0 111.051 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -85.29 -19.51 31.45 Favored 'General case' 0 C--N 1.323 -0.547 1 C-N-CA 131.81 4.044 . . . . 0.0 111.586 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.4 t -129.6 164.92 22.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.389 1.876 . . . . 0.0 110.691 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.47 156.14 27.97 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.0 154.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.418 1.887 . . . . 0.0 108.673 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.8 mm -73.27 129.55 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -103.31 -41.29 6.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 113.275 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -146.58 161.23 40.96 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.746 1.219 . . . . 0.0 109.503 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.3 mt -148.06 122.96 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.554 1.541 . . . . 0.0 108.314 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -125.07 107.07 10.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.869 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -84.95 149.15 25.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.848 0.833 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -130.75 113.35 14.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -84.25 164.3 19.14 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.396 0.678 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -71.13 -38.23 72.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -35.92 82.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.217 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.25 3.68 5.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.87 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -76.71 95.86 4.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -86.64 103.5 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 p -71.72 155.89 91.8 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.42 166.18 30.55 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.939 1.759 . . . . 0.0 110.907 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.24 112.74 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.789 2.993 . . . . 0.0 107.232 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -78.07 67.67 3.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.088 1.355 . . . . 0.0 107.369 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.41 -179.74 17.78 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 124.717 1.151 . . . . 0.0 111.143 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.07 119.09 22.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.68 1.592 . . . . 0.0 111.556 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 157.87 23.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.18 172.49 14.23 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.777 -1.202 . . . . 0.0 109.771 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -69.34 -49.29 57.01 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -66.72 138.48 57.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.1 pttt 169.54 171.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.864 2.466 . . . . 0.0 109.79 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.4 156.35 47.67 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.384 1.873 . . . . 0.0 107.153 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.6 149.39 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.829 0.851 . . . . 0.0 109.844 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.91 142.97 16.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 0.0 109.66 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.25 156.52 30.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.675 0.79 . . . . 0.0 110.077 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 175.94 9.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.626 1.97 . . . . 0.0 113.262 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -127.99 -46.87 1.38 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.423 -0.798 . . . . 0.0 112.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -127.39 13.45 7.09 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.83 0.852 . . . . 0.0 112.554 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.9 -84.31 0.32 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 107.508 -2.237 . . . . 0.0 107.508 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.36 76.07 0.11 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 125.855 1.693 . . . . 0.0 112.281 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.21 123.84 12.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.853 0.861 . . . . 0.0 111.197 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.73 115.98 6.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.44 -9.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.194 1.397 . . . . 0.0 112.757 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.65 -91.0 0.3 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 119.295 0.952 . . . . 0.0 114.617 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 78.38 152.2 0.12 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.425 2.69 . . . . 0.0 109.811 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -157.75 170.07 23.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.958 2.103 . . . . 0.0 106.172 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.31 101.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 O-C-N 121.533 -0.729 . . . . 0.0 112.737 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.57 123.16 9.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.48 164.42 38.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.274 0.63 . . . . 0.0 109.375 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.22 -110.41 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.38 -12.36 60.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.207 0.503 . . . . 0.0 112.215 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.67 174.48 12.53 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 127.839 2.456 . . . . 0.0 107.528 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -102.04 89.43 3.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.219 1.008 . . . . 0.0 108.485 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.4 -38.81 49.0 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.01 167.0 26.07 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.016 1.28 . . . . 0.0 112.283 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.93 171.24 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.85 2.06 . . . . 0.0 108.782 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.78 169.91 33.58 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.882 1.706 . . . . 0.0 110.106 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.481 ' H ' ' CG1' ' A' ' 4' ' ' VAL . . . -153.16 167.69 28.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.688 1.595 . . . . 0.0 112.296 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -129.77 163.2 26.72 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.257 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -144.4 135.87 25.62 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.957 1.303 . . . . 0.0 112.217 -178.64 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -75.67 122.23 23.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.59 0.756 . . . . 0.0 109.286 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -90.3 146.42 24.22 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.4 mt -101.08 -86.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 t -167.33 171.25 10.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.659 1.984 . . . . 0.0 109.07 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -152.73 177.2 10.95 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.24 1.816 . . . . 0.0 107.634 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 tt -138.34 -25.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -23.89 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 129.913 3.625 . . . . 0.0 117.667 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.77 41.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.029 1.776 . . . . 0.0 108.782 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.426 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 1.3 m-20 -114.96 5.71 15.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 114.303 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.98 122.33 28.15 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.28 1.4 . . . . 0.0 111.529 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.73 -168.52 13.62 Favored Glycine 0 N--CA 1.465 0.57 0 O-C-N 120.663 -1.273 . . . . 0.0 112.707 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.7 m -106.78 124.7 49.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.767 0.783 . . . . 0.0 111.121 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.71 153.84 27.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.189 1.396 . . . . 0.0 110.703 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -138.32 120.7 15.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.32 1.048 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.66 132.72 33.8 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.41 -0.807 . . . . 0.0 109.074 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.38 91.19 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.93 -72.75 0.52 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.699 -0.626 . . . . 0.0 114.157 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.12 170.65 20.78 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.221 1.408 . . . . 0.0 110.154 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.6 -179.7 3.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.659 1.184 . . . . 0.0 108.268 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.88 -23.69 55.63 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.678 -1.264 . . . . 0.0 112.297 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 170.79 168.58 32.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 128.72 3.057 . . . . 0.0 107.508 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.431 ' H ' ' CB ' ' A' ' 221' ' ' TYR . 1.8 t -122.72 156.28 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.365 1.866 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -121.53 -34.01 3.52 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -159.79 151.91 20.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.092 1.315 . . . . 0.0 110.926 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.6 t -106.25 142.36 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.48 160.18 39.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.824 2.45 . . . . 0.0 109.6 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.86 138.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.51 80.1 0.34 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.739 1.638 . . . . 0.0 109.206 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -85.59 162.48 18.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 111.018 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.3 -158.79 10.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 127.263 2.363 . . . . 0.0 109.056 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -82.85 -22.44 34.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.599 0.76 . . . . 0.0 111.358 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.88 -31.79 9.61 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.416 0.686 . . . . 0.0 112.548 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 165.82 -153.23 23.06 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.42 153.33 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.596 1.198 . . . . 0.0 109.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.1 t -134.22 -33.14 1.02 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.894 1.278 . . . . 0.0 109.625 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.17 35.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.91 0.862 . . . . 0.0 111.708 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.7 m -134.13 149.48 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -154.85 155.19 33.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 108.996 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.34 173.1 12.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.211 0.914 . . . . 0.0 113.028 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.32 141.77 48.11 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.296 3.038 . . . . 0.0 104.127 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -149.0 167.93 24.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.807 1.243 . . . . 0.0 109.578 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -135.98 96.44 3.41 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -88.8 125.48 34.92 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.25 31.17 56.36 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 76.26 -9.1 1.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.253 3.421 . . . . 0.0 114.852 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -76.47 133.14 39.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 120.835 1.652 . . . . 0.0 109.484 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -64.15 124.39 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.26 1.024 . . . . 0.0 109.197 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.6 mm -136.65 103.65 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.001 1.32 . . . . 0.0 108.415 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.96 127.43 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.09 -11.91 84.62 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.318 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.71 -172.12 52.99 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -89.35 154.36 20.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.845 0.858 . . . . 0.0 110.002 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -119.27 1.21 11.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.168 0.987 . . . . 0.0 109.651 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.94 173.64 27.05 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 120.304 -1.497 . . . . 0.0 111.182 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -68.68 114.07 20.02 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.18 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.92 167.22 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -118.25 148.33 42.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.521 1.128 . . . . 0.0 109.481 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.77 -24.83 67.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.331 0.653 . . . . 0.0 110.521 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 tt -51.65 -34.39 37.83 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 126.336 1.854 . . . . 0.0 111.495 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.0 -164.5 12.06 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -140.11 161.2 38.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.65 153.31 38.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.49 152.39 44.14 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.78 0.832 . . . . 0.0 110.75 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -142.06 140.54 32.6 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.997 -0.439 . . . . 0.0 110.956 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -65.15 97.82 0.27 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.164 2.186 . . . . 0.0 112.524 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 mm -128.94 102.82 8.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.44 125.89 46.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.015 1.28 . . . . 0.0 109.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.431 ' CB ' ' H ' ' A' ' 175' ' ' VAL . 80.0 t80 -55.49 -51.43 80.08 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.124 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.06 0.47 5.83 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.392 2.061 . . . . 0.0 114.604 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -128.54 -62.47 1.03 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.684 1.583 . . . . 0.0 112.997 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -81.26 168.13 18.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 110.697 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.17 101.33 3.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.9 mp -35.73 -52.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 128.871 2.868 . . . . 0.0 111.816 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.254 16.6 p 48.92 1.2 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.607 3.163 . . . . 0.0 118.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -173.84 169.88 4.04 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.538 1.535 . . . . 0.0 107.584 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.71 134.14 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -118.34 165.95 13.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.465 1.906 . . . . 0.0 107.617 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.07 174.31 46.37 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.2 p -135.44 147.35 48.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.754 1.277 . . . . 0.0 110.928 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -136.79 146.55 45.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -142.87 155.49 44.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.825 2.05 . . . . 0.0 108.225 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -87.55 148.55 24.84 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.596 0.758 . . . . 0.0 111.34 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.24 122.86 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.101 0.961 . . . . 0.0 108.468 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -55.89 152.3 10.21 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.268 0.556 . . . . 0.0 111.748 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.21 -9.39 20.02 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.245 0.926 . . . . 0.0 113.848 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -127.46 -176.03 3.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.383 1.873 . . . . 0.0 108.468 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.06 74.55 1.46 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.303 1.041 . . . . 0.0 110.594 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.08 -168.15 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.159 2.314 . . . . 0.0 109.106 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.93 162.11 36.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.786 1.293 . . . . 0.0 111.361 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.5 tt -139.85 102.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.891 2.076 . . . . 0.0 108.755 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 4.9 mp -50.6 126.25 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 121.267 -0.895 . . . . 0.0 109.536 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -106.35 -36.24 6.89 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -122.29 144.55 48.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.462 1.028 . . . . 0.0 108.699 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.28 147.14 49.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.854 1.261 . . . . 0.0 108.264 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -136.01 93.71 2.96 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.9 149.46 45.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.59 154.04 51.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.544 1.537 . . . . 0.0 107.606 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.2 t -161.94 168.11 23.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.654 1.182 . . . . 0.0 111.67 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -105.67 147.05 28.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 79.86 -52.48 0.39 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 129.663 3.185 . . . . 0.0 110.815 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -84.89 169.68 13.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.27 1.428 . . . . 0.0 109.424 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 m -128.35 99.7 5.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.238 1.015 . . . . 0.0 109.616 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.2 p -84.62 174.63 9.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.867 1.267 . . . . 0.0 112.441 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -141.62 170.36 9.36 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 128.153 2.581 . . . . 0.0 109.653 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.96 160.5 49.15 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.793 2.329 . . . . 0.0 111.724 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -131.2 94.65 3.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 106.457 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.51 14.27 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.381 1.467 . . . . 0.0 110.295 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.11 141.81 36.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.31 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.53 108.36 3.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.737 0.699 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.69 21.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.297 1.839 . . . . 0.0 106.519 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.37 173.16 49.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.685 0.66 . . . . 0.0 112.744 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.86 134.13 56.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.624 1.97 . . . . 0.0 109.398 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -90.81 144.13 26.02 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -133.96 159.34 41.04 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.015 1.326 . . . . 0.0 108.905 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -144.38 154.3 42.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.096 1.358 . . . . 0.0 107.858 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.7 mp -137.47 131.98 32.68 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -165.03 137.97 4.57 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.78 1.232 . . . . 0.0 108.553 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.58 96.51 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.56 164.49 4.48 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.113 0.959 . . . . 0.0 111.782 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.79 -2.06 42.87 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 121.266 -0.896 . . . . 0.0 113.318 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -138.22 167.07 22.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.262 3.025 . . . . 0.0 107.181 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 152.8 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.498 -0.751 . . . . 0.0 109.29 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 92.3 mt -74.41 135.05 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.1 -4.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -170.99 -173.48 38.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 120.521 1.51 . . . . 0.0 111.048 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.62 164.66 29.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.341 1.07 . . . . 0.0 110.204 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -132.65 157.86 43.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.18 -163.57 27.74 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.426 ' HE2' ' C ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -131.03 158.31 40.66 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.669 1.188 . . . . 0.0 109.173 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -137.1 113.91 10.43 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.678 0.791 . . . . 0.0 110.291 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 m -149.82 86.46 1.45 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 58.74 -10.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.272 2.229 . . . . 0.0 116.772 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 36.7 mt -143.37 -172.21 3.65 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.778 2.031 . . . . 0.0 109.56 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.63 88.48 2.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.78 1.232 . . . . 0.0 112.423 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.78 -84.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.628 0.728 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -85.65 128.97 34.93 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 120.894 -1.129 . . . . 0.0 109.163 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -149.41 100.05 2.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.127 0.971 . . . . 0.0 108.604 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -120.19 152.18 17.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.28 135.2 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 118.951 1.375 . . . . 0.0 111.729 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -89.74 139.01 30.99 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.54 153.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 37.0 mmm -147.53 157.21 45.13 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.37 156.89 57.52 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.391 1.394 . . . . 0.0 111.609 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--N 1.329 -0.315 0 C-N-CA 125.904 1.682 . . . . 0.0 107.619 178.457 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.57 138.49 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.39 84.99 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -56.46 140.21 46.65 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.268 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -73.42 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 O-C-N 125.139 1.524 . . . . 0.0 112.087 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.26 -14.86 23.1 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.046 -1.419 . . . . 0.0 112.672 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.38 -169.59 35.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.07 113.4 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 112.881 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.02 34.76 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.64 -151.19 2.42 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 128.244 2.831 . . . . 0.0 112.153 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.52 -170.79 41.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 112.093 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.77 33.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -69.77 69.39 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -84.09 24.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.993 1.717 . . . . 0.0 109.647 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.38 126.46 27.56 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.146 1.779 . . . . 0.0 107.032 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -70.15 -179.0 1.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.44 0.696 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.567 0 C-N-CA 125.962 1.744 . . . . 0.0 110.185 -179.677 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.457 0 N-CA-C 113.387 0.115 . . . . 0.0 113.387 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -136.61 118.7 20.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.58 -60.96 1.59 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -149.66 158.09 43.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.82 116.28 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -118.66 125.94 50.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.38 142.42 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 123.995 0.918 . . . . 0.0 109.251 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.97 164.08 25.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 124.606 1.098 . . . . 0.0 110.42 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -75.22 -148.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.162 1.385 . . . . 0.0 111.146 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.26 -163.58 35.6 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -95.35 -32.45 12.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.859 1.314 . . . . 0.0 107.54 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.67 -6.34 58.93 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 134.389 5.076 . . . . 0.0 113.24 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.3 -156.36 15.64 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.64 121.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.1 p -132.8 -58.61 0.91 Allowed 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.7 p -72.96 119.41 17.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 119.11 0.868 . . . . 0.0 109.634 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 tt -135.26 142.42 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.297 1.039 . . . . 0.0 108.959 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.97 129.72 21.64 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.617 1.967 . . . . 0.0 106.034 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.46 151.54 24.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.2 t -127.48 118.39 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -107.76 105.13 14.82 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.525 1.53 . . . . 0.0 110.488 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . . . -98.58 134.74 41.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 117.951 0.341 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 46' ' ' SER . 13.9 mptt -114.48 163.82 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.58 21.96 0.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.834 1.302 . . . . 0.0 111.095 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.473 ' H ' ' C ' ' A' ' 44' ' ' LYS . 11.9 p -128.8 -68.55 0.74 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.083 2.553 . . . . 0.0 109.875 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -148.08 133.91 19.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.288 1.435 . . . . 0.0 109.379 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 15.6 t0 -78.32 152.29 32.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.354 1.462 . . . . 0.0 109.687 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.76 108.67 13.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.973 0.892 . . . . 0.0 109.131 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.28 98.41 11.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.86 -22.09 76.87 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.46 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.09 -172.72 40.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.42 123.98 28.03 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.548 -0.971 . . . . 0.0 110.864 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.07 160.93 29.3 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 12.73 -86.99 0.0 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 128.417 2.913 . . . . 0.0 115.798 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -69.44 103.78 2.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.74 163.4 21.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.825 1.25 . . . . 0.0 112.432 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.81 10.22 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.712 2.405 . . . . 0.0 112.907 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.13 -13.51 18.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.84 1.256 . . . . 0.0 112.127 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.309 3.2 pp 49.0 -11.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.027 4.131 . . . . 0.0 117.593 -179.19 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.81 61.76 3.04 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.24 160.83 35.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.814 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.81 164.42 12.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 127.891 2.476 . . . . 0.0 109.298 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.5 m -136.03 95.58 3.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.578 0.751 . . . . 0.0 109.446 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -95.04 109.56 21.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.47 143.08 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.731 0.812 . . . . 0.0 110.675 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.5 t -103.87 156.57 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -149.21 164.14 35.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.913 1.685 . . . . 0.0 107.833 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.67 -9.78 59.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.672 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.69 -9.33 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.833 1.653 . . . . 0.0 111.462 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 135.76 52.12 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -135.88 149.35 48.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 109.208 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.7 126.64 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.49 -25.81 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.753 -0.642 . . . . 0.0 110.25 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.89 149.18 30.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.438 1.017 . . . . 0.0 110.642 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.22 75.81 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.07 134.22 52.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -139.67 153.05 23.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.1 p -133.35 142.04 48.22 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -149.84 156.35 41.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.08 169.48 20.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -126.86 157.74 38.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.723 0.773 . . . . 0.0 110.702 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.99 166.0 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.429 1.492 . . . . 0.0 108.62 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -68.42 150.1 48.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.73 20.15 58.59 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.061 -0.855 . . . . 0.0 113.372 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -131.04 166.52 20.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.621 1.569 . . . . 0.0 107.363 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -122.52 -11.98 8.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.955 1.702 . . . . 0.0 112.359 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.9 p -145.47 145.8 31.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.768 1.627 . . . . 0.0 109.667 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.72 159.48 33.44 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -135.7 156.91 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.715 0.806 . . . . 0.0 109.781 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -73.73 139.62 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-O 121.565 0.698 . . . . 0.0 112.057 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -108.38 -30.96 8.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.587 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.4 t -165.83 166.4 17.69 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.53 1.532 . . . . 0.0 110.624 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.0 mt -145.23 146.28 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 128.12 2.568 . . . . 0.0 105.677 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -150.14 101.53 3.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -86.72 148.53 25.39 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.312 -0.867 . . . . 0.0 109.479 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -133.31 121.11 21.92 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.0 p -100.5 159.03 15.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.653 1.115 . . . . 0.0 111.576 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.34 -32.89 74.43 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.714 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -56.19 -10.76 0.93 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.818 2.847 . . . . 0.0 113.042 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.51 30.56 8.5 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 119.238 0.926 . . . . 0.0 111.856 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.81 148.42 42.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.609 1.204 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 114.64 12.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 p -73.47 160.75 81.63 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.15 165.59 32.29 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 N-CA-C 107.694 -1.695 . . . . 0.0 107.694 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.09 109.59 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.022 -1.953 . . . . 0.0 107.022 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.38 66.08 0.92 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.294 1.437 . . . . 0.0 110.031 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.78 -129.35 3.5 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 tp -139.41 136.17 34.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.673 1.589 . . . . 0.0 109.833 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' C ' ' HG1' ' A' ' 111' ' ' THR . 2.7 mm-40 -60.62 158.8 11.77 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.44 1.096 . . . . 0.0 110.901 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -156.35 173.52 16.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.563 -1.335 . . . . 0.0 111.343 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.483 ' H ' HG23 ' A' ' 111' ' ' THR . 4.8 tt0 -64.74 -58.08 7.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.143 1.377 . . . . 0.0 109.254 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -70.54 105.93 3.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.48 166.42 33.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 120.604 -1.31 . . . . 0.0 109.021 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -156.72 166.85 32.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.313 0.578 . . . . 0.0 109.73 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.98 145.84 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.74 136.51 19.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 127.706 2.403 . . . . 0.0 106.354 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HZ1' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -160.58 134.44 7.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.49 161.16 21.34 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -142.65 -69.05 0.35 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.605 1.162 . . . . 0.0 111.064 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.84 15.37 6.92 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.492 1.517 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.34 -85.66 1.64 Allowed Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 125.602 1.572 . . . . 0.0 111.011 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.97 166.41 29.36 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.6 140.6 41.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.1 tp -54.91 112.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.68 -54.98 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.348 0.976 . . . . 0.0 111.283 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.43 -105.28 0.2 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -167.66 176.4 6.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.292 1.046 . . . . 0.0 111.526 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.84 151.84 35.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.48 -26.42 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.049 -1.072 . . . . 0.0 114.548 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 62.23 69.95 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.535 2.334 . . . . 0.0 113.852 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.99 112.16 20.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.55 -120.46 4.27 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 103.414 -3.875 . . . . 0.0 103.414 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.34 -10.22 59.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.259 0.624 . . . . 0.0 112.23 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.42 173.86 11.63 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.222 2.609 . . . . 0.0 107.691 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 40.8 tp -99.51 98.24 9.15 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.684 0.794 . . . . 0.0 109.245 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -76.13 -66.65 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 112.087 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.47 172.79 12.51 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.88 1.218 . . . . 0.0 109.626 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.8 tp -162.73 134.01 5.01 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.86 176.88 44.16 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 106.47 -2.652 . . . . 0.0 106.47 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.02 176.96 11.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.975 1.388 . . . . 0.0 109.055 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -147.81 161.73 40.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.684 0.754 . . . . 0.0 109.447 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.1 125.31 12.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.111 2.565 . . . . 0.0 104.398 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 118.722 0.692 . . . . 0.0 111.858 -179.611 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.1 133.87 55.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.195 0.998 . . . . 0.0 110.773 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -113.64 143.43 44.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.408 1.483 . . . . 0.0 108.658 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.48 -89.92 0.13 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.3 t -146.55 160.4 42.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.112 1.765 . . . . 0.0 107.889 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -170.38 136.61 1.36 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.099 2.159 . . . . 0.0 105.371 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.0 tt -97.99 128.45 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.2 107.59 0.62 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.34 -179.03 6.22 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 112.431 -1.885 . . . . 0.0 109.832 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.19 11.94 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 128.659 2.783 . . . . 0.0 115.319 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.429 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 11.8 mt-10 -130.99 156.35 45.26 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.207 1.367 . . . . 0.0 114.265 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 96.91 159.53 31.55 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 125.253 1.406 . . . . 0.0 112.768 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 m -102.53 134.43 45.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.51 138.86 51.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.815 0.446 . . . . 0.0 110.122 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -128.63 123.94 34.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -85.78 105.66 16.46 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.14 -117.94 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.405 1.066 . . . . 0.0 108.707 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.13 168.16 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 121.35 1.886 . . . . 0.0 111.763 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.87 157.86 37.11 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.098 -0.648 . . . . 0.0 109.254 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -135.31 176.34 8.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.691 1.196 . . . . 0.0 110.621 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -12.24 60.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.739 1.215 . . . . 0.0 113.767 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.21 171.73 22.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 125.525 1.536 . . . . 0.0 110.315 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.1 m -125.89 107.8 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -63.04 -51.1 68.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 110.629 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -149.19 169.69 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.753 1.16 . . . . 0.0 112.751 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 86.1 t -122.46 143.95 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.656 1.583 . . . . 0.0 109.208 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.79 157.39 46.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.768 1.627 . . . . 0.0 108.342 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.36 146.22 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.77 83.64 0.32 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -71.16 160.51 32.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.655 0.741 . . . . 0.0 110.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.34 -163.28 9.49 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.152 2.787 . . . . 0.0 109.029 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -89.62 -14.36 35.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.902 -1.352 . . . . 0.0 111.565 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.21 -29.1 15.28 Favored 'General case' 0 C--N 1.327 -0.379 1 C-N-CA 132.404 4.282 . . . . 0.0 112.917 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 144.45 -136.78 6.9 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.94 104.6 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.23 -26.17 28.9 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.496 0.719 . . . . 0.0 112.215 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.98 146.07 35.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.842 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.79 145.07 28.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -148.75 154.73 39.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.85 175.45 9.57 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -123.55 120.87 34.12 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.351 0.66 . . . . 0.0 109.555 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -94.85 165.7 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.397 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -144.82 130.38 18.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.109 -0.948 . . . . 0.0 108.556 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.85 151.99 43.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.714 1.143 . . . . 0.0 109.111 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.72 -103.53 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.601 1.096 . . . . 0.0 111.708 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 7.89 3.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.266 2.226 . . . . 0.0 110.936 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -109.24 177.93 4.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.011 1.324 . . . . 0.0 107.851 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -133.7 142.29 47.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.866 1.266 . . . . 0.0 108.761 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.74 99.73 9.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 119.649 1.113 . . . . 0.0 109.351 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.68 103.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.46 175.28 35.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.158 2.313 . . . . 0.0 107.698 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 134.1 23.95 0.66 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-N 118.327 1.063 . . . . 0.0 113.771 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.92 126.07 27.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.429 1.614 . . . . 0.0 108.123 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -127.68 -6.88 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.227 2.611 . . . . 0.0 113.363 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.45 159.29 25.73 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -66.29 116.56 34.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.801 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.86 134.89 52.59 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.652 2.234 . . . . 0.0 110.077 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.9 p -83.22 161.11 21.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.215 1.006 . . . . 0.0 109.821 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.76 -23.11 65.19 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.468 -0.77 . . . . 0.0 111.096 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -64.88 -30.82 71.84 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.963 1.305 . . . . 0.0 111.247 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.95 -146.47 16.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -138.67 163.95 30.78 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.523 1.129 . . . . 0.0 109.538 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -115.03 154.25 29.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.365 3.066 . . . . 0.0 105.304 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.5 148.17 28.38 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.61 0.764 . . . . 0.0 110.388 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.65 137.19 29.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.251 0.62 . . . . 0.0 109.332 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.13 120.75 33.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.607 0.718 . . . . 0.0 111.028 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.5 mt -127.47 129.35 70.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.443 1.02 . . . . 0.0 111.353 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -37.84 -55.82 2.04 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.34 1.59 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 123.02 2.114 . . . . 0.0 113.638 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 31.0 t -108.99 -46.69 3.56 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.737 -1.227 . . . . 0.0 109.522 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.83 160.49 14.55 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.435 1.112 . . . . 0.0 112.643 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -139.93 112.41 7.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.767 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.05 84.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.34 57.93 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.655 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -152.75 157.31 40.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.863 0.865 . . . . 0.0 109.752 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.7 146.13 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.603 1.561 . . . . 0.0 106.959 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.75 152.81 39.04 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -161.91 43.42 0.38 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.336 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.0 p -23.41 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.429 3.092 . . . . 0.0 109.381 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -122.31 155.37 36.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -144.86 165.79 27.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 110.275 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -74.51 137.34 42.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.864 1.666 . . . . 0.0 111.49 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.9 mt -80.4 108.17 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -47.11 125.15 7.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.03 1.332 . . . . 0.0 112.023 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.02 -19.18 38.47 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.829 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -136.16 178.23 7.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.284 1.434 . . . . 0.0 108.77 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.91 7.78 43.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.789 0.804 . . . . 0.0 110.595 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -73.8 164.31 54.76 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 162.89 34.32 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.203 1.401 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.5 tt -151.72 148.16 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.47 142.82 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.302 1.7 t -119.82 -23.68 6.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.944 0.793 . . . . 0.0 111.96 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -146.49 126.31 13.52 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 120.176 1.353 . . . . 0.0 108.048 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.8 150.02 28.23 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.096 1.358 . . . . 0.0 111.101 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -147.46 139.06 23.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -125.92 113.35 17.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 154.01 42.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.748 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.1 p -144.74 168.3 20.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.238 1.415 . . . . 0.0 108.699 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -123.66 141.0 52.44 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt 72.08 -45.96 0.63 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.164 1.786 . . . . 0.0 110.533 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.54 168.35 17.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.406 1.883 . . . . 0.0 107.629 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 88.2 m -130.5 99.52 5.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.359 1.464 . . . . 0.0 107.954 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 38.6 p -67.14 128.9 38.11 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.336 1.055 . . . . 0.0 113.497 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.21 84.41 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.65 157.41 21.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.527 2.151 . . . . 0.0 108.676 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -133.37 104.36 6.4 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.51 -169.54 20.5 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.4 mt -116.51 124.26 49.47 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.306 1.042 . . . . 0.0 110.461 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.91 109.19 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.152 2.181 . . . . 0.0 110.777 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.69 162.5 26.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 108.458 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.28 -165.95 45.48 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.251 0.917 . . . . 0.0 112.899 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.8 m -73.66 108.47 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.958 2.103 . . . . 0.0 108.26 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.88 138.89 42.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.91 120.77 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.501 0.667 . . . . 0.0 111.81 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.06 124.01 47.72 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.55 110.29 22.44 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -152.06 163.37 39.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.434 1.094 . . . . 0.0 109.934 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -144.71 137.71 26.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 129.37 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.393 0.616 . . . . 0.0 111.138 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.21 -1.57 33.11 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.43 161.23 13.74 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.331 2.065 . . . . 0.0 113.546 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -107.81 159.64 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.889 2.475 . . . . 0.0 107.722 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 54.7 mt -99.74 107.69 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.22 90.68 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.485 1.514 . . . . 0.0 109.449 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.73 159.11 9.1 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 126.046 1.784 . . . . 0.0 111.485 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -131.85 164.35 26.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.626 2.371 . . . . 0.0 108.546 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -161.88 103.13 1.16 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -150.38 -179.94 26.6 Favored Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.173 -0.954 . . . . 0.0 114.205 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 163' ' ' GLU . 21.8 ptmt -140.19 117.26 11.16 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.112 -2.922 . . . . 0.0 103.112 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.28 154.62 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 63.3 m -149.46 -72.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.95 -36.35 13.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.587 0.755 . . . . 0.0 110.755 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.6 mt -130.33 141.92 50.56 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.056 1.342 . . . . 0.0 107.881 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.57 85.09 2.63 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 110.695 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -76.19 -82.38 0.08 Allowed 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.131 0.572 . . . . 0.0 111.531 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -83.3 126.05 32.27 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.616 -0.677 . . . . 0.0 110.785 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -128.06 100.96 6.08 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.55 153.75 16.91 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.97 161.78 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.915 1.286 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.79 160.51 15.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 109.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.97 158.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 110.514 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 53.0 mmm -156.81 138.91 10.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 126.081 1.752 . . . . 0.0 107.023 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.84 123.05 8.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 105.58 -2.508 . . . . 0.0 105.58 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 121.2 0.524 . . . . 0.0 112.029 -179.225 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HE2' ' CE1' ' A' ' 142' ' ' TYR . 4.9 tmtt? -38.88 113.73 0.33 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.663 2.785 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.26 146.05 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.82 167.82 11.02 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.42 94.44 3.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.65 7.78 4.85 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.489 1.518 . . . . 0.0 115.417 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -170.14 27.74 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 118.74 1.27 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.52 -28.9 74.08 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.029 1.776 . . . . 0.0 110.204 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.13 42.27 30.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.452 1.501 . . . . 0.0 110.314 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.31 15.66 1.41 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.424 1.488 . . . . 0.0 112.883 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 174.64 22.42 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.358 1.932 . . . . 0.0 110.63 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 160.79 26.52 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.184 2.194 . . . . 0.0 112.237 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.73 138.39 6.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.686 0.795 . . . . 0.0 110.973 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -155.91 106.67 2.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' CG ' ' HH ' ' A' ' 142' ' ' TYR . 13.6 t0 -148.27 70.89 1.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.049 1.339 . . . . 0.0 110.758 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -34.53 127.76 0.46 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.345 2.258 . . . . 0.0 113.515 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 178.776 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.73 139.35 18.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.289 1.044 . . . . 0.0 112.116 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -58.37 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.328 1.851 . . . . 0.0 110.128 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -136.66 163.83 29.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 122.03 -0.419 . . . . 0.0 110.527 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.28 96.61 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.092 1.757 . . . . 0.0 106.879 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.82 136.28 33.03 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.33 148.25 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.539 1.936 . . . . 0.0 106.686 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.69 -115.1 2.01 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 119.483 1.038 . . . . 0.0 111.814 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.21 174.06 1.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 110.759 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.59 -25.59 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.747 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -60.72 -28.31 68.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.681 1.741 . . . . 0.0 112.468 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.24 1.06 25.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.978 2.511 . . . . 0.0 110.288 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.91 161.14 23.79 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 128.164 2.792 . . . . 0.0 108.996 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 t -84.65 95.66 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -80.32 -63.99 1.29 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 110.076 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 p -61.1 113.47 2.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.865 1.266 . . . . 0.0 111.162 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.2 mm -134.58 137.3 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.379 1.472 . . . . 0.0 107.386 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.96 111.3 5.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.1 p -124.37 150.19 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.41 122.61 59.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -110.2 104.6 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.12 110.35 18.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.596 0.236 . . . . 0.0 110.905 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -79.09 152.97 30.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.29 -38.87 74.64 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 m -63.71 -59.83 4.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -155.34 157.3 36.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.223 2.209 . . . . 0.0 106.364 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.23 156.39 39.19 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.96 108.66 2.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.44 138.53 33.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 109.369 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.36 -3.09 25.99 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.913 2.197 . . . . 0.0 112.124 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -166.43 21.29 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.431 1.116 . . . . 0.0 114.545 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -105.52 149.26 26.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.459 1.904 . . . . 0.0 107.812 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -129.73 155.87 45.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.286 1.434 . . . . 0.0 107.39 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.1 179.61 37.26 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -126.94 116.99 21.64 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.236 -1.155 . . . . 0.0 113.547 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -92.43 164.39 13.5 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.174 1.79 . . . . 0.0 110.204 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 p -142.9 168.0 20.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -63.95 -17.66 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.98 -9.84 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.954 1.702 . . . . 0.0 112.982 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.55 101.19 0.16 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 120.478 1.49 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -159.8 131.66 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.201 2.2 . . . . 0.0 105.752 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -143.28 162.39 35.79 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 127.302 2.241 . . . . 0.0 107.568 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -139.63 95.24 2.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -89.74 138.36 31.55 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -130.57 136.9 49.37 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.49 138.24 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.743 1.617 . . . . 0.0 109.607 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -82.25 171.08 14.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.5 65.79 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.995 -1.066 . . . . 0.0 112.587 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -124.4 19.45 8.89 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.326 1.45 . . . . 0.0 112.579 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.0 136.44 38.26 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.7 158.12 37.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.16 1.784 . . . . 0.0 109.175 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.0 mt -96.42 121.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.175 0.99 . . . . 0.0 109.22 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.3 m -118.38 -18.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.609 0.64 . . . . 0.0 111.952 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.19 141.11 25.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 t -135.54 142.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.64 118.48 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.78 138.4 54.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 m -117.02 137.31 52.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -140.27 148.97 42.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.013 0.525 . . . . 0.0 109.717 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -147.29 150.55 35.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -144.86 158.21 43.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 127.204 2.202 . . . . 0.0 109.273 177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.62 169.48 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 108.304 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.16 1.61 1.98 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.552 1.541 . . . . 0.0 113.21 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.47 17.31 14.11 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 126.904 2.192 . . . . 0.0 112.895 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -134.38 156.69 48.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.155 1.477 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -117.25 5.36 12.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.341 1.856 . . . . 0.0 112.3 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 p -134.11 173.52 11.5 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.678 2.791 . . . . 0.0 110.108 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -119.19 146.27 45.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -126.23 140.04 49.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.35 104.32 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.7 p -73.94 -31.13 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.816 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -150.21 154.35 37.82 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.652 1.581 . . . . 0.0 109.853 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 pt -139.57 148.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 128.441 2.696 . . . . 0.0 106.24 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.63 145.37 25.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -127.45 152.83 47.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -132.45 113.98 13.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 103.554 -2.758 . . . . 0.0 103.554 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.2 p -80.5 161.69 24.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.418 0.553 . . . . 0.0 112.019 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.75 -25.09 66.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.506 1.122 . . . . 0.0 111.29 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -68.62 -15.56 63.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.47 1.908 . . . . 0.0 109.721 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 6.5 61.46 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.693 2.568 . . . . 0.0 111.464 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -73.12 99.13 2.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.532 1.166 . . . . 0.0 111.359 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.12 134.95 33.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 p -107.67 162.2 20.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.763 1.225 . . . . 0.0 110.976 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.13 162.16 42.55 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.906 1.738 . . . . 0.0 109.498 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 109.73 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.615 2.21 . . . . 0.0 108.36 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -72.24 79.61 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 109.488 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.99 -137.2 5.41 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.395 -0.816 . . . . 0.0 111.611 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.99 111.13 13.72 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.597 1.959 . . . . 0.0 108.089 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.1 144.8 50.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 m -133.71 163.9 28.41 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.345 1.858 . . . . 0.0 107.055 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.87 -35.87 82.07 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.407 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -73.45 97.53 2.57 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.51 1.924 . . . . 0.0 108.947 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -150.98 170.18 19.96 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.258 1.023 . . . . 0.0 109.019 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.64 167.21 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -118.69 141.02 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.61 94.02 2.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 169.48 23.11 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.11 2.164 . . . . 0.0 108.42 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.56 150.25 38.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.473 1.909 . . . . 0.0 109.086 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.13 -61.02 2.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.189 0.904 . . . . 0.0 111.688 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -68.39 -15.55 63.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.522 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.99 -53.02 0.8 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.546 -1.697 . . . . 0.0 112.571 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 38.82 91.26 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.21 2.338 . . . . 0.0 114.055 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -52.5 120.7 5.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.658 1.729 . . . . 0.0 109.888 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.83 144.38 38.92 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.173 2.189 . . . . 0.0 110.147 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.46 -31.16 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.677 0.791 . . . . 0.0 110.084 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.73 150.89 8.54 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -121.95 84.6 2.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 123.468 1.604 . . . . 0.0 107.642 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.36 151.68 36.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 111.759 -2.473 . . . . 0.0 110.554 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.93 78.78 0.16 Allowed Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.809 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -49.33 107.11 0.13 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.045 1.738 . . . . 0.0 109.034 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.5 165.07 18.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.712 2.405 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.54 -86.65 0.2 Allowed Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 105.186 -3.166 . . . . 0.0 105.186 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -93.9 -27.59 16.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.35 166.29 25.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.832 2.453 . . . . 0.0 108.548 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.6 tp -78.81 99.05 6.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -82.95 -55.64 4.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.556 0.742 . . . . 0.0 112.945 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.81 161.27 21.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.949 0.9 . . . . 0.0 109.852 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 tp -148.43 163.39 37.28 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.717 1.607 . . . . 0.0 108.672 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.57 -179.51 40.39 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.72 151.99 29.38 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.429 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 8.5 m-85 -114.84 146.33 41.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.486 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -143.11 156.39 44.79 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.347 0 C-N-CA 123.779 0.832 . . . . 0.0 111.469 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.372 0.606 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -73.97 122.92 23.35 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -99.79 118.93 37.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.825 1.65 . . . . 0.0 106.931 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.35 -176.68 4.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.675 0.671 . . . . 0.0 111.751 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.5 m -121.52 85.74 2.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 113.426 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.25 -175.84 5.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.278 1.031 . . . . 0.0 109.13 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -123.87 165.17 20.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 127.005 2.122 . . . . 0.0 107.248 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 177.75 -83.04 0.07 OUTLIER Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.832 0.742 . . . . 0.0 114.187 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.44 -24.77 0.02 OUTLIER Glycine 0 N--CA 1.469 0.848 0 CA-C-N 117.403 0.601 . . . . 0.0 112.779 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 282' ' ' LYS . 0.3 OUTLIER 61.43 21.35 11.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -83.59 -47.85 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.54 12.79 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 122.57 1.095 . . . . 0.0 113.765 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.7 m -81.44 134.53 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.219 -0.577 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.56 124.31 22.88 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.535 0.734 . . . . 0.0 110.505 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -127.05 126.9 43.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.241 1.02 . . . . 0.0 109.362 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -98.2 156.52 16.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.624 2.369 . . . . 0.0 107.278 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.28 -53.48 2.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.776 1.63 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.8 -105.7 1.85 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -165.62 166.88 17.77 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.645 1.978 . . . . 0.0 108.378 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.33 154.3 36.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.159 0.584 . . . . 0.0 110.317 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -27.74 61.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.12 140.55 2.91 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.747 2.594 . . . . 0.0 106.754 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.8 m -91.85 157.14 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.511 1.124 . . . . 0.0 110.634 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' A' ' 176' ' ' LYS . 5.7 ptpt -123.71 -21.88 5.09 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.843 1.657 . . . . 0.0 111.086 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -166.11 159.85 15.73 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.625 0.77 . . . . 0.0 110.426 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.74 147.55 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 126.982 2.113 . . . . 0.0 107.694 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -139.4 113.28 8.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.151 1.381 . . . . 0.0 108.322 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.19 133.81 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -135.86 144.53 16.37 Favored Glycine 0 C--O 1.238 0.397 0 CA-C-O 122.029 0.794 . . . . 0.0 111.815 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -126.72 171.89 10.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.285 1.434 . . . . 0.0 107.43 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.16 -171.44 12.4 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -63.43 -6.81 5.38 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.638 1.175 . . . . 0.0 113.484 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -120.04 -4.96 10.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.756 1.622 . . . . 0.0 112.859 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 125.14 -162.08 19.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.596 1.089 . . . . 0.0 111.626 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.1 mm -55.6 126.64 13.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 m -134.27 -19.73 1.92 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.62 138.18 16.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 121.174 1.806 . . . . 0.0 111.551 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.05 146.85 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.146 0.884 . . . . 0.0 109.761 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -160.45 167.23 27.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.794 1.637 . . . . 0.0 107.459 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -138.32 172.4 12.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.592 1.157 . . . . 0.0 108.11 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -126.75 124.3 39.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -132.06 167.99 18.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.458 0.572 . . . . 0.0 111.31 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -116.6 91.46 3.59 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -112.96 136.32 52.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.771 2.428 . . . . 0.0 106.14 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.16 20.32 34.95 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.947 0.784 . . . . 0.0 113.093 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.93 4.73 3.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.638 2.375 . . . . 0.0 113.723 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -91.25 -157.33 0.49 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.495 1.518 . . . . 0.0 111.055 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -125.4 73.43 1.32 Allowed 'General case' 0 C--N 1.339 0.142 0 O-C-N 120.694 -1.254 . . . . 0.0 110.924 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.2 mt -84.87 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.0 145.05 31.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -73.57 156.54 51.03 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.35 159.06 46.38 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.18 94.41 4.74 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -63.14 -22.04 66.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.381 1.072 . . . . 0.0 113.228 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.56 -179.07 16.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.925 1.726 . . . . 0.0 112.19 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.57 117.49 68.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.567 1.547 . . . . 0.0 109.523 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.8 175.16 6.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.407 2.071 . . . . 0.0 110.196 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -139.95 162.08 36.06 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.744 -1.222 . . . . 0.0 110.546 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.38 -15.28 62.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.886 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -4.24 22.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.709 2.404 . . . . 0.0 111.062 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.46 -157.63 51.67 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.328 -0.857 . . . . 0.0 111.394 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.89 172.67 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.551 1.54 . . . . 0.0 110.482 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.77 147.08 47.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 129.568 3.147 . . . . 0.0 102.827 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.25 147.36 51.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -142.94 143.98 32.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.783 1.233 . . . . 0.0 109.278 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.18 136.4 52.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.4 mt -128.13 103.29 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.861 1.664 . . . . 0.0 109.238 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.64 98.48 0.52 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -55.57 -40.17 82.57 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.49 -29.79 44.42 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 123.187 2.174 . . . . 0.0 112.891 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -89.94 -30.07 18.08 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 116.423 -1.751 . . . . 0.0 113.233 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 225' ' ' TYR . 10.9 tp10 -162.01 175.92 11.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 121.622 2.01 . . . . 0.0 111.157 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.463 ' H ' ' CD ' ' A' ' 224' ' ' GLU . 2.6 p90 -153.17 -156.16 0.67 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.537 1.135 . . . . 0.0 109.311 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 92.6 mt -116.77 102.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 101.885 -3.376 . . . . 0.0 101.885 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.1 p -81.84 -20.64 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.018 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.26 167.5 25.84 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.516 1.526 . . . . 0.0 108.284 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.43 159.08 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.073 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 172.0 13.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.922 2.089 . . . . 0.0 107.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.81 171.62 31.28 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 p -140.8 146.41 37.6 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -122.14 145.23 48.38 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.132 0.573 . . . . 0.0 110.301 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.61 161.07 36.55 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 110.325 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.52 148.91 38.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.795 1.638 . . . . 0.0 109.873 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.3 pt -115.9 142.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -87.73 99.24 11.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.56 -22.97 1.51 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.873 0.749 . . . . 0.0 113.85 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 m -141.78 155.52 45.6 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.67 -16.92 62.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.848 0.749 . . . . 0.0 112.615 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.02 -173.7 20.56 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.915 1.721 . . . . 0.0 115.689 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.6 mt -119.07 173.52 6.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.082 2.153 . . . . 0.0 110.055 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.3 tt -139.13 130.72 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.843 1.657 . . . . 0.0 108.008 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.9 mt -90.44 76.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.1 t -70.41 -8.43 50.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -141.79 137.21 31.37 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.855 0.752 . . . . 0.0 111.868 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.2 mt -142.79 137.74 29.92 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.724 1.61 . . . . 0.0 109.121 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -139.63 139.42 36.71 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.63 113.04 25.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -65.95 115.27 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.5 m -133.6 162.17 32.64 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.071 0.949 . . . . 0.0 109.23 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.16 161.67 26.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.948 2.499 . . . . 0.0 105.074 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.5 tptt 75.47 -28.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.968 1.707 . . . . 0.0 112.808 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -138.84 167.95 20.88 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.812 1.245 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 14.4 t -121.96 142.92 49.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.934 2.093 . . . . 0.0 106.005 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 p -133.13 149.29 52.1 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.951 0.901 . . . . 0.0 109.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -66.93 159.9 73.13 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.679 0.792 . . . . 0.0 111.819 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.83 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 105.51 -2.535 . . . . 0.0 105.51 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -72.97 99.23 2.66 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.72 179.75 17.77 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.04 114.46 27.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.543 1.937 . . . . 0.0 107.966 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.68 115.84 3.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 110.136 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.42 24.77 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.873 0.844 . . . . 0.0 111.68 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.68 -93.27 1.25 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 125.799 1.666 . . . . 0.0 113.629 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.4 m -149.9 127.47 11.58 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.391 1.076 . . . . 0.0 109.207 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.76 147.69 30.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.881 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -142.24 168.28 20.12 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.527 1.531 . . . . 0.0 108.072 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -151.87 156.2 39.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 109.181 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.7 mt -139.95 138.28 35.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -160.53 160.57 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 108.968 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.16 148.18 34.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 121.85 30.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.845 1.258 . . . . 0.0 109.455 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 87.78 -75.23 2.11 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -47.14 144.88 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.316 1.846 . . . . 0.0 111.486 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -117.65 161.07 20.25 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 83.4 mt -79.13 150.47 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.46 -55.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.8 -176.67 14.81 Favored Glycine 0 C--O 1.239 0.445 0 CA-C-O 122.994 1.33 . . . . 0.0 113.947 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.52 9.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.436 2.695 . . . . 0.0 111.271 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -165.31 162.69 19.85 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.016 1.726 . . . . 0.0 106.714 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.21 -136.11 5.28 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -156.69 131.03 8.63 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.33 137.67 24.55 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.8 m -152.16 -29.99 0.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.541 1.536 . . . . 0.0 112.225 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -139.23 -57.88 0.59 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.423 1.889 . . . . 0.0 111.753 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.78 165.82 22.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.139 1.375 . . . . 0.0 108.232 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.94 92.05 8.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.569 -0.707 . . . . 0.0 110.088 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.85 -48.24 7.14 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.013 0.925 . . . . 0.0 112.865 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -112.61 141.25 46.6 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.92 99.59 3.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -113.32 157.57 14.86 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.963 1.268 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.85 174.85 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.217 1.009 . . . . 0.0 113.13 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -127.97 125.93 40.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.345 2.658 . . . . 0.0 104.787 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -110.22 139.98 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.4 mtm -132.44 144.12 51.7 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.4 140.44 27.25 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.995 -1.963 . . . . 0.0 106.995 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.235 0.29 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.558 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -149.9 97.97 2.66 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.5 131.46 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.149 1.341 . . . . 0.0 108.978 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.21 163.8 21.65 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.652 0.781 . . . . 0.0 112.226 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.97 169.83 17.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.843 1.257 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.54 87.37 0.1 Allowed Glycine 0 C--O 1.225 -0.433 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.99 -167.96 20.41 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 126.585 2.041 . . . . 0.0 108.665 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.45 177.74 2.47 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 115.679 1.031 . . . . 0.0 115.679 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.43 2.99 12.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.414 1.486 . . . . 0.0 114.903 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.99 -2.31 38.03 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.245 -1.309 . . . . 0.0 116.191 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.4 172.78 14.81 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 121.041 2.421 . . . . 0.0 113.882 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.97 157.57 25.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.783 0.833 . . . . 0.0 109.339 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -71.68 84.19 0.88 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 112.698 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -93.98 149.65 21.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.23 -10.06 0.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.799 1.24 . . . . 0.0 111.779 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -54.27 131.76 42.28 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.558 1.943 . . . . 0.0 110.805 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 125.75 1.643 . . . . 0.0 110.241 179.453 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.04 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.52 140.84 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.971 1.386 . . . . 0.0 109.511 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -62.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.893 0.877 . . . . 0.0 111.993 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -145.62 164.54 31.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.197 0.999 . . . . 0.0 109.909 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 t -141.71 150.36 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 127.043 2.137 . . . . 0.0 106.337 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -136.8 134.91 37.52 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.77 147.16 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 62' ' ' PHE . . . 135.26 124.92 2.47 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.25 -4.71 10.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.179 1.792 . . . . 0.0 111.168 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.4 -73.09 0.1 OUTLIER Glycine 0 C--O 1.224 -0.522 0 C-N-CA 129.386 3.374 . . . . 0.0 114.535 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -47.84 78.63 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.065 0.946 . . . . 0.0 110.755 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.9 1.52 56.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.432 1.493 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.86 -117.47 5.13 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 121.162 -0.962 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.2 96.76 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 111.532 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -127.12 -29.21 2.79 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.9 t -68.27 159.02 32.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.119 0.872 . . . . 0.0 110.344 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 154.37 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.503 1.521 . . . . 0.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -153.09 123.03 6.92 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.927 1.291 . . . . 0.0 107.735 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.35 100.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 123.966 0.906 . . . . 0.0 108.558 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -104.79 134.29 46.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -127.32 154.63 44.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 109.735 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.27 109.94 22.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -114.67 130.01 56.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 57.16 17.94 3.84 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.845 1.202 . . . . 0.0 112.65 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . 0.325 86.0 p 71.3 23.97 3.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.71 2.404 . . . . 0.0 111.285 -176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.95 160.49 19.49 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.113 2.965 . . . . 0.0 104.871 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -105.23 118.03 35.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 m -118.67 124.55 73.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.272 1.029 . . . . 0.0 110.503 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -122.76 161.58 23.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.282 1.833 . . . . 0.0 109.752 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.77 -21.97 2.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.211 1.386 . . . . 0.0 110.05 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.0 167.72 12.52 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 128.036 2.732 . . . . 0.0 109.942 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -73.95 159.46 32.73 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 109.951 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.49 143.69 50.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.06 -143.79 16.89 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.13 115.73 18.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.785 2.834 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 151.99 24.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.214 1.37 . . . . 0.0 110.163 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -147.72 156.1 42.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 tp -77.89 -10.43 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.86 -0.525 . . . . 0.0 111.502 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.12 -5.47 27.24 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.57 96.43 0.1 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.403 ' HA ' ' HA3' ' A' ' 29' ' ' GLY . 12.3 p90 -154.19 161.83 41.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.712 1.205 . . . . 0.0 109.66 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.66 163.61 33.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 127.197 2.199 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.7 m -131.82 140.81 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.004 2.121 . . . . 0.0 107.205 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -133.07 140.75 47.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.004 1.322 . . . . 0.0 109.295 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.5 136.24 54.97 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.175 1.79 . . . . 0.0 111.478 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.48 125.8 71.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.94 164.68 26.32 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.572 -0.705 . . . . 0.0 111.634 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -11.13 15.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.476 1.511 . . . . 0.0 113.172 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -127.5 10.0 6.65 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.788 1.635 . . . . 0.0 110.885 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -97.79 152.44 19.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.151 0.887 . . . . 0.0 111.786 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.53 134.14 41.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.61 105.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.91 -55.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.7 22.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.236 1.015 . . . . 0.0 109.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.78 151.37 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -135.17 136.0 41.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.59 135.89 27.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -116.27 156.54 26.43 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -153.55 158.64 41.55 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.486 1.039 . . . . 0.0 112.516 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -162.49 168.89 21.25 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.96 0.886 . . . . 0.0 112.14 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -125.3 141.27 52.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.479 2.712 . . . . 0.0 106.646 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -123.56 159.09 28.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.28 129.19 40.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.29 2.91 51.06 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 111.557 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -138.62 127.65 23.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.028 1.731 . . . . 0.0 106.766 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -11.18 49.46 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.3 p -80.07 -175.5 5.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.916 2.486 . . . . 0.0 109.9 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.83 134.91 17.99 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.73 171.73 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 123.827 0.851 . . . . 0.0 111.729 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.8 mm -73.93 134.06 30.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 p -104.73 -30.42 9.93 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.335 0.654 . . . . 0.0 110.172 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -156.42 160.44 39.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.325 0.966 . . . . 0.0 110.214 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.6 mt -142.58 147.62 20.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 126.667 1.987 . . . . 0.0 107.351 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -150.66 137.18 18.8 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.68 115.5 22.19 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.292 1.437 . . . . 0.0 107.747 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.12 135.11 33.41 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.4 p -110.23 159.39 17.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.658 1.117 . . . . 0.0 110.809 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -77.29 -25.88 51.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 5.3 mmpt? -63.56 -11.23 22.82 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.467 1.907 . . . . 0.0 114.491 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.52 31.26 33.99 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 120.862 1.665 . . . . 0.0 110.526 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -128.95 93.59 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.561 1.144 . . . . 0.0 108.397 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -85.74 136.28 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.82 150.3 75.27 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.92 166.73 28.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.615 1.543 . . . . 0.0 108.426 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.32 99.81 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.733 2.288 . . . . 0.0 108.265 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.32 85.43 0.16 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.488 1.515 . . . . 0.0 110.173 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.23 -123.75 3.52 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 126.07 1.795 . . . . 0.0 108.867 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.2 tp -139.51 120.92 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.417 1.487 . . . . 0.0 107.719 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 151.4 21.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.03 169.56 19.66 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.735 -1.228 . . . . 0.0 110.52 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.15 -61.23 2.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.543 1.137 . . . . 0.0 111.605 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.74 127.64 32.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -174.5 173.14 2.98 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.179 0.992 . . . . 0.0 111.1 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.34 167.52 25.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.057 0.943 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.11 150.63 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.725 1.61 . . . . 0.0 108.388 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.21 154.65 42.62 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 109.067 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.85 156.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.272 2.229 . . . . 0.0 110.02 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.413 ' HB2' ' CG ' ' A' ' 143' ' ' PHE . 31.1 t0 -117.67 175.61 5.56 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.009 2.523 . . . . 0.0 109.238 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -64.89 176.96 1.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.703 2.001 . . . . 0.0 110.482 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -68.18 -17.79 64.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.942 0.897 . . . . 0.0 112.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.44 43.02 1.71 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -133.19 154.36 21.17 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -137.61 149.55 46.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.881 0.872 . . . . 0.0 109.892 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.18 133.54 49.05 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.61 -71.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -139.54 166.34 25.59 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.268 0.486 . . . . 0.0 112.022 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -125.0 120.06 30.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.415 1.886 . . . . 0.0 107.303 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 148.85 25.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.21 96.13 0.18 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 65.4 1.2 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 109.553 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.01 165.53 12.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.526 2.331 . . . . 0.0 108.448 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.22 -102.56 0.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 103.215 -3.954 . . . . 0.0 103.215 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -86.75 -9.88 54.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.605 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 170.66 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.337 2.255 . . . . 0.0 108.786 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 tp -82.18 93.86 7.16 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.797 2.039 . . . . 0.0 110.772 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.68 -39.8 11.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.28 148.91 30.98 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.325 -0.86 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -134.84 -169.51 2.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.743 2.417 . . . . 0.0 108.827 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.507 ' H ' ' CD1' ' A' ' 139' ' ' LEU . . . 144.63 172.27 15.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.439 2.447 . . . . 0.0 109.469 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.56 166.28 33.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 120.031 1.915 . . . . 0.0 111.176 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -136.98 168.96 18.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.216 1.007 . . . . 0.0 110.88 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.413 ' CG ' ' HB2' ' A' ' 119' ' ' ASP . 7.8 m-85 -134.43 97.22 3.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 117.746 -1.121 . . . . 0.0 113.041 -178.355 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -94.99 126.18 40.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.441 ' HA ' ' CE1' ' A' ' 293' ' ' HIS . 4.3 pttp -85.86 141.31 29.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.851 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.53 157.39 18.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.5 m -75.77 126.88 31.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.852 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.23 178.8 0.24 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.088 1.355 . . . . 0.0 112.161 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.68 170.68 17.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.555 1.942 . . . . 0.0 107.259 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -34.53 111.12 0.07 OUTLIER Glycine 0 CA--C 1.493 -1.282 0 C-N-CA 125.859 1.695 . . . . 0.0 113.335 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 164.36 121.66 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 O-C-N 125.471 1.336 . . . . 0.0 113.209 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -146.67 3.43 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -119.76 111.77 18.42 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 110.168 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.56 162.64 10.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.857 1.218 . . . . 0.0 111.633 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.1 t -81.56 141.31 33.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.77 28.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -141.63 17.89 2.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.707 1.603 . . . . 0.0 110.87 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -43.12 127.08 4.21 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.221 2.208 . . . . 0.0 111.746 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.38 -7.83 58.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 77.62 -98.58 1.42 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 104.302 -3.519 . . . . 0.0 104.302 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.99 159.79 29.89 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.338 1.855 . . . . 0.0 107.425 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -131.56 179.54 5.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.832 2.053 . . . . 0.0 107.31 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.98 -44.09 97.86 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.7 160.58 30.8 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-O 122.177 0.876 . . . . 0.0 111.662 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.8 156.36 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 127.614 2.365 . . . . 0.0 105.342 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -138.42 -41.09 0.51 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.935 0.789 . . . . 0.0 112.911 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -133.65 140.91 47.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.339 -0.85 . . . . 0.0 110.871 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.53 120.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.02 112.66 24.63 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.62 128.28 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.83 97.9 0.65 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.529 1.538 . . . . 0.0 110.355 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -89.85 177.39 6.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 123.075 1.417 . . . . 0.0 111.798 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.25 -165.84 11.55 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 129.731 3.539 . . . . 0.0 106.924 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.8 -46.99 15.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.011 -0.699 . . . . 0.0 111.843 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.77 -31.87 25.7 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.079 1.351 . . . . 0.0 113.017 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.2 25.01 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.33 149.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.926 0.89 . . . . 0.0 109.657 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 p -132.29 -40.59 1.01 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.93 0.892 . . . . 0.0 110.228 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.0 165.07 20.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.746 1.218 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.05 124.61 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.02 90.34 0.68 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.862 0.756 . . . . 0.0 110.76 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -92.93 174.34 7.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.23 0.612 . . . . 0.0 110.505 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.13 140.96 47.46 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.17 168.31 20.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.742 1.617 . . . . 0.0 110.867 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -112.41 155.84 23.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.403 1.081 . . . . 0.0 110.478 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -139.83 115.31 9.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.56 -89.45 0.29 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -147.48 24.28 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.898 1.679 . . . . 0.0 109.773 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -126.17 142.24 51.61 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.35 141.01 40.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.619 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.3 mm -121.88 132.07 71.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.46 135.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.256 1.022 . . . . 0.0 108.749 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.01 -131.34 3.29 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.94 -8.78 61.99 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.373 1.94 . . . . 0.0 113.592 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 125.44 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.789 1.295 . . . . 0.0 107.823 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -136.92 -50.23 0.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.305 0.642 . . . . 0.0 109.495 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.41 -179.44 50.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.869 1.223 . . . . 0.0 113.595 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.28 105.44 4.11 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 126.649 1.979 . . . . 0.0 108.886 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.63 177.51 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.825 1.683 . . . . 0.0 108.008 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -121.77 150.86 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.2 -12.66 42.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.257 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.9 tt -51.85 -34.4 40.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.039 2.536 . . . . 0.0 110.788 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.27 -155.89 15.93 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -143.53 128.34 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.19 151.06 25.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -135.36 152.56 51.55 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.538 0.608 . . . . 0.0 112.428 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -142.24 127.03 18.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.96 115.9 31.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mm -127.67 105.05 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -51.18 117.21 2.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -46.27 -63.66 1.24 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.708 2.003 . . . . 0.0 113.519 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 -32.43 5.42 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.231 1.832 . . . . 0.0 115.822 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 m -77.59 -19.69 55.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.16 170.24 16.22 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.409 1.004 . . . . 0.0 109.889 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -149.78 108.33 3.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.649 1.179 . . . . 0.0 108.072 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.03 108.29 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -31.46 19.9 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.23 25.36 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.176 1.353 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.05 149.81 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.943 1.297 . . . . 0.0 108.239 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -132.37 177.2 7.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 130.042 3.337 . . . . 0.0 106.421 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 151.68 -176.27 30.13 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 120.683 -1.261 . . . . 0.0 110.94 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 p -147.21 155.31 41.98 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.556 1.142 . . . . 0.0 108.231 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.56 165.12 26.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.434 1.494 . . . . 0.0 108.344 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.74 168.04 25.58 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.556 0.693 . . . . 0.0 111.177 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -69.06 149.1 49.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.963 2.105 . . . . 0.0 108.826 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.0 155.36 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.749 1.619 . . . . 0.0 109.394 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.08 88.48 2.74 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 167.48 -25.7 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 15.7 m -132.52 170.67 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.102 0.953 . . . . 0.0 110.419 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -108.82 86.8 2.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.61 -146.19 11.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.661 1.6 . . . . 0.0 109.844 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.97 156.05 47.53 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.4 1.48 . . . . 0.0 108.492 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.9 tt -113.23 149.18 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.29 1.436 . . . . 0.0 109.011 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.0 mm -77.37 137.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -129.63 -35.13 1.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.013 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.5 ttt -126.55 146.65 50.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.044 0.838 . . . . 0.0 110.836 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -140.0 147.83 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.428 1.491 . . . . 0.0 109.301 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -149.21 154.92 39.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -141.72 122.4 14.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -65.15 152.12 44.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.0 p -143.15 154.46 43.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.4 158.99 15.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 67.84 -34.37 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.507 1.923 . . . . 0.0 113.794 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -141.33 174.17 10.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.697 1.999 . . . . 0.0 109.448 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.5 p -114.44 162.71 16.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.085 1.354 . . . . 0.0 110.009 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 3.6 p -98.99 177.56 5.21 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.231 1.413 . . . . 0.0 110.646 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.22 157.28 41.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.372 1.469 . . . . 0.0 109.206 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.19 99.14 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.853 2.369 . . . . 0.0 108.402 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -82.84 92.51 7.28 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 126.24 -164.77 19.69 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.942 1.258 . . . . 0.0 111.051 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.7 tp -118.88 130.09 55.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.186 1.394 . . . . 0.0 109.542 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -70.99 120.71 16.96 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.2 -178.8 7.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.239 1.416 . . . . 0.0 109.392 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 49.34 -103.59 0.08 OUTLIER Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.253 1.882 . . . . 0.0 113.417 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 16.8 m -147.98 145.42 28.54 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.701 1.201 . . . . 0.0 108.692 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.66 26.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -141.34 151.03 43.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.537 1.535 . . . . 0.0 109.557 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.91 155.44 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.335 1.054 . . . . 0.0 110.962 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 42.9 mt -143.4 119.28 10.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.65 1.18 . . . . 0.0 109.354 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -139.31 170.99 14.93 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.237 0.615 . . . . 0.0 111.795 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.93 170.79 15.47 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.927 2.491 . . . . 0.0 107.638 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.7 125.2 47.05 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.71 77.86 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.527 1.061 . . . . 0.0 115.097 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -135.18 175.63 9.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.049 1.424 . . . . 0.0 111.924 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.01 161.94 36.66 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.486 1.514 . . . . 0.0 109.742 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 91.4 mt -74.24 144.02 12.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.9 2.33 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.182 0.993 . . . . 0.0 112.565 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.0 179.03 26.39 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 120.898 -1.126 . . . . 0.0 112.401 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.22 160.52 18.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.661 2.385 . . . . 0.0 108.344 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . 0.562 ' CD2' ' HD1' ' A' ' 293' ' ' HIS . 12.1 p80 -151.67 106.54 3.26 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -160.48 -147.41 4.92 Favored Glycine 0 C--O 1.237 0.29 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.12 126.04 8.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.68 134.58 13.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.164 0.986 . . . . 0.0 109.2 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.7 t -133.9 -68.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -95.51 -32.86 12.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.172 0.989 . . . . 0.0 111.75 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.4 mp -135.9 175.14 9.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 108.895 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.55 99.92 6.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.888 1.275 . . . . 0.0 109.431 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.35 -65.65 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.37 115.85 7.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.688 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.11 160.8 39.12 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.696 0.798 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 161.43 -167.32 36.24 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 12.5 m -152.3 153.5 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.499 1.119 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . 0.562 ' HD1' ' CD2' ' A' ' 280' ' ' HIS . 0.1 OUTLIER -94.19 167.76 11.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.07 143.99 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 66.1 mtp -139.46 140.88 26.85 Favored Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.61 139.51 76.08 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 110.067 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.912 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -41.84 106.6 0.06 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.067 1.747 . . . . 0.0 111.363 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.22 146.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.67 144.32 14.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.919 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.22 151.28 31.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.89 13.77 17.05 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.739 -0.601 . . . . 0.0 112.175 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.27 102.9 0.21 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 126.508 2.004 . . . . 0.0 112.557 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.93 -19.33 2.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 116.907 1.523 . . . . 0.0 116.907 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.55 -13.93 59.59 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.676 1.59 . . . . 0.0 109.966 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.74 43.19 19.06 Favored Glycine 0 N--CA 1.416 -2.658 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.251 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 -107.5 0.16 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.6 159.23 43.44 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.628 1.171 . . . . 0.0 110.628 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -93.52 129.95 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.574 -1.328 . . . . 0.0 108.481 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -93.25 -13.43 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.479 0.712 . . . . 0.0 109.857 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.01 103.48 0.74 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.044 0.937 . . . . 0.0 110.179 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.71 -54.53 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.431 178.801 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.26 150.57 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.58 1.152 . . . . 0.0 108.8 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -126.23 -45.38 1.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -143.16 161.88 37.05 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.207 1.403 . . . . 0.0 107.314 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.43 151.17 22.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -131.65 139.83 49.2 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.7 t -150.58 144.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.83 146.47 9.41 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -58.46 146.52 34.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 110.303 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.37 -116.33 2.71 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.99 1.281 . . . . 0.0 110.712 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -87.21 -49.15 7.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.766 0.783 . . . . 0.0 111.941 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -126.42 -26.02 3.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.376 1.071 . . . . 0.0 110.259 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.27 176.35 27.13 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.497 1.523 . . . . 0.0 111.183 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.2 m -58.44 96.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 126.437 1.895 . . . . 0.0 111.612 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 t -87.42 -50.7 6.38 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.295 1.038 . . . . 0.0 111.371 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 p -66.81 119.96 12.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.706 1.139 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.64 158.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 108.064 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -166.5 141.86 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.937 1.295 . . . . 0.0 108.467 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.1 95.92 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.726 1.211 . . . . 0.0 108.37 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.63 130.27 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -100.81 131.98 46.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 109.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -114.87 115.89 27.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.33 34.76 24.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.967 0.907 . . . . 0.0 108.743 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t 72.54 -1.23 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.198 2.199 . . . . 0.0 112.481 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.08 144.56 28.16 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.838 1.199 . . . . 0.0 109.655 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.97 126.51 34.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.76 109.14 14.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -111.62 162.2 15.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.566 1.547 . . . . 0.0 111.954 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.6 57.43 0.09 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.83 -1.6 0.19 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.881 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.514 ' OE2' ' HE2' ' A' ' 57' ' ' LYS . 1.7 tt0 -73.51 112.16 9.33 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.512 1.656 . . . . 0.0 106.816 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -137.18 167.18 22.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.527 1.531 . . . . 0.0 107.286 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.5 -179.01 20.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -82.86 98.08 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.046 -1.267 . . . . 0.0 109.165 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HE2' ' OE2' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -83.53 163.1 20.65 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -132.08 172.76 11.98 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.595 1.158 . . . . 0.0 109.844 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 tp -89.79 -47.28 8.01 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.287 1.035 . . . . 0.0 111.689 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.01 75.21 1.02 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.93 -34.76 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 128.5 33.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.811 1.245 . . . . 0.0 111.125 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -143.69 163.83 32.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.337 1.855 . . . . 0.0 107.563 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.2 m -126.85 146.27 50.34 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.6 1.16 . . . . 0.0 108.654 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -129.04 140.94 51.4 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 126.057 1.743 . . . . 0.0 106.905 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.1 146.94 50.93 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.405 1.082 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.36 157.82 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.97 168.04 13.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.743 1.61 . . . . 0.0 112.087 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.51 -27.15 25.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.478 1.511 . . . . 0.0 110.483 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -121.02 5.96 10.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.924 0.784 . . . . 0.0 112.84 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -116.64 156.17 27.51 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.77 -176.78 4.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.38 136.17 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.9 m -113.89 -36.0 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.734 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.32 160.39 43.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.257 0.935 . . . . 0.0 110.206 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -146.05 110.03 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -80.73 134.46 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -132.43 122.95 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.464 1.106 . . . . 0.0 108.32 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.405 ' OG1' ' HE3' ' A' ' 114' ' ' LYS . 30.4 m -118.31 145.26 45.22 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.965 1.706 . . . . 0.0 106.477 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -149.93 168.11 24.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.536 1.134 . . . . 0.0 111.212 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -161.18 158.82 28.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.333 1.053 . . . . 0.0 108.946 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.86 135.1 24.12 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.489 1.116 . . . . 0.0 108.646 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -72.33 154.19 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.785 0.721 . . . . 0.0 109.975 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -61.67 -14.62 32.82 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.49 -7.89 41.71 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.403 -1.221 . . . . 0.0 113.762 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -135.27 105.53 6.33 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.207 1.503 . . . . 0.0 107.584 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -58.65 -24.61 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.913 1.685 . . . . 0.0 115.18 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 p -72.8 122.31 21.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.932 1.293 . . . . 0.0 109.178 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.93 164.17 16.7 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 126.331 1.853 . . . . 0.0 109.173 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.75 149.9 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.07 -1.019 . . . . 0.0 108.38 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.0 128.1 32.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 p -95.81 -39.19 9.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.994 -1.479 . . . . 0.0 108.268 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 m -160.1 152.34 20.65 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.9 1.682 . . . . 0.0 111.108 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.4 mm -132.95 139.03 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.0 m -130.17 112.58 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -82.03 155.43 25.15 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.959 0.904 . . . . 0.0 109.783 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.75 113.73 7.24 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 106.927 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 p -90.43 170.6 10.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.638 0.654 . . . . 0.0 111.182 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -60.81 -36.25 78.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -6.67 56.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.24 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 15.8 39.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.227 -1.319 . . . . 0.0 111.28 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -71.72 101.76 2.64 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -93.44 140.11 29.95 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 p -92.7 160.95 33.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.02 160.55 49.24 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 N-CA-C 105.41 -2.573 . . . . 0.0 105.41 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.64 89.0 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.753 2.302 . . . . 0.0 107.529 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -58.83 104.23 0.22 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.633 0.773 . . . . 0.0 109.125 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.78 -145.04 16.56 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.4 111.9 12.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.395 1.478 . . . . 0.0 108.154 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -46.81 139.46 5.39 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.227 1.811 . . . . 0.0 113.948 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 178.45 7.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.254 1.422 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.33 -53.17 5.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.035 1.734 . . . . 0.0 114.066 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -65.15 108.08 1.75 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.689 1.131 . . . . 0.0 108.863 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.405 ' HE3' ' OG1' ' A' ' 79' ' ' THR . 6.1 ptmt -152.91 168.76 24.72 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 123.099 0.56 . . . . 0.0 111.318 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.31 166.99 31.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 106.994 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.46 122.06 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -100.42 133.62 44.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.0 167.89 28.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.869 0.868 . . . . 0.0 111.282 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.65 168.07 10.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.694 1.197 . . . . 0.0 107.938 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.38 -27.26 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.365 2.666 . . . . 0.0 109.648 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.79 -5.47 46.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.581 2.752 . . . . 0.0 111.838 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.67 9.98 48.3 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.605 1.098 . . . . 0.0 113.153 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.01 85.98 0.89 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 124.951 1.263 . . . . 0.0 110.569 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -59.65 142.46 52.9 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.45 128.19 35.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.07 -50.54 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.54 -151.22 6.71 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.087 1.327 . . . . 0.0 109.804 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.57 169.22 18.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.165 1.483 . . . . 0.0 113.16 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -138.6 166.41 24.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.602 1.961 . . . . 0.0 106.941 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.14 125.58 2.97 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.7 -178.44 4.39 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.351 -1.088 . . . . 0.0 108.926 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -125.9 158.79 34.26 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.391 2.276 . . . . 0.0 105.993 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -116.56 -83.83 1.04 Allowed Glycine 0 CA--C 1.51 -0.271 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -107.77 -14.21 14.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.573 0.749 . . . . 0.0 110.506 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -155.43 174.2 15.58 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.883 2.473 . . . . 0.0 107.604 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 tp -75.77 131.88 40.09 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.23 0.612 . . . . 0.0 109.48 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -138.45 -55.67 0.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.478 1.911 . . . . 0.0 109.47 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -107.3 108.13 19.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.4 tp -130.78 142.05 50.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.11 -178.18 35.78 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 127.11 2.29 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.04 137.48 15.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.767 1.283 . . . . 0.0 110.38 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -81.42 141.43 33.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.878 1.271 . . . . 0.0 107.835 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -137.04 127.3 26.36 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 0 CA-C-N 118.636 0.653 . . . . 0.0 110.565 179.663 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.382 0.61 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -73.96 107.79 6.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -83.56 119.61 24.93 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.249 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.4 mt -78.41 -94.24 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -155.51 166.1 34.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.921 1.288 . . . . 0.0 109.826 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -147.27 -178.18 6.08 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 130.148 3.379 . . . . 0.0 107.706 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.46 141.86 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.31 1.414 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.12 -105.64 3.22 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.75 64.5 4.15 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.415 1.007 . . . . 0.0 111.172 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 288' ' ' HIS . 0.7 OUTLIER -76.01 57.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.224 2.21 . . . . 0.0 114.368 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 53.19 20.53 1.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.549 1.94 . . . . 0.0 114.912 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 168.94 33.0 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.8 m -65.43 116.77 7.07 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.844 1.657 . . . . 0.0 109.264 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.75 154.63 40.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.676 0.79 . . . . 0.0 110.44 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -138.39 120.67 15.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.29 104.95 17.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -107.66 93.06 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.558 1.143 . . . . 0.0 108.198 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.35 162.7 32.44 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.61 155.03 34.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 117.611 0.705 . . . . 0.0 110.393 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -112.99 167.61 10.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.431 1.11 . . . . 0.0 112.057 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 -15.76 57.61 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.189 2.196 . . . . 0.0 110.282 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 165.94 149.51 5.94 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.582 2.039 . . . . 0.0 108.063 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.99 129.56 44.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.44 -53.78 6.56 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -158.81 143.55 15.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.67 0.668 . . . . 0.0 110.086 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.96 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.95 158.01 44.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.983 1.313 . . . . 0.0 107.621 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.0 t -143.57 142.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.13 82.13 0.35 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 124.788 1.185 . . . . 0.0 112.683 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -70.89 177.26 3.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.908 1.283 . . . . 0.0 110.339 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.85 -174.24 20.98 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -63.7 -25.09 68.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -122.71 -21.07 5.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.266 1.427 . . . . 0.0 113.833 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 172.3 -178.78 44.28 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 119.53 1.059 . . . . 0.0 111.723 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.5 mm -59.13 115.84 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.476 1.11 . . . . 0.0 109.676 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.5 m -93.83 -35.67 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.415 0.686 . . . . 0.0 111.923 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.65 166.81 23.81 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.6 150.92 30.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.788 1.635 . . . . 0.0 107.015 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.581 ' HE2' ' CE2' ' A' ' 214' ' ' PHE . 0.1 OUTLIER 179.82 150.59 0.36 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.435 3.494 . . . . 0.0 106.594 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -153.78 152.22 30.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.561 1.073 . . . . 0.0 108.131 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -94.42 132.41 39.09 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -138.24 169.03 18.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.253 1.021 . . . . 0.0 111.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -119.8 139.13 52.81 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.075 1.35 . . . . 0.0 109.533 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -140.2 76.16 1.54 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.69 -128.03 46.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.99 10.39 0.55 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.156 1.382 . . . . 0.0 114.066 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.37 140.69 52.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.447 1.476 . . . . 0.0 109.247 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.07 89.35 2.85 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.9 mm -70.09 109.29 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 108.82 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.0 t -125.44 94.89 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.193 1.797 . . . . 0.0 106.241 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 125.6 176.4 14.52 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.438 1.494 . . . . 0.0 113.64 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.91 75.27 1.0 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.275 1.893 . . . . 0.0 110.281 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 191' ' ' LYS . 2.1 mp0 -63.87 155.92 29.13 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.625 -0.926 . . . . 0.0 112.33 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.6 -80.12 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.64 162.0 50.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -53.56 116.49 9.93 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 113.567 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 144.06 71.67 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.731 1.621 . . . . 0.0 108.339 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.94 135.3 42.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.488 1.115 . . . . 0.0 110.667 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 -11.09 60.55 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.094 0.558 . . . . 0.0 111.525 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.67 -31.28 69.41 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.209 1.404 . . . . 0.0 109.783 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.39 -171.43 14.63 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.581 ' CE2' ' HE2' ' A' ' 191' ' ' LYS . 13.3 m-85 -136.05 158.81 43.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -111.4 148.06 33.86 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.37 144.35 49.54 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.526 0.516 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 256' ' ' SER . 31.5 t80 -142.88 142.96 31.87 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.68 0.792 . . . . 0.0 110.959 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -92.32 124.68 36.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.409 1.484 . . . . 0.0 108.871 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.67 112.07 29.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.175 0.99 . . . . 0.0 108.749 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.06 88.48 7.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -62.63 -29.55 4.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 115.778 -2.058 . . . . 0.0 113.644 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.12 -45.01 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 123.902 2.429 . . . . 0.0 110.88 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 m -67.03 -54.0 25.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.997 1.319 . . . . 0.0 111.865 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.71 -167.66 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.599 1.96 . . . . 0.0 110.631 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -164.11 142.14 7.18 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.508 1.123 . . . . 0.0 108.976 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.7 mm -93.48 104.18 15.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.3 p -72.92 -59.76 2.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.096 0.959 . . . . 0.0 110.33 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.41 171.72 13.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.647 1.979 . . . . 0.0 111.529 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.78 148.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.39 1.876 . . . . 0.0 106.865 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -133.59 160.85 36.27 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.497 1.119 . . . . 0.0 109.997 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.78 167.37 37.69 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.671 1.129 . . . . 0.0 110.998 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.5 p -133.39 127.19 32.91 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -119.76 146.19 45.88 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -142.61 166.91 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -76.94 136.3 38.79 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.758 1.223 . . . . 0.0 112.824 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.66 156.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 127.426 2.29 . . . . 0.0 108.252 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -103.5 163.75 12.09 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.78 1.232 . . . . 0.0 111.16 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.11 -15.94 56.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.246 1.403 . . . . 0.0 110.347 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.7 t -141.45 -174.38 4.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 128.248 2.619 . . . . 0.0 106.618 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.92 101.82 5.79 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.557 1.943 . . . . 0.0 106.856 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 174.32 -173.37 45.98 Favored Glycine 0 N--CA 1.447 -0.622 0 O-C-N 123.645 0.591 . . . . 0.0 112.451 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.82 141.37 52.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.083 1.353 . . . . 0.0 109.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 10.3 tt -123.72 134.17 67.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.6 1.16 . . . . 0.0 108.773 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.06 98.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -76.0 -26.5 56.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.023 0.529 . . . . 0.0 111.766 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -140.99 152.37 44.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.083 0.856 . . . . 0.0 110.815 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.4 154.65 51.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.468 1.907 . . . . 0.0 109.965 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -145.05 152.52 40.24 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.992 2.117 . . . . 0.0 105.688 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -118.07 142.53 47.31 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -95.61 115.42 27.4 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.2 p -130.49 166.49 20.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.391 1.476 . . . . 0.0 108.776 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 254' ' ' GLN . 1.1 p30 -123.54 160.09 27.75 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.993 1.717 . . . . 0.0 106.552 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 69.35 -27.6 0.16 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.114 2.566 . . . . 0.0 112.191 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 252' ' ' ASN . 16.8 pt20 -150.88 174.83 12.65 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.23 2.212 . . . . 0.0 110.229 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.77 161.02 32.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.579 1.952 . . . . 0.0 106.914 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' SER . . . . . 0.404 ' HB3' ' CE2' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -115.29 -10.99 12.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 73.15 162.66 0.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 126.908 2.083 . . . . 0.0 109.522 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.28 149.0 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.438 2.092 . . . . 0.0 110.551 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.17 95.72 4.86 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 125.43 -176.99 17.15 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.275 1.416 . . . . 0.0 110.789 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.6 tp -88.18 126.83 35.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.353 1.061 . . . . 0.0 110.165 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -73.12 107.17 5.31 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -160.22 154.79 23.91 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 107.987 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 88.1 -174.82 44.27 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.9 m -77.33 138.47 39.36 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -92.14 142.81 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.317 0.508 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -138.74 147.88 43.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.767 0.827 . . . . 0.0 111.344 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.31 144.29 34.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.23 1.412 . . . . 0.0 109.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 mt -134.22 137.3 44.27 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -150.04 178.27 9.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.174 1.789 . . . . 0.0 108.905 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 164.83 29.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.22 1.01 . . . . 0.0 108.566 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -69.84 5.37 1.55 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.302 1.841 . . . . 0.0 114.354 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 166.45 -34.69 0.23 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.389 -1.444 . . . . 0.0 113.324 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -57.01 149.98 17.88 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.768 0.784 . . . . 0.0 109.331 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 157.47 16.85 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.623 -0.673 . . . . 0.0 110.041 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.6 mt -95.91 104.2 15.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.45 38.81 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.989 1.316 . . . . 0.0 108.548 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.44 168.03 36.57 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 121.166 -0.959 . . . . 0.0 114.477 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.11 171.23 14.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.335 3.054 . . . . 0.0 109.946 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -159.48 146.64 16.87 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.812 1.245 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -179.55 -163.64 30.68 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 121.217 -0.927 . . . . 0.0 113.423 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -146.68 138.97 24.88 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.822 1.649 . . . . 0.0 107.765 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -131.86 154.39 49.23 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.184 1.793 . . . . 0.0 110.055 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.3 m -166.39 -46.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.951 1.3 . . . . 0.0 108.691 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.13 -17.63 1.36 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -171.4 2.01 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.496 1.919 . . . . 0.0 106.617 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 13.3 tp -83.21 85.58 7.18 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 162' ' ' ASP . 87.6 m-70 -60.44 -34.79 74.49 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.264 0.483 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -161.47 163.33 30.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.642 0.734 . . . . 0.0 110.245 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -159.52 135.45 8.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -143.13 -157.71 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 128.538 2.97 . . . . 0.0 108.715 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.73 171.59 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.281 1.039 . . . . 0.0 112.139 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.76 150.16 51.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.874 2.869 . . . . 0.0 105.354 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.25 137.79 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.324 0.65 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 16.2 mmt -125.38 148.24 60.47 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.431 1.492 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 152.62 37.22 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.631 1.554 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.036 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.455 0.645 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -81.15 130.54 35.07 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 102.633 -3.099 . . . . 0.0 102.633 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.51 103.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.687 0.795 . . . . 0.0 110.02 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -55.85 142.7 34.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.49 1.116 . . . . 0.0 110.987 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.63 179.97 1.95 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.857 1.263 . . . . 0.0 110.161 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 143.81 14.48 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.77 -134.13 5.48 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.98 -148.97 18.66 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 118.0 0.9 . . . . 0.0 111.816 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.11 8.32 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.389 1.076 . . . . 0.0 112.168 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.93 -11.51 18.1 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.089 1.595 . . . . 0.0 117.089 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.45 169.21 12.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.648 2.224 . . . . 0.0 113.766 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.55 151.7 32.32 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 97.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.923 0.783 . . . . 0.0 112.736 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -103.56 55.05 0.74 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.11 18.61 19.82 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.198 1.399 . . . . 0.0 111.981 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -151.64 119.31 6.1 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.665 0.786 . . . . 0.0 110.602 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 C-N-CA 125.865 1.697 . . . . 0.0 115.352 179.174 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 m -63.2 158.64 3.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 117.853 0.827 . . . . 0.0 109.207 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -136.09 -35.7 0.76 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -147.14 157.51 43.63 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 107.691 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.0 105.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -88.02 140.61 29.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.82 143.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.9 152.54 21.5 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.813 0.733 . . . . 0.0 111.335 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -70.2 120.04 15.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.216 1.406 . . . . 0.0 112.611 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.68 -122.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 130.575 3.94 . . . . 0.0 107.876 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -95.23 -48.35 5.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 118.163 0.982 . . . . 0.0 112.256 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 -26.88 12.14 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 129.109 2.963 . . . . 0.0 114.676 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.42 -158.05 16.7 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 118.897 0.771 . . . . 0.0 111.381 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 m -72.7 96.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.61 1.205 . . . . 0.0 108.846 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -106.63 -45.09 4.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -71.02 148.31 47.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.291 1.405 . . . . 0.0 112.117 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.9 159.68 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.431 1.892 . . . . 0.0 108.091 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.05 152.35 46.15 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.882 2.473 . . . . 0.0 107.458 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.52 132.06 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.658 0.783 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.6 142.96 42.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -132.76 141.38 48.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.347 0.659 . . . . 0.0 109.362 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.25 120.41 40.35 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.086 1.354 . . . . 0.0 108.751 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -113.46 161.99 16.66 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.9 -41.92 92.71 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.2 t -68.81 -69.39 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.491 -1.243 . . . . 0.0 110.574 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -145.31 165.84 27.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 120.239 1.381 . . . . 0.0 113.677 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.49 149.55 33.13 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.777 2.031 . . . . 0.0 105.804 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -147.71 145.73 18.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 122.754 1.264 . . . . 0.0 109.277 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -105.97 162.13 13.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.375 1.47 . . . . 0.0 108.688 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.63 -15.08 2.02 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 0.0 112.09 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.78 167.03 36.22 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 118.7 1.25 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -103.62 106.39 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.32 82.23 2.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.85 -174.61 31.95 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 128.7 3.048 . . . . 0.0 105.676 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -126.78 141.05 51.94 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.286 1.043 . . . . 0.0 111.908 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -130.56 148.84 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.397 2.279 . . . . 0.0 105.149 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.5 m -133.85 -48.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.2 tp -70.05 -9.99 57.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.149 0.886 . . . . 0.0 110.494 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt 66.33 11.48 7.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.209 2.203 . . . . 0.0 112.175 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.34 86.33 1.36 Allowed Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.975 -2.45 . . . . 0.0 106.975 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -131.46 144.68 51.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.505 1.922 . . . . 0.0 108.555 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -142.78 164.69 29.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.041 1.736 . . . . 0.0 110.465 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -124.88 121.22 33.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.356 1.062 . . . . 0.0 113.55 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -87.35 141.83 28.34 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.95 141.21 50.89 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.518 1.127 . . . . 0.0 109.69 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.64 117.44 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.507 1.123 . . . . 0.0 111.538 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -62.1 156.56 21.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.781 1.633 . . . . 0.0 108.591 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.33 68.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.87 25.33 10.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.37 143.06 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.19 1.396 . . . . 0.0 111.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.94 139.74 46.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.356 2.663 . . . . 0.0 110.593 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.19 134.19 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.711 1.604 . . . . 0.0 112.332 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.0 -34.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.948 -1.095 . . . . 0.0 112.1 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.63 144.35 28.34 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.432 1.015 . . . . 0.0 108.64 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.57 92.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -79.34 120.91 24.45 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.77 132.61 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 t -110.55 153.72 24.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.979 1.711 . . . . 0.0 109.227 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -154.12 147.33 24.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.841 1.656 . . . . 0.0 109.392 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.2 169.33 22.46 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.821 0.737 . . . . 0.0 111.155 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.07 136.16 34.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.967 1.307 . . . . 0.0 109.756 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.22 130.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -61.78 114.84 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.3 41.99 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.113 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -130.49 161.47 31.38 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.192 1.496 . . . . 0.0 109.754 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -96.35 -26.48 15.35 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.768 1.227 . . . . 0.0 110.062 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 p -72.59 166.86 21.9 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.48 1.133 . . . . 0.0 109.022 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.52 135.21 42.2 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.46 166.89 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.354 1.062 . . . . 0.0 112.647 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.63 144.03 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.077 1.751 . . . . 0.0 107.445 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -108.61 -29.05 8.94 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.085 0.954 . . . . 0.0 110.849 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -166.36 164.09 17.46 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.948 1.699 . . . . 0.0 108.933 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.1 tt -157.12 154.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.999 1.319 . . . . 0.0 110.73 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 m -150.84 157.28 42.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.478 1.511 . . . . 0.0 107.235 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.86 135.33 48.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -121.33 114.05 20.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 p -81.07 161.19 24.27 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -31.12 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -58.8 -43.07 90.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 111.345 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.97 -7.4 3.8 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.814 0.721 . . . . 0.0 114.383 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.19 132.4 36.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -133.7 156.37 48.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 p -121.24 162.34 36.21 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 111.386 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.28 167.06 23.65 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.885 2.39 . . . . 0.0 110.483 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.12 112.65 3.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.663 2.909 . . . . 0.0 106.618 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -79.19 81.52 5.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.69 -138.13 9.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.372 0.987 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -129.9 121.36 26.5 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.514 1.526 . . . . 0.0 108.334 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.53 156.11 17.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.05 0.54 . . . . 0.0 110.485 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -152.7 -174.5 4.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.692 1.234 . . . . 0.0 112.683 -178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.401 ' H ' HG22 ' A' ' 111' ' ' THR . 14.1 tt0 -67.47 -64.72 0.8 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 127.219 2.208 . . . . 0.0 112.257 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -70.98 101.83 2.27 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.432 1.493 . . . . 0.0 108.633 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -147.8 153.48 39.24 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.657 -0.652 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -125.52 158.94 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.686 1.594 . . . . 0.0 109.857 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.9 t -140.46 104.67 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 139.45 53.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.69 150.69 1.76 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.944 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -120.97 176.2 5.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.559 1.144 . . . . 0.0 110.49 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -65.27 175.8 1.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.153 2.181 . . . . 0.0 108.092 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -68.38 2.43 2.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.315 1.446 . . . . 0.0 111.743 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.45 3.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.08 2.276 . . . . 0.0 111.159 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.52 165.49 31.46 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 118.248 1.024 . . . . 0.0 111.059 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -161.9 164.69 28.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.62 1.968 . . . . 0.0 107.569 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.3 158.77 11.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.965 0.888 . . . . 0.0 110.991 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.87 -25.29 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.509 2.724 . . . . 0.0 110.722 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.38 -176.27 40.31 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.08 170.59 9.39 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.62 0.724 . . . . 0.0 109.236 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -156.41 170.13 23.01 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 126.825 2.05 . . . . 0.0 107.181 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.67 -146.42 14.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -159.47 135.68 8.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.734 2.414 . . . . 0.0 106.009 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.52 164.86 38.05 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.097 2.559 . . . . 0.0 105.298 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.36 -111.91 0.26 Allowed Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 106.616 -2.594 . . . . 0.0 106.616 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -65.06 -17.83 64.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.46 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.9 175.47 12.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.749 2.02 . . . . 0.0 108.524 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.1 tp -84.8 121.48 27.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.281 1.832 . . . . 0.0 107.341 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -117.16 -31.25 5.4 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -168.74 161.72 11.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.845 1.657 . . . . 0.0 110.353 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 tt -157.68 149.14 21.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.85 168.17 37.57 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.85 134.53 35.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.43 169.23 10.21 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.272 1.429 . . . . 0.0 109.563 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -131.17 112.11 12.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.183 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 -178.729 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.688 0.28 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.12 125.28 29.62 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -111.28 146.79 36.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.778 0.717 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.78 170.84 13.73 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.5 t -87.78 118.86 27.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.271 1.028 . . . . 0.0 110.757 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.62 170.0 12.97 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.199 0.999 . . . . 0.0 111.422 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.9 mt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 129.898 3.279 . . . . 0.0 105.256 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.56 -96.05 0.16 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.593 1.088 . . . . 0.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.77 153.61 24.37 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.08 8.79 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.965 1.306 . . . . 0.0 114.192 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -122.29 106.33 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 120.965 -1.084 . . . . 0.0 110.938 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 172.43 158.11 15.86 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.1 m -66.51 119.1 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.146 0.978 . . . . 0.0 108.43 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.57 130.94 41.11 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -123.17 125.91 46.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.61 153.83 17.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.127 0.971 . . . . 0.0 110.745 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.01 135.14 19.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.48 169.74 22.71 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.48 146.62 50.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -114.75 151.37 33.86 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.97 -15.08 54.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.12 2.568 . . . . 0.0 112.179 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 177.13 177.5 46.1 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 123.793 0.711 . . . . 0.0 111.91 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.88 156.46 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.543 1.937 . . . . 0.0 107.046 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -138.38 -54.1 0.62 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.862 0.865 . . . . 0.0 109.118 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -151.23 142.46 23.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.12 0.873 . . . . 0.0 111.57 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.71 132.75 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.33 108.49 7.24 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.34 131.79 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.44 67.27 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.164 1.364 . . . . 0.0 111.562 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 182' ' ' GLN . 2.8 pm0 -70.01 160.94 31.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.182 1.393 . . . . 0.0 109.376 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.01 177.85 35.41 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -51.6 -45.63 63.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.788 0.835 . . . . 0.0 112.721 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.17 -3.09 58.89 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.323 1.049 . . . . 0.0 113.511 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 123.5 -176.31 16.72 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.982 0.81 . . . . 0.0 113.662 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.0 mm -63.26 112.38 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 m -109.29 -30.91 7.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.256 0.622 . . . . 0.0 110.242 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.701 1.201 . . . . 0.0 108.891 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.88 137.0 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 107.283 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.17 155.68 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.27 131.17 27.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.1 140.67 29.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -153.19 169.55 22.72 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.964 1.306 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -127.76 127.08 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -139.95 138.53 35.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.19 31.37 49.34 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.65 -14.18 0.51 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.417 2.687 . . . . 0.0 112.794 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.44 136.19 49.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.829 1.252 . . . . 0.0 110.424 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -89.5 80.07 6.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 109.697 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.65 144.89 14.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.405 1.882 . . . . 0.0 109.694 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.06 129.04 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.71 143.3 18.71 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.48 1.038 . . . . 0.0 112.462 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.63 160.35 52.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -92.54 83.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -62.08 -25.57 67.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.211 1.805 . . . . 0.0 112.003 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.41 176.42 25.34 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.088 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.62 138.33 80.46 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.5 179.59 2.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.408 2.738 . . . . 0.0 110.408 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 70.1 p -135.61 172.69 12.65 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 109.96 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.69 -26.01 28.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.755 0.822 . . . . 0.0 110.576 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.3 tt -63.65 -21.67 66.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.298 1.839 . . . . 0.0 112.461 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.21 171.33 46.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.59 151.3 21.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.23 0.612 . . . . 0.0 112.309 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -111.93 133.75 53.93 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.41 146.78 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -142.47 143.53 32.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.666 1.187 . . . . 0.0 109.222 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -112.33 130.12 56.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.26 107.82 17.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 125.726 1.61 . . . . 0.0 107.452 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 93.95 2.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -56.5 -34.91 29.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.94 -26.88 10.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 123.964 2.451 . . . . 0.0 113.264 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.4 m -106.91 -0.78 22.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.665 1.575 . . . . 0.0 114.798 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.8 156.8 42.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 120.337 1.426 . . . . 0.0 108.425 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.61 161.55 34.34 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.861 -1.149 . . . . 0.0 112.073 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.2 mm -92.7 97.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.2 m -64.4 -40.27 95.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.86 15.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.618 1.167 . . . . 0.0 109.368 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.16 144.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.02 173.13 11.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 155.03 -170.82 33.26 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.451 ' HG1' ' HB3' ' A' ' 246' ' ' MET . 25.8 p -144.8 154.94 43.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -131.55 145.91 51.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -121.88 145.5 48.03 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.878 0.846 . . . . 0.0 111.368 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -70.35 148.26 48.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.876 1.27 . . . . 0.0 109.486 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.5 pt -114.53 155.75 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 127.269 2.228 . . . . 0.0 106.724 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -103.59 150.33 24.06 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.86 0.362 . . . . 0.0 111.107 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.62 -3.34 87.29 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.657 1.599 . . . . 0.0 111.47 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.8 p -142.23 170.73 15.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.606 2.763 . . . . 0.0 107.742 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -108.04 8.5 28.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.672 1.189 . . . . 0.0 110.715 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -80.97 -172.04 45.57 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 122.746 1.192 . . . . 0.0 113.545 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.6 mt -137.78 157.45 46.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.895 2.478 . . . . 0.0 108.6 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.53 135.41 63.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.9 mm -94.41 77.11 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -83.1 -12.59 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.075 -0.391 . . . . 0.0 112.037 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.451 ' HB3' ' HG1' ' A' ' 232' ' ' THR . 0.1 OUTLIER -137.47 134.64 36.02 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 121.796 -0.565 . . . . 0.0 112.451 -179.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.78 152.35 46.51 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.516 1.126 . . . . 0.0 109.51 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -141.32 161.61 37.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.528 1.931 . . . . 0.0 108.352 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -131.03 121.45 25.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.996 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -80.08 115.28 19.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 15.4 p -125.17 165.03 18.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.066 1.746 . . . . 0.0 108.154 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.25 160.97 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? 63.31 -26.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.511 1.925 . . . . 0.0 115.636 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -132.25 124.4 28.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 108.216 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.0 m -78.19 113.14 15.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.695 1.598 . . . . 0.0 107.735 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.1 p -84.37 162.86 19.87 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.271 0.557 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.79 152.19 42.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.144 1.778 . . . . 0.0 108.334 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.07 130.97 13.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.251 1.968 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -102.38 92.26 4.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.68 169.3 14.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.48 1.514 . . . . 0.0 110.724 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.0 mt -95.26 146.62 24.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.93 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.39 124.34 25.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.83 106.34 4.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 89.75 -164.95 31.78 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 122.978 1.321 . . . . 0.0 115.23 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 43.2 m -64.26 132.81 51.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.466 . . . . 0.0 109.992 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -85.67 145.64 27.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -126.93 137.2 53.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.795 0.807 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -124.29 140.76 52.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 72.7 mt -144.86 114.92 7.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -143.6 172.43 12.81 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.541 1.136 . . . . 0.0 110.009 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -144.41 153.85 42.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -101.74 140.09 36.5 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.358 1.063 . . . . 0.0 109.004 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.55 21.37 79.56 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -143.47 166.65 24.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.601 1.56 . . . . 0.0 109.251 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -129.92 174.21 9.97 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.982 2.113 . . . . 0.0 106.754 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 26.8 mt -109.01 154.31 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.24 24.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.416 1.086 . . . . 0.0 113.322 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.54 -155.05 23.95 Favored Glycine 0 N--CA 1.465 0.632 0 O-C-N 120.429 -1.419 . . . . 0.0 111.693 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 174.1 10.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.297 1.839 . . . . 0.0 111.159 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -155.66 163.27 40.13 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.715 2.406 . . . . 0.0 107.974 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.64 -169.99 36.48 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 120.78 1.627 . . . . 0.0 114.78 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 130.33 18.54 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.975 1.31 . . . . 0.0 108.488 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.95 154.49 17.68 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.303 1.841 . . . . 0.0 108.355 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.0 t -125.65 -52.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.738 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.17 -31.05 5.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.245 1.418 . . . . 0.0 113.304 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 46.3 mt -138.87 159.16 42.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.88 92.92 1.29 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.782 -0.573 . . . . 0.0 111.491 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -76.56 -78.33 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -101.0 148.61 24.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.906 1.23 . . . . 0.0 113.025 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -141.18 128.03 20.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.236 1.414 . . . . 0.0 107.216 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -144.14 176.1 23.59 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.07 176.06 5.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.251 1.02 . . . . 0.0 110.6 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -122.03 150.49 42.03 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.345 1.858 . . . . 0.0 107.172 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.06 139.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 44.2 mtt -139.77 147.27 50.84 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.49 68.98 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.132 3.221 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 128.478 2.711 . . . . 0.0 113.601 -179.538 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.838 0.827 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -144.93 138.91 27.22 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.732 2.013 . . . . 0.0 106.196 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.25 146.28 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -106.89 168.12 9.41 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.27 -70.88 0.24 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.993 1.317 . . . . 0.0 111.629 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 51.87 66.05 2.82 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.275 1.417 . . . . 0.0 114.911 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.39 21.75 2.57 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 118.056 0.928 . . . . 0.0 113.767 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.26 171.04 19.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 127.05 2.262 . . . . 0.0 109.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.44 -0.25 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.414 1.086 . . . . 0.0 113.245 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.58 178.54 38.22 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 -175.46 27.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.136 0.874 . . . . 0.0 113.057 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.67 144.42 43.95 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.584 1.153 . . . . 0.0 108.113 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 p -65.74 95.49 0.24 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.711 1.205 . . . . 0.0 112.265 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -97.2 -79.28 0.46 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 63.63 19.77 11.88 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.55 1.14 . . . . 0.0 110.911 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.08 141.44 58.77 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.745 1.618 . . . . 0.0 109.174 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 -179.046 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.98 144.7 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.385 -1.068 . . . . 0.0 111.986 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -46.8 5.07 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.203 1.801 . . . . 0.0 112.881 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -138.02 163.73 30.83 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.12 144.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -136.35 141.53 43.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.93 142.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.24 114.94 1.64 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -66.44 141.84 57.78 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.39 -171.76 14.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -72.31 -48.19 44.06 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.561 0.744 . . . . 0.0 111.679 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.47 -10.51 34.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.131 1.772 . . . . 0.0 114.001 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.6 32.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.25 139.3 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -133.94 10.57 3.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -161.21 147.0 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.281 0.946 . . . . 0.0 111.673 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 155.4 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.042 1.737 . . . . 0.0 108.813 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.19 135.43 11.16 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 161.02 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.564 1.945 . . . . 0.0 111.13 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.2 t -121.87 139.95 47.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -107.94 170.41 8.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.872 0.76 . . . . 0.0 109.652 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.66 51.91 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.834 0.854 . . . . 0.0 109.978 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -116.96 166.34 12.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.498 1.119 . . . . 0.0 108.522 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.13 -3.2 15.6 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.07 -1.019 . . . . 0.0 109.746 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -108.86 -83.86 0.55 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.311 3.044 . . . . 0.0 110.641 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -133.89 159.24 41.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.975 1.71 . . . . 0.0 110.372 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.05 145.12 34.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.47 1.508 . . . . 0.0 110.295 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -144.86 146.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.044 0.938 . . . . 0.0 110.352 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.78 151.65 33.42 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.634 1.974 . . . . 0.0 109.302 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.92 -67.73 0.92 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.712 1.625 . . . . 0.0 109.905 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.7 174.88 27.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.179 1.371 . . . . 0.0 112.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.87 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.083 0.942 . . . . 0.0 109.761 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -125.04 133.11 53.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.47 -153.08 21.17 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.301 -2.72 . . . . 0.0 106.301 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -128.2 114.62 17.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.103 0.951 . . . . 0.0 112.97 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.17 134.66 49.55 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -81.28 155.62 25.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.368 1.067 . . . . 0.0 108.954 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.16 -32.8 74.67 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.575 -0.703 . . . . 0.0 111.161 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.32 26.93 7.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 110.701 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.86 96.2 0.17 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -163.05 146.05 10.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 128.954 2.902 . . . . 0.0 104.823 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -142.29 164.84 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.403 1.481 . . . . 0.0 108.856 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -144.48 103.11 3.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -108.11 140.87 40.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.056 1.743 . . . . 0.0 106.993 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.69 143.5 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 111.007 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.9 t -95.93 111.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 156.01 38.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 109.406 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.75 -27.16 61.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.172 -0.955 . . . . 0.0 111.67 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.94 13.56 27.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.555 1.942 . . . . 0.0 113.511 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.25 136.58 35.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.972 0.806 . . . . 0.0 110.332 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CG ' ' HE2' ' A' ' 124' ' ' LYS . 12.0 m-85 -128.66 162.24 27.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.689 0.796 . . . . 0.0 110.424 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mt -75.3 150.43 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -30.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.821 1.648 . . . . 0.0 109.146 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 157.44 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.164 0.893 . . . . 0.0 108.99 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 t -139.35 139.57 38.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -128.2 116.81 20.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.54 134.64 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.8 p -113.98 157.22 22.74 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -151.03 158.69 44.43 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.429 -0.794 . . . . 0.0 109.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -160.39 168.72 24.59 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.864 1.265 . . . . 0.0 108.67 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 94.36 3.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.3 138.22 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.837 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -61.25 114.3 3.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.05 -5.22 5.7 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.852 1.215 . . . . 0.0 111.935 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -134.5 158.14 44.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.161 1.384 . . . . 0.0 107.785 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.44 22.11 15.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.342 1.857 . . . . 0.0 108.759 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 p -137.95 129.24 27.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.937 -1.102 . . . . 0.0 112.578 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.17 148.76 50.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.324 2.25 . . . . 0.0 105.131 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.93 158.46 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.1 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.3 mm -83.22 103.24 10.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.587 0.755 . . . . 0.0 109.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -66.89 -41.04 87.87 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.466 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 p -156.68 165.77 35.3 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.541 1.519 . . . . 0.0 111.75 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 151.69 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.043 0.537 . . . . 0.0 111.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.7 m -149.44 154.17 38.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 0.0 108.687 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -125.04 154.59 41.08 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.738 2.015 . . . . 0.0 107.383 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -132.22 118.24 19.27 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.9 p -99.01 159.87 14.66 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.666 0.746 . . . . 0.0 112.896 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.87 -32.74 73.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.349 1.859 . . . . 0.0 113.357 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -11.37 58.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.008 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.03 49.81 3.22 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -127.69 139.69 52.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.4 p -134.76 147.53 50.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.662 0.385 . . . . 0.0 110.522 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 161.02 32.21 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 123.419 0.687 . . . . 0.0 110.673 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.33 166.6 24.15 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 122.269 1.979 . . . . 0.0 108.516 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.75 106.18 1.79 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.42 2.08 . . . . 0.0 107.502 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -75.47 85.99 2.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.1 -137.18 8.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.801 1.191 . . . . 0.0 110.379 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 tp -112.55 125.43 54.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.461 1.505 . . . . 0.0 108.985 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -64.34 143.12 58.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 m -146.07 147.34 31.49 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -52.72 -49.52 65.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.922 2.089 . . . . 0.0 110.216 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -68.3 108.25 3.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.862 1.665 . . . . 0.0 107.259 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -152.1 160.08 43.51 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.505 1.122 . . . . 0.0 108.983 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -143.08 167.72 21.43 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.449 0.7 . . . . 0.0 112.042 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.25 143.08 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.268 1.427 . . . . 0.0 107.837 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -137.85 1.95 2.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 145.01 41.99 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.824 0.85 . . . . 0.0 113.169 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.49 149.81 34.95 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.95 -35.65 64.47 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.834 -1.166 . . . . 0.0 111.866 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -69.48 -22.52 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.311 1.044 . . . . 0.0 112.508 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.67 -68.92 0.42 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.39 79.26 1.44 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 124.814 1.197 . . . . 0.0 112.348 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.449 ' HE2' ' CG ' ' A' ' 72' ' ' TYR . 39.5 ttmt -63.87 127.79 32.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 tp -77.7 88.77 3.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.69 -49.58 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.32 -174.14 21.88 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -152.56 -178.03 6.6 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.757 1.223 . . . . 0.0 108.545 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.97 148.81 30.21 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.25 110.59 0.37 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.22 54.38 1.65 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.756 1.623 . . . . 0.0 108.712 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.69 120.11 26.76 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -97.61 -108.72 2.67 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.48 -29.08 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.721 1.208 . . . . 0.0 112.353 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 169.02 20.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.115 1.766 . . . . 0.0 109.138 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.71 101.06 12.94 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.73 -71.52 0.57 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -107.18 150.08 27.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.865 0.866 . . . . 0.0 110.777 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -141.57 110.65 6.26 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 125.392 1.477 . . . . 0.0 108.786 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.32 170.65 14.73 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.96 165.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.13 0.572 . . . . 0.0 111.015 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -123.13 131.07 53.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.64 99.81 6.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.796 2.039 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.315 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -101.33 136.59 40.93 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.089 0.555 . . . . 0.0 112.463 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -114.45 146.92 40.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.804 1.642 . . . . 0.0 108.607 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.8 mt -116.35 171.38 7.87 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.319 1.848 . . . . 0.0 106.86 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 m -75.24 170.64 15.65 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.207 -0.933 . . . . 0.0 108.872 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.14 165.82 26.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.271 1.029 . . . . 0.0 108.643 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.6 mt -117.4 151.06 19.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.62 -67.22 0.45 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.341 -0.7 . . . . 0.0 111.357 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.39 -160.61 30.19 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.888 1.232 . . . . 0.0 110.106 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -140.6 27.78 2.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.225 1.41 . . . . 0.0 111.184 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -125.5 141.62 51.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.19 1.796 . . . . 0.0 108.647 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.71 167.1 12.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.817 2.151 . . . . 0.0 111.154 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 97.4 m -71.97 122.7 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.144 0.978 . . . . 0.0 111.484 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.11 117.23 20.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -131.54 35.87 3.8 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.227 0.611 . . . . 0.0 111.33 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.44 145.07 0.64 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.124 1.369 . . . . 0.0 114.363 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.62 111.41 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.096 2.558 . . . . 0.0 108.79 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.77 168.56 46.52 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.06 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.15 120.18 12.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -100.85 -172.16 2.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.588 0.755 . . . . 0.0 109.72 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' A' ' 196' ' ' LYS . 1.0 OUTLIER -68.6 -4.95 17.25 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.588 0.755 . . . . 0.0 111.341 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 142.78 161.11 8.65 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.822 2.153 . . . . 0.0 110.829 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.45 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.361 1.864 . . . . 0.0 108.68 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -131.54 -70.77 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -133.29 153.42 51.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.434 0.561 . . . . 0.0 112.461 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.29 141.18 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.738 2.015 . . . . 0.0 106.18 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.88 128.04 44.48 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.68 116.25 51.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.89 95.52 1.82 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -60.86 169.91 1.72 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.67 -174.11 13.81 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.33 -23.02 61.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.59 -0.805 . . . . 0.0 111.456 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -131.34 -19.28 2.79 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 179.18 -172.74 44.85 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 126.973 2.225 . . . . 0.0 107.689 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.94 124.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 120.101 1.95 . . . . 0.0 111.824 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.7 m -118.57 -20.42 8.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.685 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.77 156.63 47.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 119.568 -1.958 . . . . 0.0 111.301 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.02 151.01 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -162.68 165.48 25.64 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.77 2.428 . . . . 0.0 106.504 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -144.06 174.56 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.789 1.236 . . . . 0.0 110.305 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -129.63 113.0 14.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -102.66 155.58 18.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -128.37 138.31 52.3 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' A' ' 173' ' ' ASP . 19.2 ttmm -129.2 96.23 4.26 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 70.29 -95.93 0.53 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.74 -7.09 9.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.423 1.489 . . . . 0.0 110.212 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.69 153.89 32.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.86 100.23 5.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.32 106.92 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 131.75 34.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.42 176.38 40.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.426 1.012 . . . . 0.0 111.374 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.96 172.44 14.5 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.354 1.454 . . . . 0.0 111.946 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.01 104.13 16.69 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -77.59 -34.38 53.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.096 0.959 . . . . 0.0 112.335 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -108.24 -178.46 21.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 124.774 1.178 . . . . 0.0 113.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -72.8 105.2 1.37 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.565 1.546 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.48 168.69 20.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.813 1.675 . . . . 0.0 109.47 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.6 t -137.22 161.13 37.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.657 0.783 . . . . 0.0 109.181 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.76 -15.5 63.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.561 0.744 . . . . 0.0 110.399 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -19.91 65.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.252 1.021 . . . . 0.0 109.876 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.06 -153.11 20.23 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -139.95 141.23 36.46 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.74 1.616 . . . . 0.0 107.552 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.18 151.58 23.99 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -134.92 144.38 47.44 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.938 0.79 . . . . 0.0 111.996 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -142.42 113.01 7.3 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.785 0.834 . . . . 0.0 109.29 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -73.34 141.16 47.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mt -116.15 114.3 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.908 0.776 . . . . 0.0 109.268 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.82 148.71 27.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.919 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 24.67 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.6 2.36 . . . . 0.0 116.536 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.91 -27.82 9.86 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.371 2.048 . . . . 0.0 114.144 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.2 t -128.81 -66.42 0.83 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.81 172.4 13.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.589 1.556 . . . . 0.0 108.451 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -165.94 171.4 12.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.809 1.244 . . . . 0.0 108.186 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.4 mt -87.24 152.03 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.2 p -140.43 -5.12 1.24 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -166.58 170.79 12.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.836 1.255 . . . . 0.0 107.768 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.18 141.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -132.86 151.61 52.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 129.32 3.048 . . . . 0.0 108.482 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.02 179.53 44.39 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.5 p -137.15 142.87 42.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.642 1.221 . . . . 0.0 110.463 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.52 145.29 48.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.722 0.809 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -147.67 163.94 35.07 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 122.056 -0.403 . . . . 0.0 110.739 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.42 141.15 52.15 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.492 1.117 . . . . 0.0 113.794 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.73 155.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -111.03 141.89 43.92 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.94 -7.24 82.61 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.545 -0.722 . . . . 0.0 111.827 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 60.4 p -140.65 -172.11 3.38 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.858 2.063 . . . . 0.0 107.643 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.42 72.0 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.904 1.282 . . . . 0.0 108.706 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -163.17 178.54 38.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.873 1.225 . . . . 0.0 111.383 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.3 mt -108.44 159.61 16.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 110.58 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.0 tt -135.85 138.49 47.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.232 1.413 . . . . 0.0 109.305 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 25.0 mm -76.54 96.57 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.0 t -76.24 -16.86 59.73 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.677 -0.639 . . . . 0.0 112.313 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -156.79 138.61 14.28 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.622 1.169 . . . . 0.0 107.986 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 24.3 tp -135.49 123.91 23.39 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -109.58 172.48 6.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.984 0.914 . . . . 0.0 108.576 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -136.68 145.71 45.07 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -115.88 121.36 42.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.425 1.09 . . . . 0.0 109.027 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 p -138.66 168.14 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.344 2.258 . . . . 0.0 107.277 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.23 156.02 19.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.8 mttm 60.76 -17.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -98.97 175.3 5.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.33 1.452 . . . . 0.0 112.555 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -131.42 99.82 4.95 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 126.11 1.764 . . . . 0.0 108.186 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.1 p -80.18 160.18 25.74 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.083 0.553 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -94.53 155.85 39.14 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.22 88.98 0.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.072 2.514 . . . . 0.0 107.877 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -77.09 92.52 3.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.87 172.86 34.55 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.146 1.355 . . . . 0.0 111.797 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.84 122.97 41.58 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.552 1.541 . . . . 0.0 109.232 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -71.82 108.34 5.07 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.345 2.258 . . . . 0.0 110.139 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.78 168.32 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.973 1.309 . . . . 0.0 110.103 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 91.84 -98.43 2.42 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 98.8 m -145.08 118.85 9.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -87.71 136.03 33.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -126.27 166.03 17.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.06 0.944 . . . . 0.0 109.565 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.45 151.88 35.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.458 0.703 . . . . 0.0 109.816 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.5 mt -139.42 120.49 14.63 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.789 1.636 . . . . 0.0 107.563 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.37 152.27 18.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.166 0.894 . . . . 0.0 110.92 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.49 157.23 44.04 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.587 1.555 . . . . 0.0 108.756 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.15 143.25 34.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 65.15 28.65 73.8 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -142.49 152.73 42.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.08 2.44 . . . . 0.0 110.757 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.94 165.01 17.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.875 2.07 . . . . 0.0 107.563 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.8 mt -92.15 150.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.68 -10.55 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.81 -179.97 48.14 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.833 1.197 . . . . 0.0 110.84 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 135.71 53.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 108.204 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.71 137.37 52.44 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.47 -150.49 22.2 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.06 128.85 10.17 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.16 46.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 109.55 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 36.5 m -140.29 -67.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.442 1.097 . . . . 0.0 111.631 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.86 -64.48 1.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 119.001 0.819 . . . . 0.0 110.748 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.4 113.74 27.5 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -50.31 92.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.75 -73.84 0.31 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.525 1.13 . . . . 0.0 111.939 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -104.85 114.36 28.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.843 0.747 . . . . 0.0 112.346 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -117.87 156.77 27.84 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.655 1.582 . . . . 0.0 107.005 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -172.1 -179.66 43.16 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.5 m -138.81 146.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.58 1.19 . . . . 0.0 111.529 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.02 160.26 24.6 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 118.411 0.55 . . . . 0.0 110.885 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 83.8 mmm -146.02 142.9 18.29 Favored Pre-proline 0 N--CA 1.464 0.262 0 C-N-CA 124.589 1.156 . . . . 0.0 110.784 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.59 105.77 2.09 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.824 2.349 . . . . 0.0 109.461 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 178.944 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -149.05 100.94 3.11 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.223 -0.923 . . . . 0.0 112.788 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.37 142.53 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 159.7 16.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.683 0.793 . . . . 0.0 110.027 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.51 105.38 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.288 1.435 . . . . 0.0 112.512 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.09 83.23 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.02 -160.71 19.01 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 126.909 2.195 . . . . 0.0 107.657 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.86 150.23 39.66 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.02 53.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.244 1.022 . . . . 0.0 113.582 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.86 164.02 39.9 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.96 0.79 . . . . 0.0 114.59 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.37 164.85 34.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.189 1.376 . . . . 0.0 113.98 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.79 141.73 29.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.209 1.403 . . . . 0.0 107.236 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.9 123.12 22.03 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -127.33 85.7 2.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.883 1.673 . . . . 0.0 107.034 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -140.94 147.0 38.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.647 2.379 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -160.63 174.22 14.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.41 1.484 . . . . 0.0 108.534 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.563 0 N-CA-C 104.149 -3.58 . . . . 0.0 104.149 177.571 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -117.82 155.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 109.64 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -54.93 1.24 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -145.8 168.39 20.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 118.759 0.708 . . . . 0.0 110.622 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.144 2.578 . . . . 0.0 104.777 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -138.9 122.32 17.2 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -143.77 139.6 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.87 131.23 3.89 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -67.16 -168.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.212 1.405 . . . . 0.0 110.519 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.67 -177.32 43.23 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.88 -32.69 73.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.427 1.091 . . . . 0.0 111.507 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -105.63 8.29 33.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.259 1.824 . . . . 0.0 114.036 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.72 -168.41 12.93 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.258 -0.901 . . . . 0.0 112.836 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.36 95.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -101.94 -9.24 20.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.9 p -87.8 147.53 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 120.362 1.437 . . . . 0.0 109.524 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -145.01 158.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.44 1.096 . . . . 0.0 108.8 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -153.91 151.31 29.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.285 1.834 . . . . 0.0 107.266 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.73 119.86 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.97 121.27 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.55 158.64 16.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' A' ' 48' ' ' ASP . . . -156.26 109.66 2.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -111.84 154.03 25.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -33.27 62.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.64 0.776 . . . . 0.0 112.611 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.525 1.53 . . . . 0.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -156.02 120.06 4.48 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 120.401 1.455 . . . . 0.0 107.679 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.448 ' CB ' ' HA ' ' A' ' 43' ' ' ALA 0.395 0.5 OUTLIER -116.83 165.46 13.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -179.279 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.78 145.98 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.536 1.534 . . . . 0.0 111.801 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.3 139.09 37.94 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.95 -1.094 . . . . 0.0 109.377 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.35 -73.49 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.57 0.605 . . . . 0.0 111.788 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.33 171.15 17.67 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.725 1.631 . . . . 0.0 110.033 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -101.52 142.63 32.61 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.136 -0.626 . . . . 0.0 110.591 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.63 173.99 10.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.611 1.964 . . . . 0.0 109.682 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.97 -155.97 37.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -112.79 125.58 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.89 160.26 14.63 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 p -132.34 114.53 14.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.365 1.866 . . . . 0.0 108.221 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.46 -36.5 80.57 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.262 -1.524 . . . . 0.0 107.988 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -1.88 17.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.223 2.209 . . . . 0.0 115.554 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.97 -8.87 0.23 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 120.291 1.405 . . . . 0.0 115.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.99 125.04 28.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.084 1.442 . . . . 0.0 110.88 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.01 142.01 50.76 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.486 1.915 . . . . 0.0 106.273 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.6 m -104.15 143.61 32.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 108.735 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -134.68 125.1 26.4 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.883 0.873 . . . . 0.0 109.629 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.39 143.57 29.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.618 1.567 . . . . 0.0 109.142 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.69 147.52 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.631 1.173 . . . . 0.0 109.089 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -109.91 172.62 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.936 1.294 . . . . 0.0 113.35 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -38.52 19.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.473 1.509 . . . . 0.0 110.332 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -83.19 21.05 1.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.328 1.451 . . . . 0.0 109.742 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.8 136.76 22.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 0.0 110.998 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.08 150.07 48.99 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.8 mt -79.88 147.49 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.32 -28.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.765 0.826 . . . . 0.0 110.836 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.36 155.64 41.51 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.182 0.901 . . . . 0.0 108.888 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.99 95.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.67 113.66 20.5 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.69 147.91 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.1 m -131.74 138.73 48.74 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -150.28 167.11 27.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.136 2.974 . . . . 0.0 104.619 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.03 165.7 29.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -120.82 105.73 11.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.981 0.912 . . . . 0.0 109.277 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.85 144.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.05 108.15 1.17 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.61 6.32 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 117.874 -1.515 . . . . 0.0 113.403 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -131.56 118.87 20.7 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.119 1.96 . . . . 0.0 108.142 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.33 1.85 2.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.559 2.744 . . . . 0.0 114.138 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.7 t -147.97 135.53 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.625 -1.297 . . . . 0.0 109.04 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.16 158.33 33.39 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.92 141.11 43.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.189 1.796 . . . . 0.0 107.962 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.1 mm -64.29 125.68 21.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.987 0.915 . . . . 0.0 110.054 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 p -104.42 -32.54 8.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.28 1.032 . . . . 0.0 109.24 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -161.05 165.6 29.48 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 120.015 1.279 . . . . 0.0 112.689 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pt -144.76 137.44 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.402 1.881 . . . . 0.0 109.928 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.7 m -132.21 114.61 14.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.197 1.799 . . . . 0.0 107.952 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -96.82 121.8 39.07 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -100.79 127.62 47.16 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.8 p -97.48 164.51 12.41 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.151 0.887 . . . . 0.0 111.756 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.94 -41.2 82.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.378 1.071 . . . . 0.0 108.934 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -68.47 -22.8 64.54 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.22 1.408 . . . . 0.0 114.608 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.56 -7.6 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 119.809 1.186 . . . . 0.0 114.186 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -74.26 147.05 42.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.49 127.11 30.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 p -80.98 149.33 66.55 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.68 158.86 48.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.138 1.892 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.47 83.46 1.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.053 2.502 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -55.89 109.31 0.56 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.59 -134.88 10.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.3 tp -139.87 138.16 35.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.537 1.135 . . . . 0.0 109.927 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -68.42 164.83 20.13 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.37 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -149.8 -167.14 2.74 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.742 -1.849 . . . . 0.0 111.609 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.432 ' H ' HG22 ' A' ' 111' ' ' THR . 16.9 tt0 -73.25 -59.18 2.83 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.543 1.137 . . . . 0.0 109.509 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -68.73 178.24 2.2 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER 165.03 162.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.353 3.061 . . . . 0.0 108.471 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.51 149.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.344 1.058 . . . . 0.0 108.198 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 p -140.05 148.14 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.31 145.87 33.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.175 2.19 . . . . 0.0 106.512 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 174.68 12.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.632 1.173 . . . . 0.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.428 ' HB3' ' CD1' ' A' ' 143' ' ' PHE . 5.8 p30 -110.1 147.93 32.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.596 1.158 . . . . 0.0 109.0 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -143.26 -84.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -100.42 -10.81 20.77 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.717 0.69 . . . . 0.0 110.198 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 -49.04 49.3 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.248 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.05 -133.25 2.91 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 119.267 1.533 . . . . 0.0 112.187 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -132.81 153.61 51.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.934 0.893 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.6 106.92 10.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.01 3.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.456 0.702 . . . . 0.0 111.556 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.38 178.22 46.86 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.923 0.773 . . . . 0.0 111.749 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.74 177.02 8.45 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.74 2.016 . . . . 0.0 109.735 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -146.41 148.82 32.7 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.07 92.45 0.17 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 118.254 0.479 . . . . 0.0 112.388 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -60.32 121.26 11.56 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -152.8 164.82 37.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.388 0.994 . . . . 0.0 110.595 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.56 -95.72 0.13 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.73 -23.94 56.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.047 0.424 . . . . 0.0 110.201 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.4 -179.69 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.23 2.212 . . . . 0.0 106.366 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.54 153.45 33.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.846 1.658 . . . . 0.0 108.487 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -143.93 -56.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.509 0.595 . . . . 0.0 112.007 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.24 155.71 50.2 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.986 0.812 . . . . 0.0 112.592 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.11 113.21 9.24 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.21 2.204 . . . . 0.0 107.346 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.92 174.81 15.48 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 123.814 0.721 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.01 158.85 43.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 121.537 -0.978 . . . . 0.0 108.728 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.77 151.81 41.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 119' ' ' ASP . 45.4 m-85 -137.72 99.81 4.02 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.015 0.926 . . . . 0.0 109.421 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.068 0 O-C-N 121.605 -0.684 . . . . 0.0 110.678 -179.547 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.65 129.38 56.67 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.152 -0.968 . . . . 0.0 109.567 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -103.97 106.78 17.4 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.88 161.54 23.74 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.4 t -84.86 111.94 20.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.94 159.77 29.71 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.721 0.408 . . . . 0.0 110.113 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -125.21 161.24 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.009 2.924 . . . . 0.0 105.949 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.94 -72.12 0.48 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.857 1.208 . . . . 0.0 113.317 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.81 -4.89 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.217 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . 0.264 0.7 OUTLIER 53.61 -3.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.156 2.982 . . . . 0.0 117.476 179.281 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.76 164.9 12.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.839 1.655 . . . . 0.0 112.769 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.51 -175.23 16.0 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 126.341 1.924 . . . . 0.0 114.195 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.37 104.22 4.3 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.033 1.733 . . . . 0.0 109.525 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.85 154.76 29.55 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.254 0.622 . . . . 0.0 110.265 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -146.57 28.29 1.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.99 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -42.71 110.42 0.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.912 1.685 . . . . 0.0 110.235 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.38 -11.37 60.45 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.3 -85.75 1.57 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.37 147.57 5.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -109.6 155.48 21.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.352 1.061 . . . . 0.0 109.548 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -76.42 -11.02 59.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.926 -1.033 . . . . 0.0 112.901 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.05 -179.94 44.07 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.21 155.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.18 1.392 . . . . 0.0 108.596 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -138.48 -74.13 0.39 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.788 1.235 . . . . 0.0 107.873 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -150.87 165.94 32.09 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.03 139.41 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -118.48 156.89 28.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.58 131.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -109.84 83.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.68 -165.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 110.682 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.02 -168.71 37.93 Favored Glycine 0 N--CA 1.447 -0.608 0 O-C-N 120.183 -1.573 . . . . 0.0 112.064 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.09 -45.58 11.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.23 1.412 . . . . 0.0 109.618 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.78 -15.53 51.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.528 0.731 . . . . 0.0 111.479 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.06 -154.39 24.44 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 27.7 mm -58.36 150.81 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 118.559 1.179 . . . . 0.0 108.855 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.4 t -127.65 -38.36 1.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.199 1.399 . . . . 0.0 112.822 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -136.7 161.58 35.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.137 0.881 . . . . 0.0 110.027 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.91 127.85 25.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.434 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 44.7 pttt -161.67 160.53 28.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.296 1.439 . . . . 0.0 109.49 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.48 169.13 24.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.428 0.558 . . . . 0.0 109.834 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.03 148.27 24.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -151.67 165.84 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.5 92.58 2.59 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -89.2 99.44 12.43 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.36 -79.98 0.64 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.73 0.696 . . . . 0.0 111.662 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.33 -0.18 1.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.597 1.959 . . . . 0.0 111.135 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.4 102.05 7.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -77.67 67.06 3.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.295 1.438 . . . . 0.0 108.251 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.9 mm -72.13 122.69 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.189 0.995 . . . . 0.0 113.429 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 29.0 t -127.65 150.37 33.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 127.109 2.164 . . . . 0.0 105.93 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.44 -108.98 2.77 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.862 -0.966 . . . . 0.0 111.548 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 72.38 12.47 76.83 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 116.014 1.165 . . . . 0.0 116.014 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -58.81 116.44 3.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.839 2.32 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -117.64 2.78 12.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.671 1.588 . . . . 0.0 113.993 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.01 162.41 28.57 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 120.069 -1.645 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -47.07 106.37 0.58 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.744 1.617 . . . . 0.0 110.929 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.53 135.57 26.63 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.985 2.457 . . . . 0.0 109.327 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 131.66 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 29.3 tp -56.51 -26.4 54.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 pp -55.52 -30.06 60.01 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.197 1.399 . . . . 0.0 112.186 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.72 -166.01 13.91 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.019 1.295 . . . . 0.0 110.488 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.434 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 23.5 m-85 -128.88 168.13 16.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.549 1.54 . . . . 0.0 108.232 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.75 171.6 7.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.882 2.073 . . . . 0.0 106.787 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.86 158.59 44.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.451 0.7 . . . . 0.0 112.771 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -142.74 129.67 20.63 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.943 1.697 . . . . 0.0 108.311 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.19 109.54 21.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 107.707 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.85 104.45 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -88.96 92.61 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.774 1.63 . . . . 0.0 107.556 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -57.16 -35.29 33.7 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -35.27 10.01 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 123.609 2.325 . . . . 0.0 110.093 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -75.91 -77.09 0.14 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.591 1.557 . . . . 0.0 112.021 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.18 124.71 28.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.052 2.541 . . . . 0.0 112.476 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.47 83.31 3.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -45.98 128.19 2.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 109.824 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -124.42 -22.96 4.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.81 171.26 18.08 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.347 1.43 . . . . 0.0 113.46 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 1.8 p -139.1 158.19 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.73 172.18 12.89 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -172.68 171.24 44.23 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.2 p -141.33 137.81 32.66 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -135.96 160.8 37.48 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.898 0.749 . . . . 0.0 112.14 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -145.87 168.94 19.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.153 0.981 . . . . 0.0 108.985 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -75.05 147.9 40.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.902 1.281 . . . . 0.0 110.075 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.8 mt -92.98 112.46 26.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.36 104.41 5.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 119.02 -0.52 14.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.436 1.017 . . . . 0.0 112.811 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -141.19 -174.28 3.97 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.11 80.24 1.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 172.66 -176.99 45.44 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -108.66 157.61 18.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -126.78 137.2 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 125.974 1.709 . . . . 0.0 109.135 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.32 130.2 36.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.277 10.3 t -112.04 -50.35 2.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 112.622 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -128.77 150.61 50.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.149 1.341 . . . . 0.0 109.619 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.4 mt -130.53 150.32 51.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.373 1.469 . . . . 0.0 110.441 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -142.97 147.64 35.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.646 1.579 . . . . 0.0 107.62 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.75 113.19 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -71.14 136.15 48.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -142.18 165.18 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.35 1.86 . . . . 0.0 106.383 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 148.15 31.69 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 -29.42 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 128.465 2.706 . . . . 0.0 115.157 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -81.22 174.42 11.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.386 2.674 . . . . 0.0 108.295 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.4 m -144.31 152.29 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 45.3 p -146.09 174.46 11.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 112.257 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -103.98 158.66 31.44 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.872 1.669 . . . . 0.0 110.576 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.05 115.09 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.224 2.616 . . . . 0.0 106.401 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -83.94 92.38 7.81 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.71 -176.99 16.57 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.229 1.395 . . . . 0.0 111.59 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.05 116.67 26.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.108 0.963 . . . . 0.0 110.066 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.78 108.86 3.59 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.419 1.088 . . . . 0.0 109.219 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -155.17 -177.31 6.44 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.287 1.035 . . . . 0.0 110.965 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 64.15 -103.47 0.73 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 126.261 1.886 . . . . 0.0 114.657 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 91.1 m -146.92 128.62 15.2 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 107.444 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -89.92 144.41 25.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 111.431 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -129.48 165.94 20.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.592 1.157 . . . . 0.0 110.039 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -143.84 146.58 33.15 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.232 1.813 . . . . 0.0 107.092 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 73.0 mt -132.0 102.01 5.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.699 1.6 . . . . 0.0 107.239 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -127.11 163.7 23.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.146 0.978 . . . . 0.0 109.061 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.75 167.44 22.28 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.365 1.466 . . . . 0.0 107.627 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -97.04 117.59 31.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.593 1.157 . . . . 0.0 113.559 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.73 67.54 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.148 -0.97 . . . . 0.0 114.623 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -107.06 164.59 12.02 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.126 1.37 . . . . 0.0 111.606 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -127.98 151.16 49.47 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.682 2.793 . . . . 0.0 105.01 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 68.7 mt -82.49 145.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.38 -5.37 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.778 0.831 . . . . 0.0 112.842 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.17 37.3 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.626 1.103 . . . . 0.0 110.684 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -128.35 156.01 43.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.888 2.875 . . . . 0.0 107.238 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -147.83 113.27 5.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -178.52 -171.56 41.95 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 154.28 46.12 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.55 -1.325 . . . . 0.0 107.838 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.3 152.48 39.98 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.6 t -163.95 113.55 1.24 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.82 11.47 2.53 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.07 2.548 . . . . 0.0 114.447 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 167.1 -179.88 0.02 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 129.433 3.093 . . . . 0.0 106.865 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.95 102.97 15.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.441 0.696 . . . . 0.0 110.172 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -82.88 -43.42 16.59 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.237 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -133.71 142.16 47.86 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.795 1.18 . . . . 0.0 112.799 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.83 149.64 35.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 176.5 -158.89 25.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.4 m -147.89 138.66 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.98 0.912 . . . . 0.0 111.661 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.96 136.92 37.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.12 149.23 24.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.32 0.581 . . . . 0.0 111.233 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 29.7 mmm -142.47 141.61 21.26 Favored Pre-proline 0 C--O 1.234 0.277 0 C-N-CA 126.988 2.115 . . . . 0.0 107.414 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.18 146.98 71.88 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.368 2.045 . . . . 0.0 108.878 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.237 0.422 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 178.325 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.103 0.478 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -149.74 139.48 21.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 130.614 3.566 . . . . 0.0 105.166 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.36 129.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 118.931 0.787 . . . . 0.0 112.388 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.34 138.69 47.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.37 -62.52 1.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.027 0.531 . . . . 0.0 109.692 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.33 69.76 0.84 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 126.241 1.876 . . . . 0.0 109.534 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.75 -166.11 12.07 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.733 1.635 . . . . 0.0 110.075 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.29 17.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.433 1.116 . . . . 0.0 113.403 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.12 -1.13 4.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.303 1.841 . . . . 0.0 112.548 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.75 42.38 3.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 120.698 -1.251 . . . . 0.0 112.734 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.64 -154.68 6.66 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 127.095 2.283 . . . . 0.0 111.561 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.96 142.2 51.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -72.29 121.9 20.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 112.579 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -124.27 58.42 1.2 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -89.91 18.68 5.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.855 2.462 . . . . 0.0 112.277 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -148.09 160.22 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.012 -1.055 . . . . 0.0 110.913 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 C-N-CA 126.274 1.893 . . . . 0.0 108.772 -179.59 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.039 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -59.55 141.87 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 111.759 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -117.91 -32.48 4.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -150.49 160.63 43.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.36 121.1 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.513 ' CD2' HD21 ' A' ' 39' ' ' ASN . 1.2 m-70 -98.38 140.96 31.88 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 118.768 0.713 . . . . 0.0 109.557 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -143.2 145.84 22.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.04 141.83 8.59 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 146.78 35.08 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.548 1.139 . . . . 0.0 109.722 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.14 165.68 28.56 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 125.992 1.758 . . . . 0.0 109.459 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -55.72 -34.67 65.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.922 1.289 . . . . 0.0 112.327 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -94.84 -7.92 38.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.465 3.106 . . . . 0.0 113.788 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.65 -164.35 20.26 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.87 95.49 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -112.61 2.45 16.19 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.5 p -107.18 108.93 20.61 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.67 132.65 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 109.702 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.513 HD21 ' CD2' ' A' ' 27' ' ' HIS . 24.4 t30 -150.23 147.39 27.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.652 1.581 . . . . 0.0 108.562 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.0 117.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.9 t -68.22 148.23 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -128.41 126.31 40.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.275 1.398 . . . . 0.0 111.933 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.29 139.62 30.84 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -112.5 165.56 12.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.56 -23.48 67.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.093 -0.379 . . . . 0.0 111.234 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -104.67 -39.38 6.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.561 1.144 . . . . 0.0 113.608 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -154.81 158.22 39.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.043 1.292 . . . . 0.0 113.509 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 125.73 30.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.42 145.32 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.535 1.16 . . . . 0.0 112.361 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.5 153.3 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.057 2.143 . . . . 0.0 106.183 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.72 61.06 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 127.939 2.685 . . . . 0.0 107.703 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.6 14.51 4.18 Favored Glycine 0 N--CA 1.472 1.035 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.28 116.56 8.19 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.06 1.43 . . . . 0.0 111.404 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -126.59 82.12 2.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.26 -144.92 5.77 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.93 111.23 13.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.92 119.79 6.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 p -70.53 153.57 42.78 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.262 1.825 . . . . 0.0 111.291 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.18 -33.55 16.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.803 1.241 . . . . 0.0 109.781 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.2 mt -71.34 -14.43 62.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 123.66 0.6 . . . . 0.0 109.469 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.82 161.16 33.19 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-O 124.637 2.243 . . . . 0.0 109.659 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -123.89 157.61 33.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.529 -2.835 . . . . 0.0 109.334 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -121.78 165.19 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.767 2.427 . . . . 0.0 107.633 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -128.13 125.92 40.11 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.543 -0.723 . . . . 0.0 110.123 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -87.12 119.58 27.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.987 1.715 . . . . 0.0 107.414 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.07 141.99 35.33 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.878 0.847 . . . . 0.0 109.871 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.1 t -114.75 112.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.875 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.63 172.16 14.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.53 -59.0 2.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -74.73 -22.28 58.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -81.36 146.78 30.16 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.02 152.8 51.3 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 123.868 0.867 . . . . 0.0 110.617 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.2 mt -80.78 114.44 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.67 -31.04 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.687 0.795 . . . . 0.0 112.012 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.2 166.77 26.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.652 1.181 . . . . 0.0 108.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.46 117.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -95.14 126.16 40.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.8 146.26 29.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.81 0.844 . . . . 0.0 109.869 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 p -120.74 152.51 38.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -154.2 168.72 25.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.106 0.962 . . . . 0.0 108.517 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.19 168.96 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.2 108.41 10.32 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.793 2.037 . . . . 0.0 108.458 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.54 147.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.861 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -62.21 149.6 41.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.35 88.83 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.642 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -139.58 164.44 29.9 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.028 2.131 . . . . 0.0 106.704 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -125.02 0.71 7.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.418 1.087 . . . . 0.0 111.295 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.1 t -98.48 157.66 16.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.48 153.27 24.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -131.7 141.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 125.75 1.62 . . . . 0.0 107.802 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.42 128.53 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.8 p -104.7 -27.19 11.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.8 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.0 t -154.67 159.62 40.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.158 1.344 . . . . 0.0 109.022 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.5 mm -141.6 141.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 128.023 2.529 . . . . 0.0 106.368 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -151.12 108.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.383 1.473 . . . . 0.0 107.565 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -77.88 150.22 34.16 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -123.84 114.06 19.36 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.1 p -82.84 162.26 21.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.982 1.313 . . . . 0.0 111.409 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.2 -30.71 70.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -17.37 59.41 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.238 -0.914 . . . . 0.0 112.777 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 2.98 60.43 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 119.3 0.954 . . . . 0.0 111.132 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -79.36 89.45 4.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 147.46 26.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.089 0.555 . . . . 0.0 109.904 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.8 p -84.86 161.91 51.59 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.055 0.942 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.92 164.66 34.92 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 N-CA-C 108.586 -1.352 . . . . 0.0 108.586 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.05 109.61 2.92 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 N-CA-C 106.466 -2.167 . . . . 0.0 106.466 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 9.41 0.18 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -169.55 -170.12 33.66 Favored Glycine 0 N--CA 1.442 -0.9 0 O-C-N 120.76 -1.213 . . . . 0.0 111.427 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.3 106.03 8.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.617 0.767 . . . . 0.0 111.11 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.65 109.53 1.06 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 m -100.44 166.34 10.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.547 0.739 . . . . 0.0 110.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.39 -52.86 61.93 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.725 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -62.9 117.01 5.79 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -157.57 159.65 37.33 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -139.57 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.269 1.828 . . . . 0.0 110.556 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.82 114.29 3.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.812 1.245 . . . . 0.0 108.237 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.17 128.57 36.38 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 138.97 9.3 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.5 175.35 9.31 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.321 1.049 . . . . 0.0 110.855 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -106.96 -25.93 11.42 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.588 1.155 . . . . 0.0 110.967 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -119.98 33.63 5.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.571 1.548 . . . . 0.0 111.387 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.84 31.63 81.56 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 174.63 2.65 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.001 1.762 . . . . 0.0 114.853 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -125.68 137.0 53.83 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.601 1.16 . . . . 0.0 109.506 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.39 151.54 43.78 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 0.0 109.3 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.58 -62.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.09 164.5 32.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.1 160.43 14.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.941 0.896 . . . . 0.0 111.283 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.59 149.3 35.56 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.859 2.064 . . . . 0.0 107.04 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.83 172.51 24.43 Favored Glycine 0 C--O 1.229 -0.217 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -142.25 37.62 1.55 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.297 1.439 . . . . 0.0 107.412 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.02 111.8 20.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.645 1.178 . . . . 0.0 110.206 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.69 -101.34 0.32 Allowed Glycine 0 CA--C 1.519 0.305 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.37 -31.65 58.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.536 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.6 169.17 17.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.381 1.472 . . . . 0.0 110.745 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -75.91 88.44 2.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.715 1.206 . . . . 0.0 113.264 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.38 -32.77 16.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.03 139.73 19.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.165 0.986 . . . . 0.0 109.28 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.6 tp -158.85 113.1 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.182 1.393 . . . . 0.0 108.379 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.25 -175.94 14.78 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.436 1.493 . . . . 0.0 111.298 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -146.6 159.51 43.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.43 1.115 . . . . 0.0 111.261 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -99.39 154.99 17.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.384 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.51 118.37 21.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.807 1.243 . . . . 0.0 108.81 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 125.905 1.682 . . . . 0.0 108.661 178.769 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.868 0.842 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 122.09 28.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -106.0 147.56 28.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 67.9 mt -125.09 122.51 37.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.97 2.108 . . . . 0.0 107.161 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -69.15 108.39 3.59 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 127.143 2.177 . . . . 0.0 107.081 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.03 -178.58 2.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.078 0.951 . . . . 0.0 111.228 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.5 pt -108.15 156.13 8.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 108.389 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.31 -109.88 0.49 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -156.39 -162.6 11.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.989 1.757 . . . . 0.0 109.629 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -121.65 13.6 10.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.853 1.261 . . . . 0.0 111.383 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -107.65 120.77 43.14 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 112.163 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.36 -172.84 36.86 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.867 1.699 . . . . 0.0 109.506 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 m -96.3 146.21 24.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -103.08 138.37 40.01 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.582 -0.699 . . . . 0.0 110.973 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -155.74 58.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.33 104.22 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.02 -24.65 21.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.864 -0.522 . . . . 0.0 112.049 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.0 -118.71 4.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -135.42 135.66 40.78 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.353 1.577 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -91.4 170.6 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -42.62 64.78 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.58 134.01 3.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.18 156.82 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.065 1.746 . . . . 0.0 107.685 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -127.03 -64.1 1.02 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -126.3 155.31 42.17 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.512 0.597 . . . . 0.0 111.756 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -121.56 146.11 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.588 1.955 . . . . 0.0 107.255 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -137.07 146.44 45.17 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.599 0.76 . . . . 0.0 109.197 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.2 132.41 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.22 65.82 0.56 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.42 1.009 . . . . 0.0 112.404 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -78.72 176.51 9.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.375 1.07 . . . . 0.0 109.981 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.61 23.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -69.75 -20.35 63.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.683 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -115.6 -16.81 11.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.275 0.943 . . . . 0.0 113.516 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.89 30.76 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.193 0.906 . . . . 0.0 112.925 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.77 111.91 6.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.1 0.96 . . . . 0.0 108.946 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -96.02 -37.1 10.78 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.905 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.18 155.58 47.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.56 1.171 . . . . 0.0 111.777 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.51 148.16 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -168.3 142.17 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.407 1.883 . . . . 0.0 106.764 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -139.14 155.36 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -108.84 130.1 55.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -140.98 168.41 19.85 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.986 0.914 . . . . 0.0 111.741 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -147.39 133.84 19.71 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.76 1.224 . . . . 0.0 110.966 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -140.05 147.21 40.0 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.74 -100.13 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 124.657 1.122 . . . . 0.0 112.715 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.36 12.82 4.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.84 1.656 . . . . 0.0 110.881 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -127.48 110.66 12.97 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.302 1.041 . . . . 0.0 112.019 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.47 152.47 34.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.318 1.847 . . . . 0.0 107.302 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.0 mm -132.88 129.63 58.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.119 0.968 . . . . 0.0 109.534 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.22 141.5 45.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 118.34 -135.46 11.6 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.85 23.65 66.31 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.971 0.385 . . . . 0.0 112.542 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -78.75 78.98 5.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -84.7 21.49 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.582 1.153 . . . . 0.0 112.534 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.95 156.18 26.89 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 119.809 -1.807 . . . . 0.0 108.889 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -71.3 129.76 88.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.56 155.1 71.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.53 2.153 . . . . 0.0 109.084 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.5 p -98.76 173.03 7.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.953 0.901 . . . . 0.0 109.587 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 40.1 tp -75.08 -18.57 60.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.7 tt -68.3 -34.73 76.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.385 . . . . 0.0 108.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 101.78 -132.38 10.95 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -142.33 -179.67 6.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.061 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.42 158.03 43.97 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 131.414 3.885 . . . . 0.0 104.711 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.96 147.78 34.41 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.687 1.131 . . . . 0.0 113.77 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.48 32.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.741 1.217 . . . . 0.0 109.402 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.74 113.86 21.28 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.681 1.192 . . . . 0.0 107.807 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.04 103.17 9.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.58 115.74 15.56 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -56.67 -32.0 11.87 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.06 8.46 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 124.015 2.47 . . . . 0.0 113.569 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.7 m -145.45 -68.12 0.29 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.975 -1.078 . . . . 0.0 110.034 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -84.78 151.84 24.08 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 119.123 0.874 . . . . 0.0 110.095 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -143.58 168.13 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.636 1.684 . . . . 0.0 115.177 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.3 mm -109.05 124.98 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 127.742 2.417 . . . . 0.0 105.263 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 t -115.84 -15.38 11.28 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.708 1.14 . . . . 0.0 113.139 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -154.02 170.34 21.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.829 1.251 . . . . 0.0 107.913 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.91 125.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.64 170.08 8.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 157.52 -178.73 33.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.6 p -137.18 153.73 50.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -131.26 144.33 51.22 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.49 165.23 23.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.747 0.419 . . . . 0.0 110.12 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -95.44 148.22 22.71 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.124 1.37 . . . . 0.0 113.174 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.87 138.95 22.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -75.34 152.13 38.17 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.407 -0.808 . . . . 0.0 109.169 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.21 1.51 89.51 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.299 0.952 . . . . 0.0 112.979 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 59.3 m -140.79 179.54 6.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.493 1.517 . . . . 0.0 109.794 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -125.39 66.41 1.15 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -162.88 -177.82 36.2 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 121.548 -0.72 . . . . 0.0 112.395 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.77 167.23 22.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.056 1.742 . . . . 0.0 112.13 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.67 158.62 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.066 2.147 . . . . 0.0 109.338 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.4 mm -72.52 126.98 34.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.2 m -107.61 -31.11 8.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 111.712 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -144.65 154.65 43.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -140.74 130.44 24.24 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.941 1.697 . . . . 0.0 109.553 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -129.31 109.35 11.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.963 1.305 . . . . 0.0 107.759 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -76.64 139.81 40.73 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -121.95 114.13 20.57 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.2 p -112.19 165.32 12.26 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.138 2.575 . . . . 0.0 109.714 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -100.74 150.97 22.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 65.21 -35.11 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.415 2.286 . . . . 0.0 114.298 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -120.08 174.2 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.575 1.95 . . . . 0.0 110.113 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.0 t -125.77 148.51 49.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.7 m -115.09 -0.34 13.36 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 74.8 163.81 0.14 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.513 2.325 . . . . 0.0 113.537 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -86.53 150.15 8.88 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.672 2.915 . . . . 0.0 109.674 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.94 112.13 13.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.79 176.53 26.93 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.802 1.192 . . . . 0.0 110.776 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.5 tt -97.56 118.57 34.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.606 1.163 . . . . 0.0 108.397 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -59.1 109.72 0.9 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.743 1.217 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -149.5 150.93 33.08 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.065 1.746 . . . . 0.0 106.821 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 84.11 -169.54 46.16 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 67.3 m -76.55 139.81 40.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 0.0 108.406 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -94.91 137.5 33.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.317 1.047 . . . . 0.0 109.945 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -130.61 148.3 52.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.247 1.019 . . . . 0.0 108.752 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -150.9 103.67 3.09 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 122.062 -0.399 . . . . 0.0 110.296 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.89 140.85 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.79 165.05 32.62 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.31 0.504 . . . . 0.0 112.289 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -146.28 167.48 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -132.23 137.27 47.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.7 17.78 76.86 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 118.818 0.736 . . . . 0.0 112.588 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -143.44 172.24 13.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.316 1.847 . . . . 0.0 109.175 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.455 ' HE3' ' CG1' ' A' ' 277' ' ' VAL . 0.1 OUTLIER -141.42 160.69 39.61 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.035 0.934 . . . . 0.0 109.916 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.6 mt -81.93 134.99 25.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.455 ' CG1' ' HE3' ' A' ' 275' ' ' LYS . 28.0 m -141.52 1.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.47 33.71 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 120.174 1.352 . . . . 0.0 113.385 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' A' ' 290' ' ' PHE . 3.0 t80 -145.79 134.04 21.72 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.557 2.343 . . . . 0.0 107.842 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -141.54 147.39 37.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.154 2.582 . . . . 0.0 104.228 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.48 -144.62 12.71 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 149.2 29.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 122.052 0.929 . . . . 0.0 110.819 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -155.64 154.4 31.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.341 1.857 . . . . 0.0 106.797 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.2 t -146.38 -106.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.73 -23.1 60.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 119.943 1.247 . . . . 0.0 109.236 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.99 159.86 41.86 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 129.029 2.932 . . . . 0.0 108.79 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.3 tp -78.89 131.03 36.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -119.34 -32.21 4.43 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.561 -1.209 . . . . 0.0 113.001 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -140.05 125.39 18.92 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.59 1.541 . . . . 0.0 107.051 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.414 ' HA ' ' CE1' ' A' ' 279' ' ' PHE . 15.8 t80 -122.11 97.69 5.6 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.86 98.51 2.09 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 130.43 36.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -90.37 153.97 20.03 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.324 0.65 . . . . 0.0 109.81 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 18.1 m -126.43 138.11 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.1 0.96 . . . . 0.0 109.735 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 73.4 mtp -143.56 152.05 55.61 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.151 1.38 . . . . 0.0 107.667 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.24 152.98 79.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.436 2.091 . . . . 0.0 113.721 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.232 0.145 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.397 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.415 ' H ' ' HB2' ' A' ' 144' ' ' ALA . 16.2 mm-40 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -140.05 138.66 35.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.78 136.48 44.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.36 140.76 55.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.239 0.542 . . . . 0.0 110.763 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 164.82 19.26 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.157 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.23 145.96 18.01 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.62 -175.51 18.25 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 126.202 1.858 . . . . 0.0 110.829 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.55 -163.88 7.29 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.757 1.646 . . . . 0.0 113.865 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.0 0.22 43.43 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.172 1.389 . . . . 0.0 112.287 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.86 165.61 54.78 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.05 152.48 20.04 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.318 0.961 . . . . 0.0 111.941 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.5 114.51 6.16 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m 97.32 59.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 129.794 3.238 . . . . 0.0 118.284 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.429 ' CE3' ' CB ' ' A' ' 129' ' ' HIS . 30.9 p-90 -62.55 -14.96 48.04 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.592 1.557 . . . . 0.0 113.817 175.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.87 112.96 10.49 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.8 -37.42 71.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.002 0.521 . . . . 0.0 111.762 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.695 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.281 0 CA-C-O 118.142 -1.366 . . . . 0.0 114.395 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.62 128.03 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 120.116 1.958 . . . . 0.0 108.452 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -114.65 -56.75 2.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.891 1.276 . . . . 0.0 110.31 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -138.87 169.48 17.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.744 2.418 . . . . 0.0 106.897 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.03 142.65 25.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -127.76 107.93 10.3 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.97 134.89 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.87 142.59 14.03 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.21 161.23 14.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.525 1.13 . . . . 0.0 110.009 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.79 -167.99 32.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 125.587 1.565 . . . . 0.0 109.291 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.02 -38.63 83.26 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.096 0.558 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.86 11.72 2.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.221 1.408 . . . . 0.0 111.335 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.5 -136.37 15.37 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.82 106.96 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -14.38 14.87 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.0 p -131.16 139.03 49.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.152 1.342 . . . . 0.0 109.61 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 mm -142.88 140.66 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 126.328 1.851 . . . . 0.0 106.263 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -154.74 140.19 17.79 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.594 1.958 . . . . 0.0 105.886 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.54 156.17 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.32 144.04 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -116.73 105.22 12.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.59 125.21 27.47 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.906 -1.122 . . . . 0.0 108.284 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.77 160.57 19.26 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.39 -8.78 14.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.038 1.335 . . . . 0.0 111.606 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -101.56 -68.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 106.863 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -154.57 165.8 35.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.59 139.2 43.51 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.29 145.89 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -112.06 153.63 26.6 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.735 -1.228 . . . . 0.0 111.031 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 -123.75 2.03 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.18 176.6 35.96 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -75.13 142.04 43.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.21 65.1 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.268 2.227 . . . . 0.0 105.702 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.7 -164.01 37.59 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.56 123.26 43.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 143.26 51.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -106.9 -177.65 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.862 0.839 . . . . 0.0 111.86 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.2 tp -89.59 -39.59 13.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.059 0.944 . . . . 0.0 108.811 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -54.34 -38.56 66.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.988 2.115 . . . . 0.0 112.786 -178.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.06 163.37 27.68 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-O 124.102 1.946 . . . . 0.0 108.427 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -109.63 162.94 13.94 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 110.966 -2.617 . . . . 0.0 108.854 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 164.23 13.94 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.078 1.751 . . . . 0.0 110.512 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.6 m -119.38 99.28 6.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.099 0.959 . . . . 0.0 113.53 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -87.72 140.63 29.32 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.06 130.71 52.83 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.649 1.579 . . . . 0.0 111.992 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.8 t -115.18 110.07 30.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 124.858 1.263 . . . . 0.0 108.276 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -69.84 173.18 6.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.054 1.341 . . . . 0.0 109.734 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.3 87.55 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.858 -1.151 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.95 7.65 41.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.349 1.459 . . . . 0.0 112.883 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.64 135.6 38.34 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.84 125.67 27.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mt -75.25 121.65 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.28 -19.17 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.82 147.18 29.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.01 113.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.26 130.56 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.46 144.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.824 1.25 . . . . 0.0 107.697 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -128.19 137.15 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -146.34 148.15 32.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.48 169.36 21.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.73 0.695 . . . . 0.0 110.185 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.31 148.05 33.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.906 1.282 . . . . 0.0 110.546 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.4 161.16 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.821 1.248 . . . . 0.0 108.792 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -61.83 129.11 39.41 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.414 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.15 -10.43 70.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.158 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.46 77.3 1.76 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.295 -2.484 . . . . 0.0 104.295 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.4 -9.49 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.345 2.258 . . . . 0.0 113.336 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.54 127.32 37.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.02 1.328 . . . . 0.0 109.207 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.04 114.14 4.98 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.3 pt -110.08 151.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.349 0.977 . . . . 0.0 110.412 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 mm -66.12 109.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 108.084 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -80.1 -28.55 39.02 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.682 -0.636 . . . . 0.0 110.967 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.4 ' HG ' ' HB2' ' A' ' 106' ' ' PRO . 3.5 t -170.51 174.0 5.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 109.476 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.68 144.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.617 1.967 . . . . 0.0 107.28 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.5 m -138.38 104.06 5.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.236 1.414 . . . . 0.0 107.612 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -78.81 150.5 32.31 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.871 -1.143 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.48 120.51 16.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -109.25 164.6 12.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.866 0.841 . . . . 0.0 112.895 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -63.68 -25.39 68.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.198 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -79.56 -5.5 55.07 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.531 -0.731 . . . . 0.0 110.727 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.77 2.68 62.83 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.833 1.206 . . . . 0.0 111.307 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -67.06 135.27 53.41 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.84 109.87 10.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.8 p -75.96 156.68 84.16 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.68 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.84 165.14 33.6 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 106.814 -2.033 . . . . 0.0 106.814 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HB2' ' HG ' ' A' ' 93' ' ' SER . 56.3 Cg_endo -66.71 108.5 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.069 2.512 . . . . 0.0 107.393 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -79.83 71.42 6.5 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.49 -130.87 3.46 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 tp -139.78 105.9 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.732 2.013 . . . . 0.0 106.649 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 1.5 mt-10 -59.52 148.56 32.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.66 178.82 5.87 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 109.328 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.06 -54.88 35.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.59 130.76 48.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 1.1 ptpm? -160.18 166.47 29.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -150.43 160.4 43.78 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.89 2.076 . . . . 0.0 107.01 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.68 118.83 5.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -105.82 140.06 39.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 172.51 17.28 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 126.988 2.115 . . . . 0.0 108.875 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.05 175.81 7.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.913 1.685 . . . . 0.0 111.243 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -145.75 -15.39 0.48 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.081 0.553 . . . . 0.0 111.982 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.61 1.48 6.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.307 1.443 . . . . 0.0 110.871 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.01 108.48 0.99 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.39 162.96 36.75 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -110.23 159.08 17.71 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.083 1.353 . . . . 0.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.0 tt -72.86 130.13 39.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.15 -14.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.37 47.43 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -135.69 171.71 14.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.758 1.223 . . . . 0.0 112.442 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CB ' ' CE3' ' A' ' 15' ' ' TRP . 10.7 p80 -164.37 168.65 18.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.953 1.301 . . . . 0.0 109.986 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.92 -82.33 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 170.93 86.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 C-N-CA 129.359 3.064 . . . . 0.0 108.136 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -137.16 164.59 28.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.8 -99.45 0.12 Allowed Glycine 0 C--O 1.227 -0.341 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.42 -0.19 40.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.706 0.802 . . . . 0.0 113.154 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.54 166.51 26.93 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 126.19 1.796 . . . . 0.0 106.587 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -94.49 81.89 3.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -79.41 -64.75 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.584 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.45 131.18 35.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.451 0.7 . . . . 0.0 110.697 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 tp -155.38 173.64 16.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.554 0.692 . . . . 0.0 111.059 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.78 161.61 34.38 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 127.482 2.468 . . . . 0.0 107.902 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.56 159.56 35.96 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.357 1.063 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -121.91 159.01 27.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.515 0.726 . . . . 0.0 111.237 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -135.87 97.23 3.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' GLN . . . . . . . . 0 CA--C 1.533 0.327 0 C-N-CA 127.005 2.122 . . . . 0.0 111.205 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.801 0.81 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -98.38 147.53 24.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.329 0.651 . . . . 0.0 109.445 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -113.58 146.0 40.38 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -111.06 -176.4 2.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.137 0.975 . . . . 0.0 109.768 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 122.9 48.67 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.842 1.257 . . . . 0.0 110.515 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.57 177.61 8.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.252 1.421 . . . . 0.0 111.604 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.46 160.9 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 125.7 1.6 . . . . 0.0 108.096 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.77 -102.26 0.14 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 125.771 1.653 . . . . 0.0 111.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 163' ' ' GLU . . . 61.65 -117.44 11.56 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 65.65 -25.82 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 128.875 2.87 . . . . 0.0 114.481 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 161' ' ' GLY . 1.7 tm-20 -132.25 148.0 52.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.043 1.737 . . . . 0.0 108.88 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.08 176.17 15.05 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 128.212 2.815 . . . . 0.0 107.363 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.0 m -80.8 142.04 34.12 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.71 110.14 14.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.87 130.79 9.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 120.034 1.288 . . . . 0.0 113.355 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.4 148.75 23.38 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.73 -27.85 17.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.321 1.448 . . . . 0.0 109.255 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 83.24 -147.55 24.64 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.95 138.86 18.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 194' ' ' TYR . 69.1 m-85 -111.76 179.85 3.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.97 0.508 . . . . 0.0 111.849 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.96 -36.5 62.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.952 0.882 . . . . 0.0 110.361 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.24 -177.31 44.22 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 127.929 2.68 . . . . 0.0 107.504 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 20.9 m -121.94 157.79 25.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 125.989 1.716 . . . . 0.0 108.033 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -50.64 2.14 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.529 0.604 . . . . 0.0 109.591 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -140.93 140.23 34.44 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 118.791 0.723 . . . . 0.0 109.736 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.53 142.1 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -133.95 152.7 51.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.507 0.723 . . . . 0.0 109.181 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.71 144.8 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -140.42 134.54 6.54 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -141.2 174.43 10.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.921 0.867 . . . . 0.0 112.093 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.62 -172.85 13.13 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 128.591 2.996 . . . . 0.0 106.41 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -65.56 -23.75 66.93 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.044 -0.68 . . . . 0.0 110.661 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -17.58 60.65 Favored 'General case' 0 N--CA 1.451 -0.38 1 C-N-CA 132.083 4.153 . . . . 0.0 112.8 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.82 -163.04 12.37 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mm -62.38 124.12 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.09 -19.09 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.752 1.221 . . . . 0.0 113.908 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.26 150.04 47.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.458 1.026 . . . . 0.0 111.846 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.63 142.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -164.48 168.56 18.25 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.959 2.504 . . . . 0.0 106.565 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.14 175.5 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.34 128.77 38.39 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.427 ' CE2' ' CD1' ' A' ' 172' ' ' TYR . 20.0 p90 -153.26 168.32 26.4 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.991 0.917 . . . . 0.0 110.236 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -115.91 149.32 38.9 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.615 1.566 . . . . 0.0 109.567 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -125.93 123.87 39.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 60.83 -98.83 0.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.36 18.29 5.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 112.293 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -130.51 125.09 33.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.977 0.911 . . . . 0.0 111.281 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -75.76 153.43 37.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.464 1.106 . . . . 0.0 108.582 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.03 136.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.684 1.594 . . . . 0.0 107.147 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.21 128.66 72.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 149.07 -120.98 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.12 -10.26 8.08 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.025 1.774 . . . . 0.0 113.799 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.53 132.34 48.35 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.241 1.52 . . . . 0.0 109.786 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -154.93 -40.85 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.578 0.751 . . . . 0.0 112.258 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.99 151.11 36.68 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 107.314 -2.315 . . . . 0.0 107.314 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -37.79 99.59 0.19 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.529 2.331 . . . . 0.0 114.775 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.29 151.55 54.52 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.9 m -122.97 152.64 40.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.01 -11.56 40.43 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.854 -0.529 . . . . 0.0 111.172 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.77 -24.97 67.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.29 1.836 . . . . 0.0 109.497 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.21 -156.77 17.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -139.52 152.97 47.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 106.21 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.19 154.16 21.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.63 157.07 44.37 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.899 0.48 . . . . 0.0 112.134 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -142.58 139.94 31.54 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.235 1.014 . . . . 0.0 110.606 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.65 125.98 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.77 110.59 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.94 89.18 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -36.16 -52.69 1.65 Allowed Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.89 -14.39 15.47 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.32 2.013 . . . . 0.0 114.515 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -93.66 -40.71 10.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.663 1.574 . . . . 0.0 109.404 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -92.19 172.25 8.54 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 107.418 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -146.42 -20.32 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.797 -1.189 . . . . 0.0 112.325 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp 49.88 88.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 127.922 2.489 . . . . 0.0 109.036 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.0 p -90.13 -4.46 57.29 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.76 163.13 34.89 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.16 153.28 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.267 1.427 . . . . 0.0 107.49 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.4 178.22 7.09 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.196 1.798 . . . . 0.0 109.776 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.49 -179.54 40.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.6 p -141.08 141.13 34.28 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -134.87 153.26 52.12 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.951 0.5 . . . . 0.0 111.751 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.442 ' OD1' ' HE2' ' A' ' 235' ' ' LYS . 2.6 t0 -136.29 170.91 15.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.202 1.001 . . . . 0.0 109.558 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.442 ' HE2' ' OD1' ' A' ' 234' ' ' ASP . 0.0 OUTLIER -88.55 147.98 24.33 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.88 1.272 . . . . 0.0 112.732 -178.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.62 117.47 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -63.01 145.09 56.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 79.29 1.5 86.0 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.283 -0.731 . . . . 0.0 112.729 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 m -138.17 -177.5 4.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.995 2.118 . . . . 0.0 108.511 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.8 87.74 2.31 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.54 -176.25 39.26 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.022 -1.049 . . . . 0.0 111.012 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.69 149.66 49.43 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.081 0.952 . . . . 0.0 111.276 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.7 tt -134.18 130.5 54.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.962 1.705 . . . . 0.0 106.792 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.31 128.72 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.4 t -111.84 -18.79 12.62 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.723 1.209 . . . . 0.0 111.827 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -144.61 154.52 42.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.905 0.482 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.36 143.17 30.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.272 1.829 . . . . 0.0 109.195 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -142.79 153.78 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -128.54 113.48 15.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -77.89 113.71 16.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 p -98.24 164.76 12.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.924 2.089 . . . . 0.0 108.559 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -112.65 147.26 37.11 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 57.86 11.34 1.36 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -155.5 147.64 23.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.074 1.749 . . . . 0.0 106.934 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.5 p -113.14 100.24 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.438 1.495 . . . . 0.0 108.619 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -65.38 161.55 19.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.365 2.266 . . . . 0.0 114.441 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -105.2 163.1 17.84 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 127.186 2.195 . . . . 0.0 111.067 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.39 159.28 29.33 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.831 2.354 . . . . 0.0 110.415 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -137.3 110.91 8.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.96 -167.01 15.81 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 118.731 0.696 . . . . 0.0 112.417 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.48 110.6 23.0 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.906 1.283 . . . . 0.0 109.581 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -66.02 108.75 2.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.425 1.49 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.9 28.64 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.058 1.343 . . . . 0.0 109.529 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.88 -164.81 50.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 122.548 1.082 . . . . 0.0 114.236 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 59.7 m -64.54 108.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.199 2.2 . . . . 0.0 109.095 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.75 142.31 38.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -141.45 170.95 14.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.391 1.091 . . . . 0.0 111.234 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.43 155.47 39.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.427 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.95 154.78 48.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -170.45 173.07 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.567 1.147 . . . . 0.0 107.911 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -139.47 165.94 25.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -43.77 71.48 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.845 0.748 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -161.03 72.23 0.22 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-O 118.995 -0.892 . . . . 0.0 111.835 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -151.05 158.03 43.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.325 1.063 . . . . 0.0 109.742 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -88.82 177.11 6.79 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.025 1.73 . . . . 0.0 108.717 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 37.8 mt -125.0 111.33 27.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.997 1.319 . . . . 0.0 108.608 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.27 93.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.255 2.222 . . . . 0.0 108.967 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.77 6.19 Favored Glycine 0 N--CA 1.468 0.771 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -120.6 135.65 55.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.224 1.809 . . . . 0.0 111.347 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -133.04 136.73 46.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 161.51 -159.93 31.76 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.926 -1.109 . . . . 0.0 112.64 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -137.21 127.4 26.22 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.21 154.68 19.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.94 1.296 . . . . 0.0 109.278 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 37.0 t -147.04 -98.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.71 -21.26 44.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.247 1.019 . . . . 0.0 111.456 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.3 mp -136.21 153.11 51.33 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.13 83.77 4.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.616 0.766 . . . . 0.0 111.225 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -78.94 -22.11 46.22 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.425 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.44 152.62 50.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.876 1.216 . . . . 0.0 113.12 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -162.69 134.9 5.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -158.82 169.67 35.18 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 135.15 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.852 0.826 . . . . 0.0 111.565 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -74.78 145.11 43.21 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.63 136.02 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.522 0.677 . . . . 0.0 110.548 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 70.3 mtp -138.62 137.06 19.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 129.372 3.069 . . . . 0.0 106.287 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.36 165.81 30.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.765 . . . . 0.0 109.589 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.409 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -142.15 102.88 4.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.201 0.6 . . . . 0.0 109.886 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t -75.52 143.29 13.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -97.23 134.62 40.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.524 1.53 . . . . 0.0 111.587 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.29 167.63 19.05 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.762 1.225 . . . . 0.0 111.687 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.3 163.51 30.66 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.568 2.032 . . . . 0.0 108.562 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.08 -109.08 0.41 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 107.053 -2.419 . . . . 0.0 107.053 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.3 -171.43 15.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 125.318 1.437 . . . . 0.0 109.628 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.34 91.72 2.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.482 0.713 . . . . 0.0 110.253 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.59 18.77 3.01 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.167 1.365 . . . . 0.0 112.231 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.88 -177.73 16.5 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.724 1.262 . . . . 0.0 113.054 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.99 158.43 27.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.752 1.263 . . . . 0.0 111.616 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 p -63.29 131.96 50.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -134.41 -19.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.212 1.005 . . . . 0.0 110.64 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.85 100.71 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.5 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.46 1.504 . . . . 0.0 107.727 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.463 0 C-N-CA 125.058 1.313 . . . . 0.0 109.918 -179.696 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.105 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.45 155.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.738 . . . . 0.0 108.978 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ttt-85 -130.86 -32.58 1.64 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -138.9 167.95 20.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.225 1.01 . . . . 0.0 109.555 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -139.46 85.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -87.83 135.29 33.46 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.88 148.62 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 127.473 2.309 . . . . 0.0 106.861 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.44 -157.87 10.65 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -134.08 164.2 27.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.732 0.766 . . . . 0.0 110.005 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.25 37.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 129.059 3.218 . . . . 0.0 105.97 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -91.68 -32.66 15.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.168 0.484 . . . . 0.0 110.131 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -101.11 -23.61 14.44 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 130.989 3.715 . . . . 0.0 114.094 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.56 -165.78 38.33 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.639 1.563 . . . . 0.0 112.97 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.71 96.07 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 107.956 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -75.54 -21.55 57.83 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -128.44 139.62 52.25 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.926 1.694 . . . . 0.0 113.728 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -145.28 154.01 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -140.4 137.99 34.43 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.89 159.07 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.489 1.041 . . . . 0.0 112.206 -178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.01 135.84 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -124.85 104.64 8.73 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.21 110.86 17.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.87 1.268 . . . . 0.0 108.852 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -116.74 139.55 50.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 61.54 -161.29 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.914 1.286 . . . . 0.0 109.176 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -73.07 24.78 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.246 1.418 . . . . 0.0 112.131 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -141.03 165.42 27.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.468 1.907 . . . . 0.0 111.34 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -107.84 140.25 41.21 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.81 133.73 48.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -66.95 129.02 38.54 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.45 -60.2 4.86 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.24 167.73 14.21 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -118.99 85.71 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.504 1.922 . . . . 0.0 107.561 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -83.83 170.41 14.14 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.871 0.843 . . . . 0.0 109.637 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.78 -166.12 42.79 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.479 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -111.33 102.72 11.09 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.801 1.241 . . . . 0.0 109.063 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -61.04 134.05 56.68 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 p -134.31 111.86 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.152 1.381 . . . . 0.0 109.566 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -8.24 13.37 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.08 -4.82 43.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.435 0.694 . . . . 0.0 111.692 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.89 110.46 0.28 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.68 143.15 19.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.064 2.946 . . . . 0.0 106.267 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.4 164.14 30.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.528 1.931 . . . . 0.0 110.876 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.3 m -128.03 128.5 45.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.774 1.63 . . . . 0.0 108.665 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -137.18 136.11 37.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.65 142.07 51.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.889 0.876 . . . . 0.0 109.144 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.4 t -98.34 110.5 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.73 161.36 30.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 109.137 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.97 -27.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -28.66 28.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -112.03 146.95 37.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -132.98 157.07 46.09 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.441 0.696 . . . . 0.0 109.783 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.29 138.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.34 -20.77 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.261 1.424 . . . . 0.0 111.851 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.0 156.31 42.51 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.349 -0.845 . . . . 0.0 109.346 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.71 100.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -86.31 122.49 30.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 101.353 -3.573 . . . . 0.0 101.353 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.09 153.91 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -136.52 151.91 49.94 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.048 1.739 . . . . 0.0 107.108 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.29 166.28 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.444 1.098 . . . . 0.0 110.409 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.19 169.17 22.79 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.769 1.168 . . . . 0.0 111.507 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -115.07 151.45 34.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.844 2.058 . . . . 0.0 110.71 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.34 126.91 74.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.28 121.9 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 108.745 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 -3.19 26.91 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.532 1.063 . . . . 0.0 112.183 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -132.13 144.82 50.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.369 1.467 . . . . 0.0 107.617 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.89 -21.5 23.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.22 0.608 . . . . 0.0 109.516 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -67.59 -177.65 0.78 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.373 1.559 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.39 151.59 34.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.52 144.73 28.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.34 0.656 . . . . 0.0 109.846 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.35 122.34 20.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -89.71 -28.99 19.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.041 0.936 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 t -163.11 160.87 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.448 1.476 . . . . 0.0 110.644 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.82 129.11 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 126.56 1.944 . . . . 0.0 108.55 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -135.49 101.45 4.81 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.115 1.366 . . . . 0.0 109.083 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -80.85 154.45 27.1 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.591 -1.318 . . . . 0.0 108.624 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.55 125.39 27.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.7 p -93.69 167.16 11.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.148 0.975 . . . . 0.0 111.668 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -65.94 -21.97 66.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -7.07 52.74 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.295 1.038 . . . . 0.0 111.686 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.6 -4.08 75.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 125.534 1.54 . . . . 0.0 111.587 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -79.35 149.59 31.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 118.492 1.146 . . . . 0.0 108.404 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.7 p -134.3 135.73 43.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.68 163.39 61.26 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.18 162.3 42.09 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.39 101.68 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.35 2.7 . . . . 0.0 108.546 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -73.45 78.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 145.48 -135.3 5.89 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.6 tp -139.43 127.91 22.95 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 127.06 2.144 . . . . 0.0 107.386 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.47 155.5 40.36 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.217 0.917 . . . . 0.0 110.917 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -142.45 164.51 29.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.068 0.947 . . . . 0.0 108.909 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -60.98 -40.89 95.2 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -70.43 112.14 6.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -155.17 160.23 40.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.197 -0.94 . . . . 0.0 111.327 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.92 165.81 35.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.607 0.763 . . . . 0.0 112.133 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.53 150.26 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.977 1.711 . . . . 0.0 106.454 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 mt -111.7 4.47 18.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -47.09 117.99 1.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.466 1.106 . . . . 0.0 112.975 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -73.32 175.91 6.46 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.004 1.722 . . . . 0.0 108.298 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.67 -11.41 8.64 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.015 -1.053 . . . . 0.0 112.684 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -78.57 -5.97 54.24 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.43 24.63 25.79 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.318 -0.712 . . . . 0.0 112.082 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.25 175.4 11.39 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.584 1.564 . . . . 0.0 112.86 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -132.45 152.84 51.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.82 141.11 58.4 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.45 -33.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.54 -169.5 35.96 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 120.601 -1.312 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.14 172.74 12.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.614 1.566 . . . . 0.0 111.205 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -164.99 149.39 9.02 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 127.955 2.502 . . . . 0.0 105.862 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.14 115.86 0.41 Allowed Glycine 0 C--O 1.221 -0.718 0 C-N-CA 119.616 -1.278 . . . . 0.0 116.001 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -48.97 110.96 0.41 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.533 1.533 . . . . 0.0 107.664 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.22 25.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.878 1.671 . . . . 0.0 108.53 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -168.93 -97.77 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -81.89 -8.19 59.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.16 24.5 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.648 1.979 . . . . 0.0 108.545 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.78 93.98 9.65 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.17 -72.99 0.27 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.992 0.917 . . . . 0.0 111.092 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.2 143.8 38.14 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.296 1.039 . . . . 0.0 109.953 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.7 tp -134.67 115.49 13.85 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.291 1.037 . . . . 0.0 109.641 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -130.87 174.31 19.9 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.158 1.361 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.4 175.43 11.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.617 0.767 . . . . 0.0 110.473 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -117.15 133.54 55.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -126.56 99.32 5.76 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 128.017 2.527 . . . . 0.0 108.581 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 124.544 1.138 . . . . 0.0 108.666 179.287 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.415 0 CA-C-O 122.014 0.912 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -145.76 151.51 38.09 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.484 1.513 . . . . 0.0 108.729 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -112.18 133.66 54.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.227 2.211 . . . . 0.0 106.642 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.99 -173.94 3.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.24 1.016 . . . . 0.0 109.332 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 128.46 44.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -121.19 -179.87 4.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.885 1.274 . . . . 0.0 109.59 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.92 146.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.639 1.176 . . . . 0.0 107.904 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.85 -94.31 0.11 Allowed Glycine 0 C--O 1.228 -0.273 0 C-N-CA 124.979 1.276 . . . . 0.0 110.414 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.57 -157.44 19.19 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.434 ' CA ' ' HE2' ' A' ' 282' ' ' LYS . 6.7 p-10 -116.83 -4.68 11.57 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.867 1.667 . . . . 0.0 111.47 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.37 112.27 11.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.137 2.175 . . . . 0.0 111.669 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.58 161.94 10.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 124.807 1.194 . . . . 0.0 111.729 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.2 m -81.76 142.39 32.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.63 138.05 56.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -125.7 32.36 5.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.16 104.77 3.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -83.79 -50.27 8.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.689 0.795 . . . . 0.0 111.455 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.66 -123.32 1.85 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.25 160.94 43.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.878 2.071 . . . . 0.0 107.865 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.93 163.66 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.196 0.998 . . . . 0.0 109.826 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.27 -32.4 72.54 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.57 102.97 0.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.299 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.5 m -71.25 152.29 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -40.95 5.29 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -140.71 153.17 45.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.674 1.124 . . . . 0.0 108.402 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.24 143.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -126.65 164.18 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.416 0.687 . . . . 0.0 112.551 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.51 128.02 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.47 89.4 0.38 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.928 1.728 . . . . 0.0 111.626 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -74.8 -177.9 3.46 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.893 1.33 . . . . 0.0 112.916 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.08 177.13 35.77 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 128.488 2.947 . . . . 0.0 107.603 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -62.53 -45.83 91.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.261 0.625 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.81 -32.54 57.69 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.336 1.455 . . . . 0.0 110.294 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.55 -168.09 32.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 121.996 0.776 . . . . 0.0 111.321 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.76 119.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.9 m -108.22 -29.08 9.1 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.52 25.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.595 0.758 . . . . 0.0 109.766 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.53 141.7 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.45 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 58.8 pttt -161.39 159.08 27.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.091 0.957 . . . . 0.0 110.256 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.84 174.35 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 108.11 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.95 147.34 33.63 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.343 1.857 . . . . 0.0 108.035 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 196' ' ' LYS . 7.7 t80 -147.45 153.52 39.68 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -128.09 92.21 3.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.531 2.332 . . . . 0.0 105.803 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 19.4 ptmt -89.19 139.72 30.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 49.85 46.4 40.18 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.457 1.027 . . . . 0.0 112.15 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.67 3.88 0.67 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.277 1.831 . . . . 0.0 115.562 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.17 -158.53 0.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.307 1.443 . . . . 0.0 107.312 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -136.73 139.0 41.57 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.376 1.444 . . . . 0.0 110.635 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.8 mt -125.5 122.91 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.806 1.642 . . . . 0.0 107.22 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 27.8 t -112.41 134.86 53.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.98 -119.37 3.28 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.49 5.69 66.81 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.242 1.401 . . . . 0.0 114.002 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.36 118.78 11.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.472 1.509 . . . . 0.0 111.34 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -123.14 13.16 9.65 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 0.0 111.344 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.53 -178.53 21.98 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.744 1.64 . . . . 0.0 109.229 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -106.16 102.8 41.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.065 0.932 . . . . 0.0 110.945 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.18 -175.36 2.67 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.671 2.247 . . . . 0.0 108.427 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.1 p -116.18 174.18 6.19 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.52 -9.39 34.29 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.308 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.74 -27.71 68.14 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.965 0.802 . . . . 0.0 110.371 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.23 -155.51 17.0 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.45 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 41.6 m-85 -134.1 172.18 13.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.435 1.494 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.67 160.8 31.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.49 2.716 . . . . 0.0 105.686 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -137.59 153.61 49.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.307 0.643 . . . . 0.0 111.709 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 256' ' ' SER . 27.7 t80 -142.66 143.05 32.18 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.06 0.944 . . . . 0.0 110.228 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -78.52 115.3 18.13 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.761 1.625 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.36 104.25 11.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -105.75 88.15 2.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -55.29 -33.46 17.63 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.083 -1.436 . . . . 0.0 114.695 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.4 -3.26 12.08 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 CA-C-N 123.585 2.316 . . . . 0.0 111.991 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m -132.44 -8.18 3.29 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 113.31 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -140.47 159.94 41.09 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.525 1.93 . . . . 0.0 110.542 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -144.25 119.93 10.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.422 1.089 . . . . 0.0 109.136 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.3 mt -81.88 94.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -24.16 45.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.22 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -146.72 167.8 22.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.167 0.987 . . . . 0.0 111.362 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.74 150.45 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.906 1.682 . . . . 0.0 106.481 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.426 ' OE1' ' HE3' ' A' ' 250' ' ' LYS . 36.6 mt-10 -132.87 160.44 36.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.398 1.079 . . . . 0.0 108.247 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -177.82 164.74 33.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.6 p -130.9 148.96 52.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -142.34 146.83 35.42 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.548 0.739 . . . . 0.0 109.863 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -130.57 155.2 46.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -69.55 147.11 51.22 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.139 0.976 . . . . 0.0 112.358 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.99 115.9 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -52.64 133.54 36.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.278 0.561 . . . . 0.0 110.522 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.58 82.99 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.389 -1.228 . . . . 0.0 113.086 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.8 t -140.81 169.89 16.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.389 1.595 . . . . 0.0 109.391 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.51 -12.17 38.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.533 1.533 . . . . 0.0 108.183 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -74.08 175.65 47.82 Favored Glycine 0 C--N 1.345 1.062 0 C-N-CA 127.195 2.331 . . . . 0.0 112.16 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.02 169.67 20.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 111.883 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.25 143.74 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.688 1.595 . . . . 0.0 108.467 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -91.38 105.9 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.329 1.0 OUTLIER -104.11 -3.81 24.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.606 0.639 . . . . 0.0 112.165 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -149.52 143.55 25.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.036 -1.04 . . . . 0.0 111.568 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.9 mt -137.49 154.79 49.82 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.999 1.72 . . . . 0.0 111.031 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -142.48 170.84 14.96 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.494 2.317 . . . . 0.0 109.003 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -148.21 113.76 5.65 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.674 1.19 . . . . 0.0 109.406 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.426 ' HE3' ' OE1' ' A' ' 230' ' ' GLU . 67.1 mttt -77.05 114.47 15.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 5.2 p -109.9 165.84 11.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 127.059 2.144 . . . . 0.0 108.272 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -116.95 140.37 49.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 63.17 -8.29 0.14 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.306 1.442 . . . . 0.0 113.739 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -117.07 169.01 9.75 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.735 2.014 . . . . 0.0 107.852 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -130.98 108.16 9.6 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 123.622 0.769 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' SER . . . . . 0.406 ' HA ' ' CE1' ' A' ' 217' ' ' PHE . 4.5 p -79.82 -178.13 6.27 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.825 1.25 . . . . 0.0 109.411 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.87 69.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.12 0.968 . . . . 0.0 110.034 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.97 101.92 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.057 2.504 . . . . 0.0 109.357 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -79.48 95.45 5.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 122.12 -169.64 14.88 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.7 122.32 47.31 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.129 0.972 . . . . 0.0 109.099 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.42 113.26 2.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.864 1.666 . . . . 0.0 110.509 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -154.99 149.0 25.78 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.347 1.459 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 74.89 -165.15 54.72 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 121.869 0.705 . . . . 0.0 114.171 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 21.8 m -62.97 137.97 58.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.523 1.929 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -108.59 121.71 45.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.54 43.21 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.56 0.744 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.97 130.45 43.42 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.602 1.961 . . . . 0.0 107.302 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.8 mt -119.22 129.74 55.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -149.38 171.35 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -138.4 147.09 42.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.17 -4.67 30.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.295 1.438 . . . . 0.0 114.851 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -167.72 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -92.57 168.1 11.48 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.854 1.827 . . . . 0.0 110.698 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.49 162.75 13.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.717 2.007 . . . . 0.0 110.387 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.6 mt -88.64 112.57 24.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.507 1.123 . . . . 0.0 108.892 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.37 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.26 153.12 8.93 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 125.383 1.468 . . . . 0.0 111.946 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -121.86 160.21 25.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.909 2.084 . . . . 0.0 108.779 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -159.29 176.89 11.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.615 0.766 . . . . 0.0 110.262 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 119.12 -111.29 2.05 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 126.549 2.023 . . . . 0.0 108.665 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 282' ' ' LYS . 10.1 mtmp? -146.26 153.55 40.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.854 . . . . 0.0 112.498 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.92 131.22 34.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.132 1.773 . . . . 0.0 107.064 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.8 p -171.6 75.29 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 67.33 -70.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.873 2.469 . . . . 0.0 110.356 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 70.2 mt -81.33 172.56 13.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.217 2.207 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.7 tp -94.51 64.35 3.06 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.206 1.402 . . . . 0.0 109.688 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -61.4 -17.62 54.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -153.55 165.87 34.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -160.5 122.81 3.23 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -155.81 163.61 31.84 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.1 m -133.84 152.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.014 0.907 . . . . 0.0 113.116 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -85.25 167.71 15.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.969 1.708 . . . . 0.0 111.156 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.95 148.3 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.936 1.694 . . . . 0.0 109.092 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 92.1 mmm -152.99 149.07 21.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.634 1.973 . . . . 0.0 107.729 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.76 157.95 54.24 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.813 1.676 . . . . 0.0 110.037 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.341 1.056 . . . . 0.0 108.565 178.224 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -69.96 101.87 1.87 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.622 1.101 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -148.56 102.35 3.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.049 0.94 . . . . 0.0 108.889 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.5 t -77.0 146.47 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 123.803 0.841 . . . . 0.0 109.209 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.96 148.85 25.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.621 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.535 ' HB3' ' HD1' ' A' ' 129' ' ' HIS . . . -78.93 76.22 5.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.278 1.831 . . . . 0.0 109.66 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.84 113.52 4.81 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.9 35.39 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 118.215 1.007 . . . . 0.0 111.389 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.04 178.79 36.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.889 0.756 . . . . 0.0 113.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.6 87.19 2.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.921 1.289 . . . . 0.0 109.751 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.36 21.31 3.47 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.722 1.153 . . . . 0.0 112.386 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.22 -169.14 20.04 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 118.879 1.34 . . . . 0.0 113.446 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.52 105.02 3.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.221 1.809 . . . . 0.0 108.687 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 m -171.7 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.615 1.966 . . . . 0.0 113.926 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -65.35 -173.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.542 1.937 . . . . 0.0 110.494 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.68 109.19 0.2 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.103 1.361 . . . . 0.0 114.634 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.53 172.3 13.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.343 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.9 -4.91 29.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.982 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.83 -29.73 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.882 1.341 . . . . 0.0 113.31 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -65.85 114.15 4.88 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.852 0.751 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -26.0 59.88 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.742 -0.599 . . . . 0.0 109.822 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.38 -176.27 47.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.88 158.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.354 1.862 . . . . 0.0 109.979 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -140.07 -42.94 0.42 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.251 1.42 . . . . 0.0 113.674 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -142.5 150.32 40.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 120.528 1.513 . . . . 0.0 109.884 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.6 t -126.24 137.1 58.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.39 139.52 52.33 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.44 ' H ' ' HB2' ' A' ' 63' ' ' GLU . 42.8 t -140.6 94.01 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.08 108.44 3.44 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -71.49 110.78 6.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.9 2.08 . . . . 0.0 108.036 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.65 -173.98 38.37 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.28 -31.3 61.47 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.21 6.63 7.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 158.62 -175.79 35.63 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.531 1.514 . . . . 0.0 111.279 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.33 96.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.115 1.957 . . . . 0.0 108.755 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -97.86 -6.62 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.948 -1.501 . . . . 0.0 114.209 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.8 p -140.91 146.45 37.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 122.173 2.26 . . . . 0.0 112.609 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.0 171.4 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.718 1.607 . . . . 0.0 109.767 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -151.87 141.24 21.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -130.13 113.95 27.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 119.515 1.052 . . . . 0.0 109.409 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.25 154.24 13.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.525 0.73 . . . . 0.0 109.593 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -132.92 155.86 48.31 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.39 122.01 40.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 108.473 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 46' ' ' SER . 0.4 OUTLIER -109.6 167.72 9.93 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.399 1.079 . . . . 0.0 108.314 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.12 5.29 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.852 5.661 . . . . 0.0 116.424 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 44' ' ' LYS . 34.4 t -151.0 -67.96 0.18 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.874 2.07 . . . . 0.0 108.891 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -139.71 166.18 25.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.847 1.259 . . . . 0.0 111.558 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -78.01 162.95 26.36 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.73 2.012 . . . . 0.0 109.406 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.37 136.59 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -121.6 162.28 20.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.595 1.558 . . . . 0.0 109.036 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.439 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 144.46 21.49 0.16 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 128.695 3.045 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.46 20.3 45.03 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.08 121.62 19.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.473 1.637 . . . . 0.0 109.142 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.79 171.56 12.57 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 110.094 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.03 -153.49 41.81 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 98.7 5.25 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 120.421 -1.635 . . . . 0.0 113.169 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.47 149.95 49.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.3 t -144.57 158.74 43.63 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.2 -19.33 65.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.996 0.918 . . . . 0.0 112.155 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.39 15.34 26.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.765 1.226 . . . . 0.0 110.487 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.07 90.88 0.11 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.305 0.957 . . . . 0.0 112.813 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -164.0 153.16 13.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.188 2.195 . . . . 0.0 107.62 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 28' ' ' VAL . 5.4 mm-40 -144.22 164.7 29.97 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.55 1.54 . . . . 0.0 110.208 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -143.01 128.85 19.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -137.16 109.69 7.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.82 117.14 27.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.68 110.67 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.92 157.74 20.88 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.277 1.431 . . . . 0.0 111.627 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -16.02 63.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.201 1.4 . . . . 0.0 110.008 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.56 6.44 15.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.687 2.395 . . . . 0.0 110.71 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.84 141.81 31.99 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.684 -1.26 . . . . 0.0 108.969 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.434 ' CD1' ' HE2' ' A' ' 124' ' ' LYS . 54.3 m-85 -134.27 114.57 13.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -85.5 106.93 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -92.54 -21.47 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.376 1.07 . . . . 0.0 113.777 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.93 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.232 0.924 . . . . 0.0 110.472 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.44 144.67 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.36 119.75 40.21 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.95 128.19 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.681 1.128 . . . . 0.0 109.012 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 111' ' ' THR . 70.3 m -121.86 152.1 39.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.637 1.975 . . . . 0.0 109.42 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.63 168.38 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.042 1.737 . . . . 0.0 109.181 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -156.59 164.71 37.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -144.41 137.86 27.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.818 2.047 . . . . 0.0 108.337 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.8 m -132.87 161.05 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.0 104.26 0.23 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.945 1.298 . . . . 0.0 112.021 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.36 -21.76 8.06 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 124.694 1.14 . . . . 0.0 113.342 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -80.68 85.9 5.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.4 -5.01 29.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.49 1.116 . . . . 0.0 111.161 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -131.88 95.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.041 2.136 . . . . 0.0 105.575 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -54.58 147.48 14.22 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 pt -133.41 169.51 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.223 1.011 . . . . 0.0 112.657 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.6 mt -85.33 148.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.678 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -69.06 0.89 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.1 p -123.04 147.98 46.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.5 mm -131.4 148.53 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 m -151.06 104.19 3.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.02 144.77 31.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.13 113.3 13.72 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 p -92.01 165.82 13.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -76.55 -27.41 55.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -69.29 -7.21 34.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 111.75 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.37 5.5 57.97 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 125.945 1.736 . . . . 0.0 113.251 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -87.49 137.98 31.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.512 1.156 . . . . 0.0 108.869 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 110.75 9.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.66 155.26 89.26 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.32 169.59 18.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.396 2.064 . . . . 0.0 110.619 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 108' ' ' GLY . 73.2 Cg_endo -68.42 111.13 2.44 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 107.921 -1.607 . . . . 0.0 107.921 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -67.7 14.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.8 2.04 . . . . 0.0 113.917 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 106' ' ' PRO . . . 177.17 -175.95 47.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 126.242 1.877 . . . . 0.0 109.92 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.8 tp -72.73 108.1 5.54 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.707 1.603 . . . . 0.0 114.027 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.38 128.17 34.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 79' ' ' THR . 34.3 m -130.57 165.06 23.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.814 1.646 . . . . 0.0 108.815 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -57.05 -52.3 65.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.51 1.524 . . . . 0.0 111.446 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -61.94 102.88 0.31 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 109.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.47 170.19 21.47 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.187 0.518 . . . . 0.0 110.465 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -142.12 164.79 29.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.87 135.56 42.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.576 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.39 123.93 18.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.701 0.801 . . . . 0.0 110.991 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.93 39.23 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.293 1.437 . . . . 0.0 107.89 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.85 122.28 43.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.304 0.642 . . . . 0.0 110.734 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -119.7 -22.1 7.01 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.603 1.561 . . . . 0.0 110.414 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -67.62 -22.04 65.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.365 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.96 -10.4 6.65 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.984 -1.454 . . . . 0.0 114.62 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.75 162.81 33.81 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 120.083 1.942 . . . . 0.0 112.167 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HE2' ' CD1' ' A' ' 72' ' ' TYR . 35.4 ttmt -126.66 143.03 51.36 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.59 146.71 39.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 -28.88 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.31 -151.91 9.53 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.31 171.17 14.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.903 0.859 . . . . 0.0 112.528 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.535 ' HD1' ' HB3' ' A' ' 6' ' ' ALA . 20.6 p80 -144.31 159.7 42.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.484 1.914 . . . . 0.0 106.579 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.03 110.09 2.08 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.304 0.954 . . . . 0.0 115.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -53.27 131.38 37.24 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.601 1.96 . . . . 0.0 107.071 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.43 164.98 37.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.462 1.505 . . . . 0.0 108.397 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.91 -101.67 0.16 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.4 -40.08 77.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.192 0.996 . . . . 0.0 110.238 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -125.41 153.31 43.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.22 98.52 10.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -74.2 -46.51 41.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.372 0.669 . . . . 0.0 110.994 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.51 165.4 31.33 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 110.46 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.3 tp -147.89 159.11 44.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.402 1.481 . . . . 0.0 107.691 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.85 21.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.76 133.78 24.15 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -82.22 168.34 17.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -130.31 163.56 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.524 -0.735 . . . . 0.0 110.508 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -87.26 115.86 24.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 t -133.08 166.26 22.84 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.223 1.409 . . . . 0.0 108.469 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.4 p -116.0 175.59 5.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.613 0.365 . . . . 0.0 110.432 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 t -116.17 119.95 37.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.3 p -139.15 156.37 72.2 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.88 176.12 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.971 1.781 . . . . 0.0 109.563 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.89 139.98 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 p -130.15 161.22 61.41 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.535 0.734 . . . . 0.0 110.97 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.19 -172.86 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.035 3.156 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.08 140.85 56.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.032 0.933 . . . . 0.0 108.62 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.78 134.73 35.11 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.339 1.056 . . . . 0.0 110.388 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -87.02 146.59 26.06 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.9 mt -113.65 -166.66 1.11 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.2 m -146.32 125.89 13.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.84 -159.47 0.69 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.694 2.398 . . . . 0.0 108.67 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.9 tt -149.04 151.57 12.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.95 -38.77 0.42 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.842 0.746 . . . . 0.0 114.442 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.56 162.01 25.41 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.113 1.457 . . . . 0.0 112.85 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 49.2 p30 -112.73 0.88 15.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.076 1.75 . . . . 0.0 112.851 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -131.71 135.43 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.637 1.108 . . . . 0.0 109.86 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 132.6 159.13 9.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 127.713 2.577 . . . . 0.0 109.125 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.5 m -67.9 134.37 50.72 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 112.267 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.74 135.22 36.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -127.68 33.46 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.093 1.357 . . . . 0.0 110.475 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -58.03 107.63 0.49 Allowed 'General case' 0 C--N 1.334 -0.095 0 O-C-N 120.775 -1.203 . . . . 0.0 112.48 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.72 -16.73 60.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.986 0.914 . . . . 0.0 110.274 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 -75.14 1.53 Allowed Glycine 0 C--N 1.337 0.612 0 CA-C-O 118.522 -1.155 . . . . 0.0 110.53 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.89 146.81 2.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.426 2.291 . . . . 0.0 109.02 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -124.86 167.19 14.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.893 2.077 . . . . 0.0 106.831 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -24.36 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.92 -174.73 42.25 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.63 116.59 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.63 -39.03 8.08 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.642 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -145.42 150.63 36.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.46 150.36 33.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.925 0.89 . . . . 0.0 109.084 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -142.48 155.63 45.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.823 1.249 . . . . 0.0 108.677 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.59 130.49 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.84 93.43 0.54 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -70.67 155.66 40.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.117 0.961 . . . . 0.0 110.076 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.35 -167.82 14.89 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 126.674 2.083 . . . . 0.0 109.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.16 -9.05 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.326 -1.102 . . . . 0.0 110.9 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -117.25 -31.85 5.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.507 3.123 . . . . 0.0 113.686 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.07 -158.3 30.59 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.62 110.61 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 62.6 m -116.39 -12.71 11.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.017 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.21 130.75 29.25 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.91 1.232 . . . . 0.0 110.143 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.97 135.82 50.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -148.44 139.81 23.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -132.92 163.25 29.57 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.74 1.616 . . . . 0.0 109.13 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -123.03 150.99 42.35 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -161.29 167.95 24.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.252 1.021 . . . . 0.0 111.726 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -120.28 113.01 19.76 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 199' ' ' GLU . 21.7 pttp -107.19 122.52 46.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.31 -84.19 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.73 -4.95 1.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.912 2.085 . . . . 0.0 110.799 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.431 ' CD ' ' HZ1' ' A' ' 196' ' ' LYS . 33.5 mt-10 -75.4 168.28 20.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.57 1.548 . . . . 0.0 110.455 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -131.92 101.93 5.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.445 2.698 . . . . 0.0 105.94 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.78 118.18 36.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.264 1.026 . . . . 0.0 109.35 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.19 128.53 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 128.3 -140.13 11.56 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 110.06 9.86 23.47 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.433 1.117 . . . . 0.0 115.851 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -68.58 108.53 3.37 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.739 1.77 . . . . 0.0 109.499 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -129.2 27.14 5.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.084 2.153 . . . . 0.0 109.774 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -145.06 -178.74 20.88 Favored Glycine 0 N--CA 1.451 -0.322 0 O-C-N 120.444 -1.41 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -85.36 94.64 0.33 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.809 1.244 . . . . 0.0 111.024 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.4 162.51 38.51 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.571 1.597 . . . . 0.0 108.047 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.9 m -137.48 166.32 24.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -2.59 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.0 -7.16 47.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.405 1.082 . . . . 0.0 109.202 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.56 -148.92 32.84 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -141.65 157.28 45.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 108.436 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.57 154.7 28.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 128.523 2.729 . . . . 0.0 104.052 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.05 140.12 23.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.02 132.24 23.24 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.312 1.045 . . . . 0.0 108.491 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -105.61 97.02 6.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.45 141.24 15.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.98 88.76 4.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -49.02 -55.6 19.81 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 113.876 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.25 -9.62 21.93 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.51 1.575 . . . . 0.0 114.578 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.42 -38.05 6.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.63 1.105 . . . . 0.0 113.88 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 172.62 10.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.0 112.678 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -150.15 149.03 29.67 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.65 -0.656 . . . . 0.0 112.543 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.04 100.16 7.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.5 t -73.17 -29.13 62.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.525 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.04 170.63 16.29 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.71 1.604 . . . . 0.0 108.646 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.72 150.65 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.655 1.182 . . . . 0.0 108.366 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -133.77 166.76 21.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.786 2.035 . . . . 0.0 109.245 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.45 166.93 28.35 Favored Glycine 0 N--CA 1.452 -0.265 0 O-C-N 120.968 -1.083 . . . . 0.0 110.823 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 79.1 p -137.1 133.95 35.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -117.31 138.22 51.91 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 109.77 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -119.14 146.85 44.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.098 0.952 . . . . 0.0 108.586 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -69.68 129.11 38.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 112.948 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.8 155.42 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -93.33 173.63 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 77.41 -25.69 1.97 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.301 1.429 . . . . 0.0 114.62 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 11.9 p -141.56 168.85 18.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.542 1.671 . . . . 0.0 109.715 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -84.4 11.73 8.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 110.648 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.46 -175.78 27.4 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.788 1.185 . . . . 0.0 112.939 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.5 mt -149.23 166.67 28.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.662 1.985 . . . . 0.0 109.335 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.15 172.78 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.12 112.97 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.12 1.368 . . . . 0.0 108.994 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.55 -4.42 19.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.569 0.748 . . . . 0.0 112.742 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.3 tmm? -147.7 110.98 4.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 17.7 mt -125.75 132.72 52.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.14 1.376 . . . . 0.0 108.363 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -129.04 166.15 19.78 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.647 1.213 . . . . 0.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.01 134.83 44.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -73.11 130.71 40.89 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.3 m -139.0 130.64 27.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.492 HD21 ' HD3' ' A' ' 253' ' ' LYS . 3.4 p-10 -100.94 156.22 17.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.207 1.803 . . . . 0.0 107.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.492 ' HD3' HD21 ' A' ' 252' ' ' ASN . 1.0 OUTLIER 59.8 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.82 2.448 . . . . 0.0 115.268 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' A' ' 252' ' ' ASN . 49.6 mt-30 -131.63 174.78 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 129.124 2.97 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 97.3 m -130.08 108.96 10.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.319 1.447 . . . . 0.0 108.81 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -81.27 136.03 35.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.0 154.27 69.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.46 88.86 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.185 2.59 . . . . 0.0 107.363 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -69.89 105.29 2.76 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.15 -172.38 23.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.712 0.687 . . . . 0.0 113.43 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.65 113.33 21.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.799 1.64 . . . . 0.0 110.09 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.16 131.19 50.04 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.113 1.365 . . . . 0.0 110.183 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.07 1.95 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 129.272 3.029 . . . . 0.0 105.873 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.26 -166.2 45.8 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 83.4 m -84.87 144.99 28.04 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.412 1.485 . . . . 0.0 108.143 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -100.48 150.76 22.32 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -143.92 164.17 31.34 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 111.456 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.79 154.45 37.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.631 1.572 . . . . 0.0 109.657 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.3 mt -131.89 105.61 7.55 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -139.81 143.99 37.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.921 0.889 . . . . 0.0 112.686 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -144.46 153.51 41.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.696 1.998 . . . . 0.0 106.371 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -86.83 145.83 26.45 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.494 -1.379 . . . . 0.0 112.206 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.94 -43.33 0.79 Allowed Glycine 0 C--N 1.341 0.853 0 C-N-CA 127.035 2.255 . . . . 0.0 115.431 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -74.28 159.47 32.4 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.321 1.049 . . . . 0.0 111.935 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 297' ' ' LEU . 1.2 mppt? -125.59 174.31 8.35 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.943 2.097 . . . . 0.0 105.555 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.8 140.34 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.492 0.663 . . . . 0.0 109.661 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.13 -3.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 128.337 2.655 . . . . 0.0 111.717 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.11 156.89 28.38 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 120.526 1.512 . . . . 0.0 114.6 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -114.83 162.7 16.53 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 112.161 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -150.75 137.44 18.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 169.07 -160.45 33.87 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.404 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -145.6 143.66 30.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.255 0.55 . . . . 0.0 111.967 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.61 148.54 12.57 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 126.938 2.095 . . . . 0.0 107.171 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.2 m -131.41 -34.08 1.42 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 127.288 2.235 . . . . 0.0 107.003 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -144.21 -56.74 0.37 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.48 148.65 26.23 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.55 1.94 . . . . 0.0 110.076 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 86.51 4.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.554 0.616 . . . . 0.0 110.595 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -67.01 -58.73 4.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.618 0.367 . . . . 0.0 111.737 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -126.1 136.34 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.481 0.582 . . . . 0.0 110.954 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -132.32 123.1 26.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.715 1.606 . . . . 0.0 108.883 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -137.34 170.48 23.58 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.316 1.436 . . . . 0.0 109.911 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.02 171.95 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.238 0.615 . . . . 0.0 111.44 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -121.37 166.09 14.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.94 2.096 . . . . 0.0 106.131 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.58 136.7 56.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 75.1 mtp -137.03 140.62 31.95 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 108.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.2 104.83 1.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.1 3.2 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.41 ' HB2' ' HE2' ' A' ' 275' ' ' LYS . 74.9 mt -120.32 46.32 2.0 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.56 1.144 . . . . 0.0 109.263 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 9.7 t -109.06 165.83 11.29 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--O 1.245 0.852 0 CA-C-O 116.586 -1.674 . . . . 0.0 111.086 -179.795 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -74.1 100.0 3.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.402 1.096 . . . . 0.0 109.767 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -148.72 138.35 21.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 130.688 3.595 . . . . 0.0 105.202 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.73 145.86 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -89.5 161.96 15.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.562 1.172 . . . . 0.0 111.255 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.96 90.05 8.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.23 103.96 1.26 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.99 -177.29 44.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.33 1.919 . . . . 0.0 108.976 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.92 161.75 46.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 118.452 1.126 . . . . 0.0 112.85 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.44 0.37 55.35 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.67 166.28 43.16 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.61 174.35 23.09 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 123.98 0.8 . . . . 0.0 112.915 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.32 131.77 34.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.4 p -71.55 128.33 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.015 0.825 . . . . 0.0 110.341 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -121.54 4.8 10.13 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -64.36 136.1 56.8 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 71.58 12.0 6.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.892 2.477 . . . . 0.0 110.468 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.11 156.0 30.1 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 m -65.29 116.95 5.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.441 0.696 . . . . 0.0 111.694 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -143.13 170.39 15.82 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.434 2.294 . . . . 0.0 108.281 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -147.17 -11.3 0.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.18 172.51 28.6 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.56 153.6 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.024 0.912 . . . . 0.0 108.592 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -131.18 -52.27 1.03 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.862 1.665 . . . . 0.0 111.2 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -126.08 160.74 29.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.69 129.14 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.56 119.88 26.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 92.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.09 143.87 16.87 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.93 175.02 3.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.063 0.945 . . . . 0.0 110.863 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.94 175.71 43.31 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.41 -36.96 84.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.88 2.79 28.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 130.863 3.665 . . . . 0.0 110.711 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -166.89 24.81 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.45 122.76 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -136.47 -19.85 1.4 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.426 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -99.17 112.95 24.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.52 144.26 36.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 121.97 -0.456 . . . . 0.0 110.35 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -148.44 151.01 34.48 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.937 1.695 . . . . 0.0 107.837 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.78 158.53 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.918 1.287 . . . . 0.0 108.206 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.39 115.2 39.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -88.99 105.54 17.85 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.178 1.391 . . . . 0.0 109.068 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.37 126.15 28.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.088 -0.383 . . . . 0.0 110.509 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -113.78 146.27 40.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.7 -36.12 75.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.593 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -64.36 -63.66 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -156.13 141.56 17.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.048 0.939 . . . . 0.0 108.873 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.27 111.72 10.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.28 136.74 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.804 0.812 . . . . 0.0 112.395 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -78.28 162.47 26.5 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.622 1.969 . . . . 0.0 109.682 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.58 6.75 8.48 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.131 1.824 . . . . 0.0 111.238 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.26 161.04 26.16 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 125.953 1.74 . . . . 0.0 113.75 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.3 137.68 56.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.907 0.883 . . . . 0.0 109.573 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -122.88 51.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.24 -177.34 27.54 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.861 1.696 . . . . 0.0 111.3 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.61 84.89 3.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.919 1.288 . . . . 0.0 110.404 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -56.56 132.56 51.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.428 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -129.49 147.61 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -75.18 -36.73 61.45 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.856 -0.528 . . . . 0.0 111.628 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mp -102.11 23.12 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.25 91.93 0.15 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 121.761 -0.587 . . . . 0.0 112.1 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -161.64 154.79 20.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 105.01 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -150.57 164.85 35.01 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.12 1.768 . . . . 0.0 108.847 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.6 m -145.07 122.12 11.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.93 0.492 . . . . 0.0 110.541 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -131.61 131.53 43.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -107.92 141.34 39.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.213 1.005 . . . . 0.0 108.687 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.48 112.9 42.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.88 176.56 4.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.765 2.026 . . . . 0.0 111.533 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -46.38 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -101.9 -5.04 25.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.008 2.123 . . . . 0.0 113.388 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -94.53 137.13 34.03 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -123.94 162.41 23.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.342 0.973 . . . . 0.0 110.573 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.4 mt -86.92 118.27 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.16 -45.88 20.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.266 1.426 . . . . 0.0 109.823 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.38 166.15 28.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.621 1.169 . . . . 0.0 109.651 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.06 103.35 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -82.37 135.37 35.19 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -133.66 127.75 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.9 p -114.64 149.1 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -151.85 168.15 26.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.889 0.768 . . . . 0.0 110.571 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -153.78 151.96 30.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -128.46 127.88 43.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.544 2.338 . . . . 0.0 105.918 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.64 166.21 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.887 1.275 . . . . 0.0 111.086 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.83 156.9 31.89 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.42 -14.65 6.49 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.071 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -129.03 107.23 9.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.184 1.492 . . . . 0.0 108.177 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.36 -14.25 62.86 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 111.041 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.4 p -72.01 176.44 5.06 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.547 1.539 . . . . 0.0 110.011 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.68 135.65 30.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.53 154.11 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.776 0.716 . . . . 0.0 110.647 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.73 112.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.857 1.263 . . . . 0.0 107.989 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -77.24 -36.78 54.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.566 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.6 t -158.98 158.72 33.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.843 2.057 . . . . 0.0 109.243 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.06 151.49 27.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.775 2.03 . . . . 0.0 107.11 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 m -150.67 108.45 3.69 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.18 158.71 31.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -135.49 122.04 20.73 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.1 p -108.53 160.68 15.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 119.276 0.944 . . . . 0.0 112.287 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -68.76 -37.88 79.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.315 0.646 . . . . 0.0 109.746 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -15.28 63.51 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 116.772 -1.585 . . . . 0.0 113.431 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.61 3.5 49.8 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 120.188 1.358 . . . . 0.0 112.589 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -82.7 95.07 7.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.5 m -104.35 122.31 45.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.8 p -70.13 159.7 83.46 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 111.561 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.33 170.26 20.34 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.073 1.849 . . . . 0.0 107.435 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.58 109.75 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 N-CA-C 106.519 -2.147 . . . . 0.0 106.519 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -81.03 77.06 7.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.65 -149.97 20.36 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.772 1.653 . . . . 0.0 110.234 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.3 tp -105.27 125.77 51.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.113 1.365 . . . . 0.0 110.591 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.46 139.48 53.97 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.9 m -134.78 157.14 47.51 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.439 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -61.76 -45.56 93.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.217 0.607 . . . . 0.0 109.492 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -65.2 110.32 2.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 107.229 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -163.86 166.8 21.48 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.409 -0.807 . . . . 0.0 112.226 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -150.87 167.67 26.8 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.24 1.816 . . . . 0.0 108.921 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.24 142.62 38.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 129.84 55.48 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.985 0.914 . . . . 0.0 111.129 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 147.2 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.144 1.377 . . . . 0.0 108.229 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 123' ' ' GLY . 27.9 t0 -76.49 174.51 10.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -50.05 -53.73 25.02 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.928 1.691 . . . . 0.0 109.425 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -114.32 -23.81 9.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 117.835 -1.078 . . . . 0.0 113.607 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.22 55.83 0.13 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.939 1.245 . . . . 0.0 113.919 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 119' ' ' ASP . . . -71.74 138.5 27.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -65.75 144.47 56.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -62.12 97.05 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.143 1.777 . . . . 0.0 107.866 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.72 -51.99 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -174.07 141.12 5.8 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -87.55 177.76 6.98 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.642 1.177 . . . . 0.0 111.328 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -147.2 169.37 19.48 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 107.319 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.91 -177.99 47.49 Favored Glycine 0 CA--C 1.523 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.258 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -142.45 50.71 1.48 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.67 2.388 . . . . 0.0 108.629 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.43 163.53 17.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 119.902 -1.748 . . . . 0.0 109.164 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.86 -104.45 0.19 Allowed Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.09 -15.99 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.409 0.711 . . . . 0.0 111.144 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.83 174.61 12.03 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.874 2.47 . . . . 0.0 107.343 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.6 tp -98.91 88.54 4.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -79.58 -52.64 7.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.694 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.77 158.53 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 111.982 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -148.6 147.09 28.59 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.447 3.499 . . . . 0.0 106.576 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -144.18 -173.21 15.4 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.83 156.18 35.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.758 1.279 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -128.68 109.84 11.68 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.65 99.14 8.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.07 101.02 3.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.6 t -130.44 102.71 6.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 122.676 1.227 . . . . 0.0 108.059 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -163.36 164.55 24.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.46 1.904 . . . . 0.0 107.02 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.1 65.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.6 p -72.38 159.09 86.31 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 -169.27 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.983 2.456 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.9 t -52.56 149.92 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.157 1.383 . . . . 0.0 109.274 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -73.38 146.36 86.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.01 -166.03 0.15 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.702 3.601 . . . . 0.0 115.183 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.21 178.5 1.88 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.896 2.078 . . . . 0.0 110.59 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -74.74 131.09 40.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -111.92 147.9 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.633 1.973 . . . . 0.0 106.855 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.32 167.76 10.17 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.166 1.386 . . . . 0.0 107.84 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -73.51 107.33 5.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.8 171.56 10.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.667 0.787 . . . . 0.0 109.339 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.49 148.05 30.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 159.8 -112.44 0.52 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 125.006 1.289 . . . . 0.0 110.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -115.67 163.51 12.29 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.882 1.706 . . . . 0.0 110.453 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.13 -5.61 40.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.13 1.372 . . . . 0.0 112.474 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.49 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 44.7 tt0 -112.98 144.0 43.32 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.417 1.487 . . . . 0.0 109.752 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.56 171.52 12.87 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 123.795 0.712 . . . . 0.0 113.167 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.4 m -82.07 116.96 21.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.847 0.859 . . . . 0.0 108.901 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.06 126.27 29.19 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -134.13 127.07 31.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.011 0.924 . . . . 0.0 111.746 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.18 155.63 17.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.985 1.714 . . . . 0.0 108.681 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -150.81 100.19 2.79 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.55 160.36 5.02 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.54 143.71 51.53 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -104.77 178.33 4.59 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 111.317 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -53.05 -45.1 67.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.078 1.751 . . . . 0.0 112.361 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.74 -176.33 46.97 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 128.874 3.13 . . . . 0.0 106.157 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.67 141.26 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -121.86 -19.8 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.453 ' HZ3' ' CD ' ' A' ' 216' ' ' GLU . 49.2 mtpt -144.28 158.54 43.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.95 145.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -128.94 156.05 44.36 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 t -136.29 123.35 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.87 57.67 0.58 Allowed Glycine 0 C--N 1.341 0.833 0 C-N-CA 124.394 0.997 . . . . 0.0 114.834 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.412 ' H ' ' CD ' ' A' ' 182' ' ' GLN . 3.2 pm0 -68.21 159.93 30.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.964 0.905 . . . . 0.0 110.024 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.28 -140.07 3.83 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.542 1.544 . . . . 0.0 110.477 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -82.15 -37.13 26.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.192 0.997 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.55 -31.45 11.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.725 2.01 . . . . 0.0 113.759 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.16 -158.48 29.52 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 119.749 1.158 . . . . 0.0 110.975 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 105.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 m -95.13 -23.46 17.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 0.0 111.472 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.35 157.69 38.97 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.808 1.643 . . . . 0.0 109.3 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.57 156.53 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.592 1.957 . . . . 0.0 106.545 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 214' ' ' PHE . 59.8 pttt -174.13 134.0 0.43 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 128.78 2.832 . . . . 0.0 105.842 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -125.95 162.22 25.73 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.092 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -103.09 152.35 21.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.778 1.231 . . . . 0.0 109.585 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.03 163.9 23.2 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.532 1.133 . . . . 0.0 109.682 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.24 145.72 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.071 1.748 . . . . 0.0 106.978 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -140.56 97.19 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 65.34 -143.57 46.16 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.65 5.7 10.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.844 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.94 168.5 9.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.738 1.215 . . . . 0.0 110.709 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.75 142.79 49.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.821 1.648 . . . . 0.0 107.186 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.4 mm -131.81 102.41 5.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.26 105.23 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 139.31 170.5 11.9 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 121.751 0.64 . . . . 0.0 114.516 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.43 45.23 0.02 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.684 2.087 . . . . 0.0 109.28 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.62 100.61 3.38 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.665 1.186 . . . . 0.0 109.87 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -116.84 -24.45 7.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.639 1.176 . . . . 0.0 112.122 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -91.8 -179.24 41.93 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.96 91.55 0.97 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.248 1.024 . . . . 0.0 109.161 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.36 156.63 58.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 121.367 1.524 . . . . 0.0 109.324 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 71.2 p -98.91 173.48 6.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.62 -10.55 59.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.086 -1.009 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.0 tt -53.37 -39.35 64.13 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.59 175.28 29.73 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.665 1.603 . . . . 0.0 111.149 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.41 ' CG ' ' HE2' ' A' ' 191' ' ' LYS . 53.4 m-85 -102.34 138.41 39.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.355 1.062 . . . . 0.0 109.628 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.88 164.17 13.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.977 2.511 . . . . 0.0 106.326 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 177' ' ' LYS . 6.9 pt-20 -143.13 157.37 44.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 121.542 1.974 . . . . 0.0 115.684 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.55 143.63 32.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.633 1.173 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 124.2 43.75 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 108.762 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.96 117.5 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 C-N-CA 126.604 1.962 . . . . 0.0 106.304 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -93.98 106.36 18.34 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.574 1.079 . . . . 0.0 109.999 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -38.66 -61.42 0.89 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.6 -19.31 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.192 1.819 . . . . 0.0 116.301 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.5 t -106.93 -12.92 15.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.576 1.989 . . . . 0.0 114.769 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.33 160.18 15.81 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 107.229 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -152.48 106.87 3.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 119.935 -1.728 . . . . 0.0 109.894 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.93 70.48 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 t -68.12 -16.95 64.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.546 -1.346 . . . . 0.0 112.739 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -157.94 167.51 29.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.862 1.665 . . . . 0.0 107.914 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.55 159.54 37.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.413 ' OE2' ' HE3' ' A' ' 250' ' ' LYS . 31.4 mt-10 -131.51 172.92 11.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.41 1.484 . . . . 0.0 108.388 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.52 179.8 42.8 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.3 m -157.19 150.52 23.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 155.47 48.61 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -153.02 164.4 38.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.892 0.853 . . . . 0.0 108.964 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -70.07 148.36 48.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.053 2.141 . . . . 0.0 112.907 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.7 mt -90.16 151.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -108.8 76.8 1.03 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 149.22 -15.85 1.14 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-O 117.944 -1.476 . . . . 0.0 115.483 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 m -132.44 148.49 52.41 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.734 1.267 . . . . 0.0 108.293 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.62 86.23 7.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.844 1.258 . . . . 0.0 109.235 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 178.28 -169.92 41.84 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 0.0 110.065 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.65 156.44 39.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.99 2.116 . . . . 0.0 105.393 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.8 tt -134.52 167.46 25.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.958 1.303 . . . . 0.0 107.761 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.9 mm -99.05 93.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 111.708 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -87.31 -21.77 25.54 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.267 -0.896 . . . . 0.0 113.323 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -137.72 144.63 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 109.632 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.31 149.89 38.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.245 0.93 . . . . 0.0 109.624 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -148.33 159.67 43.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.917 1.687 . . . . 0.0 109.226 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -138.7 116.0 11.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.413 ' HE3' ' OE2' ' A' ' 230' ' ' GLU . 85.2 mttt -73.77 149.79 41.51 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.0 p -145.37 165.39 28.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.255 0.48 . . . . 0.0 110.493 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 254' ' ' GLN . 5.7 t30 -99.99 133.78 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.32 2.248 . . . . 0.0 105.362 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 58.2 -19.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.946 2.098 . . . . 0.0 115.498 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 252' ' ' ASN . 0.6 OUTLIER -89.98 171.61 9.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.4 2.28 . . . . 0.0 108.797 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.3 p -141.52 99.88 3.66 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.0 p -82.92 172.46 12.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.031 1.332 . . . . 0.0 111.197 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -120.62 157.82 53.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.015 1.326 . . . . 0.0 111.067 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.214 2.61 . . . . 0.0 107.521 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -81.35 92.21 6.37 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.1 174.19 17.5 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.572 1.558 . . . . 0.0 111.224 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 92.2 mt -95.95 146.57 24.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 109.087 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -71.72 146.72 47.99 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.9 -179.99 7.17 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.134 1.374 . . . . 0.0 109.986 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 37.73 -96.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.968 2.223 . . . . 0.0 116.082 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 96.2 m -146.29 129.1 16.28 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.873 0.869 . . . . 0.0 110.407 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.98 35.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -142.01 161.19 38.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.88 154.74 38.84 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.982 -1.074 . . . . 0.0 109.86 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.99 151.97 47.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -158.91 173.96 15.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.991 2.516 . . . . 0.0 107.064 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -144.93 164.09 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 107.146 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.34 -18.16 57.67 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 175.84 63.97 0.06 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -152.24 175.49 12.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.218 1.807 . . . . 0.0 106.753 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -115.46 152.24 33.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.396 1.478 . . . . 0.0 107.29 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.2 mt -86.61 119.87 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.4 m -147.22 69.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.467 0.707 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.73 -178.79 18.4 Favored Glycine 0 N--CA 1.467 0.722 0 O-C-N 120.198 -1.564 . . . . 0.0 114.316 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.89 160.97 40.44 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.69 1.196 . . . . 0.0 110.758 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -157.69 132.61 8.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -175.43 -152.74 9.62 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.49 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 16.1 ptmt -143.8 147.46 34.17 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.2 156.18 21.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 108.195 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 20.3 t -127.35 -90.66 0.52 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -79.2 -58.17 3.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 20.2 mt -110.75 165.89 11.46 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.999 1.719 . . . . 0.0 111.832 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.01 106.39 4.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 109.545 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -96.12 -45.94 6.67 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.2 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -122.05 137.68 54.72 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.068 0.849 . . . . 0.0 112.151 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -138.1 149.8 46.27 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.511 1.124 . . . . 0.0 109.945 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -169.16 154.98 24.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.32 151.47 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 118.343 1.072 . . . . 0.0 112.504 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.85 154.02 20.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 141.24 47.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.516 0.726 . . . . 0.0 111.371 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 83.2 mmm -144.73 144.45 24.58 Favored Pre-proline 0 N--CA 1.465 0.278 0 C-N-CA 126.924 2.09 . . . . 0.0 107.399 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.96 159.39 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.627 1.26 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.42 172.19 6.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.088 0.955 . . . . 0.0 110.362 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 14.5 t -119.35 -17.23 8.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.682 0.793 . . . . 0.0 111.07 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 . . . . . 0 C--O 1.247 0.933 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.622 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.005 0.431 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -130.96 154.04 48.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.393 2.277 . . . . 0.0 110.3 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -129.95 139.12 51.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.904 1.682 . . . . 0.0 107.602 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -124.83 110.07 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 103.981 -2.599 . . . . 0.0 103.981 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 165.63 17.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.983 0.897 . . . . 0.0 110.843 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 163.41 12.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.307 1.443 . . . . 0.0 107.542 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.07 154.46 25.33 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.99 -153.04 24.75 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.83 -2.508 . . . . 0.0 106.83 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.11 121.71 14.84 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 122.477 1.043 . . . . 0.0 115.087 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.85 -8.36 57.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.812 0.845 . . . . 0.0 111.859 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.96 -19.12 60.83 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.636 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.95 20.72 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.386 1.593 . . . . 0.0 113.345 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.68 157.37 27.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 108.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -69.9 119.46 14.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -86.48 -70.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 17.52 2.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.643 1.177 . . . . 0.0 113.709 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.45 134.91 55.45 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.04 -1.038 . . . . 0.0 109.686 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.62 79.38 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 106.534 -2.626 . . . . 0.0 106.534 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.72 8.03 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.755 1.222 . . . . 0.0 111.465 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -125.24 -18.15 5.47 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.887 -1.133 . . . . 0.0 113.545 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.31 36.57 4.88 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.748 2.019 . . . . 0.0 111.435 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.3 4.26 29.84 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.011 1.964 . . . . 0.0 118.011 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.0 124.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 120.839 2.319 . . . . 0.0 110.793 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -104.26 -71.18 0.74 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.839 1.256 . . . . 0.0 110.569 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -111.13 151.63 27.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.485 1.114 . . . . 0.0 109.251 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.47 141.92 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.423 ' CD2' ' HG1' ' A' ' 64' ' ' THR . 11.6 m80 -123.7 120.42 32.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.33 102.79 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.42 129.46 9.82 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.3 168.03 20.45 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.118 0.961 . . . . 0.0 109.139 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.37 163.92 31.77 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -57.42 -40.78 79.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.291 1.436 . . . . 0.0 111.034 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.3 3.22 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.074 2.949 . . . . 0.0 113.613 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.35 -171.23 13.67 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.491 1.041 . . . . 0.0 112.208 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.73 106.13 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.27 -22.23 5.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.184 0.994 . . . . 0.0 113.501 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.4 p -117.96 131.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.201 1.0 . . . . 0.0 109.784 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.88 154.45 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 121.271 -0.893 . . . . 0.0 111.159 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -146.47 150.82 36.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.9 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.68 117.68 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.14 171.61 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.289 . . . . 0.0 108.498 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.12 109.3 5.28 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.753 -1.217 . . . . 0.0 109.03 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -116.3 165.51 13.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.306 1.442 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 44.5 5.58 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.027 1.394 . . . . 0.0 110.79 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m 49.37 33.04 4.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.982 2.913 . . . . 0.0 114.448 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.79 165.26 27.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.425 1.89 . . . . 0.0 109.975 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.41 127.04 31.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.923 2.089 . . . . 0.0 109.48 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.44 116.75 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.359 1.064 . . . . 0.0 108.79 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.03 159.36 30.95 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.91 0.884 . . . . 0.0 112.205 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.23 -17.72 4.38 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-O 117.352 -1.804 . . . . 0.0 115.805 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.59 154.19 2.96 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-N 120.428 2.114 . . . . 0.0 114.033 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.66 105.5 5.78 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.392 -1.064 . . . . 0.0 113.485 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -93.1 176.48 6.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.784 2.834 . . . . 0.0 109.613 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -163.14 54.69 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.49 100.36 11.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . 0.297 0.0 OUTLIER -61.75 150.03 38.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.435 -178.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.9 p -123.53 157.76 32.89 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.324 1.049 . . . . 0.0 108.837 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 tp -90.74 -38.83 12.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.778 0.831 . . . . 0.0 112.009 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mp -101.46 32.73 3.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 112.687 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.6 108.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -162.82 146.06 10.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.828 1.651 . . . . 0.0 107.294 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.1 162.04 41.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.322 2.649 . . . . 0.0 108.249 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.423 ' HG1' ' CD2' ' A' ' 27' ' ' HIS . 95.0 m -144.7 96.04 2.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.39 116.23 24.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.32 133.64 34.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.469 1.107 . . . . 0.0 108.814 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.62 107.25 22.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.81 160.58 5.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 111.135 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.66 -40.38 76.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.764 -0.585 . . . . 0.0 111.84 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.38 -19.32 20.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.469 0.577 . . . . 0.0 112.32 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -81.03 140.22 35.28 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -135.58 154.55 51.31 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.479 0.712 . . . . 0.0 110.803 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.69 133.64 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.52 -24.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 123.791 0.836 . . . . 0.0 111.1 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.19 156.72 42.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.87 146.26 25.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.95 115.26 15.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.33 123.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.3 m -99.42 138.04 37.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.182 1.793 . . . . 0.0 107.22 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -152.79 155.69 37.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.44 169.32 23.29 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -128.21 160.09 33.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.396 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -123.85 152.1 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.814 0.846 . . . . 0.0 108.753 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.33 113.34 1.91 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.997 0.919 . . . . 0.0 108.615 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.85 3.9 42.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.468 -1.184 . . . . 0.0 113.113 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -134.17 84.58 2.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.41 24.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 130.548 3.539 . . . . 0.0 113.19 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.3 t -149.8 108.47 3.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.181 -1.575 . . . . 0.0 108.533 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.56 157.27 7.14 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.023 1.729 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -139.39 147.11 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.702 1.601 . . . . 0.0 108.524 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.8 mm -70.37 113.19 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.2 p -80.47 -34.19 36.05 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.736 -0.602 . . . . 0.0 109.745 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 p -165.45 164.32 19.55 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.881 1.672 . . . . 0.0 109.712 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.8 tt -141.45 154.41 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 142.9 29.24 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -115.3 156.7 24.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -137.25 114.06 10.47 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -104.42 164.99 11.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.311 0.577 . . . . 0.0 110.632 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.44 -36.26 75.59 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -28.85 66.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.983 0.81 . . . . 0.0 111.816 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.69 5.67 47.76 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -72.85 88.49 1.34 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -84.76 109.22 17.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 p -71.26 161.76 76.52 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 125.174 1.389 . . . . 0.0 110.18 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.84 165.34 19.92 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.034 2.49 . . . . 0.0 110.285 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.44 119.27 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.087 2.525 . . . . 0.0 108.486 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -81.75 77.55 8.58 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.72 -155.8 25.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.563 1.078 . . . . 0.0 111.188 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.0 tp -88.15 119.17 28.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.372 1.469 . . . . 0.0 109.636 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.35 152.14 45.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.59 168.98 24.37 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.966 -1.084 . . . . 0.0 109.928 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -73.22 -47.48 43.05 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 120.96 -1.087 . . . . 0.0 109.496 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.97 109.15 1.69 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.355 1.074 . . . . 0.0 109.249 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.09 166.49 21.29 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.182 1.393 . . . . 0.0 108.685 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -144.78 164.97 29.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.34 149.14 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.5 141.13 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.947 1.299 . . . . 0.0 108.807 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -157.56 164.47 37.28 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.047 1.339 . . . . 0.0 110.978 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.91 170.87 15.72 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 108.168 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.19 -56.24 12.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.048 -1.032 . . . . 0.0 109.893 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -117.95 -14.08 10.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.26 -63.96 0.29 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.47 -143.01 18.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -163.38 137.2 5.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.42 137.51 52.77 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.35 -34.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.269 0.941 . . . . 0.0 111.976 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.71 172.95 42.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.39 153.46 43.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.582 1.153 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 159.82 42.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.469 1.108 . . . . 0.0 108.055 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.08 137.96 2.89 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -61.46 135.73 57.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 110.145 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -153.23 164.93 37.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.191 1.396 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.72 -107.42 0.2 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.95 -26.59 66.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.026 0.913 . . . . 0.0 111.328 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.62 172.03 13.25 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.3 1.84 . . . . 0.0 107.615 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 38.7 tp -84.89 100.15 11.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -81.61 -39.89 23.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.87 146.25 31.04 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 124.478 1.111 . . . . 0.0 108.81 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.7 tp -155.76 100.11 2.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.335 0.516 . . . . 0.0 112.317 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.99 178.55 16.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.801 2.143 . . . . 0.0 109.293 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.4 163.55 39.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.565 1.682 . . . . 0.0 110.201 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -127.82 143.27 51.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.686 1.232 . . . . 0.0 109.534 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -110.42 105.09 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.702 2.001 . . . . 0.0 106.202 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.62 101.02 3.61 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.301 0.955 . . . . 0.0 110.848 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.1 t -121.46 105.87 10.89 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.32 87.9 1.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 107.436 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.7 m -150.74 114.19 4.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.192 0.997 . . . . 0.0 108.908 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.82 148.16 35.13 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 119.414 1.006 . . . . 0.0 111.743 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.77 -177.59 3.2 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.3 3.333 . . . . 0.0 109.163 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.55 149.75 17.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.188 0.995 . . . . 0.0 109.685 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -137.75 160.64 64.07 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.734 1.614 . . . . 0.0 109.225 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -76.65 -179.06 4.98 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.034 2.49 . . . . 0.0 107.75 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.01 152.89 44.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 133.59 52.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -114.31 121.53 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.391 0.677 . . . . 0.0 111.575 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.49 -169.65 1.52 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.7 t -136.33 115.05 12.03 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 120.463 -1.398 . . . . 0.0 108.19 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.41 -171.18 2.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.968 0.907 . . . . 0.0 109.861 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.19 152.46 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.82 -72.78 0.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 123.963 0.792 . . . . 0.0 111.295 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.46 143.07 6.0 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.444 ' HA ' ' HE3' ' A' ' 282' ' ' LYS . 10.0 p-10 -90.19 48.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.811 1.644 . . . . 0.0 111.739 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.64 152.12 26.76 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.45 1.5 . . . . 0.0 107.819 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.04 166.88 12.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.52 1.534 . . . . 0.0 114.264 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 m -65.56 129.32 39.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.355 1.062 . . . . 0.0 109.225 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.6 109.46 11.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -95.05 7.15 47.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.474 1.11 . . . . 0.0 112.443 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.99 132.34 51.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.816 -0.552 . . . . 0.0 112.331 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.82 -9.59 17.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.863 1.665 . . . . 0.0 111.601 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.45 -156.44 51.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.905 -1.122 . . . . 0.0 111.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -109.48 164.41 12.53 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.588 1.555 . . . . 0.0 110.606 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -147.79 -170.29 3.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.822 2.049 . . . . 0.0 110.45 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.04 -45.92 89.52 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.644 -0.66 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.05 40.63 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 9.3 t -123.6 156.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.024 1.33 . . . . 0.0 108.964 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -116.49 -55.69 2.36 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -150.93 165.11 34.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.61 1.096 . . . . 0.0 111.301 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.6 t -125.65 149.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.095 2.158 . . . . 0.0 108.128 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -137.93 120.92 16.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.14 138.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -118.75 83.47 0.35 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -74.08 -171.44 1.13 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.311 1.053 . . . . 0.0 111.583 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.99 45.41 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -62.31 -37.31 85.06 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.81 0.844 . . . . 0.0 111.283 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 -15.58 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.544 3.137 . . . . 0.0 113.166 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 122.42 -175.66 16.43 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.483 1.992 . . . . 0.0 108.405 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.5 mt -69.39 106.14 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 120.941 -1.329 . . . . 0.0 109.381 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 m -98.35 -24.66 15.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.636 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.39 47.78 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 122.395 1.093 . . . . 0.0 113.21 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.1 m -147.45 144.55 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.37 1.868 . . . . 0.0 106.605 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.484 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 56.0 pttt -161.61 170.01 20.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.713 1.205 . . . . 0.0 110.435 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -153.94 175.22 13.63 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.787 0.803 . . . . 0.0 113.087 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.8 114.28 17.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.319 -2.845 . . . . 0.0 103.319 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -129.98 148.37 51.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.765 1.626 . . . . 0.0 108.562 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -112.07 155.55 23.66 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.741 0.781 . . . . 0.0 110.244 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.21 86.25 2.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.01 1.324 . . . . 0.0 109.161 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.05 -79.39 0.88 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -123.49 -35.39 2.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.103 1.361 . . . . 0.0 110.246 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.95 148.61 48.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 122.195 0.997 . . . . 0.0 109.439 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.22 135.64 54.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.8 mm -120.07 116.27 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.03 109.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 127.847 2.459 . . . . 0.0 104.827 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.22 1.29 2.28 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 117.644 -1.642 . . . . 0.0 116.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.83 82.75 0.72 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 119.687 1.744 . . . . 0.0 108.942 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -112.66 135.02 53.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.586 2.755 . . . . 0.0 106.778 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -128.97 -43.55 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.76 153.1 39.87 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.98 112.51 8.3 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.29 1.836 . . . . 0.0 112.222 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.6 171.2 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.919 1.746 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 p -129.66 177.26 7.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.348 1.059 . . . . 0.0 108.413 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.1 mt -66.52 -10.43 44.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.308 -0.87 . . . . 0.0 111.321 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 -22.31 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.71 1.204 . . . . 0.0 109.988 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 86.32 -139.94 17.11 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.484 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 46.3 m-85 -143.58 158.79 43.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.667 1.187 . . . . 0.0 109.193 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -110.28 164.63 12.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.995 2.918 . . . . 0.0 106.422 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.61 139.89 44.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.961 0.8 . . . . 0.0 110.906 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -142.55 123.89 14.73 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.65 0.38 . . . . 0.0 111.035 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.07 130.78 34.55 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.442 1.097 . . . . 0.0 109.392 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.6 mt -127.69 124.58 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -80.23 88.57 5.48 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -52.97 -53.51 54.32 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.631 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.3 -0.71 10.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.2 1.933 . . . . 0.0 115.074 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 m -125.68 -29.45 3.15 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.504 1.956 . . . . 0.0 116.22 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.74 159.91 24.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.568 1.076 . . . . 0.0 109.504 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.55 124.76 36.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.85 101.31 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -69.09 -36.73 77.89 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -157.13 170.45 22.48 Favored 'General case' 0 C--N 1.343 0.294 0 O-C-N 120.703 -1.248 . . . . 0.0 112.132 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.53 151.06 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -132.44 171.59 13.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.402 1.881 . . . . 0.0 106.119 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 143.4 -175.79 23.22 Favored Glycine 0 N--CA 1.465 0.628 0 O-C-N 119.906 -1.746 . . . . 0.0 112.761 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -140.0 146.42 39.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.155 0.982 . . . . 0.0 110.598 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -128.2 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -156.08 170.82 21.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.793 0.837 . . . . 0.0 110.165 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.442 ' HZ1' ' CG ' ' A' ' 240' ' ' ASP . 62.1 mmtt -75.8 148.18 38.63 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 127.073 2.149 . . . . 0.0 110.886 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.0 pt -102.48 157.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 109.325 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -79.01 169.78 17.68 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.27 -41.41 1.57 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.863 -1.148 . . . . 0.0 114.873 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.3 m -141.28 160.37 40.26 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.597 1.698 . . . . 0.0 108.198 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.442 ' CG ' ' HZ1' ' A' ' 235' ' ' LYS . 14.8 t70 -78.79 18.44 0.6 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.91 41.4 Favored Glycine 0 C--N 1.338 0.674 0 O-C-N 120.758 -1.213 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.92 157.08 30.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.371 1.469 . . . . 0.0 108.238 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.54 168.52 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 40.4 mm -105.74 103.41 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 101.219 -3.622 . . . . 0.0 101.219 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -82.16 -17.43 46.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.595 1.089 . . . . 0.0 112.048 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -150.74 136.02 17.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.19 141.34 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -135.99 158.4 44.51 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.169 0.987 . . . . 0.0 108.576 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.92 119.1 18.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -68.13 135.55 52.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.5 p -128.11 165.4 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.602 1.161 . . . . 0.0 109.941 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -129.87 145.38 51.6 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.6 tptp 72.95 -26.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.301 1.44 . . . . 0.0 111.589 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -124.06 173.48 8.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 109.729 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.3 m -117.64 144.17 45.45 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 107.419 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.5 p -121.67 153.87 37.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.418 1.087 . . . . 0.0 109.639 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -97.84 159.07 31.79 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 111.418 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.67 115.44 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.366 2.71 . . . . 0.0 107.9 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.78 93.07 7.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.35 -179.13 16.98 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.252 0.929 . . . . 0.0 112.582 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.93 111.18 22.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.206 1.002 . . . . 0.0 108.369 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.79 107.93 0.92 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.809 0.844 . . . . 0.0 108.853 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.62 156.72 18.57 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.708 2.003 . . . . 0.0 107.345 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.06 -177.54 50.81 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.87 111.04 1.15 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.651 1.18 . . . . 0.0 111.773 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.4 146.03 28.68 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.802 0.441 . . . . 0.0 110.49 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.32 160.01 41.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.284 1.434 . . . . 0.0 110.872 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -146.88 127.53 14.23 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.94 101.32 11.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.69 1.132 . . . . 0.0 110.825 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -123.07 153.39 39.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.452 1.101 . . . . 0.0 110.648 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.73 150.26 36.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.54 1.536 . . . . 0.0 108.143 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -99.02 142.39 30.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.816 1.246 . . . . 0.0 109.894 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.73 55.8 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.847 0.736 . . . . 0.0 114.792 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -134.22 175.38 9.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.19 1.396 . . . . 0.0 110.467 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 162.21 33.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.757 1.623 . . . . 0.0 108.417 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 52.6 mt -95.12 140.91 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.63 -0.35 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.43 -167.68 38.35 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.75 166.84 19.05 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.461 1.105 . . . . 0.0 110.983 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -159.08 163.69 36.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.195 1.398 . . . . 0.0 107.964 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.06 -161.99 29.06 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 30.4 mtmm -126.97 136.82 52.78 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -158.13 96.84 1.48 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.424 1.489 . . . . 0.0 107.474 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.9 m -69.04 -23.85 64.11 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -165.46 -60.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.8 mt -84.24 147.91 27.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.18 2.592 . . . . 0.0 106.066 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.44 80.22 1.42 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.032 . . . . 0.0 112.089 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -64.53 -40.47 95.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -141.55 129.92 22.43 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.67 1.123 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -119.6 106.95 12.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.252 1.421 . . . . 0.0 107.772 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -132.2 -179.73 16.48 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.2 170.27 10.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.582 -0.952 . . . . 0.0 111.158 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.11 156.3 25.48 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.37 160.74 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.524 0.73 . . . . 0.0 109.048 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.46 144.49 42.79 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.64 149.27 79.17 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.867 1.711 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 2.7 pp -106.09 173.34 6.35 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 112.083 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 18.6 m -143.41 52.85 1.34 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.335 1.854 . . . . 0.0 108.286 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.374 1.47 . . . . 0.0 109.289 -179.641 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -69.98 110.93 5.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.192 1.397 . . . . 0.0 112.071 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -147.26 139.71 24.7 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.427 1.891 . . . . 0.0 107.057 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -132.28 118.43 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -64.48 137.91 58.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.365 0.666 . . . . 0.0 109.893 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.56 -58.46 8.38 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.708 1.603 . . . . 0.0 109.649 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.93 -23.22 24.1 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.302 1.43 . . . . 0.0 113.12 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.38 173.84 24.0 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.126 0.963 . . . . 0.0 111.581 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.68 174.27 54.81 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 122.56 1.089 . . . . 0.0 113.837 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.74 9.03 15.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.58 1.552 . . . . 0.0 113.126 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.41 174.73 44.35 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.32 -124.36 31.63 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 158.91 43.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.728 1.611 . . . . 0.0 109.489 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.9 p -101.69 102.86 13.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 116.58 22.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 103.968 -2.605 . . . . 0.0 103.968 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.08 118.61 12.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -133.87 -64.55 0.7 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.703 0.801 . . . . 0.0 110.85 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.82 -76.6 0.4 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.015 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.87 -16.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -71.98 -176.49 1.74 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.417 1.462 . . . . 0.0 110.382 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 60.27 56.2 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.287 1.435 . . . . 0.0 110.792 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.46 102.91 0.73 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.376 -2.289 . . . . 0.0 107.376 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.2 157.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.476 1.91 . . . . 0.0 112.442 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -131.59 -23.33 2.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 112.908 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -153.19 155.56 36.9 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.99 148.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -132.96 144.82 50.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.98 148.81 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.847 2.059 . . . . 0.0 106.431 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.39 -112.16 1.1 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.19 148.28 32.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.372 1.086 . . . . 0.0 108.688 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 -20.79 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 127.189 2.328 . . . . 0.0 112.912 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -56.13 -40.28 73.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.348 2.259 . . . . 0.0 110.237 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.47 7.63 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.128 3.371 . . . . 0.0 109.514 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.71 159.77 23.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 126.371 1.939 . . . . 0.0 109.655 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.58 96.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.3 m -89.78 -21.7 22.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.1 p -127.37 127.19 43.79 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 120.489 1.495 . . . . 0.0 110.83 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.76 137.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 122.891 1.329 . . . . 0.0 109.561 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -148.38 138.72 22.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.652 0.781 . . . . 0.0 109.368 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 t -95.51 123.42 47.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -115.99 165.72 12.8 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.83 0.852 . . . . 0.0 108.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.24 108.69 3.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.263 54.9 pttt -117.15 116.18 26.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.457 1.503 . . . . 0.0 110.129 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 47.5 27.28 0.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.594 1.958 . . . . 0.0 113.548 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -162.76 -159.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.309 -1.494 . . . . 0.0 108.829 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.46 165.24 19.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 116.48 17.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.19 109.03 12.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.38 162.16 29.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.971 0.908 . . . . 0.0 109.699 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 2.36 9.35 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.611 1.577 . . . . 0.0 112.21 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.37 163.95 27.41 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.237 1.518 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -70.94 147.64 48.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.906 2.082 . . . . 0.0 110.805 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -130.4 104.35 7.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.956 2.103 . . . . 0.0 106.011 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.18 -156.26 26.72 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.18 102.76 7.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.866 1.266 . . . . 0.0 108.457 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -103.29 162.7 12.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.9 m -155.6 150.59 26.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.12 -8.42 54.58 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.69 -4.94 7.17 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.25 15.12 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.625 1.102 . . . . 0.0 114.049 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -75.37 128.58 35.71 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.931 1.366 . . . . 0.0 110.145 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -132.49 164.12 27.29 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.226 2.61 . . . . 0.0 111.072 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 m -132.97 138.79 46.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.696 1.599 . . . . 0.0 108.046 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -121.2 109.6 15.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.159 1.783 . . . . 0.0 106.364 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -89.75 165.1 14.38 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.699 1.2 . . . . 0.0 109.042 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 p -111.04 152.86 12.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.202 0.525 . . . . 0.0 110.366 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.18 164.9 12.13 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.822 1.249 . . . . 0.0 110.512 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.78 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.579 0.752 . . . . 0.0 110.986 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -105.59 0.71 26.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.16 140.1 52.45 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -134.2 151.9 51.55 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.94 1.296 . . . . 0.0 108.95 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.0 mm -82.67 142.82 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.906 1.282 . . . . 0.0 108.075 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 m -136.81 -19.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.18 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 146.46 28.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -145.59 96.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -65.26 138.3 58.13 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.19 150.13 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.435 ' CG2' ' H ' ' A' ' 111' ' ' THR . 18.4 m -126.06 140.27 52.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.593 1.957 . . . . 0.0 106.754 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -151.8 149.62 29.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -158.82 168.55 26.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.829 1.195 . . . . 0.0 111.362 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -103.14 154.9 18.82 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.551 1.54 . . . . 0.0 110.581 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.93 146.46 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -75.68 76.4 2.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.06 14.89 0.1 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 127.583 2.516 . . . . 0.0 111.919 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -123.98 111.42 15.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.143 1.377 . . . . 0.0 109.078 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.54 -3.28 8.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.473 1.509 . . . . 0.0 111.42 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -153.37 137.39 16.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.716 1.606 . . . . 0.0 109.353 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.71 152.35 45.63 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.06 154.72 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.19 0.996 . . . . 0.0 109.209 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.16 119.99 22.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.8 p -95.63 -31.1 13.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.159 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.443 ' HG ' ' HG3' ' A' ' 110' ' ' GLU . 17.5 p -157.43 164.05 37.89 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.823 1.647 . . . . 0.0 110.613 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.91 147.57 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.778 1.631 . . . . 0.0 107.525 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 105.82 4.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.994 0.918 . . . . 0.0 109.387 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.42 148.61 48.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.588 -0.695 . . . . 0.0 109.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.48 114.32 11.25 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.0 p -84.97 158.75 20.42 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -30.41 70.69 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.53 -46.84 83.37 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.409 1.083 . . . . 0.0 109.087 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.01 -14.62 3.79 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.847 1.213 . . . . 0.0 112.06 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -68.24 145.07 54.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 107.97 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.1 p -133.77 148.05 51.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 108.979 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.2 p -85.43 162.46 48.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.34 165.3 32.9 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 107.285 -1.852 . . . . 0.0 107.285 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.98 105.49 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 105.738 -2.447 . . . . 0.0 105.738 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.04 81.2 5.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.18 -177.51 18.89 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.301 1.429 . . . . 0.0 111.716 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -84.0 111.5 19.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.697 1.199 . . . . 0.0 112.75 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.443 ' HG3' ' HG ' ' A' ' 93' ' ' SER . 14.6 mt-10 -65.84 140.54 58.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.435 ' H ' ' CG2' ' A' ' 79' ' ' THR . 0.6 OUTLIER -128.39 177.14 7.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.775 1.63 . . . . 0.0 109.543 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.91 -48.86 77.15 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -72.91 122.62 21.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 110' ' ' GLU . 12.9 ptmm? 176.34 163.64 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.454 1.902 . . . . 0.0 108.586 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -157.99 167.9 28.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.484 0.713 . . . . 0.0 110.56 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.59 149.54 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.856 1.662 . . . . 0.0 107.044 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.82 136.09 17.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.577 1.951 . . . . 0.0 107.116 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 162.93 34.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.098 0.559 . . . . 0.0 110.064 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -76.69 74.03 3.36 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.693 1.997 . . . . 0.0 109.055 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -54.72 -24.3 21.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.452 -2.03 . . . . 0.0 115.147 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -93.66 -7.44 43.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.506 1.122 . . . . 0.0 113.103 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.92 -5.0 75.85 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.501 1.524 . . . . 0.0 115.982 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.14 124.12 9.92 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.029 1.914 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.56 161.83 7.16 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.15 0.58 . . . . 0.0 110.398 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 148.06 43.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.343 0.657 . . . . 0.0 109.646 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.82 -35.46 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.054 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.39 -147.46 7.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.61 161.04 43.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.148 1.379 . . . . 0.0 108.722 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -122.07 149.55 43.38 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.487 1.115 . . . . 0.0 108.555 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.51 129.74 5.04 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.28 1.895 . . . . 0.0 109.047 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -93.73 -178.17 4.6 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 122.905 1.336 . . . . 0.0 107.916 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.26 164.4 27.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.469 1.907 . . . . 0.0 107.026 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.64 -103.16 0.3 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 104.313 -3.515 . . . . 0.0 104.313 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -72.83 -25.75 61.24 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.524 0.662 . . . . 0.0 110.426 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.36 -175.14 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.997 3.319 . . . . 0.0 107.684 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.9 tp -95.51 129.51 42.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 126.54 1.936 . . . . 0.0 108.47 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.24 -46.37 4.84 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.947 0.499 . . . . 0.0 111.68 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -137.76 153.09 49.75 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.359 1.063 . . . . 0.0 109.028 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.4 tp -161.83 91.51 0.82 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 172.76 14.54 Favored Glycine 0 C--O 1.229 -0.214 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.33 156.59 48.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -124.48 160.38 28.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -141.98 131.58 23.97 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 103.541 -2.762 . . . . 0.0 103.541 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.76 165.67 28.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.636 1.107 . . . . 0.0 112.993 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -134.26 167.75 20.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.875 2.07 . . . . 0.0 106.772 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.08 177.87 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.97 1.308 . . . . 0.0 110.656 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 t -135.92 171.94 13.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.166 0.986 . . . . 0.0 108.616 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -72.34 155.34 91.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 121.931 -0.481 . . . . 0.0 112.208 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.89 174.3 12.13 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.368 3.379 . . . . 0.0 112.116 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.09 144.56 11.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -73.63 152.22 89.41 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.94 -174.21 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.34 2.693 . . . . 0.0 111.755 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.05 168.91 12.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.845 0.858 . . . . 0.0 110.001 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 131.06 39.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -93.59 114.4 26.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.62 -172.33 3.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.216 1.008 . . . . 0.0 109.751 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.6 m -77.59 155.44 31.5 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.825 -1.172 . . . . 0.0 109.544 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.54 157.3 36.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.708 1.603 . . . . 0.0 109.941 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -127.66 167.3 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.251 1.82 . . . . 0.0 107.472 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.8 -113.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.67 164.46 20.23 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.604 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 9.1 p30 -105.92 6.65 31.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.641 1.577 . . . . 0.0 111.031 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.48 122.92 43.99 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 135.23 177.04 14.67 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.729 2.585 . . . . 0.0 111.894 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.0 m -102.82 153.58 20.04 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.028 1.414 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -72.49 154.67 40.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.643 1.177 . . . . 0.0 112.422 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -142.55 38.63 1.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.248 1.419 . . . . 0.0 109.089 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.3 104.63 0.08 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.082 2.553 . . . . 0.0 112.945 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.43 -40.82 16.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.863 2.865 . . . . 0.0 114.11 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.63 -95.83 1.37 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.28 169.69 10.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.37 1.468 . . . . 0.0 109.334 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -135.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.422 2.289 . . . . 0.0 106.271 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.01 -33.14 71.59 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 221' ' ' TYR . . . -179.59 -151.07 9.51 Favored Glycine 0 CA--C 1.534 1.266 1 C-N-CA 131.501 4.381 . . . . 0.0 107.935 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.8 m -135.07 155.54 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.516 1.926 . . . . 0.0 106.146 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -124.55 -53.78 1.68 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.259 0.936 . . . . 0.0 113.229 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.454 ' HE3' ' CZ ' ' A' ' 179' ' ' TYR . 29.5 ttpt -146.35 136.38 23.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.132 -1.605 . . . . 0.0 109.342 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 51.9 t -90.28 146.57 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 177' ' ' LYS . 45.2 m-85 -141.09 109.81 6.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.134 1.374 . . . . 0.0 108.333 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.76 138.58 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.86 92.29 0.56 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.76 160.88 29.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.251 1.024 . . . . 0.0 109.251 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.4 -170.41 12.04 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 125.414 1.483 . . . . 0.0 109.664 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -46.4 23.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.92 1.288 . . . . 0.0 112.182 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 -4.13 54.69 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.715 1.606 . . . . 0.0 114.236 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.12 -154.05 25.73 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.5 mm -75.08 133.78 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 119.171 1.485 . . . . 0.0 108.225 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 73.6 m -115.39 -22.41 9.36 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.461 1.104 . . . . 0.0 113.683 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.3 169.15 20.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.732 1.254 . . . . 0.0 110.31 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.53 149.48 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -160.16 175.72 12.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.824 1.649 . . . . 0.0 107.09 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -162.69 174.77 12.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.23 149.31 42.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -153.8 167.87 28.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.033 1.333 . . . . 0.0 108.293 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.87 164.89 13.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 119.962 -1.711 . . . . 0.0 108.622 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -140.24 93.33 2.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 64.03 -118.98 14.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.366 -2.694 . . . . 0.0 106.366 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.17 1.93 55.89 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.861 1.265 . . . . 0.0 113.5 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.59 157.33 17.01 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.906 1.23 . . . . 0.0 111.187 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -113.68 125.57 54.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.5 mm -120.64 143.82 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.187 1.395 . . . . 0.0 110.773 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.9 t -116.89 136.76 52.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.78 158.21 42.61 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -96.58 107.04 3.45 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -39.0 113.4 0.31 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.968 2.107 . . . . 0.0 112.252 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -93.39 29.42 1.96 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.693 0.797 . . . . 0.0 111.049 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.88 21.14 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 121.207 -0.933 . . . . 0.0 112.842 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -91.2 111.22 47.53 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.02 -0.99 . . . . 0.0 108.767 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.74 157.55 51.84 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.983 1.788 . . . . 0.0 109.462 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.6 p -133.95 166.36 22.88 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 25.6 tp -67.52 -12.83 61.26 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 112.169 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.68 -32.5 72.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.157 0.983 . . . . 0.0 109.771 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.64 -154.2 16.79 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -139.93 142.53 36.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.701 1.601 . . . . 0.0 107.887 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -97.32 110.77 23.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.69 134.39 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.541 0.736 . . . . 0.0 109.531 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.37 111.85 6.97 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.177 0.591 . . . . 0.0 110.527 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.32 131.12 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 110.414 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.0 mt -128.21 126.37 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 130.65 43.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.862 -0.524 . . . . 0.0 109.81 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' A' ' 174' ' ' GLY . 15.2 t80 -65.06 -63.54 3.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.25 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -85.96 -29.76 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.249 1.482 . . . . 0.0 114.277 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.6 t -77.32 -26.36 52.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.102 1.319 . . . . 0.0 112.829 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -126.09 172.98 9.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.304 1.041 . . . . 0.0 108.464 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -157.2 117.3 3.48 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.92 -1.113 . . . . 0.0 111.489 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.7 mt -68.22 113.44 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -26.71 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.386 0.674 . . . . 0.0 111.933 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -162.34 169.61 20.27 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.756 1.222 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.8 145.82 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.485 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 55.4 mt-10 -132.61 178.42 6.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.607 2.363 . . . . 0.0 109.141 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 166.72 -178.57 41.03 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.6 p -139.98 136.1 33.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.731 0.765 . . . . 0.0 109.241 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -131.12 156.24 45.6 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 113.157 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.02 162.03 40.75 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.657 -0.652 . . . . 0.0 110.545 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 235' ' ' LYS . 0.1 OUTLIER -76.48 136.12 39.37 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.173 1.389 . . . . 0.0 110.486 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.4 mt -72.85 109.71 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -48.3 121.37 4.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 110.647 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.94 22.0 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.492 1.52 . . . . 0.0 110.484 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.2 p -141.38 165.27 27.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.696 1.598 . . . . 0.0 109.501 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.7 -14.32 37.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.404 0.681 . . . . 0.0 110.306 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -68.47 146.32 45.43 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.16 159.45 24.86 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.418 1.487 . . . . 0.0 113.21 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 16.9 tt -136.96 152.2 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 127.207 2.203 . . . . 0.0 107.972 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 2.8 mt -97.68 134.15 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t -121.31 -8.25 9.21 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -146.6 141.16 26.65 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.347 0.659 . . . . 0.0 109.383 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.75 155.56 43.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.238 1.815 . . . . 0.0 108.697 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -144.89 154.62 42.82 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.877 1.671 . . . . 0.0 107.518 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.71 153.61 46.3 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.485 ' HZ3' ' CD ' ' A' ' 230' ' ' GLU . 18.1 mmmt -120.67 114.66 22.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.7 p -133.68 165.9 23.86 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.065 2.946 . . . . 0.0 107.209 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 254' ' ' GLN . 1.6 p30 -112.79 160.26 18.15 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 66.15 -16.49 0.12 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.877 1.671 . . . . 0.0 112.996 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 252' ' ' ASN . 0.2 OUTLIER -145.67 174.2 11.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.772 2.429 . . . . 0.0 108.788 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.3 p -143.65 107.99 4.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -10.72 3.85 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 70.12 165.88 0.13 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.29 1.836 . . . . 0.0 112.187 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.14 137.9 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.932 2.422 . . . . 0.0 109.69 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.32 93.13 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.566 1.947 . . . . 0.0 105.763 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.58 177.7 16.85 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.057 0.837 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.67 113.69 20.52 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.343 1.057 . . . . 0.0 110.243 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.21 108.49 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.354 1.061 . . . . 0.0 109.289 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.15 149.3 19.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.301 1.441 . . . . 0.0 109.056 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.56 -175.0 48.95 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.649 0.583 . . . . 0.0 112.905 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.0 m -66.7 127.53 32.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.508 1.523 . . . . 0.0 108.584 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -86.04 147.56 26.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.778 0.431 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.55 163.7 29.92 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.499 1.12 . . . . 0.0 110.749 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -145.58 147.6 32.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.764 2.425 . . . . 0.0 107.281 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.3 mt -142.01 141.77 32.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.524 1.129 . . . . 0.0 108.528 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -164.65 179.32 6.69 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.303 1.841 . . . . 0.0 110.163 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -144.05 152.95 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 104.892 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.52 71.45 10.42 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 120.398 -1.439 . . . . 0.0 112.636 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.56 -59.28 0.67 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 123.556 0.598 . . . . 0.0 113.65 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -55.49 155.68 5.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.81 0.844 . . . . 0.0 111.681 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 164.07 12.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 108.89 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.78 129.93 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.1 8.4 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.271 1.029 . . . . 0.0 111.617 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 175.11 -179.97 46.05 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -113.73 -179.07 3.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -165.68 158.98 15.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.376 0.989 . . . . 0.0 111.745 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.49 -107.48 0.44 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.604 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -160.74 165.37 30.54 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.481 1.112 . . . . 0.0 110.23 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.23 147.05 37.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.686 1.594 . . . . 0.0 107.12 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 286' ' ' LEU . 19.5 t -174.26 70.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 59.73 -7.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 129.481 3.112 . . . . 0.0 114.651 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 284' ' ' SER . 72.1 mt -136.43 167.73 20.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.603 2.361 . . . . 0.0 110.232 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.1 76.19 0.99 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.793 1.637 . . . . 0.0 109.479 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -76.54 -59.56 2.72 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 110.584 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -110.15 152.81 25.58 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.616 1.167 . . . . 0.0 111.596 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -159.33 145.93 16.66 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.027 0.531 . . . . 0.0 110.057 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -162.8 -175.91 34.32 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.902 2.191 . . . . 0.0 108.33 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.17 130.44 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.633 1.216 . . . . 0.0 113.718 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -73.98 155.59 38.46 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.9 m -130.75 149.64 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 58.2 mmm -151.29 153.65 32.81 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 127.656 2.383 . . . . 0.0 106.354 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.65 165.92 30.38 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.841 1.694 . . . . 0.0 111.556 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.6 173.26 11.85 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.251 2.22 . . . . 0.0 107.781 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 9.3 t -162.02 172.93 15.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 22.5 p30 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.741 1.216 . . . . 0.0 109.708 179.177 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -70.02 144.92 52.09 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.268 0.94 . . . . 0.0 111.441 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -149.56 132.48 16.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.012 1.325 . . . . 0.0 107.855 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.05 145.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.91 143.52 44.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.8 1.64 . . . . 0.0 108.977 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.38 174.89 4.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 109.331 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.6 44.78 0.54 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.376 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.72 -178.72 26.89 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.03 0.915 . . . . 0.0 111.222 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 161.69 2.19 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.779 1.657 . . . . 0.0 115.042 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.16 3.21 40.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.723 1.609 . . . . 0.0 113.549 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.26 -4.87 45.95 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.413 1.006 . . . . 0.0 115.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.14 158.19 18.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.46 157.52 28.92 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.235 0.517 . . . . 0.0 110.212 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -47.27 130.11 12.97 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.446 1.099 . . . . 0.0 110.67 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -130.59 121.5 25.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -161.38 141.83 10.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.32 -20.85 2.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.204 0.911 . . . . 0.0 113.406 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.51 37.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.361 1.457 . . . . 0.0 114.465 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -137.36 -171.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 125.428 1.491 . . . . 0.0 108.065 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.34 162.29 40.36 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.73 -57.99 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 117.775 -1.107 . . . . 0.0 111.917 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.52 56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.126 1.33 . . . . 0.0 112.725 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.77 90.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.902 1.681 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.51 94.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.743 1.617 . . . . 0.0 112.127 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HE3' ' CG2' ' A' ' 41' ' ' VAL . 36.8 mtmt -145.18 162.23 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.63 1.172 . . . . 0.0 108.15 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.49 115.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -113.13 132.9 55.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.52 144.36 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.45 140.09 7.46 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.73 143.62 26.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.322 1.849 . . . . 0.0 108.777 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.33 178.8 16.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 127.584 2.516 . . . . 0.0 108.58 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.81 -26.64 68.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -6.41 59.42 Favored 'General case' 0 CA--C 1.543 0.691 1 C-N-CA 131.8 4.04 . . . . 0.0 111.78 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.54 -160.35 15.02 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.04 110.45 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.6 m -140.0 0.37 1.75 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -123.45 118.41 27.38 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -144.72 155.3 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.891 0.877 . . . . 0.0 110.424 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.21 147.11 20.66 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.596 0.758 . . . . 0.0 109.567 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.26 158.56 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.424 1.49 . . . . 0.0 108.968 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.465 ' CG2' ' HE3' ' A' ' 25' ' ' LYS . 4.8 t -112.79 135.39 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.92 104.65 13.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.67 110.85 22.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -78.06 166.0 23.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.0 -9.69 23.66 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.414 -1.429 . . . . 0.0 113.82 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -119.75 -17.85 8.46 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.92 149.66 26.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.709 1.595 . . . . 0.0 109.299 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -115.75 135.97 53.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.165 1.386 . . . . 0.0 110.705 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.9 t -142.64 123.07 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 0.0 110.014 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -81.85 124.28 29.55 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.79 -3.27 87.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.64 174.05 49.77 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.956 1.378 . . . . 0.0 110.296 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -82.09 152.73 26.43 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.006 -0.702 . . . . 0.0 110.488 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -134.24 154.15 51.44 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 108.338 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.77 -160.48 31.32 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -96.95 105.52 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -53.9 121.5 8.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.438 0.695 . . . . 0.0 110.772 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -138.98 95.92 3.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.776 1.274 . . . . 0.0 108.326 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.26 3.12 13.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.593 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -16.85 7.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.489 2.316 . . . . 0.0 112.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.54 80.37 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -119.37 159.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 164.01 28.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.496 2.319 . . . . 0.0 112.763 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -132.96 95.46 3.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.54 124.87 41.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.45 135.48 44.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.434 0.694 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.2 t -81.51 109.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.46 130.35 42.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.79 67.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.221 1.373 . . . . 0.0 111.427 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.3 -8.23 59.47 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.723 1.609 . . . . 0.0 111.265 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.34 151.85 24.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.322 -0.861 . . . . 0.0 110.135 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -134.79 139.96 45.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mt -78.49 118.35 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.36 -26.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.362 0.665 . . . . 0.0 111.524 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.78 152.92 38.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.898 0.879 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.11 152.89 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -135.17 127.57 30.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.383 2.673 . . . . 0.0 106.691 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.61 116.33 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.368 0.985 . . . . 0.0 109.816 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.8 p -87.44 152.0 22.59 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.999 1.272 . . . . 0.0 107.612 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -150.34 142.64 24.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.53 160.27 28.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.42 131.8 35.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.9 m -102.55 175.11 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 122.062 0.934 . . . . 0.0 113.0 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -60.44 119.55 8.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 109.082 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 3.44 65.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.239 -1.311 . . . . 0.0 113.794 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -122.31 158.49 29.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.722 1.261 . . . . 0.0 110.979 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -107.31 -48.96 3.35 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -78.94 145.17 34.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.59 0.709 . . . . 0.0 110.57 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.99 155.83 39.9 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -139.72 159.86 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 mt -65.49 125.5 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.6 p -100.79 -28.27 12.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.402 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -157.83 165.53 35.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.302 1.41 . . . . 0.0 109.401 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.6 mt -143.69 145.96 21.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.607 1.963 . . . . 0.0 106.623 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.8 m -150.61 118.5 6.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.36 157.0 16.47 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -133.17 129.95 38.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 72.2 p -101.17 154.75 18.48 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.323 0.249 . . . . 0.0 110.838 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -73.2 -28.98 62.49 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -49.26 -44.56 43.88 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 125.095 1.358 . . . . 0.0 109.354 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.5 -6.18 3.87 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.847 -0.974 . . . . 0.0 114.402 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.256 0.3 OUTLIER -103.2 157.07 17.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.911 1.355 . . . . 0.0 111.559 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.6 p -133.11 147.9 52.14 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.043 1.737 . . . . 0.0 107.916 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.74 158.73 56.27 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.31 167.7 26.2 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 121.652 1.568 . . . . 0.0 108.096 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.4 109.91 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.847 2.364 . . . . 0.0 110.247 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -79.09 62.03 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.51 1.524 . . . . 0.0 108.442 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.54 177.77 15.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.891 1.71 . . . . 0.0 110.561 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.9 110.03 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 113.631 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.28 126.56 27.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.6 m -122.79 171.6 9.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.539 0.735 . . . . 0.0 110.916 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -61.85 -58.72 6.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.66 1.184 . . . . 0.0 109.628 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -67.01 129.57 40.34 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -160.79 169.95 21.69 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.029 0.532 . . . . 0.0 111.097 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -122.15 138.8 54.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.637 2.775 . . . . 0.0 106.431 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.65 132.59 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.06 151.99 30.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.857 0.863 . . . . 0.0 108.906 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 156.33 20.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.195 0.998 . . . . 0.0 109.559 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.02 165.22 12.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.002 0.921 . . . . 0.0 108.57 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -138.22 -75.46 0.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -127.85 13.51 6.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.574 1.15 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.25 -17.13 38.04 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 117.331 -1.816 . . . . 0.0 116.569 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.83 27.39 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.953 1.876 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -137.01 166.34 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.88 128.86 37.84 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.65 -59.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.304 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.7 176.57 17.61 Favored Glycine 0 N--CA 1.465 0.617 0 CA-C-N 119.429 1.013 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -125.3 163.58 22.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.955 1.702 . . . . 0.0 112.321 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -167.79 171.07 10.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.548 1.539 . . . . 0.0 109.466 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.64 -119.66 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -154.73 110.92 3.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.641 3.176 . . . . 0.0 103.821 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.84 18.55 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.558 1.143 . . . . 0.0 108.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.79 -131.13 1.97 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.96 -17.47 25.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.886 1.675 . . . . 0.0 114.484 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.87 19.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.324 1.05 . . . . 0.0 110.433 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 tp -86.83 87.01 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -86.57 -32.56 20.6 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.5 162.45 40.11 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.336 -0.852 . . . . 0.0 112.999 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 tp -161.93 106.08 1.22 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.317 -0.239 . . . . 0.0 110.987 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.01 166.22 13.55 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.316 2.389 . . . . 0.0 107.135 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.24 161.75 36.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.133 0.967 . . . . 0.0 109.165 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -101.04 146.13 27.83 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.82 99.82 4.28 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.27 160.4 40.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.033 0.933 . . . . 0.0 109.413 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -134.2 143.94 48.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.873 0.869 . . . . 0.0 109.534 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 p -123.9 0.59 8.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 110.893 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.0 p -92.91 11.68 26.44 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.6 -1.312 . . . . 0.0 113.02 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.9 p -125.51 152.37 71.6 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 119.826 1.194 . . . . 0.0 113.284 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -81.46 -165.67 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.562 3.508 . . . . 0.0 110.119 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.1 p -75.12 166.2 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.828 0.851 . . . . 0.0 109.434 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.7 p -99.79 153.32 37.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.618 1.167 . . . . 0.0 109.041 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.65 -161.28 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.375 3.383 . . . . 0.0 109.579 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.01 172.36 6.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.554 1.141 . . . . 0.0 110.351 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -74.97 138.34 42.21 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -106.27 110.93 23.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.17 1.388 . . . . 0.0 111.848 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 mt -69.0 173.78 5.12 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.258 1.423 . . . . 0.0 108.535 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.6 t -98.23 103.9 15.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.77 170.88 14.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 tt -164.07 160.23 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 106.82 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.68 -20.46 1.3 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.81 -23.6 0.41 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 118.56 1.18 . . . . 0.0 114.004 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.473 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 3.7 m-20 60.14 10.96 2.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.301 1.44 . . . . 0.0 114.027 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -96.2 150.64 20.31 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.821 -1.174 . . . . 0.0 109.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 -179.19 18.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.025 1.298 . . . . 0.0 110.699 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 65.7 m -75.26 124.22 26.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -86.09 131.53 34.24 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.777 0.831 . . . . 0.0 110.322 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -158.89 130.35 6.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.925 0.89 . . . . 0.0 110.028 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.18 135.18 39.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -123.44 60.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.718 2.007 . . . . 0.0 107.269 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -24.68 -82.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.646 0 C-N-CA 129.666 3.507 . . . . 0.0 115.071 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.86 162.94 7.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.682 0.793 . . . . 0.0 112.915 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.07 -165.86 1.57 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.648 2.379 . . . . 0.0 108.684 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.83 -45.16 79.12 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.895 -1.128 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.21 164.26 32.88 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.785 0.707 . . . . 0.0 112.207 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -74.83 157.5 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.08 1.352 . . . . 0.0 111.3 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -133.49 -65.17 0.69 Allowed 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.411 1.084 . . . . 0.0 109.479 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -140.64 156.2 46.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.493 0.588 . . . . 0.0 110.197 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.66 147.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.315 1.846 . . . . 0.0 107.315 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -138.99 163.46 32.33 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.826 1.251 . . . . 0.0 108.515 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.1 t -141.88 123.63 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -100.97 77.09 0.4 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.5 -175.78 0.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.805 0.812 . . . . 0.0 112.151 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.83 -172.53 38.57 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.47 -28.67 69.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 128.632 2.773 . . . . 0.0 114.901 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.76 -31.67 5.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.6 2.76 . . . . 0.0 112.398 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.8 -167.88 36.01 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.21 114.37 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.2 m -103.79 -25.24 13.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.883 1.673 . . . . 0.0 112.005 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -134.21 154.51 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.024 0.93 . . . . 0.0 109.02 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.74 155.34 27.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.418 1.087 . . . . 0.0 109.002 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -175.43 152.56 1.38 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 111.061 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.99 162.32 35.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.541 1.536 . . . . 0.0 108.217 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.37 151.22 37.45 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.517 1.127 . . . . 0.0 108.516 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -163.83 154.22 15.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.646 0.736 . . . . 0.0 111.052 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -110.27 123.75 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -139.78 145.15 37.85 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.34 35.86 61.73 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.68 0.38 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.243 3.417 . . . . 0.0 114.421 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.52 154.75 19.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.756 1.622 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.78 130.69 39.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.781 0.832 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.1 mt -119.25 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 37.2 t -122.54 121.45 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 176.96 -110.97 0.32 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 67.03 -4.63 3.16 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 127.143 2.306 . . . . 0.0 116.469 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.58 124.92 25.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.163 1.982 . . . . 0.0 108.678 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.22 16.9 1.36 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.435 1.894 . . . . 0.0 111.803 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.45 151.34 23.61 Favored Glycine 0 C--N 1.335 0.501 0 O-C-N 119.099 -2.251 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 285' ' ' GLU . 45.8 pttt -35.43 98.94 0.16 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.682 1.593 . . . . 0.0 114.009 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.37 114.26 2.79 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.243 1.962 . . . . 0.0 107.977 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.0 p -78.32 145.33 35.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.059 0.944 . . . . 0.0 110.329 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.46 -7.1 34.96 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.429 -0.795 . . . . 0.0 110.202 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.86 2.064 . . . . 0.0 108.622 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.93 -161.95 13.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -141.99 129.06 20.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -79.41 161.93 25.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -144.19 157.21 44.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 111.964 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.52 115.75 8.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.38 116.17 31.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.9 mm -127.55 107.57 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.71 103.79 1.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 123.92 0.762 . . . . 0.0 110.909 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -36.5 -56.07 1.36 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.211 2.204 . . . . 0.0 115.957 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.7 -16.96 11.35 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 115.017 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.9 m -101.24 -10.59 20.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.484 1.493 . . . . 0.0 113.288 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 225' ' ' TYR . 23.8 tt0 -139.99 -168.82 2.6 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.534 ' H ' ' HG2' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -168.27 140.7 2.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.35 115.45 49.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.372 2.269 . . . . 0.0 106.208 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 32.5 m -94.14 -72.02 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.281 0.491 . . . . 0.0 111.658 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -107.82 170.5 7.95 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.551 1.14 . . . . 0.0 113.981 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.3 p -132.68 144.97 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.81 1.644 . . . . 0.0 107.91 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -133.07 169.82 16.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.711 1.604 . . . . 0.0 107.428 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.87 -175.26 45.77 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 120.248 -1.532 . . . . 0.0 109.599 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.32 136.27 22.23 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.47 38.99 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.348 1.059 . . . . 0.0 109.339 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -136.97 166.13 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.688 0.756 . . . . 0.0 112.172 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -72.87 141.22 47.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.926 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.1 157.93 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.763 2.025 . . . . 0.0 109.1 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -107.43 106.34 16.7 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 160.25 -49.13 0.38 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.441 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 49.9 m -135.46 173.92 11.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.196 0.998 . . . . 0.0 111.965 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.86 -12.2 58.58 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.159 0.584 . . . . 0.0 112.314 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.54 120.22 5.95 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.39 172.52 9.3 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.532 1.933 . . . . 0.0 107.061 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.7 tt -125.82 134.49 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.734 1.152 . . . . 0.0 111.441 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.4 mt -79.43 122.88 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 -6.67 10.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.983 0.513 . . . . 0.0 111.828 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -143.37 147.29 34.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.95 149.13 44.41 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.033 1.733 . . . . 0.0 110.255 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -149.4 153.83 37.96 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.05 1.74 . . . . 0.0 106.613 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.43 138.47 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -89.27 114.31 25.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.27 0.941 . . . . 0.0 109.492 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.8 p -97.85 165.42 11.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.7 2.0 . . . . 0.0 110.659 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.28 134.75 55.04 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? 75.79 -50.92 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.749 2.42 . . . . 0.0 107.659 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -82.67 155.91 24.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.853 2.061 . . . . 0.0 108.262 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 59.4 m -118.83 114.52 22.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.3 p -68.88 168.22 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 111.802 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.45 154.17 42.42 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.021 1.328 . . . . 0.0 109.442 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.45 109.17 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.874 2.383 . . . . 0.0 108.234 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.54 92.34 5.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.42 -172.01 14.41 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.495 1.045 . . . . 0.0 111.495 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.98 133.94 52.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.42 -1.047 . . . . 0.0 110.516 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.2 108.33 3.12 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -147.56 125.91 12.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 97.81 -157.77 20.73 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.41 0.45 . . . . 0.0 112.095 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.3 m -77.21 117.52 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.722 1.209 . . . . 0.0 110.474 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.92 129.58 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -136.52 151.24 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.46 155.42 50.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.355 1.062 . . . . 0.0 108.58 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp -141.37 130.79 23.76 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.803 0.841 . . . . 0.0 109.017 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.47 166.29 10.26 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.069 1.348 . . . . 0.0 109.369 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -134.78 134.0 40.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.74 128.27 35.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.864 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.21 26.62 70.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -135.96 162.62 32.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.505 1.653 . . . . 0.0 111.097 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -121.62 162.49 20.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.211 1.404 . . . . 0.0 110.165 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 25.4 mt -79.63 145.64 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.1 m -145.49 -12.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.25 34.34 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 120.674 1.579 . . . . 0.0 111.136 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -144.85 157.06 44.29 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.112 1.765 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -149.64 149.29 30.42 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 128.489 2.716 . . . . 0.0 104.783 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.55 -135.99 6.45 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 11.5 mptt -140.63 157.54 45.3 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -129.87 149.37 51.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.3 p -159.75 -178.01 6.77 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.212 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.456 ' O ' ' HE2' ' A' ' 208' ' ' LYS . 5.7 mm-40 -67.83 -0.19 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.785 1.234 . . . . 0.0 111.671 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 22.6 mt -140.77 135.81 31.88 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 129.316 3.047 . . . . 0.0 103.148 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -85.74 95.62 9.45 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -88.89 -70.41 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.277 0.361 . . . . 0.0 111.722 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -106.13 111.68 24.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.563 1.145 . . . . 0.0 111.995 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -116.98 160.74 20.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.52 40.24 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.73 141.01 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 117.818 0.809 . . . . 0.0 108.943 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -84.24 155.63 22.39 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.1 m -125.12 158.49 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.861 0.864 . . . . 0.0 109.816 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 28.2 mtt -157.44 145.71 14.27 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.871 2.468 . . . . 0.0 105.491 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.54 155.91 62.39 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.182 -1.507 . . . . 0.0 108.182 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.84 150.47 49.12 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 13.0 t -159.66 143.42 14.56 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.337 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -70.5 119.59 14.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.251 0.548 . . . . 0.0 110.738 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -148.53 140.6 23.97 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.3 93.35 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.823 0.738 . . . . 0.0 109.03 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.34 146.46 19.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.477 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 150.98 47.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.093 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.12 9.67 69.99 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.7 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.28 179.88 43.78 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.305 1.552 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.37 -31.34 63.53 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.63 12.85 9.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.47 2.308 . . . . 0.0 113.448 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.04 -28.22 12.16 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.749 2.119 . . . . 0.0 116.352 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.71 -81.33 0.58 Allowed Glycine 0 C--N 1.342 0.863 0 CA-C-N 120.15 1.975 . . . . 0.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.67 158.89 43.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.986 0.915 . . . . 0.0 109.885 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.29 97.88 6.0 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.894 1.278 . . . . 0.0 111.414 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.453 ' CD1' ' HG3' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -67.38 0.6 2.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.538 1.535 . . . . 0.0 113.001 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.65 109.79 2.13 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.12 -0.987 . . . . 0.0 111.103 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.05 165.36 17.62 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 109.434 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.55 -3.46 86.43 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.376 -1.235 . . . . 0.0 113.443 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.4 m -118.24 155.13 20.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 119.368 1.584 . . . . 0.0 109.839 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -74.85 164.02 27.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.81 -93.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.71 165.92 20.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 111.875 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -143.11 96.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.62 1.568 . . . . 0.0 107.42 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -85.59 -50.56 7.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.805 1.242 . . . . 0.0 110.836 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -141.19 164.48 30.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.37 96.97 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.1 126.1 34.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.89 136.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.38 162.71 30.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -106.86 141.19 38.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.239 2.216 . . . . 0.0 111.259 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.39 -156.68 9.72 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 106.039 -2.824 . . . . 0.0 106.039 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -96.06 -9.4 30.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.705 -1.467 . . . . 0.0 109.629 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.82 2.71 38.59 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 134.132 4.973 . . . . 0.0 112.707 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.71 -139.4 14.49 Favored Glycine 0 C--N 1.339 0.736 0 O-C-N 121.146 -0.971 . . . . 0.0 111.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -77.42 96.45 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -105.43 2.74 28.91 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.47 124.91 23.43 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 122.138 2.245 . . . . 0.0 107.919 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 169.37 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -159.14 152.83 22.97 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.745 -1.222 . . . . 0.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.58 107.6 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.037 1.335 . . . . 0.0 109.585 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.42 114.88 35.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -101.93 122.97 45.05 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.781 0.719 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.81 125.64 29.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -113.98 145.32 41.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.16 -35.58 59.93 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 t -80.71 -65.08 1.06 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.207 0.458 . . . . 0.0 110.203 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -150.96 140.91 21.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.341 1.056 . . . . 0.0 108.359 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.63 135.58 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.202 1.801 . . . . 0.0 109.665 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.74 146.56 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 106.984 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 156.89 21.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.711 1.204 . . . . 0.0 109.657 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.62 35.36 3.33 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.234 1.873 . . . . 0.0 111.384 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.07 -154.36 47.09 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.012 0.906 . . . . 0.0 111.628 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.3 152.8 47.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -128.81 166.11 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.1 0.96 . . . . 0.0 109.002 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' O ' ' HE3' ' A' ' 56' ' ' LYS . . . 85.71 -157.96 31.73 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -126.66 105.56 8.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 113.358 -178.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 1.5 ttmp? -62.41 128.73 37.43 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -131.14 155.17 47.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.56 -9.88 58.96 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -0.19 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.604 1.562 . . . . 0.0 113.089 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.08 130.87 2.39 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 125.888 1.709 . . . . 0.0 108.903 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.518 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 63.7 t80 -163.58 132.32 3.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.321 2.648 . . . . 0.0 105.781 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 163.67 32.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.79 1.636 . . . . 0.0 111.817 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -134.2 96.85 3.7 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.681 1.193 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.61 138.43 31.69 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.94 119.21 32.81 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.243 1.017 . . . . 0.0 109.602 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.24 123.67 25.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.046 0.938 . . . . 0.0 109.403 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.42 159.88 31.73 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.51 1.524 . . . . 0.0 110.742 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.51 25.99 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.5 1.57 55.71 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.469 2.308 . . . . 0.0 114.254 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -127.21 155.98 42.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.721 1.146 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -135.08 137.12 42.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.49 1.116 . . . . 0.0 108.884 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mt -73.96 102.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.24 -34.77 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 113.965 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.06 43.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.827 0.739 . . . . 0.0 109.482 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.29 146.29 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -131.49 137.69 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.49 139.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 p -115.8 154.49 29.55 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -154.3 168.63 25.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.86 1.264 . . . . 0.0 108.9 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -161.07 168.51 24.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -115.88 159.02 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.848 2.059 . . . . 0.0 109.063 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.1 m -127.25 135.62 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.29 107.82 0.61 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.24 3.66 7.99 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.041 -1.421 . . . . 0.0 113.35 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.23 142.17 47.26 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 119.817 1.808 . . . . 0.0 108.203 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.71 16.2 12.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.879 2.071 . . . . 0.0 111.517 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -136.35 172.72 12.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.348 1.459 . . . . 0.0 111.469 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.84 158.4 30.36 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.811 1.644 . . . . 0.0 106.897 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 pt -131.68 150.51 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.736 1.614 . . . . 0.0 107.397 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.89 122.76 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.292 1.037 . . . . 0.0 110.348 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 p -88.8 -29.67 19.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.71 0.804 . . . . 0.0 112.274 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -164.55 161.61 21.23 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.94 1.296 . . . . 0.0 109.793 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 mt -136.35 136.71 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 m -135.81 132.66 36.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -114.74 158.88 21.23 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.522 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -140.75 144.72 35.67 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.522 2.329 . . . . 0.0 105.227 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -134.2 166.39 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.0 -41.04 95.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 10.3 mmpt? -58.33 -12.09 3.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.455 1.102 . . . . 0.0 112.275 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.0 18.61 62.76 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.194 1.378 . . . . 0.0 111.954 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -89.15 97.01 10.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 p -85.46 105.81 16.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.24 157.11 83.35 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.53 164.17 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 0.0 111.331 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 111.82 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.063 2.509 . . . . 0.0 107.02 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -75.52 74.79 2.56 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.365 0.666 . . . . 0.0 109.566 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 142.36 -141.17 10.54 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.228 1.395 . . . . 0.0 110.519 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.9 tp -108.5 132.5 53.75 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 125.544 1.538 . . . . 0.0 109.619 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 116.86 18.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 m -114.67 164.6 13.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -61.26 -51.9 66.98 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.814 1.246 . . . . 0.0 110.174 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.29 115.77 11.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.9 168.27 27.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.358 -0.839 . . . . 0.0 110.872 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.37 167.18 22.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.607 1.563 . . . . 0.0 107.887 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.65 149.8 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -142.95 157.32 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.344 0.52 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.42 160.04 15.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.719 1.608 . . . . 0.0 111.51 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -81.28 177.12 9.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.796 1.639 . . . . 0.0 107.898 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.08 -46.31 2.32 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.111 -0.993 . . . . 0.0 112.519 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -109.52 19.25 19.48 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.41 -4.93 85.23 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.001 1.286 . . . . 0.0 114.244 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 118.32 13.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.53 164.18 0.54 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.243 1.817 . . . . 0.0 113.752 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.28 111.27 1.68 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.9 t -61.75 -50.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.78 48.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.08 -2.408 . . . . 0.0 107.08 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -102.49 172.32 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 169.14 20.89 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.48 126.69 1.73 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.453 ' HG3' ' CD1' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -99.74 179.3 4.58 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 123.208 1.48 . . . . 0.0 109.075 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.23 152.85 39.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 129.663 3.185 . . . . 0.0 105.519 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.52 -87.09 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 104.214 -3.555 . . . . 0.0 104.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -95.12 -27.48 15.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.186 0.493 . . . . 0.0 111.142 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.59 160.73 37.17 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 tp -77.45 93.67 4.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.597 0.713 . . . . 0.0 110.284 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -81.76 -37.12 27.71 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.306 1.042 . . . . 0.0 112.681 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.58 152.02 39.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.813 1.188 . . . . 0.0 109.853 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.4 tp -161.77 141.89 10.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.256 1.422 . . . . 0.0 108.296 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.89 -179.73 46.85 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.55 167.43 28.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.654 1.182 . . . . 0.0 109.069 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -136.39 168.44 19.45 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.815 1.293 . . . . 0.0 111.169 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -133.04 97.37 3.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 103.151 -2.907 . . . . 0.0 103.151 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.58 4.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 t -108.83 166.68 10.63 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 m 66.99 39.13 3.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.809 0.814 . . . . 0.0 110.596 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.0 p -89.87 3.44 52.98 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.573 -1.329 . . . . 0.0 110.488 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 40.8 p -102.75 144.93 29.61 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 127.07 2.148 . . . . 0.0 114.697 -177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.47 109.72 2.7 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.573 2.182 . . . . 0.0 106.801 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.4 t -147.86 122.94 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -137.43 152.41 73.09 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.879 -0.582 . . . . 0.0 111.357 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.33 -169.29 0.63 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.96 3.107 . . . . 0.0 109.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.88 -179.04 4.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.92 0.867 . . . . 0.0 110.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 126.52 31.13 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.149 -0.969 . . . . 0.0 112.816 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.82 147.88 24.94 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.992 2.117 . . . . 0.0 109.882 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.66 162.47 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.5 t -72.63 135.49 45.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -135.37 169.43 17.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.387 1.875 . . . . 0.0 109.976 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.6 154.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.25 1.82 . . . . 0.0 108.883 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.8 -85.2 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.68 47.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.668 2.08 . . . . 0.0 108.271 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.425 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 2.9 p30 -111.19 10.15 21.84 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -83.45 150.06 26.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.35 -179.56 22.94 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.721 1.146 . . . . 0.0 115.805 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.4 m -96.3 119.39 34.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.197 1.799 . . . . 0.0 109.136 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.6 153.65 40.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.438 0.563 . . . . 0.0 110.295 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -142.46 131.2 22.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.33 1.062 . . . . 0.0 111.0 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.32 139.91 32.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.806 1.643 . . . . 0.0 108.512 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.16 124.66 19.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.78 177.68 41.99 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.386 1.47 . . . . 0.0 111.05 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.36 149.69 27.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -131.96 -175.31 3.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.216 1.007 . . . . 0.0 110.896 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.07 -32.21 54.01 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.934 1.694 . . . . 0.0 113.327 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.32 -158.64 31.36 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.512 2.006 . . . . 0.0 108.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.39 139.47 50.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.688 1.195 . . . . 0.0 108.622 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.89 -68.89 0.9 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 110.233 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -119.03 157.65 27.37 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.399 0.545 . . . . 0.0 110.749 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.83 143.73 38.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 127.303 2.241 . . . . 0.0 107.775 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -143.39 145.41 32.63 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.722 1.209 . . . . 0.0 108.041 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 t -139.39 151.3 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.381 1.072 . . . . 0.0 109.605 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.74 144.37 16.24 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -123.36 -170.05 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.359 1.464 . . . . 0.0 110.571 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.85 -175.83 45.78 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 126.002 1.763 . . . . 0.0 110.127 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.26 -17.92 2.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.428 3.091 . . . . 0.0 118.219 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -117.78 -9.91 10.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.912 0.778 . . . . 0.0 112.259 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.7 -146.69 18.58 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 mm -63.86 153.4 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.588 1.194 . . . . 0.0 108.393 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.3 p -134.81 -23.84 1.54 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.76 151.93 34.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.692 1.133 . . . . 0.0 111.718 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 m -149.51 124.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 123.543 0.737 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -149.81 161.28 42.57 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -151.3 172.91 15.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.013 0.925 . . . . 0.0 108.511 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -130.88 147.03 52.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.837 0.827 . . . . 0.0 109.767 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.47 168.42 21.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.811 2.044 . . . . 0.0 109.979 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -112.3 161.83 16.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.0 1.72 . . . . 0.0 108.764 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -134.35 83.77 2.06 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.692 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.63 -66.58 1.34 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.398 1.475 . . . . 0.0 111.477 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -135.07 -45.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.365 1.866 . . . . 0.0 108.555 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -60.9 164.43 4.88 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.872 1.32 . . . . 0.0 111.333 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.34 149.78 44.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.625 1.57 . . . . 0.0 107.414 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -140.43 143.9 28.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.53 147.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -71.79 146.49 40.17 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.46 10.66 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.334 -3.106 . . . . 0.0 105.334 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 133.57 49.31 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 118.616 1.208 . . . . 0.0 108.863 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -106.41 -15.25 14.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.559 0.744 . . . . 0.0 110.486 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -102.48 -177.62 27.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.827 1.68 . . . . 0.0 113.232 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -107.93 83.52 1.76 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 128.531 2.733 . . . . 0.0 106.323 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.4 148.97 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.75 . . . . 0.0 111.553 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 66.7 p -87.06 -179.26 6.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.45 -1.06 25.23 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.151 -1.593 . . . . 0.0 112.771 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -32.27 32.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.23 0.923 . . . . 0.0 113.239 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.56 -157.11 18.81 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -147.42 119.94 8.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -66.94 154.76 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -139.75 142.74 36.77 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -143.04 142.98 31.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.495 1.518 . . . . 0.0 107.486 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -133.14 95.85 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.76 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.97 1.308 . . . . 0.0 111.395 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.78 89.79 2.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.403 1.081 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -45.46 -47.74 35.99 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.598 1.959 . . . . 0.0 112.626 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.89 -7.03 15.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 122.048 1.767 . . . . 0.0 114.682 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.7 t -109.93 -13.15 14.48 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 120.814 1.643 . . . . 0.0 113.402 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 171.66 13.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.344 0.975 . . . . 0.0 111.328 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -145.66 90.63 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.62 101.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.3 p -87.19 -26.47 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.441 1.097 . . . . 0.0 112.46 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.52 171.02 20.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.156 0.889 . . . . 0.0 112.24 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.86 159.26 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.16 176.35 5.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.717 2.407 . . . . 0.0 107.543 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.97 41.86 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -153.18 141.3 20.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.11 153.79 48.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.761 0.825 . . . . 0.0 110.432 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . 0.326 0.3 OUTLIER -156.17 172.01 19.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -74.78 139.94 43.66 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.409 1.483 . . . . 0.0 110.953 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.25 157.54 34.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 127.221 2.208 . . . . 0.0 110.041 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -84.93 178.37 7.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.32 -69.7 1.52 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.1 p -95.48 -178.21 4.34 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.715 0.769 . . . . 0.0 111.427 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.58 14.19 24.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.613 1.565 . . . . 0.0 111.435 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -128.27 163.49 21.81 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.249 1.404 . . . . 0.0 113.099 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.82 173.28 11.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.978 1.711 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.75 146.07 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.403 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.3 mm -76.12 133.78 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 t -112.36 -21.82 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -152.27 152.7 32.48 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 140.42 34.23 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.821 2.048 . . . . 0.0 109.013 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -145.23 153.42 41.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 106.339 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.45 128.69 56.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.408 ' HE3' ' OE2' ' A' ' 268' ' ' GLU . 1.3 mtpm? -80.47 114.39 19.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -119.66 165.16 14.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.365 1.079 . . . . 0.0 109.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.93 133.51 47.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 65.95 -46.39 0.4 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.501 2.32 . . . . 0.0 111.188 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -92.11 165.5 13.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 129.283 3.033 . . . . 0.0 109.408 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 73.7 m -150.76 118.83 6.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 83.9 p -66.85 165.03 16.08 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.095 0.474 . . . . 0.0 110.613 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -67.84 153.96 94.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.84 97.77 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.439 2.093 . . . . 0.0 106.731 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -76.14 92.47 3.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 111.28 178.24 20.33 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.952 1.263 . . . . 0.0 111.534 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.75 123.44 49.0 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.09 0.956 . . . . 0.0 110.035 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.11 107.23 5.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -157.05 45.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.219 1.008 . . . . 0.0 109.357 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -167.87 -164.92 24.39 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 121.405 -0.81 . . . . 0.0 111.115 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.2 m -66.7 104.6 1.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.27 146.98 36.54 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.578 -0.701 . . . . 0.0 110.788 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -141.4 170.42 15.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.924 0.868 . . . . 0.0 112.763 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.408 ' OE2' ' HE3' ' A' ' 250' ' ' LYS . 39.7 tt0 -140.99 152.83 45.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.542 2.337 . . . . 0.0 106.891 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.6 mt -138.64 104.22 5.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -140.05 150.82 44.83 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.255 0.622 . . . . 0.0 110.461 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -144.8 130.75 19.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -67.71 138.72 56.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.63 -11.23 3.38 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.483 1.516 . . . . 0.0 115.818 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -99.21 159.75 14.76 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 120.111 1.956 . . . . 0.0 112.197 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -119.95 147.6 44.55 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.823 1.649 . . . . 0.0 107.543 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 87.9 mt -80.69 141.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.16 -29.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.46 -178.07 35.08 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.001 1.286 . . . . 0.0 110.559 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -113.37 -179.04 3.53 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.878 1.671 . . . . 0.0 111.22 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -153.35 179.36 8.84 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.822 2.049 . . . . 0.0 105.549 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 126.98 -151.73 18.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -151.54 149.53 29.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -108.11 154.6 21.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.936 1.295 . . . . 0.0 108.513 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 t -151.92 -63.03 0.17 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -149.18 -31.36 0.23 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.387 1.075 . . . . 0.0 112.542 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 79.6 mt -134.4 -112.81 0.21 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.948 1.249 . . . . 0.0 109.259 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.78 77.43 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.175 1.352 . . . . 0.0 108.628 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -60.58 -62.24 2.0 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 0.0 113.322 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -132.38 140.76 48.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.866 0.757 . . . . 0.0 109.702 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -140.99 151.32 44.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.566 1.547 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.88 165.83 37.76 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.0 m -113.52 157.02 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.788 1.294 . . . . 0.0 113.719 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.97 136.44 38.95 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.59 141.95 38.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.21 129.41 20.84 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 125.044 1.338 . . . . 0.0 108.425 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.95 86.53 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.857 3.038 . . . . 0.0 110.059 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 20.7 mt -96.46 9.41 41.43 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 35.4 m -78.93 159.04 27.9 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 . . . . . 0 C--O 1.247 0.94 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -70.33 152.57 44.0 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.738 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -140.99 140.66 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 130.442 3.497 . . . . 0.0 107.1 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 82.5 t -127.94 130.9 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.61 169.89 5.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.333 1.053 . . . . 0.0 113.836 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.37 106.55 6.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.44 134.08 13.29 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 105.67 -2.972 . . . . 0.0 105.67 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.25 -151.42 20.08 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.77 168.89 42.89 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 122.779 1.21 . . . . 0.0 114.444 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.74 -18.39 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.457 1.103 . . . . 0.0 111.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.53 169.33 41.23 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.577 0.608 . . . . 0.0 113.005 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.91 168.49 44.46 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.134 1.35 . . . . 0.0 112.462 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.74 156.06 21.59 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 84.0 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.199 1.4 . . . . 0.0 110.264 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -90.04 135.58 33.56 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.38 151.95 28.49 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 128.295 2.638 . . . . 0.0 105.41 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.78 153.0 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.28 -4.35 16.03 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 m -65.76 158.71 4.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.773 1.286 . . . . 0.0 110.122 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -67.98 -44.54 76.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -172.6 -165.89 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.66 2.784 . . . . 0.0 105.913 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.69 27.68 0.86 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.07 1.319 . . . . 0.0 112.896 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.11 142.71 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 119.397 1.598 . . . . 0.0 109.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.29 -33.33 1.3 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.265 0.626 . . . . 0.0 112.29 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -135.89 160.67 37.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.453 0.569 . . . . 0.0 110.735 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.29 90.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.63 110.45 20.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -132.92 147.58 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 172.37 22.45 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -135.12 157.27 47.35 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.835 0.854 . . . . 0.0 112.568 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.83 -153.28 8.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.389 -2.684 . . . . 0.0 106.389 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -95.86 -7.34 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.96 -1.318 . . . . 0.0 110.373 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.38 -7.23 26.48 Favored 'General case' 0 N--CA 1.446 -0.645 1 C-N-CA 133.705 4.802 . . . . 0.0 112.427 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.77 -151.91 18.07 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.78 131.69 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -148.09 13.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.758 -1.214 . . . . 0.0 113.297 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 p -131.7 125.42 32.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.5 mt -140.52 119.39 11.19 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -128.03 145.36 51.01 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 107.714 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.2 t -129.08 131.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.313 1.045 . . . . 0.0 110.407 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.59 132.51 44.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 102.184 -3.265 . . . . 0.0 102.184 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -103.07 152.63 21.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 109.834 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.26 115.87 30.92 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.16 166.73 11.33 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.357 1.075 . . . . 0.0 111.16 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.53 -5.65 25.64 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.406 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.2 m -104.91 -67.01 0.93 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 119.583 -1.948 . . . . 0.0 110.803 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -156.35 165.6 35.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.664 1.185 . . . . 0.0 107.831 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.52 141.88 42.94 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -145.79 138.44 20.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.61 136.45 57.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.152 0.981 . . . . 0.0 108.438 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.73 -65.88 1.84 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.15 171.81 20.17 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.09 146.3 23.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.483 0.659 . . . . 0.0 111.02 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -123.92 83.73 2.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.28 26.29 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -126.61 112.44 15.5 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -52.98 111.96 0.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 110.082 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -81.61 108.36 15.11 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 127.756 2.422 . . . . 0.0 109.842 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.77 -24.02 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.569 -0.707 . . . . 0.0 112.672 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.28 8.77 43.89 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.271 1.029 . . . . 0.0 113.548 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.44 121.9 0.84 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.951 1.25 . . . . 0.0 110.658 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.85 121.38 2.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.623 2.369 . . . . 0.0 105.026 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -128.4 164.45 22.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.4 m -121.87 131.22 53.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.865 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -137.47 110.27 7.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -95.52 124.66 39.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.98 1.312 . . . . 0.0 108.922 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.84 116.25 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.56 143.57 56.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -41.63 75.41 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.626 -0.671 . . . . 0.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.34 -7.4 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.677 1.191 . . . . 0.0 112.638 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.11 151.33 21.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.969 1.708 . . . . 0.0 108.23 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -130.89 143.15 50.52 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.9 mt -68.57 137.64 24.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.2 m -107.18 -46.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 123.144 0.578 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 165.32 31.07 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.215 1.406 . . . . 0.0 108.635 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.07 108.82 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -91.91 137.68 32.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.5 t -136.36 144.16 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.6 m -118.61 140.46 49.88 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.69 167.17 30.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.218 1.807 . . . . 0.0 106.308 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.18 168.54 24.03 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.53 0.605 . . . . 0.0 109.842 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -108.5 148.72 29.84 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.375 1.07 . . . . 0.0 111.313 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.48 131.13 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -60.24 -0.25 0.22 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.817 1.647 . . . . 0.0 115.201 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.36 7.66 34.77 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.18 1.847 . . . . 0.0 113.35 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -138.42 144.07 40.02 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 120.365 2.083 . . . . 0.0 109.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.59 -2.29 28.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.281 1.832 . . . . 0.0 111.664 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 t -155.02 150.38 27.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.83 -1.169 . . . . 0.0 110.137 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.52 163.87 27.24 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 pt -139.39 151.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.973 1.309 . . . . 0.0 109.246 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.16 118.92 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.4 p -89.53 -32.76 17.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.584 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -162.84 166.22 24.36 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.557 1.071 . . . . 0.0 112.863 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.6 mt -135.72 151.58 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.066 1.347 . . . . 0.0 107.681 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.3 m -141.25 101.74 4.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.392 1.877 . . . . 0.0 107.009 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -81.82 121.8 26.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.752 1.221 . . . . 0.0 108.914 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -106.13 128.24 53.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.414 1.486 . . . . 0.0 109.067 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.9 p -99.9 169.06 9.48 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.642 1.177 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -76.92 -39.93 49.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -68.75 -26.2 65.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 116.432 -1.747 . . . . 0.0 115.348 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.52 -12.58 7.01 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 121.068 1.758 . . . . 0.0 114.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -70.49 137.4 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -135.06 128.66 32.69 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.5 p -74.31 158.66 85.11 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 117.914 0.325 . . . . 0.0 110.917 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.93 164.53 35.37 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 107.128 -1.912 . . . . 0.0 107.128 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.81 83.5 1.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.783 2.322 . . . . 0.0 108.663 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -57.16 115.52 2.71 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.05 -126.45 6.89 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -139.4 131.73 28.39 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.87 1.268 . . . . 0.0 107.916 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -68.19 154.26 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.34 175.56 12.11 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.432 -1.417 . . . . 0.0 111.784 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -58.38 -64.52 0.89 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.915 1.686 . . . . 0.0 111.527 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.95 163.52 27.8 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.948 0.88 . . . . 0.0 110.927 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER 176.11 168.82 0.43 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.156 1.783 . . . . 0.0 109.047 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.48 160.96 42.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.663 1.585 . . . . 0.0 107.565 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.06 137.17 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.22 137.09 50.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.14 138.03 0.72 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.379 2.672 . . . . 0.0 107.865 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -64.31 140.28 58.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.75 -28.06 63.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.383 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.99 2.96 55.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.081 1.309 . . . . 0.0 111.641 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.7 87.24 0.75 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.526 1.057 . . . . 0.0 111.153 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.57 144.35 15.92 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.42 145.69 28.84 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.3 tt -75.86 107.66 8.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 m -86.62 -23.57 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.531 0.605 . . . . 0.0 110.135 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.24 -179.68 43.27 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -144.47 175.71 9.92 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.333 1.053 . . . . 0.0 110.265 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.53 167.95 28.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.373 2.269 . . . . 0.0 106.565 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 118.48 0.52 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.309 1.413 . . . . 0.0 114.398 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -60.1 120.87 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.13 164.88 31.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.601 1.56 . . . . 0.0 109.131 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.77 -112.59 0.26 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.97 -21.89 66.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.971 0.385 . . . . 0.0 111.004 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.65 173.31 13.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.025 2.13 . . . . 0.0 108.998 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 50.5 tp -89.94 98.64 11.89 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -82.55 -42.91 17.74 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.68 34.0 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.245 0.929 . . . . 0.0 112.53 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.45 153.64 36.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.068 0.947 . . . . 0.0 111.086 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.15 29.41 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.309 1.433 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.4 40.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.351 1.06 . . . . 0.0 110.505 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -109.66 114.52 28.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -107.94 131.75 54.21 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.671 0.788 . . . . 0.0 111.055 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.7 162.93 36.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.795 0.838 . . . . 0.0 112.264 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 t -136.23 166.23 23.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.213 1.405 . . . . 0.0 109.677 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -138.32 173.22 11.84 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.964 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 174.83 11.17 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 108.445 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.8 p -140.27 151.08 63.53 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.905 1.282 . . . . 0.0 110.69 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.2 173.59 14.13 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.958 2.438 . . . . 0.0 112.577 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -58.97 131.78 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 p -74.82 158.38 84.72 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.84 -157.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.14 1 C-N-CA 125.825 4.35 . . . . 0.0 112.915 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.12 168.29 12.4 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.827 2.451 . . . . 0.0 113.727 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -75.85 127.25 32.61 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -95.21 135.38 36.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.9 mt -89.87 178.43 6.23 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.3 m -100.1 101.71 12.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.41 173.55 7.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.575 0.702 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.5 tt -144.4 172.03 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.346 1.858 . . . . 0.0 106.76 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.36 -111.75 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -146.74 -1.61 0.6 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 125.325 1.25 . . . . 0.0 114.68 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.503 ' HA ' ' CE ' ' A' ' 282' ' ' LYS 0.388 55.0 m-20 46.68 15.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.66 -29.3 59.03 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.29 -168.2 38.74 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.0 t -82.14 112.33 19.07 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.34 1.456 . . . . 0.0 109.462 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.95 35.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -135.82 107.31 6.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 110.177 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -97.9 104.68 16.73 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.84 -1.85 15.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.01 -83.96 1.15 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.174 1.369 . . . . 0.0 113.108 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.59 170.43 8.14 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.583 2.353 . . . . 0.0 110.65 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -138.6 144.64 39.86 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.151 0.98 . . . . 0.0 109.738 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.65 -10.71 59.34 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.238 1.015 . . . . 0.0 112.665 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.05 153.36 22.04 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.287 1.422 . . . . 0.0 109.964 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.06 156.46 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.899 1.68 . . . . 0.0 108.062 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -124.71 -58.31 1.5 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.616 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -158.76 162.03 37.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.277 1.398 . . . . 0.0 112.602 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.59 144.4 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.404 1.882 . . . . 0.0 107.077 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -139.23 144.67 38.57 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.88 1.272 . . . . 0.0 107.88 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 8.9 t -132.27 126.85 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -121.3 83.01 0.35 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -86.15 172.95 10.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.396 1.093 . . . . 0.0 111.286 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.26 -168.6 11.8 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 128.573 2.987 . . . . 0.0 106.981 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -66.49 -36.64 83.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.07 -32.24 61.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.53 0.732 . . . . 0.0 112.169 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.0 -154.21 25.35 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.6 mm -64.82 124.51 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.8 m -108.96 -25.48 10.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.683 1.128 . . . . 0.0 112.485 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -140.99 141.53 34.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.174 0.989 . . . . 0.0 110.774 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.47 130.41 72.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -152.47 144.68 23.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -144.19 168.76 19.27 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.283 1.033 . . . . 0.0 109.821 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -133.53 129.39 37.04 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -131.28 168.97 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.763 1.625 . . . . 0.0 110.22 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -124.47 99.25 6.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -117.28 138.7 51.57 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.983 2.113 . . . . 0.0 105.768 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.31 29.27 45.64 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.222 -0.765 . . . . 0.0 112.174 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.78 -7.72 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.475 2.71 . . . . 0.0 114.593 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.02 158.66 18.56 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 123.554 1.645 . . . . 0.0 114.752 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -86.6 99.95 12.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.177 1.791 . . . . 0.0 106.937 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.5 143.92 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.27 129.93 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.162 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.54 -34.3 28.88 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.51 174.49 35.67 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.911 1.72 . . . . 0.0 111.113 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -62.84 100.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.005 1.322 . . . . 0.0 108.184 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -73.99 -50.4 20.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -93.19 165.27 27.7 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.529 1.061 . . . . 0.0 112.297 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -62.81 108.2 1.58 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 126.176 1.791 . . . . 0.0 110.876 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.79 178.55 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 N-CA-C 107.713 -1.687 . . . . 0.0 107.713 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 t -147.56 176.15 10.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -14.54 11.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.8 tt -65.61 -28.86 69.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.883 0.873 . . . . 0.0 110.329 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.89 -137.65 13.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.28 156.21 38.0 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.306 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.52 154.1 28.85 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.62 148.69 47.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.474 0.579 . . . . 0.0 111.676 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.06 112.54 6.82 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -83.36 109.91 17.69 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.5 mt -110.51 102.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.6 99.26 5.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -45.04 -41.55 13.61 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.46 -26.42 29.02 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 CA-C-N 123.592 2.319 . . . . 0.0 112.887 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 98.6 p -107.79 -16.12 14.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.97 1.714 . . . . 0.0 114.278 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 117.72 29.15 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.301 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.52 92.9 4.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.14 1.776 . . . . 0.0 111.374 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.46 106.17 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 22.4 m -77.86 -38.89 45.04 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.139 0.576 . . . . 0.0 110.436 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.67 36.69 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.952 0.901 . . . . 0.0 110.652 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.2 143.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.416 ' CG ' ' HE3' ' A' ' 250' ' ' LYS . 9.5 mm-40 -128.72 166.49 18.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.603 1.961 . . . . 0.0 109.094 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.08 166.84 31.34 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.7 p -128.81 132.66 47.86 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.24 147.62 43.89 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.77 171.3 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.951 0.901 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 148.1 42.52 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.63 1.572 . . . . 0.0 110.747 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.22 135.59 29.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.75 85.63 2.75 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 139.63 -6.04 2.92 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.109 1.338 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 t -123.76 170.55 10.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.61 1.705 . . . . 0.0 108.905 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -116.92 52.62 0.94 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.972 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -167.72 -174.91 37.12 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.07 1.319 . . . . 0.0 110.299 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.59 157.92 23.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.381 1.072 . . . . 0.0 109.666 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.7 tt -130.87 135.93 59.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 124.985 1.314 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.05 104.34 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.066 -2.939 . . . . 0.0 103.066 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.284 5.5 t -86.22 -19.17 30.39 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -147.24 149.73 33.46 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.269 -0.895 . . . . 0.0 110.129 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.78 143.61 43.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.307 2.243 . . . . 0.0 108.565 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -147.42 161.81 40.29 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.046 1.738 . . . . 0.0 107.645 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -131.42 118.79 20.73 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.538 ' HZ1' ' CD ' ' A' ' 268' ' ' GLU . 73.6 mttt -69.79 113.14 6.75 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 100.325 -3.954 . . . . 0.0 100.325 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 152.31 23.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.162 2.185 . . . . 0.0 107.942 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 154.9 23.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 57.29 -7.72 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -157.55 174.66 15.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 131.208 3.803 . . . . 0.0 106.875 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.8 m -138.24 124.31 20.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.1 175.96 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.669 1.223 . . . . 0.0 111.84 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -79.31 158.34 74.27 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.734 2.014 . . . . 0.0 111.94 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.66 90.35 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.924 2.416 . . . . 0.0 106.859 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -73.69 91.97 1.94 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 115.24 -179.91 18.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.623 1.106 . . . . 0.0 113.784 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.17 111.02 22.03 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.63 1.172 . . . . 0.0 109.889 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.57 107.73 1.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -168.36 141.49 3.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.303 2.241 . . . . 0.0 107.284 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 103.74 -177.13 24.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 55.3 m -72.15 122.61 21.29 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.216 -0.579 . . . . 0.0 109.79 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.68 122.08 22.67 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.95 120.28 31.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.45 0.568 . . . . 0.0 111.465 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . 0.538 ' CD ' ' HZ1' ' A' ' 250' ' ' LYS . 67.4 tt0 -100.47 144.02 29.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.873 0.869 . . . . 0.0 109.408 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 82.6 mt -122.47 103.53 8.78 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -133.95 171.35 14.31 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.681 1.992 . . . . 0.0 108.999 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -143.5 167.87 21.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.748 0.819 . . . . 0.0 110.741 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.98 7.48 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.113 1.765 . . . . 0.0 114.102 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 142.36 65.18 0.03 OUTLIER Glycine 0 C--N 1.335 0.472 0 O-C-N 121.298 -0.876 . . . . 0.0 111.583 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -147.74 153.83 39.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.231 1.412 . . . . 0.0 107.84 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.68 154.72 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.348 1.459 . . . . 0.0 107.34 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.24 153.36 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 49.8 t -132.01 -80.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.15 -151.83 11.0 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 118.913 0.778 . . . . 0.0 111.743 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.43 ' CE1' ' HA3' ' A' ' 281' ' ' GLY . 4.7 t80 -138.77 147.78 43.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.808 1.243 . . . . 0.0 110.086 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -133.73 92.19 2.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 279' ' ' PHE . . . -155.21 -138.88 2.66 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.503 ' CE ' ' HA ' ' A' ' 162' ' ' ASP 0.289 0.3 OUTLIER -156.4 162.37 40.04 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.082 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.95 50.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.519 0.676 . . . . 0.0 111.382 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 12.3 t -156.66 -167.4 2.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.696 1.998 . . . . 0.0 107.395 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -62.57 -19.43 63.68 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.076 2.15 . . . . 0.0 112.342 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 24.3 mt -139.23 150.05 45.07 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 128.987 2.915 . . . . 0.0 105.294 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 24.8 tp -85.12 86.62 7.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.007 0.821 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -78.72 -40.15 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.637 1.175 . . . . 0.0 110.895 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -128.43 130.62 47.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 120.079 1.308 . . . . 0.0 110.037 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.53 148.53 29.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.39 -164.67 27.43 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.13 137.47 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.461 0.704 . . . . 0.0 112.478 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 155.56 28.32 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 147.63 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.542 0.61 . . . . 0.0 111.641 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 80.2 mtp -139.72 149.09 58.25 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.74 118.05 5.45 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.686 2.257 . . . . 0.0 108.889 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.36 173.86 10.34 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.322 0.649 . . . . 0.0 111.042 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.7 m -125.08 -0.77 7.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.985 1.714 . . . . 0.0 111.417 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.937 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -70.78 129.93 40.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 80.6 t -133.96 124.16 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.79 164.7 20.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.117 0.96 . . . . 0.0 110.185 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.09 105.61 2.51 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.329 1.452 . . . . 0.0 109.651 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.65 47.53 2.47 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.13 1.824 . . . . 0.0 114.571 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.18 -156.91 9.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.466 1.507 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' HA3' ' H ' ' A' ' 89' ' ' ASP . . . -80.98 160.06 42.35 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.233 1.016 . . . . 0.0 114.053 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.14 5.42 41.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.333 1.453 . . . . 0.0 112.61 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.34 59.94 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.18 14.03 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 119.906 1.853 . . . . 0.0 111.771 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.73 156.69 28.77 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.735 0.814 . . . . 0.0 110.895 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 m -66.19 127.68 33.12 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.683 0.793 . . . . 0.0 111.583 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -134.36 161.4 35.09 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 160.09 149.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.599 3.16 . . . . 0.0 107.544 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -142.3 119.71 11.62 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.591 0.756 . . . . 0.0 109.346 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -39.56 -48.78 3.09 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 127.62 2.533 . . . . 0.0 117.829 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.73 146.17 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.447 1.624 . . . . 0.0 111.1 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -78.35 137.58 38.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.52 1.528 . . . . 0.0 112.236 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.31 -15.1 31.84 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.99 158.36 12.58 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.6 2.048 . . . . 0.0 110.711 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -145.38 139.84 22.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.5 mmt-85 -114.88 -60.97 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.086 1.754 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -126.36 162.85 24.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.761 1.225 . . . . 0.0 110.216 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.94 131.95 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.11 123.16 39.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.18 117.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 119.19 6.18 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.534 0.519 . . . . 0.0 112.268 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -69.98 172.58 7.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.05 1.74 . . . . 0.0 109.53 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.17 175.95 34.49 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 129.463 3.411 . . . . 0.0 104.821 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -68.06 -31.24 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -26.65 50.08 Favored 'General case' 0 N--CA 1.45 -0.447 1 C-N-CA 132.731 4.413 . . . . 0.0 113.327 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.97 -164.6 24.44 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -62.77 106.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.612 1.206 . . . . 0.0 108.217 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -97.16 -34.67 11.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.415 1.486 . . . . 0.0 114.455 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -119.34 153.26 35.39 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.534 1.133 . . . . 0.0 110.46 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.62 142.2 28.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.789 1.636 . . . . 0.0 109.088 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.44 151.62 22.8 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.59 1.956 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.85 158.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.134 1.374 . . . . 0.0 108.93 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.48 124.89 73.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -91.56 167.81 11.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.477 1.111 . . . . 0.0 110.01 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.14 111.39 19.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.731 1.212 . . . . 0.0 108.202 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -113.67 109.18 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 126.494 1.918 . . . . 0.0 108.066 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 64.0 1.01 1.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.143 1.777 . . . . 0.0 114.128 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.5 m 118.6 -11.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 1 C-N-CA 133.252 4.621 . . . . 0.0 110.498 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.3 144.72 28.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.119 0.967 . . . . 0.0 109.077 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.7 137.04 36.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.04 121.86 55.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.806 0.73 . . . . 0.0 110.074 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.98 161.84 20.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.623 2.369 . . . . 0.0 106.83 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.54 25.25 0.05 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.175 2.321 . . . . 0.0 112.384 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.33 91.91 0.1 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 121.838 2.819 . . . . 0.0 116.995 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -111.04 114.67 28.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -118.49 175.7 5.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.707 1.603 . . . . 0.0 112.061 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.4 -169.91 22.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 98.66 6.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -57.21 133.66 55.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.77 1.228 . . . . 0.0 110.856 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -129.06 124.07 33.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.384 . . . . 0.0 109.231 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.32 -21.52 66.72 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.13 -0.981 . . . . 0.0 112.851 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.54 38.3 3.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.508 1.523 . . . . 0.0 108.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.54 100.46 0.27 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.044 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.94 151.24 12.19 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.625 1.57 . . . . 0.0 109.673 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -151.14 160.58 43.78 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 130.164 3.386 . . . . 0.0 106.342 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 m -135.87 98.56 3.93 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.364 0.666 . . . . 0.0 111.465 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -95.73 108.92 21.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.56 101.79 13.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.683 1.593 . . . . 0.0 108.208 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.96 141.39 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -95.12 150.79 19.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.247 -0.908 . . . . 0.0 112.157 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.27 13.85 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.266 1.426 . . . . 0.0 111.949 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.53 -5.96 14.48 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.647 2.379 . . . . 0.0 111.345 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.08 150.99 36.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.855 1.262 . . . . 0.0 113.622 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 62.1 m-85 -135.56 132.94 37.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -71.65 113.2 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -93.9 -21.3 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.449 -0.782 . . . . 0.0 112.742 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.56 156.5 42.51 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.86 140.84 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.54 127.63 25.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.9 147.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.63 138.24 46.28 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 129.674 3.19 . . . . 0.0 108.613 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -154.57 166.14 34.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.68 0.792 . . . . 0.0 110.543 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' OD1' ' HE3' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -161.65 169.23 21.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.666 0.786 . . . . 0.0 110.968 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 158.44 20.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.512 2.325 . . . . 0.0 109.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.47 154.73 40.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.421 1.089 . . . . 0.0 108.634 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -63.89 144.08 57.35 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.37 11.96 71.03 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.839 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -142.74 142.75 32.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.891 1.276 . . . . 0.0 108.925 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.37 16.5 23.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.414 2.286 . . . . 0.0 107.701 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -115.6 179.34 4.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.681 2.392 . . . . 0.0 109.802 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.422 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 4.6 m-20 -135.15 149.34 49.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 102.896 -3.001 . . . . 0.0 102.896 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.48 143.32 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.653 1.181 . . . . 0.0 108.764 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.99 129.2 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.0 p -100.23 -38.96 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.599 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.3 169.46 18.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.91 1.284 . . . . 0.0 110.368 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.3 mm -132.24 144.83 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.171 1.388 . . . . 0.0 108.613 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 87.6 m -150.27 139.71 21.45 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.124 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -123.39 158.12 31.84 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.72 121.89 34.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.1 p -80.1 159.25 26.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.65 -33.39 73.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -21.27 66.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.301 1.44 . . . . 0.0 112.84 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.34 -10.0 30.96 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.245 1.402 . . . . 0.0 113.658 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -78.51 159.31 28.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.039 2.135 . . . . 0.0 108.259 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.8 p -134.79 156.42 48.9 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.995 1.318 . . . . 0.0 111.648 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.45 157.37 35.55 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.01 165.64 31.57 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 121.854 1.703 . . . . 0.0 109.52 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.87 83.76 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.81 3.006 . . . . 0.0 107.701 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.92 101.66 0.07 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.984 1.314 . . . . 0.0 107.698 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.41 -143.65 14.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 tp -108.63 121.73 45.62 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.74 153.55 43.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 112' ' ' GLN . 1.4 m -150.75 -179.59 7.39 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.073 -1.642 . . . . 0.0 111.074 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.404 ' H ' HG21 ' A' ' 111' ' ' THR . 41.1 tt0 -73.7 -58.68 3.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.036 -1.04 . . . . 0.0 111.246 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HE3' ' OD1' ' A' ' 81' ' ' ASP . 22.6 mttt -70.19 166.48 19.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.923 1.238 . . . . 0.0 110.223 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 175.69 167.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.237 2.215 . . . . 0.0 108.915 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.9 164.25 33.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.587 1.555 . . . . 0.0 107.83 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.04 142.39 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.57 135.33 34.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.984 1.313 . . . . 0.0 108.608 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -143.84 163.73 32.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.276 1.83 . . . . 0.0 108.784 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -118.5 175.45 5.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.679 1.992 . . . . 0.0 105.921 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -63.41 166.87 5.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.68 -9.06 40.19 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.585 -1.322 . . . . 0.0 113.795 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.78 -9.51 71.37 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.325 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.69 159.03 20.93 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.806 1.803 . . . . 0.0 113.764 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.543 ' HE3' ' CG ' ' A' ' 72' ' ' TYR . 14.3 mmtm -128.23 166.94 17.59 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.317 2.647 . . . . 0.0 107.441 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.16 -61.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.625 1.57 . . . . 0.0 107.588 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.67 31.07 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -133.25 157.43 45.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.932 1.293 . . . . 0.0 108.277 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -128.07 158.45 37.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.66 100.09 0.18 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -65.19 91.74 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.0 165.8 12.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 128.069 2.548 . . . . 0.0 113.663 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -157.3 -121.17 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 106.07 -2.812 . . . . 0.0 106.07 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -66.25 -18.23 65.23 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.16 169.76 19.32 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 125.557 1.543 . . . . 0.0 108.164 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.74 84.26 7.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -69.39 -45.68 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 110.738 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -146.41 144.28 29.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.099 0.959 . . . . 0.0 111.872 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.8 tp -140.72 144.91 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.38 -178.63 28.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.12 38.41 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.227 1.014 . . . . 0.0 108.281 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.68 113.85 24.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.829 0.852 . . . . 0.0 108.927 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.35 100.96 10.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.769 0.828 . . . . 0.0 111.801 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -121.56 130.17 53.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -105.19 166.52 10.35 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.751 1.221 . . . . 0.0 109.27 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.6 m -73.5 108.16 6.2 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.2 p -71.79 173.85 7.67 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.145 0.978 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.5 p -71.59 140.65 84.5 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.49 176.96 9.42 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.146 2.564 . . . . 0.0 109.185 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.72 145.14 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.478 1.111 . . . . 0.0 110.583 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -74.81 158.56 84.54 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 124.047 0.939 . . . . 0.0 110.411 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -80.49 178.22 7.29 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.031 1.821 . . . . 0.0 110.351 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.33 164.72 24.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.139 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 119.24 37.74 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.537 ' HE2' ' CE1' ' A' ' 293' ' ' HIS . 10.4 ptpt -88.19 123.66 33.05 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.0 mt -75.56 -166.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.312 1.045 . . . . 0.0 109.86 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 128.48 56.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.58 165.31 11.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.484 1.514 . . . . 0.0 107.653 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.05 -176.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.207 1.003 . . . . 0.0 110.883 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.21 -108.58 3.7 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.754 1.169 . . . . 0.0 111.559 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -176.0 136.9 3.46 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.06 53.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.808 2.443 . . . . 0.0 110.186 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.451 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 81.3 mm-40 -117.4 92.91 3.98 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.663 1.185 . . . . 0.0 110.692 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.79 -177.35 31.33 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.494 1.045 . . . . 0.0 112.278 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.41 113.56 3.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.786 1.634 . . . . 0.0 110.127 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.17 145.2 56.08 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.114 0.966 . . . . 0.0 110.825 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -138.51 61.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.04 104.66 6.67 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.68 99.4 10.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.263 2.625 . . . . 0.0 108.627 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.32 177.9 2.29 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.762 2.601 . . . . 0.0 112.441 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.23 25.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -118.44 -178.8 3.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.552 1.141 . . . . 0.0 109.257 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.07 -13.2 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.044 1.738 . . . . 0.0 114.198 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.32 -167.85 24.3 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 119.312 0.96 . . . . 0.0 112.291 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.44 156.8 40.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 127.824 2.45 . . . . 0.0 108.504 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -127.35 -52.08 1.39 Allowed 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.918 0.887 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.51 149.69 50.7 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.682 1.193 . . . . 0.0 108.306 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.1 139.73 50.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -127.05 112.74 15.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.594 1.157 . . . . 0.0 111.062 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.72 124.96 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.78 1.632 . . . . 0.0 107.623 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -115.78 139.59 15.51 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -138.29 -177.12 4.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.266 1.031 . . . . 0.0 112.019 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.64 -174.07 25.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 128.69 3.043 . . . . 0.0 106.846 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.97 -29.27 70.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.855 0.328 . . . . 0.0 110.854 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.36 -31.91 66.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.033 2.533 . . . . 0.0 113.01 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.88 -152.83 21.47 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.98 107.32 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.974 1.31 . . . . 0.0 109.007 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.0 p -101.79 -20.24 15.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.777 0.831 . . . . 0.0 112.564 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.06 160.72 42.11 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.084 1.311 . . . . 0.0 112.185 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 m -156.13 148.3 11.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.07 170.16 10.59 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.803 2.041 . . . . 0.0 107.011 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -160.29 164.49 32.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 109.894 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -102.53 123.21 45.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 148.19 23.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.647 1.979 . . . . 0.0 106.185 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.74 130.93 46.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -105.01 104.95 14.78 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.9 1.28 . . . . 0.0 108.019 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 71.31 -84.58 0.42 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.62 -18.29 2.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.257 . . . . 0.0 111.072 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.84 162.04 29.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.941 1.297 . . . . 0.0 109.572 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.21 145.5 39.79 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.679 0.792 . . . . 0.0 109.972 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.7 101.59 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.4 t -67.45 133.07 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.3 -169.8 42.6 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.1 -153.99 27.41 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.09 141.41 51.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -115.03 -80.22 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.44 1.018 . . . . 0.0 110.54 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.37 -179.11 50.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -99.81 103.69 23.5 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 120.931 2.365 . . . . 0.0 111.333 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.06 160.71 48.8 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 120.928 1.086 . . . . 0.0 109.367 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -102.81 178.11 4.66 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 27.2 tp -65.73 -13.57 59.58 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.795 -0.566 . . . . 0.0 111.509 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.65 -33.87 56.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.692 1.597 . . . . 0.0 110.645 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 110.83 -157.74 14.79 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.237 0.446 . . . . 0.0 112.387 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -133.93 170.74 15.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.159 2.184 . . . . 0.0 109.069 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.61 149.69 52.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 129.153 2.981 . . . . 0.0 104.765 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -133.49 149.12 51.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.954 0.797 . . . . 0.0 112.542 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -142.0 124.46 15.74 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -78.66 121.05 24.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.03 1.332 . . . . 0.0 109.682 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.76 124.71 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 128.127 2.571 . . . . 0.0 105.721 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.22 94.3 5.29 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.36 -33.6 15.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.525 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.76 13.94 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 CA-C-N 123.762 2.379 . . . . 0.0 111.198 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.31 -53.82 1.03 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.089 1.356 . . . . 0.0 109.878 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.86 177.75 4.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.461 1.504 . . . . 0.0 110.27 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.83 115.3 4.8 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.814 -0.553 . . . . 0.0 111.208 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.75 101.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -86.32 -19.5 29.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.995 1.318 . . . . 0.0 110.266 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.33 156.05 34.77 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.529 1.059 . . . . 0.0 110.833 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.7 144.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -132.08 173.27 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.647 1.979 . . . . 0.0 106.843 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.82 177.47 41.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.6 p -136.92 145.1 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -126.09 131.37 52.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.477 0.711 . . . . 0.0 111.554 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.41 170.77 15.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.136 1.375 . . . . 0.0 110.851 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -76.01 142.99 41.73 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.875 1.27 . . . . 0.0 111.882 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 20.2 pt -80.43 135.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.2 88.53 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.127 0.571 . . . . 0.0 110.808 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 151.95 -17.76 0.83 Allowed Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.296 -1.28 . . . . 0.0 112.76 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.2 m -140.27 179.16 6.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.554 1.177 . . . . 0.0 110.783 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.22 -30.09 24.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.177 2.591 . . . . 0.0 109.517 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -55.4 152.7 14.73 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 127.349 2.404 . . . . 0.0 112.976 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 66.3 mt -111.43 152.95 26.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.607 1.963 . . . . 0.0 109.222 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -143.73 160.38 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.246 1.418 . . . . 0.0 107.482 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.63 105.89 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -41.96 80.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.64 1.176 . . . . 0.0 111.582 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -147.89 159.48 43.81 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.912 0.485 . . . . 0.0 111.769 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 62.7 mt -135.13 147.11 49.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.287 1.835 . . . . 0.0 110.802 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -137.85 128.41 26.61 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.456 2.303 . . . . 0.0 107.749 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -111.38 113.61 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.71 113.83 19.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.2 p -109.99 165.84 11.41 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 126.623 1.969 . . . . 0.0 110.316 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -112.37 155.1 24.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 62.94 -16.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -135.18 172.27 13.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.619 1.568 . . . . 0.0 108.398 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.04 155.36 31.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.618 1.167 . . . . 0.0 108.005 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.6 p -123.01 178.27 5.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.421 1.889 . . . . 0.0 110.046 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -133.0 159.25 73.45 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.064 1.346 . . . . 0.0 109.73 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 108.24 2.65 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 109.01 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.24 92.94 5.17 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.01 179.78 17.2 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.687 1.137 . . . . 0.0 110.655 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 tp -82.96 111.97 19.31 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -68.47 106.95 2.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -171.23 146.51 2.37 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.838 2.455 . . . . 0.0 107.393 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 105.58 -176.69 22.46 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.1 m -67.77 122.97 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 144.2 43.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.138 -0.351 . . . . 0.0 110.317 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -138.65 144.34 39.64 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.5 1.12 . . . . 0.0 109.139 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.64 155.91 47.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.74 121.14 17.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -169.66 133.32 1.27 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.425 1.89 . . . . 0.0 109.829 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -146.0 129.21 16.67 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.0 1.32 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 30.33 52.61 0.12 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.115 2.966 . . . . 0.0 112.721 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 53.25 13.04 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 117.264 -1.853 . . . . 0.0 115.706 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.41 151.71 3.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.239 1.816 . . . . 0.0 111.228 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.28 132.61 40.1 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.15 1.78 . . . . 0.0 109.294 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.19 121.68 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.71 34.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.882 0.873 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.86 174.25 35.93 Favored Glycine 0 C--N 1.334 0.436 0 O-C-N 120.663 -1.273 . . . . 0.0 111.918 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -129.98 158.81 38.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.235 1.814 . . . . 0.0 108.509 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . 0.4 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 7.8 p-80 -149.26 165.74 31.01 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 112.23 -160.05 13.38 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.451 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -129.23 164.58 23.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.928 0.87 . . . . 0.0 110.743 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.96 149.52 50.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 m -152.37 -155.14 0.58 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 101.668 -3.456 . . . . 0.0 101.668 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -55.31 -36.45 66.21 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.008 -1.058 . . . . 0.0 110.285 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.14 164.44 21.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.128 1.371 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.72 77.4 9.79 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.92 -39.39 89.2 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -128.16 144.88 51.15 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -156.23 110.64 2.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . 0.4 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -137.26 174.45 21.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.9 m -128.45 174.93 11.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.03 0.932 . . . . 0.0 112.578 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . 0.537 ' CE1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER -118.16 128.13 54.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.9 2.48 . . . . 0.0 106.458 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.83 147.52 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.75 1.22 . . . . 0.0 109.996 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 81.2 mtp -141.97 144.15 31.07 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 126.331 1.852 . . . . 0.0 107.652 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.89 153.64 53.11 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.049 2.499 . . . . 0.0 112.433 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.95 82.54 3.0 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.579 1.152 . . . . 0.0 110.261 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.9 m -63.58 -16.52 61.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.056 1.343 . . . . 0.0 109.948 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.821 2.448 . . . . 0.0 109.899 -179.331 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.67 97.01 3.55 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.945 1.702 . . . . 0.0 110.278 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 130.43 34.62 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.35 128.11 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -72.7 155.54 39.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.693 0.679 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.44 101.62 13.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.366 1.466 . . . . 0.0 110.042 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.32 153.5 52.94 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.81 177.85 38.32 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 89' ' ' ASP . . . -72.53 -50.44 15.35 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.527 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 125.64 0.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 129.639 3.176 . . . . 0.0 118.312 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.67 -4.05 1.88 Allowed Glycine 0 CA--C 1.539 1.535 0 N-CA-C 120.706 3.042 . . . . 0.0 120.706 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.5 -174.01 22.37 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 121.336 2.568 . . . . 0.0 113.899 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.81 159.83 15.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.147 2.579 . . . . 0.0 112.991 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -3.66 109.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 1 C-N-CA 132.862 4.465 . . . . 0.0 117.531 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.404 ' HB3' ' H ' ' A' ' 130' ' ' GLY . 2.6 m0 -56.93 144.0 35.49 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 128.91 2.884 . . . . 0.0 108.353 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p30 59.1 9.38 1.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -50.67 129.32 22.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.385 0.993 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.42 30.88 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -42.13 128.49 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.482 1.913 . . . . 0.0 111.698 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -164.92 169.02 16.99 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 127.143 2.177 . . . . 0.0 106.509 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -142.29 52.78 1.45 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.498 1.142 . . . . 0.0 112.51 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.48 22.68 3.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.023 1.297 . . . . 0.0 112.426 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.27 146.48 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.712 1.756 . . . . 0.0 111.735 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.06 -28.81 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -146.15 159.03 43.86 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -142.68 115.29 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -88.28 144.52 26.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -141.56 148.08 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.496 1.119 . . . . 0.0 108.377 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.63 119.95 1.57 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.94 126.09 30.57 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.504 1.122 . . . . 0.0 108.72 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.03 -175.82 20.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -64.5 -36.8 85.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.11 17.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 131.126 3.77 . . . . 0.0 112.476 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.67 -136.79 18.45 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.48 95.68 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 p -109.41 -10.54 14.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.02 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -138.21 128.08 25.39 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.619 1.1 . . . . 0.0 109.015 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.98 154.24 23.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.114 1.366 . . . . 0.0 109.078 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.424 HD22 ' CD ' ' A' ' 50' ' ' GLU . 54.2 t30 -155.63 99.18 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.859 0.463 . . . . 0.0 110.747 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -77.97 145.04 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -127.73 134.57 65.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -115.77 169.95 8.83 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.459 1.123 . . . . 0.0 111.508 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.14 134.63 50.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.916 2.486 . . . . 0.0 106.61 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -115.88 150.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.55 -39.45 87.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.204 0.202 . . . . 0.0 110.555 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -70.89 0.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -149.45 139.91 22.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.37 141.05 48.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.473 1.509 . . . . 0.0 108.351 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.5 147.32 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 108.33 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' CD ' HD22 ' A' ' 39' ' ' ASN . 36.3 tt0 -101.1 138.05 38.64 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.06 -68.06 1.64 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.72 144.09 3.93 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 121.595 -0.944 . . . . 0.0 112.465 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.95 133.71 43.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.757 1.623 . . . . 0.0 107.687 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -119.65 169.7 9.85 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.913 1.285 . . . . 0.0 110.252 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 -151.73 20.81 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -121.36 106.1 11.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -63.41 163.16 11.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.195 0.522 . . . . 0.0 111.392 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -138.79 162.7 34.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.044 0.938 . . . . 0.0 108.579 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.9 tp -89.34 -33.22 16.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.841 1.256 . . . . 0.0 112.174 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.9 mt -100.77 12.14 38.12 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.74 106.21 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -160.63 126.27 3.92 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.255 1.422 . . . . 0.0 108.239 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -148.77 163.59 36.92 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.866 1.666 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.2 m -141.14 133.4 28.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -128.25 131.24 48.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -113.55 146.67 39.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.153 0.981 . . . . 0.0 108.515 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.3 t -109.8 117.35 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.42 156.4 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.27 -12.11 59.65 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.499 -0.75 . . . . 0.0 111.812 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -104.79 -7.79 19.22 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.465 1.506 . . . . 0.0 111.394 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -119.64 136.58 54.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.87 147.51 50.45 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.288 0.566 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.6 mt -78.23 131.2 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.96 -21.41 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 122.691 0.396 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.59 152.62 38.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.935 1.294 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.5 t -146.42 142.38 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -110.23 115.23 29.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -108.18 125.34 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.2 p -116.43 139.54 50.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -154.78 163.65 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.382 1.073 . . . . 0.0 108.6 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.03 168.89 23.59 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.44 0.564 . . . . 0.0 110.113 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -99.55 155.55 17.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.321 1.848 . . . . 0.0 112.008 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.7 137.5 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -78.56 72.26 5.08 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.49 18.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.494 1.521 . . . . 0.0 113.008 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.98 149.68 52.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.7 -16.02 61.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.037 0.935 . . . . 0.0 112.554 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 p -161.28 172.0 17.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.521 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -76.47 151.91 36.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.0 pt -134.64 152.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.594 1.158 . . . . 0.0 109.453 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.2 mm -68.35 112.05 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.422 1.089 . . . . 0.0 108.163 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -81.31 -40.61 23.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.866 1.266 . . . . 0.0 111.217 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 t -157.84 173.92 16.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.57 1.948 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.54 155.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 109.63 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.1 m -148.92 122.38 9.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.301 1.44 . . . . 0.0 108.761 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -92.74 138.22 31.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 108.73 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -123.12 115.56 22.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.006 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.6 p -91.34 168.06 11.84 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 121.546 -0.721 . . . . 0.0 110.409 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -70.88 -30.1 66.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.29 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -69.79 -6.25 30.91 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.21 66.46 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -82.08 126.6 32.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.5 m -127.66 149.8 50.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 p -99.1 161.58 24.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.006 0.923 . . . . 0.0 110.465 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.49 166.25 27.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.729 1.619 . . . . 0.0 109.778 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.6 108.53 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.067 2.511 . . . . 0.0 109.089 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.31 73.82 7.16 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 135.73 -176.15 20.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.05 112.86 15.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 110.62 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 154.01 19.88 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.414 HG21 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -144.24 176.4 9.37 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 119.916 -1.74 . . . . 0.0 112.719 -177.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.414 ' H ' HG21 ' A' ' 111' ' ' THR . 12.3 tt0 -70.36 -56.93 5.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -66.07 150.6 48.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 pttt 172.73 173.42 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 126.461 1.904 . . . . 0.0 109.321 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.91 164.82 31.67 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.617 1.967 . . . . 0.0 107.338 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.48 139.06 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -136.36 122.67 20.58 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 160.77 42.19 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.389 1.475 . . . . 0.0 109.456 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.27 176.77 8.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.068 0.849 . . . . 0.0 109.34 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -128.03 -49.48 1.34 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.315 1.446 . . . . 0.0 109.207 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -68.52 -3.05 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.072 1.749 . . . . 0.0 113.97 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.28 47.55 5.43 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 120.617 1.553 . . . . 0.0 111.275 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.73 -165.14 40.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.23 1.395 . . . . 0.0 111.657 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -131.24 151.71 51.22 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.436 1.895 . . . . 0.0 107.281 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -71.34 154.06 41.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.53 -47.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 118.762 0.71 . . . . 0.0 112.548 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -167.29 168.39 40.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 120.091 1.314 . . . . 0.0 111.022 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -114.49 169.94 8.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.967 1.307 . . . . 0.0 110.216 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -164.84 170.88 14.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.241 2.616 . . . . 0.0 106.678 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 15' ' ' TRP . . . 128.65 129.4 3.18 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 126.145 1.831 . . . . 0.0 110.027 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.61 122.36 1.94 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.179 0.99 . . . . 0.0 112.651 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.0 166.06 25.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.847 2.459 . . . . 0.0 109.628 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.29 -119.14 0.82 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -68.5 -6.3 24.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.08 175.1 13.36 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 128.782 2.833 . . . . 0.0 106.656 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.67 95.06 5.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -83.22 -30.44 27.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.845 1.658 . . . . 0.0 113.112 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.16 42.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 108.772 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 65.3 tp -154.66 134.56 12.96 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.43 179.12 37.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 125.67 1.605 . . . . 0.0 109.127 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.05 171.89 17.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.478 0.639 . . . . 0.0 111.395 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -115.7 150.67 36.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.592 1.157 . . . . 0.0 108.522 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -125.01 111.53 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.27 141.48 43.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.75 0.786 . . . . 0.0 109.587 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 t -133.49 166.0 23.57 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.495 1.918 . . . . 0.0 107.596 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.41 177.42 11.38 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.805 1.642 . . . . 0.0 106.89 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 t -158.48 59.11 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.5 p -138.05 156.27 74.11 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.441 1.496 . . . . 0.0 110.016 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.69 169.22 22.73 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.021 2.481 . . . . 0.0 110.179 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.49 118.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 75.1 p -130.24 160.69 64.39 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 123.559 0.744 . . . . 0.0 110.245 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.11 -167.66 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.405 2.737 . . . . 0.0 108.914 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -176.64 0.81 Allowed 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.103 -0.998 . . . . 0.0 112.261 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -74.09 129.72 38.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HE3' ' ND1' ' A' ' 280' ' ' HIS . 77.9 tttt -98.95 106.47 18.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.002 1.321 . . . . 0.0 108.045 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mt -74.88 173.9 9.99 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.0 t -76.08 163.66 26.9 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.838 -1.164 . . . . 0.0 109.062 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -144.41 138.19 27.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 tp -118.47 138.35 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.227 2.211 . . . . 0.0 107.321 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.57 -31.2 0.57 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 154.54 -169.55 32.84 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -136.19 6.69 3.09 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.082 1.753 . . . . 0.0 109.3 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -113.97 146.99 39.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.157 1.383 . . . . 0.0 109.82 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.56 175.36 14.04 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.955 1.264 . . . . 0.0 110.43 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.9 m -65.35 123.34 19.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 115.58 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.165 0.986 . . . . 0.0 110.038 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.501 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 7.8 m0 -78.22 125.08 28.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.41 114.45 26.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.288 1.835 . . . . 0.0 108.142 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.53 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.523 2.729 . . . . 0.0 115.012 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 64.28 -162.08 37.05 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.79 143.17 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.304 1.842 . . . . 0.0 107.866 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.28 -178.74 4.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.28 -34.0 66.03 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.423 1.011 . . . . 0.0 110.328 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.0 -163.7 33.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 124.563 1.078 . . . . 0.0 110.418 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.56 157.18 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.403 2.281 . . . . 0.0 108.22 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -120.37 -46.41 2.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.786 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.403 ' HE2' ' OE1' ' A' ' 193' ' ' GLU . 26.1 ttpt -137.19 145.24 43.46 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 145.73 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.68 157.72 38.3 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.619 1.168 . . . . 0.0 109.582 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.6 t -138.88 129.5 33.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.65 111.84 2.03 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.22 177.45 4.68 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.478 0.711 . . . . 0.0 110.794 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -160.08 -168.06 21.52 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 127.486 2.47 . . . . 0.0 107.994 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.17 -20.0 59.56 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 122.142 -0.622 . . . . 0.0 111.259 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.92 -31.57 35.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.869 3.668 . . . . 0.0 112.691 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 139.36 -132.48 5.67 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mm -88.03 105.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.87 -23.46 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 113.18 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.02 32.29 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.285 0.948 . . . . 0.0 111.717 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.32 133.6 46.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.947 0.899 . . . . 0.0 108.596 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.582 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 15.0 pttp -156.42 170.99 21.05 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 107.308 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -167.73 174.77 7.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.333 1.453 . . . . 0.0 108.367 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.403 ' OE1' ' HE2' ' A' ' 177' ' ' LYS . 21.7 mt-10 -100.65 137.06 39.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -97.79 167.82 10.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.148 0.499 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -121.01 116.78 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.021 1.728 . . . . 0.0 108.138 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -140.54 114.11 8.75 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 40.51 57.86 2.64 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.289 0.947 . . . . 0.0 113.974 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.79 -3.35 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.008 2.523 . . . . 0.0 117.165 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.66 170.2 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.349 0.977 . . . . 0.0 108.532 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -136.51 104.44 5.57 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.78 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.172 0.896 . . . . 0.0 113.018 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.01 129.33 36.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 124.831 1.252 . . . . 0.0 108.743 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -66.15 -179.36 9.64 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.718 1.627 . . . . 0.0 111.353 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.71 151.7 21.96 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.71 0.617 . . . . 0.0 113.294 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -77.39 102.8 6.98 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.219 1.408 . . . . 0.0 107.617 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -78.85 -64.35 1.2 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.65 1.18 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.74 170.86 53.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.659 1.124 . . . . 0.0 111.622 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -80.66 113.32 38.93 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.581 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.82 169.86 20.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.33 1.353 . . . . 0.0 110.748 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.4 p -126.79 173.93 9.17 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.488 1.115 . . . . 0.0 108.49 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.39 -6.33 42.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.512 -0.742 . . . . 0.0 112.494 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.7 -1.44 6.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.332 1.053 . . . . 0.0 111.069 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.48 -160.91 54.15 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.582 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 35.8 m-85 -135.8 163.08 31.02 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.98 1.312 . . . . 0.0 108.5 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -124.47 157.44 35.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.42 148.88 52.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.494 1.118 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -141.51 116.33 9.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.14 138.42 34.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.412 1.085 . . . . 0.0 109.049 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.6 mm -128.2 130.24 69.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.18 90.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -39.1 -50.99 4.31 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.19 -19.11 8.24 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 121.365 1.523 . . . . 0.0 114.388 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.0 m -106.52 -10.87 16.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.88 147.3 31.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.909 1.284 . . . . 0.0 107.643 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.37 126.3 11.21 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.5 mp -57.09 112.75 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.248 1.819 . . . . 0.0 108.056 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.6 p -84.8 -24.74 28.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 0.0 111.142 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -172.29 171.13 4.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.942 2.097 . . . . 0.0 109.207 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.5 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -83.75 171.03 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.886 -1.134 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 170.18 177.03 40.16 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 p -142.16 147.08 36.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.53 162.39 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.852 0.861 . . . . 0.0 109.415 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -146.9 156.46 43.1 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.474 ' HZ3' ' CG ' ' A' ' 240' ' ' ASP . 26.7 mmtp -71.78 138.83 48.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.963 1.705 . . . . 0.0 113.175 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -81.24 97.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -47.26 147.04 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.569 1.548 . . . . 0.0 112.089 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.6 52.46 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 62.9 p -141.13 -174.15 3.93 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.654 1.981 . . . . 0.0 107.68 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.474 ' CG ' ' HZ3' ' A' ' 235' ' ' LYS . 8.8 t0 -133.69 91.65 2.87 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -158.91 173.44 35.82 Favored Glycine 0 CA--C 1.53 0.994 1 C-N-CA 131.185 4.231 . . . . 0.0 104.154 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.18 166.01 31.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 119.602 1.701 . . . . 0.0 111.781 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 7.6 tt -141.65 144.58 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.176 1.39 . . . . 0.0 109.239 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 37.4 mt -75.45 132.82 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.255 5.4 t -116.78 -12.16 10.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.615 0.766 . . . . 0.0 112.027 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -146.63 144.01 29.21 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.602 1.161 . . . . 0.0 108.775 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.95 127.15 13.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.735 0.698 . . . . 0.0 111.206 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -130.55 154.61 47.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.451 1.5 . . . . 0.0 109.408 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -118.54 126.62 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -71.97 114.87 10.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -109.69 165.76 11.43 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.476 2.31 . . . . 0.0 109.231 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -119.83 134.13 55.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.33 7.17 0.87 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -144.23 152.07 40.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.994 2.118 . . . . 0.0 106.074 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 61.3 m -143.95 118.48 9.73 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.7 p -78.16 177.83 8.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.92 1.688 . . . . 0.0 111.793 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -73.51 154.36 89.75 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.875 . . . . 0.0 110.015 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.15 96.96 1.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 109.207 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -78.5 114.26 17.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.74 -163.03 22.38 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.9 pp -127.63 122.69 33.74 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.74 108.35 2.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.738 1.615 . . . . 0.0 109.964 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.9 9.19 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.188 0.995 . . . . 0.0 111.633 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 72.58 -98.74 0.86 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 126.311 1.91 . . . . 0.0 112.425 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 95.9 m -145.36 122.01 11.14 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.214 1.405 . . . . 0.0 107.612 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.64 145.07 33.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.101 0.56 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -132.43 158.59 41.62 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.534 1.159 . . . . 0.0 110.519 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.92 146.24 26.15 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 53.5 mt -141.87 108.77 5.42 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.861 1.664 . . . . 0.0 108.478 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -157.8 163.92 37.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.679 1.581 . . . . 0.0 111.496 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.87 157.46 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 107.85 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -75.1 140.88 43.75 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 110.013 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 63.38 5.36 11.26 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 117.389 -1.784 . . . . 0.0 116.741 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -112.1 153.7 26.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.197 1.998 . . . . 0.0 112.003 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -115.52 164.19 14.67 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.272 2.229 . . . . 0.0 107.692 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.08 134.18 31.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.89 -0.38 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.167 0.987 . . . . 0.0 113.554 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.98 157.19 27.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -131.33 124.29 30.1 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.495 1.918 . . . . 0.0 109.92 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . 0.414 ' ND1' ' HE3' ' A' ' 155' ' ' LYS . 15.0 p80 -127.27 179.51 5.41 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.03 1.332 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 120.2 -127.37 7.05 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -161.25 151.35 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.906 1.282 . . . . 0.0 111.818 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.501 ' HB2' ' HE1' ' A' ' 167' ' ' TRP . . . -113.06 146.8 38.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.397 1.479 . . . . 0.0 108.113 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -155.75 -160.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.431 1.892 . . . . 0.0 106.064 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -38.06 88.43 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.36 162.95 20.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.41 1.484 . . . . 0.0 108.884 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.33 95.68 1.76 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 109.855 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -83.56 -84.01 0.14 Allowed 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -88.55 165.6 14.73 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -167.85 99.89 0.47 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.43 1.892 . . . . 0.0 107.435 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -129.35 169.73 20.54 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 121.694 -0.629 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.06 173.36 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 122.118 0.961 . . . . 0.0 112.776 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.15 124.97 42.94 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.998 -2.594 . . . . 0.0 103.998 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.93 137.63 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.492 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.24 139.47 34.6 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 123.978 0.911 . . . . 0.0 109.606 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.43 137.09 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.493 2.795 . . . . 0.0 110.738 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.16 -12.38 61.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.202 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.75 15.13 12.66 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.342 0.973 . . . . 0.0 112.956 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--O 1.245 0.865 0 C-N-CA 127.783 2.433 . . . . 0.0 111.545 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.14 149.19 48.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.15 1.38 . . . . 0.0 110.986 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -137.81 139.77 40.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 128.339 2.656 . . . . 0.0 107.62 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.481 ' CG1' ' H ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -121.4 148.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.073 0.949 . . . . 0.0 111.267 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.11 131.3 46.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.4 87.87 1.56 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.09 116.16 5.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.39 -170.5 30.99 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.35 177.73 33.74 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 122.834 1.241 . . . . 0.0 115.87 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.5 55.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.844 1.658 . . . . 0.0 114.49 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 175.04 54.85 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.254 0.933 . . . . 0.0 110.817 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -175.06 50.51 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.57 1.081 . . . . 0.0 114.696 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.56 157.2 27.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.155 1.382 . . . . 0.0 110.36 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -77.1 88.17 3.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.023 2.529 . . . . 0.0 114.942 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -106.17 92.46 4.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.82 149.65 23.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.795 1.638 . . . . 0.0 108.797 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 31.21 58.55 0.27 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 127.753 2.421 . . . . 0.0 110.873 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.02 -161.37 37.39 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.535 2.017 . . . . 0.0 116.091 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -126.95 10.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 128.232 2.613 . . . . 0.0 112.244 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -104.54 80.24 1.65 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.64 40.08 2.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.881 1.272 . . . . 0.0 111.727 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.68 51.33 0.85 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-O 118.654 -1.081 . . . . 0.0 115.553 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.96 154.08 7.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 119.793 1.796 . . . . 0.0 110.629 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -128.77 -41.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.532 1.133 . . . . 0.0 110.696 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -133.48 171.72 13.69 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.449 1.5 . . . . 0.0 108.174 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -140.25 130.22 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -131.11 144.03 51.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.3 t -148.31 147.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 127.862 2.465 . . . . 0.0 105.69 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.13 133.15 3.47 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 107.119 -2.392 . . . . 0.0 107.119 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -75.85 176.8 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.066 0.936 . . . . 0.0 108.934 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -160.42 10.5 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -77.06 -31.53 56.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.836 0.35 . . . . 0.0 110.227 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -91.4 -27.34 18.38 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.653 3.181 . . . . 0.0 115.182 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.75 -140.7 11.46 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -75.63 96.34 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.28 -7.29 21.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.449 1.1 . . . . 0.0 113.647 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -129.86 143.72 50.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.96 1.255 . . . . 0.0 112.377 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -159.02 130.53 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.039 0.936 . . . . 0.0 109.705 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -117.85 151.43 37.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.819 1.648 . . . . 0.0 109.809 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.12 140.96 45.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.062 1.345 . . . . 0.0 110.263 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -127.47 98.77 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -81.3 105.68 12.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.99 120.44 27.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -115.16 157.39 23.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.749 -0.594 . . . . 0.0 110.879 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 6.56 4.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.59 1.956 . . . . 0.0 108.609 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -121.58 -69.55 0.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.432 2.293 . . . . 0.0 108.742 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -154.96 135.05 13.05 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.84 150.27 39.31 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.906 1.282 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 122.9 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.992 0.917 . . . . 0.0 111.37 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.21 99.66 11.24 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.91 -21.63 45.46 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.936 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.01 142.29 12.06 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.021 1.296 . . . . 0.0 111.766 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -74.08 130.23 39.4 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.612 1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -116.4 175.7 5.44 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.236 0.541 . . . . 0.0 109.949 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -134.78 12.41 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 105.653 -2.979 . . . . 0.0 105.653 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -126.77 99.24 5.68 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.24 144.97 56.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.06 142.87 30.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.776 1.274 . . . . 0.0 110.516 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.23 -4.65 58.12 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.592 -1.317 . . . . 0.0 110.447 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.49 -16.71 62.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.499 1.12 . . . . 0.0 111.455 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.3 117.83 0.42 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -163.14 135.44 5.29 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.997 2.919 . . . . 0.0 105.734 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -132.18 160.12 37.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 m -116.3 118.61 33.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.566 1.946 . . . . 0.0 108.905 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.13 109.13 13.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.8 160.91 20.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 109.747 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.72 106.12 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 156.92 23.07 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.509 -0.744 . . . . 0.0 109.617 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.68 -26.69 27.58 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.62 -34.98 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.108 1.763 . . . . 0.0 112.393 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.86 164.51 13.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.986 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.67 -178.72 5.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.127 1.771 . . . . 0.0 109.812 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.9 139.11 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.62 -36.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.074 0.95 . . . . 0.0 112.864 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.72 165.76 29.52 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.975 0.91 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.7 101.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.65 94.28 9.04 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.2 153.55 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.686 1.994 . . . . 0.0 108.134 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -139.02 148.47 43.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.357 1.063 . . . . 0.0 109.069 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.05 155.42 36.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.121 1.368 . . . . 0.0 108.515 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.84 168.49 22.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.109 0.963 . . . . 0.0 110.144 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -109.51 119.38 39.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.35 1.06 . . . . 0.0 109.213 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.7 m -90.08 151.29 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -60.89 -6.61 1.89 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 113.32 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.29 -0.65 58.24 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 117.54 -1.7 . . . . 0.0 112.703 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -133.43 158.59 42.67 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.89 1.845 . . . . 0.0 111.051 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -85.29 -19.51 31.45 Favored 'General case' 0 C--N 1.323 -0.547 1 C-N-CA 131.81 4.044 . . . . 0.0 111.586 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.4 t -129.6 164.92 22.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.389 1.876 . . . . 0.0 110.691 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.47 156.14 27.97 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.0 154.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.418 1.887 . . . . 0.0 108.673 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.8 mm -73.27 129.55 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -103.31 -41.29 6.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 113.275 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -146.58 161.23 40.96 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.746 1.219 . . . . 0.0 109.503 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.3 mt -148.06 122.96 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.554 1.541 . . . . 0.0 108.314 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -125.07 107.07 10.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.869 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -84.95 149.15 25.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.848 0.833 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -130.75 113.35 14.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -84.25 164.3 19.14 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.396 0.678 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -71.13 -38.23 72.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -35.92 82.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.217 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.25 3.68 5.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.87 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -76.71 95.86 4.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -86.64 103.5 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 p -71.72 155.89 91.8 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.42 166.18 30.55 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.939 1.759 . . . . 0.0 110.907 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.24 112.74 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.789 2.993 . . . . 0.0 107.232 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -78.07 67.67 3.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.088 1.355 . . . . 0.0 107.369 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.41 -179.74 17.78 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 124.717 1.151 . . . . 0.0 111.143 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.07 119.09 22.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.68 1.592 . . . . 0.0 111.556 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 157.87 23.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.18 172.49 14.23 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.777 -1.202 . . . . 0.0 109.771 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -69.34 -49.29 57.01 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -66.72 138.48 57.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.1 pttt 169.54 171.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.864 2.466 . . . . 0.0 109.79 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.4 156.35 47.67 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.384 1.873 . . . . 0.0 107.153 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.6 149.39 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.829 0.851 . . . . 0.0 109.844 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.91 142.97 16.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 0.0 109.66 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.25 156.52 30.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.675 0.79 . . . . 0.0 110.077 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 175.94 9.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.626 1.97 . . . . 0.0 113.262 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -127.99 -46.87 1.38 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.423 -0.798 . . . . 0.0 112.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -127.39 13.45 7.09 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.83 0.852 . . . . 0.0 112.554 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.9 -84.31 0.32 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 107.508 -2.237 . . . . 0.0 107.508 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.36 76.07 0.11 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 125.855 1.693 . . . . 0.0 112.281 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.21 123.84 12.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.853 0.861 . . . . 0.0 111.197 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.73 115.98 6.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.44 -9.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.194 1.397 . . . . 0.0 112.757 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.65 -91.0 0.3 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 119.295 0.952 . . . . 0.0 114.617 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 78.38 152.2 0.12 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.425 2.69 . . . . 0.0 109.811 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -157.75 170.07 23.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.958 2.103 . . . . 0.0 106.172 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.31 101.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 O-C-N 121.533 -0.729 . . . . 0.0 112.737 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.57 123.16 9.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.48 164.42 38.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.274 0.63 . . . . 0.0 109.375 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.22 -110.41 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.38 -12.36 60.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.207 0.503 . . . . 0.0 112.215 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.67 174.48 12.53 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 127.839 2.456 . . . . 0.0 107.528 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -102.04 89.43 3.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.219 1.008 . . . . 0.0 108.485 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.4 -38.81 49.0 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.01 167.0 26.07 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.016 1.28 . . . . 0.0 112.283 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.93 171.24 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.85 2.06 . . . . 0.0 108.782 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.78 169.91 33.58 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.882 1.706 . . . . 0.0 110.106 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.481 ' H ' ' CG1' ' A' ' 4' ' ' VAL . . . -153.16 167.69 28.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.688 1.595 . . . . 0.0 112.296 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -129.77 163.2 26.72 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.257 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -144.4 135.87 25.62 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.16 105.19 5.92 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.957 1.303 . . . . 0.0 112.217 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.3 t -135.07 143.9 46.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.392 1.077 . . . . 0.0 108.477 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 t -162.83 -54.2 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.017 0.927 . . . . 0.0 108.929 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -148.46 93.17 2.11 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.72 145.71 35.09 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.062 0.846 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.67 170.01 18.84 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 125.079 3.852 . . . . 0.0 111.258 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 87.6 t -135.47 108.61 9.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.0 p -137.42 160.78 64.09 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -84.0 4.56 6.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.438 3.425 . . . . 0.0 119.408 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.27 153.53 33.78 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.976 1.71 . . . . 0.0 112.565 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -75.67 122.23 23.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.59 0.756 . . . . 0.0 109.286 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -90.3 146.42 24.22 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.4 mt -101.08 -86.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 t -167.33 171.25 10.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.659 1.984 . . . . 0.0 109.07 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -152.73 177.2 10.95 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.24 1.816 . . . . 0.0 107.634 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 tt -138.34 -25.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -23.89 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 129.913 3.625 . . . . 0.0 117.667 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.77 41.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.029 1.776 . . . . 0.0 108.782 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.426 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 1.3 m-20 -114.96 5.71 15.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 114.303 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.98 122.33 28.15 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.28 1.4 . . . . 0.0 111.529 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.73 -168.52 13.62 Favored Glycine 0 N--CA 1.465 0.57 0 O-C-N 120.663 -1.273 . . . . 0.0 112.707 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.7 m -106.78 124.7 49.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.767 0.783 . . . . 0.0 111.121 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.71 153.84 27.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.189 1.396 . . . . 0.0 110.703 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -138.32 120.7 15.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.32 1.048 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.66 132.72 33.8 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.41 -0.807 . . . . 0.0 109.074 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.38 91.19 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.93 -72.75 0.52 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.699 -0.626 . . . . 0.0 114.157 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.12 170.65 20.78 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.221 1.408 . . . . 0.0 110.154 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.6 -179.7 3.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.659 1.184 . . . . 0.0 108.268 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.88 -23.69 55.63 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.678 -1.264 . . . . 0.0 112.297 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 170.79 168.58 32.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 128.72 3.057 . . . . 0.0 107.508 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.431 ' H ' ' CB ' ' A' ' 221' ' ' TYR . 1.8 t -122.72 156.28 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.365 1.866 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -121.53 -34.01 3.52 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -159.79 151.91 20.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.092 1.315 . . . . 0.0 110.926 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.6 t -106.25 142.36 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.48 160.18 39.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.824 2.45 . . . . 0.0 109.6 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.86 138.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.51 80.1 0.34 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.739 1.638 . . . . 0.0 109.206 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -85.59 162.48 18.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 111.018 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.3 -158.79 10.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 127.263 2.363 . . . . 0.0 109.056 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -82.85 -22.44 34.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.599 0.76 . . . . 0.0 111.358 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.88 -31.79 9.61 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.416 0.686 . . . . 0.0 112.548 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 165.82 -153.23 23.06 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.42 153.33 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.596 1.198 . . . . 0.0 109.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.1 t -134.22 -33.14 1.02 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.894 1.278 . . . . 0.0 109.625 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.17 35.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.91 0.862 . . . . 0.0 111.708 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.7 m -134.13 149.48 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -154.85 155.19 33.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 108.996 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.34 173.1 12.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.211 0.914 . . . . 0.0 113.028 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.32 141.77 48.11 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.296 3.038 . . . . 0.0 104.127 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -149.0 167.93 24.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.807 1.243 . . . . 0.0 109.578 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -135.98 96.44 3.41 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -88.8 125.48 34.92 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.25 31.17 56.36 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 76.26 -9.1 1.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.253 3.421 . . . . 0.0 114.852 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -76.47 133.14 39.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 120.835 1.652 . . . . 0.0 109.484 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -64.15 124.39 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.26 1.024 . . . . 0.0 109.197 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.6 mm -136.65 103.65 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.001 1.32 . . . . 0.0 108.415 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.96 127.43 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.09 -11.91 84.62 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.318 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.71 -172.12 52.99 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -89.35 154.36 20.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.845 0.858 . . . . 0.0 110.002 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -119.27 1.21 11.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.168 0.987 . . . . 0.0 109.651 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.94 173.64 27.05 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 120.304 -1.497 . . . . 0.0 111.182 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -68.68 114.07 20.02 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.18 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.92 167.22 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -118.25 148.33 42.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.521 1.128 . . . . 0.0 109.481 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.77 -24.83 67.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.331 0.653 . . . . 0.0 110.521 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 tt -51.65 -34.39 37.83 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 126.336 1.854 . . . . 0.0 111.495 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.0 -164.5 12.06 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -140.11 161.2 38.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.65 153.31 38.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.49 152.39 44.14 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.78 0.832 . . . . 0.0 110.75 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -142.06 140.54 32.6 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.997 -0.439 . . . . 0.0 110.956 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -65.15 97.82 0.27 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.164 2.186 . . . . 0.0 112.524 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 mm -128.94 102.82 8.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.44 125.89 46.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.015 1.28 . . . . 0.0 109.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.431 ' CB ' ' H ' ' A' ' 175' ' ' VAL . 80.0 t80 -55.49 -51.43 80.08 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.124 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.06 0.47 5.83 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.392 2.061 . . . . 0.0 114.604 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -128.54 -62.47 1.03 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.684 1.583 . . . . 0.0 112.997 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -81.26 168.13 18.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 110.697 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.17 101.33 3.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.9 mp -35.73 -52.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 128.871 2.868 . . . . 0.0 111.816 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.254 16.6 p 48.92 1.2 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.607 3.163 . . . . 0.0 118.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -173.84 169.88 4.04 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.538 1.535 . . . . 0.0 107.584 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.71 134.14 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -118.34 165.95 13.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.465 1.906 . . . . 0.0 107.617 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.07 174.31 46.37 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.2 p -135.44 147.35 48.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.754 1.277 . . . . 0.0 110.928 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -136.79 146.55 45.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -142.87 155.49 44.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.825 2.05 . . . . 0.0 108.225 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -87.55 148.55 24.84 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.596 0.758 . . . . 0.0 111.34 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.24 122.86 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.101 0.961 . . . . 0.0 108.468 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -55.89 152.3 10.21 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.268 0.556 . . . . 0.0 111.748 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.21 -9.39 20.02 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.245 0.926 . . . . 0.0 113.848 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -127.46 -176.03 3.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.383 1.873 . . . . 0.0 108.468 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.06 74.55 1.46 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.303 1.041 . . . . 0.0 110.594 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.08 -168.15 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.159 2.314 . . . . 0.0 109.106 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.93 162.11 36.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.786 1.293 . . . . 0.0 111.361 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.5 tt -139.85 102.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.891 2.076 . . . . 0.0 108.755 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 4.9 mp -50.6 126.25 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 121.267 -0.895 . . . . 0.0 109.536 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -106.35 -36.24 6.89 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -122.29 144.55 48.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.462 1.028 . . . . 0.0 108.699 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.28 147.14 49.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.854 1.261 . . . . 0.0 108.264 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -136.01 93.71 2.96 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.9 149.46 45.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.59 154.04 51.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.544 1.537 . . . . 0.0 107.606 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.2 t -161.94 168.11 23.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.654 1.182 . . . . 0.0 111.67 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -105.67 147.05 28.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 79.86 -52.48 0.39 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 129.663 3.185 . . . . 0.0 110.815 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -84.89 169.68 13.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.27 1.428 . . . . 0.0 109.424 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 m -128.35 99.7 5.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.238 1.015 . . . . 0.0 109.616 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.2 p -84.62 174.63 9.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.867 1.267 . . . . 0.0 112.441 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -141.62 170.36 9.36 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 128.153 2.581 . . . . 0.0 109.653 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.96 160.5 49.15 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.793 2.329 . . . . 0.0 111.724 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -131.2 94.65 3.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 106.457 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.51 14.27 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.381 1.467 . . . . 0.0 110.295 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.11 141.81 36.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.31 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.53 108.36 3.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.737 0.699 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.69 21.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.297 1.839 . . . . 0.0 106.519 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.37 173.16 49.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.685 0.66 . . . . 0.0 112.744 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.86 134.13 56.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.624 1.97 . . . . 0.0 109.398 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -90.81 144.13 26.02 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -133.96 159.34 41.04 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.015 1.326 . . . . 0.0 108.905 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -144.38 154.3 42.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.096 1.358 . . . . 0.0 107.858 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.7 mp -137.47 131.98 32.68 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -165.03 137.97 4.57 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.78 1.232 . . . . 0.0 108.553 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.58 96.51 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.56 164.49 4.48 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.113 0.959 . . . . 0.0 111.782 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.79 -2.06 42.87 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 121.266 -0.896 . . . . 0.0 113.318 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -138.22 167.07 22.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.262 3.025 . . . . 0.0 107.181 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 152.8 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.498 -0.751 . . . . 0.0 109.29 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 92.3 mt -74.41 135.05 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.1 -4.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -170.99 -173.48 38.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 120.521 1.51 . . . . 0.0 111.048 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.62 164.66 29.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.341 1.07 . . . . 0.0 110.204 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -132.65 157.86 43.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.18 -163.57 27.74 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.426 ' HE2' ' C ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -131.03 158.31 40.66 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.669 1.188 . . . . 0.0 109.173 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -137.1 113.91 10.43 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.678 0.791 . . . . 0.0 110.291 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 m -149.82 86.46 1.45 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 58.74 -10.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.272 2.229 . . . . 0.0 116.772 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 36.7 mt -143.37 -172.21 3.65 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.778 2.031 . . . . 0.0 109.56 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.63 88.48 2.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.78 1.232 . . . . 0.0 112.423 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.78 -84.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.628 0.728 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -85.65 128.97 34.93 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 120.894 -1.129 . . . . 0.0 109.163 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -149.41 100.05 2.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.127 0.971 . . . . 0.0 108.604 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -120.19 152.18 17.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.28 135.2 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 118.951 1.375 . . . . 0.0 111.729 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -89.74 139.01 30.99 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.54 153.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 37.0 mmm -147.53 157.21 45.13 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.37 156.89 57.52 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.391 1.394 . . . . 0.0 111.609 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp -126.9 158.89 35.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.904 1.682 . . . . 0.0 107.619 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 13.1 t -163.66 179.52 7.12 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.431 1.492 . . . . 0.0 106.998 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 178.873 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -132.28 101.81 5.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.538 -1.351 . . . . 0.0 109.058 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.57 138.49 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.39 84.99 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -56.46 140.21 46.65 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.268 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -73.42 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 O-C-N 125.139 1.524 . . . . 0.0 112.087 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.26 -14.86 23.1 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.046 -1.419 . . . . 0.0 112.672 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.38 -169.59 35.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.07 113.4 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 112.881 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.02 34.76 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.64 -151.19 2.42 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 128.244 2.831 . . . . 0.0 112.153 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.52 -170.79 41.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 112.093 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.77 33.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -69.77 69.39 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -84.09 24.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.993 1.717 . . . . 0.0 109.647 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.38 126.46 27.56 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.146 1.779 . . . . 0.0 107.032 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -70.15 -179.0 1.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.44 0.696 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -120.52 4.78 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.962 1.744 . . . . 0.0 110.185 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.3 22.76 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.739 2.416 . . . . 0.0 110.059 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 151.49 30.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.33 1.452 . . . . 0.0 109.658 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.49 96.15 9.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.61 76.43 0.34 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.276 0.465 . . . . 0.0 113.387 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -136.61 118.7 20.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.58 -60.96 1.59 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -149.66 158.09 43.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.82 116.28 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -118.66 125.94 50.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.38 142.42 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 123.995 0.918 . . . . 0.0 109.251 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.97 164.08 25.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 124.606 1.098 . . . . 0.0 110.42 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -75.22 -148.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.162 1.385 . . . . 0.0 111.146 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.26 -163.58 35.6 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -95.35 -32.45 12.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.859 1.314 . . . . 0.0 107.54 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.67 -6.34 58.93 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 134.389 5.076 . . . . 0.0 113.24 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.3 -156.36 15.64 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.64 121.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.1 p -132.8 -58.61 0.91 Allowed 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.7 p -72.96 119.41 17.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 119.11 0.868 . . . . 0.0 109.634 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 tt -135.26 142.42 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.297 1.039 . . . . 0.0 108.959 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.97 129.72 21.64 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.617 1.967 . . . . 0.0 106.034 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.46 151.54 24.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.2 t -127.48 118.39 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -107.76 105.13 14.82 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.525 1.53 . . . . 0.0 110.488 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . . . -98.58 134.74 41.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 117.951 0.341 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 46' ' ' SER . 13.9 mptt -114.48 163.82 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.58 21.96 0.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.834 1.302 . . . . 0.0 111.095 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.473 ' H ' ' C ' ' A' ' 44' ' ' LYS . 11.9 p -128.8 -68.55 0.74 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.083 2.553 . . . . 0.0 109.875 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -148.08 133.91 19.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.288 1.435 . . . . 0.0 109.379 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 15.6 t0 -78.32 152.29 32.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.354 1.462 . . . . 0.0 109.687 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.76 108.67 13.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.973 0.892 . . . . 0.0 109.131 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.28 98.41 11.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.86 -22.09 76.87 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.46 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.09 -172.72 40.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.42 123.98 28.03 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.548 -0.971 . . . . 0.0 110.864 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.07 160.93 29.3 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 12.73 -86.99 0.0 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 128.417 2.913 . . . . 0.0 115.798 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -69.44 103.78 2.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.74 163.4 21.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.825 1.25 . . . . 0.0 112.432 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.81 10.22 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.712 2.405 . . . . 0.0 112.907 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.13 -13.51 18.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.84 1.256 . . . . 0.0 112.127 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.309 3.2 pp 49.0 -11.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.027 4.131 . . . . 0.0 117.593 -179.19 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.81 61.76 3.04 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.24 160.83 35.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.814 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.81 164.42 12.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 127.891 2.476 . . . . 0.0 109.298 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.5 m -136.03 95.58 3.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.578 0.751 . . . . 0.0 109.446 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -95.04 109.56 21.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.47 143.08 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.731 0.812 . . . . 0.0 110.675 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.5 t -103.87 156.57 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -149.21 164.14 35.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.913 1.685 . . . . 0.0 107.833 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.67 -9.78 59.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.672 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.69 -9.33 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.833 1.653 . . . . 0.0 111.462 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 135.76 52.12 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -135.88 149.35 48.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 109.208 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.7 126.64 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.49 -25.81 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.753 -0.642 . . . . 0.0 110.25 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.89 149.18 30.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.438 1.017 . . . . 0.0 110.642 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.0 m -129.22 75.81 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.07 134.22 52.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -139.67 153.05 23.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.1 p -133.35 142.04 48.22 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -149.84 156.35 41.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.08 169.48 20.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -126.86 157.74 38.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.723 0.773 . . . . 0.0 110.702 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.99 166.0 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.429 1.492 . . . . 0.0 108.62 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -68.42 150.1 48.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.73 20.15 58.59 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.061 -0.855 . . . . 0.0 113.372 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -131.04 166.52 20.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.621 1.569 . . . . 0.0 107.363 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -122.52 -11.98 8.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.955 1.702 . . . . 0.0 112.359 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.9 p -145.47 145.8 31.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.768 1.627 . . . . 0.0 109.667 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.72 159.48 33.44 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -135.7 156.91 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.715 0.806 . . . . 0.0 109.781 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -73.73 139.62 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-O 121.565 0.698 . . . . 0.0 112.057 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -108.38 -30.96 8.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.587 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.4 t -165.83 166.4 17.69 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.53 1.532 . . . . 0.0 110.624 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.0 mt -145.23 146.28 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 128.12 2.568 . . . . 0.0 105.677 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -150.14 101.53 3.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -86.72 148.53 25.39 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.312 -0.867 . . . . 0.0 109.479 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -133.31 121.11 21.92 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.0 p -100.5 159.03 15.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.653 1.115 . . . . 0.0 111.576 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.34 -32.89 74.43 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.714 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -56.19 -10.76 0.93 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.818 2.847 . . . . 0.0 113.042 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.51 30.56 8.5 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 119.238 0.926 . . . . 0.0 111.856 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.81 148.42 42.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.609 1.204 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 114.64 12.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 p -73.47 160.75 81.63 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.15 165.59 32.29 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 N-CA-C 107.694 -1.695 . . . . 0.0 107.694 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.09 109.59 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.022 -1.953 . . . . 0.0 107.022 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.38 66.08 0.92 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.294 1.437 . . . . 0.0 110.031 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.78 -129.35 3.5 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 tp -139.41 136.17 34.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.673 1.589 . . . . 0.0 109.833 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' C ' ' HG1' ' A' ' 111' ' ' THR . 2.7 mm-40 -60.62 158.8 11.77 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.44 1.096 . . . . 0.0 110.901 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -156.35 173.52 16.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.563 -1.335 . . . . 0.0 111.343 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.483 ' H ' HG23 ' A' ' 111' ' ' THR . 4.8 tt0 -64.74 -58.08 7.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.143 1.377 . . . . 0.0 109.254 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -70.54 105.93 3.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.48 166.42 33.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 120.604 -1.31 . . . . 0.0 109.021 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -156.72 166.85 32.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.313 0.578 . . . . 0.0 109.73 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.98 145.84 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -149.74 136.51 19.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 127.706 2.403 . . . . 0.0 106.354 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HZ1' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -160.58 134.44 7.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.49 161.16 21.34 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -142.65 -69.05 0.35 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.605 1.162 . . . . 0.0 111.064 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.84 15.37 6.92 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.492 1.517 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.34 -85.66 1.64 Allowed Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 125.602 1.572 . . . . 0.0 111.011 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.97 166.41 29.36 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.6 140.6 41.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.1 tp -54.91 112.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.68 -54.98 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.348 0.976 . . . . 0.0 111.283 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.43 -105.28 0.2 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -167.66 176.4 6.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.292 1.046 . . . . 0.0 111.526 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.84 151.84 35.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.48 -26.42 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.049 -1.072 . . . . 0.0 114.548 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 62.23 69.95 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.535 2.334 . . . . 0.0 113.852 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.99 112.16 20.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.55 -120.46 4.27 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 103.414 -3.875 . . . . 0.0 103.414 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.34 -10.22 59.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.259 0.624 . . . . 0.0 112.23 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.42 173.86 11.63 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.222 2.609 . . . . 0.0 107.691 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 40.8 tp -99.51 98.24 9.15 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.684 0.794 . . . . 0.0 109.245 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -76.13 -66.65 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 112.087 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.47 172.79 12.51 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.88 1.218 . . . . 0.0 109.626 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.8 tp -162.73 134.01 5.01 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.86 176.88 44.16 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 106.47 -2.652 . . . . 0.0 106.47 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.02 176.96 11.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.975 1.388 . . . . 0.0 109.055 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -147.81 161.73 40.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.684 0.754 . . . . 0.0 109.447 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.1 125.31 12.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.111 2.565 . . . . 0.0 104.398 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.79 151.89 43.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.722 0.692 . . . . 0.0 111.858 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.4 t -134.93 144.47 47.48 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.185 0.994 . . . . 0.0 110.508 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -111.95 170.66 7.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.68 1.592 . . . . 0.0 107.178 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.26 172.88 15.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.913 1.285 . . . . 0.0 109.089 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.2 p -130.41 141.45 41.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.008 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 142.76 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.959 2.439 . . . . 0.0 109.935 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t -144.6 143.43 22.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 p -136.8 159.58 69.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.176 0.991 . . . . 0.0 111.318 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -88.86 -179.15 2.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.893 3.062 . . . . 0.0 113.673 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.66 178.09 7.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.97 1.308 . . . . 0.0 109.345 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.1 133.87 55.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.195 0.998 . . . . 0.0 110.773 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -113.64 143.43 44.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.408 1.483 . . . . 0.0 108.658 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.48 -89.92 0.13 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.3 t -146.55 160.4 42.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.112 1.765 . . . . 0.0 107.889 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -170.38 136.61 1.36 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.099 2.159 . . . . 0.0 105.371 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.0 tt -97.99 128.45 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.2 107.59 0.62 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.34 -179.03 6.22 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 112.431 -1.885 . . . . 0.0 109.832 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.19 11.94 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 128.659 2.783 . . . . 0.0 115.319 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.429 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 11.8 mt-10 -130.99 156.35 45.26 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.207 1.367 . . . . 0.0 114.265 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 96.91 159.53 31.55 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 125.253 1.406 . . . . 0.0 112.768 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 m -102.53 134.43 45.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.51 138.86 51.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.815 0.446 . . . . 0.0 110.122 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -128.63 123.94 34.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -85.78 105.66 16.46 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.14 -117.94 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.405 1.066 . . . . 0.0 108.707 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.13 168.16 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 121.35 1.886 . . . . 0.0 111.763 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.87 157.86 37.11 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.098 -0.648 . . . . 0.0 109.254 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -135.31 176.34 8.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.691 1.196 . . . . 0.0 110.621 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -12.24 60.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.739 1.215 . . . . 0.0 113.767 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.21 171.73 22.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 125.525 1.536 . . . . 0.0 110.315 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.1 m -125.89 107.8 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -63.04 -51.1 68.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 110.629 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -149.19 169.69 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.753 1.16 . . . . 0.0 112.751 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 86.1 t -122.46 143.95 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.656 1.583 . . . . 0.0 109.208 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.79 157.39 46.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.768 1.627 . . . . 0.0 108.342 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.36 146.22 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.77 83.64 0.32 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -71.16 160.51 32.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.655 0.741 . . . . 0.0 110.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.34 -163.28 9.49 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.152 2.787 . . . . 0.0 109.029 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -89.62 -14.36 35.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.902 -1.352 . . . . 0.0 111.565 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.21 -29.1 15.28 Favored 'General case' 0 C--N 1.327 -0.379 1 C-N-CA 132.404 4.282 . . . . 0.0 112.917 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 144.45 -136.78 6.9 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.94 104.6 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.23 -26.17 28.9 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.496 0.719 . . . . 0.0 112.215 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.98 146.07 35.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.842 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.79 145.07 28.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -148.75 154.73 39.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.85 175.45 9.57 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -123.55 120.87 34.12 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.351 0.66 . . . . 0.0 109.555 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -94.85 165.7 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.397 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -144.82 130.38 18.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.109 -0.948 . . . . 0.0 108.556 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.85 151.99 43.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.714 1.143 . . . . 0.0 109.111 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.72 -103.53 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.601 1.096 . . . . 0.0 111.708 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 7.89 3.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.266 2.226 . . . . 0.0 110.936 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -109.24 177.93 4.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.011 1.324 . . . . 0.0 107.851 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -133.7 142.29 47.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.866 1.266 . . . . 0.0 108.761 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.74 99.73 9.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 119.649 1.113 . . . . 0.0 109.351 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.68 103.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.46 175.28 35.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.158 2.313 . . . . 0.0 107.698 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 134.1 23.95 0.66 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-N 118.327 1.063 . . . . 0.0 113.771 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.92 126.07 27.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.429 1.614 . . . . 0.0 108.123 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -127.68 -6.88 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.227 2.611 . . . . 0.0 113.363 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.45 159.29 25.73 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -66.29 116.56 34.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.801 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.86 134.89 52.59 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.652 2.234 . . . . 0.0 110.077 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.9 p -83.22 161.11 21.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.215 1.006 . . . . 0.0 109.821 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.76 -23.11 65.19 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.468 -0.77 . . . . 0.0 111.096 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -64.88 -30.82 71.84 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.963 1.305 . . . . 0.0 111.247 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.95 -146.47 16.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -138.67 163.95 30.78 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.523 1.129 . . . . 0.0 109.538 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -115.03 154.25 29.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.365 3.066 . . . . 0.0 105.304 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.5 148.17 28.38 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.61 0.764 . . . . 0.0 110.388 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.65 137.19 29.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.251 0.62 . . . . 0.0 109.332 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.13 120.75 33.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.607 0.718 . . . . 0.0 111.028 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.5 mt -127.47 129.35 70.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.443 1.02 . . . . 0.0 111.353 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -37.84 -55.82 2.04 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.34 1.59 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 123.02 2.114 . . . . 0.0 113.638 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 31.0 t -108.99 -46.69 3.56 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.737 -1.227 . . . . 0.0 109.522 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.83 160.49 14.55 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.435 1.112 . . . . 0.0 112.643 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -139.93 112.41 7.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.767 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.05 84.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.34 57.93 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.655 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -152.75 157.31 40.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.863 0.865 . . . . 0.0 109.752 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.7 146.13 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.603 1.561 . . . . 0.0 106.959 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.75 152.81 39.04 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -161.91 43.42 0.38 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.336 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.0 p -23.41 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.429 3.092 . . . . 0.0 109.381 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -122.31 155.37 36.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -144.86 165.79 27.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 110.275 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -74.51 137.34 42.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.864 1.666 . . . . 0.0 111.49 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.9 mt -80.4 108.17 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -47.11 125.15 7.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.03 1.332 . . . . 0.0 112.023 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.02 -19.18 38.47 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.829 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -136.16 178.23 7.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.284 1.434 . . . . 0.0 108.77 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.91 7.78 43.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.789 0.804 . . . . 0.0 110.595 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -73.8 164.31 54.76 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 162.89 34.32 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.203 1.401 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.5 tt -151.72 148.16 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.47 142.82 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.302 1.7 t -119.82 -23.68 6.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.944 0.793 . . . . 0.0 111.96 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -146.49 126.31 13.52 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 120.176 1.353 . . . . 0.0 108.048 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.8 150.02 28.23 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.096 1.358 . . . . 0.0 111.101 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -147.46 139.06 23.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -125.92 113.35 17.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 154.01 42.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.748 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.1 p -144.74 168.3 20.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.238 1.415 . . . . 0.0 108.699 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -123.66 141.0 52.44 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt 72.08 -45.96 0.63 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.164 1.786 . . . . 0.0 110.533 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.54 168.35 17.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.406 1.883 . . . . 0.0 107.629 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 88.2 m -130.5 99.52 5.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.359 1.464 . . . . 0.0 107.954 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 38.6 p -67.14 128.9 38.11 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.336 1.055 . . . . 0.0 113.497 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.21 84.41 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.65 157.41 21.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.527 2.151 . . . . 0.0 108.676 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -133.37 104.36 6.4 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.51 -169.54 20.5 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.4 mt -116.51 124.26 49.47 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.306 1.042 . . . . 0.0 110.461 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.91 109.19 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.152 2.181 . . . . 0.0 110.777 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.69 162.5 26.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 108.458 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.28 -165.95 45.48 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.251 0.917 . . . . 0.0 112.899 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.8 m -73.66 108.47 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.958 2.103 . . . . 0.0 108.26 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.88 138.89 42.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.91 120.77 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.501 0.667 . . . . 0.0 111.81 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.06 124.01 47.72 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.55 110.29 22.44 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -152.06 163.37 39.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.434 1.094 . . . . 0.0 109.934 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -144.71 137.71 26.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 129.37 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.393 0.616 . . . . 0.0 111.138 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.21 -1.57 33.11 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.43 161.23 13.74 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.331 2.065 . . . . 0.0 113.546 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -107.81 159.64 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.889 2.475 . . . . 0.0 107.722 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 54.7 mt -99.74 107.69 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.22 90.68 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.485 1.514 . . . . 0.0 109.449 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.73 159.11 9.1 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 126.046 1.784 . . . . 0.0 111.485 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -131.85 164.35 26.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.626 2.371 . . . . 0.0 108.546 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -161.88 103.13 1.16 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -150.38 -179.94 26.6 Favored Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.173 -0.954 . . . . 0.0 114.205 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 163' ' ' GLU . 21.8 ptmt -140.19 117.26 11.16 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.112 -2.922 . . . . 0.0 103.112 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.28 154.62 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 63.3 m -149.46 -72.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.95 -36.35 13.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.587 0.755 . . . . 0.0 110.755 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.6 mt -130.33 141.92 50.56 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.056 1.342 . . . . 0.0 107.881 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.57 85.09 2.63 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 110.695 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -76.19 -82.38 0.08 Allowed 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.131 0.572 . . . . 0.0 111.531 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -83.3 126.05 32.27 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.616 -0.677 . . . . 0.0 110.785 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -128.06 100.96 6.08 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.55 153.75 16.91 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.97 161.78 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.915 1.286 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.79 160.51 15.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 109.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.97 158.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 110.514 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 53.0 mmm -156.81 138.91 10.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 126.081 1.752 . . . . 0.0 107.023 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.84 123.05 8.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 105.58 -2.508 . . . . 0.0 105.58 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.85 167.78 20.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.2 0.524 . . . . 0.0 112.029 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 10.8 p -89.9 129.91 36.19 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.894 1.278 . . . . 0.0 107.762 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 117.063 -1.446 . . . . 0.0 108.161 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.27 154.75 50.8 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 130.826 3.651 . . . . 0.0 108.582 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HE2' ' CE1' ' A' ' 142' ' ' TYR . 4.9 tmtt? -38.88 113.73 0.33 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.663 2.785 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.26 146.05 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.82 167.82 11.02 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.42 94.44 3.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.65 7.78 4.85 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.489 1.518 . . . . 0.0 115.417 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -170.14 27.74 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 118.74 1.27 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.52 -28.9 74.08 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.029 1.776 . . . . 0.0 110.204 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.13 42.27 30.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.452 1.501 . . . . 0.0 110.314 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.31 15.66 1.41 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.424 1.488 . . . . 0.0 112.883 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 174.64 22.42 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.358 1.932 . . . . 0.0 110.63 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 160.79 26.52 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.184 2.194 . . . . 0.0 112.237 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.73 138.39 6.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.686 0.795 . . . . 0.0 110.973 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -155.91 106.67 2.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' CG ' ' HH ' ' A' ' 142' ' ' TYR . 13.6 t0 -148.27 70.89 1.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.049 1.339 . . . . 0.0 110.758 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -34.53 127.76 0.46 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.345 2.258 . . . . 0.0 113.515 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.03 147.83 48.54 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.9 -40.76 5.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.893 1.677 . . . . 0.0 113.993 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -82.49 58.15 4.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -72.96 -37.54 67.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.158 1.383 . . . . 0.0 111.847 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.27 48.39 10.78 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.73 139.35 18.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.289 1.044 . . . . 0.0 112.116 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -58.37 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.328 1.851 . . . . 0.0 110.128 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -136.66 163.83 29.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 122.03 -0.419 . . . . 0.0 110.527 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.28 96.61 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.092 1.757 . . . . 0.0 106.879 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.82 136.28 33.03 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.33 148.25 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.539 1.936 . . . . 0.0 106.686 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.69 -115.1 2.01 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 119.483 1.038 . . . . 0.0 111.814 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.21 174.06 1.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 110.759 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.59 -25.59 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.747 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -60.72 -28.31 68.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.681 1.741 . . . . 0.0 112.468 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.24 1.06 25.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.978 2.511 . . . . 0.0 110.288 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.91 161.14 23.79 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 128.164 2.792 . . . . 0.0 108.996 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 t -84.65 95.66 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -80.32 -63.99 1.29 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 110.076 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 p -61.1 113.47 2.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.865 1.266 . . . . 0.0 111.162 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.2 mm -134.58 137.3 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.379 1.472 . . . . 0.0 107.386 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.96 111.3 5.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.1 p -124.37 150.19 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.41 122.61 59.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -110.2 104.6 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.12 110.35 18.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.596 0.236 . . . . 0.0 110.905 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -79.09 152.97 30.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.29 -38.87 74.64 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 m -63.71 -59.83 4.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -155.34 157.3 36.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.223 2.209 . . . . 0.0 106.364 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.23 156.39 39.19 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.96 108.66 2.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.44 138.53 33.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 109.369 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.36 -3.09 25.99 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.913 2.197 . . . . 0.0 112.124 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -166.43 21.29 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.431 1.116 . . . . 0.0 114.545 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -105.52 149.26 26.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.459 1.904 . . . . 0.0 107.812 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -129.73 155.87 45.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.286 1.434 . . . . 0.0 107.39 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.1 179.61 37.26 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -126.94 116.99 21.64 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.236 -1.155 . . . . 0.0 113.547 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -92.43 164.39 13.5 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.174 1.79 . . . . 0.0 110.204 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 p -142.9 168.0 20.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -63.95 -17.66 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.98 -9.84 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.954 1.702 . . . . 0.0 112.982 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.55 101.19 0.16 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 120.478 1.49 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -159.8 131.66 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.201 2.2 . . . . 0.0 105.752 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -143.28 162.39 35.79 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 127.302 2.241 . . . . 0.0 107.568 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -139.63 95.24 2.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -89.74 138.36 31.55 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -130.57 136.9 49.37 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.49 138.24 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.743 1.617 . . . . 0.0 109.607 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -82.25 171.08 14.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.5 65.79 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.995 -1.066 . . . . 0.0 112.587 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -124.4 19.45 8.89 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.326 1.45 . . . . 0.0 112.579 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.0 136.44 38.26 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.7 158.12 37.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.16 1.784 . . . . 0.0 109.175 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.0 mt -96.42 121.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.175 0.99 . . . . 0.0 109.22 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.3 m -118.38 -18.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.609 0.64 . . . . 0.0 111.952 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.19 141.11 25.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 t -135.54 142.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.64 118.48 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.78 138.4 54.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 m -117.02 137.31 52.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -140.27 148.97 42.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.013 0.525 . . . . 0.0 109.717 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -147.29 150.55 35.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -144.86 158.21 43.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 127.204 2.202 . . . . 0.0 109.273 177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.62 169.48 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 108.304 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.16 1.61 1.98 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.552 1.541 . . . . 0.0 113.21 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.47 17.31 14.11 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 126.904 2.192 . . . . 0.0 112.895 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -134.38 156.69 48.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.155 1.477 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -117.25 5.36 12.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.341 1.856 . . . . 0.0 112.3 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 53.2 p -134.11 173.52 11.5 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.678 2.791 . . . . 0.0 110.108 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -119.19 146.27 45.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -126.23 140.04 49.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.35 104.32 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.7 p -73.94 -31.13 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.816 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -150.21 154.35 37.82 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.652 1.581 . . . . 0.0 109.853 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 pt -139.57 148.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 128.441 2.696 . . . . 0.0 106.24 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.63 145.37 25.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -127.45 152.83 47.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -132.45 113.98 13.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 103.554 -2.758 . . . . 0.0 103.554 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.2 p -80.5 161.69 24.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.418 0.553 . . . . 0.0 112.019 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.75 -25.09 66.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.506 1.122 . . . . 0.0 111.29 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -68.62 -15.56 63.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.47 1.908 . . . . 0.0 109.721 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 6.5 61.46 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.693 2.568 . . . . 0.0 111.464 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -73.12 99.13 2.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.532 1.166 . . . . 0.0 111.359 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.12 134.95 33.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 p -107.67 162.2 20.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.763 1.225 . . . . 0.0 110.976 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.13 162.16 42.55 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.906 1.738 . . . . 0.0 109.498 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 109.73 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.615 2.21 . . . . 0.0 108.36 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -72.24 79.61 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 109.488 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.99 -137.2 5.41 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.395 -0.816 . . . . 0.0 111.611 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.99 111.13 13.72 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.597 1.959 . . . . 0.0 108.089 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.1 144.8 50.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 m -133.71 163.9 28.41 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.345 1.858 . . . . 0.0 107.055 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.87 -35.87 82.07 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.407 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -73.45 97.53 2.57 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.51 1.924 . . . . 0.0 108.947 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -150.98 170.18 19.96 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.258 1.023 . . . . 0.0 109.019 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.64 167.21 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -118.69 141.02 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.61 94.02 2.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 169.48 23.11 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.11 2.164 . . . . 0.0 108.42 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.56 150.25 38.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.473 1.909 . . . . 0.0 109.086 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.13 -61.02 2.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.189 0.904 . . . . 0.0 111.688 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -68.39 -15.55 63.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.522 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.99 -53.02 0.8 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.546 -1.697 . . . . 0.0 112.571 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 38.82 91.26 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.21 2.338 . . . . 0.0 114.055 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -52.5 120.7 5.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.658 1.729 . . . . 0.0 109.888 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.83 144.38 38.92 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.173 2.189 . . . . 0.0 110.147 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.46 -31.16 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.677 0.791 . . . . 0.0 110.084 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.73 150.89 8.54 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -121.95 84.6 2.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 123.468 1.604 . . . . 0.0 107.642 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.36 151.68 36.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 111.759 -2.473 . . . . 0.0 110.554 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.93 78.78 0.16 Allowed Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.809 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -49.33 107.11 0.13 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.045 1.738 . . . . 0.0 109.034 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.5 165.07 18.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.712 2.405 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.54 -86.65 0.2 Allowed Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 105.186 -3.166 . . . . 0.0 105.186 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -93.9 -27.59 16.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.35 166.29 25.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.832 2.453 . . . . 0.0 108.548 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.6 tp -78.81 99.05 6.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -82.95 -55.64 4.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.556 0.742 . . . . 0.0 112.945 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.81 161.27 21.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.949 0.9 . . . . 0.0 109.852 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 tp -148.43 163.39 37.28 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.717 1.607 . . . . 0.0 108.672 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.57 -179.51 40.39 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.72 151.99 29.38 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.429 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 8.5 m-85 -114.84 146.33 41.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.486 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -143.11 156.39 44.79 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.77 147.44 32.93 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.779 0.832 . . . . 0.0 111.469 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.8 t -133.67 163.46 29.4 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.662 1.185 . . . . 0.0 111.863 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m -66.56 -46.79 74.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.349 1.859 . . . . 0.0 111.323 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.13 93.22 0.05 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.579 1.552 . . . . 0.0 111.55 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -154.41 162.29 27.33 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 126.147 1.779 . . . . 0.0 108.199 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.81 -166.21 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.723 2.949 . . . . 0.0 107.745 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.1 p -54.13 142.5 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 p -135.46 163.06 53.5 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 123.813 0.845 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.42 -171.32 0.7 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.234 2.623 . . . . 0.0 112.492 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.56 -176.47 0.79 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.513 2.325 . . . . 0.0 112.385 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -73.97 122.92 23.35 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -99.79 118.93 37.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.825 1.65 . . . . 0.0 106.931 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.35 -176.68 4.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.675 0.671 . . . . 0.0 111.751 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.5 m -121.52 85.74 2.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 113.426 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.25 -175.84 5.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.278 1.031 . . . . 0.0 109.13 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -123.87 165.17 20.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 127.005 2.122 . . . . 0.0 107.248 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 177.75 -83.04 0.07 OUTLIER Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.832 0.742 . . . . 0.0 114.187 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.44 -24.77 0.02 OUTLIER Glycine 0 N--CA 1.469 0.848 0 CA-C-N 117.403 0.601 . . . . 0.0 112.779 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 282' ' ' LYS . 0.3 OUTLIER 61.43 21.35 11.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -83.59 -47.85 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.54 12.79 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 122.57 1.095 . . . . 0.0 113.765 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.7 m -81.44 134.53 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.219 -0.577 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.56 124.31 22.88 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.535 0.734 . . . . 0.0 110.505 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -127.05 126.9 43.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.241 1.02 . . . . 0.0 109.362 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -98.2 156.52 16.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.624 2.369 . . . . 0.0 107.278 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.28 -53.48 2.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.776 1.63 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.8 -105.7 1.85 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -165.62 166.88 17.77 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.645 1.978 . . . . 0.0 108.378 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.33 154.3 36.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.159 0.584 . . . . 0.0 110.317 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -27.74 61.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.12 140.55 2.91 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.747 2.594 . . . . 0.0 106.754 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.8 m -91.85 157.14 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.511 1.124 . . . . 0.0 110.634 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' A' ' 176' ' ' LYS . 5.7 ptpt -123.71 -21.88 5.09 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.843 1.657 . . . . 0.0 111.086 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -166.11 159.85 15.73 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.625 0.77 . . . . 0.0 110.426 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.74 147.55 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 126.982 2.113 . . . . 0.0 107.694 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -139.4 113.28 8.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.151 1.381 . . . . 0.0 108.322 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.19 133.81 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -135.86 144.53 16.37 Favored Glycine 0 C--O 1.238 0.397 0 CA-C-O 122.029 0.794 . . . . 0.0 111.815 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -126.72 171.89 10.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.285 1.434 . . . . 0.0 107.43 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.16 -171.44 12.4 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -63.43 -6.81 5.38 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.638 1.175 . . . . 0.0 113.484 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -120.04 -4.96 10.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.756 1.622 . . . . 0.0 112.859 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 125.14 -162.08 19.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.596 1.089 . . . . 0.0 111.626 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.1 mm -55.6 126.64 13.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 m -134.27 -19.73 1.92 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.62 138.18 16.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 121.174 1.806 . . . . 0.0 111.551 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.05 146.85 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.146 0.884 . . . . 0.0 109.761 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -160.45 167.23 27.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.794 1.637 . . . . 0.0 107.459 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -138.32 172.4 12.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.592 1.157 . . . . 0.0 108.11 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -126.75 124.3 39.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -132.06 167.99 18.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.458 0.572 . . . . 0.0 111.31 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -116.6 91.46 3.59 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -112.96 136.32 52.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.771 2.428 . . . . 0.0 106.14 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.16 20.32 34.95 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.947 0.784 . . . . 0.0 113.093 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.93 4.73 3.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.638 2.375 . . . . 0.0 113.723 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -91.25 -157.33 0.49 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.495 1.518 . . . . 0.0 111.055 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -125.4 73.43 1.32 Allowed 'General case' 0 C--N 1.339 0.142 0 O-C-N 120.694 -1.254 . . . . 0.0 110.924 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.2 mt -84.87 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.0 145.05 31.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -73.57 156.54 51.03 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.35 159.06 46.38 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.18 94.41 4.74 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -63.14 -22.04 66.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.381 1.072 . . . . 0.0 113.228 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.56 -179.07 16.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.925 1.726 . . . . 0.0 112.19 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.57 117.49 68.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.567 1.547 . . . . 0.0 109.523 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.8 175.16 6.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.407 2.071 . . . . 0.0 110.196 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -139.95 162.08 36.06 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.744 -1.222 . . . . 0.0 110.546 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.38 -15.28 62.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.886 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -4.24 22.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.709 2.404 . . . . 0.0 111.062 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.46 -157.63 51.67 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.328 -0.857 . . . . 0.0 111.394 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.89 172.67 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.551 1.54 . . . . 0.0 110.482 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.77 147.08 47.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 129.568 3.147 . . . . 0.0 102.827 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.25 147.36 51.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -142.94 143.98 32.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.783 1.233 . . . . 0.0 109.278 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.18 136.4 52.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.4 mt -128.13 103.29 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.861 1.664 . . . . 0.0 109.238 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.64 98.48 0.52 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -55.57 -40.17 82.57 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.49 -29.79 44.42 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 123.187 2.174 . . . . 0.0 112.891 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -89.94 -30.07 18.08 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 116.423 -1.751 . . . . 0.0 113.233 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 225' ' ' TYR . 10.9 tp10 -162.01 175.92 11.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 121.622 2.01 . . . . 0.0 111.157 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.463 ' H ' ' CD ' ' A' ' 224' ' ' GLU . 2.6 p90 -153.17 -156.16 0.67 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.537 1.135 . . . . 0.0 109.311 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 92.6 mt -116.77 102.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 101.885 -3.376 . . . . 0.0 101.885 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.1 p -81.84 -20.64 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.018 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.26 167.5 25.84 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.516 1.526 . . . . 0.0 108.284 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.43 159.08 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.073 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 172.0 13.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.922 2.089 . . . . 0.0 107.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.81 171.62 31.28 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 p -140.8 146.41 37.6 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -122.14 145.23 48.38 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.132 0.573 . . . . 0.0 110.301 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.61 161.07 36.55 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 110.325 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.52 148.91 38.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.795 1.638 . . . . 0.0 109.873 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.3 pt -115.9 142.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -87.73 99.24 11.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.56 -22.97 1.51 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.873 0.749 . . . . 0.0 113.85 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 m -141.78 155.52 45.6 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.67 -16.92 62.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.848 0.749 . . . . 0.0 112.615 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.02 -173.7 20.56 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.915 1.721 . . . . 0.0 115.689 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.6 mt -119.07 173.52 6.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.082 2.153 . . . . 0.0 110.055 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.3 tt -139.13 130.72 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.843 1.657 . . . . 0.0 108.008 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.9 mt -90.44 76.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.1 t -70.41 -8.43 50.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -141.79 137.21 31.37 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.855 0.752 . . . . 0.0 111.868 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.2 mt -142.79 137.74 29.92 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.724 1.61 . . . . 0.0 109.121 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -139.63 139.42 36.71 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.63 113.04 25.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -65.95 115.27 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.5 m -133.6 162.17 32.64 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.071 0.949 . . . . 0.0 109.23 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.16 161.67 26.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.948 2.499 . . . . 0.0 105.074 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.5 tptt 75.47 -28.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.968 1.707 . . . . 0.0 112.808 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -138.84 167.95 20.88 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.812 1.245 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 14.4 t -121.96 142.92 49.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.934 2.093 . . . . 0.0 106.005 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 p -133.13 149.29 52.1 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.951 0.901 . . . . 0.0 109.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -66.93 159.9 73.13 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.679 0.792 . . . . 0.0 111.819 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.83 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 105.51 -2.535 . . . . 0.0 105.51 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -72.97 99.23 2.66 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.72 179.75 17.77 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.04 114.46 27.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.543 1.937 . . . . 0.0 107.966 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.68 115.84 3.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 110.136 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.42 24.77 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.873 0.844 . . . . 0.0 111.68 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.68 -93.27 1.25 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 125.799 1.666 . . . . 0.0 113.629 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.4 m -149.9 127.47 11.58 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.391 1.076 . . . . 0.0 109.207 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.76 147.69 30.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.881 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -142.24 168.28 20.12 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.527 1.531 . . . . 0.0 108.072 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -151.87 156.2 39.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 109.181 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.7 mt -139.95 138.28 35.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -160.53 160.57 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 108.968 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.16 148.18 34.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 121.85 30.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.845 1.258 . . . . 0.0 109.455 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 87.78 -75.23 2.11 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -47.14 144.88 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.316 1.846 . . . . 0.0 111.486 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -117.65 161.07 20.25 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 83.4 mt -79.13 150.47 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.46 -55.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.8 -176.67 14.81 Favored Glycine 0 C--O 1.239 0.445 0 CA-C-O 122.994 1.33 . . . . 0.0 113.947 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.52 9.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.436 2.695 . . . . 0.0 111.271 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -165.31 162.69 19.85 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.016 1.726 . . . . 0.0 106.714 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.21 -136.11 5.28 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -156.69 131.03 8.63 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.33 137.67 24.55 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.8 m -152.16 -29.99 0.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.541 1.536 . . . . 0.0 112.225 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -139.23 -57.88 0.59 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.423 1.889 . . . . 0.0 111.753 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.78 165.82 22.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.139 1.375 . . . . 0.0 108.232 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.94 92.05 8.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.569 -0.707 . . . . 0.0 110.088 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.85 -48.24 7.14 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.013 0.925 . . . . 0.0 112.865 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -112.61 141.25 46.6 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.92 99.59 3.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -113.32 157.57 14.86 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.963 1.268 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.85 174.85 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.217 1.009 . . . . 0.0 113.13 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -127.97 125.93 40.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.345 2.658 . . . . 0.0 104.787 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -110.22 139.98 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.4 mtm -132.44 144.12 51.7 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.4 140.44 27.25 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.995 -1.963 . . . . 0.0 106.995 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -63.78 -74.51 0.1 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 31.0 m -72.88 123.09 22.72 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.702 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -137.94 141.63 40.55 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.934 1.294 . . . . 0.0 113.032 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -149.9 97.97 2.66 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.5 131.46 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.149 1.341 . . . . 0.0 108.978 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.21 163.8 21.65 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.652 0.781 . . . . 0.0 112.226 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.97 169.83 17.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.843 1.257 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.54 87.37 0.1 Allowed Glycine 0 C--O 1.225 -0.433 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.99 -167.96 20.41 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 126.585 2.041 . . . . 0.0 108.665 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.45 177.74 2.47 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 115.679 1.031 . . . . 0.0 115.679 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.43 2.99 12.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.414 1.486 . . . . 0.0 114.903 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.99 -2.31 38.03 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.245 -1.309 . . . . 0.0 116.191 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.4 172.78 14.81 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 121.041 2.421 . . . . 0.0 113.882 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.97 157.57 25.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.783 0.833 . . . . 0.0 109.339 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -71.68 84.19 0.88 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 112.698 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -93.98 149.65 21.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.23 -10.06 0.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.799 1.24 . . . . 0.0 111.779 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -54.27 131.76 42.28 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.558 1.943 . . . . 0.0 110.805 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.22 162.12 29.68 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.75 1.643 . . . . 0.0 110.241 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.73 -178.65 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.32 1.048 . . . . 0.0 111.105 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -94.19 -66.14 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -169.09 176.05 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.732 2.413 . . . . 0.0 106.311 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 28.29 6.35 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.455 1.979 . . . . 0.0 113.04 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.52 140.84 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.971 1.386 . . . . 0.0 109.511 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -62.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.893 0.877 . . . . 0.0 111.993 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -145.62 164.54 31.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.197 0.999 . . . . 0.0 109.909 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 t -141.71 150.36 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 127.043 2.137 . . . . 0.0 106.337 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -136.8 134.91 37.52 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.77 147.16 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 62' ' ' PHE . . . 135.26 124.92 2.47 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.25 -4.71 10.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.179 1.792 . . . . 0.0 111.168 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.4 -73.09 0.1 OUTLIER Glycine 0 C--O 1.224 -0.522 0 C-N-CA 129.386 3.374 . . . . 0.0 114.535 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -47.84 78.63 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.065 0.946 . . . . 0.0 110.755 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.9 1.52 56.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.432 1.493 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.86 -117.47 5.13 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 121.162 -0.962 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.2 96.76 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 111.532 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -127.12 -29.21 2.79 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.9 t -68.27 159.02 32.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.119 0.872 . . . . 0.0 110.344 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 154.37 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.503 1.521 . . . . 0.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -153.09 123.03 6.92 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.927 1.291 . . . . 0.0 107.735 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.35 100.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 123.966 0.906 . . . . 0.0 108.558 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -104.79 134.29 46.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -127.32 154.63 44.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 109.735 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.27 109.94 22.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -114.67 130.01 56.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 57.16 17.94 3.84 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.845 1.202 . . . . 0.0 112.65 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . 0.325 86.0 p 71.3 23.97 3.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.71 2.404 . . . . 0.0 111.285 -176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.95 160.49 19.49 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.113 2.965 . . . . 0.0 104.871 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -105.23 118.03 35.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 m -118.67 124.55 73.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.272 1.029 . . . . 0.0 110.503 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -122.76 161.58 23.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.282 1.833 . . . . 0.0 109.752 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.77 -21.97 2.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.211 1.386 . . . . 0.0 110.05 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.0 167.72 12.52 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 128.036 2.732 . . . . 0.0 109.942 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -73.95 159.46 32.73 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 109.951 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.49 143.69 50.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.06 -143.79 16.89 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.13 115.73 18.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.785 2.834 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 151.99 24.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.214 1.37 . . . . 0.0 110.163 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -147.72 156.1 42.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 tp -77.89 -10.43 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.86 -0.525 . . . . 0.0 111.502 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.12 -5.47 27.24 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.57 96.43 0.1 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.403 ' HA ' ' HA3' ' A' ' 29' ' ' GLY . 12.3 p90 -154.19 161.83 41.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.712 1.205 . . . . 0.0 109.66 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.66 163.61 33.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 127.197 2.199 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.7 m -131.82 140.81 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.004 2.121 . . . . 0.0 107.205 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -133.07 140.75 47.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.004 1.322 . . . . 0.0 109.295 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.5 136.24 54.97 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.175 1.79 . . . . 0.0 111.478 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.48 125.8 71.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.94 164.68 26.32 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.572 -0.705 . . . . 0.0 111.634 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -11.13 15.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.476 1.511 . . . . 0.0 113.172 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -127.5 10.0 6.65 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.788 1.635 . . . . 0.0 110.885 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -97.79 152.44 19.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.151 0.887 . . . . 0.0 111.786 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.53 134.14 41.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.61 105.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.91 -55.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.7 22.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.236 1.015 . . . . 0.0 109.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.78 151.37 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -135.17 136.0 41.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.59 135.89 27.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -116.27 156.54 26.43 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -153.55 158.64 41.55 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.486 1.039 . . . . 0.0 112.516 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -162.49 168.89 21.25 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.96 0.886 . . . . 0.0 112.14 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -125.3 141.27 52.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.479 2.712 . . . . 0.0 106.646 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -123.56 159.09 28.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.28 129.19 40.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.29 2.91 51.06 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 111.557 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -138.62 127.65 23.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.028 1.731 . . . . 0.0 106.766 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -11.18 49.46 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.3 p -80.07 -175.5 5.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.916 2.486 . . . . 0.0 109.9 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.83 134.91 17.99 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.73 171.73 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 123.827 0.851 . . . . 0.0 111.729 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.8 mm -73.93 134.06 30.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 p -104.73 -30.42 9.93 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.335 0.654 . . . . 0.0 110.172 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -156.42 160.44 39.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.325 0.966 . . . . 0.0 110.214 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.6 mt -142.58 147.62 20.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 126.667 1.987 . . . . 0.0 107.351 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -150.66 137.18 18.8 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.68 115.5 22.19 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.292 1.437 . . . . 0.0 107.747 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.12 135.11 33.41 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.4 p -110.23 159.39 17.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.658 1.117 . . . . 0.0 110.809 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -77.29 -25.88 51.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 5.3 mmpt? -63.56 -11.23 22.82 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.467 1.907 . . . . 0.0 114.491 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.52 31.26 33.99 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 120.862 1.665 . . . . 0.0 110.526 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -128.95 93.59 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.561 1.144 . . . . 0.0 108.397 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -85.74 136.28 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.82 150.3 75.27 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.92 166.73 28.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.615 1.543 . . . . 0.0 108.426 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.32 99.81 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.733 2.288 . . . . 0.0 108.265 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.32 85.43 0.16 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.488 1.515 . . . . 0.0 110.173 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.23 -123.75 3.52 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 126.07 1.795 . . . . 0.0 108.867 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.2 tp -139.51 120.92 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.417 1.487 . . . . 0.0 107.719 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 151.4 21.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.03 169.56 19.66 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.735 -1.228 . . . . 0.0 110.52 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.15 -61.23 2.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.543 1.137 . . . . 0.0 111.605 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.74 127.64 32.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -174.5 173.14 2.98 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.179 0.992 . . . . 0.0 111.1 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.34 167.52 25.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.057 0.943 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.11 150.63 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.725 1.61 . . . . 0.0 108.388 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.21 154.65 42.62 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 109.067 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.85 156.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.272 2.229 . . . . 0.0 110.02 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.413 ' HB2' ' CG ' ' A' ' 143' ' ' PHE . 31.1 t0 -117.67 175.61 5.56 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.009 2.523 . . . . 0.0 109.238 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -64.89 176.96 1.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.703 2.001 . . . . 0.0 110.482 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -68.18 -17.79 64.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.942 0.897 . . . . 0.0 112.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.44 43.02 1.71 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -133.19 154.36 21.17 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -137.61 149.55 46.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.881 0.872 . . . . 0.0 109.892 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.18 133.54 49.05 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.61 -71.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -139.54 166.34 25.59 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.268 0.486 . . . . 0.0 112.022 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -125.0 120.06 30.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.415 1.886 . . . . 0.0 107.303 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 148.85 25.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.21 96.13 0.18 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 65.4 1.2 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 109.553 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.01 165.53 12.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.526 2.331 . . . . 0.0 108.448 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.22 -102.56 0.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 103.215 -3.954 . . . . 0.0 103.215 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -86.75 -9.88 54.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.605 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 170.66 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.337 2.255 . . . . 0.0 108.786 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 tp -82.18 93.86 7.16 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.797 2.039 . . . . 0.0 110.772 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.68 -39.8 11.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.28 148.91 30.98 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.325 -0.86 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.507 ' CD1' ' H ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -134.84 -169.51 2.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.743 2.417 . . . . 0.0 108.827 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.507 ' H ' ' CD1' ' A' ' 139' ' ' LEU . . . 144.63 172.27 15.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.439 2.447 . . . . 0.0 109.469 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.56 166.28 33.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 120.031 1.915 . . . . 0.0 111.176 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -136.98 168.96 18.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.216 1.007 . . . . 0.0 110.88 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.413 ' CG ' ' HB2' ' A' ' 119' ' ' ASP . 7.8 m-85 -134.43 97.22 3.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.4 117.71 7.38 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.746 -1.121 . . . . 0.0 113.041 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.14 124.05 29.87 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.947 1.249 . . . . 0.0 109.14 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.0 p 51.34 18.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.125 2.97 . . . . 0.0 114.007 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.9 t -65.29 -26.76 68.21 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.875 1.67 . . . . 0.0 114.025 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 16.1 p -148.35 144.0 18.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 125.969 1.707 . . . . 0.0 111.002 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.97 -163.98 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.501 3.467 . . . . 0.0 109.85 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.23 108.12 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.535 -0.728 . . . . 0.0 111.87 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.13 163.95 42.47 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.959 1.703 . . . . 0.0 110.433 177.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.18 1.86 8.26 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.965 3.11 . . . . 0.0 114.579 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -87.92 174.46 8.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 130.8 3.64 . . . . 0.0 109.061 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -94.99 126.18 40.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.441 ' HA ' ' CE1' ' A' ' 293' ' ' HIS . 4.3 pttp -85.86 141.31 29.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.851 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.53 157.39 18.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.5 m -75.77 126.88 31.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.852 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.23 178.8 0.24 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.088 1.355 . . . . 0.0 112.161 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.68 170.68 17.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.555 1.942 . . . . 0.0 107.259 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -34.53 111.12 0.07 OUTLIER Glycine 0 CA--C 1.493 -1.282 0 C-N-CA 125.859 1.695 . . . . 0.0 113.335 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 164.36 121.66 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 O-C-N 125.471 1.336 . . . . 0.0 113.209 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -146.67 3.43 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -119.76 111.77 18.42 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 110.168 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.56 162.64 10.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.857 1.218 . . . . 0.0 111.633 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.1 t -81.56 141.31 33.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.77 28.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -141.63 17.89 2.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.707 1.603 . . . . 0.0 110.87 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -43.12 127.08 4.21 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.221 2.208 . . . . 0.0 111.746 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.38 -7.83 58.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 77.62 -98.58 1.42 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 104.302 -3.519 . . . . 0.0 104.302 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.99 159.79 29.89 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.338 1.855 . . . . 0.0 107.425 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -131.56 179.54 5.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.832 2.053 . . . . 0.0 107.31 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.98 -44.09 97.86 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.7 160.58 30.8 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-O 122.177 0.876 . . . . 0.0 111.662 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.8 156.36 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 127.614 2.365 . . . . 0.0 105.342 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -138.42 -41.09 0.51 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.935 0.789 . . . . 0.0 112.911 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -133.65 140.91 47.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.339 -0.85 . . . . 0.0 110.871 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.53 120.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.02 112.66 24.63 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.62 128.28 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.83 97.9 0.65 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.529 1.538 . . . . 0.0 110.355 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -89.85 177.39 6.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 123.075 1.417 . . . . 0.0 111.798 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.25 -165.84 11.55 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 129.731 3.539 . . . . 0.0 106.924 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.8 -46.99 15.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.011 -0.699 . . . . 0.0 111.843 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.77 -31.87 25.7 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.079 1.351 . . . . 0.0 113.017 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.2 25.01 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.33 149.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.926 0.89 . . . . 0.0 109.657 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 p -132.29 -40.59 1.01 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.93 0.892 . . . . 0.0 110.228 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.0 165.07 20.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.746 1.218 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.05 124.61 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.02 90.34 0.68 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.862 0.756 . . . . 0.0 110.76 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -92.93 174.34 7.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.23 0.612 . . . . 0.0 110.505 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.13 140.96 47.46 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.17 168.31 20.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.742 1.617 . . . . 0.0 110.867 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -112.41 155.84 23.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.403 1.081 . . . . 0.0 110.478 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -139.83 115.31 9.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.56 -89.45 0.29 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -147.48 24.28 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.898 1.679 . . . . 0.0 109.773 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -126.17 142.24 51.61 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.35 141.01 40.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.619 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.3 mm -121.88 132.07 71.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.46 135.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.256 1.022 . . . . 0.0 108.749 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.01 -131.34 3.29 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.94 -8.78 61.99 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.373 1.94 . . . . 0.0 113.592 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 125.44 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.789 1.295 . . . . 0.0 107.823 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -136.92 -50.23 0.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.305 0.642 . . . . 0.0 109.495 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.41 -179.44 50.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.869 1.223 . . . . 0.0 113.595 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.28 105.44 4.11 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 126.649 1.979 . . . . 0.0 108.886 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.63 177.51 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.825 1.683 . . . . 0.0 108.008 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -121.77 150.86 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.2 -12.66 42.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.257 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.9 tt -51.85 -34.4 40.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.039 2.536 . . . . 0.0 110.788 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.27 -155.89 15.93 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -143.53 128.34 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.19 151.06 25.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -135.36 152.56 51.55 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.538 0.608 . . . . 0.0 112.428 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -142.24 127.03 18.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.96 115.9 31.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mm -127.67 105.05 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -51.18 117.21 2.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -46.27 -63.66 1.24 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.708 2.003 . . . . 0.0 113.519 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 -32.43 5.42 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.231 1.832 . . . . 0.0 115.822 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 m -77.59 -19.69 55.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.16 170.24 16.22 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.409 1.004 . . . . 0.0 109.889 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -149.78 108.33 3.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.649 1.179 . . . . 0.0 108.072 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.03 108.29 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -31.46 19.9 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.23 25.36 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.176 1.353 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.05 149.81 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.943 1.297 . . . . 0.0 108.239 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -132.37 177.2 7.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 130.042 3.337 . . . . 0.0 106.421 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 151.68 -176.27 30.13 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 120.683 -1.261 . . . . 0.0 110.94 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 p -147.21 155.31 41.98 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.556 1.142 . . . . 0.0 108.231 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.56 165.12 26.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.434 1.494 . . . . 0.0 108.344 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.74 168.04 25.58 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.556 0.693 . . . . 0.0 111.177 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -69.06 149.1 49.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.963 2.105 . . . . 0.0 108.826 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.0 155.36 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.749 1.619 . . . . 0.0 109.394 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.08 88.48 2.74 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 167.48 -25.7 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 15.7 m -132.52 170.67 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.102 0.953 . . . . 0.0 110.419 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -108.82 86.8 2.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.61 -146.19 11.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.661 1.6 . . . . 0.0 109.844 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.97 156.05 47.53 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.4 1.48 . . . . 0.0 108.492 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.9 tt -113.23 149.18 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.29 1.436 . . . . 0.0 109.011 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.0 mm -77.37 137.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -129.63 -35.13 1.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.013 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.5 ttt -126.55 146.65 50.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.044 0.838 . . . . 0.0 110.836 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -140.0 147.83 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.428 1.491 . . . . 0.0 109.301 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -149.21 154.92 39.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -141.72 122.4 14.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -65.15 152.12 44.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.0 p -143.15 154.46 43.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.4 158.99 15.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 67.84 -34.37 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.507 1.923 . . . . 0.0 113.794 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -141.33 174.17 10.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.697 1.999 . . . . 0.0 109.448 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.5 p -114.44 162.71 16.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.085 1.354 . . . . 0.0 110.009 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 3.6 p -98.99 177.56 5.21 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.231 1.413 . . . . 0.0 110.646 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.22 157.28 41.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.372 1.469 . . . . 0.0 109.206 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.19 99.14 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.853 2.369 . . . . 0.0 108.402 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -82.84 92.51 7.28 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 126.24 -164.77 19.69 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.942 1.258 . . . . 0.0 111.051 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.7 tp -118.88 130.09 55.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.186 1.394 . . . . 0.0 109.542 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -70.99 120.71 16.96 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.2 -178.8 7.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.239 1.416 . . . . 0.0 109.392 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 49.34 -103.59 0.08 OUTLIER Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.253 1.882 . . . . 0.0 113.417 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 16.8 m -147.98 145.42 28.54 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.701 1.201 . . . . 0.0 108.692 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.66 26.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -141.34 151.03 43.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.537 1.535 . . . . 0.0 109.557 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.91 155.44 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.335 1.054 . . . . 0.0 110.962 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 42.9 mt -143.4 119.28 10.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.65 1.18 . . . . 0.0 109.354 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -139.31 170.99 14.93 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.237 0.615 . . . . 0.0 111.795 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.93 170.79 15.47 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.927 2.491 . . . . 0.0 107.638 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.7 125.2 47.05 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.71 77.86 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.527 1.061 . . . . 0.0 115.097 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -135.18 175.63 9.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.049 1.424 . . . . 0.0 111.924 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.01 161.94 36.66 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.486 1.514 . . . . 0.0 109.742 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 91.4 mt -74.24 144.02 12.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.9 2.33 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.182 0.993 . . . . 0.0 112.565 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.0 179.03 26.39 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 120.898 -1.126 . . . . 0.0 112.401 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.22 160.52 18.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.661 2.385 . . . . 0.0 108.344 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . 0.562 ' CD2' ' HD1' ' A' ' 293' ' ' HIS . 12.1 p80 -151.67 106.54 3.26 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -160.48 -147.41 4.92 Favored Glycine 0 C--O 1.237 0.29 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.12 126.04 8.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.68 134.58 13.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.164 0.986 . . . . 0.0 109.2 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.7 t -133.9 -68.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -95.51 -32.86 12.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.172 0.989 . . . . 0.0 111.75 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.4 mp -135.9 175.14 9.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 108.895 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.55 99.92 6.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.888 1.275 . . . . 0.0 109.431 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.35 -65.65 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.37 115.85 7.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.688 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.11 160.8 39.12 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.696 0.798 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 161.43 -167.32 36.24 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 12.5 m -152.3 153.5 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.499 1.119 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . 0.562 ' HD1' ' CD2' ' A' ' 280' ' ' HIS . 0.1 OUTLIER -94.19 167.76 11.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.07 143.99 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 66.1 mtp -139.46 140.88 26.85 Favored Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.61 139.51 76.08 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 110.067 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.14 -20.62 66.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 22.1 m -147.27 166.63 26.47 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.767 0 C-N-CA 124.861 1.265 . . . . 0.0 108.168 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 122.235 1.017 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -135.7 154.15 51.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 130.931 3.693 . . . . 0.0 106.178 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -41.84 106.6 0.06 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.067 1.747 . . . . 0.0 111.363 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.22 146.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.67 144.32 14.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.919 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.22 151.28 31.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.89 13.77 17.05 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.739 -0.601 . . . . 0.0 112.175 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.27 102.9 0.21 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 126.508 2.004 . . . . 0.0 112.557 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.93 -19.33 2.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 116.907 1.523 . . . . 0.0 116.907 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.55 -13.93 59.59 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.676 1.59 . . . . 0.0 109.966 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.74 43.19 19.06 Favored Glycine 0 N--CA 1.416 -2.658 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.251 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 -107.5 0.16 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.6 159.23 43.44 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.628 1.171 . . . . 0.0 110.628 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -93.52 129.95 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.574 -1.328 . . . . 0.0 108.481 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -93.25 -13.43 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.479 0.712 . . . . 0.0 109.857 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.01 103.48 0.74 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.044 0.937 . . . . 0.0 110.179 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.71 -54.53 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -17.09 59.79 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.431 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.85 -17.47 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.46 1.63 . . . . 0.0 112.779 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -173.11 131.31 0.49 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.699 2.8 . . . . 0.0 104.325 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -144.11 73.15 1.37 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.86 128.54 6.72 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.648 1.594 . . . . 0.0 109.541 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.26 150.57 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.58 1.152 . . . . 0.0 108.8 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -126.23 -45.38 1.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -143.16 161.88 37.05 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.207 1.403 . . . . 0.0 107.314 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.43 151.17 22.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -131.65 139.83 49.2 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.7 t -150.58 144.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.83 146.47 9.41 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -58.46 146.52 34.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 110.303 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.37 -116.33 2.71 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.99 1.281 . . . . 0.0 110.712 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -87.21 -49.15 7.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.766 0.783 . . . . 0.0 111.941 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -126.42 -26.02 3.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.376 1.071 . . . . 0.0 110.259 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.27 176.35 27.13 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.497 1.523 . . . . 0.0 111.183 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.2 m -58.44 96.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 126.437 1.895 . . . . 0.0 111.612 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 t -87.42 -50.7 6.38 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.295 1.038 . . . . 0.0 111.371 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 p -66.81 119.96 12.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.706 1.139 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.64 158.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 108.064 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -166.5 141.86 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.937 1.295 . . . . 0.0 108.467 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.1 95.92 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.726 1.211 . . . . 0.0 108.37 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.63 130.27 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -100.81 131.98 46.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 109.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -114.87 115.89 27.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.33 34.76 24.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.967 0.907 . . . . 0.0 108.743 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t 72.54 -1.23 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.198 2.199 . . . . 0.0 112.481 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.08 144.56 28.16 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.838 1.199 . . . . 0.0 109.655 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.97 126.51 34.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.76 109.14 14.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -111.62 162.2 15.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.566 1.547 . . . . 0.0 111.954 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.6 57.43 0.09 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.83 -1.6 0.19 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.881 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.514 ' OE2' ' HE2' ' A' ' 57' ' ' LYS . 1.7 tt0 -73.51 112.16 9.33 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.512 1.656 . . . . 0.0 106.816 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -137.18 167.18 22.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.527 1.531 . . . . 0.0 107.286 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.5 -179.01 20.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -82.86 98.08 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.046 -1.267 . . . . 0.0 109.165 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HE2' ' OE2' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -83.53 163.1 20.65 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -132.08 172.76 11.98 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.595 1.158 . . . . 0.0 109.844 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 tp -89.79 -47.28 8.01 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.287 1.035 . . . . 0.0 111.689 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.01 75.21 1.02 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.93 -34.76 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 128.5 33.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.811 1.245 . . . . 0.0 111.125 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -143.69 163.83 32.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.337 1.855 . . . . 0.0 107.563 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.2 m -126.85 146.27 50.34 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.6 1.16 . . . . 0.0 108.654 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -129.04 140.94 51.4 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 126.057 1.743 . . . . 0.0 106.905 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.1 146.94 50.93 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.405 1.082 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.36 157.82 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.97 168.04 13.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.743 1.61 . . . . 0.0 112.087 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.51 -27.15 25.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.478 1.511 . . . . 0.0 110.483 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -121.02 5.96 10.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.924 0.784 . . . . 0.0 112.84 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -116.64 156.17 27.51 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.77 -176.78 4.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.38 136.17 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.9 m -113.89 -36.0 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.734 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.32 160.39 43.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.257 0.935 . . . . 0.0 110.206 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -146.05 110.03 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -80.73 134.46 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -132.43 122.95 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.464 1.106 . . . . 0.0 108.32 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.405 ' OG1' ' HE3' ' A' ' 114' ' ' LYS . 30.4 m -118.31 145.26 45.22 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.965 1.706 . . . . 0.0 106.477 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -149.93 168.11 24.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.536 1.134 . . . . 0.0 111.212 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -161.18 158.82 28.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.333 1.053 . . . . 0.0 108.946 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.86 135.1 24.12 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.489 1.116 . . . . 0.0 108.646 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -72.33 154.19 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.785 0.721 . . . . 0.0 109.975 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -61.67 -14.62 32.82 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.49 -7.89 41.71 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.403 -1.221 . . . . 0.0 113.762 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -135.27 105.53 6.33 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.207 1.503 . . . . 0.0 107.584 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -58.65 -24.61 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.913 1.685 . . . . 0.0 115.18 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 p -72.8 122.31 21.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.932 1.293 . . . . 0.0 109.178 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.93 164.17 16.7 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 126.331 1.853 . . . . 0.0 109.173 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.75 149.9 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.07 -1.019 . . . . 0.0 108.38 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.0 128.1 32.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 p -95.81 -39.19 9.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.994 -1.479 . . . . 0.0 108.268 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 m -160.1 152.34 20.65 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.9 1.682 . . . . 0.0 111.108 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.4 mm -132.95 139.03 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.0 m -130.17 112.58 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -82.03 155.43 25.15 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.959 0.904 . . . . 0.0 109.783 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.75 113.73 7.24 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 106.927 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 p -90.43 170.6 10.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.638 0.654 . . . . 0.0 111.182 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -60.81 -36.25 78.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -6.67 56.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.24 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 15.8 39.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.227 -1.319 . . . . 0.0 111.28 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -71.72 101.76 2.64 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -93.44 140.11 29.95 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 p -92.7 160.95 33.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.02 160.55 49.24 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 N-CA-C 105.41 -2.573 . . . . 0.0 105.41 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.64 89.0 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.753 2.302 . . . . 0.0 107.529 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -58.83 104.23 0.22 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.633 0.773 . . . . 0.0 109.125 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.78 -145.04 16.56 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.4 111.9 12.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.395 1.478 . . . . 0.0 108.154 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -46.81 139.46 5.39 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.227 1.811 . . . . 0.0 113.948 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 178.45 7.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.254 1.422 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.33 -53.17 5.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.035 1.734 . . . . 0.0 114.066 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -65.15 108.08 1.75 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.689 1.131 . . . . 0.0 108.863 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.405 ' HE3' ' OG1' ' A' ' 79' ' ' THR . 6.1 ptmt -152.91 168.76 24.72 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 123.099 0.56 . . . . 0.0 111.318 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.31 166.99 31.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 106.994 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.46 122.06 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -100.42 133.62 44.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.0 167.89 28.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.869 0.868 . . . . 0.0 111.282 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.65 168.07 10.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.694 1.197 . . . . 0.0 107.938 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.38 -27.26 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.365 2.666 . . . . 0.0 109.648 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.79 -5.47 46.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.581 2.752 . . . . 0.0 111.838 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.67 9.98 48.3 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.605 1.098 . . . . 0.0 113.153 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.01 85.98 0.89 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 124.951 1.263 . . . . 0.0 110.569 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -59.65 142.46 52.9 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.45 128.19 35.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.07 -50.54 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.54 -151.22 6.71 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.087 1.327 . . . . 0.0 109.804 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.57 169.22 18.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.165 1.483 . . . . 0.0 113.16 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -138.6 166.41 24.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.602 1.961 . . . . 0.0 106.941 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.14 125.58 2.97 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.7 -178.44 4.39 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.351 -1.088 . . . . 0.0 108.926 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -125.9 158.79 34.26 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.391 2.276 . . . . 0.0 105.993 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -116.56 -83.83 1.04 Allowed Glycine 0 CA--C 1.51 -0.271 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -107.77 -14.21 14.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.573 0.749 . . . . 0.0 110.506 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -155.43 174.2 15.58 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.883 2.473 . . . . 0.0 107.604 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 tp -75.77 131.88 40.09 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.23 0.612 . . . . 0.0 109.48 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -138.45 -55.67 0.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.478 1.911 . . . . 0.0 109.47 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -107.3 108.13 19.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.4 tp -130.78 142.05 50.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.11 -178.18 35.78 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 127.11 2.29 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.04 137.48 15.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.767 1.283 . . . . 0.0 110.38 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -81.42 141.43 33.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.878 1.271 . . . . 0.0 107.835 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -137.04 127.3 26.36 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.8 124.49 13.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.636 0.653 . . . . 0.0 110.565 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 t -133.4 103.44 5.95 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 t -170.5 171.18 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.423 2.289 . . . . 0.0 106.837 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.5 m -140.76 73.81 1.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 p -134.48 163.07 53.82 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.142 1.777 . . . . 0.0 111.797 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.51 -159.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.988 2.459 . . . . 0.0 106.709 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.28 124.84 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 p -74.91 154.15 86.88 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 112.347 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.24 -173.32 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.733 2.955 . . . . 0.0 112.129 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.46 -174.1 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.687 1.995 . . . . 0.0 112.053 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -73.96 107.79 6.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -83.56 119.61 24.93 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.249 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.4 mt -78.41 -94.24 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -155.51 166.1 34.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.921 1.288 . . . . 0.0 109.826 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -147.27 -178.18 6.08 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 130.148 3.379 . . . . 0.0 107.706 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.46 141.86 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.31 1.414 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.12 -105.64 3.22 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.75 64.5 4.15 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.415 1.007 . . . . 0.0 111.172 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' A' ' 288' ' ' HIS . 0.7 OUTLIER -76.01 57.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.224 2.21 . . . . 0.0 114.368 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 53.19 20.53 1.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.549 1.94 . . . . 0.0 114.912 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 168.94 33.0 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.8 m -65.43 116.77 7.07 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.844 1.657 . . . . 0.0 109.264 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.75 154.63 40.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.676 0.79 . . . . 0.0 110.44 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -138.39 120.67 15.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.29 104.95 17.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -107.66 93.06 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.558 1.143 . . . . 0.0 108.198 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.35 162.7 32.44 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.61 155.03 34.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 117.611 0.705 . . . . 0.0 110.393 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -112.99 167.61 10.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.431 1.11 . . . . 0.0 112.057 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 -15.76 57.61 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.189 2.196 . . . . 0.0 110.282 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 165.94 149.51 5.94 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.582 2.039 . . . . 0.0 108.063 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.99 129.56 44.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.44 -53.78 6.56 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -158.81 143.55 15.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.67 0.668 . . . . 0.0 110.086 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.96 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.95 158.01 44.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.983 1.313 . . . . 0.0 107.621 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.0 t -143.57 142.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.13 82.13 0.35 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 124.788 1.185 . . . . 0.0 112.683 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -70.89 177.26 3.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.908 1.283 . . . . 0.0 110.339 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.85 -174.24 20.98 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -63.7 -25.09 68.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -122.71 -21.07 5.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.266 1.427 . . . . 0.0 113.833 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 172.3 -178.78 44.28 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 119.53 1.059 . . . . 0.0 111.723 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.5 mm -59.13 115.84 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.476 1.11 . . . . 0.0 109.676 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.5 m -93.83 -35.67 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.415 0.686 . . . . 0.0 111.923 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.65 166.81 23.81 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.6 150.92 30.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.788 1.635 . . . . 0.0 107.015 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.581 ' HE2' ' CE2' ' A' ' 214' ' ' PHE . 0.1 OUTLIER 179.82 150.59 0.36 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.435 3.494 . . . . 0.0 106.594 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -153.78 152.22 30.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.561 1.073 . . . . 0.0 108.131 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -94.42 132.41 39.09 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -138.24 169.03 18.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.253 1.021 . . . . 0.0 111.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -119.8 139.13 52.81 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.075 1.35 . . . . 0.0 109.533 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -140.2 76.16 1.54 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.69 -128.03 46.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.99 10.39 0.55 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.156 1.382 . . . . 0.0 114.066 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.37 140.69 52.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.447 1.476 . . . . 0.0 109.247 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.07 89.35 2.85 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.9 mm -70.09 109.29 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 108.82 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.0 t -125.44 94.89 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.193 1.797 . . . . 0.0 106.241 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 125.6 176.4 14.52 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.438 1.494 . . . . 0.0 113.64 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.91 75.27 1.0 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.275 1.893 . . . . 0.0 110.281 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 191' ' ' LYS . 2.1 mp0 -63.87 155.92 29.13 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.625 -0.926 . . . . 0.0 112.33 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.6 -80.12 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.64 162.0 50.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -53.56 116.49 9.93 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 113.567 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 144.06 71.67 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.731 1.621 . . . . 0.0 108.339 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.94 135.3 42.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.488 1.115 . . . . 0.0 110.667 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 -11.09 60.55 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.094 0.558 . . . . 0.0 111.525 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.67 -31.28 69.41 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.209 1.404 . . . . 0.0 109.783 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.39 -171.43 14.63 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.581 ' CE2' ' HE2' ' A' ' 191' ' ' LYS . 13.3 m-85 -136.05 158.81 43.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -111.4 148.06 33.86 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.37 144.35 49.54 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.526 0.516 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 256' ' ' SER . 31.5 t80 -142.88 142.96 31.87 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.68 0.792 . . . . 0.0 110.959 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -92.32 124.68 36.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.409 1.484 . . . . 0.0 108.871 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.67 112.07 29.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.175 0.99 . . . . 0.0 108.749 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.06 88.48 7.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -62.63 -29.55 4.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 115.778 -2.058 . . . . 0.0 113.644 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.12 -45.01 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 123.902 2.429 . . . . 0.0 110.88 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 m -67.03 -54.0 25.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.997 1.319 . . . . 0.0 111.865 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.71 -167.66 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.599 1.96 . . . . 0.0 110.631 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -164.11 142.14 7.18 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.508 1.123 . . . . 0.0 108.976 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.7 mm -93.48 104.18 15.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.3 p -72.92 -59.76 2.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.096 0.959 . . . . 0.0 110.33 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.41 171.72 13.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.647 1.979 . . . . 0.0 111.529 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.78 148.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.39 1.876 . . . . 0.0 106.865 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -133.59 160.85 36.27 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.497 1.119 . . . . 0.0 109.997 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.78 167.37 37.69 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.671 1.129 . . . . 0.0 110.998 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.5 p -133.39 127.19 32.91 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -119.76 146.19 45.88 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -142.61 166.91 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -76.94 136.3 38.79 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.758 1.223 . . . . 0.0 112.824 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.66 156.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 127.426 2.29 . . . . 0.0 108.252 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -103.5 163.75 12.09 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.78 1.232 . . . . 0.0 111.16 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.11 -15.94 56.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.246 1.403 . . . . 0.0 110.347 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.7 t -141.45 -174.38 4.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 128.248 2.619 . . . . 0.0 106.618 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.92 101.82 5.79 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.557 1.943 . . . . 0.0 106.856 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 174.32 -173.37 45.98 Favored Glycine 0 N--CA 1.447 -0.622 0 O-C-N 123.645 0.591 . . . . 0.0 112.451 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.82 141.37 52.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.083 1.353 . . . . 0.0 109.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 10.3 tt -123.72 134.17 67.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.6 1.16 . . . . 0.0 108.773 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.06 98.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -76.0 -26.5 56.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.023 0.529 . . . . 0.0 111.766 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -140.99 152.37 44.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.083 0.856 . . . . 0.0 110.815 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.4 154.65 51.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.468 1.907 . . . . 0.0 109.965 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -145.05 152.52 40.24 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.992 2.117 . . . . 0.0 105.688 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -118.07 142.53 47.31 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -95.61 115.42 27.4 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.2 p -130.49 166.49 20.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.391 1.476 . . . . 0.0 108.776 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 254' ' ' GLN . 1.1 p30 -123.54 160.09 27.75 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.993 1.717 . . . . 0.0 106.552 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 69.35 -27.6 0.16 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.114 2.566 . . . . 0.0 112.191 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 252' ' ' ASN . 16.8 pt20 -150.88 174.83 12.65 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.23 2.212 . . . . 0.0 110.229 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.77 161.02 32.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.579 1.952 . . . . 0.0 106.914 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.404 ' HB3' ' CE2' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -115.29 -10.99 12.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 73.15 162.66 0.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 126.908 2.083 . . . . 0.0 109.522 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.28 149.0 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.438 2.092 . . . . 0.0 110.551 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.17 95.72 4.86 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 125.43 -176.99 17.15 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.275 1.416 . . . . 0.0 110.789 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.6 tp -88.18 126.83 35.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.353 1.061 . . . . 0.0 110.165 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -73.12 107.17 5.31 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -160.22 154.79 23.91 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 107.987 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 88.1 -174.82 44.27 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.9 m -77.33 138.47 39.36 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -92.14 142.81 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.317 0.508 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -138.74 147.88 43.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.767 0.827 . . . . 0.0 111.344 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.31 144.29 34.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.23 1.412 . . . . 0.0 109.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 mt -134.22 137.3 44.27 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -150.04 178.27 9.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.174 1.789 . . . . 0.0 108.905 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 164.83 29.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.22 1.01 . . . . 0.0 108.566 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -69.84 5.37 1.55 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.302 1.841 . . . . 0.0 114.354 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 166.45 -34.69 0.23 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.389 -1.444 . . . . 0.0 113.324 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -57.01 149.98 17.88 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.768 0.784 . . . . 0.0 109.331 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 157.47 16.85 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.623 -0.673 . . . . 0.0 110.041 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.6 mt -95.91 104.2 15.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.45 38.81 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.989 1.316 . . . . 0.0 108.548 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.44 168.03 36.57 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 121.166 -0.959 . . . . 0.0 114.477 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.11 171.23 14.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.335 3.054 . . . . 0.0 109.946 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -159.48 146.64 16.87 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.812 1.245 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -179.55 -163.64 30.68 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 121.217 -0.927 . . . . 0.0 113.423 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -146.68 138.97 24.88 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.822 1.649 . . . . 0.0 107.765 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -131.86 154.39 49.23 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.184 1.793 . . . . 0.0 110.055 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.3 m -166.39 -46.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.951 1.3 . . . . 0.0 108.691 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.13 -17.63 1.36 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -171.4 2.01 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.496 1.919 . . . . 0.0 106.617 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 13.3 tp -83.21 85.58 7.18 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 162' ' ' ASP . 87.6 m-70 -60.44 -34.79 74.49 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.264 0.483 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -161.47 163.33 30.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.642 0.734 . . . . 0.0 110.245 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -159.52 135.45 8.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -143.13 -157.71 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 128.538 2.97 . . . . 0.0 108.715 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.73 171.59 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.281 1.039 . . . . 0.0 112.139 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.76 150.16 51.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.874 2.869 . . . . 0.0 105.354 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.25 137.79 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.324 0.65 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 16.2 mmt -125.38 148.24 60.47 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.431 1.492 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 152.62 37.22 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.631 1.554 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.4 mp -68.44 159.81 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 6.4 m -158.69 146.36 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 13.8 t30 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 123.824 0.85 . . . . 0.0 109.336 -179.543 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -130.07 97.73 4.54 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.78 1.632 . . . . 0.0 112.727 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -81.15 130.54 35.07 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 102.633 -3.099 . . . . 0.0 102.633 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.51 103.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.687 0.795 . . . . 0.0 110.02 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -55.85 142.7 34.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.49 1.116 . . . . 0.0 110.987 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.63 179.97 1.95 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.857 1.263 . . . . 0.0 110.161 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 143.81 14.48 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.77 -134.13 5.48 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.98 -148.97 18.66 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 118.0 0.9 . . . . 0.0 111.816 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.11 8.32 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.389 1.076 . . . . 0.0 112.168 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.93 -11.51 18.1 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.089 1.595 . . . . 0.0 117.089 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.45 169.21 12.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.648 2.224 . . . . 0.0 113.766 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.55 151.7 32.32 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 97.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.923 0.783 . . . . 0.0 112.736 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -103.56 55.05 0.74 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.11 18.61 19.82 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.198 1.399 . . . . 0.0 111.981 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -151.64 119.31 6.1 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.665 0.786 . . . . 0.0 110.602 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.12 26.7 50.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.865 1.697 . . . . 0.0 115.352 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.23 -37.17 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 119.574 1.687 . . . . 0.0 114.045 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -148.03 162.58 39.08 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.398 1.079 . . . . 0.0 110.375 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -107.35 -34.12 7.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.956 2.502 . . . . 0.0 111.806 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.98 83.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 m -63.2 158.64 3.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 117.853 0.827 . . . . 0.0 109.207 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -136.09 -35.7 0.76 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -147.14 157.51 43.63 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 107.691 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.0 105.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -88.02 140.61 29.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.82 143.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.9 152.54 21.5 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.813 0.733 . . . . 0.0 111.335 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -70.2 120.04 15.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.216 1.406 . . . . 0.0 112.611 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.68 -122.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 130.575 3.94 . . . . 0.0 107.876 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -95.23 -48.35 5.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 118.163 0.982 . . . . 0.0 112.256 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 -26.88 12.14 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 129.109 2.963 . . . . 0.0 114.676 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.42 -158.05 16.7 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 118.897 0.771 . . . . 0.0 111.381 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 m -72.7 96.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.61 1.205 . . . . 0.0 108.846 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -106.63 -45.09 4.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -71.02 148.31 47.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.291 1.405 . . . . 0.0 112.117 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.9 159.68 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.431 1.892 . . . . 0.0 108.091 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.05 152.35 46.15 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.882 2.473 . . . . 0.0 107.458 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.52 132.06 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.658 0.783 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.6 142.96 42.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -132.76 141.38 48.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.347 0.659 . . . . 0.0 109.362 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.25 120.41 40.35 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.086 1.354 . . . . 0.0 108.751 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -113.46 161.99 16.66 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.9 -41.92 92.71 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.2 t -68.81 -69.39 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.491 -1.243 . . . . 0.0 110.574 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -145.31 165.84 27.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 120.239 1.381 . . . . 0.0 113.677 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.49 149.55 33.13 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.777 2.031 . . . . 0.0 105.804 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -147.71 145.73 18.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 122.754 1.264 . . . . 0.0 109.277 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -105.97 162.13 13.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.375 1.47 . . . . 0.0 108.688 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.63 -15.08 2.02 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 0.0 112.09 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.78 167.03 36.22 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 118.7 1.25 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -103.62 106.39 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.32 82.23 2.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.85 -174.61 31.95 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 128.7 3.048 . . . . 0.0 105.676 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -126.78 141.05 51.94 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.286 1.043 . . . . 0.0 111.908 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -130.56 148.84 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.397 2.279 . . . . 0.0 105.149 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.5 m -133.85 -48.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.2 tp -70.05 -9.99 57.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.149 0.886 . . . . 0.0 110.494 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt 66.33 11.48 7.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.209 2.203 . . . . 0.0 112.175 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.34 86.33 1.36 Allowed Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.975 -2.45 . . . . 0.0 106.975 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -131.46 144.68 51.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.505 1.922 . . . . 0.0 108.555 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -142.78 164.69 29.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.041 1.736 . . . . 0.0 110.465 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -124.88 121.22 33.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.356 1.062 . . . . 0.0 113.55 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -87.35 141.83 28.34 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.95 141.21 50.89 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.518 1.127 . . . . 0.0 109.69 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.64 117.44 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.507 1.123 . . . . 0.0 111.538 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -62.1 156.56 21.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.781 1.633 . . . . 0.0 108.591 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.33 68.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.87 25.33 10.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.37 143.06 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.19 1.396 . . . . 0.0 111.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.94 139.74 46.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.356 2.663 . . . . 0.0 110.593 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.19 134.19 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.711 1.604 . . . . 0.0 112.332 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.0 -34.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.948 -1.095 . . . . 0.0 112.1 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.63 144.35 28.34 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.432 1.015 . . . . 0.0 108.64 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.57 92.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -79.34 120.91 24.45 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.77 132.61 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 t -110.55 153.72 24.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.979 1.711 . . . . 0.0 109.227 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -154.12 147.33 24.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.841 1.656 . . . . 0.0 109.392 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.2 169.33 22.46 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.821 0.737 . . . . 0.0 111.155 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.07 136.16 34.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.967 1.307 . . . . 0.0 109.756 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.22 130.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -61.78 114.84 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.3 41.99 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.113 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -130.49 161.47 31.38 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.192 1.496 . . . . 0.0 109.754 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -96.35 -26.48 15.35 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.768 1.227 . . . . 0.0 110.062 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 p -72.59 166.86 21.9 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.48 1.133 . . . . 0.0 109.022 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.52 135.21 42.2 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.46 166.89 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.354 1.062 . . . . 0.0 112.647 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.63 144.03 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.077 1.751 . . . . 0.0 107.445 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -108.61 -29.05 8.94 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.085 0.954 . . . . 0.0 110.849 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -166.36 164.09 17.46 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.948 1.699 . . . . 0.0 108.933 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.1 tt -157.12 154.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.999 1.319 . . . . 0.0 110.73 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 m -150.84 157.28 42.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.478 1.511 . . . . 0.0 107.235 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.86 135.33 48.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -121.33 114.05 20.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 p -81.07 161.19 24.27 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -31.12 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -58.8 -43.07 90.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 111.345 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.97 -7.4 3.8 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.814 0.721 . . . . 0.0 114.383 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.19 132.4 36.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -133.7 156.37 48.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 p -121.24 162.34 36.21 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 111.386 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.28 167.06 23.65 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.885 2.39 . . . . 0.0 110.483 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.12 112.65 3.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.663 2.909 . . . . 0.0 106.618 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -79.19 81.52 5.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.69 -138.13 9.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.372 0.987 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -129.9 121.36 26.5 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.514 1.526 . . . . 0.0 108.334 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.53 156.11 17.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.05 0.54 . . . . 0.0 110.485 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -152.7 -174.5 4.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.692 1.234 . . . . 0.0 112.683 -178.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.401 ' H ' HG22 ' A' ' 111' ' ' THR . 14.1 tt0 -67.47 -64.72 0.8 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 127.219 2.208 . . . . 0.0 112.257 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -70.98 101.83 2.27 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.432 1.493 . . . . 0.0 108.633 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -147.8 153.48 39.24 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.657 -0.652 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -125.52 158.94 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.686 1.594 . . . . 0.0 109.857 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.9 t -140.46 104.67 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 139.45 53.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.69 150.69 1.76 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.944 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -120.97 176.2 5.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.559 1.144 . . . . 0.0 110.49 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -65.27 175.8 1.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.153 2.181 . . . . 0.0 108.092 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -68.38 2.43 2.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.315 1.446 . . . . 0.0 111.743 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.45 3.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.08 2.276 . . . . 0.0 111.159 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.52 165.49 31.46 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 118.248 1.024 . . . . 0.0 111.059 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -161.9 164.69 28.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.62 1.968 . . . . 0.0 107.569 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.3 158.77 11.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.965 0.888 . . . . 0.0 110.991 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.87 -25.29 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.509 2.724 . . . . 0.0 110.722 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.38 -176.27 40.31 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.08 170.59 9.39 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.62 0.724 . . . . 0.0 109.236 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -156.41 170.13 23.01 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 126.825 2.05 . . . . 0.0 107.181 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.67 -146.42 14.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -159.47 135.68 8.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.734 2.414 . . . . 0.0 106.009 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.52 164.86 38.05 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.097 2.559 . . . . 0.0 105.298 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.36 -111.91 0.26 Allowed Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 106.616 -2.594 . . . . 0.0 106.616 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -65.06 -17.83 64.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.46 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.9 175.47 12.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.749 2.02 . . . . 0.0 108.524 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.1 tp -84.8 121.48 27.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.281 1.832 . . . . 0.0 107.341 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -117.16 -31.25 5.4 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -168.74 161.72 11.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.845 1.657 . . . . 0.0 110.353 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 tt -157.68 149.14 21.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.85 168.17 37.57 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.85 134.53 35.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.43 169.23 10.21 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.272 1.429 . . . . 0.0 109.563 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -131.17 112.11 12.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.16 138.96 42.5 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -135.55 102.8 5.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 t -160.95 155.77 23.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.866 1.267 . . . . 0.0 108.858 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.2 m -139.28 -98.14 0.16 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 22.1 p -144.52 157.14 56.33 Favored Pre-proline 0 C--N 1.318 -0.789 0 C-N-CA 125.849 1.66 . . . . 0.0 111.602 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.52 154.17 72.22 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.33 134.3 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 153' ' ' ALA . 2.3 p -113.54 140.54 24.66 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.173 0.442 . . . . 0.0 110.037 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.64 4.21 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.543 2.829 . . . . 0.0 116.668 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 151' ' ' THR . . . -118.39 150.97 38.65 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.959 3.304 . . . . 0.0 110.933 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.12 125.28 29.62 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -111.28 146.79 36.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.778 0.717 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.78 170.84 13.73 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.5 t -87.78 118.86 27.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.271 1.028 . . . . 0.0 110.757 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.62 170.0 12.97 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.199 0.999 . . . . 0.0 111.422 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.9 mt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 129.898 3.279 . . . . 0.0 105.256 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.56 -96.05 0.16 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.593 1.088 . . . . 0.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.77 153.61 24.37 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.08 8.79 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.965 1.306 . . . . 0.0 114.192 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -122.29 106.33 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 120.965 -1.084 . . . . 0.0 110.938 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 172.43 158.11 15.86 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.1 m -66.51 119.1 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.146 0.978 . . . . 0.0 108.43 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.57 130.94 41.11 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -123.17 125.91 46.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.61 153.83 17.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.127 0.971 . . . . 0.0 110.745 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.01 135.14 19.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.48 169.74 22.71 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.48 146.62 50.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -114.75 151.37 33.86 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.97 -15.08 54.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.12 2.568 . . . . 0.0 112.179 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 177.13 177.5 46.1 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 123.793 0.711 . . . . 0.0 111.91 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.88 156.46 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.543 1.937 . . . . 0.0 107.046 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -138.38 -54.1 0.62 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.862 0.865 . . . . 0.0 109.118 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -151.23 142.46 23.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.12 0.873 . . . . 0.0 111.57 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.71 132.75 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -136.33 108.49 7.24 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.34 131.79 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.44 67.27 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.164 1.364 . . . . 0.0 111.562 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 182' ' ' GLN . 2.8 pm0 -70.01 160.94 31.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.182 1.393 . . . . 0.0 109.376 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.01 177.85 35.41 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -51.6 -45.63 63.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.788 0.835 . . . . 0.0 112.721 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.17 -3.09 58.89 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.323 1.049 . . . . 0.0 113.511 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 123.5 -176.31 16.72 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.982 0.81 . . . . 0.0 113.662 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.0 mm -63.26 112.38 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 m -109.29 -30.91 7.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.256 0.622 . . . . 0.0 110.242 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.701 1.201 . . . . 0.0 108.891 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.88 137.0 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 107.283 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.17 155.68 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.27 131.17 27.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.1 140.67 29.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -153.19 169.55 22.72 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.964 1.306 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -127.76 127.08 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -139.95 138.53 35.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.19 31.37 49.34 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.65 -14.18 0.51 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.417 2.687 . . . . 0.0 112.794 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.44 136.19 49.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.829 1.252 . . . . 0.0 110.424 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -89.5 80.07 6.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 109.697 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.65 144.89 14.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.405 1.882 . . . . 0.0 109.694 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.06 129.04 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.71 143.3 18.71 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.48 1.038 . . . . 0.0 112.462 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.63 160.35 52.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -92.54 83.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -62.08 -25.57 67.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.211 1.805 . . . . 0.0 112.003 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.41 176.42 25.34 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.088 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.62 138.33 80.46 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.5 179.59 2.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.408 2.738 . . . . 0.0 110.408 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 70.1 p -135.61 172.69 12.65 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 109.96 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.69 -26.01 28.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.755 0.822 . . . . 0.0 110.576 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.3 tt -63.65 -21.67 66.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.298 1.839 . . . . 0.0 112.461 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.21 171.33 46.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.59 151.3 21.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.23 0.612 . . . . 0.0 112.309 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -111.93 133.75 53.93 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.41 146.78 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -142.47 143.53 32.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.666 1.187 . . . . 0.0 109.222 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -112.33 130.12 56.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.26 107.82 17.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 125.726 1.61 . . . . 0.0 107.452 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 93.95 2.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -56.5 -34.91 29.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.94 -26.88 10.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 123.964 2.451 . . . . 0.0 113.264 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.4 m -106.91 -0.78 22.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.665 1.575 . . . . 0.0 114.798 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.8 156.8 42.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 120.337 1.426 . . . . 0.0 108.425 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.61 161.55 34.34 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.861 -1.149 . . . . 0.0 112.073 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.2 mm -92.7 97.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.2 m -64.4 -40.27 95.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.86 15.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.618 1.167 . . . . 0.0 109.368 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.16 144.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.02 173.13 11.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 155.03 -170.82 33.26 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.451 ' HG1' ' HB3' ' A' ' 246' ' ' MET . 25.8 p -144.8 154.94 43.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -131.55 145.91 51.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -121.88 145.5 48.03 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.878 0.846 . . . . 0.0 111.368 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -70.35 148.26 48.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.876 1.27 . . . . 0.0 109.486 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.5 pt -114.53 155.75 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 127.269 2.228 . . . . 0.0 106.724 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -103.59 150.33 24.06 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.86 0.362 . . . . 0.0 111.107 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.62 -3.34 87.29 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.657 1.599 . . . . 0.0 111.47 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.8 p -142.23 170.73 15.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.606 2.763 . . . . 0.0 107.742 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -108.04 8.5 28.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.672 1.189 . . . . 0.0 110.715 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -80.97 -172.04 45.57 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 122.746 1.192 . . . . 0.0 113.545 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.6 mt -137.78 157.45 46.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.895 2.478 . . . . 0.0 108.6 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.53 135.41 63.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.9 mm -94.41 77.11 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -83.1 -12.59 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.075 -0.391 . . . . 0.0 112.037 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.451 ' HB3' ' HG1' ' A' ' 232' ' ' THR . 0.1 OUTLIER -137.47 134.64 36.02 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 121.796 -0.565 . . . . 0.0 112.451 -179.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.78 152.35 46.51 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.516 1.126 . . . . 0.0 109.51 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -141.32 161.61 37.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.528 1.931 . . . . 0.0 108.352 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -131.03 121.45 25.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.996 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -80.08 115.28 19.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 15.4 p -125.17 165.03 18.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.066 1.746 . . . . 0.0 108.154 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.25 160.97 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? 63.31 -26.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.511 1.925 . . . . 0.0 115.636 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -132.25 124.4 28.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 108.216 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.0 m -78.19 113.14 15.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.695 1.598 . . . . 0.0 107.735 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.1 p -84.37 162.86 19.87 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.271 0.557 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.79 152.19 42.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.144 1.778 . . . . 0.0 108.334 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.07 130.97 13.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.251 1.968 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -102.38 92.26 4.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.68 169.3 14.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.48 1.514 . . . . 0.0 110.724 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.0 mt -95.26 146.62 24.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.93 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.39 124.34 25.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.83 106.34 4.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 89.75 -164.95 31.78 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 122.978 1.321 . . . . 0.0 115.23 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 43.2 m -64.26 132.81 51.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.466 . . . . 0.0 109.992 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -85.67 145.64 27.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -126.93 137.2 53.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.795 0.807 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -124.29 140.76 52.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 72.7 mt -144.86 114.92 7.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -143.6 172.43 12.81 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.541 1.136 . . . . 0.0 110.009 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -144.41 153.85 42.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -101.74 140.09 36.5 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.358 1.063 . . . . 0.0 109.004 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.55 21.37 79.56 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -143.47 166.65 24.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.601 1.56 . . . . 0.0 109.251 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 298' ' ' THR . 34.0 pttt -129.92 174.21 9.97 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.982 2.113 . . . . 0.0 106.754 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 26.8 mt -109.01 154.31 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.24 24.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.416 1.086 . . . . 0.0 113.322 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.54 -155.05 23.95 Favored Glycine 0 N--CA 1.465 0.632 0 O-C-N 120.429 -1.419 . . . . 0.0 111.693 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 174.1 10.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.297 1.839 . . . . 0.0 111.159 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -155.66 163.27 40.13 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.715 2.406 . . . . 0.0 107.974 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.64 -169.99 36.48 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 120.78 1.627 . . . . 0.0 114.78 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 130.33 18.54 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.975 1.31 . . . . 0.0 108.488 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.95 154.49 17.68 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.303 1.841 . . . . 0.0 108.355 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.0 t -125.65 -52.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.738 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.17 -31.05 5.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.245 1.418 . . . . 0.0 113.304 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 46.3 mt -138.87 159.16 42.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.88 92.92 1.29 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.782 -0.573 . . . . 0.0 111.491 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -76.56 -78.33 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -101.0 148.61 24.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.906 1.23 . . . . 0.0 113.025 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -141.18 128.03 20.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.236 1.414 . . . . 0.0 107.216 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -144.14 176.1 23.59 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.07 176.06 5.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.251 1.02 . . . . 0.0 110.6 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -122.03 150.49 42.03 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.345 1.858 . . . . 0.0 107.172 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.06 139.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 44.2 mtt -139.77 147.27 50.84 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.49 68.98 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.132 3.221 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.1 mt 65.66 -8.56 0.29 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.478 2.711 . . . . 0.0 113.601 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.463 ' O ' ' HE2' ' A' ' 275' ' ' LYS . 4.0 p -80.94 -173.88 4.51 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.068 2.547 . . . . 0.0 110.881 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--O 1.246 0.894 0 C-N-CA 126.509 1.924 . . . . 0.0 108.868 -179.772 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -70.22 90.0 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.838 0.827 . . . . 0.0 109.213 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -144.93 138.91 27.22 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.732 2.013 . . . . 0.0 106.196 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.25 146.28 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -106.89 168.12 9.41 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.27 -70.88 0.24 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.993 1.317 . . . . 0.0 111.629 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 51.87 66.05 2.82 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.275 1.417 . . . . 0.0 114.911 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.39 21.75 2.57 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 118.056 0.928 . . . . 0.0 113.767 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.26 171.04 19.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 127.05 2.262 . . . . 0.0 109.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.44 -0.25 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.414 1.086 . . . . 0.0 113.245 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.58 178.54 38.22 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 -175.46 27.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.136 0.874 . . . . 0.0 113.057 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.67 144.42 43.95 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.584 1.153 . . . . 0.0 108.113 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 p -65.74 95.49 0.24 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.711 1.205 . . . . 0.0 112.265 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -97.2 -79.28 0.46 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 63.63 19.77 11.88 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.55 1.14 . . . . 0.0 110.911 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.08 141.44 58.77 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.745 1.618 . . . . 0.0 109.174 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.02 106.38 0.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.9 t -134.72 95.5 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.667 1.234 . . . . 0.0 108.231 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.9 p80 30.3 47.21 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.74 2.816 . . . . 0.0 117.303 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -108.34 -38.83 5.62 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.5 165.58 33.06 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.168 1.366 . . . . 0.0 111.211 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.98 144.7 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.385 -1.068 . . . . 0.0 111.986 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -46.8 5.07 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.203 1.801 . . . . 0.0 112.881 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -138.02 163.73 30.83 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.12 144.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -136.35 141.53 43.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.93 142.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.24 114.94 1.64 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -66.44 141.84 57.78 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.39 -171.76 14.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -72.31 -48.19 44.06 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.561 0.744 . . . . 0.0 111.679 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.47 -10.51 34.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.131 1.772 . . . . 0.0 114.001 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.6 32.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.25 139.3 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -133.94 10.57 3.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -161.21 147.0 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.281 0.946 . . . . 0.0 111.673 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 155.4 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.042 1.737 . . . . 0.0 108.813 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.19 135.43 11.16 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 161.02 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.564 1.945 . . . . 0.0 111.13 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.2 t -121.87 139.95 47.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -107.94 170.41 8.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.872 0.76 . . . . 0.0 109.652 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.66 51.91 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.834 0.854 . . . . 0.0 109.978 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -116.96 166.34 12.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.498 1.119 . . . . 0.0 108.522 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.13 -3.2 15.6 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.07 -1.019 . . . . 0.0 109.746 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -108.86 -83.86 0.55 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.311 3.044 . . . . 0.0 110.641 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -133.89 159.24 41.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.975 1.71 . . . . 0.0 110.372 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.05 145.12 34.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.47 1.508 . . . . 0.0 110.295 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -144.86 146.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.044 0.938 . . . . 0.0 110.352 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.78 151.65 33.42 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.634 1.974 . . . . 0.0 109.302 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.92 -67.73 0.92 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.712 1.625 . . . . 0.0 109.905 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.7 174.88 27.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.179 1.371 . . . . 0.0 112.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.87 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.083 0.942 . . . . 0.0 109.761 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -125.04 133.11 53.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.47 -153.08 21.17 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.301 -2.72 . . . . 0.0 106.301 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -128.2 114.62 17.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.103 0.951 . . . . 0.0 112.97 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.17 134.66 49.55 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -81.28 155.62 25.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.368 1.067 . . . . 0.0 108.954 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.16 -32.8 74.67 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.575 -0.703 . . . . 0.0 111.161 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.32 26.93 7.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 110.701 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.86 96.2 0.17 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -163.05 146.05 10.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 128.954 2.902 . . . . 0.0 104.823 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -142.29 164.84 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.403 1.481 . . . . 0.0 108.856 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -144.48 103.11 3.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -108.11 140.87 40.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.056 1.743 . . . . 0.0 106.993 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.69 143.5 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 111.007 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.9 t -95.93 111.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 156.01 38.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 109.406 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.75 -27.16 61.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.172 -0.955 . . . . 0.0 111.67 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.94 13.56 27.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.555 1.942 . . . . 0.0 113.511 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.25 136.58 35.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.972 0.806 . . . . 0.0 110.332 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CG ' ' HE2' ' A' ' 124' ' ' LYS . 12.0 m-85 -128.66 162.24 27.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.689 0.796 . . . . 0.0 110.424 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mt -75.3 150.43 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -30.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.821 1.648 . . . . 0.0 109.146 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 157.44 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.164 0.893 . . . . 0.0 108.99 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 t -139.35 139.57 38.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -128.2 116.81 20.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.54 134.64 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.8 p -113.98 157.22 22.74 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -151.03 158.69 44.43 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.429 -0.794 . . . . 0.0 109.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -160.39 168.72 24.59 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.864 1.265 . . . . 0.0 108.67 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 94.36 3.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.3 138.22 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.837 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -61.25 114.3 3.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.05 -5.22 5.7 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.852 1.215 . . . . 0.0 111.935 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -134.5 158.14 44.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.161 1.384 . . . . 0.0 107.785 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.44 22.11 15.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.342 1.857 . . . . 0.0 108.759 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 p -137.95 129.24 27.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.937 -1.102 . . . . 0.0 112.578 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.17 148.76 50.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.324 2.25 . . . . 0.0 105.131 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.93 158.46 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.1 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.3 mm -83.22 103.24 10.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.587 0.755 . . . . 0.0 109.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -66.89 -41.04 87.87 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.466 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 p -156.68 165.77 35.3 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.541 1.519 . . . . 0.0 111.75 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 151.69 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.043 0.537 . . . . 0.0 111.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.7 m -149.44 154.17 38.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 0.0 108.687 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -125.04 154.59 41.08 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.738 2.015 . . . . 0.0 107.383 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -132.22 118.24 19.27 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.9 p -99.01 159.87 14.66 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.666 0.746 . . . . 0.0 112.896 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.87 -32.74 73.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.349 1.859 . . . . 0.0 113.357 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -11.37 58.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.008 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.03 49.81 3.22 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -127.69 139.69 52.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.4 p -134.76 147.53 50.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.662 0.385 . . . . 0.0 110.522 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 161.02 32.21 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 123.419 0.687 . . . . 0.0 110.673 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.33 166.6 24.15 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 122.269 1.979 . . . . 0.0 108.516 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.75 106.18 1.79 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.42 2.08 . . . . 0.0 107.502 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -75.47 85.99 2.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.1 -137.18 8.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.801 1.191 . . . . 0.0 110.379 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 tp -112.55 125.43 54.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.461 1.505 . . . . 0.0 108.985 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -64.34 143.12 58.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 m -146.07 147.34 31.49 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -52.72 -49.52 65.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.922 2.089 . . . . 0.0 110.216 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -68.3 108.25 3.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.862 1.665 . . . . 0.0 107.259 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -152.1 160.08 43.51 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.505 1.122 . . . . 0.0 108.983 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -143.08 167.72 21.43 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.449 0.7 . . . . 0.0 112.042 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.25 143.08 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.268 1.427 . . . . 0.0 107.837 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -137.85 1.95 2.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 145.01 41.99 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.824 0.85 . . . . 0.0 113.169 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.49 149.81 34.95 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.95 -35.65 64.47 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.834 -1.166 . . . . 0.0 111.866 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -69.48 -22.52 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.311 1.044 . . . . 0.0 112.508 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.67 -68.92 0.42 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.39 79.26 1.44 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 124.814 1.197 . . . . 0.0 112.348 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.449 ' HE2' ' CG ' ' A' ' 72' ' ' TYR . 39.5 ttmt -63.87 127.79 32.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 tp -77.7 88.77 3.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.69 -49.58 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.32 -174.14 21.88 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -152.56 -178.03 6.6 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.757 1.223 . . . . 0.0 108.545 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.97 148.81 30.21 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.25 110.59 0.37 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.22 54.38 1.65 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.756 1.623 . . . . 0.0 108.712 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.69 120.11 26.76 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -97.61 -108.72 2.67 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.48 -29.08 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.721 1.208 . . . . 0.0 112.353 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 169.02 20.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.115 1.766 . . . . 0.0 109.138 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.71 101.06 12.94 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.73 -71.52 0.57 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -107.18 150.08 27.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.865 0.866 . . . . 0.0 110.777 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -141.57 110.65 6.26 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 125.392 1.477 . . . . 0.0 108.786 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.32 170.65 14.73 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.96 165.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.13 0.572 . . . . 0.0 111.015 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -123.13 131.07 53.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.64 99.81 6.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.796 2.039 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.38 103.54 3.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -134.95 102.79 5.34 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.442 1.019 . . . . 0.0 113.505 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.6 p -157.07 143.55 18.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.119 1.767 . . . . 0.0 107.536 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.2 m -133.07 13.53 4.27 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.171 1.788 . . . . 0.0 109.98 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.454 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 12.5 p -134.69 161.42 63.79 Favored Pre-proline 0 C--O 1.241 0.638 0 O-C-N 120.546 -1.346 . . . . 0.0 107.922 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.37 151.37 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 105.973 -2.357 . . . . 0.0 105.973 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.83 124.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.3 p -128.69 156.72 77.04 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.872 1.269 . . . . 0.0 110.193 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.99 -6.05 13.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.085 1.857 . . . . 0.0 116.509 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.13 156.68 29.34 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 129.408 3.083 . . . . 0.0 109.363 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -101.33 136.59 40.93 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.089 0.555 . . . . 0.0 112.463 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.454 ' HE3' ' HB ' ' A' ' 148' ' ' THR . 6.2 pttt -114.45 146.92 40.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.804 1.642 . . . . 0.0 108.607 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.8 mt -116.35 171.38 7.87 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.319 1.848 . . . . 0.0 106.86 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 m -75.24 170.64 15.65 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.207 -0.933 . . . . 0.0 108.872 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.14 165.82 26.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.271 1.029 . . . . 0.0 108.643 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.6 mt -117.4 151.06 19.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.62 -67.22 0.45 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.341 -0.7 . . . . 0.0 111.357 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.39 -160.61 30.19 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.888 1.232 . . . . 0.0 110.106 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -140.6 27.78 2.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.225 1.41 . . . . 0.0 111.184 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -125.5 141.62 51.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.19 1.796 . . . . 0.0 108.647 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.71 167.1 12.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.817 2.151 . . . . 0.0 111.154 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 97.4 m -71.97 122.7 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.144 0.978 . . . . 0.0 111.484 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.11 117.23 20.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -131.54 35.87 3.8 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.227 0.611 . . . . 0.0 111.33 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.44 145.07 0.64 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.124 1.369 . . . . 0.0 114.363 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.62 111.41 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.096 2.558 . . . . 0.0 108.79 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.77 168.56 46.52 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.06 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.15 120.18 12.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -100.85 -172.16 2.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.588 0.755 . . . . 0.0 109.72 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' A' ' 196' ' ' LYS . 1.0 OUTLIER -68.6 -4.95 17.25 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.588 0.755 . . . . 0.0 111.341 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 142.78 161.11 8.65 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.822 2.153 . . . . 0.0 110.829 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.45 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.361 1.864 . . . . 0.0 108.68 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -131.54 -70.77 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -133.29 153.42 51.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.434 0.561 . . . . 0.0 112.461 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.29 141.18 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.738 2.015 . . . . 0.0 106.18 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.88 128.04 44.48 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.68 116.25 51.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.89 95.52 1.82 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -60.86 169.91 1.72 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.67 -174.11 13.81 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.33 -23.02 61.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.59 -0.805 . . . . 0.0 111.456 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -131.34 -19.28 2.79 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 179.18 -172.74 44.85 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 126.973 2.225 . . . . 0.0 107.689 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.94 124.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 120.101 1.95 . . . . 0.0 111.824 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.7 m -118.57 -20.42 8.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.685 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.77 156.63 47.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 119.568 -1.958 . . . . 0.0 111.301 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.02 151.01 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -162.68 165.48 25.64 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.77 2.428 . . . . 0.0 106.504 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -144.06 174.56 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.789 1.236 . . . . 0.0 110.305 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -129.63 113.0 14.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -102.66 155.58 18.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -128.37 138.31 52.3 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' A' ' 173' ' ' ASP . 19.2 ttmm -129.2 96.23 4.26 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 70.29 -95.93 0.53 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.74 -7.09 9.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.423 1.489 . . . . 0.0 110.212 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.69 153.89 32.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.86 100.23 5.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.32 106.92 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 131.75 34.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.42 176.38 40.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.426 1.012 . . . . 0.0 111.374 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.96 172.44 14.5 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.354 1.454 . . . . 0.0 111.946 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.01 104.13 16.69 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -77.59 -34.38 53.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.096 0.959 . . . . 0.0 112.335 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -108.24 -178.46 21.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 124.774 1.178 . . . . 0.0 113.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -72.8 105.2 1.37 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.565 1.546 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.48 168.69 20.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.813 1.675 . . . . 0.0 109.47 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.6 t -137.22 161.13 37.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.657 0.783 . . . . 0.0 109.181 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.76 -15.5 63.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.561 0.744 . . . . 0.0 110.399 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -19.91 65.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.252 1.021 . . . . 0.0 109.876 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.06 -153.11 20.23 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -139.95 141.23 36.46 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.74 1.616 . . . . 0.0 107.552 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.18 151.58 23.99 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -134.92 144.38 47.44 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.938 0.79 . . . . 0.0 111.996 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -142.42 113.01 7.3 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.785 0.834 . . . . 0.0 109.29 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -73.34 141.16 47.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mt -116.15 114.3 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.908 0.776 . . . . 0.0 109.268 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.82 148.71 27.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.919 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 24.67 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.6 2.36 . . . . 0.0 116.536 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.91 -27.82 9.86 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.371 2.048 . . . . 0.0 114.144 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.2 t -128.81 -66.42 0.83 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.81 172.4 13.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.589 1.556 . . . . 0.0 108.451 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -165.94 171.4 12.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.809 1.244 . . . . 0.0 108.186 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.4 mt -87.24 152.03 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.2 p -140.43 -5.12 1.24 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -166.58 170.79 12.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.836 1.255 . . . . 0.0 107.768 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.18 141.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -132.86 151.61 52.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 129.32 3.048 . . . . 0.0 108.482 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.02 179.53 44.39 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.5 p -137.15 142.87 42.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.642 1.221 . . . . 0.0 110.463 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.52 145.29 48.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.722 0.809 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -147.67 163.94 35.07 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 122.056 -0.403 . . . . 0.0 110.739 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.42 141.15 52.15 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.492 1.117 . . . . 0.0 113.794 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.73 155.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -111.03 141.89 43.92 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.94 -7.24 82.61 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.545 -0.722 . . . . 0.0 111.827 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 60.4 p -140.65 -172.11 3.38 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.858 2.063 . . . . 0.0 107.643 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.42 72.0 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.904 1.282 . . . . 0.0 108.706 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -163.17 178.54 38.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.873 1.225 . . . . 0.0 111.383 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.3 mt -108.44 159.61 16.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 110.58 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.0 tt -135.85 138.49 47.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.232 1.413 . . . . 0.0 109.305 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 25.0 mm -76.54 96.57 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.0 t -76.24 -16.86 59.73 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.677 -0.639 . . . . 0.0 112.313 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -156.79 138.61 14.28 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.622 1.169 . . . . 0.0 107.986 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 24.3 tp -135.49 123.91 23.39 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -109.58 172.48 6.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.984 0.914 . . . . 0.0 108.576 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -136.68 145.71 45.07 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -115.88 121.36 42.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.425 1.09 . . . . 0.0 109.027 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 p -138.66 168.14 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.344 2.258 . . . . 0.0 107.277 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.23 156.02 19.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.8 mttm 60.76 -17.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -98.97 175.3 5.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.33 1.452 . . . . 0.0 112.555 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -131.42 99.82 4.95 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 126.11 1.764 . . . . 0.0 108.186 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.1 p -80.18 160.18 25.74 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.083 0.553 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -94.53 155.85 39.14 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.22 88.98 0.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.072 2.514 . . . . 0.0 107.877 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -77.09 92.52 3.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.87 172.86 34.55 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.146 1.355 . . . . 0.0 111.797 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.84 122.97 41.58 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.552 1.541 . . . . 0.0 109.232 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -71.82 108.34 5.07 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.345 2.258 . . . . 0.0 110.139 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.78 168.32 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.973 1.309 . . . . 0.0 110.103 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 91.84 -98.43 2.42 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 98.8 m -145.08 118.85 9.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -87.71 136.03 33.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -126.27 166.03 17.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.06 0.944 . . . . 0.0 109.565 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.45 151.88 35.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.458 0.703 . . . . 0.0 109.816 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.5 mt -139.42 120.49 14.63 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.789 1.636 . . . . 0.0 107.563 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.37 152.27 18.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.166 0.894 . . . . 0.0 110.92 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.49 157.23 44.04 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.587 1.555 . . . . 0.0 108.756 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.15 143.25 34.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 65.15 28.65 73.8 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -142.49 152.73 42.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.08 2.44 . . . . 0.0 110.757 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.94 165.01 17.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.875 2.07 . . . . 0.0 107.563 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.8 mt -92.15 150.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.68 -10.55 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.81 -179.97 48.14 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.833 1.197 . . . . 0.0 110.84 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 135.71 53.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 108.204 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.71 137.37 52.44 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.47 -150.49 22.2 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.06 128.85 10.17 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.16 46.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 109.55 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 36.5 m -140.29 -67.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.442 1.097 . . . . 0.0 111.631 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.86 -64.48 1.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 119.001 0.819 . . . . 0.0 110.748 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.4 113.74 27.5 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -50.31 92.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.75 -73.84 0.31 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.525 1.13 . . . . 0.0 111.939 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -104.85 114.36 28.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.843 0.747 . . . . 0.0 112.346 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -117.87 156.77 27.84 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.655 1.582 . . . . 0.0 107.005 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -172.1 -179.66 43.16 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.5 m -138.81 146.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.58 1.19 . . . . 0.0 111.529 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.02 160.26 24.6 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 118.411 0.55 . . . . 0.0 110.885 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 83.8 mmm -146.02 142.9 18.29 Favored Pre-proline 0 N--CA 1.464 0.262 0 C-N-CA 124.589 1.156 . . . . 0.0 110.784 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.59 105.77 2.09 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.824 2.349 . . . . 0.0 109.461 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.23 81.94 1.76 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.1 t -72.7 170.52 14.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 0.0 111.626 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 116.802 -1.57 . . . . 0.0 107.402 178.892 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.57 154.75 41.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.588 2.355 . . . . 0.0 110.317 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -149.05 100.94 3.11 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.223 -0.923 . . . . 0.0 112.788 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.37 142.53 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 159.7 16.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.683 0.793 . . . . 0.0 110.027 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.51 105.38 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.288 1.435 . . . . 0.0 112.512 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.09 83.23 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.02 -160.71 19.01 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 126.909 2.195 . . . . 0.0 107.657 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.86 150.23 39.66 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.02 53.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.244 1.022 . . . . 0.0 113.582 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.86 164.02 39.9 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.96 0.79 . . . . 0.0 114.59 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.37 164.85 34.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.189 1.376 . . . . 0.0 113.98 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.79 141.73 29.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.209 1.403 . . . . 0.0 107.236 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.9 123.12 22.03 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -127.33 85.7 2.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.883 1.673 . . . . 0.0 107.034 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -140.94 147.0 38.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.647 2.379 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -160.63 174.22 14.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.41 1.484 . . . . 0.0 108.534 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.11 -111.86 2.09 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 104.149 -3.58 . . . . 0.0 104.149 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t 52.37 31.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 117.777 0.789 . . . . 0.0 112.951 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -64.21 110.68 2.29 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.318 -1.489 . . . . 0.0 110.136 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -118.28 -63.6 1.39 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.928 1.291 . . . . 0.0 109.943 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.81 164.88 31.41 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -117.82 155.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 109.64 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -54.93 1.24 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -145.8 168.39 20.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 118.759 0.708 . . . . 0.0 110.622 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.144 2.578 . . . . 0.0 104.777 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -138.9 122.32 17.2 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -143.77 139.6 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.87 131.23 3.89 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -67.16 -168.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.212 1.405 . . . . 0.0 110.519 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.67 -177.32 43.23 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.88 -32.69 73.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.427 1.091 . . . . 0.0 111.507 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -105.63 8.29 33.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.259 1.824 . . . . 0.0 114.036 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.72 -168.41 12.93 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.258 -0.901 . . . . 0.0 112.836 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.36 95.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -101.94 -9.24 20.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.9 p -87.8 147.53 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 120.362 1.437 . . . . 0.0 109.524 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -145.01 158.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.44 1.096 . . . . 0.0 108.8 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -153.91 151.31 29.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.285 1.834 . . . . 0.0 107.266 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.73 119.86 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.97 121.27 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.55 158.64 16.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' A' ' 48' ' ' ASP . . . -156.26 109.66 2.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -111.84 154.03 25.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -33.27 62.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.64 0.776 . . . . 0.0 112.611 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.525 1.53 . . . . 0.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -156.02 120.06 4.48 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 120.401 1.455 . . . . 0.0 107.679 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.448 ' CB ' ' HA ' ' A' ' 43' ' ' ALA 0.395 0.5 OUTLIER -116.83 165.46 13.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -179.279 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.78 145.98 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.536 1.534 . . . . 0.0 111.801 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.3 139.09 37.94 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.95 -1.094 . . . . 0.0 109.377 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.35 -73.49 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.57 0.605 . . . . 0.0 111.788 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.33 171.15 17.67 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.725 1.631 . . . . 0.0 110.033 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -101.52 142.63 32.61 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.136 -0.626 . . . . 0.0 110.591 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.63 173.99 10.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.611 1.964 . . . . 0.0 109.682 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.97 -155.97 37.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -112.79 125.58 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.89 160.26 14.63 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 p -132.34 114.53 14.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.365 1.866 . . . . 0.0 108.221 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.46 -36.5 80.57 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.262 -1.524 . . . . 0.0 107.988 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -1.88 17.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.223 2.209 . . . . 0.0 115.554 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.97 -8.87 0.23 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 120.291 1.405 . . . . 0.0 115.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.99 125.04 28.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.084 1.442 . . . . 0.0 110.88 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.01 142.01 50.76 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.486 1.915 . . . . 0.0 106.273 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.6 m -104.15 143.61 32.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 108.735 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -134.68 125.1 26.4 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.883 0.873 . . . . 0.0 109.629 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.39 143.57 29.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.618 1.567 . . . . 0.0 109.142 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.69 147.52 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.631 1.173 . . . . 0.0 109.089 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -109.91 172.62 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.936 1.294 . . . . 0.0 113.35 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -38.52 19.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.473 1.509 . . . . 0.0 110.332 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -83.19 21.05 1.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.328 1.451 . . . . 0.0 109.742 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.8 136.76 22.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 0.0 110.998 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.08 150.07 48.99 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.8 mt -79.88 147.49 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.32 -28.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.765 0.826 . . . . 0.0 110.836 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.36 155.64 41.51 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.182 0.901 . . . . 0.0 108.888 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.99 95.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.67 113.66 20.5 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.69 147.91 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.1 m -131.74 138.73 48.74 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -150.28 167.11 27.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.136 2.974 . . . . 0.0 104.619 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.03 165.7 29.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -120.82 105.73 11.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.981 0.912 . . . . 0.0 109.277 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.85 144.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.05 108.15 1.17 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.61 6.32 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 117.874 -1.515 . . . . 0.0 113.403 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -131.56 118.87 20.7 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.119 1.96 . . . . 0.0 108.142 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.33 1.85 2.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.559 2.744 . . . . 0.0 114.138 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.7 t -147.97 135.53 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.625 -1.297 . . . . 0.0 109.04 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.16 158.33 33.39 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.92 141.11 43.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.189 1.796 . . . . 0.0 107.962 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.1 mm -64.29 125.68 21.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.987 0.915 . . . . 0.0 110.054 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 p -104.42 -32.54 8.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.28 1.032 . . . . 0.0 109.24 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -161.05 165.6 29.48 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 120.015 1.279 . . . . 0.0 112.689 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pt -144.76 137.44 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.402 1.881 . . . . 0.0 109.928 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.7 m -132.21 114.61 14.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.197 1.799 . . . . 0.0 107.952 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -96.82 121.8 39.07 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -100.79 127.62 47.16 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.8 p -97.48 164.51 12.41 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.151 0.887 . . . . 0.0 111.756 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.94 -41.2 82.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.378 1.071 . . . . 0.0 108.934 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -68.47 -22.8 64.54 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.22 1.408 . . . . 0.0 114.608 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.56 -7.6 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 119.809 1.186 . . . . 0.0 114.186 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -74.26 147.05 42.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.49 127.11 30.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 p -80.98 149.33 66.55 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.68 158.86 48.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.138 1.892 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.47 83.46 1.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.053 2.502 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -55.89 109.31 0.56 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.59 -134.88 10.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.3 tp -139.87 138.16 35.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.537 1.135 . . . . 0.0 109.927 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -68.42 164.83 20.13 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.37 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -149.8 -167.14 2.74 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.742 -1.849 . . . . 0.0 111.609 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.432 ' H ' HG22 ' A' ' 111' ' ' THR . 16.9 tt0 -73.25 -59.18 2.83 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.543 1.137 . . . . 0.0 109.509 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -68.73 178.24 2.2 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER 165.03 162.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.353 3.061 . . . . 0.0 108.471 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.51 149.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.344 1.058 . . . . 0.0 108.198 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 p -140.05 148.14 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.31 145.87 33.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.175 2.19 . . . . 0.0 106.512 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 174.68 12.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.632 1.173 . . . . 0.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.428 ' HB3' ' CD1' ' A' ' 143' ' ' PHE . 5.8 p30 -110.1 147.93 32.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.596 1.158 . . . . 0.0 109.0 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -143.26 -84.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -100.42 -10.81 20.77 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.717 0.69 . . . . 0.0 110.198 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 -49.04 49.3 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.248 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.05 -133.25 2.91 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 119.267 1.533 . . . . 0.0 112.187 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -132.81 153.61 51.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.934 0.893 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.6 106.92 10.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.01 3.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.456 0.702 . . . . 0.0 111.556 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.38 178.22 46.86 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.923 0.773 . . . . 0.0 111.749 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.74 177.02 8.45 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.74 2.016 . . . . 0.0 109.735 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -146.41 148.82 32.7 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.07 92.45 0.17 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 118.254 0.479 . . . . 0.0 112.388 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -60.32 121.26 11.56 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -152.8 164.82 37.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.388 0.994 . . . . 0.0 110.595 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.56 -95.72 0.13 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.73 -23.94 56.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.047 0.424 . . . . 0.0 110.201 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.4 -179.69 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.23 2.212 . . . . 0.0 106.366 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.54 153.45 33.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.846 1.658 . . . . 0.0 108.487 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -143.93 -56.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.509 0.595 . . . . 0.0 112.007 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.24 155.71 50.2 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.986 0.812 . . . . 0.0 112.592 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.11 113.21 9.24 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.21 2.204 . . . . 0.0 107.346 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.92 174.81 15.48 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 123.814 0.721 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.01 158.85 43.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 121.537 -0.978 . . . . 0.0 108.728 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.77 151.81 41.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 119' ' ' ASP . 45.4 m-85 -137.72 99.81 4.02 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.015 0.926 . . . . 0.0 109.421 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.16 148.66 45.11 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 121.605 -0.684 . . . . 0.0 110.678 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -135.98 131.5 35.13 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 m -153.6 148.15 26.18 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.1 t -145.34 151.88 39.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 p -150.77 145.11 17.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.209 1.804 . . . . 0.0 108.799 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.03 112.57 3.57 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.242 2.628 . . . . 0.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 86.5 t -135.37 155.51 37.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.2 p -128.85 160.1 65.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.015 0.926 . . . . 0.0 112.286 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.97 174.25 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.367 2.711 . . . . 0.0 112.181 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.3 -178.39 7.02 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.769 1.628 . . . . 0.0 108.736 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.65 129.38 56.67 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.152 -0.968 . . . . 0.0 109.567 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -103.97 106.78 17.4 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.88 161.54 23.74 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.4 t -84.86 111.94 20.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.94 159.77 29.71 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.721 0.408 . . . . 0.0 110.113 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -125.21 161.24 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.009 2.924 . . . . 0.0 105.949 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.94 -72.12 0.48 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.857 1.208 . . . . 0.0 113.317 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.81 -4.89 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.217 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . 0.264 0.7 OUTLIER 53.61 -3.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.156 2.982 . . . . 0.0 117.476 179.281 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.76 164.9 12.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.839 1.655 . . . . 0.0 112.769 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.51 -175.23 16.0 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 126.341 1.924 . . . . 0.0 114.195 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.37 104.22 4.3 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.033 1.733 . . . . 0.0 109.525 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.85 154.76 29.55 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.254 0.622 . . . . 0.0 110.265 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -146.57 28.29 1.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.99 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -42.71 110.42 0.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.912 1.685 . . . . 0.0 110.235 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.38 -11.37 60.45 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.3 -85.75 1.57 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.37 147.57 5.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -109.6 155.48 21.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.352 1.061 . . . . 0.0 109.548 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -76.42 -11.02 59.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.926 -1.033 . . . . 0.0 112.901 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.05 -179.94 44.07 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.21 155.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.18 1.392 . . . . 0.0 108.596 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -138.48 -74.13 0.39 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.788 1.235 . . . . 0.0 107.873 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -150.87 165.94 32.09 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.03 139.41 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -118.48 156.89 28.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.58 131.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -109.84 83.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.68 -165.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 110.682 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.02 -168.71 37.93 Favored Glycine 0 N--CA 1.447 -0.608 0 O-C-N 120.183 -1.573 . . . . 0.0 112.064 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.09 -45.58 11.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.23 1.412 . . . . 0.0 109.618 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.78 -15.53 51.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.528 0.731 . . . . 0.0 111.479 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.06 -154.39 24.44 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 27.7 mm -58.36 150.81 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 118.559 1.179 . . . . 0.0 108.855 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.4 t -127.65 -38.36 1.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.199 1.399 . . . . 0.0 112.822 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -136.7 161.58 35.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.137 0.881 . . . . 0.0 110.027 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.91 127.85 25.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.434 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 44.7 pttt -161.67 160.53 28.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.296 1.439 . . . . 0.0 109.49 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.48 169.13 24.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.428 0.558 . . . . 0.0 109.834 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.03 148.27 24.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -151.67 165.84 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.5 92.58 2.59 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -89.2 99.44 12.43 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.36 -79.98 0.64 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.73 0.696 . . . . 0.0 111.662 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.33 -0.18 1.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.597 1.959 . . . . 0.0 111.135 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.4 102.05 7.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -77.67 67.06 3.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.295 1.438 . . . . 0.0 108.251 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 36.9 mm -72.13 122.69 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.189 0.995 . . . . 0.0 113.429 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 29.0 t -127.65 150.37 33.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 127.109 2.164 . . . . 0.0 105.93 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.44 -108.98 2.77 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.862 -0.966 . . . . 0.0 111.548 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 72.38 12.47 76.83 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 116.014 1.165 . . . . 0.0 116.014 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -58.81 116.44 3.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.839 2.32 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -117.64 2.78 12.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.671 1.588 . . . . 0.0 113.993 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.01 162.41 28.57 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 120.069 -1.645 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -47.07 106.37 0.58 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.744 1.617 . . . . 0.0 110.929 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.53 135.57 26.63 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.985 2.457 . . . . 0.0 109.327 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 131.66 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 29.3 tp -56.51 -26.4 54.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 pp -55.52 -30.06 60.01 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.197 1.399 . . . . 0.0 112.186 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.72 -166.01 13.91 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.019 1.295 . . . . 0.0 110.488 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.434 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 23.5 m-85 -128.88 168.13 16.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.549 1.54 . . . . 0.0 108.232 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.75 171.6 7.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.882 2.073 . . . . 0.0 106.787 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.86 158.59 44.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.451 0.7 . . . . 0.0 112.771 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -142.74 129.67 20.63 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.943 1.697 . . . . 0.0 108.311 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.19 109.54 21.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 107.707 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.85 104.45 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -88.96 92.61 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.774 1.63 . . . . 0.0 107.556 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -57.16 -35.29 33.7 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -35.27 10.01 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 123.609 2.325 . . . . 0.0 110.093 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -75.91 -77.09 0.14 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.591 1.557 . . . . 0.0 112.021 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.18 124.71 28.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.052 2.541 . . . . 0.0 112.476 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.47 83.31 3.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -45.98 128.19 2.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 109.824 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -124.42 -22.96 4.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.81 171.26 18.08 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.347 1.43 . . . . 0.0 113.46 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 1.8 p -139.1 158.19 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.73 172.18 12.89 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -172.68 171.24 44.23 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.2 p -141.33 137.81 32.66 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -135.96 160.8 37.48 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.898 0.749 . . . . 0.0 112.14 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -145.87 168.94 19.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.153 0.981 . . . . 0.0 108.985 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -75.05 147.9 40.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.902 1.281 . . . . 0.0 110.075 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.8 mt -92.98 112.46 26.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.36 104.41 5.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 119.02 -0.52 14.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.436 1.017 . . . . 0.0 112.811 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -141.19 -174.28 3.97 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.11 80.24 1.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 172.66 -176.99 45.44 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -108.66 157.61 18.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -126.78 137.2 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 125.974 1.709 . . . . 0.0 109.135 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.32 130.2 36.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.277 10.3 t -112.04 -50.35 2.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 112.622 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -128.77 150.61 50.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.149 1.341 . . . . 0.0 109.619 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.4 mt -130.53 150.32 51.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.373 1.469 . . . . 0.0 110.441 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -142.97 147.64 35.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.646 1.579 . . . . 0.0 107.62 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.75 113.19 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -71.14 136.15 48.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -142.18 165.18 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.35 1.86 . . . . 0.0 106.383 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 148.15 31.69 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 -29.42 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 128.465 2.706 . . . . 0.0 115.157 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -81.22 174.42 11.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.386 2.674 . . . . 0.0 108.295 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.4 m -144.31 152.29 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 45.3 p -146.09 174.46 11.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 112.257 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -103.98 158.66 31.44 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.872 1.669 . . . . 0.0 110.576 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.05 115.09 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.224 2.616 . . . . 0.0 106.401 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -83.94 92.38 7.81 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.71 -176.99 16.57 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.229 1.395 . . . . 0.0 111.59 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.05 116.67 26.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.108 0.963 . . . . 0.0 110.066 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.78 108.86 3.59 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.419 1.088 . . . . 0.0 109.219 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -155.17 -177.31 6.44 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.287 1.035 . . . . 0.0 110.965 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 64.15 -103.47 0.73 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 126.261 1.886 . . . . 0.0 114.657 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 91.1 m -146.92 128.62 15.2 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 107.444 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -89.92 144.41 25.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 111.431 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -129.48 165.94 20.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.592 1.157 . . . . 0.0 110.039 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -143.84 146.58 33.15 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.232 1.813 . . . . 0.0 107.092 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 73.0 mt -132.0 102.01 5.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.699 1.6 . . . . 0.0 107.239 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -127.11 163.7 23.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.146 0.978 . . . . 0.0 109.061 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.75 167.44 22.28 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.365 1.466 . . . . 0.0 107.627 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -97.04 117.59 31.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.593 1.157 . . . . 0.0 113.559 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.73 67.54 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.148 -0.97 . . . . 0.0 114.623 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -107.06 164.59 12.02 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.126 1.37 . . . . 0.0 111.606 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -127.98 151.16 49.47 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.682 2.793 . . . . 0.0 105.01 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 68.7 mt -82.49 145.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.38 -5.37 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.778 0.831 . . . . 0.0 112.842 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.17 37.3 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.626 1.103 . . . . 0.0 110.684 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -128.35 156.01 43.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.888 2.875 . . . . 0.0 107.238 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -147.83 113.27 5.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -178.52 -171.56 41.95 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 154.28 46.12 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.55 -1.325 . . . . 0.0 107.838 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.3 152.48 39.98 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.6 t -163.95 113.55 1.24 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.82 11.47 2.53 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.07 2.548 . . . . 0.0 114.447 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 167.1 -179.88 0.02 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 129.433 3.093 . . . . 0.0 106.865 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.95 102.97 15.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.441 0.696 . . . . 0.0 110.172 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -82.88 -43.42 16.59 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.237 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -133.71 142.16 47.86 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.795 1.18 . . . . 0.0 112.799 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.83 149.64 35.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 176.5 -158.89 25.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.4 m -147.89 138.66 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.98 0.912 . . . . 0.0 111.661 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.96 136.92 37.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.12 149.23 24.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.32 0.581 . . . . 0.0 111.233 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 29.7 mmm -142.47 141.61 21.26 Favored Pre-proline 0 C--O 1.234 0.277 0 C-N-CA 126.988 2.115 . . . . 0.0 107.414 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.18 146.98 71.88 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.368 2.045 . . . . 0.0 108.878 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.57 153.75 41.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 22.1 m -133.66 99.63 4.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 24.4 t30 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 126.071 1.749 . . . . 0.0 108.842 179.334 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -70.47 109.68 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.394 1.078 . . . . 0.0 111.911 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -149.74 139.48 21.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 130.614 3.566 . . . . 0.0 105.166 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.36 129.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 118.931 0.787 . . . . 0.0 112.388 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.34 138.69 47.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.37 -62.52 1.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.027 0.531 . . . . 0.0 109.692 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.33 69.76 0.84 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 126.241 1.876 . . . . 0.0 109.534 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.75 -166.11 12.07 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.733 1.635 . . . . 0.0 110.075 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.29 17.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.433 1.116 . . . . 0.0 113.403 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.12 -1.13 4.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.303 1.841 . . . . 0.0 112.548 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.75 42.38 3.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 120.698 -1.251 . . . . 0.0 112.734 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.64 -154.68 6.66 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 127.095 2.283 . . . . 0.0 111.561 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.96 142.2 51.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -72.29 121.9 20.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 112.579 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -124.27 58.42 1.2 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -89.91 18.68 5.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.855 2.462 . . . . 0.0 112.277 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -148.09 160.22 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.012 -1.055 . . . . 0.0 110.913 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.98 145.27 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.274 1.893 . . . . 0.0 108.772 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.25 152.84 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.235 0.614 . . . . 0.0 109.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -63.54 -39.11 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 64.94 9.12 5.14 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 128.387 2.675 . . . . 0.0 113.891 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 63.65 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 123.515 0.579 . . . . 0.0 112.544 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -59.55 141.87 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 111.759 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -117.91 -32.48 4.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -150.49 160.63 43.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.36 121.1 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.513 ' CD2' HD21 ' A' ' 39' ' ' ASN . 1.2 m-70 -98.38 140.96 31.88 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 118.768 0.713 . . . . 0.0 109.557 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -143.2 145.84 22.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.04 141.83 8.59 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 146.78 35.08 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.548 1.139 . . . . 0.0 109.722 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.14 165.68 28.56 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 125.992 1.758 . . . . 0.0 109.459 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -55.72 -34.67 65.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.922 1.289 . . . . 0.0 112.327 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -94.84 -7.92 38.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.465 3.106 . . . . 0.0 113.788 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.65 -164.35 20.26 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.87 95.49 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -112.61 2.45 16.19 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.5 p -107.18 108.93 20.61 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.67 132.65 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 109.702 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.513 HD21 ' CD2' ' A' ' 27' ' ' HIS . 24.4 t30 -150.23 147.39 27.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.652 1.581 . . . . 0.0 108.562 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.0 117.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.9 t -68.22 148.23 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -128.41 126.31 40.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.275 1.398 . . . . 0.0 111.933 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.29 139.62 30.84 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -112.5 165.56 12.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.56 -23.48 67.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.093 -0.379 . . . . 0.0 111.234 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -104.67 -39.38 6.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.561 1.144 . . . . 0.0 113.608 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -154.81 158.22 39.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.043 1.292 . . . . 0.0 113.509 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 125.73 30.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.42 145.32 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.535 1.16 . . . . 0.0 112.361 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.5 153.3 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.057 2.143 . . . . 0.0 106.183 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.72 61.06 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 127.939 2.685 . . . . 0.0 107.703 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.6 14.51 4.18 Favored Glycine 0 N--CA 1.472 1.035 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.28 116.56 8.19 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.06 1.43 . . . . 0.0 111.404 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -126.59 82.12 2.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.26 -144.92 5.77 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.93 111.23 13.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.92 119.79 6.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 p -70.53 153.57 42.78 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.262 1.825 . . . . 0.0 111.291 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.18 -33.55 16.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.803 1.241 . . . . 0.0 109.781 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.2 mt -71.34 -14.43 62.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 123.66 0.6 . . . . 0.0 109.469 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.82 161.16 33.19 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-O 124.637 2.243 . . . . 0.0 109.659 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -123.89 157.61 33.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.529 -2.835 . . . . 0.0 109.334 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -121.78 165.19 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.767 2.427 . . . . 0.0 107.633 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -128.13 125.92 40.11 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.543 -0.723 . . . . 0.0 110.123 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -87.12 119.58 27.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.987 1.715 . . . . 0.0 107.414 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.07 141.99 35.33 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.878 0.847 . . . . 0.0 109.871 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.1 t -114.75 112.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.875 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.63 172.16 14.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.53 -59.0 2.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -74.73 -22.28 58.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -81.36 146.78 30.16 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.02 152.8 51.3 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 123.868 0.867 . . . . 0.0 110.617 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.2 mt -80.78 114.44 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.67 -31.04 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.687 0.795 . . . . 0.0 112.012 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.2 166.77 26.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.652 1.181 . . . . 0.0 108.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.46 117.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -95.14 126.16 40.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.8 146.26 29.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.81 0.844 . . . . 0.0 109.869 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 p -120.74 152.51 38.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -154.2 168.72 25.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.106 0.962 . . . . 0.0 108.517 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.19 168.96 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.2 108.41 10.32 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.793 2.037 . . . . 0.0 108.458 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.54 147.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.861 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -62.21 149.6 41.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.35 88.83 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.642 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -139.58 164.44 29.9 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.028 2.131 . . . . 0.0 106.704 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -125.02 0.71 7.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.418 1.087 . . . . 0.0 111.295 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.1 t -98.48 157.66 16.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.48 153.27 24.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -131.7 141.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 125.75 1.62 . . . . 0.0 107.802 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.42 128.53 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.8 p -104.7 -27.19 11.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.8 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.0 t -154.67 159.62 40.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.158 1.344 . . . . 0.0 109.022 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.5 mm -141.6 141.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 128.023 2.529 . . . . 0.0 106.368 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -151.12 108.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.383 1.473 . . . . 0.0 107.565 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -77.88 150.22 34.16 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -123.84 114.06 19.36 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.1 p -82.84 162.26 21.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.982 1.313 . . . . 0.0 111.409 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.2 -30.71 70.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -17.37 59.41 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.238 -0.914 . . . . 0.0 112.777 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 2.98 60.43 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 119.3 0.954 . . . . 0.0 111.132 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -79.36 89.45 4.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 147.46 26.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.089 0.555 . . . . 0.0 109.904 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.8 p -84.86 161.91 51.59 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.055 0.942 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.92 164.66 34.92 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 N-CA-C 108.586 -1.352 . . . . 0.0 108.586 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.05 109.61 2.92 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 N-CA-C 106.466 -2.167 . . . . 0.0 106.466 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 9.41 0.18 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -169.55 -170.12 33.66 Favored Glycine 0 N--CA 1.442 -0.9 0 O-C-N 120.76 -1.213 . . . . 0.0 111.427 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.3 106.03 8.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.617 0.767 . . . . 0.0 111.11 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.65 109.53 1.06 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 m -100.44 166.34 10.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.547 0.739 . . . . 0.0 110.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.39 -52.86 61.93 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.725 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -62.9 117.01 5.79 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -157.57 159.65 37.33 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -139.57 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.269 1.828 . . . . 0.0 110.556 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.82 114.29 3.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.812 1.245 . . . . 0.0 108.237 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.17 128.57 36.38 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 138.97 9.3 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.5 175.35 9.31 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.321 1.049 . . . . 0.0 110.855 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -106.96 -25.93 11.42 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.588 1.155 . . . . 0.0 110.967 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -119.98 33.63 5.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.571 1.548 . . . . 0.0 111.387 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.84 31.63 81.56 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 174.63 2.65 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.001 1.762 . . . . 0.0 114.853 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -125.68 137.0 53.83 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.601 1.16 . . . . 0.0 109.506 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.39 151.54 43.78 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 0.0 109.3 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.58 -62.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.09 164.5 32.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.1 160.43 14.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.941 0.896 . . . . 0.0 111.283 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.59 149.3 35.56 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.859 2.064 . . . . 0.0 107.04 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.83 172.51 24.43 Favored Glycine 0 C--O 1.229 -0.217 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -142.25 37.62 1.55 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.297 1.439 . . . . 0.0 107.412 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.02 111.8 20.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.645 1.178 . . . . 0.0 110.206 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.69 -101.34 0.32 Allowed Glycine 0 CA--C 1.519 0.305 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.37 -31.65 58.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.536 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.6 169.17 17.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.381 1.472 . . . . 0.0 110.745 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -75.91 88.44 2.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.715 1.206 . . . . 0.0 113.264 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.38 -32.77 16.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.03 139.73 19.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.165 0.986 . . . . 0.0 109.28 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.6 tp -158.85 113.1 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.182 1.393 . . . . 0.0 108.379 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.25 -175.94 14.78 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.436 1.493 . . . . 0.0 111.298 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -146.6 159.51 43.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.43 1.115 . . . . 0.0 111.261 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -99.39 154.99 17.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.384 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.51 118.37 21.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.807 1.243 . . . . 0.0 108.81 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.905 1.682 . . . . 0.0 108.661 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t -133.91 160.18 38.45 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.586 1.154 . . . . 0.0 109.264 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.8 m -64.46 100.9 0.39 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 t -77.12 -7.98 56.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 29.6 p -104.97 161.62 22.2 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.221 1.809 . . . . 0.0 113.932 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.97 171.97 17.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.413 2.075 . . . . 0.0 109.703 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.2 p -123.08 125.16 71.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.4 p -137.13 164.52 41.53 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.028 1.331 . . . . 0.0 110.85 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.34 6.51 5.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.391 2.727 . . . . 0.0 114.606 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.54 -173.91 0.64 Allowed 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 130.369 3.468 . . . . 0.0 112.236 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 122.09 28.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -106.0 147.56 28.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 67.9 mt -125.09 122.51 37.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.97 2.108 . . . . 0.0 107.161 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -69.15 108.39 3.59 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 127.143 2.177 . . . . 0.0 107.081 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.03 -178.58 2.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.078 0.951 . . . . 0.0 111.228 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.5 pt -108.15 156.13 8.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 108.389 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.31 -109.88 0.49 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -156.39 -162.6 11.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.989 1.757 . . . . 0.0 109.629 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -121.65 13.6 10.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.853 1.261 . . . . 0.0 111.383 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -107.65 120.77 43.14 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 112.163 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.36 -172.84 36.86 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.867 1.699 . . . . 0.0 109.506 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 m -96.3 146.21 24.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -103.08 138.37 40.01 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.582 -0.699 . . . . 0.0 110.973 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -155.74 58.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.33 104.22 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.02 -24.65 21.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.864 -0.522 . . . . 0.0 112.049 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.0 -118.71 4.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -135.42 135.66 40.78 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.353 1.577 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -91.4 170.6 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -42.62 64.78 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.58 134.01 3.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.18 156.82 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.065 1.746 . . . . 0.0 107.685 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -127.03 -64.1 1.02 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -126.3 155.31 42.17 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.512 0.597 . . . . 0.0 111.756 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -121.56 146.11 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.588 1.955 . . . . 0.0 107.255 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -137.07 146.44 45.17 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.599 0.76 . . . . 0.0 109.197 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.2 132.41 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.22 65.82 0.56 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.42 1.009 . . . . 0.0 112.404 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -78.72 176.51 9.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.375 1.07 . . . . 0.0 109.981 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.61 23.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -69.75 -20.35 63.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.683 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -115.6 -16.81 11.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.275 0.943 . . . . 0.0 113.516 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.89 30.76 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.193 0.906 . . . . 0.0 112.925 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.77 111.91 6.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.1 0.96 . . . . 0.0 108.946 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -96.02 -37.1 10.78 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.905 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.18 155.58 47.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.56 1.171 . . . . 0.0 111.777 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.51 148.16 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -168.3 142.17 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.407 1.883 . . . . 0.0 106.764 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -139.14 155.36 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -108.84 130.1 55.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -140.98 168.41 19.85 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.986 0.914 . . . . 0.0 111.741 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -147.39 133.84 19.71 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.76 1.224 . . . . 0.0 110.966 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -140.05 147.21 40.0 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.74 -100.13 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 124.657 1.122 . . . . 0.0 112.715 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.36 12.82 4.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.84 1.656 . . . . 0.0 110.881 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -127.48 110.66 12.97 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.302 1.041 . . . . 0.0 112.019 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.47 152.47 34.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.318 1.847 . . . . 0.0 107.302 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.0 mm -132.88 129.63 58.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.119 0.968 . . . . 0.0 109.534 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.22 141.5 45.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 118.34 -135.46 11.6 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.85 23.65 66.31 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.971 0.385 . . . . 0.0 112.542 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -78.75 78.98 5.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -84.7 21.49 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.582 1.153 . . . . 0.0 112.534 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.95 156.18 26.89 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 119.809 -1.807 . . . . 0.0 108.889 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -71.3 129.76 88.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.56 155.1 71.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.53 2.153 . . . . 0.0 109.084 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.5 p -98.76 173.03 7.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.953 0.901 . . . . 0.0 109.587 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 40.1 tp -75.08 -18.57 60.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.7 tt -68.3 -34.73 76.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.385 . . . . 0.0 108.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 101.78 -132.38 10.95 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -142.33 -179.67 6.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.061 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.42 158.03 43.97 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 131.414 3.885 . . . . 0.0 104.711 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.96 147.78 34.41 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.687 1.131 . . . . 0.0 113.77 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.48 32.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.741 1.217 . . . . 0.0 109.402 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.74 113.86 21.28 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.681 1.192 . . . . 0.0 107.807 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.04 103.17 9.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.58 115.74 15.56 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -56.67 -32.0 11.87 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.06 8.46 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 124.015 2.47 . . . . 0.0 113.569 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.7 m -145.45 -68.12 0.29 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.975 -1.078 . . . . 0.0 110.034 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -84.78 151.84 24.08 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 119.123 0.874 . . . . 0.0 110.095 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -143.58 168.13 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.636 1.684 . . . . 0.0 115.177 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.3 mm -109.05 124.98 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 127.742 2.417 . . . . 0.0 105.263 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 t -115.84 -15.38 11.28 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.708 1.14 . . . . 0.0 113.139 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -154.02 170.34 21.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.829 1.251 . . . . 0.0 107.913 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.91 125.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.64 170.08 8.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 157.52 -178.73 33.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.6 p -137.18 153.73 50.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -131.26 144.33 51.22 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.49 165.23 23.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.747 0.419 . . . . 0.0 110.12 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -95.44 148.22 22.71 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.124 1.37 . . . . 0.0 113.174 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.87 138.95 22.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -75.34 152.13 38.17 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.407 -0.808 . . . . 0.0 109.169 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.21 1.51 89.51 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.299 0.952 . . . . 0.0 112.979 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 59.3 m -140.79 179.54 6.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.493 1.517 . . . . 0.0 109.794 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -125.39 66.41 1.15 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -162.88 -177.82 36.2 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 121.548 -0.72 . . . . 0.0 112.395 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.77 167.23 22.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.056 1.742 . . . . 0.0 112.13 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.67 158.62 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.066 2.147 . . . . 0.0 109.338 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.4 mm -72.52 126.98 34.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.2 m -107.61 -31.11 8.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 111.712 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -144.65 154.65 43.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -140.74 130.44 24.24 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.941 1.697 . . . . 0.0 109.553 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -129.31 109.35 11.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.963 1.305 . . . . 0.0 107.759 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -76.64 139.81 40.73 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -121.95 114.13 20.57 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.2 p -112.19 165.32 12.26 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.138 2.575 . . . . 0.0 109.714 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -100.74 150.97 22.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 65.21 -35.11 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.415 2.286 . . . . 0.0 114.298 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -120.08 174.2 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.575 1.95 . . . . 0.0 110.113 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.0 t -125.77 148.51 49.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.7 m -115.09 -0.34 13.36 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 74.8 163.81 0.14 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.513 2.325 . . . . 0.0 113.537 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -86.53 150.15 8.88 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.672 2.915 . . . . 0.0 109.674 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.94 112.13 13.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.79 176.53 26.93 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.802 1.192 . . . . 0.0 110.776 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.5 tt -97.56 118.57 34.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.606 1.163 . . . . 0.0 108.397 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -59.1 109.72 0.9 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.743 1.217 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -149.5 150.93 33.08 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.065 1.746 . . . . 0.0 106.821 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 84.11 -169.54 46.16 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 67.3 m -76.55 139.81 40.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 0.0 108.406 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -94.91 137.5 33.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.317 1.047 . . . . 0.0 109.945 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -130.61 148.3 52.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.247 1.019 . . . . 0.0 108.752 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -150.9 103.67 3.09 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 122.062 -0.399 . . . . 0.0 110.296 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.89 140.85 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.79 165.05 32.62 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.31 0.504 . . . . 0.0 112.289 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -146.28 167.48 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -132.23 137.27 47.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.7 17.78 76.86 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 118.818 0.736 . . . . 0.0 112.588 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -143.44 172.24 13.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.316 1.847 . . . . 0.0 109.175 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.455 ' HE3' ' CG1' ' A' ' 277' ' ' VAL . 0.1 OUTLIER -141.42 160.69 39.61 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.035 0.934 . . . . 0.0 109.916 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.6 mt -81.93 134.99 25.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.455 ' CG1' ' HE3' ' A' ' 275' ' ' LYS . 28.0 m -141.52 1.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.47 33.71 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 120.174 1.352 . . . . 0.0 113.385 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.414 ' CE1' ' HA ' ' A' ' 290' ' ' PHE . 3.0 t80 -145.79 134.04 21.72 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.557 2.343 . . . . 0.0 107.842 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -141.54 147.39 37.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.154 2.582 . . . . 0.0 104.228 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.48 -144.62 12.71 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 149.2 29.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 122.052 0.929 . . . . 0.0 110.819 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -155.64 154.4 31.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.341 1.857 . . . . 0.0 106.797 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.2 t -146.38 -106.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.73 -23.1 60.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 119.943 1.247 . . . . 0.0 109.236 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.99 159.86 41.86 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 129.029 2.932 . . . . 0.0 108.79 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.3 tp -78.89 131.03 36.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -119.34 -32.21 4.43 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.561 -1.209 . . . . 0.0 113.001 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -140.05 125.39 18.92 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.59 1.541 . . . . 0.0 107.051 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.414 ' HA ' ' CE1' ' A' ' 279' ' ' PHE . 15.8 t80 -122.11 97.69 5.6 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.86 98.51 2.09 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 130.43 36.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -90.37 153.97 20.03 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.324 0.65 . . . . 0.0 109.81 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 18.1 m -126.43 138.11 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.1 0.96 . . . . 0.0 109.735 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 73.4 mtp -143.56 152.05 55.61 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.151 1.38 . . . . 0.0 107.667 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.24 152.98 79.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.436 2.091 . . . . 0.0 113.721 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.4 mt -75.3 111.45 10.58 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 24.4 p -74.37 177.3 6.0 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.03 0.932 . . . . 0.0 110.713 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.206 2.202 . . . . 0.0 105.895 178.787 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.536 0.207 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.415 ' H ' ' HB2' ' A' ' 144' ' ' ALA . 16.2 mm-40 -136.19 151.82 50.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.09 1.756 . . . . 0.0 108.399 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -140.05 138.66 35.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.78 136.48 44.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.36 140.76 55.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.239 0.542 . . . . 0.0 110.763 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 164.82 19.26 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.157 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.23 145.96 18.01 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.62 -175.51 18.25 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 126.202 1.858 . . . . 0.0 110.829 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.55 -163.88 7.29 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.757 1.646 . . . . 0.0 113.865 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.0 0.22 43.43 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.172 1.389 . . . . 0.0 112.287 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.86 165.61 54.78 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.05 152.48 20.04 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.318 0.961 . . . . 0.0 111.941 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.5 114.51 6.16 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m 97.32 59.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 129.794 3.238 . . . . 0.0 118.284 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.429 ' CE3' ' CB ' ' A' ' 129' ' ' HIS . 30.9 p-90 -62.55 -14.96 48.04 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.592 1.557 . . . . 0.0 113.817 175.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.87 112.96 10.49 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.8 -37.42 71.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.002 0.521 . . . . 0.0 111.762 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.67 25.36 72.87 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.71 -175.57 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 109.46 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -83.03 -173.62 4.82 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.573 -1.329 . . . . 0.0 108.178 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -93.11 99.07 11.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 28.29 1.2 Allowed Glycine 0 C--O 1.228 -0.281 0 CA-C-O 118.142 -1.366 . . . . 0.0 114.395 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.62 128.03 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 120.116 1.958 . . . . 0.0 108.452 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -114.65 -56.75 2.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.891 1.276 . . . . 0.0 110.31 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -138.87 169.48 17.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.744 2.418 . . . . 0.0 106.897 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.03 142.65 25.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -127.76 107.93 10.3 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.97 134.89 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.87 142.59 14.03 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.21 161.23 14.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.525 1.13 . . . . 0.0 110.009 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.79 -167.99 32.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 125.587 1.565 . . . . 0.0 109.291 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.02 -38.63 83.26 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.096 0.558 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.86 11.72 2.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.221 1.408 . . . . 0.0 111.335 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.5 -136.37 15.37 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.82 106.96 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -14.38 14.87 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.0 p -131.16 139.03 49.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.152 1.342 . . . . 0.0 109.61 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 mm -142.88 140.66 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 126.328 1.851 . . . . 0.0 106.263 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -154.74 140.19 17.79 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.594 1.958 . . . . 0.0 105.886 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.54 156.17 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.32 144.04 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -116.73 105.22 12.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.59 125.21 27.47 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.906 -1.122 . . . . 0.0 108.284 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.77 160.57 19.26 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.39 -8.78 14.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.038 1.335 . . . . 0.0 111.606 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -101.56 -68.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 106.863 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -154.57 165.8 35.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.59 139.2 43.51 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.29 145.89 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -112.06 153.63 26.6 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.735 -1.228 . . . . 0.0 111.031 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 -123.75 2.03 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.18 176.6 35.96 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -75.13 142.04 43.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.21 65.1 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.268 2.227 . . . . 0.0 105.702 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.7 -164.01 37.59 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.56 123.26 43.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 143.26 51.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -106.9 -177.65 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.862 0.839 . . . . 0.0 111.86 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.2 tp -89.59 -39.59 13.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.059 0.944 . . . . 0.0 108.811 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' CD2' ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -54.34 -38.56 66.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.988 2.115 . . . . 0.0 112.786 -178.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.06 163.37 27.68 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-O 124.102 1.946 . . . . 0.0 108.427 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -109.63 162.94 13.94 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 110.966 -2.617 . . . . 0.0 108.854 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 164.23 13.94 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.078 1.751 . . . . 0.0 110.512 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.6 m -119.38 99.28 6.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.099 0.959 . . . . 0.0 113.53 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -87.72 140.63 29.32 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.06 130.71 52.83 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.649 1.579 . . . . 0.0 111.992 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.8 t -115.18 110.07 30.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 124.858 1.263 . . . . 0.0 108.276 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -69.84 173.18 6.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.054 1.341 . . . . 0.0 109.734 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.3 87.55 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.858 -1.151 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.95 7.65 41.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.349 1.459 . . . . 0.0 112.883 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.64 135.6 38.34 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.84 125.67 27.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mt -75.25 121.65 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.28 -19.17 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.82 147.18 29.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.01 113.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.26 130.56 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.46 144.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.824 1.25 . . . . 0.0 107.697 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -128.19 137.15 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -146.34 148.15 32.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.48 169.36 21.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.73 0.695 . . . . 0.0 110.185 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.31 148.05 33.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.906 1.282 . . . . 0.0 110.546 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.4 161.16 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.821 1.248 . . . . 0.0 108.792 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -61.83 129.11 39.41 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.414 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.15 -10.43 70.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.158 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.46 77.3 1.76 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.295 -2.484 . . . . 0.0 104.295 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.4 -9.49 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.345 2.258 . . . . 0.0 113.336 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.54 127.32 37.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.02 1.328 . . . . 0.0 109.207 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.04 114.14 4.98 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.3 pt -110.08 151.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.349 0.977 . . . . 0.0 110.412 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 mm -66.12 109.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 108.084 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -80.1 -28.55 39.02 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.682 -0.636 . . . . 0.0 110.967 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.4 ' HG ' ' HB2' ' A' ' 106' ' ' PRO . 3.5 t -170.51 174.0 5.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 109.476 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.68 144.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.617 1.967 . . . . 0.0 107.28 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.5 m -138.38 104.06 5.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.236 1.414 . . . . 0.0 107.612 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -78.81 150.5 32.31 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.871 -1.143 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.48 120.51 16.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -109.25 164.6 12.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.866 0.841 . . . . 0.0 112.895 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -63.68 -25.39 68.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.198 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -79.56 -5.5 55.07 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.531 -0.731 . . . . 0.0 110.727 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.77 2.68 62.83 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.833 1.206 . . . . 0.0 111.307 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -67.06 135.27 53.41 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.84 109.87 10.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.8 p -75.96 156.68 84.16 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.68 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.84 165.14 33.6 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 106.814 -2.033 . . . . 0.0 106.814 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HB2' ' HG ' ' A' ' 93' ' ' SER . 56.3 Cg_endo -66.71 108.5 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.069 2.512 . . . . 0.0 107.393 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -79.83 71.42 6.5 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.49 -130.87 3.46 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 tp -139.78 105.9 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.732 2.013 . . . . 0.0 106.649 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 1.5 mt-10 -59.52 148.56 32.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.66 178.82 5.87 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 109.328 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.06 -54.88 35.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.59 130.76 48.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 1.1 ptpm? -160.18 166.47 29.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -150.43 160.4 43.78 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.89 2.076 . . . . 0.0 107.01 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.68 118.83 5.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -105.82 140.06 39.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 172.51 17.28 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 126.988 2.115 . . . . 0.0 108.875 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.05 175.81 7.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.913 1.685 . . . . 0.0 111.243 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -145.75 -15.39 0.48 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.081 0.553 . . . . 0.0 111.982 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.61 1.48 6.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.307 1.443 . . . . 0.0 110.871 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.01 108.48 0.99 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.39 162.96 36.75 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -110.23 159.08 17.71 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.083 1.353 . . . . 0.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.0 tt -72.86 130.13 39.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.15 -14.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.37 47.43 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -135.69 171.71 14.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.758 1.223 . . . . 0.0 112.442 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CB ' ' CE3' ' A' ' 15' ' ' TRP . 10.7 p80 -164.37 168.65 18.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.953 1.301 . . . . 0.0 109.986 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.92 -82.33 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 170.93 86.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 C-N-CA 129.359 3.064 . . . . 0.0 108.136 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -137.16 164.59 28.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.8 -99.45 0.12 Allowed Glycine 0 C--O 1.227 -0.341 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.42 -0.19 40.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.706 0.802 . . . . 0.0 113.154 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.54 166.51 26.93 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 126.19 1.796 . . . . 0.0 106.587 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -94.49 81.89 3.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -79.41 -64.75 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.584 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.45 131.18 35.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.451 0.7 . . . . 0.0 110.697 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 tp -155.38 173.64 16.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.554 0.692 . . . . 0.0 111.059 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.78 161.61 34.38 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 127.482 2.468 . . . . 0.0 107.902 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.56 159.56 35.96 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.357 1.063 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -121.91 159.01 27.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.515 0.726 . . . . 0.0 111.237 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -135.87 97.23 3.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.415 ' HB2' ' H ' ' A' ' 2' ' ' GLN . . . -147.14 160.72 42.1 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 127.005 2.122 . . . . 0.0 111.205 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -134.95 148.34 50.0 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.964 1.306 . . . . 0.0 107.663 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -153.82 -176.98 6.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.434 1.094 . . . . 0.0 108.412 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 m -87.76 -135.02 0.09 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.036 2.135 . . . . 0.0 106.357 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.48 144.53 28.46 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 120.431 -1.418 . . . . 0.0 111.51 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.53 145.11 23.16 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.701 2.267 . . . . 0.0 107.923 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 23.3 t -145.88 158.31 12.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 64.9 p -136.76 144.94 48.91 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.327 1.051 . . . . 0.0 108.683 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -82.31 174.79 9.61 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.933 2.422 . . . . 0.0 109.627 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.93 169.24 17.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.011 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -98.38 147.53 24.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.329 0.651 . . . . 0.0 109.445 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -113.58 146.0 40.38 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -111.06 -176.4 2.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.137 0.975 . . . . 0.0 109.768 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 122.9 48.67 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.842 1.257 . . . . 0.0 110.515 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.57 177.61 8.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.252 1.421 . . . . 0.0 111.604 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.46 160.9 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 125.7 1.6 . . . . 0.0 108.096 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.77 -102.26 0.14 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 125.771 1.653 . . . . 0.0 111.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 163' ' ' GLU . . . 61.65 -117.44 11.56 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 65.65 -25.82 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 128.875 2.87 . . . . 0.0 114.481 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 161' ' ' GLY . 1.7 tm-20 -132.25 148.0 52.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.043 1.737 . . . . 0.0 108.88 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.08 176.17 15.05 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 128.212 2.815 . . . . 0.0 107.363 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.0 m -80.8 142.04 34.12 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.71 110.14 14.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.87 130.79 9.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 120.034 1.288 . . . . 0.0 113.355 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.4 148.75 23.38 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.73 -27.85 17.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.321 1.448 . . . . 0.0 109.255 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 83.24 -147.55 24.64 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.95 138.86 18.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 194' ' ' TYR . 69.1 m-85 -111.76 179.85 3.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.97 0.508 . . . . 0.0 111.849 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.96 -36.5 62.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.952 0.882 . . . . 0.0 110.361 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.24 -177.31 44.22 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 127.929 2.68 . . . . 0.0 107.504 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 20.9 m -121.94 157.79 25.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 125.989 1.716 . . . . 0.0 108.033 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -50.64 2.14 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.529 0.604 . . . . 0.0 109.591 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -140.93 140.23 34.44 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 118.791 0.723 . . . . 0.0 109.736 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.53 142.1 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -133.95 152.7 51.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.507 0.723 . . . . 0.0 109.181 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.71 144.8 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -140.42 134.54 6.54 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -141.2 174.43 10.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.921 0.867 . . . . 0.0 112.093 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.62 -172.85 13.13 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 128.591 2.996 . . . . 0.0 106.41 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -65.56 -23.75 66.93 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.044 -0.68 . . . . 0.0 110.661 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -17.58 60.65 Favored 'General case' 0 N--CA 1.451 -0.38 1 C-N-CA 132.083 4.153 . . . . 0.0 112.8 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.82 -163.04 12.37 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mm -62.38 124.12 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.09 -19.09 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.752 1.221 . . . . 0.0 113.908 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.26 150.04 47.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.458 1.026 . . . . 0.0 111.846 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.63 142.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -164.48 168.56 18.25 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.959 2.504 . . . . 0.0 106.565 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.14 175.5 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.34 128.77 38.39 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.427 ' CE2' ' CD1' ' A' ' 172' ' ' TYR . 20.0 p90 -153.26 168.32 26.4 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.991 0.917 . . . . 0.0 110.236 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -115.91 149.32 38.9 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.615 1.566 . . . . 0.0 109.567 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -125.93 123.87 39.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 60.83 -98.83 0.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.36 18.29 5.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 112.293 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -130.51 125.09 33.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.977 0.911 . . . . 0.0 111.281 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -75.76 153.43 37.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.464 1.106 . . . . 0.0 108.582 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.03 136.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.684 1.594 . . . . 0.0 107.147 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.21 128.66 72.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 149.07 -120.98 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.12 -10.26 8.08 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.025 1.774 . . . . 0.0 113.799 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.53 132.34 48.35 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.241 1.52 . . . . 0.0 109.786 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -154.93 -40.85 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.578 0.751 . . . . 0.0 112.258 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.99 151.11 36.68 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 107.314 -2.315 . . . . 0.0 107.314 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -37.79 99.59 0.19 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.529 2.331 . . . . 0.0 114.775 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.29 151.55 54.52 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.9 m -122.97 152.64 40.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.01 -11.56 40.43 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.854 -0.529 . . . . 0.0 111.172 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.77 -24.97 67.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.29 1.836 . . . . 0.0 109.497 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.21 -156.77 17.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -139.52 152.97 47.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 106.21 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.19 154.16 21.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.63 157.07 44.37 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.899 0.48 . . . . 0.0 112.134 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -142.58 139.94 31.54 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.235 1.014 . . . . 0.0 110.606 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.65 125.98 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.77 110.59 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.94 89.18 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -36.16 -52.69 1.65 Allowed Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.89 -14.39 15.47 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.32 2.013 . . . . 0.0 114.515 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -93.66 -40.71 10.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.663 1.574 . . . . 0.0 109.404 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -92.19 172.25 8.54 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 107.418 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -146.42 -20.32 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.797 -1.189 . . . . 0.0 112.325 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp 49.88 88.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 127.922 2.489 . . . . 0.0 109.036 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.0 p -90.13 -4.46 57.29 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.76 163.13 34.89 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.16 153.28 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.267 1.427 . . . . 0.0 107.49 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.4 178.22 7.09 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.196 1.798 . . . . 0.0 109.776 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.49 -179.54 40.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.6 p -141.08 141.13 34.28 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -134.87 153.26 52.12 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.951 0.5 . . . . 0.0 111.751 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.442 ' OD1' ' HE2' ' A' ' 235' ' ' LYS . 2.6 t0 -136.29 170.91 15.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.202 1.001 . . . . 0.0 109.558 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.442 ' HE2' ' OD1' ' A' ' 234' ' ' ASP . 0.0 OUTLIER -88.55 147.98 24.33 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.88 1.272 . . . . 0.0 112.732 -178.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.62 117.47 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -63.01 145.09 56.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 79.29 1.5 86.0 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.283 -0.731 . . . . 0.0 112.729 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 m -138.17 -177.5 4.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.995 2.118 . . . . 0.0 108.511 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.8 87.74 2.31 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.54 -176.25 39.26 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.022 -1.049 . . . . 0.0 111.012 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.69 149.66 49.43 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.081 0.952 . . . . 0.0 111.276 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.7 tt -134.18 130.5 54.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.962 1.705 . . . . 0.0 106.792 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.31 128.72 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.4 t -111.84 -18.79 12.62 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.723 1.209 . . . . 0.0 111.827 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -144.61 154.52 42.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.905 0.482 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.36 143.17 30.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.272 1.829 . . . . 0.0 109.195 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -142.79 153.78 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -128.54 113.48 15.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -77.89 113.71 16.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 p -98.24 164.76 12.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.924 2.089 . . . . 0.0 108.559 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -112.65 147.26 37.11 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 57.86 11.34 1.36 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -155.5 147.64 23.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.074 1.749 . . . . 0.0 106.934 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.5 p -113.14 100.24 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.438 1.495 . . . . 0.0 108.619 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -65.38 161.55 19.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.365 2.266 . . . . 0.0 114.441 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -105.2 163.1 17.84 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 127.186 2.195 . . . . 0.0 111.067 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.39 159.28 29.33 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.831 2.354 . . . . 0.0 110.415 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -137.3 110.91 8.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.96 -167.01 15.81 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 118.731 0.696 . . . . 0.0 112.417 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.48 110.6 23.0 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.906 1.283 . . . . 0.0 109.581 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -66.02 108.75 2.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.425 1.49 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.9 28.64 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.058 1.343 . . . . 0.0 109.529 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.88 -164.81 50.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 122.548 1.082 . . . . 0.0 114.236 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 59.7 m -64.54 108.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.199 2.2 . . . . 0.0 109.095 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.75 142.31 38.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -141.45 170.95 14.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.391 1.091 . . . . 0.0 111.234 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.43 155.47 39.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.427 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.95 154.78 48.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -170.45 173.07 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.567 1.147 . . . . 0.0 107.911 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -139.47 165.94 25.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -43.77 71.48 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.845 0.748 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -161.03 72.23 0.22 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-O 118.995 -0.892 . . . . 0.0 111.835 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -151.05 158.03 43.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.325 1.063 . . . . 0.0 109.742 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -88.82 177.11 6.79 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.025 1.73 . . . . 0.0 108.717 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 37.8 mt -125.0 111.33 27.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.997 1.319 . . . . 0.0 108.608 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.27 93.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.255 2.222 . . . . 0.0 108.967 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.77 6.19 Favored Glycine 0 N--CA 1.468 0.771 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -120.6 135.65 55.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.224 1.809 . . . . 0.0 111.347 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -133.04 136.73 46.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 161.51 -159.93 31.76 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.926 -1.109 . . . . 0.0 112.64 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -137.21 127.4 26.22 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.21 154.68 19.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.94 1.296 . . . . 0.0 109.278 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 37.0 t -147.04 -98.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.71 -21.26 44.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.247 1.019 . . . . 0.0 111.456 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.3 mp -136.21 153.11 51.33 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.13 83.77 4.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.616 0.766 . . . . 0.0 111.225 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -78.94 -22.11 46.22 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.425 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.44 152.62 50.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.876 1.216 . . . . 0.0 113.12 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -162.69 134.9 5.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -158.82 169.67 35.18 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 135.15 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.852 0.826 . . . . 0.0 111.565 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -74.78 145.11 43.21 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.63 136.02 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.522 0.677 . . . . 0.0 110.548 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 70.3 mtp -138.62 137.06 19.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 129.372 3.069 . . . . 0.0 106.287 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.36 165.81 30.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.765 . . . . 0.0 109.589 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.55 -55.37 15.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 175.54 5.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.867 0.867 . . . . 0.0 111.388 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 126.733 2.013 . . . . 0.0 108.197 178.091 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -68.58 134.31 49.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -142.15 102.88 4.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.201 0.6 . . . . 0.0 109.886 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t -75.52 143.29 13.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -97.23 134.62 40.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.524 1.53 . . . . 0.0 111.587 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.29 167.63 19.05 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.762 1.225 . . . . 0.0 111.687 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.3 163.51 30.66 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.568 2.032 . . . . 0.0 108.562 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.08 -109.08 0.41 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 107.053 -2.419 . . . . 0.0 107.053 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.3 -171.43 15.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 125.318 1.437 . . . . 0.0 109.628 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.34 91.72 2.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.482 0.713 . . . . 0.0 110.253 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.59 18.77 3.01 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.167 1.365 . . . . 0.0 112.231 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.88 -177.73 16.5 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.724 1.262 . . . . 0.0 113.054 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.99 158.43 27.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.752 1.263 . . . . 0.0 111.616 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 p -63.29 131.96 50.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -134.41 -19.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.212 1.005 . . . . 0.0 110.64 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.85 100.71 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.5 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.46 1.504 . . . . 0.0 107.727 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -149.23 -163.2 10.83 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.058 1.313 . . . . 0.0 109.918 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.48 156.91 20.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.641 0.776 . . . . 0.0 109.822 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -137.63 -34.7 0.68 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.67 1.188 . . . . 0.0 109.454 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.3 p30 58.61 8.9 0.97 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.016 2.527 . . . . 0.0 114.756 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.69 5.68 68.6 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.514 1.53 . . . . 0.0 114.105 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.45 155.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.738 . . . . 0.0 108.978 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ttt-85 -130.86 -32.58 1.64 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -138.9 167.95 20.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.225 1.01 . . . . 0.0 109.555 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -139.46 85.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -87.83 135.29 33.46 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.88 148.62 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 127.473 2.309 . . . . 0.0 106.861 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.44 -157.87 10.65 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -134.08 164.2 27.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.732 0.766 . . . . 0.0 110.005 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.25 37.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 129.059 3.218 . . . . 0.0 105.97 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -91.68 -32.66 15.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.168 0.484 . . . . 0.0 110.131 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -101.11 -23.61 14.44 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 130.989 3.715 . . . . 0.0 114.094 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.56 -165.78 38.33 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.639 1.563 . . . . 0.0 112.97 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.71 96.07 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 107.956 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -75.54 -21.55 57.83 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -128.44 139.62 52.25 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.926 1.694 . . . . 0.0 113.728 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -145.28 154.01 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -140.4 137.99 34.43 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.89 159.07 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.489 1.041 . . . . 0.0 112.206 -178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.01 135.84 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -124.85 104.64 8.73 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.21 110.86 17.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.87 1.268 . . . . 0.0 108.852 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -116.74 139.55 50.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 61.54 -161.29 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.914 1.286 . . . . 0.0 109.176 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -73.07 24.78 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.246 1.418 . . . . 0.0 112.131 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -141.03 165.42 27.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.468 1.907 . . . . 0.0 111.34 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -107.84 140.25 41.21 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.81 133.73 48.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -66.95 129.02 38.54 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.45 -60.2 4.86 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.24 167.73 14.21 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -118.99 85.71 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.504 1.922 . . . . 0.0 107.561 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -83.83 170.41 14.14 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.871 0.843 . . . . 0.0 109.637 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.78 -166.12 42.79 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.479 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -111.33 102.72 11.09 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.801 1.241 . . . . 0.0 109.063 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -61.04 134.05 56.68 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 p -134.31 111.86 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.152 1.381 . . . . 0.0 109.566 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -8.24 13.37 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.08 -4.82 43.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.435 0.694 . . . . 0.0 111.692 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.89 110.46 0.28 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.68 143.15 19.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.064 2.946 . . . . 0.0 106.267 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.4 164.14 30.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.528 1.931 . . . . 0.0 110.876 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.3 m -128.03 128.5 45.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.774 1.63 . . . . 0.0 108.665 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -137.18 136.11 37.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.65 142.07 51.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.889 0.876 . . . . 0.0 109.144 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.4 t -98.34 110.5 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.73 161.36 30.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 109.137 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.97 -27.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -28.66 28.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -112.03 146.95 37.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -132.98 157.07 46.09 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.441 0.696 . . . . 0.0 109.783 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.29 138.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.34 -20.77 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.261 1.424 . . . . 0.0 111.851 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.0 156.31 42.51 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.349 -0.845 . . . . 0.0 109.346 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.71 100.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -86.31 122.49 30.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 101.353 -3.573 . . . . 0.0 101.353 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.09 153.91 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -136.52 151.91 49.94 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.048 1.739 . . . . 0.0 107.108 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.29 166.28 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.444 1.098 . . . . 0.0 110.409 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.19 169.17 22.79 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.769 1.168 . . . . 0.0 111.507 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -115.07 151.45 34.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.844 2.058 . . . . 0.0 110.71 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.34 126.91 74.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.28 121.9 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 108.745 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 -3.19 26.91 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.532 1.063 . . . . 0.0 112.183 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -132.13 144.82 50.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.369 1.467 . . . . 0.0 107.617 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.89 -21.5 23.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.22 0.608 . . . . 0.0 109.516 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -67.59 -177.65 0.78 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.373 1.559 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.39 151.59 34.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.52 144.73 28.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.34 0.656 . . . . 0.0 109.846 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.35 122.34 20.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -89.71 -28.99 19.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.041 0.936 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 t -163.11 160.87 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.448 1.476 . . . . 0.0 110.644 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.82 129.11 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 126.56 1.944 . . . . 0.0 108.55 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -135.49 101.45 4.81 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.115 1.366 . . . . 0.0 109.083 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -80.85 154.45 27.1 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.591 -1.318 . . . . 0.0 108.624 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.55 125.39 27.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.7 p -93.69 167.16 11.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.148 0.975 . . . . 0.0 111.668 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -65.94 -21.97 66.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -7.07 52.74 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.295 1.038 . . . . 0.0 111.686 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.6 -4.08 75.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 125.534 1.54 . . . . 0.0 111.587 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -79.35 149.59 31.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 118.492 1.146 . . . . 0.0 108.404 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.7 p -134.3 135.73 43.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.68 163.39 61.26 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.18 162.3 42.09 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.39 101.68 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.35 2.7 . . . . 0.0 108.546 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -73.45 78.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 145.48 -135.3 5.89 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.6 tp -139.43 127.91 22.95 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 127.06 2.144 . . . . 0.0 107.386 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.47 155.5 40.36 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.217 0.917 . . . . 0.0 110.917 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -142.45 164.51 29.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.068 0.947 . . . . 0.0 108.909 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -60.98 -40.89 95.2 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -70.43 112.14 6.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -155.17 160.23 40.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.197 -0.94 . . . . 0.0 111.327 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.92 165.81 35.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.607 0.763 . . . . 0.0 112.133 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.53 150.26 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.977 1.711 . . . . 0.0 106.454 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 mt -111.7 4.47 18.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -47.09 117.99 1.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.466 1.106 . . . . 0.0 112.975 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -73.32 175.91 6.46 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.004 1.722 . . . . 0.0 108.298 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.67 -11.41 8.64 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.015 -1.053 . . . . 0.0 112.684 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -78.57 -5.97 54.24 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.43 24.63 25.79 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.318 -0.712 . . . . 0.0 112.082 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.25 175.4 11.39 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.584 1.564 . . . . 0.0 112.86 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -132.45 152.84 51.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.82 141.11 58.4 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.45 -33.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.54 -169.5 35.96 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 120.601 -1.312 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.14 172.74 12.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.614 1.566 . . . . 0.0 111.205 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -164.99 149.39 9.02 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 127.955 2.502 . . . . 0.0 105.862 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.14 115.86 0.41 Allowed Glycine 0 C--O 1.221 -0.718 0 C-N-CA 119.616 -1.278 . . . . 0.0 116.001 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -48.97 110.96 0.41 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.533 1.533 . . . . 0.0 107.664 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.22 25.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.878 1.671 . . . . 0.0 108.53 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -168.93 -97.77 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -81.89 -8.19 59.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.16 24.5 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.648 1.979 . . . . 0.0 108.545 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.78 93.98 9.65 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.17 -72.99 0.27 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.992 0.917 . . . . 0.0 111.092 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.2 143.8 38.14 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.296 1.039 . . . . 0.0 109.953 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.7 tp -134.67 115.49 13.85 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.291 1.037 . . . . 0.0 109.641 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -130.87 174.31 19.9 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.158 1.361 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.4 175.43 11.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.617 0.767 . . . . 0.0 110.473 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -117.15 133.54 55.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -126.56 99.32 5.76 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 128.017 2.527 . . . . 0.0 108.581 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.6 162.68 36.93 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.544 1.138 . . . . 0.0 108.666 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.257 1.8 t -134.56 166.39 23.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.876 -0.515 . . . . 0.0 110.994 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 9.23 3.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.158 2.183 . . . . 0.0 109.839 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.0 p -64.37 89.1 0.06 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 126.24 1.816 . . . . 0.0 110.776 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 29.0 p -147.57 154.42 44.7 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.271 1.428 . . . . 0.0 107.511 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.95 162.74 38.5 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.14 1.893 . . . . 0.0 110.868 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.17 124.86 29.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.351 1.06 . . . . 0.0 108.185 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.0 p -136.67 157.29 75.34 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.323 0.649 . . . . 0.0 111.156 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.52 -173.07 1.65 Allowed 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.445 4.096 . . . . 0.0 112.714 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.43 -179.5 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.561 1.545 . . . . 0.0 112.231 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -145.76 151.51 38.09 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.484 1.513 . . . . 0.0 108.729 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -112.18 133.66 54.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.227 2.211 . . . . 0.0 106.642 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.99 -173.94 3.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.24 1.016 . . . . 0.0 109.332 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 128.46 44.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -121.19 -179.87 4.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.885 1.274 . . . . 0.0 109.59 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.92 146.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.639 1.176 . . . . 0.0 107.904 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.85 -94.31 0.11 Allowed Glycine 0 C--O 1.228 -0.273 0 C-N-CA 124.979 1.276 . . . . 0.0 110.414 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.57 -157.44 19.19 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.434 ' CA ' ' HE2' ' A' ' 282' ' ' LYS . 6.7 p-10 -116.83 -4.68 11.57 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.867 1.667 . . . . 0.0 111.47 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.37 112.27 11.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.137 2.175 . . . . 0.0 111.669 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.58 161.94 10.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 124.807 1.194 . . . . 0.0 111.729 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.2 m -81.76 142.39 32.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.63 138.05 56.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -125.7 32.36 5.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.16 104.77 3.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -83.79 -50.27 8.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.689 0.795 . . . . 0.0 111.455 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.66 -123.32 1.85 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.25 160.94 43.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.878 2.071 . . . . 0.0 107.865 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.93 163.66 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.196 0.998 . . . . 0.0 109.826 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.27 -32.4 72.54 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.57 102.97 0.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.299 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.5 m -71.25 152.29 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -40.95 5.29 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -140.71 153.17 45.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.674 1.124 . . . . 0.0 108.402 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.24 143.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -126.65 164.18 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.416 0.687 . . . . 0.0 112.551 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.51 128.02 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.47 89.4 0.38 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.928 1.728 . . . . 0.0 111.626 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -74.8 -177.9 3.46 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.893 1.33 . . . . 0.0 112.916 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.08 177.13 35.77 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 128.488 2.947 . . . . 0.0 107.603 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -62.53 -45.83 91.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.261 0.625 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.81 -32.54 57.69 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.336 1.455 . . . . 0.0 110.294 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.55 -168.09 32.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 121.996 0.776 . . . . 0.0 111.321 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.76 119.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.9 m -108.22 -29.08 9.1 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.52 25.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.595 0.758 . . . . 0.0 109.766 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.53 141.7 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.45 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 58.8 pttt -161.39 159.08 27.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.091 0.957 . . . . 0.0 110.256 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.84 174.35 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 108.11 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.95 147.34 33.63 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.343 1.857 . . . . 0.0 108.035 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 196' ' ' LYS . 7.7 t80 -147.45 153.52 39.68 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -128.09 92.21 3.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.531 2.332 . . . . 0.0 105.803 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 19.4 ptmt -89.19 139.72 30.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 49.85 46.4 40.18 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.457 1.027 . . . . 0.0 112.15 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.67 3.88 0.67 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.277 1.831 . . . . 0.0 115.562 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.17 -158.53 0.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.307 1.443 . . . . 0.0 107.312 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -136.73 139.0 41.57 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.376 1.444 . . . . 0.0 110.635 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.8 mt -125.5 122.91 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.806 1.642 . . . . 0.0 107.22 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 27.8 t -112.41 134.86 53.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.98 -119.37 3.28 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.49 5.69 66.81 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.242 1.401 . . . . 0.0 114.002 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.36 118.78 11.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.472 1.509 . . . . 0.0 111.34 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -123.14 13.16 9.65 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 0.0 111.344 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.53 -178.53 21.98 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.744 1.64 . . . . 0.0 109.229 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -106.16 102.8 41.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.065 0.932 . . . . 0.0 110.945 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.18 -175.36 2.67 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.671 2.247 . . . . 0.0 108.427 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.1 p -116.18 174.18 6.19 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.52 -9.39 34.29 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.308 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.74 -27.71 68.14 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.965 0.802 . . . . 0.0 110.371 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.23 -155.51 17.0 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.45 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 41.6 m-85 -134.1 172.18 13.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.435 1.494 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.67 160.8 31.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.49 2.716 . . . . 0.0 105.686 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -137.59 153.61 49.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.307 0.643 . . . . 0.0 111.709 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 256' ' ' SER . 27.7 t80 -142.66 143.05 32.18 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.06 0.944 . . . . 0.0 110.228 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -78.52 115.3 18.13 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.761 1.625 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.36 104.25 11.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -105.75 88.15 2.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -55.29 -33.46 17.63 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.083 -1.436 . . . . 0.0 114.695 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.4 -3.26 12.08 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 CA-C-N 123.585 2.316 . . . . 0.0 111.991 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m -132.44 -8.18 3.29 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 113.31 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -140.47 159.94 41.09 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.525 1.93 . . . . 0.0 110.542 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -144.25 119.93 10.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.422 1.089 . . . . 0.0 109.136 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.3 mt -81.88 94.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -24.16 45.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.22 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -146.72 167.8 22.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.167 0.987 . . . . 0.0 111.362 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.74 150.45 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.906 1.682 . . . . 0.0 106.481 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.426 ' OE1' ' HE3' ' A' ' 250' ' ' LYS . 36.6 mt-10 -132.87 160.44 36.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.398 1.079 . . . . 0.0 108.247 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -177.82 164.74 33.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.6 p -130.9 148.96 52.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -142.34 146.83 35.42 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.548 0.739 . . . . 0.0 109.863 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -130.57 155.2 46.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -69.55 147.11 51.22 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.139 0.976 . . . . 0.0 112.358 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.99 115.9 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -52.64 133.54 36.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.278 0.561 . . . . 0.0 110.522 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.58 82.99 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.389 -1.228 . . . . 0.0 113.086 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.8 t -140.81 169.89 16.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.389 1.595 . . . . 0.0 109.391 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.51 -12.17 38.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.533 1.533 . . . . 0.0 108.183 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -74.08 175.65 47.82 Favored Glycine 0 C--N 1.345 1.062 0 C-N-CA 127.195 2.331 . . . . 0.0 112.16 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.02 169.67 20.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 111.883 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.25 143.74 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.688 1.595 . . . . 0.0 108.467 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -91.38 105.9 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.329 1.0 OUTLIER -104.11 -3.81 24.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.606 0.639 . . . . 0.0 112.165 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -149.52 143.55 25.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.036 -1.04 . . . . 0.0 111.568 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.9 mt -137.49 154.79 49.82 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.999 1.72 . . . . 0.0 111.031 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -142.48 170.84 14.96 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.494 2.317 . . . . 0.0 109.003 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -148.21 113.76 5.65 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.674 1.19 . . . . 0.0 109.406 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.426 ' HE3' ' OE1' ' A' ' 230' ' ' GLU . 67.1 mttt -77.05 114.47 15.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 5.2 p -109.9 165.84 11.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 127.059 2.144 . . . . 0.0 108.272 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -116.95 140.37 49.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 63.17 -8.29 0.14 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.306 1.442 . . . . 0.0 113.739 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -117.07 169.01 9.75 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.735 2.014 . . . . 0.0 107.852 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -130.98 108.16 9.6 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 123.622 0.769 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.406 ' HA ' ' CE1' ' A' ' 217' ' ' PHE . 4.5 p -79.82 -178.13 6.27 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.825 1.25 . . . . 0.0 109.411 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.87 69.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.12 0.968 . . . . 0.0 110.034 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.97 101.92 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.057 2.504 . . . . 0.0 109.357 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -79.48 95.45 5.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 122.12 -169.64 14.88 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.7 122.32 47.31 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.129 0.972 . . . . 0.0 109.099 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.42 113.26 2.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.864 1.666 . . . . 0.0 110.509 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -154.99 149.0 25.78 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.347 1.459 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 74.89 -165.15 54.72 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 121.869 0.705 . . . . 0.0 114.171 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 21.8 m -62.97 137.97 58.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.523 1.929 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -108.59 121.71 45.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.54 43.21 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.56 0.744 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.97 130.45 43.42 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.602 1.961 . . . . 0.0 107.302 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.8 mt -119.22 129.74 55.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -149.38 171.35 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -138.4 147.09 42.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.17 -4.67 30.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.295 1.438 . . . . 0.0 114.851 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -167.72 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -92.57 168.1 11.48 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.854 1.827 . . . . 0.0 110.698 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.49 162.75 13.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.717 2.007 . . . . 0.0 110.387 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 21.6 mt -88.64 112.57 24.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.507 1.123 . . . . 0.0 108.892 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.37 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.26 153.12 8.93 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 125.383 1.468 . . . . 0.0 111.946 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -121.86 160.21 25.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.909 2.084 . . . . 0.0 108.779 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -159.29 176.89 11.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.615 0.766 . . . . 0.0 110.262 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 119.12 -111.29 2.05 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 126.549 2.023 . . . . 0.0 108.665 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 282' ' ' LYS . 10.1 mtmp? -146.26 153.55 40.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.854 . . . . 0.0 112.498 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.92 131.22 34.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.132 1.773 . . . . 0.0 107.064 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.8 p -171.6 75.29 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 67.33 -70.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.873 2.469 . . . . 0.0 110.356 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 70.2 mt -81.33 172.56 13.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.217 2.207 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.7 tp -94.51 64.35 3.06 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.206 1.402 . . . . 0.0 109.688 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -61.4 -17.62 54.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -153.55 165.87 34.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -160.5 122.81 3.23 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -155.81 163.61 31.84 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.1 m -133.84 152.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.014 0.907 . . . . 0.0 113.116 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -85.25 167.71 15.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.969 1.708 . . . . 0.0 111.156 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.95 148.3 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.936 1.694 . . . . 0.0 109.092 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 92.1 mmm -152.99 149.07 21.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.634 1.973 . . . . 0.0 107.729 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.76 157.95 54.24 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.813 1.676 . . . . 0.0 110.037 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.41 29.51 1.26 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.341 1.056 . . . . 0.0 108.565 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.3 m -141.28 164.35 30.47 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.254 2.222 . . . . 0.0 105.585 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 C--O 1.247 0.936 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 179.215 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 C--O 1.237 0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -148.56 102.35 3.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.049 0.94 . . . . 0.0 108.889 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.5 t -77.0 146.47 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 123.803 0.841 . . . . 0.0 109.209 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.96 148.85 25.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.621 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.93 76.22 5.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.278 1.831 . . . . 0.0 109.66 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.84 113.52 4.81 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.9 35.39 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 118.215 1.007 . . . . 0.0 111.389 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.04 178.79 36.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.889 0.756 . . . . 0.0 113.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.6 87.19 2.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.921 1.289 . . . . 0.0 109.751 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.36 21.31 3.47 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.722 1.153 . . . . 0.0 112.386 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.22 -169.14 20.04 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 118.879 1.34 . . . . 0.0 113.446 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.52 105.02 3.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.221 1.809 . . . . 0.0 108.687 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 7.8 m -171.7 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.615 1.966 . . . . 0.0 113.926 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -65.35 -173.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.542 1.937 . . . . 0.0 110.494 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.68 109.19 0.2 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.103 1.361 . . . . 0.0 114.634 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.53 172.3 13.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.343 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.982 -179.115 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.88 158.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.354 1.862 . . . . 0.0 109.979 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -140.07 -42.94 0.42 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.251 1.42 . . . . 0.0 113.674 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -142.5 150.32 40.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 120.528 1.513 . . . . 0.0 109.884 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.6 t -126.24 137.1 58.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.39 139.52 52.33 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' H ' ' HB2' ' A' ' 63' ' ' GLU . 42.8 t -140.6 94.01 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.08 108.44 3.44 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -71.49 110.78 6.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.9 2.08 . . . . 0.0 108.036 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.65 -173.98 38.37 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.28 -31.3 61.47 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.21 6.63 7.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 158.62 -175.79 35.63 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.531 1.514 . . . . 0.0 111.279 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.33 96.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.115 1.957 . . . . 0.0 108.755 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -97.86 -6.62 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.948 -1.501 . . . . 0.0 114.209 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.8 p -140.91 146.45 37.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 122.173 2.26 . . . . 0.0 112.609 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.0 171.4 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.718 1.607 . . . . 0.0 109.767 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -151.87 141.24 21.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -130.13 113.95 27.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 119.515 1.052 . . . . 0.0 109.409 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.25 154.24 13.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.525 0.73 . . . . 0.0 109.593 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -132.92 155.86 48.31 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.39 122.01 40.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 108.473 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.6 167.72 9.93 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.399 1.079 . . . . 0.0 108.314 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.12 5.29 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.852 5.661 . . . . 0.0 116.424 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.4 t -151.0 -67.96 0.18 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.874 2.07 . . . . 0.0 108.891 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -139.71 166.18 25.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.847 1.259 . . . . 0.0 111.558 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -78.01 162.95 26.36 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.73 2.012 . . . . 0.0 109.406 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.37 136.59 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -121.6 162.28 20.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.595 1.558 . . . . 0.0 109.036 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 144.46 21.49 0.16 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 128.695 3.045 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.46 20.3 45.03 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.08 121.62 19.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.473 1.637 . . . . 0.0 109.142 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.79 171.56 12.57 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 110.094 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.03 -153.49 41.81 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 98.7 5.25 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 120.421 -1.635 . . . . 0.0 113.169 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.47 149.95 49.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.3 t -144.57 158.74 43.63 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.2 -19.33 65.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.996 0.918 . . . . 0.0 112.155 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.39 15.34 26.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.765 1.226 . . . . 0.0 110.487 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.07 90.88 0.11 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.305 0.957 . . . . 0.0 112.813 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -164.0 153.16 13.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.188 2.195 . . . . 0.0 107.62 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 28' ' ' VAL . 5.4 mm-40 -144.22 164.7 29.97 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.55 1.54 . . . . 0.0 110.208 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -143.01 128.85 19.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -137.16 109.69 7.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.82 117.14 27.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.68 110.67 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.92 157.74 20.88 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.277 1.431 . . . . 0.0 111.627 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -16.02 63.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.201 1.4 . . . . 0.0 110.008 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.56 6.44 15.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.687 2.395 . . . . 0.0 110.71 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.84 141.81 31.99 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.684 -1.26 . . . . 0.0 108.969 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CD1' ' HE2' ' A' ' 124' ' ' LYS . 54.3 m-85 -134.27 114.57 13.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -85.5 106.93 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -92.54 -21.47 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.376 1.07 . . . . 0.0 113.777 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.93 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.232 0.924 . . . . 0.0 110.472 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.44 144.67 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.36 119.75 40.21 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.95 128.19 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.681 1.128 . . . . 0.0 109.012 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.733 HG21 ' H ' ' A' ' 111' ' ' THR . 70.3 m -121.86 152.1 39.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.637 1.975 . . . . 0.0 109.42 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.63 168.38 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.042 1.737 . . . . 0.0 109.181 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -156.59 164.71 37.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -144.41 137.86 27.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.818 2.047 . . . . 0.0 108.337 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.8 m -132.87 161.05 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.0 104.26 0.23 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.945 1.298 . . . . 0.0 112.021 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.36 -21.76 8.06 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 124.694 1.14 . . . . 0.0 113.342 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -80.68 85.9 5.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.4 -5.01 29.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.49 1.116 . . . . 0.0 111.161 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -131.88 95.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.041 2.136 . . . . 0.0 105.575 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -54.58 147.48 14.22 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 pt -133.41 169.51 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.223 1.011 . . . . 0.0 112.657 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 94' ' ' ILE . 1.6 mt -85.33 148.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.678 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -69.06 0.89 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.1 p -123.04 147.98 46.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.47 HD12 HD23 ' A' ' 139' ' ' LEU . 43.5 mm -131.4 148.53 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 m -151.06 104.19 3.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.02 144.77 31.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.13 113.3 13.72 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 p -92.01 165.82 13.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -76.55 -27.41 55.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -69.29 -7.21 34.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 111.75 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.37 5.5 57.97 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 125.945 1.736 . . . . 0.0 113.251 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -87.49 137.98 31.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.512 1.156 . . . . 0.0 108.869 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 110.75 9.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.66 155.26 89.26 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.32 169.59 18.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.396 2.064 . . . . 0.0 110.619 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 111.13 2.44 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 107.921 -1.607 . . . . 0.0 107.921 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -67.7 14.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.8 2.04 . . . . 0.0 113.917 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 177.17 -175.95 47.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 126.242 1.877 . . . . 0.0 109.92 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.8 tp -72.73 108.1 5.54 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.707 1.603 . . . . 0.0 114.027 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.38 128.17 34.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.733 ' H ' HG21 ' A' ' 79' ' ' THR . 34.3 m -130.57 165.06 23.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.814 1.646 . . . . 0.0 108.815 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -57.05 -52.3 65.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.51 1.524 . . . . 0.0 111.446 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -61.94 102.88 0.31 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 109.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.47 170.19 21.47 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.187 0.518 . . . . 0.0 110.465 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -142.12 164.79 29.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.87 135.56 42.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.576 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.39 123.93 18.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.701 0.801 . . . . 0.0 110.991 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.93 39.23 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.293 1.437 . . . . 0.0 107.89 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.85 122.28 43.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.304 0.642 . . . . 0.0 110.734 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -119.7 -22.1 7.01 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.603 1.561 . . . . 0.0 110.414 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -67.62 -22.04 65.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.365 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.96 -10.4 6.65 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.984 -1.454 . . . . 0.0 114.62 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.75 162.81 33.81 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 120.083 1.942 . . . . 0.0 112.167 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 72' ' ' TYR . 35.4 ttmt -126.66 143.03 51.36 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.59 146.71 39.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 -28.88 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.31 -151.91 9.53 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.31 171.17 14.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.903 0.859 . . . . 0.0 112.528 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -144.31 159.7 42.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.484 1.914 . . . . 0.0 106.579 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.03 110.09 2.08 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.304 0.954 . . . . 0.0 115.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -53.27 131.38 37.24 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.601 1.96 . . . . 0.0 107.071 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 14' ' ' SER . . . -154.43 164.98 37.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.462 1.505 . . . . 0.0 108.397 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.91 -101.67 0.16 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.4 -40.08 77.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.192 0.996 . . . . 0.0 110.238 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -125.41 153.31 43.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.22 98.52 10.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -74.2 -46.51 41.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.372 0.669 . . . . 0.0 110.994 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.51 165.4 31.33 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 110.46 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.47 HD23 HD12 ' A' ' 94' ' ' ILE . 36.3 tp -147.89 159.11 44.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.402 1.481 . . . . 0.0 107.691 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.85 21.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.76 133.78 24.15 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -82.22 168.34 17.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -130.31 163.56 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.524 -0.735 . . . . 0.0 110.508 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.362 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.78 134.73 35.11 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.339 1.056 . . . . 0.0 110.388 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -87.02 146.59 26.06 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.9 mt -113.65 -166.66 1.11 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.2 m -146.32 125.89 13.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.84 -159.47 0.69 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.694 2.398 . . . . 0.0 108.67 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.9 tt -149.04 151.57 12.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.95 -38.77 0.42 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.842 0.746 . . . . 0.0 114.442 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.56 162.01 25.41 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.113 1.457 . . . . 0.0 112.85 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 49.2 p30 -112.73 0.88 15.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.076 1.75 . . . . 0.0 112.851 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -131.71 135.43 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.637 1.108 . . . . 0.0 109.86 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 132.6 159.13 9.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 127.713 2.577 . . . . 0.0 109.125 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.5 m -67.9 134.37 50.72 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 112.267 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.74 135.22 36.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -127.68 33.46 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.093 1.357 . . . . 0.0 110.475 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -58.03 107.63 0.49 Allowed 'General case' 0 C--N 1.334 -0.095 0 O-C-N 120.775 -1.203 . . . . 0.0 112.48 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.72 -16.73 60.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.986 0.914 . . . . 0.0 110.274 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 -75.14 1.53 Allowed Glycine 0 C--N 1.337 0.612 0 CA-C-O 118.522 -1.155 . . . . 0.0 110.53 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.89 146.81 2.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.426 2.291 . . . . 0.0 109.02 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -124.86 167.19 14.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.893 2.077 . . . . 0.0 106.831 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -24.36 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.92 -174.73 42.25 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.63 116.59 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.63 -39.03 8.08 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.642 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -145.42 150.63 36.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.559 HG13 ' CE2' ' A' ' 192' ' ' PHE . 41.2 t -132.46 150.36 33.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.925 0.89 . . . . 0.0 109.084 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -142.48 155.63 45.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.823 1.249 . . . . 0.0 108.677 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.59 130.49 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.84 93.43 0.54 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -70.67 155.66 40.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.117 0.961 . . . . 0.0 110.076 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.35 -167.82 14.89 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 126.674 2.083 . . . . 0.0 109.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -89.16 -9.05 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.326 -1.102 . . . . 0.0 110.9 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -117.25 -31.85 5.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.507 3.123 . . . . 0.0 113.686 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.07 -158.3 30.59 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.62 110.61 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 62.6 m -116.39 -12.71 11.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.017 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.21 130.75 29.25 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.91 1.232 . . . . 0.0 110.143 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.97 135.82 50.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -148.44 139.81 23.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 178' ' ' VAL . 14.2 m-85 -132.92 163.25 29.57 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.74 1.616 . . . . 0.0 109.13 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -123.03 150.99 42.35 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -161.29 167.95 24.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.252 1.021 . . . . 0.0 111.726 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -120.28 113.01 19.76 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -107.19 122.52 46.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.31 -84.19 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.73 -4.95 1.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.912 2.085 . . . . 0.0 110.799 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.4 168.28 20.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.57 1.548 . . . . 0.0 110.455 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.92 101.93 5.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.445 2.698 . . . . 0.0 105.94 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.78 118.18 36.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.264 1.026 . . . . 0.0 109.35 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.19 128.53 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 128.3 -140.13 11.56 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 110.06 9.86 23.47 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.433 1.117 . . . . 0.0 115.851 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -68.58 108.53 3.37 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.739 1.77 . . . . 0.0 109.499 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -129.2 27.14 5.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.084 2.153 . . . . 0.0 109.774 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -145.06 -178.74 20.88 Favored Glycine 0 N--CA 1.451 -0.322 0 O-C-N 120.444 -1.41 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -85.36 94.64 0.33 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.809 1.244 . . . . 0.0 111.024 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.4 162.51 38.51 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.571 1.597 . . . . 0.0 108.047 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.9 m -137.48 166.32 24.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -2.59 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.0 -7.16 47.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.405 1.082 . . . . 0.0 109.202 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.56 -148.92 32.84 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -141.65 157.28 45.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 108.436 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.57 154.7 28.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 128.523 2.729 . . . . 0.0 104.052 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.05 140.12 23.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.02 132.24 23.24 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.312 1.045 . . . . 0.0 108.491 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -105.61 97.02 6.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.45 141.24 15.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.98 88.76 4.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -49.02 -55.6 19.81 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 113.876 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.25 -9.62 21.93 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.51 1.575 . . . . 0.0 114.578 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.42 -38.05 6.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.63 1.105 . . . . 0.0 113.88 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 172.62 10.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.0 112.678 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -150.15 149.03 29.67 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.65 -0.656 . . . . 0.0 112.543 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.04 100.16 7.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.5 t -73.17 -29.13 62.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.525 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.04 170.63 16.29 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.71 1.604 . . . . 0.0 108.646 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.72 150.65 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.655 1.182 . . . . 0.0 108.366 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -133.77 166.76 21.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.786 2.035 . . . . 0.0 109.245 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.45 166.93 28.35 Favored Glycine 0 N--CA 1.452 -0.265 0 O-C-N 120.968 -1.083 . . . . 0.0 110.823 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 79.1 p -137.1 133.95 35.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -117.31 138.22 51.91 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 109.77 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -119.14 146.85 44.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.098 0.952 . . . . 0.0 108.586 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -69.68 129.11 38.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 112.948 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.8 155.42 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -93.33 173.63 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 77.41 -25.69 1.97 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.301 1.429 . . . . 0.0 114.62 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 11.9 p -141.56 168.85 18.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.542 1.671 . . . . 0.0 109.715 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -84.4 11.73 8.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 110.648 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.46 -175.78 27.4 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.788 1.185 . . . . 0.0 112.939 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.5 mt -149.23 166.67 28.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.662 1.985 . . . . 0.0 109.335 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.15 172.78 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.12 112.97 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.12 1.368 . . . . 0.0 108.994 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.55 -4.42 19.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.569 0.748 . . . . 0.0 112.742 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.3 tmm? -147.7 110.98 4.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 17.7 mt -125.75 132.72 52.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.14 1.376 . . . . 0.0 108.363 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -129.04 166.15 19.78 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.647 1.213 . . . . 0.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.01 134.83 44.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -73.11 130.71 40.89 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.3 m -139.0 130.64 27.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 254' ' ' GLN . 8.2 p30 -100.94 156.22 17.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.207 1.803 . . . . 0.0 107.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.8 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.82 2.448 . . . . 0.0 115.268 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 252' ' ' ASN . 49.6 mt-30 -131.63 174.78 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 129.124 2.97 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 97.3 m -130.08 108.96 10.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.319 1.447 . . . . 0.0 108.81 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -81.27 136.03 35.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.0 154.27 69.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.46 88.86 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.185 2.59 . . . . 0.0 107.363 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -69.89 105.29 2.76 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.15 -172.38 23.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.712 0.687 . . . . 0.0 113.43 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.65 113.33 21.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.799 1.64 . . . . 0.0 110.09 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.16 131.19 50.04 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.113 1.365 . . . . 0.0 110.183 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.07 1.95 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 129.272 3.029 . . . . 0.0 105.873 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.26 -166.2 45.8 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 83.4 m -84.87 144.99 28.04 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.412 1.485 . . . . 0.0 108.143 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -100.48 150.76 22.32 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -143.92 164.17 31.34 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 111.456 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.79 154.45 37.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.631 1.572 . . . . 0.0 109.657 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.3 mt -131.89 105.61 7.55 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -139.81 143.99 37.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.921 0.889 . . . . 0.0 112.686 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -144.46 153.51 41.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.696 1.998 . . . . 0.0 106.371 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -86.83 145.83 26.45 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.494 -1.379 . . . . 0.0 112.206 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.94 -43.33 0.79 Allowed Glycine 0 C--N 1.341 0.853 0 C-N-CA 127.035 2.255 . . . . 0.0 115.431 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -74.28 159.47 32.4 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.321 1.049 . . . . 0.0 111.935 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 297' ' ' LEU . 1.2 mppt? -125.59 174.31 8.35 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.943 2.097 . . . . 0.0 105.555 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.8 140.34 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.492 0.663 . . . . 0.0 109.661 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.13 -3.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 128.337 2.655 . . . . 0.0 111.717 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.11 156.89 28.38 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 120.526 1.512 . . . . 0.0 114.6 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -114.83 162.7 16.53 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 112.161 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -150.75 137.44 18.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 169.07 -160.45 33.87 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -145.6 143.66 30.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.255 0.55 . . . . 0.0 111.967 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.61 148.54 12.57 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 126.938 2.095 . . . . 0.0 107.171 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.2 m -131.41 -34.08 1.42 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 127.288 2.235 . . . . 0.0 107.003 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -144.21 -56.74 0.37 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.48 148.65 26.23 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.55 1.94 . . . . 0.0 110.076 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 86.51 4.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.554 0.616 . . . . 0.0 110.595 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -67.01 -58.73 4.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.618 0.367 . . . . 0.0 111.737 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -126.1 136.34 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.481 0.582 . . . . 0.0 110.954 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -132.32 123.1 26.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.715 1.606 . . . . 0.0 108.883 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -137.34 170.48 23.58 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.316 1.436 . . . . 0.0 109.911 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.02 171.95 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.238 0.615 . . . . 0.0 111.44 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -121.37 166.09 14.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.94 2.096 . . . . 0.0 106.131 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.58 136.7 56.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 75.1 mtp -137.03 140.62 31.95 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 108.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.2 104.83 1.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.1 3.2 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 275' ' ' LYS . 74.9 mt . . . . . 0 N--CA 1.462 0.171 0 C-N-CA 124.56 1.144 . . . . 0.0 109.263 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.402 1.096 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -148.72 138.35 21.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 130.688 3.595 . . . . 0.0 105.202 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.73 145.86 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -89.5 161.96 15.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.562 1.172 . . . . 0.0 111.255 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.96 90.05 8.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.23 103.96 1.26 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.99 -177.29 44.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.33 1.919 . . . . 0.0 108.976 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.92 161.75 46.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 118.452 1.126 . . . . 0.0 112.85 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.44 0.37 55.35 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.67 166.28 43.16 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.61 174.35 23.09 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 123.98 0.8 . . . . 0.0 112.915 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.32 131.77 34.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.4 p -71.55 128.33 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.015 0.825 . . . . 0.0 110.341 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -121.54 4.8 10.13 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -64.36 136.1 56.8 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 71.58 12.0 6.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.892 2.477 . . . . 0.0 110.468 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.868 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.178 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.56 153.6 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.024 0.912 . . . . 0.0 108.592 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 43' ' ' ALA . 17.1 mmt85 -131.18 -52.27 1.03 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.862 1.665 . . . . 0.0 111.2 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -126.08 160.74 29.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.69 129.14 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.56 119.88 26.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 92.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.09 143.87 16.87 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.93 175.02 3.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.063 0.945 . . . . 0.0 110.863 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.94 175.71 43.31 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -66.41 -36.96 84.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.88 2.79 28.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 130.863 3.665 . . . . 0.0 110.711 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -166.89 24.81 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.45 122.76 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -136.47 -19.85 1.4 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.426 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -99.17 112.95 24.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.52 144.26 36.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 121.97 -0.456 . . . . 0.0 110.35 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -148.44 151.01 34.48 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.937 1.695 . . . . 0.0 107.837 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.78 158.53 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.918 1.287 . . . . 0.0 108.206 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.39 115.2 39.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -88.99 105.54 17.85 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.178 1.391 . . . . 0.0 109.068 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HB2' ' HG2' ' A' ' 24' ' ' ARG . . . -68.37 126.15 28.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.088 -0.383 . . . . 0.0 110.509 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -113.78 146.27 40.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.7 -36.12 75.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.593 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -64.36 -63.66 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -156.13 141.56 17.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.048 0.939 . . . . 0.0 108.873 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.27 111.72 10.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.28 136.74 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.804 0.812 . . . . 0.0 112.395 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -78.28 162.47 26.5 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.622 1.969 . . . . 0.0 109.682 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.58 6.75 8.48 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.131 1.824 . . . . 0.0 111.238 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.26 161.04 26.16 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 125.953 1.74 . . . . 0.0 113.75 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.3 137.68 56.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.907 0.883 . . . . 0.0 109.573 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -122.88 51.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.24 -177.34 27.54 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.861 1.696 . . . . 0.0 111.3 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.61 84.89 3.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.919 1.288 . . . . 0.0 110.404 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -56.56 132.56 51.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.428 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -129.49 147.61 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -75.18 -36.73 61.45 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.856 -0.528 . . . . 0.0 111.628 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mp -102.11 23.12 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.25 91.93 0.15 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 121.761 -0.587 . . . . 0.0 112.1 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -161.64 154.79 20.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 105.01 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -150.57 164.85 35.01 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.12 1.768 . . . . 0.0 108.847 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.6 m -145.07 122.12 11.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.93 0.492 . . . . 0.0 110.541 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -131.61 131.53 43.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -107.92 141.34 39.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.213 1.005 . . . . 0.0 108.687 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.48 112.9 42.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.88 176.56 4.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.765 2.026 . . . . 0.0 111.533 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -46.38 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -101.9 -5.04 25.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.008 2.123 . . . . 0.0 113.388 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -94.53 137.13 34.03 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -123.94 162.41 23.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.342 0.973 . . . . 0.0 110.573 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.4 mt -86.92 118.27 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.16 -45.88 20.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.266 1.426 . . . . 0.0 109.823 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.38 166.15 28.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.621 1.169 . . . . 0.0 109.651 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.06 103.35 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -82.37 135.37 35.19 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -133.66 127.75 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.9 p -114.64 149.1 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -151.85 168.15 26.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.889 0.768 . . . . 0.0 110.571 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -153.78 151.96 30.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -128.46 127.88 43.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.544 2.338 . . . . 0.0 105.918 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.64 166.21 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.887 1.275 . . . . 0.0 111.086 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.83 156.9 31.89 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.42 -14.65 6.49 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.071 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -129.03 107.23 9.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.184 1.492 . . . . 0.0 108.177 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.36 -14.25 62.86 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 111.041 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.4 p -72.01 176.44 5.06 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.547 1.539 . . . . 0.0 110.011 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.68 135.65 30.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.53 154.11 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.776 0.716 . . . . 0.0 110.647 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.73 112.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.857 1.263 . . . . 0.0 107.989 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -77.24 -36.78 54.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.566 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.6 t -158.98 158.72 33.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.843 2.057 . . . . 0.0 109.243 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.06 151.49 27.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.775 2.03 . . . . 0.0 107.11 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 m -150.67 108.45 3.69 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.18 158.71 31.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -135.49 122.04 20.73 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.1 p -108.53 160.68 15.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 119.276 0.944 . . . . 0.0 112.287 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -68.76 -37.88 79.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.315 0.646 . . . . 0.0 109.746 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -15.28 63.51 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 116.772 -1.585 . . . . 0.0 113.431 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.61 3.5 49.8 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 120.188 1.358 . . . . 0.0 112.589 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -82.7 95.07 7.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.5 m -104.35 122.31 45.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.8 p -70.13 159.7 83.46 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 111.561 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.33 170.26 20.34 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.073 1.849 . . . . 0.0 107.435 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.58 109.75 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 N-CA-C 106.519 -2.147 . . . . 0.0 106.519 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -81.03 77.06 7.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.65 -149.97 20.36 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.772 1.653 . . . . 0.0 110.234 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.3 tp -105.27 125.77 51.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.113 1.365 . . . . 0.0 110.591 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.46 139.48 53.97 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.9 m -134.78 157.14 47.51 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.439 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -61.76 -45.56 93.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.217 0.607 . . . . 0.0 109.492 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -65.2 110.32 2.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 107.229 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -163.86 166.8 21.48 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.409 -0.807 . . . . 0.0 112.226 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -150.87 167.67 26.8 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.24 1.816 . . . . 0.0 108.921 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.24 142.62 38.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 129.84 55.48 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.985 0.914 . . . . 0.0 111.129 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 147.2 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.144 1.377 . . . . 0.0 108.229 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 123' ' ' GLY . 27.9 t0 -76.49 174.51 10.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -50.05 -53.73 25.02 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.928 1.691 . . . . 0.0 109.425 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -114.32 -23.81 9.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 117.835 -1.078 . . . . 0.0 113.607 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.22 55.83 0.13 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.939 1.245 . . . . 0.0 113.919 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 119' ' ' ASP . . . -71.74 138.5 27.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -65.75 144.47 56.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -62.12 97.05 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.143 1.777 . . . . 0.0 107.866 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.72 -51.99 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -174.07 141.12 5.8 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -87.55 177.76 6.98 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.642 1.177 . . . . 0.0 111.328 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -147.2 169.37 19.48 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 107.319 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.91 -177.99 47.49 Favored Glycine 0 CA--C 1.523 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.258 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -142.45 50.71 1.48 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.67 2.388 . . . . 0.0 108.629 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.43 163.53 17.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 119.902 -1.748 . . . . 0.0 109.164 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.86 -104.45 0.19 Allowed Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.09 -15.99 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.409 0.711 . . . . 0.0 111.144 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.83 174.61 12.03 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.874 2.47 . . . . 0.0 107.343 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.6 tp -98.91 88.54 4.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -79.58 -52.64 7.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.694 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.77 158.53 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 111.982 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -148.6 147.09 28.59 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.447 3.499 . . . . 0.0 106.576 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -144.18 -173.21 15.4 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.83 156.18 35.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.758 1.279 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -128.68 109.84 11.68 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.65 99.14 8.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -74.74 131.09 40.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -111.92 147.9 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.633 1.973 . . . . 0.0 106.855 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.32 167.76 10.17 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.166 1.386 . . . . 0.0 107.84 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -73.51 107.33 5.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.8 171.56 10.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.667 0.787 . . . . 0.0 109.339 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.49 148.05 30.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 159.8 -112.44 0.52 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 125.006 1.289 . . . . 0.0 110.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -115.67 163.51 12.29 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.882 1.706 . . . . 0.0 110.453 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.13 -5.61 40.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.13 1.372 . . . . 0.0 112.474 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.506 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 44.7 tt0 -112.98 144.0 43.32 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.417 1.487 . . . . 0.0 109.752 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.56 171.52 12.87 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 123.795 0.712 . . . . 0.0 113.167 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.4 m -82.07 116.96 21.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.847 0.859 . . . . 0.0 108.901 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.06 126.27 29.19 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -134.13 127.07 31.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.011 0.924 . . . . 0.0 111.746 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.18 155.63 17.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.985 1.714 . . . . 0.0 108.681 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -150.81 100.19 2.79 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.55 160.36 5.02 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.54 143.71 51.53 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -104.77 178.33 4.59 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 111.317 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -53.05 -45.1 67.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.078 1.751 . . . . 0.0 112.361 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.74 -176.33 46.97 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 128.874 3.13 . . . . 0.0 106.157 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.67 141.26 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -121.86 -19.8 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -144.28 158.54 43.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.95 145.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -128.94 156.05 44.36 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 t -136.29 123.35 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.87 57.67 0.58 Allowed Glycine 0 C--N 1.341 0.833 0 C-N-CA 124.394 0.997 . . . . 0.0 114.834 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.471 ' CD ' ' H ' ' A' ' 182' ' ' GLN . 3.2 pm0 -68.21 159.93 30.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.964 0.905 . . . . 0.0 110.024 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.28 -140.07 3.83 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.542 1.544 . . . . 0.0 110.477 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -82.15 -37.13 26.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.192 0.997 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.55 -31.45 11.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.725 2.01 . . . . 0.0 113.759 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.16 -158.48 29.52 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 119.749 1.158 . . . . 0.0 110.975 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 105.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 m -95.13 -23.46 17.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 0.0 111.472 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.35 157.69 38.97 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.808 1.643 . . . . 0.0 109.3 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.57 156.53 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.592 1.957 . . . . 0.0 106.545 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.417 ' HE2' ' CG ' ' A' ' 214' ' ' PHE . 59.8 pttt -174.13 134.0 0.43 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 128.78 2.832 . . . . 0.0 105.842 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -125.95 162.22 25.73 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.092 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -103.09 152.35 21.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.778 1.231 . . . . 0.0 109.585 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.03 163.9 23.2 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.532 1.133 . . . . 0.0 109.682 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.24 145.72 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.071 1.748 . . . . 0.0 106.978 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -140.56 97.19 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 65.34 -143.57 46.16 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.65 5.7 10.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.844 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.94 168.5 9.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.738 1.215 . . . . 0.0 110.709 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.75 142.79 49.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.821 1.648 . . . . 0.0 107.186 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.4 mm -131.81 102.41 5.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.26 105.23 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 139.31 170.5 11.9 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 121.751 0.64 . . . . 0.0 114.516 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.43 45.23 0.02 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.684 2.087 . . . . 0.0 109.28 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.62 100.61 3.38 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.665 1.186 . . . . 0.0 109.87 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -116.84 -24.45 7.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.639 1.176 . . . . 0.0 112.122 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -91.8 -179.24 41.93 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.96 91.55 0.97 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.248 1.024 . . . . 0.0 109.161 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.36 156.63 58.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 121.367 1.524 . . . . 0.0 109.324 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 71.2 p -98.91 173.48 6.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.62 -10.55 59.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.086 -1.009 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.0 tt -53.37 -39.35 64.13 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.59 175.28 29.73 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.665 1.603 . . . . 0.0 111.149 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CG ' ' HE2' ' A' ' 191' ' ' LYS . 53.4 m-85 -102.34 138.41 39.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.355 1.062 . . . . 0.0 109.628 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.88 164.17 13.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.977 2.511 . . . . 0.0 106.326 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.13 157.37 44.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 121.542 1.974 . . . . 0.0 115.684 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.55 143.63 32.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.633 1.173 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 124.2 43.75 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 108.762 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.96 117.5 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 C-N-CA 126.604 1.962 . . . . 0.0 106.304 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -93.98 106.36 18.34 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.574 1.079 . . . . 0.0 109.999 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -38.66 -61.42 0.89 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.6 -19.31 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.192 1.819 . . . . 0.0 116.301 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.5 t -106.93 -12.92 15.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.576 1.989 . . . . 0.0 114.769 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.33 160.18 15.81 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 107.229 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -152.48 106.87 3.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 119.935 -1.728 . . . . 0.0 109.894 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.93 70.48 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 t -68.12 -16.95 64.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.546 -1.346 . . . . 0.0 112.739 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -157.94 167.51 29.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.862 1.665 . . . . 0.0 107.914 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.55 159.54 37.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.424 ' OE2' ' HE3' ' A' ' 250' ' ' LYS . 31.4 mt-10 -131.51 172.92 11.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.41 1.484 . . . . 0.0 108.388 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.52 179.8 42.8 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.3 m -157.19 150.52 23.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 155.47 48.61 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -153.02 164.4 38.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.892 0.853 . . . . 0.0 108.964 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -70.07 148.36 48.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.053 2.141 . . . . 0.0 112.907 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.7 mt -90.16 151.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -108.8 76.8 1.03 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 149.22 -15.85 1.14 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-O 117.944 -1.476 . . . . 0.0 115.483 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 m -132.44 148.49 52.41 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.734 1.267 . . . . 0.0 108.293 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.62 86.23 7.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.844 1.258 . . . . 0.0 109.235 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 178.28 -169.92 41.84 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 0.0 110.065 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.65 156.44 39.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.99 2.116 . . . . 0.0 105.393 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.8 tt -134.52 167.46 25.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.958 1.303 . . . . 0.0 107.761 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.9 mm -99.05 93.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 111.708 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -87.31 -21.77 25.54 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.267 -0.896 . . . . 0.0 113.323 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -137.72 144.63 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 109.632 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -143.31 149.89 38.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.245 0.93 . . . . 0.0 109.624 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ARG . . . . . 0.547 ' H ' HD23 ' A' ' 247' ' ' LEU . 73.4 mtt180 -148.33 159.67 43.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.917 1.687 . . . . 0.0 109.226 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -138.7 116.0 11.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 230' ' ' GLU . 85.2 mttt -73.77 149.79 41.51 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.0 p -145.37 165.39 28.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.255 0.48 . . . . 0.0 110.493 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -99.99 133.78 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.32 2.248 . . . . 0.0 105.362 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 58.2 -19.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.946 2.098 . . . . 0.0 115.498 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.98 171.61 9.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.4 2.28 . . . . 0.0 108.797 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.3 p -141.52 99.88 3.66 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.0 p -82.92 172.46 12.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.031 1.332 . . . . 0.0 111.197 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -120.62 157.82 53.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.015 1.326 . . . . 0.0 111.067 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.214 2.61 . . . . 0.0 107.521 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -81.35 92.21 6.37 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.1 174.19 17.5 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.572 1.558 . . . . 0.0 111.224 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 92.2 mt -95.95 146.57 24.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 109.087 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -71.72 146.72 47.99 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.9 -179.99 7.17 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.134 1.374 . . . . 0.0 109.986 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 37.73 -96.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.968 2.223 . . . . 0.0 116.082 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 96.2 m -146.29 129.1 16.28 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.873 0.869 . . . . 0.0 110.407 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.98 35.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -142.01 161.19 38.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.88 154.74 38.84 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.982 -1.074 . . . . 0.0 109.86 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.99 151.97 47.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -158.91 173.96 15.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.991 2.516 . . . . 0.0 107.064 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -144.93 164.09 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 107.146 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.34 -18.16 57.67 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 175.84 63.97 0.06 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -152.24 175.49 12.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.218 1.807 . . . . 0.0 106.753 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -115.46 152.24 33.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.396 1.478 . . . . 0.0 107.29 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.2 mt -86.61 119.87 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.4 m -147.22 69.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.467 0.707 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.73 -178.79 18.4 Favored Glycine 0 N--CA 1.467 0.722 0 O-C-N 120.198 -1.564 . . . . 0.0 114.316 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.89 160.97 40.44 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.69 1.196 . . . . 0.0 110.758 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -157.69 132.61 8.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -175.43 -152.74 9.62 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.506 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 16.1 ptmt -143.8 147.46 34.17 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.2 156.18 21.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 108.195 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 20.3 t -127.35 -90.66 0.52 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -79.2 -58.17 3.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 20.2 mt -110.75 165.89 11.46 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.999 1.719 . . . . 0.0 111.832 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.01 106.39 4.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 109.545 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -96.12 -45.94 6.67 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.2 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.4 ' HB3' ' H ' ' A' ' 282' ' ' LYS . 50.4 tt0 -122.05 137.68 54.72 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.068 0.849 . . . . 0.0 112.151 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -138.1 149.8 46.27 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.511 1.124 . . . . 0.0 109.945 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -169.16 154.98 24.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.32 151.47 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 118.343 1.072 . . . . 0.0 112.504 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.85 154.02 20.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 141.24 47.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.516 0.726 . . . . 0.0 111.371 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 83.2 mmm -144.73 144.45 24.58 Favored Pre-proline 0 N--CA 1.465 0.278 0 C-N-CA 126.924 2.09 . . . . 0.0 107.399 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.96 159.39 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.627 1.26 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--O 1.238 0.482 0 C-N-CA 124.088 0.955 . . . . 0.0 110.362 179.538 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 121.79 0.805 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -129.95 139.12 51.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.904 1.682 . . . . 0.0 107.602 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -124.83 110.07 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 103.981 -2.599 . . . . 0.0 103.981 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 165.63 17.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.983 0.897 . . . . 0.0 110.843 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 163.41 12.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.307 1.443 . . . . 0.0 107.542 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.07 154.46 25.33 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.99 -153.04 24.75 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.83 -2.508 . . . . 0.0 106.83 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.11 121.71 14.84 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 122.477 1.043 . . . . 0.0 115.087 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.85 -8.36 57.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.812 0.845 . . . . 0.0 111.859 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.96 -19.12 60.83 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.636 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.95 20.72 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.386 1.593 . . . . 0.0 113.345 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.68 157.37 27.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 108.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -69.9 119.46 14.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -86.48 -70.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 17.52 2.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.643 1.177 . . . . 0.0 113.709 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.45 134.91 55.45 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.04 -1.038 . . . . 0.0 109.686 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 106.534 -2.626 . . . . 0.0 106.534 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 N-CA-C 118.011 1.964 . . . . 0.0 118.011 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.0 124.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 120.839 2.319 . . . . 0.0 110.793 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -104.26 -71.18 0.74 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.839 1.256 . . . . 0.0 110.569 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -111.13 151.63 27.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.485 1.114 . . . . 0.0 109.251 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.47 141.92 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -123.7 120.42 32.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.33 102.79 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.42 129.46 9.82 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.3 168.03 20.45 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.118 0.961 . . . . 0.0 109.139 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.37 163.92 31.77 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -57.42 -40.78 79.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.291 1.436 . . . . 0.0 111.034 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.3 3.22 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.074 2.949 . . . . 0.0 113.613 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.35 -171.23 13.67 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.491 1.041 . . . . 0.0 112.208 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.73 106.13 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.27 -22.23 5.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.184 0.994 . . . . 0.0 113.501 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 42.4 p -117.96 131.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.201 1.0 . . . . 0.0 109.784 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.88 154.45 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 121.271 -0.893 . . . . 0.0 111.159 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -146.47 150.82 36.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.9 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.68 117.68 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.14 171.61 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.289 . . . . 0.0 108.498 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.12 109.3 5.28 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.753 -1.217 . . . . 0.0 109.03 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -116.3 165.51 13.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.306 1.442 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 44.5 5.58 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.027 1.394 . . . . 0.0 110.79 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m 49.37 33.04 4.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.982 2.913 . . . . 0.0 114.448 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.79 165.26 27.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.425 1.89 . . . . 0.0 109.975 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.41 127.04 31.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.923 2.089 . . . . 0.0 109.48 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.44 116.75 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.359 1.064 . . . . 0.0 108.79 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.03 159.36 30.95 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.91 0.884 . . . . 0.0 112.205 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.23 -17.72 4.38 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-O 117.352 -1.804 . . . . 0.0 115.805 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.59 154.19 2.96 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-N 120.428 2.114 . . . . 0.0 114.033 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.66 105.5 5.78 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.392 -1.064 . . . . 0.0 113.485 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -93.1 176.48 6.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.784 2.834 . . . . 0.0 109.613 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -163.14 54.69 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.49 100.36 11.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 37' ' ' SER 0.297 0.0 OUTLIER -61.75 150.03 38.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.435 -178.541 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.9 p -123.53 157.76 32.89 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.324 1.049 . . . . 0.0 108.837 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 tp -90.74 -38.83 12.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.778 0.831 . . . . 0.0 112.009 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mp -101.46 32.73 3.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 112.687 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.6 108.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -162.82 146.06 10.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.828 1.651 . . . . 0.0 107.294 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.1 162.04 41.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.322 2.649 . . . . 0.0 108.249 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.0 m -144.7 96.04 2.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.39 116.23 24.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.32 133.64 34.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.469 1.107 . . . . 0.0 108.814 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.62 107.25 22.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . 8.8 t70 -58.81 160.58 5.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.66 -40.38 76.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.764 -0.585 . . . . 0.0 111.84 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.38 -19.32 20.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.469 0.577 . . . . 0.0 112.32 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 68' ' ' ASP . 37.5 t0 -81.03 140.22 35.28 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -135.58 154.55 51.31 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.479 0.712 . . . . 0.0 110.803 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.69 133.64 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.52 -24.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 123.791 0.836 . . . . 0.0 111.1 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.19 156.72 42.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.87 146.26 25.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.95 115.26 15.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.33 123.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.447 HG21 ' H ' ' A' ' 111' ' ' THR . 29.3 m -99.42 138.04 37.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.182 1.793 . . . . 0.0 107.22 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -152.79 155.69 37.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.44 169.32 23.29 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -128.21 160.09 33.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.396 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -123.85 152.1 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.814 0.846 . . . . 0.0 108.753 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.33 113.34 1.91 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.997 0.919 . . . . 0.0 108.615 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.85 3.9 42.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.468 -1.184 . . . . 0.0 113.113 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -134.17 84.58 2.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.41 24.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 130.548 3.539 . . . . 0.0 113.19 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.3 t -149.8 108.47 3.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.181 -1.575 . . . . 0.0 108.533 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.56 157.27 7.14 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.023 1.729 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -139.39 147.11 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.702 1.601 . . . . 0.0 108.524 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.8 mm -70.37 113.19 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.2 p -80.47 -34.19 36.05 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.736 -0.602 . . . . 0.0 109.745 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 p -165.45 164.32 19.55 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.881 1.672 . . . . 0.0 109.712 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.8 tt -141.45 154.41 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 142.9 29.24 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -115.3 156.7 24.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -137.25 114.06 10.47 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -104.42 164.99 11.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.311 0.577 . . . . 0.0 110.632 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.44 -36.26 75.59 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -28.85 66.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.983 0.81 . . . . 0.0 111.816 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.69 5.67 47.76 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -72.85 88.49 1.34 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -84.76 109.22 17.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 p -71.26 161.76 76.52 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 125.174 1.389 . . . . 0.0 110.18 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.84 165.34 19.92 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.034 2.49 . . . . 0.0 110.285 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.44 119.27 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.087 2.525 . . . . 0.0 108.486 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -81.75 77.55 8.58 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.72 -155.8 25.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.563 1.078 . . . . 0.0 111.188 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.0 tp -88.15 119.17 28.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.372 1.469 . . . . 0.0 109.636 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.35 152.14 45.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.447 ' H ' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -153.59 168.98 24.37 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.966 -1.084 . . . . 0.0 109.928 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -73.22 -47.48 43.05 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 120.96 -1.087 . . . . 0.0 109.496 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.97 109.15 1.69 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.355 1.074 . . . . 0.0 109.249 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.09 166.49 21.29 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.182 1.393 . . . . 0.0 108.685 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -144.78 164.97 29.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.34 149.14 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.5 141.13 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.947 1.299 . . . . 0.0 108.807 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -157.56 164.47 37.28 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.047 1.339 . . . . 0.0 110.978 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.91 170.87 15.72 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 108.168 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.19 -56.24 12.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.048 -1.032 . . . . 0.0 109.893 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -117.95 -14.08 10.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.26 -63.96 0.29 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.47 -143.01 18.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -163.38 137.2 5.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.42 137.51 52.77 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.35 -34.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.269 0.941 . . . . 0.0 111.976 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.71 172.95 42.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.39 153.46 43.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.582 1.153 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 159.82 42.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.469 1.108 . . . . 0.0 108.055 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.08 137.96 2.89 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -61.46 135.73 57.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 110.145 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -153.23 164.93 37.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.191 1.396 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.72 -107.42 0.2 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.95 -26.59 66.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.026 0.913 . . . . 0.0 111.328 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.62 172.03 13.25 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.3 1.84 . . . . 0.0 107.615 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 38.7 tp -84.89 100.15 11.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -81.61 -39.89 23.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.87 146.25 31.04 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 124.478 1.111 . . . . 0.0 108.81 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.7 tp -155.76 100.11 2.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.335 0.516 . . . . 0.0 112.317 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.99 178.55 16.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.801 2.143 . . . . 0.0 109.293 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.4 163.55 39.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.565 1.682 . . . . 0.0 110.201 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -127.82 143.27 51.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.686 1.232 . . . . 0.0 109.534 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -110.42 105.09 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.702 2.001 . . . . 0.0 106.202 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 119.301 0.955 . . . . 0.0 110.848 -179.157 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.245 0.545 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 133.59 52.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -114.31 121.53 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.391 0.677 . . . . 0.0 111.575 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.49 -169.65 1.52 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.7 t -136.33 115.05 12.03 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 120.463 -1.398 . . . . 0.0 108.19 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.41 -171.18 2.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.968 0.907 . . . . 0.0 109.861 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.19 152.46 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.82 -72.78 0.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 123.963 0.792 . . . . 0.0 111.295 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.46 143.07 6.0 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 282' ' ' LYS . 10.0 p-10 -90.19 48.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.811 1.644 . . . . 0.0 111.739 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.64 152.12 26.76 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.45 1.5 . . . . 0.0 107.819 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.04 166.88 12.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.52 1.534 . . . . 0.0 114.264 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 m -65.56 129.32 39.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.355 1.062 . . . . 0.0 109.225 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.6 109.46 11.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -95.05 7.15 47.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.474 1.11 . . . . 0.0 112.443 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.99 132.34 51.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.816 -0.552 . . . . 0.0 112.331 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.82 -9.59 17.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.863 1.665 . . . . 0.0 111.601 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.45 -156.44 51.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.905 -1.122 . . . . 0.0 111.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -109.48 164.41 12.53 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.588 1.555 . . . . 0.0 110.606 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -147.79 -170.29 3.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.822 2.049 . . . . 0.0 110.45 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.04 -45.92 89.52 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.644 -0.66 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.05 40.63 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.46 HG22 ' CZ ' ' A' ' 194' ' ' TYR . 9.3 t -123.6 156.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.024 1.33 . . . . 0.0 108.964 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -116.49 -55.69 2.36 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -150.93 165.11 34.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.61 1.096 . . . . 0.0 111.301 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.6 t -125.65 149.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.095 2.158 . . . . 0.0 108.128 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -137.93 120.92 16.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.14 138.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -118.75 83.47 0.35 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 187' ' ' ILE . 6.3 pt20 -74.08 -171.44 1.13 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.311 1.053 . . . . 0.0 111.583 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.99 45.41 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -62.31 -37.31 85.06 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.81 0.844 . . . . 0.0 111.283 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 -15.58 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.544 3.137 . . . . 0.0 113.166 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 122.42 -175.66 16.43 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.483 1.992 . . . . 0.0 108.405 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 182' ' ' GLN . 19.5 mt -69.39 106.14 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 120.941 -1.329 . . . . 0.0 109.381 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 m -98.35 -24.66 15.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.636 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.39 47.78 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 122.395 1.093 . . . . 0.0 113.21 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.1 m -147.45 144.55 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.37 1.868 . . . . 0.0 106.605 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 56.0 pttt -161.61 170.01 20.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.713 1.205 . . . . 0.0 110.435 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -153.94 175.22 13.63 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.787 0.803 . . . . 0.0 113.087 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.8 114.28 17.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.319 -2.845 . . . . 0.0 103.319 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.46 ' CZ ' HG22 ' A' ' 175' ' ' VAL . 7.2 m-85 -129.98 148.37 51.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.765 1.626 . . . . 0.0 108.562 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -112.07 155.55 23.66 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.741 0.781 . . . . 0.0 110.244 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.21 86.25 2.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.01 1.324 . . . . 0.0 109.161 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.05 -79.39 0.88 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -123.49 -35.39 2.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.103 1.361 . . . . 0.0 110.246 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.95 148.61 48.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 122.195 0.997 . . . . 0.0 109.439 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.22 135.64 54.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.8 mm -120.07 116.27 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.03 109.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 127.847 2.459 . . . . 0.0 104.827 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.22 1.29 2.28 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 117.644 -1.642 . . . . 0.0 116.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.83 82.75 0.72 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 119.687 1.744 . . . . 0.0 108.942 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -112.66 135.02 53.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.586 2.755 . . . . 0.0 106.778 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -128.97 -43.55 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.76 153.1 39.87 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.98 112.51 8.3 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.29 1.836 . . . . 0.0 112.222 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.6 171.2 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.919 1.746 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 p -129.66 177.26 7.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.348 1.059 . . . . 0.0 108.413 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.1 mt -66.52 -10.43 44.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.308 -0.87 . . . . 0.0 111.321 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 -22.31 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.71 1.204 . . . . 0.0 109.988 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 86.32 -139.94 17.11 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.464 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 46.3 m-85 -143.58 158.79 43.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.667 1.187 . . . . 0.0 109.193 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -110.28 164.63 12.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.995 2.918 . . . . 0.0 106.422 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.61 139.89 44.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.961 0.8 . . . . 0.0 110.906 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -142.55 123.89 14.73 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.65 0.38 . . . . 0.0 111.035 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.07 130.78 34.55 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.442 1.097 . . . . 0.0 109.392 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.6 mt -127.69 124.58 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -80.23 88.57 5.48 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -52.97 -53.51 54.32 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.631 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.3 -0.71 10.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.2 1.933 . . . . 0.0 115.074 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 m -125.68 -29.45 3.15 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.504 1.956 . . . . 0.0 116.22 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.74 159.91 24.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.568 1.076 . . . . 0.0 109.504 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.55 124.76 36.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.85 101.31 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -69.09 -36.73 77.89 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.471 ' HB3' ' HD3' ' A' ' 250' ' ' LYS . . . -157.13 170.45 22.48 Favored 'General case' 0 C--N 1.343 0.294 0 O-C-N 120.703 -1.248 . . . . 0.0 112.132 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.53 151.06 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -132.44 171.59 13.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.402 1.881 . . . . 0.0 106.119 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 143.4 -175.79 23.22 Favored Glycine 0 N--CA 1.465 0.628 0 O-C-N 119.906 -1.746 . . . . 0.0 112.761 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -140.0 146.42 39.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.155 0.982 . . . . 0.0 110.598 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -128.2 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -156.08 170.82 21.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.793 0.837 . . . . 0.0 110.165 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -75.8 148.18 38.63 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 127.073 2.149 . . . . 0.0 110.886 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.0 pt -102.48 157.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 109.325 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -79.01 169.78 17.68 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.27 -41.41 1.57 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.863 -1.148 . . . . 0.0 114.873 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.3 m -141.28 160.37 40.26 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.597 1.698 . . . . 0.0 108.198 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.79 18.44 0.6 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.91 41.4 Favored Glycine 0 C--N 1.338 0.674 0 O-C-N 120.758 -1.213 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.92 157.08 30.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.371 1.469 . . . . 0.0 108.238 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.54 168.52 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 40.4 mm -105.74 103.41 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 101.219 -3.622 . . . . 0.0 101.219 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -82.16 -17.43 46.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.595 1.089 . . . . 0.0 112.048 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -150.74 136.02 17.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.19 141.34 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -135.99 158.4 44.51 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.169 0.987 . . . . 0.0 108.576 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.92 119.1 18.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 228' ' ' ALA . 36.8 mtpt -68.13 135.55 52.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.5 p -128.11 165.4 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.602 1.161 . . . . 0.0 109.941 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -129.87 145.38 51.6 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.6 tptp 72.95 -26.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.301 1.44 . . . . 0.0 111.589 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -124.06 173.48 8.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 109.729 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.3 m -117.64 144.17 45.45 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 107.419 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.5 p -121.67 153.87 37.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.418 1.087 . . . . 0.0 109.639 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -97.84 159.07 31.79 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 111.418 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.67 115.44 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.366 2.71 . . . . 0.0 107.9 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.78 93.07 7.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.35 -179.13 16.98 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.252 0.929 . . . . 0.0 112.582 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.93 111.18 22.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.206 1.002 . . . . 0.0 108.369 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.79 107.93 0.92 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.809 0.844 . . . . 0.0 108.853 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.62 156.72 18.57 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.708 2.003 . . . . 0.0 107.345 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.06 -177.54 50.81 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.87 111.04 1.15 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.651 1.18 . . . . 0.0 111.773 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.4 146.03 28.68 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.802 0.441 . . . . 0.0 110.49 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.32 160.01 41.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.284 1.434 . . . . 0.0 110.872 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -146.88 127.53 14.23 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.94 101.32 11.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.69 1.132 . . . . 0.0 110.825 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -123.07 153.39 39.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.452 1.101 . . . . 0.0 110.648 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.73 150.26 36.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.54 1.536 . . . . 0.0 108.143 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -99.02 142.39 30.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.816 1.246 . . . . 0.0 109.894 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.73 55.8 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.847 0.736 . . . . 0.0 114.792 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -134.22 175.38 9.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.19 1.396 . . . . 0.0 110.467 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 162.21 33.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.757 1.623 . . . . 0.0 108.417 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 52.6 mt -95.12 140.91 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.63 -0.35 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.43 -167.68 38.35 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.75 166.84 19.05 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.461 1.105 . . . . 0.0 110.983 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -159.08 163.69 36.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.195 1.398 . . . . 0.0 107.964 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.06 -161.99 29.06 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 30.4 mtmm -126.97 136.82 52.78 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -158.13 96.84 1.48 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.424 1.489 . . . . 0.0 107.474 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.9 m -69.04 -23.85 64.11 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -165.46 -60.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.8 mt -84.24 147.91 27.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.18 2.592 . . . . 0.0 106.066 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.44 80.22 1.42 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.032 . . . . 0.0 112.089 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -64.53 -40.47 95.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -141.55 129.92 22.43 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.67 1.123 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -119.6 106.95 12.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.252 1.421 . . . . 0.0 107.772 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -132.2 -179.73 16.48 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.2 170.27 10.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.582 -0.952 . . . . 0.0 111.158 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -115.11 156.3 25.48 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.37 160.74 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.524 0.73 . . . . 0.0 109.048 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.46 144.49 42.79 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.64 149.27 79.17 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.867 1.711 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.466 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 112.083 179.568 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.207 0.527 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -147.26 139.71 24.7 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.427 1.891 . . . . 0.0 107.057 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -132.28 118.43 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -64.48 137.91 58.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.365 0.666 . . . . 0.0 109.893 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.56 -58.46 8.38 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.708 1.603 . . . . 0.0 109.649 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.93 -23.22 24.1 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.302 1.43 . . . . 0.0 113.12 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.38 173.84 24.0 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.126 0.963 . . . . 0.0 111.581 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.68 174.27 54.81 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 122.56 1.089 . . . . 0.0 113.837 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.74 9.03 15.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.58 1.552 . . . . 0.0 113.126 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.41 174.73 44.35 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.32 -124.36 31.63 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 158.91 43.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.728 1.611 . . . . 0.0 109.489 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.9 p -101.69 102.86 13.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 116.58 22.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 103.968 -2.605 . . . . 0.0 103.968 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.08 118.61 12.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -133.87 -64.55 0.7 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.703 0.801 . . . . 0.0 110.85 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.015 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 107.376 -2.289 . . . . 0.0 107.376 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.2 157.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.476 1.91 . . . . 0.0 112.442 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -131.59 -23.33 2.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 112.908 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -153.19 155.56 36.9 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.99 148.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -132.96 144.82 50.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.98 148.81 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.847 2.059 . . . . 0.0 106.431 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 62' ' ' PHE . . . -137.39 -112.16 1.1 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.19 148.28 32.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.372 1.086 . . . . 0.0 108.688 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 -20.79 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 127.189 2.328 . . . . 0.0 112.912 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -56.13 -40.28 73.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.348 2.259 . . . . 0.0 110.237 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.47 7.63 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.128 3.371 . . . . 0.0 109.514 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.71 159.77 23.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 126.371 1.939 . . . . 0.0 109.655 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.58 96.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.3 m -89.78 -21.7 22.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.1 p -127.37 127.19 43.79 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 120.489 1.495 . . . . 0.0 110.83 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 136' ' ' LEU . 4.3 mp -135.76 137.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 122.891 1.329 . . . . 0.0 109.561 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -148.38 138.72 22.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.652 0.781 . . . . 0.0 109.368 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 t -95.51 123.42 47.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -115.99 165.72 12.8 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.83 0.852 . . . . 0.0 108.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.24 108.69 3.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.263 54.9 pttt -117.15 116.18 26.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.457 1.503 . . . . 0.0 110.129 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 47.5 27.28 0.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.594 1.958 . . . . 0.0 113.548 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -162.76 -159.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.309 -1.494 . . . . 0.0 108.829 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.46 165.24 19.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 116.48 17.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.19 109.03 12.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.38 162.16 29.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.971 0.908 . . . . 0.0 109.699 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 2.36 9.35 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.611 1.577 . . . . 0.0 112.21 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.37 163.95 27.41 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.237 1.518 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -70.94 147.64 48.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.906 2.082 . . . . 0.0 110.805 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -130.4 104.35 7.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.956 2.103 . . . . 0.0 106.011 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.18 -156.26 26.72 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.18 102.76 7.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.866 1.266 . . . . 0.0 108.457 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -103.29 162.7 12.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.9 m -155.6 150.59 26.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.12 -8.42 54.58 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.69 -4.94 7.17 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.25 15.12 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.625 1.102 . . . . 0.0 114.049 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 4.1 t80 -75.37 128.58 35.71 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.931 1.366 . . . . 0.0 110.145 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -132.49 164.12 27.29 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.226 2.61 . . . . 0.0 111.072 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 m -132.97 138.79 46.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.696 1.599 . . . . 0.0 108.046 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -121.2 109.6 15.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.159 1.783 . . . . 0.0 106.364 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -89.75 165.1 14.38 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.699 1.2 . . . . 0.0 109.042 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 p -111.04 152.86 12.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.202 0.525 . . . . 0.0 110.366 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.18 164.9 12.13 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.822 1.249 . . . . 0.0 110.512 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.78 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.579 0.752 . . . . 0.0 110.986 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -105.59 0.71 26.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.16 140.1 52.45 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -134.2 151.9 51.55 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.94 1.296 . . . . 0.0 108.95 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.0 mm -82.67 142.82 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.906 1.282 . . . . 0.0 108.075 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 m -136.81 -19.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.18 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 146.46 28.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -145.59 96.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -65.26 138.3 58.13 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.19 150.13 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.599 HG21 ' H ' ' A' ' 111' ' ' THR . 18.4 m -126.06 140.27 52.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.593 1.957 . . . . 0.0 106.754 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -151.8 149.62 29.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -158.82 168.55 26.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.829 1.195 . . . . 0.0 111.362 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -103.14 154.9 18.82 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.551 1.54 . . . . 0.0 110.581 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.93 146.46 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -75.68 76.4 2.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.06 14.89 0.1 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 127.583 2.516 . . . . 0.0 111.919 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -123.98 111.42 15.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.143 1.377 . . . . 0.0 109.078 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.54 -3.28 8.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.473 1.509 . . . . 0.0 111.42 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -153.37 137.39 16.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.716 1.606 . . . . 0.0 109.353 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.71 152.35 45.63 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.06 154.72 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.19 0.996 . . . . 0.0 109.209 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.16 119.99 22.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.8 p -95.63 -31.1 13.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.159 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.5 p -157.43 164.05 37.89 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.823 1.647 . . . . 0.0 110.613 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.91 147.57 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.778 1.631 . . . . 0.0 107.525 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 105.82 4.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.994 0.918 . . . . 0.0 109.387 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.42 148.61 48.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.588 -0.695 . . . . 0.0 109.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.48 114.32 11.25 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.0 p -84.97 158.75 20.42 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -30.41 70.69 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.53 -46.84 83.37 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.409 1.083 . . . . 0.0 109.087 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.01 -14.62 3.79 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.847 1.213 . . . . 0.0 112.06 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -68.24 145.07 54.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 107.97 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.1 p -133.77 148.05 51.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 108.979 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.2 p -85.43 162.46 48.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.34 165.3 32.9 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 107.285 -1.852 . . . . 0.0 107.285 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.98 105.49 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 105.738 -2.447 . . . . 0.0 105.738 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.04 81.2 5.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.18 -177.51 18.89 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.301 1.429 . . . . 0.0 111.716 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -84.0 111.5 19.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.697 1.199 . . . . 0.0 112.75 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.436 ' OE2' ' HE3' ' A' ' 114' ' ' LYS . 14.6 mt-10 -65.84 140.54 58.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.599 ' H ' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -128.39 177.14 7.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.775 1.63 . . . . 0.0 109.543 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.91 -48.86 77.15 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -72.91 122.62 21.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.436 ' HE3' ' OE2' ' A' ' 110' ' ' GLU . 12.9 ptmm? 176.34 163.64 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.454 1.902 . . . . 0.0 108.586 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 117' ' ' LEU . 5.4 p90 -157.99 167.9 28.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.484 0.713 . . . . 0.0 110.56 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.59 149.54 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.856 1.662 . . . . 0.0 107.044 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -150.82 136.09 17.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.577 1.951 . . . . 0.0 107.116 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 162.93 34.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.098 0.559 . . . . 0.0 110.064 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -76.69 74.03 3.36 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.693 1.997 . . . . 0.0 109.055 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -54.72 -24.3 21.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.452 -2.03 . . . . 0.0 115.147 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -93.66 -7.44 43.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.506 1.122 . . . . 0.0 113.103 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.92 -5.0 75.85 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.501 1.524 . . . . 0.0 115.982 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.14 124.12 9.92 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.029 1.914 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.56 161.83 7.16 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.15 0.58 . . . . 0.0 110.398 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 148.06 43.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.343 0.657 . . . . 0.0 109.646 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.82 -35.46 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.054 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.39 -147.46 7.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.61 161.04 43.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.148 1.379 . . . . 0.0 108.722 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -122.07 149.55 43.38 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.487 1.115 . . . . 0.0 108.555 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.51 129.74 5.04 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.28 1.895 . . . . 0.0 109.047 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -93.73 -178.17 4.6 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 122.905 1.336 . . . . 0.0 107.916 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.26 164.4 27.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.469 1.907 . . . . 0.0 107.026 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.64 -103.16 0.3 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 104.313 -3.515 . . . . 0.0 104.313 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -72.83 -25.75 61.24 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.524 0.662 . . . . 0.0 110.426 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.36 -175.14 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.997 3.319 . . . . 0.0 107.684 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 38' ' ' ILE . 46.9 tp -95.51 129.51 42.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 126.54 1.936 . . . . 0.0 108.47 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.24 -46.37 4.84 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.947 0.499 . . . . 0.0 111.68 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -137.76 153.09 49.75 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.359 1.063 . . . . 0.0 109.028 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.4 tp -161.83 91.51 0.82 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 172.76 14.54 Favored Glycine 0 C--O 1.229 -0.214 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.33 156.59 48.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -124.48 160.38 28.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -141.98 131.58 23.97 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 103.541 -2.762 . . . . 0.0 103.541 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.275 0 CA-C-N 119.636 1.107 . . . . 0.0 112.993 -178.466 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 131.06 39.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -93.59 114.4 26.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.62 -172.33 3.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.216 1.008 . . . . 0.0 109.751 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.6 m -77.59 155.44 31.5 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.825 -1.172 . . . . 0.0 109.544 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.54 157.3 36.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.708 1.603 . . . . 0.0 109.941 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -127.66 167.3 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.251 1.82 . . . . 0.0 107.472 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.8 -113.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.67 164.46 20.23 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.662 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 9.1 p30 -105.92 6.65 31.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.641 1.577 . . . . 0.0 111.031 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.48 122.92 43.99 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 135.23 177.04 14.67 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.729 2.585 . . . . 0.0 111.894 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.0 m -102.82 153.58 20.04 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.028 1.414 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -72.49 154.67 40.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.643 1.177 . . . . 0.0 112.422 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -142.55 38.63 1.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.248 1.419 . . . . 0.0 109.089 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.3 104.63 0.08 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.082 2.553 . . . . 0.0 112.945 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.43 -40.82 16.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.863 2.865 . . . . 0.0 114.11 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.63 -95.83 1.37 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.28 169.69 10.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.37 1.468 . . . . 0.0 109.334 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -135.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.422 2.289 . . . . 0.0 106.271 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.01 -33.14 71.59 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 221' ' ' TYR . . . -179.59 -151.07 9.51 Favored Glycine 0 CA--C 1.534 1.266 1 C-N-CA 131.501 4.381 . . . . 0.0 107.935 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.8 m -135.07 155.54 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.516 1.926 . . . . 0.0 106.146 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -124.55 -53.78 1.68 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.259 0.936 . . . . 0.0 113.229 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.467 ' HE3' ' CZ ' ' A' ' 179' ' ' TYR . 29.5 ttpt -146.35 136.38 23.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.132 -1.605 . . . . 0.0 109.342 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 51.9 t -90.28 146.57 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.467 ' CZ ' ' HE3' ' A' ' 177' ' ' LYS . 45.2 m-85 -141.09 109.81 6.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.134 1.374 . . . . 0.0 108.333 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.76 138.58 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.86 92.29 0.56 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.76 160.88 29.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.251 1.024 . . . . 0.0 109.251 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.4 -170.41 12.04 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 125.414 1.483 . . . . 0.0 109.664 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -46.4 23.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.92 1.288 . . . . 0.0 112.182 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 -4.13 54.69 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.715 1.606 . . . . 0.0 114.236 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.12 -154.05 25.73 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.5 mm -75.08 133.78 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 119.171 1.485 . . . . 0.0 108.225 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 73.6 m -115.39 -22.41 9.36 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.461 1.104 . . . . 0.0 113.683 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.3 169.15 20.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.732 1.254 . . . . 0.0 110.31 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.53 149.48 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -160.16 175.72 12.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.824 1.649 . . . . 0.0 107.09 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -162.69 174.77 12.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.23 149.31 42.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -153.8 167.87 28.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.033 1.333 . . . . 0.0 108.293 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.87 164.89 13.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 119.962 -1.711 . . . . 0.0 108.622 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -140.24 93.33 2.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 64.03 -118.98 14.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.366 -2.694 . . . . 0.0 106.366 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.17 1.93 55.89 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.861 1.265 . . . . 0.0 113.5 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.59 157.33 17.01 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.906 1.23 . . . . 0.0 111.187 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -113.68 125.57 54.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.5 mm -120.64 143.82 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.187 1.395 . . . . 0.0 110.773 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.9 t -116.89 136.76 52.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.78 158.21 42.61 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -96.58 107.04 3.45 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -39.0 113.4 0.31 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.968 2.107 . . . . 0.0 112.252 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -93.39 29.42 1.96 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.693 0.797 . . . . 0.0 111.049 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.88 21.14 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 121.207 -0.933 . . . . 0.0 112.842 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -91.2 111.22 47.53 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.02 -0.99 . . . . 0.0 108.767 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.74 157.55 51.84 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.983 1.788 . . . . 0.0 109.462 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.6 p -133.95 166.36 22.88 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 25.6 tp -67.52 -12.83 61.26 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 112.169 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.68 -32.5 72.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.157 0.983 . . . . 0.0 109.771 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.64 -154.2 16.79 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -139.93 142.53 36.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.701 1.601 . . . . 0.0 107.887 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -97.32 110.77 23.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.69 134.39 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.541 0.736 . . . . 0.0 109.531 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.37 111.85 6.97 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.177 0.591 . . . . 0.0 110.527 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.32 131.12 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 110.414 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.0 mt -128.21 126.37 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 130.65 43.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.862 -0.524 . . . . 0.0 109.81 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.461 ' CE1' ' HA3' ' A' ' 174' ' ' GLY . 15.2 t80 -65.06 -63.54 3.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.25 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 221' ' ' TYR . 21.3 Cg_endo -85.96 -29.76 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.249 1.482 . . . . 0.0 114.277 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.6 t -77.32 -26.36 52.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.102 1.319 . . . . 0.0 112.829 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -126.09 172.98 9.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.304 1.041 . . . . 0.0 108.464 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -157.2 117.3 3.48 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.92 -1.113 . . . . 0.0 111.489 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.7 mt -68.22 113.44 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -26.71 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.386 0.674 . . . . 0.0 111.933 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -162.34 169.61 20.27 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.756 1.222 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.8 145.82 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -132.61 178.42 6.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.607 2.363 . . . . 0.0 109.141 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 166.72 -178.57 41.03 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.6 p -139.98 136.1 33.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.731 0.765 . . . . 0.0 109.241 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -131.12 156.24 45.6 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 113.157 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.02 162.03 40.75 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.657 -0.652 . . . . 0.0 110.545 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.48 136.12 39.37 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.173 1.389 . . . . 0.0 110.486 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.4 mt -72.85 109.71 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -48.3 121.37 4.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 110.647 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.94 22.0 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.492 1.52 . . . . 0.0 110.484 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.2 p -141.38 165.27 27.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.696 1.598 . . . . 0.0 109.501 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.7 -14.32 37.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.404 0.681 . . . . 0.0 110.306 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -68.47 146.32 45.43 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.16 159.45 24.86 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.418 1.487 . . . . 0.0 113.21 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 16.9 tt -136.96 152.2 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 127.207 2.203 . . . . 0.0 107.972 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 2.8 mt -97.68 134.15 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t -121.31 -8.25 9.21 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -146.6 141.16 26.65 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.347 0.659 . . . . 0.0 109.383 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.75 155.56 43.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.238 1.815 . . . . 0.0 108.697 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -144.89 154.62 42.82 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.877 1.671 . . . . 0.0 107.518 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.71 153.61 46.3 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -120.67 114.66 22.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.7 p -133.68 165.9 23.86 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.065 2.946 . . . . 0.0 107.209 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -112.79 160.26 18.15 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 66.15 -16.49 0.12 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.877 1.671 . . . . 0.0 112.996 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 174.2 11.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.772 2.429 . . . . 0.0 108.788 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.3 p -143.65 107.99 4.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -10.72 3.85 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 70.12 165.88 0.13 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.29 1.836 . . . . 0.0 112.187 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 98.5 Cg_endo -78.14 137.9 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.932 2.422 . . . . 0.0 109.69 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.32 93.13 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.566 1.947 . . . . 0.0 105.763 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.58 177.7 16.85 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.057 0.837 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.67 113.69 20.52 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.343 1.057 . . . . 0.0 110.243 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.21 108.49 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.354 1.061 . . . . 0.0 109.289 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.15 149.3 19.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.301 1.441 . . . . 0.0 109.056 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.56 -175.0 48.95 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.649 0.583 . . . . 0.0 112.905 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.0 m -66.7 127.53 32.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.508 1.523 . . . . 0.0 108.584 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -86.04 147.56 26.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.778 0.431 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.55 163.7 29.92 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.499 1.12 . . . . 0.0 110.749 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -145.58 147.6 32.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.764 2.425 . . . . 0.0 107.281 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.3 mt -142.01 141.77 32.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.524 1.129 . . . . 0.0 108.528 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -164.65 179.32 6.69 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.303 1.841 . . . . 0.0 110.163 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -144.05 152.95 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 104.892 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.52 71.45 10.42 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 120.398 -1.439 . . . . 0.0 112.636 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.56 -59.28 0.67 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 123.556 0.598 . . . . 0.0 113.65 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -55.49 155.68 5.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.81 0.844 . . . . 0.0 111.681 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 164.07 12.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 108.89 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.78 129.93 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.1 8.4 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.271 1.029 . . . . 0.0 111.617 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 175.11 -179.97 46.05 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -113.73 -179.07 3.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' HIS . . . . . 0.404 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 15.6 p80 -165.68 158.98 15.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.376 0.989 . . . . 0.0 111.745 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.49 -107.48 0.44 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.662 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -160.74 165.37 30.54 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.481 1.112 . . . . 0.0 110.23 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.23 147.05 37.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.686 1.594 . . . . 0.0 107.12 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 19.5 t -174.26 70.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 59.73 -7.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 129.481 3.112 . . . . 0.0 114.651 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 72.1 mt -136.43 167.73 20.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.603 2.361 . . . . 0.0 110.232 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.1 76.19 0.99 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.793 1.637 . . . . 0.0 109.479 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -76.54 -59.56 2.72 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 110.584 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -110.15 152.81 25.58 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.616 1.167 . . . . 0.0 111.596 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -159.33 145.93 16.66 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.027 0.531 . . . . 0.0 110.057 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -162.8 -175.91 34.32 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.902 2.191 . . . . 0.0 108.33 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.17 130.44 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.633 1.216 . . . . 0.0 113.718 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -73.98 155.59 38.46 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.9 m -130.75 149.64 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 58.2 mmm -151.29 153.65 32.81 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 127.656 2.383 . . . . 0.0 106.354 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.65 165.92 30.38 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.841 1.694 . . . . 0.0 111.556 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.237 0.404 0 C-N-CA 127.251 2.22 . . . . 0.0 107.781 178.45 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -149.56 132.48 16.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.012 1.325 . . . . 0.0 107.855 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.05 145.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.91 143.52 44.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.8 1.64 . . . . 0.0 108.977 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.38 174.89 4.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 109.331 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.6 44.78 0.54 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.376 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.72 -178.72 26.89 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.03 0.915 . . . . 0.0 111.222 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 161.69 2.19 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.779 1.657 . . . . 0.0 115.042 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.16 3.21 40.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.723 1.609 . . . . 0.0 113.549 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.26 -4.87 45.95 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.413 1.006 . . . . 0.0 115.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.14 158.19 18.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.46 157.52 28.92 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.235 0.517 . . . . 0.0 110.212 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -47.27 130.11 12.97 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.446 1.099 . . . . 0.0 110.67 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -130.59 121.5 25.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -161.38 141.83 10.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.32 -20.85 2.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.204 0.911 . . . . 0.0 113.406 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.045 0 C-N-CA 125.361 1.457 . . . . 0.0 114.465 179.459 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.392 0 CA-C-O 119.339 -0.701 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.77 90.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.902 1.681 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -62.8 -39.51 94.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.743 1.617 . . . . 0.0 112.127 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 41' ' ' VAL . 36.8 mtmt -145.18 162.23 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.63 1.172 . . . . 0.0 108.15 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.49 115.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -113.13 132.9 55.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.52 144.36 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 62' ' ' PHE . . . -152.45 140.09 7.46 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.73 143.62 26.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.322 1.849 . . . . 0.0 108.777 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.33 178.8 16.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 127.584 2.516 . . . . 0.0 108.58 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.81 -26.64 68.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -6.41 59.42 Favored 'General case' 0 CA--C 1.543 0.691 1 C-N-CA 131.8 4.04 . . . . 0.0 111.78 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.54 -160.35 15.02 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.04 110.45 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.6 m -140.0 0.37 1.75 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -123.45 118.41 27.38 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -144.72 155.3 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.891 0.877 . . . . 0.0 110.424 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.21 147.11 20.66 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.596 0.758 . . . . 0.0 109.567 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.26 158.56 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.424 1.49 . . . . 0.0 108.968 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 25' ' ' LYS . 4.8 t -112.79 135.39 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.92 104.65 13.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.67 110.85 22.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -78.06 166.0 23.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.0 -9.69 23.66 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.414 -1.429 . . . . 0.0 113.82 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -119.75 -17.85 8.46 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.92 149.66 26.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.709 1.595 . . . . 0.0 109.299 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -115.75 135.97 53.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.165 1.386 . . . . 0.0 110.705 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.9 t -142.64 123.07 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 0.0 110.014 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -81.85 124.28 29.55 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.79 -3.27 87.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.64 174.05 49.77 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.956 1.378 . . . . 0.0 110.296 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -82.09 152.73 26.43 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.006 -0.702 . . . . 0.0 110.488 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -134.24 154.15 51.44 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 108.338 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.77 -160.48 31.32 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -96.95 105.52 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -53.9 121.5 8.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.438 0.695 . . . . 0.0 110.772 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -138.98 95.92 3.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.776 1.274 . . . . 0.0 108.326 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.26 3.12 13.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.593 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -16.85 7.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.489 2.316 . . . . 0.0 112.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.54 80.37 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 12.4 p90 -119.37 159.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 164.01 28.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.496 2.319 . . . . 0.0 112.763 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -132.96 95.46 3.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.54 124.87 41.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.45 135.48 44.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.434 0.694 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.2 t -81.51 109.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.46 130.35 42.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.79 67.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.221 1.373 . . . . 0.0 111.427 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.3 -8.23 59.47 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.723 1.609 . . . . 0.0 111.265 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.34 151.85 24.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.322 -0.861 . . . . 0.0 110.135 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -134.79 139.96 45.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mt -78.49 118.35 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.36 -26.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.362 0.665 . . . . 0.0 111.524 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.78 152.92 38.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.898 0.879 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.11 152.89 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.419 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 46.2 mt-30 -135.17 127.57 30.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.383 2.673 . . . . 0.0 106.691 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.61 116.33 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.368 0.985 . . . . 0.0 109.816 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.8 p -87.44 152.0 22.59 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.999 1.272 . . . . 0.0 107.612 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -150.34 142.64 24.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.53 160.27 28.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.42 131.8 35.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.9 m -102.55 175.11 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 122.062 0.934 . . . . 0.0 113.0 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -60.44 119.55 8.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 109.082 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 3.44 65.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.239 -1.311 . . . . 0.0 113.794 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -122.31 158.49 29.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.722 1.261 . . . . 0.0 110.979 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -107.31 -48.96 3.35 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -78.94 145.17 34.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.59 0.709 . . . . 0.0 110.57 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.99 155.83 39.9 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -139.72 159.86 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 mt -65.49 125.5 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.6 p -100.79 -28.27 12.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.402 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -157.83 165.53 35.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.302 1.41 . . . . 0.0 109.401 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.6 mt -143.69 145.96 21.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.607 1.963 . . . . 0.0 106.623 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 77' ' ' GLN . 57.8 m -150.61 118.5 6.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.36 157.0 16.47 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -133.17 129.95 38.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 72.2 p -101.17 154.75 18.48 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.323 0.249 . . . . 0.0 110.838 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -73.2 -28.98 62.49 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 9.2 mmpt? -49.26 -44.56 43.88 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 125.095 1.358 . . . . 0.0 109.354 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.5 -6.18 3.87 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.847 -0.974 . . . . 0.0 114.402 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.256 0.3 OUTLIER -103.2 157.07 17.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.911 1.355 . . . . 0.0 111.559 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.6 p -133.11 147.9 52.14 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.043 1.737 . . . . 0.0 107.916 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.74 158.73 56.27 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.31 167.7 26.2 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 121.652 1.568 . . . . 0.0 108.096 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.4 109.91 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.847 2.364 . . . . 0.0 110.247 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -79.09 62.03 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.51 1.524 . . . . 0.0 108.442 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.54 177.77 15.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.891 1.71 . . . . 0.0 110.561 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.9 110.03 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 113.631 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.28 126.56 27.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.6 m -122.79 171.6 9.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.539 0.735 . . . . 0.0 110.916 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -61.85 -58.72 6.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.66 1.184 . . . . 0.0 109.628 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -67.01 129.57 40.34 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -160.79 169.95 21.69 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.029 0.532 . . . . 0.0 111.097 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 117' ' ' LEU . 60.8 t80 -122.15 138.8 54.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.637 2.775 . . . . 0.0 106.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.65 132.59 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 115' ' ' PHE . 2.5 pt? -153.06 151.99 30.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.857 0.863 . . . . 0.0 108.906 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 156.33 20.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.195 0.998 . . . . 0.0 109.559 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.02 165.22 12.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.002 0.921 . . . . 0.0 108.57 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -138.22 -75.46 0.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -127.85 13.51 6.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.574 1.15 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.25 -17.13 38.04 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 117.331 -1.816 . . . . 0.0 116.569 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.83 27.39 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.953 1.876 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -137.01 166.34 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.88 128.86 37.84 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.65 -59.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.304 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.7 176.57 17.61 Favored Glycine 0 N--CA 1.465 0.617 0 CA-C-N 119.429 1.013 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -125.3 163.58 22.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.955 1.702 . . . . 0.0 112.321 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -167.79 171.07 10.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.548 1.539 . . . . 0.0 109.466 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.64 -119.66 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -154.73 110.92 3.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.641 3.176 . . . . 0.0 103.821 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.84 18.55 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.558 1.143 . . . . 0.0 108.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.79 -131.13 1.97 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.96 -17.47 25.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.886 1.675 . . . . 0.0 114.484 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.87 19.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.324 1.05 . . . . 0.0 110.433 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 tp -86.83 87.01 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -86.57 -32.56 20.6 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.5 162.45 40.11 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.336 -0.852 . . . . 0.0 112.999 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 tp -161.93 106.08 1.22 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.317 -0.239 . . . . 0.0 110.987 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.01 166.22 13.55 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.316 2.389 . . . . 0.0 107.135 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.24 161.75 36.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.133 0.967 . . . . 0.0 109.165 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -101.04 146.13 27.83 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.82 99.82 4.28 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 C-N-CA 124.033 0.933 . . . . 0.0 109.413 179.902 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -74.97 138.34 42.21 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -106.27 110.93 23.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.17 1.388 . . . . 0.0 111.848 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 mt -69.0 173.78 5.12 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.258 1.423 . . . . 0.0 108.535 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.6 t -98.23 103.9 15.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.77 170.88 14.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 tt -164.07 160.23 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 106.82 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.68 -20.46 1.3 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.81 -23.6 0.41 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 118.56 1.18 . . . . 0.0 114.004 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.445 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 3.7 m-20 60.14 10.96 2.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.301 1.44 . . . . 0.0 114.027 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -96.2 150.64 20.31 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.821 -1.174 . . . . 0.0 109.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 -179.19 18.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.025 1.298 . . . . 0.0 110.699 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 65.7 m -75.26 124.22 26.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -86.09 131.53 34.24 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.777 0.831 . . . . 0.0 110.322 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.448 ' HE1' ' HB3' ' A' ' 283' ' ' ALA . 54.6 p-90 -158.89 130.35 6.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.925 0.89 . . . . 0.0 110.028 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.18 135.18 39.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -123.44 60.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.718 2.007 . . . . 0.0 107.269 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -24.68 -82.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.646 0 C-N-CA 129.666 3.507 . . . . 0.0 115.071 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.86 162.94 7.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.682 0.793 . . . . 0.0 112.915 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.07 -165.86 1.57 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.648 2.379 . . . . 0.0 108.684 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.83 -45.16 79.12 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.895 -1.128 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.21 164.26 32.88 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.785 0.707 . . . . 0.0 112.207 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -74.83 157.5 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.08 1.352 . . . . 0.0 111.3 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -133.49 -65.17 0.69 Allowed 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.411 1.084 . . . . 0.0 109.479 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -140.64 156.2 46.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.493 0.588 . . . . 0.0 110.197 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.66 147.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.315 1.846 . . . . 0.0 107.315 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -138.99 163.46 32.33 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.826 1.251 . . . . 0.0 108.515 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.1 t -141.88 123.63 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -100.97 77.09 0.4 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.5 -175.78 0.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.805 0.812 . . . . 0.0 112.151 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.83 -172.53 38.57 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.47 -28.67 69.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 128.632 2.773 . . . . 0.0 114.901 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.76 -31.67 5.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.6 2.76 . . . . 0.0 112.398 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.8 -167.88 36.01 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.21 114.37 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.2 m -103.79 -25.24 13.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.883 1.673 . . . . 0.0 112.005 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -134.21 154.51 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.024 0.93 . . . . 0.0 109.02 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.74 155.34 27.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.418 1.087 . . . . 0.0 109.002 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -175.43 152.56 1.38 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 111.061 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.99 162.32 35.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.541 1.536 . . . . 0.0 108.217 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.37 151.22 37.45 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.517 1.127 . . . . 0.0 108.516 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -163.83 154.22 15.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.646 0.736 . . . . 0.0 111.052 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -110.27 123.75 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -139.78 145.15 37.85 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.34 35.86 61.73 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.68 0.38 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.243 3.417 . . . . 0.0 114.421 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.52 154.75 19.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.756 1.622 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.78 130.69 39.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.781 0.832 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.1 mt -119.25 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 37.2 t -122.54 121.45 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 176.96 -110.97 0.32 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 67.03 -4.63 3.16 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 127.143 2.306 . . . . 0.0 116.469 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.58 124.92 25.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.163 1.982 . . . . 0.0 108.678 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.22 16.9 1.36 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.435 1.894 . . . . 0.0 111.803 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.45 151.34 23.61 Favored Glycine 0 C--N 1.335 0.501 0 O-C-N 119.099 -2.251 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 285' ' ' GLU . 45.8 pttt -35.43 98.94 0.16 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.682 1.593 . . . . 0.0 114.009 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.37 114.26 2.79 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.243 1.962 . . . . 0.0 107.977 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.0 p -78.32 145.33 35.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.059 0.944 . . . . 0.0 110.329 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.46 -7.1 34.96 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.429 -0.795 . . . . 0.0 110.202 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.86 2.064 . . . . 0.0 108.622 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.93 -161.95 13.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -141.99 129.06 20.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -79.41 161.93 25.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -144.19 157.21 44.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 111.964 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.52 115.75 8.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.38 116.17 31.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.9 mm -127.55 107.57 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.71 103.79 1.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 123.92 0.762 . . . . 0.0 110.909 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -36.5 -56.07 1.36 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.211 2.204 . . . . 0.0 115.957 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.7 -16.96 11.35 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 115.017 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.9 m -101.24 -10.59 20.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.484 1.493 . . . . 0.0 113.288 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.532 ' HG2' ' H ' ' A' ' 225' ' ' TYR . 23.8 tt0 -139.99 -168.82 2.6 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.532 ' H ' ' HG2' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -168.27 140.7 2.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.35 115.45 49.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.372 2.269 . . . . 0.0 106.208 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 32.5 m -94.14 -72.02 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.281 0.491 . . . . 0.0 111.658 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -107.82 170.5 7.95 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.551 1.14 . . . . 0.0 113.981 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.3 p -132.68 144.97 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.81 1.644 . . . . 0.0 107.91 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -133.07 169.82 16.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.711 1.604 . . . . 0.0 107.428 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.87 -175.26 45.77 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 120.248 -1.532 . . . . 0.0 109.599 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.32 136.27 22.23 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.47 38.99 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.348 1.059 . . . . 0.0 109.339 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -136.97 166.13 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.688 0.756 . . . . 0.0 112.172 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -72.87 141.22 47.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.926 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.1 157.93 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.763 2.025 . . . . 0.0 109.1 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -107.43 106.34 16.7 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 160.25 -49.13 0.38 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.441 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 49.9 m -135.46 173.92 11.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.196 0.998 . . . . 0.0 111.965 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.86 -12.2 58.58 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.159 0.584 . . . . 0.0 112.314 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.54 120.22 5.95 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.39 172.52 9.3 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.532 1.933 . . . . 0.0 107.061 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.7 tt -125.82 134.49 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.734 1.152 . . . . 0.0 111.441 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.4 mt -79.43 122.88 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 -6.67 10.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.983 0.513 . . . . 0.0 111.828 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -143.37 147.29 34.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -138.95 149.13 44.41 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.033 1.733 . . . . 0.0 110.255 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ARG . . . . . 0.41 ' H ' HD23 ' A' ' 247' ' ' LEU . 18.8 mtt180 -149.4 153.83 37.96 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.05 1.74 . . . . 0.0 106.613 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.43 138.47 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -89.27 114.31 25.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.27 0.941 . . . . 0.0 109.492 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.8 p -97.85 165.42 11.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.7 2.0 . . . . 0.0 110.659 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.28 134.75 55.04 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? 75.79 -50.92 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.749 2.42 . . . . 0.0 107.659 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -82.67 155.91 24.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.853 2.061 . . . . 0.0 108.262 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 59.4 m -118.83 114.52 22.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.3 p -68.88 168.22 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 111.802 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.45 154.17 42.42 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.021 1.328 . . . . 0.0 109.442 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.45 109.17 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.874 2.383 . . . . 0.0 108.234 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.54 92.34 5.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.42 -172.01 14.41 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.495 1.045 . . . . 0.0 111.495 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.98 133.94 52.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.42 -1.047 . . . . 0.0 110.516 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.2 108.33 3.12 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -147.56 125.91 12.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 97.81 -157.77 20.73 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.41 0.45 . . . . 0.0 112.095 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.3 m -77.21 117.52 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.722 1.209 . . . . 0.0 110.474 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.92 129.58 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -136.52 151.24 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.46 155.42 50.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.355 1.062 . . . . 0.0 108.58 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp -141.37 130.79 23.76 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.803 0.841 . . . . 0.0 109.017 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.47 166.29 10.26 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.069 1.348 . . . . 0.0 109.369 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -134.78 134.0 40.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.74 128.27 35.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.864 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.21 26.62 70.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -135.96 162.62 32.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.505 1.653 . . . . 0.0 111.097 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -121.62 162.49 20.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.211 1.404 . . . . 0.0 110.165 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 25.4 mt -79.63 145.64 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.1 m -145.49 -12.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.25 34.34 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 120.674 1.579 . . . . 0.0 111.136 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -144.85 157.06 44.29 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.112 1.765 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -149.64 149.29 30.42 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 128.489 2.716 . . . . 0.0 104.783 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.55 -135.99 6.45 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 11.5 mptt -140.63 157.54 45.3 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.448 ' HB3' ' HE1' ' A' ' 167' ' ' TRP . . . -129.87 149.37 51.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.3 p -159.75 -178.01 6.77 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.212 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' A' ' 208' ' ' LYS . 5.7 mm-40 -67.83 -0.19 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.785 1.234 . . . . 0.0 111.671 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 22.6 mt -140.77 135.81 31.88 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 129.316 3.047 . . . . 0.0 103.148 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -85.74 95.62 9.45 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -88.89 -70.41 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.277 0.361 . . . . 0.0 111.722 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -106.13 111.68 24.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.563 1.145 . . . . 0.0 111.995 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -116.98 160.74 20.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.52 40.24 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.73 141.01 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 117.818 0.809 . . . . 0.0 108.943 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -84.24 155.63 22.39 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.1 m -125.12 158.49 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.861 0.864 . . . . 0.0 109.816 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 28.2 mtt -157.44 145.71 14.27 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.871 2.468 . . . . 0.0 105.491 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.54 155.91 62.39 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.182 -1.507 . . . . 0.0 108.182 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.624 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.251 0.548 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -148.53 140.6 23.97 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.3 93.35 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.823 0.738 . . . . 0.0 109.03 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.34 146.46 19.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.477 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 150.98 47.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.093 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.12 9.67 69.99 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.7 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.28 179.88 43.78 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.305 1.552 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.37 -31.34 63.53 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.63 12.85 9.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.47 2.308 . . . . 0.0 113.448 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.04 -28.22 12.16 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.749 2.119 . . . . 0.0 116.352 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.71 -81.33 0.58 Allowed Glycine 0 C--N 1.342 0.863 0 CA-C-N 120.15 1.975 . . . . 0.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 131' ' ' ARG . . . -145.67 158.89 43.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.986 0.915 . . . . 0.0 109.885 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.29 97.88 6.0 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.894 1.278 . . . . 0.0 111.414 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.501 ' CD1' ' HG3' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -67.38 0.6 2.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.538 1.535 . . . . 0.0 113.001 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.65 109.79 2.13 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.12 -0.987 . . . . 0.0 111.103 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.05 165.36 17.62 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 109.434 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 118.376 -1.235 . . . . 0.0 113.443 179.829 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.379 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -143.11 96.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.62 1.568 . . . . 0.0 107.42 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.407 ' HD2' ' HB2' ' A' ' 43' ' ' ALA . 7.9 tpm_? -85.59 -50.56 7.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.805 1.242 . . . . 0.0 110.836 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -141.19 164.48 30.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.37 96.97 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.1 126.1 34.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.89 136.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.38 162.71 30.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -106.86 141.19 38.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.239 2.216 . . . . 0.0 111.259 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.39 -156.68 9.72 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 106.039 -2.824 . . . . 0.0 106.039 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -96.06 -9.4 30.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.705 -1.467 . . . . 0.0 109.629 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.82 2.71 38.59 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 134.132 4.973 . . . . 0.0 112.707 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.71 -139.4 14.49 Favored Glycine 0 C--N 1.339 0.736 0 O-C-N 121.146 -0.971 . . . . 0.0 111.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -77.42 96.45 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -105.43 2.74 28.91 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.47 124.91 23.43 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 122.138 2.245 . . . . 0.0 107.919 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 169.37 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -159.14 152.83 22.97 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.745 -1.222 . . . . 0.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.58 107.6 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.037 1.335 . . . . 0.0 109.585 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.42 114.88 35.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -101.93 122.97 45.05 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.781 0.719 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . -77.81 125.64 29.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -113.98 145.32 41.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.16 -35.58 59.93 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 t -80.71 -65.08 1.06 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.207 0.458 . . . . 0.0 110.203 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -150.96 140.91 21.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.341 1.056 . . . . 0.0 108.359 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.63 135.58 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.202 1.801 . . . . 0.0 109.665 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.74 146.56 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 106.984 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 156.89 21.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.711 1.204 . . . . 0.0 109.657 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.62 35.36 3.33 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.234 1.873 . . . . 0.0 111.384 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.07 -154.36 47.09 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.012 0.906 . . . . 0.0 111.628 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.3 152.8 47.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -128.81 166.11 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.1 0.96 . . . . 0.0 109.002 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' A' ' 56' ' ' LYS . . . 85.71 -157.96 31.73 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -126.66 105.56 8.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 113.358 -178.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 1.5 ttmp? -62.41 128.73 37.43 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -131.14 155.17 47.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.6 pt? -75.56 -9.88 58.96 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -0.19 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.604 1.562 . . . . 0.0 113.089 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.08 130.87 2.39 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 125.888 1.709 . . . . 0.0 108.903 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.523 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 63.7 t80 -163.58 132.32 3.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.321 2.648 . . . . 0.0 105.781 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 163.67 32.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.79 1.636 . . . . 0.0 111.817 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -134.2 96.85 3.7 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.681 1.193 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.61 138.43 31.69 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.94 119.21 32.81 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.243 1.017 . . . . 0.0 109.602 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.24 123.67 25.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.046 0.938 . . . . 0.0 109.403 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.42 159.88 31.73 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.51 1.524 . . . . 0.0 110.742 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.51 25.99 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.5 1.57 55.71 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.469 2.308 . . . . 0.0 114.254 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -127.21 155.98 42.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.721 1.146 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -135.08 137.12 42.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.49 1.116 . . . . 0.0 108.884 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mt -73.96 102.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.24 -34.77 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 113.965 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.06 43.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.827 0.739 . . . . 0.0 109.482 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.29 146.29 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -131.49 137.69 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.49 139.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 p -115.8 154.49 29.55 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -154.3 168.63 25.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.86 1.264 . . . . 0.0 108.9 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -161.07 168.51 24.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -115.88 159.02 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.848 2.059 . . . . 0.0 109.063 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.1 m -127.25 135.62 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.29 107.82 0.61 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.24 3.66 7.99 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.041 -1.421 . . . . 0.0 113.35 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.23 142.17 47.26 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 119.817 1.808 . . . . 0.0 108.203 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.71 16.2 12.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.879 2.071 . . . . 0.0 111.517 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -136.35 172.72 12.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.348 1.459 . . . . 0.0 111.469 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.84 158.4 30.36 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.811 1.644 . . . . 0.0 106.897 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 pt -131.68 150.51 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.736 1.614 . . . . 0.0 107.397 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.89 122.76 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.292 1.037 . . . . 0.0 110.348 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 p -88.8 -29.67 19.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.71 0.804 . . . . 0.0 112.274 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -164.55 161.61 21.23 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.94 1.296 . . . . 0.0 109.793 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 mt -136.35 136.71 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 m -135.81 132.66 36.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -114.74 158.88 21.23 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.522 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -140.75 144.72 35.67 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.522 2.329 . . . . 0.0 105.227 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -134.2 166.39 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.0 -41.04 95.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 10.3 mmpt? -58.33 -12.09 3.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.455 1.102 . . . . 0.0 112.275 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.0 18.61 62.76 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.194 1.378 . . . . 0.0 111.954 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -89.15 97.01 10.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 p -85.46 105.81 16.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.24 157.11 83.35 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.53 164.17 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 0.0 111.331 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 111.82 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.063 2.509 . . . . 0.0 107.02 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -75.52 74.79 2.56 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.365 0.666 . . . . 0.0 109.566 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 142.36 -141.17 10.54 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.228 1.395 . . . . 0.0 110.519 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.9 tp -108.5 132.5 53.75 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 125.544 1.538 . . . . 0.0 109.619 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 116.86 18.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 m -114.67 164.6 13.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -61.26 -51.9 66.98 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.814 1.246 . . . . 0.0 110.174 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.29 115.77 11.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.9 168.27 27.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.358 -0.839 . . . . 0.0 110.872 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.37 167.18 22.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.607 1.563 . . . . 0.0 107.887 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.65 149.8 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -142.95 157.32 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.344 0.52 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.42 160.04 15.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.719 1.608 . . . . 0.0 111.51 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -81.28 177.12 9.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.796 1.639 . . . . 0.0 107.898 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.08 -46.31 2.32 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.111 -0.993 . . . . 0.0 112.519 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -109.52 19.25 19.48 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.41 -4.93 85.23 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.001 1.286 . . . . 0.0 114.244 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 118.32 13.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.53 164.18 0.54 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.243 1.817 . . . . 0.0 113.752 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.28 111.27 1.68 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.9 t -61.75 -50.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.78 48.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.08 -2.408 . . . . 0.0 107.08 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -102.49 172.32 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 169.14 20.89 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.48 126.69 1.73 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.501 ' HG3' ' CD1' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -99.74 179.3 4.58 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 123.208 1.48 . . . . 0.0 109.075 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.23 152.85 39.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 129.663 3.185 . . . . 0.0 105.519 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.52 -87.09 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 104.214 -3.555 . . . . 0.0 104.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -95.12 -27.48 15.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.186 0.493 . . . . 0.0 111.142 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.59 160.73 37.17 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 tp -77.45 93.67 4.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.597 0.713 . . . . 0.0 110.284 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -81.76 -37.12 27.71 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.306 1.042 . . . . 0.0 112.681 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.58 152.02 39.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.813 1.188 . . . . 0.0 109.853 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.4 tp -161.77 141.89 10.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.256 1.422 . . . . 0.0 108.296 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.89 -179.73 46.85 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.55 167.43 28.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.654 1.182 . . . . 0.0 109.069 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -136.39 168.44 19.45 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.815 1.293 . . . . 0.0 111.169 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -133.04 97.37 3.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 103.151 -2.907 . . . . 0.0 103.151 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -178.744 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.92 0.867 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 126.52 31.13 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.149 -0.969 . . . . 0.0 112.816 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.82 147.88 24.94 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.992 2.117 . . . . 0.0 109.882 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.66 162.47 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.5 t -72.63 135.49 45.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -135.37 169.43 17.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.387 1.875 . . . . 0.0 109.976 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.6 154.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.25 1.82 . . . . 0.0 108.883 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.8 -85.2 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.68 47.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.668 2.08 . . . . 0.0 108.271 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 2.9 p30 -111.19 10.15 21.84 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -83.45 150.06 26.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.35 -179.56 22.94 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.721 1.146 . . . . 0.0 115.805 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.4 m -96.3 119.39 34.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.197 1.799 . . . . 0.0 109.136 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.6 153.65 40.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.438 0.563 . . . . 0.0 110.295 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -142.46 131.2 22.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.33 1.062 . . . . 0.0 111.0 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.32 139.91 32.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.806 1.643 . . . . 0.0 108.512 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.16 124.66 19.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.78 177.68 41.99 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.386 1.47 . . . . 0.0 111.05 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.36 149.69 27.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -131.96 -175.31 3.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.216 1.007 . . . . 0.0 110.896 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.07 -32.21 54.01 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.934 1.694 . . . . 0.0 113.327 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.32 -158.64 31.36 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.512 2.006 . . . . 0.0 108.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.39 139.47 50.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.688 1.195 . . . . 0.0 108.622 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.89 -68.89 0.9 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 110.233 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 193' ' ' GLU . 49.8 mtpt -119.03 157.65 27.37 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.399 0.545 . . . . 0.0 110.749 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.83 143.73 38.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 127.303 2.241 . . . . 0.0 107.775 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -143.39 145.41 32.63 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.722 1.209 . . . . 0.0 108.041 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 t -139.39 151.3 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.381 1.072 . . . . 0.0 109.605 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.74 144.37 16.24 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -123.36 -170.05 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.359 1.464 . . . . 0.0 110.571 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.85 -175.83 45.78 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 126.002 1.763 . . . . 0.0 110.127 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.26 -17.92 2.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.428 3.091 . . . . 0.0 118.219 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -117.78 -9.91 10.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.912 0.778 . . . . 0.0 112.259 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.7 -146.69 18.58 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 mm -63.86 153.4 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.588 1.194 . . . . 0.0 108.393 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.3 p -134.81 -23.84 1.54 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.76 151.93 34.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.692 1.133 . . . . 0.0 111.718 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 m -149.51 124.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 123.543 0.737 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -149.81 161.28 42.57 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -151.3 172.91 15.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.013 0.925 . . . . 0.0 108.511 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 177' ' ' LYS . 25.2 mp0 -130.88 147.03 52.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.837 0.827 . . . . 0.0 109.767 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.47 168.42 21.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.811 2.044 . . . . 0.0 109.979 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -112.3 161.83 16.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.0 1.72 . . . . 0.0 108.764 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -134.35 83.77 2.06 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.692 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.63 -66.58 1.34 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.398 1.475 . . . . 0.0 111.477 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -135.07 -45.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.365 1.866 . . . . 0.0 108.555 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -60.9 164.43 4.88 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.872 1.32 . . . . 0.0 111.333 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -123.34 149.78 44.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.625 1.57 . . . . 0.0 107.414 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -140.43 143.9 28.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.53 147.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -71.79 146.49 40.17 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.46 10.66 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.334 -3.106 . . . . 0.0 105.334 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 133.57 49.31 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 118.616 1.208 . . . . 0.0 108.863 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -106.41 -15.25 14.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.559 0.744 . . . . 0.0 110.486 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -102.48 -177.62 27.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.827 1.68 . . . . 0.0 113.232 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -107.93 83.52 1.76 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 128.531 2.733 . . . . 0.0 106.323 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.4 148.97 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.75 . . . . 0.0 111.553 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 66.7 p -87.06 -179.26 6.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.45 -1.06 25.23 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.151 -1.593 . . . . 0.0 112.771 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -32.27 32.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.23 0.923 . . . . 0.0 113.239 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.56 -157.11 18.81 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -147.42 119.94 8.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -66.94 154.76 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -139.75 142.74 36.77 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -143.04 142.98 31.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.495 1.518 . . . . 0.0 107.486 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -133.14 95.85 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.76 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.97 1.308 . . . . 0.0 111.395 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.78 89.79 2.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.403 1.081 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -45.46 -47.74 35.99 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.598 1.959 . . . . 0.0 112.626 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.89 -7.03 15.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 122.048 1.767 . . . . 0.0 114.682 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.7 t -109.93 -13.15 14.48 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 120.814 1.643 . . . . 0.0 113.402 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 171.66 13.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.344 0.975 . . . . 0.0 111.328 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -145.66 90.63 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.62 101.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.3 p -87.19 -26.47 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.441 1.097 . . . . 0.0 112.46 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.52 171.02 20.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.156 0.889 . . . . 0.0 112.24 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.86 159.26 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.16 176.35 5.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.717 2.407 . . . . 0.0 107.543 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.97 41.86 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -153.18 141.3 20.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.11 153.79 48.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.761 0.825 . . . . 0.0 110.432 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . 0.326 0.3 OUTLIER -156.17 172.01 19.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -74.78 139.94 43.66 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.409 1.483 . . . . 0.0 110.953 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.25 157.54 34.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 127.221 2.208 . . . . 0.0 110.041 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -84.93 178.37 7.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.32 -69.7 1.52 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.1 p -95.48 -178.21 4.34 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.715 0.769 . . . . 0.0 111.427 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.58 14.19 24.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.613 1.565 . . . . 0.0 111.435 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -128.27 163.49 21.81 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.249 1.404 . . . . 0.0 113.099 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.82 173.28 11.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.978 1.711 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.75 146.07 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.403 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.3 mm -76.12 133.78 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 t -112.36 -21.82 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -152.27 152.7 32.48 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 140.42 34.23 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.821 2.048 . . . . 0.0 109.013 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -145.23 153.42 41.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 106.339 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.45 128.69 56.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -80.47 114.39 19.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -119.66 165.16 14.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.365 1.079 . . . . 0.0 109.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.93 133.51 47.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 65.95 -46.39 0.4 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.501 2.32 . . . . 0.0 111.188 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -92.11 165.5 13.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 129.283 3.033 . . . . 0.0 109.408 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 73.7 m -150.76 118.83 6.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 83.9 p -66.85 165.03 16.08 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.095 0.474 . . . . 0.0 110.613 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -67.84 153.96 94.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.84 97.77 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.439 2.093 . . . . 0.0 106.731 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -76.14 92.47 3.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 111.28 178.24 20.33 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.952 1.263 . . . . 0.0 111.534 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.75 123.44 49.0 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.09 0.956 . . . . 0.0 110.035 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.11 107.23 5.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -157.05 45.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.219 1.008 . . . . 0.0 109.357 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -167.87 -164.92 24.39 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 121.405 -0.81 . . . . 0.0 111.115 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.2 m -66.7 104.6 1.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.27 146.98 36.54 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.578 -0.701 . . . . 0.0 110.788 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -141.4 170.42 15.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.924 0.868 . . . . 0.0 112.763 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -140.99 152.83 45.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.542 2.337 . . . . 0.0 106.891 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.6 mt -138.64 104.22 5.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -140.05 150.82 44.83 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.255 0.622 . . . . 0.0 110.461 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -144.8 130.75 19.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -67.71 138.72 56.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.63 -11.23 3.38 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.483 1.516 . . . . 0.0 115.818 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -99.21 159.75 14.76 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 120.111 1.956 . . . . 0.0 112.197 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -119.95 147.6 44.55 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.823 1.649 . . . . 0.0 107.543 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 87.9 mt -80.69 141.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.16 -29.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.46 -178.07 35.08 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.001 1.286 . . . . 0.0 110.559 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -113.37 -179.04 3.53 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.878 1.671 . . . . 0.0 111.22 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -153.35 179.36 8.84 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.822 2.049 . . . . 0.0 105.549 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 126.98 -151.73 18.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -151.54 149.53 29.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -108.11 154.6 21.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.936 1.295 . . . . 0.0 108.513 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 t -151.92 -63.03 0.17 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -149.18 -31.36 0.23 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.387 1.075 . . . . 0.0 112.542 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 79.6 mt -134.4 -112.81 0.21 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.948 1.249 . . . . 0.0 109.259 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.78 77.43 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.175 1.352 . . . . 0.0 108.628 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -60.58 -62.24 2.0 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 0.0 113.322 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -132.38 140.76 48.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.866 0.757 . . . . 0.0 109.702 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -140.99 151.32 44.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.566 1.547 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.88 165.83 37.76 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.0 m -113.52 157.02 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.788 1.294 . . . . 0.0 113.719 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -98.97 136.44 38.95 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.59 141.95 38.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.21 129.41 20.84 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 125.044 1.338 . . . . 0.0 108.425 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.95 86.53 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.857 3.038 . . . . 0.0 110.059 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 20.7 mt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.455 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.391 0.615 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -140.99 140.66 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 130.442 3.497 . . . . 0.0 107.1 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 82.5 t -127.94 130.9 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.61 169.89 5.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.333 1.053 . . . . 0.0 113.836 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.37 106.55 6.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.44 134.08 13.29 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 105.67 -2.972 . . . . 0.0 105.67 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.25 -151.42 20.08 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.77 168.89 42.89 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 122.779 1.21 . . . . 0.0 114.444 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.74 -18.39 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.457 1.103 . . . . 0.0 111.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.53 169.33 41.23 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.577 0.608 . . . . 0.0 113.005 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.91 168.49 44.46 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.134 1.35 . . . . 0.0 112.462 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.74 156.06 21.59 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 84.0 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.199 1.4 . . . . 0.0 110.264 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -90.04 135.58 33.56 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.38 151.95 28.49 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 128.295 2.638 . . . . 0.0 105.41 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.78 153.0 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.842 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -178.952 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.11 142.71 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 119.397 1.598 . . . . 0.0 109.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.29 -33.33 1.3 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.265 0.626 . . . . 0.0 112.29 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -135.89 160.67 37.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.453 0.569 . . . . 0.0 110.735 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.29 90.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.63 110.45 20.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -132.92 147.58 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 172.37 22.45 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -135.12 157.27 47.35 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.835 0.854 . . . . 0.0 112.568 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.83 -153.28 8.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.389 -2.684 . . . . 0.0 106.389 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -95.86 -7.34 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.96 -1.318 . . . . 0.0 110.373 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.38 -7.23 26.48 Favored 'General case' 0 N--CA 1.446 -0.645 1 C-N-CA 133.705 4.802 . . . . 0.0 112.427 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.77 -151.91 18.07 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.78 131.69 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -148.09 13.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.758 -1.214 . . . . 0.0 113.297 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 p -131.7 125.42 32.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.5 mt -140.52 119.39 11.19 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -128.03 145.36 51.01 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 107.714 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.2 t -129.08 131.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.313 1.045 . . . . 0.0 110.407 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.59 132.51 44.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 102.184 -3.265 . . . . 0.0 102.184 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -103.07 152.63 21.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 109.834 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.26 115.87 30.92 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.16 166.73 11.33 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.357 1.075 . . . . 0.0 111.16 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.53 -5.65 25.64 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.406 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.2 m -104.91 -67.01 0.93 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 119.583 -1.948 . . . . 0.0 110.803 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -156.35 165.6 35.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.664 1.185 . . . . 0.0 107.831 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.52 141.88 42.94 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -145.79 138.44 20.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.61 136.45 57.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.152 0.981 . . . . 0.0 108.438 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.73 -65.88 1.84 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.15 171.81 20.17 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.09 146.3 23.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.483 0.659 . . . . 0.0 111.02 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -123.92 83.73 2.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.28 26.29 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -126.61 112.44 15.5 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -52.98 111.96 0.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 110.082 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -81.61 108.36 15.11 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 127.756 2.422 . . . . 0.0 109.842 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.77 -24.02 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.569 -0.707 . . . . 0.0 112.672 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.28 8.77 43.89 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.271 1.029 . . . . 0.0 113.548 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.44 121.9 0.84 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.951 1.25 . . . . 0.0 110.658 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.85 121.38 2.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.623 2.369 . . . . 0.0 105.026 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -128.4 164.45 22.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.4 m -121.87 131.22 53.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.865 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -137.47 110.27 7.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -95.52 124.66 39.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.98 1.312 . . . . 0.0 108.922 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.84 116.25 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.56 143.57 56.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -41.63 75.41 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.626 -0.671 . . . . 0.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.34 -7.4 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.677 1.191 . . . . 0.0 112.638 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.11 151.33 21.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.969 1.708 . . . . 0.0 108.23 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -130.89 143.15 50.52 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.9 mt -68.57 137.64 24.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.2 m -107.18 -46.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 123.144 0.578 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 165.32 31.07 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.215 1.406 . . . . 0.0 108.635 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.07 108.82 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -91.91 137.68 32.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.5 t -136.36 144.16 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.523 HG21 ' H ' ' A' ' 111' ' ' THR . 75.6 m -118.61 140.46 49.88 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.69 167.17 30.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.218 1.807 . . . . 0.0 106.308 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.18 168.54 24.03 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.53 0.605 . . . . 0.0 109.842 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -108.5 148.72 29.84 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.375 1.07 . . . . 0.0 111.313 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.48 131.13 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -60.24 -0.25 0.22 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.817 1.647 . . . . 0.0 115.201 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.36 7.66 34.77 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.18 1.847 . . . . 0.0 113.35 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -138.42 144.07 40.02 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 120.365 2.083 . . . . 0.0 109.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.59 -2.29 28.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.281 1.832 . . . . 0.0 111.664 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 t -155.02 150.38 27.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.83 -1.169 . . . . 0.0 110.137 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.52 163.87 27.24 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 pt -139.39 151.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.973 1.309 . . . . 0.0 109.246 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.16 118.92 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.429 ' OG1' HG22 ' A' ' 79' ' ' THR . 23.4 p -89.53 -32.76 17.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.584 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -162.84 166.22 24.36 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.557 1.071 . . . . 0.0 112.863 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.6 mt -135.72 151.58 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.066 1.347 . . . . 0.0 107.681 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.3 m -141.25 101.74 4.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.392 1.877 . . . . 0.0 107.009 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -81.82 121.8 26.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.752 1.221 . . . . 0.0 108.914 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -106.13 128.24 53.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.414 1.486 . . . . 0.0 109.067 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.9 p -99.9 169.06 9.48 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.642 1.177 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -76.92 -39.93 49.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -68.75 -26.2 65.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 116.432 -1.747 . . . . 0.0 115.348 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.52 -12.58 7.01 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 121.068 1.758 . . . . 0.0 114.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -70.49 137.4 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -135.06 128.66 32.69 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.5 p -74.31 158.66 85.11 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 117.914 0.325 . . . . 0.0 110.917 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.93 164.53 35.37 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 107.128 -1.912 . . . . 0.0 107.128 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.81 83.5 1.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.783 2.322 . . . . 0.0 108.663 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -57.16 115.52 2.71 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.05 -126.45 6.89 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -139.4 131.73 28.39 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.87 1.268 . . . . 0.0 107.916 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -68.19 154.26 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.523 ' H ' HG21 ' A' ' 79' ' ' THR . 0.2 OUTLIER -151.34 175.56 12.11 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.432 -1.417 . . . . 0.0 111.784 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.41 ' H ' HG22 ' A' ' 111' ' ' THR . 5.3 tt0 -58.38 -64.52 0.89 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.915 1.686 . . . . 0.0 111.527 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.95 163.52 27.8 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.948 0.88 . . . . 0.0 110.927 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER 176.11 168.82 0.43 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.156 1.783 . . . . 0.0 109.047 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.48 160.96 42.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.663 1.585 . . . . 0.0 107.565 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.06 137.17 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.22 137.09 50.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.14 138.03 0.72 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.379 2.672 . . . . 0.0 107.865 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -64.31 140.28 58.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.75 -28.06 63.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.383 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.99 2.96 55.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.081 1.309 . . . . 0.0 111.641 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.7 87.24 0.75 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.526 1.057 . . . . 0.0 111.153 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.57 144.35 15.92 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.42 145.69 28.84 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.3 tt -75.86 107.66 8.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 m -86.62 -23.57 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.531 0.605 . . . . 0.0 110.135 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.24 -179.68 43.27 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -144.47 175.71 9.92 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.333 1.053 . . . . 0.0 110.265 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.53 167.95 28.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.373 2.269 . . . . 0.0 106.565 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 118.48 0.52 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.309 1.413 . . . . 0.0 114.398 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -60.1 120.87 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.13 164.88 31.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.601 1.56 . . . . 0.0 109.131 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.77 -112.59 0.26 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.97 -21.89 66.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.971 0.385 . . . . 0.0 111.004 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.65 173.31 13.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.025 2.13 . . . . 0.0 108.998 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 50.5 tp -89.94 98.64 11.89 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -82.55 -42.91 17.74 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.68 34.0 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.245 0.929 . . . . 0.0 112.53 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.45 153.64 36.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.068 0.947 . . . . 0.0 111.086 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.15 29.41 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.309 1.433 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.4 40.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.351 1.06 . . . . 0.0 110.505 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -109.66 114.52 28.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -107.94 131.75 54.21 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.671 0.788 . . . . 0.0 111.055 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.795 0.838 . . . . 0.0 112.264 179.425 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -75.85 127.25 32.61 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -95.21 135.38 36.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.9 mt -89.87 178.43 6.23 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.3 m -100.1 101.71 12.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.41 173.55 7.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.575 0.702 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.5 tt -144.4 172.03 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.346 1.858 . . . . 0.0 106.76 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.36 -111.75 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -146.74 -1.61 0.6 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 125.325 1.25 . . . . 0.0 114.68 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.589 ' HA ' ' CE ' ' A' ' 282' ' ' LYS 0.388 55.0 m-20 46.68 15.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.66 -29.3 59.03 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.29 -168.2 38.74 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.0 t -82.14 112.33 19.07 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.34 1.456 . . . . 0.0 109.462 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.95 35.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -135.82 107.31 6.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 110.177 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 280' ' ' HIS . 12.4 p-10 -97.9 104.68 16.73 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.84 -1.85 15.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.01 -83.96 1.15 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.174 1.369 . . . . 0.0 113.108 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.59 170.43 8.14 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.583 2.353 . . . . 0.0 110.65 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -138.6 144.64 39.86 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.151 0.98 . . . . 0.0 109.738 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.65 -10.71 59.34 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.238 1.015 . . . . 0.0 112.665 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.05 153.36 22.04 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.287 1.422 . . . . 0.0 109.964 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.06 156.46 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.899 1.68 . . . . 0.0 108.062 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -124.71 -58.31 1.5 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.616 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -158.76 162.03 37.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.277 1.398 . . . . 0.0 112.602 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.59 144.4 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.404 1.882 . . . . 0.0 107.077 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -139.23 144.67 38.57 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.88 1.272 . . . . 0.0 107.88 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 8.9 t -132.27 126.85 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -121.3 83.01 0.35 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -86.15 172.95 10.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.396 1.093 . . . . 0.0 111.286 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.26 -168.6 11.8 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 128.573 2.987 . . . . 0.0 106.981 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -66.49 -36.64 83.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.07 -32.24 61.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.53 0.732 . . . . 0.0 112.169 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.0 -154.21 25.35 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.6 mm -64.82 124.51 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.8 m -108.96 -25.48 10.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.683 1.128 . . . . 0.0 112.485 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -140.99 141.53 34.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.174 0.989 . . . . 0.0 110.774 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.47 130.41 72.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -152.47 144.68 23.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -144.19 168.76 19.27 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.283 1.033 . . . . 0.0 109.821 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -133.53 129.39 37.04 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -131.28 168.97 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.763 1.625 . . . . 0.0 110.22 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -124.47 99.25 6.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -117.28 138.7 51.57 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.983 2.113 . . . . 0.0 105.768 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.31 29.27 45.64 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.222 -0.765 . . . . 0.0 112.174 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.78 -7.72 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.475 2.71 . . . . 0.0 114.593 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.02 158.66 18.56 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 123.554 1.645 . . . . 0.0 114.752 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -86.6 99.95 12.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.177 1.791 . . . . 0.0 106.937 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.5 143.92 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.27 129.93 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.162 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.54 -34.3 28.88 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.51 174.49 35.67 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.911 1.72 . . . . 0.0 111.113 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -62.84 100.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.005 1.322 . . . . 0.0 108.184 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -73.99 -50.4 20.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -93.19 165.27 27.7 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.529 1.061 . . . . 0.0 112.297 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -62.81 108.2 1.58 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 126.176 1.791 . . . . 0.0 110.876 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.79 178.55 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 N-CA-C 107.713 -1.687 . . . . 0.0 107.713 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 212' ' ' LEU . 1.2 t -147.56 176.15 10.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -14.54 11.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.462 ' H ' HG23 ' A' ' 210' ' ' THR . 9.8 tt -65.61 -28.86 69.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.883 0.873 . . . . 0.0 110.329 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.89 -137.65 13.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.28 156.21 38.0 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.306 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.52 154.1 28.85 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.62 148.69 47.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.474 0.579 . . . . 0.0 111.676 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.06 112.54 6.82 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -83.36 109.91 17.69 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.5 mt -110.51 102.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.6 99.26 5.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -45.04 -41.55 13.61 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.46 -26.42 29.02 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 CA-C-N 123.592 2.319 . . . . 0.0 112.887 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 98.6 p -107.79 -16.12 14.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.97 1.714 . . . . 0.0 114.278 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 117.72 29.15 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.301 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.52 92.9 4.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.14 1.776 . . . . 0.0 111.374 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.46 106.17 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 22.4 m -77.86 -38.89 45.04 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.139 0.576 . . . . 0.0 110.436 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.67 36.69 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.952 0.901 . . . . 0.0 110.652 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.2 143.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.453 ' CG ' ' HE3' ' A' ' 250' ' ' LYS . 9.5 mm-40 -128.72 166.49 18.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.603 1.961 . . . . 0.0 109.094 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.08 166.84 31.34 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.7 p -128.81 132.66 47.86 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.24 147.62 43.89 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.77 171.3 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.951 0.901 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 148.1 42.52 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.63 1.572 . . . . 0.0 110.747 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 236' ' ' ILE . 1.9 mp -96.22 135.59 29.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.75 85.63 2.75 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 139.63 -6.04 2.92 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.109 1.338 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 t -123.76 170.55 10.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.61 1.705 . . . . 0.0 108.905 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -116.92 52.62 0.94 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.972 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -167.72 -174.91 37.12 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.07 1.319 . . . . 0.0 110.299 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.59 157.92 23.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.381 1.072 . . . . 0.0 109.666 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.7 tt -130.87 135.93 59.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 124.985 1.314 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.05 104.34 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.066 -2.939 . . . . 0.0 103.066 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.284 5.5 t -86.22 -19.17 30.39 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -147.24 149.73 33.46 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.269 -0.895 . . . . 0.0 110.129 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 249' ' ' PHE . 0.2 OUTLIER -136.78 143.61 43.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.307 2.243 . . . . 0.0 108.565 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -147.42 161.81 40.29 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.046 1.738 . . . . 0.0 107.645 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.426 ' CZ ' HD12 ' A' ' 247' ' ' LEU . 71.4 m-85 -131.42 118.79 20.73 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 230' ' ' GLU . 73.6 mttt -69.79 113.14 6.75 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 100.325 -3.954 . . . . 0.0 100.325 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 152.31 23.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.162 2.185 . . . . 0.0 107.942 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 154.9 23.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 57.29 -7.72 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -157.55 174.66 15.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 131.208 3.803 . . . . 0.0 106.875 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.8 m -138.24 124.31 20.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.1 175.96 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.669 1.223 . . . . 0.0 111.84 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -79.31 158.34 74.27 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.734 2.014 . . . . 0.0 111.94 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.66 90.35 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.924 2.416 . . . . 0.0 106.859 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -73.69 91.97 1.94 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 115.24 -179.91 18.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.623 1.106 . . . . 0.0 113.784 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.17 111.02 22.03 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.63 1.172 . . . . 0.0 109.889 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.57 107.73 1.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -168.36 141.49 3.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.303 2.241 . . . . 0.0 107.284 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 103.74 -177.13 24.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 55.3 m -72.15 122.61 21.29 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.216 -0.579 . . . . 0.0 109.79 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.68 122.08 22.67 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.95 120.28 31.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.45 0.568 . . . . 0.0 111.465 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -100.47 144.02 29.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.873 0.869 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 82.6 mt -122.47 103.53 8.78 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -133.95 171.35 14.31 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.681 1.992 . . . . 0.0 108.999 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -143.5 167.87 21.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.748 0.819 . . . . 0.0 110.741 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.98 7.48 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.113 1.765 . . . . 0.0 114.102 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 142.36 65.18 0.03 OUTLIER Glycine 0 C--N 1.335 0.472 0 O-C-N 121.298 -0.876 . . . . 0.0 111.583 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -147.74 153.83 39.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.231 1.412 . . . . 0.0 107.84 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.68 154.72 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.348 1.459 . . . . 0.0 107.34 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.24 153.36 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 49.8 t -132.01 -80.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.15 -151.83 11.0 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 118.913 0.778 . . . . 0.0 111.743 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CE1' ' HA3' ' A' ' 281' ' ' GLY . 4.7 t80 -138.77 147.78 43.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.808 1.243 . . . . 0.0 110.086 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.6 p80 -133.73 92.19 2.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 279' ' ' PHE . . . -155.21 -138.88 2.66 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.589 ' CE ' ' HA ' ' A' ' 162' ' ' ASP 0.289 0.3 OUTLIER -156.4 162.37 40.04 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.082 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.95 50.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.519 0.676 . . . . 0.0 111.382 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 12.3 t -156.66 -167.4 2.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.696 1.998 . . . . 0.0 107.395 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -62.57 -19.43 63.68 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.076 2.15 . . . . 0.0 112.342 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 24.3 mt -139.23 150.05 45.07 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 128.987 2.915 . . . . 0.0 105.294 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 24.8 tp -85.12 86.62 7.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.007 0.821 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -78.72 -40.15 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.637 1.175 . . . . 0.0 110.895 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -128.43 130.62 47.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 120.079 1.308 . . . . 0.0 110.037 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.53 148.53 29.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.39 -164.67 27.43 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.13 137.47 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.461 0.704 . . . . 0.0 112.478 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 155.56 28.32 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 147.63 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.542 0.61 . . . . 0.0 111.641 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 80.2 mtp -139.72 149.09 58.25 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.74 118.05 5.45 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.686 2.257 . . . . 0.0 108.889 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.234 0.263 0 C-N-CA 123.322 0.649 . . . . 0.0 111.042 179.481 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--O 1.235 0.29 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 80.6 t -133.96 124.16 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.79 164.7 20.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.117 0.96 . . . . 0.0 110.185 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 138' ' ' ALA . . . -69.09 105.61 2.51 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.329 1.452 . . . . 0.0 109.651 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.65 47.53 2.47 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.13 1.824 . . . . 0.0 114.571 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.18 -156.91 9.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.466 1.507 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 89' ' ' ASP . . . -80.98 160.06 42.35 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.233 1.016 . . . . 0.0 114.053 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.14 5.42 41.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.333 1.453 . . . . 0.0 112.61 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.34 59.94 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.18 14.03 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 119.906 1.853 . . . . 0.0 111.771 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 131' ' ' ARG . . . -78.73 156.69 28.77 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.735 0.814 . . . . 0.0 110.895 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 m -66.19 127.68 33.12 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.683 0.793 . . . . 0.0 111.583 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -134.36 161.4 35.09 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 160.09 149.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.599 3.16 . . . . 0.0 107.544 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -142.3 119.71 11.62 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.591 0.756 . . . . 0.0 109.346 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 C-N-CA 127.62 2.533 . . . . 0.0 117.829 -178.411 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.332 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -145.38 139.84 22.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.5 mmt-85 -114.88 -60.97 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.086 1.754 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -126.36 162.85 24.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.761 1.225 . . . . 0.0 110.216 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.94 131.95 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.11 123.16 39.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.18 117.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 119.19 6.18 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.534 0.519 . . . . 0.0 112.268 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -69.98 172.58 7.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.05 1.74 . . . . 0.0 109.53 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.17 175.95 34.49 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 129.463 3.411 . . . . 0.0 104.821 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -68.06 -31.24 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -26.65 50.08 Favored 'General case' 0 N--CA 1.45 -0.447 1 C-N-CA 132.731 4.413 . . . . 0.0 113.327 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.97 -164.6 24.44 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -62.77 106.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.612 1.206 . . . . 0.0 108.217 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -97.16 -34.67 11.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.415 1.486 . . . . 0.0 114.455 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -119.34 153.26 35.39 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.534 1.133 . . . . 0.0 110.46 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.62 142.2 28.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.789 1.636 . . . . 0.0 109.088 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.44 151.62 22.8 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.59 1.956 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.85 158.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.134 1.374 . . . . 0.0 108.93 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.48 124.89 73.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -91.56 167.81 11.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.477 1.111 . . . . 0.0 110.01 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.14 111.39 19.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.731 1.212 . . . . 0.0 108.202 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -113.67 109.18 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 126.494 1.918 . . . . 0.0 108.066 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 64.0 1.01 1.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.143 1.777 . . . . 0.0 114.128 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.5 m 118.6 -11.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 1 C-N-CA 133.252 4.621 . . . . 0.0 110.498 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.3 144.72 28.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.119 0.967 . . . . 0.0 109.077 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.7 137.04 36.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.04 121.86 55.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.806 0.73 . . . . 0.0 110.074 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.98 161.84 20.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.623 2.369 . . . . 0.0 106.83 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.54 25.25 0.05 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.175 2.321 . . . . 0.0 112.384 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.33 91.91 0.1 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 121.838 2.819 . . . . 0.0 116.995 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -111.04 114.67 28.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -118.49 175.7 5.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.707 1.603 . . . . 0.0 112.061 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.4 -169.91 22.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 98.66 6.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -57.21 133.66 55.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.77 1.228 . . . . 0.0 110.856 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -129.06 124.07 33.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.384 . . . . 0.0 109.231 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.32 -21.52 66.72 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.13 -0.981 . . . . 0.0 112.851 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.54 38.3 3.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.508 1.523 . . . . 0.0 108.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.54 100.46 0.27 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.044 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.94 151.24 12.19 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.625 1.57 . . . . 0.0 109.673 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -151.14 160.58 43.78 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 130.164 3.386 . . . . 0.0 106.342 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 m -135.87 98.56 3.93 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.364 0.666 . . . . 0.0 111.465 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -95.73 108.92 21.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.56 101.79 13.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.683 1.593 . . . . 0.0 108.208 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.96 141.39 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -95.12 150.79 19.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.247 -0.908 . . . . 0.0 112.157 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.27 13.85 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.266 1.426 . . . . 0.0 111.949 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.53 -5.96 14.48 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.647 2.379 . . . . 0.0 111.345 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.08 150.99 36.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.855 1.262 . . . . 0.0 113.622 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.531 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 62.1 m-85 -135.56 132.94 37.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -71.65 113.2 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -93.9 -21.3 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.449 -0.782 . . . . 0.0 112.742 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.56 156.5 42.51 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.86 140.84 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.54 127.63 25.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.9 147.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -109.63 138.24 46.28 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 129.674 3.19 . . . . 0.0 108.613 -178.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -154.57 166.14 34.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.68 0.792 . . . . 0.0 110.543 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.452 ' OD1' ' HE3' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -161.65 169.23 21.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.666 0.786 . . . . 0.0 110.968 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 158.44 20.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.512 2.325 . . . . 0.0 109.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.47 154.73 40.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.421 1.089 . . . . 0.0 108.634 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -63.89 144.08 57.35 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.37 11.96 71.03 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.839 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -142.74 142.75 32.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.891 1.276 . . . . 0.0 108.925 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.37 16.5 23.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.414 2.286 . . . . 0.0 107.701 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -115.6 179.34 4.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.681 2.392 . . . . 0.0 109.802 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.479 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 4.6 m-20 -135.15 149.34 49.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 102.896 -3.001 . . . . 0.0 102.896 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.48 143.32 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.653 1.181 . . . . 0.0 108.764 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.99 129.2 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.0 p -100.23 -38.96 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.599 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.3 169.46 18.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.91 1.284 . . . . 0.0 110.368 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.3 mm -132.24 144.83 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.171 1.388 . . . . 0.0 108.613 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 87.6 m -150.27 139.71 21.45 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.124 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -123.39 158.12 31.84 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.72 121.89 34.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.1 p -80.1 159.25 26.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.65 -33.39 73.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -21.27 66.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.301 1.44 . . . . 0.0 112.84 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.34 -10.0 30.96 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.245 1.402 . . . . 0.0 113.658 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -78.51 159.31 28.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.039 2.135 . . . . 0.0 108.259 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.8 p -134.79 156.42 48.9 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.995 1.318 . . . . 0.0 111.648 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.45 157.37 35.55 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.01 165.64 31.57 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 121.854 1.703 . . . . 0.0 109.52 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.87 83.76 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.81 3.006 . . . . 0.0 107.701 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.92 101.66 0.07 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.984 1.314 . . . . 0.0 107.698 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.41 -143.65 14.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 tp -108.63 121.73 45.62 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.74 153.55 43.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 112' ' ' GLN . 1.4 m -150.75 -179.59 7.39 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.073 -1.642 . . . . 0.0 111.074 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' H ' HG22 ' A' ' 111' ' ' THR . 41.1 tt0 -73.7 -58.68 3.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.036 -1.04 . . . . 0.0 111.246 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HE3' ' OD1' ' A' ' 81' ' ' ASP . 22.6 mttt -70.19 166.48 19.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.923 1.238 . . . . 0.0 110.223 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER 175.69 167.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.237 2.215 . . . . 0.0 108.915 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.9 164.25 33.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.587 1.555 . . . . 0.0 107.83 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.04 142.39 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.57 135.33 34.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.984 1.313 . . . . 0.0 108.608 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -143.84 163.73 32.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.276 1.83 . . . . 0.0 108.784 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -118.5 175.45 5.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.679 1.992 . . . . 0.0 105.921 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -63.41 166.87 5.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.68 -9.06 40.19 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.585 -1.322 . . . . 0.0 113.795 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.78 -9.51 71.37 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.325 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.69 159.03 20.93 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.806 1.803 . . . . 0.0 113.764 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.531 ' HE3' ' CG ' ' A' ' 72' ' ' TYR . 14.3 mmtm -128.23 166.94 17.59 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.317 2.647 . . . . 0.0 107.441 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.16 -61.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.625 1.57 . . . . 0.0 107.588 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.67 31.07 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -133.25 157.43 45.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.932 1.293 . . . . 0.0 108.277 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -128.07 158.45 37.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.66 100.09 0.18 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 54.6 mtt180 -65.19 91.74 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.0 165.8 12.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 128.069 2.548 . . . . 0.0 113.663 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -157.3 -121.17 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 106.07 -2.812 . . . . 0.0 106.07 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -66.25 -18.23 65.23 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.16 169.76 19.32 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 125.557 1.543 . . . . 0.0 108.164 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.74 84.26 7.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -69.39 -45.68 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 110.738 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 6' ' ' ALA . . . -146.41 144.28 29.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.099 0.959 . . . . 0.0 111.872 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.8 tp -140.72 144.91 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.38 -178.63 28.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.12 38.41 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.227 1.014 . . . . 0.0 108.281 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.68 113.85 24.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.829 0.852 . . . . 0.0 108.927 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.35 100.96 10.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.769 0.828 . . . . 0.0 111.801 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.582 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.598 0.714 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 119.24 37.74 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 293' ' ' HIS . 10.4 ptpt -88.19 123.66 33.05 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.0 mt -75.56 -166.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.312 1.045 . . . . 0.0 109.86 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 128.48 56.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.58 165.31 11.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.484 1.514 . . . . 0.0 107.653 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.05 -176.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.207 1.003 . . . . 0.0 110.883 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.21 -108.58 3.7 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.754 1.169 . . . . 0.0 111.559 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -176.0 136.9 3.46 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.06 53.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.808 2.443 . . . . 0.0 110.186 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.462 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 81.3 mm-40 -117.4 92.91 3.98 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.663 1.185 . . . . 0.0 110.692 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.79 -177.35 31.33 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.494 1.045 . . . . 0.0 112.278 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.41 113.56 3.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.786 1.634 . . . . 0.0 110.127 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.17 145.2 56.08 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.114 0.966 . . . . 0.0 110.825 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -138.51 61.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.04 104.66 6.67 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.68 99.4 10.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.263 2.625 . . . . 0.0 108.627 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.32 177.9 2.29 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.762 2.601 . . . . 0.0 112.441 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.23 25.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -118.44 -178.8 3.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.552 1.141 . . . . 0.0 109.257 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.07 -13.2 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.044 1.738 . . . . 0.0 114.198 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.32 -167.85 24.3 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 119.312 0.96 . . . . 0.0 112.291 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.44 156.8 40.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 127.824 2.45 . . . . 0.0 108.504 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -127.35 -52.08 1.39 Allowed 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.918 0.887 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.51 149.69 50.7 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.682 1.193 . . . . 0.0 108.306 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.1 139.73 50.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -127.05 112.74 15.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.594 1.157 . . . . 0.0 111.062 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.72 124.96 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.78 1.632 . . . . 0.0 107.623 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -115.78 139.59 15.51 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -138.29 -177.12 4.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.266 1.031 . . . . 0.0 112.019 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.64 -174.07 25.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 128.69 3.043 . . . . 0.0 106.846 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.97 -29.27 70.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.855 0.328 . . . . 0.0 110.854 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.36 -31.91 66.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.033 2.533 . . . . 0.0 113.01 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.88 -152.83 21.47 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.98 107.32 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.974 1.31 . . . . 0.0 109.007 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.0 p -101.79 -20.24 15.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.777 0.831 . . . . 0.0 112.564 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.06 160.72 42.11 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.084 1.311 . . . . 0.0 112.185 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 m -156.13 148.3 11.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.07 170.16 10.59 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.803 2.041 . . . . 0.0 107.011 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -160.29 164.49 32.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 109.894 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -102.53 123.21 45.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 148.19 23.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.647 1.979 . . . . 0.0 106.185 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.74 130.93 46.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -105.01 104.95 14.78 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.9 1.28 . . . . 0.0 108.019 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 71.31 -84.58 0.42 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.62 -18.29 2.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.257 . . . . 0.0 111.072 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.84 162.04 29.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.941 1.297 . . . . 0.0 109.572 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -112.21 145.5 39.79 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.679 0.792 . . . . 0.0 109.972 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.7 101.59 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.4 t -67.45 133.07 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.3 -169.8 42.6 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.1 -153.99 27.41 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.09 141.41 51.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -115.03 -80.22 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.44 1.018 . . . . 0.0 110.54 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.37 -179.11 50.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -99.81 103.69 23.5 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 120.931 2.365 . . . . 0.0 111.333 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.06 160.71 48.8 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 120.928 1.086 . . . . 0.0 109.367 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -102.81 178.11 4.66 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 27.2 tp -65.73 -13.57 59.58 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.795 -0.566 . . . . 0.0 111.509 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.65 -33.87 56.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.692 1.597 . . . . 0.0 110.645 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 110.83 -157.74 14.79 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.237 0.446 . . . . 0.0 112.387 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -133.93 170.74 15.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.159 2.184 . . . . 0.0 109.069 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.61 149.69 52.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 129.153 2.981 . . . . 0.0 104.765 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -133.49 149.12 51.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.954 0.797 . . . . 0.0 112.542 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -142.0 124.46 15.74 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -78.66 121.05 24.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.03 1.332 . . . . 0.0 109.682 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.76 124.71 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 128.127 2.571 . . . . 0.0 105.721 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.22 94.3 5.29 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.36 -33.6 15.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.525 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.76 13.94 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 CA-C-N 123.762 2.379 . . . . 0.0 111.198 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.31 -53.82 1.03 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.089 1.356 . . . . 0.0 109.878 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.86 177.75 4.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.461 1.504 . . . . 0.0 110.27 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.83 115.3 4.8 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.814 -0.553 . . . . 0.0 111.208 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.75 101.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -86.32 -19.5 29.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.995 1.318 . . . . 0.0 110.266 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.33 156.05 34.77 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.529 1.059 . . . . 0.0 110.833 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.7 144.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -132.08 173.27 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.647 1.979 . . . . 0.0 106.843 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.82 177.47 41.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.6 p -136.92 145.1 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -126.09 131.37 52.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.477 0.711 . . . . 0.0 111.554 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.41 170.77 15.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.136 1.375 . . . . 0.0 110.851 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 235' ' ' LYS . 2.6 mppt? -76.01 142.99 41.73 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.875 1.27 . . . . 0.0 111.882 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 20.2 pt -80.43 135.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.2 88.53 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.127 0.571 . . . . 0.0 110.808 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 151.95 -17.76 0.83 Allowed Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.296 -1.28 . . . . 0.0 112.76 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.2 m -140.27 179.16 6.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.554 1.177 . . . . 0.0 110.783 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.22 -30.09 24.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.177 2.591 . . . . 0.0 109.517 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -55.4 152.7 14.73 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 127.349 2.404 . . . . 0.0 112.976 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 66.3 mt -111.43 152.95 26.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.607 1.963 . . . . 0.0 109.222 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -143.73 160.38 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.246 1.418 . . . . 0.0 107.482 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.63 105.89 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -41.96 80.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.64 1.176 . . . . 0.0 111.582 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -147.89 159.48 43.81 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.912 0.485 . . . . 0.0 111.769 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 62.7 mt -135.13 147.11 49.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.287 1.835 . . . . 0.0 110.802 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -137.85 128.41 26.61 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.456 2.303 . . . . 0.0 107.749 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -111.38 113.61 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.71 113.83 19.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.2 p -109.99 165.84 11.41 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 126.623 1.969 . . . . 0.0 110.316 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -112.37 155.1 24.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 62.94 -16.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -135.18 172.27 13.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.619 1.568 . . . . 0.0 108.398 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.04 155.36 31.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.618 1.167 . . . . 0.0 108.005 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.6 p -123.01 178.27 5.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.421 1.889 . . . . 0.0 110.046 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -133.0 159.25 73.45 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.064 1.346 . . . . 0.0 109.73 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 108.24 2.65 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 109.01 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.24 92.94 5.17 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.01 179.78 17.2 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.687 1.137 . . . . 0.0 110.655 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 tp -82.96 111.97 19.31 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -68.47 106.95 2.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -171.23 146.51 2.37 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.838 2.455 . . . . 0.0 107.393 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 105.58 -176.69 22.46 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.1 m -67.77 122.97 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 144.2 43.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.138 -0.351 . . . . 0.0 110.317 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -138.65 144.34 39.64 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.5 1.12 . . . . 0.0 109.139 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.64 155.91 47.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.74 121.14 17.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -169.66 133.32 1.27 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.425 1.89 . . . . 0.0 109.829 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -146.0 129.21 16.67 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.0 1.32 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 30.33 52.61 0.12 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.115 2.966 . . . . 0.0 112.721 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 53.25 13.04 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 117.264 -1.853 . . . . 0.0 115.706 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.41 151.71 3.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.239 1.816 . . . . 0.0 111.228 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.28 132.61 40.1 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.15 1.78 . . . . 0.0 109.294 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.19 121.68 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.71 34.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.882 0.873 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.86 174.25 35.93 Favored Glycine 0 C--N 1.334 0.436 0 O-C-N 120.663 -1.273 . . . . 0.0 111.918 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 292' ' ' VAL . 48.8 m-85 -129.98 158.81 38.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.235 1.814 . . . . 0.0 108.509 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' HIS . . . . . 0.409 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 7.8 p-80 -149.26 165.74 31.01 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 112.23 -160.05 13.38 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.462 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -129.23 164.58 23.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.928 0.87 . . . . 0.0 110.743 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.96 149.52 50.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 m -152.37 -155.14 0.58 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 101.668 -3.456 . . . . 0.0 101.668 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -55.31 -36.45 66.21 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.008 -1.058 . . . . 0.0 110.285 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.14 164.44 21.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.128 1.371 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.72 77.4 9.79 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.92 -39.39 89.2 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -128.16 144.88 51.15 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -156.23 110.64 2.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -137.26 174.45 21.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 279' ' ' PHE . 8.9 m -128.45 174.93 11.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.03 0.932 . . . . 0.0 112.578 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' HIS . . . . . 0.567 ' CE1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER -118.16 128.13 54.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.9 2.48 . . . . 0.0 106.458 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.83 147.52 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.75 1.22 . . . . 0.0 109.996 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 81.2 mtp -141.97 144.15 31.07 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 126.331 1.852 . . . . 0.0 107.652 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.89 153.64 53.11 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.049 2.499 . . . . 0.0 112.433 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.237 0.396 0 C-N-CA 124.579 1.152 . . . . 0.0 110.261 179.36 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 . . . . . 0 C--O 1.235 0.333 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 130.43 34.62 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.35 128.11 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -72.7 155.54 39.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.693 0.679 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.44 101.62 13.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.366 1.466 . . . . 0.0 110.042 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.32 153.5 52.94 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.81 177.85 38.32 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 88' ' ' SER . . . -72.53 -50.44 15.35 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.527 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 125.64 0.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 129.639 3.176 . . . . 0.0 118.312 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.67 -4.05 1.88 Allowed Glycine 0 CA--C 1.539 1.535 0 N-CA-C 120.706 3.042 . . . . 0.0 120.706 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 137' ' ' TYR . . . -107.5 -174.01 22.37 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 121.336 2.568 . . . . 0.0 113.899 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.81 159.83 15.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.147 2.579 . . . . 0.0 112.991 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -3.66 109.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 1 C-N-CA 132.862 4.465 . . . . 0.0 117.531 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.489 ' HB3' ' H ' ' A' ' 130' ' ' GLY . 2.6 m0 -56.93 144.0 35.49 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 128.91 2.884 . . . . 0.0 108.353 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p30 59.1 9.38 1.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -50.67 129.32 22.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.385 0.993 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.169 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.484 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 CA-C-O 118.842 -0.976 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.27 146.48 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.712 1.756 . . . . 0.0 111.735 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.06 -28.81 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -146.15 159.03 43.86 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -142.68 115.29 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -88.28 144.52 26.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -141.56 148.08 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.496 1.119 . . . . 0.0 108.377 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.63 119.95 1.57 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.94 126.09 30.57 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.504 1.122 . . . . 0.0 108.72 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.03 -175.82 20.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -64.5 -36.8 85.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.11 17.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 131.126 3.77 . . . . 0.0 112.476 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.67 -136.79 18.45 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.48 95.68 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 p -109.41 -10.54 14.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.02 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -138.21 128.08 25.39 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.619 1.1 . . . . 0.0 109.015 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.98 154.24 23.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.114 1.366 . . . . 0.0 109.078 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.63 99.18 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.859 0.463 . . . . 0.0 110.747 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -77.97 145.04 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -127.73 134.57 65.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -115.77 169.95 8.83 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.459 1.123 . . . . 0.0 111.508 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.14 134.63 50.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.916 2.486 . . . . 0.0 106.61 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -115.88 150.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.55 -39.45 87.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.204 0.202 . . . . 0.0 110.555 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -70.89 0.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -149.45 139.91 22.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.37 141.05 48.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.473 1.509 . . . . 0.0 108.351 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.5 147.32 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 108.33 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.1 138.05 38.64 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.06 -68.06 1.64 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.72 144.09 3.93 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 121.595 -0.944 . . . . 0.0 112.465 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.95 133.71 43.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.757 1.623 . . . . 0.0 107.687 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -119.65 169.7 9.85 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.913 1.285 . . . . 0.0 110.252 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 -151.73 20.81 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -121.36 106.1 11.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -63.41 163.16 11.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.195 0.522 . . . . 0.0 111.392 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -138.79 162.7 34.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.044 0.938 . . . . 0.0 108.579 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.9 tp -89.34 -33.22 16.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.841 1.256 . . . . 0.0 112.174 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.9 mt -100.77 12.14 38.12 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.74 106.21 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -160.63 126.27 3.92 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.255 1.422 . . . . 0.0 108.239 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -148.77 163.59 36.92 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.866 1.666 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.2 m -141.14 133.4 28.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -128.25 131.24 48.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -113.55 146.67 39.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.153 0.981 . . . . 0.0 108.515 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.3 t -109.8 117.35 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.42 156.4 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.27 -12.11 59.65 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.499 -0.75 . . . . 0.0 111.812 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -104.79 -7.79 19.22 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.465 1.506 . . . . 0.0 111.394 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -119.64 136.58 54.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.87 147.51 50.45 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.288 0.566 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.6 mt -78.23 131.2 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.96 -21.41 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 122.691 0.396 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.59 152.62 38.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.935 1.294 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.5 t -146.42 142.38 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -110.23 115.23 29.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -108.18 125.34 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.2 p -116.43 139.54 50.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -154.78 163.65 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.382 1.073 . . . . 0.0 108.6 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.03 168.89 23.59 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.44 0.564 . . . . 0.0 110.113 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -99.55 155.55 17.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.321 1.848 . . . . 0.0 112.008 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.7 137.5 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -78.56 72.26 5.08 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.49 18.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.494 1.521 . . . . 0.0 113.008 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.98 149.68 52.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.7 -16.02 61.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.037 0.935 . . . . 0.0 112.554 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 2.2 p -161.28 172.0 17.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.462 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -76.47 151.91 36.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.0 pt -134.64 152.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.594 1.158 . . . . 0.0 109.453 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.2 mm -68.35 112.05 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.422 1.089 . . . . 0.0 108.163 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -81.31 -40.61 23.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.866 1.266 . . . . 0.0 111.217 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 t -157.84 173.92 16.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.57 1.948 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.54 155.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 109.63 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.1 m -148.92 122.38 9.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.301 1.44 . . . . 0.0 108.761 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -92.74 138.22 31.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 108.73 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -123.12 115.56 22.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.006 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.6 p -91.34 168.06 11.84 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 121.546 -0.721 . . . . 0.0 110.409 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -70.88 -30.1 66.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.29 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -69.79 -6.25 30.91 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.21 66.46 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -82.08 126.6 32.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.5 m -127.66 149.8 50.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 p -99.1 161.58 24.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.006 0.923 . . . . 0.0 110.465 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.49 166.25 27.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.729 1.619 . . . . 0.0 109.778 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.6 108.53 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.067 2.511 . . . . 0.0 109.089 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.31 73.82 7.16 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 135.73 -176.15 20.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.05 112.86 15.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 110.62 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 154.01 19.88 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -144.24 176.4 9.37 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 119.916 -1.74 . . . . 0.0 112.719 -177.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.489 ' H ' HG22 ' A' ' 111' ' ' THR . 12.3 tt0 -70.36 -56.93 5.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -66.07 150.6 48.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 pttt 172.73 173.42 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 126.461 1.904 . . . . 0.0 109.321 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.91 164.82 31.67 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.617 1.967 . . . . 0.0 107.338 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.48 139.06 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -136.36 122.67 20.58 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 160.77 42.19 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.389 1.475 . . . . 0.0 109.456 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.27 176.77 8.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.068 0.849 . . . . 0.0 109.34 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -128.03 -49.48 1.34 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.315 1.446 . . . . 0.0 109.207 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -68.52 -3.05 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.072 1.749 . . . . 0.0 113.97 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.28 47.55 5.43 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 120.617 1.553 . . . . 0.0 111.275 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.73 -165.14 40.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.23 1.395 . . . . 0.0 111.657 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -131.24 151.71 51.22 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.436 1.895 . . . . 0.0 107.281 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -71.34 154.06 41.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.53 -47.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 118.762 0.71 . . . . 0.0 112.548 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -167.29 168.39 40.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 120.091 1.314 . . . . 0.0 111.022 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -114.49 169.94 8.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.967 1.307 . . . . 0.0 110.216 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -164.84 170.88 14.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.241 2.616 . . . . 0.0 106.678 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 15' ' ' TRP . . . 128.65 129.4 3.18 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 126.145 1.831 . . . . 0.0 110.027 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.61 122.36 1.94 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.179 0.99 . . . . 0.0 112.651 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.0 166.06 25.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.847 2.459 . . . . 0.0 109.628 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.29 -119.14 0.82 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -68.5 -6.3 24.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.08 175.1 13.36 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 128.782 2.833 . . . . 0.0 106.656 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.67 95.06 5.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CD1' ' HA3' ' A' ' 12' ' ' GLY . 14.2 m-85 -83.22 -30.44 27.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.845 1.658 . . . . 0.0 113.112 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.16 42.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 108.772 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 65.3 tp -154.66 134.56 12.96 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.43 179.12 37.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 125.67 1.605 . . . . 0.0 109.127 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.05 171.89 17.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.478 0.639 . . . . 0.0 111.395 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -115.7 150.67 36.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.592 1.157 . . . . 0.0 108.522 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -125.01 111.53 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.75 0.786 . . . . 0.0 109.587 179.839 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 CA-C-O 121.927 0.87 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -74.09 129.72 38.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.416 ' HE3' ' ND1' ' A' ' 280' ' ' HIS . 77.9 tttt -98.95 106.47 18.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.002 1.321 . . . . 0.0 108.045 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mt -74.88 173.9 9.99 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.0 t -76.08 163.66 26.9 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.838 -1.164 . . . . 0.0 109.062 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -144.41 138.19 27.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 tp -118.47 138.35 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.227 2.211 . . . . 0.0 107.321 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.57 -31.2 0.57 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 154.54 -169.55 32.84 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -136.19 6.69 3.09 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.082 1.753 . . . . 0.0 109.3 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -113.97 146.99 39.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.157 1.383 . . . . 0.0 109.82 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.56 175.36 14.04 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.955 1.264 . . . . 0.0 110.43 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.9 m -65.35 123.34 19.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 115.58 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.165 0.986 . . . . 0.0 110.038 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.845 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 7.8 m0 -78.22 125.08 28.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.41 114.45 26.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.288 1.835 . . . . 0.0 108.142 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.53 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.523 2.729 . . . . 0.0 115.012 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 64.28 -162.08 37.05 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.79 143.17 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.304 1.842 . . . . 0.0 107.866 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.28 -178.74 4.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.28 -34.0 66.03 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.423 1.011 . . . . 0.0 110.328 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.0 -163.7 33.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 124.563 1.078 . . . . 0.0 110.418 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.56 157.18 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.403 2.281 . . . . 0.0 108.22 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -120.37 -46.41 2.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.786 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.403 ' HE2' ' OE1' ' A' ' 193' ' ' GLU . 26.1 ttpt -137.19 145.24 43.46 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 145.73 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.68 157.72 38.3 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.619 1.168 . . . . 0.0 109.582 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.6 t -138.88 129.5 33.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.65 111.84 2.03 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.22 177.45 4.68 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.478 0.711 . . . . 0.0 110.794 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -160.08 -168.06 21.52 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 127.486 2.47 . . . . 0.0 107.994 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.17 -20.0 59.56 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 122.142 -0.622 . . . . 0.0 111.259 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.92 -31.57 35.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.869 3.668 . . . . 0.0 112.691 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 139.36 -132.48 5.67 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mm -88.03 105.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.87 -23.46 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 113.18 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.02 32.29 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.285 0.948 . . . . 0.0 111.717 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.32 133.6 46.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.947 0.899 . . . . 0.0 108.596 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 15.0 pttp -156.42 170.99 21.05 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 107.308 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -167.73 174.77 7.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.333 1.453 . . . . 0.0 108.367 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.403 ' OE1' ' HE2' ' A' ' 177' ' ' LYS . 21.7 mt-10 -100.65 137.06 39.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -97.79 167.82 10.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.148 0.499 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -121.01 116.78 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.021 1.728 . . . . 0.0 108.138 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -140.54 114.11 8.75 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 40.51 57.86 2.64 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.289 0.947 . . . . 0.0 113.974 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.79 -3.35 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.008 2.523 . . . . 0.0 117.165 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.66 170.2 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.349 0.977 . . . . 0.0 108.532 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -136.51 104.44 5.57 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.78 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.172 0.896 . . . . 0.0 113.018 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.01 129.33 36.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 124.831 1.252 . . . . 0.0 108.743 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -66.15 -179.36 9.64 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.718 1.627 . . . . 0.0 111.353 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.71 151.7 21.96 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.71 0.617 . . . . 0.0 113.294 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -77.39 102.8 6.98 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.219 1.408 . . . . 0.0 107.617 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -78.85 -64.35 1.2 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.65 1.18 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.74 170.86 53.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.659 1.124 . . . . 0.0 111.622 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -80.66 113.32 38.93 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.581 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.82 169.86 20.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.33 1.353 . . . . 0.0 110.748 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.4 p -126.79 173.93 9.17 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.488 1.115 . . . . 0.0 108.49 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.39 -6.33 42.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.512 -0.742 . . . . 0.0 112.494 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.7 -1.44 6.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.332 1.053 . . . . 0.0 111.069 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.48 -160.91 54.15 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.585 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 35.8 m-85 -135.8 163.08 31.02 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.98 1.312 . . . . 0.0 108.5 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -124.47 157.44 35.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.42 148.88 52.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.494 1.118 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -141.51 116.33 9.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.14 138.42 34.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.412 1.085 . . . . 0.0 109.049 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.6 mm -128.2 130.24 69.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.18 90.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -39.1 -50.99 4.31 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.19 -19.11 8.24 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 121.365 1.523 . . . . 0.0 114.388 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.0 m -106.52 -10.87 16.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.88 147.3 31.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.909 1.284 . . . . 0.0 107.643 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.37 126.3 11.21 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.565 ' H ' HD12 ' A' ' 226' ' ' ILE . 4.5 mp -57.09 112.75 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.248 1.819 . . . . 0.0 108.056 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.6 p -84.8 -24.74 28.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 0.0 111.142 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 250' ' ' LYS . . . -172.29 171.13 4.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.942 2.097 . . . . 0.0 109.207 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.5 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -83.75 171.03 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.886 -1.134 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 170.18 177.03 40.16 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 p -142.16 147.08 36.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.53 162.39 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.852 0.861 . . . . 0.0 109.415 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -146.9 156.46 43.1 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -71.78 138.83 48.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.963 1.705 . . . . 0.0 113.175 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -81.24 97.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -47.26 147.04 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.569 1.548 . . . . 0.0 112.089 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.6 52.46 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 62.9 p -141.13 -174.15 3.93 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.654 1.981 . . . . 0.0 107.68 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -133.69 91.65 2.87 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -158.91 173.44 35.82 Favored Glycine 0 CA--C 1.53 0.994 1 C-N-CA 131.185 4.231 . . . . 0.0 104.154 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.18 166.01 31.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 119.602 1.701 . . . . 0.0 111.781 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 7.6 tt -141.65 144.58 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.176 1.39 . . . . 0.0 109.239 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 37.4 mt -75.45 132.82 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.255 5.4 t -116.78 -12.16 10.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.615 0.766 . . . . 0.0 112.027 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -146.63 144.01 29.21 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.602 1.161 . . . . 0.0 108.775 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.95 127.15 13.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.735 0.698 . . . . 0.0 111.206 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -130.55 154.61 47.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.451 1.5 . . . . 0.0 109.408 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -118.54 126.62 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.534 ' HD3' ' HB3' ' A' ' 228' ' ' ALA . 44.0 mtpt -71.97 114.87 10.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -109.69 165.76 11.43 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.476 2.31 . . . . 0.0 109.231 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -119.83 134.13 55.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.33 7.17 0.87 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -144.23 152.07 40.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.994 2.118 . . . . 0.0 106.074 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 61.3 m -143.95 118.48 9.73 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.7 p -78.16 177.83 8.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.92 1.688 . . . . 0.0 111.793 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -73.51 154.36 89.75 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.875 . . . . 0.0 110.015 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.15 96.96 1.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 109.207 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -78.5 114.26 17.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.74 -163.03 22.38 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.9 pp -127.63 122.69 33.74 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.74 108.35 2.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.738 1.615 . . . . 0.0 109.964 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.9 9.19 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.188 0.995 . . . . 0.0 111.633 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 72.58 -98.74 0.86 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 126.311 1.91 . . . . 0.0 112.425 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 95.9 m -145.36 122.01 11.14 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.214 1.405 . . . . 0.0 107.612 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.64 145.07 33.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.101 0.56 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -132.43 158.59 41.62 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.534 1.159 . . . . 0.0 110.519 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.92 146.24 26.15 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 53.5 mt -141.87 108.77 5.42 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.861 1.664 . . . . 0.0 108.478 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 228' ' ' ALA . 10.2 pttp -157.8 163.92 37.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.679 1.581 . . . . 0.0 111.496 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.87 157.46 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 107.85 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -75.1 140.88 43.75 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 110.013 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 63.38 5.36 11.26 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 117.389 -1.784 . . . . 0.0 116.741 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -112.1 153.7 26.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.197 1.998 . . . . 0.0 112.003 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -115.52 164.19 14.67 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.272 2.229 . . . . 0.0 107.692 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.08 134.18 31.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.89 -0.38 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.167 0.987 . . . . 0.0 113.554 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.98 157.19 27.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -131.33 124.29 30.1 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.495 1.918 . . . . 0.0 109.92 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' HIS . . . . . 0.416 ' ND1' ' HE3' ' A' ' 155' ' ' LYS . 15.0 p80 -127.27 179.51 5.41 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.03 1.332 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 120.2 -127.37 7.05 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -161.25 151.35 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.906 1.282 . . . . 0.0 111.818 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.845 ' HB2' ' HE1' ' A' ' 167' ' ' TRP . . . -113.06 146.8 38.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.397 1.479 . . . . 0.0 108.113 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -155.75 -160.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.431 1.892 . . . . 0.0 106.064 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -38.06 88.43 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.36 162.95 20.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.41 1.484 . . . . 0.0 108.884 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.33 95.68 1.76 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 109.855 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -83.56 -84.01 0.14 Allowed 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -88.55 165.6 14.73 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -167.85 99.89 0.47 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.43 1.892 . . . . 0.0 107.435 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -129.35 169.73 20.54 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 121.694 -0.629 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.06 173.36 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 122.118 0.961 . . . . 0.0 112.776 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.15 124.97 42.94 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.998 -2.594 . . . . 0.0 103.998 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.93 137.63 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.492 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.24 139.47 34.6 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 123.978 0.911 . . . . 0.0 109.606 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.43 137.09 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.493 2.795 . . . . 0.0 110.738 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.202 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HD3' ' CD1' ' A' ' 142' ' ' TYR . 71.6 mmtt -137.81 139.77 40.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 128.339 2.656 . . . . 0.0 107.62 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.487 ' CG1' ' H ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -121.4 148.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.073 0.949 . . . . 0.0 111.267 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.11 131.3 46.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.4 87.87 1.56 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.09 116.16 5.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.39 -170.5 30.99 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.35 177.73 33.74 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 122.834 1.241 . . . . 0.0 115.87 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.5 55.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.844 1.658 . . . . 0.0 114.49 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 175.04 54.85 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.254 0.933 . . . . 0.0 110.817 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -175.06 50.51 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.57 1.081 . . . . 0.0 114.696 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.56 157.2 27.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.155 1.382 . . . . 0.0 110.36 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -77.1 88.17 3.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.023 2.529 . . . . 0.0 114.942 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -106.17 92.46 4.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.82 149.65 23.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.795 1.638 . . . . 0.0 108.797 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 31.21 58.55 0.27 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 127.753 2.421 . . . . 0.0 110.873 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 C-N-CA 126.535 2.017 . . . . 0.0 116.091 -177.544 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 118.654 -1.081 . . . . 0.0 115.553 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.96 154.08 7.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 119.793 1.796 . . . . 0.0 110.629 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -128.77 -41.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.532 1.133 . . . . 0.0 110.696 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -133.48 171.72 13.69 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.449 1.5 . . . . 0.0 108.174 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -140.25 130.22 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -131.11 144.03 51.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.3 t -148.31 147.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 127.862 2.465 . . . . 0.0 105.69 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.13 133.15 3.47 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 107.119 -2.392 . . . . 0.0 107.119 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -75.85 176.8 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.066 0.936 . . . . 0.0 108.934 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -160.42 10.5 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -77.06 -31.53 56.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.836 0.35 . . . . 0.0 110.227 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -91.4 -27.34 18.38 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.653 3.181 . . . . 0.0 115.182 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.75 -140.7 11.46 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -75.63 96.34 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.28 -7.29 21.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.449 1.1 . . . . 0.0 113.647 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -129.86 143.72 50.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.96 1.255 . . . . 0.0 112.377 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -159.02 130.53 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.039 0.936 . . . . 0.0 109.705 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -117.85 151.43 37.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.819 1.648 . . . . 0.0 109.809 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.12 140.96 45.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.062 1.345 . . . . 0.0 110.263 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -127.47 98.77 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -81.3 105.68 12.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.99 120.44 27.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -115.16 157.39 23.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.749 -0.594 . . . . 0.0 110.879 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 6.56 4.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.59 1.956 . . . . 0.0 108.609 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -121.58 -69.55 0.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.432 2.293 . . . . 0.0 108.742 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -154.96 135.05 13.05 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.84 150.27 39.31 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.906 1.282 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 122.9 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.992 0.917 . . . . 0.0 111.37 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.21 99.66 11.24 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.91 -21.63 45.46 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.936 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.01 142.29 12.06 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.021 1.296 . . . . 0.0 111.766 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -74.08 130.23 39.4 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.612 1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -116.4 175.7 5.44 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.236 0.541 . . . . 0.0 109.949 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -134.78 12.41 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 105.653 -2.979 . . . . 0.0 105.653 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -126.77 99.24 5.68 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.24 144.97 56.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.06 142.87 30.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.776 1.274 . . . . 0.0 110.516 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.23 -4.65 58.12 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.592 -1.317 . . . . 0.0 110.447 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.49 -16.71 62.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.499 1.12 . . . . 0.0 111.455 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.3 117.83 0.42 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -163.14 135.44 5.29 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.997 2.919 . . . . 0.0 105.734 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -132.18 160.12 37.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 m -116.3 118.61 33.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.566 1.946 . . . . 0.0 108.905 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.13 109.13 13.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.8 160.91 20.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 109.747 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.72 106.12 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 156.92 23.07 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.509 -0.744 . . . . 0.0 109.617 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.68 -26.69 27.58 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.62 -34.98 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.108 1.763 . . . . 0.0 112.393 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.86 164.51 13.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.986 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.67 -178.72 5.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.127 1.771 . . . . 0.0 109.812 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.9 139.11 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.62 -36.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.074 0.95 . . . . 0.0 112.864 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.72 165.76 29.52 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.975 0.91 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.7 101.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.65 94.28 9.04 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.2 153.55 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.686 1.994 . . . . 0.0 108.134 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.491 HG21 ' N ' ' A' ' 111' ' ' THR . 7.3 m -139.02 148.47 43.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.357 1.063 . . . . 0.0 109.069 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.05 155.42 36.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.121 1.368 . . . . 0.0 108.515 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.84 168.49 22.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.109 0.963 . . . . 0.0 110.144 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -109.51 119.38 39.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.35 1.06 . . . . 0.0 109.213 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.7 m -90.08 151.29 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -60.89 -6.61 1.89 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 113.32 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.29 -0.65 58.24 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 117.54 -1.7 . . . . 0.0 112.703 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -133.43 158.59 42.67 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.89 1.845 . . . . 0.0 111.051 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -85.29 -19.51 31.45 Favored 'General case' 0 C--N 1.323 -0.547 1 C-N-CA 131.81 4.044 . . . . 0.0 111.586 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.4 t -129.6 164.92 22.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.389 1.876 . . . . 0.0 110.691 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.47 156.14 27.97 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.0 154.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.418 1.887 . . . . 0.0 108.673 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.8 mm -73.27 129.55 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -103.31 -41.29 6.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 113.275 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -146.58 161.23 40.96 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.746 1.219 . . . . 0.0 109.503 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.3 mt -148.06 122.96 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.554 1.541 . . . . 0.0 108.314 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -125.07 107.07 10.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.869 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -84.95 149.15 25.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.848 0.833 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -130.75 113.35 14.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -84.25 164.3 19.14 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.396 0.678 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -71.13 -38.23 72.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -35.92 82.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.217 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.25 3.68 5.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.87 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -76.71 95.86 4.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -86.64 103.5 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 p -71.72 155.89 91.8 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.42 166.18 30.55 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.939 1.759 . . . . 0.0 110.907 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.24 112.74 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.789 2.993 . . . . 0.0 107.232 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -78.07 67.67 3.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.088 1.355 . . . . 0.0 107.369 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.41 -179.74 17.78 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 124.717 1.151 . . . . 0.0 111.143 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.07 119.09 22.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.68 1.592 . . . . 0.0 111.556 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 157.87 23.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.491 ' N ' HG21 ' A' ' 79' ' ' THR . 0.2 OUTLIER -148.18 172.49 14.23 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.777 -1.202 . . . . 0.0 109.771 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -69.34 -49.29 57.01 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -66.72 138.48 57.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.1 pttt 169.54 171.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.864 2.466 . . . . 0.0 109.79 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.4 156.35 47.67 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.384 1.873 . . . . 0.0 107.153 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.6 149.39 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.829 0.851 . . . . 0.0 109.844 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.91 142.97 16.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 0.0 109.66 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.25 156.52 30.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.675 0.79 . . . . 0.0 110.077 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 175.94 9.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.626 1.97 . . . . 0.0 113.262 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -127.99 -46.87 1.38 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.423 -0.798 . . . . 0.0 112.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -127.39 13.45 7.09 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.83 0.852 . . . . 0.0 112.554 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.9 -84.31 0.32 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 107.508 -2.237 . . . . 0.0 107.508 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.36 76.07 0.11 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 125.855 1.693 . . . . 0.0 112.281 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.21 123.84 12.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.853 0.861 . . . . 0.0 111.197 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.73 115.98 6.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.44 -9.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.194 1.397 . . . . 0.0 112.757 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.65 -91.0 0.3 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 119.295 0.952 . . . . 0.0 114.617 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 78.38 152.2 0.12 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.425 2.69 . . . . 0.0 109.811 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -157.75 170.07 23.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.958 2.103 . . . . 0.0 106.172 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.31 101.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 O-C-N 121.533 -0.729 . . . . 0.0 112.737 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.57 123.16 9.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.48 164.42 38.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.274 0.63 . . . . 0.0 109.375 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.22 -110.41 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.38 -12.36 60.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.207 0.503 . . . . 0.0 112.215 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.67 174.48 12.53 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 127.839 2.456 . . . . 0.0 107.528 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -102.04 89.43 3.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.219 1.008 . . . . 0.0 108.485 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.4 -38.81 49.0 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.01 167.0 26.07 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.016 1.28 . . . . 0.0 112.283 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.93 171.24 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.85 2.06 . . . . 0.0 108.782 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.78 169.91 33.58 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.882 1.706 . . . . 0.0 110.106 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.487 ' H ' ' CG1' ' A' ' 4' ' ' VAL . . . -153.16 167.69 28.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.688 1.595 . . . . 0.0 112.296 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.4 ' CD1' ' HD3' ' A' ' 3' ' ' LYS . 6.9 m-85 -129.77 163.2 26.72 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.257 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -144.4 135.87 25.62 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.957 1.303 . . . . 0.0 112.217 -178.64 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -75.67 122.23 23.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.59 0.756 . . . . 0.0 109.286 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -90.3 146.42 24.22 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.4 mt -101.08 -86.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 t -167.33 171.25 10.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.659 1.984 . . . . 0.0 109.07 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -152.73 177.2 10.95 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.24 1.816 . . . . 0.0 107.634 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 tt -138.34 -25.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -23.89 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 129.913 3.625 . . . . 0.0 117.667 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.77 41.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.029 1.776 . . . . 0.0 108.782 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.415 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 1.3 m-20 -114.96 5.71 15.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 114.303 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.98 122.33 28.15 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.28 1.4 . . . . 0.0 111.529 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.73 -168.52 13.62 Favored Glycine 0 N--CA 1.465 0.57 0 O-C-N 120.663 -1.273 . . . . 0.0 112.707 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.7 m -106.78 124.7 49.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.767 0.783 . . . . 0.0 111.121 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.71 153.84 27.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.189 1.396 . . . . 0.0 110.703 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -138.32 120.7 15.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.32 1.048 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.66 132.72 33.8 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.41 -0.807 . . . . 0.0 109.074 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.38 91.19 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.93 -72.75 0.52 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.699 -0.626 . . . . 0.0 114.157 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.12 170.65 20.78 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.221 1.408 . . . . 0.0 110.154 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.6 -179.7 3.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.659 1.184 . . . . 0.0 108.268 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.88 -23.69 55.63 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.678 -1.264 . . . . 0.0 112.297 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 170.79 168.58 32.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 128.72 3.057 . . . . 0.0 107.508 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.472 ' H ' ' HB2' ' A' ' 221' ' ' TYR . 1.8 t -122.72 156.28 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.365 1.866 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -121.53 -34.01 3.52 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -159.79 151.91 20.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.092 1.315 . . . . 0.0 110.926 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.6 t -106.25 142.36 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.48 160.18 39.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.824 2.45 . . . . 0.0 109.6 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.86 138.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.51 80.1 0.34 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.739 1.638 . . . . 0.0 109.206 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -85.59 162.48 18.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 111.018 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.3 -158.79 10.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 127.263 2.363 . . . . 0.0 109.056 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -82.85 -22.44 34.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.599 0.76 . . . . 0.0 111.358 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.88 -31.79 9.61 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.416 0.686 . . . . 0.0 112.548 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 165.82 -153.23 23.06 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.42 153.33 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.596 1.198 . . . . 0.0 109.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.1 t -134.22 -33.14 1.02 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.894 1.278 . . . . 0.0 109.625 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.17 35.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.91 0.862 . . . . 0.0 111.708 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.7 m -134.13 149.48 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -154.85 155.19 33.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 108.996 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.34 173.1 12.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.211 0.914 . . . . 0.0 113.028 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.32 141.77 48.11 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.296 3.038 . . . . 0.0 104.127 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -149.0 167.93 24.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.807 1.243 . . . . 0.0 109.578 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -135.98 96.44 3.41 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -88.8 125.48 34.92 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.25 31.17 56.36 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 76.26 -9.1 1.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.253 3.421 . . . . 0.0 114.852 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -76.47 133.14 39.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 120.835 1.652 . . . . 0.0 109.484 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -64.15 124.39 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.26 1.024 . . . . 0.0 109.197 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.6 mm -136.65 103.65 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.001 1.32 . . . . 0.0 108.415 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.96 127.43 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.09 -11.91 84.62 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.318 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.71 -172.12 52.99 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -89.35 154.36 20.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.845 0.858 . . . . 0.0 110.002 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -119.27 1.21 11.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.168 0.987 . . . . 0.0 109.651 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.94 173.64 27.05 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 120.304 -1.497 . . . . 0.0 111.182 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -68.68 114.07 20.02 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.18 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.92 167.22 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -118.25 148.33 42.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.521 1.128 . . . . 0.0 109.481 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.77 -24.83 67.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.331 0.653 . . . . 0.0 110.521 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 tt -51.65 -34.39 37.83 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 126.336 1.854 . . . . 0.0 111.495 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.0 -164.5 12.06 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -140.11 161.2 38.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.65 153.31 38.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.49 152.39 44.14 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.78 0.832 . . . . 0.0 110.75 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -142.06 140.54 32.6 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.997 -0.439 . . . . 0.0 110.956 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -65.15 97.82 0.27 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.164 2.186 . . . . 0.0 112.524 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 mm -128.94 102.82 8.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.44 125.89 46.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.015 1.28 . . . . 0.0 109.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.472 ' HB2' ' H ' ' A' ' 175' ' ' VAL . 80.0 t80 -55.49 -51.43 80.08 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.124 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.06 0.47 5.83 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.392 2.061 . . . . 0.0 114.604 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -128.54 -62.47 1.03 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.684 1.583 . . . . 0.0 112.997 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -81.26 168.13 18.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 110.697 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.17 101.33 3.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.9 mp -35.73 -52.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 128.871 2.868 . . . . 0.0 111.816 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.254 16.6 p 48.92 1.2 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.607 3.163 . . . . 0.0 118.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -173.84 169.88 4.04 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.538 1.535 . . . . 0.0 107.584 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.71 134.14 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -118.34 165.95 13.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.465 1.906 . . . . 0.0 107.617 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.07 174.31 46.37 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.2 p -135.44 147.35 48.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.754 1.277 . . . . 0.0 110.928 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -136.79 146.55 45.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -142.87 155.49 44.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.825 2.05 . . . . 0.0 108.225 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -87.55 148.55 24.84 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.596 0.758 . . . . 0.0 111.34 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.24 122.86 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.101 0.961 . . . . 0.0 108.468 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -55.89 152.3 10.21 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.268 0.556 . . . . 0.0 111.748 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.21 -9.39 20.02 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.245 0.926 . . . . 0.0 113.848 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -127.46 -176.03 3.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.383 1.873 . . . . 0.0 108.468 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.06 74.55 1.46 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.303 1.041 . . . . 0.0 110.594 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.08 -168.15 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.159 2.314 . . . . 0.0 109.106 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.93 162.11 36.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.786 1.293 . . . . 0.0 111.361 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.5 tt -139.85 102.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.891 2.076 . . . . 0.0 108.755 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 244' ' ' ILE . 4.9 mp -50.6 126.25 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 121.267 -0.895 . . . . 0.0 109.536 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -106.35 -36.24 6.89 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -122.29 144.55 48.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.462 1.028 . . . . 0.0 108.699 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.28 147.14 49.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.854 1.261 . . . . 0.0 108.264 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -136.01 93.71 2.96 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.9 149.46 45.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.59 154.04 51.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.544 1.537 . . . . 0.0 107.606 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.2 t -161.94 168.11 23.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.654 1.182 . . . . 0.0 111.67 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -105.67 147.05 28.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 79.86 -52.48 0.39 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 129.663 3.185 . . . . 0.0 110.815 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -84.89 169.68 13.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.27 1.428 . . . . 0.0 109.424 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 m -128.35 99.7 5.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.238 1.015 . . . . 0.0 109.616 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.2 p -84.62 174.63 9.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.867 1.267 . . . . 0.0 112.441 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . -141.62 170.36 9.36 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 128.153 2.581 . . . . 0.0 109.653 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 82.4 Cg_endo -70.96 160.5 49.15 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.793 2.329 . . . . 0.0 111.724 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -131.2 94.65 3.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 106.457 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.51 14.27 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.381 1.467 . . . . 0.0 110.295 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.11 141.81 36.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.31 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.53 108.36 3.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.737 0.699 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.69 21.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.297 1.839 . . . . 0.0 106.519 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.37 173.16 49.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.685 0.66 . . . . 0.0 112.744 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.86 134.13 56.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.624 1.97 . . . . 0.0 109.398 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -90.81 144.13 26.02 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -133.96 159.34 41.04 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.015 1.326 . . . . 0.0 108.905 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -144.38 154.3 42.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.096 1.358 . . . . 0.0 107.858 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.7 mp -137.47 131.98 32.68 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -165.03 137.97 4.57 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.78 1.232 . . . . 0.0 108.553 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.58 96.51 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.56 164.49 4.48 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.113 0.959 . . . . 0.0 111.782 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.79 -2.06 42.87 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 121.266 -0.896 . . . . 0.0 113.318 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -138.22 167.07 22.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.262 3.025 . . . . 0.0 107.181 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 152.8 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.498 -0.751 . . . . 0.0 109.29 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 92.3 mt -74.41 135.05 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.1 -4.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -170.99 -173.48 38.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 120.521 1.51 . . . . 0.0 111.048 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.62 164.66 29.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.341 1.07 . . . . 0.0 110.204 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -132.65 157.86 43.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.18 -163.57 27.74 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.415 ' HE2' ' C ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -131.03 158.31 40.66 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.669 1.188 . . . . 0.0 109.173 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -137.1 113.91 10.43 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.678 0.791 . . . . 0.0 110.291 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 m -149.82 86.46 1.45 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 58.74 -10.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.272 2.229 . . . . 0.0 116.772 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 36.7 mt -143.37 -172.21 3.65 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.778 2.031 . . . . 0.0 109.56 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.63 88.48 2.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.78 1.232 . . . . 0.0 112.423 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.78 -84.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.628 0.728 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -85.65 128.97 34.93 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 120.894 -1.129 . . . . 0.0 109.163 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -149.41 100.05 2.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.127 0.971 . . . . 0.0 108.604 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -120.19 152.18 17.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.28 135.2 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 118.951 1.375 . . . . 0.0 111.729 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -89.74 139.01 30.99 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.54 153.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 37.0 mmm -147.53 157.21 45.13 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.37 156.89 57.52 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.391 1.394 . . . . 0.0 111.609 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--N 1.329 -0.315 0 C-N-CA 125.904 1.682 . . . . 0.0 107.619 178.457 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.57 138.49 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 117' ' ' LEU . 2.3 t -126.39 84.99 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -56.46 140.21 46.65 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.268 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -73.42 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 O-C-N 125.139 1.524 . . . . 0.0 112.087 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.26 -14.86 23.1 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.046 -1.419 . . . . 0.0 112.672 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.38 -169.59 35.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.07 113.4 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 112.881 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.02 34.76 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.64 -151.19 2.42 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 128.244 2.831 . . . . 0.0 112.153 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.52 -170.79 41.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 112.093 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.77 33.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -69.77 69.39 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -84.09 24.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.993 1.717 . . . . 0.0 109.647 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.38 126.46 27.56 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.146 1.779 . . . . 0.0 107.032 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -70.15 -179.0 1.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.44 0.696 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.567 0 C-N-CA 125.962 1.744 . . . . 0.0 110.185 -179.677 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.457 0 N-CA-C 113.387 0.115 . . . . 0.0 113.387 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -136.61 118.7 20.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.58 -60.96 1.59 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -149.66 158.09 43.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.82 116.28 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.464 ' CE1' HG23 ' A' ' 64' ' ' THR . 12.1 m-70 -118.66 125.94 50.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.38 142.42 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 123.995 0.918 . . . . 0.0 109.251 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.97 164.08 25.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 124.606 1.098 . . . . 0.0 110.42 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -75.22 -148.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.162 1.385 . . . . 0.0 111.146 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.26 -163.58 35.6 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -95.35 -32.45 12.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.859 1.314 . . . . 0.0 107.54 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.67 -6.34 58.93 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 134.389 5.076 . . . . 0.0 113.24 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.3 -156.36 15.64 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.64 121.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.1 p -132.8 -58.61 0.91 Allowed 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.7 p -72.96 119.41 17.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 119.11 0.868 . . . . 0.0 109.634 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 tt -135.26 142.42 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.297 1.039 . . . . 0.0 108.959 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.97 129.72 21.64 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.617 1.967 . . . . 0.0 106.034 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.46 151.54 24.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.2 t -127.48 118.39 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -107.76 105.13 14.82 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.525 1.53 . . . . 0.0 110.488 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . . . -98.58 134.74 41.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 117.951 0.341 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -114.48 163.82 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.58 21.96 0.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.834 1.302 . . . . 0.0 111.095 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.9 p -128.8 -68.55 0.74 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.083 2.553 . . . . 0.0 109.875 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -148.08 133.91 19.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.288 1.435 . . . . 0.0 109.379 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 15.6 t0 -78.32 152.29 32.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.354 1.462 . . . . 0.0 109.687 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.76 108.67 13.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.973 0.892 . . . . 0.0 109.131 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.28 98.41 11.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.86 -22.09 76.87 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.46 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.09 -172.72 40.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.42 123.98 28.03 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.548 -0.971 . . . . 0.0 110.864 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.07 160.93 29.3 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 12.73 -86.99 0.0 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 128.417 2.913 . . . . 0.0 115.798 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -69.44 103.78 2.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.74 163.4 21.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.825 1.25 . . . . 0.0 112.432 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.81 10.22 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.712 2.405 . . . . 0.0 112.907 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.13 -13.51 18.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.84 1.256 . . . . 0.0 112.127 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.309 3.2 pp 49.0 -11.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.027 4.131 . . . . 0.0 117.593 -179.19 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.81 61.76 3.04 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.24 160.83 35.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.814 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.81 164.42 12.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 127.891 2.476 . . . . 0.0 109.298 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.464 HG23 ' CE1' ' A' ' 27' ' ' HIS . 23.5 m -136.03 95.58 3.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.578 0.751 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -95.04 109.56 21.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.47 143.08 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.731 0.812 . . . . 0.0 110.675 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.5 t -103.87 156.57 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -149.21 164.14 35.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.913 1.685 . . . . 0.0 107.833 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.67 -9.78 59.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.672 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.69 -9.33 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.833 1.653 . . . . 0.0 111.462 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 135.76 52.12 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -135.88 149.35 48.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 109.208 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.7 126.64 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.49 -25.81 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.753 -0.642 . . . . 0.0 110.25 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.89 149.18 30.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.438 1.017 . . . . 0.0 110.642 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.467 ' O ' HD21 ' A' ' 117' ' ' LEU . 19.0 m -129.22 75.81 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.07 134.22 52.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -139.67 153.05 23.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.1 p -133.35 142.04 48.22 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 44.8 p90 -149.84 156.35 41.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.08 169.48 20.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -126.86 157.74 38.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.723 0.773 . . . . 0.0 110.702 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.99 166.0 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.429 1.492 . . . . 0.0 108.62 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -68.42 150.1 48.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.73 20.15 58.59 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.061 -0.855 . . . . 0.0 113.372 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -131.04 166.52 20.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.621 1.569 . . . . 0.0 107.363 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -122.52 -11.98 8.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.955 1.702 . . . . 0.0 112.359 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.9 p -145.47 145.8 31.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.768 1.627 . . . . 0.0 109.667 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.72 159.48 33.44 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -135.7 156.91 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.715 0.806 . . . . 0.0 109.781 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -73.73 139.62 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-O 121.565 0.698 . . . . 0.0 112.057 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -108.38 -30.96 8.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.587 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.4 t -165.83 166.4 17.69 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.53 1.532 . . . . 0.0 110.624 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.0 mt -145.23 146.28 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 128.12 2.568 . . . . 0.0 105.677 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -150.14 101.53 3.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -86.72 148.53 25.39 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.312 -0.867 . . . . 0.0 109.479 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -133.31 121.11 21.92 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.0 p -100.5 159.03 15.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.653 1.115 . . . . 0.0 111.576 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.34 -32.89 74.43 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.714 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -56.19 -10.76 0.93 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.818 2.847 . . . . 0.0 113.042 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.51 30.56 8.5 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 119.238 0.926 . . . . 0.0 111.856 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.81 148.42 42.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.609 1.204 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 114.64 12.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 p -73.47 160.75 81.63 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.15 165.59 32.29 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 N-CA-C 107.694 -1.695 . . . . 0.0 107.694 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.09 109.59 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.022 -1.953 . . . . 0.0 107.022 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.38 66.08 0.92 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.294 1.437 . . . . 0.0 110.031 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.78 -129.35 3.5 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 tp -139.41 136.17 34.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.673 1.589 . . . . 0.0 109.833 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 158.8 11.77 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.44 1.096 . . . . 0.0 110.901 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -156.35 173.52 16.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.563 -1.335 . . . . 0.0 111.343 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.485 ' H ' HG22 ' A' ' 111' ' ' THR . 4.8 tt0 -64.74 -58.08 7.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.143 1.377 . . . . 0.0 109.254 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 80' ' ' TYR . 16.3 mmtm -70.54 105.93 3.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.48 166.42 33.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 120.604 -1.31 . . . . 0.0 109.021 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 117' ' ' LEU . 15.6 p90 -156.72 166.85 32.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.313 0.578 . . . . 0.0 109.73 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.98 145.84 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 115' ' ' PHE . 1.1 pt? -149.74 136.51 19.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 127.706 2.403 . . . . 0.0 106.354 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 134.44 7.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.49 161.16 21.34 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -142.65 -69.05 0.35 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.605 1.162 . . . . 0.0 111.064 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.84 15.37 6.92 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.492 1.517 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.34 -85.66 1.64 Allowed Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 125.602 1.572 . . . . 0.0 111.011 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.97 166.41 29.36 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.6 140.6 41.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.503 HD11 ' CB ' ' A' ' 141' ' ' ALA . 20.1 tp -54.91 112.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.68 -54.98 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.348 0.976 . . . . 0.0 111.283 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.43 -105.28 0.2 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -167.66 176.4 6.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.292 1.046 . . . . 0.0 111.526 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.84 151.84 35.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.48 -26.42 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.049 -1.072 . . . . 0.0 114.548 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 62.23 69.95 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.535 2.334 . . . . 0.0 113.852 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.99 112.16 20.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.55 -120.46 4.27 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 103.414 -3.875 . . . . 0.0 103.414 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.34 -10.22 59.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.259 0.624 . . . . 0.0 112.23 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.42 173.86 11.63 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.222 2.609 . . . . 0.0 107.691 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 40.8 tp -99.51 98.24 9.15 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.684 0.794 . . . . 0.0 109.245 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -76.13 -66.65 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 112.087 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.47 172.79 12.51 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.88 1.218 . . . . 0.0 109.626 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.8 tp -162.73 134.01 5.01 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.86 176.88 44.16 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 106.47 -2.652 . . . . 0.0 106.47 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' HD11 ' A' ' 125' ' ' LEU . . . -153.02 176.96 11.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.975 1.388 . . . . 0.0 109.055 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -147.81 161.73 40.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.684 0.754 . . . . 0.0 109.447 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.1 125.31 12.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.111 2.565 . . . . 0.0 104.398 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 118.722 0.692 . . . . 0.0 111.858 -179.611 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.1 133.87 55.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.195 0.998 . . . . 0.0 110.773 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -113.64 143.43 44.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.408 1.483 . . . . 0.0 108.658 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.48 -89.92 0.13 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.3 t -146.55 160.4 42.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.112 1.765 . . . . 0.0 107.889 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -170.38 136.61 1.36 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.099 2.159 . . . . 0.0 105.371 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.0 tt -97.99 128.45 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.2 107.59 0.62 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.34 -179.03 6.22 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 112.431 -1.885 . . . . 0.0 109.832 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.19 11.94 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 128.659 2.783 . . . . 0.0 115.319 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 11.8 mt-10 -130.99 156.35 45.26 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.207 1.367 . . . . 0.0 114.265 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 96.91 159.53 31.55 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 125.253 1.406 . . . . 0.0 112.768 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 m -102.53 134.43 45.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.51 138.86 51.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.815 0.446 . . . . 0.0 110.122 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -128.63 123.94 34.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -85.78 105.66 16.46 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.14 -117.94 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.405 1.066 . . . . 0.0 108.707 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.13 168.16 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 121.35 1.886 . . . . 0.0 111.763 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.87 157.86 37.11 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.098 -0.648 . . . . 0.0 109.254 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -135.31 176.34 8.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.691 1.196 . . . . 0.0 110.621 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -12.24 60.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.739 1.215 . . . . 0.0 113.767 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.21 171.73 22.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 125.525 1.536 . . . . 0.0 110.315 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.1 m -125.89 107.8 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -63.04 -51.1 68.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 110.629 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -149.19 169.69 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.753 1.16 . . . . 0.0 112.751 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 86.1 t -122.46 143.95 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.656 1.583 . . . . 0.0 109.208 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.79 157.39 46.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.768 1.627 . . . . 0.0 108.342 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.36 146.22 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.77 83.64 0.32 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -71.16 160.51 32.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.655 0.741 . . . . 0.0 110.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.34 -163.28 9.49 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.152 2.787 . . . . 0.0 109.029 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -89.62 -14.36 35.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.902 -1.352 . . . . 0.0 111.565 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.21 -29.1 15.28 Favored 'General case' 0 C--N 1.327 -0.379 1 C-N-CA 132.404 4.282 . . . . 0.0 112.917 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 144.45 -136.78 6.9 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.94 104.6 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.23 -26.17 28.9 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.496 0.719 . . . . 0.0 112.215 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.98 146.07 35.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.842 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.79 145.07 28.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -148.75 154.73 39.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.85 175.45 9.57 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -123.55 120.87 34.12 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.351 0.66 . . . . 0.0 109.555 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -94.85 165.7 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.397 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -144.82 130.38 18.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.109 -0.948 . . . . 0.0 108.556 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.85 151.99 43.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.714 1.143 . . . . 0.0 109.111 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.72 -103.53 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.601 1.096 . . . . 0.0 111.708 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 7.89 3.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.266 2.226 . . . . 0.0 110.936 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -109.24 177.93 4.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.011 1.324 . . . . 0.0 107.851 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -133.7 142.29 47.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.866 1.266 . . . . 0.0 108.761 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 201' ' ' ILE . 1.8 mp -111.74 99.73 9.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 119.649 1.113 . . . . 0.0 109.351 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.68 103.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.46 175.28 35.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.158 2.313 . . . . 0.0 107.698 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 134.1 23.95 0.66 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-N 118.327 1.063 . . . . 0.0 113.771 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.92 126.07 27.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.429 1.614 . . . . 0.0 108.123 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -127.68 -6.88 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.227 2.611 . . . . 0.0 113.363 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.45 159.29 25.73 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -66.29 116.56 34.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.801 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.86 134.89 52.59 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.652 2.234 . . . . 0.0 110.077 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.9 p -83.22 161.11 21.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.215 1.006 . . . . 0.0 109.821 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.76 -23.11 65.19 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.468 -0.77 . . . . 0.0 111.096 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -64.88 -30.82 71.84 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.963 1.305 . . . . 0.0 111.247 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.95 -146.47 16.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -138.67 163.95 30.78 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.523 1.129 . . . . 0.0 109.538 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -115.03 154.25 29.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.365 3.066 . . . . 0.0 105.304 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.5 148.17 28.38 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.61 0.764 . . . . 0.0 110.388 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.65 137.19 29.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.251 0.62 . . . . 0.0 109.332 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.13 120.75 33.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.607 0.718 . . . . 0.0 111.028 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.5 mt -127.47 129.35 70.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.443 1.02 . . . . 0.0 111.353 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -37.84 -55.82 2.04 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.34 1.59 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 123.02 2.114 . . . . 0.0 113.638 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 31.0 t -108.99 -46.69 3.56 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.737 -1.227 . . . . 0.0 109.522 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.83 160.49 14.55 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.435 1.112 . . . . 0.0 112.643 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -139.93 112.41 7.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.767 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.05 84.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.34 57.93 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.655 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -152.75 157.31 40.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.863 0.865 . . . . 0.0 109.752 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.7 146.13 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.603 1.561 . . . . 0.0 106.959 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.75 152.81 39.04 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -161.91 43.42 0.38 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.336 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.0 p -23.41 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.429 3.092 . . . . 0.0 109.381 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -122.31 155.37 36.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -144.86 165.79 27.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 110.275 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -74.51 137.34 42.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.864 1.666 . . . . 0.0 111.49 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.9 mt -80.4 108.17 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -47.11 125.15 7.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.03 1.332 . . . . 0.0 112.023 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.02 -19.18 38.47 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.829 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -136.16 178.23 7.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.284 1.434 . . . . 0.0 108.77 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.91 7.78 43.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.789 0.804 . . . . 0.0 110.595 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -73.8 164.31 54.76 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 162.89 34.32 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.203 1.401 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.5 tt -151.72 148.16 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.47 142.82 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.302 1.7 t -119.82 -23.68 6.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.944 0.793 . . . . 0.0 111.96 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -146.49 126.31 13.52 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 120.176 1.353 . . . . 0.0 108.048 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.8 150.02 28.23 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.096 1.358 . . . . 0.0 111.101 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -147.46 139.06 23.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -125.92 113.35 17.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 154.01 42.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.748 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.1 p -144.74 168.3 20.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.238 1.415 . . . . 0.0 108.699 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -123.66 141.0 52.44 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt 72.08 -45.96 0.63 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.164 1.786 . . . . 0.0 110.533 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.54 168.35 17.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.406 1.883 . . . . 0.0 107.629 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 88.2 m -130.5 99.52 5.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.359 1.464 . . . . 0.0 107.954 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 38.6 p -67.14 128.9 38.11 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.336 1.055 . . . . 0.0 113.497 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.21 84.41 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.65 157.41 21.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.527 2.151 . . . . 0.0 108.676 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -133.37 104.36 6.4 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.51 -169.54 20.5 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.4 mt -116.51 124.26 49.47 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.306 1.042 . . . . 0.0 110.461 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.91 109.19 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.152 2.181 . . . . 0.0 110.777 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.69 162.5 26.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 108.458 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.28 -165.95 45.48 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.251 0.917 . . . . 0.0 112.899 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.8 m -73.66 108.47 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.958 2.103 . . . . 0.0 108.26 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.88 138.89 42.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.91 120.77 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.501 0.667 . . . . 0.0 111.81 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.06 124.01 47.72 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.55 110.29 22.44 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -152.06 163.37 39.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.434 1.094 . . . . 0.0 109.934 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -144.71 137.71 26.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 129.37 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.393 0.616 . . . . 0.0 111.138 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.21 -1.57 33.11 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.43 161.23 13.74 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.331 2.065 . . . . 0.0 113.546 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -107.81 159.64 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.889 2.475 . . . . 0.0 107.722 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 54.7 mt -99.74 107.69 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.22 90.68 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.485 1.514 . . . . 0.0 109.449 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.73 159.11 9.1 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 126.046 1.784 . . . . 0.0 111.485 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -131.85 164.35 26.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.626 2.371 . . . . 0.0 108.546 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -161.88 103.13 1.16 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -150.38 -179.94 26.6 Favored Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.173 -0.954 . . . . 0.0 114.205 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 163' ' ' GLU . 21.8 ptmt -140.19 117.26 11.16 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.112 -2.922 . . . . 0.0 103.112 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.28 154.62 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 63.3 m -149.46 -72.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.95 -36.35 13.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.587 0.755 . . . . 0.0 110.755 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.6 mt -130.33 141.92 50.56 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.056 1.342 . . . . 0.0 107.881 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.57 85.09 2.63 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 110.695 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -76.19 -82.38 0.08 Allowed 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.131 0.572 . . . . 0.0 111.531 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 282' ' ' LYS . 33.5 tt0 -83.3 126.05 32.27 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.616 -0.677 . . . . 0.0 110.785 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -128.06 100.96 6.08 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.55 153.75 16.91 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.97 161.78 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.915 1.286 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.79 160.51 15.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 109.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.97 158.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 110.514 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 53.0 mmm -156.81 138.91 10.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 126.081 1.752 . . . . 0.0 107.023 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.84 123.05 8.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 105.58 -2.508 . . . . 0.0 105.58 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 121.2 0.524 . . . . 0.0 112.029 -179.225 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HE2' ' CE1' ' A' ' 142' ' ' TYR . 4.9 tmtt? -38.88 113.73 0.33 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.663 2.785 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.26 146.05 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.82 167.82 11.02 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.42 94.44 3.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.65 7.78 4.85 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.489 1.518 . . . . 0.0 115.417 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -170.14 27.74 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 118.74 1.27 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 89' ' ' ASP . . . -65.52 -28.9 74.08 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.029 1.776 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.13 42.27 30.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.452 1.501 . . . . 0.0 110.314 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.31 15.66 1.41 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.424 1.488 . . . . 0.0 112.883 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 174.64 22.42 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.358 1.932 . . . . 0.0 110.63 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 160.79 26.52 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.184 2.194 . . . . 0.0 112.237 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.73 138.39 6.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.686 0.795 . . . . 0.0 110.973 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -155.91 106.67 2.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -148.27 70.89 1.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.049 1.339 . . . . 0.0 110.758 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -34.53 127.76 0.46 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.345 2.258 . . . . 0.0 113.515 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 178.776 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.73 139.35 18.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.289 1.044 . . . . 0.0 112.116 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -58.37 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.328 1.851 . . . . 0.0 110.128 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -136.66 163.83 29.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 122.03 -0.419 . . . . 0.0 110.527 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.28 96.61 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.092 1.757 . . . . 0.0 106.879 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.82 136.28 33.03 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.33 148.25 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.539 1.936 . . . . 0.0 106.686 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.69 -115.1 2.01 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 119.483 1.038 . . . . 0.0 111.814 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.21 174.06 1.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 110.759 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.59 -25.59 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.747 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -60.72 -28.31 68.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.681 1.741 . . . . 0.0 112.468 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.24 1.06 25.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.978 2.511 . . . . 0.0 110.288 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.91 161.14 23.79 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 128.164 2.792 . . . . 0.0 108.996 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 t -84.65 95.66 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -80.32 -63.99 1.29 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 110.076 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 p -61.1 113.47 2.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.865 1.266 . . . . 0.0 111.162 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.2 mm -134.58 137.3 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.379 1.472 . . . . 0.0 107.386 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.96 111.3 5.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.1 p -124.37 150.19 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.41 122.61 59.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -110.2 104.6 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.12 110.35 18.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.596 0.236 . . . . 0.0 110.905 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -79.09 152.97 30.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.29 -38.87 74.64 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 m -63.71 -59.83 4.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -155.34 157.3 36.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.223 2.209 . . . . 0.0 106.364 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.23 156.39 39.19 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.96 108.66 2.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.44 138.53 33.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 109.369 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.36 -3.09 25.99 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.913 2.197 . . . . 0.0 112.124 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -166.43 21.29 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.431 1.116 . . . . 0.0 114.545 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -105.52 149.26 26.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.459 1.904 . . . . 0.0 107.812 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -129.73 155.87 45.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.286 1.434 . . . . 0.0 107.39 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.1 179.61 37.26 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -126.94 116.99 21.64 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.236 -1.155 . . . . 0.0 113.547 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -92.43 164.39 13.5 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.174 1.79 . . . . 0.0 110.204 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 p -142.9 168.0 20.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -63.95 -17.66 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.98 -9.84 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.954 1.702 . . . . 0.0 112.982 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.55 101.19 0.16 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 120.478 1.49 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -159.8 131.66 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.201 2.2 . . . . 0.0 105.752 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -143.28 162.39 35.79 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 127.302 2.241 . . . . 0.0 107.568 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -139.63 95.24 2.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -89.74 138.36 31.55 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -130.57 136.9 49.37 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.49 138.24 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.743 1.617 . . . . 0.0 109.607 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 5.8 t0 -82.25 171.08 14.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.5 65.79 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.995 -1.066 . . . . 0.0 112.587 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -124.4 19.45 8.89 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.326 1.45 . . . . 0.0 112.579 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.0 136.44 38.26 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.175 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.7 158.12 37.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.16 1.784 . . . . 0.0 109.175 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.0 mt -96.42 121.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.175 0.99 . . . . 0.0 109.22 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.3 m -118.38 -18.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.609 0.64 . . . . 0.0 111.952 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.19 141.11 25.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 t -135.54 142.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.64 118.48 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.78 138.4 54.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 111' ' ' THR . 17.0 m -117.02 137.31 52.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -140.27 148.97 42.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.013 0.525 . . . . 0.0 109.717 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -147.29 150.55 35.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -144.86 158.21 43.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 127.204 2.202 . . . . 0.0 109.273 177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.62 169.48 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 108.304 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.16 1.61 1.98 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.552 1.541 . . . . 0.0 113.21 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.47 17.31 14.11 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 126.904 2.192 . . . . 0.0 112.895 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -134.38 156.69 48.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.155 1.477 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -117.25 5.36 12.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.341 1.856 . . . . 0.0 112.3 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.408 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 53.2 p -134.11 173.52 11.5 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.678 2.791 . . . . 0.0 110.108 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 9' ' ' GLY . 7.2 m-20 -119.19 146.27 45.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -126.23 140.04 49.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.35 104.32 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.7 p -73.94 -31.13 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.816 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -150.21 154.35 37.82 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.652 1.581 . . . . 0.0 109.853 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 pt -139.57 148.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 128.441 2.696 . . . . 0.0 106.24 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.63 145.37 25.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -127.45 152.83 47.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -132.45 113.98 13.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 103.554 -2.758 . . . . 0.0 103.554 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.2 p -80.5 161.69 24.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.418 0.553 . . . . 0.0 112.019 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.75 -25.09 66.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.506 1.122 . . . . 0.0 111.29 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -68.62 -15.56 63.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.47 1.908 . . . . 0.0 109.721 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 6.5 61.46 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.693 2.568 . . . . 0.0 111.464 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -73.12 99.13 2.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.532 1.166 . . . . 0.0 111.359 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.12 134.95 33.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 p -107.67 162.2 20.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.763 1.225 . . . . 0.0 110.976 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.13 162.16 42.55 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.906 1.738 . . . . 0.0 109.498 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 109.73 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.615 2.21 . . . . 0.0 108.36 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -72.24 79.61 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 109.488 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.99 -137.2 5.41 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.395 -0.816 . . . . 0.0 111.611 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.99 111.13 13.72 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.597 1.959 . . . . 0.0 108.089 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.1 144.8 50.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.557 ' H ' HG21 ' A' ' 79' ' ' THR . 7.4 m -133.71 163.9 28.41 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.345 1.858 . . . . 0.0 107.055 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.87 -35.87 82.07 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.407 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -73.45 97.53 2.57 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.51 1.924 . . . . 0.0 108.947 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -150.98 170.18 19.96 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.258 1.023 . . . . 0.0 109.019 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.64 167.21 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -118.69 141.02 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.61 94.02 2.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 169.48 23.11 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.11 2.164 . . . . 0.0 108.42 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.56 150.25 38.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.473 1.909 . . . . 0.0 109.086 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.13 -61.02 2.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.189 0.904 . . . . 0.0 111.688 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -68.39 -15.55 63.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.522 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.99 -53.02 0.8 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.546 -1.697 . . . . 0.0 112.571 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 38.82 91.26 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.21 2.338 . . . . 0.0 114.055 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -52.5 120.7 5.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.658 1.729 . . . . 0.0 109.888 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.83 144.38 38.92 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.173 2.189 . . . . 0.0 110.147 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.46 -31.16 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.677 0.791 . . . . 0.0 110.084 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.73 150.89 8.54 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -121.95 84.6 2.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 123.468 1.604 . . . . 0.0 107.642 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.36 151.68 36.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 111.759 -2.473 . . . . 0.0 110.554 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.93 78.78 0.16 Allowed Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.809 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -49.33 107.11 0.13 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.045 1.738 . . . . 0.0 109.034 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.5 165.07 18.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.712 2.405 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.54 -86.65 0.2 Allowed Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 105.186 -3.166 . . . . 0.0 105.186 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -93.9 -27.59 16.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.35 166.29 25.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.832 2.453 . . . . 0.0 108.548 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.6 tp -78.81 99.05 6.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -82.95 -55.64 4.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.556 0.742 . . . . 0.0 112.945 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.81 161.27 21.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.949 0.9 . . . . 0.0 109.852 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 tp -148.43 163.39 37.28 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.717 1.607 . . . . 0.0 108.672 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.57 -179.51 40.39 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.72 151.99 29.38 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.449 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 8.5 m-85 -114.84 146.33 41.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.486 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -143.11 156.39 44.79 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.347 0 C-N-CA 123.779 0.832 . . . . 0.0 111.469 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.372 0.606 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -73.97 122.92 23.35 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -99.79 118.93 37.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.825 1.65 . . . . 0.0 106.931 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.35 -176.68 4.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.675 0.671 . . . . 0.0 111.751 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.5 m -121.52 85.74 2.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 113.426 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.25 -175.84 5.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.278 1.031 . . . . 0.0 109.13 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -123.87 165.17 20.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 127.005 2.122 . . . . 0.0 107.248 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 177.75 -83.04 0.07 OUTLIER Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.832 0.742 . . . . 0.0 114.187 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.44 -24.77 0.02 OUTLIER Glycine 0 N--CA 1.469 0.848 0 CA-C-N 117.403 0.601 . . . . 0.0 112.779 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 282' ' ' LYS . 0.3 OUTLIER 61.43 21.35 11.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -83.59 -47.85 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.54 12.79 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 122.57 1.095 . . . . 0.0 113.765 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.7 m -81.44 134.53 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.219 -0.577 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.56 124.31 22.88 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.535 0.734 . . . . 0.0 110.505 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -127.05 126.9 43.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.241 1.02 . . . . 0.0 109.362 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -98.2 156.52 16.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.624 2.369 . . . . 0.0 107.278 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.28 -53.48 2.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.776 1.63 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.8 -105.7 1.85 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -165.62 166.88 17.77 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.645 1.978 . . . . 0.0 108.378 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.33 154.3 36.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.159 0.584 . . . . 0.0 110.317 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -27.74 61.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.12 140.55 2.91 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.747 2.594 . . . . 0.0 106.754 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.8 m -91.85 157.14 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.511 1.124 . . . . 0.0 110.634 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -123.71 -21.88 5.09 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.843 1.657 . . . . 0.0 111.086 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -166.11 159.85 15.73 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.625 0.77 . . . . 0.0 110.426 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.74 147.55 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 126.982 2.113 . . . . 0.0 107.694 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -139.4 113.28 8.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.151 1.381 . . . . 0.0 108.322 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.19 133.81 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -135.86 144.53 16.37 Favored Glycine 0 C--O 1.238 0.397 0 CA-C-O 122.029 0.794 . . . . 0.0 111.815 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -126.72 171.89 10.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.285 1.434 . . . . 0.0 107.43 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.16 -171.44 12.4 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -63.43 -6.81 5.38 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.638 1.175 . . . . 0.0 113.484 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -120.04 -4.96 10.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.756 1.622 . . . . 0.0 112.859 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 125.14 -162.08 19.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.596 1.089 . . . . 0.0 111.626 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.1 mm -55.6 126.64 13.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 m -134.27 -19.73 1.92 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.62 138.18 16.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 121.174 1.806 . . . . 0.0 111.551 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.05 146.85 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.146 0.884 . . . . 0.0 109.761 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -160.45 167.23 27.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.794 1.637 . . . . 0.0 107.459 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -138.32 172.4 12.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.592 1.157 . . . . 0.0 108.11 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -126.75 124.3 39.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -132.06 167.99 18.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.458 0.572 . . . . 0.0 111.31 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -116.6 91.46 3.59 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -112.96 136.32 52.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.771 2.428 . . . . 0.0 106.14 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.16 20.32 34.95 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.947 0.784 . . . . 0.0 113.093 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.93 4.73 3.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.638 2.375 . . . . 0.0 113.723 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -91.25 -157.33 0.49 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.495 1.518 . . . . 0.0 111.055 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -125.4 73.43 1.32 Allowed 'General case' 0 C--N 1.339 0.142 0 O-C-N 120.694 -1.254 . . . . 0.0 110.924 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.2 mt -84.87 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.0 145.05 31.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -73.57 156.54 51.03 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.35 159.06 46.38 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.18 94.41 4.74 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -63.14 -22.04 66.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.381 1.072 . . . . 0.0 113.228 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.56 -179.07 16.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.925 1.726 . . . . 0.0 112.19 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.57 117.49 68.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.567 1.547 . . . . 0.0 109.523 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.8 175.16 6.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.407 2.071 . . . . 0.0 110.196 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -139.95 162.08 36.06 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.744 -1.222 . . . . 0.0 110.546 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.38 -15.28 62.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.886 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -4.24 22.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.709 2.404 . . . . 0.0 111.062 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.46 -157.63 51.67 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.328 -0.857 . . . . 0.0 111.394 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.89 172.67 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.551 1.54 . . . . 0.0 110.482 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.77 147.08 47.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 129.568 3.147 . . . . 0.0 102.827 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.25 147.36 51.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -142.94 143.98 32.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.783 1.233 . . . . 0.0 109.278 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.18 136.4 52.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.4 mt -128.13 103.29 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.861 1.664 . . . . 0.0 109.238 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.64 98.48 0.52 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -55.57 -40.17 82.57 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.49 -29.79 44.42 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 123.187 2.174 . . . . 0.0 112.891 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -89.94 -30.07 18.08 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 116.423 -1.751 . . . . 0.0 113.233 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 225' ' ' TYR . 10.9 tp10 -162.01 175.92 11.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 121.622 2.01 . . . . 0.0 111.157 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.439 ' H ' ' CD ' ' A' ' 224' ' ' GLU . 2.6 p90 -153.17 -156.16 0.67 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.537 1.135 . . . . 0.0 109.311 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 92.6 mt -116.77 102.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 101.885 -3.376 . . . . 0.0 101.885 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.1 p -81.84 -20.64 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.018 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.26 167.5 25.84 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.516 1.526 . . . . 0.0 108.284 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.43 159.08 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.073 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 172.0 13.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.922 2.089 . . . . 0.0 107.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.81 171.62 31.28 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.483 HG21 ' HG2' ' A' ' 262' ' ' GLU . 3.1 p -140.8 146.41 37.6 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -122.14 145.23 48.38 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.132 0.573 . . . . 0.0 110.301 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.61 161.07 36.55 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 110.325 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.52 148.91 38.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.795 1.638 . . . . 0.0 109.873 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.3 pt -115.9 142.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -87.73 99.24 11.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.56 -22.97 1.51 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.873 0.749 . . . . 0.0 113.85 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 m -141.78 155.52 45.6 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.67 -16.92 62.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.848 0.749 . . . . 0.0 112.615 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.02 -173.7 20.56 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.915 1.721 . . . . 0.0 115.689 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.6 mt -119.07 173.52 6.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.082 2.153 . . . . 0.0 110.055 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.3 tt -139.13 130.72 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.843 1.657 . . . . 0.0 108.008 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.9 mt -90.44 76.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.1 t -70.41 -8.43 50.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -141.79 137.21 31.37 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.855 0.752 . . . . 0.0 111.868 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.2 mt -142.79 137.74 29.92 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.724 1.61 . . . . 0.0 109.121 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -139.63 139.42 36.71 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.63 113.04 25.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -65.95 115.27 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.5 m -133.6 162.17 32.64 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.071 0.949 . . . . 0.0 109.23 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.16 161.67 26.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.948 2.499 . . . . 0.0 105.074 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.5 tptt 75.47 -28.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.968 1.707 . . . . 0.0 112.808 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -138.84 167.95 20.88 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.812 1.245 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 14.4 t -121.96 142.92 49.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.934 2.093 . . . . 0.0 106.005 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 p -133.13 149.29 52.1 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.951 0.901 . . . . 0.0 109.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -66.93 159.9 73.13 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.679 0.792 . . . . 0.0 111.819 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.83 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 105.51 -2.535 . . . . 0.0 105.51 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -72.97 99.23 2.66 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.72 179.75 17.77 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.04 114.46 27.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.543 1.937 . . . . 0.0 107.966 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.483 ' HG2' HG21 ' A' ' 232' ' ' THR . 0.9 OUTLIER -59.68 115.84 3.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 110.136 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.42 24.77 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.873 0.844 . . . . 0.0 111.68 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.68 -93.27 1.25 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 125.799 1.666 . . . . 0.0 113.629 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.4 m -149.9 127.47 11.58 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.391 1.076 . . . . 0.0 109.207 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.76 147.69 30.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.881 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -142.24 168.28 20.12 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.527 1.531 . . . . 0.0 108.072 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -151.87 156.2 39.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 109.181 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.7 mt -139.95 138.28 35.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -160.53 160.57 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 108.968 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.16 148.18 34.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 121.85 30.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.845 1.258 . . . . 0.0 109.455 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 87.78 -75.23 2.11 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -47.14 144.88 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.316 1.846 . . . . 0.0 111.486 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -117.65 161.07 20.25 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 83.4 mt -79.13 150.47 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.46 -55.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.8 -176.67 14.81 Favored Glycine 0 C--O 1.239 0.445 0 CA-C-O 122.994 1.33 . . . . 0.0 113.947 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.52 9.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.436 2.695 . . . . 0.0 111.271 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -165.31 162.69 19.85 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.016 1.726 . . . . 0.0 106.714 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.21 -136.11 5.28 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -156.69 131.03 8.63 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.33 137.67 24.55 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.8 m -152.16 -29.99 0.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.541 1.536 . . . . 0.0 112.225 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -139.23 -57.88 0.59 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.423 1.889 . . . . 0.0 111.753 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.78 165.82 22.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.139 1.375 . . . . 0.0 108.232 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.94 92.05 8.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.569 -0.707 . . . . 0.0 110.088 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.85 -48.24 7.14 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.013 0.925 . . . . 0.0 112.865 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -112.61 141.25 46.6 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.92 99.59 3.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -113.32 157.57 14.86 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.963 1.268 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.85 174.85 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.217 1.009 . . . . 0.0 113.13 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -127.97 125.93 40.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.345 2.658 . . . . 0.0 104.787 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -110.22 139.98 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.4 mtm -132.44 144.12 51.7 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.4 140.44 27.25 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.995 -1.963 . . . . 0.0 106.995 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.235 0.29 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.558 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -149.9 97.97 2.66 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.5 131.46 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.149 1.341 . . . . 0.0 108.978 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.21 163.8 21.65 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.652 0.781 . . . . 0.0 112.226 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.97 169.83 17.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.843 1.257 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.54 87.37 0.1 Allowed Glycine 0 C--O 1.225 -0.433 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.99 -167.96 20.41 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 126.585 2.041 . . . . 0.0 108.665 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.45 177.74 2.47 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 115.679 1.031 . . . . 0.0 115.679 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.43 2.99 12.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.414 1.486 . . . . 0.0 114.903 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.99 -2.31 38.03 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.245 -1.309 . . . . 0.0 116.191 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.4 172.78 14.81 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 121.041 2.421 . . . . 0.0 113.882 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.97 157.57 25.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.783 0.833 . . . . 0.0 109.339 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -71.68 84.19 0.88 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 112.698 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -93.98 149.65 21.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.23 -10.06 0.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.799 1.24 . . . . 0.0 111.779 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -54.27 131.76 42.28 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.558 1.943 . . . . 0.0 110.805 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 125.75 1.643 . . . . 0.0 110.241 179.453 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.04 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.52 140.84 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.971 1.386 . . . . 0.0 109.511 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -62.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.893 0.877 . . . . 0.0 111.993 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -145.62 164.54 31.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.197 0.999 . . . . 0.0 109.909 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 t -141.71 150.36 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 127.043 2.137 . . . . 0.0 106.337 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -136.8 134.91 37.52 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.77 147.16 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 62' ' ' PHE . . . 135.26 124.92 2.47 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.25 -4.71 10.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.179 1.792 . . . . 0.0 111.168 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.4 -73.09 0.1 OUTLIER Glycine 0 C--O 1.224 -0.522 0 C-N-CA 129.386 3.374 . . . . 0.0 114.535 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -56.56 -47.84 78.63 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.065 0.946 . . . . 0.0 110.755 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.9 1.52 56.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.432 1.493 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.86 -117.47 5.13 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 121.162 -0.962 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.2 96.76 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 111.532 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -127.12 -29.21 2.79 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.9 t -68.27 159.02 32.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.119 0.872 . . . . 0.0 110.344 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 154.37 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.503 1.521 . . . . 0.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -153.09 123.03 6.92 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.927 1.291 . . . . 0.0 107.735 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.35 100.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 123.966 0.906 . . . . 0.0 108.558 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -104.79 134.29 46.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -127.32 154.63 44.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 109.735 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.27 109.94 22.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -114.67 130.01 56.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 57.16 17.94 3.84 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.845 1.202 . . . . 0.0 112.65 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . 0.325 86.0 p 71.3 23.97 3.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.71 2.404 . . . . 0.0 111.285 -176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.95 160.49 19.49 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.113 2.965 . . . . 0.0 104.871 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -105.23 118.03 35.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 m -118.67 124.55 73.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.272 1.029 . . . . 0.0 110.503 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -122.76 161.58 23.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.282 1.833 . . . . 0.0 109.752 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.77 -21.97 2.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.211 1.386 . . . . 0.0 110.05 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.0 167.72 12.52 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 128.036 2.732 . . . . 0.0 109.942 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -73.95 159.46 32.73 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 109.951 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.49 143.69 50.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.06 -143.79 16.89 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.13 115.73 18.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.785 2.834 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 151.99 24.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.214 1.37 . . . . 0.0 110.163 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -147.72 156.1 42.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 tp -77.89 -10.43 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.86 -0.525 . . . . 0.0 111.502 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.12 -5.47 27.24 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.57 96.43 0.1 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.492 ' HA ' ' HA3' ' A' ' 29' ' ' GLY . 12.3 p90 -154.19 161.83 41.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.712 1.205 . . . . 0.0 109.66 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.66 163.61 33.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 127.197 2.199 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.7 m -131.82 140.81 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.004 2.121 . . . . 0.0 107.205 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -133.07 140.75 47.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.004 1.322 . . . . 0.0 109.295 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.5 136.24 54.97 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.175 1.79 . . . . 0.0 111.478 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.48 125.8 71.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.94 164.68 26.32 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.572 -0.705 . . . . 0.0 111.634 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -11.13 15.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.476 1.511 . . . . 0.0 113.172 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -127.5 10.0 6.65 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.788 1.635 . . . . 0.0 110.885 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -97.79 152.44 19.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.151 0.887 . . . . 0.0 111.786 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.53 134.14 41.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.61 105.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.91 -55.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.7 22.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.236 1.015 . . . . 0.0 109.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.78 151.37 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -135.17 136.0 41.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.59 135.89 27.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -116.27 156.54 26.43 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -153.55 158.64 41.55 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.486 1.039 . . . . 0.0 112.516 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -162.49 168.89 21.25 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.96 0.886 . . . . 0.0 112.14 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -125.3 141.27 52.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.479 2.712 . . . . 0.0 106.646 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -123.56 159.09 28.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.28 129.19 40.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.29 2.91 51.06 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 111.557 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -138.62 127.65 23.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.028 1.731 . . . . 0.0 106.766 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -11.18 49.46 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.3 p -80.07 -175.5 5.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.916 2.486 . . . . 0.0 109.9 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.83 134.91 17.99 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.73 171.73 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 123.827 0.851 . . . . 0.0 111.729 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.8 mm -73.93 134.06 30.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 p -104.73 -30.42 9.93 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.335 0.654 . . . . 0.0 110.172 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -156.42 160.44 39.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.325 0.966 . . . . 0.0 110.214 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.6 mt -142.58 147.62 20.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 126.667 1.987 . . . . 0.0 107.351 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -150.66 137.18 18.8 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.68 115.5 22.19 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.292 1.437 . . . . 0.0 107.747 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.12 135.11 33.41 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.4 p -110.23 159.39 17.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.658 1.117 . . . . 0.0 110.809 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -77.29 -25.88 51.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 5.3 mmpt? -63.56 -11.23 22.82 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.467 1.907 . . . . 0.0 114.491 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.52 31.26 33.99 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 120.862 1.665 . . . . 0.0 110.526 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -128.95 93.59 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.561 1.144 . . . . 0.0 108.397 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -85.74 136.28 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.82 150.3 75.27 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.92 166.73 28.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.615 1.543 . . . . 0.0 108.426 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.32 99.81 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.733 2.288 . . . . 0.0 108.265 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.32 85.43 0.16 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.488 1.515 . . . . 0.0 110.173 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.23 -123.75 3.52 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 126.07 1.795 . . . . 0.0 108.867 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.2 tp -139.51 120.92 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.417 1.487 . . . . 0.0 107.719 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 151.4 21.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.03 169.56 19.66 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.735 -1.228 . . . . 0.0 110.52 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.15 -61.23 2.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.543 1.137 . . . . 0.0 111.605 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.74 127.64 32.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -174.5 173.14 2.98 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.179 0.992 . . . . 0.0 111.1 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.34 167.52 25.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.057 0.943 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.11 150.63 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.725 1.61 . . . . 0.0 108.388 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.21 154.65 42.62 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 109.067 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.85 156.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.272 2.229 . . . . 0.0 110.02 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 143' ' ' PHE . 31.1 t0 -117.67 175.61 5.56 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.009 2.523 . . . . 0.0 109.238 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -64.89 176.96 1.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.703 2.001 . . . . 0.0 110.482 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -68.18 -17.79 64.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.942 0.897 . . . . 0.0 112.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.44 43.02 1.71 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -133.19 154.36 21.17 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -137.61 149.55 46.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.881 0.872 . . . . 0.0 109.892 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.18 133.54 49.05 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.61 -71.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -139.54 166.34 25.59 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.268 0.486 . . . . 0.0 112.022 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -125.0 120.06 30.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.415 1.886 . . . . 0.0 107.303 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 148.85 25.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.21 96.13 0.18 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 65.4 1.2 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 109.553 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.01 165.53 12.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.526 2.331 . . . . 0.0 108.448 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.22 -102.56 0.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 103.215 -3.954 . . . . 0.0 103.215 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -86.75 -9.88 54.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.605 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 170.66 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.337 2.255 . . . . 0.0 108.786 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.452 HD11 HD23 ' A' ' 139' ' ' LEU . 12.9 tp -82.18 93.86 7.16 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.797 2.039 . . . . 0.0 110.772 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.68 -39.8 11.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.28 148.91 30.98 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.325 -0.86 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.501 ' CD1' ' H ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -134.84 -169.51 2.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.743 2.417 . . . . 0.0 108.827 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.501 ' H ' ' CD1' ' A' ' 139' ' ' LEU . . . 144.63 172.27 15.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.439 2.447 . . . . 0.0 109.469 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.56 166.28 33.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 120.031 1.915 . . . . 0.0 111.176 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -136.98 168.96 18.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.216 1.007 . . . . 0.0 110.88 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.431 ' CG ' ' HB2' ' A' ' 119' ' ' ASP . 7.8 m-85 -134.43 97.22 3.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 117.746 -1.121 . . . . 0.0 113.041 -178.355 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -94.99 126.18 40.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HA ' ' CE1' ' A' ' 293' ' ' HIS . 4.3 pttp -85.86 141.31 29.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.851 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.53 157.39 18.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.5 m -75.77 126.88 31.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.852 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.23 178.8 0.24 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.088 1.355 . . . . 0.0 112.161 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.421 HG22 ' H ' ' A' ' 160' ' ' GLY . 8.2 mt -128.68 170.68 17.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.555 1.942 . . . . 0.0 107.259 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.421 ' H ' HG22 ' A' ' 159' ' ' ILE . . . -34.53 111.12 0.07 OUTLIER Glycine 0 CA--C 1.493 -1.282 0 C-N-CA 125.859 1.695 . . . . 0.0 113.335 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 164.36 121.66 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 O-C-N 125.471 1.336 . . . . 0.0 113.209 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -146.67 3.43 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -119.76 111.77 18.42 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 110.168 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.56 162.64 10.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.857 1.218 . . . . 0.0 111.633 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.1 t -81.56 141.31 33.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.77 28.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -141.63 17.89 2.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.707 1.603 . . . . 0.0 110.87 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -43.12 127.08 4.21 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.221 2.208 . . . . 0.0 111.746 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.38 -7.83 58.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 77.62 -98.58 1.42 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 104.302 -3.519 . . . . 0.0 104.302 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.99 159.79 29.89 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.338 1.855 . . . . 0.0 107.425 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -131.56 179.54 5.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.832 2.053 . . . . 0.0 107.31 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.98 -44.09 97.86 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.7 160.58 30.8 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-O 122.177 0.876 . . . . 0.0 111.662 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.8 156.36 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 127.614 2.365 . . . . 0.0 105.342 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -138.42 -41.09 0.51 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.935 0.789 . . . . 0.0 112.911 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -133.65 140.91 47.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.339 -0.85 . . . . 0.0 110.871 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.53 120.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.02 112.66 24.63 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.62 128.28 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.83 97.9 0.65 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.529 1.538 . . . . 0.0 110.355 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -89.85 177.39 6.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 123.075 1.417 . . . . 0.0 111.798 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.25 -165.84 11.55 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 129.731 3.539 . . . . 0.0 106.924 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.8 -46.99 15.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.011 -0.699 . . . . 0.0 111.843 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.77 -31.87 25.7 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.079 1.351 . . . . 0.0 113.017 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.2 25.01 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.33 149.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.926 0.89 . . . . 0.0 109.657 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 p -132.29 -40.59 1.01 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.93 0.892 . . . . 0.0 110.228 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.0 165.07 20.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.746 1.218 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.05 124.61 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.02 90.34 0.68 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.862 0.756 . . . . 0.0 110.76 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -92.93 174.34 7.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.23 0.612 . . . . 0.0 110.505 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.13 140.96 47.46 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.17 168.31 20.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.742 1.617 . . . . 0.0 110.867 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -112.41 155.84 23.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.403 1.081 . . . . 0.0 110.478 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -139.83 115.31 9.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.56 -89.45 0.29 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -147.48 24.28 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.898 1.679 . . . . 0.0 109.773 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -126.17 142.24 51.61 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.35 141.01 40.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.619 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.3 mm -121.88 132.07 71.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.46 135.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.256 1.022 . . . . 0.0 108.749 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.01 -131.34 3.29 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.94 -8.78 61.99 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.373 1.94 . . . . 0.0 113.592 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 125.44 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.789 1.295 . . . . 0.0 107.823 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -136.92 -50.23 0.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.305 0.642 . . . . 0.0 109.495 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.41 -179.44 50.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.869 1.223 . . . . 0.0 113.595 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.28 105.44 4.11 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 126.649 1.979 . . . . 0.0 108.886 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.63 177.51 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.825 1.683 . . . . 0.0 108.008 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -121.77 150.86 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.2 -12.66 42.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.257 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.9 tt -51.85 -34.4 40.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.039 2.536 . . . . 0.0 110.788 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.27 -155.89 15.93 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -143.53 128.34 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.19 151.06 25.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -135.36 152.56 51.55 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.538 0.608 . . . . 0.0 112.428 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -142.24 127.03 18.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.96 115.9 31.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mm -127.67 105.05 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -51.18 117.21 2.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -46.27 -63.66 1.24 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.708 2.003 . . . . 0.0 113.519 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 -32.43 5.42 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.231 1.832 . . . . 0.0 115.822 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 m -77.59 -19.69 55.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.16 170.24 16.22 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.409 1.004 . . . . 0.0 109.889 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -149.78 108.33 3.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.649 1.179 . . . . 0.0 108.072 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.507 HG22 HD12 ' A' ' 276' ' ' ILE . 4.2 mp -65.03 108.29 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -31.46 19.9 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.23 25.36 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.176 1.353 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.05 149.81 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.943 1.297 . . . . 0.0 108.239 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -132.37 177.2 7.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 130.042 3.337 . . . . 0.0 106.421 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 151.68 -176.27 30.13 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 120.683 -1.261 . . . . 0.0 110.94 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 p -147.21 155.31 41.98 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.556 1.142 . . . . 0.0 108.231 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.56 165.12 26.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.434 1.494 . . . . 0.0 108.344 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.74 168.04 25.58 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.556 0.693 . . . . 0.0 111.177 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -69.06 149.1 49.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.963 2.105 . . . . 0.0 108.826 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.0 155.36 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.749 1.619 . . . . 0.0 109.394 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.08 88.48 2.74 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 167.48 -25.7 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 15.7 m -132.52 170.67 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.102 0.953 . . . . 0.0 110.419 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -108.82 86.8 2.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.61 -146.19 11.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.661 1.6 . . . . 0.0 109.844 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.97 156.05 47.53 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.4 1.48 . . . . 0.0 108.492 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.9 tt -113.23 149.18 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.29 1.436 . . . . 0.0 109.011 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.0 mm -77.37 137.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -129.63 -35.13 1.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.013 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.5 ttt -126.55 146.65 50.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.044 0.838 . . . . 0.0 110.836 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -140.0 147.83 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.428 1.491 . . . . 0.0 109.301 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -149.21 154.92 39.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -141.72 122.4 14.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -65.15 152.12 44.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.0 p -143.15 154.46 43.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.4 158.99 15.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 67.84 -34.37 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.507 1.923 . . . . 0.0 113.794 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -141.33 174.17 10.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.697 1.999 . . . . 0.0 109.448 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.5 p -114.44 162.71 16.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.085 1.354 . . . . 0.0 110.009 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 3.6 p -98.99 177.56 5.21 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.231 1.413 . . . . 0.0 110.646 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.22 157.28 41.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.372 1.469 . . . . 0.0 109.206 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.19 99.14 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.853 2.369 . . . . 0.0 108.402 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -82.84 92.51 7.28 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 126.24 -164.77 19.69 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.942 1.258 . . . . 0.0 111.051 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.7 tp -118.88 130.09 55.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.186 1.394 . . . . 0.0 109.542 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -70.99 120.71 16.96 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.2 -178.8 7.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.239 1.416 . . . . 0.0 109.392 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 49.34 -103.59 0.08 OUTLIER Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.253 1.882 . . . . 0.0 113.417 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 16.8 m -147.98 145.42 28.54 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.701 1.201 . . . . 0.0 108.692 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.66 26.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -141.34 151.03 43.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.537 1.535 . . . . 0.0 109.557 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.91 155.44 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.335 1.054 . . . . 0.0 110.962 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 42.9 mt -143.4 119.28 10.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.65 1.18 . . . . 0.0 109.354 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -139.31 170.99 14.93 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.237 0.615 . . . . 0.0 111.795 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.93 170.79 15.47 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.927 2.491 . . . . 0.0 107.638 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.7 125.2 47.05 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.71 77.86 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.527 1.061 . . . . 0.0 115.097 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -135.18 175.63 9.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.049 1.424 . . . . 0.0 111.924 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.01 161.94 36.66 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.486 1.514 . . . . 0.0 109.742 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 226' ' ' ILE . 91.4 mt -74.24 144.02 12.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.9 2.33 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.182 0.993 . . . . 0.0 112.565 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.0 179.03 26.39 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 120.898 -1.126 . . . . 0.0 112.401 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.22 160.52 18.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.661 2.385 . . . . 0.0 108.344 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' HIS . . . . . 0.502 ' CD2' ' HD1' ' A' ' 293' ' ' HIS . 12.1 p80 -151.67 106.54 3.26 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -160.48 -147.41 4.92 Favored Glycine 0 C--O 1.237 0.29 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.12 126.04 8.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.68 134.58 13.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.164 0.986 . . . . 0.0 109.2 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.7 t -133.9 -68.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -95.51 -32.86 12.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.172 0.989 . . . . 0.0 111.75 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.4 mp -135.9 175.14 9.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 108.895 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.55 99.92 6.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.888 1.275 . . . . 0.0 109.431 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.35 -65.65 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.37 115.85 7.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.688 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.11 160.8 39.12 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.696 0.798 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 161.43 -167.32 36.24 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 12.5 m -152.3 153.5 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.499 1.119 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' HIS . . . . . 0.502 ' HD1' ' CD2' ' A' ' 280' ' ' HIS . 0.1 OUTLIER -94.19 167.76 11.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.07 143.99 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 66.1 mtp -139.46 140.88 26.85 Favored Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.61 139.51 76.08 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 110.067 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.912 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HD3' ' CD2' ' A' ' 142' ' ' TYR . 29.7 ttpt -41.84 106.6 0.06 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.067 1.747 . . . . 0.0 111.363 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.22 146.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.67 144.32 14.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.919 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.22 151.28 31.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.89 13.77 17.05 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.739 -0.601 . . . . 0.0 112.175 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.27 102.9 0.21 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 126.508 2.004 . . . . 0.0 112.557 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' SER . . . -126.93 -19.33 2.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 116.907 1.523 . . . . 0.0 116.907 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 137' ' ' TYR . . . -78.55 -13.93 59.59 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.676 1.59 . . . . 0.0 109.966 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.74 43.19 19.06 Favored Glycine 0 N--CA 1.416 -2.658 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.251 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 -107.5 0.16 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.6 159.23 43.44 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.628 1.171 . . . . 0.0 110.628 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -93.52 129.95 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.574 -1.328 . . . . 0.0 108.481 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -93.25 -13.43 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.479 0.712 . . . . 0.0 109.857 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.01 103.48 0.74 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.044 0.937 . . . . 0.0 110.179 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.71 -54.53 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.431 178.801 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.26 150.57 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.58 1.152 . . . . 0.0 108.8 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -126.23 -45.38 1.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -143.16 161.88 37.05 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.207 1.403 . . . . 0.0 107.314 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.43 151.17 22.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -131.65 139.83 49.2 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.7 t -150.58 144.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.83 146.47 9.41 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -58.46 146.52 34.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 110.303 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.37 -116.33 2.71 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.99 1.281 . . . . 0.0 110.712 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -87.21 -49.15 7.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.766 0.783 . . . . 0.0 111.941 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -126.42 -26.02 3.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.376 1.071 . . . . 0.0 110.259 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.27 176.35 27.13 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.497 1.523 . . . . 0.0 111.183 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.2 m -58.44 96.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 126.437 1.895 . . . . 0.0 111.612 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 t -87.42 -50.7 6.38 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.295 1.038 . . . . 0.0 111.371 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 p -66.81 119.96 12.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.706 1.139 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.64 158.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 108.064 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -166.5 141.86 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.937 1.295 . . . . 0.0 108.467 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.1 95.92 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.726 1.211 . . . . 0.0 108.37 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.63 130.27 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -100.81 131.98 46.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 109.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -114.87 115.89 27.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.33 34.76 24.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.967 0.907 . . . . 0.0 108.743 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t 72.54 -1.23 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.198 2.199 . . . . 0.0 112.481 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.08 144.56 28.16 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.838 1.199 . . . . 0.0 109.655 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.97 126.51 34.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.76 109.14 14.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -111.62 162.2 15.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.566 1.547 . . . . 0.0 111.954 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.6 57.43 0.09 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.83 -1.6 0.19 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.881 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.515 ' OE2' ' HE2' ' A' ' 57' ' ' LYS . 1.7 tt0 -73.51 112.16 9.33 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.512 1.656 . . . . 0.0 106.816 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -137.18 167.18 22.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.527 1.531 . . . . 0.0 107.286 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.5 -179.01 20.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -82.86 98.08 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.046 -1.267 . . . . 0.0 109.165 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HE2' ' OE2' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -83.53 163.1 20.65 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -132.08 172.76 11.98 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.595 1.158 . . . . 0.0 109.844 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 tp -89.79 -47.28 8.01 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.287 1.035 . . . . 0.0 111.689 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.01 75.21 1.02 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.93 -34.76 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 128.5 33.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.811 1.245 . . . . 0.0 111.125 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -143.69 163.83 32.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.337 1.855 . . . . 0.0 107.563 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.2 m -126.85 146.27 50.34 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.6 1.16 . . . . 0.0 108.654 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -129.04 140.94 51.4 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 126.057 1.743 . . . . 0.0 106.905 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.1 146.94 50.93 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.405 1.082 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.36 157.82 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.97 168.04 13.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.743 1.61 . . . . 0.0 112.087 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.51 -27.15 25.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.478 1.511 . . . . 0.0 110.483 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -121.02 5.96 10.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.924 0.784 . . . . 0.0 112.84 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -116.64 156.17 27.51 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.77 -176.78 4.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.38 136.17 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.9 m -113.89 -36.0 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.734 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.32 160.39 43.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.257 0.935 . . . . 0.0 110.206 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -146.05 110.03 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.73 134.46 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -132.43 122.95 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.464 1.106 . . . . 0.0 108.32 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.41 ' OG1' ' HE3' ' A' ' 114' ' ' LYS . 30.4 m -118.31 145.26 45.22 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.965 1.706 . . . . 0.0 106.477 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -149.93 168.11 24.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.536 1.134 . . . . 0.0 111.212 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -161.18 158.82 28.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.333 1.053 . . . . 0.0 108.946 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.86 135.1 24.12 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.489 1.116 . . . . 0.0 108.646 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -72.33 154.19 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.785 0.721 . . . . 0.0 109.975 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -61.67 -14.62 32.82 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.49 -7.89 41.71 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.403 -1.221 . . . . 0.0 113.762 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -135.27 105.53 6.33 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.207 1.503 . . . . 0.0 107.584 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -58.65 -24.61 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.913 1.685 . . . . 0.0 115.18 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . 46.1 p -72.8 122.31 21.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.932 1.293 . . . . 0.0 109.178 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.93 164.17 16.7 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 126.331 1.853 . . . . 0.0 109.173 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.75 149.9 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.07 -1.019 . . . . 0.0 108.38 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.0 128.1 32.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 p -95.81 -39.19 9.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.994 -1.479 . . . . 0.0 108.268 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 m -160.1 152.34 20.65 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.9 1.682 . . . . 0.0 111.108 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.4 mm -132.95 139.03 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.0 m -130.17 112.58 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -82.03 155.43 25.15 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.959 0.904 . . . . 0.0 109.783 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -143.75 113.73 7.24 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 106.927 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 p -90.43 170.6 10.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.638 0.654 . . . . 0.0 111.182 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -60.81 -36.25 78.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -6.67 56.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.24 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 15.8 39.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.227 -1.319 . . . . 0.0 111.28 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -71.72 101.76 2.64 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -93.44 140.11 29.95 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 p -92.7 160.95 33.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.02 160.55 49.24 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 N-CA-C 105.41 -2.573 . . . . 0.0 105.41 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.64 89.0 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.753 2.302 . . . . 0.0 107.529 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -58.83 104.23 0.22 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.633 0.773 . . . . 0.0 109.125 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.78 -145.04 16.56 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.4 111.9 12.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.395 1.478 . . . . 0.0 108.154 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -46.81 139.46 5.39 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.227 1.811 . . . . 0.0 113.948 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 178.45 7.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.254 1.422 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.33 -53.17 5.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.035 1.734 . . . . 0.0 114.066 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -65.15 108.08 1.75 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.689 1.131 . . . . 0.0 108.863 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.41 ' HE3' ' OG1' ' A' ' 79' ' ' THR . 6.1 ptmt -152.91 168.76 24.72 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 123.099 0.56 . . . . 0.0 111.318 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.31 166.99 31.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 106.994 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.46 122.06 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 117' ' ' LEU . 1.5 pt? -100.42 133.62 44.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.0 167.89 28.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.869 0.868 . . . . 0.0 111.282 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.65 168.07 10.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.694 1.197 . . . . 0.0 107.938 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.38 -27.26 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.365 2.666 . . . . 0.0 109.648 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.79 -5.47 46.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.581 2.752 . . . . 0.0 111.838 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.67 9.98 48.3 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.605 1.098 . . . . 0.0 113.153 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.01 85.98 0.89 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 124.951 1.263 . . . . 0.0 110.569 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -59.65 142.46 52.9 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.45 128.19 35.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.07 -50.54 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.54 -151.22 6.71 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.087 1.327 . . . . 0.0 109.804 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.57 169.22 18.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.165 1.483 . . . . 0.0 113.16 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -138.6 166.41 24.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.602 1.961 . . . . 0.0 106.941 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.14 125.58 2.97 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.7 -178.44 4.39 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.351 -1.088 . . . . 0.0 108.926 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -125.9 158.79 34.26 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.391 2.276 . . . . 0.0 105.993 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -116.56 -83.83 1.04 Allowed Glycine 0 CA--C 1.51 -0.271 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -107.77 -14.21 14.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.573 0.749 . . . . 0.0 110.506 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -155.43 174.2 15.58 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.883 2.473 . . . . 0.0 107.604 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 tp -75.77 131.88 40.09 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.23 0.612 . . . . 0.0 109.48 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-85 -138.45 -55.67 0.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.478 1.911 . . . . 0.0 109.47 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -107.3 108.13 19.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.4 tp -130.78 142.05 50.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.11 -178.18 35.78 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 127.11 2.29 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.04 137.48 15.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.767 1.283 . . . . 0.0 110.38 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CD2' ' HD3' ' A' ' 3' ' ' LYS . 41.7 m-85 -81.42 141.43 33.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.878 1.271 . . . . 0.0 107.835 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -137.04 127.3 26.36 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 0 CA-C-N 118.636 0.653 . . . . 0.0 110.565 179.663 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.382 0.61 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -73.96 107.79 6.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -83.56 119.61 24.93 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.249 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.4 mt -78.41 -94.24 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -155.51 166.1 34.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.921 1.288 . . . . 0.0 109.826 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -147.27 -178.18 6.08 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 130.148 3.379 . . . . 0.0 107.706 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.46 141.86 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.31 1.414 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.12 -105.64 3.22 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.75 64.5 4.15 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.415 1.007 . . . . 0.0 111.172 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.444 ' H ' ' HB3' ' A' ' 288' ' ' HIS . 0.7 OUTLIER -76.01 57.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.224 2.21 . . . . 0.0 114.368 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 53.19 20.53 1.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.549 1.94 . . . . 0.0 114.912 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 168.94 33.0 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.8 m -65.43 116.77 7.07 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.844 1.657 . . . . 0.0 109.264 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.75 154.63 40.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.676 0.79 . . . . 0.0 110.44 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -138.39 120.67 15.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.29 104.95 17.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -107.66 93.06 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.558 1.143 . . . . 0.0 108.198 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.35 162.7 32.44 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.61 155.03 34.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 117.611 0.705 . . . . 0.0 110.393 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -112.99 167.61 10.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.431 1.11 . . . . 0.0 112.057 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 -15.76 57.61 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.189 2.196 . . . . 0.0 110.282 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 165.94 149.51 5.94 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.582 2.039 . . . . 0.0 108.063 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.99 129.56 44.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.44 -53.78 6.56 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -158.81 143.55 15.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.67 0.668 . . . . 0.0 110.086 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.96 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.95 158.01 44.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.983 1.313 . . . . 0.0 107.621 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.0 t -143.57 142.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.13 82.13 0.35 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 124.788 1.185 . . . . 0.0 112.683 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -70.89 177.26 3.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.908 1.283 . . . . 0.0 110.339 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.85 -174.24 20.98 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -63.7 -25.09 68.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -122.71 -21.07 5.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.266 1.427 . . . . 0.0 113.833 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 172.3 -178.78 44.28 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 119.53 1.059 . . . . 0.0 111.723 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.5 mm -59.13 115.84 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.476 1.11 . . . . 0.0 109.676 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.5 m -93.83 -35.67 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.415 0.686 . . . . 0.0 111.923 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.65 166.81 23.81 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.6 150.92 30.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.788 1.635 . . . . 0.0 107.015 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.606 ' HE2' ' CE2' ' A' ' 214' ' ' PHE . 0.1 OUTLIER 179.82 150.59 0.36 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.435 3.494 . . . . 0.0 106.594 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -153.78 152.22 30.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.561 1.073 . . . . 0.0 108.131 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -94.42 132.41 39.09 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -138.24 169.03 18.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.253 1.021 . . . . 0.0 111.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -119.8 139.13 52.81 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.075 1.35 . . . . 0.0 109.533 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -140.2 76.16 1.54 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.69 -128.03 46.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.99 10.39 0.55 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.156 1.382 . . . . 0.0 114.066 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.37 140.69 52.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.447 1.476 . . . . 0.0 109.247 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.07 89.35 2.85 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.9 mm -70.09 109.29 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 108.82 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.0 t -125.44 94.89 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.193 1.797 . . . . 0.0 106.241 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 125.6 176.4 14.52 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.438 1.494 . . . . 0.0 113.64 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.91 75.27 1.0 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.275 1.893 . . . . 0.0 110.281 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.87 155.92 29.13 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.625 -0.926 . . . . 0.0 112.33 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.6 -80.12 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.64 162.0 50.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -53.56 116.49 9.93 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 113.567 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 144.06 71.67 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.731 1.621 . . . . 0.0 108.339 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.94 135.3 42.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.488 1.115 . . . . 0.0 110.667 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 -11.09 60.55 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.094 0.558 . . . . 0.0 111.525 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.67 -31.28 69.41 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.209 1.404 . . . . 0.0 109.783 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.39 -171.43 14.63 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.606 ' CE2' ' HE2' ' A' ' 191' ' ' LYS . 13.3 m-85 -136.05 158.81 43.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -111.4 148.06 33.86 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.37 144.35 49.54 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.526 0.516 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 256' ' ' SER . 31.5 t80 -142.88 142.96 31.87 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.68 0.792 . . . . 0.0 110.959 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -92.32 124.68 36.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.409 1.484 . . . . 0.0 108.871 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.67 112.07 29.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.175 0.99 . . . . 0.0 108.749 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.06 88.48 7.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -62.63 -29.55 4.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 115.778 -2.058 . . . . 0.0 113.644 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.12 -45.01 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 123.902 2.429 . . . . 0.0 110.88 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 m -67.03 -54.0 25.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.997 1.319 . . . . 0.0 111.865 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.71 -167.66 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.599 1.96 . . . . 0.0 110.631 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -164.11 142.14 7.18 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.508 1.123 . . . . 0.0 108.976 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.7 mm -93.48 104.18 15.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.3 p -72.92 -59.76 2.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.096 0.959 . . . . 0.0 110.33 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.41 171.72 13.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.647 1.979 . . . . 0.0 111.529 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.78 148.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.39 1.876 . . . . 0.0 106.865 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -133.59 160.85 36.27 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.497 1.119 . . . . 0.0 109.997 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.78 167.37 37.69 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.671 1.129 . . . . 0.0 110.998 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.5 p -133.39 127.19 32.91 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -119.76 146.19 45.88 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -142.61 166.91 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -76.94 136.3 38.79 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.758 1.223 . . . . 0.0 112.824 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.66 156.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 127.426 2.29 . . . . 0.0 108.252 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -103.5 163.75 12.09 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.78 1.232 . . . . 0.0 111.16 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.11 -15.94 56.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.246 1.403 . . . . 0.0 110.347 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.7 t -141.45 -174.38 4.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 128.248 2.619 . . . . 0.0 106.618 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.92 101.82 5.79 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.557 1.943 . . . . 0.0 106.856 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 174.32 -173.37 45.98 Favored Glycine 0 N--CA 1.447 -0.622 0 O-C-N 123.645 0.591 . . . . 0.0 112.451 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.82 141.37 52.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.083 1.353 . . . . 0.0 109.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 10.3 tt -123.72 134.17 67.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.6 1.16 . . . . 0.0 108.773 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.06 98.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -76.0 -26.5 56.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.023 0.529 . . . . 0.0 111.766 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -140.99 152.37 44.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.083 0.856 . . . . 0.0 110.815 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.4 154.65 51.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.468 1.907 . . . . 0.0 109.965 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -145.05 152.52 40.24 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.992 2.117 . . . . 0.0 105.688 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -118.07 142.53 47.31 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -95.61 115.42 27.4 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.2 p -130.49 166.49 20.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.391 1.476 . . . . 0.0 108.776 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -123.54 160.09 27.75 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.993 1.717 . . . . 0.0 106.552 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 69.35 -27.6 0.16 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.114 2.566 . . . . 0.0 112.191 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -150.88 174.83 12.65 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.23 2.212 . . . . 0.0 110.229 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.77 161.02 32.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.579 1.952 . . . . 0.0 106.914 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' SER . . . . . 0.412 ' HB3' ' CE2' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -115.29 -10.99 12.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 73.15 162.66 0.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 126.908 2.083 . . . . 0.0 109.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 95.5 Cg_endo -76.28 149.0 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.438 2.092 . . . . 0.0 110.551 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.17 95.72 4.86 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 125.43 -176.99 17.15 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.275 1.416 . . . . 0.0 110.789 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.6 tp -88.18 126.83 35.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.353 1.061 . . . . 0.0 110.165 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -73.12 107.17 5.31 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -160.22 154.79 23.91 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 107.987 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 88.1 -174.82 44.27 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.9 m -77.33 138.47 39.36 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -92.14 142.81 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.317 0.508 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -138.74 147.88 43.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.767 0.827 . . . . 0.0 111.344 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.31 144.29 34.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.23 1.412 . . . . 0.0 109.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 mt -134.22 137.3 44.27 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -150.04 178.27 9.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.174 1.789 . . . . 0.0 108.905 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 164.83 29.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.22 1.01 . . . . 0.0 108.566 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -69.84 5.37 1.55 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.302 1.841 . . . . 0.0 114.354 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 166.45 -34.69 0.23 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.389 -1.444 . . . . 0.0 113.324 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -57.01 149.98 17.88 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.768 0.784 . . . . 0.0 109.331 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 157.47 16.85 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.623 -0.673 . . . . 0.0 110.041 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.6 mt -95.91 104.2 15.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.45 38.81 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.989 1.316 . . . . 0.0 108.548 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.44 168.03 36.57 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 121.166 -0.959 . . . . 0.0 114.477 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.11 171.23 14.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.335 3.054 . . . . 0.0 109.946 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -159.48 146.64 16.87 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.812 1.245 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -179.55 -163.64 30.68 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 121.217 -0.927 . . . . 0.0 113.423 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -146.68 138.97 24.88 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.822 1.649 . . . . 0.0 107.765 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -131.86 154.39 49.23 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.184 1.793 . . . . 0.0 110.055 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.3 m -166.39 -46.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.951 1.3 . . . . 0.0 108.691 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.13 -17.63 1.36 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -171.4 2.01 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.496 1.919 . . . . 0.0 106.617 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 13.3 tp -83.21 85.58 7.18 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 162' ' ' ASP . 87.6 m-70 -60.44 -34.79 74.49 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.264 0.483 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -161.47 163.33 30.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.642 0.734 . . . . 0.0 110.245 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -159.52 135.45 8.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -143.13 -157.71 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 128.538 2.97 . . . . 0.0 108.715 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.73 171.59 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.281 1.039 . . . . 0.0 112.139 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.76 150.16 51.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.874 2.869 . . . . 0.0 105.354 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.25 137.79 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.324 0.65 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 16.2 mmt -125.38 148.24 60.47 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.431 1.492 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 152.62 37.22 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.631 1.554 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.036 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.455 0.645 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -81.15 130.54 35.07 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 102.633 -3.099 . . . . 0.0 102.633 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.51 103.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.687 0.795 . . . . 0.0 110.02 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -55.85 142.7 34.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.49 1.116 . . . . 0.0 110.987 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.63 179.97 1.95 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.857 1.263 . . . . 0.0 110.161 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 143.81 14.48 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.77 -134.13 5.48 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.98 -148.97 18.66 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 118.0 0.9 . . . . 0.0 111.816 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.11 8.32 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.389 1.076 . . . . 0.0 112.168 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.93 -11.51 18.1 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.089 1.595 . . . . 0.0 117.089 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.45 169.21 12.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.648 2.224 . . . . 0.0 113.766 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.55 151.7 32.32 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 97.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.923 0.783 . . . . 0.0 112.736 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -103.56 55.05 0.74 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.11 18.61 19.82 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.198 1.399 . . . . 0.0 111.981 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -151.64 119.31 6.1 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.665 0.786 . . . . 0.0 110.602 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 C-N-CA 125.865 1.697 . . . . 0.0 115.352 179.174 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 m -63.2 158.64 3.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 117.853 0.827 . . . . 0.0 109.207 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 10.5 mmm180 -136.09 -35.7 0.76 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -147.14 157.51 43.63 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 107.691 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.0 105.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -88.02 140.61 29.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.82 143.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.9 152.54 21.5 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.813 0.733 . . . . 0.0 111.335 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -70.2 120.04 15.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.216 1.406 . . . . 0.0 112.611 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.68 -122.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 130.575 3.94 . . . . 0.0 107.876 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -95.23 -48.35 5.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 118.163 0.982 . . . . 0.0 112.256 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 -26.88 12.14 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 129.109 2.963 . . . . 0.0 114.676 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.42 -158.05 16.7 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 118.897 0.771 . . . . 0.0 111.381 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 m -72.7 96.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.61 1.205 . . . . 0.0 108.846 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -106.63 -45.09 4.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -71.02 148.31 47.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.291 1.405 . . . . 0.0 112.117 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.9 159.68 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.431 1.892 . . . . 0.0 108.091 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.05 152.35 46.15 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.882 2.473 . . . . 0.0 107.458 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.52 132.06 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.658 0.783 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.6 142.96 42.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -132.76 141.38 48.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.347 0.659 . . . . 0.0 109.362 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.476 ' HB2' ' CG ' ' A' ' 24' ' ' ARG . . . -114.25 120.41 40.35 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.086 1.354 . . . . 0.0 108.751 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -113.46 161.99 16.66 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.9 -41.92 92.71 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.2 t -68.81 -69.39 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.491 -1.243 . . . . 0.0 110.574 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -145.31 165.84 27.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 120.239 1.381 . . . . 0.0 113.677 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.49 149.55 33.13 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.777 2.031 . . . . 0.0 105.804 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -147.71 145.73 18.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 122.754 1.264 . . . . 0.0 109.277 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -105.97 162.13 13.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.375 1.47 . . . . 0.0 108.688 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.63 -15.08 2.02 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 0.0 112.09 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.78 167.03 36.22 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 118.7 1.25 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -103.62 106.39 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.32 82.23 2.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.85 -174.61 31.95 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 128.7 3.048 . . . . 0.0 105.676 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -126.78 141.05 51.94 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.286 1.043 . . . . 0.0 111.908 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -130.56 148.84 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.397 2.279 . . . . 0.0 105.149 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.5 m -133.85 -48.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.2 tp -70.05 -9.99 57.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.149 0.886 . . . . 0.0 110.494 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt 66.33 11.48 7.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.209 2.203 . . . . 0.0 112.175 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.34 86.33 1.36 Allowed Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.975 -2.45 . . . . 0.0 106.975 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -131.46 144.68 51.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.505 1.922 . . . . 0.0 108.555 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -142.78 164.69 29.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.041 1.736 . . . . 0.0 110.465 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -124.88 121.22 33.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.356 1.062 . . . . 0.0 113.55 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -87.35 141.83 28.34 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.95 141.21 50.89 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.518 1.127 . . . . 0.0 109.69 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.64 117.44 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.507 1.123 . . . . 0.0 111.538 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -62.1 156.56 21.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.781 1.633 . . . . 0.0 108.591 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.33 68.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.87 25.33 10.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.37 143.06 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.19 1.396 . . . . 0.0 111.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.94 139.74 46.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.356 2.663 . . . . 0.0 110.593 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.19 134.19 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.711 1.604 . . . . 0.0 112.332 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.0 -34.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.948 -1.095 . . . . 0.0 112.1 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.63 144.35 28.34 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.432 1.015 . . . . 0.0 108.64 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.57 92.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -79.34 120.91 24.45 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.506 HG13 ' CE1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -151.77 132.61 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.531 HG21 ' HA ' ' A' ' 110' ' ' GLU . 4.1 t -110.55 153.72 24.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.979 1.711 . . . . 0.0 109.227 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -154.12 147.33 24.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.841 1.656 . . . . 0.0 109.392 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.2 169.33 22.46 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.821 0.737 . . . . 0.0 111.155 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.07 136.16 34.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.967 1.307 . . . . 0.0 109.756 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.22 130.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -61.78 114.84 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.3 41.99 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.113 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -130.49 161.47 31.38 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.192 1.496 . . . . 0.0 109.754 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -96.35 -26.48 15.35 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.768 1.227 . . . . 0.0 110.062 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 p -72.59 166.86 21.9 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.48 1.133 . . . . 0.0 109.022 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.52 135.21 42.2 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.46 166.89 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.354 1.062 . . . . 0.0 112.647 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 138' ' ' ALA . 2.9 mp -74.63 144.03 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.077 1.751 . . . . 0.0 107.445 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -108.61 -29.05 8.94 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.085 0.954 . . . . 0.0 110.849 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -166.36 164.09 17.46 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.948 1.699 . . . . 0.0 108.933 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.1 tt -157.12 154.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.999 1.319 . . . . 0.0 110.73 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 m -150.84 157.28 42.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.478 1.511 . . . . 0.0 107.235 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.86 135.33 48.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -121.33 114.05 20.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 p -81.07 161.19 24.27 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -31.12 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -58.8 -43.07 90.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 111.345 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.97 -7.4 3.8 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.814 0.721 . . . . 0.0 114.383 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.19 132.4 36.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -133.7 156.37 48.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 p -121.24 162.34 36.21 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 111.386 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.28 167.06 23.65 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.885 2.39 . . . . 0.0 110.483 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.12 112.65 3.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.663 2.909 . . . . 0.0 106.618 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -79.19 81.52 5.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.69 -138.13 9.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.372 0.987 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -129.9 121.36 26.5 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.514 1.526 . . . . 0.0 108.334 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HA ' HG21 ' A' ' 79' ' ' THR . 10.1 mm-40 -60.53 156.11 17.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.05 0.54 . . . . 0.0 110.485 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -152.7 -174.5 4.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.692 1.234 . . . . 0.0 112.683 -178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.418 ' H ' HG22 ' A' ' 111' ' ' THR . 14.1 tt0 -67.47 -64.72 0.8 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 127.219 2.208 . . . . 0.0 112.257 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -70.98 101.83 2.27 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.432 1.493 . . . . 0.0 108.633 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -147.8 153.48 39.24 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.657 -0.652 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CE1' HG13 ' A' ' 78' ' ' VAL . 28.2 p90 -125.52 158.94 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.686 1.594 . . . . 0.0 109.857 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.9 t -140.46 104.67 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 139.45 53.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.69 150.69 1.76 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.944 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 143' ' ' PHE . 25.3 t0 -120.97 176.2 5.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.559 1.144 . . . . 0.0 110.49 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -65.27 175.8 1.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.153 2.181 . . . . 0.0 108.092 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -68.38 2.43 2.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.315 1.446 . . . . 0.0 111.743 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.45 3.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.08 2.276 . . . . 0.0 111.159 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.52 165.49 31.46 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 118.248 1.024 . . . . 0.0 111.059 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -161.9 164.69 28.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.62 1.968 . . . . 0.0 107.569 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.3 158.77 11.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.965 0.888 . . . . 0.0 110.991 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.87 -25.29 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.509 2.724 . . . . 0.0 110.722 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.38 -176.27 40.31 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.08 170.59 9.39 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.62 0.724 . . . . 0.0 109.236 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -156.41 170.13 23.01 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 126.825 2.05 . . . . 0.0 107.181 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.67 -146.42 14.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -159.47 135.68 8.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.734 2.414 . . . . 0.0 106.009 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.52 164.86 38.05 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.097 2.559 . . . . 0.0 105.298 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.36 -111.91 0.26 Allowed Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 106.616 -2.594 . . . . 0.0 106.616 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -65.06 -17.83 64.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.46 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.9 175.47 12.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.749 2.02 . . . . 0.0 108.524 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HG ' HD13 ' A' ' 91' ' ' ILE . 26.1 tp -84.8 121.48 27.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.281 1.832 . . . . 0.0 107.341 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -117.16 -31.25 5.4 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 91' ' ' ILE . . . -168.74 161.72 11.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.845 1.657 . . . . 0.0 110.353 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 tt -157.68 149.14 21.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.85 168.17 37.57 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.85 134.53 35.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.43 169.23 10.21 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.272 1.429 . . . . 0.0 109.563 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 119' ' ' ASP . 66.1 m-85 -131.17 112.11 12.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.183 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 -178.729 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.688 0.28 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.12 125.28 29.62 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -111.28 146.79 36.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.778 0.717 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.78 170.84 13.73 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.5 t -87.78 118.86 27.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.271 1.028 . . . . 0.0 110.757 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.62 170.0 12.97 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.199 0.999 . . . . 0.0 111.422 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.9 mt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 129.898 3.279 . . . . 0.0 105.256 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.56 -96.05 0.16 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.593 1.088 . . . . 0.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.77 153.61 24.37 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.08 8.79 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.965 1.306 . . . . 0.0 114.192 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -122.29 106.33 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 120.965 -1.084 . . . . 0.0 110.938 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 172.43 158.11 15.86 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.1 m -66.51 119.1 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.146 0.978 . . . . 0.0 108.43 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.57 130.94 41.11 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -123.17 125.91 46.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.61 153.83 17.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.127 0.971 . . . . 0.0 110.745 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.01 135.14 19.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.48 169.74 22.71 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.48 146.62 50.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -114.75 151.37 33.86 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.97 -15.08 54.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.12 2.568 . . . . 0.0 112.179 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 177.13 177.5 46.1 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 123.793 0.711 . . . . 0.0 111.91 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.88 156.46 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.543 1.937 . . . . 0.0 107.046 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -138.38 -54.1 0.62 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.862 0.865 . . . . 0.0 109.118 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' A' ' 179' ' ' TYR . 2.3 tppt? -151.23 142.46 23.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.12 0.873 . . . . 0.0 111.57 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.71 132.75 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 177' ' ' LYS . 13.3 m-85 -136.33 108.49 7.24 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.34 131.79 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.44 67.27 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.164 1.364 . . . . 0.0 111.562 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 182' ' ' GLN . 2.8 pm0 -70.01 160.94 31.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.182 1.393 . . . . 0.0 109.376 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.01 177.85 35.41 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -51.6 -45.63 63.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.788 0.835 . . . . 0.0 112.721 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.17 -3.09 58.89 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.323 1.049 . . . . 0.0 113.511 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 123.5 -176.31 16.72 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.982 0.81 . . . . 0.0 113.662 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.0 mm -63.26 112.38 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 m -109.29 -30.91 7.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.256 0.622 . . . . 0.0 110.242 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.701 1.201 . . . . 0.0 108.891 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.88 137.0 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 107.283 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.17 155.68 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.27 131.17 27.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.1 140.67 29.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -153.19 169.55 22.72 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.964 1.306 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -127.76 127.08 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -139.95 138.53 35.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.19 31.37 49.34 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.65 -14.18 0.51 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.417 2.687 . . . . 0.0 112.794 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.44 136.19 49.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.829 1.252 . . . . 0.0 110.424 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -89.5 80.07 6.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 109.697 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.65 144.89 14.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.405 1.882 . . . . 0.0 109.694 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.06 129.04 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.71 143.3 18.71 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.48 1.038 . . . . 0.0 112.462 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.63 160.35 52.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -92.54 83.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -62.08 -25.57 67.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.211 1.805 . . . . 0.0 112.003 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.41 176.42 25.34 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.088 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.62 138.33 80.46 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.5 179.59 2.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.408 2.738 . . . . 0.0 110.408 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 70.1 p -135.61 172.69 12.65 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 109.96 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.69 -26.01 28.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.755 0.822 . . . . 0.0 110.576 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 212' ' ' LEU . 2.3 tt -63.65 -21.67 66.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.298 1.839 . . . . 0.0 112.461 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.21 171.33 46.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.59 151.3 21.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.23 0.612 . . . . 0.0 112.309 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -111.93 133.75 53.93 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.41 146.78 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -142.47 143.53 32.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.666 1.187 . . . . 0.0 109.222 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -112.33 130.12 56.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.26 107.82 17.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 125.726 1.61 . . . . 0.0 107.452 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 93.95 2.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -56.5 -34.91 29.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.94 -26.88 10.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 123.964 2.451 . . . . 0.0 113.264 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.4 m -106.91 -0.78 22.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.665 1.575 . . . . 0.0 114.798 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.8 156.8 42.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 120.337 1.426 . . . . 0.0 108.425 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.61 161.55 34.34 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.861 -1.149 . . . . 0.0 112.073 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.2 mm -92.7 97.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.2 m -64.4 -40.27 95.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.86 15.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.618 1.167 . . . . 0.0 109.368 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.16 144.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.416 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 0.8 OUTLIER -132.02 173.13 11.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.295 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 155.03 -170.82 33.26 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.8 p -144.8 154.94 43.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -131.55 145.91 51.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -121.88 145.5 48.03 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.878 0.846 . . . . 0.0 111.368 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -70.35 148.26 48.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.876 1.27 . . . . 0.0 109.486 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.5 pt -114.53 155.75 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 127.269 2.228 . . . . 0.0 106.724 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -103.59 150.33 24.06 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.86 0.362 . . . . 0.0 111.107 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.62 -3.34 87.29 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.657 1.599 . . . . 0.0 111.47 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.8 p -142.23 170.73 15.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.606 2.763 . . . . 0.0 107.742 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -108.04 8.5 28.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.672 1.189 . . . . 0.0 110.715 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -80.97 -172.04 45.57 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 122.746 1.192 . . . . 0.0 113.545 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.6 mt -137.78 157.45 46.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.895 2.478 . . . . 0.0 108.6 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.53 135.41 63.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.9 mm -94.41 77.11 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -83.1 -12.59 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.075 -0.391 . . . . 0.0 112.037 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -137.47 134.64 36.02 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 121.796 -0.565 . . . . 0.0 112.451 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.78 152.35 46.51 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.516 1.126 . . . . 0.0 109.51 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -141.32 161.61 37.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.528 1.931 . . . . 0.0 108.352 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -131.03 121.45 25.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.996 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.416 ' HE3' ' HG3' ' A' ' 230' ' ' GLU . 69.8 mttt -80.08 115.28 19.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 15.4 p -125.17 165.03 18.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.066 1.746 . . . . 0.0 108.154 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.25 160.97 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? 63.31 -26.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.511 1.925 . . . . 0.0 115.636 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -132.25 124.4 28.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 108.216 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.0 m -78.19 113.14 15.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.695 1.598 . . . . 0.0 107.735 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.1 p -84.37 162.86 19.87 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.271 0.557 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.79 152.19 42.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.144 1.778 . . . . 0.0 108.334 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.07 130.97 13.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.251 1.968 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -102.38 92.26 4.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.68 169.3 14.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.48 1.514 . . . . 0.0 110.724 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.0 mt -95.26 146.62 24.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.93 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.39 124.34 25.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.83 106.34 4.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 89.75 -164.95 31.78 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 122.978 1.321 . . . . 0.0 115.23 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 43.2 m -64.26 132.81 51.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.466 . . . . 0.0 109.992 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -85.67 145.64 27.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -126.93 137.2 53.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.795 0.807 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -124.29 140.76 52.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 72.7 mt -144.86 114.92 7.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -143.6 172.43 12.81 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.541 1.136 . . . . 0.0 110.009 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -144.41 153.85 42.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -101.74 140.09 36.5 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.358 1.063 . . . . 0.0 109.004 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.55 21.37 79.56 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -143.47 166.65 24.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.601 1.56 . . . . 0.0 109.251 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -129.92 174.21 9.97 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.982 2.113 . . . . 0.0 106.754 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 26.8 mt -109.01 154.31 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.24 24.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.416 1.086 . . . . 0.0 113.322 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.54 -155.05 23.95 Favored Glycine 0 N--CA 1.465 0.632 0 O-C-N 120.429 -1.419 . . . . 0.0 111.693 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 174.1 10.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.297 1.839 . . . . 0.0 111.159 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -155.66 163.27 40.13 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.715 2.406 . . . . 0.0 107.974 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.64 -169.99 36.48 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 120.78 1.627 . . . . 0.0 114.78 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 130.33 18.54 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.975 1.31 . . . . 0.0 108.488 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.95 154.49 17.68 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.303 1.841 . . . . 0.0 108.355 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.0 t -125.65 -52.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.738 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.17 -31.05 5.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.245 1.418 . . . . 0.0 113.304 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 46.3 mt -138.87 159.16 42.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.88 92.92 1.29 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.782 -0.573 . . . . 0.0 111.491 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -76.56 -78.33 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -101.0 148.61 24.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.906 1.23 . . . . 0.0 113.025 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -141.18 128.03 20.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.236 1.414 . . . . 0.0 107.216 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -144.14 176.1 23.59 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.07 176.06 5.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.251 1.02 . . . . 0.0 110.6 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -122.03 150.49 42.03 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.345 1.858 . . . . 0.0 107.172 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.06 139.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 44.2 mtt -139.77 147.27 50.84 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.49 68.98 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.132 3.221 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 128.478 2.711 . . . . 0.0 113.601 -179.538 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.838 0.827 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -144.93 138.91 27.22 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.732 2.013 . . . . 0.0 106.196 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.25 146.28 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -106.89 168.12 9.41 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB1' ' HB1' ' A' ' 138' ' ' ALA . . . -68.27 -70.88 0.24 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.993 1.317 . . . . 0.0 111.629 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 51.87 66.05 2.82 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.275 1.417 . . . . 0.0 114.911 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 138' ' ' ALA . . . -141.39 21.75 2.57 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 118.056 0.928 . . . . 0.0 113.767 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.26 171.04 19.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 127.05 2.262 . . . . 0.0 109.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.44 -0.25 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.414 1.086 . . . . 0.0 113.245 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.58 178.54 38.22 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 -175.46 27.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.136 0.874 . . . . 0.0 113.057 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.67 144.42 43.95 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.584 1.153 . . . . 0.0 108.113 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 p -65.74 95.49 0.24 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.711 1.205 . . . . 0.0 112.265 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -97.2 -79.28 0.46 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 63.63 19.77 11.88 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.55 1.14 . . . . 0.0 110.911 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.08 141.44 58.77 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.745 1.618 . . . . 0.0 109.174 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 -179.046 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.98 144.7 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.385 -1.068 . . . . 0.0 111.986 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -46.8 5.07 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.203 1.801 . . . . 0.0 112.881 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -138.02 163.73 30.83 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.12 144.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -136.35 141.53 43.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.93 142.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.24 114.94 1.64 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -66.44 141.84 57.78 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.39 -171.76 14.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -72.31 -48.19 44.06 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.561 0.744 . . . . 0.0 111.679 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.47 -10.51 34.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.131 1.772 . . . . 0.0 114.001 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.6 32.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.25 139.3 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -133.94 10.57 3.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -161.21 147.0 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.281 0.946 . . . . 0.0 111.673 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 155.4 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.042 1.737 . . . . 0.0 108.813 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.19 135.43 11.16 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 161.02 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.564 1.945 . . . . 0.0 111.13 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.2 t -121.87 139.95 47.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -107.94 170.41 8.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.872 0.76 . . . . 0.0 109.652 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.66 51.91 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.834 0.854 . . . . 0.0 109.978 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -116.96 166.34 12.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.498 1.119 . . . . 0.0 108.522 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.13 -3.2 15.6 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.07 -1.019 . . . . 0.0 109.746 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -108.86 -83.86 0.55 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.311 3.044 . . . . 0.0 110.641 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -133.89 159.24 41.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.975 1.71 . . . . 0.0 110.372 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.05 145.12 34.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.47 1.508 . . . . 0.0 110.295 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -144.86 146.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.044 0.938 . . . . 0.0 110.352 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.78 151.65 33.42 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.634 1.974 . . . . 0.0 109.302 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.92 -67.73 0.92 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.712 1.625 . . . . 0.0 109.905 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.7 174.88 27.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.179 1.371 . . . . 0.0 112.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.87 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.083 0.942 . . . . 0.0 109.761 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -125.04 133.11 53.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.47 -153.08 21.17 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.301 -2.72 . . . . 0.0 106.301 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -128.2 114.62 17.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.103 0.951 . . . . 0.0 112.97 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.17 134.66 49.55 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -81.28 155.62 25.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.368 1.067 . . . . 0.0 108.954 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.16 -32.8 74.67 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.575 -0.703 . . . . 0.0 111.161 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.32 26.93 7.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 110.701 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.86 96.2 0.17 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -163.05 146.05 10.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 128.954 2.902 . . . . 0.0 104.823 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -142.29 164.84 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.403 1.481 . . . . 0.0 108.856 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -144.48 103.11 3.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -108.11 140.87 40.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.056 1.743 . . . . 0.0 106.993 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.69 143.5 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 111.007 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.9 t -95.93 111.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 156.01 38.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 109.406 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.75 -27.16 61.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.172 -0.955 . . . . 0.0 111.67 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.94 13.56 27.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.555 1.942 . . . . 0.0 113.511 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.25 136.58 35.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.972 0.806 . . . . 0.0 110.332 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.452 ' CG ' ' HE2' ' A' ' 124' ' ' LYS . 12.0 m-85 -128.66 162.24 27.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.689 0.796 . . . . 0.0 110.424 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mt -75.3 150.43 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -30.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.821 1.648 . . . . 0.0 109.146 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 157.44 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.164 0.893 . . . . 0.0 108.99 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 t -139.35 139.57 38.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -128.2 116.81 20.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.54 134.64 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.8 p -113.98 157.22 22.74 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -151.03 158.69 44.43 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.429 -0.794 . . . . 0.0 109.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -160.39 168.72 24.59 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.864 1.265 . . . . 0.0 108.67 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 94.36 3.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.3 138.22 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.837 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -61.25 114.3 3.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.05 -5.22 5.7 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.852 1.215 . . . . 0.0 111.935 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -134.5 158.14 44.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.161 1.384 . . . . 0.0 107.785 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.44 22.11 15.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.342 1.857 . . . . 0.0 108.759 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 p -137.95 129.24 27.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.937 -1.102 . . . . 0.0 112.578 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.17 148.76 50.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.324 2.25 . . . . 0.0 105.131 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.93 158.46 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.1 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.3 mm -83.22 103.24 10.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.587 0.755 . . . . 0.0 109.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -66.89 -41.04 87.87 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.466 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 p -156.68 165.77 35.3 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.541 1.519 . . . . 0.0 111.75 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 151.69 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.043 0.537 . . . . 0.0 111.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.7 m -149.44 154.17 38.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 0.0 108.687 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -125.04 154.59 41.08 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.738 2.015 . . . . 0.0 107.383 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -132.22 118.24 19.27 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.9 p -99.01 159.87 14.66 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.666 0.746 . . . . 0.0 112.896 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.87 -32.74 73.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.349 1.859 . . . . 0.0 113.357 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -67.8 -11.37 58.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.008 178.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.03 49.81 3.22 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -127.69 139.69 52.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.4 p -134.76 147.53 50.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.662 0.385 . . . . 0.0 110.522 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 161.02 32.21 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 123.419 0.687 . . . . 0.0 110.673 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.33 166.6 24.15 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 122.269 1.979 . . . . 0.0 108.516 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.75 106.18 1.79 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.42 2.08 . . . . 0.0 107.502 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -75.47 85.99 2.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.1 -137.18 8.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.801 1.191 . . . . 0.0 110.379 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 tp -112.55 125.43 54.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.461 1.505 . . . . 0.0 108.985 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -64.34 143.12 58.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 m -146.07 147.34 31.49 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -52.72 -49.52 65.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.922 2.089 . . . . 0.0 110.216 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -68.3 108.25 3.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.862 1.665 . . . . 0.0 107.259 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -152.1 160.08 43.51 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.505 1.122 . . . . 0.0 108.983 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -143.08 167.72 21.43 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.449 0.7 . . . . 0.0 112.042 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.25 143.08 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.268 1.427 . . . . 0.0 107.837 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -137.85 1.95 2.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 145.01 41.99 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.824 0.85 . . . . 0.0 113.169 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.49 149.81 34.95 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.95 -35.65 64.47 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.834 -1.166 . . . . 0.0 111.866 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -69.48 -22.52 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.311 1.044 . . . . 0.0 112.508 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.67 -68.92 0.42 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.39 79.26 1.44 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 124.814 1.197 . . . . 0.0 112.348 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 72' ' ' TYR . 39.5 ttmt -63.87 127.79 32.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 tp -77.7 88.77 3.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.69 -49.58 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.32 -174.14 21.88 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -152.56 -178.03 6.6 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.757 1.223 . . . . 0.0 108.545 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.97 148.81 30.21 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.25 110.59 0.37 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.22 54.38 1.65 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.756 1.623 . . . . 0.0 108.712 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.69 120.11 26.76 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -97.61 -108.72 2.67 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.48 -29.08 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.721 1.208 . . . . 0.0 112.353 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 169.02 20.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.115 1.766 . . . . 0.0 109.138 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.71 101.06 12.94 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.73 -71.52 0.57 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HB1' ' HB1' ' A' ' 6' ' ' ALA . . . -107.18 150.08 27.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.865 0.866 . . . . 0.0 110.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -141.57 110.65 6.26 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 125.392 1.477 . . . . 0.0 108.786 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.32 170.65 14.73 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.96 165.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.13 0.572 . . . . 0.0 111.015 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -123.13 131.07 53.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.64 99.81 6.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.796 2.039 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.315 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.435 ' HA ' ' SD ' ' A' ' 295' ' ' MET . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -101.33 136.59 40.93 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.089 0.555 . . . . 0.0 112.463 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -114.45 146.92 40.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.804 1.642 . . . . 0.0 108.607 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.8 mt -116.35 171.38 7.87 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.319 1.848 . . . . 0.0 106.86 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 m -75.24 170.64 15.65 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.207 -0.933 . . . . 0.0 108.872 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.14 165.82 26.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.271 1.029 . . . . 0.0 108.643 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.6 mt -117.4 151.06 19.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.62 -67.22 0.45 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.341 -0.7 . . . . 0.0 111.357 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.39 -160.61 30.19 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.888 1.232 . . . . 0.0 110.106 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -140.6 27.78 2.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.225 1.41 . . . . 0.0 111.184 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -125.5 141.62 51.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.19 1.796 . . . . 0.0 108.647 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.71 167.1 12.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.817 2.151 . . . . 0.0 111.154 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 97.4 m -71.97 122.7 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.144 0.978 . . . . 0.0 111.484 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.11 117.23 20.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -131.54 35.87 3.8 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.227 0.611 . . . . 0.0 111.33 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.44 145.07 0.64 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.124 1.369 . . . . 0.0 114.363 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.62 111.41 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.096 2.558 . . . . 0.0 108.79 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.77 168.56 46.52 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.06 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.15 120.18 12.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -100.85 -172.16 2.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.588 0.755 . . . . 0.0 109.72 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -4.95 17.25 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.588 0.755 . . . . 0.0 111.341 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 142.78 161.11 8.65 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.822 2.153 . . . . 0.0 110.829 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.45 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.361 1.864 . . . . 0.0 108.68 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -131.54 -70.77 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -133.29 153.42 51.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.434 0.561 . . . . 0.0 112.461 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.29 141.18 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.738 2.015 . . . . 0.0 106.18 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.88 128.04 44.48 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.68 116.25 51.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.89 95.52 1.82 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -60.86 169.91 1.72 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.67 -174.11 13.81 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.33 -23.02 61.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.59 -0.805 . . . . 0.0 111.456 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -131.34 -19.28 2.79 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 179.18 -172.74 44.85 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 126.973 2.225 . . . . 0.0 107.689 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.94 124.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 120.101 1.95 . . . . 0.0 111.824 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.7 m -118.57 -20.42 8.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.685 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.77 156.63 47.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 119.568 -1.958 . . . . 0.0 111.301 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.02 151.01 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -162.68 165.48 25.64 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.77 2.428 . . . . 0.0 106.504 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -144.06 174.56 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.789 1.236 . . . . 0.0 110.305 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -129.63 113.0 14.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -102.66 155.58 18.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -128.37 138.31 52.3 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -129.2 96.23 4.26 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 70.29 -95.93 0.53 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.74 -7.09 9.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.423 1.489 . . . . 0.0 110.212 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.69 153.89 32.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.86 100.23 5.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.32 106.92 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 131.75 34.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.42 176.38 40.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.426 1.012 . . . . 0.0 111.374 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.96 172.44 14.5 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.354 1.454 . . . . 0.0 111.946 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.01 104.13 16.69 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -77.59 -34.38 53.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.096 0.959 . . . . 0.0 112.335 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -108.24 -178.46 21.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 124.774 1.178 . . . . 0.0 113.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -72.8 105.2 1.37 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.565 1.546 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.48 168.69 20.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.813 1.675 . . . . 0.0 109.47 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.6 t -137.22 161.13 37.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.657 0.783 . . . . 0.0 109.181 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.76 -15.5 63.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.561 0.744 . . . . 0.0 110.399 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -19.91 65.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.252 1.021 . . . . 0.0 109.876 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.06 -153.11 20.23 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -139.95 141.23 36.46 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.74 1.616 . . . . 0.0 107.552 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.18 151.58 23.99 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -134.92 144.38 47.44 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.938 0.79 . . . . 0.0 111.996 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -142.42 113.01 7.3 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.785 0.834 . . . . 0.0 109.29 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -73.34 141.16 47.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mt -116.15 114.3 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.908 0.776 . . . . 0.0 109.268 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.82 148.71 27.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.919 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 24.67 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.6 2.36 . . . . 0.0 116.536 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.91 -27.82 9.86 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.371 2.048 . . . . 0.0 114.144 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.2 t -128.81 -66.42 0.83 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.81 172.4 13.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.589 1.556 . . . . 0.0 108.451 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -165.94 171.4 12.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.809 1.244 . . . . 0.0 108.186 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.4 mt -87.24 152.03 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.2 p -140.43 -5.12 1.24 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -166.58 170.79 12.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.836 1.255 . . . . 0.0 107.768 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.18 141.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -132.86 151.61 52.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 129.32 3.048 . . . . 0.0 108.482 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.02 179.53 44.39 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 266' ' ' ALA . 25.5 p -137.15 142.87 42.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.642 1.221 . . . . 0.0 110.463 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.52 145.29 48.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.722 0.809 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -147.67 163.94 35.07 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 122.056 -0.403 . . . . 0.0 110.739 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.42 141.15 52.15 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.492 1.117 . . . . 0.0 113.794 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.73 155.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -111.03 141.89 43.92 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.94 -7.24 82.61 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.545 -0.722 . . . . 0.0 111.827 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 60.4 p -140.65 -172.11 3.38 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.858 2.063 . . . . 0.0 107.643 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.42 72.0 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.904 1.282 . . . . 0.0 108.706 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -163.17 178.54 38.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.873 1.225 . . . . 0.0 111.383 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.3 mt -108.44 159.61 16.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 110.58 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.0 tt -135.85 138.49 47.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.232 1.413 . . . . 0.0 109.305 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 25.0 mm -76.54 96.57 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.0 t -76.24 -16.86 59.73 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.677 -0.639 . . . . 0.0 112.313 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -156.79 138.61 14.28 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.622 1.169 . . . . 0.0 107.986 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 24.3 tp -135.49 123.91 23.39 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -109.58 172.48 6.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.984 0.914 . . . . 0.0 108.576 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -136.68 145.71 45.07 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -115.88 121.36 42.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.425 1.09 . . . . 0.0 109.027 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 p -138.66 168.14 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.344 2.258 . . . . 0.0 107.277 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.23 156.02 19.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.8 mttm 60.76 -17.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -98.97 175.3 5.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.33 1.452 . . . . 0.0 112.555 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -131.42 99.82 4.95 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 126.11 1.764 . . . . 0.0 108.186 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.1 p -80.18 160.18 25.74 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.083 0.553 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -94.53 155.85 39.14 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.22 88.98 0.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.072 2.514 . . . . 0.0 107.877 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -77.09 92.52 3.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.87 172.86 34.55 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.146 1.355 . . . . 0.0 111.797 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.84 122.97 41.58 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.552 1.541 . . . . 0.0 109.232 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -71.82 108.34 5.07 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.345 2.258 . . . . 0.0 110.139 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.78 168.32 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.973 1.309 . . . . 0.0 110.103 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 91.84 -98.43 2.42 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 98.8 m -145.08 118.85 9.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 232' ' ' THR . . . -87.71 136.03 33.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -126.27 166.03 17.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.06 0.944 . . . . 0.0 109.565 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.45 151.88 35.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.458 0.703 . . . . 0.0 109.816 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.5 mt -139.42 120.49 14.63 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.789 1.636 . . . . 0.0 107.563 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.37 152.27 18.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.166 0.894 . . . . 0.0 110.92 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.49 157.23 44.04 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.587 1.555 . . . . 0.0 108.756 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.15 143.25 34.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 65.15 28.65 73.8 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -142.49 152.73 42.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.08 2.44 . . . . 0.0 110.757 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.94 165.01 17.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.875 2.07 . . . . 0.0 107.563 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.8 mt -92.15 150.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.68 -10.55 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.81 -179.97 48.14 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.833 1.197 . . . . 0.0 110.84 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 135.71 53.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 108.204 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.71 137.37 52.44 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.47 -150.49 22.2 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.06 128.85 10.17 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.16 46.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 109.55 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 36.5 m -140.29 -67.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.442 1.097 . . . . 0.0 111.631 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.86 -64.48 1.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 119.001 0.819 . . . . 0.0 110.748 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.4 113.74 27.5 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -50.31 92.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.75 -73.84 0.31 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.525 1.13 . . . . 0.0 111.939 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -104.85 114.36 28.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.843 0.747 . . . . 0.0 112.346 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -117.87 156.77 27.84 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.655 1.582 . . . . 0.0 107.005 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -172.1 -179.66 43.16 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.5 m -138.81 146.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.58 1.19 . . . . 0.0 111.529 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.02 160.26 24.6 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 118.411 0.55 . . . . 0.0 110.885 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 153' ' ' ALA . 83.8 mmm -146.02 142.9 18.29 Favored Pre-proline 0 N--CA 1.464 0.262 0 C-N-CA 124.589 1.156 . . . . 0.0 110.784 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.59 105.77 2.09 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.824 2.349 . . . . 0.0 109.461 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 178.944 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -149.05 100.94 3.11 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.223 -0.923 . . . . 0.0 112.788 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.37 142.53 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 159.7 16.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.683 0.793 . . . . 0.0 110.027 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.51 105.38 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.288 1.435 . . . . 0.0 112.512 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.09 83.23 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.02 -160.71 19.01 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 126.909 2.195 . . . . 0.0 107.657 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.86 150.23 39.66 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.02 53.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.244 1.022 . . . . 0.0 113.582 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.86 164.02 39.9 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.96 0.79 . . . . 0.0 114.59 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.37 164.85 34.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.189 1.376 . . . . 0.0 113.98 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.79 141.73 29.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.209 1.403 . . . . 0.0 107.236 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.9 123.12 22.03 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -127.33 85.7 2.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.883 1.673 . . . . 0.0 107.034 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -140.94 147.0 38.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.647 2.379 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -160.63 174.22 14.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.41 1.484 . . . . 0.0 108.534 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.563 0 N-CA-C 104.149 -3.58 . . . . 0.0 104.149 177.571 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -117.82 155.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 109.64 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -54.93 1.24 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -145.8 168.39 20.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 118.759 0.708 . . . . 0.0 110.622 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.144 2.578 . . . . 0.0 104.777 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -138.9 122.32 17.2 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -143.77 139.6 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.87 131.23 3.89 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -67.16 -168.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.212 1.405 . . . . 0.0 110.519 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.67 -177.32 43.23 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.88 -32.69 73.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.427 1.091 . . . . 0.0 111.507 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -105.63 8.29 33.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.259 1.824 . . . . 0.0 114.036 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.72 -168.41 12.93 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.258 -0.901 . . . . 0.0 112.836 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.36 95.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -101.94 -9.24 20.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.9 p -87.8 147.53 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 120.362 1.437 . . . . 0.0 109.524 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -145.01 158.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.44 1.096 . . . . 0.0 108.8 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -153.91 151.31 29.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.285 1.834 . . . . 0.0 107.266 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.73 119.86 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.97 121.27 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.55 158.64 16.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 48' ' ' ASP . . . -156.26 109.66 2.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -111.84 154.03 25.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -33.27 62.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.64 0.776 . . . . 0.0 112.611 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.525 1.53 . . . . 0.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -156.02 120.06 4.48 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 120.401 1.455 . . . . 0.0 107.679 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 43' ' ' ALA 0.395 0.5 OUTLIER -116.83 165.46 13.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -179.279 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.78 145.98 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.536 1.534 . . . . 0.0 111.801 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.3 139.09 37.94 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.95 -1.094 . . . . 0.0 109.377 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.35 -73.49 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.57 0.605 . . . . 0.0 111.788 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.33 171.15 17.67 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.725 1.631 . . . . 0.0 110.033 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -101.52 142.63 32.61 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.136 -0.626 . . . . 0.0 110.591 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.63 173.99 10.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.611 1.964 . . . . 0.0 109.682 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.97 -155.97 37.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -112.79 125.58 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.89 160.26 14.63 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 p -132.34 114.53 14.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.365 1.866 . . . . 0.0 108.221 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.46 -36.5 80.57 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.262 -1.524 . . . . 0.0 107.988 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -72.44 -1.88 17.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.223 2.209 . . . . 0.0 115.554 179.272 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.97 -8.87 0.23 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 120.291 1.405 . . . . 0.0 115.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.99 125.04 28.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.084 1.442 . . . . 0.0 110.88 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.01 142.01 50.76 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.486 1.915 . . . . 0.0 106.273 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.6 m -104.15 143.61 32.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 108.735 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -134.68 125.1 26.4 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.883 0.873 . . . . 0.0 109.629 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.39 143.57 29.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.618 1.567 . . . . 0.0 109.142 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.69 147.52 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.631 1.173 . . . . 0.0 109.089 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -109.91 172.62 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.936 1.294 . . . . 0.0 113.35 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -38.52 19.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.473 1.509 . . . . 0.0 110.332 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -83.19 21.05 1.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.328 1.451 . . . . 0.0 109.742 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.8 136.76 22.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 0.0 110.998 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.08 150.07 48.99 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.8 mt -79.88 147.49 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.32 -28.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.765 0.826 . . . . 0.0 110.836 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.36 155.64 41.51 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.182 0.901 . . . . 0.0 108.888 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.99 95.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.67 113.66 20.5 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.69 147.91 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 113' ' ' LYS . 39.1 m -131.74 138.73 48.74 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -150.28 167.11 27.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.136 2.974 . . . . 0.0 104.619 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.03 165.7 29.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -120.82 105.73 11.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.981 0.912 . . . . 0.0 109.277 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.85 144.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.05 108.15 1.17 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.61 6.32 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 117.874 -1.515 . . . . 0.0 113.403 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -131.56 118.87 20.7 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.119 1.96 . . . . 0.0 108.142 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.33 1.85 2.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.559 2.744 . . . . 0.0 114.138 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.7 t -147.97 135.53 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.625 -1.297 . . . . 0.0 109.04 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.16 158.33 33.39 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.92 141.11 43.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.189 1.796 . . . . 0.0 107.962 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 138' ' ' ALA . 44.1 mm -64.29 125.68 21.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.987 0.915 . . . . 0.0 110.054 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 p -104.42 -32.54 8.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.28 1.032 . . . . 0.0 109.24 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -161.05 165.6 29.48 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 120.015 1.279 . . . . 0.0 112.689 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pt -144.76 137.44 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.402 1.881 . . . . 0.0 109.928 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.7 m -132.21 114.61 14.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.197 1.799 . . . . 0.0 107.952 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -96.82 121.8 39.07 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -100.79 127.62 47.16 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.8 p -97.48 164.51 12.41 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.151 0.887 . . . . 0.0 111.756 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.94 -41.2 82.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.378 1.071 . . . . 0.0 108.934 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -68.47 -22.8 64.54 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.22 1.408 . . . . 0.0 114.608 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.56 -7.6 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 119.809 1.186 . . . . 0.0 114.186 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -74.26 147.05 42.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.49 127.11 30.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 p -80.98 149.33 66.55 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.68 158.86 48.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.138 1.892 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.47 83.46 1.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.053 2.502 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -55.89 109.31 0.56 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.59 -134.88 10.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.3 tp -139.87 138.16 35.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.537 1.135 . . . . 0.0 109.927 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 164.83 20.13 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -149.8 -167.14 2.74 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.742 -1.849 . . . . 0.0 111.609 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 111' ' ' THR . 16.9 tt0 -73.25 -59.18 2.83 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.543 1.137 . . . . 0.0 109.509 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 79' ' ' THR . 50.3 mttp -68.73 178.24 2.2 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.03 162.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.353 3.061 . . . . 0.0 108.471 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.51 149.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.344 1.058 . . . . 0.0 108.198 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 p -140.05 148.14 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -143.31 145.87 33.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.175 2.19 . . . . 0.0 106.512 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 174.68 12.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.632 1.173 . . . . 0.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 143' ' ' PHE . 5.8 p30 -110.1 147.93 32.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.596 1.158 . . . . 0.0 109.0 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -143.26 -84.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -100.42 -10.81 20.77 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.717 0.69 . . . . 0.0 110.198 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 -49.04 49.3 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.248 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.05 -133.25 2.91 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 119.267 1.533 . . . . 0.0 112.187 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -132.81 153.61 51.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.934 0.893 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.6 106.92 10.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.01 3.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.456 0.702 . . . . 0.0 111.556 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.38 178.22 46.86 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.923 0.773 . . . . 0.0 111.749 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.74 177.02 8.45 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.74 2.016 . . . . 0.0 109.735 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -146.41 148.82 32.7 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.07 92.45 0.17 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 118.254 0.479 . . . . 0.0 112.388 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -60.32 121.26 11.56 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -152.8 164.82 37.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.388 0.994 . . . . 0.0 110.595 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.56 -95.72 0.13 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.73 -23.94 56.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.047 0.424 . . . . 0.0 110.201 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.4 -179.69 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.23 2.212 . . . . 0.0 106.366 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.54 153.45 33.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.846 1.658 . . . . 0.0 108.487 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -143.93 -56.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.509 0.595 . . . . 0.0 112.007 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 91' ' ' ILE . . . -135.24 155.71 50.2 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.986 0.812 . . . . 0.0 112.592 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.11 113.21 9.24 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.21 2.204 . . . . 0.0 107.346 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.92 174.81 15.48 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 123.814 0.721 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.01 158.85 43.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 121.537 -0.978 . . . . 0.0 108.728 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.77 151.81 41.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 119' ' ' ASP . 45.4 m-85 -137.72 99.81 4.02 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.015 0.926 . . . . 0.0 109.421 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.068 0 O-C-N 121.605 -0.684 . . . . 0.0 110.678 -179.547 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.65 129.38 56.67 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.152 -0.968 . . . . 0.0 109.567 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -103.97 106.78 17.4 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.88 161.54 23.74 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.4 t -84.86 111.94 20.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.94 159.77 29.71 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.721 0.408 . . . . 0.0 110.113 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -125.21 161.24 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.009 2.924 . . . . 0.0 105.949 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.94 -72.12 0.48 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.857 1.208 . . . . 0.0 113.317 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.81 -4.89 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.217 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . 0.264 0.7 OUTLIER 53.61 -3.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.156 2.982 . . . . 0.0 117.476 179.281 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.76 164.9 12.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.839 1.655 . . . . 0.0 112.769 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.51 -175.23 16.0 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 126.341 1.924 . . . . 0.0 114.195 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.37 104.22 4.3 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.033 1.733 . . . . 0.0 109.525 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.85 154.76 29.55 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.254 0.622 . . . . 0.0 110.265 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -146.57 28.29 1.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.99 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -42.71 110.42 0.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.912 1.685 . . . . 0.0 110.235 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.38 -11.37 60.45 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.3 -85.75 1.57 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.37 147.57 5.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -109.6 155.48 21.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.352 1.061 . . . . 0.0 109.548 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -76.42 -11.02 59.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.926 -1.033 . . . . 0.0 112.901 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.05 -179.94 44.07 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.21 155.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.18 1.392 . . . . 0.0 108.596 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -138.48 -74.13 0.39 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.788 1.235 . . . . 0.0 107.873 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -150.87 165.94 32.09 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.03 139.41 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -118.48 156.89 28.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.58 131.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -109.84 83.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.68 -165.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 110.682 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.02 -168.71 37.93 Favored Glycine 0 N--CA 1.447 -0.608 0 O-C-N 120.183 -1.573 . . . . 0.0 112.064 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -86.09 -45.58 11.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.23 1.412 . . . . 0.0 109.618 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.78 -15.53 51.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.528 0.731 . . . . 0.0 111.479 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.06 -154.39 24.44 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 27.7 mm -58.36 150.81 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 118.559 1.179 . . . . 0.0 108.855 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.4 t -127.65 -38.36 1.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.199 1.399 . . . . 0.0 112.822 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -136.7 161.58 35.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.137 0.881 . . . . 0.0 110.027 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.91 127.85 25.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 44.7 pttt -161.67 160.53 28.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.296 1.439 . . . . 0.0 109.49 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.48 169.13 24.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.428 0.558 . . . . 0.0 109.834 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.03 148.27 24.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.465 ' CZ ' HG21 ' A' ' 201' ' ' ILE . 1.2 p90 -151.67 165.84 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.5 92.58 2.59 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -89.2 99.44 12.43 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.36 -79.98 0.64 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.73 0.696 . . . . 0.0 111.662 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.33 -0.18 1.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.597 1.959 . . . . 0.0 111.135 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.4 102.05 7.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -77.67 67.06 3.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.295 1.438 . . . . 0.0 108.251 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.465 HG21 ' CZ ' ' A' ' 194' ' ' TYR . 36.9 mm -72.13 122.69 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.189 0.995 . . . . 0.0 113.429 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 29.0 t -127.65 150.37 33.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 127.109 2.164 . . . . 0.0 105.93 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.44 -108.98 2.77 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.862 -0.966 . . . . 0.0 111.548 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 72.38 12.47 76.83 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 116.014 1.165 . . . . 0.0 116.014 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -58.81 116.44 3.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.839 2.32 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -117.64 2.78 12.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.671 1.588 . . . . 0.0 113.993 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.01 162.41 28.57 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 120.069 -1.645 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -47.07 106.37 0.58 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.744 1.617 . . . . 0.0 110.929 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.53 135.57 26.63 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.985 2.457 . . . . 0.0 109.327 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 131.66 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 29.3 tp -56.51 -26.4 54.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 pp -55.52 -30.06 60.01 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.197 1.399 . . . . 0.0 112.186 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.72 -166.01 13.91 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.019 1.295 . . . . 0.0 110.488 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 23.5 m-85 -128.88 168.13 16.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.549 1.54 . . . . 0.0 108.232 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.75 171.6 7.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.882 2.073 . . . . 0.0 106.787 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.86 158.59 44.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.451 0.7 . . . . 0.0 112.771 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -142.74 129.67 20.63 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.943 1.697 . . . . 0.0 108.311 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.19 109.54 21.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 107.707 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.85 104.45 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -88.96 92.61 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.774 1.63 . . . . 0.0 107.556 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -57.16 -35.29 33.7 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -35.27 10.01 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 123.609 2.325 . . . . 0.0 110.093 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -75.91 -77.09 0.14 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.591 1.557 . . . . 0.0 112.021 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.18 124.71 28.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.052 2.541 . . . . 0.0 112.476 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.47 83.31 3.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 226' ' ' ILE . 0.0 OUTLIER -45.98 128.19 2.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 109.824 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -124.42 -22.96 4.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.81 171.26 18.08 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.347 1.43 . . . . 0.0 113.46 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 1.8 p -139.1 158.19 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.73 172.18 12.89 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -172.68 171.24 44.23 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.2 p -141.33 137.81 32.66 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.498 ' CD1' HD13 ' A' ' 242' ' ' LEU . 5.2 p90 -135.96 160.8 37.48 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.898 0.749 . . . . 0.0 112.14 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -145.87 168.94 19.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.153 0.981 . . . . 0.0 108.985 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -75.05 147.9 40.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.902 1.281 . . . . 0.0 110.075 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.8 mt -92.98 112.46 26.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.36 104.41 5.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 119.02 -0.52 14.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.436 1.017 . . . . 0.0 112.811 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -141.19 -174.28 3.97 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.11 80.24 1.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 172.66 -176.99 45.44 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 233' ' ' TYR . 22.1 mt -108.66 157.61 18.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -126.78 137.2 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 125.974 1.709 . . . . 0.0 109.135 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.32 130.2 36.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.277 10.3 t -112.04 -50.35 2.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 112.622 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -128.77 150.61 50.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.149 1.341 . . . . 0.0 109.619 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.4 mt -130.53 150.32 51.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.373 1.469 . . . . 0.0 110.441 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -142.97 147.64 35.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.646 1.579 . . . . 0.0 107.62 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.75 113.19 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -71.14 136.15 48.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -142.18 165.18 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.35 1.86 . . . . 0.0 106.383 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 148.15 31.69 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 -29.42 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 128.465 2.706 . . . . 0.0 115.157 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -81.22 174.42 11.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.386 2.674 . . . . 0.0 108.295 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.4 m -144.31 152.29 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 45.3 p -146.09 174.46 11.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 112.257 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -103.98 158.66 31.44 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.872 1.669 . . . . 0.0 110.576 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.05 115.09 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.224 2.616 . . . . 0.0 106.401 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -83.94 92.38 7.81 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.71 -176.99 16.57 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.229 1.395 . . . . 0.0 111.59 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.05 116.67 26.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.108 0.963 . . . . 0.0 110.066 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.78 108.86 3.59 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.419 1.088 . . . . 0.0 109.219 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -155.17 -177.31 6.44 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.287 1.035 . . . . 0.0 110.965 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 64.15 -103.47 0.73 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 126.261 1.886 . . . . 0.0 114.657 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 91.1 m -146.92 128.62 15.2 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 107.444 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -89.92 144.41 25.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 111.431 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -129.48 165.94 20.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.592 1.157 . . . . 0.0 110.039 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -143.84 146.58 33.15 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.232 1.813 . . . . 0.0 107.092 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 73.0 mt -132.0 102.01 5.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.699 1.6 . . . . 0.0 107.239 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -127.11 163.7 23.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.146 0.978 . . . . 0.0 109.061 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.75 167.44 22.28 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.365 1.466 . . . . 0.0 107.627 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -97.04 117.59 31.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.593 1.157 . . . . 0.0 113.559 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.73 67.54 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.148 -0.97 . . . . 0.0 114.623 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -107.06 164.59 12.02 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.126 1.37 . . . . 0.0 111.606 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -127.98 151.16 49.47 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.682 2.793 . . . . 0.0 105.01 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 68.7 mt -82.49 145.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.38 -5.37 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.778 0.831 . . . . 0.0 112.842 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.17 37.3 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.626 1.103 . . . . 0.0 110.684 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -128.35 156.01 43.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.888 2.875 . . . . 0.0 107.238 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -147.83 113.27 5.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -178.52 -171.56 41.95 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 154.28 46.12 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.55 -1.325 . . . . 0.0 107.838 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.3 152.48 39.98 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.6 t -163.95 113.55 1.24 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.82 11.47 2.53 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.07 2.548 . . . . 0.0 114.447 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 167.1 -179.88 0.02 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 129.433 3.093 . . . . 0.0 106.865 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.95 102.97 15.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.441 0.696 . . . . 0.0 110.172 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -82.88 -43.42 16.59 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.237 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -133.71 142.16 47.86 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.795 1.18 . . . . 0.0 112.799 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.83 149.64 35.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 176.5 -158.89 25.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.4 m -147.89 138.66 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.98 0.912 . . . . 0.0 111.661 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.96 136.92 37.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.12 149.23 24.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.32 0.581 . . . . 0.0 111.233 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 29.7 mmm -142.47 141.61 21.26 Favored Pre-proline 0 C--O 1.234 0.277 0 C-N-CA 126.988 2.115 . . . . 0.0 107.414 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.18 146.98 71.88 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.368 2.045 . . . . 0.0 108.878 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.237 0.422 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 178.325 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.103 0.478 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -149.74 139.48 21.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 130.614 3.566 . . . . 0.0 105.166 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.36 129.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 118.931 0.787 . . . . 0.0 112.388 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.34 138.69 47.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.37 -62.52 1.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.027 0.531 . . . . 0.0 109.692 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.33 69.76 0.84 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 126.241 1.876 . . . . 0.0 109.534 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.75 -166.11 12.07 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.733 1.635 . . . . 0.0 110.075 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.29 17.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.433 1.116 . . . . 0.0 113.403 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.12 -1.13 4.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.303 1.841 . . . . 0.0 112.548 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.75 42.38 3.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 120.698 -1.251 . . . . 0.0 112.734 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.64 -154.68 6.66 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 127.095 2.283 . . . . 0.0 111.561 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.96 142.2 51.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -72.29 121.9 20.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 112.579 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -124.27 58.42 1.2 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -89.91 18.68 5.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.855 2.462 . . . . 0.0 112.277 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -148.09 160.22 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.012 -1.055 . . . . 0.0 110.913 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 C-N-CA 126.274 1.893 . . . . 0.0 108.772 -179.59 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.039 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -59.55 141.87 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 111.759 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 13.2 mmm180 -117.91 -32.48 4.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -150.49 160.63 43.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.36 121.1 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.558 ' CD2' HD22 ' A' ' 39' ' ' ASN . 1.2 m-70 -98.38 140.96 31.88 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 118.768 0.713 . . . . 0.0 109.557 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -143.2 145.84 22.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.04 141.83 8.59 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 146.78 35.08 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.548 1.139 . . . . 0.0 109.722 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.14 165.68 28.56 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 125.992 1.758 . . . . 0.0 109.459 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -55.72 -34.67 65.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.922 1.289 . . . . 0.0 112.327 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -94.84 -7.92 38.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.465 3.106 . . . . 0.0 113.788 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.65 -164.35 20.26 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.87 95.49 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -112.61 2.45 16.19 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.5 p -107.18 108.93 20.61 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.67 132.65 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 109.702 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.558 HD22 ' CD2' ' A' ' 27' ' ' HIS . 24.4 t30 -150.23 147.39 27.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.652 1.581 . . . . 0.0 108.562 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.0 117.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.9 t -68.22 148.23 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -128.41 126.31 40.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.275 1.398 . . . . 0.0 111.933 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB2' ' CG ' ' A' ' 24' ' ' ARG . . . -86.29 139.62 30.84 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -112.5 165.56 12.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.56 -23.48 67.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.093 -0.379 . . . . 0.0 111.234 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -104.67 -39.38 6.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.561 1.144 . . . . 0.0 113.608 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -154.81 158.22 39.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.043 1.292 . . . . 0.0 113.509 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 125.73 30.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.42 145.32 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.535 1.16 . . . . 0.0 112.361 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.5 153.3 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.057 2.143 . . . . 0.0 106.183 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.72 61.06 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 127.939 2.685 . . . . 0.0 107.703 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.6 14.51 4.18 Favored Glycine 0 N--CA 1.472 1.035 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.28 116.56 8.19 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.06 1.43 . . . . 0.0 111.404 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -126.59 82.12 2.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.26 -144.92 5.77 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.93 111.23 13.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.92 119.79 6.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 p -70.53 153.57 42.78 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.262 1.825 . . . . 0.0 111.291 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.18 -33.55 16.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.803 1.241 . . . . 0.0 109.781 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.2 mt -71.34 -14.43 62.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 123.66 0.6 . . . . 0.0 109.469 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.82 161.16 33.19 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-O 124.637 2.243 . . . . 0.0 109.659 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -123.89 157.61 33.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.529 -2.835 . . . . 0.0 109.334 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -121.78 165.19 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.767 2.427 . . . . 0.0 107.633 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -128.13 125.92 40.11 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.543 -0.723 . . . . 0.0 110.123 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -87.12 119.58 27.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.987 1.715 . . . . 0.0 107.414 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.07 141.99 35.33 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.878 0.847 . . . . 0.0 109.871 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.1 t -114.75 112.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.875 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.63 172.16 14.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.53 -59.0 2.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -74.73 -22.28 58.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -81.36 146.78 30.16 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.02 152.8 51.3 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 123.868 0.867 . . . . 0.0 110.617 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.2 mt -80.78 114.44 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.67 -31.04 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.687 0.795 . . . . 0.0 112.012 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.2 166.77 26.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.652 1.181 . . . . 0.0 108.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.46 117.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -95.14 126.16 40.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.8 146.26 29.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.81 0.844 . . . . 0.0 109.869 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 p -120.74 152.51 38.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -154.2 168.72 25.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.106 0.962 . . . . 0.0 108.517 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.19 168.96 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.2 108.41 10.32 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.793 2.037 . . . . 0.0 108.458 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.54 147.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.861 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -62.21 149.6 41.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.35 88.83 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.642 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -139.58 164.44 29.9 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.028 2.131 . . . . 0.0 106.704 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -125.02 0.71 7.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.418 1.087 . . . . 0.0 111.295 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.1 t -98.48 157.66 16.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.48 153.27 24.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -131.7 141.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 125.75 1.62 . . . . 0.0 107.802 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.42 128.53 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.8 p -104.7 -27.19 11.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.8 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.0 t -154.67 159.62 40.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.158 1.344 . . . . 0.0 109.022 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.5 mm -141.6 141.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 128.023 2.529 . . . . 0.0 106.368 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -151.12 108.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.383 1.473 . . . . 0.0 107.565 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -77.88 150.22 34.16 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -123.84 114.06 19.36 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.1 p -82.84 162.26 21.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.982 1.313 . . . . 0.0 111.409 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.2 -30.71 70.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -17.37 59.41 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.238 -0.914 . . . . 0.0 112.777 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 2.98 60.43 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 119.3 0.954 . . . . 0.0 111.132 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -79.36 89.45 4.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 147.46 26.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.089 0.555 . . . . 0.0 109.904 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.8 p -84.86 161.91 51.59 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.055 0.942 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.92 164.66 34.92 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 N-CA-C 108.586 -1.352 . . . . 0.0 108.586 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.05 109.61 2.92 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 N-CA-C 106.466 -2.167 . . . . 0.0 106.466 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 9.41 0.18 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -169.55 -170.12 33.66 Favored Glycine 0 N--CA 1.442 -0.9 0 O-C-N 120.76 -1.213 . . . . 0.0 111.427 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.3 106.03 8.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.617 0.767 . . . . 0.0 111.11 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.65 109.53 1.06 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 m -100.44 166.34 10.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.547 0.739 . . . . 0.0 110.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.39 -52.86 61.93 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.725 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -62.9 117.01 5.79 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -157.57 159.65 37.33 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -139.57 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.269 1.828 . . . . 0.0 110.556 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.82 114.29 3.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.812 1.245 . . . . 0.0 108.237 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.17 128.57 36.38 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 138.97 9.3 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.5 175.35 9.31 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.321 1.049 . . . . 0.0 110.855 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -106.96 -25.93 11.42 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.588 1.155 . . . . 0.0 110.967 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -119.98 33.63 5.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.571 1.548 . . . . 0.0 111.387 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.84 31.63 81.56 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 174.63 2.65 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.001 1.762 . . . . 0.0 114.853 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -125.68 137.0 53.83 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.601 1.16 . . . . 0.0 109.506 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.39 151.54 43.78 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 0.0 109.3 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.58 -62.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.09 164.5 32.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.1 160.43 14.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.941 0.896 . . . . 0.0 111.283 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.59 149.3 35.56 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.859 2.064 . . . . 0.0 107.04 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.83 172.51 24.43 Favored Glycine 0 C--O 1.229 -0.217 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -142.25 37.62 1.55 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.297 1.439 . . . . 0.0 107.412 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.02 111.8 20.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.645 1.178 . . . . 0.0 110.206 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.69 -101.34 0.32 Allowed Glycine 0 CA--C 1.519 0.305 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.37 -31.65 58.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.536 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.6 169.17 17.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.381 1.472 . . . . 0.0 110.745 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -75.91 88.44 2.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.715 1.206 . . . . 0.0 113.264 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.38 -32.77 16.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.03 139.73 19.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.165 0.986 . . . . 0.0 109.28 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.6 tp -158.85 113.1 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.182 1.393 . . . . 0.0 108.379 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.25 -175.94 14.78 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.436 1.493 . . . . 0.0 111.298 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -146.6 159.51 43.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.43 1.115 . . . . 0.0 111.261 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -99.39 154.99 17.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.384 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.51 118.37 21.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.807 1.243 . . . . 0.0 108.81 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 125.905 1.682 . . . . 0.0 108.661 178.769 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.868 0.842 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 122.09 28.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -106.0 147.56 28.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 67.9 mt -125.09 122.51 37.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.97 2.108 . . . . 0.0 107.161 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -69.15 108.39 3.59 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 127.143 2.177 . . . . 0.0 107.081 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.03 -178.58 2.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.078 0.951 . . . . 0.0 111.228 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.447 HD12 ' CE2' ' A' ' 233' ' ' TYR . 17.5 pt -108.15 156.13 8.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 108.389 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.31 -109.88 0.49 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -156.39 -162.6 11.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.989 1.757 . . . . 0.0 109.629 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -121.65 13.6 10.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.853 1.261 . . . . 0.0 111.383 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -107.65 120.77 43.14 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 112.163 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.36 -172.84 36.86 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.867 1.699 . . . . 0.0 109.506 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 m -96.3 146.21 24.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -103.08 138.37 40.01 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.582 -0.699 . . . . 0.0 110.973 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -155.74 58.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.33 104.22 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.02 -24.65 21.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.864 -0.522 . . . . 0.0 112.049 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.0 -118.71 4.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -135.42 135.66 40.78 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.353 1.577 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -91.4 170.6 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -42.62 64.78 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.58 134.01 3.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.18 156.82 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.065 1.746 . . . . 0.0 107.685 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -127.03 -64.1 1.02 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -126.3 155.31 42.17 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.512 0.597 . . . . 0.0 111.756 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -121.56 146.11 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.588 1.955 . . . . 0.0 107.255 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -137.07 146.44 45.17 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.599 0.76 . . . . 0.0 109.197 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.2 132.41 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.22 65.82 0.56 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.42 1.009 . . . . 0.0 112.404 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -78.72 176.51 9.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.375 1.07 . . . . 0.0 109.981 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.61 23.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -69.75 -20.35 63.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.683 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -115.6 -16.81 11.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.275 0.943 . . . . 0.0 113.516 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.89 30.76 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.193 0.906 . . . . 0.0 112.925 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.77 111.91 6.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.1 0.96 . . . . 0.0 108.946 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -96.02 -37.1 10.78 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.905 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.18 155.58 47.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.56 1.171 . . . . 0.0 111.777 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.51 148.16 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -168.3 142.17 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.407 1.883 . . . . 0.0 106.764 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -139.14 155.36 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -108.84 130.1 55.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -140.98 168.41 19.85 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.986 0.914 . . . . 0.0 111.741 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -147.39 133.84 19.71 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.76 1.224 . . . . 0.0 110.966 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -140.05 147.21 40.0 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.74 -100.13 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 124.657 1.122 . . . . 0.0 112.715 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.36 12.82 4.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.84 1.656 . . . . 0.0 110.881 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -127.48 110.66 12.97 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.302 1.041 . . . . 0.0 112.019 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.47 152.47 34.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.318 1.847 . . . . 0.0 107.302 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.0 mm -132.88 129.63 58.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.119 0.968 . . . . 0.0 109.534 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.22 141.5 45.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 118.34 -135.46 11.6 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.85 23.65 66.31 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.971 0.385 . . . . 0.0 112.542 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -78.75 78.98 5.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -84.7 21.49 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.582 1.153 . . . . 0.0 112.534 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.95 156.18 26.89 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 119.809 -1.807 . . . . 0.0 108.889 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -71.3 129.76 88.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.56 155.1 71.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.53 2.153 . . . . 0.0 109.084 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.5 p -98.76 173.03 7.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.953 0.901 . . . . 0.0 109.587 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 40.1 tp -75.08 -18.57 60.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.7 tt -68.3 -34.73 76.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.385 . . . . 0.0 108.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 101.78 -132.38 10.95 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -142.33 -179.67 6.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.061 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.42 158.03 43.97 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 131.414 3.885 . . . . 0.0 104.711 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.96 147.78 34.41 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.687 1.131 . . . . 0.0 113.77 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.48 32.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.741 1.217 . . . . 0.0 109.402 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.74 113.86 21.28 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.681 1.192 . . . . 0.0 107.807 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.04 103.17 9.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.58 115.74 15.56 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -56.67 -32.0 11.87 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.06 8.46 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 124.015 2.47 . . . . 0.0 113.569 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.7 m -145.45 -68.12 0.29 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.975 -1.078 . . . . 0.0 110.034 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -84.78 151.84 24.08 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 119.123 0.874 . . . . 0.0 110.095 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -143.58 168.13 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.636 1.684 . . . . 0.0 115.177 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.3 mm -109.05 124.98 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 127.742 2.417 . . . . 0.0 105.263 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 t -115.84 -15.38 11.28 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.708 1.14 . . . . 0.0 113.139 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -154.02 170.34 21.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.829 1.251 . . . . 0.0 107.913 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.91 125.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.64 170.08 8.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 157.52 -178.73 33.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.6 p -137.18 153.73 50.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.447 ' CE2' HD12 ' A' ' 159' ' ' ILE . 35.7 p90 -131.26 144.33 51.22 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.49 165.23 23.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.747 0.419 . . . . 0.0 110.12 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -95.44 148.22 22.71 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.124 1.37 . . . . 0.0 113.174 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 236' ' ' ILE . 1.5 mp -99.87 138.95 22.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -75.34 152.13 38.17 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.407 -0.808 . . . . 0.0 109.169 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.21 1.51 89.51 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.299 0.952 . . . . 0.0 112.979 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 59.3 m -140.79 179.54 6.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.493 1.517 . . . . 0.0 109.794 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -125.39 66.41 1.15 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -162.88 -177.82 36.2 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 121.548 -0.72 . . . . 0.0 112.395 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.77 167.23 22.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.056 1.742 . . . . 0.0 112.13 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.67 158.62 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.066 2.147 . . . . 0.0 109.338 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.4 mm -72.52 126.98 34.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.2 m -107.61 -31.11 8.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 111.712 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -144.65 154.65 43.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -140.74 130.44 24.24 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.941 1.697 . . . . 0.0 109.553 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -129.31 109.35 11.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.963 1.305 . . . . 0.0 107.759 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -76.64 139.81 40.73 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -121.95 114.13 20.57 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.2 p -112.19 165.32 12.26 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.138 2.575 . . . . 0.0 109.714 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -100.74 150.97 22.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 65.21 -35.11 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.415 2.286 . . . . 0.0 114.298 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -120.08 174.2 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.575 1.95 . . . . 0.0 110.113 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.0 t -125.77 148.51 49.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.7 m -115.09 -0.34 13.36 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 74.8 163.81 0.14 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.513 2.325 . . . . 0.0 113.537 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 56.5 Cg_endo -86.53 150.15 8.88 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.672 2.915 . . . . 0.0 109.674 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.94 112.13 13.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.79 176.53 26.93 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.802 1.192 . . . . 0.0 110.776 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.5 tt -97.56 118.57 34.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.606 1.163 . . . . 0.0 108.397 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -59.1 109.72 0.9 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.743 1.217 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -149.5 150.93 33.08 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.065 1.746 . . . . 0.0 106.821 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 84.11 -169.54 46.16 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 67.3 m -76.55 139.81 40.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 0.0 108.406 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -94.91 137.5 33.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.317 1.047 . . . . 0.0 109.945 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -130.61 148.3 52.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.247 1.019 . . . . 0.0 108.752 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -150.9 103.67 3.09 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 122.062 -0.399 . . . . 0.0 110.296 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.89 140.85 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.79 165.05 32.62 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.31 0.504 . . . . 0.0 112.289 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -146.28 167.48 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -132.23 137.27 47.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.7 17.78 76.86 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 118.818 0.736 . . . . 0.0 112.588 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -143.44 172.24 13.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.316 1.847 . . . . 0.0 109.175 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.461 ' HE3' ' CG1' ' A' ' 277' ' ' VAL . 0.1 OUTLIER -141.42 160.69 39.61 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.035 0.934 . . . . 0.0 109.916 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.6 mt -81.93 134.99 25.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.461 ' CG1' ' HE3' ' A' ' 275' ' ' LYS . 28.0 m -141.52 1.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.47 33.71 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 120.174 1.352 . . . . 0.0 113.385 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 290' ' ' PHE . 3.0 t80 -145.79 134.04 21.72 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.557 2.343 . . . . 0.0 107.842 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -141.54 147.39 37.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.154 2.582 . . . . 0.0 104.228 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.48 -144.62 12.71 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 149.2 29.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 122.052 0.929 . . . . 0.0 110.819 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -155.64 154.4 31.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.341 1.857 . . . . 0.0 106.797 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.2 t -146.38 -106.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.73 -23.1 60.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 119.943 1.247 . . . . 0.0 109.236 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.99 159.86 41.86 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 129.029 2.932 . . . . 0.0 108.79 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.3 tp -78.89 131.03 36.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -119.34 -32.21 4.43 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.561 -1.209 . . . . 0.0 113.001 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -140.05 125.39 18.92 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.59 1.541 . . . . 0.0 107.051 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.431 ' HA ' ' CE1' ' A' ' 279' ' ' PHE . 15.8 t80 -122.11 97.69 5.6 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.86 98.51 2.09 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 130.43 36.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -90.37 153.97 20.03 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.324 0.65 . . . . 0.0 109.81 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 18.1 m -126.43 138.11 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.1 0.96 . . . . 0.0 109.735 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 73.4 mtp -143.56 152.05 55.61 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.151 1.38 . . . . 0.0 107.667 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.24 152.98 79.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.436 2.091 . . . . 0.0 113.721 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.232 0.145 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.397 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -140.05 138.66 35.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.78 136.48 44.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.36 140.76 55.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.239 0.542 . . . . 0.0 110.763 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 164.82 19.26 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.157 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.23 145.96 18.01 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.62 -175.51 18.25 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 126.202 1.858 . . . . 0.0 110.829 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.55 -163.88 7.29 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.757 1.646 . . . . 0.0 113.865 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.0 0.22 43.43 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.172 1.389 . . . . 0.0 112.287 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.86 165.61 54.78 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.05 152.48 20.04 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.318 0.961 . . . . 0.0 111.941 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.5 114.51 6.16 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m 97.32 59.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 129.794 3.238 . . . . 0.0 118.284 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.429 ' CE3' ' CB ' ' A' ' 129' ' ' HIS . 30.9 p-90 -62.55 -14.96 48.04 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.592 1.557 . . . . 0.0 113.817 175.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.87 112.96 10.49 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.8 -37.42 71.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.002 0.521 . . . . 0.0 111.762 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.695 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.281 0 CA-C-O 118.142 -1.366 . . . . 0.0 114.395 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.62 128.03 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 120.116 1.958 . . . . 0.0 108.452 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -114.65 -56.75 2.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.891 1.276 . . . . 0.0 110.31 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -138.87 169.48 17.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.744 2.418 . . . . 0.0 106.897 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.03 142.65 25.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -127.76 107.93 10.3 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.97 134.89 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.87 142.59 14.03 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.21 161.23 14.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.525 1.13 . . . . 0.0 110.009 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.79 -167.99 32.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 125.587 1.565 . . . . 0.0 109.291 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.02 -38.63 83.26 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.096 0.558 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.86 11.72 2.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.221 1.408 . . . . 0.0 111.335 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.5 -136.37 15.37 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.82 106.96 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -14.38 14.87 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.0 p -131.16 139.03 49.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.152 1.342 . . . . 0.0 109.61 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 mm -142.88 140.66 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 126.328 1.851 . . . . 0.0 106.263 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -154.74 140.19 17.79 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.594 1.958 . . . . 0.0 105.886 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.54 156.17 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.32 144.04 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -116.73 105.22 12.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.59 125.21 27.47 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.906 -1.122 . . . . 0.0 108.284 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.77 160.57 19.26 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.39 -8.78 14.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.038 1.335 . . . . 0.0 111.606 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -101.56 -68.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 106.863 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -154.57 165.8 35.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.59 139.2 43.51 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.29 145.89 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -112.06 153.63 26.6 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.735 -1.228 . . . . 0.0 111.031 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 -123.75 2.03 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.18 176.6 35.96 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -75.13 142.04 43.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.21 65.1 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.268 2.227 . . . . 0.0 105.702 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.7 -164.01 37.59 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.56 123.26 43.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 143.26 51.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -106.9 -177.65 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.862 0.839 . . . . 0.0 111.86 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.2 tp -89.59 -39.59 13.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.059 0.944 . . . . 0.0 108.811 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -54.34 -38.56 66.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.988 2.115 . . . . 0.0 112.786 -178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.06 163.37 27.68 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-O 124.102 1.946 . . . . 0.0 108.427 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -109.63 162.94 13.94 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 110.966 -2.617 . . . . 0.0 108.854 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 164.23 13.94 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.078 1.751 . . . . 0.0 110.512 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.6 m -119.38 99.28 6.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.099 0.959 . . . . 0.0 113.53 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -87.72 140.63 29.32 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.06 130.71 52.83 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.649 1.579 . . . . 0.0 111.992 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.8 t -115.18 110.07 30.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 124.858 1.263 . . . . 0.0 108.276 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -69.84 173.18 6.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.054 1.341 . . . . 0.0 109.734 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.3 87.55 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.858 -1.151 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.95 7.65 41.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.349 1.459 . . . . 0.0 112.883 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.64 135.6 38.34 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.84 125.67 27.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mt -75.25 121.65 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.28 -19.17 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.82 147.18 29.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.01 113.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.26 130.56 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.46 144.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.824 1.25 . . . . 0.0 107.697 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -128.19 137.15 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -146.34 148.15 32.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.48 169.36 21.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.73 0.695 . . . . 0.0 110.185 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.31 148.05 33.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.906 1.282 . . . . 0.0 110.546 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.4 161.16 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.821 1.248 . . . . 0.0 108.792 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -61.83 129.11 39.41 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.414 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.15 -10.43 70.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.158 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.46 77.3 1.76 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.295 -2.484 . . . . 0.0 104.295 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.4 -9.49 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.345 2.258 . . . . 0.0 113.336 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.54 127.32 37.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.02 1.328 . . . . 0.0 109.207 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.04 114.14 4.98 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.3 pt -110.08 151.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.349 0.977 . . . . 0.0 110.412 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 mm -66.12 109.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 108.084 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -80.1 -28.55 39.02 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.682 -0.636 . . . . 0.0 110.967 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -170.51 174.0 5.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 109.476 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.68 144.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.617 1.967 . . . . 0.0 107.28 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.5 m -138.38 104.06 5.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.236 1.414 . . . . 0.0 107.612 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -78.81 150.5 32.31 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.871 -1.143 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -137.48 120.51 16.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -109.25 164.6 12.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.866 0.841 . . . . 0.0 112.895 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -63.68 -25.39 68.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.198 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -79.56 -5.5 55.07 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.531 -0.731 . . . . 0.0 110.727 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.77 2.68 62.83 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.833 1.206 . . . . 0.0 111.307 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -67.06 135.27 53.41 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.84 109.87 10.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.8 p -75.96 156.68 84.16 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.68 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.84 165.14 33.6 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 106.814 -2.033 . . . . 0.0 106.814 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.71 108.5 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.069 2.512 . . . . 0.0 107.393 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -79.83 71.42 6.5 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.49 -130.87 3.46 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 tp -139.78 105.9 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.732 2.013 . . . . 0.0 106.649 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 1.5 mt-10 -59.52 148.56 32.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.9 OUTLIER -127.66 178.82 5.87 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 109.328 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.413 ' H ' HG22 ' A' ' 111' ' ' THR . 21.7 tt0 -62.06 -54.88 35.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.59 130.76 48.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 1.1 ptpm? -160.18 166.47 29.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -150.43 160.4 43.78 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.89 2.076 . . . . 0.0 107.01 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.68 118.83 5.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -105.82 140.06 39.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 172.51 17.28 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 126.988 2.115 . . . . 0.0 108.875 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.05 175.81 7.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.913 1.685 . . . . 0.0 111.243 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -145.75 -15.39 0.48 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.081 0.553 . . . . 0.0 111.982 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.61 1.48 6.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.307 1.443 . . . . 0.0 110.871 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.01 108.48 0.99 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.39 162.96 36.75 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -110.23 159.08 17.71 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.083 1.353 . . . . 0.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.0 tt -72.86 130.13 39.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.15 -14.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.37 47.43 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -135.69 171.71 14.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.758 1.223 . . . . 0.0 112.442 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CB ' ' CE3' ' A' ' 15' ' ' TRP . 10.7 p80 -164.37 168.65 18.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.953 1.301 . . . . 0.0 109.986 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.92 -82.33 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 170.93 86.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 C-N-CA 129.359 3.064 . . . . 0.0 108.136 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -137.16 164.59 28.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.8 -99.45 0.12 Allowed Glycine 0 C--O 1.227 -0.341 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.42 -0.19 40.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.706 0.802 . . . . 0.0 113.154 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.54 166.51 26.93 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 126.19 1.796 . . . . 0.0 106.587 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -94.49 81.89 3.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -79.41 -64.75 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.584 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.45 131.18 35.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.451 0.7 . . . . 0.0 110.697 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 tp -155.38 173.64 16.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.554 0.692 . . . . 0.0 111.059 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.78 161.61 34.38 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 127.482 2.468 . . . . 0.0 107.902 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.56 159.56 35.96 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.357 1.063 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -121.91 159.01 27.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.515 0.726 . . . . 0.0 111.237 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -135.87 97.23 3.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.327 0 C-N-CA 127.005 2.122 . . . . 0.0 111.205 179.167 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.801 0.81 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -98.38 147.53 24.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.329 0.651 . . . . 0.0 109.445 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -113.58 146.0 40.38 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -111.06 -176.4 2.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.137 0.975 . . . . 0.0 109.768 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 122.9 48.67 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.842 1.257 . . . . 0.0 110.515 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.57 177.61 8.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.252 1.421 . . . . 0.0 111.604 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.46 160.9 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 125.7 1.6 . . . . 0.0 108.096 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.77 -102.26 0.14 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 125.771 1.653 . . . . 0.0 111.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.65 -117.44 11.56 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 65.65 -25.82 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 128.875 2.87 . . . . 0.0 114.481 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -132.25 148.0 52.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.043 1.737 . . . . 0.0 108.88 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.08 176.17 15.05 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 128.212 2.815 . . . . 0.0 107.363 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.0 m -80.8 142.04 34.12 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.71 110.14 14.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.87 130.79 9.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 120.034 1.288 . . . . 0.0 113.355 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.4 148.75 23.38 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.73 -27.85 17.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.321 1.448 . . . . 0.0 109.255 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 83.24 -147.55 24.64 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.95 138.86 18.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 194' ' ' TYR . 69.1 m-85 -111.76 179.85 3.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.97 0.508 . . . . 0.0 111.849 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.96 -36.5 62.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.952 0.882 . . . . 0.0 110.361 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.24 -177.31 44.22 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 127.929 2.68 . . . . 0.0 107.504 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 20.9 m -121.94 157.79 25.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 125.989 1.716 . . . . 0.0 108.033 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -50.64 2.14 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.529 0.604 . . . . 0.0 109.591 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -140.93 140.23 34.44 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 118.791 0.723 . . . . 0.0 109.736 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.53 142.1 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -133.95 152.7 51.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.507 0.723 . . . . 0.0 109.181 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.71 144.8 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -140.42 134.54 6.54 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -141.2 174.43 10.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.921 0.867 . . . . 0.0 112.093 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.62 -172.85 13.13 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 128.591 2.996 . . . . 0.0 106.41 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -65.56 -23.75 66.93 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.044 -0.68 . . . . 0.0 110.661 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -17.58 60.65 Favored 'General case' 0 N--CA 1.451 -0.38 1 C-N-CA 132.083 4.153 . . . . 0.0 112.8 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.82 -163.04 12.37 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mm -62.38 124.12 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.09 -19.09 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.752 1.221 . . . . 0.0 113.908 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.26 150.04 47.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.458 1.026 . . . . 0.0 111.846 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.63 142.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -164.48 168.56 18.25 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.959 2.504 . . . . 0.0 106.565 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.14 175.5 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.34 128.77 38.39 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.427 ' CE2' ' CD1' ' A' ' 172' ' ' TYR . 20.0 p90 -153.26 168.32 26.4 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.991 0.917 . . . . 0.0 110.236 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -115.91 149.32 38.9 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.615 1.566 . . . . 0.0 109.567 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -125.93 123.87 39.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 60.83 -98.83 0.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.36 18.29 5.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 112.293 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -130.51 125.09 33.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.977 0.911 . . . . 0.0 111.281 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -75.76 153.43 37.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.464 1.106 . . . . 0.0 108.582 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 194' ' ' TYR . 12.7 mt -127.03 136.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.684 1.594 . . . . 0.0 107.147 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.21 128.66 72.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 149.07 -120.98 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.12 -10.26 8.08 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.025 1.774 . . . . 0.0 113.799 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.53 132.34 48.35 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.241 1.52 . . . . 0.0 109.786 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -154.93 -40.85 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.578 0.751 . . . . 0.0 112.258 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.99 151.11 36.68 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 107.314 -2.315 . . . . 0.0 107.314 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -37.79 99.59 0.19 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.529 2.331 . . . . 0.0 114.775 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.29 151.55 54.52 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.9 m -122.97 152.64 40.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.01 -11.56 40.43 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.854 -0.529 . . . . 0.0 111.172 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.77 -24.97 67.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.29 1.836 . . . . 0.0 109.497 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.21 -156.77 17.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -139.52 152.97 47.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 106.21 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.19 154.16 21.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.63 157.07 44.37 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.899 0.48 . . . . 0.0 112.134 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -142.58 139.94 31.54 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.235 1.014 . . . . 0.0 110.606 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.65 125.98 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.77 110.59 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.94 89.18 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -36.16 -52.69 1.65 Allowed Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.89 -14.39 15.47 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.32 2.013 . . . . 0.0 114.515 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -93.66 -40.71 10.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.663 1.574 . . . . 0.0 109.404 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -92.19 172.25 8.54 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 107.418 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -146.42 -20.32 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.797 -1.189 . . . . 0.0 112.325 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp 49.88 88.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 127.922 2.489 . . . . 0.0 109.036 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.0 p -90.13 -4.46 57.29 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.76 163.13 34.89 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.16 153.28 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.267 1.427 . . . . 0.0 107.49 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.4 178.22 7.09 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.196 1.798 . . . . 0.0 109.776 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.49 -179.54 40.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 262' ' ' GLU . 18.6 p -141.08 141.13 34.28 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -134.87 153.26 52.12 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.951 0.5 . . . . 0.0 111.751 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.439 ' OD1' ' HE2' ' A' ' 235' ' ' LYS . 2.6 t0 -136.29 170.91 15.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.202 1.001 . . . . 0.0 109.558 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.439 ' HE2' ' OD1' ' A' ' 234' ' ' ASP . 0.0 OUTLIER -88.55 147.98 24.33 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.88 1.272 . . . . 0.0 112.732 -178.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.62 117.47 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -63.01 145.09 56.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 79.29 1.5 86.0 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.283 -0.731 . . . . 0.0 112.729 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 m -138.17 -177.5 4.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.995 2.118 . . . . 0.0 108.511 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.8 87.74 2.31 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.54 -176.25 39.26 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.022 -1.049 . . . . 0.0 111.012 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.69 149.66 49.43 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.081 0.952 . . . . 0.0 111.276 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.7 tt -134.18 130.5 54.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.962 1.705 . . . . 0.0 106.792 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.31 128.72 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.4 t -111.84 -18.79 12.62 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.723 1.209 . . . . 0.0 111.827 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -144.61 154.52 42.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.905 0.482 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.36 143.17 30.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.272 1.829 . . . . 0.0 109.195 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -142.79 153.78 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -128.54 113.48 15.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -77.89 113.71 16.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 p -98.24 164.76 12.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.924 2.089 . . . . 0.0 108.559 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -112.65 147.26 37.11 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 57.86 11.34 1.36 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -155.5 147.64 23.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.074 1.749 . . . . 0.0 106.934 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.5 p -113.14 100.24 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.438 1.495 . . . . 0.0 108.619 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -65.38 161.55 19.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.365 2.266 . . . . 0.0 114.441 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -105.2 163.1 17.84 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 127.186 2.195 . . . . 0.0 111.067 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.39 159.28 29.33 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.831 2.354 . . . . 0.0 110.415 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -137.3 110.91 8.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.96 -167.01 15.81 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 118.731 0.696 . . . . 0.0 112.417 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.48 110.6 23.0 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.906 1.283 . . . . 0.0 109.581 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 232' ' ' THR . 48.2 tt0 -66.02 108.75 2.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.425 1.49 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.9 28.64 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.058 1.343 . . . . 0.0 109.529 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.88 -164.81 50.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 122.548 1.082 . . . . 0.0 114.236 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 59.7 m -64.54 108.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.199 2.2 . . . . 0.0 109.095 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.75 142.31 38.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -141.45 170.95 14.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.391 1.091 . . . . 0.0 111.234 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.43 155.47 39.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.427 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.95 154.78 48.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -170.45 173.07 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.567 1.147 . . . . 0.0 107.911 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -139.47 165.94 25.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -43.77 71.48 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.845 0.748 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -161.03 72.23 0.22 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-O 118.995 -0.892 . . . . 0.0 111.835 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -151.05 158.03 43.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.325 1.063 . . . . 0.0 109.742 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -88.82 177.11 6.79 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.025 1.73 . . . . 0.0 108.717 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 37.8 mt -125.0 111.33 27.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.997 1.319 . . . . 0.0 108.608 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.27 93.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.255 2.222 . . . . 0.0 108.967 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.77 6.19 Favored Glycine 0 N--CA 1.468 0.771 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -120.6 135.65 55.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.224 1.809 . . . . 0.0 111.347 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -133.04 136.73 46.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 161.51 -159.93 31.76 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.926 -1.109 . . . . 0.0 112.64 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -137.21 127.4 26.22 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.21 154.68 19.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.94 1.296 . . . . 0.0 109.278 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 37.0 t -147.04 -98.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.71 -21.26 44.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.247 1.019 . . . . 0.0 111.456 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.3 mp -136.21 153.11 51.33 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.13 83.77 4.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.616 0.766 . . . . 0.0 111.225 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -78.94 -22.11 46.22 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.425 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.44 152.62 50.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.876 1.216 . . . . 0.0 113.12 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -162.69 134.9 5.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -158.82 169.67 35.18 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 135.15 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.852 0.826 . . . . 0.0 111.565 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -74.78 145.11 43.21 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.63 136.02 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.522 0.677 . . . . 0.0 110.548 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 70.3 mtp -138.62 137.06 19.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 129.372 3.069 . . . . 0.0 106.287 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.36 165.81 30.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.765 . . . . 0.0 109.589 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.409 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -142.15 102.88 4.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.201 0.6 . . . . 0.0 109.886 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t -75.52 143.29 13.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -97.23 134.62 40.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.524 1.53 . . . . 0.0 111.587 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.29 167.63 19.05 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.762 1.225 . . . . 0.0 111.687 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.3 163.51 30.66 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.568 2.032 . . . . 0.0 108.562 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.08 -109.08 0.41 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 107.053 -2.419 . . . . 0.0 107.053 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.3 -171.43 15.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 125.318 1.437 . . . . 0.0 109.628 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.34 91.72 2.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.482 0.713 . . . . 0.0 110.253 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.59 18.77 3.01 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.167 1.365 . . . . 0.0 112.231 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.88 -177.73 16.5 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.724 1.262 . . . . 0.0 113.054 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.99 158.43 27.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.752 1.263 . . . . 0.0 111.616 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 p -63.29 131.96 50.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -134.41 -19.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.212 1.005 . . . . 0.0 110.64 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.85 100.71 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.5 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.46 1.504 . . . . 0.0 107.727 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.463 0 C-N-CA 125.058 1.313 . . . . 0.0 109.918 -179.696 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.105 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.45 155.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.738 . . . . 0.0 108.978 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ttt-85 -130.86 -32.58 1.64 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -138.9 167.95 20.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.225 1.01 . . . . 0.0 109.555 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -139.46 85.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -87.83 135.29 33.46 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.88 148.62 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 127.473 2.309 . . . . 0.0 106.861 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.44 -157.87 10.65 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -134.08 164.2 27.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.732 0.766 . . . . 0.0 110.005 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.25 37.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 129.059 3.218 . . . . 0.0 105.97 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -91.68 -32.66 15.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.168 0.484 . . . . 0.0 110.131 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -101.11 -23.61 14.44 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 130.989 3.715 . . . . 0.0 114.094 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.56 -165.78 38.33 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.639 1.563 . . . . 0.0 112.97 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.71 96.07 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 107.956 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -75.54 -21.55 57.83 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -128.44 139.62 52.25 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.926 1.694 . . . . 0.0 113.728 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -145.28 154.01 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -140.4 137.99 34.43 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.89 159.07 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.489 1.041 . . . . 0.0 112.206 -178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.01 135.84 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -124.85 104.64 8.73 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.21 110.86 17.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.87 1.268 . . . . 0.0 108.852 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -116.74 139.55 50.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 61.54 -161.29 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.914 1.286 . . . . 0.0 109.176 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -73.07 24.78 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.246 1.418 . . . . 0.0 112.131 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -141.03 165.42 27.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.468 1.907 . . . . 0.0 111.34 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -107.84 140.25 41.21 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.81 133.73 48.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -66.95 129.02 38.54 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.45 -60.2 4.86 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.24 167.73 14.21 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -118.99 85.71 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.504 1.922 . . . . 0.0 107.561 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -83.83 170.41 14.14 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.871 0.843 . . . . 0.0 109.637 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.78 -166.12 42.79 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.479 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -111.33 102.72 11.09 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.801 1.241 . . . . 0.0 109.063 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -61.04 134.05 56.68 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 p -134.31 111.86 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.152 1.381 . . . . 0.0 109.566 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -8.24 13.37 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.08 -4.82 43.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.435 0.694 . . . . 0.0 111.692 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.89 110.46 0.28 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.68 143.15 19.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.064 2.946 . . . . 0.0 106.267 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.4 164.14 30.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.528 1.931 . . . . 0.0 110.876 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.3 m -128.03 128.5 45.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.774 1.63 . . . . 0.0 108.665 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -137.18 136.11 37.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.65 142.07 51.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.889 0.876 . . . . 0.0 109.144 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.4 t -98.34 110.5 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.73 161.36 30.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 109.137 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.97 -27.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -28.66 28.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -112.03 146.95 37.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -132.98 157.07 46.09 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.441 0.696 . . . . 0.0 109.783 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.29 138.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.34 -20.77 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.261 1.424 . . . . 0.0 111.851 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.0 156.31 42.51 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.349 -0.845 . . . . 0.0 109.346 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.71 100.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -86.31 122.49 30.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 101.353 -3.573 . . . . 0.0 101.353 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 115' ' ' PHE . 2.3 p -139.09 153.91 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 110' ' ' GLU . 9.8 t -136.52 151.91 49.94 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.048 1.739 . . . . 0.0 107.108 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.29 166.28 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.444 1.098 . . . . 0.0 110.409 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.19 169.17 22.79 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.769 1.168 . . . . 0.0 111.507 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -115.07 151.45 34.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.844 2.058 . . . . 0.0 110.71 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.34 126.91 74.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.28 121.9 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 108.745 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 -3.19 26.91 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.532 1.063 . . . . 0.0 112.183 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -132.13 144.82 50.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.369 1.467 . . . . 0.0 107.617 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.89 -21.5 23.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.22 0.608 . . . . 0.0 109.516 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -67.59 -177.65 0.78 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.373 1.559 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.39 151.59 34.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.52 144.73 28.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.34 0.656 . . . . 0.0 109.846 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.35 122.34 20.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -89.71 -28.99 19.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.041 0.936 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 t -163.11 160.87 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.448 1.476 . . . . 0.0 110.644 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.82 129.11 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 126.56 1.944 . . . . 0.0 108.55 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -135.49 101.45 4.81 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.115 1.366 . . . . 0.0 109.083 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -80.85 154.45 27.1 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.591 -1.318 . . . . 0.0 108.624 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.55 125.39 27.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.7 p -93.69 167.16 11.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.148 0.975 . . . . 0.0 111.668 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -65.94 -21.97 66.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -7.07 52.74 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.295 1.038 . . . . 0.0 111.686 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.6 -4.08 75.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 125.534 1.54 . . . . 0.0 111.587 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -79.35 149.59 31.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 118.492 1.146 . . . . 0.0 108.404 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.7 p -134.3 135.73 43.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.68 163.39 61.26 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.18 162.3 42.09 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.39 101.68 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.35 2.7 . . . . 0.0 108.546 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -73.45 78.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 145.48 -135.3 5.89 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.6 tp -139.43 127.91 22.95 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 127.06 2.144 . . . . 0.0 107.386 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.741 ' HA ' HG21 ' A' ' 79' ' ' THR . 1.1 tt0 -69.47 155.5 40.36 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.217 0.917 . . . . 0.0 110.917 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -142.45 164.51 29.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.068 0.947 . . . . 0.0 108.909 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -60.98 -40.89 95.2 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -70.43 112.14 6.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -155.17 160.23 40.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.197 -0.94 . . . . 0.0 111.327 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.424 ' CD1' HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -155.92 165.81 35.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.607 0.763 . . . . 0.0 112.133 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.53 150.26 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.977 1.711 . . . . 0.0 106.454 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 mt -111.7 4.47 18.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -47.09 117.99 1.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.466 1.106 . . . . 0.0 112.975 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -73.32 175.91 6.46 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.004 1.722 . . . . 0.0 108.298 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.67 -11.41 8.64 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.015 -1.053 . . . . 0.0 112.684 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -78.57 -5.97 54.24 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.43 24.63 25.79 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.318 -0.712 . . . . 0.0 112.082 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.25 175.4 11.39 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.584 1.564 . . . . 0.0 112.86 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -132.45 152.84 51.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.82 141.11 58.4 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.45 -33.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.54 -169.5 35.96 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 120.601 -1.312 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 0.4 OUTLIER -134.14 172.74 12.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.614 1.566 . . . . 0.0 111.205 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -164.99 149.39 9.02 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 127.955 2.502 . . . . 0.0 105.862 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.14 115.86 0.41 Allowed Glycine 0 C--O 1.221 -0.718 0 C-N-CA 119.616 -1.278 . . . . 0.0 116.001 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -48.97 110.96 0.41 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.533 1.533 . . . . 0.0 107.664 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.22 25.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.878 1.671 . . . . 0.0 108.53 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -168.93 -97.77 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -81.89 -8.19 59.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.16 24.5 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.648 1.979 . . . . 0.0 108.545 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.78 93.98 9.65 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.17 -72.99 0.27 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.992 0.917 . . . . 0.0 111.092 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.2 143.8 38.14 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.296 1.039 . . . . 0.0 109.953 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.7 tp -134.67 115.49 13.85 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.291 1.037 . . . . 0.0 109.641 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -130.87 174.31 19.9 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.158 1.361 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . . . -150.4 175.43 11.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.617 0.767 . . . . 0.0 110.473 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -117.15 133.54 55.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -126.56 99.32 5.76 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 128.017 2.527 . . . . 0.0 108.581 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 124.544 1.138 . . . . 0.0 108.666 179.287 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.415 0 CA-C-O 122.014 0.912 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -145.76 151.51 38.09 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.484 1.513 . . . . 0.0 108.729 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -112.18 133.66 54.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.227 2.211 . . . . 0.0 106.642 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.99 -173.94 3.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.24 1.016 . . . . 0.0 109.332 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 128.46 44.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -121.19 -179.87 4.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.885 1.274 . . . . 0.0 109.59 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.92 146.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.639 1.176 . . . . 0.0 107.904 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.85 -94.31 0.11 Allowed Glycine 0 C--O 1.228 -0.273 0 C-N-CA 124.979 1.276 . . . . 0.0 110.414 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.57 -157.44 19.19 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' CA ' ' HE2' ' A' ' 282' ' ' LYS . 6.7 p-10 -116.83 -4.68 11.57 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.867 1.667 . . . . 0.0 111.47 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.37 112.27 11.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.137 2.175 . . . . 0.0 111.669 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.58 161.94 10.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 124.807 1.194 . . . . 0.0 111.729 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.2 m -81.76 142.39 32.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.63 138.05 56.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -125.7 32.36 5.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.16 104.77 3.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -83.79 -50.27 8.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.689 0.795 . . . . 0.0 111.455 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.66 -123.32 1.85 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.25 160.94 43.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.878 2.071 . . . . 0.0 107.865 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.93 163.66 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.196 0.998 . . . . 0.0 109.826 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.27 -32.4 72.54 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.57 102.97 0.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.299 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.5 m -71.25 152.29 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -40.95 5.29 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -140.71 153.17 45.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.674 1.124 . . . . 0.0 108.402 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.24 143.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -126.65 164.18 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.416 0.687 . . . . 0.0 112.551 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 259' ' ' PHE . 3.6 t -131.51 128.02 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.47 89.4 0.38 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.928 1.728 . . . . 0.0 111.626 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -74.8 -177.9 3.46 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.893 1.33 . . . . 0.0 112.916 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.08 177.13 35.77 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 128.488 2.947 . . . . 0.0 107.603 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -62.53 -45.83 91.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.261 0.625 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.81 -32.54 57.69 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.336 1.455 . . . . 0.0 110.294 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.55 -168.09 32.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 121.996 0.776 . . . . 0.0 111.321 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.76 119.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.9 m -108.22 -29.08 9.1 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.52 25.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.595 0.758 . . . . 0.0 109.766 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.53 141.7 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 58.8 pttt -161.39 159.08 27.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.091 0.957 . . . . 0.0 110.256 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.84 174.35 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 108.11 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.95 147.34 33.63 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.343 1.857 . . . . 0.0 108.035 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 196' ' ' LYS . 7.7 t80 -147.45 153.52 39.68 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -128.09 92.21 3.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.531 2.332 . . . . 0.0 105.803 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 19.4 ptmt -89.19 139.72 30.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 49.85 46.4 40.18 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.457 1.027 . . . . 0.0 112.15 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.67 3.88 0.67 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.277 1.831 . . . . 0.0 115.562 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.17 -158.53 0.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.307 1.443 . . . . 0.0 107.312 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -136.73 139.0 41.57 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.376 1.444 . . . . 0.0 110.635 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.8 mt -125.5 122.91 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.806 1.642 . . . . 0.0 107.22 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 27.8 t -112.41 134.86 53.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.98 -119.37 3.28 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.49 5.69 66.81 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.242 1.401 . . . . 0.0 114.002 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.36 118.78 11.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.472 1.509 . . . . 0.0 111.34 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -123.14 13.16 9.65 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 0.0 111.344 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.53 -178.53 21.98 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.744 1.64 . . . . 0.0 109.229 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -106.16 102.8 41.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.065 0.932 . . . . 0.0 110.945 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.18 -175.36 2.67 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.671 2.247 . . . . 0.0 108.427 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.1 p -116.18 174.18 6.19 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.52 -9.39 34.29 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.308 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.74 -27.71 68.14 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.965 0.802 . . . . 0.0 110.371 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.23 -155.51 17.0 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.442 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 41.6 m-85 -134.1 172.18 13.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.435 1.494 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.67 160.8 31.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.49 2.716 . . . . 0.0 105.686 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -137.59 153.61 49.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.307 0.643 . . . . 0.0 111.709 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 256' ' ' SER . 27.7 t80 -142.66 143.05 32.18 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.06 0.944 . . . . 0.0 110.228 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -78.52 115.3 18.13 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.761 1.625 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.36 104.25 11.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -105.75 88.15 2.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -55.29 -33.46 17.63 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.083 -1.436 . . . . 0.0 114.695 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.4 -3.26 12.08 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 CA-C-N 123.585 2.316 . . . . 0.0 111.991 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m -132.44 -8.18 3.29 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 113.31 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -140.47 159.94 41.09 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.525 1.93 . . . . 0.0 110.542 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -144.25 119.93 10.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.422 1.089 . . . . 0.0 109.136 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.58 HG22 HD12 ' A' ' 276' ' ' ILE . 89.3 mt -81.88 94.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -24.16 45.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.22 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -146.72 167.8 22.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.167 0.987 . . . . 0.0 111.362 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.74 150.45 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.906 1.682 . . . . 0.0 106.481 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.444 ' OE1' ' HE3' ' A' ' 250' ' ' LYS . 36.6 mt-10 -132.87 160.44 36.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.398 1.079 . . . . 0.0 108.247 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -177.82 164.74 33.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.6 p -130.9 148.96 52.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -142.34 146.83 35.42 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.548 0.739 . . . . 0.0 109.863 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -130.57 155.2 46.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -69.55 147.11 51.22 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.139 0.976 . . . . 0.0 112.358 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.99 115.9 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -52.64 133.54 36.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.278 0.561 . . . . 0.0 110.522 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.58 82.99 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.389 -1.228 . . . . 0.0 113.086 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.8 t -140.81 169.89 16.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.389 1.595 . . . . 0.0 109.391 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.51 -12.17 38.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.533 1.533 . . . . 0.0 108.183 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -74.08 175.65 47.82 Favored Glycine 0 C--N 1.345 1.062 0 C-N-CA 127.195 2.331 . . . . 0.0 112.16 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 242' ' ' LEU . 0.0 OUTLIER -149.02 169.67 20.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 111.883 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.25 143.74 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.688 1.595 . . . . 0.0 108.467 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -91.38 105.9 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.329 1.0 OUTLIER -104.11 -3.81 24.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.606 0.639 . . . . 0.0 112.165 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -149.52 143.55 25.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.036 -1.04 . . . . 0.0 111.568 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.9 mt -137.49 154.79 49.82 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.999 1.72 . . . . 0.0 111.031 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -142.48 170.84 14.96 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.494 2.317 . . . . 0.0 109.003 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -148.21 113.76 5.65 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.674 1.19 . . . . 0.0 109.406 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.444 ' HE3' ' OE1' ' A' ' 230' ' ' GLU . 67.1 mttt -77.05 114.47 15.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 5.2 p -109.9 165.84 11.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 127.059 2.144 . . . . 0.0 108.272 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -116.95 140.37 49.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 63.17 -8.29 0.14 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.306 1.442 . . . . 0.0 113.739 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -117.07 169.01 9.75 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.735 2.014 . . . . 0.0 107.852 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -130.98 108.16 9.6 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 123.622 0.769 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' SER . . . . . 0.403 ' HA ' ' CE1' ' A' ' 217' ' ' PHE . 4.5 p -79.82 -178.13 6.27 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.825 1.25 . . . . 0.0 109.411 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.87 69.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.12 0.968 . . . . 0.0 110.034 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.97 101.92 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.057 2.504 . . . . 0.0 109.357 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 180' ' ' VAL . 91.7 m-85 -79.48 95.45 5.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 122.12 -169.64 14.88 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.7 122.32 47.31 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.129 0.972 . . . . 0.0 109.099 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.42 113.26 2.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.864 1.666 . . . . 0.0 110.509 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -154.99 149.0 25.78 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.347 1.459 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 74.89 -165.15 54.72 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 121.869 0.705 . . . . 0.0 114.171 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 21.8 m -62.97 137.97 58.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.523 1.929 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -108.59 121.71 45.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.54 43.21 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.56 0.744 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.97 130.45 43.42 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.602 1.961 . . . . 0.0 107.302 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.8 mt -119.22 129.74 55.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -149.38 171.35 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -138.4 147.09 42.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.17 -4.67 30.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.295 1.438 . . . . 0.0 114.851 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -167.72 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -92.57 168.1 11.48 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.854 1.827 . . . . 0.0 110.698 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.49 162.75 13.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.717 2.007 . . . . 0.0 110.387 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.58 HD12 HG22 ' A' ' 226' ' ' ILE . 21.6 mt -88.64 112.57 24.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.507 1.123 . . . . 0.0 108.892 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.37 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.26 153.12 8.93 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 125.383 1.468 . . . . 0.0 111.946 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -121.86 160.21 25.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.909 2.084 . . . . 0.0 108.779 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -159.29 176.89 11.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.615 0.766 . . . . 0.0 110.262 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 119.12 -111.29 2.05 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 126.549 2.023 . . . . 0.0 108.665 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.451 ' HE2' ' CA ' ' A' ' 162' ' ' ASP . 10.1 mtmp? -146.26 153.55 40.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.854 . . . . 0.0 112.498 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.92 131.22 34.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.132 1.773 . . . . 0.0 107.064 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.8 p -171.6 75.29 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 67.33 -70.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.873 2.469 . . . . 0.0 110.356 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 70.2 mt -81.33 172.56 13.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.217 2.207 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.7 tp -94.51 64.35 3.06 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.206 1.402 . . . . 0.0 109.688 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -61.4 -17.62 54.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -153.55 165.87 34.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -160.5 122.81 3.23 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -155.81 163.61 31.84 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.1 m -133.84 152.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.014 0.907 . . . . 0.0 113.116 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -85.25 167.71 15.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.969 1.708 . . . . 0.0 111.156 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.95 148.3 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.936 1.694 . . . . 0.0 109.092 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 92.1 mmm -152.99 149.07 21.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.634 1.973 . . . . 0.0 107.729 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.76 157.95 54.24 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.813 1.676 . . . . 0.0 110.037 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.341 1.056 . . . . 0.0 108.565 178.224 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -69.96 101.87 1.87 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.622 1.101 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -148.56 102.35 3.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.049 0.94 . . . . 0.0 108.889 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.5 t -77.0 146.47 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 123.803 0.841 . . . . 0.0 109.209 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.96 148.85 25.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.621 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.93 76.22 5.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.278 1.831 . . . . 0.0 109.66 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.84 113.52 4.81 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.9 35.39 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 118.215 1.007 . . . . 0.0 111.389 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.04 178.79 36.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.889 0.756 . . . . 0.0 113.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.6 87.19 2.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.921 1.289 . . . . 0.0 109.751 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.36 21.31 3.47 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.722 1.153 . . . . 0.0 112.386 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.22 -169.14 20.04 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 118.879 1.34 . . . . 0.0 113.446 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.52 105.02 3.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.221 1.809 . . . . 0.0 108.687 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 7.8 m -171.7 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.615 1.966 . . . . 0.0 113.926 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -65.35 -173.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.542 1.937 . . . . 0.0 110.494 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.68 109.19 0.2 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.103 1.361 . . . . 0.0 114.634 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.53 172.3 13.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.343 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.9 -4.91 29.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.982 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.83 -29.73 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.882 1.341 . . . . 0.0 113.31 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -65.85 114.15 4.88 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.852 0.751 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -26.0 59.88 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.742 -0.599 . . . . 0.0 109.822 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.38 -176.27 47.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.88 158.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.354 1.862 . . . . 0.0 109.979 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -140.07 -42.94 0.42 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.251 1.42 . . . . 0.0 113.674 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -142.5 150.32 40.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 120.528 1.513 . . . . 0.0 109.884 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.6 t -126.24 137.1 58.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.39 139.52 52.33 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' H ' ' HB2' ' A' ' 63' ' ' GLU . 42.8 t -140.6 94.01 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.08 108.44 3.44 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -71.49 110.78 6.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.9 2.08 . . . . 0.0 108.036 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.65 -173.98 38.37 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.28 -31.3 61.47 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.21 6.63 7.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 158.62 -175.79 35.63 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.531 1.514 . . . . 0.0 111.279 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.33 96.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.115 1.957 . . . . 0.0 108.755 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -97.86 -6.62 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.948 -1.501 . . . . 0.0 114.209 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.8 p -140.91 146.45 37.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 122.173 2.26 . . . . 0.0 112.609 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.0 171.4 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.718 1.607 . . . . 0.0 109.767 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -151.87 141.24 21.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -130.13 113.95 27.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 119.515 1.052 . . . . 0.0 109.409 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.25 154.24 13.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.525 0.73 . . . . 0.0 109.593 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -132.92 155.86 48.31 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.39 122.01 40.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 108.473 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.6 167.72 9.93 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.399 1.079 . . . . 0.0 108.314 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.12 5.29 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.852 5.661 . . . . 0.0 116.424 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.4 t -151.0 -67.96 0.18 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.874 2.07 . . . . 0.0 108.891 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -139.71 166.18 25.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.847 1.259 . . . . 0.0 111.558 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -78.01 162.95 26.36 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.73 2.012 . . . . 0.0 109.406 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.37 136.59 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -121.6 162.28 20.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.595 1.558 . . . . 0.0 109.036 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 144.46 21.49 0.16 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 128.695 3.045 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.46 20.3 45.03 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.08 121.62 19.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.473 1.637 . . . . 0.0 109.142 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.79 171.56 12.57 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 110.094 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.03 -153.49 41.81 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 98.7 5.25 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 120.421 -1.635 . . . . 0.0 113.169 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.47 149.95 49.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.3 t -144.57 158.74 43.63 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.2 -19.33 65.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.996 0.918 . . . . 0.0 112.155 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.39 15.34 26.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.765 1.226 . . . . 0.0 110.487 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.07 90.88 0.11 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.305 0.957 . . . . 0.0 112.813 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -164.0 153.16 13.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.188 2.195 . . . . 0.0 107.62 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 28' ' ' VAL . 5.4 mm-40 -144.22 164.7 29.97 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.55 1.54 . . . . 0.0 110.208 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -143.01 128.85 19.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -137.16 109.69 7.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.82 117.14 27.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.68 110.67 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.92 157.74 20.88 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.277 1.431 . . . . 0.0 111.627 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -16.02 63.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.201 1.4 . . . . 0.0 110.008 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.56 6.44 15.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.687 2.395 . . . . 0.0 110.71 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.84 141.81 31.99 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.684 -1.26 . . . . 0.0 108.969 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CD1' ' HE2' ' A' ' 124' ' ' LYS . 54.3 m-85 -134.27 114.57 13.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -85.5 106.93 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -92.54 -21.47 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.376 1.07 . . . . 0.0 113.777 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.93 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.232 0.924 . . . . 0.0 110.472 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.44 144.67 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.36 119.75 40.21 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.95 128.19 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.681 1.128 . . . . 0.0 109.012 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.733 HG21 ' H ' ' A' ' 111' ' ' THR . 70.3 m -121.86 152.1 39.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.637 1.975 . . . . 0.0 109.42 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.63 168.38 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.042 1.737 . . . . 0.0 109.181 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -156.59 164.71 37.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -144.41 137.86 27.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.818 2.047 . . . . 0.0 108.337 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.8 m -132.87 161.05 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.0 104.26 0.23 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.945 1.298 . . . . 0.0 112.021 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.36 -21.76 8.06 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 124.694 1.14 . . . . 0.0 113.342 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -80.68 85.9 5.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.4 -5.01 29.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.49 1.116 . . . . 0.0 111.161 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -131.88 95.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.041 2.136 . . . . 0.0 105.575 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -54.58 147.48 14.22 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 pt -133.41 169.51 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.223 1.011 . . . . 0.0 112.657 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 94' ' ' ILE . 1.6 mt -85.33 148.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.678 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -69.06 0.89 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.1 p -123.04 147.98 46.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.47 HD12 HD23 ' A' ' 139' ' ' LEU . 43.5 mm -131.4 148.53 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 m -151.06 104.19 3.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.02 144.77 31.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.13 113.3 13.72 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 p -92.01 165.82 13.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -76.55 -27.41 55.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -69.29 -7.21 34.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 111.75 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.37 5.5 57.97 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 125.945 1.736 . . . . 0.0 113.251 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -87.49 137.98 31.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.512 1.156 . . . . 0.0 108.869 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 110.75 9.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.66 155.26 89.26 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.32 169.59 18.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.396 2.064 . . . . 0.0 110.619 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 111.13 2.44 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 107.921 -1.607 . . . . 0.0 107.921 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -67.7 14.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.8 2.04 . . . . 0.0 113.917 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 177.17 -175.95 47.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 126.242 1.877 . . . . 0.0 109.92 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.8 tp -72.73 108.1 5.54 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.707 1.603 . . . . 0.0 114.027 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.38 128.17 34.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.733 ' H ' HG21 ' A' ' 79' ' ' THR . 34.3 m -130.57 165.06 23.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.814 1.646 . . . . 0.0 108.815 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -57.05 -52.3 65.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.51 1.524 . . . . 0.0 111.446 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -61.94 102.88 0.31 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 109.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.47 170.19 21.47 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.187 0.518 . . . . 0.0 110.465 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -142.12 164.79 29.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.87 135.56 42.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.576 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.39 123.93 18.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.701 0.801 . . . . 0.0 110.991 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.93 39.23 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.293 1.437 . . . . 0.0 107.89 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.85 122.28 43.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.304 0.642 . . . . 0.0 110.734 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -119.7 -22.1 7.01 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.603 1.561 . . . . 0.0 110.414 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -67.62 -22.04 65.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.365 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.96 -10.4 6.65 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.984 -1.454 . . . . 0.0 114.62 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.75 162.81 33.81 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 120.083 1.942 . . . . 0.0 112.167 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 72' ' ' TYR . 35.4 ttmt -126.66 143.03 51.36 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.59 146.71 39.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 -28.88 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.31 -151.91 9.53 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.31 171.17 14.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.903 0.859 . . . . 0.0 112.528 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -144.31 159.7 42.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.484 1.914 . . . . 0.0 106.579 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.03 110.09 2.08 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.304 0.954 . . . . 0.0 115.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -53.27 131.38 37.24 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.601 1.96 . . . . 0.0 107.071 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 14' ' ' SER . . . -154.43 164.98 37.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.462 1.505 . . . . 0.0 108.397 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.91 -101.67 0.16 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.4 -40.08 77.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.192 0.996 . . . . 0.0 110.238 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -125.41 153.31 43.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.22 98.52 10.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -74.2 -46.51 41.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.372 0.669 . . . . 0.0 110.994 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.51 165.4 31.33 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 110.46 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.47 HD23 HD12 ' A' ' 94' ' ' ILE . 36.3 tp -147.89 159.11 44.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.402 1.481 . . . . 0.0 107.691 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.85 21.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.76 133.78 24.15 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -82.22 168.34 17.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -130.31 163.56 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.524 -0.735 . . . . 0.0 110.508 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -87.26 115.86 24.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 1' ' ' ALA . 6.2 t -133.08 166.26 22.84 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.223 1.409 . . . . 0.0 108.469 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.4 p -116.0 175.59 5.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.613 0.365 . . . . 0.0 110.432 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 t -116.17 119.95 37.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.3 p -139.15 156.37 72.2 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.88 176.12 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.971 1.781 . . . . 0.0 109.563 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.89 139.98 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 p -130.15 161.22 61.41 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.535 0.734 . . . . 0.0 110.97 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.19 -172.86 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.035 3.156 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.08 140.85 56.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.032 0.933 . . . . 0.0 108.62 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.78 134.73 35.11 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.339 1.056 . . . . 0.0 110.388 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -87.02 146.59 26.06 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.9 mt -113.65 -166.66 1.11 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.2 m -146.32 125.89 13.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.84 -159.47 0.69 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.694 2.398 . . . . 0.0 108.67 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.9 tt -149.04 151.57 12.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.95 -38.77 0.42 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.842 0.746 . . . . 0.0 114.442 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.56 162.01 25.41 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.113 1.457 . . . . 0.0 112.85 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 49.2 p30 -112.73 0.88 15.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.076 1.75 . . . . 0.0 112.851 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -131.71 135.43 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.637 1.108 . . . . 0.0 109.86 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 132.6 159.13 9.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 127.713 2.577 . . . . 0.0 109.125 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.5 m -67.9 134.37 50.72 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 112.267 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.74 135.22 36.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -127.68 33.46 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.093 1.357 . . . . 0.0 110.475 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -58.03 107.63 0.49 Allowed 'General case' 0 C--N 1.334 -0.095 0 O-C-N 120.775 -1.203 . . . . 0.0 112.48 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.72 -16.73 60.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.986 0.914 . . . . 0.0 110.274 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 -75.14 1.53 Allowed Glycine 0 C--N 1.337 0.612 0 CA-C-O 118.522 -1.155 . . . . 0.0 110.53 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.89 146.81 2.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.426 2.291 . . . . 0.0 109.02 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -124.86 167.19 14.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.893 2.077 . . . . 0.0 106.831 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -24.36 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.92 -174.73 42.25 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.63 116.59 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.63 -39.03 8.08 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.642 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -145.42 150.63 36.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.559 HG13 ' CE2' ' A' ' 192' ' ' PHE . 41.2 t -132.46 150.36 33.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.925 0.89 . . . . 0.0 109.084 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -142.48 155.63 45.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.823 1.249 . . . . 0.0 108.677 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.59 130.49 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.84 93.43 0.54 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -70.67 155.66 40.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.117 0.961 . . . . 0.0 110.076 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.35 -167.82 14.89 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 126.674 2.083 . . . . 0.0 109.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -89.16 -9.05 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.326 -1.102 . . . . 0.0 110.9 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -117.25 -31.85 5.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.507 3.123 . . . . 0.0 113.686 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.07 -158.3 30.59 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.62 110.61 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 62.6 m -116.39 -12.71 11.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.017 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.21 130.75 29.25 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.91 1.232 . . . . 0.0 110.143 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.97 135.82 50.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -148.44 139.81 23.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 178' ' ' VAL . 14.2 m-85 -132.92 163.25 29.57 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.74 1.616 . . . . 0.0 109.13 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -123.03 150.99 42.35 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -161.29 167.95 24.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.252 1.021 . . . . 0.0 111.726 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -120.28 113.01 19.76 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -107.19 122.52 46.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.31 -84.19 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.73 -4.95 1.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.912 2.085 . . . . 0.0 110.799 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.4 168.28 20.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.57 1.548 . . . . 0.0 110.455 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.92 101.93 5.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.445 2.698 . . . . 0.0 105.94 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.78 118.18 36.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.264 1.026 . . . . 0.0 109.35 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.19 128.53 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 128.3 -140.13 11.56 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 110.06 9.86 23.47 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.433 1.117 . . . . 0.0 115.851 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -68.58 108.53 3.37 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.739 1.77 . . . . 0.0 109.499 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -129.2 27.14 5.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.084 2.153 . . . . 0.0 109.774 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -145.06 -178.74 20.88 Favored Glycine 0 N--CA 1.451 -0.322 0 O-C-N 120.444 -1.41 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -85.36 94.64 0.33 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.809 1.244 . . . . 0.0 111.024 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.4 162.51 38.51 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.571 1.597 . . . . 0.0 108.047 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.9 m -137.48 166.32 24.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -2.59 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.0 -7.16 47.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.405 1.082 . . . . 0.0 109.202 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.56 -148.92 32.84 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -141.65 157.28 45.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 108.436 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.57 154.7 28.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 128.523 2.729 . . . . 0.0 104.052 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.05 140.12 23.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.02 132.24 23.24 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.312 1.045 . . . . 0.0 108.491 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -105.61 97.02 6.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.45 141.24 15.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.98 88.76 4.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -49.02 -55.6 19.81 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 113.876 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.25 -9.62 21.93 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.51 1.575 . . . . 0.0 114.578 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.42 -38.05 6.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.63 1.105 . . . . 0.0 113.88 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 172.62 10.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.0 112.678 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -150.15 149.03 29.67 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.65 -0.656 . . . . 0.0 112.543 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.04 100.16 7.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.5 t -73.17 -29.13 62.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.525 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.04 170.63 16.29 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.71 1.604 . . . . 0.0 108.646 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.72 150.65 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.655 1.182 . . . . 0.0 108.366 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -133.77 166.76 21.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.786 2.035 . . . . 0.0 109.245 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.45 166.93 28.35 Favored Glycine 0 N--CA 1.452 -0.265 0 O-C-N 120.968 -1.083 . . . . 0.0 110.823 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 79.1 p -137.1 133.95 35.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -117.31 138.22 51.91 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 109.77 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -119.14 146.85 44.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.098 0.952 . . . . 0.0 108.586 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -69.68 129.11 38.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 112.948 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.8 155.42 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -93.33 173.63 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 77.41 -25.69 1.97 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.301 1.429 . . . . 0.0 114.62 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 11.9 p -141.56 168.85 18.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.542 1.671 . . . . 0.0 109.715 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -84.4 11.73 8.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 110.648 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.46 -175.78 27.4 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.788 1.185 . . . . 0.0 112.939 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.5 mt -149.23 166.67 28.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.662 1.985 . . . . 0.0 109.335 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.15 172.78 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.12 112.97 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.12 1.368 . . . . 0.0 108.994 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.55 -4.42 19.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.569 0.748 . . . . 0.0 112.742 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.3 tmm? -147.7 110.98 4.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 17.7 mt -125.75 132.72 52.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.14 1.376 . . . . 0.0 108.363 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -129.04 166.15 19.78 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.647 1.213 . . . . 0.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.01 134.83 44.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -73.11 130.71 40.89 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.3 m -139.0 130.64 27.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 254' ' ' GLN . 8.2 p30 -100.94 156.22 17.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.207 1.803 . . . . 0.0 107.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.8 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.82 2.448 . . . . 0.0 115.268 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 252' ' ' ASN . 49.6 mt-30 -131.63 174.78 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 129.124 2.97 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 97.3 m -130.08 108.96 10.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.319 1.447 . . . . 0.0 108.81 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -81.27 136.03 35.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.0 154.27 69.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.46 88.86 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.185 2.59 . . . . 0.0 107.363 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -69.89 105.29 2.76 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.15 -172.38 23.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.712 0.687 . . . . 0.0 113.43 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.65 113.33 21.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.799 1.64 . . . . 0.0 110.09 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.16 131.19 50.04 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.113 1.365 . . . . 0.0 110.183 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.07 1.95 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 129.272 3.029 . . . . 0.0 105.873 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.26 -166.2 45.8 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 83.4 m -84.87 144.99 28.04 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.412 1.485 . . . . 0.0 108.143 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -100.48 150.76 22.32 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -143.92 164.17 31.34 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 111.456 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.79 154.45 37.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.631 1.572 . . . . 0.0 109.657 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.3 mt -131.89 105.61 7.55 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -139.81 143.99 37.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.921 0.889 . . . . 0.0 112.686 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -144.46 153.51 41.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.696 1.998 . . . . 0.0 106.371 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -86.83 145.83 26.45 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.494 -1.379 . . . . 0.0 112.206 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.94 -43.33 0.79 Allowed Glycine 0 C--N 1.341 0.853 0 C-N-CA 127.035 2.255 . . . . 0.0 115.431 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -74.28 159.47 32.4 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.321 1.049 . . . . 0.0 111.935 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 297' ' ' LEU . 1.2 mppt? -125.59 174.31 8.35 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.943 2.097 . . . . 0.0 105.555 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.8 140.34 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.492 0.663 . . . . 0.0 109.661 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.13 -3.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 128.337 2.655 . . . . 0.0 111.717 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.11 156.89 28.38 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 120.526 1.512 . . . . 0.0 114.6 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -114.83 162.7 16.53 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 112.161 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -150.75 137.44 18.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 169.07 -160.45 33.87 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -145.6 143.66 30.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.255 0.55 . . . . 0.0 111.967 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.61 148.54 12.57 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 126.938 2.095 . . . . 0.0 107.171 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.2 m -131.41 -34.08 1.42 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 127.288 2.235 . . . . 0.0 107.003 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -144.21 -56.74 0.37 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.48 148.65 26.23 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.55 1.94 . . . . 0.0 110.076 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 86.51 4.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.554 0.616 . . . . 0.0 110.595 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -67.01 -58.73 4.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.618 0.367 . . . . 0.0 111.737 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -126.1 136.34 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.481 0.582 . . . . 0.0 110.954 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -132.32 123.1 26.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.715 1.606 . . . . 0.0 108.883 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -137.34 170.48 23.58 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.316 1.436 . . . . 0.0 109.911 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.02 171.95 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.238 0.615 . . . . 0.0 111.44 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -121.37 166.09 14.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.94 2.096 . . . . 0.0 106.131 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.58 136.7 56.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 75.1 mtp -137.03 140.62 31.95 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 108.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.2 104.83 1.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.1 3.2 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 275' ' ' LYS . 74.9 mt -120.32 46.32 2.0 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.56 1.144 . . . . 0.0 109.263 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 9.7 t -109.06 165.83 11.29 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--O 1.245 0.852 0 CA-C-O 116.586 -1.674 . . . . 0.0 111.086 -179.795 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.1 100.0 3.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.402 1.096 . . . . 0.0 109.767 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -148.72 138.35 21.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 130.688 3.595 . . . . 0.0 105.202 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.73 145.86 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -89.5 161.96 15.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.562 1.172 . . . . 0.0 111.255 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.96 90.05 8.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.23 103.96 1.26 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.99 -177.29 44.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.33 1.919 . . . . 0.0 108.976 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.92 161.75 46.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 118.452 1.126 . . . . 0.0 112.85 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.44 0.37 55.35 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.67 166.28 43.16 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.61 174.35 23.09 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 123.98 0.8 . . . . 0.0 112.915 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.32 131.77 34.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.4 p -71.55 128.33 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.015 0.825 . . . . 0.0 110.341 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -121.54 4.8 10.13 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -64.36 136.1 56.8 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 71.58 12.0 6.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.892 2.477 . . . . 0.0 110.468 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.11 156.0 30.1 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 m -65.29 116.95 5.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.441 0.696 . . . . 0.0 111.694 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -143.13 170.39 15.82 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.434 2.294 . . . . 0.0 108.281 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -147.17 -11.3 0.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.18 172.51 28.6 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.56 153.6 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.024 0.912 . . . . 0.0 108.592 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 43' ' ' ALA . 17.1 mmt85 -131.18 -52.27 1.03 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.862 1.665 . . . . 0.0 111.2 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -126.08 160.74 29.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.69 129.14 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.56 119.88 26.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 92.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.09 143.87 16.87 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.93 175.02 3.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.063 0.945 . . . . 0.0 110.863 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.94 175.71 43.31 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -66.41 -36.96 84.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.88 2.79 28.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 130.863 3.665 . . . . 0.0 110.711 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -166.89 24.81 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.45 122.76 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -136.47 -19.85 1.4 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.426 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -99.17 112.95 24.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.52 144.26 36.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 121.97 -0.456 . . . . 0.0 110.35 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -148.44 151.01 34.48 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.937 1.695 . . . . 0.0 107.837 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.78 158.53 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.918 1.287 . . . . 0.0 108.206 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.39 115.2 39.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -88.99 105.54 17.85 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.178 1.391 . . . . 0.0 109.068 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HB2' ' HG2' ' A' ' 24' ' ' ARG . . . -68.37 126.15 28.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.088 -0.383 . . . . 0.0 110.509 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -113.78 146.27 40.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.7 -36.12 75.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.593 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -64.36 -63.66 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -156.13 141.56 17.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.048 0.939 . . . . 0.0 108.873 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.27 111.72 10.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.28 136.74 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.804 0.812 . . . . 0.0 112.395 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -78.28 162.47 26.5 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.622 1.969 . . . . 0.0 109.682 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.58 6.75 8.48 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.131 1.824 . . . . 0.0 111.238 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.26 161.04 26.16 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 125.953 1.74 . . . . 0.0 113.75 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.3 137.68 56.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.907 0.883 . . . . 0.0 109.573 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -122.88 51.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.24 -177.34 27.54 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.861 1.696 . . . . 0.0 111.3 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.61 84.89 3.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.919 1.288 . . . . 0.0 110.404 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -56.56 132.56 51.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.428 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -129.49 147.61 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -75.18 -36.73 61.45 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.856 -0.528 . . . . 0.0 111.628 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mp -102.11 23.12 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.25 91.93 0.15 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 121.761 -0.587 . . . . 0.0 112.1 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -161.64 154.79 20.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 105.01 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -150.57 164.85 35.01 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.12 1.768 . . . . 0.0 108.847 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.6 m -145.07 122.12 11.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.93 0.492 . . . . 0.0 110.541 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -131.61 131.53 43.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -107.92 141.34 39.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.213 1.005 . . . . 0.0 108.687 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.48 112.9 42.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.88 176.56 4.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.765 2.026 . . . . 0.0 111.533 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -46.38 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -101.9 -5.04 25.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.008 2.123 . . . . 0.0 113.388 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -94.53 137.13 34.03 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -123.94 162.41 23.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.342 0.973 . . . . 0.0 110.573 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.4 mt -86.92 118.27 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.16 -45.88 20.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.266 1.426 . . . . 0.0 109.823 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.38 166.15 28.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.621 1.169 . . . . 0.0 109.651 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.06 103.35 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -82.37 135.37 35.19 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -133.66 127.75 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.9 p -114.64 149.1 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -151.85 168.15 26.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.889 0.768 . . . . 0.0 110.571 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -153.78 151.96 30.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -128.46 127.88 43.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.544 2.338 . . . . 0.0 105.918 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.64 166.21 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.887 1.275 . . . . 0.0 111.086 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.83 156.9 31.89 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.42 -14.65 6.49 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.071 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -129.03 107.23 9.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.184 1.492 . . . . 0.0 108.177 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.36 -14.25 62.86 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 111.041 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.4 p -72.01 176.44 5.06 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.547 1.539 . . . . 0.0 110.011 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.68 135.65 30.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.53 154.11 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.776 0.716 . . . . 0.0 110.647 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.73 112.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.857 1.263 . . . . 0.0 107.989 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -77.24 -36.78 54.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.566 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.6 t -158.98 158.72 33.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.843 2.057 . . . . 0.0 109.243 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.06 151.49 27.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.775 2.03 . . . . 0.0 107.11 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 m -150.67 108.45 3.69 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.18 158.71 31.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -135.49 122.04 20.73 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.1 p -108.53 160.68 15.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 119.276 0.944 . . . . 0.0 112.287 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -68.76 -37.88 79.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.315 0.646 . . . . 0.0 109.746 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -15.28 63.51 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 116.772 -1.585 . . . . 0.0 113.431 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.61 3.5 49.8 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 120.188 1.358 . . . . 0.0 112.589 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -82.7 95.07 7.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.5 m -104.35 122.31 45.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.8 p -70.13 159.7 83.46 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 111.561 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.33 170.26 20.34 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.073 1.849 . . . . 0.0 107.435 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.58 109.75 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 N-CA-C 106.519 -2.147 . . . . 0.0 106.519 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -81.03 77.06 7.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.65 -149.97 20.36 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.772 1.653 . . . . 0.0 110.234 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.3 tp -105.27 125.77 51.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.113 1.365 . . . . 0.0 110.591 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.46 139.48 53.97 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.9 m -134.78 157.14 47.51 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.439 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -61.76 -45.56 93.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.217 0.607 . . . . 0.0 109.492 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -65.2 110.32 2.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 107.229 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -163.86 166.8 21.48 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.409 -0.807 . . . . 0.0 112.226 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -150.87 167.67 26.8 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.24 1.816 . . . . 0.0 108.921 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.24 142.62 38.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 129.84 55.48 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.985 0.914 . . . . 0.0 111.129 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 147.2 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.144 1.377 . . . . 0.0 108.229 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 123' ' ' GLY . 27.9 t0 -76.49 174.51 10.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -50.05 -53.73 25.02 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.928 1.691 . . . . 0.0 109.425 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -114.32 -23.81 9.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 117.835 -1.078 . . . . 0.0 113.607 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.22 55.83 0.13 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.939 1.245 . . . . 0.0 113.919 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 119' ' ' ASP . . . -71.74 138.5 27.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -65.75 144.47 56.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -62.12 97.05 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.143 1.777 . . . . 0.0 107.866 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.72 -51.99 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -174.07 141.12 5.8 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -87.55 177.76 6.98 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.642 1.177 . . . . 0.0 111.328 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -147.2 169.37 19.48 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 107.319 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.91 -177.99 47.49 Favored Glycine 0 CA--C 1.523 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.258 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -142.45 50.71 1.48 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.67 2.388 . . . . 0.0 108.629 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.43 163.53 17.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 119.902 -1.748 . . . . 0.0 109.164 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.86 -104.45 0.19 Allowed Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.09 -15.99 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.409 0.711 . . . . 0.0 111.144 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.83 174.61 12.03 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.874 2.47 . . . . 0.0 107.343 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.6 tp -98.91 88.54 4.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -79.58 -52.64 7.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.694 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.77 158.53 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 111.982 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -148.6 147.09 28.59 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.447 3.499 . . . . 0.0 106.576 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -144.18 -173.21 15.4 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.83 156.18 35.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.758 1.279 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -128.68 109.84 11.68 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.65 99.14 8.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.07 101.02 3.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.6 t -130.44 102.71 6.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 122.676 1.227 . . . . 0.0 108.059 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -163.36 164.55 24.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.46 1.904 . . . . 0.0 107.02 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.1 65.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.6 p -72.38 159.09 86.31 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 -169.27 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.983 2.456 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.9 t -52.56 149.92 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.157 1.383 . . . . 0.0 109.274 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -73.38 146.36 86.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.01 -166.03 0.15 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.702 3.601 . . . . 0.0 115.183 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.21 178.5 1.88 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.896 2.078 . . . . 0.0 110.59 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -74.74 131.09 40.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -111.92 147.9 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.633 1.973 . . . . 0.0 106.855 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.32 167.76 10.17 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.166 1.386 . . . . 0.0 107.84 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -73.51 107.33 5.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.8 171.56 10.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.667 0.787 . . . . 0.0 109.339 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.49 148.05 30.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 159.8 -112.44 0.52 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 125.006 1.289 . . . . 0.0 110.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -115.67 163.51 12.29 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.882 1.706 . . . . 0.0 110.453 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.13 -5.61 40.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.13 1.372 . . . . 0.0 112.474 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.506 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 44.7 tt0 -112.98 144.0 43.32 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.417 1.487 . . . . 0.0 109.752 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.56 171.52 12.87 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 123.795 0.712 . . . . 0.0 113.167 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.4 m -82.07 116.96 21.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.847 0.859 . . . . 0.0 108.901 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.06 126.27 29.19 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -134.13 127.07 31.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.011 0.924 . . . . 0.0 111.746 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.18 155.63 17.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.985 1.714 . . . . 0.0 108.681 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -150.81 100.19 2.79 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.55 160.36 5.02 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.54 143.71 51.53 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -104.77 178.33 4.59 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 111.317 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -53.05 -45.1 67.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.078 1.751 . . . . 0.0 112.361 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.74 -176.33 46.97 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 128.874 3.13 . . . . 0.0 106.157 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.67 141.26 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -121.86 -19.8 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -144.28 158.54 43.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.95 145.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -128.94 156.05 44.36 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 t -136.29 123.35 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.87 57.67 0.58 Allowed Glycine 0 C--N 1.341 0.833 0 C-N-CA 124.394 0.997 . . . . 0.0 114.834 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.471 ' CD ' ' H ' ' A' ' 182' ' ' GLN . 3.2 pm0 -68.21 159.93 30.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.964 0.905 . . . . 0.0 110.024 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.28 -140.07 3.83 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.542 1.544 . . . . 0.0 110.477 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -82.15 -37.13 26.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.192 0.997 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.55 -31.45 11.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.725 2.01 . . . . 0.0 113.759 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.16 -158.48 29.52 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 119.749 1.158 . . . . 0.0 110.975 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 105.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 m -95.13 -23.46 17.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 0.0 111.472 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.35 157.69 38.97 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.808 1.643 . . . . 0.0 109.3 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.57 156.53 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.592 1.957 . . . . 0.0 106.545 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.417 ' HE2' ' CG ' ' A' ' 214' ' ' PHE . 59.8 pttt -174.13 134.0 0.43 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 128.78 2.832 . . . . 0.0 105.842 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -125.95 162.22 25.73 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.092 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -103.09 152.35 21.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.778 1.231 . . . . 0.0 109.585 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.03 163.9 23.2 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.532 1.133 . . . . 0.0 109.682 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.24 145.72 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.071 1.748 . . . . 0.0 106.978 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -140.56 97.19 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 65.34 -143.57 46.16 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.65 5.7 10.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.844 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.94 168.5 9.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.738 1.215 . . . . 0.0 110.709 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.75 142.79 49.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.821 1.648 . . . . 0.0 107.186 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.4 mm -131.81 102.41 5.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.26 105.23 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 139.31 170.5 11.9 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 121.751 0.64 . . . . 0.0 114.516 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.43 45.23 0.02 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.684 2.087 . . . . 0.0 109.28 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.62 100.61 3.38 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.665 1.186 . . . . 0.0 109.87 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -116.84 -24.45 7.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.639 1.176 . . . . 0.0 112.122 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -91.8 -179.24 41.93 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.96 91.55 0.97 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.248 1.024 . . . . 0.0 109.161 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.36 156.63 58.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 121.367 1.524 . . . . 0.0 109.324 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 71.2 p -98.91 173.48 6.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.62 -10.55 59.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.086 -1.009 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.0 tt -53.37 -39.35 64.13 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.59 175.28 29.73 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.665 1.603 . . . . 0.0 111.149 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CG ' ' HE2' ' A' ' 191' ' ' LYS . 53.4 m-85 -102.34 138.41 39.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.355 1.062 . . . . 0.0 109.628 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.88 164.17 13.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.977 2.511 . . . . 0.0 106.326 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.13 157.37 44.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 121.542 1.974 . . . . 0.0 115.684 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.55 143.63 32.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.633 1.173 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 124.2 43.75 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 108.762 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.96 117.5 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 C-N-CA 126.604 1.962 . . . . 0.0 106.304 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -93.98 106.36 18.34 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.574 1.079 . . . . 0.0 109.999 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -38.66 -61.42 0.89 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.6 -19.31 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.192 1.819 . . . . 0.0 116.301 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.5 t -106.93 -12.92 15.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.576 1.989 . . . . 0.0 114.769 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.33 160.18 15.81 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 107.229 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -152.48 106.87 3.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 119.935 -1.728 . . . . 0.0 109.894 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.93 70.48 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 t -68.12 -16.95 64.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.546 -1.346 . . . . 0.0 112.739 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -157.94 167.51 29.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.862 1.665 . . . . 0.0 107.914 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.55 159.54 37.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.424 ' OE2' ' HE3' ' A' ' 250' ' ' LYS . 31.4 mt-10 -131.51 172.92 11.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.41 1.484 . . . . 0.0 108.388 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.52 179.8 42.8 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.3 m -157.19 150.52 23.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 155.47 48.61 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -153.02 164.4 38.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.892 0.853 . . . . 0.0 108.964 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -70.07 148.36 48.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.053 2.141 . . . . 0.0 112.907 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.7 mt -90.16 151.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -108.8 76.8 1.03 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 149.22 -15.85 1.14 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-O 117.944 -1.476 . . . . 0.0 115.483 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 m -132.44 148.49 52.41 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.734 1.267 . . . . 0.0 108.293 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.62 86.23 7.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.844 1.258 . . . . 0.0 109.235 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 178.28 -169.92 41.84 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 0.0 110.065 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.65 156.44 39.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.99 2.116 . . . . 0.0 105.393 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.8 tt -134.52 167.46 25.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.958 1.303 . . . . 0.0 107.761 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.9 mm -99.05 93.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 111.708 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -87.31 -21.77 25.54 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.267 -0.896 . . . . 0.0 113.323 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -137.72 144.63 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 109.632 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -143.31 149.89 38.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.245 0.93 . . . . 0.0 109.624 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.547 ' H ' HD23 ' A' ' 247' ' ' LEU . 73.4 mtt180 -148.33 159.67 43.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.917 1.687 . . . . 0.0 109.226 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -138.7 116.0 11.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 230' ' ' GLU . 85.2 mttt -73.77 149.79 41.51 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.0 p -145.37 165.39 28.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.255 0.48 . . . . 0.0 110.493 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -99.99 133.78 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.32 2.248 . . . . 0.0 105.362 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 58.2 -19.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.946 2.098 . . . . 0.0 115.498 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.98 171.61 9.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.4 2.28 . . . . 0.0 108.797 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.3 p -141.52 99.88 3.66 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.0 p -82.92 172.46 12.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.031 1.332 . . . . 0.0 111.197 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -120.62 157.82 53.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.015 1.326 . . . . 0.0 111.067 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.214 2.61 . . . . 0.0 107.521 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -81.35 92.21 6.37 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.1 174.19 17.5 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.572 1.558 . . . . 0.0 111.224 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 92.2 mt -95.95 146.57 24.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 109.087 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -71.72 146.72 47.99 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.9 -179.99 7.17 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.134 1.374 . . . . 0.0 109.986 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 37.73 -96.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.968 2.223 . . . . 0.0 116.082 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 96.2 m -146.29 129.1 16.28 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.873 0.869 . . . . 0.0 110.407 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.98 35.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -142.01 161.19 38.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.88 154.74 38.84 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.982 -1.074 . . . . 0.0 109.86 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.99 151.97 47.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -158.91 173.96 15.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.991 2.516 . . . . 0.0 107.064 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -144.93 164.09 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 107.146 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.34 -18.16 57.67 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 175.84 63.97 0.06 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -152.24 175.49 12.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.218 1.807 . . . . 0.0 106.753 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -115.46 152.24 33.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.396 1.478 . . . . 0.0 107.29 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.2 mt -86.61 119.87 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.4 m -147.22 69.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.467 0.707 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.73 -178.79 18.4 Favored Glycine 0 N--CA 1.467 0.722 0 O-C-N 120.198 -1.564 . . . . 0.0 114.316 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.89 160.97 40.44 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.69 1.196 . . . . 0.0 110.758 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -157.69 132.61 8.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -175.43 -152.74 9.62 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.506 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 16.1 ptmt -143.8 147.46 34.17 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.2 156.18 21.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 108.195 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 20.3 t -127.35 -90.66 0.52 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -79.2 -58.17 3.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 20.2 mt -110.75 165.89 11.46 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.999 1.719 . . . . 0.0 111.832 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.01 106.39 4.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 109.545 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -96.12 -45.94 6.67 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.2 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.4 ' HB3' ' H ' ' A' ' 282' ' ' LYS . 50.4 tt0 -122.05 137.68 54.72 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.068 0.849 . . . . 0.0 112.151 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -138.1 149.8 46.27 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.511 1.124 . . . . 0.0 109.945 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -169.16 154.98 24.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.32 151.47 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 118.343 1.072 . . . . 0.0 112.504 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.85 154.02 20.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 141.24 47.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.516 0.726 . . . . 0.0 111.371 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 83.2 mmm -144.73 144.45 24.58 Favored Pre-proline 0 N--CA 1.465 0.278 0 C-N-CA 126.924 2.09 . . . . 0.0 107.399 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.96 159.39 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.627 1.26 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.42 172.19 6.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.088 0.955 . . . . 0.0 110.362 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 14.5 t -119.35 -17.23 8.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.682 0.793 . . . . 0.0 111.07 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 . . . . . 0 C--O 1.247 0.933 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.622 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.005 0.431 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -130.96 154.04 48.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.393 2.277 . . . . 0.0 110.3 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -129.95 139.12 51.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.904 1.682 . . . . 0.0 107.602 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -124.83 110.07 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 103.981 -2.599 . . . . 0.0 103.981 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 165.63 17.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.983 0.897 . . . . 0.0 110.843 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 163.41 12.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.307 1.443 . . . . 0.0 107.542 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.07 154.46 25.33 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.99 -153.04 24.75 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.83 -2.508 . . . . 0.0 106.83 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.11 121.71 14.84 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 122.477 1.043 . . . . 0.0 115.087 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.85 -8.36 57.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.812 0.845 . . . . 0.0 111.859 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.96 -19.12 60.83 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.636 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.95 20.72 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.386 1.593 . . . . 0.0 113.345 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.68 157.37 27.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 108.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -69.9 119.46 14.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -86.48 -70.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 17.52 2.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.643 1.177 . . . . 0.0 113.709 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.45 134.91 55.45 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.04 -1.038 . . . . 0.0 109.686 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.62 79.38 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 106.534 -2.626 . . . . 0.0 106.534 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.72 8.03 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.755 1.222 . . . . 0.0 111.465 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -125.24 -18.15 5.47 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.887 -1.133 . . . . 0.0 113.545 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.31 36.57 4.88 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.748 2.019 . . . . 0.0 111.435 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.3 4.26 29.84 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.011 1.964 . . . . 0.0 118.011 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.0 124.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 120.839 2.319 . . . . 0.0 110.793 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -104.26 -71.18 0.74 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.839 1.256 . . . . 0.0 110.569 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -111.13 151.63 27.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.485 1.114 . . . . 0.0 109.251 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.47 141.92 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -123.7 120.42 32.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.33 102.79 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.42 129.46 9.82 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.3 168.03 20.45 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.118 0.961 . . . . 0.0 109.139 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.37 163.92 31.77 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -57.42 -40.78 79.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.291 1.436 . . . . 0.0 111.034 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.3 3.22 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.074 2.949 . . . . 0.0 113.613 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.35 -171.23 13.67 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.491 1.041 . . . . 0.0 112.208 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.73 106.13 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.27 -22.23 5.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.184 0.994 . . . . 0.0 113.501 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 42.4 p -117.96 131.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.201 1.0 . . . . 0.0 109.784 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.88 154.45 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 121.271 -0.893 . . . . 0.0 111.159 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -146.47 150.82 36.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.9 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.68 117.68 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.14 171.61 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.289 . . . . 0.0 108.498 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.12 109.3 5.28 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.753 -1.217 . . . . 0.0 109.03 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -116.3 165.51 13.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.306 1.442 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 44.5 5.58 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.027 1.394 . . . . 0.0 110.79 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m 49.37 33.04 4.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.982 2.913 . . . . 0.0 114.448 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.79 165.26 27.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.425 1.89 . . . . 0.0 109.975 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.41 127.04 31.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.923 2.089 . . . . 0.0 109.48 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.44 116.75 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.359 1.064 . . . . 0.0 108.79 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.03 159.36 30.95 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.91 0.884 . . . . 0.0 112.205 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.23 -17.72 4.38 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-O 117.352 -1.804 . . . . 0.0 115.805 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.59 154.19 2.96 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-N 120.428 2.114 . . . . 0.0 114.033 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.66 105.5 5.78 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.392 -1.064 . . . . 0.0 113.485 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -93.1 176.48 6.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.784 2.834 . . . . 0.0 109.613 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -163.14 54.69 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.49 100.36 11.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 37' ' ' SER 0.297 0.0 OUTLIER -61.75 150.03 38.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.435 -178.541 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.9 p -123.53 157.76 32.89 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.324 1.049 . . . . 0.0 108.837 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 tp -90.74 -38.83 12.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.778 0.831 . . . . 0.0 112.009 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mp -101.46 32.73 3.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 112.687 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.6 108.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -162.82 146.06 10.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.828 1.651 . . . . 0.0 107.294 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.1 162.04 41.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.322 2.649 . . . . 0.0 108.249 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.0 m -144.7 96.04 2.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.39 116.23 24.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.32 133.64 34.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.469 1.107 . . . . 0.0 108.814 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.62 107.25 22.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . 8.8 t70 -58.81 160.58 5.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.66 -40.38 76.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.764 -0.585 . . . . 0.0 111.84 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.38 -19.32 20.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.469 0.577 . . . . 0.0 112.32 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 68' ' ' ASP . 37.5 t0 -81.03 140.22 35.28 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -135.58 154.55 51.31 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.479 0.712 . . . . 0.0 110.803 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.69 133.64 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.52 -24.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 123.791 0.836 . . . . 0.0 111.1 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.19 156.72 42.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.87 146.26 25.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.95 115.26 15.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.33 123.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.447 HG21 ' H ' ' A' ' 111' ' ' THR . 29.3 m -99.42 138.04 37.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.182 1.793 . . . . 0.0 107.22 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -152.79 155.69 37.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.44 169.32 23.29 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -128.21 160.09 33.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.396 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -123.85 152.1 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.814 0.846 . . . . 0.0 108.753 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.33 113.34 1.91 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.997 0.919 . . . . 0.0 108.615 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.85 3.9 42.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.468 -1.184 . . . . 0.0 113.113 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -134.17 84.58 2.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.41 24.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 130.548 3.539 . . . . 0.0 113.19 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.3 t -149.8 108.47 3.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.181 -1.575 . . . . 0.0 108.533 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.56 157.27 7.14 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.023 1.729 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -139.39 147.11 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.702 1.601 . . . . 0.0 108.524 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.8 mm -70.37 113.19 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.2 p -80.47 -34.19 36.05 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.736 -0.602 . . . . 0.0 109.745 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 p -165.45 164.32 19.55 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.881 1.672 . . . . 0.0 109.712 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.8 tt -141.45 154.41 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 142.9 29.24 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -115.3 156.7 24.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -137.25 114.06 10.47 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -104.42 164.99 11.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.311 0.577 . . . . 0.0 110.632 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.44 -36.26 75.59 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -28.85 66.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.983 0.81 . . . . 0.0 111.816 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.69 5.67 47.76 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -72.85 88.49 1.34 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -84.76 109.22 17.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 p -71.26 161.76 76.52 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 125.174 1.389 . . . . 0.0 110.18 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.84 165.34 19.92 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.034 2.49 . . . . 0.0 110.285 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.44 119.27 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.087 2.525 . . . . 0.0 108.486 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -81.75 77.55 8.58 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.72 -155.8 25.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.563 1.078 . . . . 0.0 111.188 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.0 tp -88.15 119.17 28.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.372 1.469 . . . . 0.0 109.636 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.35 152.14 45.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.447 ' H ' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -153.59 168.98 24.37 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.966 -1.084 . . . . 0.0 109.928 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -73.22 -47.48 43.05 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 120.96 -1.087 . . . . 0.0 109.496 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.97 109.15 1.69 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.355 1.074 . . . . 0.0 109.249 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.09 166.49 21.29 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.182 1.393 . . . . 0.0 108.685 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -144.78 164.97 29.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.34 149.14 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.5 141.13 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.947 1.299 . . . . 0.0 108.807 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -157.56 164.47 37.28 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.047 1.339 . . . . 0.0 110.978 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.91 170.87 15.72 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 108.168 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.19 -56.24 12.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.048 -1.032 . . . . 0.0 109.893 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -117.95 -14.08 10.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.26 -63.96 0.29 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.47 -143.01 18.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -163.38 137.2 5.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.42 137.51 52.77 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.35 -34.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.269 0.941 . . . . 0.0 111.976 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.71 172.95 42.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.39 153.46 43.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.582 1.153 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 159.82 42.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.469 1.108 . . . . 0.0 108.055 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.08 137.96 2.89 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -61.46 135.73 57.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 110.145 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -153.23 164.93 37.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.191 1.396 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.72 -107.42 0.2 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.95 -26.59 66.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.026 0.913 . . . . 0.0 111.328 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.62 172.03 13.25 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.3 1.84 . . . . 0.0 107.615 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 38.7 tp -84.89 100.15 11.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -81.61 -39.89 23.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.87 146.25 31.04 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 124.478 1.111 . . . . 0.0 108.81 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.7 tp -155.76 100.11 2.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.335 0.516 . . . . 0.0 112.317 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.99 178.55 16.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.801 2.143 . . . . 0.0 109.293 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.4 163.55 39.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.565 1.682 . . . . 0.0 110.201 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -127.82 143.27 51.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.686 1.232 . . . . 0.0 109.534 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -110.42 105.09 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.702 2.001 . . . . 0.0 106.202 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.62 101.02 3.61 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.301 0.955 . . . . 0.0 110.848 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.1 t -121.46 105.87 10.89 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.32 87.9 1.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 107.436 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.7 m -150.74 114.19 4.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.192 0.997 . . . . 0.0 108.908 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.82 148.16 35.13 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 119.414 1.006 . . . . 0.0 111.743 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.77 -177.59 3.2 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.3 3.333 . . . . 0.0 109.163 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.55 149.75 17.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.188 0.995 . . . . 0.0 109.685 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -137.75 160.64 64.07 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.734 1.614 . . . . 0.0 109.225 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -76.65 -179.06 4.98 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.034 2.49 . . . . 0.0 107.75 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.01 152.89 44.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 133.59 52.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -114.31 121.53 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.391 0.677 . . . . 0.0 111.575 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.49 -169.65 1.52 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.7 t -136.33 115.05 12.03 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 120.463 -1.398 . . . . 0.0 108.19 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.41 -171.18 2.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.968 0.907 . . . . 0.0 109.861 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.19 152.46 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.82 -72.78 0.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 123.963 0.792 . . . . 0.0 111.295 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.46 143.07 6.0 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 282' ' ' LYS . 10.0 p-10 -90.19 48.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.811 1.644 . . . . 0.0 111.739 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.64 152.12 26.76 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.45 1.5 . . . . 0.0 107.819 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.04 166.88 12.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.52 1.534 . . . . 0.0 114.264 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 m -65.56 129.32 39.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.355 1.062 . . . . 0.0 109.225 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.6 109.46 11.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -95.05 7.15 47.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.474 1.11 . . . . 0.0 112.443 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.99 132.34 51.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.816 -0.552 . . . . 0.0 112.331 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.82 -9.59 17.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.863 1.665 . . . . 0.0 111.601 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.45 -156.44 51.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.905 -1.122 . . . . 0.0 111.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -109.48 164.41 12.53 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.588 1.555 . . . . 0.0 110.606 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -147.79 -170.29 3.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.822 2.049 . . . . 0.0 110.45 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.04 -45.92 89.52 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.644 -0.66 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.05 40.63 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.46 HG22 ' CZ ' ' A' ' 194' ' ' TYR . 9.3 t -123.6 156.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.024 1.33 . . . . 0.0 108.964 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -116.49 -55.69 2.36 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -150.93 165.11 34.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.61 1.096 . . . . 0.0 111.301 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.6 t -125.65 149.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.095 2.158 . . . . 0.0 108.128 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -137.93 120.92 16.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.14 138.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -118.75 83.47 0.35 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 187' ' ' ILE . 6.3 pt20 -74.08 -171.44 1.13 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.311 1.053 . . . . 0.0 111.583 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.99 45.41 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -62.31 -37.31 85.06 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.81 0.844 . . . . 0.0 111.283 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 -15.58 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.544 3.137 . . . . 0.0 113.166 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 122.42 -175.66 16.43 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.483 1.992 . . . . 0.0 108.405 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 182' ' ' GLN . 19.5 mt -69.39 106.14 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 120.941 -1.329 . . . . 0.0 109.381 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 m -98.35 -24.66 15.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.636 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.39 47.78 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 122.395 1.093 . . . . 0.0 113.21 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.1 m -147.45 144.55 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.37 1.868 . . . . 0.0 106.605 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 56.0 pttt -161.61 170.01 20.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.713 1.205 . . . . 0.0 110.435 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -153.94 175.22 13.63 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.787 0.803 . . . . 0.0 113.087 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.8 114.28 17.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.319 -2.845 . . . . 0.0 103.319 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.46 ' CZ ' HG22 ' A' ' 175' ' ' VAL . 7.2 m-85 -129.98 148.37 51.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.765 1.626 . . . . 0.0 108.562 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -112.07 155.55 23.66 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.741 0.781 . . . . 0.0 110.244 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.21 86.25 2.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.01 1.324 . . . . 0.0 109.161 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.05 -79.39 0.88 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -123.49 -35.39 2.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.103 1.361 . . . . 0.0 110.246 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.95 148.61 48.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 122.195 0.997 . . . . 0.0 109.439 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.22 135.64 54.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.8 mm -120.07 116.27 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.03 109.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 127.847 2.459 . . . . 0.0 104.827 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.22 1.29 2.28 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 117.644 -1.642 . . . . 0.0 116.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.83 82.75 0.72 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 119.687 1.744 . . . . 0.0 108.942 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -112.66 135.02 53.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.586 2.755 . . . . 0.0 106.778 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -128.97 -43.55 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.76 153.1 39.87 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.98 112.51 8.3 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.29 1.836 . . . . 0.0 112.222 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.6 171.2 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.919 1.746 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 p -129.66 177.26 7.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.348 1.059 . . . . 0.0 108.413 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.1 mt -66.52 -10.43 44.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.308 -0.87 . . . . 0.0 111.321 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 -22.31 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.71 1.204 . . . . 0.0 109.988 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 86.32 -139.94 17.11 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.464 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 46.3 m-85 -143.58 158.79 43.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.667 1.187 . . . . 0.0 109.193 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -110.28 164.63 12.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.995 2.918 . . . . 0.0 106.422 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.61 139.89 44.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.961 0.8 . . . . 0.0 110.906 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -142.55 123.89 14.73 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.65 0.38 . . . . 0.0 111.035 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.07 130.78 34.55 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.442 1.097 . . . . 0.0 109.392 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.6 mt -127.69 124.58 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -80.23 88.57 5.48 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -52.97 -53.51 54.32 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.631 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.3 -0.71 10.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.2 1.933 . . . . 0.0 115.074 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 m -125.68 -29.45 3.15 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.504 1.956 . . . . 0.0 116.22 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.74 159.91 24.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.568 1.076 . . . . 0.0 109.504 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.55 124.76 36.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.85 101.31 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -69.09 -36.73 77.89 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.471 ' HB3' ' HD3' ' A' ' 250' ' ' LYS . . . -157.13 170.45 22.48 Favored 'General case' 0 C--N 1.343 0.294 0 O-C-N 120.703 -1.248 . . . . 0.0 112.132 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.53 151.06 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -132.44 171.59 13.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.402 1.881 . . . . 0.0 106.119 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 143.4 -175.79 23.22 Favored Glycine 0 N--CA 1.465 0.628 0 O-C-N 119.906 -1.746 . . . . 0.0 112.761 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -140.0 146.42 39.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.155 0.982 . . . . 0.0 110.598 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -128.2 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -156.08 170.82 21.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.793 0.837 . . . . 0.0 110.165 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -75.8 148.18 38.63 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 127.073 2.149 . . . . 0.0 110.886 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.0 pt -102.48 157.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 109.325 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -79.01 169.78 17.68 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.27 -41.41 1.57 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.863 -1.148 . . . . 0.0 114.873 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.3 m -141.28 160.37 40.26 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.597 1.698 . . . . 0.0 108.198 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.79 18.44 0.6 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.91 41.4 Favored Glycine 0 C--N 1.338 0.674 0 O-C-N 120.758 -1.213 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.92 157.08 30.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.371 1.469 . . . . 0.0 108.238 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.54 168.52 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 40.4 mm -105.74 103.41 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 101.219 -3.622 . . . . 0.0 101.219 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -82.16 -17.43 46.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.595 1.089 . . . . 0.0 112.048 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -150.74 136.02 17.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.19 141.34 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -135.99 158.4 44.51 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.169 0.987 . . . . 0.0 108.576 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.92 119.1 18.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 228' ' ' ALA . 36.8 mtpt -68.13 135.55 52.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.5 p -128.11 165.4 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.602 1.161 . . . . 0.0 109.941 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -129.87 145.38 51.6 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.6 tptp 72.95 -26.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.301 1.44 . . . . 0.0 111.589 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -124.06 173.48 8.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 109.729 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.3 m -117.64 144.17 45.45 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 107.419 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.5 p -121.67 153.87 37.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.418 1.087 . . . . 0.0 109.639 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -97.84 159.07 31.79 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 111.418 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.67 115.44 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.366 2.71 . . . . 0.0 107.9 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.78 93.07 7.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.35 -179.13 16.98 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.252 0.929 . . . . 0.0 112.582 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.93 111.18 22.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.206 1.002 . . . . 0.0 108.369 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.79 107.93 0.92 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.809 0.844 . . . . 0.0 108.853 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.62 156.72 18.57 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.708 2.003 . . . . 0.0 107.345 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.06 -177.54 50.81 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.87 111.04 1.15 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.651 1.18 . . . . 0.0 111.773 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.4 146.03 28.68 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.802 0.441 . . . . 0.0 110.49 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.32 160.01 41.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.284 1.434 . . . . 0.0 110.872 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -146.88 127.53 14.23 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.94 101.32 11.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.69 1.132 . . . . 0.0 110.825 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -123.07 153.39 39.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.452 1.101 . . . . 0.0 110.648 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.73 150.26 36.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.54 1.536 . . . . 0.0 108.143 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -99.02 142.39 30.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.816 1.246 . . . . 0.0 109.894 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.73 55.8 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.847 0.736 . . . . 0.0 114.792 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -134.22 175.38 9.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.19 1.396 . . . . 0.0 110.467 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 162.21 33.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.757 1.623 . . . . 0.0 108.417 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 52.6 mt -95.12 140.91 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.63 -0.35 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.43 -167.68 38.35 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.75 166.84 19.05 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.461 1.105 . . . . 0.0 110.983 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -159.08 163.69 36.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.195 1.398 . . . . 0.0 107.964 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.06 -161.99 29.06 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 30.4 mtmm -126.97 136.82 52.78 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -158.13 96.84 1.48 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.424 1.489 . . . . 0.0 107.474 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.9 m -69.04 -23.85 64.11 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -165.46 -60.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.8 mt -84.24 147.91 27.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.18 2.592 . . . . 0.0 106.066 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.44 80.22 1.42 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.032 . . . . 0.0 112.089 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -64.53 -40.47 95.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -141.55 129.92 22.43 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.67 1.123 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -119.6 106.95 12.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.252 1.421 . . . . 0.0 107.772 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -132.2 -179.73 16.48 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.2 170.27 10.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.582 -0.952 . . . . 0.0 111.158 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -115.11 156.3 25.48 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.37 160.74 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.524 0.73 . . . . 0.0 109.048 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.46 144.49 42.79 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.64 149.27 79.17 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.867 1.711 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 2.7 pp -106.09 173.34 6.35 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 112.083 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 18.6 m -143.41 52.85 1.34 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.335 1.854 . . . . 0.0 108.286 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.374 1.47 . . . . 0.0 109.289 -179.641 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -69.98 110.93 5.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.192 1.397 . . . . 0.0 112.071 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -147.26 139.71 24.7 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.427 1.891 . . . . 0.0 107.057 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -132.28 118.43 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -64.48 137.91 58.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.365 0.666 . . . . 0.0 109.893 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.56 -58.46 8.38 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.708 1.603 . . . . 0.0 109.649 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.93 -23.22 24.1 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.302 1.43 . . . . 0.0 113.12 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.38 173.84 24.0 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.126 0.963 . . . . 0.0 111.581 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.68 174.27 54.81 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 122.56 1.089 . . . . 0.0 113.837 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.74 9.03 15.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.58 1.552 . . . . 0.0 113.126 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.41 174.73 44.35 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.32 -124.36 31.63 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 158.91 43.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.728 1.611 . . . . 0.0 109.489 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.9 p -101.69 102.86 13.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 116.58 22.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 103.968 -2.605 . . . . 0.0 103.968 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.08 118.61 12.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -133.87 -64.55 0.7 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.703 0.801 . . . . 0.0 110.85 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.82 -76.6 0.4 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.015 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.87 -16.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -71.98 -176.49 1.74 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.417 1.462 . . . . 0.0 110.382 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 60.27 56.2 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.287 1.435 . . . . 0.0 110.792 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.46 102.91 0.73 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.376 -2.289 . . . . 0.0 107.376 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.2 157.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.476 1.91 . . . . 0.0 112.442 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -131.59 -23.33 2.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 112.908 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -153.19 155.56 36.9 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.99 148.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -132.96 144.82 50.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.98 148.81 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.847 2.059 . . . . 0.0 106.431 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 62' ' ' PHE . . . -137.39 -112.16 1.1 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.19 148.28 32.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.372 1.086 . . . . 0.0 108.688 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 -20.79 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 127.189 2.328 . . . . 0.0 112.912 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -56.13 -40.28 73.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.348 2.259 . . . . 0.0 110.237 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.47 7.63 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.128 3.371 . . . . 0.0 109.514 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.71 159.77 23.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 126.371 1.939 . . . . 0.0 109.655 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.58 96.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.3 m -89.78 -21.7 22.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.1 p -127.37 127.19 43.79 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 120.489 1.495 . . . . 0.0 110.83 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 136' ' ' LEU . 4.3 mp -135.76 137.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 122.891 1.329 . . . . 0.0 109.561 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -148.38 138.72 22.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.652 0.781 . . . . 0.0 109.368 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 t -95.51 123.42 47.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -115.99 165.72 12.8 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.83 0.852 . . . . 0.0 108.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.24 108.69 3.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.263 54.9 pttt -117.15 116.18 26.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.457 1.503 . . . . 0.0 110.129 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 47.5 27.28 0.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.594 1.958 . . . . 0.0 113.548 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -162.76 -159.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.309 -1.494 . . . . 0.0 108.829 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.46 165.24 19.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 116.48 17.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.19 109.03 12.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.38 162.16 29.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.971 0.908 . . . . 0.0 109.699 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 2.36 9.35 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.611 1.577 . . . . 0.0 112.21 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.37 163.95 27.41 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.237 1.518 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -70.94 147.64 48.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.906 2.082 . . . . 0.0 110.805 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -130.4 104.35 7.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.956 2.103 . . . . 0.0 106.011 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.18 -156.26 26.72 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.18 102.76 7.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.866 1.266 . . . . 0.0 108.457 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -103.29 162.7 12.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.9 m -155.6 150.59 26.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.12 -8.42 54.58 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.69 -4.94 7.17 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.25 15.12 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.625 1.102 . . . . 0.0 114.049 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 4.1 t80 -75.37 128.58 35.71 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.931 1.366 . . . . 0.0 110.145 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -132.49 164.12 27.29 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.226 2.61 . . . . 0.0 111.072 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 m -132.97 138.79 46.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.696 1.599 . . . . 0.0 108.046 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -121.2 109.6 15.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.159 1.783 . . . . 0.0 106.364 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -89.75 165.1 14.38 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.699 1.2 . . . . 0.0 109.042 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 p -111.04 152.86 12.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.202 0.525 . . . . 0.0 110.366 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.18 164.9 12.13 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.822 1.249 . . . . 0.0 110.512 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.78 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.579 0.752 . . . . 0.0 110.986 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -105.59 0.71 26.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.16 140.1 52.45 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -134.2 151.9 51.55 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.94 1.296 . . . . 0.0 108.95 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.0 mm -82.67 142.82 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.906 1.282 . . . . 0.0 108.075 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 m -136.81 -19.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.18 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 146.46 28.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -145.59 96.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -65.26 138.3 58.13 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.19 150.13 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.599 HG21 ' H ' ' A' ' 111' ' ' THR . 18.4 m -126.06 140.27 52.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.593 1.957 . . . . 0.0 106.754 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -151.8 149.62 29.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -158.82 168.55 26.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.829 1.195 . . . . 0.0 111.362 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -103.14 154.9 18.82 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.551 1.54 . . . . 0.0 110.581 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.93 146.46 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -75.68 76.4 2.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.06 14.89 0.1 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 127.583 2.516 . . . . 0.0 111.919 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -123.98 111.42 15.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.143 1.377 . . . . 0.0 109.078 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.54 -3.28 8.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.473 1.509 . . . . 0.0 111.42 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -153.37 137.39 16.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.716 1.606 . . . . 0.0 109.353 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.71 152.35 45.63 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.06 154.72 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.19 0.996 . . . . 0.0 109.209 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.16 119.99 22.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.8 p -95.63 -31.1 13.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.159 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.5 p -157.43 164.05 37.89 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.823 1.647 . . . . 0.0 110.613 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.91 147.57 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.778 1.631 . . . . 0.0 107.525 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 105.82 4.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.994 0.918 . . . . 0.0 109.387 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.42 148.61 48.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.588 -0.695 . . . . 0.0 109.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.48 114.32 11.25 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.0 p -84.97 158.75 20.42 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -30.41 70.69 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.53 -46.84 83.37 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.409 1.083 . . . . 0.0 109.087 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.01 -14.62 3.79 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.847 1.213 . . . . 0.0 112.06 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -68.24 145.07 54.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 107.97 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.1 p -133.77 148.05 51.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 108.979 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.2 p -85.43 162.46 48.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.34 165.3 32.9 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 107.285 -1.852 . . . . 0.0 107.285 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.98 105.49 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 105.738 -2.447 . . . . 0.0 105.738 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.04 81.2 5.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.18 -177.51 18.89 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.301 1.429 . . . . 0.0 111.716 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -84.0 111.5 19.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.697 1.199 . . . . 0.0 112.75 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.436 ' OE2' ' HE3' ' A' ' 114' ' ' LYS . 14.6 mt-10 -65.84 140.54 58.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.599 ' H ' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -128.39 177.14 7.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.775 1.63 . . . . 0.0 109.543 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.91 -48.86 77.15 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -72.91 122.62 21.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.436 ' HE3' ' OE2' ' A' ' 110' ' ' GLU . 12.9 ptmm? 176.34 163.64 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.454 1.902 . . . . 0.0 108.586 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 117' ' ' LEU . 5.4 p90 -157.99 167.9 28.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.484 0.713 . . . . 0.0 110.56 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.59 149.54 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.856 1.662 . . . . 0.0 107.044 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -150.82 136.09 17.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.577 1.951 . . . . 0.0 107.116 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 162.93 34.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.098 0.559 . . . . 0.0 110.064 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -76.69 74.03 3.36 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.693 1.997 . . . . 0.0 109.055 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -54.72 -24.3 21.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.452 -2.03 . . . . 0.0 115.147 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -93.66 -7.44 43.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.506 1.122 . . . . 0.0 113.103 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.92 -5.0 75.85 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.501 1.524 . . . . 0.0 115.982 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.14 124.12 9.92 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.029 1.914 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.56 161.83 7.16 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.15 0.58 . . . . 0.0 110.398 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 148.06 43.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.343 0.657 . . . . 0.0 109.646 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.82 -35.46 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.054 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.39 -147.46 7.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.61 161.04 43.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.148 1.379 . . . . 0.0 108.722 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -122.07 149.55 43.38 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.487 1.115 . . . . 0.0 108.555 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.51 129.74 5.04 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.28 1.895 . . . . 0.0 109.047 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -93.73 -178.17 4.6 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 122.905 1.336 . . . . 0.0 107.916 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.26 164.4 27.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.469 1.907 . . . . 0.0 107.026 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.64 -103.16 0.3 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 104.313 -3.515 . . . . 0.0 104.313 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -72.83 -25.75 61.24 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.524 0.662 . . . . 0.0 110.426 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.36 -175.14 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.997 3.319 . . . . 0.0 107.684 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 38' ' ' ILE . 46.9 tp -95.51 129.51 42.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 126.54 1.936 . . . . 0.0 108.47 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.24 -46.37 4.84 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.947 0.499 . . . . 0.0 111.68 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -137.76 153.09 49.75 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.359 1.063 . . . . 0.0 109.028 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.4 tp -161.83 91.51 0.82 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 172.76 14.54 Favored Glycine 0 C--O 1.229 -0.214 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.33 156.59 48.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -124.48 160.38 28.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -141.98 131.58 23.97 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 103.541 -2.762 . . . . 0.0 103.541 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.76 165.67 28.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.636 1.107 . . . . 0.0 112.993 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -134.26 167.75 20.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.875 2.07 . . . . 0.0 106.772 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.08 177.87 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.97 1.308 . . . . 0.0 110.656 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 t -135.92 171.94 13.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.166 0.986 . . . . 0.0 108.616 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -72.34 155.34 91.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 121.931 -0.481 . . . . 0.0 112.208 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.89 174.3 12.13 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.368 3.379 . . . . 0.0 112.116 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.09 144.56 11.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -73.63 152.22 89.41 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.94 -174.21 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.34 2.693 . . . . 0.0 111.755 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.05 168.91 12.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.845 0.858 . . . . 0.0 110.001 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 131.06 39.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -93.59 114.4 26.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.62 -172.33 3.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.216 1.008 . . . . 0.0 109.751 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.6 m -77.59 155.44 31.5 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.825 -1.172 . . . . 0.0 109.544 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.54 157.3 36.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.708 1.603 . . . . 0.0 109.941 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -127.66 167.3 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.251 1.82 . . . . 0.0 107.472 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.8 -113.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.67 164.46 20.23 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.662 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 9.1 p30 -105.92 6.65 31.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.641 1.577 . . . . 0.0 111.031 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.48 122.92 43.99 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 135.23 177.04 14.67 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.729 2.585 . . . . 0.0 111.894 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.0 m -102.82 153.58 20.04 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.028 1.414 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -72.49 154.67 40.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.643 1.177 . . . . 0.0 112.422 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -142.55 38.63 1.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.248 1.419 . . . . 0.0 109.089 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.3 104.63 0.08 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.082 2.553 . . . . 0.0 112.945 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.43 -40.82 16.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.863 2.865 . . . . 0.0 114.11 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.63 -95.83 1.37 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.28 169.69 10.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.37 1.468 . . . . 0.0 109.334 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -135.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.422 2.289 . . . . 0.0 106.271 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.01 -33.14 71.59 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 221' ' ' TYR . . . -179.59 -151.07 9.51 Favored Glycine 0 CA--C 1.534 1.266 1 C-N-CA 131.501 4.381 . . . . 0.0 107.935 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.8 m -135.07 155.54 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.516 1.926 . . . . 0.0 106.146 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -124.55 -53.78 1.68 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.259 0.936 . . . . 0.0 113.229 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.467 ' HE3' ' CZ ' ' A' ' 179' ' ' TYR . 29.5 ttpt -146.35 136.38 23.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.132 -1.605 . . . . 0.0 109.342 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 51.9 t -90.28 146.57 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.467 ' CZ ' ' HE3' ' A' ' 177' ' ' LYS . 45.2 m-85 -141.09 109.81 6.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.134 1.374 . . . . 0.0 108.333 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.76 138.58 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.86 92.29 0.56 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.76 160.88 29.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.251 1.024 . . . . 0.0 109.251 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.4 -170.41 12.04 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 125.414 1.483 . . . . 0.0 109.664 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -46.4 23.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.92 1.288 . . . . 0.0 112.182 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 -4.13 54.69 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.715 1.606 . . . . 0.0 114.236 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.12 -154.05 25.73 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.5 mm -75.08 133.78 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 119.171 1.485 . . . . 0.0 108.225 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 73.6 m -115.39 -22.41 9.36 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.461 1.104 . . . . 0.0 113.683 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.3 169.15 20.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.732 1.254 . . . . 0.0 110.31 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.53 149.48 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -160.16 175.72 12.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.824 1.649 . . . . 0.0 107.09 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -162.69 174.77 12.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.23 149.31 42.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -153.8 167.87 28.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.033 1.333 . . . . 0.0 108.293 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.87 164.89 13.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 119.962 -1.711 . . . . 0.0 108.622 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -140.24 93.33 2.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 64.03 -118.98 14.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.366 -2.694 . . . . 0.0 106.366 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.17 1.93 55.89 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.861 1.265 . . . . 0.0 113.5 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.59 157.33 17.01 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.906 1.23 . . . . 0.0 111.187 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -113.68 125.57 54.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.5 mm -120.64 143.82 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.187 1.395 . . . . 0.0 110.773 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.9 t -116.89 136.76 52.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.78 158.21 42.61 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -96.58 107.04 3.45 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -39.0 113.4 0.31 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.968 2.107 . . . . 0.0 112.252 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -93.39 29.42 1.96 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.693 0.797 . . . . 0.0 111.049 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.88 21.14 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 121.207 -0.933 . . . . 0.0 112.842 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -91.2 111.22 47.53 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.02 -0.99 . . . . 0.0 108.767 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.74 157.55 51.84 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.983 1.788 . . . . 0.0 109.462 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.6 p -133.95 166.36 22.88 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 25.6 tp -67.52 -12.83 61.26 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 112.169 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.68 -32.5 72.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.157 0.983 . . . . 0.0 109.771 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.64 -154.2 16.79 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -139.93 142.53 36.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.701 1.601 . . . . 0.0 107.887 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -97.32 110.77 23.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.69 134.39 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.541 0.736 . . . . 0.0 109.531 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.37 111.85 6.97 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.177 0.591 . . . . 0.0 110.527 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.32 131.12 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 110.414 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.0 mt -128.21 126.37 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 130.65 43.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.862 -0.524 . . . . 0.0 109.81 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.461 ' CE1' ' HA3' ' A' ' 174' ' ' GLY . 15.2 t80 -65.06 -63.54 3.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.25 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 221' ' ' TYR . 21.3 Cg_endo -85.96 -29.76 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.249 1.482 . . . . 0.0 114.277 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.6 t -77.32 -26.36 52.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.102 1.319 . . . . 0.0 112.829 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -126.09 172.98 9.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.304 1.041 . . . . 0.0 108.464 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -157.2 117.3 3.48 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.92 -1.113 . . . . 0.0 111.489 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.7 mt -68.22 113.44 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -26.71 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.386 0.674 . . . . 0.0 111.933 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -162.34 169.61 20.27 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.756 1.222 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.8 145.82 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -132.61 178.42 6.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.607 2.363 . . . . 0.0 109.141 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 166.72 -178.57 41.03 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.6 p -139.98 136.1 33.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.731 0.765 . . . . 0.0 109.241 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -131.12 156.24 45.6 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 113.157 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.02 162.03 40.75 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.657 -0.652 . . . . 0.0 110.545 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.48 136.12 39.37 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.173 1.389 . . . . 0.0 110.486 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.4 mt -72.85 109.71 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -48.3 121.37 4.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 110.647 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.94 22.0 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.492 1.52 . . . . 0.0 110.484 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.2 p -141.38 165.27 27.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.696 1.598 . . . . 0.0 109.501 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.7 -14.32 37.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.404 0.681 . . . . 0.0 110.306 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -68.47 146.32 45.43 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.16 159.45 24.86 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.418 1.487 . . . . 0.0 113.21 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 16.9 tt -136.96 152.2 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 127.207 2.203 . . . . 0.0 107.972 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 2.8 mt -97.68 134.15 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t -121.31 -8.25 9.21 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -146.6 141.16 26.65 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.347 0.659 . . . . 0.0 109.383 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.75 155.56 43.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.238 1.815 . . . . 0.0 108.697 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -144.89 154.62 42.82 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.877 1.671 . . . . 0.0 107.518 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.71 153.61 46.3 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -120.67 114.66 22.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.7 p -133.68 165.9 23.86 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.065 2.946 . . . . 0.0 107.209 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -112.79 160.26 18.15 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 66.15 -16.49 0.12 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.877 1.671 . . . . 0.0 112.996 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 174.2 11.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.772 2.429 . . . . 0.0 108.788 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.3 p -143.65 107.99 4.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -10.72 3.85 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 70.12 165.88 0.13 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.29 1.836 . . . . 0.0 112.187 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 98.5 Cg_endo -78.14 137.9 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.932 2.422 . . . . 0.0 109.69 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.32 93.13 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.566 1.947 . . . . 0.0 105.763 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.58 177.7 16.85 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.057 0.837 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.67 113.69 20.52 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.343 1.057 . . . . 0.0 110.243 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.21 108.49 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.354 1.061 . . . . 0.0 109.289 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.15 149.3 19.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.301 1.441 . . . . 0.0 109.056 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.56 -175.0 48.95 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.649 0.583 . . . . 0.0 112.905 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.0 m -66.7 127.53 32.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.508 1.523 . . . . 0.0 108.584 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -86.04 147.56 26.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.778 0.431 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.55 163.7 29.92 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.499 1.12 . . . . 0.0 110.749 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -145.58 147.6 32.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.764 2.425 . . . . 0.0 107.281 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.3 mt -142.01 141.77 32.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.524 1.129 . . . . 0.0 108.528 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -164.65 179.32 6.69 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.303 1.841 . . . . 0.0 110.163 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -144.05 152.95 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 104.892 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.52 71.45 10.42 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 120.398 -1.439 . . . . 0.0 112.636 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.56 -59.28 0.67 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 123.556 0.598 . . . . 0.0 113.65 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -55.49 155.68 5.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.81 0.844 . . . . 0.0 111.681 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 164.07 12.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 108.89 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.78 129.93 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.1 8.4 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.271 1.029 . . . . 0.0 111.617 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 175.11 -179.97 46.05 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -113.73 -179.07 3.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' HIS . . . . . 0.404 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 15.6 p80 -165.68 158.98 15.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.376 0.989 . . . . 0.0 111.745 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.49 -107.48 0.44 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.662 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -160.74 165.37 30.54 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.481 1.112 . . . . 0.0 110.23 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.23 147.05 37.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.686 1.594 . . . . 0.0 107.12 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 19.5 t -174.26 70.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 59.73 -7.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 129.481 3.112 . . . . 0.0 114.651 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 72.1 mt -136.43 167.73 20.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.603 2.361 . . . . 0.0 110.232 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.1 76.19 0.99 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.793 1.637 . . . . 0.0 109.479 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -76.54 -59.56 2.72 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 110.584 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -110.15 152.81 25.58 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.616 1.167 . . . . 0.0 111.596 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -159.33 145.93 16.66 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.027 0.531 . . . . 0.0 110.057 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -162.8 -175.91 34.32 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.902 2.191 . . . . 0.0 108.33 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.17 130.44 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.633 1.216 . . . . 0.0 113.718 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -73.98 155.59 38.46 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.9 m -130.75 149.64 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 58.2 mmm -151.29 153.65 32.81 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 127.656 2.383 . . . . 0.0 106.354 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.65 165.92 30.38 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.841 1.694 . . . . 0.0 111.556 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.6 173.26 11.85 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.251 2.22 . . . . 0.0 107.781 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 9.3 t -162.02 172.93 15.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 22.5 p30 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.741 1.216 . . . . 0.0 109.708 179.177 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -70.02 144.92 52.09 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.268 0.94 . . . . 0.0 111.441 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -149.56 132.48 16.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.012 1.325 . . . . 0.0 107.855 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.05 145.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.91 143.52 44.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.8 1.64 . . . . 0.0 108.977 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.38 174.89 4.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 109.331 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.6 44.78 0.54 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.376 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.72 -178.72 26.89 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.03 0.915 . . . . 0.0 111.222 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 161.69 2.19 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.779 1.657 . . . . 0.0 115.042 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.16 3.21 40.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.723 1.609 . . . . 0.0 113.549 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.26 -4.87 45.95 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.413 1.006 . . . . 0.0 115.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.14 158.19 18.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.46 157.52 28.92 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.235 0.517 . . . . 0.0 110.212 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -47.27 130.11 12.97 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.446 1.099 . . . . 0.0 110.67 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -130.59 121.5 25.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -161.38 141.83 10.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.32 -20.85 2.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.204 0.911 . . . . 0.0 113.406 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.51 37.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.361 1.457 . . . . 0.0 114.465 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 20' ' ' HIS . 9.4 p -137.36 -171.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 125.428 1.491 . . . . 0.0 108.065 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.541 ' H ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -149.34 162.29 40.36 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 178.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.73 -57.99 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 117.775 -1.107 . . . . 0.0 111.917 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.52 56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.126 1.33 . . . . 0.0 112.725 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.77 90.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.902 1.681 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -62.8 -39.51 94.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.743 1.617 . . . . 0.0 112.127 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 41' ' ' VAL . 36.8 mtmt -145.18 162.23 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.63 1.172 . . . . 0.0 108.15 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.49 115.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -113.13 132.9 55.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.52 144.36 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 62' ' ' PHE . . . -152.45 140.09 7.46 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.73 143.62 26.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.322 1.849 . . . . 0.0 108.777 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.33 178.8 16.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 127.584 2.516 . . . . 0.0 108.58 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.81 -26.64 68.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -6.41 59.42 Favored 'General case' 0 CA--C 1.543 0.691 1 C-N-CA 131.8 4.04 . . . . 0.0 111.78 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.54 -160.35 15.02 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.04 110.45 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.6 m -140.0 0.37 1.75 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -123.45 118.41 27.38 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -144.72 155.3 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.891 0.877 . . . . 0.0 110.424 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.21 147.11 20.66 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.596 0.758 . . . . 0.0 109.567 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.26 158.56 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.424 1.49 . . . . 0.0 108.968 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 25' ' ' LYS . 4.8 t -112.79 135.39 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.92 104.65 13.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.67 110.85 22.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -78.06 166.0 23.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.0 -9.69 23.66 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.414 -1.429 . . . . 0.0 113.82 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -119.75 -17.85 8.46 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.92 149.66 26.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.709 1.595 . . . . 0.0 109.299 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -115.75 135.97 53.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.165 1.386 . . . . 0.0 110.705 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.9 t -142.64 123.07 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 0.0 110.014 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -81.85 124.28 29.55 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.79 -3.27 87.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.64 174.05 49.77 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.956 1.378 . . . . 0.0 110.296 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -82.09 152.73 26.43 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.006 -0.702 . . . . 0.0 110.488 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -134.24 154.15 51.44 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 108.338 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.77 -160.48 31.32 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -96.95 105.52 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -53.9 121.5 8.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.438 0.695 . . . . 0.0 110.772 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -138.98 95.92 3.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.776 1.274 . . . . 0.0 108.326 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.26 3.12 13.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.593 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -16.85 7.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.489 2.316 . . . . 0.0 112.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.54 80.37 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 12.4 p90 -119.37 159.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 164.01 28.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.496 2.319 . . . . 0.0 112.763 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -132.96 95.46 3.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.54 124.87 41.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.45 135.48 44.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.434 0.694 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.2 t -81.51 109.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.46 130.35 42.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.79 67.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.221 1.373 . . . . 0.0 111.427 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.3 -8.23 59.47 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.723 1.609 . . . . 0.0 111.265 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.34 151.85 24.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.322 -0.861 . . . . 0.0 110.135 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -134.79 139.96 45.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mt -78.49 118.35 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.36 -26.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.362 0.665 . . . . 0.0 111.524 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.78 152.92 38.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.898 0.879 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.11 152.89 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 46.2 mt-30 -135.17 127.57 30.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.383 2.673 . . . . 0.0 106.691 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.61 116.33 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.368 0.985 . . . . 0.0 109.816 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.8 p -87.44 152.0 22.59 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.999 1.272 . . . . 0.0 107.612 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -150.34 142.64 24.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.53 160.27 28.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.42 131.8 35.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.9 m -102.55 175.11 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 122.062 0.934 . . . . 0.0 113.0 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -60.44 119.55 8.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 109.082 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 3.44 65.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.239 -1.311 . . . . 0.0 113.794 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -122.31 158.49 29.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.722 1.261 . . . . 0.0 110.979 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -107.31 -48.96 3.35 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -78.94 145.17 34.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.59 0.709 . . . . 0.0 110.57 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.99 155.83 39.9 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -139.72 159.86 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 mt -65.49 125.5 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.6 p -100.79 -28.27 12.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.402 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -157.83 165.53 35.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.302 1.41 . . . . 0.0 109.401 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.6 mt -143.69 145.96 21.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.607 1.963 . . . . 0.0 106.623 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 77' ' ' GLN . 57.8 m -150.61 118.5 6.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.36 157.0 16.47 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -133.17 129.95 38.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 72.2 p -101.17 154.75 18.48 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.323 0.249 . . . . 0.0 110.838 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -73.2 -28.98 62.49 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 9.2 mmpt? -49.26 -44.56 43.88 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 125.095 1.358 . . . . 0.0 109.354 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.5 -6.18 3.87 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.847 -0.974 . . . . 0.0 114.402 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.256 0.3 OUTLIER -103.2 157.07 17.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.911 1.355 . . . . 0.0 111.559 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.6 p -133.11 147.9 52.14 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.043 1.737 . . . . 0.0 107.916 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.74 158.73 56.27 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.31 167.7 26.2 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 121.652 1.568 . . . . 0.0 108.096 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.4 109.91 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.847 2.364 . . . . 0.0 110.247 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -79.09 62.03 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.51 1.524 . . . . 0.0 108.442 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.54 177.77 15.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.891 1.71 . . . . 0.0 110.561 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.9 110.03 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 113.631 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.28 126.56 27.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.6 m -122.79 171.6 9.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.539 0.735 . . . . 0.0 110.916 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -61.85 -58.72 6.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.66 1.184 . . . . 0.0 109.628 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -67.01 129.57 40.34 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -160.79 169.95 21.69 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.029 0.532 . . . . 0.0 111.097 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 117' ' ' LEU . 60.8 t80 -122.15 138.8 54.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.637 2.775 . . . . 0.0 106.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.65 132.59 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 115' ' ' PHE . 2.5 pt? -153.06 151.99 30.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.857 0.863 . . . . 0.0 108.906 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 156.33 20.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.195 0.998 . . . . 0.0 109.559 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.02 165.22 12.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.002 0.921 . . . . 0.0 108.57 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -138.22 -75.46 0.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -127.85 13.51 6.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.574 1.15 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.25 -17.13 38.04 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 117.331 -1.816 . . . . 0.0 116.569 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.83 27.39 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.953 1.876 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -137.01 166.34 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.88 128.86 37.84 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.65 -59.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.304 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.7 176.57 17.61 Favored Glycine 0 N--CA 1.465 0.617 0 CA-C-N 119.429 1.013 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -125.3 163.58 22.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.955 1.702 . . . . 0.0 112.321 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -167.79 171.07 10.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.548 1.539 . . . . 0.0 109.466 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.64 -119.66 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -154.73 110.92 3.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.641 3.176 . . . . 0.0 103.821 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.84 18.55 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.558 1.143 . . . . 0.0 108.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.79 -131.13 1.97 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.96 -17.47 25.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.886 1.675 . . . . 0.0 114.484 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.87 19.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.324 1.05 . . . . 0.0 110.433 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 tp -86.83 87.01 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -86.57 -32.56 20.6 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.5 162.45 40.11 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.336 -0.852 . . . . 0.0 112.999 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 tp -161.93 106.08 1.22 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.317 -0.239 . . . . 0.0 110.987 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.01 166.22 13.55 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.316 2.389 . . . . 0.0 107.135 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.24 161.75 36.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.133 0.967 . . . . 0.0 109.165 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -101.04 146.13 27.83 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.82 99.82 4.28 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.27 160.4 40.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.033 0.933 . . . . 0.0 109.413 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -134.2 143.94 48.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.873 0.869 . . . . 0.0 109.534 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 p -123.9 0.59 8.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 110.893 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.0 p -92.91 11.68 26.44 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.6 -1.312 . . . . 0.0 113.02 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.9 p -125.51 152.37 71.6 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 119.826 1.194 . . . . 0.0 113.284 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -81.46 -165.67 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.562 3.508 . . . . 0.0 110.119 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.1 p -75.12 166.2 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.828 0.851 . . . . 0.0 109.434 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.7 p -99.79 153.32 37.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.618 1.167 . . . . 0.0 109.041 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.65 -161.28 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.375 3.383 . . . . 0.0 109.579 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.01 172.36 6.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.554 1.141 . . . . 0.0 110.351 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -74.97 138.34 42.21 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -106.27 110.93 23.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.17 1.388 . . . . 0.0 111.848 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 mt -69.0 173.78 5.12 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.258 1.423 . . . . 0.0 108.535 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.6 t -98.23 103.9 15.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.77 170.88 14.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 tt -164.07 160.23 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 106.82 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.68 -20.46 1.3 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.81 -23.6 0.41 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 118.56 1.18 . . . . 0.0 114.004 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.445 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 3.7 m-20 60.14 10.96 2.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.301 1.44 . . . . 0.0 114.027 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -96.2 150.64 20.31 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.821 -1.174 . . . . 0.0 109.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 -179.19 18.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.025 1.298 . . . . 0.0 110.699 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 65.7 m -75.26 124.22 26.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -86.09 131.53 34.24 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.777 0.831 . . . . 0.0 110.322 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.448 ' HE1' ' HB3' ' A' ' 283' ' ' ALA . 54.6 p-90 -158.89 130.35 6.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.925 0.89 . . . . 0.0 110.028 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.18 135.18 39.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -123.44 60.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.718 2.007 . . . . 0.0 107.269 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -24.68 -82.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.646 0 C-N-CA 129.666 3.507 . . . . 0.0 115.071 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.86 162.94 7.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.682 0.793 . . . . 0.0 112.915 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.07 -165.86 1.57 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.648 2.379 . . . . 0.0 108.684 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.83 -45.16 79.12 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.895 -1.128 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.21 164.26 32.88 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.785 0.707 . . . . 0.0 112.207 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -74.83 157.5 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.08 1.352 . . . . 0.0 111.3 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -133.49 -65.17 0.69 Allowed 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.411 1.084 . . . . 0.0 109.479 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -140.64 156.2 46.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.493 0.588 . . . . 0.0 110.197 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.66 147.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.315 1.846 . . . . 0.0 107.315 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -138.99 163.46 32.33 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.826 1.251 . . . . 0.0 108.515 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.1 t -141.88 123.63 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -100.97 77.09 0.4 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.5 -175.78 0.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.805 0.812 . . . . 0.0 112.151 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.83 -172.53 38.57 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.47 -28.67 69.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 128.632 2.773 . . . . 0.0 114.901 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.76 -31.67 5.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.6 2.76 . . . . 0.0 112.398 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.8 -167.88 36.01 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.21 114.37 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.2 m -103.79 -25.24 13.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.883 1.673 . . . . 0.0 112.005 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -134.21 154.51 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.024 0.93 . . . . 0.0 109.02 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.74 155.34 27.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.418 1.087 . . . . 0.0 109.002 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -175.43 152.56 1.38 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 111.061 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.99 162.32 35.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.541 1.536 . . . . 0.0 108.217 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.37 151.22 37.45 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.517 1.127 . . . . 0.0 108.516 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -163.83 154.22 15.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.646 0.736 . . . . 0.0 111.052 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -110.27 123.75 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -139.78 145.15 37.85 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.34 35.86 61.73 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.68 0.38 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.243 3.417 . . . . 0.0 114.421 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.52 154.75 19.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.756 1.622 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.78 130.69 39.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.781 0.832 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.1 mt -119.25 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 37.2 t -122.54 121.45 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 176.96 -110.97 0.32 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 67.03 -4.63 3.16 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 127.143 2.306 . . . . 0.0 116.469 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.58 124.92 25.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.163 1.982 . . . . 0.0 108.678 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.22 16.9 1.36 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.435 1.894 . . . . 0.0 111.803 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.45 151.34 23.61 Favored Glycine 0 C--N 1.335 0.501 0 O-C-N 119.099 -2.251 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 285' ' ' GLU . 45.8 pttt -35.43 98.94 0.16 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.682 1.593 . . . . 0.0 114.009 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.37 114.26 2.79 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.243 1.962 . . . . 0.0 107.977 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.0 p -78.32 145.33 35.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.059 0.944 . . . . 0.0 110.329 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.46 -7.1 34.96 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.429 -0.795 . . . . 0.0 110.202 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.86 2.064 . . . . 0.0 108.622 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.93 -161.95 13.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -141.99 129.06 20.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -79.41 161.93 25.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -144.19 157.21 44.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 111.964 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.52 115.75 8.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.38 116.17 31.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.9 mm -127.55 107.57 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.71 103.79 1.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 123.92 0.762 . . . . 0.0 110.909 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -36.5 -56.07 1.36 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.211 2.204 . . . . 0.0 115.957 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.7 -16.96 11.35 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 115.017 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.9 m -101.24 -10.59 20.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.484 1.493 . . . . 0.0 113.288 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.532 ' HG2' ' H ' ' A' ' 225' ' ' TYR . 23.8 tt0 -139.99 -168.82 2.6 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.532 ' H ' ' HG2' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -168.27 140.7 2.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.35 115.45 49.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.372 2.269 . . . . 0.0 106.208 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 32.5 m -94.14 -72.02 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.281 0.491 . . . . 0.0 111.658 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -107.82 170.5 7.95 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.551 1.14 . . . . 0.0 113.981 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.3 p -132.68 144.97 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.81 1.644 . . . . 0.0 107.91 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -133.07 169.82 16.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.711 1.604 . . . . 0.0 107.428 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.87 -175.26 45.77 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 120.248 -1.532 . . . . 0.0 109.599 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.32 136.27 22.23 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.47 38.99 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.348 1.059 . . . . 0.0 109.339 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -136.97 166.13 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.688 0.756 . . . . 0.0 112.172 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -72.87 141.22 47.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.926 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.1 157.93 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.763 2.025 . . . . 0.0 109.1 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -107.43 106.34 16.7 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 160.25 -49.13 0.38 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.441 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 49.9 m -135.46 173.92 11.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.196 0.998 . . . . 0.0 111.965 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.86 -12.2 58.58 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.159 0.584 . . . . 0.0 112.314 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.54 120.22 5.95 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.39 172.52 9.3 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.532 1.933 . . . . 0.0 107.061 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.7 tt -125.82 134.49 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.734 1.152 . . . . 0.0 111.441 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.4 mt -79.43 122.88 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 -6.67 10.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.983 0.513 . . . . 0.0 111.828 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -143.37 147.29 34.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -138.95 149.13 44.41 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.033 1.733 . . . . 0.0 110.255 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.41 ' H ' HD23 ' A' ' 247' ' ' LEU . 18.8 mtt180 -149.4 153.83 37.96 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.05 1.74 . . . . 0.0 106.613 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.43 138.47 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -89.27 114.31 25.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.27 0.941 . . . . 0.0 109.492 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.8 p -97.85 165.42 11.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.7 2.0 . . . . 0.0 110.659 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.28 134.75 55.04 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? 75.79 -50.92 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.749 2.42 . . . . 0.0 107.659 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -82.67 155.91 24.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.853 2.061 . . . . 0.0 108.262 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 59.4 m -118.83 114.52 22.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.3 p -68.88 168.22 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 111.802 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.45 154.17 42.42 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.021 1.328 . . . . 0.0 109.442 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.45 109.17 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.874 2.383 . . . . 0.0 108.234 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.54 92.34 5.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.42 -172.01 14.41 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.495 1.045 . . . . 0.0 111.495 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.98 133.94 52.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.42 -1.047 . . . . 0.0 110.516 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.2 108.33 3.12 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -147.56 125.91 12.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 97.81 -157.77 20.73 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.41 0.45 . . . . 0.0 112.095 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.3 m -77.21 117.52 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.722 1.209 . . . . 0.0 110.474 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.92 129.58 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -136.52 151.24 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.46 155.42 50.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.355 1.062 . . . . 0.0 108.58 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp -141.37 130.79 23.76 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.803 0.841 . . . . 0.0 109.017 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.47 166.29 10.26 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.069 1.348 . . . . 0.0 109.369 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -134.78 134.0 40.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.74 128.27 35.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.864 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.21 26.62 70.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -135.96 162.62 32.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.505 1.653 . . . . 0.0 111.097 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -121.62 162.49 20.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.211 1.404 . . . . 0.0 110.165 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 25.4 mt -79.63 145.64 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.1 m -145.49 -12.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.25 34.34 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 120.674 1.579 . . . . 0.0 111.136 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -144.85 157.06 44.29 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.112 1.765 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -149.64 149.29 30.42 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 128.489 2.716 . . . . 0.0 104.783 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.55 -135.99 6.45 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 11.5 mptt -140.63 157.54 45.3 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.448 ' HB3' ' HE1' ' A' ' 167' ' ' TRP . . . -129.87 149.37 51.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.3 p -159.75 -178.01 6.77 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.212 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' A' ' 208' ' ' LYS . 5.7 mm-40 -67.83 -0.19 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.785 1.234 . . . . 0.0 111.671 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 22.6 mt -140.77 135.81 31.88 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 129.316 3.047 . . . . 0.0 103.148 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -85.74 95.62 9.45 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -88.89 -70.41 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.277 0.361 . . . . 0.0 111.722 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -106.13 111.68 24.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.563 1.145 . . . . 0.0 111.995 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -116.98 160.74 20.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.52 40.24 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.73 141.01 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 117.818 0.809 . . . . 0.0 108.943 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -84.24 155.63 22.39 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.1 m -125.12 158.49 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.861 0.864 . . . . 0.0 109.816 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 28.2 mtt -157.44 145.71 14.27 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.871 2.468 . . . . 0.0 105.491 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.54 155.91 62.39 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.182 -1.507 . . . . 0.0 108.182 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.84 150.47 49.12 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 13.0 t -159.66 143.42 14.56 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.337 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -70.5 119.59 14.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.251 0.548 . . . . 0.0 110.738 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -148.53 140.6 23.97 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.3 93.35 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.823 0.738 . . . . 0.0 109.03 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.34 146.46 19.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.477 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 150.98 47.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.093 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.12 9.67 69.99 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.7 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.28 179.88 43.78 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.305 1.552 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.37 -31.34 63.53 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.63 12.85 9.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.47 2.308 . . . . 0.0 113.448 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.04 -28.22 12.16 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.749 2.119 . . . . 0.0 116.352 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.71 -81.33 0.58 Allowed Glycine 0 C--N 1.342 0.863 0 CA-C-N 120.15 1.975 . . . . 0.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 131' ' ' ARG . . . -145.67 158.89 43.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.986 0.915 . . . . 0.0 109.885 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.29 97.88 6.0 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.894 1.278 . . . . 0.0 111.414 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.501 ' CD1' ' HG3' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -67.38 0.6 2.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.538 1.535 . . . . 0.0 113.001 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.65 109.79 2.13 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.12 -0.987 . . . . 0.0 111.103 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.05 165.36 17.62 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 109.434 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.55 -3.46 86.43 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.376 -1.235 . . . . 0.0 113.443 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.4 m -118.24 155.13 20.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 119.368 1.584 . . . . 0.0 109.839 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -74.85 164.02 27.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.81 -93.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.71 165.92 20.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 111.875 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -143.11 96.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.62 1.568 . . . . 0.0 107.42 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.407 ' HD2' ' HB2' ' A' ' 43' ' ' ALA . 7.9 tpm_? -85.59 -50.56 7.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.805 1.242 . . . . 0.0 110.836 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -141.19 164.48 30.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.37 96.97 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.1 126.1 34.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.89 136.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.38 162.71 30.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -106.86 141.19 38.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.239 2.216 . . . . 0.0 111.259 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.39 -156.68 9.72 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 106.039 -2.824 . . . . 0.0 106.039 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -96.06 -9.4 30.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.705 -1.467 . . . . 0.0 109.629 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.82 2.71 38.59 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 134.132 4.973 . . . . 0.0 112.707 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.71 -139.4 14.49 Favored Glycine 0 C--N 1.339 0.736 0 O-C-N 121.146 -0.971 . . . . 0.0 111.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -77.42 96.45 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -105.43 2.74 28.91 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.47 124.91 23.43 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 122.138 2.245 . . . . 0.0 107.919 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 169.37 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -159.14 152.83 22.97 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.745 -1.222 . . . . 0.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.58 107.6 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.037 1.335 . . . . 0.0 109.585 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.42 114.88 35.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -101.93 122.97 45.05 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.781 0.719 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . -77.81 125.64 29.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -113.98 145.32 41.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.16 -35.58 59.93 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 t -80.71 -65.08 1.06 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.207 0.458 . . . . 0.0 110.203 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -150.96 140.91 21.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.341 1.056 . . . . 0.0 108.359 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.63 135.58 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.202 1.801 . . . . 0.0 109.665 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.74 146.56 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 106.984 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 156.89 21.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.711 1.204 . . . . 0.0 109.657 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.62 35.36 3.33 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.234 1.873 . . . . 0.0 111.384 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.07 -154.36 47.09 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.012 0.906 . . . . 0.0 111.628 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.3 152.8 47.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -128.81 166.11 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.1 0.96 . . . . 0.0 109.002 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' A' ' 56' ' ' LYS . . . 85.71 -157.96 31.73 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -126.66 105.56 8.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 113.358 -178.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 1.5 ttmp? -62.41 128.73 37.43 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -131.14 155.17 47.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.6 pt? -75.56 -9.88 58.96 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -0.19 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.604 1.562 . . . . 0.0 113.089 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.08 130.87 2.39 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 125.888 1.709 . . . . 0.0 108.903 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.523 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 63.7 t80 -163.58 132.32 3.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.321 2.648 . . . . 0.0 105.781 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 163.67 32.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.79 1.636 . . . . 0.0 111.817 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -134.2 96.85 3.7 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.681 1.193 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.61 138.43 31.69 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.94 119.21 32.81 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.243 1.017 . . . . 0.0 109.602 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.24 123.67 25.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.046 0.938 . . . . 0.0 109.403 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.42 159.88 31.73 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.51 1.524 . . . . 0.0 110.742 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.51 25.99 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.5 1.57 55.71 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.469 2.308 . . . . 0.0 114.254 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -127.21 155.98 42.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.721 1.146 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -135.08 137.12 42.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.49 1.116 . . . . 0.0 108.884 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mt -73.96 102.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.24 -34.77 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 113.965 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.06 43.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.827 0.739 . . . . 0.0 109.482 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.29 146.29 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -131.49 137.69 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.49 139.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 p -115.8 154.49 29.55 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -154.3 168.63 25.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.86 1.264 . . . . 0.0 108.9 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -161.07 168.51 24.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -115.88 159.02 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.848 2.059 . . . . 0.0 109.063 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.1 m -127.25 135.62 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.29 107.82 0.61 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.24 3.66 7.99 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.041 -1.421 . . . . 0.0 113.35 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.23 142.17 47.26 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 119.817 1.808 . . . . 0.0 108.203 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.71 16.2 12.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.879 2.071 . . . . 0.0 111.517 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -136.35 172.72 12.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.348 1.459 . . . . 0.0 111.469 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.84 158.4 30.36 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.811 1.644 . . . . 0.0 106.897 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 pt -131.68 150.51 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.736 1.614 . . . . 0.0 107.397 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.89 122.76 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.292 1.037 . . . . 0.0 110.348 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 p -88.8 -29.67 19.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.71 0.804 . . . . 0.0 112.274 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -164.55 161.61 21.23 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.94 1.296 . . . . 0.0 109.793 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 mt -136.35 136.71 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 m -135.81 132.66 36.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -114.74 158.88 21.23 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.522 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -140.75 144.72 35.67 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.522 2.329 . . . . 0.0 105.227 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -134.2 166.39 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.0 -41.04 95.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 10.3 mmpt? -58.33 -12.09 3.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.455 1.102 . . . . 0.0 112.275 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.0 18.61 62.76 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.194 1.378 . . . . 0.0 111.954 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -89.15 97.01 10.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 p -85.46 105.81 16.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.24 157.11 83.35 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.53 164.17 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 0.0 111.331 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 111.82 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.063 2.509 . . . . 0.0 107.02 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -75.52 74.79 2.56 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.365 0.666 . . . . 0.0 109.566 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 142.36 -141.17 10.54 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.228 1.395 . . . . 0.0 110.519 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.9 tp -108.5 132.5 53.75 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 125.544 1.538 . . . . 0.0 109.619 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 116.86 18.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 m -114.67 164.6 13.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -61.26 -51.9 66.98 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.814 1.246 . . . . 0.0 110.174 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.29 115.77 11.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.9 168.27 27.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.358 -0.839 . . . . 0.0 110.872 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.37 167.18 22.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.607 1.563 . . . . 0.0 107.887 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.65 149.8 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -142.95 157.32 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.344 0.52 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.42 160.04 15.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.719 1.608 . . . . 0.0 111.51 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -81.28 177.12 9.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.796 1.639 . . . . 0.0 107.898 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.08 -46.31 2.32 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.111 -0.993 . . . . 0.0 112.519 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -109.52 19.25 19.48 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.41 -4.93 85.23 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.001 1.286 . . . . 0.0 114.244 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 118.32 13.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.53 164.18 0.54 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.243 1.817 . . . . 0.0 113.752 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.28 111.27 1.68 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.9 t -61.75 -50.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.78 48.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.08 -2.408 . . . . 0.0 107.08 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -102.49 172.32 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 169.14 20.89 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.48 126.69 1.73 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.501 ' HG3' ' CD1' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -99.74 179.3 4.58 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 123.208 1.48 . . . . 0.0 109.075 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.23 152.85 39.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 129.663 3.185 . . . . 0.0 105.519 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.52 -87.09 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 104.214 -3.555 . . . . 0.0 104.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -95.12 -27.48 15.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.186 0.493 . . . . 0.0 111.142 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.59 160.73 37.17 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 tp -77.45 93.67 4.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.597 0.713 . . . . 0.0 110.284 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -81.76 -37.12 27.71 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.306 1.042 . . . . 0.0 112.681 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.58 152.02 39.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.813 1.188 . . . . 0.0 109.853 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.4 tp -161.77 141.89 10.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.256 1.422 . . . . 0.0 108.296 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.89 -179.73 46.85 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.55 167.43 28.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.654 1.182 . . . . 0.0 109.069 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -136.39 168.44 19.45 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.815 1.293 . . . . 0.0 111.169 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -133.04 97.37 3.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 103.151 -2.907 . . . . 0.0 103.151 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.58 4.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 t -108.83 166.68 10.63 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 m 66.99 39.13 3.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.809 0.814 . . . . 0.0 110.596 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.0 p -89.87 3.44 52.98 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.573 -1.329 . . . . 0.0 110.488 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 40.8 p -102.75 144.93 29.61 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 127.07 2.148 . . . . 0.0 114.697 -177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.47 109.72 2.7 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.573 2.182 . . . . 0.0 106.801 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.4 t -147.86 122.94 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -137.43 152.41 73.09 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.879 -0.582 . . . . 0.0 111.357 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.33 -169.29 0.63 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.96 3.107 . . . . 0.0 109.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.88 -179.04 4.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.92 0.867 . . . . 0.0 110.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 126.52 31.13 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.149 -0.969 . . . . 0.0 112.816 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.82 147.88 24.94 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.992 2.117 . . . . 0.0 109.882 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.66 162.47 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.5 t -72.63 135.49 45.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -135.37 169.43 17.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.387 1.875 . . . . 0.0 109.976 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.6 154.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.25 1.82 . . . . 0.0 108.883 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.8 -85.2 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.68 47.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.668 2.08 . . . . 0.0 108.271 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 2.9 p30 -111.19 10.15 21.84 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -83.45 150.06 26.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.35 -179.56 22.94 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.721 1.146 . . . . 0.0 115.805 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.4 m -96.3 119.39 34.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.197 1.799 . . . . 0.0 109.136 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.6 153.65 40.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.438 0.563 . . . . 0.0 110.295 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -142.46 131.2 22.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.33 1.062 . . . . 0.0 111.0 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.32 139.91 32.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.806 1.643 . . . . 0.0 108.512 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.16 124.66 19.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.78 177.68 41.99 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.386 1.47 . . . . 0.0 111.05 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.36 149.69 27.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -131.96 -175.31 3.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.216 1.007 . . . . 0.0 110.896 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.07 -32.21 54.01 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.934 1.694 . . . . 0.0 113.327 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.32 -158.64 31.36 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.512 2.006 . . . . 0.0 108.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.39 139.47 50.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.688 1.195 . . . . 0.0 108.622 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.89 -68.89 0.9 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 110.233 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 193' ' ' GLU . 49.8 mtpt -119.03 157.65 27.37 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.399 0.545 . . . . 0.0 110.749 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.83 143.73 38.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 127.303 2.241 . . . . 0.0 107.775 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -143.39 145.41 32.63 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.722 1.209 . . . . 0.0 108.041 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 t -139.39 151.3 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.381 1.072 . . . . 0.0 109.605 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.74 144.37 16.24 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -123.36 -170.05 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.359 1.464 . . . . 0.0 110.571 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.85 -175.83 45.78 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 126.002 1.763 . . . . 0.0 110.127 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.26 -17.92 2.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.428 3.091 . . . . 0.0 118.219 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -117.78 -9.91 10.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.912 0.778 . . . . 0.0 112.259 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.7 -146.69 18.58 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 mm -63.86 153.4 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.588 1.194 . . . . 0.0 108.393 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.3 p -134.81 -23.84 1.54 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.76 151.93 34.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.692 1.133 . . . . 0.0 111.718 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 m -149.51 124.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 123.543 0.737 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -149.81 161.28 42.57 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -151.3 172.91 15.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.013 0.925 . . . . 0.0 108.511 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 177' ' ' LYS . 25.2 mp0 -130.88 147.03 52.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.837 0.827 . . . . 0.0 109.767 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.47 168.42 21.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.811 2.044 . . . . 0.0 109.979 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -112.3 161.83 16.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.0 1.72 . . . . 0.0 108.764 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -134.35 83.77 2.06 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.692 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.63 -66.58 1.34 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.398 1.475 . . . . 0.0 111.477 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -135.07 -45.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.365 1.866 . . . . 0.0 108.555 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -60.9 164.43 4.88 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.872 1.32 . . . . 0.0 111.333 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -123.34 149.78 44.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.625 1.57 . . . . 0.0 107.414 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -140.43 143.9 28.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.53 147.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -71.79 146.49 40.17 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.46 10.66 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.334 -3.106 . . . . 0.0 105.334 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 133.57 49.31 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 118.616 1.208 . . . . 0.0 108.863 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -106.41 -15.25 14.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.559 0.744 . . . . 0.0 110.486 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -102.48 -177.62 27.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.827 1.68 . . . . 0.0 113.232 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -107.93 83.52 1.76 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 128.531 2.733 . . . . 0.0 106.323 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.4 148.97 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.75 . . . . 0.0 111.553 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 66.7 p -87.06 -179.26 6.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.45 -1.06 25.23 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.151 -1.593 . . . . 0.0 112.771 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -32.27 32.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.23 0.923 . . . . 0.0 113.239 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.56 -157.11 18.81 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -147.42 119.94 8.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -66.94 154.76 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -139.75 142.74 36.77 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -143.04 142.98 31.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.495 1.518 . . . . 0.0 107.486 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -133.14 95.85 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.76 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.97 1.308 . . . . 0.0 111.395 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.78 89.79 2.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.403 1.081 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -45.46 -47.74 35.99 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.598 1.959 . . . . 0.0 112.626 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.89 -7.03 15.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 122.048 1.767 . . . . 0.0 114.682 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.7 t -109.93 -13.15 14.48 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 120.814 1.643 . . . . 0.0 113.402 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 171.66 13.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.344 0.975 . . . . 0.0 111.328 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -145.66 90.63 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.62 101.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.3 p -87.19 -26.47 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.441 1.097 . . . . 0.0 112.46 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.52 171.02 20.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.156 0.889 . . . . 0.0 112.24 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.86 159.26 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.16 176.35 5.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.717 2.407 . . . . 0.0 107.543 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.97 41.86 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -153.18 141.3 20.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.11 153.79 48.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.761 0.825 . . . . 0.0 110.432 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . 0.326 0.3 OUTLIER -156.17 172.01 19.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -74.78 139.94 43.66 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.409 1.483 . . . . 0.0 110.953 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.25 157.54 34.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 127.221 2.208 . . . . 0.0 110.041 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -84.93 178.37 7.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.32 -69.7 1.52 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.1 p -95.48 -178.21 4.34 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.715 0.769 . . . . 0.0 111.427 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.58 14.19 24.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.613 1.565 . . . . 0.0 111.435 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -128.27 163.49 21.81 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.249 1.404 . . . . 0.0 113.099 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.82 173.28 11.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.978 1.711 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.75 146.07 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.403 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.3 mm -76.12 133.78 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 t -112.36 -21.82 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -152.27 152.7 32.48 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 140.42 34.23 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.821 2.048 . . . . 0.0 109.013 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -145.23 153.42 41.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 106.339 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.45 128.69 56.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -80.47 114.39 19.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -119.66 165.16 14.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.365 1.079 . . . . 0.0 109.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.93 133.51 47.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 65.95 -46.39 0.4 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.501 2.32 . . . . 0.0 111.188 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -92.11 165.5 13.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 129.283 3.033 . . . . 0.0 109.408 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 73.7 m -150.76 118.83 6.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 83.9 p -66.85 165.03 16.08 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.095 0.474 . . . . 0.0 110.613 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -67.84 153.96 94.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.84 97.77 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.439 2.093 . . . . 0.0 106.731 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -76.14 92.47 3.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 111.28 178.24 20.33 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.952 1.263 . . . . 0.0 111.534 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.75 123.44 49.0 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.09 0.956 . . . . 0.0 110.035 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.11 107.23 5.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -157.05 45.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.219 1.008 . . . . 0.0 109.357 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -167.87 -164.92 24.39 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 121.405 -0.81 . . . . 0.0 111.115 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.2 m -66.7 104.6 1.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.27 146.98 36.54 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.578 -0.701 . . . . 0.0 110.788 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -141.4 170.42 15.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.924 0.868 . . . . 0.0 112.763 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -140.99 152.83 45.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.542 2.337 . . . . 0.0 106.891 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.6 mt -138.64 104.22 5.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -140.05 150.82 44.83 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.255 0.622 . . . . 0.0 110.461 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -144.8 130.75 19.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -67.71 138.72 56.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.63 -11.23 3.38 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.483 1.516 . . . . 0.0 115.818 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -99.21 159.75 14.76 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 120.111 1.956 . . . . 0.0 112.197 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -119.95 147.6 44.55 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.823 1.649 . . . . 0.0 107.543 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 87.9 mt -80.69 141.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.16 -29.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.46 -178.07 35.08 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.001 1.286 . . . . 0.0 110.559 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -113.37 -179.04 3.53 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.878 1.671 . . . . 0.0 111.22 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -153.35 179.36 8.84 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.822 2.049 . . . . 0.0 105.549 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 126.98 -151.73 18.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -151.54 149.53 29.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -108.11 154.6 21.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.936 1.295 . . . . 0.0 108.513 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 t -151.92 -63.03 0.17 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -149.18 -31.36 0.23 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.387 1.075 . . . . 0.0 112.542 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 79.6 mt -134.4 -112.81 0.21 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.948 1.249 . . . . 0.0 109.259 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.78 77.43 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.175 1.352 . . . . 0.0 108.628 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -60.58 -62.24 2.0 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 0.0 113.322 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -132.38 140.76 48.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.866 0.757 . . . . 0.0 109.702 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -140.99 151.32 44.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.566 1.547 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.88 165.83 37.76 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.0 m -113.52 157.02 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.788 1.294 . . . . 0.0 113.719 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -98.97 136.44 38.95 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.59 141.95 38.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.21 129.41 20.84 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 125.044 1.338 . . . . 0.0 108.425 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.95 86.53 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.857 3.038 . . . . 0.0 110.059 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 20.7 mt -96.46 9.41 41.43 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 35.4 m -78.93 159.04 27.9 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 . . . . . 0 C--O 1.247 0.94 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -70.33 152.57 44.0 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.738 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -140.99 140.66 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 130.442 3.497 . . . . 0.0 107.1 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 82.5 t -127.94 130.9 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.61 169.89 5.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.333 1.053 . . . . 0.0 113.836 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.37 106.55 6.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.44 134.08 13.29 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 105.67 -2.972 . . . . 0.0 105.67 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.25 -151.42 20.08 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.77 168.89 42.89 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 122.779 1.21 . . . . 0.0 114.444 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.74 -18.39 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.457 1.103 . . . . 0.0 111.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.53 169.33 41.23 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.577 0.608 . . . . 0.0 113.005 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.91 168.49 44.46 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.134 1.35 . . . . 0.0 112.462 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.74 156.06 21.59 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 84.0 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.199 1.4 . . . . 0.0 110.264 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -90.04 135.58 33.56 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.38 151.95 28.49 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 128.295 2.638 . . . . 0.0 105.41 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.78 153.0 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.28 -4.35 16.03 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 m -65.76 158.71 4.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.773 1.286 . . . . 0.0 110.122 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -67.98 -44.54 76.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -172.6 -165.89 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.66 2.784 . . . . 0.0 105.913 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.69 27.68 0.86 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.07 1.319 . . . . 0.0 112.896 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.11 142.71 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 119.397 1.598 . . . . 0.0 109.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.29 -33.33 1.3 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.265 0.626 . . . . 0.0 112.29 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -135.89 160.67 37.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.453 0.569 . . . . 0.0 110.735 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.29 90.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.63 110.45 20.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -132.92 147.58 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 172.37 22.45 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -135.12 157.27 47.35 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.835 0.854 . . . . 0.0 112.568 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.83 -153.28 8.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.389 -2.684 . . . . 0.0 106.389 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -95.86 -7.34 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.96 -1.318 . . . . 0.0 110.373 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.38 -7.23 26.48 Favored 'General case' 0 N--CA 1.446 -0.645 1 C-N-CA 133.705 4.802 . . . . 0.0 112.427 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.77 -151.91 18.07 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.78 131.69 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -148.09 13.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.758 -1.214 . . . . 0.0 113.297 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 p -131.7 125.42 32.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.5 mt -140.52 119.39 11.19 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -128.03 145.36 51.01 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 107.714 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.2 t -129.08 131.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.313 1.045 . . . . 0.0 110.407 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.59 132.51 44.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 102.184 -3.265 . . . . 0.0 102.184 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -103.07 152.63 21.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 109.834 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.26 115.87 30.92 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.16 166.73 11.33 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.357 1.075 . . . . 0.0 111.16 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.53 -5.65 25.64 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.406 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.2 m -104.91 -67.01 0.93 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 119.583 -1.948 . . . . 0.0 110.803 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -156.35 165.6 35.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.664 1.185 . . . . 0.0 107.831 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.52 141.88 42.94 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -145.79 138.44 20.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.61 136.45 57.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.152 0.981 . . . . 0.0 108.438 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.73 -65.88 1.84 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.15 171.81 20.17 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.09 146.3 23.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.483 0.659 . . . . 0.0 111.02 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -123.92 83.73 2.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.28 26.29 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -126.61 112.44 15.5 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -52.98 111.96 0.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 110.082 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -81.61 108.36 15.11 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 127.756 2.422 . . . . 0.0 109.842 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.77 -24.02 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.569 -0.707 . . . . 0.0 112.672 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.28 8.77 43.89 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.271 1.029 . . . . 0.0 113.548 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.44 121.9 0.84 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.951 1.25 . . . . 0.0 110.658 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.85 121.38 2.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.623 2.369 . . . . 0.0 105.026 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -128.4 164.45 22.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.4 m -121.87 131.22 53.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.865 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -137.47 110.27 7.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -95.52 124.66 39.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.98 1.312 . . . . 0.0 108.922 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.84 116.25 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.56 143.57 56.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -41.63 75.41 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.626 -0.671 . . . . 0.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.34 -7.4 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.677 1.191 . . . . 0.0 112.638 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.11 151.33 21.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.969 1.708 . . . . 0.0 108.23 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -130.89 143.15 50.52 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.9 mt -68.57 137.64 24.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.2 m -107.18 -46.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 123.144 0.578 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 165.32 31.07 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.215 1.406 . . . . 0.0 108.635 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.07 108.82 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -91.91 137.68 32.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.5 t -136.36 144.16 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.523 HG21 ' H ' ' A' ' 111' ' ' THR . 75.6 m -118.61 140.46 49.88 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.69 167.17 30.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.218 1.807 . . . . 0.0 106.308 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.18 168.54 24.03 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.53 0.605 . . . . 0.0 109.842 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -108.5 148.72 29.84 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.375 1.07 . . . . 0.0 111.313 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.48 131.13 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -60.24 -0.25 0.22 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.817 1.647 . . . . 0.0 115.201 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.36 7.66 34.77 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.18 1.847 . . . . 0.0 113.35 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -138.42 144.07 40.02 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 120.365 2.083 . . . . 0.0 109.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.59 -2.29 28.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.281 1.832 . . . . 0.0 111.664 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 t -155.02 150.38 27.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.83 -1.169 . . . . 0.0 110.137 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.52 163.87 27.24 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 pt -139.39 151.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.973 1.309 . . . . 0.0 109.246 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.16 118.92 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.429 ' OG1' HG22 ' A' ' 79' ' ' THR . 23.4 p -89.53 -32.76 17.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.584 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -162.84 166.22 24.36 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.557 1.071 . . . . 0.0 112.863 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.6 mt -135.72 151.58 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.066 1.347 . . . . 0.0 107.681 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.3 m -141.25 101.74 4.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.392 1.877 . . . . 0.0 107.009 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -81.82 121.8 26.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.752 1.221 . . . . 0.0 108.914 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -106.13 128.24 53.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.414 1.486 . . . . 0.0 109.067 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.9 p -99.9 169.06 9.48 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.642 1.177 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -76.92 -39.93 49.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -68.75 -26.2 65.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 116.432 -1.747 . . . . 0.0 115.348 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.52 -12.58 7.01 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 121.068 1.758 . . . . 0.0 114.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -70.49 137.4 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -135.06 128.66 32.69 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.5 p -74.31 158.66 85.11 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 117.914 0.325 . . . . 0.0 110.917 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.93 164.53 35.37 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 107.128 -1.912 . . . . 0.0 107.128 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.81 83.5 1.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.783 2.322 . . . . 0.0 108.663 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -57.16 115.52 2.71 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.05 -126.45 6.89 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -139.4 131.73 28.39 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.87 1.268 . . . . 0.0 107.916 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -68.19 154.26 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.523 ' H ' HG21 ' A' ' 79' ' ' THR . 0.2 OUTLIER -151.34 175.56 12.11 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.432 -1.417 . . . . 0.0 111.784 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.41 ' H ' HG22 ' A' ' 111' ' ' THR . 5.3 tt0 -58.38 -64.52 0.89 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.915 1.686 . . . . 0.0 111.527 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.95 163.52 27.8 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.948 0.88 . . . . 0.0 110.927 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER 176.11 168.82 0.43 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.156 1.783 . . . . 0.0 109.047 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.48 160.96 42.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.663 1.585 . . . . 0.0 107.565 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.06 137.17 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.22 137.09 50.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.14 138.03 0.72 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.379 2.672 . . . . 0.0 107.865 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -64.31 140.28 58.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.75 -28.06 63.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.383 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.99 2.96 55.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.081 1.309 . . . . 0.0 111.641 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.7 87.24 0.75 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.526 1.057 . . . . 0.0 111.153 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.57 144.35 15.92 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.42 145.69 28.84 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.3 tt -75.86 107.66 8.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 m -86.62 -23.57 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.531 0.605 . . . . 0.0 110.135 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.24 -179.68 43.27 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -144.47 175.71 9.92 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.333 1.053 . . . . 0.0 110.265 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.53 167.95 28.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.373 2.269 . . . . 0.0 106.565 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 118.48 0.52 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.309 1.413 . . . . 0.0 114.398 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -60.1 120.87 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.13 164.88 31.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.601 1.56 . . . . 0.0 109.131 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.77 -112.59 0.26 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.97 -21.89 66.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.971 0.385 . . . . 0.0 111.004 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.65 173.31 13.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.025 2.13 . . . . 0.0 108.998 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 50.5 tp -89.94 98.64 11.89 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -82.55 -42.91 17.74 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.68 34.0 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.245 0.929 . . . . 0.0 112.53 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.45 153.64 36.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.068 0.947 . . . . 0.0 111.086 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.15 29.41 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.309 1.433 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.4 40.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.351 1.06 . . . . 0.0 110.505 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -109.66 114.52 28.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -107.94 131.75 54.21 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.671 0.788 . . . . 0.0 111.055 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.7 162.93 36.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.795 0.838 . . . . 0.0 112.264 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 t -136.23 166.23 23.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.213 1.405 . . . . 0.0 109.677 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -138.32 173.22 11.84 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.964 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 174.83 11.17 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 108.445 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.8 p -140.27 151.08 63.53 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.905 1.282 . . . . 0.0 110.69 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.2 173.59 14.13 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.958 2.438 . . . . 0.0 112.577 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -58.97 131.78 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 p -74.82 158.38 84.72 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.84 -157.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.14 1 C-N-CA 125.825 4.35 . . . . 0.0 112.915 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.12 168.29 12.4 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.827 2.451 . . . . 0.0 113.727 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -75.85 127.25 32.61 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -95.21 135.38 36.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.9 mt -89.87 178.43 6.23 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.3 m -100.1 101.71 12.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.41 173.55 7.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.575 0.702 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.5 tt -144.4 172.03 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.346 1.858 . . . . 0.0 106.76 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.36 -111.75 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -146.74 -1.61 0.6 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 125.325 1.25 . . . . 0.0 114.68 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.589 ' HA ' ' CE ' ' A' ' 282' ' ' LYS 0.388 55.0 m-20 46.68 15.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.66 -29.3 59.03 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.29 -168.2 38.74 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.0 t -82.14 112.33 19.07 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.34 1.456 . . . . 0.0 109.462 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.95 35.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -135.82 107.31 6.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 110.177 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 280' ' ' HIS . 12.4 p-10 -97.9 104.68 16.73 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.84 -1.85 15.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.01 -83.96 1.15 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.174 1.369 . . . . 0.0 113.108 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.59 170.43 8.14 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.583 2.353 . . . . 0.0 110.65 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -138.6 144.64 39.86 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.151 0.98 . . . . 0.0 109.738 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.65 -10.71 59.34 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.238 1.015 . . . . 0.0 112.665 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.05 153.36 22.04 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.287 1.422 . . . . 0.0 109.964 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.06 156.46 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.899 1.68 . . . . 0.0 108.062 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -124.71 -58.31 1.5 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.616 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -158.76 162.03 37.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.277 1.398 . . . . 0.0 112.602 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.59 144.4 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.404 1.882 . . . . 0.0 107.077 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -139.23 144.67 38.57 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.88 1.272 . . . . 0.0 107.88 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 8.9 t -132.27 126.85 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -121.3 83.01 0.35 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -86.15 172.95 10.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.396 1.093 . . . . 0.0 111.286 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.26 -168.6 11.8 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 128.573 2.987 . . . . 0.0 106.981 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -66.49 -36.64 83.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.07 -32.24 61.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.53 0.732 . . . . 0.0 112.169 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.0 -154.21 25.35 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.6 mm -64.82 124.51 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.8 m -108.96 -25.48 10.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.683 1.128 . . . . 0.0 112.485 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -140.99 141.53 34.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.174 0.989 . . . . 0.0 110.774 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.47 130.41 72.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -152.47 144.68 23.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -144.19 168.76 19.27 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.283 1.033 . . . . 0.0 109.821 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -133.53 129.39 37.04 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -131.28 168.97 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.763 1.625 . . . . 0.0 110.22 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -124.47 99.25 6.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -117.28 138.7 51.57 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.983 2.113 . . . . 0.0 105.768 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.31 29.27 45.64 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.222 -0.765 . . . . 0.0 112.174 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.78 -7.72 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.475 2.71 . . . . 0.0 114.593 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.02 158.66 18.56 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 123.554 1.645 . . . . 0.0 114.752 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -86.6 99.95 12.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.177 1.791 . . . . 0.0 106.937 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.5 143.92 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.27 129.93 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.162 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.54 -34.3 28.88 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.51 174.49 35.67 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.911 1.72 . . . . 0.0 111.113 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -62.84 100.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.005 1.322 . . . . 0.0 108.184 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -73.99 -50.4 20.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -93.19 165.27 27.7 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.529 1.061 . . . . 0.0 112.297 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -62.81 108.2 1.58 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 126.176 1.791 . . . . 0.0 110.876 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.79 178.55 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 N-CA-C 107.713 -1.687 . . . . 0.0 107.713 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 212' ' ' LEU . 1.2 t -147.56 176.15 10.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -14.54 11.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.462 ' H ' HG23 ' A' ' 210' ' ' THR . 9.8 tt -65.61 -28.86 69.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.883 0.873 . . . . 0.0 110.329 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.89 -137.65 13.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.28 156.21 38.0 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.306 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.52 154.1 28.85 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.62 148.69 47.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.474 0.579 . . . . 0.0 111.676 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.06 112.54 6.82 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -83.36 109.91 17.69 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.5 mt -110.51 102.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.6 99.26 5.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -45.04 -41.55 13.61 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.46 -26.42 29.02 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 CA-C-N 123.592 2.319 . . . . 0.0 112.887 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 98.6 p -107.79 -16.12 14.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.97 1.714 . . . . 0.0 114.278 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 117.72 29.15 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.301 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.52 92.9 4.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.14 1.776 . . . . 0.0 111.374 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.46 106.17 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 22.4 m -77.86 -38.89 45.04 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.139 0.576 . . . . 0.0 110.436 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.67 36.69 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.952 0.901 . . . . 0.0 110.652 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.2 143.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.453 ' CG ' ' HE3' ' A' ' 250' ' ' LYS . 9.5 mm-40 -128.72 166.49 18.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.603 1.961 . . . . 0.0 109.094 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.08 166.84 31.34 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.7 p -128.81 132.66 47.86 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.24 147.62 43.89 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.77 171.3 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.951 0.901 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 148.1 42.52 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.63 1.572 . . . . 0.0 110.747 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 236' ' ' ILE . 1.9 mp -96.22 135.59 29.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.75 85.63 2.75 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 139.63 -6.04 2.92 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.109 1.338 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 t -123.76 170.55 10.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.61 1.705 . . . . 0.0 108.905 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -116.92 52.62 0.94 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.972 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -167.72 -174.91 37.12 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.07 1.319 . . . . 0.0 110.299 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.59 157.92 23.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.381 1.072 . . . . 0.0 109.666 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.7 tt -130.87 135.93 59.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 124.985 1.314 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.05 104.34 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.066 -2.939 . . . . 0.0 103.066 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.284 5.5 t -86.22 -19.17 30.39 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -147.24 149.73 33.46 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.269 -0.895 . . . . 0.0 110.129 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 249' ' ' PHE . 0.2 OUTLIER -136.78 143.61 43.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.307 2.243 . . . . 0.0 108.565 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -147.42 161.81 40.29 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.046 1.738 . . . . 0.0 107.645 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.426 ' CZ ' HD12 ' A' ' 247' ' ' LEU . 71.4 m-85 -131.42 118.79 20.73 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 230' ' ' GLU . 73.6 mttt -69.79 113.14 6.75 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 100.325 -3.954 . . . . 0.0 100.325 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 152.31 23.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.162 2.185 . . . . 0.0 107.942 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 154.9 23.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 57.29 -7.72 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -157.55 174.66 15.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 131.208 3.803 . . . . 0.0 106.875 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.8 m -138.24 124.31 20.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.1 175.96 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.669 1.223 . . . . 0.0 111.84 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -79.31 158.34 74.27 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.734 2.014 . . . . 0.0 111.94 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.66 90.35 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.924 2.416 . . . . 0.0 106.859 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -73.69 91.97 1.94 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 115.24 -179.91 18.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.623 1.106 . . . . 0.0 113.784 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.17 111.02 22.03 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.63 1.172 . . . . 0.0 109.889 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.57 107.73 1.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -168.36 141.49 3.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.303 2.241 . . . . 0.0 107.284 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 103.74 -177.13 24.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 55.3 m -72.15 122.61 21.29 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.216 -0.579 . . . . 0.0 109.79 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.68 122.08 22.67 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.95 120.28 31.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.45 0.568 . . . . 0.0 111.465 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -100.47 144.02 29.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.873 0.869 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 82.6 mt -122.47 103.53 8.78 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -133.95 171.35 14.31 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.681 1.992 . . . . 0.0 108.999 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -143.5 167.87 21.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.748 0.819 . . . . 0.0 110.741 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.98 7.48 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.113 1.765 . . . . 0.0 114.102 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 142.36 65.18 0.03 OUTLIER Glycine 0 C--N 1.335 0.472 0 O-C-N 121.298 -0.876 . . . . 0.0 111.583 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -147.74 153.83 39.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.231 1.412 . . . . 0.0 107.84 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.68 154.72 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.348 1.459 . . . . 0.0 107.34 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.24 153.36 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 49.8 t -132.01 -80.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.15 -151.83 11.0 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 118.913 0.778 . . . . 0.0 111.743 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CE1' ' HA3' ' A' ' 281' ' ' GLY . 4.7 t80 -138.77 147.78 43.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.808 1.243 . . . . 0.0 110.086 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.6 p80 -133.73 92.19 2.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 279' ' ' PHE . . . -155.21 -138.88 2.66 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.589 ' CE ' ' HA ' ' A' ' 162' ' ' ASP 0.289 0.3 OUTLIER -156.4 162.37 40.04 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.082 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.95 50.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.519 0.676 . . . . 0.0 111.382 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 12.3 t -156.66 -167.4 2.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.696 1.998 . . . . 0.0 107.395 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -62.57 -19.43 63.68 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.076 2.15 . . . . 0.0 112.342 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 24.3 mt -139.23 150.05 45.07 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 128.987 2.915 . . . . 0.0 105.294 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 24.8 tp -85.12 86.62 7.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.007 0.821 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -78.72 -40.15 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.637 1.175 . . . . 0.0 110.895 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -128.43 130.62 47.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 120.079 1.308 . . . . 0.0 110.037 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.53 148.53 29.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.39 -164.67 27.43 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.13 137.47 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.461 0.704 . . . . 0.0 112.478 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 155.56 28.32 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 147.63 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.542 0.61 . . . . 0.0 111.641 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 80.2 mtp -139.72 149.09 58.25 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.74 118.05 5.45 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.686 2.257 . . . . 0.0 108.889 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.36 173.86 10.34 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.322 0.649 . . . . 0.0 111.042 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.7 m -125.08 -0.77 7.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.985 1.714 . . . . 0.0 111.417 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--O 1.247 0.937 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -179.757 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -70.78 129.93 40.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 80.6 t -133.96 124.16 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.79 164.7 20.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.117 0.96 . . . . 0.0 110.185 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 138' ' ' ALA . . . -69.09 105.61 2.51 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.329 1.452 . . . . 0.0 109.651 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.65 47.53 2.47 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.13 1.824 . . . . 0.0 114.571 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.18 -156.91 9.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.466 1.507 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 89' ' ' ASP . . . -80.98 160.06 42.35 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.233 1.016 . . . . 0.0 114.053 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.14 5.42 41.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.333 1.453 . . . . 0.0 112.61 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.34 59.94 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.18 14.03 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 119.906 1.853 . . . . 0.0 111.771 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 131' ' ' ARG . . . -78.73 156.69 28.77 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.735 0.814 . . . . 0.0 110.895 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 m -66.19 127.68 33.12 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.683 0.793 . . . . 0.0 111.583 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -134.36 161.4 35.09 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 160.09 149.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.599 3.16 . . . . 0.0 107.544 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -142.3 119.71 11.62 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.591 0.756 . . . . 0.0 109.346 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -39.56 -48.78 3.09 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 127.62 2.533 . . . . 0.0 117.829 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.73 146.17 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.447 1.624 . . . . 0.0 111.1 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -78.35 137.58 38.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.52 1.528 . . . . 0.0 112.236 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.31 -15.1 31.84 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.99 158.36 12.58 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.6 2.048 . . . . 0.0 110.711 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -145.38 139.84 22.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.5 mmt-85 -114.88 -60.97 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.086 1.754 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -126.36 162.85 24.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.761 1.225 . . . . 0.0 110.216 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.94 131.95 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.11 123.16 39.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.18 117.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 119.19 6.18 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.534 0.519 . . . . 0.0 112.268 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -69.98 172.58 7.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.05 1.74 . . . . 0.0 109.53 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.17 175.95 34.49 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 129.463 3.411 . . . . 0.0 104.821 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -68.06 -31.24 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -26.65 50.08 Favored 'General case' 0 N--CA 1.45 -0.447 1 C-N-CA 132.731 4.413 . . . . 0.0 113.327 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.97 -164.6 24.44 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -62.77 106.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.612 1.206 . . . . 0.0 108.217 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -97.16 -34.67 11.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.415 1.486 . . . . 0.0 114.455 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -119.34 153.26 35.39 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.534 1.133 . . . . 0.0 110.46 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.62 142.2 28.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.789 1.636 . . . . 0.0 109.088 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.44 151.62 22.8 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.59 1.956 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.85 158.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.134 1.374 . . . . 0.0 108.93 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.48 124.89 73.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -91.56 167.81 11.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.477 1.111 . . . . 0.0 110.01 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.14 111.39 19.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.731 1.212 . . . . 0.0 108.202 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -113.67 109.18 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 126.494 1.918 . . . . 0.0 108.066 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 64.0 1.01 1.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.143 1.777 . . . . 0.0 114.128 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.5 m 118.6 -11.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 1 C-N-CA 133.252 4.621 . . . . 0.0 110.498 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.3 144.72 28.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.119 0.967 . . . . 0.0 109.077 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.7 137.04 36.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.04 121.86 55.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.806 0.73 . . . . 0.0 110.074 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.98 161.84 20.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.623 2.369 . . . . 0.0 106.83 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.54 25.25 0.05 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.175 2.321 . . . . 0.0 112.384 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.33 91.91 0.1 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 121.838 2.819 . . . . 0.0 116.995 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -111.04 114.67 28.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -118.49 175.7 5.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.707 1.603 . . . . 0.0 112.061 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.4 -169.91 22.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 98.66 6.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -57.21 133.66 55.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.77 1.228 . . . . 0.0 110.856 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -129.06 124.07 33.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.384 . . . . 0.0 109.231 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.32 -21.52 66.72 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.13 -0.981 . . . . 0.0 112.851 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.54 38.3 3.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.508 1.523 . . . . 0.0 108.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.54 100.46 0.27 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.044 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.94 151.24 12.19 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.625 1.57 . . . . 0.0 109.673 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -151.14 160.58 43.78 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 130.164 3.386 . . . . 0.0 106.342 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 m -135.87 98.56 3.93 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.364 0.666 . . . . 0.0 111.465 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -95.73 108.92 21.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.56 101.79 13.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.683 1.593 . . . . 0.0 108.208 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.96 141.39 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -95.12 150.79 19.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.247 -0.908 . . . . 0.0 112.157 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.27 13.85 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.266 1.426 . . . . 0.0 111.949 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.53 -5.96 14.48 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.647 2.379 . . . . 0.0 111.345 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.08 150.99 36.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.855 1.262 . . . . 0.0 113.622 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.531 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 62.1 m-85 -135.56 132.94 37.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -71.65 113.2 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -93.9 -21.3 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.449 -0.782 . . . . 0.0 112.742 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.56 156.5 42.51 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.86 140.84 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.54 127.63 25.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.9 147.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -109.63 138.24 46.28 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 129.674 3.19 . . . . 0.0 108.613 -178.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -154.57 166.14 34.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.68 0.792 . . . . 0.0 110.543 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.452 ' OD1' ' HE3' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -161.65 169.23 21.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.666 0.786 . . . . 0.0 110.968 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 158.44 20.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.512 2.325 . . . . 0.0 109.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.47 154.73 40.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.421 1.089 . . . . 0.0 108.634 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -63.89 144.08 57.35 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.37 11.96 71.03 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.839 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -142.74 142.75 32.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.891 1.276 . . . . 0.0 108.925 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.37 16.5 23.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.414 2.286 . . . . 0.0 107.701 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -115.6 179.34 4.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.681 2.392 . . . . 0.0 109.802 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.479 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 4.6 m-20 -135.15 149.34 49.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 102.896 -3.001 . . . . 0.0 102.896 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.48 143.32 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.653 1.181 . . . . 0.0 108.764 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.99 129.2 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.0 p -100.23 -38.96 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.599 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.3 169.46 18.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.91 1.284 . . . . 0.0 110.368 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.3 mm -132.24 144.83 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.171 1.388 . . . . 0.0 108.613 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 87.6 m -150.27 139.71 21.45 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.124 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -123.39 158.12 31.84 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.72 121.89 34.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.1 p -80.1 159.25 26.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.65 -33.39 73.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -21.27 66.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.301 1.44 . . . . 0.0 112.84 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.34 -10.0 30.96 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.245 1.402 . . . . 0.0 113.658 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -78.51 159.31 28.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.039 2.135 . . . . 0.0 108.259 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.8 p -134.79 156.42 48.9 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.995 1.318 . . . . 0.0 111.648 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.45 157.37 35.55 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.01 165.64 31.57 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 121.854 1.703 . . . . 0.0 109.52 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.87 83.76 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.81 3.006 . . . . 0.0 107.701 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.92 101.66 0.07 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.984 1.314 . . . . 0.0 107.698 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.41 -143.65 14.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 tp -108.63 121.73 45.62 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.74 153.55 43.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 112' ' ' GLN . 1.4 m -150.75 -179.59 7.39 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.073 -1.642 . . . . 0.0 111.074 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' H ' HG22 ' A' ' 111' ' ' THR . 41.1 tt0 -73.7 -58.68 3.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.036 -1.04 . . . . 0.0 111.246 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HE3' ' OD1' ' A' ' 81' ' ' ASP . 22.6 mttt -70.19 166.48 19.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.923 1.238 . . . . 0.0 110.223 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER 175.69 167.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.237 2.215 . . . . 0.0 108.915 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.9 164.25 33.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.587 1.555 . . . . 0.0 107.83 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.04 142.39 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.57 135.33 34.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.984 1.313 . . . . 0.0 108.608 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -143.84 163.73 32.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.276 1.83 . . . . 0.0 108.784 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -118.5 175.45 5.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.679 1.992 . . . . 0.0 105.921 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -63.41 166.87 5.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.68 -9.06 40.19 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.585 -1.322 . . . . 0.0 113.795 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.78 -9.51 71.37 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.325 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.69 159.03 20.93 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.806 1.803 . . . . 0.0 113.764 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.531 ' HE3' ' CG ' ' A' ' 72' ' ' TYR . 14.3 mmtm -128.23 166.94 17.59 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.317 2.647 . . . . 0.0 107.441 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.16 -61.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.625 1.57 . . . . 0.0 107.588 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.67 31.07 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -133.25 157.43 45.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.932 1.293 . . . . 0.0 108.277 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -128.07 158.45 37.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.66 100.09 0.18 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 54.6 mtt180 -65.19 91.74 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.0 165.8 12.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 128.069 2.548 . . . . 0.0 113.663 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -157.3 -121.17 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 106.07 -2.812 . . . . 0.0 106.07 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -66.25 -18.23 65.23 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.16 169.76 19.32 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 125.557 1.543 . . . . 0.0 108.164 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.74 84.26 7.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -69.39 -45.68 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 110.738 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 6' ' ' ALA . . . -146.41 144.28 29.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.099 0.959 . . . . 0.0 111.872 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.8 tp -140.72 144.91 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.38 -178.63 28.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.12 38.41 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.227 1.014 . . . . 0.0 108.281 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.68 113.85 24.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.829 0.852 . . . . 0.0 108.927 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.35 100.96 10.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.769 0.828 . . . . 0.0 111.801 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -121.56 130.17 53.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -105.19 166.52 10.35 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.751 1.221 . . . . 0.0 109.27 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.6 m -73.5 108.16 6.2 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.2 p -71.79 173.85 7.67 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.145 0.978 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.5 p -71.59 140.65 84.5 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.49 176.96 9.42 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.146 2.564 . . . . 0.0 109.185 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.72 145.14 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.478 1.111 . . . . 0.0 110.583 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -74.81 158.56 84.54 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 124.047 0.939 . . . . 0.0 110.411 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -80.49 178.22 7.29 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.031 1.821 . . . . 0.0 110.351 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.33 164.72 24.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.139 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 119.24 37.74 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 293' ' ' HIS . 10.4 ptpt -88.19 123.66 33.05 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.0 mt -75.56 -166.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.312 1.045 . . . . 0.0 109.86 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 128.48 56.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.58 165.31 11.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.484 1.514 . . . . 0.0 107.653 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.05 -176.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.207 1.003 . . . . 0.0 110.883 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.21 -108.58 3.7 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.754 1.169 . . . . 0.0 111.559 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -176.0 136.9 3.46 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.06 53.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.808 2.443 . . . . 0.0 110.186 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.462 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 81.3 mm-40 -117.4 92.91 3.98 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.663 1.185 . . . . 0.0 110.692 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.79 -177.35 31.33 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.494 1.045 . . . . 0.0 112.278 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.41 113.56 3.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.786 1.634 . . . . 0.0 110.127 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.17 145.2 56.08 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.114 0.966 . . . . 0.0 110.825 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -138.51 61.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.04 104.66 6.67 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.68 99.4 10.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.263 2.625 . . . . 0.0 108.627 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.32 177.9 2.29 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.762 2.601 . . . . 0.0 112.441 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.23 25.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -118.44 -178.8 3.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.552 1.141 . . . . 0.0 109.257 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.07 -13.2 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.044 1.738 . . . . 0.0 114.198 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.32 -167.85 24.3 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 119.312 0.96 . . . . 0.0 112.291 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.44 156.8 40.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 127.824 2.45 . . . . 0.0 108.504 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -127.35 -52.08 1.39 Allowed 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.918 0.887 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.51 149.69 50.7 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.682 1.193 . . . . 0.0 108.306 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.1 139.73 50.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -127.05 112.74 15.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.594 1.157 . . . . 0.0 111.062 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.72 124.96 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.78 1.632 . . . . 0.0 107.623 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -115.78 139.59 15.51 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -138.29 -177.12 4.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.266 1.031 . . . . 0.0 112.019 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.64 -174.07 25.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 128.69 3.043 . . . . 0.0 106.846 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.97 -29.27 70.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.855 0.328 . . . . 0.0 110.854 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.36 -31.91 66.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.033 2.533 . . . . 0.0 113.01 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.88 -152.83 21.47 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.98 107.32 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.974 1.31 . . . . 0.0 109.007 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.0 p -101.79 -20.24 15.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.777 0.831 . . . . 0.0 112.564 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.06 160.72 42.11 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.084 1.311 . . . . 0.0 112.185 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 m -156.13 148.3 11.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.07 170.16 10.59 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.803 2.041 . . . . 0.0 107.011 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -160.29 164.49 32.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 109.894 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -102.53 123.21 45.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 148.19 23.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.647 1.979 . . . . 0.0 106.185 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.74 130.93 46.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -105.01 104.95 14.78 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.9 1.28 . . . . 0.0 108.019 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 71.31 -84.58 0.42 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.62 -18.29 2.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.257 . . . . 0.0 111.072 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.84 162.04 29.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.941 1.297 . . . . 0.0 109.572 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -112.21 145.5 39.79 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.679 0.792 . . . . 0.0 109.972 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.7 101.59 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.4 t -67.45 133.07 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.3 -169.8 42.6 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.1 -153.99 27.41 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.09 141.41 51.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -115.03 -80.22 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.44 1.018 . . . . 0.0 110.54 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.37 -179.11 50.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -99.81 103.69 23.5 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 120.931 2.365 . . . . 0.0 111.333 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.06 160.71 48.8 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 120.928 1.086 . . . . 0.0 109.367 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -102.81 178.11 4.66 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 27.2 tp -65.73 -13.57 59.58 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.795 -0.566 . . . . 0.0 111.509 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.65 -33.87 56.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.692 1.597 . . . . 0.0 110.645 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 110.83 -157.74 14.79 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.237 0.446 . . . . 0.0 112.387 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -133.93 170.74 15.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.159 2.184 . . . . 0.0 109.069 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.61 149.69 52.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 129.153 2.981 . . . . 0.0 104.765 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -133.49 149.12 51.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.954 0.797 . . . . 0.0 112.542 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -142.0 124.46 15.74 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -78.66 121.05 24.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.03 1.332 . . . . 0.0 109.682 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.76 124.71 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 128.127 2.571 . . . . 0.0 105.721 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.22 94.3 5.29 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.36 -33.6 15.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.525 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.76 13.94 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 CA-C-N 123.762 2.379 . . . . 0.0 111.198 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.31 -53.82 1.03 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.089 1.356 . . . . 0.0 109.878 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.86 177.75 4.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.461 1.504 . . . . 0.0 110.27 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.83 115.3 4.8 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.814 -0.553 . . . . 0.0 111.208 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.75 101.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -86.32 -19.5 29.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.995 1.318 . . . . 0.0 110.266 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.33 156.05 34.77 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.529 1.059 . . . . 0.0 110.833 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.7 144.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -132.08 173.27 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.647 1.979 . . . . 0.0 106.843 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.82 177.47 41.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.6 p -136.92 145.1 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -126.09 131.37 52.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.477 0.711 . . . . 0.0 111.554 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.41 170.77 15.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.136 1.375 . . . . 0.0 110.851 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 235' ' ' LYS . 2.6 mppt? -76.01 142.99 41.73 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.875 1.27 . . . . 0.0 111.882 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 20.2 pt -80.43 135.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.2 88.53 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.127 0.571 . . . . 0.0 110.808 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 151.95 -17.76 0.83 Allowed Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.296 -1.28 . . . . 0.0 112.76 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.2 m -140.27 179.16 6.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.554 1.177 . . . . 0.0 110.783 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.22 -30.09 24.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.177 2.591 . . . . 0.0 109.517 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -55.4 152.7 14.73 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 127.349 2.404 . . . . 0.0 112.976 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 66.3 mt -111.43 152.95 26.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.607 1.963 . . . . 0.0 109.222 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -143.73 160.38 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.246 1.418 . . . . 0.0 107.482 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.63 105.89 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -41.96 80.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.64 1.176 . . . . 0.0 111.582 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -147.89 159.48 43.81 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.912 0.485 . . . . 0.0 111.769 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 62.7 mt -135.13 147.11 49.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.287 1.835 . . . . 0.0 110.802 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -137.85 128.41 26.61 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.456 2.303 . . . . 0.0 107.749 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -111.38 113.61 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.71 113.83 19.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.2 p -109.99 165.84 11.41 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 126.623 1.969 . . . . 0.0 110.316 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -112.37 155.1 24.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 62.94 -16.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -135.18 172.27 13.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.619 1.568 . . . . 0.0 108.398 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.04 155.36 31.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.618 1.167 . . . . 0.0 108.005 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.6 p -123.01 178.27 5.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.421 1.889 . . . . 0.0 110.046 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -133.0 159.25 73.45 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.064 1.346 . . . . 0.0 109.73 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 108.24 2.65 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 109.01 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.24 92.94 5.17 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.01 179.78 17.2 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.687 1.137 . . . . 0.0 110.655 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 tp -82.96 111.97 19.31 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -68.47 106.95 2.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -171.23 146.51 2.37 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.838 2.455 . . . . 0.0 107.393 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 105.58 -176.69 22.46 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.1 m -67.77 122.97 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 144.2 43.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.138 -0.351 . . . . 0.0 110.317 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -138.65 144.34 39.64 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.5 1.12 . . . . 0.0 109.139 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.64 155.91 47.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.74 121.14 17.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -169.66 133.32 1.27 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.425 1.89 . . . . 0.0 109.829 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -146.0 129.21 16.67 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.0 1.32 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 30.33 52.61 0.12 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.115 2.966 . . . . 0.0 112.721 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 53.25 13.04 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 117.264 -1.853 . . . . 0.0 115.706 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.41 151.71 3.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.239 1.816 . . . . 0.0 111.228 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.28 132.61 40.1 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.15 1.78 . . . . 0.0 109.294 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.19 121.68 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.71 34.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.882 0.873 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.86 174.25 35.93 Favored Glycine 0 C--N 1.334 0.436 0 O-C-N 120.663 -1.273 . . . . 0.0 111.918 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 292' ' ' VAL . 48.8 m-85 -129.98 158.81 38.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.235 1.814 . . . . 0.0 108.509 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' HIS . . . . . 0.409 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 7.8 p-80 -149.26 165.74 31.01 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 112.23 -160.05 13.38 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.462 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -129.23 164.58 23.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.928 0.87 . . . . 0.0 110.743 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.96 149.52 50.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 m -152.37 -155.14 0.58 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 101.668 -3.456 . . . . 0.0 101.668 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -55.31 -36.45 66.21 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.008 -1.058 . . . . 0.0 110.285 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.14 164.44 21.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.128 1.371 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.72 77.4 9.79 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.92 -39.39 89.2 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -128.16 144.88 51.15 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -156.23 110.64 2.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -137.26 174.45 21.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 279' ' ' PHE . 8.9 m -128.45 174.93 11.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.03 0.932 . . . . 0.0 112.578 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' HIS . . . . . 0.567 ' CE1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER -118.16 128.13 54.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.9 2.48 . . . . 0.0 106.458 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.83 147.52 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.75 1.22 . . . . 0.0 109.996 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 81.2 mtp -141.97 144.15 31.07 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 126.331 1.852 . . . . 0.0 107.652 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.89 153.64 53.11 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.049 2.499 . . . . 0.0 112.433 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.95 82.54 3.0 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.579 1.152 . . . . 0.0 110.261 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.9 m -63.58 -16.52 61.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.056 1.343 . . . . 0.0 109.948 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.821 2.448 . . . . 0.0 109.899 -179.331 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.67 97.01 3.55 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.945 1.702 . . . . 0.0 110.278 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 130.43 34.62 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.35 128.11 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -72.7 155.54 39.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.693 0.679 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.44 101.62 13.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.366 1.466 . . . . 0.0 110.042 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.32 153.5 52.94 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.81 177.85 38.32 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 88' ' ' SER . . . -72.53 -50.44 15.35 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.527 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 125.64 0.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 129.639 3.176 . . . . 0.0 118.312 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.67 -4.05 1.88 Allowed Glycine 0 CA--C 1.539 1.535 0 N-CA-C 120.706 3.042 . . . . 0.0 120.706 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 137' ' ' TYR . . . -107.5 -174.01 22.37 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 121.336 2.568 . . . . 0.0 113.899 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.81 159.83 15.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.147 2.579 . . . . 0.0 112.991 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -3.66 109.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 1 C-N-CA 132.862 4.465 . . . . 0.0 117.531 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.489 ' HB3' ' H ' ' A' ' 130' ' ' GLY . 2.6 m0 -56.93 144.0 35.49 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 128.91 2.884 . . . . 0.0 108.353 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p30 59.1 9.38 1.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -50.67 129.32 22.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.385 0.993 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.42 30.88 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -42.13 128.49 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.482 1.913 . . . . 0.0 111.698 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -164.92 169.02 16.99 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 127.143 2.177 . . . . 0.0 106.509 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -142.29 52.78 1.45 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.498 1.142 . . . . 0.0 112.51 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.48 22.68 3.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.023 1.297 . . . . 0.0 112.426 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.27 146.48 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.712 1.756 . . . . 0.0 111.735 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.06 -28.81 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -146.15 159.03 43.86 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -142.68 115.29 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -88.28 144.52 26.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -141.56 148.08 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.496 1.119 . . . . 0.0 108.377 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.63 119.95 1.57 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.94 126.09 30.57 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.504 1.122 . . . . 0.0 108.72 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.03 -175.82 20.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -64.5 -36.8 85.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.11 17.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 131.126 3.77 . . . . 0.0 112.476 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.67 -136.79 18.45 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.48 95.68 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 p -109.41 -10.54 14.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.02 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -138.21 128.08 25.39 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.619 1.1 . . . . 0.0 109.015 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.98 154.24 23.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.114 1.366 . . . . 0.0 109.078 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.63 99.18 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.859 0.463 . . . . 0.0 110.747 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -77.97 145.04 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -127.73 134.57 65.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -115.77 169.95 8.83 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.459 1.123 . . . . 0.0 111.508 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.14 134.63 50.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.916 2.486 . . . . 0.0 106.61 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -115.88 150.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.55 -39.45 87.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.204 0.202 . . . . 0.0 110.555 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -70.89 0.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -149.45 139.91 22.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.37 141.05 48.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.473 1.509 . . . . 0.0 108.351 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.5 147.32 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 108.33 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.1 138.05 38.64 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.06 -68.06 1.64 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.72 144.09 3.93 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 121.595 -0.944 . . . . 0.0 112.465 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.95 133.71 43.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.757 1.623 . . . . 0.0 107.687 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -119.65 169.7 9.85 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.913 1.285 . . . . 0.0 110.252 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 -151.73 20.81 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -121.36 106.1 11.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -63.41 163.16 11.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.195 0.522 . . . . 0.0 111.392 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -138.79 162.7 34.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.044 0.938 . . . . 0.0 108.579 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.9 tp -89.34 -33.22 16.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.841 1.256 . . . . 0.0 112.174 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.9 mt -100.77 12.14 38.12 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.74 106.21 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -160.63 126.27 3.92 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.255 1.422 . . . . 0.0 108.239 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -148.77 163.59 36.92 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.866 1.666 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.2 m -141.14 133.4 28.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -128.25 131.24 48.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -113.55 146.67 39.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.153 0.981 . . . . 0.0 108.515 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.3 t -109.8 117.35 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.42 156.4 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.27 -12.11 59.65 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.499 -0.75 . . . . 0.0 111.812 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -104.79 -7.79 19.22 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.465 1.506 . . . . 0.0 111.394 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -119.64 136.58 54.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.87 147.51 50.45 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.288 0.566 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.6 mt -78.23 131.2 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.96 -21.41 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 122.691 0.396 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.59 152.62 38.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.935 1.294 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.5 t -146.42 142.38 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -110.23 115.23 29.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -108.18 125.34 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.2 p -116.43 139.54 50.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -154.78 163.65 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.382 1.073 . . . . 0.0 108.6 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.03 168.89 23.59 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.44 0.564 . . . . 0.0 110.113 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -99.55 155.55 17.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.321 1.848 . . . . 0.0 112.008 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.7 137.5 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -78.56 72.26 5.08 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.49 18.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.494 1.521 . . . . 0.0 113.008 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.98 149.68 52.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.7 -16.02 61.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.037 0.935 . . . . 0.0 112.554 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 2.2 p -161.28 172.0 17.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.462 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -76.47 151.91 36.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.0 pt -134.64 152.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.594 1.158 . . . . 0.0 109.453 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.2 mm -68.35 112.05 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.422 1.089 . . . . 0.0 108.163 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -81.31 -40.61 23.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.866 1.266 . . . . 0.0 111.217 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 t -157.84 173.92 16.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.57 1.948 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.54 155.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 109.63 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.1 m -148.92 122.38 9.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.301 1.44 . . . . 0.0 108.761 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -92.74 138.22 31.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 108.73 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -123.12 115.56 22.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.006 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.6 p -91.34 168.06 11.84 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 121.546 -0.721 . . . . 0.0 110.409 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -70.88 -30.1 66.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.29 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -69.79 -6.25 30.91 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.21 66.46 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -82.08 126.6 32.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.5 m -127.66 149.8 50.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 p -99.1 161.58 24.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.006 0.923 . . . . 0.0 110.465 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.49 166.25 27.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.729 1.619 . . . . 0.0 109.778 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.6 108.53 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.067 2.511 . . . . 0.0 109.089 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.31 73.82 7.16 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 135.73 -176.15 20.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.05 112.86 15.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 110.62 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 154.01 19.88 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -144.24 176.4 9.37 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 119.916 -1.74 . . . . 0.0 112.719 -177.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.489 ' H ' HG22 ' A' ' 111' ' ' THR . 12.3 tt0 -70.36 -56.93 5.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -66.07 150.6 48.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 pttt 172.73 173.42 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 126.461 1.904 . . . . 0.0 109.321 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.91 164.82 31.67 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.617 1.967 . . . . 0.0 107.338 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.48 139.06 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -136.36 122.67 20.58 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 160.77 42.19 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.389 1.475 . . . . 0.0 109.456 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.27 176.77 8.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.068 0.849 . . . . 0.0 109.34 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -128.03 -49.48 1.34 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.315 1.446 . . . . 0.0 109.207 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -68.52 -3.05 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.072 1.749 . . . . 0.0 113.97 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.28 47.55 5.43 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 120.617 1.553 . . . . 0.0 111.275 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.73 -165.14 40.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.23 1.395 . . . . 0.0 111.657 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -131.24 151.71 51.22 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.436 1.895 . . . . 0.0 107.281 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -71.34 154.06 41.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.53 -47.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 118.762 0.71 . . . . 0.0 112.548 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -167.29 168.39 40.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 120.091 1.314 . . . . 0.0 111.022 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -114.49 169.94 8.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.967 1.307 . . . . 0.0 110.216 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -164.84 170.88 14.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.241 2.616 . . . . 0.0 106.678 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 15' ' ' TRP . . . 128.65 129.4 3.18 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 126.145 1.831 . . . . 0.0 110.027 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.61 122.36 1.94 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.179 0.99 . . . . 0.0 112.651 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.0 166.06 25.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.847 2.459 . . . . 0.0 109.628 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.29 -119.14 0.82 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -68.5 -6.3 24.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.08 175.1 13.36 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 128.782 2.833 . . . . 0.0 106.656 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.67 95.06 5.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CD1' ' HA3' ' A' ' 12' ' ' GLY . 14.2 m-85 -83.22 -30.44 27.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.845 1.658 . . . . 0.0 113.112 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.16 42.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 108.772 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 65.3 tp -154.66 134.56 12.96 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.43 179.12 37.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 125.67 1.605 . . . . 0.0 109.127 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.05 171.89 17.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.478 0.639 . . . . 0.0 111.395 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -115.7 150.67 36.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.592 1.157 . . . . 0.0 108.522 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -125.01 111.53 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.27 141.48 43.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.75 0.786 . . . . 0.0 109.587 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 t -133.49 166.0 23.57 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.495 1.918 . . . . 0.0 107.596 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.41 177.42 11.38 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.805 1.642 . . . . 0.0 106.89 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 t -158.48 59.11 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.5 p -138.05 156.27 74.11 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.441 1.496 . . . . 0.0 110.016 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.69 169.22 22.73 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.021 2.481 . . . . 0.0 110.179 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.49 118.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 152' ' ' PRO . 75.1 p -130.24 160.69 64.39 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 123.559 0.744 . . . . 0.0 110.245 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 151' ' ' THR . 92.5 Cg_endo -74.11 -167.66 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.405 2.737 . . . . 0.0 108.914 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -176.64 0.81 Allowed 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.103 -0.998 . . . . 0.0 112.261 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -74.09 129.72 38.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.416 ' HE3' ' ND1' ' A' ' 280' ' ' HIS . 77.9 tttt -98.95 106.47 18.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.002 1.321 . . . . 0.0 108.045 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mt -74.88 173.9 9.99 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.0 t -76.08 163.66 26.9 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.838 -1.164 . . . . 0.0 109.062 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -144.41 138.19 27.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 tp -118.47 138.35 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.227 2.211 . . . . 0.0 107.321 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.57 -31.2 0.57 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 154.54 -169.55 32.84 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -136.19 6.69 3.09 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.082 1.753 . . . . 0.0 109.3 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -113.97 146.99 39.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.157 1.383 . . . . 0.0 109.82 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.56 175.36 14.04 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.955 1.264 . . . . 0.0 110.43 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.9 m -65.35 123.34 19.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 115.58 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.165 0.986 . . . . 0.0 110.038 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.845 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 7.8 m0 -78.22 125.08 28.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.41 114.45 26.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.288 1.835 . . . . 0.0 108.142 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.53 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.523 2.729 . . . . 0.0 115.012 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 64.28 -162.08 37.05 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.79 143.17 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.304 1.842 . . . . 0.0 107.866 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.28 -178.74 4.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.28 -34.0 66.03 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.423 1.011 . . . . 0.0 110.328 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.0 -163.7 33.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 124.563 1.078 . . . . 0.0 110.418 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.56 157.18 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.403 2.281 . . . . 0.0 108.22 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -120.37 -46.41 2.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.786 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.403 ' HE2' ' OE1' ' A' ' 193' ' ' GLU . 26.1 ttpt -137.19 145.24 43.46 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 145.73 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.68 157.72 38.3 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.619 1.168 . . . . 0.0 109.582 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.6 t -138.88 129.5 33.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.65 111.84 2.03 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.22 177.45 4.68 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.478 0.711 . . . . 0.0 110.794 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -160.08 -168.06 21.52 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 127.486 2.47 . . . . 0.0 107.994 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.17 -20.0 59.56 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 122.142 -0.622 . . . . 0.0 111.259 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.92 -31.57 35.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.869 3.668 . . . . 0.0 112.691 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 139.36 -132.48 5.67 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mm -88.03 105.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.87 -23.46 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 113.18 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.02 32.29 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.285 0.948 . . . . 0.0 111.717 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.32 133.6 46.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.947 0.899 . . . . 0.0 108.596 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 15.0 pttp -156.42 170.99 21.05 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 107.308 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -167.73 174.77 7.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.333 1.453 . . . . 0.0 108.367 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.403 ' OE1' ' HE2' ' A' ' 177' ' ' LYS . 21.7 mt-10 -100.65 137.06 39.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -97.79 167.82 10.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.148 0.499 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -121.01 116.78 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.021 1.728 . . . . 0.0 108.138 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -140.54 114.11 8.75 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 40.51 57.86 2.64 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.289 0.947 . . . . 0.0 113.974 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.79 -3.35 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.008 2.523 . . . . 0.0 117.165 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.66 170.2 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.349 0.977 . . . . 0.0 108.532 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -136.51 104.44 5.57 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.78 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.172 0.896 . . . . 0.0 113.018 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.01 129.33 36.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 124.831 1.252 . . . . 0.0 108.743 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -66.15 -179.36 9.64 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.718 1.627 . . . . 0.0 111.353 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.71 151.7 21.96 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.71 0.617 . . . . 0.0 113.294 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -77.39 102.8 6.98 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.219 1.408 . . . . 0.0 107.617 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -78.85 -64.35 1.2 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.65 1.18 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.74 170.86 53.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.659 1.124 . . . . 0.0 111.622 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -80.66 113.32 38.93 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.581 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.82 169.86 20.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.33 1.353 . . . . 0.0 110.748 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.4 p -126.79 173.93 9.17 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.488 1.115 . . . . 0.0 108.49 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.39 -6.33 42.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.512 -0.742 . . . . 0.0 112.494 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.7 -1.44 6.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.332 1.053 . . . . 0.0 111.069 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.48 -160.91 54.15 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.585 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 35.8 m-85 -135.8 163.08 31.02 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.98 1.312 . . . . 0.0 108.5 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -124.47 157.44 35.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.42 148.88 52.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.494 1.118 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -141.51 116.33 9.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.14 138.42 34.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.412 1.085 . . . . 0.0 109.049 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.6 mm -128.2 130.24 69.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.18 90.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -39.1 -50.99 4.31 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.19 -19.11 8.24 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 121.365 1.523 . . . . 0.0 114.388 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.0 m -106.52 -10.87 16.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.88 147.3 31.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.909 1.284 . . . . 0.0 107.643 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.37 126.3 11.21 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.565 ' H ' HD12 ' A' ' 226' ' ' ILE . 4.5 mp -57.09 112.75 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.248 1.819 . . . . 0.0 108.056 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.6 p -84.8 -24.74 28.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 0.0 111.142 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 250' ' ' LYS . . . -172.29 171.13 4.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.942 2.097 . . . . 0.0 109.207 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.5 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -83.75 171.03 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.886 -1.134 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 170.18 177.03 40.16 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 p -142.16 147.08 36.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.53 162.39 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.852 0.861 . . . . 0.0 109.415 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -146.9 156.46 43.1 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -71.78 138.83 48.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.963 1.705 . . . . 0.0 113.175 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -81.24 97.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -47.26 147.04 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.569 1.548 . . . . 0.0 112.089 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.6 52.46 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 62.9 p -141.13 -174.15 3.93 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.654 1.981 . . . . 0.0 107.68 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -133.69 91.65 2.87 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -158.91 173.44 35.82 Favored Glycine 0 CA--C 1.53 0.994 1 C-N-CA 131.185 4.231 . . . . 0.0 104.154 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.18 166.01 31.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 119.602 1.701 . . . . 0.0 111.781 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 7.6 tt -141.65 144.58 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.176 1.39 . . . . 0.0 109.239 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 37.4 mt -75.45 132.82 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.255 5.4 t -116.78 -12.16 10.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.615 0.766 . . . . 0.0 112.027 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -146.63 144.01 29.21 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.602 1.161 . . . . 0.0 108.775 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.95 127.15 13.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.735 0.698 . . . . 0.0 111.206 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -130.55 154.61 47.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.451 1.5 . . . . 0.0 109.408 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -118.54 126.62 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.534 ' HD3' ' HB3' ' A' ' 228' ' ' ALA . 44.0 mtpt -71.97 114.87 10.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -109.69 165.76 11.43 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.476 2.31 . . . . 0.0 109.231 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -119.83 134.13 55.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.33 7.17 0.87 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -144.23 152.07 40.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.994 2.118 . . . . 0.0 106.074 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 61.3 m -143.95 118.48 9.73 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.7 p -78.16 177.83 8.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.92 1.688 . . . . 0.0 111.793 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -73.51 154.36 89.75 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.875 . . . . 0.0 110.015 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.15 96.96 1.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 109.207 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -78.5 114.26 17.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.74 -163.03 22.38 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.9 pp -127.63 122.69 33.74 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.74 108.35 2.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.738 1.615 . . . . 0.0 109.964 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.9 9.19 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.188 0.995 . . . . 0.0 111.633 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 72.58 -98.74 0.86 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 126.311 1.91 . . . . 0.0 112.425 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 95.9 m -145.36 122.01 11.14 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.214 1.405 . . . . 0.0 107.612 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.64 145.07 33.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.101 0.56 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -132.43 158.59 41.62 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.534 1.159 . . . . 0.0 110.519 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.92 146.24 26.15 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 53.5 mt -141.87 108.77 5.42 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.861 1.664 . . . . 0.0 108.478 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 228' ' ' ALA . 10.2 pttp -157.8 163.92 37.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.679 1.581 . . . . 0.0 111.496 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.87 157.46 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 107.85 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -75.1 140.88 43.75 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 110.013 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 63.38 5.36 11.26 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 117.389 -1.784 . . . . 0.0 116.741 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -112.1 153.7 26.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.197 1.998 . . . . 0.0 112.003 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -115.52 164.19 14.67 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.272 2.229 . . . . 0.0 107.692 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.08 134.18 31.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.89 -0.38 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.167 0.987 . . . . 0.0 113.554 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.98 157.19 27.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -131.33 124.29 30.1 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.495 1.918 . . . . 0.0 109.92 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' HIS . . . . . 0.416 ' ND1' ' HE3' ' A' ' 155' ' ' LYS . 15.0 p80 -127.27 179.51 5.41 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.03 1.332 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 120.2 -127.37 7.05 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -161.25 151.35 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.906 1.282 . . . . 0.0 111.818 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.845 ' HB2' ' HE1' ' A' ' 167' ' ' TRP . . . -113.06 146.8 38.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.397 1.479 . . . . 0.0 108.113 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -155.75 -160.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.431 1.892 . . . . 0.0 106.064 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -38.06 88.43 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.36 162.95 20.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.41 1.484 . . . . 0.0 108.884 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.33 95.68 1.76 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 109.855 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -83.56 -84.01 0.14 Allowed 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -88.55 165.6 14.73 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -167.85 99.89 0.47 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.43 1.892 . . . . 0.0 107.435 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -129.35 169.73 20.54 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 121.694 -0.629 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.06 173.36 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 122.118 0.961 . . . . 0.0 112.776 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.15 124.97 42.94 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.998 -2.594 . . . . 0.0 103.998 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.93 137.63 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.492 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.24 139.47 34.6 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 123.978 0.911 . . . . 0.0 109.606 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.43 137.09 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.493 2.795 . . . . 0.0 110.738 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.16 -12.38 61.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.202 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.75 15.13 12.66 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.342 0.973 . . . . 0.0 112.956 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--O 1.245 0.865 0 C-N-CA 127.783 2.433 . . . . 0.0 111.545 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.14 149.19 48.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.15 1.38 . . . . 0.0 110.986 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HD3' ' CD1' ' A' ' 142' ' ' TYR . 71.6 mmtt -137.81 139.77 40.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 128.339 2.656 . . . . 0.0 107.62 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.487 ' CG1' ' H ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -121.4 148.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.073 0.949 . . . . 0.0 111.267 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.11 131.3 46.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.4 87.87 1.56 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.09 116.16 5.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.39 -170.5 30.99 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.35 177.73 33.74 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 122.834 1.241 . . . . 0.0 115.87 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.5 55.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.844 1.658 . . . . 0.0 114.49 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 175.04 54.85 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.254 0.933 . . . . 0.0 110.817 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -175.06 50.51 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.57 1.081 . . . . 0.0 114.696 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.56 157.2 27.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.155 1.382 . . . . 0.0 110.36 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -77.1 88.17 3.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.023 2.529 . . . . 0.0 114.942 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -106.17 92.46 4.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.82 149.65 23.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.795 1.638 . . . . 0.0 108.797 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 31.21 58.55 0.27 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 127.753 2.421 . . . . 0.0 110.873 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.02 -161.37 37.39 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.535 2.017 . . . . 0.0 116.091 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -126.95 10.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 128.232 2.613 . . . . 0.0 112.244 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -104.54 80.24 1.65 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.64 40.08 2.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.881 1.272 . . . . 0.0 111.727 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.68 51.33 0.85 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-O 118.654 -1.081 . . . . 0.0 115.553 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.96 154.08 7.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 119.793 1.796 . . . . 0.0 110.629 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -128.77 -41.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.532 1.133 . . . . 0.0 110.696 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -133.48 171.72 13.69 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.449 1.5 . . . . 0.0 108.174 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -140.25 130.22 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -131.11 144.03 51.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.3 t -148.31 147.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 127.862 2.465 . . . . 0.0 105.69 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.13 133.15 3.47 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 107.119 -2.392 . . . . 0.0 107.119 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -75.85 176.8 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.066 0.936 . . . . 0.0 108.934 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -160.42 10.5 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -77.06 -31.53 56.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.836 0.35 . . . . 0.0 110.227 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -91.4 -27.34 18.38 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.653 3.181 . . . . 0.0 115.182 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.75 -140.7 11.46 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -75.63 96.34 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.28 -7.29 21.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.449 1.1 . . . . 0.0 113.647 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -129.86 143.72 50.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.96 1.255 . . . . 0.0 112.377 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -159.02 130.53 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.039 0.936 . . . . 0.0 109.705 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -117.85 151.43 37.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.819 1.648 . . . . 0.0 109.809 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.12 140.96 45.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.062 1.345 . . . . 0.0 110.263 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -127.47 98.77 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -81.3 105.68 12.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.99 120.44 27.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -115.16 157.39 23.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.749 -0.594 . . . . 0.0 110.879 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 6.56 4.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.59 1.956 . . . . 0.0 108.609 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -121.58 -69.55 0.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.432 2.293 . . . . 0.0 108.742 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -154.96 135.05 13.05 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.84 150.27 39.31 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.906 1.282 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 122.9 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.992 0.917 . . . . 0.0 111.37 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.21 99.66 11.24 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.91 -21.63 45.46 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.936 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.01 142.29 12.06 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.021 1.296 . . . . 0.0 111.766 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -74.08 130.23 39.4 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.612 1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -116.4 175.7 5.44 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.236 0.541 . . . . 0.0 109.949 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -134.78 12.41 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 105.653 -2.979 . . . . 0.0 105.653 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -126.77 99.24 5.68 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.24 144.97 56.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.06 142.87 30.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.776 1.274 . . . . 0.0 110.516 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.23 -4.65 58.12 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.592 -1.317 . . . . 0.0 110.447 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.49 -16.71 62.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.499 1.12 . . . . 0.0 111.455 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.3 117.83 0.42 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -163.14 135.44 5.29 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.997 2.919 . . . . 0.0 105.734 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -132.18 160.12 37.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 m -116.3 118.61 33.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.566 1.946 . . . . 0.0 108.905 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.13 109.13 13.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.8 160.91 20.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 109.747 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.72 106.12 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 156.92 23.07 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.509 -0.744 . . . . 0.0 109.617 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.68 -26.69 27.58 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.62 -34.98 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.108 1.763 . . . . 0.0 112.393 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.86 164.51 13.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.986 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.67 -178.72 5.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.127 1.771 . . . . 0.0 109.812 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.9 139.11 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.62 -36.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.074 0.95 . . . . 0.0 112.864 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.72 165.76 29.52 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.975 0.91 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.7 101.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.65 94.28 9.04 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.2 153.55 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.686 1.994 . . . . 0.0 108.134 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.491 HG21 ' N ' ' A' ' 111' ' ' THR . 7.3 m -139.02 148.47 43.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.357 1.063 . . . . 0.0 109.069 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.05 155.42 36.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.121 1.368 . . . . 0.0 108.515 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.84 168.49 22.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.109 0.963 . . . . 0.0 110.144 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -109.51 119.38 39.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.35 1.06 . . . . 0.0 109.213 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.7 m -90.08 151.29 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -60.89 -6.61 1.89 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 113.32 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.29 -0.65 58.24 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 117.54 -1.7 . . . . 0.0 112.703 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -133.43 158.59 42.67 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.89 1.845 . . . . 0.0 111.051 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -85.29 -19.51 31.45 Favored 'General case' 0 C--N 1.323 -0.547 1 C-N-CA 131.81 4.044 . . . . 0.0 111.586 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.4 t -129.6 164.92 22.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.389 1.876 . . . . 0.0 110.691 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.47 156.14 27.97 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.0 154.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.418 1.887 . . . . 0.0 108.673 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.8 mm -73.27 129.55 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -103.31 -41.29 6.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 113.275 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -146.58 161.23 40.96 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.746 1.219 . . . . 0.0 109.503 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.3 mt -148.06 122.96 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.554 1.541 . . . . 0.0 108.314 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -125.07 107.07 10.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.869 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -84.95 149.15 25.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.848 0.833 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -130.75 113.35 14.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -84.25 164.3 19.14 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.396 0.678 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -71.13 -38.23 72.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -35.92 82.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.217 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.25 3.68 5.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.87 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -76.71 95.86 4.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -86.64 103.5 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 p -71.72 155.89 91.8 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.42 166.18 30.55 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.939 1.759 . . . . 0.0 110.907 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.24 112.74 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.789 2.993 . . . . 0.0 107.232 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -78.07 67.67 3.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.088 1.355 . . . . 0.0 107.369 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.41 -179.74 17.78 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 124.717 1.151 . . . . 0.0 111.143 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.07 119.09 22.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.68 1.592 . . . . 0.0 111.556 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 157.87 23.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.491 ' N ' HG21 ' A' ' 79' ' ' THR . 0.2 OUTLIER -148.18 172.49 14.23 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.777 -1.202 . . . . 0.0 109.771 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -69.34 -49.29 57.01 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -66.72 138.48 57.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.1 pttt 169.54 171.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.864 2.466 . . . . 0.0 109.79 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.4 156.35 47.67 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.384 1.873 . . . . 0.0 107.153 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.6 149.39 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.829 0.851 . . . . 0.0 109.844 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.91 142.97 16.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 0.0 109.66 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.25 156.52 30.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.675 0.79 . . . . 0.0 110.077 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 175.94 9.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.626 1.97 . . . . 0.0 113.262 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -127.99 -46.87 1.38 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.423 -0.798 . . . . 0.0 112.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -127.39 13.45 7.09 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.83 0.852 . . . . 0.0 112.554 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.9 -84.31 0.32 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 107.508 -2.237 . . . . 0.0 107.508 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.36 76.07 0.11 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 125.855 1.693 . . . . 0.0 112.281 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.21 123.84 12.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.853 0.861 . . . . 0.0 111.197 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.73 115.98 6.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.44 -9.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.194 1.397 . . . . 0.0 112.757 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.65 -91.0 0.3 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 119.295 0.952 . . . . 0.0 114.617 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 78.38 152.2 0.12 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.425 2.69 . . . . 0.0 109.811 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -157.75 170.07 23.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.958 2.103 . . . . 0.0 106.172 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.31 101.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 O-C-N 121.533 -0.729 . . . . 0.0 112.737 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.57 123.16 9.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.48 164.42 38.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.274 0.63 . . . . 0.0 109.375 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.22 -110.41 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.38 -12.36 60.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.207 0.503 . . . . 0.0 112.215 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.67 174.48 12.53 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 127.839 2.456 . . . . 0.0 107.528 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -102.04 89.43 3.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.219 1.008 . . . . 0.0 108.485 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.4 -38.81 49.0 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.01 167.0 26.07 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.016 1.28 . . . . 0.0 112.283 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.93 171.24 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.85 2.06 . . . . 0.0 108.782 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.78 169.91 33.58 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.882 1.706 . . . . 0.0 110.106 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' H ' ' CG1' ' A' ' 4' ' ' VAL . . . -153.16 167.69 28.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.688 1.595 . . . . 0.0 112.296 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.4 ' CD1' ' HD3' ' A' ' 3' ' ' LYS . 6.9 m-85 -129.77 163.2 26.72 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.257 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -144.4 135.87 25.62 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.16 105.19 5.92 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.957 1.303 . . . . 0.0 112.217 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.3 t -135.07 143.9 46.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.392 1.077 . . . . 0.0 108.477 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 t -162.83 -54.2 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.017 0.927 . . . . 0.0 108.929 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -148.46 93.17 2.11 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.72 145.71 35.09 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.062 0.846 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.67 170.01 18.84 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 125.079 3.852 . . . . 0.0 111.258 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 87.6 t -135.47 108.61 9.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.0 p -137.42 160.78 64.09 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -84.0 4.56 6.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.438 3.425 . . . . 0.0 119.408 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.27 153.53 33.78 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.976 1.71 . . . . 0.0 112.565 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -75.67 122.23 23.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.59 0.756 . . . . 0.0 109.286 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -90.3 146.42 24.22 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.4 mt -101.08 -86.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 t -167.33 171.25 10.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.659 1.984 . . . . 0.0 109.07 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -152.73 177.2 10.95 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.24 1.816 . . . . 0.0 107.634 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 tt -138.34 -25.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -23.89 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 129.913 3.625 . . . . 0.0 117.667 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.77 41.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.029 1.776 . . . . 0.0 108.782 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.415 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 1.3 m-20 -114.96 5.71 15.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 114.303 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.98 122.33 28.15 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.28 1.4 . . . . 0.0 111.529 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.73 -168.52 13.62 Favored Glycine 0 N--CA 1.465 0.57 0 O-C-N 120.663 -1.273 . . . . 0.0 112.707 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.7 m -106.78 124.7 49.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.767 0.783 . . . . 0.0 111.121 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.71 153.84 27.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.189 1.396 . . . . 0.0 110.703 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -138.32 120.7 15.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.32 1.048 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.66 132.72 33.8 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.41 -0.807 . . . . 0.0 109.074 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.38 91.19 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.93 -72.75 0.52 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.699 -0.626 . . . . 0.0 114.157 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.12 170.65 20.78 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.221 1.408 . . . . 0.0 110.154 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.6 -179.7 3.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.659 1.184 . . . . 0.0 108.268 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.88 -23.69 55.63 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.678 -1.264 . . . . 0.0 112.297 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 170.79 168.58 32.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 128.72 3.057 . . . . 0.0 107.508 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.472 ' H ' ' HB2' ' A' ' 221' ' ' TYR . 1.8 t -122.72 156.28 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.365 1.866 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -121.53 -34.01 3.52 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -159.79 151.91 20.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.092 1.315 . . . . 0.0 110.926 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.6 t -106.25 142.36 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.48 160.18 39.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.824 2.45 . . . . 0.0 109.6 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.86 138.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.51 80.1 0.34 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.739 1.638 . . . . 0.0 109.206 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -85.59 162.48 18.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 111.018 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.3 -158.79 10.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 127.263 2.363 . . . . 0.0 109.056 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -82.85 -22.44 34.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.599 0.76 . . . . 0.0 111.358 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.88 -31.79 9.61 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.416 0.686 . . . . 0.0 112.548 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 165.82 -153.23 23.06 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.42 153.33 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.596 1.198 . . . . 0.0 109.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.1 t -134.22 -33.14 1.02 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.894 1.278 . . . . 0.0 109.625 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.17 35.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.91 0.862 . . . . 0.0 111.708 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.7 m -134.13 149.48 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -154.85 155.19 33.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 108.996 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.34 173.1 12.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.211 0.914 . . . . 0.0 113.028 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.32 141.77 48.11 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.296 3.038 . . . . 0.0 104.127 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -149.0 167.93 24.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.807 1.243 . . . . 0.0 109.578 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -135.98 96.44 3.41 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -88.8 125.48 34.92 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.25 31.17 56.36 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 76.26 -9.1 1.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.253 3.421 . . . . 0.0 114.852 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -76.47 133.14 39.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 120.835 1.652 . . . . 0.0 109.484 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -64.15 124.39 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.26 1.024 . . . . 0.0 109.197 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.6 mm -136.65 103.65 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.001 1.32 . . . . 0.0 108.415 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.96 127.43 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.09 -11.91 84.62 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.318 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.71 -172.12 52.99 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -89.35 154.36 20.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.845 0.858 . . . . 0.0 110.002 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -119.27 1.21 11.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.168 0.987 . . . . 0.0 109.651 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.94 173.64 27.05 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 120.304 -1.497 . . . . 0.0 111.182 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -68.68 114.07 20.02 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.18 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.92 167.22 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -118.25 148.33 42.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.521 1.128 . . . . 0.0 109.481 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.77 -24.83 67.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.331 0.653 . . . . 0.0 110.521 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 tt -51.65 -34.39 37.83 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 126.336 1.854 . . . . 0.0 111.495 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.0 -164.5 12.06 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -140.11 161.2 38.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.65 153.31 38.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.49 152.39 44.14 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.78 0.832 . . . . 0.0 110.75 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -142.06 140.54 32.6 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.997 -0.439 . . . . 0.0 110.956 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -65.15 97.82 0.27 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.164 2.186 . . . . 0.0 112.524 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 mm -128.94 102.82 8.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.44 125.89 46.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.015 1.28 . . . . 0.0 109.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.472 ' HB2' ' H ' ' A' ' 175' ' ' VAL . 80.0 t80 -55.49 -51.43 80.08 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.124 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.06 0.47 5.83 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.392 2.061 . . . . 0.0 114.604 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -128.54 -62.47 1.03 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.684 1.583 . . . . 0.0 112.997 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -81.26 168.13 18.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 110.697 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.17 101.33 3.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.9 mp -35.73 -52.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 128.871 2.868 . . . . 0.0 111.816 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.254 16.6 p 48.92 1.2 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.607 3.163 . . . . 0.0 118.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -173.84 169.88 4.04 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.538 1.535 . . . . 0.0 107.584 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.71 134.14 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -118.34 165.95 13.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.465 1.906 . . . . 0.0 107.617 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.07 174.31 46.37 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.2 p -135.44 147.35 48.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.754 1.277 . . . . 0.0 110.928 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -136.79 146.55 45.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -142.87 155.49 44.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.825 2.05 . . . . 0.0 108.225 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -87.55 148.55 24.84 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.596 0.758 . . . . 0.0 111.34 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.24 122.86 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.101 0.961 . . . . 0.0 108.468 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -55.89 152.3 10.21 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.268 0.556 . . . . 0.0 111.748 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.21 -9.39 20.02 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.245 0.926 . . . . 0.0 113.848 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -127.46 -176.03 3.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.383 1.873 . . . . 0.0 108.468 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.06 74.55 1.46 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.303 1.041 . . . . 0.0 110.594 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.08 -168.15 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.159 2.314 . . . . 0.0 109.106 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.93 162.11 36.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.786 1.293 . . . . 0.0 111.361 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.5 tt -139.85 102.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.891 2.076 . . . . 0.0 108.755 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 244' ' ' ILE . 4.9 mp -50.6 126.25 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 121.267 -0.895 . . . . 0.0 109.536 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -106.35 -36.24 6.89 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -122.29 144.55 48.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.462 1.028 . . . . 0.0 108.699 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.28 147.14 49.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.854 1.261 . . . . 0.0 108.264 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -136.01 93.71 2.96 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.9 149.46 45.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.59 154.04 51.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.544 1.537 . . . . 0.0 107.606 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.2 t -161.94 168.11 23.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.654 1.182 . . . . 0.0 111.67 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -105.67 147.05 28.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 79.86 -52.48 0.39 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 129.663 3.185 . . . . 0.0 110.815 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -84.89 169.68 13.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.27 1.428 . . . . 0.0 109.424 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 m -128.35 99.7 5.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.238 1.015 . . . . 0.0 109.616 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.2 p -84.62 174.63 9.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.867 1.267 . . . . 0.0 112.441 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . -141.62 170.36 9.36 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 128.153 2.581 . . . . 0.0 109.653 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 82.4 Cg_endo -70.96 160.5 49.15 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.793 2.329 . . . . 0.0 111.724 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -131.2 94.65 3.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 106.457 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.51 14.27 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.381 1.467 . . . . 0.0 110.295 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.11 141.81 36.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.31 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.53 108.36 3.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.737 0.699 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.69 21.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.297 1.839 . . . . 0.0 106.519 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.37 173.16 49.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.685 0.66 . . . . 0.0 112.744 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.86 134.13 56.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.624 1.97 . . . . 0.0 109.398 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -90.81 144.13 26.02 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -133.96 159.34 41.04 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.015 1.326 . . . . 0.0 108.905 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -144.38 154.3 42.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.096 1.358 . . . . 0.0 107.858 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.7 mp -137.47 131.98 32.68 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -165.03 137.97 4.57 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.78 1.232 . . . . 0.0 108.553 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.58 96.51 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.56 164.49 4.48 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.113 0.959 . . . . 0.0 111.782 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.79 -2.06 42.87 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 121.266 -0.896 . . . . 0.0 113.318 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -138.22 167.07 22.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.262 3.025 . . . . 0.0 107.181 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 152.8 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.498 -0.751 . . . . 0.0 109.29 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 92.3 mt -74.41 135.05 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.1 -4.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -170.99 -173.48 38.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 120.521 1.51 . . . . 0.0 111.048 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.62 164.66 29.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.341 1.07 . . . . 0.0 110.204 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -132.65 157.86 43.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.18 -163.57 27.74 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.415 ' HE2' ' C ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -131.03 158.31 40.66 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.669 1.188 . . . . 0.0 109.173 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -137.1 113.91 10.43 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.678 0.791 . . . . 0.0 110.291 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 m -149.82 86.46 1.45 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 58.74 -10.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.272 2.229 . . . . 0.0 116.772 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 36.7 mt -143.37 -172.21 3.65 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.778 2.031 . . . . 0.0 109.56 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.63 88.48 2.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.78 1.232 . . . . 0.0 112.423 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.78 -84.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.628 0.728 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -85.65 128.97 34.93 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 120.894 -1.129 . . . . 0.0 109.163 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -149.41 100.05 2.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.127 0.971 . . . . 0.0 108.604 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -120.19 152.18 17.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.28 135.2 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 118.951 1.375 . . . . 0.0 111.729 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -89.74 139.01 30.99 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.54 153.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 37.0 mmm -147.53 157.21 45.13 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.37 156.89 57.52 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.391 1.394 . . . . 0.0 111.609 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp -126.9 158.89 35.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.904 1.682 . . . . 0.0 107.619 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 13.1 t -163.66 179.52 7.12 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.431 1.492 . . . . 0.0 106.998 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 178.873 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -132.28 101.81 5.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.538 -1.351 . . . . 0.0 109.058 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.57 138.49 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 117' ' ' LEU . 2.3 t -126.39 84.99 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -56.46 140.21 46.65 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.268 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -73.42 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 O-C-N 125.139 1.524 . . . . 0.0 112.087 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.26 -14.86 23.1 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.046 -1.419 . . . . 0.0 112.672 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.38 -169.59 35.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.07 113.4 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 112.881 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.02 34.76 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.64 -151.19 2.42 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 128.244 2.831 . . . . 0.0 112.153 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.52 -170.79 41.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 112.093 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.77 33.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -69.77 69.39 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -84.09 24.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.993 1.717 . . . . 0.0 109.647 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.38 126.46 27.56 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.146 1.779 . . . . 0.0 107.032 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -70.15 -179.0 1.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.44 0.696 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -120.52 4.78 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.962 1.744 . . . . 0.0 110.185 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.3 22.76 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.739 2.416 . . . . 0.0 110.059 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 151.49 30.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.33 1.452 . . . . 0.0 109.658 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.49 96.15 9.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.61 76.43 0.34 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.276 0.465 . . . . 0.0 113.387 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -136.61 118.7 20.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.58 -60.96 1.59 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -149.66 158.09 43.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.82 116.28 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.464 ' CE1' HG23 ' A' ' 64' ' ' THR . 12.1 m-70 -118.66 125.94 50.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.38 142.42 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 123.995 0.918 . . . . 0.0 109.251 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.97 164.08 25.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 124.606 1.098 . . . . 0.0 110.42 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -75.22 -148.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.162 1.385 . . . . 0.0 111.146 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.26 -163.58 35.6 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -95.35 -32.45 12.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.859 1.314 . . . . 0.0 107.54 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.67 -6.34 58.93 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 134.389 5.076 . . . . 0.0 113.24 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.3 -156.36 15.64 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.64 121.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.1 p -132.8 -58.61 0.91 Allowed 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.7 p -72.96 119.41 17.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 119.11 0.868 . . . . 0.0 109.634 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 tt -135.26 142.42 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.297 1.039 . . . . 0.0 108.959 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.97 129.72 21.64 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.617 1.967 . . . . 0.0 106.034 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.46 151.54 24.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.2 t -127.48 118.39 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -107.76 105.13 14.82 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.525 1.53 . . . . 0.0 110.488 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . . . -98.58 134.74 41.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 117.951 0.341 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -114.48 163.82 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.58 21.96 0.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.834 1.302 . . . . 0.0 111.095 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.9 p -128.8 -68.55 0.74 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.083 2.553 . . . . 0.0 109.875 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -148.08 133.91 19.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.288 1.435 . . . . 0.0 109.379 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 15.6 t0 -78.32 152.29 32.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.354 1.462 . . . . 0.0 109.687 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.76 108.67 13.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.973 0.892 . . . . 0.0 109.131 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.28 98.41 11.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.86 -22.09 76.87 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.46 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.09 -172.72 40.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.42 123.98 28.03 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.548 -0.971 . . . . 0.0 110.864 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.07 160.93 29.3 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 12.73 -86.99 0.0 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 128.417 2.913 . . . . 0.0 115.798 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -69.44 103.78 2.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.74 163.4 21.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.825 1.25 . . . . 0.0 112.432 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.81 10.22 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.712 2.405 . . . . 0.0 112.907 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.13 -13.51 18.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.84 1.256 . . . . 0.0 112.127 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.309 3.2 pp 49.0 -11.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.027 4.131 . . . . 0.0 117.593 -179.19 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.81 61.76 3.04 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.24 160.83 35.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.814 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.81 164.42 12.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 127.891 2.476 . . . . 0.0 109.298 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.464 HG23 ' CE1' ' A' ' 27' ' ' HIS . 23.5 m -136.03 95.58 3.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.578 0.751 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -95.04 109.56 21.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.47 143.08 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.731 0.812 . . . . 0.0 110.675 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.5 t -103.87 156.57 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -149.21 164.14 35.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.913 1.685 . . . . 0.0 107.833 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.67 -9.78 59.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.672 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.69 -9.33 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.833 1.653 . . . . 0.0 111.462 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 135.76 52.12 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -135.88 149.35 48.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 109.208 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.7 126.64 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.49 -25.81 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.753 -0.642 . . . . 0.0 110.25 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.89 149.18 30.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.438 1.017 . . . . 0.0 110.642 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.467 ' O ' HD21 ' A' ' 117' ' ' LEU . 19.0 m -129.22 75.81 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.07 134.22 52.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -139.67 153.05 23.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.1 p -133.35 142.04 48.22 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 44.8 p90 -149.84 156.35 41.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.08 169.48 20.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -126.86 157.74 38.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.723 0.773 . . . . 0.0 110.702 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.99 166.0 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.429 1.492 . . . . 0.0 108.62 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -68.42 150.1 48.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.73 20.15 58.59 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.061 -0.855 . . . . 0.0 113.372 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -131.04 166.52 20.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.621 1.569 . . . . 0.0 107.363 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -122.52 -11.98 8.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.955 1.702 . . . . 0.0 112.359 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.9 p -145.47 145.8 31.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.768 1.627 . . . . 0.0 109.667 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.72 159.48 33.44 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -135.7 156.91 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.715 0.806 . . . . 0.0 109.781 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -73.73 139.62 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-O 121.565 0.698 . . . . 0.0 112.057 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -108.38 -30.96 8.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.587 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.4 t -165.83 166.4 17.69 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.53 1.532 . . . . 0.0 110.624 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.0 mt -145.23 146.28 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 128.12 2.568 . . . . 0.0 105.677 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -150.14 101.53 3.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -86.72 148.53 25.39 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.312 -0.867 . . . . 0.0 109.479 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -133.31 121.11 21.92 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.0 p -100.5 159.03 15.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.653 1.115 . . . . 0.0 111.576 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.34 -32.89 74.43 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.714 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -56.19 -10.76 0.93 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.818 2.847 . . . . 0.0 113.042 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.51 30.56 8.5 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 119.238 0.926 . . . . 0.0 111.856 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.81 148.42 42.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.609 1.204 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 114.64 12.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 p -73.47 160.75 81.63 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.15 165.59 32.29 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 N-CA-C 107.694 -1.695 . . . . 0.0 107.694 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.09 109.59 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.022 -1.953 . . . . 0.0 107.022 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.38 66.08 0.92 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.294 1.437 . . . . 0.0 110.031 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.78 -129.35 3.5 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 tp -139.41 136.17 34.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.673 1.589 . . . . 0.0 109.833 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 158.8 11.77 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.44 1.096 . . . . 0.0 110.901 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -156.35 173.52 16.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.563 -1.335 . . . . 0.0 111.343 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.485 ' H ' HG22 ' A' ' 111' ' ' THR . 4.8 tt0 -64.74 -58.08 7.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.143 1.377 . . . . 0.0 109.254 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 80' ' ' TYR . 16.3 mmtm -70.54 105.93 3.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.48 166.42 33.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 120.604 -1.31 . . . . 0.0 109.021 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 117' ' ' LEU . 15.6 p90 -156.72 166.85 32.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.313 0.578 . . . . 0.0 109.73 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.98 145.84 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 115' ' ' PHE . 1.1 pt? -149.74 136.51 19.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 127.706 2.403 . . . . 0.0 106.354 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 134.44 7.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.49 161.16 21.34 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -142.65 -69.05 0.35 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.605 1.162 . . . . 0.0 111.064 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.84 15.37 6.92 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.492 1.517 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.34 -85.66 1.64 Allowed Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 125.602 1.572 . . . . 0.0 111.011 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.97 166.41 29.36 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.6 140.6 41.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.503 HD11 ' CB ' ' A' ' 141' ' ' ALA . 20.1 tp -54.91 112.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.68 -54.98 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.348 0.976 . . . . 0.0 111.283 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.43 -105.28 0.2 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -167.66 176.4 6.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.292 1.046 . . . . 0.0 111.526 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.84 151.84 35.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.48 -26.42 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.049 -1.072 . . . . 0.0 114.548 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 62.23 69.95 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.535 2.334 . . . . 0.0 113.852 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.99 112.16 20.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.55 -120.46 4.27 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 103.414 -3.875 . . . . 0.0 103.414 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.34 -10.22 59.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.259 0.624 . . . . 0.0 112.23 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.42 173.86 11.63 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.222 2.609 . . . . 0.0 107.691 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 40.8 tp -99.51 98.24 9.15 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.684 0.794 . . . . 0.0 109.245 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -76.13 -66.65 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 112.087 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.47 172.79 12.51 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.88 1.218 . . . . 0.0 109.626 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.8 tp -162.73 134.01 5.01 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.86 176.88 44.16 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 106.47 -2.652 . . . . 0.0 106.47 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' HD11 ' A' ' 125' ' ' LEU . . . -153.02 176.96 11.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.975 1.388 . . . . 0.0 109.055 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -147.81 161.73 40.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.684 0.754 . . . . 0.0 109.447 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.1 125.31 12.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.111 2.565 . . . . 0.0 104.398 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.79 151.89 43.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.722 0.692 . . . . 0.0 111.858 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.4 t -134.93 144.47 47.48 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.185 0.994 . . . . 0.0 110.508 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -111.95 170.66 7.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.68 1.592 . . . . 0.0 107.178 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.26 172.88 15.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.913 1.285 . . . . 0.0 109.089 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.2 p -130.41 141.45 41.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.008 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 142.76 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.959 2.439 . . . . 0.0 109.935 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t -144.6 143.43 22.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 p -136.8 159.58 69.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.176 0.991 . . . . 0.0 111.318 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -88.86 -179.15 2.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.893 3.062 . . . . 0.0 113.673 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.66 178.09 7.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.97 1.308 . . . . 0.0 109.345 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.1 133.87 55.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.195 0.998 . . . . 0.0 110.773 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -113.64 143.43 44.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.408 1.483 . . . . 0.0 108.658 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.48 -89.92 0.13 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.3 t -146.55 160.4 42.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.112 1.765 . . . . 0.0 107.889 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -170.38 136.61 1.36 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.099 2.159 . . . . 0.0 105.371 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.0 tt -97.99 128.45 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.2 107.59 0.62 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.34 -179.03 6.22 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 112.431 -1.885 . . . . 0.0 109.832 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.19 11.94 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 128.659 2.783 . . . . 0.0 115.319 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 11.8 mt-10 -130.99 156.35 45.26 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.207 1.367 . . . . 0.0 114.265 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 96.91 159.53 31.55 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 125.253 1.406 . . . . 0.0 112.768 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 m -102.53 134.43 45.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.51 138.86 51.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.815 0.446 . . . . 0.0 110.122 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -128.63 123.94 34.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -85.78 105.66 16.46 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.14 -117.94 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.405 1.066 . . . . 0.0 108.707 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.13 168.16 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 121.35 1.886 . . . . 0.0 111.763 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.87 157.86 37.11 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.098 -0.648 . . . . 0.0 109.254 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -135.31 176.34 8.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.691 1.196 . . . . 0.0 110.621 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -12.24 60.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.739 1.215 . . . . 0.0 113.767 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.21 171.73 22.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 125.525 1.536 . . . . 0.0 110.315 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.1 m -125.89 107.8 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -63.04 -51.1 68.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 110.629 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -149.19 169.69 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.753 1.16 . . . . 0.0 112.751 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 86.1 t -122.46 143.95 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.656 1.583 . . . . 0.0 109.208 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.79 157.39 46.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.768 1.627 . . . . 0.0 108.342 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.36 146.22 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.77 83.64 0.32 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -71.16 160.51 32.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.655 0.741 . . . . 0.0 110.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.34 -163.28 9.49 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.152 2.787 . . . . 0.0 109.029 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -89.62 -14.36 35.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.902 -1.352 . . . . 0.0 111.565 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.21 -29.1 15.28 Favored 'General case' 0 C--N 1.327 -0.379 1 C-N-CA 132.404 4.282 . . . . 0.0 112.917 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 144.45 -136.78 6.9 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.94 104.6 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.23 -26.17 28.9 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.496 0.719 . . . . 0.0 112.215 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.98 146.07 35.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.842 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.79 145.07 28.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -148.75 154.73 39.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.85 175.45 9.57 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -123.55 120.87 34.12 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.351 0.66 . . . . 0.0 109.555 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -94.85 165.7 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.397 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -144.82 130.38 18.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.109 -0.948 . . . . 0.0 108.556 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.85 151.99 43.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.714 1.143 . . . . 0.0 109.111 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.72 -103.53 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.601 1.096 . . . . 0.0 111.708 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 7.89 3.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.266 2.226 . . . . 0.0 110.936 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -109.24 177.93 4.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.011 1.324 . . . . 0.0 107.851 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -133.7 142.29 47.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.866 1.266 . . . . 0.0 108.761 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 201' ' ' ILE . 1.8 mp -111.74 99.73 9.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 119.649 1.113 . . . . 0.0 109.351 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.68 103.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.46 175.28 35.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.158 2.313 . . . . 0.0 107.698 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 134.1 23.95 0.66 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-N 118.327 1.063 . . . . 0.0 113.771 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.92 126.07 27.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.429 1.614 . . . . 0.0 108.123 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -127.68 -6.88 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.227 2.611 . . . . 0.0 113.363 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.45 159.29 25.73 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -66.29 116.56 34.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.801 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.86 134.89 52.59 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.652 2.234 . . . . 0.0 110.077 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.9 p -83.22 161.11 21.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.215 1.006 . . . . 0.0 109.821 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.76 -23.11 65.19 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.468 -0.77 . . . . 0.0 111.096 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -64.88 -30.82 71.84 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.963 1.305 . . . . 0.0 111.247 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.95 -146.47 16.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -138.67 163.95 30.78 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.523 1.129 . . . . 0.0 109.538 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -115.03 154.25 29.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.365 3.066 . . . . 0.0 105.304 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.5 148.17 28.38 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.61 0.764 . . . . 0.0 110.388 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.65 137.19 29.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.251 0.62 . . . . 0.0 109.332 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.13 120.75 33.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.607 0.718 . . . . 0.0 111.028 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.5 mt -127.47 129.35 70.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.443 1.02 . . . . 0.0 111.353 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -37.84 -55.82 2.04 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.34 1.59 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 123.02 2.114 . . . . 0.0 113.638 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 31.0 t -108.99 -46.69 3.56 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.737 -1.227 . . . . 0.0 109.522 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.83 160.49 14.55 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.435 1.112 . . . . 0.0 112.643 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -139.93 112.41 7.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.767 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.05 84.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.34 57.93 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.655 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -152.75 157.31 40.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.863 0.865 . . . . 0.0 109.752 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.7 146.13 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.603 1.561 . . . . 0.0 106.959 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.75 152.81 39.04 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -161.91 43.42 0.38 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.336 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.0 p -23.41 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.429 3.092 . . . . 0.0 109.381 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -122.31 155.37 36.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -144.86 165.79 27.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 110.275 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -74.51 137.34 42.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.864 1.666 . . . . 0.0 111.49 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.9 mt -80.4 108.17 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -47.11 125.15 7.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.03 1.332 . . . . 0.0 112.023 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.02 -19.18 38.47 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.829 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -136.16 178.23 7.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.284 1.434 . . . . 0.0 108.77 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.91 7.78 43.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.789 0.804 . . . . 0.0 110.595 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -73.8 164.31 54.76 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 162.89 34.32 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.203 1.401 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.5 tt -151.72 148.16 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.47 142.82 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.302 1.7 t -119.82 -23.68 6.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.944 0.793 . . . . 0.0 111.96 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -146.49 126.31 13.52 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 120.176 1.353 . . . . 0.0 108.048 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.8 150.02 28.23 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.096 1.358 . . . . 0.0 111.101 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -147.46 139.06 23.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -125.92 113.35 17.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 154.01 42.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.748 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.1 p -144.74 168.3 20.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.238 1.415 . . . . 0.0 108.699 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -123.66 141.0 52.44 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt 72.08 -45.96 0.63 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.164 1.786 . . . . 0.0 110.533 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.54 168.35 17.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.406 1.883 . . . . 0.0 107.629 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 88.2 m -130.5 99.52 5.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.359 1.464 . . . . 0.0 107.954 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 38.6 p -67.14 128.9 38.11 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.336 1.055 . . . . 0.0 113.497 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.21 84.41 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.65 157.41 21.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.527 2.151 . . . . 0.0 108.676 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -133.37 104.36 6.4 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.51 -169.54 20.5 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.4 mt -116.51 124.26 49.47 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.306 1.042 . . . . 0.0 110.461 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.91 109.19 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.152 2.181 . . . . 0.0 110.777 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.69 162.5 26.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 108.458 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.28 -165.95 45.48 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.251 0.917 . . . . 0.0 112.899 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.8 m -73.66 108.47 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.958 2.103 . . . . 0.0 108.26 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.88 138.89 42.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.91 120.77 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.501 0.667 . . . . 0.0 111.81 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.06 124.01 47.72 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.55 110.29 22.44 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -152.06 163.37 39.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.434 1.094 . . . . 0.0 109.934 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -144.71 137.71 26.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 129.37 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.393 0.616 . . . . 0.0 111.138 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.21 -1.57 33.11 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.43 161.23 13.74 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.331 2.065 . . . . 0.0 113.546 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -107.81 159.64 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.889 2.475 . . . . 0.0 107.722 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 54.7 mt -99.74 107.69 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.22 90.68 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.485 1.514 . . . . 0.0 109.449 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.73 159.11 9.1 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 126.046 1.784 . . . . 0.0 111.485 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -131.85 164.35 26.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.626 2.371 . . . . 0.0 108.546 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -161.88 103.13 1.16 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -150.38 -179.94 26.6 Favored Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.173 -0.954 . . . . 0.0 114.205 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 163' ' ' GLU . 21.8 ptmt -140.19 117.26 11.16 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.112 -2.922 . . . . 0.0 103.112 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.28 154.62 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 63.3 m -149.46 -72.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.95 -36.35 13.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.587 0.755 . . . . 0.0 110.755 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.6 mt -130.33 141.92 50.56 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.056 1.342 . . . . 0.0 107.881 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.57 85.09 2.63 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 110.695 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -76.19 -82.38 0.08 Allowed 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.131 0.572 . . . . 0.0 111.531 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 282' ' ' LYS . 33.5 tt0 -83.3 126.05 32.27 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.616 -0.677 . . . . 0.0 110.785 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -128.06 100.96 6.08 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.55 153.75 16.91 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.97 161.78 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.915 1.286 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.79 160.51 15.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 109.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.97 158.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 110.514 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 53.0 mmm -156.81 138.91 10.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 126.081 1.752 . . . . 0.0 107.023 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.84 123.05 8.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 105.58 -2.508 . . . . 0.0 105.58 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.85 167.78 20.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.2 0.524 . . . . 0.0 112.029 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 10.8 p -89.9 129.91 36.19 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.894 1.278 . . . . 0.0 107.762 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 117.063 -1.446 . . . . 0.0 108.161 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -136.27 154.75 50.8 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 130.826 3.651 . . . . 0.0 108.582 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HE2' ' CE1' ' A' ' 142' ' ' TYR . 4.9 tmtt? -38.88 113.73 0.33 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.663 2.785 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.26 146.05 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.82 167.82 11.02 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.42 94.44 3.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.65 7.78 4.85 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.489 1.518 . . . . 0.0 115.417 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -170.14 27.74 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 118.74 1.27 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 89' ' ' ASP . . . -65.52 -28.9 74.08 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.029 1.776 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.13 42.27 30.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.452 1.501 . . . . 0.0 110.314 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.31 15.66 1.41 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.424 1.488 . . . . 0.0 112.883 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 174.64 22.42 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.358 1.932 . . . . 0.0 110.63 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 160.79 26.52 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.184 2.194 . . . . 0.0 112.237 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.73 138.39 6.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.686 0.795 . . . . 0.0 110.973 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -155.91 106.67 2.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -148.27 70.89 1.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.049 1.339 . . . . 0.0 110.758 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -34.53 127.76 0.46 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.345 2.258 . . . . 0.0 113.515 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.03 147.83 48.54 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.9 -40.76 5.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.893 1.677 . . . . 0.0 113.993 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -82.49 58.15 4.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -72.96 -37.54 67.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.158 1.383 . . . . 0.0 111.847 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.27 48.39 10.78 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.73 139.35 18.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.289 1.044 . . . . 0.0 112.116 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -58.37 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.328 1.851 . . . . 0.0 110.128 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -136.66 163.83 29.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 122.03 -0.419 . . . . 0.0 110.527 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.28 96.61 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.092 1.757 . . . . 0.0 106.879 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.82 136.28 33.03 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.33 148.25 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.539 1.936 . . . . 0.0 106.686 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.69 -115.1 2.01 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 119.483 1.038 . . . . 0.0 111.814 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.21 174.06 1.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 110.759 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.59 -25.59 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.747 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -60.72 -28.31 68.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.681 1.741 . . . . 0.0 112.468 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.24 1.06 25.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.978 2.511 . . . . 0.0 110.288 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.91 161.14 23.79 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 128.164 2.792 . . . . 0.0 108.996 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 t -84.65 95.66 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -80.32 -63.99 1.29 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 110.076 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 p -61.1 113.47 2.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.865 1.266 . . . . 0.0 111.162 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.2 mm -134.58 137.3 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.379 1.472 . . . . 0.0 107.386 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.96 111.3 5.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.1 p -124.37 150.19 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.41 122.61 59.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -110.2 104.6 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.12 110.35 18.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.596 0.236 . . . . 0.0 110.905 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -79.09 152.97 30.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.29 -38.87 74.64 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 m -63.71 -59.83 4.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -155.34 157.3 36.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.223 2.209 . . . . 0.0 106.364 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.23 156.39 39.19 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.96 108.66 2.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.44 138.53 33.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 109.369 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.36 -3.09 25.99 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.913 2.197 . . . . 0.0 112.124 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -166.43 21.29 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.431 1.116 . . . . 0.0 114.545 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -105.52 149.26 26.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.459 1.904 . . . . 0.0 107.812 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -129.73 155.87 45.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.286 1.434 . . . . 0.0 107.39 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.1 179.61 37.26 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -126.94 116.99 21.64 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.236 -1.155 . . . . 0.0 113.547 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -92.43 164.39 13.5 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.174 1.79 . . . . 0.0 110.204 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 p -142.9 168.0 20.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -63.95 -17.66 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.98 -9.84 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.954 1.702 . . . . 0.0 112.982 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.55 101.19 0.16 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 120.478 1.49 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -159.8 131.66 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.201 2.2 . . . . 0.0 105.752 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -143.28 162.39 35.79 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 127.302 2.241 . . . . 0.0 107.568 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -139.63 95.24 2.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -89.74 138.36 31.55 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -130.57 136.9 49.37 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.49 138.24 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.743 1.617 . . . . 0.0 109.607 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 5.8 t0 -82.25 171.08 14.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.5 65.79 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.995 -1.066 . . . . 0.0 112.587 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -124.4 19.45 8.89 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.326 1.45 . . . . 0.0 112.579 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.0 136.44 38.26 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.175 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.7 158.12 37.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.16 1.784 . . . . 0.0 109.175 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.0 mt -96.42 121.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.175 0.99 . . . . 0.0 109.22 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.3 m -118.38 -18.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.609 0.64 . . . . 0.0 111.952 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.19 141.11 25.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 t -135.54 142.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.64 118.48 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.78 138.4 54.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 111' ' ' THR . 17.0 m -117.02 137.31 52.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -140.27 148.97 42.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.013 0.525 . . . . 0.0 109.717 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -147.29 150.55 35.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -144.86 158.21 43.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 127.204 2.202 . . . . 0.0 109.273 177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.62 169.48 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 108.304 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.16 1.61 1.98 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.552 1.541 . . . . 0.0 113.21 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.47 17.31 14.11 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 126.904 2.192 . . . . 0.0 112.895 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -134.38 156.69 48.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.155 1.477 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -117.25 5.36 12.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.341 1.856 . . . . 0.0 112.3 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.408 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 53.2 p -134.11 173.52 11.5 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.678 2.791 . . . . 0.0 110.108 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 9' ' ' GLY . 7.2 m-20 -119.19 146.27 45.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -126.23 140.04 49.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.35 104.32 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.7 p -73.94 -31.13 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.816 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -150.21 154.35 37.82 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.652 1.581 . . . . 0.0 109.853 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 pt -139.57 148.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 128.441 2.696 . . . . 0.0 106.24 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.63 145.37 25.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -127.45 152.83 47.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -132.45 113.98 13.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 103.554 -2.758 . . . . 0.0 103.554 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.2 p -80.5 161.69 24.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.418 0.553 . . . . 0.0 112.019 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.75 -25.09 66.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.506 1.122 . . . . 0.0 111.29 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -68.62 -15.56 63.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.47 1.908 . . . . 0.0 109.721 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 6.5 61.46 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.693 2.568 . . . . 0.0 111.464 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -73.12 99.13 2.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.532 1.166 . . . . 0.0 111.359 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.12 134.95 33.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 p -107.67 162.2 20.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.763 1.225 . . . . 0.0 110.976 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.13 162.16 42.55 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.906 1.738 . . . . 0.0 109.498 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 109.73 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.615 2.21 . . . . 0.0 108.36 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -72.24 79.61 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 109.488 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.99 -137.2 5.41 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.395 -0.816 . . . . 0.0 111.611 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.99 111.13 13.72 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.597 1.959 . . . . 0.0 108.089 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.1 144.8 50.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.557 ' H ' HG21 ' A' ' 79' ' ' THR . 7.4 m -133.71 163.9 28.41 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.345 1.858 . . . . 0.0 107.055 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.87 -35.87 82.07 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.407 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -73.45 97.53 2.57 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.51 1.924 . . . . 0.0 108.947 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -150.98 170.18 19.96 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.258 1.023 . . . . 0.0 109.019 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.64 167.21 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -118.69 141.02 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.61 94.02 2.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 169.48 23.11 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.11 2.164 . . . . 0.0 108.42 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.56 150.25 38.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.473 1.909 . . . . 0.0 109.086 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.13 -61.02 2.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.189 0.904 . . . . 0.0 111.688 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -68.39 -15.55 63.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.522 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.99 -53.02 0.8 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.546 -1.697 . . . . 0.0 112.571 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 38.82 91.26 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.21 2.338 . . . . 0.0 114.055 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -52.5 120.7 5.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.658 1.729 . . . . 0.0 109.888 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.83 144.38 38.92 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.173 2.189 . . . . 0.0 110.147 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.46 -31.16 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.677 0.791 . . . . 0.0 110.084 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.73 150.89 8.54 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -121.95 84.6 2.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 123.468 1.604 . . . . 0.0 107.642 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.36 151.68 36.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 111.759 -2.473 . . . . 0.0 110.554 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.93 78.78 0.16 Allowed Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.809 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -49.33 107.11 0.13 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.045 1.738 . . . . 0.0 109.034 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.5 165.07 18.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.712 2.405 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.54 -86.65 0.2 Allowed Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 105.186 -3.166 . . . . 0.0 105.186 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -93.9 -27.59 16.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.35 166.29 25.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.832 2.453 . . . . 0.0 108.548 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.6 tp -78.81 99.05 6.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -82.95 -55.64 4.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.556 0.742 . . . . 0.0 112.945 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.81 161.27 21.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.949 0.9 . . . . 0.0 109.852 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 tp -148.43 163.39 37.28 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.717 1.607 . . . . 0.0 108.672 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.57 -179.51 40.39 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.72 151.99 29.38 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.449 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 8.5 m-85 -114.84 146.33 41.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.486 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -143.11 156.39 44.79 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.77 147.44 32.93 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.779 0.832 . . . . 0.0 111.469 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.8 t -133.67 163.46 29.4 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.662 1.185 . . . . 0.0 111.863 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m -66.56 -46.79 74.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.349 1.859 . . . . 0.0 111.323 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.13 93.22 0.05 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.579 1.552 . . . . 0.0 111.55 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -154.41 162.29 27.33 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 126.147 1.779 . . . . 0.0 108.199 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.81 -166.21 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.723 2.949 . . . . 0.0 107.745 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.1 p -54.13 142.5 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 p -135.46 163.06 53.5 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 123.813 0.845 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.42 -171.32 0.7 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.234 2.623 . . . . 0.0 112.492 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.56 -176.47 0.79 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.513 2.325 . . . . 0.0 112.385 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -73.97 122.92 23.35 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -99.79 118.93 37.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.825 1.65 . . . . 0.0 106.931 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.35 -176.68 4.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.675 0.671 . . . . 0.0 111.751 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.5 m -121.52 85.74 2.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 113.426 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.25 -175.84 5.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.278 1.031 . . . . 0.0 109.13 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -123.87 165.17 20.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 127.005 2.122 . . . . 0.0 107.248 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 177.75 -83.04 0.07 OUTLIER Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.832 0.742 . . . . 0.0 114.187 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.44 -24.77 0.02 OUTLIER Glycine 0 N--CA 1.469 0.848 0 CA-C-N 117.403 0.601 . . . . 0.0 112.779 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 282' ' ' LYS . 0.3 OUTLIER 61.43 21.35 11.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -83.59 -47.85 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.54 12.79 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 122.57 1.095 . . . . 0.0 113.765 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.7 m -81.44 134.53 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.219 -0.577 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.56 124.31 22.88 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.535 0.734 . . . . 0.0 110.505 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -127.05 126.9 43.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.241 1.02 . . . . 0.0 109.362 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -98.2 156.52 16.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.624 2.369 . . . . 0.0 107.278 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.28 -53.48 2.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.776 1.63 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.8 -105.7 1.85 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -165.62 166.88 17.77 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.645 1.978 . . . . 0.0 108.378 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.33 154.3 36.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.159 0.584 . . . . 0.0 110.317 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -27.74 61.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.12 140.55 2.91 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.747 2.594 . . . . 0.0 106.754 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.8 m -91.85 157.14 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.511 1.124 . . . . 0.0 110.634 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -123.71 -21.88 5.09 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.843 1.657 . . . . 0.0 111.086 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -166.11 159.85 15.73 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.625 0.77 . . . . 0.0 110.426 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.74 147.55 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 126.982 2.113 . . . . 0.0 107.694 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -139.4 113.28 8.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.151 1.381 . . . . 0.0 108.322 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.19 133.81 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -135.86 144.53 16.37 Favored Glycine 0 C--O 1.238 0.397 0 CA-C-O 122.029 0.794 . . . . 0.0 111.815 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -126.72 171.89 10.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.285 1.434 . . . . 0.0 107.43 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.16 -171.44 12.4 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -63.43 -6.81 5.38 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.638 1.175 . . . . 0.0 113.484 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -120.04 -4.96 10.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.756 1.622 . . . . 0.0 112.859 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 125.14 -162.08 19.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.596 1.089 . . . . 0.0 111.626 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.1 mm -55.6 126.64 13.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 m -134.27 -19.73 1.92 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.62 138.18 16.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 121.174 1.806 . . . . 0.0 111.551 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.05 146.85 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.146 0.884 . . . . 0.0 109.761 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -160.45 167.23 27.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.794 1.637 . . . . 0.0 107.459 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -138.32 172.4 12.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.592 1.157 . . . . 0.0 108.11 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -126.75 124.3 39.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -132.06 167.99 18.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.458 0.572 . . . . 0.0 111.31 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -116.6 91.46 3.59 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -112.96 136.32 52.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.771 2.428 . . . . 0.0 106.14 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.16 20.32 34.95 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.947 0.784 . . . . 0.0 113.093 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.93 4.73 3.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.638 2.375 . . . . 0.0 113.723 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -91.25 -157.33 0.49 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.495 1.518 . . . . 0.0 111.055 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -125.4 73.43 1.32 Allowed 'General case' 0 C--N 1.339 0.142 0 O-C-N 120.694 -1.254 . . . . 0.0 110.924 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.2 mt -84.87 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.0 145.05 31.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -73.57 156.54 51.03 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.35 159.06 46.38 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.18 94.41 4.74 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -63.14 -22.04 66.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.381 1.072 . . . . 0.0 113.228 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.56 -179.07 16.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.925 1.726 . . . . 0.0 112.19 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.57 117.49 68.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.567 1.547 . . . . 0.0 109.523 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.8 175.16 6.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.407 2.071 . . . . 0.0 110.196 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -139.95 162.08 36.06 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.744 -1.222 . . . . 0.0 110.546 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.38 -15.28 62.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.886 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -4.24 22.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.709 2.404 . . . . 0.0 111.062 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.46 -157.63 51.67 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.328 -0.857 . . . . 0.0 111.394 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.89 172.67 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.551 1.54 . . . . 0.0 110.482 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.77 147.08 47.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 129.568 3.147 . . . . 0.0 102.827 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.25 147.36 51.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -142.94 143.98 32.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.783 1.233 . . . . 0.0 109.278 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.18 136.4 52.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.4 mt -128.13 103.29 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.861 1.664 . . . . 0.0 109.238 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.64 98.48 0.52 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -55.57 -40.17 82.57 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.49 -29.79 44.42 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 123.187 2.174 . . . . 0.0 112.891 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -89.94 -30.07 18.08 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 116.423 -1.751 . . . . 0.0 113.233 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 225' ' ' TYR . 10.9 tp10 -162.01 175.92 11.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 121.622 2.01 . . . . 0.0 111.157 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.439 ' H ' ' CD ' ' A' ' 224' ' ' GLU . 2.6 p90 -153.17 -156.16 0.67 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.537 1.135 . . . . 0.0 109.311 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 92.6 mt -116.77 102.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 101.885 -3.376 . . . . 0.0 101.885 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.1 p -81.84 -20.64 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.018 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.26 167.5 25.84 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.516 1.526 . . . . 0.0 108.284 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.43 159.08 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.073 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 172.0 13.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.922 2.089 . . . . 0.0 107.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.81 171.62 31.28 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.483 HG21 ' HG2' ' A' ' 262' ' ' GLU . 3.1 p -140.8 146.41 37.6 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -122.14 145.23 48.38 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.132 0.573 . . . . 0.0 110.301 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.61 161.07 36.55 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 110.325 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.52 148.91 38.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.795 1.638 . . . . 0.0 109.873 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.3 pt -115.9 142.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -87.73 99.24 11.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.56 -22.97 1.51 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.873 0.749 . . . . 0.0 113.85 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 m -141.78 155.52 45.6 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.67 -16.92 62.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.848 0.749 . . . . 0.0 112.615 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.02 -173.7 20.56 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.915 1.721 . . . . 0.0 115.689 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.6 mt -119.07 173.52 6.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.082 2.153 . . . . 0.0 110.055 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.3 tt -139.13 130.72 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.843 1.657 . . . . 0.0 108.008 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.9 mt -90.44 76.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.1 t -70.41 -8.43 50.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -141.79 137.21 31.37 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.855 0.752 . . . . 0.0 111.868 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.2 mt -142.79 137.74 29.92 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.724 1.61 . . . . 0.0 109.121 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -139.63 139.42 36.71 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.63 113.04 25.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -65.95 115.27 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.5 m -133.6 162.17 32.64 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.071 0.949 . . . . 0.0 109.23 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.16 161.67 26.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.948 2.499 . . . . 0.0 105.074 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.5 tptt 75.47 -28.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.968 1.707 . . . . 0.0 112.808 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -138.84 167.95 20.88 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.812 1.245 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 14.4 t -121.96 142.92 49.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.934 2.093 . . . . 0.0 106.005 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 p -133.13 149.29 52.1 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.951 0.901 . . . . 0.0 109.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -66.93 159.9 73.13 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.679 0.792 . . . . 0.0 111.819 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.83 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 105.51 -2.535 . . . . 0.0 105.51 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -72.97 99.23 2.66 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.72 179.75 17.77 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.04 114.46 27.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.543 1.937 . . . . 0.0 107.966 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.483 ' HG2' HG21 ' A' ' 232' ' ' THR . 0.9 OUTLIER -59.68 115.84 3.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 110.136 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.42 24.77 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.873 0.844 . . . . 0.0 111.68 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.68 -93.27 1.25 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 125.799 1.666 . . . . 0.0 113.629 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.4 m -149.9 127.47 11.58 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.391 1.076 . . . . 0.0 109.207 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.76 147.69 30.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.881 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -142.24 168.28 20.12 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.527 1.531 . . . . 0.0 108.072 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -151.87 156.2 39.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 109.181 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.7 mt -139.95 138.28 35.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -160.53 160.57 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 108.968 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.16 148.18 34.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 121.85 30.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.845 1.258 . . . . 0.0 109.455 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 87.78 -75.23 2.11 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -47.14 144.88 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.316 1.846 . . . . 0.0 111.486 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -117.65 161.07 20.25 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 83.4 mt -79.13 150.47 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.46 -55.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.8 -176.67 14.81 Favored Glycine 0 C--O 1.239 0.445 0 CA-C-O 122.994 1.33 . . . . 0.0 113.947 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.52 9.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.436 2.695 . . . . 0.0 111.271 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -165.31 162.69 19.85 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.016 1.726 . . . . 0.0 106.714 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.21 -136.11 5.28 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -156.69 131.03 8.63 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.33 137.67 24.55 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.8 m -152.16 -29.99 0.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.541 1.536 . . . . 0.0 112.225 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -139.23 -57.88 0.59 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.423 1.889 . . . . 0.0 111.753 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.78 165.82 22.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.139 1.375 . . . . 0.0 108.232 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.94 92.05 8.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.569 -0.707 . . . . 0.0 110.088 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.85 -48.24 7.14 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.013 0.925 . . . . 0.0 112.865 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -112.61 141.25 46.6 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.92 99.59 3.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -113.32 157.57 14.86 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.963 1.268 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.85 174.85 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.217 1.009 . . . . 0.0 113.13 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -127.97 125.93 40.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.345 2.658 . . . . 0.0 104.787 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -110.22 139.98 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.4 mtm -132.44 144.12 51.7 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.4 140.44 27.25 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.995 -1.963 . . . . 0.0 106.995 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -63.78 -74.51 0.1 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 31.0 m -72.88 123.09 22.72 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.702 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -137.94 141.63 40.55 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.934 1.294 . . . . 0.0 113.032 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -149.9 97.97 2.66 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.5 131.46 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.149 1.341 . . . . 0.0 108.978 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.21 163.8 21.65 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.652 0.781 . . . . 0.0 112.226 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.97 169.83 17.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.843 1.257 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.54 87.37 0.1 Allowed Glycine 0 C--O 1.225 -0.433 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.99 -167.96 20.41 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 126.585 2.041 . . . . 0.0 108.665 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.45 177.74 2.47 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 115.679 1.031 . . . . 0.0 115.679 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.43 2.99 12.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.414 1.486 . . . . 0.0 114.903 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.99 -2.31 38.03 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.245 -1.309 . . . . 0.0 116.191 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.4 172.78 14.81 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 121.041 2.421 . . . . 0.0 113.882 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.97 157.57 25.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.783 0.833 . . . . 0.0 109.339 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -71.68 84.19 0.88 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 112.698 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -93.98 149.65 21.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.23 -10.06 0.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.799 1.24 . . . . 0.0 111.779 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -54.27 131.76 42.28 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.558 1.943 . . . . 0.0 110.805 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.22 162.12 29.68 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.75 1.643 . . . . 0.0 110.241 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.73 -178.65 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.32 1.048 . . . . 0.0 111.105 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -94.19 -66.14 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -169.09 176.05 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.732 2.413 . . . . 0.0 106.311 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 28.29 6.35 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.455 1.979 . . . . 0.0 113.04 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.52 140.84 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.971 1.386 . . . . 0.0 109.511 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -62.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.893 0.877 . . . . 0.0 111.993 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -145.62 164.54 31.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.197 0.999 . . . . 0.0 109.909 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 t -141.71 150.36 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 127.043 2.137 . . . . 0.0 106.337 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -136.8 134.91 37.52 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.77 147.16 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 62' ' ' PHE . . . 135.26 124.92 2.47 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.25 -4.71 10.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.179 1.792 . . . . 0.0 111.168 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.4 -73.09 0.1 OUTLIER Glycine 0 C--O 1.224 -0.522 0 C-N-CA 129.386 3.374 . . . . 0.0 114.535 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -56.56 -47.84 78.63 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.065 0.946 . . . . 0.0 110.755 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.9 1.52 56.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.432 1.493 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.86 -117.47 5.13 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 121.162 -0.962 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.2 96.76 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 111.532 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -127.12 -29.21 2.79 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.9 t -68.27 159.02 32.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.119 0.872 . . . . 0.0 110.344 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 154.37 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.503 1.521 . . . . 0.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -153.09 123.03 6.92 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.927 1.291 . . . . 0.0 107.735 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.35 100.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 123.966 0.906 . . . . 0.0 108.558 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -104.79 134.29 46.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -127.32 154.63 44.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 109.735 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.27 109.94 22.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -114.67 130.01 56.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 57.16 17.94 3.84 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.845 1.202 . . . . 0.0 112.65 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . 0.325 86.0 p 71.3 23.97 3.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.71 2.404 . . . . 0.0 111.285 -176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.95 160.49 19.49 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.113 2.965 . . . . 0.0 104.871 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -105.23 118.03 35.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 m -118.67 124.55 73.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.272 1.029 . . . . 0.0 110.503 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -122.76 161.58 23.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.282 1.833 . . . . 0.0 109.752 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.77 -21.97 2.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.211 1.386 . . . . 0.0 110.05 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.0 167.72 12.52 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 128.036 2.732 . . . . 0.0 109.942 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -73.95 159.46 32.73 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 109.951 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.49 143.69 50.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.06 -143.79 16.89 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.13 115.73 18.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.785 2.834 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 151.99 24.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.214 1.37 . . . . 0.0 110.163 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -147.72 156.1 42.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 tp -77.89 -10.43 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.86 -0.525 . . . . 0.0 111.502 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.12 -5.47 27.24 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.57 96.43 0.1 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.492 ' HA ' ' HA3' ' A' ' 29' ' ' GLY . 12.3 p90 -154.19 161.83 41.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.712 1.205 . . . . 0.0 109.66 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.66 163.61 33.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 127.197 2.199 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.7 m -131.82 140.81 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.004 2.121 . . . . 0.0 107.205 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -133.07 140.75 47.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.004 1.322 . . . . 0.0 109.295 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.5 136.24 54.97 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.175 1.79 . . . . 0.0 111.478 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.48 125.8 71.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.94 164.68 26.32 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.572 -0.705 . . . . 0.0 111.634 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -11.13 15.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.476 1.511 . . . . 0.0 113.172 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -127.5 10.0 6.65 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.788 1.635 . . . . 0.0 110.885 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -97.79 152.44 19.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.151 0.887 . . . . 0.0 111.786 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.53 134.14 41.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.61 105.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.91 -55.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.7 22.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.236 1.015 . . . . 0.0 109.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.78 151.37 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -135.17 136.0 41.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.59 135.89 27.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -116.27 156.54 26.43 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -153.55 158.64 41.55 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.486 1.039 . . . . 0.0 112.516 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -162.49 168.89 21.25 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.96 0.886 . . . . 0.0 112.14 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -125.3 141.27 52.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.479 2.712 . . . . 0.0 106.646 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -123.56 159.09 28.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.28 129.19 40.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.29 2.91 51.06 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 111.557 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -138.62 127.65 23.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.028 1.731 . . . . 0.0 106.766 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -11.18 49.46 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.3 p -80.07 -175.5 5.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.916 2.486 . . . . 0.0 109.9 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.83 134.91 17.99 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.73 171.73 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 123.827 0.851 . . . . 0.0 111.729 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.8 mm -73.93 134.06 30.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 p -104.73 -30.42 9.93 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.335 0.654 . . . . 0.0 110.172 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -156.42 160.44 39.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.325 0.966 . . . . 0.0 110.214 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.6 mt -142.58 147.62 20.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 126.667 1.987 . . . . 0.0 107.351 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -150.66 137.18 18.8 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.68 115.5 22.19 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.292 1.437 . . . . 0.0 107.747 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.12 135.11 33.41 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.4 p -110.23 159.39 17.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.658 1.117 . . . . 0.0 110.809 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -77.29 -25.88 51.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 5.3 mmpt? -63.56 -11.23 22.82 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.467 1.907 . . . . 0.0 114.491 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.52 31.26 33.99 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 120.862 1.665 . . . . 0.0 110.526 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -128.95 93.59 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.561 1.144 . . . . 0.0 108.397 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -85.74 136.28 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.82 150.3 75.27 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.92 166.73 28.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.615 1.543 . . . . 0.0 108.426 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.32 99.81 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.733 2.288 . . . . 0.0 108.265 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.32 85.43 0.16 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.488 1.515 . . . . 0.0 110.173 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.23 -123.75 3.52 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 126.07 1.795 . . . . 0.0 108.867 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.2 tp -139.51 120.92 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.417 1.487 . . . . 0.0 107.719 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 151.4 21.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.03 169.56 19.66 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.735 -1.228 . . . . 0.0 110.52 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.15 -61.23 2.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.543 1.137 . . . . 0.0 111.605 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.74 127.64 32.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -174.5 173.14 2.98 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.179 0.992 . . . . 0.0 111.1 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.34 167.52 25.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.057 0.943 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.11 150.63 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.725 1.61 . . . . 0.0 108.388 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.21 154.65 42.62 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 109.067 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.85 156.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.272 2.229 . . . . 0.0 110.02 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 143' ' ' PHE . 31.1 t0 -117.67 175.61 5.56 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.009 2.523 . . . . 0.0 109.238 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -64.89 176.96 1.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.703 2.001 . . . . 0.0 110.482 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -68.18 -17.79 64.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.942 0.897 . . . . 0.0 112.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.44 43.02 1.71 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -133.19 154.36 21.17 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -137.61 149.55 46.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.881 0.872 . . . . 0.0 109.892 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.18 133.54 49.05 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.61 -71.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -139.54 166.34 25.59 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.268 0.486 . . . . 0.0 112.022 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -125.0 120.06 30.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.415 1.886 . . . . 0.0 107.303 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 148.85 25.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.21 96.13 0.18 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 65.4 1.2 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 109.553 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.01 165.53 12.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.526 2.331 . . . . 0.0 108.448 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.22 -102.56 0.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 103.215 -3.954 . . . . 0.0 103.215 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -86.75 -9.88 54.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.605 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 170.66 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.337 2.255 . . . . 0.0 108.786 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.452 HD11 HD23 ' A' ' 139' ' ' LEU . 12.9 tp -82.18 93.86 7.16 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.797 2.039 . . . . 0.0 110.772 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.68 -39.8 11.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.28 148.91 30.98 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.325 -0.86 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.501 ' CD1' ' H ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -134.84 -169.51 2.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.743 2.417 . . . . 0.0 108.827 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.501 ' H ' ' CD1' ' A' ' 139' ' ' LEU . . . 144.63 172.27 15.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.439 2.447 . . . . 0.0 109.469 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.56 166.28 33.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 120.031 1.915 . . . . 0.0 111.176 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -136.98 168.96 18.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.216 1.007 . . . . 0.0 110.88 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.431 ' CG ' ' HB2' ' A' ' 119' ' ' ASP . 7.8 m-85 -134.43 97.22 3.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.4 117.71 7.38 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.746 -1.121 . . . . 0.0 113.041 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.14 124.05 29.87 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.947 1.249 . . . . 0.0 109.14 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.0 p 51.34 18.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.125 2.97 . . . . 0.0 114.007 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.9 t -65.29 -26.76 68.21 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.875 1.67 . . . . 0.0 114.025 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 16.1 p -148.35 144.0 18.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 125.969 1.707 . . . . 0.0 111.002 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.97 -163.98 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.501 3.467 . . . . 0.0 109.85 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.23 108.12 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.535 -0.728 . . . . 0.0 111.87 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.13 163.95 42.47 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.959 1.703 . . . . 0.0 110.433 177.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.18 1.86 8.26 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.965 3.11 . . . . 0.0 114.579 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -87.92 174.46 8.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 130.8 3.64 . . . . 0.0 109.061 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -94.99 126.18 40.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HA ' ' CE1' ' A' ' 293' ' ' HIS . 4.3 pttp -85.86 141.31 29.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.851 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.53 157.39 18.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.5 m -75.77 126.88 31.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.852 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.23 178.8 0.24 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.088 1.355 . . . . 0.0 112.161 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.421 HG22 ' H ' ' A' ' 160' ' ' GLY . 8.2 mt -128.68 170.68 17.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.555 1.942 . . . . 0.0 107.259 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.421 ' H ' HG22 ' A' ' 159' ' ' ILE . . . -34.53 111.12 0.07 OUTLIER Glycine 0 CA--C 1.493 -1.282 0 C-N-CA 125.859 1.695 . . . . 0.0 113.335 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 164.36 121.66 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 O-C-N 125.471 1.336 . . . . 0.0 113.209 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -146.67 3.43 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -119.76 111.77 18.42 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 110.168 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.56 162.64 10.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.857 1.218 . . . . 0.0 111.633 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.1 t -81.56 141.31 33.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.77 28.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -141.63 17.89 2.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.707 1.603 . . . . 0.0 110.87 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -43.12 127.08 4.21 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.221 2.208 . . . . 0.0 111.746 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.38 -7.83 58.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 77.62 -98.58 1.42 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 104.302 -3.519 . . . . 0.0 104.302 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.99 159.79 29.89 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.338 1.855 . . . . 0.0 107.425 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -131.56 179.54 5.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.832 2.053 . . . . 0.0 107.31 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.98 -44.09 97.86 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.7 160.58 30.8 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-O 122.177 0.876 . . . . 0.0 111.662 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.8 156.36 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 127.614 2.365 . . . . 0.0 105.342 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -138.42 -41.09 0.51 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.935 0.789 . . . . 0.0 112.911 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -133.65 140.91 47.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.339 -0.85 . . . . 0.0 110.871 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.53 120.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.02 112.66 24.63 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.62 128.28 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.83 97.9 0.65 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.529 1.538 . . . . 0.0 110.355 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -89.85 177.39 6.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 123.075 1.417 . . . . 0.0 111.798 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.25 -165.84 11.55 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 129.731 3.539 . . . . 0.0 106.924 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.8 -46.99 15.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.011 -0.699 . . . . 0.0 111.843 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.77 -31.87 25.7 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.079 1.351 . . . . 0.0 113.017 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.2 25.01 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.33 149.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.926 0.89 . . . . 0.0 109.657 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 p -132.29 -40.59 1.01 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.93 0.892 . . . . 0.0 110.228 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.0 165.07 20.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.746 1.218 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.05 124.61 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.02 90.34 0.68 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.862 0.756 . . . . 0.0 110.76 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -92.93 174.34 7.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.23 0.612 . . . . 0.0 110.505 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.13 140.96 47.46 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.17 168.31 20.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.742 1.617 . . . . 0.0 110.867 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -112.41 155.84 23.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.403 1.081 . . . . 0.0 110.478 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -139.83 115.31 9.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.56 -89.45 0.29 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -147.48 24.28 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.898 1.679 . . . . 0.0 109.773 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -126.17 142.24 51.61 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.35 141.01 40.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.619 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.3 mm -121.88 132.07 71.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.46 135.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.256 1.022 . . . . 0.0 108.749 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.01 -131.34 3.29 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.94 -8.78 61.99 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.373 1.94 . . . . 0.0 113.592 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 125.44 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.789 1.295 . . . . 0.0 107.823 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -136.92 -50.23 0.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.305 0.642 . . . . 0.0 109.495 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.41 -179.44 50.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.869 1.223 . . . . 0.0 113.595 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.28 105.44 4.11 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 126.649 1.979 . . . . 0.0 108.886 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.63 177.51 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.825 1.683 . . . . 0.0 108.008 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -121.77 150.86 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.2 -12.66 42.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.257 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.9 tt -51.85 -34.4 40.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.039 2.536 . . . . 0.0 110.788 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.27 -155.89 15.93 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -143.53 128.34 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.19 151.06 25.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -135.36 152.56 51.55 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.538 0.608 . . . . 0.0 112.428 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -142.24 127.03 18.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.96 115.9 31.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mm -127.67 105.05 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -51.18 117.21 2.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -46.27 -63.66 1.24 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.708 2.003 . . . . 0.0 113.519 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 -32.43 5.42 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.231 1.832 . . . . 0.0 115.822 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 m -77.59 -19.69 55.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.16 170.24 16.22 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.409 1.004 . . . . 0.0 109.889 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -149.78 108.33 3.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.649 1.179 . . . . 0.0 108.072 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.507 HG22 HD12 ' A' ' 276' ' ' ILE . 4.2 mp -65.03 108.29 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -31.46 19.9 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.23 25.36 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.176 1.353 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.05 149.81 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.943 1.297 . . . . 0.0 108.239 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -132.37 177.2 7.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 130.042 3.337 . . . . 0.0 106.421 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 151.68 -176.27 30.13 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 120.683 -1.261 . . . . 0.0 110.94 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 p -147.21 155.31 41.98 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.556 1.142 . . . . 0.0 108.231 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.56 165.12 26.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.434 1.494 . . . . 0.0 108.344 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.74 168.04 25.58 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.556 0.693 . . . . 0.0 111.177 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -69.06 149.1 49.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.963 2.105 . . . . 0.0 108.826 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.0 155.36 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.749 1.619 . . . . 0.0 109.394 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.08 88.48 2.74 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 167.48 -25.7 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 15.7 m -132.52 170.67 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.102 0.953 . . . . 0.0 110.419 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -108.82 86.8 2.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.61 -146.19 11.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.661 1.6 . . . . 0.0 109.844 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.97 156.05 47.53 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.4 1.48 . . . . 0.0 108.492 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.9 tt -113.23 149.18 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.29 1.436 . . . . 0.0 109.011 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.0 mm -77.37 137.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -129.63 -35.13 1.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.013 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.5 ttt -126.55 146.65 50.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.044 0.838 . . . . 0.0 110.836 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -140.0 147.83 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.428 1.491 . . . . 0.0 109.301 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -149.21 154.92 39.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -141.72 122.4 14.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -65.15 152.12 44.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.0 p -143.15 154.46 43.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.4 158.99 15.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 67.84 -34.37 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.507 1.923 . . . . 0.0 113.794 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -141.33 174.17 10.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.697 1.999 . . . . 0.0 109.448 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.5 p -114.44 162.71 16.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.085 1.354 . . . . 0.0 110.009 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 3.6 p -98.99 177.56 5.21 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.231 1.413 . . . . 0.0 110.646 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.22 157.28 41.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.372 1.469 . . . . 0.0 109.206 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.19 99.14 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.853 2.369 . . . . 0.0 108.402 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -82.84 92.51 7.28 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 126.24 -164.77 19.69 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.942 1.258 . . . . 0.0 111.051 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.7 tp -118.88 130.09 55.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.186 1.394 . . . . 0.0 109.542 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -70.99 120.71 16.96 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.2 -178.8 7.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.239 1.416 . . . . 0.0 109.392 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 49.34 -103.59 0.08 OUTLIER Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.253 1.882 . . . . 0.0 113.417 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 16.8 m -147.98 145.42 28.54 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.701 1.201 . . . . 0.0 108.692 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.66 26.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -141.34 151.03 43.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.537 1.535 . . . . 0.0 109.557 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.91 155.44 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.335 1.054 . . . . 0.0 110.962 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 42.9 mt -143.4 119.28 10.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.65 1.18 . . . . 0.0 109.354 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -139.31 170.99 14.93 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.237 0.615 . . . . 0.0 111.795 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.93 170.79 15.47 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.927 2.491 . . . . 0.0 107.638 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.7 125.2 47.05 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.71 77.86 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.527 1.061 . . . . 0.0 115.097 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -135.18 175.63 9.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.049 1.424 . . . . 0.0 111.924 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.01 161.94 36.66 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.486 1.514 . . . . 0.0 109.742 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 226' ' ' ILE . 91.4 mt -74.24 144.02 12.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.9 2.33 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.182 0.993 . . . . 0.0 112.565 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.0 179.03 26.39 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 120.898 -1.126 . . . . 0.0 112.401 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.22 160.52 18.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.661 2.385 . . . . 0.0 108.344 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' HIS . . . . . 0.502 ' CD2' ' HD1' ' A' ' 293' ' ' HIS . 12.1 p80 -151.67 106.54 3.26 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -160.48 -147.41 4.92 Favored Glycine 0 C--O 1.237 0.29 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.12 126.04 8.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.68 134.58 13.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.164 0.986 . . . . 0.0 109.2 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.7 t -133.9 -68.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -95.51 -32.86 12.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.172 0.989 . . . . 0.0 111.75 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.4 mp -135.9 175.14 9.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 108.895 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.55 99.92 6.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.888 1.275 . . . . 0.0 109.431 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.35 -65.65 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.37 115.85 7.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.688 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.11 160.8 39.12 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.696 0.798 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 161.43 -167.32 36.24 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 12.5 m -152.3 153.5 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.499 1.119 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' HIS . . . . . 0.502 ' HD1' ' CD2' ' A' ' 280' ' ' HIS . 0.1 OUTLIER -94.19 167.76 11.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.07 143.99 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 66.1 mtp -139.46 140.88 26.85 Favored Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.61 139.51 76.08 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 110.067 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.14 -20.62 66.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 22.1 m -147.27 166.63 26.47 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.767 0 C-N-CA 124.861 1.265 . . . . 0.0 108.168 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 122.235 1.017 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -135.7 154.15 51.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 130.931 3.693 . . . . 0.0 106.178 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HD3' ' CD2' ' A' ' 142' ' ' TYR . 29.7 ttpt -41.84 106.6 0.06 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.067 1.747 . . . . 0.0 111.363 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.22 146.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.67 144.32 14.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.919 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.22 151.28 31.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.89 13.77 17.05 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.739 -0.601 . . . . 0.0 112.175 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.27 102.9 0.21 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 126.508 2.004 . . . . 0.0 112.557 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' SER . . . -126.93 -19.33 2.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 116.907 1.523 . . . . 0.0 116.907 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 137' ' ' TYR . . . -78.55 -13.93 59.59 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.676 1.59 . . . . 0.0 109.966 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.74 43.19 19.06 Favored Glycine 0 N--CA 1.416 -2.658 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.251 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 -107.5 0.16 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.6 159.23 43.44 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.628 1.171 . . . . 0.0 110.628 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -93.52 129.95 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.574 -1.328 . . . . 0.0 108.481 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -93.25 -13.43 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.479 0.712 . . . . 0.0 109.857 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.01 103.48 0.74 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.044 0.937 . . . . 0.0 110.179 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.71 -54.53 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -17.09 59.79 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.431 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.85 -17.47 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.46 1.63 . . . . 0.0 112.779 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -173.11 131.31 0.49 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.699 2.8 . . . . 0.0 104.325 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -144.11 73.15 1.37 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.86 128.54 6.72 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.648 1.594 . . . . 0.0 109.541 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.26 150.57 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.58 1.152 . . . . 0.0 108.8 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -126.23 -45.38 1.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -143.16 161.88 37.05 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.207 1.403 . . . . 0.0 107.314 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.43 151.17 22.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -131.65 139.83 49.2 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.7 t -150.58 144.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.83 146.47 9.41 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -58.46 146.52 34.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 110.303 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.37 -116.33 2.71 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.99 1.281 . . . . 0.0 110.712 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -87.21 -49.15 7.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.766 0.783 . . . . 0.0 111.941 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -126.42 -26.02 3.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.376 1.071 . . . . 0.0 110.259 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.27 176.35 27.13 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.497 1.523 . . . . 0.0 111.183 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.2 m -58.44 96.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 126.437 1.895 . . . . 0.0 111.612 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 t -87.42 -50.7 6.38 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.295 1.038 . . . . 0.0 111.371 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 p -66.81 119.96 12.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.706 1.139 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.64 158.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 108.064 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -166.5 141.86 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.937 1.295 . . . . 0.0 108.467 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.1 95.92 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.726 1.211 . . . . 0.0 108.37 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.63 130.27 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -100.81 131.98 46.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 109.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -114.87 115.89 27.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.33 34.76 24.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.967 0.907 . . . . 0.0 108.743 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t 72.54 -1.23 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.198 2.199 . . . . 0.0 112.481 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.08 144.56 28.16 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.838 1.199 . . . . 0.0 109.655 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.97 126.51 34.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.76 109.14 14.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -111.62 162.2 15.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.566 1.547 . . . . 0.0 111.954 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.6 57.43 0.09 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.83 -1.6 0.19 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.881 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.515 ' OE2' ' HE2' ' A' ' 57' ' ' LYS . 1.7 tt0 -73.51 112.16 9.33 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.512 1.656 . . . . 0.0 106.816 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -137.18 167.18 22.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.527 1.531 . . . . 0.0 107.286 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.5 -179.01 20.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -82.86 98.08 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.046 -1.267 . . . . 0.0 109.165 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HE2' ' OE2' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -83.53 163.1 20.65 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -132.08 172.76 11.98 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.595 1.158 . . . . 0.0 109.844 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 tp -89.79 -47.28 8.01 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.287 1.035 . . . . 0.0 111.689 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.01 75.21 1.02 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.93 -34.76 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 128.5 33.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.811 1.245 . . . . 0.0 111.125 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -143.69 163.83 32.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.337 1.855 . . . . 0.0 107.563 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.2 m -126.85 146.27 50.34 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.6 1.16 . . . . 0.0 108.654 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -129.04 140.94 51.4 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 126.057 1.743 . . . . 0.0 106.905 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.1 146.94 50.93 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.405 1.082 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.36 157.82 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.97 168.04 13.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.743 1.61 . . . . 0.0 112.087 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.51 -27.15 25.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.478 1.511 . . . . 0.0 110.483 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -121.02 5.96 10.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.924 0.784 . . . . 0.0 112.84 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -116.64 156.17 27.51 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.77 -176.78 4.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.38 136.17 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.9 m -113.89 -36.0 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.734 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.32 160.39 43.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.257 0.935 . . . . 0.0 110.206 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -146.05 110.03 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.73 134.46 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -132.43 122.95 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.464 1.106 . . . . 0.0 108.32 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.41 ' OG1' ' HE3' ' A' ' 114' ' ' LYS . 30.4 m -118.31 145.26 45.22 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.965 1.706 . . . . 0.0 106.477 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -149.93 168.11 24.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.536 1.134 . . . . 0.0 111.212 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -161.18 158.82 28.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.333 1.053 . . . . 0.0 108.946 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.86 135.1 24.12 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.489 1.116 . . . . 0.0 108.646 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -72.33 154.19 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.785 0.721 . . . . 0.0 109.975 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -61.67 -14.62 32.82 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.49 -7.89 41.71 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.403 -1.221 . . . . 0.0 113.762 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -135.27 105.53 6.33 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.207 1.503 . . . . 0.0 107.584 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -58.65 -24.61 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.913 1.685 . . . . 0.0 115.18 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . 46.1 p -72.8 122.31 21.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.932 1.293 . . . . 0.0 109.178 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.93 164.17 16.7 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 126.331 1.853 . . . . 0.0 109.173 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.75 149.9 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.07 -1.019 . . . . 0.0 108.38 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.0 128.1 32.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 p -95.81 -39.19 9.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.994 -1.479 . . . . 0.0 108.268 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 m -160.1 152.34 20.65 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.9 1.682 . . . . 0.0 111.108 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.4 mm -132.95 139.03 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.0 m -130.17 112.58 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -82.03 155.43 25.15 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.959 0.904 . . . . 0.0 109.783 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -143.75 113.73 7.24 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 106.927 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 p -90.43 170.6 10.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.638 0.654 . . . . 0.0 111.182 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -60.81 -36.25 78.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -6.67 56.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.24 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 15.8 39.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.227 -1.319 . . . . 0.0 111.28 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -71.72 101.76 2.64 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -93.44 140.11 29.95 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 p -92.7 160.95 33.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.02 160.55 49.24 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 N-CA-C 105.41 -2.573 . . . . 0.0 105.41 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.64 89.0 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.753 2.302 . . . . 0.0 107.529 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -58.83 104.23 0.22 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.633 0.773 . . . . 0.0 109.125 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.78 -145.04 16.56 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.4 111.9 12.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.395 1.478 . . . . 0.0 108.154 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -46.81 139.46 5.39 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.227 1.811 . . . . 0.0 113.948 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 178.45 7.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.254 1.422 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.33 -53.17 5.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.035 1.734 . . . . 0.0 114.066 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -65.15 108.08 1.75 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.689 1.131 . . . . 0.0 108.863 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.41 ' HE3' ' OG1' ' A' ' 79' ' ' THR . 6.1 ptmt -152.91 168.76 24.72 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 123.099 0.56 . . . . 0.0 111.318 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.31 166.99 31.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 106.994 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.46 122.06 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 117' ' ' LEU . 1.5 pt? -100.42 133.62 44.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.0 167.89 28.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.869 0.868 . . . . 0.0 111.282 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.65 168.07 10.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.694 1.197 . . . . 0.0 107.938 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.38 -27.26 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.365 2.666 . . . . 0.0 109.648 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.79 -5.47 46.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.581 2.752 . . . . 0.0 111.838 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.67 9.98 48.3 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.605 1.098 . . . . 0.0 113.153 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.01 85.98 0.89 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 124.951 1.263 . . . . 0.0 110.569 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -59.65 142.46 52.9 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.45 128.19 35.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.07 -50.54 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.54 -151.22 6.71 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.087 1.327 . . . . 0.0 109.804 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.57 169.22 18.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.165 1.483 . . . . 0.0 113.16 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -138.6 166.41 24.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.602 1.961 . . . . 0.0 106.941 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.14 125.58 2.97 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.7 -178.44 4.39 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.351 -1.088 . . . . 0.0 108.926 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -125.9 158.79 34.26 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.391 2.276 . . . . 0.0 105.993 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -116.56 -83.83 1.04 Allowed Glycine 0 CA--C 1.51 -0.271 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -107.77 -14.21 14.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.573 0.749 . . . . 0.0 110.506 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -155.43 174.2 15.58 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.883 2.473 . . . . 0.0 107.604 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 tp -75.77 131.88 40.09 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.23 0.612 . . . . 0.0 109.48 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-85 -138.45 -55.67 0.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.478 1.911 . . . . 0.0 109.47 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -107.3 108.13 19.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.4 tp -130.78 142.05 50.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.11 -178.18 35.78 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 127.11 2.29 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.04 137.48 15.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.767 1.283 . . . . 0.0 110.38 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CD2' ' HD3' ' A' ' 3' ' ' LYS . 41.7 m-85 -81.42 141.43 33.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.878 1.271 . . . . 0.0 107.835 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -137.04 127.3 26.36 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.8 124.49 13.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.636 0.653 . . . . 0.0 110.565 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 t -133.4 103.44 5.95 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 t -170.5 171.18 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.423 2.289 . . . . 0.0 106.837 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.5 m -140.76 73.81 1.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 p -134.48 163.07 53.82 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.142 1.777 . . . . 0.0 111.797 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.51 -159.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.988 2.459 . . . . 0.0 106.709 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.28 124.84 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 p -74.91 154.15 86.88 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 112.347 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.24 -173.32 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.733 2.955 . . . . 0.0 112.129 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.46 -174.1 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.687 1.995 . . . . 0.0 112.053 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -73.96 107.79 6.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -83.56 119.61 24.93 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.249 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.4 mt -78.41 -94.24 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -155.51 166.1 34.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.921 1.288 . . . . 0.0 109.826 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -147.27 -178.18 6.08 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 130.148 3.379 . . . . 0.0 107.706 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.46 141.86 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.31 1.414 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.12 -105.64 3.22 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.75 64.5 4.15 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.415 1.007 . . . . 0.0 111.172 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.444 ' H ' ' HB3' ' A' ' 288' ' ' HIS . 0.7 OUTLIER -76.01 57.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.224 2.21 . . . . 0.0 114.368 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 53.19 20.53 1.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.549 1.94 . . . . 0.0 114.912 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 168.94 33.0 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.8 m -65.43 116.77 7.07 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.844 1.657 . . . . 0.0 109.264 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.75 154.63 40.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.676 0.79 . . . . 0.0 110.44 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -138.39 120.67 15.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.29 104.95 17.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -107.66 93.06 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.558 1.143 . . . . 0.0 108.198 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.35 162.7 32.44 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.61 155.03 34.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 117.611 0.705 . . . . 0.0 110.393 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -112.99 167.61 10.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.431 1.11 . . . . 0.0 112.057 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 -15.76 57.61 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.189 2.196 . . . . 0.0 110.282 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 165.94 149.51 5.94 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.582 2.039 . . . . 0.0 108.063 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.99 129.56 44.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.44 -53.78 6.56 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -158.81 143.55 15.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.67 0.668 . . . . 0.0 110.086 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.96 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.95 158.01 44.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.983 1.313 . . . . 0.0 107.621 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.0 t -143.57 142.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.13 82.13 0.35 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 124.788 1.185 . . . . 0.0 112.683 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -70.89 177.26 3.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.908 1.283 . . . . 0.0 110.339 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.85 -174.24 20.98 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -63.7 -25.09 68.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -122.71 -21.07 5.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.266 1.427 . . . . 0.0 113.833 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 172.3 -178.78 44.28 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 119.53 1.059 . . . . 0.0 111.723 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.5 mm -59.13 115.84 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.476 1.11 . . . . 0.0 109.676 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.5 m -93.83 -35.67 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.415 0.686 . . . . 0.0 111.923 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.65 166.81 23.81 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.6 150.92 30.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.788 1.635 . . . . 0.0 107.015 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.606 ' HE2' ' CE2' ' A' ' 214' ' ' PHE . 0.1 OUTLIER 179.82 150.59 0.36 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.435 3.494 . . . . 0.0 106.594 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -153.78 152.22 30.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.561 1.073 . . . . 0.0 108.131 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -94.42 132.41 39.09 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -138.24 169.03 18.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.253 1.021 . . . . 0.0 111.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -119.8 139.13 52.81 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.075 1.35 . . . . 0.0 109.533 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -140.2 76.16 1.54 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.69 -128.03 46.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.99 10.39 0.55 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.156 1.382 . . . . 0.0 114.066 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.37 140.69 52.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.447 1.476 . . . . 0.0 109.247 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.07 89.35 2.85 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.9 mm -70.09 109.29 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 108.82 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.0 t -125.44 94.89 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.193 1.797 . . . . 0.0 106.241 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 125.6 176.4 14.52 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.438 1.494 . . . . 0.0 113.64 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.91 75.27 1.0 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.275 1.893 . . . . 0.0 110.281 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.87 155.92 29.13 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.625 -0.926 . . . . 0.0 112.33 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.6 -80.12 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.64 162.0 50.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -53.56 116.49 9.93 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 113.567 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 144.06 71.67 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.731 1.621 . . . . 0.0 108.339 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.94 135.3 42.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.488 1.115 . . . . 0.0 110.667 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 -11.09 60.55 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.094 0.558 . . . . 0.0 111.525 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.67 -31.28 69.41 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.209 1.404 . . . . 0.0 109.783 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.39 -171.43 14.63 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.606 ' CE2' ' HE2' ' A' ' 191' ' ' LYS . 13.3 m-85 -136.05 158.81 43.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -111.4 148.06 33.86 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.37 144.35 49.54 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.526 0.516 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 256' ' ' SER . 31.5 t80 -142.88 142.96 31.87 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.68 0.792 . . . . 0.0 110.959 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -92.32 124.68 36.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.409 1.484 . . . . 0.0 108.871 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.67 112.07 29.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.175 0.99 . . . . 0.0 108.749 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.06 88.48 7.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -62.63 -29.55 4.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 115.778 -2.058 . . . . 0.0 113.644 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.12 -45.01 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 123.902 2.429 . . . . 0.0 110.88 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 m -67.03 -54.0 25.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.997 1.319 . . . . 0.0 111.865 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.71 -167.66 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.599 1.96 . . . . 0.0 110.631 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -164.11 142.14 7.18 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.508 1.123 . . . . 0.0 108.976 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.7 mm -93.48 104.18 15.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.3 p -72.92 -59.76 2.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.096 0.959 . . . . 0.0 110.33 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.41 171.72 13.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.647 1.979 . . . . 0.0 111.529 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.78 148.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.39 1.876 . . . . 0.0 106.865 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -133.59 160.85 36.27 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.497 1.119 . . . . 0.0 109.997 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.78 167.37 37.69 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.671 1.129 . . . . 0.0 110.998 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.5 p -133.39 127.19 32.91 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -119.76 146.19 45.88 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -142.61 166.91 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -76.94 136.3 38.79 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.758 1.223 . . . . 0.0 112.824 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.66 156.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 127.426 2.29 . . . . 0.0 108.252 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -103.5 163.75 12.09 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.78 1.232 . . . . 0.0 111.16 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.11 -15.94 56.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.246 1.403 . . . . 0.0 110.347 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.7 t -141.45 -174.38 4.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 128.248 2.619 . . . . 0.0 106.618 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.92 101.82 5.79 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.557 1.943 . . . . 0.0 106.856 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 174.32 -173.37 45.98 Favored Glycine 0 N--CA 1.447 -0.622 0 O-C-N 123.645 0.591 . . . . 0.0 112.451 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.82 141.37 52.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.083 1.353 . . . . 0.0 109.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 10.3 tt -123.72 134.17 67.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.6 1.16 . . . . 0.0 108.773 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.06 98.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -76.0 -26.5 56.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.023 0.529 . . . . 0.0 111.766 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -140.99 152.37 44.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.083 0.856 . . . . 0.0 110.815 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.4 154.65 51.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.468 1.907 . . . . 0.0 109.965 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -145.05 152.52 40.24 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.992 2.117 . . . . 0.0 105.688 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -118.07 142.53 47.31 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -95.61 115.42 27.4 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.2 p -130.49 166.49 20.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.391 1.476 . . . . 0.0 108.776 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -123.54 160.09 27.75 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.993 1.717 . . . . 0.0 106.552 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 69.35 -27.6 0.16 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.114 2.566 . . . . 0.0 112.191 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -150.88 174.83 12.65 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.23 2.212 . . . . 0.0 110.229 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.77 161.02 32.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.579 1.952 . . . . 0.0 106.914 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.412 ' HB3' ' CE2' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -115.29 -10.99 12.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 73.15 162.66 0.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 126.908 2.083 . . . . 0.0 109.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 95.5 Cg_endo -76.28 149.0 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.438 2.092 . . . . 0.0 110.551 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.17 95.72 4.86 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 125.43 -176.99 17.15 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.275 1.416 . . . . 0.0 110.789 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.6 tp -88.18 126.83 35.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.353 1.061 . . . . 0.0 110.165 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -73.12 107.17 5.31 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -160.22 154.79 23.91 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 107.987 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 88.1 -174.82 44.27 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.9 m -77.33 138.47 39.36 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -92.14 142.81 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.317 0.508 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -138.74 147.88 43.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.767 0.827 . . . . 0.0 111.344 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.31 144.29 34.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.23 1.412 . . . . 0.0 109.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 mt -134.22 137.3 44.27 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -150.04 178.27 9.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.174 1.789 . . . . 0.0 108.905 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 164.83 29.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.22 1.01 . . . . 0.0 108.566 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -69.84 5.37 1.55 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.302 1.841 . . . . 0.0 114.354 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 166.45 -34.69 0.23 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.389 -1.444 . . . . 0.0 113.324 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -57.01 149.98 17.88 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.768 0.784 . . . . 0.0 109.331 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 157.47 16.85 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.623 -0.673 . . . . 0.0 110.041 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.6 mt -95.91 104.2 15.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.45 38.81 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.989 1.316 . . . . 0.0 108.548 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.44 168.03 36.57 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 121.166 -0.959 . . . . 0.0 114.477 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.11 171.23 14.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.335 3.054 . . . . 0.0 109.946 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -159.48 146.64 16.87 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.812 1.245 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -179.55 -163.64 30.68 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 121.217 -0.927 . . . . 0.0 113.423 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -146.68 138.97 24.88 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.822 1.649 . . . . 0.0 107.765 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -131.86 154.39 49.23 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.184 1.793 . . . . 0.0 110.055 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.3 m -166.39 -46.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.951 1.3 . . . . 0.0 108.691 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.13 -17.63 1.36 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -171.4 2.01 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.496 1.919 . . . . 0.0 106.617 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 13.3 tp -83.21 85.58 7.18 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 162' ' ' ASP . 87.6 m-70 -60.44 -34.79 74.49 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.264 0.483 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -161.47 163.33 30.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.642 0.734 . . . . 0.0 110.245 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -159.52 135.45 8.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -143.13 -157.71 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 128.538 2.97 . . . . 0.0 108.715 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.73 171.59 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.281 1.039 . . . . 0.0 112.139 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.76 150.16 51.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.874 2.869 . . . . 0.0 105.354 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.25 137.79 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.324 0.65 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 16.2 mmt -125.38 148.24 60.47 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.431 1.492 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 152.62 37.22 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.631 1.554 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.4 mp -68.44 159.81 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 6.4 m -158.69 146.36 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 13.8 t30 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 123.824 0.85 . . . . 0.0 109.336 -179.543 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -130.07 97.73 4.54 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.78 1.632 . . . . 0.0 112.727 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -81.15 130.54 35.07 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 102.633 -3.099 . . . . 0.0 102.633 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.51 103.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.687 0.795 . . . . 0.0 110.02 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -55.85 142.7 34.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.49 1.116 . . . . 0.0 110.987 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.63 179.97 1.95 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.857 1.263 . . . . 0.0 110.161 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 143.81 14.48 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.77 -134.13 5.48 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.98 -148.97 18.66 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 118.0 0.9 . . . . 0.0 111.816 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.11 8.32 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.389 1.076 . . . . 0.0 112.168 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.93 -11.51 18.1 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.089 1.595 . . . . 0.0 117.089 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.45 169.21 12.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.648 2.224 . . . . 0.0 113.766 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.55 151.7 32.32 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 97.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.923 0.783 . . . . 0.0 112.736 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -103.56 55.05 0.74 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.11 18.61 19.82 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.198 1.399 . . . . 0.0 111.981 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -151.64 119.31 6.1 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.665 0.786 . . . . 0.0 110.602 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.12 26.7 50.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.865 1.697 . . . . 0.0 115.352 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.23 -37.17 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 119.574 1.687 . . . . 0.0 114.045 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -148.03 162.58 39.08 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.398 1.079 . . . . 0.0 110.375 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -107.35 -34.12 7.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.956 2.502 . . . . 0.0 111.806 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.98 83.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 m -63.2 158.64 3.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 117.853 0.827 . . . . 0.0 109.207 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 10.5 mmm180 -136.09 -35.7 0.76 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -147.14 157.51 43.63 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 107.691 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.0 105.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -88.02 140.61 29.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.82 143.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.9 152.54 21.5 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.813 0.733 . . . . 0.0 111.335 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -70.2 120.04 15.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.216 1.406 . . . . 0.0 112.611 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.68 -122.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 130.575 3.94 . . . . 0.0 107.876 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -95.23 -48.35 5.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 118.163 0.982 . . . . 0.0 112.256 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 -26.88 12.14 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 129.109 2.963 . . . . 0.0 114.676 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.42 -158.05 16.7 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 118.897 0.771 . . . . 0.0 111.381 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 m -72.7 96.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.61 1.205 . . . . 0.0 108.846 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -106.63 -45.09 4.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -71.02 148.31 47.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.291 1.405 . . . . 0.0 112.117 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.9 159.68 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.431 1.892 . . . . 0.0 108.091 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.05 152.35 46.15 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.882 2.473 . . . . 0.0 107.458 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.52 132.06 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.658 0.783 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.6 142.96 42.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -132.76 141.38 48.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.347 0.659 . . . . 0.0 109.362 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' HB2' ' CG ' ' A' ' 24' ' ' ARG . . . -114.25 120.41 40.35 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.086 1.354 . . . . 0.0 108.751 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -113.46 161.99 16.66 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.9 -41.92 92.71 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.2 t -68.81 -69.39 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.491 -1.243 . . . . 0.0 110.574 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -145.31 165.84 27.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 120.239 1.381 . . . . 0.0 113.677 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.49 149.55 33.13 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.777 2.031 . . . . 0.0 105.804 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -147.71 145.73 18.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 122.754 1.264 . . . . 0.0 109.277 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -105.97 162.13 13.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.375 1.47 . . . . 0.0 108.688 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.63 -15.08 2.02 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 0.0 112.09 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.78 167.03 36.22 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 118.7 1.25 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -103.62 106.39 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.32 82.23 2.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.85 -174.61 31.95 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 128.7 3.048 . . . . 0.0 105.676 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -126.78 141.05 51.94 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.286 1.043 . . . . 0.0 111.908 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -130.56 148.84 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.397 2.279 . . . . 0.0 105.149 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.5 m -133.85 -48.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.2 tp -70.05 -9.99 57.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.149 0.886 . . . . 0.0 110.494 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt 66.33 11.48 7.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.209 2.203 . . . . 0.0 112.175 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.34 86.33 1.36 Allowed Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.975 -2.45 . . . . 0.0 106.975 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -131.46 144.68 51.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.505 1.922 . . . . 0.0 108.555 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -142.78 164.69 29.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.041 1.736 . . . . 0.0 110.465 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -124.88 121.22 33.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.356 1.062 . . . . 0.0 113.55 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -87.35 141.83 28.34 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.95 141.21 50.89 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.518 1.127 . . . . 0.0 109.69 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.64 117.44 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.507 1.123 . . . . 0.0 111.538 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -62.1 156.56 21.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.781 1.633 . . . . 0.0 108.591 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.33 68.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.87 25.33 10.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.37 143.06 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.19 1.396 . . . . 0.0 111.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.94 139.74 46.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.356 2.663 . . . . 0.0 110.593 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.19 134.19 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.711 1.604 . . . . 0.0 112.332 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.0 -34.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.948 -1.095 . . . . 0.0 112.1 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.63 144.35 28.34 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.432 1.015 . . . . 0.0 108.64 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.57 92.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -79.34 120.91 24.45 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.506 HG13 ' CE1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -151.77 132.61 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.531 HG21 ' HA ' ' A' ' 110' ' ' GLU . 4.1 t -110.55 153.72 24.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.979 1.711 . . . . 0.0 109.227 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -154.12 147.33 24.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.841 1.656 . . . . 0.0 109.392 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.2 169.33 22.46 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.821 0.737 . . . . 0.0 111.155 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.07 136.16 34.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.967 1.307 . . . . 0.0 109.756 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.22 130.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -61.78 114.84 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.3 41.99 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.113 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -130.49 161.47 31.38 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.192 1.496 . . . . 0.0 109.754 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -96.35 -26.48 15.35 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.768 1.227 . . . . 0.0 110.062 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 p -72.59 166.86 21.9 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.48 1.133 . . . . 0.0 109.022 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.52 135.21 42.2 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.46 166.89 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.354 1.062 . . . . 0.0 112.647 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 138' ' ' ALA . 2.9 mp -74.63 144.03 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.077 1.751 . . . . 0.0 107.445 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -108.61 -29.05 8.94 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.085 0.954 . . . . 0.0 110.849 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -166.36 164.09 17.46 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.948 1.699 . . . . 0.0 108.933 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.1 tt -157.12 154.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.999 1.319 . . . . 0.0 110.73 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 m -150.84 157.28 42.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.478 1.511 . . . . 0.0 107.235 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.86 135.33 48.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -121.33 114.05 20.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 p -81.07 161.19 24.27 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -31.12 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -58.8 -43.07 90.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 111.345 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.97 -7.4 3.8 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.814 0.721 . . . . 0.0 114.383 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.19 132.4 36.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -133.7 156.37 48.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 p -121.24 162.34 36.21 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 111.386 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.28 167.06 23.65 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.885 2.39 . . . . 0.0 110.483 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.12 112.65 3.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.663 2.909 . . . . 0.0 106.618 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -79.19 81.52 5.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.69 -138.13 9.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.372 0.987 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -129.9 121.36 26.5 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.514 1.526 . . . . 0.0 108.334 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HA ' HG21 ' A' ' 79' ' ' THR . 10.1 mm-40 -60.53 156.11 17.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.05 0.54 . . . . 0.0 110.485 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -152.7 -174.5 4.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.692 1.234 . . . . 0.0 112.683 -178.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.418 ' H ' HG22 ' A' ' 111' ' ' THR . 14.1 tt0 -67.47 -64.72 0.8 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 127.219 2.208 . . . . 0.0 112.257 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -70.98 101.83 2.27 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.432 1.493 . . . . 0.0 108.633 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -147.8 153.48 39.24 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.657 -0.652 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CE1' HG13 ' A' ' 78' ' ' VAL . 28.2 p90 -125.52 158.94 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.686 1.594 . . . . 0.0 109.857 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.9 t -140.46 104.67 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 139.45 53.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.69 150.69 1.76 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.944 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 143' ' ' PHE . 25.3 t0 -120.97 176.2 5.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.559 1.144 . . . . 0.0 110.49 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -65.27 175.8 1.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.153 2.181 . . . . 0.0 108.092 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -68.38 2.43 2.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.315 1.446 . . . . 0.0 111.743 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.45 3.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.08 2.276 . . . . 0.0 111.159 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.52 165.49 31.46 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 118.248 1.024 . . . . 0.0 111.059 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -161.9 164.69 28.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.62 1.968 . . . . 0.0 107.569 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.3 158.77 11.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.965 0.888 . . . . 0.0 110.991 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.87 -25.29 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.509 2.724 . . . . 0.0 110.722 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.38 -176.27 40.31 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.08 170.59 9.39 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.62 0.724 . . . . 0.0 109.236 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -156.41 170.13 23.01 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 126.825 2.05 . . . . 0.0 107.181 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.67 -146.42 14.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -159.47 135.68 8.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.734 2.414 . . . . 0.0 106.009 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.52 164.86 38.05 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.097 2.559 . . . . 0.0 105.298 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.36 -111.91 0.26 Allowed Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 106.616 -2.594 . . . . 0.0 106.616 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -65.06 -17.83 64.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.46 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.9 175.47 12.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.749 2.02 . . . . 0.0 108.524 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HG ' HD13 ' A' ' 91' ' ' ILE . 26.1 tp -84.8 121.48 27.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.281 1.832 . . . . 0.0 107.341 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -117.16 -31.25 5.4 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 91' ' ' ILE . . . -168.74 161.72 11.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.845 1.657 . . . . 0.0 110.353 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 tt -157.68 149.14 21.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.85 168.17 37.57 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.85 134.53 35.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.43 169.23 10.21 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.272 1.429 . . . . 0.0 109.563 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 119' ' ' ASP . 66.1 m-85 -131.17 112.11 12.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.16 138.96 42.5 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -135.55 102.8 5.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 t -160.95 155.77 23.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.866 1.267 . . . . 0.0 108.858 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.2 m -139.28 -98.14 0.16 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 22.1 p -144.52 157.14 56.33 Favored Pre-proline 0 C--N 1.318 -0.789 0 C-N-CA 125.849 1.66 . . . . 0.0 111.602 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.52 154.17 72.22 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.33 134.3 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.3 p -113.54 140.54 24.66 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.173 0.442 . . . . 0.0 110.037 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.64 4.21 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.543 2.829 . . . . 0.0 116.668 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.39 150.97 38.65 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.959 3.304 . . . . 0.0 110.933 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.12 125.28 29.62 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -111.28 146.79 36.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.778 0.717 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.78 170.84 13.73 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.5 t -87.78 118.86 27.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.271 1.028 . . . . 0.0 110.757 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.62 170.0 12.97 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.199 0.999 . . . . 0.0 111.422 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.9 mt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 129.898 3.279 . . . . 0.0 105.256 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.56 -96.05 0.16 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.593 1.088 . . . . 0.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.77 153.61 24.37 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.08 8.79 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.965 1.306 . . . . 0.0 114.192 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -122.29 106.33 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 120.965 -1.084 . . . . 0.0 110.938 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 172.43 158.11 15.86 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.1 m -66.51 119.1 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.146 0.978 . . . . 0.0 108.43 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.57 130.94 41.11 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -123.17 125.91 46.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.61 153.83 17.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.127 0.971 . . . . 0.0 110.745 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.01 135.14 19.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.48 169.74 22.71 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.48 146.62 50.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -114.75 151.37 33.86 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.97 -15.08 54.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.12 2.568 . . . . 0.0 112.179 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 177.13 177.5 46.1 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 123.793 0.711 . . . . 0.0 111.91 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.88 156.46 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.543 1.937 . . . . 0.0 107.046 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -138.38 -54.1 0.62 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.862 0.865 . . . . 0.0 109.118 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' A' ' 179' ' ' TYR . 2.3 tppt? -151.23 142.46 23.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.12 0.873 . . . . 0.0 111.57 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.71 132.75 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 177' ' ' LYS . 13.3 m-85 -136.33 108.49 7.24 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.34 131.79 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.44 67.27 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.164 1.364 . . . . 0.0 111.562 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 182' ' ' GLN . 2.8 pm0 -70.01 160.94 31.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.182 1.393 . . . . 0.0 109.376 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.01 177.85 35.41 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -51.6 -45.63 63.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.788 0.835 . . . . 0.0 112.721 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.17 -3.09 58.89 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.323 1.049 . . . . 0.0 113.511 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 123.5 -176.31 16.72 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.982 0.81 . . . . 0.0 113.662 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.0 mm -63.26 112.38 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 m -109.29 -30.91 7.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.256 0.622 . . . . 0.0 110.242 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.701 1.201 . . . . 0.0 108.891 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.88 137.0 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 107.283 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.17 155.68 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.27 131.17 27.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.1 140.67 29.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -153.19 169.55 22.72 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.964 1.306 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -127.76 127.08 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -139.95 138.53 35.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.19 31.37 49.34 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.65 -14.18 0.51 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.417 2.687 . . . . 0.0 112.794 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.44 136.19 49.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.829 1.252 . . . . 0.0 110.424 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -89.5 80.07 6.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 109.697 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.65 144.89 14.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.405 1.882 . . . . 0.0 109.694 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.06 129.04 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.71 143.3 18.71 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.48 1.038 . . . . 0.0 112.462 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.63 160.35 52.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -92.54 83.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -62.08 -25.57 67.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.211 1.805 . . . . 0.0 112.003 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.41 176.42 25.34 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.088 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.62 138.33 80.46 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.5 179.59 2.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.408 2.738 . . . . 0.0 110.408 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 70.1 p -135.61 172.69 12.65 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 109.96 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.69 -26.01 28.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.755 0.822 . . . . 0.0 110.576 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 212' ' ' LEU . 2.3 tt -63.65 -21.67 66.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.298 1.839 . . . . 0.0 112.461 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.21 171.33 46.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.59 151.3 21.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.23 0.612 . . . . 0.0 112.309 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -111.93 133.75 53.93 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.41 146.78 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -142.47 143.53 32.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.666 1.187 . . . . 0.0 109.222 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -112.33 130.12 56.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.26 107.82 17.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 125.726 1.61 . . . . 0.0 107.452 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 93.95 2.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -56.5 -34.91 29.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.94 -26.88 10.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 123.964 2.451 . . . . 0.0 113.264 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.4 m -106.91 -0.78 22.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.665 1.575 . . . . 0.0 114.798 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.8 156.8 42.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 120.337 1.426 . . . . 0.0 108.425 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.61 161.55 34.34 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.861 -1.149 . . . . 0.0 112.073 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.2 mm -92.7 97.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.2 m -64.4 -40.27 95.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.86 15.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.618 1.167 . . . . 0.0 109.368 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.16 144.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.416 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 0.8 OUTLIER -132.02 173.13 11.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.295 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 155.03 -170.82 33.26 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.8 p -144.8 154.94 43.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -131.55 145.91 51.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -121.88 145.5 48.03 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.878 0.846 . . . . 0.0 111.368 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -70.35 148.26 48.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.876 1.27 . . . . 0.0 109.486 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.5 pt -114.53 155.75 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 127.269 2.228 . . . . 0.0 106.724 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -103.59 150.33 24.06 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.86 0.362 . . . . 0.0 111.107 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.62 -3.34 87.29 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.657 1.599 . . . . 0.0 111.47 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.8 p -142.23 170.73 15.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.606 2.763 . . . . 0.0 107.742 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -108.04 8.5 28.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.672 1.189 . . . . 0.0 110.715 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -80.97 -172.04 45.57 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 122.746 1.192 . . . . 0.0 113.545 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.6 mt -137.78 157.45 46.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.895 2.478 . . . . 0.0 108.6 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.53 135.41 63.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.9 mm -94.41 77.11 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -83.1 -12.59 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.075 -0.391 . . . . 0.0 112.037 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -137.47 134.64 36.02 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 121.796 -0.565 . . . . 0.0 112.451 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.78 152.35 46.51 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.516 1.126 . . . . 0.0 109.51 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -141.32 161.61 37.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.528 1.931 . . . . 0.0 108.352 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -131.03 121.45 25.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.996 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.416 ' HE3' ' HG3' ' A' ' 230' ' ' GLU . 69.8 mttt -80.08 115.28 19.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 15.4 p -125.17 165.03 18.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.066 1.746 . . . . 0.0 108.154 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.25 160.97 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? 63.31 -26.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.511 1.925 . . . . 0.0 115.636 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -132.25 124.4 28.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 108.216 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.0 m -78.19 113.14 15.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.695 1.598 . . . . 0.0 107.735 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.1 p -84.37 162.86 19.87 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.271 0.557 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.79 152.19 42.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.144 1.778 . . . . 0.0 108.334 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.07 130.97 13.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.251 1.968 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -102.38 92.26 4.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.68 169.3 14.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.48 1.514 . . . . 0.0 110.724 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.0 mt -95.26 146.62 24.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.93 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.39 124.34 25.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.83 106.34 4.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 89.75 -164.95 31.78 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 122.978 1.321 . . . . 0.0 115.23 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 43.2 m -64.26 132.81 51.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.466 . . . . 0.0 109.992 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -85.67 145.64 27.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -126.93 137.2 53.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.795 0.807 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -124.29 140.76 52.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 72.7 mt -144.86 114.92 7.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -143.6 172.43 12.81 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.541 1.136 . . . . 0.0 110.009 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -144.41 153.85 42.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -101.74 140.09 36.5 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.358 1.063 . . . . 0.0 109.004 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.55 21.37 79.56 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -143.47 166.65 24.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.601 1.56 . . . . 0.0 109.251 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 298' ' ' THR . 34.0 pttt -129.92 174.21 9.97 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.982 2.113 . . . . 0.0 106.754 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 26.8 mt -109.01 154.31 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.24 24.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.416 1.086 . . . . 0.0 113.322 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.54 -155.05 23.95 Favored Glycine 0 N--CA 1.465 0.632 0 O-C-N 120.429 -1.419 . . . . 0.0 111.693 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 174.1 10.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.297 1.839 . . . . 0.0 111.159 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -155.66 163.27 40.13 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.715 2.406 . . . . 0.0 107.974 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.64 -169.99 36.48 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 120.78 1.627 . . . . 0.0 114.78 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 130.33 18.54 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.975 1.31 . . . . 0.0 108.488 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.95 154.49 17.68 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.303 1.841 . . . . 0.0 108.355 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.0 t -125.65 -52.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.738 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.17 -31.05 5.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.245 1.418 . . . . 0.0 113.304 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 46.3 mt -138.87 159.16 42.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.88 92.92 1.29 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.782 -0.573 . . . . 0.0 111.491 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -76.56 -78.33 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -101.0 148.61 24.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.906 1.23 . . . . 0.0 113.025 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -141.18 128.03 20.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.236 1.414 . . . . 0.0 107.216 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -144.14 176.1 23.59 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.07 176.06 5.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.251 1.02 . . . . 0.0 110.6 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -122.03 150.49 42.03 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.345 1.858 . . . . 0.0 107.172 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.06 139.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 44.2 mtt -139.77 147.27 50.84 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.49 68.98 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.132 3.221 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.1 mt 65.66 -8.56 0.29 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.478 2.711 . . . . 0.0 113.601 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.464 ' O ' ' HE2' ' A' ' 275' ' ' LYS . 4.0 p -80.94 -173.88 4.51 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.068 2.547 . . . . 0.0 110.881 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--O 1.246 0.894 0 C-N-CA 126.509 1.924 . . . . 0.0 108.868 -179.772 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -70.22 90.0 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.838 0.827 . . . . 0.0 109.213 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -144.93 138.91 27.22 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.732 2.013 . . . . 0.0 106.196 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.25 146.28 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -106.89 168.12 9.41 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB1' ' HB1' ' A' ' 138' ' ' ALA . . . -68.27 -70.88 0.24 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.993 1.317 . . . . 0.0 111.629 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 51.87 66.05 2.82 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.275 1.417 . . . . 0.0 114.911 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 138' ' ' ALA . . . -141.39 21.75 2.57 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 118.056 0.928 . . . . 0.0 113.767 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.26 171.04 19.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 127.05 2.262 . . . . 0.0 109.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.44 -0.25 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.414 1.086 . . . . 0.0 113.245 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.58 178.54 38.22 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 -175.46 27.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.136 0.874 . . . . 0.0 113.057 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.67 144.42 43.95 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.584 1.153 . . . . 0.0 108.113 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 p -65.74 95.49 0.24 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.711 1.205 . . . . 0.0 112.265 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -97.2 -79.28 0.46 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 63.63 19.77 11.88 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.55 1.14 . . . . 0.0 110.911 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.08 141.44 58.77 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.745 1.618 . . . . 0.0 109.174 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.02 106.38 0.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.9 t -134.72 95.5 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.667 1.234 . . . . 0.0 108.231 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.9 p80 30.3 47.21 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.74 2.816 . . . . 0.0 117.303 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -108.34 -38.83 5.62 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.5 165.58 33.06 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.168 1.366 . . . . 0.0 111.211 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.98 144.7 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.385 -1.068 . . . . 0.0 111.986 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -46.8 5.07 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.203 1.801 . . . . 0.0 112.881 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -138.02 163.73 30.83 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.12 144.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -136.35 141.53 43.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.93 142.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.24 114.94 1.64 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -66.44 141.84 57.78 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.39 -171.76 14.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -72.31 -48.19 44.06 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.561 0.744 . . . . 0.0 111.679 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.47 -10.51 34.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.131 1.772 . . . . 0.0 114.001 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.6 32.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.25 139.3 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -133.94 10.57 3.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -161.21 147.0 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.281 0.946 . . . . 0.0 111.673 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 155.4 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.042 1.737 . . . . 0.0 108.813 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.19 135.43 11.16 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 161.02 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.564 1.945 . . . . 0.0 111.13 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.2 t -121.87 139.95 47.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -107.94 170.41 8.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.872 0.76 . . . . 0.0 109.652 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.66 51.91 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.834 0.854 . . . . 0.0 109.978 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -116.96 166.34 12.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.498 1.119 . . . . 0.0 108.522 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.13 -3.2 15.6 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.07 -1.019 . . . . 0.0 109.746 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -108.86 -83.86 0.55 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.311 3.044 . . . . 0.0 110.641 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -133.89 159.24 41.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.975 1.71 . . . . 0.0 110.372 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.05 145.12 34.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.47 1.508 . . . . 0.0 110.295 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -144.86 146.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.044 0.938 . . . . 0.0 110.352 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.78 151.65 33.42 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.634 1.974 . . . . 0.0 109.302 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.92 -67.73 0.92 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.712 1.625 . . . . 0.0 109.905 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.7 174.88 27.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.179 1.371 . . . . 0.0 112.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.87 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.083 0.942 . . . . 0.0 109.761 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -125.04 133.11 53.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.47 -153.08 21.17 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.301 -2.72 . . . . 0.0 106.301 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -128.2 114.62 17.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.103 0.951 . . . . 0.0 112.97 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.17 134.66 49.55 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -81.28 155.62 25.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.368 1.067 . . . . 0.0 108.954 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.16 -32.8 74.67 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.575 -0.703 . . . . 0.0 111.161 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.32 26.93 7.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 110.701 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.86 96.2 0.17 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -163.05 146.05 10.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 128.954 2.902 . . . . 0.0 104.823 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -142.29 164.84 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.403 1.481 . . . . 0.0 108.856 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -144.48 103.11 3.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -108.11 140.87 40.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.056 1.743 . . . . 0.0 106.993 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.69 143.5 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 111.007 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.9 t -95.93 111.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 156.01 38.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 109.406 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.75 -27.16 61.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.172 -0.955 . . . . 0.0 111.67 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.94 13.56 27.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.555 1.942 . . . . 0.0 113.511 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.25 136.58 35.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.972 0.806 . . . . 0.0 110.332 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.452 ' CG ' ' HE2' ' A' ' 124' ' ' LYS . 12.0 m-85 -128.66 162.24 27.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.689 0.796 . . . . 0.0 110.424 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mt -75.3 150.43 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -30.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.821 1.648 . . . . 0.0 109.146 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 157.44 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.164 0.893 . . . . 0.0 108.99 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 t -139.35 139.57 38.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -128.2 116.81 20.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.54 134.64 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.8 p -113.98 157.22 22.74 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -151.03 158.69 44.43 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.429 -0.794 . . . . 0.0 109.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -160.39 168.72 24.59 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.864 1.265 . . . . 0.0 108.67 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 94.36 3.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.3 138.22 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.837 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -61.25 114.3 3.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.05 -5.22 5.7 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.852 1.215 . . . . 0.0 111.935 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -134.5 158.14 44.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.161 1.384 . . . . 0.0 107.785 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.44 22.11 15.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.342 1.857 . . . . 0.0 108.759 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 p -137.95 129.24 27.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.937 -1.102 . . . . 0.0 112.578 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.17 148.76 50.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.324 2.25 . . . . 0.0 105.131 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.93 158.46 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.1 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.3 mm -83.22 103.24 10.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.587 0.755 . . . . 0.0 109.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -66.89 -41.04 87.87 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.466 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 p -156.68 165.77 35.3 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.541 1.519 . . . . 0.0 111.75 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 151.69 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.043 0.537 . . . . 0.0 111.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.7 m -149.44 154.17 38.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 0.0 108.687 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -125.04 154.59 41.08 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.738 2.015 . . . . 0.0 107.383 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -132.22 118.24 19.27 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.9 p -99.01 159.87 14.66 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.666 0.746 . . . . 0.0 112.896 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.87 -32.74 73.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.349 1.859 . . . . 0.0 113.357 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -67.8 -11.37 58.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.008 178.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.03 49.81 3.22 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -127.69 139.69 52.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.4 p -134.76 147.53 50.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.662 0.385 . . . . 0.0 110.522 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 161.02 32.21 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 123.419 0.687 . . . . 0.0 110.673 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.33 166.6 24.15 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 122.269 1.979 . . . . 0.0 108.516 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.75 106.18 1.79 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.42 2.08 . . . . 0.0 107.502 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -75.47 85.99 2.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.1 -137.18 8.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.801 1.191 . . . . 0.0 110.379 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 tp -112.55 125.43 54.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.461 1.505 . . . . 0.0 108.985 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -64.34 143.12 58.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 m -146.07 147.34 31.49 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -52.72 -49.52 65.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.922 2.089 . . . . 0.0 110.216 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -68.3 108.25 3.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.862 1.665 . . . . 0.0 107.259 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -152.1 160.08 43.51 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.505 1.122 . . . . 0.0 108.983 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -143.08 167.72 21.43 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.449 0.7 . . . . 0.0 112.042 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.25 143.08 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.268 1.427 . . . . 0.0 107.837 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -137.85 1.95 2.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 145.01 41.99 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.824 0.85 . . . . 0.0 113.169 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.49 149.81 34.95 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.95 -35.65 64.47 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.834 -1.166 . . . . 0.0 111.866 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -69.48 -22.52 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.311 1.044 . . . . 0.0 112.508 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.67 -68.92 0.42 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.39 79.26 1.44 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 124.814 1.197 . . . . 0.0 112.348 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 72' ' ' TYR . 39.5 ttmt -63.87 127.79 32.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 tp -77.7 88.77 3.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.69 -49.58 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.32 -174.14 21.88 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -152.56 -178.03 6.6 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.757 1.223 . . . . 0.0 108.545 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.97 148.81 30.21 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.25 110.59 0.37 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.22 54.38 1.65 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.756 1.623 . . . . 0.0 108.712 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.69 120.11 26.76 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -97.61 -108.72 2.67 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.48 -29.08 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.721 1.208 . . . . 0.0 112.353 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 169.02 20.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.115 1.766 . . . . 0.0 109.138 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.71 101.06 12.94 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.73 -71.52 0.57 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HB1' ' HB1' ' A' ' 6' ' ' ALA . . . -107.18 150.08 27.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.865 0.866 . . . . 0.0 110.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -141.57 110.65 6.26 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 125.392 1.477 . . . . 0.0 108.786 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.32 170.65 14.73 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.96 165.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.13 0.572 . . . . 0.0 111.015 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -123.13 131.07 53.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.64 99.81 6.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.796 2.039 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.38 103.54 3.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -134.95 102.79 5.34 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.442 1.019 . . . . 0.0 113.505 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.6 p -157.07 143.55 18.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.119 1.767 . . . . 0.0 107.536 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.2 m -133.07 13.53 4.27 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.171 1.788 . . . . 0.0 109.98 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.442 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 12.5 p -134.69 161.42 63.79 Favored Pre-proline 0 C--O 1.241 0.638 0 O-C-N 120.546 -1.346 . . . . 0.0 107.922 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.37 151.37 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 105.973 -2.357 . . . . 0.0 105.973 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.83 124.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.3 p -128.69 156.72 77.04 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.872 1.269 . . . . 0.0 110.193 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.99 -6.05 13.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.085 1.857 . . . . 0.0 116.509 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.435 ' HA ' ' SD ' ' A' ' 295' ' ' MET . . . -119.13 156.68 29.34 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 129.408 3.083 . . . . 0.0 109.363 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -101.33 136.59 40.93 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.089 0.555 . . . . 0.0 112.463 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HE3' ' HB ' ' A' ' 148' ' ' THR . 6.2 pttt -114.45 146.92 40.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.804 1.642 . . . . 0.0 108.607 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.8 mt -116.35 171.38 7.87 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.319 1.848 . . . . 0.0 106.86 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 m -75.24 170.64 15.65 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.207 -0.933 . . . . 0.0 108.872 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.14 165.82 26.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.271 1.029 . . . . 0.0 108.643 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.6 mt -117.4 151.06 19.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.62 -67.22 0.45 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.341 -0.7 . . . . 0.0 111.357 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.39 -160.61 30.19 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.888 1.232 . . . . 0.0 110.106 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -140.6 27.78 2.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.225 1.41 . . . . 0.0 111.184 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -125.5 141.62 51.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.19 1.796 . . . . 0.0 108.647 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.71 167.1 12.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.817 2.151 . . . . 0.0 111.154 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 97.4 m -71.97 122.7 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.144 0.978 . . . . 0.0 111.484 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.11 117.23 20.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -131.54 35.87 3.8 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.227 0.611 . . . . 0.0 111.33 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.44 145.07 0.64 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.124 1.369 . . . . 0.0 114.363 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.62 111.41 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.096 2.558 . . . . 0.0 108.79 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.77 168.56 46.52 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.06 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.15 120.18 12.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -100.85 -172.16 2.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.588 0.755 . . . . 0.0 109.72 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -4.95 17.25 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.588 0.755 . . . . 0.0 111.341 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 142.78 161.11 8.65 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.822 2.153 . . . . 0.0 110.829 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.45 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.361 1.864 . . . . 0.0 108.68 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -131.54 -70.77 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -133.29 153.42 51.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.434 0.561 . . . . 0.0 112.461 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.29 141.18 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.738 2.015 . . . . 0.0 106.18 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.88 128.04 44.48 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.68 116.25 51.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.89 95.52 1.82 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -60.86 169.91 1.72 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.67 -174.11 13.81 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.33 -23.02 61.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.59 -0.805 . . . . 0.0 111.456 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -131.34 -19.28 2.79 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 179.18 -172.74 44.85 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 126.973 2.225 . . . . 0.0 107.689 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.94 124.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 120.101 1.95 . . . . 0.0 111.824 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.7 m -118.57 -20.42 8.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.685 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.77 156.63 47.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 119.568 -1.958 . . . . 0.0 111.301 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.02 151.01 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -162.68 165.48 25.64 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.77 2.428 . . . . 0.0 106.504 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -144.06 174.56 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.789 1.236 . . . . 0.0 110.305 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -129.63 113.0 14.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -102.66 155.58 18.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -128.37 138.31 52.3 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -129.2 96.23 4.26 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 70.29 -95.93 0.53 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.74 -7.09 9.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.423 1.489 . . . . 0.0 110.212 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.69 153.89 32.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.86 100.23 5.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.32 106.92 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 131.75 34.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.42 176.38 40.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.426 1.012 . . . . 0.0 111.374 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.96 172.44 14.5 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.354 1.454 . . . . 0.0 111.946 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.01 104.13 16.69 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -77.59 -34.38 53.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.096 0.959 . . . . 0.0 112.335 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -108.24 -178.46 21.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 124.774 1.178 . . . . 0.0 113.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -72.8 105.2 1.37 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.565 1.546 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.48 168.69 20.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.813 1.675 . . . . 0.0 109.47 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.6 t -137.22 161.13 37.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.657 0.783 . . . . 0.0 109.181 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.76 -15.5 63.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.561 0.744 . . . . 0.0 110.399 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -19.91 65.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.252 1.021 . . . . 0.0 109.876 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.06 -153.11 20.23 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -139.95 141.23 36.46 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.74 1.616 . . . . 0.0 107.552 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.18 151.58 23.99 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -134.92 144.38 47.44 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.938 0.79 . . . . 0.0 111.996 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -142.42 113.01 7.3 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.785 0.834 . . . . 0.0 109.29 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -73.34 141.16 47.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mt -116.15 114.3 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.908 0.776 . . . . 0.0 109.268 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.82 148.71 27.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.919 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 24.67 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.6 2.36 . . . . 0.0 116.536 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.91 -27.82 9.86 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.371 2.048 . . . . 0.0 114.144 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.2 t -128.81 -66.42 0.83 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.81 172.4 13.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.589 1.556 . . . . 0.0 108.451 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -165.94 171.4 12.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.809 1.244 . . . . 0.0 108.186 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.4 mt -87.24 152.03 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.2 p -140.43 -5.12 1.24 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -166.58 170.79 12.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.836 1.255 . . . . 0.0 107.768 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.18 141.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -132.86 151.61 52.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 129.32 3.048 . . . . 0.0 108.482 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.02 179.53 44.39 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 266' ' ' ALA . 25.5 p -137.15 142.87 42.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.642 1.221 . . . . 0.0 110.463 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.52 145.29 48.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.722 0.809 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -147.67 163.94 35.07 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 122.056 -0.403 . . . . 0.0 110.739 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.42 141.15 52.15 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.492 1.117 . . . . 0.0 113.794 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.73 155.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -111.03 141.89 43.92 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.94 -7.24 82.61 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.545 -0.722 . . . . 0.0 111.827 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 60.4 p -140.65 -172.11 3.38 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.858 2.063 . . . . 0.0 107.643 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.42 72.0 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.904 1.282 . . . . 0.0 108.706 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -163.17 178.54 38.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.873 1.225 . . . . 0.0 111.383 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.3 mt -108.44 159.61 16.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 110.58 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.0 tt -135.85 138.49 47.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.232 1.413 . . . . 0.0 109.305 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 25.0 mm -76.54 96.57 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.0 t -76.24 -16.86 59.73 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.677 -0.639 . . . . 0.0 112.313 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -156.79 138.61 14.28 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.622 1.169 . . . . 0.0 107.986 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 24.3 tp -135.49 123.91 23.39 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -109.58 172.48 6.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.984 0.914 . . . . 0.0 108.576 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -136.68 145.71 45.07 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -115.88 121.36 42.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.425 1.09 . . . . 0.0 109.027 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 p -138.66 168.14 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.344 2.258 . . . . 0.0 107.277 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.23 156.02 19.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.8 mttm 60.76 -17.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -98.97 175.3 5.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.33 1.452 . . . . 0.0 112.555 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -131.42 99.82 4.95 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 126.11 1.764 . . . . 0.0 108.186 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.1 p -80.18 160.18 25.74 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.083 0.553 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -94.53 155.85 39.14 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.22 88.98 0.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.072 2.514 . . . . 0.0 107.877 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -77.09 92.52 3.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.87 172.86 34.55 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.146 1.355 . . . . 0.0 111.797 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.84 122.97 41.58 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.552 1.541 . . . . 0.0 109.232 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -71.82 108.34 5.07 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.345 2.258 . . . . 0.0 110.139 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.78 168.32 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.973 1.309 . . . . 0.0 110.103 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 91.84 -98.43 2.42 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 98.8 m -145.08 118.85 9.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 232' ' ' THR . . . -87.71 136.03 33.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -126.27 166.03 17.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.06 0.944 . . . . 0.0 109.565 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.45 151.88 35.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.458 0.703 . . . . 0.0 109.816 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.5 mt -139.42 120.49 14.63 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.789 1.636 . . . . 0.0 107.563 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.37 152.27 18.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.166 0.894 . . . . 0.0 110.92 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.49 157.23 44.04 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.587 1.555 . . . . 0.0 108.756 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.15 143.25 34.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 65.15 28.65 73.8 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -142.49 152.73 42.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.08 2.44 . . . . 0.0 110.757 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.94 165.01 17.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.875 2.07 . . . . 0.0 107.563 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.8 mt -92.15 150.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.68 -10.55 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.81 -179.97 48.14 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.833 1.197 . . . . 0.0 110.84 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 135.71 53.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 108.204 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.71 137.37 52.44 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.47 -150.49 22.2 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.06 128.85 10.17 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.16 46.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 109.55 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 36.5 m -140.29 -67.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.442 1.097 . . . . 0.0 111.631 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.86 -64.48 1.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 119.001 0.819 . . . . 0.0 110.748 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.4 113.74 27.5 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -50.31 92.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.75 -73.84 0.31 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.525 1.13 . . . . 0.0 111.939 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -104.85 114.36 28.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.843 0.747 . . . . 0.0 112.346 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -117.87 156.77 27.84 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.655 1.582 . . . . 0.0 107.005 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -172.1 -179.66 43.16 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.5 m -138.81 146.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.58 1.19 . . . . 0.0 111.529 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.02 160.26 24.6 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 118.411 0.55 . . . . 0.0 110.885 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 153' ' ' ALA . 83.8 mmm -146.02 142.9 18.29 Favored Pre-proline 0 N--CA 1.464 0.262 0 C-N-CA 124.589 1.156 . . . . 0.0 110.784 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.59 105.77 2.09 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.824 2.349 . . . . 0.0 109.461 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.23 81.94 1.76 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.1 t -72.7 170.52 14.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 0.0 111.626 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 116.802 -1.57 . . . . 0.0 107.402 178.892 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.57 154.75 41.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.588 2.355 . . . . 0.0 110.317 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -149.05 100.94 3.11 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.223 -0.923 . . . . 0.0 112.788 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.37 142.53 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 159.7 16.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.683 0.793 . . . . 0.0 110.027 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.51 105.38 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.288 1.435 . . . . 0.0 112.512 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.09 83.23 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.02 -160.71 19.01 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 126.909 2.195 . . . . 0.0 107.657 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.86 150.23 39.66 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.02 53.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.244 1.022 . . . . 0.0 113.582 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.86 164.02 39.9 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.96 0.79 . . . . 0.0 114.59 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.37 164.85 34.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.189 1.376 . . . . 0.0 113.98 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.79 141.73 29.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.209 1.403 . . . . 0.0 107.236 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.9 123.12 22.03 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -127.33 85.7 2.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.883 1.673 . . . . 0.0 107.034 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -140.94 147.0 38.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.647 2.379 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -160.63 174.22 14.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.41 1.484 . . . . 0.0 108.534 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.11 -111.86 2.09 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 104.149 -3.58 . . . . 0.0 104.149 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t 52.37 31.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 117.777 0.789 . . . . 0.0 112.951 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -64.21 110.68 2.29 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.318 -1.489 . . . . 0.0 110.136 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -118.28 -63.6 1.39 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.928 1.291 . . . . 0.0 109.943 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.81 164.88 31.41 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -117.82 155.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 109.64 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -54.93 1.24 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -145.8 168.39 20.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 118.759 0.708 . . . . 0.0 110.622 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.144 2.578 . . . . 0.0 104.777 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -138.9 122.32 17.2 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -143.77 139.6 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.87 131.23 3.89 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -67.16 -168.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.212 1.405 . . . . 0.0 110.519 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.67 -177.32 43.23 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.88 -32.69 73.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.427 1.091 . . . . 0.0 111.507 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -105.63 8.29 33.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.259 1.824 . . . . 0.0 114.036 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.72 -168.41 12.93 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.258 -0.901 . . . . 0.0 112.836 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.36 95.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -101.94 -9.24 20.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.9 p -87.8 147.53 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 120.362 1.437 . . . . 0.0 109.524 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -145.01 158.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.44 1.096 . . . . 0.0 108.8 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -153.91 151.31 29.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.285 1.834 . . . . 0.0 107.266 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.73 119.86 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.97 121.27 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.55 158.64 16.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 48' ' ' ASP . . . -156.26 109.66 2.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -111.84 154.03 25.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -33.27 62.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.64 0.776 . . . . 0.0 112.611 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.525 1.53 . . . . 0.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -156.02 120.06 4.48 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 120.401 1.455 . . . . 0.0 107.679 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 43' ' ' ALA 0.395 0.5 OUTLIER -116.83 165.46 13.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -179.279 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.78 145.98 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.536 1.534 . . . . 0.0 111.801 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.3 139.09 37.94 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.95 -1.094 . . . . 0.0 109.377 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.35 -73.49 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.57 0.605 . . . . 0.0 111.788 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.33 171.15 17.67 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.725 1.631 . . . . 0.0 110.033 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -101.52 142.63 32.61 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.136 -0.626 . . . . 0.0 110.591 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.63 173.99 10.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.611 1.964 . . . . 0.0 109.682 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.97 -155.97 37.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -112.79 125.58 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.89 160.26 14.63 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 p -132.34 114.53 14.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.365 1.866 . . . . 0.0 108.221 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.46 -36.5 80.57 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.262 -1.524 . . . . 0.0 107.988 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -72.44 -1.88 17.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.223 2.209 . . . . 0.0 115.554 179.272 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.97 -8.87 0.23 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 120.291 1.405 . . . . 0.0 115.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.99 125.04 28.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.084 1.442 . . . . 0.0 110.88 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.01 142.01 50.76 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.486 1.915 . . . . 0.0 106.273 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.6 m -104.15 143.61 32.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 108.735 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -134.68 125.1 26.4 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.883 0.873 . . . . 0.0 109.629 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.39 143.57 29.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.618 1.567 . . . . 0.0 109.142 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.69 147.52 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.631 1.173 . . . . 0.0 109.089 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -109.91 172.62 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.936 1.294 . . . . 0.0 113.35 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -38.52 19.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.473 1.509 . . . . 0.0 110.332 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -83.19 21.05 1.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.328 1.451 . . . . 0.0 109.742 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.8 136.76 22.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 0.0 110.998 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.08 150.07 48.99 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.8 mt -79.88 147.49 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.32 -28.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.765 0.826 . . . . 0.0 110.836 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.36 155.64 41.51 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.182 0.901 . . . . 0.0 108.888 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.99 95.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.67 113.66 20.5 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.69 147.91 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 113' ' ' LYS . 39.1 m -131.74 138.73 48.74 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -150.28 167.11 27.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.136 2.974 . . . . 0.0 104.619 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.03 165.7 29.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -120.82 105.73 11.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.981 0.912 . . . . 0.0 109.277 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.85 144.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.05 108.15 1.17 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.61 6.32 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 117.874 -1.515 . . . . 0.0 113.403 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -131.56 118.87 20.7 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.119 1.96 . . . . 0.0 108.142 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.33 1.85 2.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.559 2.744 . . . . 0.0 114.138 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.7 t -147.97 135.53 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.625 -1.297 . . . . 0.0 109.04 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.16 158.33 33.39 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.92 141.11 43.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.189 1.796 . . . . 0.0 107.962 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 138' ' ' ALA . 44.1 mm -64.29 125.68 21.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.987 0.915 . . . . 0.0 110.054 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 p -104.42 -32.54 8.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.28 1.032 . . . . 0.0 109.24 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -161.05 165.6 29.48 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 120.015 1.279 . . . . 0.0 112.689 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pt -144.76 137.44 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.402 1.881 . . . . 0.0 109.928 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.7 m -132.21 114.61 14.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.197 1.799 . . . . 0.0 107.952 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -96.82 121.8 39.07 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -100.79 127.62 47.16 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.8 p -97.48 164.51 12.41 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.151 0.887 . . . . 0.0 111.756 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.94 -41.2 82.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.378 1.071 . . . . 0.0 108.934 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -68.47 -22.8 64.54 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.22 1.408 . . . . 0.0 114.608 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.56 -7.6 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 119.809 1.186 . . . . 0.0 114.186 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -74.26 147.05 42.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.49 127.11 30.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 p -80.98 149.33 66.55 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.68 158.86 48.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.138 1.892 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.47 83.46 1.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.053 2.502 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -55.89 109.31 0.56 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.59 -134.88 10.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.3 tp -139.87 138.16 35.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.537 1.135 . . . . 0.0 109.927 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 164.83 20.13 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -149.8 -167.14 2.74 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.742 -1.849 . . . . 0.0 111.609 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 111' ' ' THR . 16.9 tt0 -73.25 -59.18 2.83 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.543 1.137 . . . . 0.0 109.509 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 79' ' ' THR . 50.3 mttp -68.73 178.24 2.2 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.03 162.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.353 3.061 . . . . 0.0 108.471 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.51 149.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.344 1.058 . . . . 0.0 108.198 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 p -140.05 148.14 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -143.31 145.87 33.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.175 2.19 . . . . 0.0 106.512 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 174.68 12.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.632 1.173 . . . . 0.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 143' ' ' PHE . 5.8 p30 -110.1 147.93 32.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.596 1.158 . . . . 0.0 109.0 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -143.26 -84.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -100.42 -10.81 20.77 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.717 0.69 . . . . 0.0 110.198 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 -49.04 49.3 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.248 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.05 -133.25 2.91 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 119.267 1.533 . . . . 0.0 112.187 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -132.81 153.61 51.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.934 0.893 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.6 106.92 10.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.01 3.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.456 0.702 . . . . 0.0 111.556 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.38 178.22 46.86 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.923 0.773 . . . . 0.0 111.749 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.74 177.02 8.45 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.74 2.016 . . . . 0.0 109.735 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -146.41 148.82 32.7 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.07 92.45 0.17 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 118.254 0.479 . . . . 0.0 112.388 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -60.32 121.26 11.56 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -152.8 164.82 37.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.388 0.994 . . . . 0.0 110.595 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.56 -95.72 0.13 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.73 -23.94 56.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.047 0.424 . . . . 0.0 110.201 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.4 -179.69 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.23 2.212 . . . . 0.0 106.366 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.54 153.45 33.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.846 1.658 . . . . 0.0 108.487 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -143.93 -56.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.509 0.595 . . . . 0.0 112.007 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 91' ' ' ILE . . . -135.24 155.71 50.2 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.986 0.812 . . . . 0.0 112.592 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.11 113.21 9.24 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.21 2.204 . . . . 0.0 107.346 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.92 174.81 15.48 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 123.814 0.721 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.01 158.85 43.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 121.537 -0.978 . . . . 0.0 108.728 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.77 151.81 41.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 119' ' ' ASP . 45.4 m-85 -137.72 99.81 4.02 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.015 0.926 . . . . 0.0 109.421 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.16 148.66 45.11 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 121.605 -0.684 . . . . 0.0 110.678 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -135.98 131.5 35.13 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 m -153.6 148.15 26.18 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.1 t -145.34 151.88 39.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 p -150.77 145.11 17.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.209 1.804 . . . . 0.0 108.799 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.03 112.57 3.57 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.242 2.628 . . . . 0.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 86.5 t -135.37 155.51 37.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.2 p -128.85 160.1 65.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.015 0.926 . . . . 0.0 112.286 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.97 174.25 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.367 2.711 . . . . 0.0 112.181 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.3 -178.39 7.02 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.769 1.628 . . . . 0.0 108.736 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.65 129.38 56.67 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.152 -0.968 . . . . 0.0 109.567 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -103.97 106.78 17.4 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.88 161.54 23.74 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.4 t -84.86 111.94 20.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.94 159.77 29.71 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.721 0.408 . . . . 0.0 110.113 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -125.21 161.24 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.009 2.924 . . . . 0.0 105.949 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.94 -72.12 0.48 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.857 1.208 . . . . 0.0 113.317 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.81 -4.89 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.217 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . 0.264 0.7 OUTLIER 53.61 -3.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.156 2.982 . . . . 0.0 117.476 179.281 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.76 164.9 12.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.839 1.655 . . . . 0.0 112.769 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.51 -175.23 16.0 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 126.341 1.924 . . . . 0.0 114.195 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.37 104.22 4.3 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.033 1.733 . . . . 0.0 109.525 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.85 154.76 29.55 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.254 0.622 . . . . 0.0 110.265 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -146.57 28.29 1.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.99 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -42.71 110.42 0.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.912 1.685 . . . . 0.0 110.235 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.38 -11.37 60.45 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.3 -85.75 1.57 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.37 147.57 5.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -109.6 155.48 21.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.352 1.061 . . . . 0.0 109.548 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -76.42 -11.02 59.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.926 -1.033 . . . . 0.0 112.901 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.05 -179.94 44.07 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.21 155.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.18 1.392 . . . . 0.0 108.596 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -138.48 -74.13 0.39 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.788 1.235 . . . . 0.0 107.873 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -150.87 165.94 32.09 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.03 139.41 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -118.48 156.89 28.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.58 131.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -109.84 83.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.68 -165.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 110.682 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.02 -168.71 37.93 Favored Glycine 0 N--CA 1.447 -0.608 0 O-C-N 120.183 -1.573 . . . . 0.0 112.064 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -86.09 -45.58 11.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.23 1.412 . . . . 0.0 109.618 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.78 -15.53 51.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.528 0.731 . . . . 0.0 111.479 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.06 -154.39 24.44 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 27.7 mm -58.36 150.81 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 118.559 1.179 . . . . 0.0 108.855 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.4 t -127.65 -38.36 1.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.199 1.399 . . . . 0.0 112.822 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -136.7 161.58 35.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.137 0.881 . . . . 0.0 110.027 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.91 127.85 25.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 44.7 pttt -161.67 160.53 28.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.296 1.439 . . . . 0.0 109.49 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.48 169.13 24.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.428 0.558 . . . . 0.0 109.834 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.03 148.27 24.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.465 ' CZ ' HG21 ' A' ' 201' ' ' ILE . 1.2 p90 -151.67 165.84 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.5 92.58 2.59 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -89.2 99.44 12.43 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.36 -79.98 0.64 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.73 0.696 . . . . 0.0 111.662 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.33 -0.18 1.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.597 1.959 . . . . 0.0 111.135 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.4 102.05 7.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -77.67 67.06 3.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.295 1.438 . . . . 0.0 108.251 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.465 HG21 ' CZ ' ' A' ' 194' ' ' TYR . 36.9 mm -72.13 122.69 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.189 0.995 . . . . 0.0 113.429 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 29.0 t -127.65 150.37 33.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 127.109 2.164 . . . . 0.0 105.93 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.44 -108.98 2.77 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.862 -0.966 . . . . 0.0 111.548 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 72.38 12.47 76.83 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 116.014 1.165 . . . . 0.0 116.014 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -58.81 116.44 3.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.839 2.32 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -117.64 2.78 12.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.671 1.588 . . . . 0.0 113.993 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.01 162.41 28.57 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 120.069 -1.645 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -47.07 106.37 0.58 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.744 1.617 . . . . 0.0 110.929 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.53 135.57 26.63 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.985 2.457 . . . . 0.0 109.327 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 131.66 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 29.3 tp -56.51 -26.4 54.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 pp -55.52 -30.06 60.01 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.197 1.399 . . . . 0.0 112.186 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.72 -166.01 13.91 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.019 1.295 . . . . 0.0 110.488 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 23.5 m-85 -128.88 168.13 16.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.549 1.54 . . . . 0.0 108.232 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.75 171.6 7.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.882 2.073 . . . . 0.0 106.787 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.86 158.59 44.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.451 0.7 . . . . 0.0 112.771 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -142.74 129.67 20.63 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.943 1.697 . . . . 0.0 108.311 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.19 109.54 21.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 107.707 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.85 104.45 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -88.96 92.61 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.774 1.63 . . . . 0.0 107.556 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -57.16 -35.29 33.7 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -35.27 10.01 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 123.609 2.325 . . . . 0.0 110.093 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -75.91 -77.09 0.14 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.591 1.557 . . . . 0.0 112.021 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.18 124.71 28.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.052 2.541 . . . . 0.0 112.476 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.47 83.31 3.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 226' ' ' ILE . 0.0 OUTLIER -45.98 128.19 2.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 109.824 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -124.42 -22.96 4.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.81 171.26 18.08 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.347 1.43 . . . . 0.0 113.46 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 1.8 p -139.1 158.19 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.73 172.18 12.89 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -172.68 171.24 44.23 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.2 p -141.33 137.81 32.66 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.498 ' CD1' HD13 ' A' ' 242' ' ' LEU . 5.2 p90 -135.96 160.8 37.48 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.898 0.749 . . . . 0.0 112.14 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -145.87 168.94 19.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.153 0.981 . . . . 0.0 108.985 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -75.05 147.9 40.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.902 1.281 . . . . 0.0 110.075 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.8 mt -92.98 112.46 26.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.36 104.41 5.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 119.02 -0.52 14.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.436 1.017 . . . . 0.0 112.811 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -141.19 -174.28 3.97 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.11 80.24 1.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 172.66 -176.99 45.44 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 233' ' ' TYR . 22.1 mt -108.66 157.61 18.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -126.78 137.2 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 125.974 1.709 . . . . 0.0 109.135 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.32 130.2 36.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.277 10.3 t -112.04 -50.35 2.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 112.622 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -128.77 150.61 50.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.149 1.341 . . . . 0.0 109.619 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.4 mt -130.53 150.32 51.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.373 1.469 . . . . 0.0 110.441 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -142.97 147.64 35.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.646 1.579 . . . . 0.0 107.62 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.75 113.19 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -71.14 136.15 48.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -142.18 165.18 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.35 1.86 . . . . 0.0 106.383 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 148.15 31.69 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 -29.42 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 128.465 2.706 . . . . 0.0 115.157 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -81.22 174.42 11.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.386 2.674 . . . . 0.0 108.295 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.4 m -144.31 152.29 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 45.3 p -146.09 174.46 11.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 112.257 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -103.98 158.66 31.44 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.872 1.669 . . . . 0.0 110.576 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.05 115.09 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.224 2.616 . . . . 0.0 106.401 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -83.94 92.38 7.81 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.71 -176.99 16.57 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.229 1.395 . . . . 0.0 111.59 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.05 116.67 26.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.108 0.963 . . . . 0.0 110.066 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.78 108.86 3.59 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.419 1.088 . . . . 0.0 109.219 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -155.17 -177.31 6.44 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.287 1.035 . . . . 0.0 110.965 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 64.15 -103.47 0.73 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 126.261 1.886 . . . . 0.0 114.657 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 91.1 m -146.92 128.62 15.2 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 107.444 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -89.92 144.41 25.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 111.431 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -129.48 165.94 20.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.592 1.157 . . . . 0.0 110.039 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -143.84 146.58 33.15 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.232 1.813 . . . . 0.0 107.092 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 73.0 mt -132.0 102.01 5.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.699 1.6 . . . . 0.0 107.239 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -127.11 163.7 23.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.146 0.978 . . . . 0.0 109.061 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.75 167.44 22.28 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.365 1.466 . . . . 0.0 107.627 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -97.04 117.59 31.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.593 1.157 . . . . 0.0 113.559 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.73 67.54 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.148 -0.97 . . . . 0.0 114.623 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -107.06 164.59 12.02 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.126 1.37 . . . . 0.0 111.606 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -127.98 151.16 49.47 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.682 2.793 . . . . 0.0 105.01 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 68.7 mt -82.49 145.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.38 -5.37 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.778 0.831 . . . . 0.0 112.842 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.17 37.3 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.626 1.103 . . . . 0.0 110.684 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -128.35 156.01 43.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.888 2.875 . . . . 0.0 107.238 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -147.83 113.27 5.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -178.52 -171.56 41.95 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 154.28 46.12 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.55 -1.325 . . . . 0.0 107.838 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.3 152.48 39.98 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.6 t -163.95 113.55 1.24 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.82 11.47 2.53 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.07 2.548 . . . . 0.0 114.447 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 167.1 -179.88 0.02 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 129.433 3.093 . . . . 0.0 106.865 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.95 102.97 15.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.441 0.696 . . . . 0.0 110.172 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -82.88 -43.42 16.59 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.237 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -133.71 142.16 47.86 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.795 1.18 . . . . 0.0 112.799 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.83 149.64 35.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 176.5 -158.89 25.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.4 m -147.89 138.66 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.98 0.912 . . . . 0.0 111.661 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.96 136.92 37.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.12 149.23 24.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.32 0.581 . . . . 0.0 111.233 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 29.7 mmm -142.47 141.61 21.26 Favored Pre-proline 0 C--O 1.234 0.277 0 C-N-CA 126.988 2.115 . . . . 0.0 107.414 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.18 146.98 71.88 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.368 2.045 . . . . 0.0 108.878 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.57 153.75 41.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 22.1 m -133.66 99.63 4.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 24.4 t30 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 126.071 1.749 . . . . 0.0 108.842 179.334 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -70.47 109.68 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.394 1.078 . . . . 0.0 111.911 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -149.74 139.48 21.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 130.614 3.566 . . . . 0.0 105.166 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.36 129.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 118.931 0.787 . . . . 0.0 112.388 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.34 138.69 47.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.37 -62.52 1.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.027 0.531 . . . . 0.0 109.692 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.33 69.76 0.84 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 126.241 1.876 . . . . 0.0 109.534 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.75 -166.11 12.07 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.733 1.635 . . . . 0.0 110.075 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.29 17.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.433 1.116 . . . . 0.0 113.403 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.12 -1.13 4.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.303 1.841 . . . . 0.0 112.548 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.75 42.38 3.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 120.698 -1.251 . . . . 0.0 112.734 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.64 -154.68 6.66 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 127.095 2.283 . . . . 0.0 111.561 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.96 142.2 51.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -72.29 121.9 20.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 112.579 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -124.27 58.42 1.2 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -89.91 18.68 5.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.855 2.462 . . . . 0.0 112.277 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -148.09 160.22 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.012 -1.055 . . . . 0.0 110.913 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.98 145.27 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.274 1.893 . . . . 0.0 108.772 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.25 152.84 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.235 0.614 . . . . 0.0 109.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -63.54 -39.11 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 64.94 9.12 5.14 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 128.387 2.675 . . . . 0.0 113.891 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 63.65 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 123.515 0.579 . . . . 0.0 112.544 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -59.55 141.87 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 111.759 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 13.2 mmm180 -117.91 -32.48 4.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -150.49 160.63 43.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.36 121.1 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.558 ' CD2' HD22 ' A' ' 39' ' ' ASN . 1.2 m-70 -98.38 140.96 31.88 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 118.768 0.713 . . . . 0.0 109.557 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -143.2 145.84 22.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.04 141.83 8.59 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 146.78 35.08 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.548 1.139 . . . . 0.0 109.722 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.14 165.68 28.56 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 125.992 1.758 . . . . 0.0 109.459 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -55.72 -34.67 65.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.922 1.289 . . . . 0.0 112.327 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -94.84 -7.92 38.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.465 3.106 . . . . 0.0 113.788 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.65 -164.35 20.26 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.87 95.49 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -112.61 2.45 16.19 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.5 p -107.18 108.93 20.61 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.67 132.65 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 109.702 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.558 HD22 ' CD2' ' A' ' 27' ' ' HIS . 24.4 t30 -150.23 147.39 27.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.652 1.581 . . . . 0.0 108.562 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.0 117.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.9 t -68.22 148.23 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -128.41 126.31 40.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.275 1.398 . . . . 0.0 111.933 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB2' ' CG ' ' A' ' 24' ' ' ARG . . . -86.29 139.62 30.84 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -112.5 165.56 12.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.56 -23.48 67.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.093 -0.379 . . . . 0.0 111.234 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -104.67 -39.38 6.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.561 1.144 . . . . 0.0 113.608 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -154.81 158.22 39.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.043 1.292 . . . . 0.0 113.509 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 125.73 30.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.42 145.32 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.535 1.16 . . . . 0.0 112.361 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.5 153.3 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.057 2.143 . . . . 0.0 106.183 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.72 61.06 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 127.939 2.685 . . . . 0.0 107.703 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.6 14.51 4.18 Favored Glycine 0 N--CA 1.472 1.035 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.28 116.56 8.19 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.06 1.43 . . . . 0.0 111.404 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -126.59 82.12 2.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.26 -144.92 5.77 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.93 111.23 13.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.92 119.79 6.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 p -70.53 153.57 42.78 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.262 1.825 . . . . 0.0 111.291 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.18 -33.55 16.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.803 1.241 . . . . 0.0 109.781 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.2 mt -71.34 -14.43 62.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 123.66 0.6 . . . . 0.0 109.469 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.82 161.16 33.19 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-O 124.637 2.243 . . . . 0.0 109.659 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -123.89 157.61 33.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.529 -2.835 . . . . 0.0 109.334 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -121.78 165.19 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.767 2.427 . . . . 0.0 107.633 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -128.13 125.92 40.11 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.543 -0.723 . . . . 0.0 110.123 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -87.12 119.58 27.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.987 1.715 . . . . 0.0 107.414 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.07 141.99 35.33 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.878 0.847 . . . . 0.0 109.871 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.1 t -114.75 112.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.875 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.63 172.16 14.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.53 -59.0 2.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -74.73 -22.28 58.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -81.36 146.78 30.16 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.02 152.8 51.3 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 123.868 0.867 . . . . 0.0 110.617 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.2 mt -80.78 114.44 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.67 -31.04 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.687 0.795 . . . . 0.0 112.012 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.2 166.77 26.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.652 1.181 . . . . 0.0 108.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.46 117.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -95.14 126.16 40.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.8 146.26 29.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.81 0.844 . . . . 0.0 109.869 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 p -120.74 152.51 38.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -154.2 168.72 25.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.106 0.962 . . . . 0.0 108.517 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.19 168.96 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.2 108.41 10.32 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.793 2.037 . . . . 0.0 108.458 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.54 147.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.861 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -62.21 149.6 41.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.35 88.83 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.642 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -139.58 164.44 29.9 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.028 2.131 . . . . 0.0 106.704 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -125.02 0.71 7.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.418 1.087 . . . . 0.0 111.295 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.1 t -98.48 157.66 16.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.48 153.27 24.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -131.7 141.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 125.75 1.62 . . . . 0.0 107.802 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.42 128.53 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.8 p -104.7 -27.19 11.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.8 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.0 t -154.67 159.62 40.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.158 1.344 . . . . 0.0 109.022 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.5 mm -141.6 141.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 128.023 2.529 . . . . 0.0 106.368 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -151.12 108.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.383 1.473 . . . . 0.0 107.565 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -77.88 150.22 34.16 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -123.84 114.06 19.36 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.1 p -82.84 162.26 21.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.982 1.313 . . . . 0.0 111.409 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.2 -30.71 70.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -17.37 59.41 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.238 -0.914 . . . . 0.0 112.777 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 2.98 60.43 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 119.3 0.954 . . . . 0.0 111.132 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -79.36 89.45 4.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 147.46 26.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.089 0.555 . . . . 0.0 109.904 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.8 p -84.86 161.91 51.59 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.055 0.942 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.92 164.66 34.92 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 N-CA-C 108.586 -1.352 . . . . 0.0 108.586 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.05 109.61 2.92 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 N-CA-C 106.466 -2.167 . . . . 0.0 106.466 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 9.41 0.18 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -169.55 -170.12 33.66 Favored Glycine 0 N--CA 1.442 -0.9 0 O-C-N 120.76 -1.213 . . . . 0.0 111.427 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.3 106.03 8.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.617 0.767 . . . . 0.0 111.11 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.65 109.53 1.06 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 m -100.44 166.34 10.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.547 0.739 . . . . 0.0 110.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.39 -52.86 61.93 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.725 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -62.9 117.01 5.79 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -157.57 159.65 37.33 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -139.57 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.269 1.828 . . . . 0.0 110.556 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.82 114.29 3.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.812 1.245 . . . . 0.0 108.237 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.17 128.57 36.38 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 138.97 9.3 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.5 175.35 9.31 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.321 1.049 . . . . 0.0 110.855 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -106.96 -25.93 11.42 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.588 1.155 . . . . 0.0 110.967 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -119.98 33.63 5.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.571 1.548 . . . . 0.0 111.387 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.84 31.63 81.56 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 174.63 2.65 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.001 1.762 . . . . 0.0 114.853 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -125.68 137.0 53.83 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.601 1.16 . . . . 0.0 109.506 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.39 151.54 43.78 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 0.0 109.3 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.58 -62.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.09 164.5 32.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.1 160.43 14.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.941 0.896 . . . . 0.0 111.283 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.59 149.3 35.56 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.859 2.064 . . . . 0.0 107.04 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.83 172.51 24.43 Favored Glycine 0 C--O 1.229 -0.217 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -142.25 37.62 1.55 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.297 1.439 . . . . 0.0 107.412 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.02 111.8 20.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.645 1.178 . . . . 0.0 110.206 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.69 -101.34 0.32 Allowed Glycine 0 CA--C 1.519 0.305 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.37 -31.65 58.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.536 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.6 169.17 17.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.381 1.472 . . . . 0.0 110.745 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -75.91 88.44 2.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.715 1.206 . . . . 0.0 113.264 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.38 -32.77 16.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.03 139.73 19.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.165 0.986 . . . . 0.0 109.28 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.6 tp -158.85 113.1 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.182 1.393 . . . . 0.0 108.379 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.25 -175.94 14.78 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.436 1.493 . . . . 0.0 111.298 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -146.6 159.51 43.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.43 1.115 . . . . 0.0 111.261 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -99.39 154.99 17.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.384 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.51 118.37 21.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.807 1.243 . . . . 0.0 108.81 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.905 1.682 . . . . 0.0 108.661 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t -133.91 160.18 38.45 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.586 1.154 . . . . 0.0 109.264 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.8 m -64.46 100.9 0.39 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 t -77.12 -7.98 56.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 29.6 p -104.97 161.62 22.2 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.221 1.809 . . . . 0.0 113.932 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.97 171.97 17.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.413 2.075 . . . . 0.0 109.703 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.2 p -123.08 125.16 71.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.4 p -137.13 164.52 41.53 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.028 1.331 . . . . 0.0 110.85 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.34 6.51 5.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.391 2.727 . . . . 0.0 114.606 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.54 -173.91 0.64 Allowed 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 130.369 3.468 . . . . 0.0 112.236 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 122.09 28.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -106.0 147.56 28.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 67.9 mt -125.09 122.51 37.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.97 2.108 . . . . 0.0 107.161 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -69.15 108.39 3.59 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 127.143 2.177 . . . . 0.0 107.081 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.03 -178.58 2.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.078 0.951 . . . . 0.0 111.228 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.447 HD12 ' CE2' ' A' ' 233' ' ' TYR . 17.5 pt -108.15 156.13 8.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 108.389 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.31 -109.88 0.49 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -156.39 -162.6 11.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.989 1.757 . . . . 0.0 109.629 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -121.65 13.6 10.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.853 1.261 . . . . 0.0 111.383 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -107.65 120.77 43.14 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 112.163 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.36 -172.84 36.86 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.867 1.699 . . . . 0.0 109.506 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 m -96.3 146.21 24.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -103.08 138.37 40.01 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.582 -0.699 . . . . 0.0 110.973 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -155.74 58.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.33 104.22 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.02 -24.65 21.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.864 -0.522 . . . . 0.0 112.049 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.0 -118.71 4.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -135.42 135.66 40.78 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.353 1.577 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -91.4 170.6 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -42.62 64.78 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.58 134.01 3.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.18 156.82 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.065 1.746 . . . . 0.0 107.685 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -127.03 -64.1 1.02 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -126.3 155.31 42.17 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.512 0.597 . . . . 0.0 111.756 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -121.56 146.11 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.588 1.955 . . . . 0.0 107.255 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -137.07 146.44 45.17 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.599 0.76 . . . . 0.0 109.197 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.2 132.41 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.22 65.82 0.56 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.42 1.009 . . . . 0.0 112.404 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -78.72 176.51 9.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.375 1.07 . . . . 0.0 109.981 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.61 23.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -69.75 -20.35 63.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.683 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -115.6 -16.81 11.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.275 0.943 . . . . 0.0 113.516 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.89 30.76 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.193 0.906 . . . . 0.0 112.925 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.77 111.91 6.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.1 0.96 . . . . 0.0 108.946 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -96.02 -37.1 10.78 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.905 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.18 155.58 47.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.56 1.171 . . . . 0.0 111.777 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.51 148.16 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -168.3 142.17 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.407 1.883 . . . . 0.0 106.764 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -139.14 155.36 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -108.84 130.1 55.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -140.98 168.41 19.85 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.986 0.914 . . . . 0.0 111.741 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -147.39 133.84 19.71 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.76 1.224 . . . . 0.0 110.966 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -140.05 147.21 40.0 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.74 -100.13 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 124.657 1.122 . . . . 0.0 112.715 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.36 12.82 4.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.84 1.656 . . . . 0.0 110.881 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -127.48 110.66 12.97 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.302 1.041 . . . . 0.0 112.019 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.47 152.47 34.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.318 1.847 . . . . 0.0 107.302 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.0 mm -132.88 129.63 58.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.119 0.968 . . . . 0.0 109.534 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.22 141.5 45.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 118.34 -135.46 11.6 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.85 23.65 66.31 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.971 0.385 . . . . 0.0 112.542 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -78.75 78.98 5.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -84.7 21.49 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.582 1.153 . . . . 0.0 112.534 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.95 156.18 26.89 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 119.809 -1.807 . . . . 0.0 108.889 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -71.3 129.76 88.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.56 155.1 71.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.53 2.153 . . . . 0.0 109.084 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.5 p -98.76 173.03 7.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.953 0.901 . . . . 0.0 109.587 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 40.1 tp -75.08 -18.57 60.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.7 tt -68.3 -34.73 76.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.385 . . . . 0.0 108.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 101.78 -132.38 10.95 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -142.33 -179.67 6.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.061 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.42 158.03 43.97 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 131.414 3.885 . . . . 0.0 104.711 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.96 147.78 34.41 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.687 1.131 . . . . 0.0 113.77 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.48 32.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.741 1.217 . . . . 0.0 109.402 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.74 113.86 21.28 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.681 1.192 . . . . 0.0 107.807 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.04 103.17 9.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.58 115.74 15.56 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -56.67 -32.0 11.87 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.06 8.46 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 124.015 2.47 . . . . 0.0 113.569 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.7 m -145.45 -68.12 0.29 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.975 -1.078 . . . . 0.0 110.034 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -84.78 151.84 24.08 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 119.123 0.874 . . . . 0.0 110.095 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -143.58 168.13 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.636 1.684 . . . . 0.0 115.177 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.3 mm -109.05 124.98 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 127.742 2.417 . . . . 0.0 105.263 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 t -115.84 -15.38 11.28 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.708 1.14 . . . . 0.0 113.139 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -154.02 170.34 21.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.829 1.251 . . . . 0.0 107.913 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.91 125.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.64 170.08 8.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 157.52 -178.73 33.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.6 p -137.18 153.73 50.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.447 ' CE2' HD12 ' A' ' 159' ' ' ILE . 35.7 p90 -131.26 144.33 51.22 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.49 165.23 23.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.747 0.419 . . . . 0.0 110.12 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -95.44 148.22 22.71 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.124 1.37 . . . . 0.0 113.174 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 236' ' ' ILE . 1.5 mp -99.87 138.95 22.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -75.34 152.13 38.17 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.407 -0.808 . . . . 0.0 109.169 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.21 1.51 89.51 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.299 0.952 . . . . 0.0 112.979 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 59.3 m -140.79 179.54 6.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.493 1.517 . . . . 0.0 109.794 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -125.39 66.41 1.15 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -162.88 -177.82 36.2 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 121.548 -0.72 . . . . 0.0 112.395 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.77 167.23 22.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.056 1.742 . . . . 0.0 112.13 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.67 158.62 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.066 2.147 . . . . 0.0 109.338 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.4 mm -72.52 126.98 34.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.2 m -107.61 -31.11 8.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 111.712 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -144.65 154.65 43.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -140.74 130.44 24.24 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.941 1.697 . . . . 0.0 109.553 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -129.31 109.35 11.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.963 1.305 . . . . 0.0 107.759 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -76.64 139.81 40.73 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -121.95 114.13 20.57 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.2 p -112.19 165.32 12.26 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.138 2.575 . . . . 0.0 109.714 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -100.74 150.97 22.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 65.21 -35.11 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.415 2.286 . . . . 0.0 114.298 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -120.08 174.2 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.575 1.95 . . . . 0.0 110.113 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.0 t -125.77 148.51 49.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.7 m -115.09 -0.34 13.36 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 74.8 163.81 0.14 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.513 2.325 . . . . 0.0 113.537 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 56.5 Cg_endo -86.53 150.15 8.88 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.672 2.915 . . . . 0.0 109.674 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.94 112.13 13.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.79 176.53 26.93 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.802 1.192 . . . . 0.0 110.776 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.5 tt -97.56 118.57 34.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.606 1.163 . . . . 0.0 108.397 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -59.1 109.72 0.9 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.743 1.217 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -149.5 150.93 33.08 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.065 1.746 . . . . 0.0 106.821 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 84.11 -169.54 46.16 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 67.3 m -76.55 139.81 40.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 0.0 108.406 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -94.91 137.5 33.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.317 1.047 . . . . 0.0 109.945 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -130.61 148.3 52.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.247 1.019 . . . . 0.0 108.752 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -150.9 103.67 3.09 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 122.062 -0.399 . . . . 0.0 110.296 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.89 140.85 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.79 165.05 32.62 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.31 0.504 . . . . 0.0 112.289 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -146.28 167.48 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -132.23 137.27 47.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.7 17.78 76.86 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 118.818 0.736 . . . . 0.0 112.588 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -143.44 172.24 13.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.316 1.847 . . . . 0.0 109.175 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.461 ' HE3' ' CG1' ' A' ' 277' ' ' VAL . 0.1 OUTLIER -141.42 160.69 39.61 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.035 0.934 . . . . 0.0 109.916 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.6 mt -81.93 134.99 25.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.461 ' CG1' ' HE3' ' A' ' 275' ' ' LYS . 28.0 m -141.52 1.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.47 33.71 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 120.174 1.352 . . . . 0.0 113.385 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 290' ' ' PHE . 3.0 t80 -145.79 134.04 21.72 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.557 2.343 . . . . 0.0 107.842 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -141.54 147.39 37.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.154 2.582 . . . . 0.0 104.228 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.48 -144.62 12.71 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 149.2 29.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 122.052 0.929 . . . . 0.0 110.819 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -155.64 154.4 31.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.341 1.857 . . . . 0.0 106.797 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.2 t -146.38 -106.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.73 -23.1 60.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 119.943 1.247 . . . . 0.0 109.236 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.99 159.86 41.86 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 129.029 2.932 . . . . 0.0 108.79 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.3 tp -78.89 131.03 36.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -119.34 -32.21 4.43 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.561 -1.209 . . . . 0.0 113.001 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -140.05 125.39 18.92 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.59 1.541 . . . . 0.0 107.051 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.431 ' HA ' ' CE1' ' A' ' 279' ' ' PHE . 15.8 t80 -122.11 97.69 5.6 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.86 98.51 2.09 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 130.43 36.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -90.37 153.97 20.03 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.324 0.65 . . . . 0.0 109.81 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 18.1 m -126.43 138.11 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.1 0.96 . . . . 0.0 109.735 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 73.4 mtp -143.56 152.05 55.61 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.151 1.38 . . . . 0.0 107.667 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.24 152.98 79.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.436 2.091 . . . . 0.0 113.721 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.4 mt -75.3 111.45 10.58 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 24.4 p -74.37 177.3 6.0 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.03 0.932 . . . . 0.0 110.713 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.206 2.202 . . . . 0.0 105.895 178.787 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.536 0.207 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' H ' ' HB2' ' A' ' 144' ' ' ALA . 16.2 mm-40 -136.19 151.82 50.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.09 1.756 . . . . 0.0 108.399 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -140.05 138.66 35.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.78 136.48 44.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.36 140.76 55.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.239 0.542 . . . . 0.0 110.763 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 164.82 19.26 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.157 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.23 145.96 18.01 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.62 -175.51 18.25 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 126.202 1.858 . . . . 0.0 110.829 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.55 -163.88 7.29 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.757 1.646 . . . . 0.0 113.865 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.0 0.22 43.43 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.172 1.389 . . . . 0.0 112.287 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.86 165.61 54.78 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.05 152.48 20.04 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.318 0.961 . . . . 0.0 111.941 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.5 114.51 6.16 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m 97.32 59.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 129.794 3.238 . . . . 0.0 118.284 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.429 ' CE3' ' CB ' ' A' ' 129' ' ' HIS . 30.9 p-90 -62.55 -14.96 48.04 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.592 1.557 . . . . 0.0 113.817 175.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.87 112.96 10.49 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.8 -37.42 71.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.002 0.521 . . . . 0.0 111.762 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.67 25.36 72.87 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.71 -175.57 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 109.46 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -83.03 -173.62 4.82 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.573 -1.329 . . . . 0.0 108.178 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -93.11 99.07 11.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 28.29 1.2 Allowed Glycine 0 C--O 1.228 -0.281 0 CA-C-O 118.142 -1.366 . . . . 0.0 114.395 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.62 128.03 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 120.116 1.958 . . . . 0.0 108.452 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -114.65 -56.75 2.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.891 1.276 . . . . 0.0 110.31 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -138.87 169.48 17.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.744 2.418 . . . . 0.0 106.897 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.03 142.65 25.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -127.76 107.93 10.3 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.97 134.89 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.87 142.59 14.03 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.21 161.23 14.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.525 1.13 . . . . 0.0 110.009 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.79 -167.99 32.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 125.587 1.565 . . . . 0.0 109.291 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.02 -38.63 83.26 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.096 0.558 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.86 11.72 2.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.221 1.408 . . . . 0.0 111.335 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.5 -136.37 15.37 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.82 106.96 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -14.38 14.87 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.0 p -131.16 139.03 49.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.152 1.342 . . . . 0.0 109.61 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 mm -142.88 140.66 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 126.328 1.851 . . . . 0.0 106.263 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -154.74 140.19 17.79 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.594 1.958 . . . . 0.0 105.886 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.54 156.17 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.32 144.04 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -116.73 105.22 12.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.59 125.21 27.47 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.906 -1.122 . . . . 0.0 108.284 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.77 160.57 19.26 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.39 -8.78 14.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.038 1.335 . . . . 0.0 111.606 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -101.56 -68.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 106.863 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -154.57 165.8 35.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.59 139.2 43.51 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.29 145.89 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -112.06 153.63 26.6 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.735 -1.228 . . . . 0.0 111.031 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 -123.75 2.03 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.18 176.6 35.96 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -75.13 142.04 43.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.21 65.1 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.268 2.227 . . . . 0.0 105.702 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.7 -164.01 37.59 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.56 123.26 43.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 143.26 51.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -106.9 -177.65 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.862 0.839 . . . . 0.0 111.86 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.2 tp -89.59 -39.59 13.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.059 0.944 . . . . 0.0 108.811 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -54.34 -38.56 66.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.988 2.115 . . . . 0.0 112.786 -178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.06 163.37 27.68 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-O 124.102 1.946 . . . . 0.0 108.427 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -109.63 162.94 13.94 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 110.966 -2.617 . . . . 0.0 108.854 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 164.23 13.94 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.078 1.751 . . . . 0.0 110.512 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.6 m -119.38 99.28 6.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.099 0.959 . . . . 0.0 113.53 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -87.72 140.63 29.32 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.06 130.71 52.83 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.649 1.579 . . . . 0.0 111.992 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.8 t -115.18 110.07 30.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 124.858 1.263 . . . . 0.0 108.276 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -69.84 173.18 6.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.054 1.341 . . . . 0.0 109.734 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.3 87.55 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.858 -1.151 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.95 7.65 41.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.349 1.459 . . . . 0.0 112.883 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.64 135.6 38.34 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.84 125.67 27.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mt -75.25 121.65 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.28 -19.17 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.82 147.18 29.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.01 113.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.26 130.56 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.46 144.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.824 1.25 . . . . 0.0 107.697 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -128.19 137.15 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -146.34 148.15 32.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.48 169.36 21.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.73 0.695 . . . . 0.0 110.185 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.31 148.05 33.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.906 1.282 . . . . 0.0 110.546 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.4 161.16 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.821 1.248 . . . . 0.0 108.792 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -61.83 129.11 39.41 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.414 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.15 -10.43 70.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.158 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.46 77.3 1.76 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.295 -2.484 . . . . 0.0 104.295 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.4 -9.49 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.345 2.258 . . . . 0.0 113.336 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.54 127.32 37.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.02 1.328 . . . . 0.0 109.207 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.04 114.14 4.98 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.3 pt -110.08 151.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.349 0.977 . . . . 0.0 110.412 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 mm -66.12 109.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 108.084 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -80.1 -28.55 39.02 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.682 -0.636 . . . . 0.0 110.967 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -170.51 174.0 5.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 109.476 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.68 144.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.617 1.967 . . . . 0.0 107.28 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.5 m -138.38 104.06 5.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.236 1.414 . . . . 0.0 107.612 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -78.81 150.5 32.31 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.871 -1.143 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -137.48 120.51 16.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -109.25 164.6 12.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.866 0.841 . . . . 0.0 112.895 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -63.68 -25.39 68.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.198 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -79.56 -5.5 55.07 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.531 -0.731 . . . . 0.0 110.727 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.77 2.68 62.83 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.833 1.206 . . . . 0.0 111.307 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -67.06 135.27 53.41 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.84 109.87 10.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.8 p -75.96 156.68 84.16 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.68 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.84 165.14 33.6 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 106.814 -2.033 . . . . 0.0 106.814 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.71 108.5 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.069 2.512 . . . . 0.0 107.393 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -79.83 71.42 6.5 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.49 -130.87 3.46 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 tp -139.78 105.9 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.732 2.013 . . . . 0.0 106.649 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 1.5 mt-10 -59.52 148.56 32.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.9 OUTLIER -127.66 178.82 5.87 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 109.328 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.413 ' H ' HG22 ' A' ' 111' ' ' THR . 21.7 tt0 -62.06 -54.88 35.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.59 130.76 48.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 1.1 ptpm? -160.18 166.47 29.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -150.43 160.4 43.78 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.89 2.076 . . . . 0.0 107.01 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.68 118.83 5.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -105.82 140.06 39.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 172.51 17.28 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 126.988 2.115 . . . . 0.0 108.875 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.05 175.81 7.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.913 1.685 . . . . 0.0 111.243 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -145.75 -15.39 0.48 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.081 0.553 . . . . 0.0 111.982 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.61 1.48 6.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.307 1.443 . . . . 0.0 110.871 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.01 108.48 0.99 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.39 162.96 36.75 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -110.23 159.08 17.71 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.083 1.353 . . . . 0.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.0 tt -72.86 130.13 39.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.15 -14.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.37 47.43 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -135.69 171.71 14.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.758 1.223 . . . . 0.0 112.442 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CB ' ' CE3' ' A' ' 15' ' ' TRP . 10.7 p80 -164.37 168.65 18.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.953 1.301 . . . . 0.0 109.986 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.92 -82.33 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 170.93 86.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 C-N-CA 129.359 3.064 . . . . 0.0 108.136 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -137.16 164.59 28.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.8 -99.45 0.12 Allowed Glycine 0 C--O 1.227 -0.341 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.42 -0.19 40.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.706 0.802 . . . . 0.0 113.154 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.54 166.51 26.93 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 126.19 1.796 . . . . 0.0 106.587 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -94.49 81.89 3.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -79.41 -64.75 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.584 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.45 131.18 35.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.451 0.7 . . . . 0.0 110.697 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 tp -155.38 173.64 16.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.554 0.692 . . . . 0.0 111.059 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.78 161.61 34.38 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 127.482 2.468 . . . . 0.0 107.902 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.56 159.56 35.96 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.357 1.063 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -121.91 159.01 27.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.515 0.726 . . . . 0.0 111.237 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -135.87 97.23 3.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.465 ' HB2' ' H ' ' A' ' 2' ' ' GLN . . . -147.14 160.72 42.1 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 127.005 2.122 . . . . 0.0 111.205 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -134.95 148.34 50.0 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.964 1.306 . . . . 0.0 107.663 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -153.82 -176.98 6.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.434 1.094 . . . . 0.0 108.412 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 m -87.76 -135.02 0.09 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.036 2.135 . . . . 0.0 106.357 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.48 144.53 28.46 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 120.431 -1.418 . . . . 0.0 111.51 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.53 145.11 23.16 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.701 2.267 . . . . 0.0 107.923 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 23.3 t -145.88 158.31 12.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 64.9 p -136.76 144.94 48.91 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.327 1.051 . . . . 0.0 108.683 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -82.31 174.79 9.61 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.933 2.422 . . . . 0.0 109.627 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.93 169.24 17.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.011 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -98.38 147.53 24.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.329 0.651 . . . . 0.0 109.445 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -113.58 146.0 40.38 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -111.06 -176.4 2.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.137 0.975 . . . . 0.0 109.768 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 122.9 48.67 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.842 1.257 . . . . 0.0 110.515 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.57 177.61 8.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.252 1.421 . . . . 0.0 111.604 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.46 160.9 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 125.7 1.6 . . . . 0.0 108.096 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.77 -102.26 0.14 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 125.771 1.653 . . . . 0.0 111.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.65 -117.44 11.56 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 65.65 -25.82 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 128.875 2.87 . . . . 0.0 114.481 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -132.25 148.0 52.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.043 1.737 . . . . 0.0 108.88 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.08 176.17 15.05 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 128.212 2.815 . . . . 0.0 107.363 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.0 m -80.8 142.04 34.12 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.71 110.14 14.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.87 130.79 9.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 120.034 1.288 . . . . 0.0 113.355 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.4 148.75 23.38 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.73 -27.85 17.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.321 1.448 . . . . 0.0 109.255 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 83.24 -147.55 24.64 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.95 138.86 18.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 194' ' ' TYR . 69.1 m-85 -111.76 179.85 3.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.97 0.508 . . . . 0.0 111.849 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.96 -36.5 62.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.952 0.882 . . . . 0.0 110.361 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.24 -177.31 44.22 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 127.929 2.68 . . . . 0.0 107.504 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 20.9 m -121.94 157.79 25.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 125.989 1.716 . . . . 0.0 108.033 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -50.64 2.14 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.529 0.604 . . . . 0.0 109.591 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -140.93 140.23 34.44 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 118.791 0.723 . . . . 0.0 109.736 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.53 142.1 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -133.95 152.7 51.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.507 0.723 . . . . 0.0 109.181 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.71 144.8 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -140.42 134.54 6.54 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -141.2 174.43 10.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.921 0.867 . . . . 0.0 112.093 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.62 -172.85 13.13 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 128.591 2.996 . . . . 0.0 106.41 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -65.56 -23.75 66.93 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.044 -0.68 . . . . 0.0 110.661 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -17.58 60.65 Favored 'General case' 0 N--CA 1.451 -0.38 1 C-N-CA 132.083 4.153 . . . . 0.0 112.8 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.82 -163.04 12.37 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mm -62.38 124.12 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.09 -19.09 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.752 1.221 . . . . 0.0 113.908 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.26 150.04 47.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.458 1.026 . . . . 0.0 111.846 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.63 142.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -164.48 168.56 18.25 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.959 2.504 . . . . 0.0 106.565 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.14 175.5 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.34 128.77 38.39 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.427 ' CE2' ' CD1' ' A' ' 172' ' ' TYR . 20.0 p90 -153.26 168.32 26.4 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.991 0.917 . . . . 0.0 110.236 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -115.91 149.32 38.9 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.615 1.566 . . . . 0.0 109.567 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -125.93 123.87 39.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 60.83 -98.83 0.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.36 18.29 5.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 112.293 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -130.51 125.09 33.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.977 0.911 . . . . 0.0 111.281 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -75.76 153.43 37.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.464 1.106 . . . . 0.0 108.582 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 194' ' ' TYR . 12.7 mt -127.03 136.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.684 1.594 . . . . 0.0 107.147 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.21 128.66 72.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 149.07 -120.98 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.12 -10.26 8.08 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.025 1.774 . . . . 0.0 113.799 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.53 132.34 48.35 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.241 1.52 . . . . 0.0 109.786 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -154.93 -40.85 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.578 0.751 . . . . 0.0 112.258 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.99 151.11 36.68 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 107.314 -2.315 . . . . 0.0 107.314 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -37.79 99.59 0.19 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.529 2.331 . . . . 0.0 114.775 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.29 151.55 54.52 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.9 m -122.97 152.64 40.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.01 -11.56 40.43 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.854 -0.529 . . . . 0.0 111.172 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.77 -24.97 67.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.29 1.836 . . . . 0.0 109.497 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.21 -156.77 17.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -139.52 152.97 47.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 106.21 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.19 154.16 21.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.63 157.07 44.37 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.899 0.48 . . . . 0.0 112.134 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -142.58 139.94 31.54 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.235 1.014 . . . . 0.0 110.606 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.65 125.98 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.77 110.59 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.94 89.18 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -36.16 -52.69 1.65 Allowed Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.89 -14.39 15.47 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.32 2.013 . . . . 0.0 114.515 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -93.66 -40.71 10.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.663 1.574 . . . . 0.0 109.404 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -92.19 172.25 8.54 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 107.418 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -146.42 -20.32 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.797 -1.189 . . . . 0.0 112.325 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp 49.88 88.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 127.922 2.489 . . . . 0.0 109.036 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.0 p -90.13 -4.46 57.29 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.76 163.13 34.89 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.16 153.28 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.267 1.427 . . . . 0.0 107.49 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.4 178.22 7.09 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.196 1.798 . . . . 0.0 109.776 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.49 -179.54 40.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 262' ' ' GLU . 18.6 p -141.08 141.13 34.28 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -134.87 153.26 52.12 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.951 0.5 . . . . 0.0 111.751 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.439 ' OD1' ' HE2' ' A' ' 235' ' ' LYS . 2.6 t0 -136.29 170.91 15.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.202 1.001 . . . . 0.0 109.558 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.439 ' HE2' ' OD1' ' A' ' 234' ' ' ASP . 0.0 OUTLIER -88.55 147.98 24.33 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.88 1.272 . . . . 0.0 112.732 -178.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.62 117.47 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -63.01 145.09 56.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 79.29 1.5 86.0 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.283 -0.731 . . . . 0.0 112.729 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 m -138.17 -177.5 4.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.995 2.118 . . . . 0.0 108.511 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.8 87.74 2.31 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.54 -176.25 39.26 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.022 -1.049 . . . . 0.0 111.012 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.69 149.66 49.43 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.081 0.952 . . . . 0.0 111.276 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.7 tt -134.18 130.5 54.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.962 1.705 . . . . 0.0 106.792 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.31 128.72 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.4 t -111.84 -18.79 12.62 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.723 1.209 . . . . 0.0 111.827 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -144.61 154.52 42.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.905 0.482 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.36 143.17 30.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.272 1.829 . . . . 0.0 109.195 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -142.79 153.78 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -128.54 113.48 15.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -77.89 113.71 16.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 p -98.24 164.76 12.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.924 2.089 . . . . 0.0 108.559 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -112.65 147.26 37.11 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 57.86 11.34 1.36 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -155.5 147.64 23.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.074 1.749 . . . . 0.0 106.934 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.5 p -113.14 100.24 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.438 1.495 . . . . 0.0 108.619 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -65.38 161.55 19.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.365 2.266 . . . . 0.0 114.441 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -105.2 163.1 17.84 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 127.186 2.195 . . . . 0.0 111.067 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.39 159.28 29.33 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.831 2.354 . . . . 0.0 110.415 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -137.3 110.91 8.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.96 -167.01 15.81 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 118.731 0.696 . . . . 0.0 112.417 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.48 110.6 23.0 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.906 1.283 . . . . 0.0 109.581 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 232' ' ' THR . 48.2 tt0 -66.02 108.75 2.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.425 1.49 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.9 28.64 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.058 1.343 . . . . 0.0 109.529 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.88 -164.81 50.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 122.548 1.082 . . . . 0.0 114.236 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 59.7 m -64.54 108.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.199 2.2 . . . . 0.0 109.095 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.75 142.31 38.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -141.45 170.95 14.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.391 1.091 . . . . 0.0 111.234 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.43 155.47 39.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.427 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.95 154.78 48.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -170.45 173.07 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.567 1.147 . . . . 0.0 107.911 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -139.47 165.94 25.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -43.77 71.48 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.845 0.748 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -161.03 72.23 0.22 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-O 118.995 -0.892 . . . . 0.0 111.835 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -151.05 158.03 43.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.325 1.063 . . . . 0.0 109.742 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -88.82 177.11 6.79 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.025 1.73 . . . . 0.0 108.717 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 37.8 mt -125.0 111.33 27.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.997 1.319 . . . . 0.0 108.608 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.27 93.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.255 2.222 . . . . 0.0 108.967 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.77 6.19 Favored Glycine 0 N--CA 1.468 0.771 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -120.6 135.65 55.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.224 1.809 . . . . 0.0 111.347 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -133.04 136.73 46.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 161.51 -159.93 31.76 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.926 -1.109 . . . . 0.0 112.64 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -137.21 127.4 26.22 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.21 154.68 19.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.94 1.296 . . . . 0.0 109.278 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 37.0 t -147.04 -98.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.71 -21.26 44.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.247 1.019 . . . . 0.0 111.456 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.3 mp -136.21 153.11 51.33 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.13 83.77 4.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.616 0.766 . . . . 0.0 111.225 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -78.94 -22.11 46.22 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.425 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.44 152.62 50.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.876 1.216 . . . . 0.0 113.12 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -162.69 134.9 5.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -158.82 169.67 35.18 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 135.15 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.852 0.826 . . . . 0.0 111.565 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -74.78 145.11 43.21 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.63 136.02 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.522 0.677 . . . . 0.0 110.548 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 70.3 mtp -138.62 137.06 19.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 129.372 3.069 . . . . 0.0 106.287 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.36 165.81 30.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.765 . . . . 0.0 109.589 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.55 -55.37 15.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 175.54 5.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.867 0.867 . . . . 0.0 111.388 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 126.733 2.013 . . . . 0.0 108.197 178.091 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -68.58 134.31 49.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -142.15 102.88 4.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.201 0.6 . . . . 0.0 109.886 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t -75.52 143.29 13.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -97.23 134.62 40.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.524 1.53 . . . . 0.0 111.587 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.29 167.63 19.05 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.762 1.225 . . . . 0.0 111.687 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.3 163.51 30.66 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.568 2.032 . . . . 0.0 108.562 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.08 -109.08 0.41 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 107.053 -2.419 . . . . 0.0 107.053 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.3 -171.43 15.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 125.318 1.437 . . . . 0.0 109.628 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.34 91.72 2.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.482 0.713 . . . . 0.0 110.253 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.59 18.77 3.01 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.167 1.365 . . . . 0.0 112.231 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.88 -177.73 16.5 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.724 1.262 . . . . 0.0 113.054 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.99 158.43 27.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.752 1.263 . . . . 0.0 111.616 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 p -63.29 131.96 50.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -134.41 -19.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.212 1.005 . . . . 0.0 110.64 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.85 100.71 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.5 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.46 1.504 . . . . 0.0 107.727 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -149.23 -163.2 10.83 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.058 1.313 . . . . 0.0 109.918 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.48 156.91 20.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.641 0.776 . . . . 0.0 109.822 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -137.63 -34.7 0.68 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.67 1.188 . . . . 0.0 109.454 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.3 p30 58.61 8.9 0.97 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.016 2.527 . . . . 0.0 114.756 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.69 5.68 68.6 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.514 1.53 . . . . 0.0 114.105 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.45 155.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.738 . . . . 0.0 108.978 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ttt-85 -130.86 -32.58 1.64 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -138.9 167.95 20.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.225 1.01 . . . . 0.0 109.555 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -139.46 85.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -87.83 135.29 33.46 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.88 148.62 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 127.473 2.309 . . . . 0.0 106.861 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.44 -157.87 10.65 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -134.08 164.2 27.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.732 0.766 . . . . 0.0 110.005 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.25 37.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 129.059 3.218 . . . . 0.0 105.97 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -91.68 -32.66 15.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.168 0.484 . . . . 0.0 110.131 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -101.11 -23.61 14.44 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 130.989 3.715 . . . . 0.0 114.094 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.56 -165.78 38.33 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.639 1.563 . . . . 0.0 112.97 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.71 96.07 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 107.956 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -75.54 -21.55 57.83 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -128.44 139.62 52.25 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.926 1.694 . . . . 0.0 113.728 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -145.28 154.01 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -140.4 137.99 34.43 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.89 159.07 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.489 1.041 . . . . 0.0 112.206 -178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.01 135.84 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -124.85 104.64 8.73 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.21 110.86 17.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.87 1.268 . . . . 0.0 108.852 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -116.74 139.55 50.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 61.54 -161.29 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.914 1.286 . . . . 0.0 109.176 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -73.07 24.78 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.246 1.418 . . . . 0.0 112.131 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -141.03 165.42 27.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.468 1.907 . . . . 0.0 111.34 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -107.84 140.25 41.21 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.81 133.73 48.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -66.95 129.02 38.54 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.45 -60.2 4.86 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.24 167.73 14.21 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -118.99 85.71 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.504 1.922 . . . . 0.0 107.561 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -83.83 170.41 14.14 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.871 0.843 . . . . 0.0 109.637 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.78 -166.12 42.79 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.479 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -111.33 102.72 11.09 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.801 1.241 . . . . 0.0 109.063 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -61.04 134.05 56.68 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 p -134.31 111.86 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.152 1.381 . . . . 0.0 109.566 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -8.24 13.37 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.08 -4.82 43.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.435 0.694 . . . . 0.0 111.692 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.89 110.46 0.28 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.68 143.15 19.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.064 2.946 . . . . 0.0 106.267 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.4 164.14 30.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.528 1.931 . . . . 0.0 110.876 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.3 m -128.03 128.5 45.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.774 1.63 . . . . 0.0 108.665 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -137.18 136.11 37.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.65 142.07 51.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.889 0.876 . . . . 0.0 109.144 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.4 t -98.34 110.5 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.73 161.36 30.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 109.137 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.97 -27.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -28.66 28.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -112.03 146.95 37.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -132.98 157.07 46.09 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.441 0.696 . . . . 0.0 109.783 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.29 138.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.34 -20.77 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.261 1.424 . . . . 0.0 111.851 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.0 156.31 42.51 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.349 -0.845 . . . . 0.0 109.346 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.71 100.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -86.31 122.49 30.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 101.353 -3.573 . . . . 0.0 101.353 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 115' ' ' PHE . 2.3 p -139.09 153.91 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 110' ' ' GLU . 9.8 t -136.52 151.91 49.94 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.048 1.739 . . . . 0.0 107.108 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.29 166.28 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.444 1.098 . . . . 0.0 110.409 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.19 169.17 22.79 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.769 1.168 . . . . 0.0 111.507 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -115.07 151.45 34.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.844 2.058 . . . . 0.0 110.71 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.34 126.91 74.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.28 121.9 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 108.745 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 -3.19 26.91 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.532 1.063 . . . . 0.0 112.183 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -132.13 144.82 50.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.369 1.467 . . . . 0.0 107.617 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.89 -21.5 23.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.22 0.608 . . . . 0.0 109.516 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -67.59 -177.65 0.78 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.373 1.559 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.39 151.59 34.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.52 144.73 28.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.34 0.656 . . . . 0.0 109.846 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.35 122.34 20.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -89.71 -28.99 19.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.041 0.936 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 t -163.11 160.87 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.448 1.476 . . . . 0.0 110.644 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.82 129.11 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 126.56 1.944 . . . . 0.0 108.55 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -135.49 101.45 4.81 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.115 1.366 . . . . 0.0 109.083 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -80.85 154.45 27.1 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.591 -1.318 . . . . 0.0 108.624 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.55 125.39 27.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.7 p -93.69 167.16 11.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.148 0.975 . . . . 0.0 111.668 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -65.94 -21.97 66.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -7.07 52.74 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.295 1.038 . . . . 0.0 111.686 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.6 -4.08 75.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 125.534 1.54 . . . . 0.0 111.587 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -79.35 149.59 31.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 118.492 1.146 . . . . 0.0 108.404 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.7 p -134.3 135.73 43.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.68 163.39 61.26 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.18 162.3 42.09 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.39 101.68 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.35 2.7 . . . . 0.0 108.546 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -73.45 78.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 145.48 -135.3 5.89 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.6 tp -139.43 127.91 22.95 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 127.06 2.144 . . . . 0.0 107.386 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.741 ' HA ' HG21 ' A' ' 79' ' ' THR . 1.1 tt0 -69.47 155.5 40.36 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.217 0.917 . . . . 0.0 110.917 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -142.45 164.51 29.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.068 0.947 . . . . 0.0 108.909 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -60.98 -40.89 95.2 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -70.43 112.14 6.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -155.17 160.23 40.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.197 -0.94 . . . . 0.0 111.327 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.424 ' CD1' HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -155.92 165.81 35.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.607 0.763 . . . . 0.0 112.133 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.53 150.26 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.977 1.711 . . . . 0.0 106.454 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 mt -111.7 4.47 18.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -47.09 117.99 1.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.466 1.106 . . . . 0.0 112.975 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -73.32 175.91 6.46 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.004 1.722 . . . . 0.0 108.298 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.67 -11.41 8.64 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.015 -1.053 . . . . 0.0 112.684 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -78.57 -5.97 54.24 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.43 24.63 25.79 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.318 -0.712 . . . . 0.0 112.082 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.25 175.4 11.39 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.584 1.564 . . . . 0.0 112.86 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -132.45 152.84 51.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.82 141.11 58.4 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.45 -33.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.54 -169.5 35.96 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 120.601 -1.312 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 0.4 OUTLIER -134.14 172.74 12.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.614 1.566 . . . . 0.0 111.205 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -164.99 149.39 9.02 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 127.955 2.502 . . . . 0.0 105.862 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.14 115.86 0.41 Allowed Glycine 0 C--O 1.221 -0.718 0 C-N-CA 119.616 -1.278 . . . . 0.0 116.001 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -48.97 110.96 0.41 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.533 1.533 . . . . 0.0 107.664 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.22 25.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.878 1.671 . . . . 0.0 108.53 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -168.93 -97.77 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -81.89 -8.19 59.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.16 24.5 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.648 1.979 . . . . 0.0 108.545 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.78 93.98 9.65 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.17 -72.99 0.27 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.992 0.917 . . . . 0.0 111.092 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.2 143.8 38.14 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.296 1.039 . . . . 0.0 109.953 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.7 tp -134.67 115.49 13.85 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.291 1.037 . . . . 0.0 109.641 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -130.87 174.31 19.9 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.158 1.361 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . . . -150.4 175.43 11.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.617 0.767 . . . . 0.0 110.473 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -117.15 133.54 55.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -126.56 99.32 5.76 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 128.017 2.527 . . . . 0.0 108.581 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.6 162.68 36.93 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.544 1.138 . . . . 0.0 108.666 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.257 1.8 t -134.56 166.39 23.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.876 -0.515 . . . . 0.0 110.994 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 9.23 3.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.158 2.183 . . . . 0.0 109.839 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.0 p -64.37 89.1 0.06 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 126.24 1.816 . . . . 0.0 110.776 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 29.0 p -147.57 154.42 44.7 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.271 1.428 . . . . 0.0 107.511 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.95 162.74 38.5 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.14 1.893 . . . . 0.0 110.868 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.17 124.86 29.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.351 1.06 . . . . 0.0 108.185 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.0 p -136.67 157.29 75.34 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.323 0.649 . . . . 0.0 111.156 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.52 -173.07 1.65 Allowed 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.445 4.096 . . . . 0.0 112.714 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.43 -179.5 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.561 1.545 . . . . 0.0 112.231 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -145.76 151.51 38.09 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.484 1.513 . . . . 0.0 108.729 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -112.18 133.66 54.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.227 2.211 . . . . 0.0 106.642 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.99 -173.94 3.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.24 1.016 . . . . 0.0 109.332 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 128.46 44.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -121.19 -179.87 4.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.885 1.274 . . . . 0.0 109.59 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.92 146.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.639 1.176 . . . . 0.0 107.904 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.85 -94.31 0.11 Allowed Glycine 0 C--O 1.228 -0.273 0 C-N-CA 124.979 1.276 . . . . 0.0 110.414 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.57 -157.44 19.19 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' CA ' ' HE2' ' A' ' 282' ' ' LYS . 6.7 p-10 -116.83 -4.68 11.57 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.867 1.667 . . . . 0.0 111.47 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.37 112.27 11.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.137 2.175 . . . . 0.0 111.669 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.58 161.94 10.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 124.807 1.194 . . . . 0.0 111.729 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.2 m -81.76 142.39 32.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.63 138.05 56.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -125.7 32.36 5.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.16 104.77 3.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -83.79 -50.27 8.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.689 0.795 . . . . 0.0 111.455 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.66 -123.32 1.85 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.25 160.94 43.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.878 2.071 . . . . 0.0 107.865 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.93 163.66 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.196 0.998 . . . . 0.0 109.826 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.27 -32.4 72.54 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.57 102.97 0.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.299 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.5 m -71.25 152.29 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -40.95 5.29 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -140.71 153.17 45.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.674 1.124 . . . . 0.0 108.402 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.24 143.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -126.65 164.18 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.416 0.687 . . . . 0.0 112.551 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 259' ' ' PHE . 3.6 t -131.51 128.02 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.47 89.4 0.38 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.928 1.728 . . . . 0.0 111.626 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -74.8 -177.9 3.46 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.893 1.33 . . . . 0.0 112.916 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.08 177.13 35.77 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 128.488 2.947 . . . . 0.0 107.603 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -62.53 -45.83 91.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.261 0.625 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.81 -32.54 57.69 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.336 1.455 . . . . 0.0 110.294 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.55 -168.09 32.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 121.996 0.776 . . . . 0.0 111.321 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.76 119.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.9 m -108.22 -29.08 9.1 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.52 25.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.595 0.758 . . . . 0.0 109.766 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.53 141.7 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 58.8 pttt -161.39 159.08 27.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.091 0.957 . . . . 0.0 110.256 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.84 174.35 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 108.11 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.95 147.34 33.63 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.343 1.857 . . . . 0.0 108.035 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 196' ' ' LYS . 7.7 t80 -147.45 153.52 39.68 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -128.09 92.21 3.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.531 2.332 . . . . 0.0 105.803 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 19.4 ptmt -89.19 139.72 30.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 49.85 46.4 40.18 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.457 1.027 . . . . 0.0 112.15 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.67 3.88 0.67 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.277 1.831 . . . . 0.0 115.562 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.17 -158.53 0.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.307 1.443 . . . . 0.0 107.312 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -136.73 139.0 41.57 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.376 1.444 . . . . 0.0 110.635 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.8 mt -125.5 122.91 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.806 1.642 . . . . 0.0 107.22 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 27.8 t -112.41 134.86 53.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.98 -119.37 3.28 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.49 5.69 66.81 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.242 1.401 . . . . 0.0 114.002 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.36 118.78 11.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.472 1.509 . . . . 0.0 111.34 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -123.14 13.16 9.65 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 0.0 111.344 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.53 -178.53 21.98 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.744 1.64 . . . . 0.0 109.229 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -106.16 102.8 41.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.065 0.932 . . . . 0.0 110.945 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.18 -175.36 2.67 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.671 2.247 . . . . 0.0 108.427 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.1 p -116.18 174.18 6.19 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.52 -9.39 34.29 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.308 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.74 -27.71 68.14 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.965 0.802 . . . . 0.0 110.371 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.23 -155.51 17.0 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.442 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 41.6 m-85 -134.1 172.18 13.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.435 1.494 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.67 160.8 31.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.49 2.716 . . . . 0.0 105.686 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -137.59 153.61 49.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.307 0.643 . . . . 0.0 111.709 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 256' ' ' SER . 27.7 t80 -142.66 143.05 32.18 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.06 0.944 . . . . 0.0 110.228 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -78.52 115.3 18.13 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.761 1.625 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.36 104.25 11.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -105.75 88.15 2.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -55.29 -33.46 17.63 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.083 -1.436 . . . . 0.0 114.695 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.4 -3.26 12.08 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 CA-C-N 123.585 2.316 . . . . 0.0 111.991 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m -132.44 -8.18 3.29 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 113.31 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -140.47 159.94 41.09 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.525 1.93 . . . . 0.0 110.542 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -144.25 119.93 10.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.422 1.089 . . . . 0.0 109.136 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.58 HG22 HD12 ' A' ' 276' ' ' ILE . 89.3 mt -81.88 94.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -24.16 45.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.22 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -146.72 167.8 22.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.167 0.987 . . . . 0.0 111.362 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.74 150.45 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.906 1.682 . . . . 0.0 106.481 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.444 ' OE1' ' HE3' ' A' ' 250' ' ' LYS . 36.6 mt-10 -132.87 160.44 36.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.398 1.079 . . . . 0.0 108.247 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -177.82 164.74 33.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.6 p -130.9 148.96 52.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -142.34 146.83 35.42 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.548 0.739 . . . . 0.0 109.863 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -130.57 155.2 46.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -69.55 147.11 51.22 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.139 0.976 . . . . 0.0 112.358 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.99 115.9 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -52.64 133.54 36.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.278 0.561 . . . . 0.0 110.522 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.58 82.99 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.389 -1.228 . . . . 0.0 113.086 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.8 t -140.81 169.89 16.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.389 1.595 . . . . 0.0 109.391 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.51 -12.17 38.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.533 1.533 . . . . 0.0 108.183 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -74.08 175.65 47.82 Favored Glycine 0 C--N 1.345 1.062 0 C-N-CA 127.195 2.331 . . . . 0.0 112.16 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 242' ' ' LEU . 0.0 OUTLIER -149.02 169.67 20.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 111.883 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.25 143.74 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.688 1.595 . . . . 0.0 108.467 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -91.38 105.9 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.329 1.0 OUTLIER -104.11 -3.81 24.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.606 0.639 . . . . 0.0 112.165 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -149.52 143.55 25.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.036 -1.04 . . . . 0.0 111.568 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.9 mt -137.49 154.79 49.82 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.999 1.72 . . . . 0.0 111.031 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -142.48 170.84 14.96 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.494 2.317 . . . . 0.0 109.003 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -148.21 113.76 5.65 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.674 1.19 . . . . 0.0 109.406 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.444 ' HE3' ' OE1' ' A' ' 230' ' ' GLU . 67.1 mttt -77.05 114.47 15.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 5.2 p -109.9 165.84 11.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 127.059 2.144 . . . . 0.0 108.272 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -116.95 140.37 49.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 63.17 -8.29 0.14 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.306 1.442 . . . . 0.0 113.739 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -117.07 169.01 9.75 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.735 2.014 . . . . 0.0 107.852 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -130.98 108.16 9.6 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 123.622 0.769 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' SER . . . . . 0.403 ' HA ' ' CE1' ' A' ' 217' ' ' PHE . 4.5 p -79.82 -178.13 6.27 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.825 1.25 . . . . 0.0 109.411 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.87 69.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.12 0.968 . . . . 0.0 110.034 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.97 101.92 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.057 2.504 . . . . 0.0 109.357 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 180' ' ' VAL . 91.7 m-85 -79.48 95.45 5.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 122.12 -169.64 14.88 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.7 122.32 47.31 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.129 0.972 . . . . 0.0 109.099 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.42 113.26 2.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.864 1.666 . . . . 0.0 110.509 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -154.99 149.0 25.78 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.347 1.459 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 74.89 -165.15 54.72 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 121.869 0.705 . . . . 0.0 114.171 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 21.8 m -62.97 137.97 58.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.523 1.929 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -108.59 121.71 45.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.54 43.21 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.56 0.744 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.97 130.45 43.42 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.602 1.961 . . . . 0.0 107.302 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.8 mt -119.22 129.74 55.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -149.38 171.35 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -138.4 147.09 42.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.17 -4.67 30.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.295 1.438 . . . . 0.0 114.851 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -167.72 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -92.57 168.1 11.48 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.854 1.827 . . . . 0.0 110.698 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.49 162.75 13.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.717 2.007 . . . . 0.0 110.387 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.58 HD12 HG22 ' A' ' 226' ' ' ILE . 21.6 mt -88.64 112.57 24.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.507 1.123 . . . . 0.0 108.892 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.37 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.26 153.12 8.93 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 125.383 1.468 . . . . 0.0 111.946 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -121.86 160.21 25.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.909 2.084 . . . . 0.0 108.779 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -159.29 176.89 11.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.615 0.766 . . . . 0.0 110.262 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 119.12 -111.29 2.05 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 126.549 2.023 . . . . 0.0 108.665 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.451 ' HE2' ' CA ' ' A' ' 162' ' ' ASP . 10.1 mtmp? -146.26 153.55 40.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.854 . . . . 0.0 112.498 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.92 131.22 34.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.132 1.773 . . . . 0.0 107.064 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.8 p -171.6 75.29 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 67.33 -70.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.873 2.469 . . . . 0.0 110.356 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 70.2 mt -81.33 172.56 13.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.217 2.207 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.7 tp -94.51 64.35 3.06 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.206 1.402 . . . . 0.0 109.688 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -61.4 -17.62 54.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -153.55 165.87 34.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -160.5 122.81 3.23 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -155.81 163.61 31.84 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.1 m -133.84 152.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.014 0.907 . . . . 0.0 113.116 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -85.25 167.71 15.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.969 1.708 . . . . 0.0 111.156 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.95 148.3 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.936 1.694 . . . . 0.0 109.092 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 92.1 mmm -152.99 149.07 21.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.634 1.973 . . . . 0.0 107.729 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.76 157.95 54.24 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.813 1.676 . . . . 0.0 110.037 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.41 29.51 1.26 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.341 1.056 . . . . 0.0 108.565 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.3 m -141.28 164.35 30.47 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.254 2.222 . . . . 0.0 105.585 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 C--O 1.247 0.936 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 179.215 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 C--O 1.237 0.44 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -148.56 102.35 3.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.049 0.94 . . . . 0.0 108.889 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.5 t -77.0 146.47 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 123.803 0.841 . . . . 0.0 109.209 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.96 148.85 25.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.621 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.93 76.22 5.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.278 1.831 . . . . 0.0 109.66 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.84 113.52 4.81 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.9 35.39 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 118.215 1.007 . . . . 0.0 111.389 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.04 178.79 36.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.889 0.756 . . . . 0.0 113.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.6 87.19 2.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.921 1.289 . . . . 0.0 109.751 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.36 21.31 3.47 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.722 1.153 . . . . 0.0 112.386 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.22 -169.14 20.04 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 118.879 1.34 . . . . 0.0 113.446 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.52 105.02 3.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.221 1.809 . . . . 0.0 108.687 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 7.8 m -171.7 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.615 1.966 . . . . 0.0 113.926 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -65.35 -173.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.542 1.937 . . . . 0.0 110.494 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.68 109.19 0.2 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.103 1.361 . . . . 0.0 114.634 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.53 172.3 13.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.343 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.982 -179.115 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.88 158.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.354 1.862 . . . . 0.0 109.979 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -140.07 -42.94 0.42 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.251 1.42 . . . . 0.0 113.674 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -142.5 150.32 40.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 120.528 1.513 . . . . 0.0 109.884 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.6 t -126.24 137.1 58.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.39 139.52 52.33 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' H ' ' HB2' ' A' ' 63' ' ' GLU . 42.8 t -140.6 94.01 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.08 108.44 3.44 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -71.49 110.78 6.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.9 2.08 . . . . 0.0 108.036 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.65 -173.98 38.37 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.28 -31.3 61.47 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.21 6.63 7.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 158.62 -175.79 35.63 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.531 1.514 . . . . 0.0 111.279 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.33 96.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.115 1.957 . . . . 0.0 108.755 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -97.86 -6.62 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.948 -1.501 . . . . 0.0 114.209 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.8 p -140.91 146.45 37.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 122.173 2.26 . . . . 0.0 112.609 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.0 171.4 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.718 1.607 . . . . 0.0 109.767 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -151.87 141.24 21.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -130.13 113.95 27.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 119.515 1.052 . . . . 0.0 109.409 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.25 154.24 13.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.525 0.73 . . . . 0.0 109.593 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -132.92 155.86 48.31 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.39 122.01 40.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 108.473 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.6 167.72 9.93 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.399 1.079 . . . . 0.0 108.314 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.12 5.29 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.852 5.661 . . . . 0.0 116.424 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.4 t -151.0 -67.96 0.18 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.874 2.07 . . . . 0.0 108.891 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -139.71 166.18 25.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.847 1.259 . . . . 0.0 111.558 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -78.01 162.95 26.36 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.73 2.012 . . . . 0.0 109.406 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.37 136.59 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -121.6 162.28 20.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.595 1.558 . . . . 0.0 109.036 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 144.46 21.49 0.16 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 128.695 3.045 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.46 20.3 45.03 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.08 121.62 19.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.473 1.637 . . . . 0.0 109.142 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.79 171.56 12.57 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 110.094 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.03 -153.49 41.81 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 98.7 5.25 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 120.421 -1.635 . . . . 0.0 113.169 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.47 149.95 49.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.3 t -144.57 158.74 43.63 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.2 -19.33 65.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.996 0.918 . . . . 0.0 112.155 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.39 15.34 26.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.765 1.226 . . . . 0.0 110.487 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.07 90.88 0.11 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.305 0.957 . . . . 0.0 112.813 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -164.0 153.16 13.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.188 2.195 . . . . 0.0 107.62 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 28' ' ' VAL . 5.4 mm-40 -144.22 164.7 29.97 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.55 1.54 . . . . 0.0 110.208 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -143.01 128.85 19.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -137.16 109.69 7.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.82 117.14 27.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.68 110.67 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.92 157.74 20.88 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.277 1.431 . . . . 0.0 111.627 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -16.02 63.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.201 1.4 . . . . 0.0 110.008 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.56 6.44 15.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.687 2.395 . . . . 0.0 110.71 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.84 141.81 31.99 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.684 -1.26 . . . . 0.0 108.969 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CD1' ' HE2' ' A' ' 124' ' ' LYS . 54.3 m-85 -134.27 114.57 13.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -85.5 106.93 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -92.54 -21.47 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.376 1.07 . . . . 0.0 113.777 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.93 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.232 0.924 . . . . 0.0 110.472 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.44 144.67 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.36 119.75 40.21 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.95 128.19 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.681 1.128 . . . . 0.0 109.012 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.733 HG21 ' H ' ' A' ' 111' ' ' THR . 70.3 m -121.86 152.1 39.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.637 1.975 . . . . 0.0 109.42 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.63 168.38 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.042 1.737 . . . . 0.0 109.181 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -156.59 164.71 37.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -144.41 137.86 27.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.818 2.047 . . . . 0.0 108.337 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.8 m -132.87 161.05 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.0 104.26 0.23 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.945 1.298 . . . . 0.0 112.021 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.36 -21.76 8.06 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 124.694 1.14 . . . . 0.0 113.342 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -80.68 85.9 5.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.4 -5.01 29.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.49 1.116 . . . . 0.0 111.161 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -131.88 95.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.041 2.136 . . . . 0.0 105.575 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -54.58 147.48 14.22 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 pt -133.41 169.51 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.223 1.011 . . . . 0.0 112.657 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 94' ' ' ILE . 1.6 mt -85.33 148.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.678 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -69.06 0.89 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.1 p -123.04 147.98 46.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.47 HD12 HD23 ' A' ' 139' ' ' LEU . 43.5 mm -131.4 148.53 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 m -151.06 104.19 3.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.02 144.77 31.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.13 113.3 13.72 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 p -92.01 165.82 13.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -76.55 -27.41 55.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -69.29 -7.21 34.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 111.75 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.37 5.5 57.97 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 125.945 1.736 . . . . 0.0 113.251 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -87.49 137.98 31.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.512 1.156 . . . . 0.0 108.869 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 110.75 9.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.66 155.26 89.26 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.32 169.59 18.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.396 2.064 . . . . 0.0 110.619 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 111.13 2.44 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 107.921 -1.607 . . . . 0.0 107.921 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -67.7 14.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.8 2.04 . . . . 0.0 113.917 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 177.17 -175.95 47.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 126.242 1.877 . . . . 0.0 109.92 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.8 tp -72.73 108.1 5.54 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.707 1.603 . . . . 0.0 114.027 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.38 128.17 34.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.733 ' H ' HG21 ' A' ' 79' ' ' THR . 34.3 m -130.57 165.06 23.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.814 1.646 . . . . 0.0 108.815 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -57.05 -52.3 65.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.51 1.524 . . . . 0.0 111.446 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -61.94 102.88 0.31 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 109.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.47 170.19 21.47 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.187 0.518 . . . . 0.0 110.465 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -142.12 164.79 29.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.87 135.56 42.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.576 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.39 123.93 18.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.701 0.801 . . . . 0.0 110.991 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.93 39.23 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.293 1.437 . . . . 0.0 107.89 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.85 122.28 43.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.304 0.642 . . . . 0.0 110.734 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -119.7 -22.1 7.01 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.603 1.561 . . . . 0.0 110.414 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -67.62 -22.04 65.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.365 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.96 -10.4 6.65 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.984 -1.454 . . . . 0.0 114.62 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.75 162.81 33.81 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 120.083 1.942 . . . . 0.0 112.167 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 72' ' ' TYR . 35.4 ttmt -126.66 143.03 51.36 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.59 146.71 39.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 -28.88 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.31 -151.91 9.53 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.31 171.17 14.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.903 0.859 . . . . 0.0 112.528 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -144.31 159.7 42.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.484 1.914 . . . . 0.0 106.579 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.03 110.09 2.08 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.304 0.954 . . . . 0.0 115.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -53.27 131.38 37.24 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.601 1.96 . . . . 0.0 107.071 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 14' ' ' SER . . . -154.43 164.98 37.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.462 1.505 . . . . 0.0 108.397 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.91 -101.67 0.16 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.4 -40.08 77.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.192 0.996 . . . . 0.0 110.238 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -125.41 153.31 43.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.22 98.52 10.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -74.2 -46.51 41.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.372 0.669 . . . . 0.0 110.994 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.51 165.4 31.33 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 110.46 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.47 HD23 HD12 ' A' ' 94' ' ' ILE . 36.3 tp -147.89 159.11 44.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.402 1.481 . . . . 0.0 107.691 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.85 21.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.76 133.78 24.15 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -82.22 168.34 17.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -130.31 163.56 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.524 -0.735 . . . . 0.0 110.508 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.362 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.78 134.73 35.11 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.339 1.056 . . . . 0.0 110.388 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -87.02 146.59 26.06 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.9 mt -113.65 -166.66 1.11 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.2 m -146.32 125.89 13.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.84 -159.47 0.69 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.694 2.398 . . . . 0.0 108.67 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.9 tt -149.04 151.57 12.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.95 -38.77 0.42 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.842 0.746 . . . . 0.0 114.442 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.56 162.01 25.41 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.113 1.457 . . . . 0.0 112.85 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 49.2 p30 -112.73 0.88 15.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.076 1.75 . . . . 0.0 112.851 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -131.71 135.43 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.637 1.108 . . . . 0.0 109.86 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 132.6 159.13 9.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 127.713 2.577 . . . . 0.0 109.125 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.5 m -67.9 134.37 50.72 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 112.267 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.74 135.22 36.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -127.68 33.46 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.093 1.357 . . . . 0.0 110.475 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -58.03 107.63 0.49 Allowed 'General case' 0 C--N 1.334 -0.095 0 O-C-N 120.775 -1.203 . . . . 0.0 112.48 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.72 -16.73 60.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.986 0.914 . . . . 0.0 110.274 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 -75.14 1.53 Allowed Glycine 0 C--N 1.337 0.612 0 CA-C-O 118.522 -1.155 . . . . 0.0 110.53 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.89 146.81 2.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.426 2.291 . . . . 0.0 109.02 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -124.86 167.19 14.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.893 2.077 . . . . 0.0 106.831 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -24.36 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.92 -174.73 42.25 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.63 116.59 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.63 -39.03 8.08 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.642 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -145.42 150.63 36.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.559 HG13 ' CE2' ' A' ' 192' ' ' PHE . 41.2 t -132.46 150.36 33.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.925 0.89 . . . . 0.0 109.084 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -142.48 155.63 45.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.823 1.249 . . . . 0.0 108.677 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.59 130.49 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.84 93.43 0.54 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -70.67 155.66 40.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.117 0.961 . . . . 0.0 110.076 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.35 -167.82 14.89 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 126.674 2.083 . . . . 0.0 109.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.16 -9.05 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.326 -1.102 . . . . 0.0 110.9 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -117.25 -31.85 5.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.507 3.123 . . . . 0.0 113.686 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.07 -158.3 30.59 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.62 110.61 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 62.6 m -116.39 -12.71 11.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.017 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.21 130.75 29.25 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.91 1.232 . . . . 0.0 110.143 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.97 135.82 50.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -148.44 139.81 23.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 178' ' ' VAL . 14.2 m-85 -132.92 163.25 29.57 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.74 1.616 . . . . 0.0 109.13 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -123.03 150.99 42.35 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -161.29 167.95 24.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.252 1.021 . . . . 0.0 111.726 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . 0.4 HD21 ' ND2' ' A' ' 200' ' ' ASN . 16.2 m120 -120.28 113.01 19.76 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -107.19 122.52 46.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.31 -84.19 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.73 -4.95 1.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.912 2.085 . . . . 0.0 110.799 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.4 168.28 20.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.57 1.548 . . . . 0.0 110.455 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.4 ' ND2' HD21 ' A' ' 195' ' ' ASN . 14.2 t-20 -131.92 101.93 5.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.445 2.698 . . . . 0.0 105.94 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.78 118.18 36.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.264 1.026 . . . . 0.0 109.35 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.19 128.53 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 128.3 -140.13 11.56 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 110.06 9.86 23.47 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.433 1.117 . . . . 0.0 115.851 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -68.58 108.53 3.37 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.739 1.77 . . . . 0.0 109.499 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -129.2 27.14 5.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.084 2.153 . . . . 0.0 109.774 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -145.06 -178.74 20.88 Favored Glycine 0 N--CA 1.451 -0.322 0 O-C-N 120.444 -1.41 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -85.36 94.64 0.33 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.809 1.244 . . . . 0.0 111.024 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.4 162.51 38.51 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.571 1.597 . . . . 0.0 108.047 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.9 m -137.48 166.32 24.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -2.59 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.0 -7.16 47.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.405 1.082 . . . . 0.0 109.202 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.56 -148.92 32.84 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -141.65 157.28 45.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 108.436 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.57 154.7 28.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 128.523 2.729 . . . . 0.0 104.052 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.05 140.12 23.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.02 132.24 23.24 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.312 1.045 . . . . 0.0 108.491 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -105.61 97.02 6.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.45 141.24 15.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.98 88.76 4.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -49.02 -55.6 19.81 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 113.876 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.25 -9.62 21.93 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.51 1.575 . . . . 0.0 114.578 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.42 -38.05 6.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.63 1.105 . . . . 0.0 113.88 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 172.62 10.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.0 112.678 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -150.15 149.03 29.67 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.65 -0.656 . . . . 0.0 112.543 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.04 100.16 7.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.5 t -73.17 -29.13 62.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.525 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.04 170.63 16.29 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.71 1.604 . . . . 0.0 108.646 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.72 150.65 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.655 1.182 . . . . 0.0 108.366 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -133.77 166.76 21.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.786 2.035 . . . . 0.0 109.245 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.45 166.93 28.35 Favored Glycine 0 N--CA 1.452 -0.265 0 O-C-N 120.968 -1.083 . . . . 0.0 110.823 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 79.1 p -137.1 133.95 35.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -117.31 138.22 51.91 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 109.77 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -119.14 146.85 44.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.098 0.952 . . . . 0.0 108.586 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -69.68 129.11 38.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 112.948 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.8 155.42 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -93.33 173.63 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 77.41 -25.69 1.97 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.301 1.429 . . . . 0.0 114.62 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 11.9 p -141.56 168.85 18.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.542 1.671 . . . . 0.0 109.715 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -84.4 11.73 8.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 110.648 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.46 -175.78 27.4 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.788 1.185 . . . . 0.0 112.939 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.5 mt -149.23 166.67 28.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.662 1.985 . . . . 0.0 109.335 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.15 172.78 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.12 112.97 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.12 1.368 . . . . 0.0 108.994 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.55 -4.42 19.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.569 0.748 . . . . 0.0 112.742 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.3 tmm? -147.7 110.98 4.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 17.7 mt -125.75 132.72 52.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.14 1.376 . . . . 0.0 108.363 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -129.04 166.15 19.78 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.647 1.213 . . . . 0.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.01 134.83 44.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -73.11 130.71 40.89 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.3 m -139.0 130.64 27.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.515 HD22 ' HD3' ' A' ' 253' ' ' LYS . 3.4 p-10 -100.94 156.22 17.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.207 1.803 . . . . 0.0 107.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.515 ' HD3' HD22 ' A' ' 252' ' ' ASN . 1.0 OUTLIER 59.8 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.82 2.448 . . . . 0.0 115.268 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 252' ' ' ASN . 49.6 mt-30 -131.63 174.78 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 129.124 2.97 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 97.3 m -130.08 108.96 10.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.319 1.447 . . . . 0.0 108.81 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -81.27 136.03 35.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.0 154.27 69.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.46 88.86 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.185 2.59 . . . . 0.0 107.363 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -69.89 105.29 2.76 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.15 -172.38 23.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.712 0.687 . . . . 0.0 113.43 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.65 113.33 21.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.799 1.64 . . . . 0.0 110.09 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.16 131.19 50.04 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.113 1.365 . . . . 0.0 110.183 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.07 1.95 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 129.272 3.029 . . . . 0.0 105.873 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.26 -166.2 45.8 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 83.4 m -84.87 144.99 28.04 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.412 1.485 . . . . 0.0 108.143 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -100.48 150.76 22.32 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -143.92 164.17 31.34 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 111.456 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.79 154.45 37.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.631 1.572 . . . . 0.0 109.657 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.3 mt -131.89 105.61 7.55 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -139.81 143.99 37.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.921 0.889 . . . . 0.0 112.686 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -144.46 153.51 41.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.696 1.998 . . . . 0.0 106.371 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -86.83 145.83 26.45 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.494 -1.379 . . . . 0.0 112.206 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.94 -43.33 0.79 Allowed Glycine 0 C--N 1.341 0.853 0 C-N-CA 127.035 2.255 . . . . 0.0 115.431 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -74.28 159.47 32.4 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.321 1.049 . . . . 0.0 111.935 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 297' ' ' LEU . 1.2 mppt? -125.59 174.31 8.35 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.943 2.097 . . . . 0.0 105.555 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.8 140.34 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.492 0.663 . . . . 0.0 109.661 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.13 -3.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 128.337 2.655 . . . . 0.0 111.717 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.11 156.89 28.38 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 120.526 1.512 . . . . 0.0 114.6 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -114.83 162.7 16.53 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 112.161 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -150.75 137.44 18.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 169.07 -160.45 33.87 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -145.6 143.66 30.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.255 0.55 . . . . 0.0 111.967 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.61 148.54 12.57 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 126.938 2.095 . . . . 0.0 107.171 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.2 m -131.41 -34.08 1.42 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 127.288 2.235 . . . . 0.0 107.003 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -144.21 -56.74 0.37 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.48 148.65 26.23 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.55 1.94 . . . . 0.0 110.076 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 86.51 4.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.554 0.616 . . . . 0.0 110.595 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -67.01 -58.73 4.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.618 0.367 . . . . 0.0 111.737 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -126.1 136.34 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.481 0.582 . . . . 0.0 110.954 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -132.32 123.1 26.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.715 1.606 . . . . 0.0 108.883 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -137.34 170.48 23.58 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.316 1.436 . . . . 0.0 109.911 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.02 171.95 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.238 0.615 . . . . 0.0 111.44 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -121.37 166.09 14.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.94 2.096 . . . . 0.0 106.131 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.58 136.7 56.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 75.1 mtp -137.03 140.62 31.95 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 108.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.2 104.83 1.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.1 3.2 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 275' ' ' LYS . 74.9 mt . . . . . 0 N--CA 1.462 0.171 0 C-N-CA 124.56 1.144 . . . . 0.0 109.263 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 122.402 1.096 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -148.72 138.35 21.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 130.688 3.595 . . . . 0.0 105.202 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.73 145.86 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -89.5 161.96 15.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.562 1.172 . . . . 0.0 111.255 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.96 90.05 8.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.23 103.96 1.26 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.99 -177.29 44.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.33 1.919 . . . . 0.0 108.976 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.92 161.75 46.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 118.452 1.126 . . . . 0.0 112.85 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.44 0.37 55.35 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.67 166.28 43.16 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.61 174.35 23.09 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 123.98 0.8 . . . . 0.0 112.915 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.32 131.77 34.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.4 p -71.55 128.33 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.015 0.825 . . . . 0.0 110.341 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -121.54 4.8 10.13 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -64.36 136.1 56.8 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 71.58 12.0 6.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.892 2.477 . . . . 0.0 110.468 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.868 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.178 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.56 153.6 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.024 0.912 . . . . 0.0 108.592 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 43' ' ' ALA . 17.1 mmt85 -131.18 -52.27 1.03 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.862 1.665 . . . . 0.0 111.2 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -126.08 160.74 29.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.69 129.14 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.56 119.88 26.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 92.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.09 143.87 16.87 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.93 175.02 3.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.063 0.945 . . . . 0.0 110.863 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.94 175.71 43.31 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.41 -36.96 84.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.88 2.79 28.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 130.863 3.665 . . . . 0.0 110.711 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -166.89 24.81 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.45 122.76 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -136.47 -19.85 1.4 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.426 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -99.17 112.95 24.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.52 144.26 36.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 121.97 -0.456 . . . . 0.0 110.35 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -148.44 151.01 34.48 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.937 1.695 . . . . 0.0 107.837 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.78 158.53 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.918 1.287 . . . . 0.0 108.206 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.39 115.2 39.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -88.99 105.54 17.85 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.178 1.391 . . . . 0.0 109.068 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HB2' ' HG2' ' A' ' 24' ' ' ARG . . . -68.37 126.15 28.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.088 -0.383 . . . . 0.0 110.509 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -113.78 146.27 40.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.7 -36.12 75.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.593 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -64.36 -63.66 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -156.13 141.56 17.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.048 0.939 . . . . 0.0 108.873 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.27 111.72 10.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.28 136.74 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.804 0.812 . . . . 0.0 112.395 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -78.28 162.47 26.5 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.622 1.969 . . . . 0.0 109.682 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.58 6.75 8.48 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.131 1.824 . . . . 0.0 111.238 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.26 161.04 26.16 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 125.953 1.74 . . . . 0.0 113.75 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.3 137.68 56.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.907 0.883 . . . . 0.0 109.573 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -122.88 51.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.24 -177.34 27.54 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.861 1.696 . . . . 0.0 111.3 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.61 84.89 3.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.919 1.288 . . . . 0.0 110.404 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -56.56 132.56 51.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.428 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -129.49 147.61 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -75.18 -36.73 61.45 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.856 -0.528 . . . . 0.0 111.628 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mp -102.11 23.12 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.25 91.93 0.15 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 121.761 -0.587 . . . . 0.0 112.1 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -161.64 154.79 20.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 105.01 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -150.57 164.85 35.01 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.12 1.768 . . . . 0.0 108.847 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.6 m -145.07 122.12 11.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.93 0.492 . . . . 0.0 110.541 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -131.61 131.53 43.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -107.92 141.34 39.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.213 1.005 . . . . 0.0 108.687 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.48 112.9 42.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.88 176.56 4.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.765 2.026 . . . . 0.0 111.533 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -46.38 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -101.9 -5.04 25.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.008 2.123 . . . . 0.0 113.388 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -94.53 137.13 34.03 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -123.94 162.41 23.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.342 0.973 . . . . 0.0 110.573 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.4 mt -86.92 118.27 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.16 -45.88 20.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.266 1.426 . . . . 0.0 109.823 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.38 166.15 28.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.621 1.169 . . . . 0.0 109.651 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.06 103.35 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -82.37 135.37 35.19 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -133.66 127.75 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.9 p -114.64 149.1 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -151.85 168.15 26.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.889 0.768 . . . . 0.0 110.571 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -153.78 151.96 30.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -128.46 127.88 43.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.544 2.338 . . . . 0.0 105.918 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.64 166.21 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.887 1.275 . . . . 0.0 111.086 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.83 156.9 31.89 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.42 -14.65 6.49 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.071 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -129.03 107.23 9.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.184 1.492 . . . . 0.0 108.177 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.36 -14.25 62.86 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 111.041 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.4 p -72.01 176.44 5.06 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.547 1.539 . . . . 0.0 110.011 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.68 135.65 30.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.53 154.11 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.776 0.716 . . . . 0.0 110.647 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.73 112.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.857 1.263 . . . . 0.0 107.989 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -77.24 -36.78 54.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.566 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.6 t -158.98 158.72 33.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.843 2.057 . . . . 0.0 109.243 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.06 151.49 27.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.775 2.03 . . . . 0.0 107.11 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 m -150.67 108.45 3.69 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.18 158.71 31.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -135.49 122.04 20.73 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.1 p -108.53 160.68 15.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 119.276 0.944 . . . . 0.0 112.287 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -68.76 -37.88 79.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.315 0.646 . . . . 0.0 109.746 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -15.28 63.51 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 116.772 -1.585 . . . . 0.0 113.431 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.61 3.5 49.8 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 120.188 1.358 . . . . 0.0 112.589 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -82.7 95.07 7.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.5 m -104.35 122.31 45.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.8 p -70.13 159.7 83.46 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 111.561 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.33 170.26 20.34 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.073 1.849 . . . . 0.0 107.435 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.58 109.75 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 N-CA-C 106.519 -2.147 . . . . 0.0 106.519 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -81.03 77.06 7.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.65 -149.97 20.36 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.772 1.653 . . . . 0.0 110.234 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.3 tp -105.27 125.77 51.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.113 1.365 . . . . 0.0 110.591 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.46 139.48 53.97 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.9 m -134.78 157.14 47.51 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.439 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -61.76 -45.56 93.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.217 0.607 . . . . 0.0 109.492 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -65.2 110.32 2.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 107.229 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -163.86 166.8 21.48 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.409 -0.807 . . . . 0.0 112.226 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -150.87 167.67 26.8 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.24 1.816 . . . . 0.0 108.921 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.24 142.62 38.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 129.84 55.48 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.985 0.914 . . . . 0.0 111.129 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 147.2 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.144 1.377 . . . . 0.0 108.229 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 123' ' ' GLY . 27.9 t0 -76.49 174.51 10.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -50.05 -53.73 25.02 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.928 1.691 . . . . 0.0 109.425 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -114.32 -23.81 9.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 117.835 -1.078 . . . . 0.0 113.607 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.22 55.83 0.13 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.939 1.245 . . . . 0.0 113.919 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 119' ' ' ASP . . . -71.74 138.5 27.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -65.75 144.47 56.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -62.12 97.05 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.143 1.777 . . . . 0.0 107.866 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.72 -51.99 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -174.07 141.12 5.8 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -87.55 177.76 6.98 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.642 1.177 . . . . 0.0 111.328 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -147.2 169.37 19.48 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 107.319 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.91 -177.99 47.49 Favored Glycine 0 CA--C 1.523 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.258 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -142.45 50.71 1.48 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.67 2.388 . . . . 0.0 108.629 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.43 163.53 17.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 119.902 -1.748 . . . . 0.0 109.164 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.86 -104.45 0.19 Allowed Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.09 -15.99 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.409 0.711 . . . . 0.0 111.144 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.83 174.61 12.03 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.874 2.47 . . . . 0.0 107.343 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.6 tp -98.91 88.54 4.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -79.58 -52.64 7.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.694 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.77 158.53 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 111.982 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -148.6 147.09 28.59 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.447 3.499 . . . . 0.0 106.576 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -144.18 -173.21 15.4 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.83 156.18 35.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.758 1.279 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -128.68 109.84 11.68 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.65 99.14 8.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -179.894 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -74.74 131.09 40.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -111.92 147.9 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.633 1.973 . . . . 0.0 106.855 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.32 167.76 10.17 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.166 1.386 . . . . 0.0 107.84 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -73.51 107.33 5.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.8 171.56 10.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.667 0.787 . . . . 0.0 109.339 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.49 148.05 30.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 159.8 -112.44 0.52 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 125.006 1.289 . . . . 0.0 110.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -115.67 163.51 12.29 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.882 1.706 . . . . 0.0 110.453 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.13 -5.61 40.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.13 1.372 . . . . 0.0 112.474 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.506 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 44.7 tt0 -112.98 144.0 43.32 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.417 1.487 . . . . 0.0 109.752 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.56 171.52 12.87 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 123.795 0.712 . . . . 0.0 113.167 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.4 m -82.07 116.96 21.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.847 0.859 . . . . 0.0 108.901 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.06 126.27 29.19 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -134.13 127.07 31.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.011 0.924 . . . . 0.0 111.746 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.18 155.63 17.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.985 1.714 . . . . 0.0 108.681 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -150.81 100.19 2.79 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.55 160.36 5.02 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.54 143.71 51.53 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -104.77 178.33 4.59 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 111.317 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -53.05 -45.1 67.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.078 1.751 . . . . 0.0 112.361 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.74 -176.33 46.97 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 128.874 3.13 . . . . 0.0 106.157 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.67 141.26 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -121.86 -19.8 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -144.28 158.54 43.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.95 145.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -128.94 156.05 44.36 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 t -136.29 123.35 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.87 57.67 0.58 Allowed Glycine 0 C--N 1.341 0.833 0 C-N-CA 124.394 0.997 . . . . 0.0 114.834 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.471 ' CD ' ' H ' ' A' ' 182' ' ' GLN . 3.2 pm0 -68.21 159.93 30.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.964 0.905 . . . . 0.0 110.024 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.28 -140.07 3.83 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.542 1.544 . . . . 0.0 110.477 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -82.15 -37.13 26.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.192 0.997 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.55 -31.45 11.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.725 2.01 . . . . 0.0 113.759 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.16 -158.48 29.52 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 119.749 1.158 . . . . 0.0 110.975 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 105.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 m -95.13 -23.46 17.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 0.0 111.472 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.35 157.69 38.97 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.808 1.643 . . . . 0.0 109.3 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.57 156.53 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.592 1.957 . . . . 0.0 106.545 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.417 ' HE2' ' CG ' ' A' ' 214' ' ' PHE . 59.8 pttt -174.13 134.0 0.43 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 128.78 2.832 . . . . 0.0 105.842 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -125.95 162.22 25.73 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.092 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -103.09 152.35 21.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.778 1.231 . . . . 0.0 109.585 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.03 163.9 23.2 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.532 1.133 . . . . 0.0 109.682 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.24 145.72 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.071 1.748 . . . . 0.0 106.978 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -140.56 97.19 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 65.34 -143.57 46.16 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.65 5.7 10.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.844 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.94 168.5 9.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.738 1.215 . . . . 0.0 110.709 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.75 142.79 49.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.821 1.648 . . . . 0.0 107.186 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.4 mm -131.81 102.41 5.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.26 105.23 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 139.31 170.5 11.9 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 121.751 0.64 . . . . 0.0 114.516 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.43 45.23 0.02 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.684 2.087 . . . . 0.0 109.28 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.62 100.61 3.38 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.665 1.186 . . . . 0.0 109.87 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -116.84 -24.45 7.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.639 1.176 . . . . 0.0 112.122 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -91.8 -179.24 41.93 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.96 91.55 0.97 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.248 1.024 . . . . 0.0 109.161 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.36 156.63 58.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 121.367 1.524 . . . . 0.0 109.324 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 71.2 p -98.91 173.48 6.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.62 -10.55 59.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.086 -1.009 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.0 tt -53.37 -39.35 64.13 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.59 175.28 29.73 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.665 1.603 . . . . 0.0 111.149 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CG ' ' HE2' ' A' ' 191' ' ' LYS . 53.4 m-85 -102.34 138.41 39.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.355 1.062 . . . . 0.0 109.628 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.88 164.17 13.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.977 2.511 . . . . 0.0 106.326 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.13 157.37 44.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 121.542 1.974 . . . . 0.0 115.684 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.55 143.63 32.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.633 1.173 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 124.2 43.75 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 108.762 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.96 117.5 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 C-N-CA 126.604 1.962 . . . . 0.0 106.304 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -93.98 106.36 18.34 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.574 1.079 . . . . 0.0 109.999 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -38.66 -61.42 0.89 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.6 -19.31 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.192 1.819 . . . . 0.0 116.301 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.5 t -106.93 -12.92 15.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.576 1.989 . . . . 0.0 114.769 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.33 160.18 15.81 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 107.229 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -152.48 106.87 3.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 119.935 -1.728 . . . . 0.0 109.894 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.93 70.48 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 t -68.12 -16.95 64.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.546 -1.346 . . . . 0.0 112.739 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -157.94 167.51 29.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.862 1.665 . . . . 0.0 107.914 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.55 159.54 37.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.424 ' OE2' ' HE3' ' A' ' 250' ' ' LYS . 31.4 mt-10 -131.51 172.92 11.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.41 1.484 . . . . 0.0 108.388 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.52 179.8 42.8 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.3 m -157.19 150.52 23.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 155.47 48.61 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -153.02 164.4 38.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.892 0.853 . . . . 0.0 108.964 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -70.07 148.36 48.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.053 2.141 . . . . 0.0 112.907 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.7 mt -90.16 151.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -108.8 76.8 1.03 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 149.22 -15.85 1.14 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-O 117.944 -1.476 . . . . 0.0 115.483 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 m -132.44 148.49 52.41 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.734 1.267 . . . . 0.0 108.293 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.62 86.23 7.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.844 1.258 . . . . 0.0 109.235 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 178.28 -169.92 41.84 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 0.0 110.065 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.65 156.44 39.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.99 2.116 . . . . 0.0 105.393 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.8 tt -134.52 167.46 25.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.958 1.303 . . . . 0.0 107.761 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.9 mm -99.05 93.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 111.708 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -87.31 -21.77 25.54 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.267 -0.896 . . . . 0.0 113.323 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -137.72 144.63 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 109.632 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -143.31 149.89 38.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.245 0.93 . . . . 0.0 109.624 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . 0.547 ' H ' HD23 ' A' ' 247' ' ' LEU . 73.4 mtt180 -148.33 159.67 43.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.917 1.687 . . . . 0.0 109.226 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -138.7 116.0 11.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 230' ' ' GLU . 85.2 mttt -73.77 149.79 41.51 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.0 p -145.37 165.39 28.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.255 0.48 . . . . 0.0 110.493 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -99.99 133.78 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.32 2.248 . . . . 0.0 105.362 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 58.2 -19.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.946 2.098 . . . . 0.0 115.498 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.98 171.61 9.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.4 2.28 . . . . 0.0 108.797 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.3 p -141.52 99.88 3.66 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.0 p -82.92 172.46 12.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.031 1.332 . . . . 0.0 111.197 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -120.62 157.82 53.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.015 1.326 . . . . 0.0 111.067 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.214 2.61 . . . . 0.0 107.521 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -81.35 92.21 6.37 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.1 174.19 17.5 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.572 1.558 . . . . 0.0 111.224 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 92.2 mt -95.95 146.57 24.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 109.087 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -71.72 146.72 47.99 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.9 -179.99 7.17 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.134 1.374 . . . . 0.0 109.986 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 37.73 -96.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.968 2.223 . . . . 0.0 116.082 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 96.2 m -146.29 129.1 16.28 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.873 0.869 . . . . 0.0 110.407 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.98 35.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -142.01 161.19 38.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.88 154.74 38.84 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.982 -1.074 . . . . 0.0 109.86 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.99 151.97 47.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -158.91 173.96 15.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.991 2.516 . . . . 0.0 107.064 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -144.93 164.09 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 107.146 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.34 -18.16 57.67 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 175.84 63.97 0.06 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -152.24 175.49 12.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.218 1.807 . . . . 0.0 106.753 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -115.46 152.24 33.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.396 1.478 . . . . 0.0 107.29 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.2 mt -86.61 119.87 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.4 m -147.22 69.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.467 0.707 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.73 -178.79 18.4 Favored Glycine 0 N--CA 1.467 0.722 0 O-C-N 120.198 -1.564 . . . . 0.0 114.316 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.89 160.97 40.44 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.69 1.196 . . . . 0.0 110.758 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -157.69 132.61 8.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -175.43 -152.74 9.62 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.506 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 16.1 ptmt -143.8 147.46 34.17 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.2 156.18 21.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 108.195 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 20.3 t -127.35 -90.66 0.52 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -79.2 -58.17 3.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 20.2 mt -110.75 165.89 11.46 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.999 1.719 . . . . 0.0 111.832 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.01 106.39 4.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 109.545 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -96.12 -45.94 6.67 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.2 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.4 ' HB3' ' H ' ' A' ' 282' ' ' LYS . 11.4 tt0 -122.05 137.68 54.72 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.068 0.849 . . . . 0.0 112.151 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -138.1 149.8 46.27 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.511 1.124 . . . . 0.0 109.945 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -169.16 154.98 24.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.32 151.47 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 118.343 1.072 . . . . 0.0 112.504 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.85 154.02 20.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 141.24 47.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.516 0.726 . . . . 0.0 111.371 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 83.2 mmm -144.73 144.45 24.58 Favored Pre-proline 0 N--CA 1.465 0.278 0 C-N-CA 126.924 2.09 . . . . 0.0 107.399 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.96 159.39 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.627 1.26 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--O 1.238 0.482 0 C-N-CA 124.088 0.955 . . . . 0.0 110.362 179.538 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 121.79 0.805 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -129.95 139.12 51.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.904 1.682 . . . . 0.0 107.602 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -124.83 110.07 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 103.981 -2.599 . . . . 0.0 103.981 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 165.63 17.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.983 0.897 . . . . 0.0 110.843 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 163.41 12.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.307 1.443 . . . . 0.0 107.542 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.07 154.46 25.33 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.99 -153.04 24.75 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.83 -2.508 . . . . 0.0 106.83 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.11 121.71 14.84 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 122.477 1.043 . . . . 0.0 115.087 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.85 -8.36 57.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.812 0.845 . . . . 0.0 111.859 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.96 -19.12 60.83 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.636 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.95 20.72 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.386 1.593 . . . . 0.0 113.345 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.68 157.37 27.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 108.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -69.9 119.46 14.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -86.48 -70.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 17.52 2.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.643 1.177 . . . . 0.0 113.709 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.45 134.91 55.45 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.04 -1.038 . . . . 0.0 109.686 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 106.534 -2.626 . . . . 0.0 106.534 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 N-CA-C 118.011 1.964 . . . . 0.0 118.011 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.0 124.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 120.839 2.319 . . . . 0.0 110.793 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -104.26 -71.18 0.74 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.839 1.256 . . . . 0.0 110.569 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -111.13 151.63 27.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.485 1.114 . . . . 0.0 109.251 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.47 141.92 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -123.7 120.42 32.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.33 102.79 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.42 129.46 9.82 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.3 168.03 20.45 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.118 0.961 . . . . 0.0 109.139 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.37 163.92 31.77 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -57.42 -40.78 79.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.291 1.436 . . . . 0.0 111.034 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.3 3.22 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.074 2.949 . . . . 0.0 113.613 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.35 -171.23 13.67 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.491 1.041 . . . . 0.0 112.208 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.73 106.13 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.27 -22.23 5.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.184 0.994 . . . . 0.0 113.501 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 42.4 p -117.96 131.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.201 1.0 . . . . 0.0 109.784 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.88 154.45 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 121.271 -0.893 . . . . 0.0 111.159 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -146.47 150.82 36.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.9 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.68 117.68 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.14 171.61 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.289 . . . . 0.0 108.498 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.12 109.3 5.28 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.753 -1.217 . . . . 0.0 109.03 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -116.3 165.51 13.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.306 1.442 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 44.5 5.58 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.027 1.394 . . . . 0.0 110.79 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m 49.37 33.04 4.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.982 2.913 . . . . 0.0 114.448 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.79 165.26 27.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.425 1.89 . . . . 0.0 109.975 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.41 127.04 31.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.923 2.089 . . . . 0.0 109.48 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.44 116.75 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.359 1.064 . . . . 0.0 108.79 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.03 159.36 30.95 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.91 0.884 . . . . 0.0 112.205 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.23 -17.72 4.38 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-O 117.352 -1.804 . . . . 0.0 115.805 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.59 154.19 2.96 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-N 120.428 2.114 . . . . 0.0 114.033 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.66 105.5 5.78 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.392 -1.064 . . . . 0.0 113.485 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -93.1 176.48 6.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.784 2.834 . . . . 0.0 109.613 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -163.14 54.69 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.49 100.36 11.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 37' ' ' SER 0.297 0.0 OUTLIER -61.75 150.03 38.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.435 -178.541 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.9 p -123.53 157.76 32.89 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.324 1.049 . . . . 0.0 108.837 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 tp -90.74 -38.83 12.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.778 0.831 . . . . 0.0 112.009 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mp -101.46 32.73 3.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 112.687 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.6 108.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -162.82 146.06 10.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.828 1.651 . . . . 0.0 107.294 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.1 162.04 41.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.322 2.649 . . . . 0.0 108.249 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.0 m -144.7 96.04 2.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.39 116.23 24.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.32 133.64 34.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.469 1.107 . . . . 0.0 108.814 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.62 107.25 22.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . 8.8 t70 -58.81 160.58 5.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.66 -40.38 76.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.764 -0.585 . . . . 0.0 111.84 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.38 -19.32 20.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.469 0.577 . . . . 0.0 112.32 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 68' ' ' ASP . 37.5 t0 -81.03 140.22 35.28 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -135.58 154.55 51.31 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.479 0.712 . . . . 0.0 110.803 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.69 133.64 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.52 -24.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 123.791 0.836 . . . . 0.0 111.1 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.19 156.72 42.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.87 146.26 25.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.95 115.26 15.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.33 123.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.447 HG21 ' H ' ' A' ' 111' ' ' THR . 29.3 m -99.42 138.04 37.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.182 1.793 . . . . 0.0 107.22 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -152.79 155.69 37.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.44 169.32 23.29 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -128.21 160.09 33.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.396 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -123.85 152.1 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.814 0.846 . . . . 0.0 108.753 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.33 113.34 1.91 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.997 0.919 . . . . 0.0 108.615 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.85 3.9 42.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.468 -1.184 . . . . 0.0 113.113 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -134.17 84.58 2.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.41 24.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 130.548 3.539 . . . . 0.0 113.19 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.3 t -149.8 108.47 3.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.181 -1.575 . . . . 0.0 108.533 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.56 157.27 7.14 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.023 1.729 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -139.39 147.11 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.702 1.601 . . . . 0.0 108.524 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.8 mm -70.37 113.19 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.2 p -80.47 -34.19 36.05 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.736 -0.602 . . . . 0.0 109.745 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 p -165.45 164.32 19.55 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.881 1.672 . . . . 0.0 109.712 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.8 tt -141.45 154.41 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 142.9 29.24 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -115.3 156.7 24.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.461 HD22 HG22 ' A' ' 103' ' ' THR . 7.7 m120 -137.25 114.06 10.47 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -104.42 164.99 11.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.311 0.577 . . . . 0.0 110.632 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.44 -36.26 75.59 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -28.85 66.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.983 0.81 . . . . 0.0 111.816 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.69 5.67 47.76 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -72.85 88.49 1.34 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.461 HG22 HD22 ' A' ' 97' ' ' ASN . 1.1 p -84.76 109.22 17.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 p -71.26 161.76 76.52 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 125.174 1.389 . . . . 0.0 110.18 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.84 165.34 19.92 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.034 2.49 . . . . 0.0 110.285 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.44 119.27 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.087 2.525 . . . . 0.0 108.486 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -81.75 77.55 8.58 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.72 -155.8 25.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.563 1.078 . . . . 0.0 111.188 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.0 tp -88.15 119.17 28.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.372 1.469 . . . . 0.0 109.636 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.35 152.14 45.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.447 ' H ' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -153.59 168.98 24.37 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.966 -1.084 . . . . 0.0 109.928 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -73.22 -47.48 43.05 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 120.96 -1.087 . . . . 0.0 109.496 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.97 109.15 1.69 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.355 1.074 . . . . 0.0 109.249 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.09 166.49 21.29 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.182 1.393 . . . . 0.0 108.685 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -144.78 164.97 29.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.34 149.14 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.5 141.13 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.947 1.299 . . . . 0.0 108.807 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -157.56 164.47 37.28 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.047 1.339 . . . . 0.0 110.978 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.91 170.87 15.72 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 108.168 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.19 -56.24 12.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.048 -1.032 . . . . 0.0 109.893 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -117.95 -14.08 10.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.26 -63.96 0.29 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.47 -143.01 18.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -163.38 137.2 5.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.42 137.51 52.77 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.35 -34.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.269 0.941 . . . . 0.0 111.976 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.71 172.95 42.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.39 153.46 43.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.582 1.153 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 159.82 42.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.469 1.108 . . . . 0.0 108.055 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.08 137.96 2.89 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -61.46 135.73 57.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 110.145 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -153.23 164.93 37.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.191 1.396 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.72 -107.42 0.2 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.95 -26.59 66.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.026 0.913 . . . . 0.0 111.328 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.62 172.03 13.25 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.3 1.84 . . . . 0.0 107.615 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 38.7 tp -84.89 100.15 11.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -81.61 -39.89 23.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.87 146.25 31.04 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 124.478 1.111 . . . . 0.0 108.81 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.7 tp -155.76 100.11 2.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.335 0.516 . . . . 0.0 112.317 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.99 178.55 16.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.801 2.143 . . . . 0.0 109.293 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.4 163.55 39.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.565 1.682 . . . . 0.0 110.201 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -127.82 143.27 51.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.686 1.232 . . . . 0.0 109.534 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -110.42 105.09 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.702 2.001 . . . . 0.0 106.202 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 119.301 0.955 . . . . 0.0 110.848 -179.157 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.245 0.545 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 133.59 52.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -114.31 121.53 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.391 0.677 . . . . 0.0 111.575 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.49 -169.65 1.52 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.7 t -136.33 115.05 12.03 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 120.463 -1.398 . . . . 0.0 108.19 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.41 -171.18 2.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.968 0.907 . . . . 0.0 109.861 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.19 152.46 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.82 -72.78 0.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 123.963 0.792 . . . . 0.0 111.295 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.46 143.07 6.0 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 282' ' ' LYS . 10.0 p-10 -90.19 48.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.811 1.644 . . . . 0.0 111.739 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.64 152.12 26.76 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.45 1.5 . . . . 0.0 107.819 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.04 166.88 12.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.52 1.534 . . . . 0.0 114.264 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 m -65.56 129.32 39.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.355 1.062 . . . . 0.0 109.225 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.6 109.46 11.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -95.05 7.15 47.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.474 1.11 . . . . 0.0 112.443 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.99 132.34 51.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.816 -0.552 . . . . 0.0 112.331 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.82 -9.59 17.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.863 1.665 . . . . 0.0 111.601 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.45 -156.44 51.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.905 -1.122 . . . . 0.0 111.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -109.48 164.41 12.53 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.588 1.555 . . . . 0.0 110.606 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -147.79 -170.29 3.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.822 2.049 . . . . 0.0 110.45 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.04 -45.92 89.52 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.644 -0.66 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.05 40.63 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.46 HG22 ' CZ ' ' A' ' 194' ' ' TYR . 9.3 t -123.6 156.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.024 1.33 . . . . 0.0 108.964 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -116.49 -55.69 2.36 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -150.93 165.11 34.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.61 1.096 . . . . 0.0 111.301 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.6 t -125.65 149.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.095 2.158 . . . . 0.0 108.128 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -137.93 120.92 16.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.14 138.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -118.75 83.47 0.35 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 187' ' ' ILE . 6.3 pt20 -74.08 -171.44 1.13 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.311 1.053 . . . . 0.0 111.583 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.99 45.41 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -62.31 -37.31 85.06 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.81 0.844 . . . . 0.0 111.283 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 -15.58 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.544 3.137 . . . . 0.0 113.166 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 122.42 -175.66 16.43 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.483 1.992 . . . . 0.0 108.405 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 182' ' ' GLN . 19.5 mt -69.39 106.14 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 120.941 -1.329 . . . . 0.0 109.381 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 m -98.35 -24.66 15.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.636 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.39 47.78 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 122.395 1.093 . . . . 0.0 113.21 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.1 m -147.45 144.55 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.37 1.868 . . . . 0.0 106.605 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 56.0 pttt -161.61 170.01 20.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.713 1.205 . . . . 0.0 110.435 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -153.94 175.22 13.63 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.787 0.803 . . . . 0.0 113.087 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.8 114.28 17.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.319 -2.845 . . . . 0.0 103.319 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.46 ' CZ ' HG22 ' A' ' 175' ' ' VAL . 7.2 m-85 -129.98 148.37 51.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.765 1.626 . . . . 0.0 108.562 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -112.07 155.55 23.66 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.741 0.781 . . . . 0.0 110.244 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.21 86.25 2.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.01 1.324 . . . . 0.0 109.161 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.05 -79.39 0.88 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -123.49 -35.39 2.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.103 1.361 . . . . 0.0 110.246 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.95 148.61 48.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 122.195 0.997 . . . . 0.0 109.439 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.22 135.64 54.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.8 mm -120.07 116.27 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.03 109.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 127.847 2.459 . . . . 0.0 104.827 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.22 1.29 2.28 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 117.644 -1.642 . . . . 0.0 116.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.83 82.75 0.72 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 119.687 1.744 . . . . 0.0 108.942 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -112.66 135.02 53.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.586 2.755 . . . . 0.0 106.778 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -128.97 -43.55 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.76 153.1 39.87 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.98 112.51 8.3 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.29 1.836 . . . . 0.0 112.222 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.6 171.2 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.919 1.746 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 p -129.66 177.26 7.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.348 1.059 . . . . 0.0 108.413 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.1 mt -66.52 -10.43 44.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.308 -0.87 . . . . 0.0 111.321 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 -22.31 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.71 1.204 . . . . 0.0 109.988 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 86.32 -139.94 17.11 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.464 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 46.3 m-85 -143.58 158.79 43.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.667 1.187 . . . . 0.0 109.193 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -110.28 164.63 12.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.995 2.918 . . . . 0.0 106.422 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.61 139.89 44.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.961 0.8 . . . . 0.0 110.906 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -142.55 123.89 14.73 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.65 0.38 . . . . 0.0 111.035 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.07 130.78 34.55 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.442 1.097 . . . . 0.0 109.392 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.6 mt -127.69 124.58 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -80.23 88.57 5.48 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -52.97 -53.51 54.32 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.631 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.3 -0.71 10.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.2 1.933 . . . . 0.0 115.074 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 m -125.68 -29.45 3.15 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.504 1.956 . . . . 0.0 116.22 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.74 159.91 24.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.568 1.076 . . . . 0.0 109.504 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.55 124.76 36.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.85 101.31 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -69.09 -36.73 77.89 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.471 ' HB3' ' HD3' ' A' ' 250' ' ' LYS . . . -157.13 170.45 22.48 Favored 'General case' 0 C--N 1.343 0.294 0 O-C-N 120.703 -1.248 . . . . 0.0 112.132 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.53 151.06 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -132.44 171.59 13.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.402 1.881 . . . . 0.0 106.119 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 143.4 -175.79 23.22 Favored Glycine 0 N--CA 1.465 0.628 0 O-C-N 119.906 -1.746 . . . . 0.0 112.761 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -140.0 146.42 39.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.155 0.982 . . . . 0.0 110.598 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -128.2 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -156.08 170.82 21.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.793 0.837 . . . . 0.0 110.165 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -75.8 148.18 38.63 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 127.073 2.149 . . . . 0.0 110.886 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.0 pt -102.48 157.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 109.325 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -79.01 169.78 17.68 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.27 -41.41 1.57 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.863 -1.148 . . . . 0.0 114.873 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.3 m -141.28 160.37 40.26 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.597 1.698 . . . . 0.0 108.198 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.79 18.44 0.6 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.91 41.4 Favored Glycine 0 C--N 1.338 0.674 0 O-C-N 120.758 -1.213 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.92 157.08 30.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.371 1.469 . . . . 0.0 108.238 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.54 168.52 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 40.4 mm -105.74 103.41 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 101.219 -3.622 . . . . 0.0 101.219 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -82.16 -17.43 46.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.595 1.089 . . . . 0.0 112.048 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -150.74 136.02 17.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.19 141.34 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -135.99 158.4 44.51 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.169 0.987 . . . . 0.0 108.576 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.92 119.1 18.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 228' ' ' ALA . 36.8 mtpt -68.13 135.55 52.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.5 p -128.11 165.4 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.602 1.161 . . . . 0.0 109.941 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -129.87 145.38 51.6 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.6 tptp 72.95 -26.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.301 1.44 . . . . 0.0 111.589 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -124.06 173.48 8.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 109.729 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.3 m -117.64 144.17 45.45 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 107.419 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.5 p -121.67 153.87 37.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.418 1.087 . . . . 0.0 109.639 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -97.84 159.07 31.79 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 111.418 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.67 115.44 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.366 2.71 . . . . 0.0 107.9 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.78 93.07 7.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.35 -179.13 16.98 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.252 0.929 . . . . 0.0 112.582 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.93 111.18 22.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.206 1.002 . . . . 0.0 108.369 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.79 107.93 0.92 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.809 0.844 . . . . 0.0 108.853 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.62 156.72 18.57 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.708 2.003 . . . . 0.0 107.345 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.06 -177.54 50.81 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.87 111.04 1.15 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.651 1.18 . . . . 0.0 111.773 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.4 146.03 28.68 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.802 0.441 . . . . 0.0 110.49 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.32 160.01 41.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.284 1.434 . . . . 0.0 110.872 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -146.88 127.53 14.23 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.94 101.32 11.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.69 1.132 . . . . 0.0 110.825 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -123.07 153.39 39.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.452 1.101 . . . . 0.0 110.648 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.73 150.26 36.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.54 1.536 . . . . 0.0 108.143 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -99.02 142.39 30.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.816 1.246 . . . . 0.0 109.894 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.73 55.8 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.847 0.736 . . . . 0.0 114.792 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -134.22 175.38 9.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.19 1.396 . . . . 0.0 110.467 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 162.21 33.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.757 1.623 . . . . 0.0 108.417 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 52.6 mt -95.12 140.91 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.63 -0.35 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.43 -167.68 38.35 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.75 166.84 19.05 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.461 1.105 . . . . 0.0 110.983 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -159.08 163.69 36.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.195 1.398 . . . . 0.0 107.964 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.06 -161.99 29.06 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 30.4 mtmm -126.97 136.82 52.78 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -158.13 96.84 1.48 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.424 1.489 . . . . 0.0 107.474 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.9 m -69.04 -23.85 64.11 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -165.46 -60.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.8 mt -84.24 147.91 27.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.18 2.592 . . . . 0.0 106.066 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.44 80.22 1.42 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.032 . . . . 0.0 112.089 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -64.53 -40.47 95.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -141.55 129.92 22.43 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.67 1.123 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -119.6 106.95 12.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.252 1.421 . . . . 0.0 107.772 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -132.2 -179.73 16.48 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.2 170.27 10.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.582 -0.952 . . . . 0.0 111.158 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.11 156.3 25.48 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.37 160.74 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.524 0.73 . . . . 0.0 109.048 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.46 144.49 42.79 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.64 149.27 79.17 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.867 1.711 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.466 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 112.083 179.568 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.207 0.527 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -147.26 139.71 24.7 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.427 1.891 . . . . 0.0 107.057 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -132.28 118.43 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -64.48 137.91 58.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.365 0.666 . . . . 0.0 109.893 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.56 -58.46 8.38 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.708 1.603 . . . . 0.0 109.649 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.93 -23.22 24.1 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.302 1.43 . . . . 0.0 113.12 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.38 173.84 24.0 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.126 0.963 . . . . 0.0 111.581 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.68 174.27 54.81 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 122.56 1.089 . . . . 0.0 113.837 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.74 9.03 15.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.58 1.552 . . . . 0.0 113.126 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.41 174.73 44.35 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.32 -124.36 31.63 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 158.91 43.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.728 1.611 . . . . 0.0 109.489 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.9 p -101.69 102.86 13.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 116.58 22.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 103.968 -2.605 . . . . 0.0 103.968 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.08 118.61 12.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -133.87 -64.55 0.7 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.703 0.801 . . . . 0.0 110.85 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.015 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 107.376 -2.289 . . . . 0.0 107.376 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.2 157.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.476 1.91 . . . . 0.0 112.442 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -131.59 -23.33 2.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 112.908 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -153.19 155.56 36.9 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.99 148.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -132.96 144.82 50.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.98 148.81 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.847 2.059 . . . . 0.0 106.431 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 62' ' ' PHE . . . -137.39 -112.16 1.1 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.19 148.28 32.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.372 1.086 . . . . 0.0 108.688 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 -20.79 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 127.189 2.328 . . . . 0.0 112.912 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -56.13 -40.28 73.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.348 2.259 . . . . 0.0 110.237 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.47 7.63 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.128 3.371 . . . . 0.0 109.514 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.71 159.77 23.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 126.371 1.939 . . . . 0.0 109.655 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.58 96.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.3 m -89.78 -21.7 22.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.1 p -127.37 127.19 43.79 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 120.489 1.495 . . . . 0.0 110.83 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 136' ' ' LEU . 4.3 mp -135.76 137.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 122.891 1.329 . . . . 0.0 109.561 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -148.38 138.72 22.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.652 0.781 . . . . 0.0 109.368 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 t -95.51 123.42 47.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -115.99 165.72 12.8 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.83 0.852 . . . . 0.0 108.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.24 108.69 3.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.263 54.9 pttt -117.15 116.18 26.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.457 1.503 . . . . 0.0 110.129 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 47.5 27.28 0.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.594 1.958 . . . . 0.0 113.548 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -162.76 -159.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.309 -1.494 . . . . 0.0 108.829 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.46 165.24 19.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 116.48 17.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.19 109.03 12.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.38 162.16 29.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.971 0.908 . . . . 0.0 109.699 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 2.36 9.35 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.611 1.577 . . . . 0.0 112.21 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.37 163.95 27.41 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.237 1.518 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -70.94 147.64 48.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.906 2.082 . . . . 0.0 110.805 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -130.4 104.35 7.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.956 2.103 . . . . 0.0 106.011 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.18 -156.26 26.72 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.18 102.76 7.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.866 1.266 . . . . 0.0 108.457 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -103.29 162.7 12.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.9 m -155.6 150.59 26.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.12 -8.42 54.58 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.69 -4.94 7.17 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.25 15.12 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.625 1.102 . . . . 0.0 114.049 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 4.1 t80 -75.37 128.58 35.71 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.931 1.366 . . . . 0.0 110.145 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -132.49 164.12 27.29 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.226 2.61 . . . . 0.0 111.072 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 m -132.97 138.79 46.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.696 1.599 . . . . 0.0 108.046 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -121.2 109.6 15.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.159 1.783 . . . . 0.0 106.364 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -89.75 165.1 14.38 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.699 1.2 . . . . 0.0 109.042 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 p -111.04 152.86 12.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.202 0.525 . . . . 0.0 110.366 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.18 164.9 12.13 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.822 1.249 . . . . 0.0 110.512 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.78 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.579 0.752 . . . . 0.0 110.986 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -105.59 0.71 26.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.16 140.1 52.45 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -134.2 151.9 51.55 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.94 1.296 . . . . 0.0 108.95 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.0 mm -82.67 142.82 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.906 1.282 . . . . 0.0 108.075 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 m -136.81 -19.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.18 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 146.46 28.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -145.59 96.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -65.26 138.3 58.13 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.19 150.13 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.599 HG21 ' H ' ' A' ' 111' ' ' THR . 18.4 m -126.06 140.27 52.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.593 1.957 . . . . 0.0 106.754 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -151.8 149.62 29.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -158.82 168.55 26.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.829 1.195 . . . . 0.0 111.362 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -103.14 154.9 18.82 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.551 1.54 . . . . 0.0 110.581 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.93 146.46 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -75.68 76.4 2.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.06 14.89 0.1 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 127.583 2.516 . . . . 0.0 111.919 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -123.98 111.42 15.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.143 1.377 . . . . 0.0 109.078 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.54 -3.28 8.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.473 1.509 . . . . 0.0 111.42 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -153.37 137.39 16.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.716 1.606 . . . . 0.0 109.353 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.71 152.35 45.63 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.06 154.72 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.19 0.996 . . . . 0.0 109.209 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.16 119.99 22.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.8 p -95.63 -31.1 13.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.159 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.5 p -157.43 164.05 37.89 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.823 1.647 . . . . 0.0 110.613 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.91 147.57 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.778 1.631 . . . . 0.0 107.525 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 105.82 4.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.994 0.918 . . . . 0.0 109.387 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.42 148.61 48.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.588 -0.695 . . . . 0.0 109.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.48 114.32 11.25 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.0 p -84.97 158.75 20.42 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -30.41 70.69 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.53 -46.84 83.37 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.409 1.083 . . . . 0.0 109.087 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.01 -14.62 3.79 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.847 1.213 . . . . 0.0 112.06 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -68.24 145.07 54.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 107.97 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.1 p -133.77 148.05 51.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 108.979 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.2 p -85.43 162.46 48.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.34 165.3 32.9 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 107.285 -1.852 . . . . 0.0 107.285 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.98 105.49 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 105.738 -2.447 . . . . 0.0 105.738 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.04 81.2 5.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.18 -177.51 18.89 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.301 1.429 . . . . 0.0 111.716 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -84.0 111.5 19.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.697 1.199 . . . . 0.0 112.75 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.436 ' OE2' ' HE3' ' A' ' 114' ' ' LYS . 14.6 mt-10 -65.84 140.54 58.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.599 ' H ' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -128.39 177.14 7.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.775 1.63 . . . . 0.0 109.543 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.91 -48.86 77.15 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -72.91 122.62 21.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.436 ' HE3' ' OE2' ' A' ' 110' ' ' GLU . 12.9 ptmm? 176.34 163.64 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.454 1.902 . . . . 0.0 108.586 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 117' ' ' LEU . 5.4 p90 -157.99 167.9 28.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.484 0.713 . . . . 0.0 110.56 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.59 149.54 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.856 1.662 . . . . 0.0 107.044 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -150.82 136.09 17.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.577 1.951 . . . . 0.0 107.116 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 162.93 34.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.098 0.559 . . . . 0.0 110.064 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -76.69 74.03 3.36 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.693 1.997 . . . . 0.0 109.055 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -54.72 -24.3 21.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.452 -2.03 . . . . 0.0 115.147 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -93.66 -7.44 43.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.506 1.122 . . . . 0.0 113.103 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.92 -5.0 75.85 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.501 1.524 . . . . 0.0 115.982 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.14 124.12 9.92 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.029 1.914 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.56 161.83 7.16 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.15 0.58 . . . . 0.0 110.398 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 148.06 43.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.343 0.657 . . . . 0.0 109.646 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.82 -35.46 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.054 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.39 -147.46 7.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.61 161.04 43.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.148 1.379 . . . . 0.0 108.722 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -122.07 149.55 43.38 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.487 1.115 . . . . 0.0 108.555 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.51 129.74 5.04 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.28 1.895 . . . . 0.0 109.047 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -93.73 -178.17 4.6 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 122.905 1.336 . . . . 0.0 107.916 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.26 164.4 27.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.469 1.907 . . . . 0.0 107.026 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.64 -103.16 0.3 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 104.313 -3.515 . . . . 0.0 104.313 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -72.83 -25.75 61.24 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.524 0.662 . . . . 0.0 110.426 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.36 -175.14 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.997 3.319 . . . . 0.0 107.684 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 38' ' ' ILE . 46.9 tp -95.51 129.51 42.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 126.54 1.936 . . . . 0.0 108.47 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.24 -46.37 4.84 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.947 0.499 . . . . 0.0 111.68 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -137.76 153.09 49.75 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.359 1.063 . . . . 0.0 109.028 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.4 tp -161.83 91.51 0.82 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 172.76 14.54 Favored Glycine 0 C--O 1.229 -0.214 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.33 156.59 48.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -124.48 160.38 28.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -141.98 131.58 23.97 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 103.541 -2.762 . . . . 0.0 103.541 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.275 0 CA-C-N 119.636 1.107 . . . . 0.0 112.993 -178.466 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 131.06 39.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -93.59 114.4 26.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.62 -172.33 3.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.216 1.008 . . . . 0.0 109.751 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.6 m -77.59 155.44 31.5 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.825 -1.172 . . . . 0.0 109.544 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.54 157.3 36.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.708 1.603 . . . . 0.0 109.941 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -127.66 167.3 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.251 1.82 . . . . 0.0 107.472 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.8 -113.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.67 164.46 20.23 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.662 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 9.1 p30 -105.92 6.65 31.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.641 1.577 . . . . 0.0 111.031 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.48 122.92 43.99 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 135.23 177.04 14.67 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.729 2.585 . . . . 0.0 111.894 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.0 m -102.82 153.58 20.04 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.028 1.414 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -72.49 154.67 40.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.643 1.177 . . . . 0.0 112.422 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -142.55 38.63 1.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.248 1.419 . . . . 0.0 109.089 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.3 104.63 0.08 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.082 2.553 . . . . 0.0 112.945 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.43 -40.82 16.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.863 2.865 . . . . 0.0 114.11 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.63 -95.83 1.37 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.28 169.69 10.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.37 1.468 . . . . 0.0 109.334 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -135.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.422 2.289 . . . . 0.0 106.271 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.01 -33.14 71.59 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 221' ' ' TYR . . . -179.59 -151.07 9.51 Favored Glycine 0 CA--C 1.534 1.266 1 C-N-CA 131.501 4.381 . . . . 0.0 107.935 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.8 m -135.07 155.54 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.516 1.926 . . . . 0.0 106.146 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -124.55 -53.78 1.68 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.259 0.936 . . . . 0.0 113.229 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.467 ' HE3' ' CZ ' ' A' ' 179' ' ' TYR . 29.5 ttpt -146.35 136.38 23.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.132 -1.605 . . . . 0.0 109.342 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 51.9 t -90.28 146.57 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.467 ' CZ ' ' HE3' ' A' ' 177' ' ' LYS . 45.2 m-85 -141.09 109.81 6.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.134 1.374 . . . . 0.0 108.333 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.76 138.58 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.86 92.29 0.56 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.76 160.88 29.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.251 1.024 . . . . 0.0 109.251 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.4 -170.41 12.04 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 125.414 1.483 . . . . 0.0 109.664 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -46.4 23.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.92 1.288 . . . . 0.0 112.182 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 -4.13 54.69 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.715 1.606 . . . . 0.0 114.236 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.12 -154.05 25.73 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.5 mm -75.08 133.78 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 119.171 1.485 . . . . 0.0 108.225 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 73.6 m -115.39 -22.41 9.36 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.461 1.104 . . . . 0.0 113.683 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.3 169.15 20.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.732 1.254 . . . . 0.0 110.31 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.53 149.48 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -160.16 175.72 12.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.824 1.649 . . . . 0.0 107.09 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -162.69 174.77 12.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.23 149.31 42.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -153.8 167.87 28.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.033 1.333 . . . . 0.0 108.293 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.87 164.89 13.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 119.962 -1.711 . . . . 0.0 108.622 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -140.24 93.33 2.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 64.03 -118.98 14.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.366 -2.694 . . . . 0.0 106.366 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.17 1.93 55.89 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.861 1.265 . . . . 0.0 113.5 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.59 157.33 17.01 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.906 1.23 . . . . 0.0 111.187 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -113.68 125.57 54.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.5 mm -120.64 143.82 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.187 1.395 . . . . 0.0 110.773 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.9 t -116.89 136.76 52.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.78 158.21 42.61 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -96.58 107.04 3.45 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -39.0 113.4 0.31 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.968 2.107 . . . . 0.0 112.252 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -93.39 29.42 1.96 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.693 0.797 . . . . 0.0 111.049 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.88 21.14 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 121.207 -0.933 . . . . 0.0 112.842 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -91.2 111.22 47.53 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.02 -0.99 . . . . 0.0 108.767 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.74 157.55 51.84 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.983 1.788 . . . . 0.0 109.462 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.6 p -133.95 166.36 22.88 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 25.6 tp -67.52 -12.83 61.26 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 112.169 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.68 -32.5 72.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.157 0.983 . . . . 0.0 109.771 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.64 -154.2 16.79 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -139.93 142.53 36.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.701 1.601 . . . . 0.0 107.887 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -97.32 110.77 23.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.69 134.39 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.541 0.736 . . . . 0.0 109.531 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.37 111.85 6.97 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.177 0.591 . . . . 0.0 110.527 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.32 131.12 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 110.414 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.0 mt -128.21 126.37 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 130.65 43.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.862 -0.524 . . . . 0.0 109.81 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.461 ' CE1' ' HA3' ' A' ' 174' ' ' GLY . 15.2 t80 -65.06 -63.54 3.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.25 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 221' ' ' TYR . 21.3 Cg_endo -85.96 -29.76 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.249 1.482 . . . . 0.0 114.277 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.6 t -77.32 -26.36 52.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.102 1.319 . . . . 0.0 112.829 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -126.09 172.98 9.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.304 1.041 . . . . 0.0 108.464 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -157.2 117.3 3.48 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.92 -1.113 . . . . 0.0 111.489 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.7 mt -68.22 113.44 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -26.71 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.386 0.674 . . . . 0.0 111.933 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -162.34 169.61 20.27 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.756 1.222 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.8 145.82 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -132.61 178.42 6.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.607 2.363 . . . . 0.0 109.141 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 166.72 -178.57 41.03 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.6 p -139.98 136.1 33.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.731 0.765 . . . . 0.0 109.241 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -131.12 156.24 45.6 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 113.157 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.02 162.03 40.75 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.657 -0.652 . . . . 0.0 110.545 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.48 136.12 39.37 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.173 1.389 . . . . 0.0 110.486 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.4 mt -72.85 109.71 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -48.3 121.37 4.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 110.647 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.94 22.0 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.492 1.52 . . . . 0.0 110.484 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.2 p -141.38 165.27 27.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.696 1.598 . . . . 0.0 109.501 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.7 -14.32 37.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.404 0.681 . . . . 0.0 110.306 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -68.47 146.32 45.43 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.16 159.45 24.86 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.418 1.487 . . . . 0.0 113.21 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 16.9 tt -136.96 152.2 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 127.207 2.203 . . . . 0.0 107.972 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 2.8 mt -97.68 134.15 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t -121.31 -8.25 9.21 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -146.6 141.16 26.65 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.347 0.659 . . . . 0.0 109.383 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.75 155.56 43.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.238 1.815 . . . . 0.0 108.697 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -144.89 154.62 42.82 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.877 1.671 . . . . 0.0 107.518 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.71 153.61 46.3 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -120.67 114.66 22.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.7 p -133.68 165.9 23.86 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.065 2.946 . . . . 0.0 107.209 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -112.79 160.26 18.15 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 66.15 -16.49 0.12 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.877 1.671 . . . . 0.0 112.996 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 174.2 11.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.772 2.429 . . . . 0.0 108.788 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.3 p -143.65 107.99 4.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -10.72 3.85 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 70.12 165.88 0.13 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.29 1.836 . . . . 0.0 112.187 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 98.5 Cg_endo -78.14 137.9 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.932 2.422 . . . . 0.0 109.69 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.32 93.13 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.566 1.947 . . . . 0.0 105.763 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.58 177.7 16.85 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.057 0.837 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.67 113.69 20.52 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.343 1.057 . . . . 0.0 110.243 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.21 108.49 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.354 1.061 . . . . 0.0 109.289 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.15 149.3 19.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.301 1.441 . . . . 0.0 109.056 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.56 -175.0 48.95 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.649 0.583 . . . . 0.0 112.905 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.0 m -66.7 127.53 32.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.508 1.523 . . . . 0.0 108.584 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -86.04 147.56 26.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.778 0.431 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.55 163.7 29.92 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.499 1.12 . . . . 0.0 110.749 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -145.58 147.6 32.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.764 2.425 . . . . 0.0 107.281 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.3 mt -142.01 141.77 32.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.524 1.129 . . . . 0.0 108.528 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -164.65 179.32 6.69 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.303 1.841 . . . . 0.0 110.163 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -144.05 152.95 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 104.892 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.52 71.45 10.42 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 120.398 -1.439 . . . . 0.0 112.636 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.56 -59.28 0.67 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 123.556 0.598 . . . . 0.0 113.65 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -55.49 155.68 5.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.81 0.844 . . . . 0.0 111.681 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 164.07 12.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 108.89 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.78 129.93 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.1 8.4 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.271 1.029 . . . . 0.0 111.617 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 175.11 -179.97 46.05 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -113.73 -179.07 3.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . 0.404 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 15.6 p80 -165.68 158.98 15.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.376 0.989 . . . . 0.0 111.745 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.49 -107.48 0.44 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.662 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -160.74 165.37 30.54 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.481 1.112 . . . . 0.0 110.23 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.23 147.05 37.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.686 1.594 . . . . 0.0 107.12 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 19.5 t -174.26 70.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 59.73 -7.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 129.481 3.112 . . . . 0.0 114.651 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 72.1 mt -136.43 167.73 20.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.603 2.361 . . . . 0.0 110.232 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.1 76.19 0.99 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.793 1.637 . . . . 0.0 109.479 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -76.54 -59.56 2.72 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 110.584 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -110.15 152.81 25.58 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.616 1.167 . . . . 0.0 111.596 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -159.33 145.93 16.66 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.027 0.531 . . . . 0.0 110.057 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -162.8 -175.91 34.32 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.902 2.191 . . . . 0.0 108.33 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.17 130.44 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.633 1.216 . . . . 0.0 113.718 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -73.98 155.59 38.46 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.9 m -130.75 149.64 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 58.2 mmm -151.29 153.65 32.81 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 127.656 2.383 . . . . 0.0 106.354 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.65 165.92 30.38 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.841 1.694 . . . . 0.0 111.556 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--O 1.237 0.404 0 C-N-CA 127.251 2.22 . . . . 0.0 107.781 178.45 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.622 0.725 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -149.56 132.48 16.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.012 1.325 . . . . 0.0 107.855 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.05 145.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.91 143.52 44.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.8 1.64 . . . . 0.0 108.977 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.38 174.89 4.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 109.331 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.6 44.78 0.54 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.376 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.72 -178.72 26.89 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.03 0.915 . . . . 0.0 111.222 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 161.69 2.19 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.779 1.657 . . . . 0.0 115.042 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.16 3.21 40.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.723 1.609 . . . . 0.0 113.549 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.26 -4.87 45.95 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.413 1.006 . . . . 0.0 115.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.14 158.19 18.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.46 157.52 28.92 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.235 0.517 . . . . 0.0 110.212 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -47.27 130.11 12.97 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.446 1.099 . . . . 0.0 110.67 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -130.59 121.5 25.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -161.38 141.83 10.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.32 -20.85 2.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.204 0.911 . . . . 0.0 113.406 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.045 0 C-N-CA 125.361 1.457 . . . . 0.0 114.465 179.459 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.392 0 CA-C-O 119.339 -0.701 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.77 90.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.902 1.681 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -62.8 -39.51 94.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.743 1.617 . . . . 0.0 112.127 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 41' ' ' VAL . 36.8 mtmt -145.18 162.23 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.63 1.172 . . . . 0.0 108.15 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.49 115.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -113.13 132.9 55.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.52 144.36 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 62' ' ' PHE . . . -152.45 140.09 7.46 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.73 143.62 26.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.322 1.849 . . . . 0.0 108.777 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.33 178.8 16.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 127.584 2.516 . . . . 0.0 108.58 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.81 -26.64 68.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -6.41 59.42 Favored 'General case' 0 CA--C 1.543 0.691 1 C-N-CA 131.8 4.04 . . . . 0.0 111.78 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.54 -160.35 15.02 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.04 110.45 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.6 m -140.0 0.37 1.75 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -123.45 118.41 27.38 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -144.72 155.3 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.891 0.877 . . . . 0.0 110.424 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.21 147.11 20.66 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.596 0.758 . . . . 0.0 109.567 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.26 158.56 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.424 1.49 . . . . 0.0 108.968 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 25' ' ' LYS . 4.8 t -112.79 135.39 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.92 104.65 13.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.67 110.85 22.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -78.06 166.0 23.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.0 -9.69 23.66 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.414 -1.429 . . . . 0.0 113.82 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -119.75 -17.85 8.46 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.92 149.66 26.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.709 1.595 . . . . 0.0 109.299 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -115.75 135.97 53.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.165 1.386 . . . . 0.0 110.705 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.9 t -142.64 123.07 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 0.0 110.014 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -81.85 124.28 29.55 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.79 -3.27 87.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.64 174.05 49.77 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.956 1.378 . . . . 0.0 110.296 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -82.09 152.73 26.43 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.006 -0.702 . . . . 0.0 110.488 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -134.24 154.15 51.44 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 108.338 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.77 -160.48 31.32 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -96.95 105.52 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -53.9 121.5 8.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.438 0.695 . . . . 0.0 110.772 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -138.98 95.92 3.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.776 1.274 . . . . 0.0 108.326 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.26 3.12 13.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.593 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -16.85 7.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.489 2.316 . . . . 0.0 112.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.54 80.37 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 12.4 p90 -119.37 159.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 164.01 28.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.496 2.319 . . . . 0.0 112.763 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -132.96 95.46 3.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.54 124.87 41.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.45 135.48 44.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.434 0.694 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.2 t -81.51 109.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.46 130.35 42.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.79 67.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.221 1.373 . . . . 0.0 111.427 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.3 -8.23 59.47 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.723 1.609 . . . . 0.0 111.265 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.34 151.85 24.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.322 -0.861 . . . . 0.0 110.135 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -134.79 139.96 45.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mt -78.49 118.35 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.36 -26.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.362 0.665 . . . . 0.0 111.524 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.78 152.92 38.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.898 0.879 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.11 152.89 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.419 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 46.2 mt-30 -135.17 127.57 30.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.383 2.673 . . . . 0.0 106.691 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.61 116.33 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.368 0.985 . . . . 0.0 109.816 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.8 p -87.44 152.0 22.59 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.999 1.272 . . . . 0.0 107.612 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -150.34 142.64 24.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.53 160.27 28.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.42 131.8 35.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.9 m -102.55 175.11 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 122.062 0.934 . . . . 0.0 113.0 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -60.44 119.55 8.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 109.082 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 3.44 65.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.239 -1.311 . . . . 0.0 113.794 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -122.31 158.49 29.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.722 1.261 . . . . 0.0 110.979 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -107.31 -48.96 3.35 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -78.94 145.17 34.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.59 0.709 . . . . 0.0 110.57 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.99 155.83 39.9 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -139.72 159.86 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 mt -65.49 125.5 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.6 p -100.79 -28.27 12.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.402 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -157.83 165.53 35.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.302 1.41 . . . . 0.0 109.401 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.6 mt -143.69 145.96 21.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.607 1.963 . . . . 0.0 106.623 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 77' ' ' GLN . 57.8 m -150.61 118.5 6.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.36 157.0 16.47 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -133.17 129.95 38.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 72.2 p -101.17 154.75 18.48 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.323 0.249 . . . . 0.0 110.838 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -73.2 -28.98 62.49 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 9.2 mmpt? -49.26 -44.56 43.88 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 125.095 1.358 . . . . 0.0 109.354 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.5 -6.18 3.87 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.847 -0.974 . . . . 0.0 114.402 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.256 0.3 OUTLIER -103.2 157.07 17.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.911 1.355 . . . . 0.0 111.559 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.6 p -133.11 147.9 52.14 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.043 1.737 . . . . 0.0 107.916 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.74 158.73 56.27 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.31 167.7 26.2 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 121.652 1.568 . . . . 0.0 108.096 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.4 109.91 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.847 2.364 . . . . 0.0 110.247 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -79.09 62.03 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.51 1.524 . . . . 0.0 108.442 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.54 177.77 15.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.891 1.71 . . . . 0.0 110.561 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.9 110.03 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 113.631 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.28 126.56 27.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.6 m -122.79 171.6 9.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.539 0.735 . . . . 0.0 110.916 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -61.85 -58.72 6.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.66 1.184 . . . . 0.0 109.628 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -67.01 129.57 40.34 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -160.79 169.95 21.69 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.029 0.532 . . . . 0.0 111.097 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 117' ' ' LEU . 60.8 t80 -122.15 138.8 54.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.637 2.775 . . . . 0.0 106.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.65 132.59 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 115' ' ' PHE . 2.5 pt? -153.06 151.99 30.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.857 0.863 . . . . 0.0 108.906 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 156.33 20.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.195 0.998 . . . . 0.0 109.559 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.02 165.22 12.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.002 0.921 . . . . 0.0 108.57 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -138.22 -75.46 0.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -127.85 13.51 6.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.574 1.15 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.25 -17.13 38.04 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 117.331 -1.816 . . . . 0.0 116.569 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.83 27.39 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.953 1.876 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -137.01 166.34 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.88 128.86 37.84 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.65 -59.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.304 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.7 176.57 17.61 Favored Glycine 0 N--CA 1.465 0.617 0 CA-C-N 119.429 1.013 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -125.3 163.58 22.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.955 1.702 . . . . 0.0 112.321 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -167.79 171.07 10.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.548 1.539 . . . . 0.0 109.466 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.64 -119.66 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -154.73 110.92 3.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.641 3.176 . . . . 0.0 103.821 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.84 18.55 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.558 1.143 . . . . 0.0 108.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.79 -131.13 1.97 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.96 -17.47 25.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.886 1.675 . . . . 0.0 114.484 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.87 19.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.324 1.05 . . . . 0.0 110.433 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 tp -86.83 87.01 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -86.57 -32.56 20.6 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.5 162.45 40.11 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.336 -0.852 . . . . 0.0 112.999 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 tp -161.93 106.08 1.22 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.317 -0.239 . . . . 0.0 110.987 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.01 166.22 13.55 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.316 2.389 . . . . 0.0 107.135 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.24 161.75 36.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.133 0.967 . . . . 0.0 109.165 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -101.04 146.13 27.83 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.82 99.82 4.28 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.434 0 C-N-CA 124.033 0.933 . . . . 0.0 109.413 179.902 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.848 0.832 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -74.97 138.34 42.21 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -106.27 110.93 23.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.17 1.388 . . . . 0.0 111.848 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 mt -69.0 173.78 5.12 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.258 1.423 . . . . 0.0 108.535 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.6 t -98.23 103.9 15.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.77 170.88 14.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 tt -164.07 160.23 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 106.82 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.68 -20.46 1.3 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.81 -23.6 0.41 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 118.56 1.18 . . . . 0.0 114.004 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.445 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 3.7 m-20 60.14 10.96 2.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.301 1.44 . . . . 0.0 114.027 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -96.2 150.64 20.31 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.821 -1.174 . . . . 0.0 109.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 -179.19 18.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.025 1.298 . . . . 0.0 110.699 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 65.7 m -75.26 124.22 26.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -86.09 131.53 34.24 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.777 0.831 . . . . 0.0 110.322 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.448 ' HE1' ' HB3' ' A' ' 283' ' ' ALA . 54.6 p-90 -158.89 130.35 6.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.925 0.89 . . . . 0.0 110.028 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.18 135.18 39.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -123.44 60.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.718 2.007 . . . . 0.0 107.269 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -24.68 -82.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.646 0 C-N-CA 129.666 3.507 . . . . 0.0 115.071 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.86 162.94 7.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.682 0.793 . . . . 0.0 112.915 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.07 -165.86 1.57 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.648 2.379 . . . . 0.0 108.684 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.83 -45.16 79.12 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.895 -1.128 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.21 164.26 32.88 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.785 0.707 . . . . 0.0 112.207 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -74.83 157.5 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.08 1.352 . . . . 0.0 111.3 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -133.49 -65.17 0.69 Allowed 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.411 1.084 . . . . 0.0 109.479 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -140.64 156.2 46.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.493 0.588 . . . . 0.0 110.197 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.66 147.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.315 1.846 . . . . 0.0 107.315 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -138.99 163.46 32.33 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.826 1.251 . . . . 0.0 108.515 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.1 t -141.88 123.63 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -100.97 77.09 0.4 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.5 -175.78 0.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.805 0.812 . . . . 0.0 112.151 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.83 -172.53 38.57 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.47 -28.67 69.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 128.632 2.773 . . . . 0.0 114.901 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.76 -31.67 5.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.6 2.76 . . . . 0.0 112.398 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.8 -167.88 36.01 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.21 114.37 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.2 m -103.79 -25.24 13.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.883 1.673 . . . . 0.0 112.005 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -134.21 154.51 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.024 0.93 . . . . 0.0 109.02 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.74 155.34 27.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.418 1.087 . . . . 0.0 109.002 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -175.43 152.56 1.38 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 111.061 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.99 162.32 35.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.541 1.536 . . . . 0.0 108.217 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.37 151.22 37.45 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.517 1.127 . . . . 0.0 108.516 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -163.83 154.22 15.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.646 0.736 . . . . 0.0 111.052 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -110.27 123.75 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -139.78 145.15 37.85 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.34 35.86 61.73 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.68 0.38 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.243 3.417 . . . . 0.0 114.421 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.52 154.75 19.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.756 1.622 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.78 130.69 39.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.781 0.832 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.1 mt -119.25 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 37.2 t -122.54 121.45 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 176.96 -110.97 0.32 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 67.03 -4.63 3.16 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 127.143 2.306 . . . . 0.0 116.469 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.58 124.92 25.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.163 1.982 . . . . 0.0 108.678 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.22 16.9 1.36 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.435 1.894 . . . . 0.0 111.803 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.45 151.34 23.61 Favored Glycine 0 C--N 1.335 0.501 0 O-C-N 119.099 -2.251 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 285' ' ' GLU . 45.8 pttt -35.43 98.94 0.16 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.682 1.593 . . . . 0.0 114.009 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.37 114.26 2.79 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.243 1.962 . . . . 0.0 107.977 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.0 p -78.32 145.33 35.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.059 0.944 . . . . 0.0 110.329 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.46 -7.1 34.96 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.429 -0.795 . . . . 0.0 110.202 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.86 2.064 . . . . 0.0 108.622 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.93 -161.95 13.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -141.99 129.06 20.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -79.41 161.93 25.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -144.19 157.21 44.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 111.964 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.52 115.75 8.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.38 116.17 31.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.9 mm -127.55 107.57 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.71 103.79 1.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 123.92 0.762 . . . . 0.0 110.909 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -36.5 -56.07 1.36 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.211 2.204 . . . . 0.0 115.957 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.7 -16.96 11.35 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 115.017 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.9 m -101.24 -10.59 20.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.484 1.493 . . . . 0.0 113.288 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.532 ' HG2' ' H ' ' A' ' 225' ' ' TYR . 23.8 tt0 -139.99 -168.82 2.6 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.532 ' H ' ' HG2' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -168.27 140.7 2.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.35 115.45 49.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.372 2.269 . . . . 0.0 106.208 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 32.5 m -94.14 -72.02 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.281 0.491 . . . . 0.0 111.658 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -107.82 170.5 7.95 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.551 1.14 . . . . 0.0 113.981 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.3 p -132.68 144.97 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.81 1.644 . . . . 0.0 107.91 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -133.07 169.82 16.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.711 1.604 . . . . 0.0 107.428 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.87 -175.26 45.77 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 120.248 -1.532 . . . . 0.0 109.599 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.32 136.27 22.23 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.47 38.99 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.348 1.059 . . . . 0.0 109.339 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -136.97 166.13 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.688 0.756 . . . . 0.0 112.172 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -72.87 141.22 47.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.926 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.1 157.93 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.763 2.025 . . . . 0.0 109.1 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -107.43 106.34 16.7 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 160.25 -49.13 0.38 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.441 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 49.9 m -135.46 173.92 11.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.196 0.998 . . . . 0.0 111.965 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.86 -12.2 58.58 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.159 0.584 . . . . 0.0 112.314 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.54 120.22 5.95 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.39 172.52 9.3 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.532 1.933 . . . . 0.0 107.061 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.7 tt -125.82 134.49 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.734 1.152 . . . . 0.0 111.441 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.4 mt -79.43 122.88 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 -6.67 10.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.983 0.513 . . . . 0.0 111.828 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -143.37 147.29 34.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -138.95 149.13 44.41 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.033 1.733 . . . . 0.0 110.255 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . 0.41 ' H ' HD23 ' A' ' 247' ' ' LEU . 18.8 mtt180 -149.4 153.83 37.96 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.05 1.74 . . . . 0.0 106.613 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.43 138.47 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -89.27 114.31 25.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.27 0.941 . . . . 0.0 109.492 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.8 p -97.85 165.42 11.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.7 2.0 . . . . 0.0 110.659 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.28 134.75 55.04 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? 75.79 -50.92 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.749 2.42 . . . . 0.0 107.659 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -82.67 155.91 24.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.853 2.061 . . . . 0.0 108.262 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 59.4 m -118.83 114.52 22.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.3 p -68.88 168.22 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 111.802 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.45 154.17 42.42 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.021 1.328 . . . . 0.0 109.442 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.45 109.17 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.874 2.383 . . . . 0.0 108.234 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.54 92.34 5.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.42 -172.01 14.41 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.495 1.045 . . . . 0.0 111.495 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.98 133.94 52.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.42 -1.047 . . . . 0.0 110.516 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.2 108.33 3.12 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -147.56 125.91 12.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 97.81 -157.77 20.73 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.41 0.45 . . . . 0.0 112.095 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.3 m -77.21 117.52 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.722 1.209 . . . . 0.0 110.474 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.92 129.58 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -136.52 151.24 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.46 155.42 50.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.355 1.062 . . . . 0.0 108.58 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp -141.37 130.79 23.76 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.803 0.841 . . . . 0.0 109.017 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.47 166.29 10.26 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.069 1.348 . . . . 0.0 109.369 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -134.78 134.0 40.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.74 128.27 35.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.864 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.21 26.62 70.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -135.96 162.62 32.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.505 1.653 . . . . 0.0 111.097 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -121.62 162.49 20.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.211 1.404 . . . . 0.0 110.165 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 25.4 mt -79.63 145.64 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.1 m -145.49 -12.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.25 34.34 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 120.674 1.579 . . . . 0.0 111.136 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -144.85 157.06 44.29 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.112 1.765 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -149.64 149.29 30.42 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 128.489 2.716 . . . . 0.0 104.783 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.55 -135.99 6.45 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 11.5 mptt -140.63 157.54 45.3 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.448 ' HB3' ' HE1' ' A' ' 167' ' ' TRP . . . -129.87 149.37 51.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.3 p -159.75 -178.01 6.77 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.212 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' A' ' 208' ' ' LYS . 5.7 mm-40 -67.83 -0.19 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.785 1.234 . . . . 0.0 111.671 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 22.6 mt -140.77 135.81 31.88 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 129.316 3.047 . . . . 0.0 103.148 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -85.74 95.62 9.45 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -88.89 -70.41 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.277 0.361 . . . . 0.0 111.722 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -106.13 111.68 24.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.563 1.145 . . . . 0.0 111.995 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -116.98 160.74 20.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.52 40.24 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.73 141.01 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 117.818 0.809 . . . . 0.0 108.943 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -84.24 155.63 22.39 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.1 m -125.12 158.49 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.861 0.864 . . . . 0.0 109.816 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 28.2 mtt -157.44 145.71 14.27 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.871 2.468 . . . . 0.0 105.491 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.54 155.91 62.39 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.182 -1.507 . . . . 0.0 108.182 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.624 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.251 0.548 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -148.53 140.6 23.97 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.3 93.35 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.823 0.738 . . . . 0.0 109.03 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.34 146.46 19.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.477 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 150.98 47.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.093 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.12 9.67 69.99 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.7 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.28 179.88 43.78 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.305 1.552 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.37 -31.34 63.53 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.63 12.85 9.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.47 2.308 . . . . 0.0 113.448 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.04 -28.22 12.16 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.749 2.119 . . . . 0.0 116.352 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.71 -81.33 0.58 Allowed Glycine 0 C--N 1.342 0.863 0 CA-C-N 120.15 1.975 . . . . 0.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 131' ' ' ARG . . . -145.67 158.89 43.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.986 0.915 . . . . 0.0 109.885 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.29 97.88 6.0 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.894 1.278 . . . . 0.0 111.414 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.501 ' CD1' ' HG3' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -67.38 0.6 2.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.538 1.535 . . . . 0.0 113.001 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.65 109.79 2.13 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.12 -0.987 . . . . 0.0 111.103 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.05 165.36 17.62 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 109.434 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 118.376 -1.235 . . . . 0.0 113.443 179.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.379 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -143.11 96.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.62 1.568 . . . . 0.0 107.42 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.407 ' HD2' ' HB2' ' A' ' 43' ' ' ALA . 7.9 tpm_? -85.59 -50.56 7.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.805 1.242 . . . . 0.0 110.836 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -141.19 164.48 30.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.37 96.97 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.1 126.1 34.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.89 136.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.38 162.71 30.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -106.86 141.19 38.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.239 2.216 . . . . 0.0 111.259 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.39 -156.68 9.72 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 106.039 -2.824 . . . . 0.0 106.039 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -96.06 -9.4 30.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.705 -1.467 . . . . 0.0 109.629 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.82 2.71 38.59 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 134.132 4.973 . . . . 0.0 112.707 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.71 -139.4 14.49 Favored Glycine 0 C--N 1.339 0.736 0 O-C-N 121.146 -0.971 . . . . 0.0 111.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -77.42 96.45 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -105.43 2.74 28.91 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.47 124.91 23.43 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 122.138 2.245 . . . . 0.0 107.919 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 169.37 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -159.14 152.83 22.97 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.745 -1.222 . . . . 0.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.58 107.6 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.037 1.335 . . . . 0.0 109.585 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.42 114.88 35.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -101.93 122.97 45.05 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.781 0.719 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . -77.81 125.64 29.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -113.98 145.32 41.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.16 -35.58 59.93 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 t -80.71 -65.08 1.06 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.207 0.458 . . . . 0.0 110.203 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -150.96 140.91 21.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.341 1.056 . . . . 0.0 108.359 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.63 135.58 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.202 1.801 . . . . 0.0 109.665 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.74 146.56 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 106.984 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 156.89 21.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.711 1.204 . . . . 0.0 109.657 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.62 35.36 3.33 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.234 1.873 . . . . 0.0 111.384 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.07 -154.36 47.09 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.012 0.906 . . . . 0.0 111.628 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.3 152.8 47.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -128.81 166.11 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.1 0.96 . . . . 0.0 109.002 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' A' ' 56' ' ' LYS . . . 85.71 -157.96 31.73 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -126.66 105.56 8.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 113.358 -178.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 1.5 ttmp? -62.41 128.73 37.43 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -131.14 155.17 47.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.6 pt? -75.56 -9.88 58.96 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -0.19 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.604 1.562 . . . . 0.0 113.089 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.08 130.87 2.39 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 125.888 1.709 . . . . 0.0 108.903 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.523 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 63.7 t80 -163.58 132.32 3.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.321 2.648 . . . . 0.0 105.781 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 163.67 32.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.79 1.636 . . . . 0.0 111.817 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -134.2 96.85 3.7 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.681 1.193 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.61 138.43 31.69 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.94 119.21 32.81 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.243 1.017 . . . . 0.0 109.602 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.24 123.67 25.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.046 0.938 . . . . 0.0 109.403 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.42 159.88 31.73 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.51 1.524 . . . . 0.0 110.742 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.51 25.99 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.5 1.57 55.71 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.469 2.308 . . . . 0.0 114.254 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -127.21 155.98 42.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.721 1.146 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -135.08 137.12 42.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.49 1.116 . . . . 0.0 108.884 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mt -73.96 102.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.24 -34.77 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 113.965 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.06 43.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.827 0.739 . . . . 0.0 109.482 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.29 146.29 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -131.49 137.69 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.49 139.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 p -115.8 154.49 29.55 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -154.3 168.63 25.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.86 1.264 . . . . 0.0 108.9 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -161.07 168.51 24.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -115.88 159.02 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.848 2.059 . . . . 0.0 109.063 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.1 m -127.25 135.62 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.29 107.82 0.61 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.24 3.66 7.99 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.041 -1.421 . . . . 0.0 113.35 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.23 142.17 47.26 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 119.817 1.808 . . . . 0.0 108.203 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.71 16.2 12.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.879 2.071 . . . . 0.0 111.517 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -136.35 172.72 12.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.348 1.459 . . . . 0.0 111.469 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.84 158.4 30.36 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.811 1.644 . . . . 0.0 106.897 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 pt -131.68 150.51 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.736 1.614 . . . . 0.0 107.397 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.89 122.76 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.292 1.037 . . . . 0.0 110.348 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 p -88.8 -29.67 19.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.71 0.804 . . . . 0.0 112.274 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -164.55 161.61 21.23 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.94 1.296 . . . . 0.0 109.793 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 mt -136.35 136.71 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 m -135.81 132.66 36.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -114.74 158.88 21.23 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.522 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -140.75 144.72 35.67 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.522 2.329 . . . . 0.0 105.227 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -134.2 166.39 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.0 -41.04 95.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 10.3 mmpt? -58.33 -12.09 3.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.455 1.102 . . . . 0.0 112.275 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.0 18.61 62.76 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.194 1.378 . . . . 0.0 111.954 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -89.15 97.01 10.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 p -85.46 105.81 16.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.24 157.11 83.35 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.53 164.17 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 0.0 111.331 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 111.82 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.063 2.509 . . . . 0.0 107.02 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -75.52 74.79 2.56 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.365 0.666 . . . . 0.0 109.566 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 142.36 -141.17 10.54 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.228 1.395 . . . . 0.0 110.519 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.9 tp -108.5 132.5 53.75 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 125.544 1.538 . . . . 0.0 109.619 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 116.86 18.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 m -114.67 164.6 13.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -61.26 -51.9 66.98 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.814 1.246 . . . . 0.0 110.174 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.29 115.77 11.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.9 168.27 27.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.358 -0.839 . . . . 0.0 110.872 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.37 167.18 22.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.607 1.563 . . . . 0.0 107.887 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.65 149.8 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -142.95 157.32 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.344 0.52 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.42 160.04 15.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.719 1.608 . . . . 0.0 111.51 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -81.28 177.12 9.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.796 1.639 . . . . 0.0 107.898 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.08 -46.31 2.32 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.111 -0.993 . . . . 0.0 112.519 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -109.52 19.25 19.48 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.41 -4.93 85.23 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.001 1.286 . . . . 0.0 114.244 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 118.32 13.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.53 164.18 0.54 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.243 1.817 . . . . 0.0 113.752 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.28 111.27 1.68 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.9 t -61.75 -50.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.78 48.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.08 -2.408 . . . . 0.0 107.08 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -102.49 172.32 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 169.14 20.89 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.48 126.69 1.73 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.501 ' HG3' ' CD1' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -99.74 179.3 4.58 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 123.208 1.48 . . . . 0.0 109.075 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.23 152.85 39.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 129.663 3.185 . . . . 0.0 105.519 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.52 -87.09 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 104.214 -3.555 . . . . 0.0 104.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -95.12 -27.48 15.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.186 0.493 . . . . 0.0 111.142 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.59 160.73 37.17 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 tp -77.45 93.67 4.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.597 0.713 . . . . 0.0 110.284 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -81.76 -37.12 27.71 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.306 1.042 . . . . 0.0 112.681 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.58 152.02 39.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.813 1.188 . . . . 0.0 109.853 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.4 tp -161.77 141.89 10.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.256 1.422 . . . . 0.0 108.296 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.89 -179.73 46.85 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.55 167.43 28.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.654 1.182 . . . . 0.0 109.069 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -136.39 168.44 19.45 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.815 1.293 . . . . 0.0 111.169 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -133.04 97.37 3.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 103.151 -2.907 . . . . 0.0 103.151 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -178.744 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.92 0.867 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 126.52 31.13 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.149 -0.969 . . . . 0.0 112.816 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.82 147.88 24.94 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.992 2.117 . . . . 0.0 109.882 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.66 162.47 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.5 t -72.63 135.49 45.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -135.37 169.43 17.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.387 1.875 . . . . 0.0 109.976 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.6 154.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.25 1.82 . . . . 0.0 108.883 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.8 -85.2 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.68 47.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.668 2.08 . . . . 0.0 108.271 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 2.9 p30 -111.19 10.15 21.84 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -83.45 150.06 26.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.35 -179.56 22.94 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.721 1.146 . . . . 0.0 115.805 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.4 m -96.3 119.39 34.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.197 1.799 . . . . 0.0 109.136 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.6 153.65 40.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.438 0.563 . . . . 0.0 110.295 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -142.46 131.2 22.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.33 1.062 . . . . 0.0 111.0 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.32 139.91 32.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.806 1.643 . . . . 0.0 108.512 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.16 124.66 19.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.78 177.68 41.99 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.386 1.47 . . . . 0.0 111.05 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.36 149.69 27.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -131.96 -175.31 3.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.216 1.007 . . . . 0.0 110.896 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.07 -32.21 54.01 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.934 1.694 . . . . 0.0 113.327 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.32 -158.64 31.36 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.512 2.006 . . . . 0.0 108.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.39 139.47 50.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.688 1.195 . . . . 0.0 108.622 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.89 -68.89 0.9 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 110.233 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 193' ' ' GLU . 49.8 mtpt -119.03 157.65 27.37 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.399 0.545 . . . . 0.0 110.749 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.83 143.73 38.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 127.303 2.241 . . . . 0.0 107.775 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -143.39 145.41 32.63 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.722 1.209 . . . . 0.0 108.041 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 t -139.39 151.3 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.381 1.072 . . . . 0.0 109.605 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.74 144.37 16.24 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -123.36 -170.05 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.359 1.464 . . . . 0.0 110.571 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.85 -175.83 45.78 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 126.002 1.763 . . . . 0.0 110.127 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.26 -17.92 2.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.428 3.091 . . . . 0.0 118.219 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -117.78 -9.91 10.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.912 0.778 . . . . 0.0 112.259 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.7 -146.69 18.58 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 mm -63.86 153.4 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.588 1.194 . . . . 0.0 108.393 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.3 p -134.81 -23.84 1.54 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.76 151.93 34.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.692 1.133 . . . . 0.0 111.718 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 m -149.51 124.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 123.543 0.737 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -149.81 161.28 42.57 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -151.3 172.91 15.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.013 0.925 . . . . 0.0 108.511 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 177' ' ' LYS . 25.2 mp0 -130.88 147.03 52.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.837 0.827 . . . . 0.0 109.767 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.47 168.42 21.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.811 2.044 . . . . 0.0 109.979 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -112.3 161.83 16.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.0 1.72 . . . . 0.0 108.764 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -134.35 83.77 2.06 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.692 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.63 -66.58 1.34 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.398 1.475 . . . . 0.0 111.477 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -135.07 -45.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.365 1.866 . . . . 0.0 108.555 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -60.9 164.43 4.88 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.872 1.32 . . . . 0.0 111.333 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.34 149.78 44.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.625 1.57 . . . . 0.0 107.414 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -140.43 143.9 28.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.53 147.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -71.79 146.49 40.17 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.46 10.66 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.334 -3.106 . . . . 0.0 105.334 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 133.57 49.31 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 118.616 1.208 . . . . 0.0 108.863 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -106.41 -15.25 14.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.559 0.744 . . . . 0.0 110.486 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -102.48 -177.62 27.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.827 1.68 . . . . 0.0 113.232 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -107.93 83.52 1.76 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 128.531 2.733 . . . . 0.0 106.323 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.4 148.97 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.75 . . . . 0.0 111.553 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 66.7 p -87.06 -179.26 6.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.45 -1.06 25.23 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.151 -1.593 . . . . 0.0 112.771 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -32.27 32.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.23 0.923 . . . . 0.0 113.239 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.56 -157.11 18.81 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -147.42 119.94 8.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -66.94 154.76 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -139.75 142.74 36.77 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -143.04 142.98 31.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.495 1.518 . . . . 0.0 107.486 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -133.14 95.85 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.76 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.97 1.308 . . . . 0.0 111.395 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.78 89.79 2.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.403 1.081 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -45.46 -47.74 35.99 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.598 1.959 . . . . 0.0 112.626 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.89 -7.03 15.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 122.048 1.767 . . . . 0.0 114.682 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.7 t -109.93 -13.15 14.48 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 120.814 1.643 . . . . 0.0 113.402 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 171.66 13.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.344 0.975 . . . . 0.0 111.328 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -145.66 90.63 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.62 101.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.3 p -87.19 -26.47 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.441 1.097 . . . . 0.0 112.46 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.52 171.02 20.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.156 0.889 . . . . 0.0 112.24 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.86 159.26 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.16 176.35 5.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.717 2.407 . . . . 0.0 107.543 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.97 41.86 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -153.18 141.3 20.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.11 153.79 48.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.761 0.825 . . . . 0.0 110.432 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . 0.326 0.3 OUTLIER -156.17 172.01 19.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -74.78 139.94 43.66 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.409 1.483 . . . . 0.0 110.953 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.25 157.54 34.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 127.221 2.208 . . . . 0.0 110.041 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -84.93 178.37 7.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.32 -69.7 1.52 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.1 p -95.48 -178.21 4.34 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.715 0.769 . . . . 0.0 111.427 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.58 14.19 24.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.613 1.565 . . . . 0.0 111.435 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -128.27 163.49 21.81 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.249 1.404 . . . . 0.0 113.099 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.82 173.28 11.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.978 1.711 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.75 146.07 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.403 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.3 mm -76.12 133.78 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 t -112.36 -21.82 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -152.27 152.7 32.48 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 140.42 34.23 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.821 2.048 . . . . 0.0 109.013 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -145.23 153.42 41.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 106.339 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.45 128.69 56.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -80.47 114.39 19.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -119.66 165.16 14.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.365 1.079 . . . . 0.0 109.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.93 133.51 47.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 65.95 -46.39 0.4 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.501 2.32 . . . . 0.0 111.188 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -92.11 165.5 13.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 129.283 3.033 . . . . 0.0 109.408 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 73.7 m -150.76 118.83 6.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 83.9 p -66.85 165.03 16.08 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.095 0.474 . . . . 0.0 110.613 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -67.84 153.96 94.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.84 97.77 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.439 2.093 . . . . 0.0 106.731 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -76.14 92.47 3.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 111.28 178.24 20.33 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.952 1.263 . . . . 0.0 111.534 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.75 123.44 49.0 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.09 0.956 . . . . 0.0 110.035 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.11 107.23 5.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -157.05 45.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.219 1.008 . . . . 0.0 109.357 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -167.87 -164.92 24.39 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 121.405 -0.81 . . . . 0.0 111.115 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.2 m -66.7 104.6 1.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.27 146.98 36.54 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.578 -0.701 . . . . 0.0 110.788 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -141.4 170.42 15.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.924 0.868 . . . . 0.0 112.763 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -140.99 152.83 45.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.542 2.337 . . . . 0.0 106.891 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.6 mt -138.64 104.22 5.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -140.05 150.82 44.83 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.255 0.622 . . . . 0.0 110.461 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -144.8 130.75 19.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -67.71 138.72 56.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.63 -11.23 3.38 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.483 1.516 . . . . 0.0 115.818 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -99.21 159.75 14.76 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 120.111 1.956 . . . . 0.0 112.197 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -119.95 147.6 44.55 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.823 1.649 . . . . 0.0 107.543 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 87.9 mt -80.69 141.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.16 -29.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.46 -178.07 35.08 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.001 1.286 . . . . 0.0 110.559 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -113.37 -179.04 3.53 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.878 1.671 . . . . 0.0 111.22 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -153.35 179.36 8.84 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.822 2.049 . . . . 0.0 105.549 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 126.98 -151.73 18.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -151.54 149.53 29.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -108.11 154.6 21.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.936 1.295 . . . . 0.0 108.513 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 t -151.92 -63.03 0.17 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -149.18 -31.36 0.23 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.387 1.075 . . . . 0.0 112.542 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 79.6 mt -134.4 -112.81 0.21 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.948 1.249 . . . . 0.0 109.259 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.78 77.43 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.175 1.352 . . . . 0.0 108.628 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -60.58 -62.24 2.0 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 0.0 113.322 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -132.38 140.76 48.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.866 0.757 . . . . 0.0 109.702 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -140.99 151.32 44.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.566 1.547 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.88 165.83 37.76 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.0 m -113.52 157.02 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.788 1.294 . . . . 0.0 113.719 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.97 136.44 38.95 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.59 141.95 38.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.21 129.41 20.84 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 125.044 1.338 . . . . 0.0 108.425 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.95 86.53 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.857 3.038 . . . . 0.0 110.059 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 20.7 mt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.455 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.391 0.615 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -140.99 140.66 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 130.442 3.497 . . . . 0.0 107.1 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 82.5 t -127.94 130.9 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.61 169.89 5.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.333 1.053 . . . . 0.0 113.836 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.37 106.55 6.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.44 134.08 13.29 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 105.67 -2.972 . . . . 0.0 105.67 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.25 -151.42 20.08 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.77 168.89 42.89 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 122.779 1.21 . . . . 0.0 114.444 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.74 -18.39 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.457 1.103 . . . . 0.0 111.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.53 169.33 41.23 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.577 0.608 . . . . 0.0 113.005 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.91 168.49 44.46 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.134 1.35 . . . . 0.0 112.462 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.74 156.06 21.59 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 84.0 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.199 1.4 . . . . 0.0 110.264 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -90.04 135.58 33.56 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.38 151.95 28.49 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 128.295 2.638 . . . . 0.0 105.41 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.78 153.0 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.842 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -178.952 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.11 142.71 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 119.397 1.598 . . . . 0.0 109.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.29 -33.33 1.3 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.265 0.626 . . . . 0.0 112.29 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -135.89 160.67 37.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.453 0.569 . . . . 0.0 110.735 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.29 90.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.63 110.45 20.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -132.92 147.58 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 172.37 22.45 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -135.12 157.27 47.35 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.835 0.854 . . . . 0.0 112.568 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.83 -153.28 8.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.389 -2.684 . . . . 0.0 106.389 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -95.86 -7.34 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.96 -1.318 . . . . 0.0 110.373 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.38 -7.23 26.48 Favored 'General case' 0 N--CA 1.446 -0.645 1 C-N-CA 133.705 4.802 . . . . 0.0 112.427 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.77 -151.91 18.07 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.78 131.69 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -148.09 13.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.758 -1.214 . . . . 0.0 113.297 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 p -131.7 125.42 32.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.5 mt -140.52 119.39 11.19 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -128.03 145.36 51.01 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 107.714 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.2 t -129.08 131.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.313 1.045 . . . . 0.0 110.407 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.59 132.51 44.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 102.184 -3.265 . . . . 0.0 102.184 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -103.07 152.63 21.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 109.834 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.26 115.87 30.92 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.16 166.73 11.33 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.357 1.075 . . . . 0.0 111.16 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.53 -5.65 25.64 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.406 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.2 m -104.91 -67.01 0.93 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 119.583 -1.948 . . . . 0.0 110.803 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -156.35 165.6 35.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.664 1.185 . . . . 0.0 107.831 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.52 141.88 42.94 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -145.79 138.44 20.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.61 136.45 57.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.152 0.981 . . . . 0.0 108.438 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.73 -65.88 1.84 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.15 171.81 20.17 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.09 146.3 23.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.483 0.659 . . . . 0.0 111.02 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -123.92 83.73 2.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.28 26.29 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -126.61 112.44 15.5 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -52.98 111.96 0.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 110.082 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -81.61 108.36 15.11 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 127.756 2.422 . . . . 0.0 109.842 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.77 -24.02 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.569 -0.707 . . . . 0.0 112.672 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.28 8.77 43.89 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.271 1.029 . . . . 0.0 113.548 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.44 121.9 0.84 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.951 1.25 . . . . 0.0 110.658 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.85 121.38 2.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.623 2.369 . . . . 0.0 105.026 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -128.4 164.45 22.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.4 m -121.87 131.22 53.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.865 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -137.47 110.27 7.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -95.52 124.66 39.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.98 1.312 . . . . 0.0 108.922 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.84 116.25 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.56 143.57 56.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -41.63 75.41 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.626 -0.671 . . . . 0.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.34 -7.4 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.677 1.191 . . . . 0.0 112.638 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.11 151.33 21.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.969 1.708 . . . . 0.0 108.23 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -130.89 143.15 50.52 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.9 mt -68.57 137.64 24.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.2 m -107.18 -46.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 123.144 0.578 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 165.32 31.07 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.215 1.406 . . . . 0.0 108.635 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.07 108.82 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -91.91 137.68 32.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.5 t -136.36 144.16 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.523 HG21 ' H ' ' A' ' 111' ' ' THR . 75.6 m -118.61 140.46 49.88 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.69 167.17 30.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.218 1.807 . . . . 0.0 106.308 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.18 168.54 24.03 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.53 0.605 . . . . 0.0 109.842 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -108.5 148.72 29.84 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.375 1.07 . . . . 0.0 111.313 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.48 131.13 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -60.24 -0.25 0.22 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.817 1.647 . . . . 0.0 115.201 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.36 7.66 34.77 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.18 1.847 . . . . 0.0 113.35 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -138.42 144.07 40.02 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 120.365 2.083 . . . . 0.0 109.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.59 -2.29 28.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.281 1.832 . . . . 0.0 111.664 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 t -155.02 150.38 27.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.83 -1.169 . . . . 0.0 110.137 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.52 163.87 27.24 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 pt -139.39 151.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.973 1.309 . . . . 0.0 109.246 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.16 118.92 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.429 ' OG1' HG22 ' A' ' 79' ' ' THR . 23.4 p -89.53 -32.76 17.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.584 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -162.84 166.22 24.36 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.557 1.071 . . . . 0.0 112.863 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.6 mt -135.72 151.58 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.066 1.347 . . . . 0.0 107.681 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.3 m -141.25 101.74 4.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.392 1.877 . . . . 0.0 107.009 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -81.82 121.8 26.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.752 1.221 . . . . 0.0 108.914 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -106.13 128.24 53.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.414 1.486 . . . . 0.0 109.067 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.9 p -99.9 169.06 9.48 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.642 1.177 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -76.92 -39.93 49.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -68.75 -26.2 65.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 116.432 -1.747 . . . . 0.0 115.348 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.52 -12.58 7.01 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 121.068 1.758 . . . . 0.0 114.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -70.49 137.4 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -135.06 128.66 32.69 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.5 p -74.31 158.66 85.11 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 117.914 0.325 . . . . 0.0 110.917 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.93 164.53 35.37 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 107.128 -1.912 . . . . 0.0 107.128 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.81 83.5 1.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.783 2.322 . . . . 0.0 108.663 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -57.16 115.52 2.71 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.05 -126.45 6.89 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -139.4 131.73 28.39 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.87 1.268 . . . . 0.0 107.916 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -68.19 154.26 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.523 ' H ' HG21 ' A' ' 79' ' ' THR . 0.2 OUTLIER -151.34 175.56 12.11 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.432 -1.417 . . . . 0.0 111.784 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.41 ' H ' HG22 ' A' ' 111' ' ' THR . 5.3 tt0 -58.38 -64.52 0.89 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.915 1.686 . . . . 0.0 111.527 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.95 163.52 27.8 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.948 0.88 . . . . 0.0 110.927 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER 176.11 168.82 0.43 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.156 1.783 . . . . 0.0 109.047 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.48 160.96 42.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.663 1.585 . . . . 0.0 107.565 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.06 137.17 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.22 137.09 50.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.14 138.03 0.72 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.379 2.672 . . . . 0.0 107.865 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -64.31 140.28 58.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.75 -28.06 63.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.383 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.99 2.96 55.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.081 1.309 . . . . 0.0 111.641 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.7 87.24 0.75 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.526 1.057 . . . . 0.0 111.153 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.57 144.35 15.92 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.42 145.69 28.84 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.3 tt -75.86 107.66 8.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 m -86.62 -23.57 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.531 0.605 . . . . 0.0 110.135 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.24 -179.68 43.27 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -144.47 175.71 9.92 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.333 1.053 . . . . 0.0 110.265 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.53 167.95 28.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.373 2.269 . . . . 0.0 106.565 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 118.48 0.52 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.309 1.413 . . . . 0.0 114.398 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -60.1 120.87 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.13 164.88 31.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.601 1.56 . . . . 0.0 109.131 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.77 -112.59 0.26 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.97 -21.89 66.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.971 0.385 . . . . 0.0 111.004 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.65 173.31 13.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.025 2.13 . . . . 0.0 108.998 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 50.5 tp -89.94 98.64 11.89 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -82.55 -42.91 17.74 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.68 34.0 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.245 0.929 . . . . 0.0 112.53 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.45 153.64 36.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.068 0.947 . . . . 0.0 111.086 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.15 29.41 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.309 1.433 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.4 40.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.351 1.06 . . . . 0.0 110.505 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -109.66 114.52 28.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -107.94 131.75 54.21 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.671 0.788 . . . . 0.0 111.055 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.795 0.838 . . . . 0.0 112.264 179.425 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -75.85 127.25 32.61 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -95.21 135.38 36.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.9 mt -89.87 178.43 6.23 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.3 m -100.1 101.71 12.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.41 173.55 7.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.575 0.702 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.5 tt -144.4 172.03 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.346 1.858 . . . . 0.0 106.76 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.36 -111.75 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -146.74 -1.61 0.6 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 125.325 1.25 . . . . 0.0 114.68 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.589 ' HA ' ' CE ' ' A' ' 282' ' ' LYS 0.388 55.0 m-20 46.68 15.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.66 -29.3 59.03 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.29 -168.2 38.74 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.0 t -82.14 112.33 19.07 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.34 1.456 . . . . 0.0 109.462 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.95 35.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -135.82 107.31 6.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 110.177 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 280' ' ' HIS . 12.4 p-10 -97.9 104.68 16.73 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.84 -1.85 15.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.01 -83.96 1.15 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.174 1.369 . . . . 0.0 113.108 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.59 170.43 8.14 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.583 2.353 . . . . 0.0 110.65 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -138.6 144.64 39.86 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.151 0.98 . . . . 0.0 109.738 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.65 -10.71 59.34 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.238 1.015 . . . . 0.0 112.665 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.05 153.36 22.04 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.287 1.422 . . . . 0.0 109.964 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.06 156.46 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.899 1.68 . . . . 0.0 108.062 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -124.71 -58.31 1.5 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.616 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -158.76 162.03 37.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.277 1.398 . . . . 0.0 112.602 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.59 144.4 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.404 1.882 . . . . 0.0 107.077 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -139.23 144.67 38.57 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.88 1.272 . . . . 0.0 107.88 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 8.9 t -132.27 126.85 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -121.3 83.01 0.35 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -86.15 172.95 10.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.396 1.093 . . . . 0.0 111.286 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.26 -168.6 11.8 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 128.573 2.987 . . . . 0.0 106.981 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -66.49 -36.64 83.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.07 -32.24 61.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.53 0.732 . . . . 0.0 112.169 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.0 -154.21 25.35 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.6 mm -64.82 124.51 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.8 m -108.96 -25.48 10.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.683 1.128 . . . . 0.0 112.485 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -140.99 141.53 34.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.174 0.989 . . . . 0.0 110.774 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.47 130.41 72.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -152.47 144.68 23.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -144.19 168.76 19.27 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.283 1.033 . . . . 0.0 109.821 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -133.53 129.39 37.04 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -131.28 168.97 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.763 1.625 . . . . 0.0 110.22 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -124.47 99.25 6.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -117.28 138.7 51.57 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.983 2.113 . . . . 0.0 105.768 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.31 29.27 45.64 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.222 -0.765 . . . . 0.0 112.174 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.78 -7.72 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.475 2.71 . . . . 0.0 114.593 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.02 158.66 18.56 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 123.554 1.645 . . . . 0.0 114.752 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -86.6 99.95 12.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.177 1.791 . . . . 0.0 106.937 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.5 143.92 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.27 129.93 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.162 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.54 -34.3 28.88 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.51 174.49 35.67 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.911 1.72 . . . . 0.0 111.113 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -62.84 100.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.005 1.322 . . . . 0.0 108.184 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -73.99 -50.4 20.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -93.19 165.27 27.7 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.529 1.061 . . . . 0.0 112.297 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -62.81 108.2 1.58 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 126.176 1.791 . . . . 0.0 110.876 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.79 178.55 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 N-CA-C 107.713 -1.687 . . . . 0.0 107.713 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 212' ' ' LEU . 1.2 t -147.56 176.15 10.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -14.54 11.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.462 ' H ' HG23 ' A' ' 210' ' ' THR . 9.8 tt -65.61 -28.86 69.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.883 0.873 . . . . 0.0 110.329 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.89 -137.65 13.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.28 156.21 38.0 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.306 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.52 154.1 28.85 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.62 148.69 47.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.474 0.579 . . . . 0.0 111.676 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.06 112.54 6.82 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -83.36 109.91 17.69 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.5 mt -110.51 102.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.6 99.26 5.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -45.04 -41.55 13.61 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.46 -26.42 29.02 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 CA-C-N 123.592 2.319 . . . . 0.0 112.887 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 98.6 p -107.79 -16.12 14.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.97 1.714 . . . . 0.0 114.278 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 117.72 29.15 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.301 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.52 92.9 4.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.14 1.776 . . . . 0.0 111.374 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.46 106.17 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 22.4 m -77.86 -38.89 45.04 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.139 0.576 . . . . 0.0 110.436 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.67 36.69 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.952 0.901 . . . . 0.0 110.652 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.2 143.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.453 ' CG ' ' HE3' ' A' ' 250' ' ' LYS . 9.5 mm-40 -128.72 166.49 18.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.603 1.961 . . . . 0.0 109.094 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.08 166.84 31.34 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.7 p -128.81 132.66 47.86 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.24 147.62 43.89 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.77 171.3 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.951 0.901 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 148.1 42.52 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.63 1.572 . . . . 0.0 110.747 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 236' ' ' ILE . 1.9 mp -96.22 135.59 29.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.75 85.63 2.75 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 139.63 -6.04 2.92 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.109 1.338 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 t -123.76 170.55 10.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.61 1.705 . . . . 0.0 108.905 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -116.92 52.62 0.94 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.972 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -167.72 -174.91 37.12 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.07 1.319 . . . . 0.0 110.299 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.59 157.92 23.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.381 1.072 . . . . 0.0 109.666 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.7 tt -130.87 135.93 59.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 124.985 1.314 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.05 104.34 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.066 -2.939 . . . . 0.0 103.066 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.284 5.5 t -86.22 -19.17 30.39 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -147.24 149.73 33.46 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.269 -0.895 . . . . 0.0 110.129 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 249' ' ' PHE . 0.2 OUTLIER -136.78 143.61 43.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.307 2.243 . . . . 0.0 108.565 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -147.42 161.81 40.29 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.046 1.738 . . . . 0.0 107.645 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.426 ' CZ ' HD12 ' A' ' 247' ' ' LEU . 71.4 m-85 -131.42 118.79 20.73 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 230' ' ' GLU . 73.6 mttt -69.79 113.14 6.75 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 100.325 -3.954 . . . . 0.0 100.325 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 152.31 23.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.162 2.185 . . . . 0.0 107.942 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 154.9 23.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 57.29 -7.72 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -157.55 174.66 15.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 131.208 3.803 . . . . 0.0 106.875 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.8 m -138.24 124.31 20.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.1 175.96 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.669 1.223 . . . . 0.0 111.84 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -79.31 158.34 74.27 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.734 2.014 . . . . 0.0 111.94 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.66 90.35 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.924 2.416 . . . . 0.0 106.859 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -73.69 91.97 1.94 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 115.24 -179.91 18.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.623 1.106 . . . . 0.0 113.784 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.17 111.02 22.03 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.63 1.172 . . . . 0.0 109.889 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.57 107.73 1.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -168.36 141.49 3.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.303 2.241 . . . . 0.0 107.284 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 103.74 -177.13 24.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 55.3 m -72.15 122.61 21.29 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.216 -0.579 . . . . 0.0 109.79 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.68 122.08 22.67 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.95 120.28 31.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.45 0.568 . . . . 0.0 111.465 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -100.47 144.02 29.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.873 0.869 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 82.6 mt -122.47 103.53 8.78 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -133.95 171.35 14.31 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.681 1.992 . . . . 0.0 108.999 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -143.5 167.87 21.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.748 0.819 . . . . 0.0 110.741 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.98 7.48 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.113 1.765 . . . . 0.0 114.102 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 142.36 65.18 0.03 OUTLIER Glycine 0 C--N 1.335 0.472 0 O-C-N 121.298 -0.876 . . . . 0.0 111.583 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -147.74 153.83 39.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.231 1.412 . . . . 0.0 107.84 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.68 154.72 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.348 1.459 . . . . 0.0 107.34 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.24 153.36 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 49.8 t -132.01 -80.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.15 -151.83 11.0 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 118.913 0.778 . . . . 0.0 111.743 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CE1' ' HA3' ' A' ' 281' ' ' GLY . 4.7 t80 -138.77 147.78 43.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.808 1.243 . . . . 0.0 110.086 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.6 p80 -133.73 92.19 2.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 279' ' ' PHE . . . -155.21 -138.88 2.66 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.589 ' CE ' ' HA ' ' A' ' 162' ' ' ASP 0.289 0.3 OUTLIER -156.4 162.37 40.04 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.082 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.95 50.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.519 0.676 . . . . 0.0 111.382 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 12.3 t -156.66 -167.4 2.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.696 1.998 . . . . 0.0 107.395 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -62.57 -19.43 63.68 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.076 2.15 . . . . 0.0 112.342 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 24.3 mt -139.23 150.05 45.07 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 128.987 2.915 . . . . 0.0 105.294 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 24.8 tp -85.12 86.62 7.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.007 0.821 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -78.72 -40.15 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.637 1.175 . . . . 0.0 110.895 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -128.43 130.62 47.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 120.079 1.308 . . . . 0.0 110.037 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.53 148.53 29.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.39 -164.67 27.43 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.13 137.47 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.461 0.704 . . . . 0.0 112.478 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 155.56 28.32 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 147.63 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.542 0.61 . . . . 0.0 111.641 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 80.2 mtp -139.72 149.09 58.25 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.74 118.05 5.45 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.686 2.257 . . . . 0.0 108.889 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.234 0.263 0 C-N-CA 123.322 0.649 . . . . 0.0 111.042 179.481 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--O 1.235 0.29 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 80.6 t -133.96 124.16 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.79 164.7 20.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.117 0.96 . . . . 0.0 110.185 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 138' ' ' ALA . . . -69.09 105.61 2.51 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.329 1.452 . . . . 0.0 109.651 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.65 47.53 2.47 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.13 1.824 . . . . 0.0 114.571 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.18 -156.91 9.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.466 1.507 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 89' ' ' ASP . . . -80.98 160.06 42.35 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.233 1.016 . . . . 0.0 114.053 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.14 5.42 41.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.333 1.453 . . . . 0.0 112.61 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.34 59.94 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.18 14.03 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 119.906 1.853 . . . . 0.0 111.771 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 131' ' ' ARG . . . -78.73 156.69 28.77 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.735 0.814 . . . . 0.0 110.895 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 m -66.19 127.68 33.12 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.683 0.793 . . . . 0.0 111.583 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -134.36 161.4 35.09 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 160.09 149.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.599 3.16 . . . . 0.0 107.544 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -142.3 119.71 11.62 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.591 0.756 . . . . 0.0 109.346 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 C-N-CA 127.62 2.533 . . . . 0.0 117.829 -178.411 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.332 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -145.38 139.84 22.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.5 mmt-85 -114.88 -60.97 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.086 1.754 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -126.36 162.85 24.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.761 1.225 . . . . 0.0 110.216 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.94 131.95 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.11 123.16 39.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.18 117.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 119.19 6.18 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.534 0.519 . . . . 0.0 112.268 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -69.98 172.58 7.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.05 1.74 . . . . 0.0 109.53 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.17 175.95 34.49 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 129.463 3.411 . . . . 0.0 104.821 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -68.06 -31.24 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -26.65 50.08 Favored 'General case' 0 N--CA 1.45 -0.447 1 C-N-CA 132.731 4.413 . . . . 0.0 113.327 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.97 -164.6 24.44 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -62.77 106.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.612 1.206 . . . . 0.0 108.217 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -97.16 -34.67 11.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.415 1.486 . . . . 0.0 114.455 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -119.34 153.26 35.39 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.534 1.133 . . . . 0.0 110.46 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.62 142.2 28.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.789 1.636 . . . . 0.0 109.088 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.44 151.62 22.8 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.59 1.956 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.85 158.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.134 1.374 . . . . 0.0 108.93 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.48 124.89 73.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -91.56 167.81 11.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.477 1.111 . . . . 0.0 110.01 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.14 111.39 19.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.731 1.212 . . . . 0.0 108.202 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -113.67 109.18 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 126.494 1.918 . . . . 0.0 108.066 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 64.0 1.01 1.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.143 1.777 . . . . 0.0 114.128 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.5 m 118.6 -11.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 1 C-N-CA 133.252 4.621 . . . . 0.0 110.498 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.3 144.72 28.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.119 0.967 . . . . 0.0 109.077 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.7 137.04 36.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.04 121.86 55.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.806 0.73 . . . . 0.0 110.074 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.98 161.84 20.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.623 2.369 . . . . 0.0 106.83 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.54 25.25 0.05 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.175 2.321 . . . . 0.0 112.384 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.33 91.91 0.1 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 121.838 2.819 . . . . 0.0 116.995 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -111.04 114.67 28.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -118.49 175.7 5.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.707 1.603 . . . . 0.0 112.061 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.4 -169.91 22.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 98.66 6.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -57.21 133.66 55.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.77 1.228 . . . . 0.0 110.856 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -129.06 124.07 33.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.384 . . . . 0.0 109.231 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.32 -21.52 66.72 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.13 -0.981 . . . . 0.0 112.851 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.54 38.3 3.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.508 1.523 . . . . 0.0 108.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.54 100.46 0.27 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.044 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.94 151.24 12.19 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.625 1.57 . . . . 0.0 109.673 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -151.14 160.58 43.78 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 130.164 3.386 . . . . 0.0 106.342 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 m -135.87 98.56 3.93 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.364 0.666 . . . . 0.0 111.465 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -95.73 108.92 21.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.56 101.79 13.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.683 1.593 . . . . 0.0 108.208 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.96 141.39 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -95.12 150.79 19.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.247 -0.908 . . . . 0.0 112.157 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.27 13.85 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.266 1.426 . . . . 0.0 111.949 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.53 -5.96 14.48 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.647 2.379 . . . . 0.0 111.345 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.08 150.99 36.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.855 1.262 . . . . 0.0 113.622 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.531 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 62.1 m-85 -135.56 132.94 37.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -71.65 113.2 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -93.9 -21.3 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.449 -0.782 . . . . 0.0 112.742 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.56 156.5 42.51 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.86 140.84 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.54 127.63 25.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.9 147.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -109.63 138.24 46.28 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 129.674 3.19 . . . . 0.0 108.613 -178.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -154.57 166.14 34.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.68 0.792 . . . . 0.0 110.543 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.452 ' OD1' ' HE3' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -161.65 169.23 21.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.666 0.786 . . . . 0.0 110.968 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 158.44 20.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.512 2.325 . . . . 0.0 109.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.47 154.73 40.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.421 1.089 . . . . 0.0 108.634 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -63.89 144.08 57.35 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.37 11.96 71.03 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.839 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -142.74 142.75 32.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.891 1.276 . . . . 0.0 108.925 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.37 16.5 23.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.414 2.286 . . . . 0.0 107.701 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -115.6 179.34 4.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.681 2.392 . . . . 0.0 109.802 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.479 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 4.6 m-20 -135.15 149.34 49.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 102.896 -3.001 . . . . 0.0 102.896 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.48 143.32 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.653 1.181 . . . . 0.0 108.764 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.99 129.2 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.0 p -100.23 -38.96 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.599 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.3 169.46 18.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.91 1.284 . . . . 0.0 110.368 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.3 mm -132.24 144.83 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.171 1.388 . . . . 0.0 108.613 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 87.6 m -150.27 139.71 21.45 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.124 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -123.39 158.12 31.84 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.72 121.89 34.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.1 p -80.1 159.25 26.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.65 -33.39 73.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -21.27 66.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.301 1.44 . . . . 0.0 112.84 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.34 -10.0 30.96 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.245 1.402 . . . . 0.0 113.658 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -78.51 159.31 28.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.039 2.135 . . . . 0.0 108.259 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.8 p -134.79 156.42 48.9 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.995 1.318 . . . . 0.0 111.648 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.45 157.37 35.55 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.01 165.64 31.57 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 121.854 1.703 . . . . 0.0 109.52 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.87 83.76 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.81 3.006 . . . . 0.0 107.701 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.92 101.66 0.07 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.984 1.314 . . . . 0.0 107.698 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.41 -143.65 14.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 tp -108.63 121.73 45.62 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.74 153.55 43.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 112' ' ' GLN . 1.4 m -150.75 -179.59 7.39 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.073 -1.642 . . . . 0.0 111.074 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.55 ' H ' HG22 ' A' ' 111' ' ' THR . 41.1 tt0 -73.7 -58.68 3.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.036 -1.04 . . . . 0.0 111.246 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HE3' ' OD1' ' A' ' 81' ' ' ASP . 22.6 mttt -70.19 166.48 19.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.923 1.238 . . . . 0.0 110.223 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER 175.69 167.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.237 2.215 . . . . 0.0 108.915 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.9 164.25 33.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.587 1.555 . . . . 0.0 107.83 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.04 142.39 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.57 135.33 34.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.984 1.313 . . . . 0.0 108.608 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -143.84 163.73 32.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.276 1.83 . . . . 0.0 108.784 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -118.5 175.45 5.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.679 1.992 . . . . 0.0 105.921 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -63.41 166.87 5.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.68 -9.06 40.19 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.585 -1.322 . . . . 0.0 113.795 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.78 -9.51 71.37 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.325 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.69 159.03 20.93 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.806 1.803 . . . . 0.0 113.764 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.531 ' HE3' ' CG ' ' A' ' 72' ' ' TYR . 14.3 mmtm -128.23 166.94 17.59 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.317 2.647 . . . . 0.0 107.441 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.16 -61.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.625 1.57 . . . . 0.0 107.588 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.67 31.07 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -133.25 157.43 45.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.932 1.293 . . . . 0.0 108.277 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -128.07 158.45 37.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.66 100.09 0.18 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 54.6 mtt180 -65.19 91.74 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.0 165.8 12.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 128.069 2.548 . . . . 0.0 113.663 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -157.3 -121.17 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 106.07 -2.812 . . . . 0.0 106.07 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -66.25 -18.23 65.23 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.16 169.76 19.32 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 125.557 1.543 . . . . 0.0 108.164 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.74 84.26 7.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -69.39 -45.68 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 110.738 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 6' ' ' ALA . . . -146.41 144.28 29.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.099 0.959 . . . . 0.0 111.872 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.8 tp -140.72 144.91 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.38 -178.63 28.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.12 38.41 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.227 1.014 . . . . 0.0 108.281 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.68 113.85 24.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.829 0.852 . . . . 0.0 108.927 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.35 100.96 10.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.769 0.828 . . . . 0.0 111.801 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.582 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 121.598 0.714 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 119.24 37.74 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 293' ' ' HIS . 10.4 ptpt -88.19 123.66 33.05 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.0 mt -75.56 -166.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.312 1.045 . . . . 0.0 109.86 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 128.48 56.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.58 165.31 11.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.484 1.514 . . . . 0.0 107.653 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.05 -176.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.207 1.003 . . . . 0.0 110.883 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.21 -108.58 3.7 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.754 1.169 . . . . 0.0 111.559 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -176.0 136.9 3.46 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.06 53.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.808 2.443 . . . . 0.0 110.186 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.462 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 81.3 mm-40 -117.4 92.91 3.98 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.663 1.185 . . . . 0.0 110.692 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.79 -177.35 31.33 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.494 1.045 . . . . 0.0 112.278 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.41 113.56 3.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.786 1.634 . . . . 0.0 110.127 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.17 145.2 56.08 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.114 0.966 . . . . 0.0 110.825 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -138.51 61.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.04 104.66 6.67 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.68 99.4 10.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.263 2.625 . . . . 0.0 108.627 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.32 177.9 2.29 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.762 2.601 . . . . 0.0 112.441 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.23 25.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -118.44 -178.8 3.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.552 1.141 . . . . 0.0 109.257 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.07 -13.2 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.044 1.738 . . . . 0.0 114.198 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.32 -167.85 24.3 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 119.312 0.96 . . . . 0.0 112.291 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.44 156.8 40.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 127.824 2.45 . . . . 0.0 108.504 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -127.35 -52.08 1.39 Allowed 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.918 0.887 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.51 149.69 50.7 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.682 1.193 . . . . 0.0 108.306 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.1 139.73 50.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -127.05 112.74 15.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.594 1.157 . . . . 0.0 111.062 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.72 124.96 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.78 1.632 . . . . 0.0 107.623 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -115.78 139.59 15.51 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -138.29 -177.12 4.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.266 1.031 . . . . 0.0 112.019 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.64 -174.07 25.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 128.69 3.043 . . . . 0.0 106.846 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.97 -29.27 70.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.855 0.328 . . . . 0.0 110.854 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.36 -31.91 66.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.033 2.533 . . . . 0.0 113.01 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.88 -152.83 21.47 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.98 107.32 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.974 1.31 . . . . 0.0 109.007 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.0 p -101.79 -20.24 15.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.777 0.831 . . . . 0.0 112.564 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.06 160.72 42.11 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.084 1.311 . . . . 0.0 112.185 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 m -156.13 148.3 11.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.07 170.16 10.59 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.803 2.041 . . . . 0.0 107.011 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -160.29 164.49 32.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 109.894 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -102.53 123.21 45.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 148.19 23.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.647 1.979 . . . . 0.0 106.185 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.74 130.93 46.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -105.01 104.95 14.78 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.9 1.28 . . . . 0.0 108.019 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 71.31 -84.58 0.42 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.62 -18.29 2.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.257 . . . . 0.0 111.072 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.84 162.04 29.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.941 1.297 . . . . 0.0 109.572 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.21 145.5 39.79 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.679 0.792 . . . . 0.0 109.972 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.7 101.59 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.4 t -67.45 133.07 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.3 -169.8 42.6 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.1 -153.99 27.41 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.09 141.41 51.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -115.03 -80.22 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.44 1.018 . . . . 0.0 110.54 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.37 -179.11 50.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -99.81 103.69 23.5 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 120.931 2.365 . . . . 0.0 111.333 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.06 160.71 48.8 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 120.928 1.086 . . . . 0.0 109.367 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -102.81 178.11 4.66 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 27.2 tp -65.73 -13.57 59.58 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.795 -0.566 . . . . 0.0 111.509 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.65 -33.87 56.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.692 1.597 . . . . 0.0 110.645 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 110.83 -157.74 14.79 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.237 0.446 . . . . 0.0 112.387 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -133.93 170.74 15.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.159 2.184 . . . . 0.0 109.069 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.61 149.69 52.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 129.153 2.981 . . . . 0.0 104.765 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -133.49 149.12 51.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.954 0.797 . . . . 0.0 112.542 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -142.0 124.46 15.74 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -78.66 121.05 24.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.03 1.332 . . . . 0.0 109.682 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.76 124.71 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 128.127 2.571 . . . . 0.0 105.721 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.22 94.3 5.29 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.36 -33.6 15.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.525 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.76 13.94 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 CA-C-N 123.762 2.379 . . . . 0.0 111.198 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.31 -53.82 1.03 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.089 1.356 . . . . 0.0 109.878 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.86 177.75 4.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.461 1.504 . . . . 0.0 110.27 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.83 115.3 4.8 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.814 -0.553 . . . . 0.0 111.208 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.75 101.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -86.32 -19.5 29.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.995 1.318 . . . . 0.0 110.266 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.33 156.05 34.77 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.529 1.059 . . . . 0.0 110.833 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.7 144.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -132.08 173.27 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.647 1.979 . . . . 0.0 106.843 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.82 177.47 41.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.6 p -136.92 145.1 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -126.09 131.37 52.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.477 0.711 . . . . 0.0 111.554 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.41 170.77 15.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.136 1.375 . . . . 0.0 110.851 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 235' ' ' LYS . 2.6 mppt? -76.01 142.99 41.73 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.875 1.27 . . . . 0.0 111.882 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 20.2 pt -80.43 135.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.2 88.53 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.127 0.571 . . . . 0.0 110.808 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 151.95 -17.76 0.83 Allowed Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.296 -1.28 . . . . 0.0 112.76 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.2 m -140.27 179.16 6.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.554 1.177 . . . . 0.0 110.783 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.22 -30.09 24.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.177 2.591 . . . . 0.0 109.517 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -55.4 152.7 14.73 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 127.349 2.404 . . . . 0.0 112.976 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 66.3 mt -111.43 152.95 26.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.607 1.963 . . . . 0.0 109.222 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -143.73 160.38 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.246 1.418 . . . . 0.0 107.482 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.63 105.89 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -41.96 80.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.64 1.176 . . . . 0.0 111.582 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -147.89 159.48 43.81 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.912 0.485 . . . . 0.0 111.769 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 62.7 mt -135.13 147.11 49.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.287 1.835 . . . . 0.0 110.802 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -137.85 128.41 26.61 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.456 2.303 . . . . 0.0 107.749 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -111.38 113.61 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.71 113.83 19.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.2 p -109.99 165.84 11.41 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 126.623 1.969 . . . . 0.0 110.316 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -112.37 155.1 24.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 62.94 -16.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -135.18 172.27 13.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.619 1.568 . . . . 0.0 108.398 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.04 155.36 31.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.618 1.167 . . . . 0.0 108.005 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.6 p -123.01 178.27 5.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.421 1.889 . . . . 0.0 110.046 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -133.0 159.25 73.45 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.064 1.346 . . . . 0.0 109.73 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 108.24 2.65 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 109.01 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.24 92.94 5.17 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.01 179.78 17.2 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.687 1.137 . . . . 0.0 110.655 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 tp -82.96 111.97 19.31 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -68.47 106.95 2.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -171.23 146.51 2.37 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.838 2.455 . . . . 0.0 107.393 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 105.58 -176.69 22.46 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.1 m -67.77 122.97 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 144.2 43.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.138 -0.351 . . . . 0.0 110.317 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -138.65 144.34 39.64 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.5 1.12 . . . . 0.0 109.139 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.64 155.91 47.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.74 121.14 17.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -169.66 133.32 1.27 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.425 1.89 . . . . 0.0 109.829 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -146.0 129.21 16.67 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.0 1.32 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 30.33 52.61 0.12 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.115 2.966 . . . . 0.0 112.721 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 53.25 13.04 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 117.264 -1.853 . . . . 0.0 115.706 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.41 151.71 3.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.239 1.816 . . . . 0.0 111.228 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.28 132.61 40.1 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.15 1.78 . . . . 0.0 109.294 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.19 121.68 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.71 34.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.882 0.873 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.86 174.25 35.93 Favored Glycine 0 C--N 1.334 0.436 0 O-C-N 120.663 -1.273 . . . . 0.0 111.918 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 292' ' ' VAL . 48.8 m-85 -129.98 158.81 38.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.235 1.814 . . . . 0.0 108.509 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . 0.409 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 7.8 p-80 -149.26 165.74 31.01 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 112.23 -160.05 13.38 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.462 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -129.23 164.58 23.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.928 0.87 . . . . 0.0 110.743 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.96 149.52 50.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 m -152.37 -155.14 0.58 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 101.668 -3.456 . . . . 0.0 101.668 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -55.31 -36.45 66.21 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.008 -1.058 . . . . 0.0 110.285 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.14 164.44 21.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.128 1.371 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.72 77.4 9.79 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.92 -39.39 89.2 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -128.16 144.88 51.15 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -156.23 110.64 2.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -137.26 174.45 21.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 279' ' ' PHE . 8.9 m -128.45 174.93 11.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.03 0.932 . . . . 0.0 112.578 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . 0.567 ' CE1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER -118.16 128.13 54.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.9 2.48 . . . . 0.0 106.458 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.83 147.52 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.75 1.22 . . . . 0.0 109.996 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 81.2 mtp -141.97 144.15 31.07 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 126.331 1.852 . . . . 0.0 107.652 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.89 153.64 53.11 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.049 2.499 . . . . 0.0 112.433 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.237 0.396 0 C-N-CA 124.579 1.152 . . . . 0.0 110.261 179.36 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 . . . . . 0 C--O 1.235 0.333 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 130.43 34.62 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.35 128.11 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -72.7 155.54 39.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.693 0.679 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.44 101.62 13.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.366 1.466 . . . . 0.0 110.042 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.32 153.5 52.94 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.81 177.85 38.32 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 88' ' ' SER . . . -72.53 -50.44 15.35 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.527 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 125.64 0.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 129.639 3.176 . . . . 0.0 118.312 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.67 -4.05 1.88 Allowed Glycine 0 CA--C 1.539 1.535 0 N-CA-C 120.706 3.042 . . . . 0.0 120.706 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 137' ' ' TYR . . . -107.5 -174.01 22.37 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 121.336 2.568 . . . . 0.0 113.899 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.81 159.83 15.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.147 2.579 . . . . 0.0 112.991 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -3.66 109.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 1 C-N-CA 132.862 4.465 . . . . 0.0 117.531 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.489 ' HB3' ' H ' ' A' ' 130' ' ' GLY . 2.6 m0 -56.93 144.0 35.49 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 128.91 2.884 . . . . 0.0 108.353 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p30 59.1 9.38 1.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -50.67 129.32 22.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.385 0.993 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.169 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.484 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 CA-C-O 118.842 -0.976 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.27 146.48 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.712 1.756 . . . . 0.0 111.735 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.06 -28.81 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -146.15 159.03 43.86 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -142.68 115.29 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -88.28 144.52 26.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -141.56 148.08 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.496 1.119 . . . . 0.0 108.377 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.63 119.95 1.57 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.94 126.09 30.57 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.504 1.122 . . . . 0.0 108.72 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.03 -175.82 20.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -64.5 -36.8 85.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.11 17.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 131.126 3.77 . . . . 0.0 112.476 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.67 -136.79 18.45 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.48 95.68 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 p -109.41 -10.54 14.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.02 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -138.21 128.08 25.39 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.619 1.1 . . . . 0.0 109.015 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.98 154.24 23.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.114 1.366 . . . . 0.0 109.078 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.418 HD21 ' CD ' ' A' ' 50' ' ' GLU . 54.2 t30 -155.63 99.18 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.859 0.463 . . . . 0.0 110.747 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -77.97 145.04 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -127.73 134.57 65.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -115.77 169.95 8.83 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.459 1.123 . . . . 0.0 111.508 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.14 134.63 50.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.916 2.486 . . . . 0.0 106.61 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -115.88 150.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.55 -39.45 87.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.204 0.202 . . . . 0.0 110.555 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -70.89 0.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -149.45 139.91 22.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.37 141.05 48.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.473 1.509 . . . . 0.0 108.351 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.5 147.32 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 108.33 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' CD ' HD21 ' A' ' 39' ' ' ASN . 36.3 tt0 -101.1 138.05 38.64 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.06 -68.06 1.64 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.72 144.09 3.93 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 121.595 -0.944 . . . . 0.0 112.465 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.95 133.71 43.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.757 1.623 . . . . 0.0 107.687 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -119.65 169.7 9.85 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.913 1.285 . . . . 0.0 110.252 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 -151.73 20.81 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -121.36 106.1 11.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -63.41 163.16 11.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.195 0.522 . . . . 0.0 111.392 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -138.79 162.7 34.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.044 0.938 . . . . 0.0 108.579 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.9 tp -89.34 -33.22 16.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.841 1.256 . . . . 0.0 112.174 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.9 mt -100.77 12.14 38.12 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.74 106.21 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -160.63 126.27 3.92 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.255 1.422 . . . . 0.0 108.239 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -148.77 163.59 36.92 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.866 1.666 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.2 m -141.14 133.4 28.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -128.25 131.24 48.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -113.55 146.67 39.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.153 0.981 . . . . 0.0 108.515 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.3 t -109.8 117.35 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.42 156.4 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.27 -12.11 59.65 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.499 -0.75 . . . . 0.0 111.812 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -104.79 -7.79 19.22 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.465 1.506 . . . . 0.0 111.394 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -119.64 136.58 54.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.87 147.51 50.45 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.288 0.566 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.6 mt -78.23 131.2 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.96 -21.41 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 122.691 0.396 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.59 152.62 38.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.935 1.294 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.5 t -146.42 142.38 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -110.23 115.23 29.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -108.18 125.34 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.2 p -116.43 139.54 50.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -154.78 163.65 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.382 1.073 . . . . 0.0 108.6 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.03 168.89 23.59 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.44 0.564 . . . . 0.0 110.113 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -99.55 155.55 17.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.321 1.848 . . . . 0.0 112.008 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.7 137.5 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -78.56 72.26 5.08 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.49 18.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.494 1.521 . . . . 0.0 113.008 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.98 149.68 52.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.7 -16.02 61.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.037 0.935 . . . . 0.0 112.554 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 2.2 p -161.28 172.0 17.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.462 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -76.47 151.91 36.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.0 pt -134.64 152.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.594 1.158 . . . . 0.0 109.453 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.2 mm -68.35 112.05 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.422 1.089 . . . . 0.0 108.163 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -81.31 -40.61 23.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.866 1.266 . . . . 0.0 111.217 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 t -157.84 173.92 16.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.57 1.948 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.54 155.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 109.63 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.1 m -148.92 122.38 9.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.301 1.44 . . . . 0.0 108.761 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -92.74 138.22 31.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 108.73 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -123.12 115.56 22.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.006 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.6 p -91.34 168.06 11.84 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 121.546 -0.721 . . . . 0.0 110.409 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -70.88 -30.1 66.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.29 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -69.79 -6.25 30.91 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.21 66.46 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -82.08 126.6 32.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.5 m -127.66 149.8 50.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 p -99.1 161.58 24.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.006 0.923 . . . . 0.0 110.465 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.49 166.25 27.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.729 1.619 . . . . 0.0 109.778 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.6 108.53 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.067 2.511 . . . . 0.0 109.089 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.31 73.82 7.16 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 135.73 -176.15 20.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.05 112.86 15.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 110.62 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 154.01 19.88 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -144.24 176.4 9.37 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 119.916 -1.74 . . . . 0.0 112.719 -177.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.489 ' H ' HG22 ' A' ' 111' ' ' THR . 12.3 tt0 -70.36 -56.93 5.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -66.07 150.6 48.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 pttt 172.73 173.42 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 126.461 1.904 . . . . 0.0 109.321 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.91 164.82 31.67 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.617 1.967 . . . . 0.0 107.338 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.48 139.06 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -136.36 122.67 20.58 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 160.77 42.19 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.389 1.475 . . . . 0.0 109.456 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.27 176.77 8.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.068 0.849 . . . . 0.0 109.34 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -128.03 -49.48 1.34 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.315 1.446 . . . . 0.0 109.207 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -68.52 -3.05 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.072 1.749 . . . . 0.0 113.97 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.28 47.55 5.43 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 120.617 1.553 . . . . 0.0 111.275 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.73 -165.14 40.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.23 1.395 . . . . 0.0 111.657 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -131.24 151.71 51.22 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.436 1.895 . . . . 0.0 107.281 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -71.34 154.06 41.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.53 -47.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 118.762 0.71 . . . . 0.0 112.548 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -167.29 168.39 40.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 120.091 1.314 . . . . 0.0 111.022 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -114.49 169.94 8.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.967 1.307 . . . . 0.0 110.216 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -164.84 170.88 14.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.241 2.616 . . . . 0.0 106.678 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 15' ' ' TRP . . . 128.65 129.4 3.18 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 126.145 1.831 . . . . 0.0 110.027 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.61 122.36 1.94 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.179 0.99 . . . . 0.0 112.651 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.0 166.06 25.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.847 2.459 . . . . 0.0 109.628 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.29 -119.14 0.82 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -68.5 -6.3 24.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.08 175.1 13.36 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 128.782 2.833 . . . . 0.0 106.656 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.67 95.06 5.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CD1' ' HA3' ' A' ' 12' ' ' GLY . 14.2 m-85 -83.22 -30.44 27.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.845 1.658 . . . . 0.0 113.112 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.16 42.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 108.772 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 65.3 tp -154.66 134.56 12.96 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.43 179.12 37.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 125.67 1.605 . . . . 0.0 109.127 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.05 171.89 17.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.478 0.639 . . . . 0.0 111.395 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -115.7 150.67 36.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.592 1.157 . . . . 0.0 108.522 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -125.01 111.53 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.75 0.786 . . . . 0.0 109.587 179.839 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 CA-C-O 121.927 0.87 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -74.09 129.72 38.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.416 ' HE3' ' ND1' ' A' ' 280' ' ' HIS . 77.9 tttt -98.95 106.47 18.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.002 1.321 . . . . 0.0 108.045 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mt -74.88 173.9 9.99 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.0 t -76.08 163.66 26.9 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.838 -1.164 . . . . 0.0 109.062 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -144.41 138.19 27.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 tp -118.47 138.35 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.227 2.211 . . . . 0.0 107.321 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.57 -31.2 0.57 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 154.54 -169.55 32.84 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -136.19 6.69 3.09 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.082 1.753 . . . . 0.0 109.3 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -113.97 146.99 39.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.157 1.383 . . . . 0.0 109.82 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.56 175.36 14.04 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.955 1.264 . . . . 0.0 110.43 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.9 m -65.35 123.34 19.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 115.58 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.165 0.986 . . . . 0.0 110.038 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.845 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 7.8 m0 -78.22 125.08 28.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.41 114.45 26.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.288 1.835 . . . . 0.0 108.142 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.53 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.523 2.729 . . . . 0.0 115.012 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 64.28 -162.08 37.05 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.79 143.17 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.304 1.842 . . . . 0.0 107.866 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.28 -178.74 4.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.28 -34.0 66.03 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.423 1.011 . . . . 0.0 110.328 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.0 -163.7 33.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 124.563 1.078 . . . . 0.0 110.418 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.56 157.18 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.403 2.281 . . . . 0.0 108.22 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -120.37 -46.41 2.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.786 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.403 ' HE2' ' OE1' ' A' ' 193' ' ' GLU . 26.1 ttpt -137.19 145.24 43.46 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 145.73 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.68 157.72 38.3 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.619 1.168 . . . . 0.0 109.582 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.6 t -138.88 129.5 33.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.65 111.84 2.03 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.22 177.45 4.68 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.478 0.711 . . . . 0.0 110.794 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -160.08 -168.06 21.52 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 127.486 2.47 . . . . 0.0 107.994 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.17 -20.0 59.56 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 122.142 -0.622 . . . . 0.0 111.259 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.92 -31.57 35.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.869 3.668 . . . . 0.0 112.691 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 139.36 -132.48 5.67 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mm -88.03 105.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.87 -23.46 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 113.18 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.02 32.29 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.285 0.948 . . . . 0.0 111.717 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.32 133.6 46.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.947 0.899 . . . . 0.0 108.596 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 15.0 pttp -156.42 170.99 21.05 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 107.308 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -167.73 174.77 7.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.333 1.453 . . . . 0.0 108.367 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.403 ' OE1' ' HE2' ' A' ' 177' ' ' LYS . 21.7 mt-10 -100.65 137.06 39.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -97.79 167.82 10.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.148 0.499 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -121.01 116.78 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.021 1.728 . . . . 0.0 108.138 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -140.54 114.11 8.75 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 40.51 57.86 2.64 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.289 0.947 . . . . 0.0 113.974 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.79 -3.35 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.008 2.523 . . . . 0.0 117.165 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.66 170.2 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.349 0.977 . . . . 0.0 108.532 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -136.51 104.44 5.57 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.78 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.172 0.896 . . . . 0.0 113.018 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.01 129.33 36.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 124.831 1.252 . . . . 0.0 108.743 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -66.15 -179.36 9.64 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.718 1.627 . . . . 0.0 111.353 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.71 151.7 21.96 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.71 0.617 . . . . 0.0 113.294 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -77.39 102.8 6.98 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.219 1.408 . . . . 0.0 107.617 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -78.85 -64.35 1.2 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.65 1.18 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.74 170.86 53.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.659 1.124 . . . . 0.0 111.622 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -80.66 113.32 38.93 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.581 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.82 169.86 20.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.33 1.353 . . . . 0.0 110.748 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.4 p -126.79 173.93 9.17 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.488 1.115 . . . . 0.0 108.49 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.39 -6.33 42.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.512 -0.742 . . . . 0.0 112.494 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.7 -1.44 6.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.332 1.053 . . . . 0.0 111.069 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.48 -160.91 54.15 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.585 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 35.8 m-85 -135.8 163.08 31.02 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.98 1.312 . . . . 0.0 108.5 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -124.47 157.44 35.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.42 148.88 52.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.494 1.118 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -141.51 116.33 9.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.14 138.42 34.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.412 1.085 . . . . 0.0 109.049 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.6 mm -128.2 130.24 69.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.18 90.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -39.1 -50.99 4.31 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.19 -19.11 8.24 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 121.365 1.523 . . . . 0.0 114.388 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.0 m -106.52 -10.87 16.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.88 147.3 31.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.909 1.284 . . . . 0.0 107.643 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.37 126.3 11.21 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.565 HD12 ' H ' ' A' ' 226' ' ' ILE . 4.5 mp -57.09 112.75 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.248 1.819 . . . . 0.0 108.056 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.6 p -84.8 -24.74 28.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 0.0 111.142 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 250' ' ' LYS . . . -172.29 171.13 4.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.942 2.097 . . . . 0.0 109.207 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.5 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -83.75 171.03 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.886 -1.134 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 170.18 177.03 40.16 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 p -142.16 147.08 36.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.53 162.39 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.852 0.861 . . . . 0.0 109.415 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -146.9 156.46 43.1 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -71.78 138.83 48.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.963 1.705 . . . . 0.0 113.175 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -81.24 97.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -47.26 147.04 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.569 1.548 . . . . 0.0 112.089 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.6 52.46 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 62.9 p -141.13 -174.15 3.93 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.654 1.981 . . . . 0.0 107.68 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -133.69 91.65 2.87 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -158.91 173.44 35.82 Favored Glycine 0 CA--C 1.53 0.994 1 C-N-CA 131.185 4.231 . . . . 0.0 104.154 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.18 166.01 31.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 119.602 1.701 . . . . 0.0 111.781 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 7.6 tt -141.65 144.58 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.176 1.39 . . . . 0.0 109.239 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 37.4 mt -75.45 132.82 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.255 5.4 t -116.78 -12.16 10.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.615 0.766 . . . . 0.0 112.027 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -146.63 144.01 29.21 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.602 1.161 . . . . 0.0 108.775 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.95 127.15 13.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.735 0.698 . . . . 0.0 111.206 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -130.55 154.61 47.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.451 1.5 . . . . 0.0 109.408 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -118.54 126.62 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.534 ' HD3' ' HB3' ' A' ' 228' ' ' ALA . 44.0 mtpt -71.97 114.87 10.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -109.69 165.76 11.43 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.476 2.31 . . . . 0.0 109.231 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -119.83 134.13 55.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.33 7.17 0.87 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -144.23 152.07 40.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.994 2.118 . . . . 0.0 106.074 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 61.3 m -143.95 118.48 9.73 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.7 p -78.16 177.83 8.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.92 1.688 . . . . 0.0 111.793 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -73.51 154.36 89.75 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.875 . . . . 0.0 110.015 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.15 96.96 1.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 109.207 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -78.5 114.26 17.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.74 -163.03 22.38 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.9 pp -127.63 122.69 33.74 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.74 108.35 2.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.738 1.615 . . . . 0.0 109.964 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.9 9.19 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.188 0.995 . . . . 0.0 111.633 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 72.58 -98.74 0.86 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 126.311 1.91 . . . . 0.0 112.425 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 95.9 m -145.36 122.01 11.14 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.214 1.405 . . . . 0.0 107.612 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.64 145.07 33.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.101 0.56 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -132.43 158.59 41.62 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.534 1.159 . . . . 0.0 110.519 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.92 146.24 26.15 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 53.5 mt -141.87 108.77 5.42 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.861 1.664 . . . . 0.0 108.478 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 228' ' ' ALA . 10.2 pttp -157.8 163.92 37.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.679 1.581 . . . . 0.0 111.496 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.87 157.46 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 107.85 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -75.1 140.88 43.75 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 110.013 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 63.38 5.36 11.26 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 117.389 -1.784 . . . . 0.0 116.741 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -112.1 153.7 26.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.197 1.998 . . . . 0.0 112.003 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -115.52 164.19 14.67 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.272 2.229 . . . . 0.0 107.692 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.08 134.18 31.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.89 -0.38 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.167 0.987 . . . . 0.0 113.554 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.98 157.19 27.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -131.33 124.29 30.1 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.495 1.918 . . . . 0.0 109.92 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . 0.416 ' ND1' ' HE3' ' A' ' 155' ' ' LYS . 15.0 p80 -127.27 179.51 5.41 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.03 1.332 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 120.2 -127.37 7.05 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -161.25 151.35 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.906 1.282 . . . . 0.0 111.818 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.845 ' HB2' ' HE1' ' A' ' 167' ' ' TRP . . . -113.06 146.8 38.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.397 1.479 . . . . 0.0 108.113 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -155.75 -160.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.431 1.892 . . . . 0.0 106.064 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -38.06 88.43 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.36 162.95 20.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.41 1.484 . . . . 0.0 108.884 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.33 95.68 1.76 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 109.855 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -83.56 -84.01 0.14 Allowed 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -88.55 165.6 14.73 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -167.85 99.89 0.47 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.43 1.892 . . . . 0.0 107.435 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -129.35 169.73 20.54 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 121.694 -0.629 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.06 173.36 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 122.118 0.961 . . . . 0.0 112.776 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.15 124.97 42.94 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.998 -2.594 . . . . 0.0 103.998 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.93 137.63 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.492 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.24 139.47 34.6 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 123.978 0.911 . . . . 0.0 109.606 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.43 137.09 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.493 2.795 . . . . 0.0 110.738 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.202 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.165 0.507 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HD3' ' CD1' ' A' ' 142' ' ' TYR . 71.6 mmtt -137.81 139.77 40.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 128.339 2.656 . . . . 0.0 107.62 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.487 ' CG1' ' H ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -121.4 148.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.073 0.949 . . . . 0.0 111.267 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.11 131.3 46.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.4 87.87 1.56 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.09 116.16 5.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.39 -170.5 30.99 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.35 177.73 33.74 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 122.834 1.241 . . . . 0.0 115.87 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.5 55.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.844 1.658 . . . . 0.0 114.49 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 175.04 54.85 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.254 0.933 . . . . 0.0 110.817 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -175.06 50.51 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.57 1.081 . . . . 0.0 114.696 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.56 157.2 27.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.155 1.382 . . . . 0.0 110.36 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -77.1 88.17 3.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.023 2.529 . . . . 0.0 114.942 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -106.17 92.46 4.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.82 149.65 23.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.795 1.638 . . . . 0.0 108.797 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 31.21 58.55 0.27 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 127.753 2.421 . . . . 0.0 110.873 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 C-N-CA 126.535 2.017 . . . . 0.0 116.091 -177.544 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 118.654 -1.081 . . . . 0.0 115.553 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.96 154.08 7.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 119.793 1.796 . . . . 0.0 110.629 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -128.77 -41.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.532 1.133 . . . . 0.0 110.696 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -133.48 171.72 13.69 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.449 1.5 . . . . 0.0 108.174 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -140.25 130.22 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -131.11 144.03 51.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.3 t -148.31 147.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 127.862 2.465 . . . . 0.0 105.69 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.13 133.15 3.47 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 107.119 -2.392 . . . . 0.0 107.119 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -75.85 176.8 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.066 0.936 . . . . 0.0 108.934 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -160.42 10.5 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -77.06 -31.53 56.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.836 0.35 . . . . 0.0 110.227 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -91.4 -27.34 18.38 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.653 3.181 . . . . 0.0 115.182 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.75 -140.7 11.46 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -75.63 96.34 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.28 -7.29 21.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.449 1.1 . . . . 0.0 113.647 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -129.86 143.72 50.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.96 1.255 . . . . 0.0 112.377 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -159.02 130.53 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.039 0.936 . . . . 0.0 109.705 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -117.85 151.43 37.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.819 1.648 . . . . 0.0 109.809 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.12 140.96 45.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.062 1.345 . . . . 0.0 110.263 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -127.47 98.77 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -81.3 105.68 12.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.99 120.44 27.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -115.16 157.39 23.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.749 -0.594 . . . . 0.0 110.879 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 6.56 4.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.59 1.956 . . . . 0.0 108.609 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -121.58 -69.55 0.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.432 2.293 . . . . 0.0 108.742 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -154.96 135.05 13.05 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.84 150.27 39.31 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.906 1.282 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 122.9 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.992 0.917 . . . . 0.0 111.37 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.21 99.66 11.24 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.91 -21.63 45.46 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.936 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.01 142.29 12.06 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.021 1.296 . . . . 0.0 111.766 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -74.08 130.23 39.4 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.612 1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -116.4 175.7 5.44 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.236 0.541 . . . . 0.0 109.949 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -134.78 12.41 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 105.653 -2.979 . . . . 0.0 105.653 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -126.77 99.24 5.68 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.24 144.97 56.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.06 142.87 30.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.776 1.274 . . . . 0.0 110.516 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.23 -4.65 58.12 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.592 -1.317 . . . . 0.0 110.447 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.49 -16.71 62.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.499 1.12 . . . . 0.0 111.455 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.3 117.83 0.42 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -163.14 135.44 5.29 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.997 2.919 . . . . 0.0 105.734 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -132.18 160.12 37.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 m -116.3 118.61 33.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.566 1.946 . . . . 0.0 108.905 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.13 109.13 13.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.8 160.91 20.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 109.747 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.72 106.12 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 156.92 23.07 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.509 -0.744 . . . . 0.0 109.617 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.68 -26.69 27.58 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.62 -34.98 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.108 1.763 . . . . 0.0 112.393 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.86 164.51 13.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.986 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.67 -178.72 5.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.127 1.771 . . . . 0.0 109.812 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.9 139.11 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.62 -36.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.074 0.95 . . . . 0.0 112.864 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.72 165.76 29.52 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.975 0.91 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.7 101.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.65 94.28 9.04 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.2 153.55 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.686 1.994 . . . . 0.0 108.134 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.491 HG21 ' N ' ' A' ' 111' ' ' THR . 7.3 m -139.02 148.47 43.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.357 1.063 . . . . 0.0 109.069 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.05 155.42 36.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.121 1.368 . . . . 0.0 108.515 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.84 168.49 22.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.109 0.963 . . . . 0.0 110.144 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -109.51 119.38 39.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.35 1.06 . . . . 0.0 109.213 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.7 m -90.08 151.29 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -60.89 -6.61 1.89 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 113.32 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.29 -0.65 58.24 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 117.54 -1.7 . . . . 0.0 112.703 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -133.43 158.59 42.67 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.89 1.845 . . . . 0.0 111.051 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -85.29 -19.51 31.45 Favored 'General case' 0 C--N 1.323 -0.547 1 C-N-CA 131.81 4.044 . . . . 0.0 111.586 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.4 t -129.6 164.92 22.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.389 1.876 . . . . 0.0 110.691 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.47 156.14 27.97 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.0 154.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.418 1.887 . . . . 0.0 108.673 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.8 mm -73.27 129.55 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -103.31 -41.29 6.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 113.275 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -146.58 161.23 40.96 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.746 1.219 . . . . 0.0 109.503 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.3 mt -148.06 122.96 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.554 1.541 . . . . 0.0 108.314 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -125.07 107.07 10.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.869 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -84.95 149.15 25.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.848 0.833 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -130.75 113.35 14.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -84.25 164.3 19.14 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.396 0.678 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -71.13 -38.23 72.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -35.92 82.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.217 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.25 3.68 5.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.87 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -76.71 95.86 4.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -86.64 103.5 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 p -71.72 155.89 91.8 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.42 166.18 30.55 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.939 1.759 . . . . 0.0 110.907 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.24 112.74 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.789 2.993 . . . . 0.0 107.232 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -78.07 67.67 3.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.088 1.355 . . . . 0.0 107.369 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.41 -179.74 17.78 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 124.717 1.151 . . . . 0.0 111.143 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.07 119.09 22.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.68 1.592 . . . . 0.0 111.556 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 157.87 23.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.491 ' N ' HG21 ' A' ' 79' ' ' THR . 0.2 OUTLIER -148.18 172.49 14.23 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.777 -1.202 . . . . 0.0 109.771 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -69.34 -49.29 57.01 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -66.72 138.48 57.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.1 pttt 169.54 171.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.864 2.466 . . . . 0.0 109.79 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.4 156.35 47.67 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.384 1.873 . . . . 0.0 107.153 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.6 149.39 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.829 0.851 . . . . 0.0 109.844 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.91 142.97 16.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 0.0 109.66 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.25 156.52 30.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.675 0.79 . . . . 0.0 110.077 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 175.94 9.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.626 1.97 . . . . 0.0 113.262 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -127.99 -46.87 1.38 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.423 -0.798 . . . . 0.0 112.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -127.39 13.45 7.09 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.83 0.852 . . . . 0.0 112.554 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.9 -84.31 0.32 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 107.508 -2.237 . . . . 0.0 107.508 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.36 76.07 0.11 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 125.855 1.693 . . . . 0.0 112.281 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.21 123.84 12.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.853 0.861 . . . . 0.0 111.197 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.73 115.98 6.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.44 -9.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.194 1.397 . . . . 0.0 112.757 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.65 -91.0 0.3 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 119.295 0.952 . . . . 0.0 114.617 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 78.38 152.2 0.12 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.425 2.69 . . . . 0.0 109.811 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -157.75 170.07 23.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.958 2.103 . . . . 0.0 106.172 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.31 101.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 O-C-N 121.533 -0.729 . . . . 0.0 112.737 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.57 123.16 9.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.48 164.42 38.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.274 0.63 . . . . 0.0 109.375 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.22 -110.41 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.38 -12.36 60.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.207 0.503 . . . . 0.0 112.215 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.67 174.48 12.53 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 127.839 2.456 . . . . 0.0 107.528 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -102.04 89.43 3.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.219 1.008 . . . . 0.0 108.485 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.4 -38.81 49.0 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.01 167.0 26.07 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.016 1.28 . . . . 0.0 112.283 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.93 171.24 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.85 2.06 . . . . 0.0 108.782 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.78 169.91 33.58 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.882 1.706 . . . . 0.0 110.106 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.487 ' H ' ' CG1' ' A' ' 4' ' ' VAL . . . -153.16 167.69 28.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.688 1.595 . . . . 0.0 112.296 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.4 ' CD1' ' HD3' ' A' ' 3' ' ' LYS . 6.9 m-85 -129.77 163.2 26.72 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.257 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -144.4 135.87 25.62 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.957 1.303 . . . . 0.0 112.217 -178.64 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -75.67 122.23 23.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.59 0.756 . . . . 0.0 109.286 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -90.3 146.42 24.22 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.4 mt -101.08 -86.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 t -167.33 171.25 10.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.659 1.984 . . . . 0.0 109.07 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -152.73 177.2 10.95 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.24 1.816 . . . . 0.0 107.634 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 tt -138.34 -25.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -23.89 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 129.913 3.625 . . . . 0.0 117.667 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.77 41.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.029 1.776 . . . . 0.0 108.782 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.415 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 1.3 m-20 -114.96 5.71 15.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 114.303 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.98 122.33 28.15 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.28 1.4 . . . . 0.0 111.529 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.73 -168.52 13.62 Favored Glycine 0 N--CA 1.465 0.57 0 O-C-N 120.663 -1.273 . . . . 0.0 112.707 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.7 m -106.78 124.7 49.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.767 0.783 . . . . 0.0 111.121 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.71 153.84 27.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.189 1.396 . . . . 0.0 110.703 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -138.32 120.7 15.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.32 1.048 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.66 132.72 33.8 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.41 -0.807 . . . . 0.0 109.074 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.38 91.19 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.93 -72.75 0.52 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.699 -0.626 . . . . 0.0 114.157 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.12 170.65 20.78 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.221 1.408 . . . . 0.0 110.154 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.6 -179.7 3.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.659 1.184 . . . . 0.0 108.268 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.88 -23.69 55.63 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.678 -1.264 . . . . 0.0 112.297 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 170.79 168.58 32.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 128.72 3.057 . . . . 0.0 107.508 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.472 ' H ' ' HB2' ' A' ' 221' ' ' TYR . 1.8 t -122.72 156.28 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.365 1.866 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -121.53 -34.01 3.52 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -159.79 151.91 20.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.092 1.315 . . . . 0.0 110.926 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.6 t -106.25 142.36 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.48 160.18 39.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.824 2.45 . . . . 0.0 109.6 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.86 138.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.51 80.1 0.34 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.739 1.638 . . . . 0.0 109.206 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -85.59 162.48 18.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 111.018 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.3 -158.79 10.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 127.263 2.363 . . . . 0.0 109.056 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -82.85 -22.44 34.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.599 0.76 . . . . 0.0 111.358 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.88 -31.79 9.61 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.416 0.686 . . . . 0.0 112.548 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 165.82 -153.23 23.06 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.42 153.33 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.596 1.198 . . . . 0.0 109.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.1 t -134.22 -33.14 1.02 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.894 1.278 . . . . 0.0 109.625 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.17 35.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.91 0.862 . . . . 0.0 111.708 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.7 m -134.13 149.48 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -154.85 155.19 33.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 108.996 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.34 173.1 12.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.211 0.914 . . . . 0.0 113.028 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.32 141.77 48.11 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.296 3.038 . . . . 0.0 104.127 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -149.0 167.93 24.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.807 1.243 . . . . 0.0 109.578 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -135.98 96.44 3.41 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -88.8 125.48 34.92 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.25 31.17 56.36 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 76.26 -9.1 1.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.253 3.421 . . . . 0.0 114.852 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -76.47 133.14 39.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 120.835 1.652 . . . . 0.0 109.484 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -64.15 124.39 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.26 1.024 . . . . 0.0 109.197 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.6 mm -136.65 103.65 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.001 1.32 . . . . 0.0 108.415 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.96 127.43 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.09 -11.91 84.62 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.318 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.71 -172.12 52.99 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -89.35 154.36 20.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.845 0.858 . . . . 0.0 110.002 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -119.27 1.21 11.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.168 0.987 . . . . 0.0 109.651 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.94 173.64 27.05 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 120.304 -1.497 . . . . 0.0 111.182 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -68.68 114.07 20.02 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.18 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.92 167.22 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -118.25 148.33 42.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.521 1.128 . . . . 0.0 109.481 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.77 -24.83 67.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.331 0.653 . . . . 0.0 110.521 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 tt -51.65 -34.39 37.83 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 126.336 1.854 . . . . 0.0 111.495 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.0 -164.5 12.06 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -140.11 161.2 38.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.65 153.31 38.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.49 152.39 44.14 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.78 0.832 . . . . 0.0 110.75 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -142.06 140.54 32.6 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.997 -0.439 . . . . 0.0 110.956 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -65.15 97.82 0.27 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.164 2.186 . . . . 0.0 112.524 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 mm -128.94 102.82 8.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.44 125.89 46.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.015 1.28 . . . . 0.0 109.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.472 ' HB2' ' H ' ' A' ' 175' ' ' VAL . 80.0 t80 -55.49 -51.43 80.08 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.124 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.06 0.47 5.83 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.392 2.061 . . . . 0.0 114.604 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -128.54 -62.47 1.03 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.684 1.583 . . . . 0.0 112.997 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -81.26 168.13 18.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 110.697 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.17 101.33 3.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.9 mp -35.73 -52.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 128.871 2.868 . . . . 0.0 111.816 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.254 16.6 p 48.92 1.2 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.607 3.163 . . . . 0.0 118.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -173.84 169.88 4.04 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.538 1.535 . . . . 0.0 107.584 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.71 134.14 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -118.34 165.95 13.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.465 1.906 . . . . 0.0 107.617 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.07 174.31 46.37 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.2 p -135.44 147.35 48.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.754 1.277 . . . . 0.0 110.928 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -136.79 146.55 45.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -142.87 155.49 44.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.825 2.05 . . . . 0.0 108.225 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -87.55 148.55 24.84 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.596 0.758 . . . . 0.0 111.34 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.24 122.86 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.101 0.961 . . . . 0.0 108.468 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -55.89 152.3 10.21 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.268 0.556 . . . . 0.0 111.748 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.21 -9.39 20.02 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.245 0.926 . . . . 0.0 113.848 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -127.46 -176.03 3.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.383 1.873 . . . . 0.0 108.468 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.06 74.55 1.46 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.303 1.041 . . . . 0.0 110.594 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.08 -168.15 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.159 2.314 . . . . 0.0 109.106 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.93 162.11 36.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.786 1.293 . . . . 0.0 111.361 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.5 tt -139.85 102.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.891 2.076 . . . . 0.0 108.755 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 244' ' ' ILE . 4.9 mp -50.6 126.25 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 121.267 -0.895 . . . . 0.0 109.536 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -106.35 -36.24 6.89 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -122.29 144.55 48.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.462 1.028 . . . . 0.0 108.699 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.28 147.14 49.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.854 1.261 . . . . 0.0 108.264 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -136.01 93.71 2.96 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.9 149.46 45.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.59 154.04 51.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.544 1.537 . . . . 0.0 107.606 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.2 t -161.94 168.11 23.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.654 1.182 . . . . 0.0 111.67 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -105.67 147.05 28.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 79.86 -52.48 0.39 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 129.663 3.185 . . . . 0.0 110.815 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -84.89 169.68 13.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.27 1.428 . . . . 0.0 109.424 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 m -128.35 99.7 5.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.238 1.015 . . . . 0.0 109.616 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.2 p -84.62 174.63 9.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.867 1.267 . . . . 0.0 112.441 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . -141.62 170.36 9.36 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 128.153 2.581 . . . . 0.0 109.653 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 82.4 Cg_endo -70.96 160.5 49.15 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.793 2.329 . . . . 0.0 111.724 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -131.2 94.65 3.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 106.457 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.51 14.27 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.381 1.467 . . . . 0.0 110.295 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.11 141.81 36.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.31 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.53 108.36 3.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.737 0.699 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.69 21.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.297 1.839 . . . . 0.0 106.519 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.37 173.16 49.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.685 0.66 . . . . 0.0 112.744 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.86 134.13 56.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.624 1.97 . . . . 0.0 109.398 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -90.81 144.13 26.02 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -133.96 159.34 41.04 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.015 1.326 . . . . 0.0 108.905 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -144.38 154.3 42.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.096 1.358 . . . . 0.0 107.858 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.7 mp -137.47 131.98 32.68 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -165.03 137.97 4.57 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.78 1.232 . . . . 0.0 108.553 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.58 96.51 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.56 164.49 4.48 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.113 0.959 . . . . 0.0 111.782 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.79 -2.06 42.87 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 121.266 -0.896 . . . . 0.0 113.318 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -138.22 167.07 22.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.262 3.025 . . . . 0.0 107.181 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 152.8 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.498 -0.751 . . . . 0.0 109.29 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 92.3 mt -74.41 135.05 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.1 -4.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -170.99 -173.48 38.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 120.521 1.51 . . . . 0.0 111.048 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.62 164.66 29.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.341 1.07 . . . . 0.0 110.204 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -132.65 157.86 43.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.18 -163.57 27.74 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.415 ' HE2' ' C ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -131.03 158.31 40.66 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.669 1.188 . . . . 0.0 109.173 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -137.1 113.91 10.43 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.678 0.791 . . . . 0.0 110.291 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 m -149.82 86.46 1.45 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 58.74 -10.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.272 2.229 . . . . 0.0 116.772 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 36.7 mt -143.37 -172.21 3.65 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.778 2.031 . . . . 0.0 109.56 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.63 88.48 2.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.78 1.232 . . . . 0.0 112.423 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.78 -84.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.628 0.728 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -85.65 128.97 34.93 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 120.894 -1.129 . . . . 0.0 109.163 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -149.41 100.05 2.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.127 0.971 . . . . 0.0 108.604 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -120.19 152.18 17.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.28 135.2 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 118.951 1.375 . . . . 0.0 111.729 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -89.74 139.01 30.99 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.54 153.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 37.0 mmm -147.53 157.21 45.13 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.37 156.89 57.52 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.391 1.394 . . . . 0.0 111.609 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--N 1.329 -0.315 0 C-N-CA 125.904 1.682 . . . . 0.0 107.619 178.457 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.57 138.49 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 117' ' ' LEU . 2.3 t -126.39 84.99 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -56.46 140.21 46.65 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.268 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -73.42 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 O-C-N 125.139 1.524 . . . . 0.0 112.087 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.26 -14.86 23.1 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.046 -1.419 . . . . 0.0 112.672 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.38 -169.59 35.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.07 113.4 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 112.881 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.02 34.76 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.64 -151.19 2.42 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 128.244 2.831 . . . . 0.0 112.153 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.52 -170.79 41.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 112.093 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.77 33.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -69.77 69.39 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -84.09 24.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.993 1.717 . . . . 0.0 109.647 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.38 126.46 27.56 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.146 1.779 . . . . 0.0 107.032 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -70.15 -179.0 1.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.44 0.696 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.567 0 C-N-CA 125.962 1.744 . . . . 0.0 110.185 -179.677 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.457 0 N-CA-C 113.387 0.115 . . . . 0.0 113.387 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -136.61 118.7 20.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.58 -60.96 1.59 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -149.66 158.09 43.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.82 116.28 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.464 ' CE1' HG23 ' A' ' 64' ' ' THR . 12.1 m-70 -118.66 125.94 50.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.38 142.42 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 123.995 0.918 . . . . 0.0 109.251 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.97 164.08 25.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 124.606 1.098 . . . . 0.0 110.42 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -75.22 -148.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.162 1.385 . . . . 0.0 111.146 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.26 -163.58 35.6 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -95.35 -32.45 12.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.859 1.314 . . . . 0.0 107.54 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.67 -6.34 58.93 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 134.389 5.076 . . . . 0.0 113.24 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.3 -156.36 15.64 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.64 121.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.1 p -132.8 -58.61 0.91 Allowed 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.7 p -72.96 119.41 17.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 119.11 0.868 . . . . 0.0 109.634 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 tt -135.26 142.42 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.297 1.039 . . . . 0.0 108.959 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.97 129.72 21.64 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.617 1.967 . . . . 0.0 106.034 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.46 151.54 24.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.2 t -127.48 118.39 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -107.76 105.13 14.82 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.525 1.53 . . . . 0.0 110.488 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . . . -98.58 134.74 41.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 117.951 0.341 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -114.48 163.82 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.58 21.96 0.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.834 1.302 . . . . 0.0 111.095 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.9 p -128.8 -68.55 0.74 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.083 2.553 . . . . 0.0 109.875 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -148.08 133.91 19.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.288 1.435 . . . . 0.0 109.379 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 15.6 t0 -78.32 152.29 32.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.354 1.462 . . . . 0.0 109.687 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.76 108.67 13.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.973 0.892 . . . . 0.0 109.131 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.28 98.41 11.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.86 -22.09 76.87 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.46 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.09 -172.72 40.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.42 123.98 28.03 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.548 -0.971 . . . . 0.0 110.864 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.07 160.93 29.3 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 12.73 -86.99 0.0 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 128.417 2.913 . . . . 0.0 115.798 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -69.44 103.78 2.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.74 163.4 21.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.825 1.25 . . . . 0.0 112.432 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.81 10.22 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.712 2.405 . . . . 0.0 112.907 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.13 -13.51 18.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.84 1.256 . . . . 0.0 112.127 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.309 3.2 pp 49.0 -11.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.027 4.131 . . . . 0.0 117.593 -179.19 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.81 61.76 3.04 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.24 160.83 35.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.814 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.81 164.42 12.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 127.891 2.476 . . . . 0.0 109.298 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.464 HG23 ' CE1' ' A' ' 27' ' ' HIS . 23.5 m -136.03 95.58 3.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.578 0.751 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -95.04 109.56 21.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.47 143.08 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.731 0.812 . . . . 0.0 110.675 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.5 t -103.87 156.57 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -149.21 164.14 35.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.913 1.685 . . . . 0.0 107.833 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.67 -9.78 59.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.672 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.69 -9.33 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.833 1.653 . . . . 0.0 111.462 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 135.76 52.12 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -135.88 149.35 48.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 109.208 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.7 126.64 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.49 -25.81 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.753 -0.642 . . . . 0.0 110.25 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.89 149.18 30.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.438 1.017 . . . . 0.0 110.642 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.467 ' O ' HD21 ' A' ' 117' ' ' LEU . 19.0 m -129.22 75.81 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.07 134.22 52.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -139.67 153.05 23.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.1 p -133.35 142.04 48.22 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 44.8 p90 -149.84 156.35 41.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.08 169.48 20.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -126.86 157.74 38.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.723 0.773 . . . . 0.0 110.702 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.99 166.0 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.429 1.492 . . . . 0.0 108.62 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -68.42 150.1 48.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.73 20.15 58.59 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.061 -0.855 . . . . 0.0 113.372 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -131.04 166.52 20.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.621 1.569 . . . . 0.0 107.363 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -122.52 -11.98 8.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.955 1.702 . . . . 0.0 112.359 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.9 p -145.47 145.8 31.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.768 1.627 . . . . 0.0 109.667 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.72 159.48 33.44 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -135.7 156.91 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.715 0.806 . . . . 0.0 109.781 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -73.73 139.62 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-O 121.565 0.698 . . . . 0.0 112.057 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -108.38 -30.96 8.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.587 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.4 t -165.83 166.4 17.69 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.53 1.532 . . . . 0.0 110.624 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.0 mt -145.23 146.28 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 128.12 2.568 . . . . 0.0 105.677 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -150.14 101.53 3.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -86.72 148.53 25.39 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.312 -0.867 . . . . 0.0 109.479 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -133.31 121.11 21.92 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.0 p -100.5 159.03 15.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.653 1.115 . . . . 0.0 111.576 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.34 -32.89 74.43 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.714 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -56.19 -10.76 0.93 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.818 2.847 . . . . 0.0 113.042 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.51 30.56 8.5 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 119.238 0.926 . . . . 0.0 111.856 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.81 148.42 42.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.609 1.204 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 114.64 12.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 p -73.47 160.75 81.63 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.15 165.59 32.29 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 N-CA-C 107.694 -1.695 . . . . 0.0 107.694 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.09 109.59 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.022 -1.953 . . . . 0.0 107.022 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.38 66.08 0.92 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.294 1.437 . . . . 0.0 110.031 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.78 -129.35 3.5 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 tp -139.41 136.17 34.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.673 1.589 . . . . 0.0 109.833 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 158.8 11.77 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.44 1.096 . . . . 0.0 110.901 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -156.35 173.52 16.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.563 -1.335 . . . . 0.0 111.343 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.485 ' H ' HG22 ' A' ' 111' ' ' THR . 4.8 tt0 -64.74 -58.08 7.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.143 1.377 . . . . 0.0 109.254 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 80' ' ' TYR . 16.3 mmtm -70.54 105.93 3.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.48 166.42 33.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 120.604 -1.31 . . . . 0.0 109.021 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 117' ' ' LEU . 15.6 p90 -156.72 166.85 32.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.313 0.578 . . . . 0.0 109.73 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.98 145.84 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 115' ' ' PHE . 1.1 pt? -149.74 136.51 19.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 127.706 2.403 . . . . 0.0 106.354 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 134.44 7.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.49 161.16 21.34 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -142.65 -69.05 0.35 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.605 1.162 . . . . 0.0 111.064 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.84 15.37 6.92 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.492 1.517 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.34 -85.66 1.64 Allowed Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 125.602 1.572 . . . . 0.0 111.011 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.97 166.41 29.36 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.6 140.6 41.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.503 HD11 ' CB ' ' A' ' 141' ' ' ALA . 20.1 tp -54.91 112.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.68 -54.98 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.348 0.976 . . . . 0.0 111.283 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.43 -105.28 0.2 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -167.66 176.4 6.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.292 1.046 . . . . 0.0 111.526 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.84 151.84 35.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.48 -26.42 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.049 -1.072 . . . . 0.0 114.548 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 62.23 69.95 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.535 2.334 . . . . 0.0 113.852 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.99 112.16 20.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.55 -120.46 4.27 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 103.414 -3.875 . . . . 0.0 103.414 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.34 -10.22 59.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.259 0.624 . . . . 0.0 112.23 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.42 173.86 11.63 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.222 2.609 . . . . 0.0 107.691 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 40.8 tp -99.51 98.24 9.15 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.684 0.794 . . . . 0.0 109.245 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -76.13 -66.65 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 112.087 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.47 172.79 12.51 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.88 1.218 . . . . 0.0 109.626 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.8 tp -162.73 134.01 5.01 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.86 176.88 44.16 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 106.47 -2.652 . . . . 0.0 106.47 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' HD11 ' A' ' 125' ' ' LEU . . . -153.02 176.96 11.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.975 1.388 . . . . 0.0 109.055 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -147.81 161.73 40.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.684 0.754 . . . . 0.0 109.447 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.1 125.31 12.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.111 2.565 . . . . 0.0 104.398 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 118.722 0.692 . . . . 0.0 111.858 -179.611 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.1 133.87 55.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.195 0.998 . . . . 0.0 110.773 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -113.64 143.43 44.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.408 1.483 . . . . 0.0 108.658 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.48 -89.92 0.13 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.3 t -146.55 160.4 42.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.112 1.765 . . . . 0.0 107.889 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -170.38 136.61 1.36 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.099 2.159 . . . . 0.0 105.371 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.0 tt -97.99 128.45 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.2 107.59 0.62 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.34 -179.03 6.22 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 112.431 -1.885 . . . . 0.0 109.832 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.19 11.94 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 128.659 2.783 . . . . 0.0 115.319 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 11.8 mt-10 -130.99 156.35 45.26 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.207 1.367 . . . . 0.0 114.265 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 96.91 159.53 31.55 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 125.253 1.406 . . . . 0.0 112.768 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 m -102.53 134.43 45.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.51 138.86 51.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.815 0.446 . . . . 0.0 110.122 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -128.63 123.94 34.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -85.78 105.66 16.46 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.14 -117.94 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.405 1.066 . . . . 0.0 108.707 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.13 168.16 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 121.35 1.886 . . . . 0.0 111.763 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.87 157.86 37.11 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.098 -0.648 . . . . 0.0 109.254 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -135.31 176.34 8.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.691 1.196 . . . . 0.0 110.621 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -12.24 60.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.739 1.215 . . . . 0.0 113.767 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.21 171.73 22.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 125.525 1.536 . . . . 0.0 110.315 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.1 m -125.89 107.8 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -63.04 -51.1 68.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 110.629 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -149.19 169.69 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.753 1.16 . . . . 0.0 112.751 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 86.1 t -122.46 143.95 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.656 1.583 . . . . 0.0 109.208 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.79 157.39 46.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.768 1.627 . . . . 0.0 108.342 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.36 146.22 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.77 83.64 0.32 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -71.16 160.51 32.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.655 0.741 . . . . 0.0 110.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.34 -163.28 9.49 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.152 2.787 . . . . 0.0 109.029 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -89.62 -14.36 35.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.902 -1.352 . . . . 0.0 111.565 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.21 -29.1 15.28 Favored 'General case' 0 C--N 1.327 -0.379 1 C-N-CA 132.404 4.282 . . . . 0.0 112.917 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 144.45 -136.78 6.9 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.94 104.6 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.23 -26.17 28.9 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.496 0.719 . . . . 0.0 112.215 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.98 146.07 35.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.842 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.79 145.07 28.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -148.75 154.73 39.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.85 175.45 9.57 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -123.55 120.87 34.12 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.351 0.66 . . . . 0.0 109.555 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -94.85 165.7 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.397 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -144.82 130.38 18.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.109 -0.948 . . . . 0.0 108.556 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.85 151.99 43.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.714 1.143 . . . . 0.0 109.111 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.72 -103.53 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.601 1.096 . . . . 0.0 111.708 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 7.89 3.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.266 2.226 . . . . 0.0 110.936 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -109.24 177.93 4.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.011 1.324 . . . . 0.0 107.851 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -133.7 142.29 47.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.866 1.266 . . . . 0.0 108.761 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 201' ' ' ILE . 1.8 mp -111.74 99.73 9.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 119.649 1.113 . . . . 0.0 109.351 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.68 103.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.46 175.28 35.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.158 2.313 . . . . 0.0 107.698 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 134.1 23.95 0.66 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-N 118.327 1.063 . . . . 0.0 113.771 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.92 126.07 27.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.429 1.614 . . . . 0.0 108.123 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -127.68 -6.88 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.227 2.611 . . . . 0.0 113.363 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.45 159.29 25.73 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -66.29 116.56 34.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.801 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.86 134.89 52.59 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.652 2.234 . . . . 0.0 110.077 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.9 p -83.22 161.11 21.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.215 1.006 . . . . 0.0 109.821 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.76 -23.11 65.19 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.468 -0.77 . . . . 0.0 111.096 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -64.88 -30.82 71.84 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.963 1.305 . . . . 0.0 111.247 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.95 -146.47 16.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -138.67 163.95 30.78 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.523 1.129 . . . . 0.0 109.538 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -115.03 154.25 29.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.365 3.066 . . . . 0.0 105.304 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.5 148.17 28.38 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.61 0.764 . . . . 0.0 110.388 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.65 137.19 29.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.251 0.62 . . . . 0.0 109.332 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.13 120.75 33.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.607 0.718 . . . . 0.0 111.028 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.5 mt -127.47 129.35 70.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.443 1.02 . . . . 0.0 111.353 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -37.84 -55.82 2.04 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.34 1.59 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 123.02 2.114 . . . . 0.0 113.638 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 31.0 t -108.99 -46.69 3.56 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.737 -1.227 . . . . 0.0 109.522 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.83 160.49 14.55 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.435 1.112 . . . . 0.0 112.643 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -139.93 112.41 7.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.767 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.05 84.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.34 57.93 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.655 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -152.75 157.31 40.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.863 0.865 . . . . 0.0 109.752 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.7 146.13 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.603 1.561 . . . . 0.0 106.959 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.75 152.81 39.04 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -161.91 43.42 0.38 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.336 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.0 p -23.41 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.429 3.092 . . . . 0.0 109.381 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -122.31 155.37 36.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -144.86 165.79 27.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 110.275 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -74.51 137.34 42.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.864 1.666 . . . . 0.0 111.49 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.9 mt -80.4 108.17 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -47.11 125.15 7.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.03 1.332 . . . . 0.0 112.023 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.02 -19.18 38.47 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.829 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -136.16 178.23 7.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.284 1.434 . . . . 0.0 108.77 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.91 7.78 43.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.789 0.804 . . . . 0.0 110.595 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -73.8 164.31 54.76 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 162.89 34.32 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.203 1.401 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.5 tt -151.72 148.16 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.47 142.82 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.302 1.7 t -119.82 -23.68 6.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.944 0.793 . . . . 0.0 111.96 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -146.49 126.31 13.52 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 120.176 1.353 . . . . 0.0 108.048 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.8 150.02 28.23 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.096 1.358 . . . . 0.0 111.101 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -147.46 139.06 23.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -125.92 113.35 17.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 154.01 42.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.748 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.1 p -144.74 168.3 20.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.238 1.415 . . . . 0.0 108.699 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -123.66 141.0 52.44 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt 72.08 -45.96 0.63 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.164 1.786 . . . . 0.0 110.533 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.54 168.35 17.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.406 1.883 . . . . 0.0 107.629 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 88.2 m -130.5 99.52 5.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.359 1.464 . . . . 0.0 107.954 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 38.6 p -67.14 128.9 38.11 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.336 1.055 . . . . 0.0 113.497 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.21 84.41 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.65 157.41 21.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.527 2.151 . . . . 0.0 108.676 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -133.37 104.36 6.4 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.51 -169.54 20.5 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.4 mt -116.51 124.26 49.47 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.306 1.042 . . . . 0.0 110.461 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.91 109.19 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.152 2.181 . . . . 0.0 110.777 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.69 162.5 26.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 108.458 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.28 -165.95 45.48 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.251 0.917 . . . . 0.0 112.899 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.8 m -73.66 108.47 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.958 2.103 . . . . 0.0 108.26 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.88 138.89 42.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.91 120.77 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.501 0.667 . . . . 0.0 111.81 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.06 124.01 47.72 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.55 110.29 22.44 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -152.06 163.37 39.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.434 1.094 . . . . 0.0 109.934 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -144.71 137.71 26.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 129.37 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.393 0.616 . . . . 0.0 111.138 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.21 -1.57 33.11 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.43 161.23 13.74 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.331 2.065 . . . . 0.0 113.546 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -107.81 159.64 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.889 2.475 . . . . 0.0 107.722 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 54.7 mt -99.74 107.69 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.22 90.68 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.485 1.514 . . . . 0.0 109.449 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.73 159.11 9.1 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 126.046 1.784 . . . . 0.0 111.485 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -131.85 164.35 26.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.626 2.371 . . . . 0.0 108.546 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -161.88 103.13 1.16 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -150.38 -179.94 26.6 Favored Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.173 -0.954 . . . . 0.0 114.205 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 163' ' ' GLU . 21.8 ptmt -140.19 117.26 11.16 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.112 -2.922 . . . . 0.0 103.112 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.28 154.62 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 63.3 m -149.46 -72.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.95 -36.35 13.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.587 0.755 . . . . 0.0 110.755 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.6 mt -130.33 141.92 50.56 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.056 1.342 . . . . 0.0 107.881 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.57 85.09 2.63 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 110.695 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -76.19 -82.38 0.08 Allowed 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.131 0.572 . . . . 0.0 111.531 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 282' ' ' LYS . 33.5 tt0 -83.3 126.05 32.27 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.616 -0.677 . . . . 0.0 110.785 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -128.06 100.96 6.08 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.55 153.75 16.91 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.97 161.78 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.915 1.286 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.79 160.51 15.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 109.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.97 158.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 110.514 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 53.0 mmm -156.81 138.91 10.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 126.081 1.752 . . . . 0.0 107.023 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.84 123.05 8.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 105.58 -2.508 . . . . 0.0 105.58 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 121.2 0.524 . . . . 0.0 112.029 -179.225 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HE2' ' CE1' ' A' ' 142' ' ' TYR . 4.9 tmtt? -38.88 113.73 0.33 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.663 2.785 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.26 146.05 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.82 167.82 11.02 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.42 94.44 3.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.65 7.78 4.85 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.489 1.518 . . . . 0.0 115.417 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -170.14 27.74 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 118.74 1.27 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 89' ' ' ASP . . . -65.52 -28.9 74.08 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.029 1.776 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.13 42.27 30.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.452 1.501 . . . . 0.0 110.314 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.31 15.66 1.41 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.424 1.488 . . . . 0.0 112.883 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 174.64 22.42 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.358 1.932 . . . . 0.0 110.63 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 160.79 26.52 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.184 2.194 . . . . 0.0 112.237 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.73 138.39 6.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.686 0.795 . . . . 0.0 110.973 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -155.91 106.67 2.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -148.27 70.89 1.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.049 1.339 . . . . 0.0 110.758 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -34.53 127.76 0.46 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.345 2.258 . . . . 0.0 113.515 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 178.776 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.006 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.73 139.35 18.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.289 1.044 . . . . 0.0 112.116 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -58.37 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.328 1.851 . . . . 0.0 110.128 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -136.66 163.83 29.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 122.03 -0.419 . . . . 0.0 110.527 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.28 96.61 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.092 1.757 . . . . 0.0 106.879 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.82 136.28 33.03 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.33 148.25 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.539 1.936 . . . . 0.0 106.686 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.69 -115.1 2.01 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 119.483 1.038 . . . . 0.0 111.814 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.21 174.06 1.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 110.759 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.59 -25.59 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.747 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -60.72 -28.31 68.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.681 1.741 . . . . 0.0 112.468 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.24 1.06 25.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.978 2.511 . . . . 0.0 110.288 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.91 161.14 23.79 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 128.164 2.792 . . . . 0.0 108.996 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 t -84.65 95.66 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -80.32 -63.99 1.29 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 110.076 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 p -61.1 113.47 2.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.865 1.266 . . . . 0.0 111.162 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.2 mm -134.58 137.3 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.379 1.472 . . . . 0.0 107.386 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.96 111.3 5.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.1 p -124.37 150.19 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.41 122.61 59.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -110.2 104.6 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.12 110.35 18.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.596 0.236 . . . . 0.0 110.905 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -79.09 152.97 30.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.29 -38.87 74.64 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 m -63.71 -59.83 4.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -155.34 157.3 36.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.223 2.209 . . . . 0.0 106.364 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.23 156.39 39.19 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.96 108.66 2.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.44 138.53 33.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 109.369 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.36 -3.09 25.99 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.913 2.197 . . . . 0.0 112.124 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -166.43 21.29 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.431 1.116 . . . . 0.0 114.545 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -105.52 149.26 26.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.459 1.904 . . . . 0.0 107.812 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -129.73 155.87 45.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.286 1.434 . . . . 0.0 107.39 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.1 179.61 37.26 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -126.94 116.99 21.64 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.236 -1.155 . . . . 0.0 113.547 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -92.43 164.39 13.5 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.174 1.79 . . . . 0.0 110.204 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 p -142.9 168.0 20.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -63.95 -17.66 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.98 -9.84 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.954 1.702 . . . . 0.0 112.982 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.55 101.19 0.16 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 120.478 1.49 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -159.8 131.66 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.201 2.2 . . . . 0.0 105.752 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -143.28 162.39 35.79 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 127.302 2.241 . . . . 0.0 107.568 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -139.63 95.24 2.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -89.74 138.36 31.55 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -130.57 136.9 49.37 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.49 138.24 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.743 1.617 . . . . 0.0 109.607 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 5.8 t0 -82.25 171.08 14.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.5 65.79 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.995 -1.066 . . . . 0.0 112.587 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -124.4 19.45 8.89 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.326 1.45 . . . . 0.0 112.579 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.0 136.44 38.26 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.7 158.12 37.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.16 1.784 . . . . 0.0 109.175 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.0 mt -96.42 121.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.175 0.99 . . . . 0.0 109.22 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.3 m -118.38 -18.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.609 0.64 . . . . 0.0 111.952 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.19 141.11 25.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 t -135.54 142.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.64 118.48 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.78 138.4 54.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 111' ' ' THR . 17.0 m -117.02 137.31 52.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -140.27 148.97 42.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.013 0.525 . . . . 0.0 109.717 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -147.29 150.55 35.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -144.86 158.21 43.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 127.204 2.202 . . . . 0.0 109.273 177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.62 169.48 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 108.304 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.16 1.61 1.98 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.552 1.541 . . . . 0.0 113.21 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.47 17.31 14.11 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 126.904 2.192 . . . . 0.0 112.895 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -134.38 156.69 48.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.155 1.477 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -117.25 5.36 12.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.341 1.856 . . . . 0.0 112.3 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.408 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 53.2 p -134.11 173.52 11.5 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.678 2.791 . . . . 0.0 110.108 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 9' ' ' GLY . 7.2 m-20 -119.19 146.27 45.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -126.23 140.04 49.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.35 104.32 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.7 p -73.94 -31.13 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.816 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -150.21 154.35 37.82 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.652 1.581 . . . . 0.0 109.853 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 pt -139.57 148.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 128.441 2.696 . . . . 0.0 106.24 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.63 145.37 25.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -127.45 152.83 47.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -132.45 113.98 13.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 103.554 -2.758 . . . . 0.0 103.554 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.2 p -80.5 161.69 24.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.418 0.553 . . . . 0.0 112.019 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.75 -25.09 66.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.506 1.122 . . . . 0.0 111.29 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -68.62 -15.56 63.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.47 1.908 . . . . 0.0 109.721 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 6.5 61.46 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.693 2.568 . . . . 0.0 111.464 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -73.12 99.13 2.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.532 1.166 . . . . 0.0 111.359 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.12 134.95 33.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 p -107.67 162.2 20.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.763 1.225 . . . . 0.0 110.976 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.13 162.16 42.55 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.906 1.738 . . . . 0.0 109.498 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 109.73 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.615 2.21 . . . . 0.0 108.36 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -72.24 79.61 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 109.488 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.99 -137.2 5.41 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.395 -0.816 . . . . 0.0 111.611 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.99 111.13 13.72 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.597 1.959 . . . . 0.0 108.089 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.1 144.8 50.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.557 ' H ' HG21 ' A' ' 79' ' ' THR . 7.4 m -133.71 163.9 28.41 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.345 1.858 . . . . 0.0 107.055 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.87 -35.87 82.07 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.407 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -73.45 97.53 2.57 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.51 1.924 . . . . 0.0 108.947 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -150.98 170.18 19.96 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.258 1.023 . . . . 0.0 109.019 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.64 167.21 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -118.69 141.02 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.61 94.02 2.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 169.48 23.11 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.11 2.164 . . . . 0.0 108.42 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.56 150.25 38.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.473 1.909 . . . . 0.0 109.086 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.13 -61.02 2.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.189 0.904 . . . . 0.0 111.688 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -68.39 -15.55 63.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.522 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.99 -53.02 0.8 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.546 -1.697 . . . . 0.0 112.571 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 38.82 91.26 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.21 2.338 . . . . 0.0 114.055 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -52.5 120.7 5.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.658 1.729 . . . . 0.0 109.888 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.83 144.38 38.92 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.173 2.189 . . . . 0.0 110.147 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.46 -31.16 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.677 0.791 . . . . 0.0 110.084 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.73 150.89 8.54 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -121.95 84.6 2.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 123.468 1.604 . . . . 0.0 107.642 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.36 151.68 36.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 111.759 -2.473 . . . . 0.0 110.554 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.93 78.78 0.16 Allowed Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.809 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -49.33 107.11 0.13 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.045 1.738 . . . . 0.0 109.034 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.5 165.07 18.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.712 2.405 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.54 -86.65 0.2 Allowed Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 105.186 -3.166 . . . . 0.0 105.186 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -93.9 -27.59 16.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.35 166.29 25.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.832 2.453 . . . . 0.0 108.548 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.6 tp -78.81 99.05 6.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -82.95 -55.64 4.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.556 0.742 . . . . 0.0 112.945 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.81 161.27 21.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.949 0.9 . . . . 0.0 109.852 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 tp -148.43 163.39 37.28 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.717 1.607 . . . . 0.0 108.672 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.57 -179.51 40.39 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.72 151.99 29.38 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.449 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 8.5 m-85 -114.84 146.33 41.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.486 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -143.11 156.39 44.79 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.347 0 C-N-CA 123.779 0.832 . . . . 0.0 111.469 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.372 0.606 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -73.97 122.92 23.35 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -99.79 118.93 37.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.825 1.65 . . . . 0.0 106.931 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.35 -176.68 4.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.675 0.671 . . . . 0.0 111.751 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.5 m -121.52 85.74 2.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 113.426 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.25 -175.84 5.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.278 1.031 . . . . 0.0 109.13 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -123.87 165.17 20.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 127.005 2.122 . . . . 0.0 107.248 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 177.75 -83.04 0.07 OUTLIER Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.832 0.742 . . . . 0.0 114.187 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.44 -24.77 0.02 OUTLIER Glycine 0 N--CA 1.469 0.848 0 CA-C-N 117.403 0.601 . . . . 0.0 112.779 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 282' ' ' LYS . 0.3 OUTLIER 61.43 21.35 11.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -83.59 -47.85 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.54 12.79 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 122.57 1.095 . . . . 0.0 113.765 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.7 m -81.44 134.53 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.219 -0.577 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.56 124.31 22.88 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.535 0.734 . . . . 0.0 110.505 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -127.05 126.9 43.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.241 1.02 . . . . 0.0 109.362 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -98.2 156.52 16.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.624 2.369 . . . . 0.0 107.278 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.28 -53.48 2.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.776 1.63 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.8 -105.7 1.85 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -165.62 166.88 17.77 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.645 1.978 . . . . 0.0 108.378 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.33 154.3 36.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.159 0.584 . . . . 0.0 110.317 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -27.74 61.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.12 140.55 2.91 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.747 2.594 . . . . 0.0 106.754 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.8 m -91.85 157.14 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.511 1.124 . . . . 0.0 110.634 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -123.71 -21.88 5.09 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.843 1.657 . . . . 0.0 111.086 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -166.11 159.85 15.73 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.625 0.77 . . . . 0.0 110.426 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.74 147.55 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 126.982 2.113 . . . . 0.0 107.694 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -139.4 113.28 8.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.151 1.381 . . . . 0.0 108.322 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.19 133.81 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -135.86 144.53 16.37 Favored Glycine 0 C--O 1.238 0.397 0 CA-C-O 122.029 0.794 . . . . 0.0 111.815 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -126.72 171.89 10.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.285 1.434 . . . . 0.0 107.43 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.16 -171.44 12.4 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -63.43 -6.81 5.38 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.638 1.175 . . . . 0.0 113.484 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -120.04 -4.96 10.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.756 1.622 . . . . 0.0 112.859 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 125.14 -162.08 19.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.596 1.089 . . . . 0.0 111.626 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.1 mm -55.6 126.64 13.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 m -134.27 -19.73 1.92 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.62 138.18 16.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 121.174 1.806 . . . . 0.0 111.551 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.05 146.85 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.146 0.884 . . . . 0.0 109.761 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -160.45 167.23 27.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.794 1.637 . . . . 0.0 107.459 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -138.32 172.4 12.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.592 1.157 . . . . 0.0 108.11 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -126.75 124.3 39.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -132.06 167.99 18.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.458 0.572 . . . . 0.0 111.31 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -116.6 91.46 3.59 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -112.96 136.32 52.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.771 2.428 . . . . 0.0 106.14 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.16 20.32 34.95 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.947 0.784 . . . . 0.0 113.093 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.93 4.73 3.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.638 2.375 . . . . 0.0 113.723 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -91.25 -157.33 0.49 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.495 1.518 . . . . 0.0 111.055 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -125.4 73.43 1.32 Allowed 'General case' 0 C--N 1.339 0.142 0 O-C-N 120.694 -1.254 . . . . 0.0 110.924 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.2 mt -84.87 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.0 145.05 31.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -73.57 156.54 51.03 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.35 159.06 46.38 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.18 94.41 4.74 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -63.14 -22.04 66.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.381 1.072 . . . . 0.0 113.228 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.56 -179.07 16.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.925 1.726 . . . . 0.0 112.19 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.57 117.49 68.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.567 1.547 . . . . 0.0 109.523 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.8 175.16 6.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.407 2.071 . . . . 0.0 110.196 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -139.95 162.08 36.06 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.744 -1.222 . . . . 0.0 110.546 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.38 -15.28 62.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.886 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -4.24 22.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.709 2.404 . . . . 0.0 111.062 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.46 -157.63 51.67 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.328 -0.857 . . . . 0.0 111.394 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.89 172.67 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.551 1.54 . . . . 0.0 110.482 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.77 147.08 47.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 129.568 3.147 . . . . 0.0 102.827 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.25 147.36 51.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -142.94 143.98 32.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.783 1.233 . . . . 0.0 109.278 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.18 136.4 52.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.4 mt -128.13 103.29 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.861 1.664 . . . . 0.0 109.238 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.64 98.48 0.52 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -55.57 -40.17 82.57 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.49 -29.79 44.42 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 123.187 2.174 . . . . 0.0 112.891 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -89.94 -30.07 18.08 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 116.423 -1.751 . . . . 0.0 113.233 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 225' ' ' TYR . 10.9 tp10 -162.01 175.92 11.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 121.622 2.01 . . . . 0.0 111.157 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.439 ' H ' ' CD ' ' A' ' 224' ' ' GLU . 2.6 p90 -153.17 -156.16 0.67 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.537 1.135 . . . . 0.0 109.311 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 92.6 mt -116.77 102.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 101.885 -3.376 . . . . 0.0 101.885 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.1 p -81.84 -20.64 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.018 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.26 167.5 25.84 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.516 1.526 . . . . 0.0 108.284 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.43 159.08 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.073 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 172.0 13.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.922 2.089 . . . . 0.0 107.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.81 171.62 31.28 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.483 HG21 ' HG2' ' A' ' 262' ' ' GLU . 3.1 p -140.8 146.41 37.6 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -122.14 145.23 48.38 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.132 0.573 . . . . 0.0 110.301 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.61 161.07 36.55 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 110.325 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.52 148.91 38.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.795 1.638 . . . . 0.0 109.873 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.3 pt -115.9 142.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -87.73 99.24 11.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.56 -22.97 1.51 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.873 0.749 . . . . 0.0 113.85 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 m -141.78 155.52 45.6 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.67 -16.92 62.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.848 0.749 . . . . 0.0 112.615 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.02 -173.7 20.56 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.915 1.721 . . . . 0.0 115.689 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.6 mt -119.07 173.52 6.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.082 2.153 . . . . 0.0 110.055 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.3 tt -139.13 130.72 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.843 1.657 . . . . 0.0 108.008 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.9 mt -90.44 76.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.1 t -70.41 -8.43 50.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -141.79 137.21 31.37 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.855 0.752 . . . . 0.0 111.868 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.2 mt -142.79 137.74 29.92 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.724 1.61 . . . . 0.0 109.121 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -139.63 139.42 36.71 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.63 113.04 25.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -65.95 115.27 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.5 m -133.6 162.17 32.64 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.071 0.949 . . . . 0.0 109.23 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.16 161.67 26.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.948 2.499 . . . . 0.0 105.074 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.5 tptt 75.47 -28.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.968 1.707 . . . . 0.0 112.808 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -138.84 167.95 20.88 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.812 1.245 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 14.4 t -121.96 142.92 49.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.934 2.093 . . . . 0.0 106.005 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 p -133.13 149.29 52.1 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.951 0.901 . . . . 0.0 109.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -66.93 159.9 73.13 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.679 0.792 . . . . 0.0 111.819 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.83 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 105.51 -2.535 . . . . 0.0 105.51 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -72.97 99.23 2.66 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.72 179.75 17.77 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.04 114.46 27.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.543 1.937 . . . . 0.0 107.966 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.483 ' HG2' HG21 ' A' ' 232' ' ' THR . 0.9 OUTLIER -59.68 115.84 3.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 110.136 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.42 24.77 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.873 0.844 . . . . 0.0 111.68 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.68 -93.27 1.25 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 125.799 1.666 . . . . 0.0 113.629 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.4 m -149.9 127.47 11.58 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.391 1.076 . . . . 0.0 109.207 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.76 147.69 30.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.881 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -142.24 168.28 20.12 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.527 1.531 . . . . 0.0 108.072 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -151.87 156.2 39.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 109.181 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.7 mt -139.95 138.28 35.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -160.53 160.57 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 108.968 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.16 148.18 34.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 121.85 30.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.845 1.258 . . . . 0.0 109.455 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 87.78 -75.23 2.11 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -47.14 144.88 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.316 1.846 . . . . 0.0 111.486 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -117.65 161.07 20.25 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 83.4 mt -79.13 150.47 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.46 -55.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.8 -176.67 14.81 Favored Glycine 0 C--O 1.239 0.445 0 CA-C-O 122.994 1.33 . . . . 0.0 113.947 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.52 9.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.436 2.695 . . . . 0.0 111.271 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -165.31 162.69 19.85 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.016 1.726 . . . . 0.0 106.714 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.21 -136.11 5.28 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -156.69 131.03 8.63 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.33 137.67 24.55 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.8 m -152.16 -29.99 0.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.541 1.536 . . . . 0.0 112.225 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -139.23 -57.88 0.59 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.423 1.889 . . . . 0.0 111.753 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.78 165.82 22.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.139 1.375 . . . . 0.0 108.232 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.94 92.05 8.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.569 -0.707 . . . . 0.0 110.088 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.85 -48.24 7.14 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.013 0.925 . . . . 0.0 112.865 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -112.61 141.25 46.6 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.92 99.59 3.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -113.32 157.57 14.86 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.963 1.268 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.85 174.85 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.217 1.009 . . . . 0.0 113.13 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -127.97 125.93 40.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.345 2.658 . . . . 0.0 104.787 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -110.22 139.98 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.4 mtm -132.44 144.12 51.7 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.4 140.44 27.25 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.995 -1.963 . . . . 0.0 106.995 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.235 0.29 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.558 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -149.9 97.97 2.66 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.5 131.46 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.149 1.341 . . . . 0.0 108.978 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.21 163.8 21.65 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.652 0.781 . . . . 0.0 112.226 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.97 169.83 17.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.843 1.257 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.54 87.37 0.1 Allowed Glycine 0 C--O 1.225 -0.433 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.99 -167.96 20.41 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 126.585 2.041 . . . . 0.0 108.665 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.45 177.74 2.47 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 115.679 1.031 . . . . 0.0 115.679 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.43 2.99 12.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.414 1.486 . . . . 0.0 114.903 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.99 -2.31 38.03 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.245 -1.309 . . . . 0.0 116.191 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.4 172.78 14.81 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 121.041 2.421 . . . . 0.0 113.882 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.97 157.57 25.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.783 0.833 . . . . 0.0 109.339 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -71.68 84.19 0.88 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 112.698 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -93.98 149.65 21.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.23 -10.06 0.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.799 1.24 . . . . 0.0 111.779 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -54.27 131.76 42.28 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.558 1.943 . . . . 0.0 110.805 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 125.75 1.643 . . . . 0.0 110.241 179.453 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 118.732 -1.038 . . . . 0.0 113.04 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.52 140.84 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.971 1.386 . . . . 0.0 109.511 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -62.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.893 0.877 . . . . 0.0 111.993 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -145.62 164.54 31.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.197 0.999 . . . . 0.0 109.909 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 t -141.71 150.36 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 127.043 2.137 . . . . 0.0 106.337 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -136.8 134.91 37.52 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.77 147.16 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 62' ' ' PHE . . . 135.26 124.92 2.47 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.25 -4.71 10.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.179 1.792 . . . . 0.0 111.168 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.4 -73.09 0.1 OUTLIER Glycine 0 C--O 1.224 -0.522 0 C-N-CA 129.386 3.374 . . . . 0.0 114.535 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -56.56 -47.84 78.63 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.065 0.946 . . . . 0.0 110.755 -178.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.9 1.52 56.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.432 1.493 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.86 -117.47 5.13 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 121.162 -0.962 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.2 96.76 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 111.532 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -127.12 -29.21 2.79 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.9 t -68.27 159.02 32.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.119 0.872 . . . . 0.0 110.344 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 154.37 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.503 1.521 . . . . 0.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -153.09 123.03 6.92 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.927 1.291 . . . . 0.0 107.735 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.35 100.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 123.966 0.906 . . . . 0.0 108.558 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -104.79 134.29 46.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -127.32 154.63 44.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 109.735 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.27 109.94 22.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -114.67 130.01 56.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 57.16 17.94 3.84 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.845 1.202 . . . . 0.0 112.65 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . 0.325 86.0 p 71.3 23.97 3.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.71 2.404 . . . . 0.0 111.285 -176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.95 160.49 19.49 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.113 2.965 . . . . 0.0 104.871 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -105.23 118.03 35.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 m -118.67 124.55 73.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.272 1.029 . . . . 0.0 110.503 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -122.76 161.58 23.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.282 1.833 . . . . 0.0 109.752 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.77 -21.97 2.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.211 1.386 . . . . 0.0 110.05 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.0 167.72 12.52 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 128.036 2.732 . . . . 0.0 109.942 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -73.95 159.46 32.73 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 109.951 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.49 143.69 50.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.06 -143.79 16.89 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.13 115.73 18.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.785 2.834 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 151.99 24.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.214 1.37 . . . . 0.0 110.163 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -147.72 156.1 42.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 tp -77.89 -10.43 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.86 -0.525 . . . . 0.0 111.502 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.12 -5.47 27.24 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.57 96.43 0.1 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.492 ' HA ' ' HA3' ' A' ' 29' ' ' GLY . 12.3 p90 -154.19 161.83 41.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.712 1.205 . . . . 0.0 109.66 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.66 163.61 33.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 127.197 2.199 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.7 m -131.82 140.81 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.004 2.121 . . . . 0.0 107.205 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -133.07 140.75 47.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.004 1.322 . . . . 0.0 109.295 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.5 136.24 54.97 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.175 1.79 . . . . 0.0 111.478 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.48 125.8 71.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.94 164.68 26.32 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.572 -0.705 . . . . 0.0 111.634 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -11.13 15.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.476 1.511 . . . . 0.0 113.172 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -127.5 10.0 6.65 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.788 1.635 . . . . 0.0 110.885 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -97.79 152.44 19.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.151 0.887 . . . . 0.0 111.786 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.53 134.14 41.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.61 105.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.91 -55.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.7 22.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.236 1.015 . . . . 0.0 109.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.78 151.37 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -135.17 136.0 41.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.59 135.89 27.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -116.27 156.54 26.43 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -153.55 158.64 41.55 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.486 1.039 . . . . 0.0 112.516 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -162.49 168.89 21.25 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.96 0.886 . . . . 0.0 112.14 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -125.3 141.27 52.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.479 2.712 . . . . 0.0 106.646 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -123.56 159.09 28.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.28 129.19 40.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.29 2.91 51.06 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 111.557 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -138.62 127.65 23.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.028 1.731 . . . . 0.0 106.766 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -11.18 49.46 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.3 p -80.07 -175.5 5.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.916 2.486 . . . . 0.0 109.9 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.83 134.91 17.99 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.73 171.73 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 123.827 0.851 . . . . 0.0 111.729 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.8 mm -73.93 134.06 30.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 p -104.73 -30.42 9.93 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.335 0.654 . . . . 0.0 110.172 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -156.42 160.44 39.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.325 0.966 . . . . 0.0 110.214 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.6 mt -142.58 147.62 20.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 126.667 1.987 . . . . 0.0 107.351 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -150.66 137.18 18.8 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.68 115.5 22.19 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.292 1.437 . . . . 0.0 107.747 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.12 135.11 33.41 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.4 p -110.23 159.39 17.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.658 1.117 . . . . 0.0 110.809 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -77.29 -25.88 51.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 5.3 mmpt? -63.56 -11.23 22.82 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.467 1.907 . . . . 0.0 114.491 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.52 31.26 33.99 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 120.862 1.665 . . . . 0.0 110.526 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -128.95 93.59 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.561 1.144 . . . . 0.0 108.397 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -85.74 136.28 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.82 150.3 75.27 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.92 166.73 28.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.615 1.543 . . . . 0.0 108.426 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.32 99.81 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.733 2.288 . . . . 0.0 108.265 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.32 85.43 0.16 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.488 1.515 . . . . 0.0 110.173 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.23 -123.75 3.52 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 126.07 1.795 . . . . 0.0 108.867 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.2 tp -139.51 120.92 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.417 1.487 . . . . 0.0 107.719 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 151.4 21.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.03 169.56 19.66 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.735 -1.228 . . . . 0.0 110.52 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.15 -61.23 2.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.543 1.137 . . . . 0.0 111.605 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.74 127.64 32.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -174.5 173.14 2.98 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.179 0.992 . . . . 0.0 111.1 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.34 167.52 25.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.057 0.943 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.11 150.63 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.725 1.61 . . . . 0.0 108.388 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.21 154.65 42.62 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 109.067 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.85 156.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.272 2.229 . . . . 0.0 110.02 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 143' ' ' PHE . 31.1 t0 -117.67 175.61 5.56 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.009 2.523 . . . . 0.0 109.238 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -64.89 176.96 1.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.703 2.001 . . . . 0.0 110.482 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -68.18 -17.79 64.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.942 0.897 . . . . 0.0 112.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.44 43.02 1.71 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -133.19 154.36 21.17 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -137.61 149.55 46.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.881 0.872 . . . . 0.0 109.892 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.18 133.54 49.05 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.61 -71.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -139.54 166.34 25.59 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.268 0.486 . . . . 0.0 112.022 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -125.0 120.06 30.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.415 1.886 . . . . 0.0 107.303 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 148.85 25.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.21 96.13 0.18 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 65.4 1.2 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 109.553 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.01 165.53 12.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.526 2.331 . . . . 0.0 108.448 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.22 -102.56 0.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 103.215 -3.954 . . . . 0.0 103.215 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -86.75 -9.88 54.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.605 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 170.66 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.337 2.255 . . . . 0.0 108.786 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.452 HD11 HD23 ' A' ' 139' ' ' LEU . 12.9 tp -82.18 93.86 7.16 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.797 2.039 . . . . 0.0 110.772 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.68 -39.8 11.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.28 148.91 30.98 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.325 -0.86 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.501 ' CD1' ' H ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -134.84 -169.51 2.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.743 2.417 . . . . 0.0 108.827 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.501 ' H ' ' CD1' ' A' ' 139' ' ' LEU . . . 144.63 172.27 15.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.439 2.447 . . . . 0.0 109.469 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.56 166.28 33.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 120.031 1.915 . . . . 0.0 111.176 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -136.98 168.96 18.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.216 1.007 . . . . 0.0 110.88 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.431 ' CG ' ' HB2' ' A' ' 119' ' ' ASP . 7.8 m-85 -134.43 97.22 3.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 117.746 -1.121 . . . . 0.0 113.041 -178.355 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -94.99 126.18 40.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HA ' ' CE1' ' A' ' 293' ' ' HIS . 4.3 pttp -85.86 141.31 29.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.851 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.53 157.39 18.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.5 m -75.77 126.88 31.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.852 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.23 178.8 0.24 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.088 1.355 . . . . 0.0 112.161 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.421 HG22 ' H ' ' A' ' 160' ' ' GLY . 8.2 mt -128.68 170.68 17.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.555 1.942 . . . . 0.0 107.259 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.421 ' H ' HG22 ' A' ' 159' ' ' ILE . . . -34.53 111.12 0.07 OUTLIER Glycine 0 CA--C 1.493 -1.282 0 C-N-CA 125.859 1.695 . . . . 0.0 113.335 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 164.36 121.66 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 O-C-N 125.471 1.336 . . . . 0.0 113.209 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -146.67 3.43 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -119.76 111.77 18.42 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 110.168 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.56 162.64 10.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.857 1.218 . . . . 0.0 111.633 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.1 t -81.56 141.31 33.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.77 28.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -141.63 17.89 2.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.707 1.603 . . . . 0.0 110.87 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -43.12 127.08 4.21 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.221 2.208 . . . . 0.0 111.746 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.38 -7.83 58.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 77.62 -98.58 1.42 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 104.302 -3.519 . . . . 0.0 104.302 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.99 159.79 29.89 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.338 1.855 . . . . 0.0 107.425 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -131.56 179.54 5.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.832 2.053 . . . . 0.0 107.31 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.98 -44.09 97.86 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.7 160.58 30.8 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-O 122.177 0.876 . . . . 0.0 111.662 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.8 156.36 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 127.614 2.365 . . . . 0.0 105.342 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -138.42 -41.09 0.51 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.935 0.789 . . . . 0.0 112.911 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -133.65 140.91 47.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.339 -0.85 . . . . 0.0 110.871 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.53 120.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.02 112.66 24.63 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.62 128.28 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.83 97.9 0.65 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.529 1.538 . . . . 0.0 110.355 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -89.85 177.39 6.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 123.075 1.417 . . . . 0.0 111.798 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.25 -165.84 11.55 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 129.731 3.539 . . . . 0.0 106.924 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.8 -46.99 15.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.011 -0.699 . . . . 0.0 111.843 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.77 -31.87 25.7 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.079 1.351 . . . . 0.0 113.017 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.2 25.01 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.33 149.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.926 0.89 . . . . 0.0 109.657 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 p -132.29 -40.59 1.01 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.93 0.892 . . . . 0.0 110.228 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.0 165.07 20.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.746 1.218 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.05 124.61 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.02 90.34 0.68 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.862 0.756 . . . . 0.0 110.76 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -92.93 174.34 7.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.23 0.612 . . . . 0.0 110.505 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.13 140.96 47.46 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.17 168.31 20.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.742 1.617 . . . . 0.0 110.867 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -112.41 155.84 23.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.403 1.081 . . . . 0.0 110.478 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -139.83 115.31 9.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.56 -89.45 0.29 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -147.48 24.28 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.898 1.679 . . . . 0.0 109.773 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -126.17 142.24 51.61 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.35 141.01 40.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.619 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.3 mm -121.88 132.07 71.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.46 135.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.256 1.022 . . . . 0.0 108.749 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.01 -131.34 3.29 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.94 -8.78 61.99 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.373 1.94 . . . . 0.0 113.592 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 125.44 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.789 1.295 . . . . 0.0 107.823 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -136.92 -50.23 0.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.305 0.642 . . . . 0.0 109.495 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.41 -179.44 50.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.869 1.223 . . . . 0.0 113.595 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.28 105.44 4.11 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 126.649 1.979 . . . . 0.0 108.886 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.63 177.51 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.825 1.683 . . . . 0.0 108.008 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -121.77 150.86 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.2 -12.66 42.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.257 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.9 tt -51.85 -34.4 40.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.039 2.536 . . . . 0.0 110.788 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.27 -155.89 15.93 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -143.53 128.34 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.19 151.06 25.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -135.36 152.56 51.55 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.538 0.608 . . . . 0.0 112.428 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -142.24 127.03 18.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.96 115.9 31.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mm -127.67 105.05 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -51.18 117.21 2.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -46.27 -63.66 1.24 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.708 2.003 . . . . 0.0 113.519 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 -32.43 5.42 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.231 1.832 . . . . 0.0 115.822 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 m -77.59 -19.69 55.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.16 170.24 16.22 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.409 1.004 . . . . 0.0 109.889 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -149.78 108.33 3.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.649 1.179 . . . . 0.0 108.072 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.507 HG22 HD12 ' A' ' 276' ' ' ILE . 4.2 mp -65.03 108.29 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -31.46 19.9 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.23 25.36 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.176 1.353 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.05 149.81 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.943 1.297 . . . . 0.0 108.239 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -132.37 177.2 7.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 130.042 3.337 . . . . 0.0 106.421 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 151.68 -176.27 30.13 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 120.683 -1.261 . . . . 0.0 110.94 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 p -147.21 155.31 41.98 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.556 1.142 . . . . 0.0 108.231 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.56 165.12 26.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.434 1.494 . . . . 0.0 108.344 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.74 168.04 25.58 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.556 0.693 . . . . 0.0 111.177 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -69.06 149.1 49.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.963 2.105 . . . . 0.0 108.826 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.0 155.36 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.749 1.619 . . . . 0.0 109.394 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.08 88.48 2.74 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 167.48 -25.7 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 15.7 m -132.52 170.67 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.102 0.953 . . . . 0.0 110.419 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -108.82 86.8 2.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.61 -146.19 11.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.661 1.6 . . . . 0.0 109.844 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.97 156.05 47.53 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.4 1.48 . . . . 0.0 108.492 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.9 tt -113.23 149.18 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.29 1.436 . . . . 0.0 109.011 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.0 mm -77.37 137.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -129.63 -35.13 1.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.013 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.5 ttt -126.55 146.65 50.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.044 0.838 . . . . 0.0 110.836 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -140.0 147.83 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.428 1.491 . . . . 0.0 109.301 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -149.21 154.92 39.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -141.72 122.4 14.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -65.15 152.12 44.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.0 p -143.15 154.46 43.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.4 158.99 15.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 67.84 -34.37 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.507 1.923 . . . . 0.0 113.794 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -141.33 174.17 10.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.697 1.999 . . . . 0.0 109.448 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.5 p -114.44 162.71 16.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.085 1.354 . . . . 0.0 110.009 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 3.6 p -98.99 177.56 5.21 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.231 1.413 . . . . 0.0 110.646 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.22 157.28 41.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.372 1.469 . . . . 0.0 109.206 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.19 99.14 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.853 2.369 . . . . 0.0 108.402 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -82.84 92.51 7.28 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 126.24 -164.77 19.69 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.942 1.258 . . . . 0.0 111.051 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.7 tp -118.88 130.09 55.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.186 1.394 . . . . 0.0 109.542 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -70.99 120.71 16.96 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.2 -178.8 7.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.239 1.416 . . . . 0.0 109.392 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 49.34 -103.59 0.08 OUTLIER Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.253 1.882 . . . . 0.0 113.417 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 16.8 m -147.98 145.42 28.54 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.701 1.201 . . . . 0.0 108.692 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.66 26.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -141.34 151.03 43.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.537 1.535 . . . . 0.0 109.557 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.91 155.44 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.335 1.054 . . . . 0.0 110.962 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 42.9 mt -143.4 119.28 10.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.65 1.18 . . . . 0.0 109.354 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -139.31 170.99 14.93 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.237 0.615 . . . . 0.0 111.795 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.93 170.79 15.47 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.927 2.491 . . . . 0.0 107.638 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.7 125.2 47.05 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.71 77.86 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.527 1.061 . . . . 0.0 115.097 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -135.18 175.63 9.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.049 1.424 . . . . 0.0 111.924 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.01 161.94 36.66 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.486 1.514 . . . . 0.0 109.742 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 226' ' ' ILE . 91.4 mt -74.24 144.02 12.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.9 2.33 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.182 0.993 . . . . 0.0 112.565 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.0 179.03 26.39 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 120.898 -1.126 . . . . 0.0 112.401 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.22 160.52 18.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.661 2.385 . . . . 0.0 108.344 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . 0.502 ' CD2' ' HD1' ' A' ' 293' ' ' HIS . 12.1 p80 -151.67 106.54 3.26 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -160.48 -147.41 4.92 Favored Glycine 0 C--O 1.237 0.29 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.12 126.04 8.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.68 134.58 13.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.164 0.986 . . . . 0.0 109.2 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.7 t -133.9 -68.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -95.51 -32.86 12.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.172 0.989 . . . . 0.0 111.75 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.4 mp -135.9 175.14 9.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 108.895 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.55 99.92 6.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.888 1.275 . . . . 0.0 109.431 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.35 -65.65 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.37 115.85 7.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.688 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.11 160.8 39.12 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.696 0.798 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 161.43 -167.32 36.24 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 12.5 m -152.3 153.5 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.499 1.119 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . 0.502 ' HD1' ' CD2' ' A' ' 280' ' ' HIS . 0.1 OUTLIER -94.19 167.76 11.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.07 143.99 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 66.1 mtp -139.46 140.88 26.85 Favored Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.61 139.51 76.08 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 110.067 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.912 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HD3' ' CD2' ' A' ' 142' ' ' TYR . 29.7 ttpt -41.84 106.6 0.06 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.067 1.747 . . . . 0.0 111.363 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.22 146.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.67 144.32 14.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.919 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.22 151.28 31.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.89 13.77 17.05 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.739 -0.601 . . . . 0.0 112.175 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.27 102.9 0.21 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 126.508 2.004 . . . . 0.0 112.557 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' SER . . . -126.93 -19.33 2.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 116.907 1.523 . . . . 0.0 116.907 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 137' ' ' TYR . . . -78.55 -13.93 59.59 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.676 1.59 . . . . 0.0 109.966 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.74 43.19 19.06 Favored Glycine 0 N--CA 1.416 -2.658 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.251 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 -107.5 0.16 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.6 159.23 43.44 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.628 1.171 . . . . 0.0 110.628 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -93.52 129.95 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.574 -1.328 . . . . 0.0 108.481 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -93.25 -13.43 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.479 0.712 . . . . 0.0 109.857 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.01 103.48 0.74 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.044 0.937 . . . . 0.0 110.179 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.71 -54.53 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.431 178.801 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.26 150.57 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.58 1.152 . . . . 0.0 108.8 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -126.23 -45.38 1.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -143.16 161.88 37.05 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.207 1.403 . . . . 0.0 107.314 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.43 151.17 22.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -131.65 139.83 49.2 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.7 t -150.58 144.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.83 146.47 9.41 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -58.46 146.52 34.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 110.303 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.37 -116.33 2.71 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.99 1.281 . . . . 0.0 110.712 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -87.21 -49.15 7.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.766 0.783 . . . . 0.0 111.941 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -126.42 -26.02 3.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.376 1.071 . . . . 0.0 110.259 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.27 176.35 27.13 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.497 1.523 . . . . 0.0 111.183 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.2 m -58.44 96.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 126.437 1.895 . . . . 0.0 111.612 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 t -87.42 -50.7 6.38 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.295 1.038 . . . . 0.0 111.371 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 p -66.81 119.96 12.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.706 1.139 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.64 158.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 108.064 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -166.5 141.86 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.937 1.295 . . . . 0.0 108.467 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.1 95.92 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.726 1.211 . . . . 0.0 108.37 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.63 130.27 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -100.81 131.98 46.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 109.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -114.87 115.89 27.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.33 34.76 24.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.967 0.907 . . . . 0.0 108.743 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t 72.54 -1.23 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.198 2.199 . . . . 0.0 112.481 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.08 144.56 28.16 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.838 1.199 . . . . 0.0 109.655 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.97 126.51 34.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.76 109.14 14.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -111.62 162.2 15.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.566 1.547 . . . . 0.0 111.954 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.6 57.43 0.09 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.83 -1.6 0.19 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.881 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.515 ' OE2' ' HE2' ' A' ' 57' ' ' LYS . 1.7 tt0 -73.51 112.16 9.33 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.512 1.656 . . . . 0.0 106.816 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -137.18 167.18 22.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.527 1.531 . . . . 0.0 107.286 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.5 -179.01 20.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -82.86 98.08 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.046 -1.267 . . . . 0.0 109.165 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HE2' ' OE2' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -83.53 163.1 20.65 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -132.08 172.76 11.98 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.595 1.158 . . . . 0.0 109.844 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 tp -89.79 -47.28 8.01 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.287 1.035 . . . . 0.0 111.689 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.01 75.21 1.02 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.93 -34.76 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 128.5 33.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.811 1.245 . . . . 0.0 111.125 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -143.69 163.83 32.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.337 1.855 . . . . 0.0 107.563 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.2 m -126.85 146.27 50.34 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.6 1.16 . . . . 0.0 108.654 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -129.04 140.94 51.4 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 126.057 1.743 . . . . 0.0 106.905 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.1 146.94 50.93 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.405 1.082 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.36 157.82 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.97 168.04 13.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.743 1.61 . . . . 0.0 112.087 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.51 -27.15 25.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.478 1.511 . . . . 0.0 110.483 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -121.02 5.96 10.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.924 0.784 . . . . 0.0 112.84 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -116.64 156.17 27.51 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.77 -176.78 4.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.38 136.17 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.9 m -113.89 -36.0 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.734 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.32 160.39 43.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.257 0.935 . . . . 0.0 110.206 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -146.05 110.03 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -80.73 134.46 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -132.43 122.95 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.464 1.106 . . . . 0.0 108.32 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.41 ' OG1' ' HE3' ' A' ' 114' ' ' LYS . 30.4 m -118.31 145.26 45.22 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.965 1.706 . . . . 0.0 106.477 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -149.93 168.11 24.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.536 1.134 . . . . 0.0 111.212 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -161.18 158.82 28.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.333 1.053 . . . . 0.0 108.946 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.86 135.1 24.12 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.489 1.116 . . . . 0.0 108.646 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -72.33 154.19 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.785 0.721 . . . . 0.0 109.975 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -61.67 -14.62 32.82 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.49 -7.89 41.71 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.403 -1.221 . . . . 0.0 113.762 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -135.27 105.53 6.33 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.207 1.503 . . . . 0.0 107.584 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -58.65 -24.61 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.913 1.685 . . . . 0.0 115.18 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . 46.1 p -72.8 122.31 21.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.932 1.293 . . . . 0.0 109.178 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.93 164.17 16.7 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 126.331 1.853 . . . . 0.0 109.173 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.75 149.9 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.07 -1.019 . . . . 0.0 108.38 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.0 128.1 32.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 p -95.81 -39.19 9.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.994 -1.479 . . . . 0.0 108.268 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 m -160.1 152.34 20.65 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.9 1.682 . . . . 0.0 111.108 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.4 mm -132.95 139.03 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.0 m -130.17 112.58 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -82.03 155.43 25.15 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.959 0.904 . . . . 0.0 109.783 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.75 113.73 7.24 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 106.927 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 p -90.43 170.6 10.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.638 0.654 . . . . 0.0 111.182 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -60.81 -36.25 78.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -6.67 56.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.24 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 15.8 39.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.227 -1.319 . . . . 0.0 111.28 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -71.72 101.76 2.64 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -93.44 140.11 29.95 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 p -92.7 160.95 33.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.02 160.55 49.24 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 N-CA-C 105.41 -2.573 . . . . 0.0 105.41 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.64 89.0 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.753 2.302 . . . . 0.0 107.529 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -58.83 104.23 0.22 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.633 0.773 . . . . 0.0 109.125 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.78 -145.04 16.56 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.4 111.9 12.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.395 1.478 . . . . 0.0 108.154 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -46.81 139.46 5.39 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.227 1.811 . . . . 0.0 113.948 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 178.45 7.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.254 1.422 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.33 -53.17 5.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.035 1.734 . . . . 0.0 114.066 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -65.15 108.08 1.75 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.689 1.131 . . . . 0.0 108.863 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.41 ' HE3' ' OG1' ' A' ' 79' ' ' THR . 6.1 ptmt -152.91 168.76 24.72 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 123.099 0.56 . . . . 0.0 111.318 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.31 166.99 31.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 106.994 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.46 122.06 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 117' ' ' LEU . 1.5 pt? -100.42 133.62 44.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.0 167.89 28.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.869 0.868 . . . . 0.0 111.282 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.65 168.07 10.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.694 1.197 . . . . 0.0 107.938 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.38 -27.26 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.365 2.666 . . . . 0.0 109.648 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.79 -5.47 46.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.581 2.752 . . . . 0.0 111.838 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.67 9.98 48.3 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.605 1.098 . . . . 0.0 113.153 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.01 85.98 0.89 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 124.951 1.263 . . . . 0.0 110.569 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -59.65 142.46 52.9 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.45 128.19 35.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.07 -50.54 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.54 -151.22 6.71 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.087 1.327 . . . . 0.0 109.804 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.57 169.22 18.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.165 1.483 . . . . 0.0 113.16 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -138.6 166.41 24.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.602 1.961 . . . . 0.0 106.941 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.14 125.58 2.97 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.7 -178.44 4.39 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.351 -1.088 . . . . 0.0 108.926 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -125.9 158.79 34.26 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.391 2.276 . . . . 0.0 105.993 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -116.56 -83.83 1.04 Allowed Glycine 0 CA--C 1.51 -0.271 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -107.77 -14.21 14.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.573 0.749 . . . . 0.0 110.506 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -155.43 174.2 15.58 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.883 2.473 . . . . 0.0 107.604 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 tp -75.77 131.88 40.09 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.23 0.612 . . . . 0.0 109.48 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-85 -138.45 -55.67 0.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.478 1.911 . . . . 0.0 109.47 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -107.3 108.13 19.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.4 tp -130.78 142.05 50.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.11 -178.18 35.78 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 127.11 2.29 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.04 137.48 15.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.767 1.283 . . . . 0.0 110.38 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CD2' ' HD3' ' A' ' 3' ' ' LYS . 41.7 m-85 -81.42 141.43 33.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.878 1.271 . . . . 0.0 107.835 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -137.04 127.3 26.36 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 0 CA-C-N 118.636 0.653 . . . . 0.0 110.565 179.663 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.382 0.61 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -73.96 107.79 6.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -83.56 119.61 24.93 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.249 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.4 mt -78.41 -94.24 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -155.51 166.1 34.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.921 1.288 . . . . 0.0 109.826 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -147.27 -178.18 6.08 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 130.148 3.379 . . . . 0.0 107.706 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.46 141.86 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.31 1.414 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.12 -105.64 3.22 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.75 64.5 4.15 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.415 1.007 . . . . 0.0 111.172 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.444 ' H ' ' HB3' ' A' ' 288' ' ' HIS . 0.7 OUTLIER -76.01 57.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.224 2.21 . . . . 0.0 114.368 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 53.19 20.53 1.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.549 1.94 . . . . 0.0 114.912 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 168.94 33.0 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.8 m -65.43 116.77 7.07 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.844 1.657 . . . . 0.0 109.264 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.75 154.63 40.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.676 0.79 . . . . 0.0 110.44 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -138.39 120.67 15.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.29 104.95 17.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -107.66 93.06 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.558 1.143 . . . . 0.0 108.198 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.35 162.7 32.44 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.61 155.03 34.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 117.611 0.705 . . . . 0.0 110.393 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -112.99 167.61 10.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.431 1.11 . . . . 0.0 112.057 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 -15.76 57.61 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.189 2.196 . . . . 0.0 110.282 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 165.94 149.51 5.94 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.582 2.039 . . . . 0.0 108.063 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.99 129.56 44.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.44 -53.78 6.56 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -158.81 143.55 15.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.67 0.668 . . . . 0.0 110.086 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.96 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.95 158.01 44.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.983 1.313 . . . . 0.0 107.621 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.0 t -143.57 142.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.13 82.13 0.35 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 124.788 1.185 . . . . 0.0 112.683 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -70.89 177.26 3.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.908 1.283 . . . . 0.0 110.339 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.85 -174.24 20.98 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -63.7 -25.09 68.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -122.71 -21.07 5.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.266 1.427 . . . . 0.0 113.833 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 172.3 -178.78 44.28 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 119.53 1.059 . . . . 0.0 111.723 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.5 mm -59.13 115.84 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.476 1.11 . . . . 0.0 109.676 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.5 m -93.83 -35.67 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.415 0.686 . . . . 0.0 111.923 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.65 166.81 23.81 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.6 150.92 30.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.788 1.635 . . . . 0.0 107.015 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.606 ' HE2' ' CE2' ' A' ' 214' ' ' PHE . 0.1 OUTLIER 179.82 150.59 0.36 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.435 3.494 . . . . 0.0 106.594 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -153.78 152.22 30.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.561 1.073 . . . . 0.0 108.131 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -94.42 132.41 39.09 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -138.24 169.03 18.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.253 1.021 . . . . 0.0 111.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -119.8 139.13 52.81 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.075 1.35 . . . . 0.0 109.533 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -140.2 76.16 1.54 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.69 -128.03 46.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.99 10.39 0.55 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.156 1.382 . . . . 0.0 114.066 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.37 140.69 52.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.447 1.476 . . . . 0.0 109.247 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.07 89.35 2.85 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.9 mm -70.09 109.29 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 108.82 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.0 t -125.44 94.89 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.193 1.797 . . . . 0.0 106.241 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 125.6 176.4 14.52 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.438 1.494 . . . . 0.0 113.64 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.91 75.27 1.0 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.275 1.893 . . . . 0.0 110.281 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.87 155.92 29.13 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.625 -0.926 . . . . 0.0 112.33 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.6 -80.12 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.64 162.0 50.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -53.56 116.49 9.93 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 113.567 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 144.06 71.67 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.731 1.621 . . . . 0.0 108.339 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.94 135.3 42.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.488 1.115 . . . . 0.0 110.667 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 -11.09 60.55 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.094 0.558 . . . . 0.0 111.525 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.67 -31.28 69.41 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.209 1.404 . . . . 0.0 109.783 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.39 -171.43 14.63 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.606 ' CE2' ' HE2' ' A' ' 191' ' ' LYS . 13.3 m-85 -136.05 158.81 43.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -111.4 148.06 33.86 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.37 144.35 49.54 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.526 0.516 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 256' ' ' SER . 31.5 t80 -142.88 142.96 31.87 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.68 0.792 . . . . 0.0 110.959 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -92.32 124.68 36.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.409 1.484 . . . . 0.0 108.871 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.67 112.07 29.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.175 0.99 . . . . 0.0 108.749 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.06 88.48 7.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -62.63 -29.55 4.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 115.778 -2.058 . . . . 0.0 113.644 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.12 -45.01 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 123.902 2.429 . . . . 0.0 110.88 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 m -67.03 -54.0 25.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.997 1.319 . . . . 0.0 111.865 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.71 -167.66 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.599 1.96 . . . . 0.0 110.631 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -164.11 142.14 7.18 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.508 1.123 . . . . 0.0 108.976 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.7 mm -93.48 104.18 15.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.3 p -72.92 -59.76 2.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.096 0.959 . . . . 0.0 110.33 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.41 171.72 13.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.647 1.979 . . . . 0.0 111.529 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.78 148.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.39 1.876 . . . . 0.0 106.865 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -133.59 160.85 36.27 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.497 1.119 . . . . 0.0 109.997 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.78 167.37 37.69 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.671 1.129 . . . . 0.0 110.998 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.5 p -133.39 127.19 32.91 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -119.76 146.19 45.88 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -142.61 166.91 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -76.94 136.3 38.79 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.758 1.223 . . . . 0.0 112.824 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.66 156.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 127.426 2.29 . . . . 0.0 108.252 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -103.5 163.75 12.09 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.78 1.232 . . . . 0.0 111.16 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.11 -15.94 56.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.246 1.403 . . . . 0.0 110.347 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.7 t -141.45 -174.38 4.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 128.248 2.619 . . . . 0.0 106.618 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.92 101.82 5.79 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.557 1.943 . . . . 0.0 106.856 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 174.32 -173.37 45.98 Favored Glycine 0 N--CA 1.447 -0.622 0 O-C-N 123.645 0.591 . . . . 0.0 112.451 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.82 141.37 52.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.083 1.353 . . . . 0.0 109.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 10.3 tt -123.72 134.17 67.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.6 1.16 . . . . 0.0 108.773 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.06 98.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -76.0 -26.5 56.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.023 0.529 . . . . 0.0 111.766 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -140.99 152.37 44.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.083 0.856 . . . . 0.0 110.815 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.4 154.65 51.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.468 1.907 . . . . 0.0 109.965 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -145.05 152.52 40.24 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.992 2.117 . . . . 0.0 105.688 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -118.07 142.53 47.31 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -95.61 115.42 27.4 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.2 p -130.49 166.49 20.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.391 1.476 . . . . 0.0 108.776 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -123.54 160.09 27.75 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.993 1.717 . . . . 0.0 106.552 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 69.35 -27.6 0.16 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.114 2.566 . . . . 0.0 112.191 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -150.88 174.83 12.65 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.23 2.212 . . . . 0.0 110.229 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.77 161.02 32.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.579 1.952 . . . . 0.0 106.914 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . 0.412 ' HB3' ' CE2' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -115.29 -10.99 12.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 73.15 162.66 0.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 126.908 2.083 . . . . 0.0 109.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 95.5 Cg_endo -76.28 149.0 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.438 2.092 . . . . 0.0 110.551 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.17 95.72 4.86 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 125.43 -176.99 17.15 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.275 1.416 . . . . 0.0 110.789 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.6 tp -88.18 126.83 35.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.353 1.061 . . . . 0.0 110.165 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -73.12 107.17 5.31 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -160.22 154.79 23.91 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 107.987 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 88.1 -174.82 44.27 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.9 m -77.33 138.47 39.36 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -92.14 142.81 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.317 0.508 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -138.74 147.88 43.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.767 0.827 . . . . 0.0 111.344 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.31 144.29 34.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.23 1.412 . . . . 0.0 109.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 mt -134.22 137.3 44.27 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -150.04 178.27 9.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.174 1.789 . . . . 0.0 108.905 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 164.83 29.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.22 1.01 . . . . 0.0 108.566 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -69.84 5.37 1.55 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.302 1.841 . . . . 0.0 114.354 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 166.45 -34.69 0.23 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.389 -1.444 . . . . 0.0 113.324 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -57.01 149.98 17.88 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.768 0.784 . . . . 0.0 109.331 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 157.47 16.85 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.623 -0.673 . . . . 0.0 110.041 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.6 mt -95.91 104.2 15.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.45 38.81 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.989 1.316 . . . . 0.0 108.548 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.44 168.03 36.57 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 121.166 -0.959 . . . . 0.0 114.477 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.11 171.23 14.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.335 3.054 . . . . 0.0 109.946 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -159.48 146.64 16.87 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.812 1.245 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -179.55 -163.64 30.68 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 121.217 -0.927 . . . . 0.0 113.423 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -146.68 138.97 24.88 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.822 1.649 . . . . 0.0 107.765 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -131.86 154.39 49.23 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.184 1.793 . . . . 0.0 110.055 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.3 m -166.39 -46.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.951 1.3 . . . . 0.0 108.691 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.13 -17.63 1.36 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -171.4 2.01 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.496 1.919 . . . . 0.0 106.617 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 13.3 tp -83.21 85.58 7.18 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 162' ' ' ASP . 87.6 m-70 -60.44 -34.79 74.49 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.264 0.483 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -161.47 163.33 30.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.642 0.734 . . . . 0.0 110.245 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -159.52 135.45 8.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -143.13 -157.71 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 128.538 2.97 . . . . 0.0 108.715 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.73 171.59 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.281 1.039 . . . . 0.0 112.139 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.76 150.16 51.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.874 2.869 . . . . 0.0 105.354 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.25 137.79 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.324 0.65 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 16.2 mmt -125.38 148.24 60.47 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.431 1.492 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 152.62 37.22 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.631 1.554 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.036 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.455 0.645 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -81.15 130.54 35.07 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 102.633 -3.099 . . . . 0.0 102.633 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.51 103.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.687 0.795 . . . . 0.0 110.02 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -55.85 142.7 34.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.49 1.116 . . . . 0.0 110.987 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.63 179.97 1.95 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.857 1.263 . . . . 0.0 110.161 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 143.81 14.48 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.77 -134.13 5.48 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.98 -148.97 18.66 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 118.0 0.9 . . . . 0.0 111.816 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.11 8.32 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.389 1.076 . . . . 0.0 112.168 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.93 -11.51 18.1 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.089 1.595 . . . . 0.0 117.089 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.45 169.21 12.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.648 2.224 . . . . 0.0 113.766 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.55 151.7 32.32 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 97.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.923 0.783 . . . . 0.0 112.736 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -103.56 55.05 0.74 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.11 18.61 19.82 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.198 1.399 . . . . 0.0 111.981 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -151.64 119.31 6.1 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.665 0.786 . . . . 0.0 110.602 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.005 0 C-N-CA 125.865 1.697 . . . . 0.0 115.352 179.174 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 m -63.2 158.64 3.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 117.853 0.827 . . . . 0.0 109.207 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 10.5 mmm180 -136.09 -35.7 0.76 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -147.14 157.51 43.63 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 107.691 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.0 105.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -88.02 140.61 29.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.82 143.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.9 152.54 21.5 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.813 0.733 . . . . 0.0 111.335 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -70.2 120.04 15.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.216 1.406 . . . . 0.0 112.611 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.68 -122.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 130.575 3.94 . . . . 0.0 107.876 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -95.23 -48.35 5.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 118.163 0.982 . . . . 0.0 112.256 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 -26.88 12.14 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 129.109 2.963 . . . . 0.0 114.676 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.42 -158.05 16.7 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 118.897 0.771 . . . . 0.0 111.381 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 m -72.7 96.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.61 1.205 . . . . 0.0 108.846 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -106.63 -45.09 4.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -71.02 148.31 47.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.291 1.405 . . . . 0.0 112.117 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.9 159.68 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.431 1.892 . . . . 0.0 108.091 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.05 152.35 46.15 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.882 2.473 . . . . 0.0 107.458 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.52 132.06 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.658 0.783 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.6 142.96 42.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -132.76 141.38 48.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.347 0.659 . . . . 0.0 109.362 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.476 ' HB2' ' CG ' ' A' ' 24' ' ' ARG . . . -114.25 120.41 40.35 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.086 1.354 . . . . 0.0 108.751 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -113.46 161.99 16.66 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.9 -41.92 92.71 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.2 t -68.81 -69.39 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.491 -1.243 . . . . 0.0 110.574 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -145.31 165.84 27.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 120.239 1.381 . . . . 0.0 113.677 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.49 149.55 33.13 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.777 2.031 . . . . 0.0 105.804 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -147.71 145.73 18.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 122.754 1.264 . . . . 0.0 109.277 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -105.97 162.13 13.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.375 1.47 . . . . 0.0 108.688 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.63 -15.08 2.02 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 0.0 112.09 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.78 167.03 36.22 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 118.7 1.25 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -103.62 106.39 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.32 82.23 2.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.85 -174.61 31.95 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 128.7 3.048 . . . . 0.0 105.676 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -126.78 141.05 51.94 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.286 1.043 . . . . 0.0 111.908 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -130.56 148.84 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.397 2.279 . . . . 0.0 105.149 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.5 m -133.85 -48.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.2 tp -70.05 -9.99 57.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.149 0.886 . . . . 0.0 110.494 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt 66.33 11.48 7.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.209 2.203 . . . . 0.0 112.175 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.34 86.33 1.36 Allowed Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.975 -2.45 . . . . 0.0 106.975 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -131.46 144.68 51.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.505 1.922 . . . . 0.0 108.555 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -142.78 164.69 29.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.041 1.736 . . . . 0.0 110.465 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -124.88 121.22 33.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.356 1.062 . . . . 0.0 113.55 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -87.35 141.83 28.34 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.95 141.21 50.89 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.518 1.127 . . . . 0.0 109.69 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.64 117.44 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.507 1.123 . . . . 0.0 111.538 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -62.1 156.56 21.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.781 1.633 . . . . 0.0 108.591 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.33 68.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.87 25.33 10.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.37 143.06 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.19 1.396 . . . . 0.0 111.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.94 139.74 46.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.356 2.663 . . . . 0.0 110.593 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.19 134.19 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.711 1.604 . . . . 0.0 112.332 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.0 -34.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.948 -1.095 . . . . 0.0 112.1 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.63 144.35 28.34 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.432 1.015 . . . . 0.0 108.64 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.57 92.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -79.34 120.91 24.45 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.506 HG13 ' CE1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -151.77 132.61 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.531 HG21 ' HA ' ' A' ' 110' ' ' GLU . 4.1 t -110.55 153.72 24.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.979 1.711 . . . . 0.0 109.227 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -154.12 147.33 24.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.841 1.656 . . . . 0.0 109.392 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.2 169.33 22.46 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.821 0.737 . . . . 0.0 111.155 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.07 136.16 34.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.967 1.307 . . . . 0.0 109.756 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.22 130.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -61.78 114.84 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.3 41.99 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.113 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -130.49 161.47 31.38 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.192 1.496 . . . . 0.0 109.754 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -96.35 -26.48 15.35 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.768 1.227 . . . . 0.0 110.062 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 p -72.59 166.86 21.9 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.48 1.133 . . . . 0.0 109.022 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.52 135.21 42.2 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.46 166.89 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.354 1.062 . . . . 0.0 112.647 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 138' ' ' ALA . 2.9 mp -74.63 144.03 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.077 1.751 . . . . 0.0 107.445 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -108.61 -29.05 8.94 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.085 0.954 . . . . 0.0 110.849 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -166.36 164.09 17.46 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.948 1.699 . . . . 0.0 108.933 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.1 tt -157.12 154.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.999 1.319 . . . . 0.0 110.73 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 m -150.84 157.28 42.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.478 1.511 . . . . 0.0 107.235 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.86 135.33 48.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -121.33 114.05 20.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 p -81.07 161.19 24.27 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -31.12 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -58.8 -43.07 90.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 111.345 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.97 -7.4 3.8 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.814 0.721 . . . . 0.0 114.383 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.19 132.4 36.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -133.7 156.37 48.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 p -121.24 162.34 36.21 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 111.386 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.28 167.06 23.65 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.885 2.39 . . . . 0.0 110.483 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.12 112.65 3.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.663 2.909 . . . . 0.0 106.618 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -79.19 81.52 5.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.69 -138.13 9.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.372 0.987 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -129.9 121.36 26.5 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.514 1.526 . . . . 0.0 108.334 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HA ' HG21 ' A' ' 79' ' ' THR . 10.1 mm-40 -60.53 156.11 17.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.05 0.54 . . . . 0.0 110.485 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -152.7 -174.5 4.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.692 1.234 . . . . 0.0 112.683 -178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.418 ' H ' HG22 ' A' ' 111' ' ' THR . 14.1 tt0 -67.47 -64.72 0.8 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 127.219 2.208 . . . . 0.0 112.257 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -70.98 101.83 2.27 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.432 1.493 . . . . 0.0 108.633 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -147.8 153.48 39.24 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.657 -0.652 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CE1' HG13 ' A' ' 78' ' ' VAL . 28.2 p90 -125.52 158.94 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.686 1.594 . . . . 0.0 109.857 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.9 t -140.46 104.67 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 139.45 53.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.69 150.69 1.76 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.944 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 143' ' ' PHE . 25.3 t0 -120.97 176.2 5.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.559 1.144 . . . . 0.0 110.49 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -65.27 175.8 1.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.153 2.181 . . . . 0.0 108.092 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -68.38 2.43 2.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.315 1.446 . . . . 0.0 111.743 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.45 3.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.08 2.276 . . . . 0.0 111.159 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.52 165.49 31.46 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 118.248 1.024 . . . . 0.0 111.059 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -161.9 164.69 28.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.62 1.968 . . . . 0.0 107.569 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.3 158.77 11.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.965 0.888 . . . . 0.0 110.991 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.87 -25.29 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.509 2.724 . . . . 0.0 110.722 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.38 -176.27 40.31 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.08 170.59 9.39 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.62 0.724 . . . . 0.0 109.236 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -156.41 170.13 23.01 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 126.825 2.05 . . . . 0.0 107.181 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.67 -146.42 14.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -159.47 135.68 8.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.734 2.414 . . . . 0.0 106.009 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.52 164.86 38.05 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.097 2.559 . . . . 0.0 105.298 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.36 -111.91 0.26 Allowed Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 106.616 -2.594 . . . . 0.0 106.616 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -65.06 -17.83 64.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.46 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.9 175.47 12.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.749 2.02 . . . . 0.0 108.524 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HG ' HD13 ' A' ' 91' ' ' ILE . 26.1 tp -84.8 121.48 27.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.281 1.832 . . . . 0.0 107.341 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -117.16 -31.25 5.4 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 91' ' ' ILE . . . -168.74 161.72 11.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.845 1.657 . . . . 0.0 110.353 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 tt -157.68 149.14 21.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.85 168.17 37.57 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.85 134.53 35.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.43 169.23 10.21 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.272 1.429 . . . . 0.0 109.563 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 119' ' ' ASP . 66.1 m-85 -131.17 112.11 12.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.183 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 -178.729 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.688 0.28 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.12 125.28 29.62 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -111.28 146.79 36.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.778 0.717 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.78 170.84 13.73 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.5 t -87.78 118.86 27.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.271 1.028 . . . . 0.0 110.757 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.62 170.0 12.97 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.199 0.999 . . . . 0.0 111.422 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.9 mt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 129.898 3.279 . . . . 0.0 105.256 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.56 -96.05 0.16 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.593 1.088 . . . . 0.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.77 153.61 24.37 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.08 8.79 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.965 1.306 . . . . 0.0 114.192 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -122.29 106.33 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 120.965 -1.084 . . . . 0.0 110.938 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 172.43 158.11 15.86 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.1 m -66.51 119.1 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.146 0.978 . . . . 0.0 108.43 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.57 130.94 41.11 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -123.17 125.91 46.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.61 153.83 17.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.127 0.971 . . . . 0.0 110.745 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.01 135.14 19.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.48 169.74 22.71 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.48 146.62 50.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -114.75 151.37 33.86 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.97 -15.08 54.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.12 2.568 . . . . 0.0 112.179 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 177.13 177.5 46.1 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 123.793 0.711 . . . . 0.0 111.91 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.88 156.46 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.543 1.937 . . . . 0.0 107.046 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -138.38 -54.1 0.62 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.862 0.865 . . . . 0.0 109.118 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' A' ' 179' ' ' TYR . 2.3 tppt? -151.23 142.46 23.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.12 0.873 . . . . 0.0 111.57 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.71 132.75 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 177' ' ' LYS . 13.3 m-85 -136.33 108.49 7.24 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.34 131.79 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.44 67.27 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.164 1.364 . . . . 0.0 111.562 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 182' ' ' GLN . 2.8 pm0 -70.01 160.94 31.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.182 1.393 . . . . 0.0 109.376 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.01 177.85 35.41 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -51.6 -45.63 63.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.788 0.835 . . . . 0.0 112.721 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.17 -3.09 58.89 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.323 1.049 . . . . 0.0 113.511 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 123.5 -176.31 16.72 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.982 0.81 . . . . 0.0 113.662 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.0 mm -63.26 112.38 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 m -109.29 -30.91 7.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.256 0.622 . . . . 0.0 110.242 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.701 1.201 . . . . 0.0 108.891 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.88 137.0 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 107.283 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.17 155.68 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.27 131.17 27.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.1 140.67 29.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -153.19 169.55 22.72 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.964 1.306 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -127.76 127.08 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -139.95 138.53 35.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.19 31.37 49.34 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.65 -14.18 0.51 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.417 2.687 . . . . 0.0 112.794 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.44 136.19 49.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.829 1.252 . . . . 0.0 110.424 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -89.5 80.07 6.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 109.697 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.65 144.89 14.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.405 1.882 . . . . 0.0 109.694 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.06 129.04 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.71 143.3 18.71 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.48 1.038 . . . . 0.0 112.462 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.63 160.35 52.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -92.54 83.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -62.08 -25.57 67.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.211 1.805 . . . . 0.0 112.003 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.41 176.42 25.34 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.088 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.62 138.33 80.46 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.5 179.59 2.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.408 2.738 . . . . 0.0 110.408 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 70.1 p -135.61 172.69 12.65 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 109.96 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.69 -26.01 28.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.755 0.822 . . . . 0.0 110.576 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 212' ' ' LEU . 2.3 tt -63.65 -21.67 66.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.298 1.839 . . . . 0.0 112.461 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.21 171.33 46.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.59 151.3 21.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.23 0.612 . . . . 0.0 112.309 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -111.93 133.75 53.93 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.41 146.78 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -142.47 143.53 32.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.666 1.187 . . . . 0.0 109.222 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -112.33 130.12 56.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.26 107.82 17.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 125.726 1.61 . . . . 0.0 107.452 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 93.95 2.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -56.5 -34.91 29.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.94 -26.88 10.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 123.964 2.451 . . . . 0.0 113.264 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.4 m -106.91 -0.78 22.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.665 1.575 . . . . 0.0 114.798 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.8 156.8 42.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 120.337 1.426 . . . . 0.0 108.425 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.61 161.55 34.34 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.861 -1.149 . . . . 0.0 112.073 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.2 mm -92.7 97.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.2 m -64.4 -40.27 95.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.86 15.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.618 1.167 . . . . 0.0 109.368 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.16 144.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.416 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 0.8 OUTLIER -132.02 173.13 11.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 155.03 -170.82 33.26 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.8 p -144.8 154.94 43.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -131.55 145.91 51.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -121.88 145.5 48.03 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.878 0.846 . . . . 0.0 111.368 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -70.35 148.26 48.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.876 1.27 . . . . 0.0 109.486 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.5 pt -114.53 155.75 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 127.269 2.228 . . . . 0.0 106.724 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -103.59 150.33 24.06 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.86 0.362 . . . . 0.0 111.107 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.62 -3.34 87.29 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.657 1.599 . . . . 0.0 111.47 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.8 p -142.23 170.73 15.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.606 2.763 . . . . 0.0 107.742 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -108.04 8.5 28.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.672 1.189 . . . . 0.0 110.715 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -80.97 -172.04 45.57 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 122.746 1.192 . . . . 0.0 113.545 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.6 mt -137.78 157.45 46.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.895 2.478 . . . . 0.0 108.6 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.53 135.41 63.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.9 mm -94.41 77.11 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -83.1 -12.59 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.075 -0.391 . . . . 0.0 112.037 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -137.47 134.64 36.02 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 121.796 -0.565 . . . . 0.0 112.451 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.78 152.35 46.51 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.516 1.126 . . . . 0.0 109.51 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -141.32 161.61 37.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.528 1.931 . . . . 0.0 108.352 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -131.03 121.45 25.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.996 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.416 ' HE3' ' HG3' ' A' ' 230' ' ' GLU . 69.8 mttt -80.08 115.28 19.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 15.4 p -125.17 165.03 18.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.066 1.746 . . . . 0.0 108.154 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.25 160.97 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? 63.31 -26.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.511 1.925 . . . . 0.0 115.636 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -132.25 124.4 28.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 108.216 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.0 m -78.19 113.14 15.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.695 1.598 . . . . 0.0 107.735 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.1 p -84.37 162.86 19.87 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.271 0.557 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.79 152.19 42.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.144 1.778 . . . . 0.0 108.334 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.07 130.97 13.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.251 1.968 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -102.38 92.26 4.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.68 169.3 14.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.48 1.514 . . . . 0.0 110.724 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.0 mt -95.26 146.62 24.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.93 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.39 124.34 25.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.83 106.34 4.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 89.75 -164.95 31.78 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 122.978 1.321 . . . . 0.0 115.23 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 43.2 m -64.26 132.81 51.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.466 . . . . 0.0 109.992 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -85.67 145.64 27.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -126.93 137.2 53.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.795 0.807 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -124.29 140.76 52.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 72.7 mt -144.86 114.92 7.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -143.6 172.43 12.81 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.541 1.136 . . . . 0.0 110.009 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -144.41 153.85 42.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -101.74 140.09 36.5 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.358 1.063 . . . . 0.0 109.004 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.55 21.37 79.56 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -143.47 166.65 24.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.601 1.56 . . . . 0.0 109.251 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 34.0 pttt -129.92 174.21 9.97 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.982 2.113 . . . . 0.0 106.754 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 26.8 mt -109.01 154.31 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.24 24.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.416 1.086 . . . . 0.0 113.322 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.54 -155.05 23.95 Favored Glycine 0 N--CA 1.465 0.632 0 O-C-N 120.429 -1.419 . . . . 0.0 111.693 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 174.1 10.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.297 1.839 . . . . 0.0 111.159 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -155.66 163.27 40.13 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.715 2.406 . . . . 0.0 107.974 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.64 -169.99 36.48 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 120.78 1.627 . . . . 0.0 114.78 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 130.33 18.54 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.975 1.31 . . . . 0.0 108.488 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.95 154.49 17.68 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.303 1.841 . . . . 0.0 108.355 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.0 t -125.65 -52.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.738 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.17 -31.05 5.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.245 1.418 . . . . 0.0 113.304 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 46.3 mt -138.87 159.16 42.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.88 92.92 1.29 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.782 -0.573 . . . . 0.0 111.491 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -76.56 -78.33 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -101.0 148.61 24.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.906 1.23 . . . . 0.0 113.025 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -141.18 128.03 20.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.236 1.414 . . . . 0.0 107.216 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -144.14 176.1 23.59 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.07 176.06 5.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.251 1.02 . . . . 0.0 110.6 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -122.03 150.49 42.03 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.345 1.858 . . . . 0.0 107.172 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.06 139.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 44.2 mtt -139.77 147.27 50.84 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.49 68.98 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.132 3.221 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 128.478 2.711 . . . . 0.0 113.601 -179.538 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.838 0.827 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -144.93 138.91 27.22 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.732 2.013 . . . . 0.0 106.196 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.25 146.28 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -106.89 168.12 9.41 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB1' ' HB1' ' A' ' 138' ' ' ALA . . . -68.27 -70.88 0.24 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.993 1.317 . . . . 0.0 111.629 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 51.87 66.05 2.82 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.275 1.417 . . . . 0.0 114.911 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 138' ' ' ALA . . . -141.39 21.75 2.57 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 118.056 0.928 . . . . 0.0 113.767 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.26 171.04 19.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 127.05 2.262 . . . . 0.0 109.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.44 -0.25 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.414 1.086 . . . . 0.0 113.245 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.58 178.54 38.22 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 -175.46 27.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.136 0.874 . . . . 0.0 113.057 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.67 144.42 43.95 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.584 1.153 . . . . 0.0 108.113 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 p -65.74 95.49 0.24 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.711 1.205 . . . . 0.0 112.265 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -97.2 -79.28 0.46 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 63.63 19.77 11.88 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.55 1.14 . . . . 0.0 110.911 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.08 141.44 58.77 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.745 1.618 . . . . 0.0 109.174 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 -179.046 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.98 144.7 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.385 -1.068 . . . . 0.0 111.986 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -46.8 5.07 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.203 1.801 . . . . 0.0 112.881 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -138.02 163.73 30.83 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.12 144.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -136.35 141.53 43.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.93 142.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.24 114.94 1.64 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -66.44 141.84 57.78 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.39 -171.76 14.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -72.31 -48.19 44.06 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.561 0.744 . . . . 0.0 111.679 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.47 -10.51 34.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.131 1.772 . . . . 0.0 114.001 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.6 32.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.25 139.3 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -133.94 10.57 3.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -161.21 147.0 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.281 0.946 . . . . 0.0 111.673 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 155.4 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.042 1.737 . . . . 0.0 108.813 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.19 135.43 11.16 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 161.02 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.564 1.945 . . . . 0.0 111.13 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.2 t -121.87 139.95 47.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -107.94 170.41 8.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.872 0.76 . . . . 0.0 109.652 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.66 51.91 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.834 0.854 . . . . 0.0 109.978 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -116.96 166.34 12.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.498 1.119 . . . . 0.0 108.522 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.13 -3.2 15.6 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.07 -1.019 . . . . 0.0 109.746 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -108.86 -83.86 0.55 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.311 3.044 . . . . 0.0 110.641 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -133.89 159.24 41.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.975 1.71 . . . . 0.0 110.372 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.05 145.12 34.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.47 1.508 . . . . 0.0 110.295 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -144.86 146.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.044 0.938 . . . . 0.0 110.352 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.78 151.65 33.42 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.634 1.974 . . . . 0.0 109.302 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.92 -67.73 0.92 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.712 1.625 . . . . 0.0 109.905 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.7 174.88 27.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.179 1.371 . . . . 0.0 112.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.87 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.083 0.942 . . . . 0.0 109.761 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -125.04 133.11 53.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.47 -153.08 21.17 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.301 -2.72 . . . . 0.0 106.301 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -128.2 114.62 17.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.103 0.951 . . . . 0.0 112.97 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.17 134.66 49.55 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -81.28 155.62 25.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.368 1.067 . . . . 0.0 108.954 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.16 -32.8 74.67 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.575 -0.703 . . . . 0.0 111.161 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.32 26.93 7.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 110.701 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.86 96.2 0.17 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -163.05 146.05 10.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 128.954 2.902 . . . . 0.0 104.823 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -142.29 164.84 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.403 1.481 . . . . 0.0 108.856 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -144.48 103.11 3.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -108.11 140.87 40.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.056 1.743 . . . . 0.0 106.993 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.69 143.5 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 111.007 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.9 t -95.93 111.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 156.01 38.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 109.406 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.75 -27.16 61.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.172 -0.955 . . . . 0.0 111.67 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.94 13.56 27.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.555 1.942 . . . . 0.0 113.511 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.25 136.58 35.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.972 0.806 . . . . 0.0 110.332 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.452 ' CG ' ' HE2' ' A' ' 124' ' ' LYS . 12.0 m-85 -128.66 162.24 27.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.689 0.796 . . . . 0.0 110.424 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mt -75.3 150.43 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -30.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.821 1.648 . . . . 0.0 109.146 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 157.44 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.164 0.893 . . . . 0.0 108.99 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 t -139.35 139.57 38.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -128.2 116.81 20.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.54 134.64 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.8 p -113.98 157.22 22.74 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -151.03 158.69 44.43 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.429 -0.794 . . . . 0.0 109.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -160.39 168.72 24.59 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.864 1.265 . . . . 0.0 108.67 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 94.36 3.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.3 138.22 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.837 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -61.25 114.3 3.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.05 -5.22 5.7 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.852 1.215 . . . . 0.0 111.935 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -134.5 158.14 44.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.161 1.384 . . . . 0.0 107.785 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.44 22.11 15.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.342 1.857 . . . . 0.0 108.759 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 p -137.95 129.24 27.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.937 -1.102 . . . . 0.0 112.578 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.17 148.76 50.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.324 2.25 . . . . 0.0 105.131 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.93 158.46 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.1 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.3 mm -83.22 103.24 10.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.587 0.755 . . . . 0.0 109.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -66.89 -41.04 87.87 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.466 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 p -156.68 165.77 35.3 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.541 1.519 . . . . 0.0 111.75 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 151.69 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.043 0.537 . . . . 0.0 111.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.7 m -149.44 154.17 38.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 0.0 108.687 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -125.04 154.59 41.08 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.738 2.015 . . . . 0.0 107.383 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -132.22 118.24 19.27 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.9 p -99.01 159.87 14.66 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.666 0.746 . . . . 0.0 112.896 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.87 -32.74 73.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.349 1.859 . . . . 0.0 113.357 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -67.8 -11.37 58.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.008 178.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.03 49.81 3.22 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -127.69 139.69 52.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.4 p -134.76 147.53 50.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.662 0.385 . . . . 0.0 110.522 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 161.02 32.21 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 123.419 0.687 . . . . 0.0 110.673 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.33 166.6 24.15 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 122.269 1.979 . . . . 0.0 108.516 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.75 106.18 1.79 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.42 2.08 . . . . 0.0 107.502 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -75.47 85.99 2.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.1 -137.18 8.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.801 1.191 . . . . 0.0 110.379 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 tp -112.55 125.43 54.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.461 1.505 . . . . 0.0 108.985 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -64.34 143.12 58.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 m -146.07 147.34 31.49 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -52.72 -49.52 65.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.922 2.089 . . . . 0.0 110.216 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -68.3 108.25 3.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.862 1.665 . . . . 0.0 107.259 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -152.1 160.08 43.51 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.505 1.122 . . . . 0.0 108.983 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -143.08 167.72 21.43 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.449 0.7 . . . . 0.0 112.042 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.25 143.08 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.268 1.427 . . . . 0.0 107.837 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -137.85 1.95 2.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 145.01 41.99 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.824 0.85 . . . . 0.0 113.169 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.49 149.81 34.95 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.95 -35.65 64.47 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.834 -1.166 . . . . 0.0 111.866 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -69.48 -22.52 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.311 1.044 . . . . 0.0 112.508 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.67 -68.92 0.42 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.39 79.26 1.44 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 124.814 1.197 . . . . 0.0 112.348 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 72' ' ' TYR . 39.5 ttmt -63.87 127.79 32.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 tp -77.7 88.77 3.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.69 -49.58 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.32 -174.14 21.88 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -152.56 -178.03 6.6 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.757 1.223 . . . . 0.0 108.545 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.97 148.81 30.21 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.25 110.59 0.37 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.22 54.38 1.65 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.756 1.623 . . . . 0.0 108.712 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.69 120.11 26.76 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -97.61 -108.72 2.67 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.48 -29.08 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.721 1.208 . . . . 0.0 112.353 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 169.02 20.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.115 1.766 . . . . 0.0 109.138 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.71 101.06 12.94 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.73 -71.52 0.57 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HB1' ' HB1' ' A' ' 6' ' ' ALA . . . -107.18 150.08 27.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.865 0.866 . . . . 0.0 110.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -141.57 110.65 6.26 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 125.392 1.477 . . . . 0.0 108.786 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.32 170.65 14.73 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.96 165.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.13 0.572 . . . . 0.0 111.015 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -123.13 131.07 53.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.64 99.81 6.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.796 2.039 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.315 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.435 ' HA ' ' SD ' ' A' ' 295' ' ' MET . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -101.33 136.59 40.93 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.089 0.555 . . . . 0.0 112.463 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -114.45 146.92 40.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.804 1.642 . . . . 0.0 108.607 177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.8 mt -116.35 171.38 7.87 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.319 1.848 . . . . 0.0 106.86 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 m -75.24 170.64 15.65 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.207 -0.933 . . . . 0.0 108.872 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.14 165.82 26.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.271 1.029 . . . . 0.0 108.643 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.6 mt -117.4 151.06 19.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.62 -67.22 0.45 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.341 -0.7 . . . . 0.0 111.357 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.39 -160.61 30.19 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.888 1.232 . . . . 0.0 110.106 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -140.6 27.78 2.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.225 1.41 . . . . 0.0 111.184 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -125.5 141.62 51.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.19 1.796 . . . . 0.0 108.647 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.71 167.1 12.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.817 2.151 . . . . 0.0 111.154 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 97.4 m -71.97 122.7 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.144 0.978 . . . . 0.0 111.484 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.11 117.23 20.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -131.54 35.87 3.8 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.227 0.611 . . . . 0.0 111.33 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.44 145.07 0.64 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.124 1.369 . . . . 0.0 114.363 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.62 111.41 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.096 2.558 . . . . 0.0 108.79 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.77 168.56 46.52 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.06 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.15 120.18 12.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -100.85 -172.16 2.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.588 0.755 . . . . 0.0 109.72 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -4.95 17.25 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.588 0.755 . . . . 0.0 111.341 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 142.78 161.11 8.65 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.822 2.153 . . . . 0.0 110.829 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.45 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.361 1.864 . . . . 0.0 108.68 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -131.54 -70.77 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -133.29 153.42 51.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.434 0.561 . . . . 0.0 112.461 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.29 141.18 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.738 2.015 . . . . 0.0 106.18 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.88 128.04 44.48 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.68 116.25 51.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.89 95.52 1.82 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -60.86 169.91 1.72 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.67 -174.11 13.81 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.33 -23.02 61.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.59 -0.805 . . . . 0.0 111.456 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -131.34 -19.28 2.79 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 179.18 -172.74 44.85 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 126.973 2.225 . . . . 0.0 107.689 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.94 124.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 120.101 1.95 . . . . 0.0 111.824 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.7 m -118.57 -20.42 8.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.685 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.77 156.63 47.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 119.568 -1.958 . . . . 0.0 111.301 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.02 151.01 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -162.68 165.48 25.64 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.77 2.428 . . . . 0.0 106.504 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -144.06 174.56 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.789 1.236 . . . . 0.0 110.305 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -129.63 113.0 14.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -102.66 155.58 18.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -128.37 138.31 52.3 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -129.2 96.23 4.26 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 70.29 -95.93 0.53 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.74 -7.09 9.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.423 1.489 . . . . 0.0 110.212 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.69 153.89 32.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.86 100.23 5.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.32 106.92 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 131.75 34.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.42 176.38 40.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.426 1.012 . . . . 0.0 111.374 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.96 172.44 14.5 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.354 1.454 . . . . 0.0 111.946 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.01 104.13 16.69 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -77.59 -34.38 53.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.096 0.959 . . . . 0.0 112.335 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -108.24 -178.46 21.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 124.774 1.178 . . . . 0.0 113.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -72.8 105.2 1.37 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.565 1.546 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.48 168.69 20.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.813 1.675 . . . . 0.0 109.47 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.6 t -137.22 161.13 37.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.657 0.783 . . . . 0.0 109.181 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.76 -15.5 63.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.561 0.744 . . . . 0.0 110.399 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -19.91 65.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.252 1.021 . . . . 0.0 109.876 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.06 -153.11 20.23 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -139.95 141.23 36.46 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.74 1.616 . . . . 0.0 107.552 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.18 151.58 23.99 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -134.92 144.38 47.44 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.938 0.79 . . . . 0.0 111.996 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -142.42 113.01 7.3 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.785 0.834 . . . . 0.0 109.29 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -73.34 141.16 47.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mt -116.15 114.3 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.908 0.776 . . . . 0.0 109.268 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.82 148.71 27.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.919 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 24.67 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.6 2.36 . . . . 0.0 116.536 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.91 -27.82 9.86 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.371 2.048 . . . . 0.0 114.144 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.2 t -128.81 -66.42 0.83 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.81 172.4 13.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.589 1.556 . . . . 0.0 108.451 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -165.94 171.4 12.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.809 1.244 . . . . 0.0 108.186 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.4 mt -87.24 152.03 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.2 p -140.43 -5.12 1.24 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -166.58 170.79 12.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.836 1.255 . . . . 0.0 107.768 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.18 141.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -132.86 151.61 52.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 129.32 3.048 . . . . 0.0 108.482 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.02 179.53 44.39 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 266' ' ' ALA . 25.5 p -137.15 142.87 42.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.642 1.221 . . . . 0.0 110.463 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.52 145.29 48.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.722 0.809 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -147.67 163.94 35.07 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 122.056 -0.403 . . . . 0.0 110.739 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.42 141.15 52.15 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.492 1.117 . . . . 0.0 113.794 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.73 155.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -111.03 141.89 43.92 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.94 -7.24 82.61 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.545 -0.722 . . . . 0.0 111.827 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 60.4 p -140.65 -172.11 3.38 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.858 2.063 . . . . 0.0 107.643 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.42 72.0 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.904 1.282 . . . . 0.0 108.706 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -163.17 178.54 38.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.873 1.225 . . . . 0.0 111.383 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.3 mt -108.44 159.61 16.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 110.58 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.0 tt -135.85 138.49 47.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.232 1.413 . . . . 0.0 109.305 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 25.0 mm -76.54 96.57 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.0 t -76.24 -16.86 59.73 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.677 -0.639 . . . . 0.0 112.313 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -156.79 138.61 14.28 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.622 1.169 . . . . 0.0 107.986 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 24.3 tp -135.49 123.91 23.39 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -109.58 172.48 6.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.984 0.914 . . . . 0.0 108.576 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -136.68 145.71 45.07 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -115.88 121.36 42.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.425 1.09 . . . . 0.0 109.027 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 p -138.66 168.14 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.344 2.258 . . . . 0.0 107.277 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.23 156.02 19.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.8 mttm 60.76 -17.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -98.97 175.3 5.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.33 1.452 . . . . 0.0 112.555 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -131.42 99.82 4.95 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 126.11 1.764 . . . . 0.0 108.186 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.1 p -80.18 160.18 25.74 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.083 0.553 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -94.53 155.85 39.14 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.22 88.98 0.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.072 2.514 . . . . 0.0 107.877 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -77.09 92.52 3.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.87 172.86 34.55 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.146 1.355 . . . . 0.0 111.797 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.84 122.97 41.58 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.552 1.541 . . . . 0.0 109.232 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -71.82 108.34 5.07 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.345 2.258 . . . . 0.0 110.139 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.78 168.32 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.973 1.309 . . . . 0.0 110.103 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 91.84 -98.43 2.42 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 98.8 m -145.08 118.85 9.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 232' ' ' THR . . . -87.71 136.03 33.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -126.27 166.03 17.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.06 0.944 . . . . 0.0 109.565 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.45 151.88 35.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.458 0.703 . . . . 0.0 109.816 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.5 mt -139.42 120.49 14.63 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.789 1.636 . . . . 0.0 107.563 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.37 152.27 18.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.166 0.894 . . . . 0.0 110.92 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.49 157.23 44.04 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.587 1.555 . . . . 0.0 108.756 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.15 143.25 34.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 65.15 28.65 73.8 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -142.49 152.73 42.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.08 2.44 . . . . 0.0 110.757 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.94 165.01 17.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.875 2.07 . . . . 0.0 107.563 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.8 mt -92.15 150.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.68 -10.55 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.81 -179.97 48.14 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.833 1.197 . . . . 0.0 110.84 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 135.71 53.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 108.204 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.71 137.37 52.44 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.47 -150.49 22.2 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.06 128.85 10.17 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.16 46.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 109.55 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 36.5 m -140.29 -67.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.442 1.097 . . . . 0.0 111.631 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.86 -64.48 1.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 119.001 0.819 . . . . 0.0 110.748 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.4 113.74 27.5 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -50.31 92.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.75 -73.84 0.31 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.525 1.13 . . . . 0.0 111.939 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -104.85 114.36 28.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.843 0.747 . . . . 0.0 112.346 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -117.87 156.77 27.84 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.655 1.582 . . . . 0.0 107.005 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -172.1 -179.66 43.16 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.5 m -138.81 146.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.58 1.19 . . . . 0.0 111.529 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.02 160.26 24.6 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 118.411 0.55 . . . . 0.0 110.885 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 153' ' ' ALA . 83.8 mmm -146.02 142.9 18.29 Favored Pre-proline 0 N--CA 1.464 0.262 0 C-N-CA 124.589 1.156 . . . . 0.0 110.784 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.59 105.77 2.09 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.824 2.349 . . . . 0.0 109.461 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.333 -0.146 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 178.944 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -149.05 100.94 3.11 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.223 -0.923 . . . . 0.0 112.788 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.37 142.53 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 159.7 16.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.683 0.793 . . . . 0.0 110.027 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.51 105.38 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.288 1.435 . . . . 0.0 112.512 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.09 83.23 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.02 -160.71 19.01 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 126.909 2.195 . . . . 0.0 107.657 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.86 150.23 39.66 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.02 53.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.244 1.022 . . . . 0.0 113.582 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.86 164.02 39.9 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.96 0.79 . . . . 0.0 114.59 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.37 164.85 34.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.189 1.376 . . . . 0.0 113.98 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.79 141.73 29.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.209 1.403 . . . . 0.0 107.236 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.9 123.12 22.03 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -127.33 85.7 2.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.883 1.673 . . . . 0.0 107.034 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -140.94 147.0 38.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.647 2.379 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -160.63 174.22 14.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.41 1.484 . . . . 0.0 108.534 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.563 0 N-CA-C 104.149 -3.58 . . . . 0.0 104.149 177.571 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -117.82 155.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 109.64 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -54.93 1.24 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -145.8 168.39 20.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 118.759 0.708 . . . . 0.0 110.622 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.144 2.578 . . . . 0.0 104.777 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -138.9 122.32 17.2 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -143.77 139.6 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.87 131.23 3.89 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -67.16 -168.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.212 1.405 . . . . 0.0 110.519 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.67 -177.32 43.23 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.88 -32.69 73.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.427 1.091 . . . . 0.0 111.507 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -105.63 8.29 33.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.259 1.824 . . . . 0.0 114.036 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.72 -168.41 12.93 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.258 -0.901 . . . . 0.0 112.836 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.36 95.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -101.94 -9.24 20.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.9 p -87.8 147.53 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 120.362 1.437 . . . . 0.0 109.524 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -145.01 158.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.44 1.096 . . . . 0.0 108.8 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -153.91 151.31 29.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.285 1.834 . . . . 0.0 107.266 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.73 119.86 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.97 121.27 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.55 158.64 16.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 48' ' ' ASP . . . -156.26 109.66 2.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -111.84 154.03 25.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -33.27 62.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.64 0.776 . . . . 0.0 112.611 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.525 1.53 . . . . 0.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -156.02 120.06 4.48 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 120.401 1.455 . . . . 0.0 107.679 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 43' ' ' ALA 0.395 0.5 OUTLIER -116.83 165.46 13.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -179.279 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.78 145.98 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.536 1.534 . . . . 0.0 111.801 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.3 139.09 37.94 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.95 -1.094 . . . . 0.0 109.377 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.35 -73.49 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.57 0.605 . . . . 0.0 111.788 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.33 171.15 17.67 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.725 1.631 . . . . 0.0 110.033 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -101.52 142.63 32.61 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.136 -0.626 . . . . 0.0 110.591 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.63 173.99 10.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.611 1.964 . . . . 0.0 109.682 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.97 -155.97 37.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -112.79 125.58 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.89 160.26 14.63 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 p -132.34 114.53 14.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.365 1.866 . . . . 0.0 108.221 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.46 -36.5 80.57 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.262 -1.524 . . . . 0.0 107.988 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -72.44 -1.88 17.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.223 2.209 . . . . 0.0 115.554 179.272 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.97 -8.87 0.23 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 120.291 1.405 . . . . 0.0 115.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.99 125.04 28.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.084 1.442 . . . . 0.0 110.88 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.01 142.01 50.76 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.486 1.915 . . . . 0.0 106.273 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.6 m -104.15 143.61 32.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 108.735 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -134.68 125.1 26.4 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.883 0.873 . . . . 0.0 109.629 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.39 143.57 29.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.618 1.567 . . . . 0.0 109.142 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.69 147.52 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.631 1.173 . . . . 0.0 109.089 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -109.91 172.62 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.936 1.294 . . . . 0.0 113.35 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -38.52 19.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.473 1.509 . . . . 0.0 110.332 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -83.19 21.05 1.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.328 1.451 . . . . 0.0 109.742 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.8 136.76 22.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 0.0 110.998 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.08 150.07 48.99 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.8 mt -79.88 147.49 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.32 -28.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.765 0.826 . . . . 0.0 110.836 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.36 155.64 41.51 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.182 0.901 . . . . 0.0 108.888 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.99 95.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.67 113.66 20.5 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.69 147.91 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 113' ' ' LYS . 39.1 m -131.74 138.73 48.74 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -150.28 167.11 27.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.136 2.974 . . . . 0.0 104.619 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.03 165.7 29.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -120.82 105.73 11.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.981 0.912 . . . . 0.0 109.277 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.85 144.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.05 108.15 1.17 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.61 6.32 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 117.874 -1.515 . . . . 0.0 113.403 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -131.56 118.87 20.7 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.119 1.96 . . . . 0.0 108.142 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.33 1.85 2.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.559 2.744 . . . . 0.0 114.138 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.7 t -147.97 135.53 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.625 -1.297 . . . . 0.0 109.04 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.16 158.33 33.39 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.92 141.11 43.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.189 1.796 . . . . 0.0 107.962 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 138' ' ' ALA . 44.1 mm -64.29 125.68 21.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.987 0.915 . . . . 0.0 110.054 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 p -104.42 -32.54 8.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.28 1.032 . . . . 0.0 109.24 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -161.05 165.6 29.48 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 120.015 1.279 . . . . 0.0 112.689 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pt -144.76 137.44 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.402 1.881 . . . . 0.0 109.928 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.7 m -132.21 114.61 14.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.197 1.799 . . . . 0.0 107.952 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -96.82 121.8 39.07 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -100.79 127.62 47.16 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.8 p -97.48 164.51 12.41 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.151 0.887 . . . . 0.0 111.756 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.94 -41.2 82.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.378 1.071 . . . . 0.0 108.934 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -68.47 -22.8 64.54 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.22 1.408 . . . . 0.0 114.608 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.56 -7.6 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 119.809 1.186 . . . . 0.0 114.186 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -74.26 147.05 42.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.49 127.11 30.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 p -80.98 149.33 66.55 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.68 158.86 48.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.138 1.892 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.47 83.46 1.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.053 2.502 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -55.89 109.31 0.56 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.59 -134.88 10.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.3 tp -139.87 138.16 35.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.537 1.135 . . . . 0.0 109.927 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 164.83 20.13 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -149.8 -167.14 2.74 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.742 -1.849 . . . . 0.0 111.609 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 111' ' ' THR . 16.9 tt0 -73.25 -59.18 2.83 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.543 1.137 . . . . 0.0 109.509 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 79' ' ' THR . 50.3 mttp -68.73 178.24 2.2 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.03 162.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.353 3.061 . . . . 0.0 108.471 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.51 149.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.344 1.058 . . . . 0.0 108.198 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 p -140.05 148.14 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -143.31 145.87 33.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.175 2.19 . . . . 0.0 106.512 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 174.68 12.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.632 1.173 . . . . 0.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 143' ' ' PHE . 5.8 p30 -110.1 147.93 32.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.596 1.158 . . . . 0.0 109.0 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -143.26 -84.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -100.42 -10.81 20.77 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.717 0.69 . . . . 0.0 110.198 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 -49.04 49.3 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.248 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.05 -133.25 2.91 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 119.267 1.533 . . . . 0.0 112.187 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -132.81 153.61 51.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.934 0.893 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.6 106.92 10.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.01 3.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.456 0.702 . . . . 0.0 111.556 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.38 178.22 46.86 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.923 0.773 . . . . 0.0 111.749 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.74 177.02 8.45 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.74 2.016 . . . . 0.0 109.735 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -146.41 148.82 32.7 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.07 92.45 0.17 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 118.254 0.479 . . . . 0.0 112.388 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -60.32 121.26 11.56 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -152.8 164.82 37.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.388 0.994 . . . . 0.0 110.595 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.56 -95.72 0.13 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.73 -23.94 56.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.047 0.424 . . . . 0.0 110.201 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.4 -179.69 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.23 2.212 . . . . 0.0 106.366 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.54 153.45 33.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.846 1.658 . . . . 0.0 108.487 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -143.93 -56.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.509 0.595 . . . . 0.0 112.007 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 91' ' ' ILE . . . -135.24 155.71 50.2 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.986 0.812 . . . . 0.0 112.592 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.11 113.21 9.24 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.21 2.204 . . . . 0.0 107.346 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.92 174.81 15.48 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 123.814 0.721 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.01 158.85 43.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 121.537 -0.978 . . . . 0.0 108.728 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.77 151.81 41.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 119' ' ' ASP . 45.4 m-85 -137.72 99.81 4.02 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.015 0.926 . . . . 0.0 109.421 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.068 0 O-C-N 121.605 -0.684 . . . . 0.0 110.678 -179.547 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.465 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.65 129.38 56.67 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.152 -0.968 . . . . 0.0 109.567 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -103.97 106.78 17.4 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.88 161.54 23.74 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.4 t -84.86 111.94 20.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.94 159.77 29.71 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.721 0.408 . . . . 0.0 110.113 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -125.21 161.24 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.009 2.924 . . . . 0.0 105.949 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.94 -72.12 0.48 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.857 1.208 . . . . 0.0 113.317 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.81 -4.89 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.217 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . 0.264 0.7 OUTLIER 53.61 -3.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.156 2.982 . . . . 0.0 117.476 179.281 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.76 164.9 12.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.839 1.655 . . . . 0.0 112.769 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.51 -175.23 16.0 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 126.341 1.924 . . . . 0.0 114.195 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.37 104.22 4.3 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.033 1.733 . . . . 0.0 109.525 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.85 154.76 29.55 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.254 0.622 . . . . 0.0 110.265 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -146.57 28.29 1.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.99 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -42.71 110.42 0.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.912 1.685 . . . . 0.0 110.235 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.38 -11.37 60.45 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.3 -85.75 1.57 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.37 147.57 5.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -109.6 155.48 21.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.352 1.061 . . . . 0.0 109.548 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -76.42 -11.02 59.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.926 -1.033 . . . . 0.0 112.901 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.05 -179.94 44.07 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.21 155.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.18 1.392 . . . . 0.0 108.596 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -138.48 -74.13 0.39 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.788 1.235 . . . . 0.0 107.873 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -150.87 165.94 32.09 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.03 139.41 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -118.48 156.89 28.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.58 131.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -109.84 83.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.68 -165.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 110.682 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.02 -168.71 37.93 Favored Glycine 0 N--CA 1.447 -0.608 0 O-C-N 120.183 -1.573 . . . . 0.0 112.064 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.09 -45.58 11.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.23 1.412 . . . . 0.0 109.618 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.78 -15.53 51.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.528 0.731 . . . . 0.0 111.479 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.06 -154.39 24.44 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 27.7 mm -58.36 150.81 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 118.559 1.179 . . . . 0.0 108.855 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.4 t -127.65 -38.36 1.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.199 1.399 . . . . 0.0 112.822 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -136.7 161.58 35.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.137 0.881 . . . . 0.0 110.027 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.91 127.85 25.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 44.7 pttt -161.67 160.53 28.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.296 1.439 . . . . 0.0 109.49 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.48 169.13 24.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.428 0.558 . . . . 0.0 109.834 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.03 148.27 24.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.465 ' CZ ' HG21 ' A' ' 201' ' ' ILE . 1.2 p90 -151.67 165.84 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.5 92.58 2.59 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -89.2 99.44 12.43 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.36 -79.98 0.64 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.73 0.696 . . . . 0.0 111.662 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.33 -0.18 1.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.597 1.959 . . . . 0.0 111.135 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.4 102.05 7.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -77.67 67.06 3.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.295 1.438 . . . . 0.0 108.251 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.465 HG21 ' CZ ' ' A' ' 194' ' ' TYR . 36.9 mm -72.13 122.69 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.189 0.995 . . . . 0.0 113.429 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 29.0 t -127.65 150.37 33.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 127.109 2.164 . . . . 0.0 105.93 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.44 -108.98 2.77 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.862 -0.966 . . . . 0.0 111.548 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 72.38 12.47 76.83 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 116.014 1.165 . . . . 0.0 116.014 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -58.81 116.44 3.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.839 2.32 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -117.64 2.78 12.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.671 1.588 . . . . 0.0 113.993 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.01 162.41 28.57 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 120.069 -1.645 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -47.07 106.37 0.58 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.744 1.617 . . . . 0.0 110.929 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.53 135.57 26.63 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.985 2.457 . . . . 0.0 109.327 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 131.66 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 29.3 tp -56.51 -26.4 54.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 pp -55.52 -30.06 60.01 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.197 1.399 . . . . 0.0 112.186 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.72 -166.01 13.91 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.019 1.295 . . . . 0.0 110.488 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 23.5 m-85 -128.88 168.13 16.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.549 1.54 . . . . 0.0 108.232 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.75 171.6 7.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.882 2.073 . . . . 0.0 106.787 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.86 158.59 44.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.451 0.7 . . . . 0.0 112.771 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -142.74 129.67 20.63 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.943 1.697 . . . . 0.0 108.311 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.19 109.54 21.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 107.707 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.85 104.45 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -88.96 92.61 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.774 1.63 . . . . 0.0 107.556 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -57.16 -35.29 33.7 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -35.27 10.01 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 123.609 2.325 . . . . 0.0 110.093 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -75.91 -77.09 0.14 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.591 1.557 . . . . 0.0 112.021 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.18 124.71 28.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.052 2.541 . . . . 0.0 112.476 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.47 83.31 3.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 226' ' ' ILE . 0.0 OUTLIER -45.98 128.19 2.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 109.824 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -124.42 -22.96 4.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.81 171.26 18.08 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.347 1.43 . . . . 0.0 113.46 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 1.8 p -139.1 158.19 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.73 172.18 12.89 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -172.68 171.24 44.23 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.2 p -141.33 137.81 32.66 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.498 ' CD1' HD13 ' A' ' 242' ' ' LEU . 5.2 p90 -135.96 160.8 37.48 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.898 0.749 . . . . 0.0 112.14 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -145.87 168.94 19.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.153 0.981 . . . . 0.0 108.985 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -75.05 147.9 40.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.902 1.281 . . . . 0.0 110.075 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.8 mt -92.98 112.46 26.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.36 104.41 5.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 119.02 -0.52 14.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.436 1.017 . . . . 0.0 112.811 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -141.19 -174.28 3.97 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.11 80.24 1.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 172.66 -176.99 45.44 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 233' ' ' TYR . 22.1 mt -108.66 157.61 18.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -126.78 137.2 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 125.974 1.709 . . . . 0.0 109.135 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.32 130.2 36.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.277 10.3 t -112.04 -50.35 2.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 112.622 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -128.77 150.61 50.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.149 1.341 . . . . 0.0 109.619 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.4 mt -130.53 150.32 51.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.373 1.469 . . . . 0.0 110.441 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -142.97 147.64 35.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.646 1.579 . . . . 0.0 107.62 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.75 113.19 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -71.14 136.15 48.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -142.18 165.18 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.35 1.86 . . . . 0.0 106.383 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 148.15 31.69 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 -29.42 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 128.465 2.706 . . . . 0.0 115.157 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -81.22 174.42 11.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.386 2.674 . . . . 0.0 108.295 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.4 m -144.31 152.29 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 45.3 p -146.09 174.46 11.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 112.257 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -103.98 158.66 31.44 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.872 1.669 . . . . 0.0 110.576 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.05 115.09 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.224 2.616 . . . . 0.0 106.401 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -83.94 92.38 7.81 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.71 -176.99 16.57 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.229 1.395 . . . . 0.0 111.59 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.05 116.67 26.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.108 0.963 . . . . 0.0 110.066 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.78 108.86 3.59 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.419 1.088 . . . . 0.0 109.219 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -155.17 -177.31 6.44 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.287 1.035 . . . . 0.0 110.965 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 64.15 -103.47 0.73 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 126.261 1.886 . . . . 0.0 114.657 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 91.1 m -146.92 128.62 15.2 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 107.444 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -89.92 144.41 25.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 111.431 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -129.48 165.94 20.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.592 1.157 . . . . 0.0 110.039 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -143.84 146.58 33.15 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.232 1.813 . . . . 0.0 107.092 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 73.0 mt -132.0 102.01 5.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.699 1.6 . . . . 0.0 107.239 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -127.11 163.7 23.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.146 0.978 . . . . 0.0 109.061 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.75 167.44 22.28 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.365 1.466 . . . . 0.0 107.627 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -97.04 117.59 31.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.593 1.157 . . . . 0.0 113.559 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.73 67.54 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.148 -0.97 . . . . 0.0 114.623 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -107.06 164.59 12.02 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.126 1.37 . . . . 0.0 111.606 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -127.98 151.16 49.47 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.682 2.793 . . . . 0.0 105.01 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 68.7 mt -82.49 145.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.38 -5.37 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.778 0.831 . . . . 0.0 112.842 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.17 37.3 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.626 1.103 . . . . 0.0 110.684 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -128.35 156.01 43.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.888 2.875 . . . . 0.0 107.238 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -147.83 113.27 5.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -178.52 -171.56 41.95 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 154.28 46.12 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.55 -1.325 . . . . 0.0 107.838 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.3 152.48 39.98 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.6 t -163.95 113.55 1.24 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.82 11.47 2.53 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.07 2.548 . . . . 0.0 114.447 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 167.1 -179.88 0.02 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 129.433 3.093 . . . . 0.0 106.865 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.95 102.97 15.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.441 0.696 . . . . 0.0 110.172 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -82.88 -43.42 16.59 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.237 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -133.71 142.16 47.86 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.795 1.18 . . . . 0.0 112.799 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.83 149.64 35.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 176.5 -158.89 25.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.4 m -147.89 138.66 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.98 0.912 . . . . 0.0 111.661 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.96 136.92 37.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.12 149.23 24.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.32 0.581 . . . . 0.0 111.233 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 29.7 mmm -142.47 141.61 21.26 Favored Pre-proline 0 C--O 1.234 0.277 0 C-N-CA 126.988 2.115 . . . . 0.0 107.414 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.18 146.98 71.88 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.368 2.045 . . . . 0.0 108.878 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.237 0.422 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 178.325 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.103 0.478 . . . . 0.0 111.911 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -149.74 139.48 21.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 130.614 3.566 . . . . 0.0 105.166 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.36 129.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 118.931 0.787 . . . . 0.0 112.388 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.34 138.69 47.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.37 -62.52 1.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.027 0.531 . . . . 0.0 109.692 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.33 69.76 0.84 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 126.241 1.876 . . . . 0.0 109.534 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.75 -166.11 12.07 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.733 1.635 . . . . 0.0 110.075 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.29 17.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.433 1.116 . . . . 0.0 113.403 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.12 -1.13 4.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.303 1.841 . . . . 0.0 112.548 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.75 42.38 3.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 120.698 -1.251 . . . . 0.0 112.734 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.64 -154.68 6.66 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 127.095 2.283 . . . . 0.0 111.561 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.96 142.2 51.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -72.29 121.9 20.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 112.579 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -124.27 58.42 1.2 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -89.91 18.68 5.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.855 2.462 . . . . 0.0 112.277 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -148.09 160.22 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.012 -1.055 . . . . 0.0 110.913 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 C-N-CA 126.274 1.893 . . . . 0.0 108.772 -179.59 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.039 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -59.55 141.87 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 111.759 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 13.2 mmm180 -117.91 -32.48 4.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -150.49 160.63 43.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.36 121.1 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.558 ' CD2' HD22 ' A' ' 39' ' ' ASN . 1.2 m-70 -98.38 140.96 31.88 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 118.768 0.713 . . . . 0.0 109.557 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -143.2 145.84 22.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.04 141.83 8.59 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 146.78 35.08 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.548 1.139 . . . . 0.0 109.722 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.14 165.68 28.56 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 125.992 1.758 . . . . 0.0 109.459 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -55.72 -34.67 65.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.922 1.289 . . . . 0.0 112.327 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -94.84 -7.92 38.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.465 3.106 . . . . 0.0 113.788 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.65 -164.35 20.26 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.87 95.49 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -112.61 2.45 16.19 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.5 p -107.18 108.93 20.61 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.67 132.65 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 109.702 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.558 HD22 ' CD2' ' A' ' 27' ' ' HIS . 24.4 t30 -150.23 147.39 27.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.652 1.581 . . . . 0.0 108.562 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.0 117.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.9 t -68.22 148.23 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -128.41 126.31 40.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.275 1.398 . . . . 0.0 111.933 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB2' ' CG ' ' A' ' 24' ' ' ARG . . . -86.29 139.62 30.84 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -112.5 165.56 12.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.56 -23.48 67.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.093 -0.379 . . . . 0.0 111.234 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -104.67 -39.38 6.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.561 1.144 . . . . 0.0 113.608 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -154.81 158.22 39.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.043 1.292 . . . . 0.0 113.509 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 125.73 30.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.42 145.32 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.535 1.16 . . . . 0.0 112.361 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.5 153.3 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.057 2.143 . . . . 0.0 106.183 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.72 61.06 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 127.939 2.685 . . . . 0.0 107.703 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.6 14.51 4.18 Favored Glycine 0 N--CA 1.472 1.035 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.28 116.56 8.19 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.06 1.43 . . . . 0.0 111.404 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -126.59 82.12 2.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.26 -144.92 5.77 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.93 111.23 13.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.92 119.79 6.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 p -70.53 153.57 42.78 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.262 1.825 . . . . 0.0 111.291 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.18 -33.55 16.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.803 1.241 . . . . 0.0 109.781 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.2 mt -71.34 -14.43 62.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 123.66 0.6 . . . . 0.0 109.469 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.82 161.16 33.19 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-O 124.637 2.243 . . . . 0.0 109.659 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -123.89 157.61 33.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.529 -2.835 . . . . 0.0 109.334 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -121.78 165.19 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.767 2.427 . . . . 0.0 107.633 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -128.13 125.92 40.11 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.543 -0.723 . . . . 0.0 110.123 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -87.12 119.58 27.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.987 1.715 . . . . 0.0 107.414 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.07 141.99 35.33 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.878 0.847 . . . . 0.0 109.871 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.1 t -114.75 112.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.875 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.63 172.16 14.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.53 -59.0 2.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -74.73 -22.28 58.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -81.36 146.78 30.16 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.02 152.8 51.3 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 123.868 0.867 . . . . 0.0 110.617 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.2 mt -80.78 114.44 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.67 -31.04 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.687 0.795 . . . . 0.0 112.012 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.2 166.77 26.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.652 1.181 . . . . 0.0 108.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.46 117.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -95.14 126.16 40.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.8 146.26 29.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.81 0.844 . . . . 0.0 109.869 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 p -120.74 152.51 38.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -154.2 168.72 25.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.106 0.962 . . . . 0.0 108.517 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.19 168.96 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.2 108.41 10.32 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.793 2.037 . . . . 0.0 108.458 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.54 147.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.861 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -62.21 149.6 41.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.35 88.83 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.642 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -139.58 164.44 29.9 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.028 2.131 . . . . 0.0 106.704 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -125.02 0.71 7.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.418 1.087 . . . . 0.0 111.295 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.1 t -98.48 157.66 16.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.48 153.27 24.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -131.7 141.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 125.75 1.62 . . . . 0.0 107.802 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.42 128.53 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.8 p -104.7 -27.19 11.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.8 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.0 t -154.67 159.62 40.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.158 1.344 . . . . 0.0 109.022 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.5 mm -141.6 141.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 128.023 2.529 . . . . 0.0 106.368 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -151.12 108.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.383 1.473 . . . . 0.0 107.565 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -77.88 150.22 34.16 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -123.84 114.06 19.36 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.1 p -82.84 162.26 21.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.982 1.313 . . . . 0.0 111.409 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.2 -30.71 70.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -17.37 59.41 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.238 -0.914 . . . . 0.0 112.777 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 2.98 60.43 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 119.3 0.954 . . . . 0.0 111.132 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -79.36 89.45 4.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 147.46 26.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.089 0.555 . . . . 0.0 109.904 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.8 p -84.86 161.91 51.59 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.055 0.942 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.92 164.66 34.92 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 N-CA-C 108.586 -1.352 . . . . 0.0 108.586 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.05 109.61 2.92 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 N-CA-C 106.466 -2.167 . . . . 0.0 106.466 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 9.41 0.18 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -169.55 -170.12 33.66 Favored Glycine 0 N--CA 1.442 -0.9 0 O-C-N 120.76 -1.213 . . . . 0.0 111.427 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.3 106.03 8.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.617 0.767 . . . . 0.0 111.11 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.65 109.53 1.06 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 m -100.44 166.34 10.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.547 0.739 . . . . 0.0 110.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.39 -52.86 61.93 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.725 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -62.9 117.01 5.79 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -157.57 159.65 37.33 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -139.57 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.269 1.828 . . . . 0.0 110.556 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.82 114.29 3.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.812 1.245 . . . . 0.0 108.237 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.17 128.57 36.38 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 138.97 9.3 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.5 175.35 9.31 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.321 1.049 . . . . 0.0 110.855 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -106.96 -25.93 11.42 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.588 1.155 . . . . 0.0 110.967 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -119.98 33.63 5.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.571 1.548 . . . . 0.0 111.387 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.84 31.63 81.56 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 174.63 2.65 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.001 1.762 . . . . 0.0 114.853 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -125.68 137.0 53.83 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.601 1.16 . . . . 0.0 109.506 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.39 151.54 43.78 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 0.0 109.3 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.58 -62.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.09 164.5 32.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.1 160.43 14.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.941 0.896 . . . . 0.0 111.283 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.59 149.3 35.56 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.859 2.064 . . . . 0.0 107.04 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.83 172.51 24.43 Favored Glycine 0 C--O 1.229 -0.217 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -142.25 37.62 1.55 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.297 1.439 . . . . 0.0 107.412 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.02 111.8 20.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.645 1.178 . . . . 0.0 110.206 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.69 -101.34 0.32 Allowed Glycine 0 CA--C 1.519 0.305 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.37 -31.65 58.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.536 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.6 169.17 17.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.381 1.472 . . . . 0.0 110.745 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -75.91 88.44 2.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.715 1.206 . . . . 0.0 113.264 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.38 -32.77 16.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.03 139.73 19.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.165 0.986 . . . . 0.0 109.28 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.6 tp -158.85 113.1 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.182 1.393 . . . . 0.0 108.379 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.25 -175.94 14.78 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.436 1.493 . . . . 0.0 111.298 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -146.6 159.51 43.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.43 1.115 . . . . 0.0 111.261 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -99.39 154.99 17.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.384 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.51 118.37 21.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.807 1.243 . . . . 0.0 108.81 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 125.905 1.682 . . . . 0.0 108.661 178.769 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.868 0.842 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 122.09 28.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -106.0 147.56 28.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 67.9 mt -125.09 122.51 37.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.97 2.108 . . . . 0.0 107.161 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -69.15 108.39 3.59 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 127.143 2.177 . . . . 0.0 107.081 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.03 -178.58 2.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.078 0.951 . . . . 0.0 111.228 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.447 HD12 ' CE2' ' A' ' 233' ' ' TYR . 17.5 pt -108.15 156.13 8.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 108.389 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.31 -109.88 0.49 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -156.39 -162.6 11.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.989 1.757 . . . . 0.0 109.629 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -121.65 13.6 10.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.853 1.261 . . . . 0.0 111.383 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -107.65 120.77 43.14 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 112.163 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.36 -172.84 36.86 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.867 1.699 . . . . 0.0 109.506 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 m -96.3 146.21 24.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -103.08 138.37 40.01 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.582 -0.699 . . . . 0.0 110.973 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -155.74 58.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.33 104.22 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.02 -24.65 21.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.864 -0.522 . . . . 0.0 112.049 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.0 -118.71 4.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -135.42 135.66 40.78 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.353 1.577 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -91.4 170.6 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -42.62 64.78 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.58 134.01 3.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.18 156.82 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.065 1.746 . . . . 0.0 107.685 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -127.03 -64.1 1.02 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -126.3 155.31 42.17 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.512 0.597 . . . . 0.0 111.756 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -121.56 146.11 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.588 1.955 . . . . 0.0 107.255 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -137.07 146.44 45.17 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.599 0.76 . . . . 0.0 109.197 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.2 132.41 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.22 65.82 0.56 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.42 1.009 . . . . 0.0 112.404 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -78.72 176.51 9.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.375 1.07 . . . . 0.0 109.981 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.61 23.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -69.75 -20.35 63.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.683 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -115.6 -16.81 11.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.275 0.943 . . . . 0.0 113.516 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.89 30.76 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.193 0.906 . . . . 0.0 112.925 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.77 111.91 6.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.1 0.96 . . . . 0.0 108.946 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -96.02 -37.1 10.78 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.905 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.18 155.58 47.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.56 1.171 . . . . 0.0 111.777 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.51 148.16 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -168.3 142.17 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.407 1.883 . . . . 0.0 106.764 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -139.14 155.36 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -108.84 130.1 55.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -140.98 168.41 19.85 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.986 0.914 . . . . 0.0 111.741 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -147.39 133.84 19.71 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.76 1.224 . . . . 0.0 110.966 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -140.05 147.21 40.0 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.74 -100.13 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 124.657 1.122 . . . . 0.0 112.715 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.36 12.82 4.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.84 1.656 . . . . 0.0 110.881 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -127.48 110.66 12.97 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.302 1.041 . . . . 0.0 112.019 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.47 152.47 34.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.318 1.847 . . . . 0.0 107.302 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.0 mm -132.88 129.63 58.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.119 0.968 . . . . 0.0 109.534 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.22 141.5 45.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 118.34 -135.46 11.6 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.85 23.65 66.31 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.971 0.385 . . . . 0.0 112.542 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -78.75 78.98 5.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -84.7 21.49 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.582 1.153 . . . . 0.0 112.534 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.95 156.18 26.89 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 119.809 -1.807 . . . . 0.0 108.889 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -71.3 129.76 88.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.56 155.1 71.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.53 2.153 . . . . 0.0 109.084 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.5 p -98.76 173.03 7.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.953 0.901 . . . . 0.0 109.587 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 40.1 tp -75.08 -18.57 60.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.7 tt -68.3 -34.73 76.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.385 . . . . 0.0 108.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 101.78 -132.38 10.95 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -142.33 -179.67 6.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.061 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.42 158.03 43.97 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 131.414 3.885 . . . . 0.0 104.711 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.96 147.78 34.41 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.687 1.131 . . . . 0.0 113.77 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.48 32.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.741 1.217 . . . . 0.0 109.402 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.74 113.86 21.28 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.681 1.192 . . . . 0.0 107.807 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.04 103.17 9.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.58 115.74 15.56 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -56.67 -32.0 11.87 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.06 8.46 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 124.015 2.47 . . . . 0.0 113.569 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.7 m -145.45 -68.12 0.29 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.975 -1.078 . . . . 0.0 110.034 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -84.78 151.84 24.08 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 119.123 0.874 . . . . 0.0 110.095 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -143.58 168.13 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.636 1.684 . . . . 0.0 115.177 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.3 mm -109.05 124.98 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 127.742 2.417 . . . . 0.0 105.263 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 t -115.84 -15.38 11.28 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.708 1.14 . . . . 0.0 113.139 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -154.02 170.34 21.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.829 1.251 . . . . 0.0 107.913 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.91 125.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.64 170.08 8.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 157.52 -178.73 33.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.6 p -137.18 153.73 50.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.447 ' CE2' HD12 ' A' ' 159' ' ' ILE . 35.7 p90 -131.26 144.33 51.22 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.49 165.23 23.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.747 0.419 . . . . 0.0 110.12 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -95.44 148.22 22.71 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.124 1.37 . . . . 0.0 113.174 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 236' ' ' ILE . 1.5 mp -99.87 138.95 22.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -75.34 152.13 38.17 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.407 -0.808 . . . . 0.0 109.169 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.21 1.51 89.51 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.299 0.952 . . . . 0.0 112.979 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 59.3 m -140.79 179.54 6.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.493 1.517 . . . . 0.0 109.794 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -125.39 66.41 1.15 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -162.88 -177.82 36.2 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 121.548 -0.72 . . . . 0.0 112.395 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.77 167.23 22.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.056 1.742 . . . . 0.0 112.13 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.67 158.62 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.066 2.147 . . . . 0.0 109.338 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.4 mm -72.52 126.98 34.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.2 m -107.61 -31.11 8.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 111.712 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -144.65 154.65 43.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -140.74 130.44 24.24 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.941 1.697 . . . . 0.0 109.553 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -129.31 109.35 11.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.963 1.305 . . . . 0.0 107.759 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -76.64 139.81 40.73 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -121.95 114.13 20.57 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.2 p -112.19 165.32 12.26 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.138 2.575 . . . . 0.0 109.714 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -100.74 150.97 22.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 65.21 -35.11 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.415 2.286 . . . . 0.0 114.298 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -120.08 174.2 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.575 1.95 . . . . 0.0 110.113 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.0 t -125.77 148.51 49.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.7 m -115.09 -0.34 13.36 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 74.8 163.81 0.14 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.513 2.325 . . . . 0.0 113.537 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 56.5 Cg_endo -86.53 150.15 8.88 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.672 2.915 . . . . 0.0 109.674 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.94 112.13 13.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.79 176.53 26.93 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.802 1.192 . . . . 0.0 110.776 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.5 tt -97.56 118.57 34.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.606 1.163 . . . . 0.0 108.397 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -59.1 109.72 0.9 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.743 1.217 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -149.5 150.93 33.08 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.065 1.746 . . . . 0.0 106.821 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 84.11 -169.54 46.16 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 67.3 m -76.55 139.81 40.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 0.0 108.406 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -94.91 137.5 33.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.317 1.047 . . . . 0.0 109.945 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -130.61 148.3 52.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.247 1.019 . . . . 0.0 108.752 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -150.9 103.67 3.09 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 122.062 -0.399 . . . . 0.0 110.296 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.89 140.85 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.79 165.05 32.62 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.31 0.504 . . . . 0.0 112.289 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -146.28 167.48 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -132.23 137.27 47.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.7 17.78 76.86 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 118.818 0.736 . . . . 0.0 112.588 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -143.44 172.24 13.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.316 1.847 . . . . 0.0 109.175 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.461 ' HE3' ' CG1' ' A' ' 277' ' ' VAL . 0.1 OUTLIER -141.42 160.69 39.61 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.035 0.934 . . . . 0.0 109.916 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.6 mt -81.93 134.99 25.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.461 ' CG1' ' HE3' ' A' ' 275' ' ' LYS . 28.0 m -141.52 1.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.47 33.71 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 120.174 1.352 . . . . 0.0 113.385 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 290' ' ' PHE . 3.0 t80 -145.79 134.04 21.72 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.557 2.343 . . . . 0.0 107.842 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -141.54 147.39 37.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.154 2.582 . . . . 0.0 104.228 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.48 -144.62 12.71 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 149.2 29.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 122.052 0.929 . . . . 0.0 110.819 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -155.64 154.4 31.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.341 1.857 . . . . 0.0 106.797 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.2 t -146.38 -106.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.73 -23.1 60.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 119.943 1.247 . . . . 0.0 109.236 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.99 159.86 41.86 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 129.029 2.932 . . . . 0.0 108.79 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.3 tp -78.89 131.03 36.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -119.34 -32.21 4.43 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.561 -1.209 . . . . 0.0 113.001 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -140.05 125.39 18.92 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.59 1.541 . . . . 0.0 107.051 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.431 ' HA ' ' CE1' ' A' ' 279' ' ' PHE . 15.8 t80 -122.11 97.69 5.6 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.86 98.51 2.09 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 130.43 36.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -90.37 153.97 20.03 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.324 0.65 . . . . 0.0 109.81 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 18.1 m -126.43 138.11 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.1 0.96 . . . . 0.0 109.735 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 73.4 mtp -143.56 152.05 55.61 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.151 1.38 . . . . 0.0 107.667 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.24 152.98 79.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.436 2.091 . . . . 0.0 113.721 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.232 0.145 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.397 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -140.05 138.66 35.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.78 136.48 44.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.36 140.76 55.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.239 0.542 . . . . 0.0 110.763 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 164.82 19.26 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.157 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.23 145.96 18.01 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.62 -175.51 18.25 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 126.202 1.858 . . . . 0.0 110.829 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.55 -163.88 7.29 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.757 1.646 . . . . 0.0 113.865 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.0 0.22 43.43 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.172 1.389 . . . . 0.0 112.287 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.86 165.61 54.78 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.05 152.48 20.04 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.318 0.961 . . . . 0.0 111.941 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.5 114.51 6.16 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m 97.32 59.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 129.794 3.238 . . . . 0.0 118.284 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.429 ' CE3' ' CB ' ' A' ' 129' ' ' HIS . 30.9 p-90 -62.55 -14.96 48.04 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.592 1.557 . . . . 0.0 113.817 175.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.87 112.96 10.49 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.8 -37.42 71.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.002 0.521 . . . . 0.0 111.762 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.695 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.281 0 CA-C-O 118.142 -1.366 . . . . 0.0 114.395 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.62 128.03 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 120.116 1.958 . . . . 0.0 108.452 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -114.65 -56.75 2.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.891 1.276 . . . . 0.0 110.31 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -138.87 169.48 17.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.744 2.418 . . . . 0.0 106.897 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.03 142.65 25.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -127.76 107.93 10.3 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.97 134.89 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.87 142.59 14.03 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.21 161.23 14.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.525 1.13 . . . . 0.0 110.009 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.79 -167.99 32.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 125.587 1.565 . . . . 0.0 109.291 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.02 -38.63 83.26 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.096 0.558 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.86 11.72 2.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.221 1.408 . . . . 0.0 111.335 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.5 -136.37 15.37 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.82 106.96 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -14.38 14.87 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.0 p -131.16 139.03 49.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.152 1.342 . . . . 0.0 109.61 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 mm -142.88 140.66 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 126.328 1.851 . . . . 0.0 106.263 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -154.74 140.19 17.79 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.594 1.958 . . . . 0.0 105.886 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.54 156.17 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.32 144.04 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -116.73 105.22 12.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.59 125.21 27.47 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.906 -1.122 . . . . 0.0 108.284 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.77 160.57 19.26 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.39 -8.78 14.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.038 1.335 . . . . 0.0 111.606 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -101.56 -68.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 106.863 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -154.57 165.8 35.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.59 139.2 43.51 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.29 145.89 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -112.06 153.63 26.6 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.735 -1.228 . . . . 0.0 111.031 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 -123.75 2.03 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.18 176.6 35.96 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -75.13 142.04 43.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.21 65.1 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.268 2.227 . . . . 0.0 105.702 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.7 -164.01 37.59 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.56 123.26 43.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 143.26 51.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -106.9 -177.65 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.862 0.839 . . . . 0.0 111.86 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.2 tp -89.59 -39.59 13.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.059 0.944 . . . . 0.0 108.811 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -54.34 -38.56 66.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.988 2.115 . . . . 0.0 112.786 -178.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.06 163.37 27.68 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-O 124.102 1.946 . . . . 0.0 108.427 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -109.63 162.94 13.94 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 110.966 -2.617 . . . . 0.0 108.854 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 164.23 13.94 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.078 1.751 . . . . 0.0 110.512 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.6 m -119.38 99.28 6.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.099 0.959 . . . . 0.0 113.53 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -87.72 140.63 29.32 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.06 130.71 52.83 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.649 1.579 . . . . 0.0 111.992 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.8 t -115.18 110.07 30.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 124.858 1.263 . . . . 0.0 108.276 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -69.84 173.18 6.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.054 1.341 . . . . 0.0 109.734 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.3 87.55 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.858 -1.151 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.95 7.65 41.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.349 1.459 . . . . 0.0 112.883 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.64 135.6 38.34 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.84 125.67 27.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mt -75.25 121.65 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.28 -19.17 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.82 147.18 29.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.01 113.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.26 130.56 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.46 144.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.824 1.25 . . . . 0.0 107.697 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -128.19 137.15 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -146.34 148.15 32.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.48 169.36 21.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.73 0.695 . . . . 0.0 110.185 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.31 148.05 33.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.906 1.282 . . . . 0.0 110.546 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.4 161.16 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.821 1.248 . . . . 0.0 108.792 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -61.83 129.11 39.41 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.414 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.15 -10.43 70.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.158 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.46 77.3 1.76 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.295 -2.484 . . . . 0.0 104.295 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.4 -9.49 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.345 2.258 . . . . 0.0 113.336 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.54 127.32 37.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.02 1.328 . . . . 0.0 109.207 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.04 114.14 4.98 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.3 pt -110.08 151.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.349 0.977 . . . . 0.0 110.412 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 mm -66.12 109.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 108.084 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -80.1 -28.55 39.02 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.682 -0.636 . . . . 0.0 110.967 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -170.51 174.0 5.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 109.476 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.68 144.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.617 1.967 . . . . 0.0 107.28 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.5 m -138.38 104.06 5.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.236 1.414 . . . . 0.0 107.612 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -78.81 150.5 32.31 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.871 -1.143 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.48 120.51 16.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -109.25 164.6 12.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.866 0.841 . . . . 0.0 112.895 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -63.68 -25.39 68.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.198 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -79.56 -5.5 55.07 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.531 -0.731 . . . . 0.0 110.727 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.77 2.68 62.83 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.833 1.206 . . . . 0.0 111.307 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -67.06 135.27 53.41 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.84 109.87 10.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.8 p -75.96 156.68 84.16 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.68 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.84 165.14 33.6 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 106.814 -2.033 . . . . 0.0 106.814 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.71 108.5 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.069 2.512 . . . . 0.0 107.393 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -79.83 71.42 6.5 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.49 -130.87 3.46 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 tp -139.78 105.9 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.732 2.013 . . . . 0.0 106.649 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 1.5 mt-10 -59.52 148.56 32.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.9 OUTLIER -127.66 178.82 5.87 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 109.328 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.413 ' H ' HG22 ' A' ' 111' ' ' THR . 21.7 tt0 -62.06 -54.88 35.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.59 130.76 48.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 1.1 ptpm? -160.18 166.47 29.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -150.43 160.4 43.78 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.89 2.076 . . . . 0.0 107.01 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.68 118.83 5.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -105.82 140.06 39.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 172.51 17.28 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 126.988 2.115 . . . . 0.0 108.875 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.05 175.81 7.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.913 1.685 . . . . 0.0 111.243 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -145.75 -15.39 0.48 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.081 0.553 . . . . 0.0 111.982 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.61 1.48 6.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.307 1.443 . . . . 0.0 110.871 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.01 108.48 0.99 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.39 162.96 36.75 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -110.23 159.08 17.71 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.083 1.353 . . . . 0.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.0 tt -72.86 130.13 39.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.15 -14.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.37 47.43 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -135.69 171.71 14.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.758 1.223 . . . . 0.0 112.442 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CB ' ' CE3' ' A' ' 15' ' ' TRP . 10.7 p80 -164.37 168.65 18.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.953 1.301 . . . . 0.0 109.986 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.92 -82.33 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 170.93 86.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 C-N-CA 129.359 3.064 . . . . 0.0 108.136 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -137.16 164.59 28.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.8 -99.45 0.12 Allowed Glycine 0 C--O 1.227 -0.341 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.42 -0.19 40.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.706 0.802 . . . . 0.0 113.154 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.54 166.51 26.93 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 126.19 1.796 . . . . 0.0 106.587 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -94.49 81.89 3.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -79.41 -64.75 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.584 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.45 131.18 35.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.451 0.7 . . . . 0.0 110.697 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 tp -155.38 173.64 16.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.554 0.692 . . . . 0.0 111.059 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.78 161.61 34.38 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 127.482 2.468 . . . . 0.0 107.902 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.56 159.56 35.96 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.357 1.063 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -121.91 159.01 27.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.515 0.726 . . . . 0.0 111.237 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -135.87 97.23 3.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.327 0 C-N-CA 127.005 2.122 . . . . 0.0 111.205 179.167 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.801 0.81 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -98.38 147.53 24.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.329 0.651 . . . . 0.0 109.445 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -113.58 146.0 40.38 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -111.06 -176.4 2.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.137 0.975 . . . . 0.0 109.768 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 122.9 48.67 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.842 1.257 . . . . 0.0 110.515 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.57 177.61 8.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.252 1.421 . . . . 0.0 111.604 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.46 160.9 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 125.7 1.6 . . . . 0.0 108.096 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.77 -102.26 0.14 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 125.771 1.653 . . . . 0.0 111.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.65 -117.44 11.56 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 65.65 -25.82 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 128.875 2.87 . . . . 0.0 114.481 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -132.25 148.0 52.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.043 1.737 . . . . 0.0 108.88 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.08 176.17 15.05 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 128.212 2.815 . . . . 0.0 107.363 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.0 m -80.8 142.04 34.12 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.71 110.14 14.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.87 130.79 9.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 120.034 1.288 . . . . 0.0 113.355 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.4 148.75 23.38 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.73 -27.85 17.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.321 1.448 . . . . 0.0 109.255 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 83.24 -147.55 24.64 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.95 138.86 18.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 194' ' ' TYR . 69.1 m-85 -111.76 179.85 3.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.97 0.508 . . . . 0.0 111.849 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.96 -36.5 62.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.952 0.882 . . . . 0.0 110.361 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.24 -177.31 44.22 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 127.929 2.68 . . . . 0.0 107.504 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 20.9 m -121.94 157.79 25.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 125.989 1.716 . . . . 0.0 108.033 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -50.64 2.14 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.529 0.604 . . . . 0.0 109.591 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -140.93 140.23 34.44 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 118.791 0.723 . . . . 0.0 109.736 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.53 142.1 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -133.95 152.7 51.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.507 0.723 . . . . 0.0 109.181 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.71 144.8 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -140.42 134.54 6.54 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -141.2 174.43 10.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.921 0.867 . . . . 0.0 112.093 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.62 -172.85 13.13 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 128.591 2.996 . . . . 0.0 106.41 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -65.56 -23.75 66.93 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.044 -0.68 . . . . 0.0 110.661 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -17.58 60.65 Favored 'General case' 0 N--CA 1.451 -0.38 1 C-N-CA 132.083 4.153 . . . . 0.0 112.8 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.82 -163.04 12.37 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mm -62.38 124.12 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.09 -19.09 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.752 1.221 . . . . 0.0 113.908 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.26 150.04 47.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.458 1.026 . . . . 0.0 111.846 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.63 142.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -164.48 168.56 18.25 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.959 2.504 . . . . 0.0 106.565 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.14 175.5 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.34 128.77 38.39 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.427 ' CE2' ' CD1' ' A' ' 172' ' ' TYR . 20.0 p90 -153.26 168.32 26.4 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.991 0.917 . . . . 0.0 110.236 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -115.91 149.32 38.9 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.615 1.566 . . . . 0.0 109.567 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -125.93 123.87 39.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 60.83 -98.83 0.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.36 18.29 5.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 112.293 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -130.51 125.09 33.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.977 0.911 . . . . 0.0 111.281 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -75.76 153.43 37.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.464 1.106 . . . . 0.0 108.582 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 194' ' ' TYR . 12.7 mt -127.03 136.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.684 1.594 . . . . 0.0 107.147 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.21 128.66 72.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 149.07 -120.98 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.12 -10.26 8.08 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.025 1.774 . . . . 0.0 113.799 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.53 132.34 48.35 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.241 1.52 . . . . 0.0 109.786 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -154.93 -40.85 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.578 0.751 . . . . 0.0 112.258 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.99 151.11 36.68 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 107.314 -2.315 . . . . 0.0 107.314 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -37.79 99.59 0.19 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.529 2.331 . . . . 0.0 114.775 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.29 151.55 54.52 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.9 m -122.97 152.64 40.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.01 -11.56 40.43 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.854 -0.529 . . . . 0.0 111.172 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.77 -24.97 67.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.29 1.836 . . . . 0.0 109.497 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.21 -156.77 17.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -139.52 152.97 47.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 106.21 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.19 154.16 21.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.63 157.07 44.37 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.899 0.48 . . . . 0.0 112.134 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -142.58 139.94 31.54 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.235 1.014 . . . . 0.0 110.606 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.65 125.98 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.77 110.59 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.94 89.18 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -36.16 -52.69 1.65 Allowed Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.89 -14.39 15.47 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.32 2.013 . . . . 0.0 114.515 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -93.66 -40.71 10.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.663 1.574 . . . . 0.0 109.404 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -92.19 172.25 8.54 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 107.418 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -146.42 -20.32 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.797 -1.189 . . . . 0.0 112.325 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp 49.88 88.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 127.922 2.489 . . . . 0.0 109.036 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.0 p -90.13 -4.46 57.29 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.76 163.13 34.89 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.16 153.28 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.267 1.427 . . . . 0.0 107.49 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.4 178.22 7.09 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.196 1.798 . . . . 0.0 109.776 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.49 -179.54 40.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 262' ' ' GLU . 18.6 p -141.08 141.13 34.28 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -134.87 153.26 52.12 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.951 0.5 . . . . 0.0 111.751 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.439 ' OD1' ' HE2' ' A' ' 235' ' ' LYS . 2.6 t0 -136.29 170.91 15.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.202 1.001 . . . . 0.0 109.558 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.439 ' HE2' ' OD1' ' A' ' 234' ' ' ASP . 0.0 OUTLIER -88.55 147.98 24.33 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.88 1.272 . . . . 0.0 112.732 -178.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.62 117.47 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -63.01 145.09 56.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 79.29 1.5 86.0 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.283 -0.731 . . . . 0.0 112.729 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 m -138.17 -177.5 4.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.995 2.118 . . . . 0.0 108.511 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.8 87.74 2.31 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.54 -176.25 39.26 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.022 -1.049 . . . . 0.0 111.012 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.69 149.66 49.43 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.081 0.952 . . . . 0.0 111.276 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.7 tt -134.18 130.5 54.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.962 1.705 . . . . 0.0 106.792 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.31 128.72 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.4 t -111.84 -18.79 12.62 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.723 1.209 . . . . 0.0 111.827 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -144.61 154.52 42.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.905 0.482 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.36 143.17 30.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.272 1.829 . . . . 0.0 109.195 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -142.79 153.78 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -128.54 113.48 15.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -77.89 113.71 16.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 p -98.24 164.76 12.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.924 2.089 . . . . 0.0 108.559 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -112.65 147.26 37.11 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 57.86 11.34 1.36 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -155.5 147.64 23.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.074 1.749 . . . . 0.0 106.934 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.5 p -113.14 100.24 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.438 1.495 . . . . 0.0 108.619 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -65.38 161.55 19.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.365 2.266 . . . . 0.0 114.441 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -105.2 163.1 17.84 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 127.186 2.195 . . . . 0.0 111.067 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.39 159.28 29.33 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.831 2.354 . . . . 0.0 110.415 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -137.3 110.91 8.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.96 -167.01 15.81 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 118.731 0.696 . . . . 0.0 112.417 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.48 110.6 23.0 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.906 1.283 . . . . 0.0 109.581 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 232' ' ' THR . 48.2 tt0 -66.02 108.75 2.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.425 1.49 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.9 28.64 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.058 1.343 . . . . 0.0 109.529 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.88 -164.81 50.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 122.548 1.082 . . . . 0.0 114.236 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 59.7 m -64.54 108.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.199 2.2 . . . . 0.0 109.095 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.75 142.31 38.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -141.45 170.95 14.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.391 1.091 . . . . 0.0 111.234 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.43 155.47 39.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.427 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.95 154.78 48.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -170.45 173.07 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.567 1.147 . . . . 0.0 107.911 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -139.47 165.94 25.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -43.77 71.48 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.845 0.748 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -161.03 72.23 0.22 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-O 118.995 -0.892 . . . . 0.0 111.835 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -151.05 158.03 43.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.325 1.063 . . . . 0.0 109.742 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -88.82 177.11 6.79 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.025 1.73 . . . . 0.0 108.717 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 37.8 mt -125.0 111.33 27.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.997 1.319 . . . . 0.0 108.608 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.27 93.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.255 2.222 . . . . 0.0 108.967 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.77 6.19 Favored Glycine 0 N--CA 1.468 0.771 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -120.6 135.65 55.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.224 1.809 . . . . 0.0 111.347 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -133.04 136.73 46.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 161.51 -159.93 31.76 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.926 -1.109 . . . . 0.0 112.64 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -137.21 127.4 26.22 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.21 154.68 19.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.94 1.296 . . . . 0.0 109.278 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 37.0 t -147.04 -98.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.71 -21.26 44.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.247 1.019 . . . . 0.0 111.456 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.3 mp -136.21 153.11 51.33 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.13 83.77 4.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.616 0.766 . . . . 0.0 111.225 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -78.94 -22.11 46.22 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.425 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.44 152.62 50.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.876 1.216 . . . . 0.0 113.12 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -162.69 134.9 5.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -158.82 169.67 35.18 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 135.15 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.852 0.826 . . . . 0.0 111.565 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -74.78 145.11 43.21 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.63 136.02 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.522 0.677 . . . . 0.0 110.548 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 70.3 mtp -138.62 137.06 19.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 129.372 3.069 . . . . 0.0 106.287 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.36 165.81 30.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.765 . . . . 0.0 109.589 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.409 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -142.15 102.88 4.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.201 0.6 . . . . 0.0 109.886 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t -75.52 143.29 13.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -97.23 134.62 40.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.524 1.53 . . . . 0.0 111.587 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.29 167.63 19.05 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.762 1.225 . . . . 0.0 111.687 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.3 163.51 30.66 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.568 2.032 . . . . 0.0 108.562 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.08 -109.08 0.41 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 107.053 -2.419 . . . . 0.0 107.053 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.3 -171.43 15.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 125.318 1.437 . . . . 0.0 109.628 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.34 91.72 2.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.482 0.713 . . . . 0.0 110.253 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.59 18.77 3.01 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.167 1.365 . . . . 0.0 112.231 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.88 -177.73 16.5 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.724 1.262 . . . . 0.0 113.054 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.99 158.43 27.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.752 1.263 . . . . 0.0 111.616 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 p -63.29 131.96 50.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -134.41 -19.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.212 1.005 . . . . 0.0 110.64 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.85 100.71 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.5 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.46 1.504 . . . . 0.0 107.727 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.463 0 C-N-CA 125.058 1.313 . . . . 0.0 109.918 -179.696 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.105 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.45 155.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.738 . . . . 0.0 108.978 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ttt-85 -130.86 -32.58 1.64 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -138.9 167.95 20.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.225 1.01 . . . . 0.0 109.555 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -139.46 85.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -87.83 135.29 33.46 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.88 148.62 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 127.473 2.309 . . . . 0.0 106.861 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.44 -157.87 10.65 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -134.08 164.2 27.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.732 0.766 . . . . 0.0 110.005 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.25 37.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 129.059 3.218 . . . . 0.0 105.97 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -91.68 -32.66 15.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.168 0.484 . . . . 0.0 110.131 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -101.11 -23.61 14.44 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 130.989 3.715 . . . . 0.0 114.094 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.56 -165.78 38.33 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.639 1.563 . . . . 0.0 112.97 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.71 96.07 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 107.956 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -75.54 -21.55 57.83 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -128.44 139.62 52.25 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.926 1.694 . . . . 0.0 113.728 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -145.28 154.01 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -140.4 137.99 34.43 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.89 159.07 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.489 1.041 . . . . 0.0 112.206 -178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.01 135.84 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -124.85 104.64 8.73 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.21 110.86 17.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.87 1.268 . . . . 0.0 108.852 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -116.74 139.55 50.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 61.54 -161.29 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.914 1.286 . . . . 0.0 109.176 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -73.07 24.78 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.246 1.418 . . . . 0.0 112.131 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -141.03 165.42 27.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.468 1.907 . . . . 0.0 111.34 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -107.84 140.25 41.21 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.81 133.73 48.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -66.95 129.02 38.54 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.45 -60.2 4.86 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.24 167.73 14.21 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -118.99 85.71 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.504 1.922 . . . . 0.0 107.561 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -83.83 170.41 14.14 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.871 0.843 . . . . 0.0 109.637 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.78 -166.12 42.79 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.479 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -111.33 102.72 11.09 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.801 1.241 . . . . 0.0 109.063 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -61.04 134.05 56.68 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 p -134.31 111.86 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.152 1.381 . . . . 0.0 109.566 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -8.24 13.37 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.08 -4.82 43.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.435 0.694 . . . . 0.0 111.692 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.89 110.46 0.28 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.68 143.15 19.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.064 2.946 . . . . 0.0 106.267 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.4 164.14 30.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.528 1.931 . . . . 0.0 110.876 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.3 m -128.03 128.5 45.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.774 1.63 . . . . 0.0 108.665 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -137.18 136.11 37.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.65 142.07 51.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.889 0.876 . . . . 0.0 109.144 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.4 t -98.34 110.5 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.73 161.36 30.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 109.137 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.97 -27.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -28.66 28.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -112.03 146.95 37.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -132.98 157.07 46.09 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.441 0.696 . . . . 0.0 109.783 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.29 138.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.34 -20.77 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.261 1.424 . . . . 0.0 111.851 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.0 156.31 42.51 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.349 -0.845 . . . . 0.0 109.346 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.71 100.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -86.31 122.49 30.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 101.353 -3.573 . . . . 0.0 101.353 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 115' ' ' PHE . 2.3 p -139.09 153.91 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 110' ' ' GLU . 9.8 t -136.52 151.91 49.94 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.048 1.739 . . . . 0.0 107.108 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.29 166.28 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.444 1.098 . . . . 0.0 110.409 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.19 169.17 22.79 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.769 1.168 . . . . 0.0 111.507 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -115.07 151.45 34.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.844 2.058 . . . . 0.0 110.71 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.34 126.91 74.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.28 121.9 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 108.745 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 -3.19 26.91 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.532 1.063 . . . . 0.0 112.183 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -132.13 144.82 50.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.369 1.467 . . . . 0.0 107.617 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.89 -21.5 23.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.22 0.608 . . . . 0.0 109.516 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -67.59 -177.65 0.78 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.373 1.559 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.39 151.59 34.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.52 144.73 28.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.34 0.656 . . . . 0.0 109.846 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.35 122.34 20.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -89.71 -28.99 19.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.041 0.936 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 t -163.11 160.87 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.448 1.476 . . . . 0.0 110.644 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.82 129.11 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 126.56 1.944 . . . . 0.0 108.55 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -135.49 101.45 4.81 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.115 1.366 . . . . 0.0 109.083 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -80.85 154.45 27.1 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.591 -1.318 . . . . 0.0 108.624 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.55 125.39 27.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.7 p -93.69 167.16 11.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.148 0.975 . . . . 0.0 111.668 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -65.94 -21.97 66.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -7.07 52.74 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.295 1.038 . . . . 0.0 111.686 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.6 -4.08 75.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 125.534 1.54 . . . . 0.0 111.587 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -79.35 149.59 31.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 118.492 1.146 . . . . 0.0 108.404 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.7 p -134.3 135.73 43.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.68 163.39 61.26 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.18 162.3 42.09 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.39 101.68 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.35 2.7 . . . . 0.0 108.546 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -73.45 78.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 145.48 -135.3 5.89 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.6 tp -139.43 127.91 22.95 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 127.06 2.144 . . . . 0.0 107.386 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.741 ' HA ' HG21 ' A' ' 79' ' ' THR . 1.1 tt0 -69.47 155.5 40.36 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.217 0.917 . . . . 0.0 110.917 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -142.45 164.51 29.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.068 0.947 . . . . 0.0 108.909 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -60.98 -40.89 95.2 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -70.43 112.14 6.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -155.17 160.23 40.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.197 -0.94 . . . . 0.0 111.327 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.424 ' CD1' HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -155.92 165.81 35.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.607 0.763 . . . . 0.0 112.133 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.53 150.26 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.977 1.711 . . . . 0.0 106.454 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 mt -111.7 4.47 18.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -47.09 117.99 1.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.466 1.106 . . . . 0.0 112.975 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -73.32 175.91 6.46 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.004 1.722 . . . . 0.0 108.298 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.67 -11.41 8.64 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.015 -1.053 . . . . 0.0 112.684 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -78.57 -5.97 54.24 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.43 24.63 25.79 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.318 -0.712 . . . . 0.0 112.082 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.25 175.4 11.39 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.584 1.564 . . . . 0.0 112.86 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -132.45 152.84 51.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.82 141.11 58.4 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.45 -33.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.54 -169.5 35.96 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 120.601 -1.312 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 0.4 OUTLIER -134.14 172.74 12.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.614 1.566 . . . . 0.0 111.205 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -164.99 149.39 9.02 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 127.955 2.502 . . . . 0.0 105.862 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.14 115.86 0.41 Allowed Glycine 0 C--O 1.221 -0.718 0 C-N-CA 119.616 -1.278 . . . . 0.0 116.001 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -48.97 110.96 0.41 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.533 1.533 . . . . 0.0 107.664 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.22 25.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.878 1.671 . . . . 0.0 108.53 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -168.93 -97.77 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -81.89 -8.19 59.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.16 24.5 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.648 1.979 . . . . 0.0 108.545 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.78 93.98 9.65 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.17 -72.99 0.27 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.992 0.917 . . . . 0.0 111.092 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.2 143.8 38.14 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.296 1.039 . . . . 0.0 109.953 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.7 tp -134.67 115.49 13.85 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.291 1.037 . . . . 0.0 109.641 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -130.87 174.31 19.9 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.158 1.361 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . . . -150.4 175.43 11.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.617 0.767 . . . . 0.0 110.473 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -117.15 133.54 55.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -126.56 99.32 5.76 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 128.017 2.527 . . . . 0.0 108.581 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 124.544 1.138 . . . . 0.0 108.666 179.287 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.415 0 CA-C-O 122.014 0.912 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -145.76 151.51 38.09 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.484 1.513 . . . . 0.0 108.729 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -112.18 133.66 54.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.227 2.211 . . . . 0.0 106.642 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.99 -173.94 3.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.24 1.016 . . . . 0.0 109.332 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 128.46 44.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -121.19 -179.87 4.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.885 1.274 . . . . 0.0 109.59 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.92 146.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.639 1.176 . . . . 0.0 107.904 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.85 -94.31 0.11 Allowed Glycine 0 C--O 1.228 -0.273 0 C-N-CA 124.979 1.276 . . . . 0.0 110.414 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.57 -157.44 19.19 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.451 ' CA ' ' HE2' ' A' ' 282' ' ' LYS . 6.7 p-10 -116.83 -4.68 11.57 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.867 1.667 . . . . 0.0 111.47 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.37 112.27 11.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.137 2.175 . . . . 0.0 111.669 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.58 161.94 10.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 124.807 1.194 . . . . 0.0 111.729 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.2 m -81.76 142.39 32.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.63 138.05 56.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -125.7 32.36 5.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.16 104.77 3.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -83.79 -50.27 8.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.689 0.795 . . . . 0.0 111.455 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.66 -123.32 1.85 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.25 160.94 43.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.878 2.071 . . . . 0.0 107.865 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.93 163.66 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.196 0.998 . . . . 0.0 109.826 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.27 -32.4 72.54 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.57 102.97 0.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.299 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.5 m -71.25 152.29 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -40.95 5.29 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -140.71 153.17 45.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.674 1.124 . . . . 0.0 108.402 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.24 143.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -126.65 164.18 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.416 0.687 . . . . 0.0 112.551 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 259' ' ' PHE . 3.6 t -131.51 128.02 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.47 89.4 0.38 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.928 1.728 . . . . 0.0 111.626 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -74.8 -177.9 3.46 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.893 1.33 . . . . 0.0 112.916 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.08 177.13 35.77 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 128.488 2.947 . . . . 0.0 107.603 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -62.53 -45.83 91.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.261 0.625 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.81 -32.54 57.69 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.336 1.455 . . . . 0.0 110.294 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.55 -168.09 32.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 121.996 0.776 . . . . 0.0 111.321 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.76 119.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.9 m -108.22 -29.08 9.1 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.52 25.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.595 0.758 . . . . 0.0 109.766 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.53 141.7 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 58.8 pttt -161.39 159.08 27.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.091 0.957 . . . . 0.0 110.256 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.84 174.35 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 108.11 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.95 147.34 33.63 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.343 1.857 . . . . 0.0 108.035 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 196' ' ' LYS . 7.7 t80 -147.45 153.52 39.68 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -128.09 92.21 3.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.531 2.332 . . . . 0.0 105.803 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 19.4 ptmt -89.19 139.72 30.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 49.85 46.4 40.18 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.457 1.027 . . . . 0.0 112.15 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.67 3.88 0.67 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.277 1.831 . . . . 0.0 115.562 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.17 -158.53 0.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.307 1.443 . . . . 0.0 107.312 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -136.73 139.0 41.57 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.376 1.444 . . . . 0.0 110.635 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.8 mt -125.5 122.91 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.806 1.642 . . . . 0.0 107.22 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 27.8 t -112.41 134.86 53.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.98 -119.37 3.28 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.49 5.69 66.81 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.242 1.401 . . . . 0.0 114.002 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.36 118.78 11.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.472 1.509 . . . . 0.0 111.34 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -123.14 13.16 9.65 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 0.0 111.344 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.53 -178.53 21.98 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.744 1.64 . . . . 0.0 109.229 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -106.16 102.8 41.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.065 0.932 . . . . 0.0 110.945 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.18 -175.36 2.67 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.671 2.247 . . . . 0.0 108.427 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.1 p -116.18 174.18 6.19 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.52 -9.39 34.29 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.308 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.74 -27.71 68.14 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.965 0.802 . . . . 0.0 110.371 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.23 -155.51 17.0 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.442 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 41.6 m-85 -134.1 172.18 13.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.435 1.494 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.67 160.8 31.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.49 2.716 . . . . 0.0 105.686 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -137.59 153.61 49.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.307 0.643 . . . . 0.0 111.709 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 256' ' ' SER . 27.7 t80 -142.66 143.05 32.18 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.06 0.944 . . . . 0.0 110.228 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -78.52 115.3 18.13 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.761 1.625 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.36 104.25 11.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -105.75 88.15 2.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -55.29 -33.46 17.63 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.083 -1.436 . . . . 0.0 114.695 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.4 -3.26 12.08 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 CA-C-N 123.585 2.316 . . . . 0.0 111.991 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m -132.44 -8.18 3.29 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 113.31 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -140.47 159.94 41.09 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.525 1.93 . . . . 0.0 110.542 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -144.25 119.93 10.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.422 1.089 . . . . 0.0 109.136 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.58 HG22 HD12 ' A' ' 276' ' ' ILE . 89.3 mt -81.88 94.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -24.16 45.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.22 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -146.72 167.8 22.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.167 0.987 . . . . 0.0 111.362 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.74 150.45 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.906 1.682 . . . . 0.0 106.481 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.444 ' OE1' ' HE3' ' A' ' 250' ' ' LYS . 36.6 mt-10 -132.87 160.44 36.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.398 1.079 . . . . 0.0 108.247 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -177.82 164.74 33.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.6 p -130.9 148.96 52.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -142.34 146.83 35.42 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.548 0.739 . . . . 0.0 109.863 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -130.57 155.2 46.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -69.55 147.11 51.22 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.139 0.976 . . . . 0.0 112.358 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.99 115.9 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -52.64 133.54 36.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.278 0.561 . . . . 0.0 110.522 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.58 82.99 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.389 -1.228 . . . . 0.0 113.086 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.8 t -140.81 169.89 16.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.389 1.595 . . . . 0.0 109.391 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.51 -12.17 38.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.533 1.533 . . . . 0.0 108.183 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -74.08 175.65 47.82 Favored Glycine 0 C--N 1.345 1.062 0 C-N-CA 127.195 2.331 . . . . 0.0 112.16 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 242' ' ' LEU . 0.0 OUTLIER -149.02 169.67 20.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 111.883 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.25 143.74 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.688 1.595 . . . . 0.0 108.467 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -91.38 105.9 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.329 1.0 OUTLIER -104.11 -3.81 24.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.606 0.639 . . . . 0.0 112.165 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -149.52 143.55 25.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.036 -1.04 . . . . 0.0 111.568 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.9 mt -137.49 154.79 49.82 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.999 1.72 . . . . 0.0 111.031 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -142.48 170.84 14.96 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.494 2.317 . . . . 0.0 109.003 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -148.21 113.76 5.65 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.674 1.19 . . . . 0.0 109.406 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.444 ' HE3' ' OE1' ' A' ' 230' ' ' GLU . 67.1 mttt -77.05 114.47 15.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 5.2 p -109.9 165.84 11.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 127.059 2.144 . . . . 0.0 108.272 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -116.95 140.37 49.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 63.17 -8.29 0.14 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.306 1.442 . . . . 0.0 113.739 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -117.07 169.01 9.75 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.735 2.014 . . . . 0.0 107.852 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -130.98 108.16 9.6 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 123.622 0.769 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . 0.403 ' HA ' ' CE1' ' A' ' 217' ' ' PHE . 4.5 p -79.82 -178.13 6.27 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.825 1.25 . . . . 0.0 109.411 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.87 69.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.12 0.968 . . . . 0.0 110.034 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.97 101.92 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.057 2.504 . . . . 0.0 109.357 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 180' ' ' VAL . 91.7 m-85 -79.48 95.45 5.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 122.12 -169.64 14.88 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.7 122.32 47.31 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.129 0.972 . . . . 0.0 109.099 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.42 113.26 2.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.864 1.666 . . . . 0.0 110.509 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -154.99 149.0 25.78 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.347 1.459 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 74.89 -165.15 54.72 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 121.869 0.705 . . . . 0.0 114.171 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 21.8 m -62.97 137.97 58.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.523 1.929 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -108.59 121.71 45.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.54 43.21 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.56 0.744 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.97 130.45 43.42 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.602 1.961 . . . . 0.0 107.302 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.8 mt -119.22 129.74 55.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -149.38 171.35 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -138.4 147.09 42.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.17 -4.67 30.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.295 1.438 . . . . 0.0 114.851 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -167.72 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -92.57 168.1 11.48 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.854 1.827 . . . . 0.0 110.698 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.49 162.75 13.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.717 2.007 . . . . 0.0 110.387 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.58 HD12 HG22 ' A' ' 226' ' ' ILE . 21.6 mt -88.64 112.57 24.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.507 1.123 . . . . 0.0 108.892 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.37 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.26 153.12 8.93 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 125.383 1.468 . . . . 0.0 111.946 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -121.86 160.21 25.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.909 2.084 . . . . 0.0 108.779 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -159.29 176.89 11.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.615 0.766 . . . . 0.0 110.262 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 119.12 -111.29 2.05 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 126.549 2.023 . . . . 0.0 108.665 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.451 ' HE2' ' CA ' ' A' ' 162' ' ' ASP . 10.1 mtmp? -146.26 153.55 40.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.854 . . . . 0.0 112.498 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.92 131.22 34.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.132 1.773 . . . . 0.0 107.064 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.8 p -171.6 75.29 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 67.33 -70.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.873 2.469 . . . . 0.0 110.356 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 70.2 mt -81.33 172.56 13.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.217 2.207 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.7 tp -94.51 64.35 3.06 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.206 1.402 . . . . 0.0 109.688 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -61.4 -17.62 54.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -153.55 165.87 34.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -160.5 122.81 3.23 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -155.81 163.61 31.84 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.1 m -133.84 152.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.014 0.907 . . . . 0.0 113.116 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -85.25 167.71 15.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.969 1.708 . . . . 0.0 111.156 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.95 148.3 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.936 1.694 . . . . 0.0 109.092 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 92.1 mmm -152.99 149.07 21.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.634 1.973 . . . . 0.0 107.729 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.76 157.95 54.24 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.813 1.676 . . . . 0.0 110.037 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.341 1.056 . . . . 0.0 108.565 178.224 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HB3' ' OG1' ' A' ' 145' ' ' THR . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 118.261 -0.876 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -69.96 101.87 1.87 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.622 1.101 . . . . 0.0 109.771 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -148.56 102.35 3.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.049 0.94 . . . . 0.0 108.889 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.5 t -77.0 146.47 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 123.803 0.841 . . . . 0.0 109.209 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.96 148.85 25.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.621 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.93 76.22 5.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.278 1.831 . . . . 0.0 109.66 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.84 113.52 4.81 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.9 35.39 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 118.215 1.007 . . . . 0.0 111.389 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.04 178.79 36.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.889 0.756 . . . . 0.0 113.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.6 87.19 2.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.921 1.289 . . . . 0.0 109.751 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.36 21.31 3.47 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.722 1.153 . . . . 0.0 112.386 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.22 -169.14 20.04 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 118.879 1.34 . . . . 0.0 113.446 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.52 105.02 3.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.221 1.809 . . . . 0.0 108.687 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 7.8 m -171.7 5.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.615 1.966 . . . . 0.0 113.926 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -65.35 -173.1 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.542 1.937 . . . . 0.0 110.494 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.68 109.19 0.2 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.103 1.361 . . . . 0.0 114.634 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.53 172.3 13.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.823 -1.535 . . . . 0.0 109.343 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.9 -4.91 29.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.035 -0.869 . . . . 0.0 114.982 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.83 -29.73 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.882 1.341 . . . . 0.0 113.31 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -65.85 114.15 4.88 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.852 0.751 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -26.0 59.88 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.742 -0.599 . . . . 0.0 109.822 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.38 -176.27 47.64 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.88 158.99 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.354 1.862 . . . . 0.0 109.979 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -140.07 -42.94 0.42 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.251 1.42 . . . . 0.0 113.674 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -142.5 150.32 40.33 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 120.528 1.513 . . . . 0.0 109.884 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.6 t -126.24 137.1 58.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.39 139.52 52.33 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' H ' ' HB2' ' A' ' 63' ' ' GLU . 42.8 t -140.6 94.01 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.08 108.44 3.44 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -71.49 110.78 6.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.9 2.08 . . . . 0.0 108.036 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.65 -173.98 38.37 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -55.28 -31.3 61.47 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.21 6.63 7.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 158.62 -175.79 35.63 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 120.531 1.514 . . . . 0.0 111.279 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.33 96.1 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.115 1.957 . . . . 0.0 108.755 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 m -97.86 -6.62 32.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.948 -1.501 . . . . 0.0 114.209 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.8 p -140.91 146.45 37.44 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 122.173 2.26 . . . . 0.0 112.609 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.0 171.4 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.718 1.607 . . . . 0.0 109.767 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -151.87 141.24 21.52 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -130.13 113.95 27.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 119.515 1.052 . . . . 0.0 109.409 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.25 154.24 13.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.525 0.73 . . . . 0.0 109.593 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -132.92 155.86 48.31 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.39 122.01 40.81 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 108.473 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.6 167.72 9.93 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.399 1.079 . . . . 0.0 108.314 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.12 5.29 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.852 5.661 . . . . 0.0 116.424 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.4 t -151.0 -67.96 0.18 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.874 2.07 . . . . 0.0 108.891 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -139.71 166.18 25.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.847 1.259 . . . . 0.0 111.558 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -78.01 162.95 26.36 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.73 2.012 . . . . 0.0 109.406 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.0 t -142.37 136.59 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -121.6 162.28 20.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.595 1.558 . . . . 0.0 109.036 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 144.46 21.49 0.16 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 128.695 3.045 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.46 20.3 45.03 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -72.08 121.62 19.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.473 1.637 . . . . 0.0 109.142 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -129.79 171.56 12.57 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 110.094 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.03 -153.49 41.81 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.559 -2.616 . . . . 0.0 106.559 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 98.7 5.25 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 120.421 -1.635 . . . . 0.0 113.169 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.47 149.95 49.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.3 t -144.57 158.74 43.63 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.2 -19.33 65.54 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.996 0.918 . . . . 0.0 112.155 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.39 15.34 26.16 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.765 1.226 . . . . 0.0 110.487 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.07 90.88 0.11 Allowed Glycine 0 C--N 1.34 0.762 0 CA-C-N 119.305 0.957 . . . . 0.0 112.813 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -164.0 153.16 13.93 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.188 2.195 . . . . 0.0 107.62 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 28' ' ' VAL . 5.4 mm-40 -144.22 164.7 29.97 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.55 1.54 . . . . 0.0 110.208 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 m -143.01 128.85 19.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -137.16 109.69 7.45 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -88.82 117.14 27.61 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.68 110.67 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.92 157.74 20.88 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.277 1.431 . . . . 0.0 111.627 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -16.02 63.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.201 1.4 . . . . 0.0 110.008 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.56 6.44 15.81 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.687 2.395 . . . . 0.0 110.71 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.84 141.81 31.99 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.684 -1.26 . . . . 0.0 108.969 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.423 ' CD1' ' HE2' ' A' ' 124' ' ' LYS . 54.3 m-85 -134.27 114.57 13.16 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -85.5 106.93 15.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 m -92.54 -21.47 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.376 1.07 . . . . 0.0 113.777 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.53 148.93 31.71 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.232 0.924 . . . . 0.0 110.472 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.44 144.67 17.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -110.36 119.75 40.21 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.95 128.19 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 119.681 1.128 . . . . 0.0 109.012 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.733 HG21 ' H ' ' A' ' 111' ' ' THR . 70.3 m -121.86 152.1 39.94 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.637 1.975 . . . . 0.0 109.42 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -140.63 168.38 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.042 1.737 . . . . 0.0 109.181 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -156.59 164.71 37.87 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -144.41 137.86 27.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.818 2.047 . . . . 0.0 108.337 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.8 m -132.87 161.05 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.0 104.26 0.23 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.945 1.298 . . . . 0.0 112.021 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.36 -21.76 8.06 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 124.694 1.14 . . . . 0.0 113.342 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -80.68 85.9 5.99 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.4 -5.01 29.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.49 1.116 . . . . 0.0 111.161 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.5 p -131.88 95.78 3.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.041 2.136 . . . . 0.0 105.575 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -54.58 147.48 14.22 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 pt -133.41 169.51 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 122.223 1.011 . . . . 0.0 112.657 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 94' ' ' ILE . 1.6 mt -85.33 148.51 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.678 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.0 p -112.69 -69.06 0.89 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.1 p -123.04 147.98 46.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.47 HD12 HD23 ' A' ' 139' ' ' LEU . 43.5 mm -131.4 148.53 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.94 -2.245 . . . . 0.0 104.94 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.0 m -151.06 104.19 3.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.02 144.77 31.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.13 113.3 13.72 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 p -92.01 165.82 13.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -76.55 -27.41 55.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -69.29 -7.21 34.97 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 111.75 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.37 5.5 57.97 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 125.945 1.736 . . . . 0.0 113.251 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -87.49 137.98 31.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.512 1.156 . . . . 0.0 108.869 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 110.75 9.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.66 155.26 89.26 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.32 169.59 18.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.396 2.064 . . . . 0.0 110.619 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.42 111.13 2.44 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 107.921 -1.607 . . . . 0.0 107.921 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -67.7 14.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.8 2.04 . . . . 0.0 113.917 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 177.17 -175.95 47.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 126.242 1.877 . . . . 0.0 109.92 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.8 tp -72.73 108.1 5.54 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.707 1.603 . . . . 0.0 114.027 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.38 128.17 34.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.733 ' H ' HG21 ' A' ' 79' ' ' THR . 34.3 m -130.57 165.06 23.54 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.814 1.646 . . . . 0.0 108.815 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -57.05 -52.3 65.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.51 1.524 . . . . 0.0 111.446 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -61.94 102.88 0.31 Allowed 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.477 1.511 . . . . 0.0 109.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.47 170.19 21.47 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.187 0.518 . . . . 0.0 110.465 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -142.12 164.79 29.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.87 135.56 42.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.576 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.39 123.93 18.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.701 0.801 . . . . 0.0 110.991 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.93 39.23 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.293 1.437 . . . . 0.0 107.89 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.85 122.28 43.94 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.304 0.642 . . . . 0.0 110.734 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -119.7 -22.1 7.01 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.603 1.561 . . . . 0.0 110.414 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -67.62 -22.04 65.36 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.365 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.96 -10.4 6.65 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.984 -1.454 . . . . 0.0 114.62 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.75 162.81 33.81 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 120.083 1.942 . . . . 0.0 112.167 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 72' ' ' TYR . 35.4 ttmt -126.66 143.03 51.36 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.5 tt -59.59 146.71 39.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 -28.88 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -177.31 -151.91 9.53 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.31 171.17 14.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.903 0.859 . . . . 0.0 112.528 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -144.31 159.7 42.25 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.484 1.914 . . . . 0.0 106.579 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.03 110.09 2.08 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.304 0.954 . . . . 0.0 115.353 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -53.27 131.38 37.24 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.601 1.96 . . . . 0.0 107.071 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 14' ' ' SER . . . -154.43 164.98 37.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.462 1.505 . . . . 0.0 108.397 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 178.91 -101.67 0.16 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -69.4 -40.08 77.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.192 0.996 . . . . 0.0 110.238 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -125.41 153.31 43.63 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.7 tp -85.22 98.52 10.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -74.2 -46.51 41.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.372 0.669 . . . . 0.0 110.994 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.51 165.4 31.33 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 110.46 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.47 HD23 HD12 ' A' ' 94' ' ' ILE . 36.3 tp -147.89 159.11 44.21 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.402 1.481 . . . . 0.0 107.691 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.44 161.85 21.72 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.76 133.78 24.15 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -82.22 168.34 17.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -130.31 163.56 26.55 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.524 -0.735 . . . . 0.0 110.508 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -87.26 115.86 24.95 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 1' ' ' ALA . 6.2 t -133.08 166.26 22.84 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.223 1.409 . . . . 0.0 108.469 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.4 p -116.0 175.59 5.47 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.613 0.365 . . . . 0.0 110.432 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 t -116.17 119.95 37.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.3 p -139.15 156.37 72.2 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.88 176.12 10.29 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.971 1.781 . . . . 0.0 109.563 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.89 139.98 20.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 p -130.15 161.22 61.41 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.535 0.734 . . . . 0.0 110.97 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.19 -172.86 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.035 3.156 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.08 140.85 56.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.032 0.933 . . . . 0.0 108.62 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.78 134.73 35.11 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.339 1.056 . . . . 0.0 110.388 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -87.02 146.59 26.06 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.9 mt -113.65 -166.66 1.11 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.2 m -146.32 125.89 13.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.84 -159.47 0.69 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.694 2.398 . . . . 0.0 108.67 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 18.9 tt -149.04 151.57 12.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 160.95 -38.77 0.42 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 118.842 0.746 . . . . 0.0 114.442 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.56 162.01 25.41 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 119.113 1.457 . . . . 0.0 112.85 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 49.2 p30 -112.73 0.88 15.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.076 1.75 . . . . 0.0 112.851 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -131.71 135.43 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.637 1.108 . . . . 0.0 109.86 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 132.6 159.13 9.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 127.713 2.577 . . . . 0.0 109.125 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.5 m -67.9 134.37 50.72 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 126.011 1.724 . . . . 0.0 112.267 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.74 135.22 36.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -127.68 33.46 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.093 1.357 . . . . 0.0 110.475 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -58.03 107.63 0.49 Allowed 'General case' 0 C--N 1.334 -0.095 0 O-C-N 120.775 -1.203 . . . . 0.0 112.48 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.72 -16.73 60.11 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.986 0.914 . . . . 0.0 110.274 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 75.92 -75.14 1.53 Allowed Glycine 0 C--N 1.337 0.612 0 CA-C-O 118.522 -1.155 . . . . 0.0 110.53 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.89 146.81 2.6 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.426 2.291 . . . . 0.0 109.02 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -124.86 167.19 14.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.893 2.077 . . . . 0.0 106.831 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -24.36 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.92 -174.73 42.25 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 33.7 m -125.63 116.59 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.63 -39.03 8.08 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.642 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -145.42 150.63 36.88 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.559 HG13 ' CE2' ' A' ' 192' ' ' PHE . 41.2 t -132.46 150.36 33.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.925 0.89 . . . . 0.0 109.084 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -142.48 155.63 45.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.823 1.249 . . . . 0.0 108.677 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.59 130.49 64.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.84 93.43 0.54 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -70.67 155.66 40.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.117 0.961 . . . . 0.0 110.076 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.35 -167.82 14.89 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 126.674 2.083 . . . . 0.0 109.509 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.16 -9.05 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.326 -1.102 . . . . 0.0 110.9 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -117.25 -31.85 5.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.507 3.123 . . . . 0.0 113.686 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 163.07 -158.3 30.59 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.62 110.61 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 62.6 m -116.39 -12.71 11.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.017 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.21 130.75 29.25 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.91 1.232 . . . . 0.0 110.143 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.97 135.82 50.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -148.44 139.81 23.42 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 178' ' ' VAL . 14.2 m-85 -132.92 163.25 29.57 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.74 1.616 . . . . 0.0 109.13 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -123.03 150.99 42.35 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -161.29 167.95 24.93 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.252 1.021 . . . . 0.0 111.726 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . 0.4 HD21 ' ND2' ' A' ' 200' ' ' ASN . 16.2 m120 -120.28 113.01 19.76 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -107.19 122.52 46.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.31 -84.19 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -140.73 -4.95 1.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.912 2.085 . . . . 0.0 110.799 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -75.4 168.28 20.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.57 1.548 . . . . 0.0 110.455 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.4 ' ND2' HD21 ' A' ' 195' ' ' ASN . 14.2 t-20 -131.92 101.93 5.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.445 2.698 . . . . 0.0 105.94 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.9 mm -91.78 118.18 36.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.264 1.026 . . . . 0.0 109.35 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 61.8 t -123.19 128.53 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 128.3 -140.13 11.56 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 110.06 9.86 23.47 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.433 1.117 . . . . 0.0 115.851 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -68.58 108.53 3.37 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.739 1.77 . . . . 0.0 109.499 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -129.2 27.14 5.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.084 2.153 . . . . 0.0 109.774 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -145.06 -178.74 20.88 Favored Glycine 0 N--CA 1.451 -0.322 0 O-C-N 120.444 -1.41 . . . . 0.0 109.759 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -85.36 94.64 0.33 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.809 1.244 . . . . 0.0 111.024 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.4 162.51 38.51 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.571 1.597 . . . . 0.0 108.047 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.9 m -137.48 166.32 24.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -2.59 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.0 -7.16 47.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.405 1.082 . . . . 0.0 109.202 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.56 -148.92 32.84 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -141.65 157.28 45.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 108.436 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.57 154.7 28.93 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 128.523 2.729 . . . . 0.0 104.052 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.05 140.12 23.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -143.02 132.24 23.24 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.312 1.045 . . . . 0.0 108.491 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -105.61 97.02 6.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.23 -1.766 . . . . 0.0 106.23 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.45 141.24 15.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -78.98 88.76 4.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -49.02 -55.6 19.81 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 113.876 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.25 -9.62 21.93 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 CA-C-N 121.51 1.575 . . . . 0.0 114.578 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.42 -38.05 6.96 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.63 1.105 . . . . 0.0 113.88 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 172.62 10.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.0 112.678 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -150.15 149.03 29.67 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.65 -0.656 . . . . 0.0 112.543 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.04 100.16 7.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.5 t -73.17 -29.13 62.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.525 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.04 170.63 16.29 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.71 1.604 . . . . 0.0 108.646 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.2 t -121.72 150.65 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.655 1.182 . . . . 0.0 108.366 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -133.77 166.76 21.9 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.786 2.035 . . . . 0.0 109.245 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.45 166.93 28.35 Favored Glycine 0 N--CA 1.452 -0.265 0 O-C-N 120.968 -1.083 . . . . 0.0 110.823 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 79.1 p -137.1 133.95 35.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -117.31 138.22 51.91 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.357 1.063 . . . . 0.0 109.77 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -119.14 146.85 44.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.098 0.952 . . . . 0.0 108.586 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -69.68 129.11 38.71 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.579 1.151 . . . . 0.0 112.948 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.8 155.42 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -93.33 173.63 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 77.41 -25.69 1.97 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.301 1.429 . . . . 0.0 114.62 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 11.9 p -141.56 168.85 18.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.542 1.671 . . . . 0.0 109.715 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -84.4 11.73 8.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 110.648 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.46 -175.78 27.4 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.788 1.185 . . . . 0.0 112.939 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.5 mt -149.23 166.67 28.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.662 1.985 . . . . 0.0 109.335 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.15 172.78 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.12 112.97 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.12 1.368 . . . . 0.0 108.994 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.55 -4.42 19.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.569 0.748 . . . . 0.0 112.742 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.3 tmm? -147.7 110.98 4.88 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 17.7 mt -125.75 132.72 52.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.14 1.376 . . . . 0.0 108.363 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -129.04 166.15 19.78 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.647 1.213 . . . . 0.0 111.185 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.01 134.83 44.97 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -73.11 130.71 40.89 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.3 m -139.0 130.64 27.37 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.515 HD22 ' HD3' ' A' ' 253' ' ' LYS . 3.4 p-10 -100.94 156.22 17.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.207 1.803 . . . . 0.0 107.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.515 ' HD3' HD22 ' A' ' 252' ' ' ASN . 1.0 OUTLIER 59.8 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.82 2.448 . . . . 0.0 115.268 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 252' ' ' ASN . 49.6 mt-30 -131.63 174.78 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 129.124 2.97 . . . . 0.0 108.89 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 97.3 m -130.08 108.96 10.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.319 1.447 . . . . 0.0 108.81 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -81.27 136.03 35.76 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -62.0 154.27 69.48 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.46 88.86 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.185 2.59 . . . . 0.0 107.363 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -69.89 105.29 2.76 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.15 -172.38 23.28 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.712 0.687 . . . . 0.0 113.43 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 31.9 tp -117.65 113.33 21.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.799 1.64 . . . . 0.0 110.09 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.16 131.19 50.04 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.113 1.365 . . . . 0.0 110.183 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -178.11 169.07 1.95 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 129.272 3.029 . . . . 0.0 105.873 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.26 -166.2 45.8 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 83.4 m -84.87 144.99 28.04 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.412 1.485 . . . . 0.0 108.143 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -100.48 150.76 22.32 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -143.92 164.17 31.34 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 111.456 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.79 154.45 37.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.631 1.572 . . . . 0.0 109.657 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.3 mt -131.89 105.61 7.55 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -139.81 143.99 37.12 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.921 0.889 . . . . 0.0 112.686 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -144.46 153.51 41.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.696 1.998 . . . . 0.0 106.371 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -86.83 145.83 26.45 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.494 -1.379 . . . . 0.0 112.206 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.94 -43.33 0.79 Allowed Glycine 0 C--N 1.341 0.853 0 C-N-CA 127.035 2.255 . . . . 0.0 115.431 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -74.28 159.47 32.4 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 124.321 1.049 . . . . 0.0 111.935 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 297' ' ' LEU . 1.2 mppt? -125.59 174.31 8.35 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.943 2.097 . . . . 0.0 105.555 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 18.6 mt -108.8 140.34 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 121.492 0.663 . . . . 0.0 109.661 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.13 -3.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 128.337 2.655 . . . . 0.0 111.717 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.11 156.89 28.38 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 120.526 1.512 . . . . 0.0 114.6 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -114.83 162.7 16.53 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 112.161 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -150.75 137.44 18.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 169.07 -160.45 33.87 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -145.6 143.66 30.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.255 0.55 . . . . 0.0 111.967 179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.61 148.54 12.57 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 126.938 2.095 . . . . 0.0 107.171 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.2 m -131.41 -34.08 1.42 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 127.288 2.235 . . . . 0.0 107.003 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -144.21 -56.74 0.37 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.339 1.856 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.48 148.65 26.23 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.55 1.94 . . . . 0.0 110.076 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 86.51 4.95 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.554 0.616 . . . . 0.0 110.595 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -67.01 -58.73 4.38 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.618 0.367 . . . . 0.0 111.737 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -126.1 136.34 52.79 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.481 0.582 . . . . 0.0 110.954 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -132.32 123.1 26.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.715 1.606 . . . . 0.0 108.883 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -137.34 170.48 23.58 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.316 1.436 . . . . 0.0 109.911 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.02 171.95 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.238 0.615 . . . . 0.0 111.44 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -121.37 166.09 14.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.94 2.096 . . . . 0.0 106.131 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.58 136.7 56.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 75.1 mtp -137.03 140.62 31.95 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 108.461 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.2 104.83 1.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.1 3.2 . . . . 0.0 109.499 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.43 ' HB2' ' HE2' ' A' ' 275' ' ' LYS . 74.9 mt -120.32 46.32 2.0 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.56 1.144 . . . . 0.0 109.263 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 9.7 t -109.06 165.83 11.29 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--O 1.245 0.852 0 CA-C-O 116.586 -1.674 . . . . 0.0 111.086 -179.795 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -74.1 100.0 3.5 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.402 1.096 . . . . 0.0 109.767 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -148.72 138.35 21.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 130.688 3.595 . . . . 0.0 105.202 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.73 145.86 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -89.5 161.96 15.96 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.562 1.172 . . . . 0.0 111.255 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.96 90.05 8.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.23 103.96 1.26 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.99 -177.29 44.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.33 1.919 . . . . 0.0 108.976 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.92 161.75 46.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 118.452 1.126 . . . . 0.0 112.85 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.44 0.37 55.35 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.67 166.28 43.16 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.61 174.35 23.09 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 123.98 0.8 . . . . 0.0 112.915 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.32 131.77 34.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.4 p -71.55 128.33 35.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.015 0.825 . . . . 0.0 110.341 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -121.54 4.8 10.13 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -64.36 136.1 56.8 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 71.58 12.0 6.46 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.892 2.477 . . . . 0.0 110.468 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.11 156.0 30.1 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 m -65.29 116.95 5.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.441 0.696 . . . . 0.0 111.694 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -143.13 170.39 15.82 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.434 2.294 . . . . 0.0 108.281 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -147.17 -11.3 0.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.18 172.51 28.6 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.56 153.6 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.024 0.912 . . . . 0.0 108.592 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 43' ' ' ALA . 17.1 mmt85 -131.18 -52.27 1.03 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.862 1.665 . . . . 0.0 111.2 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -126.08 160.74 29.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.69 129.14 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 102.972 -2.973 . . . . 0.0 102.972 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.56 119.88 26.98 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.24 92.4 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.09 143.87 16.87 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.93 175.02 3.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.063 0.945 . . . . 0.0 110.863 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -168.94 175.71 43.31 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.41 -36.96 84.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.88 2.79 28.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 130.863 3.665 . . . . 0.0 110.711 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.13 -166.89 24.81 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.45 122.76 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.5 m -136.47 -19.85 1.4 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.426 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -99.17 112.95 24.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.52 144.26 36.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 121.97 -0.456 . . . . 0.0 110.35 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -148.44 151.01 34.48 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.937 1.695 . . . . 0.0 107.837 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.2 p -138.78 158.53 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.918 1.287 . . . . 0.0 108.206 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.39 115.2 39.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -88.99 105.54 17.85 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.178 1.391 . . . . 0.0 109.068 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HB2' ' HG2' ' A' ' 24' ' ' ARG . . . -68.37 126.15 28.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 122.088 -0.383 . . . . 0.0 110.509 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -113.78 146.27 40.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.7 -36.12 75.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.593 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -64.36 -63.66 1.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -156.13 141.56 17.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.048 0.939 . . . . 0.0 108.873 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.27 111.72 10.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.28 136.74 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.804 0.812 . . . . 0.0 112.395 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -78.28 162.47 26.5 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.622 1.969 . . . . 0.0 109.682 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.58 6.75 8.48 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.131 1.824 . . . . 0.0 111.238 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.26 161.04 26.16 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 125.953 1.74 . . . . 0.0 113.75 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.3 137.68 56.26 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.907 0.883 . . . . 0.0 109.573 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -122.88 51.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.24 -177.34 27.54 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.861 1.696 . . . . 0.0 111.3 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.61 84.89 3.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.919 1.288 . . . . 0.0 110.404 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -56.56 132.56 51.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.428 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 m -129.49 147.61 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -75.18 -36.73 61.45 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.856 -0.528 . . . . 0.0 111.628 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mp -102.11 23.12 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.25 91.93 0.15 Allowed Glycine 0 C--N 1.342 0.883 0 O-C-N 121.761 -0.587 . . . . 0.0 112.1 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -161.64 154.79 20.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.9 2.48 . . . . 0.0 105.01 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -150.57 164.85 35.01 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.12 1.768 . . . . 0.0 108.847 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.6 m -145.07 122.12 11.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.93 0.492 . . . . 0.0 110.541 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -131.61 131.53 43.33 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -107.92 141.34 39.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.213 1.005 . . . . 0.0 108.687 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.4 t -110.48 112.9 42.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.88 176.56 4.87 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.765 2.026 . . . . 0.0 111.533 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -46.38 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -101.9 -5.04 25.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.008 2.123 . . . . 0.0 113.388 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -94.53 137.13 34.03 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -123.94 162.41 23.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.342 0.973 . . . . 0.0 110.573 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.4 mt -86.92 118.27 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.3 t -81.16 -45.88 20.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.266 1.426 . . . . 0.0 109.823 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.38 166.15 28.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.621 1.169 . . . . 0.0 109.651 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.06 103.35 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -82.37 135.37 35.19 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -133.66 127.75 53.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.9 p -114.64 149.1 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -151.85 168.15 26.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.889 0.768 . . . . 0.0 110.571 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -153.78 151.96 30.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -128.46 127.88 43.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.544 2.338 . . . . 0.0 105.918 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.64 166.21 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.887 1.275 . . . . 0.0 111.086 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.83 156.9 31.89 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.42 -14.65 6.49 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.071 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -129.03 107.23 9.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.184 1.492 . . . . 0.0 108.177 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.36 -14.25 62.86 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 111.041 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.4 p -72.01 176.44 5.06 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.547 1.539 . . . . 0.0 110.011 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.68 135.65 30.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 103.088 -2.93 . . . . 0.0 103.088 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.53 154.11 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.776 0.716 . . . . 0.0 110.647 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 mm -76.73 112.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 124.857 1.263 . . . . 0.0 107.989 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 p -77.24 -36.78 54.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.566 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.6 t -158.98 158.72 33.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.843 2.057 . . . . 0.0 109.243 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.2 tt -137.06 151.49 27.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 126.775 2.03 . . . . 0.0 107.11 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 m -150.67 108.45 3.69 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -76.18 158.71 31.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -135.49 122.04 20.73 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.1 p -108.53 160.68 15.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 119.276 0.944 . . . . 0.0 112.287 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -68.76 -37.88 79.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.315 0.646 . . . . 0.0 109.746 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -15.28 63.51 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 116.772 -1.585 . . . . 0.0 113.431 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.61 3.5 49.8 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 120.188 1.358 . . . . 0.0 112.589 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -82.7 95.07 7.72 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 17.5 m -104.35 122.31 45.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.8 p -70.13 159.7 83.46 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 111.561 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.33 170.26 20.34 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.073 1.849 . . . . 0.0 107.435 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.58 109.75 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 N-CA-C 106.519 -2.147 . . . . 0.0 106.519 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -81.03 77.06 7.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.65 -149.97 20.36 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.772 1.653 . . . . 0.0 110.234 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 60.3 tp -105.27 125.77 51.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.113 1.365 . . . . 0.0 110.591 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.46 139.48 53.97 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.9 m -134.78 157.14 47.51 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.439 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -61.76 -45.56 93.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.217 0.607 . . . . 0.0 109.492 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -65.2 110.32 2.52 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 107.229 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -163.86 166.8 21.48 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.409 -0.807 . . . . 0.0 112.226 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -150.87 167.67 26.8 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.24 1.816 . . . . 0.0 108.921 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.24 142.62 38.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 129.84 55.48 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.985 0.914 . . . . 0.0 111.129 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 147.2 24.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.144 1.377 . . . . 0.0 108.229 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 123' ' ' GLY . 27.9 t0 -76.49 174.51 10.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -50.05 -53.73 25.02 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.928 1.691 . . . . 0.0 109.425 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -114.32 -23.81 9.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 117.835 -1.078 . . . . 0.0 113.607 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.22 55.83 0.13 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 119.939 1.245 . . . . 0.0 113.919 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.454 ' H ' ' HB3' ' A' ' 119' ' ' ASP . . . -71.74 138.5 27.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -65.75 144.47 56.86 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tp -62.12 97.05 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.143 1.777 . . . . 0.0 107.866 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.72 -51.99 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -174.07 141.12 5.8 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -87.55 177.76 6.98 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.642 1.177 . . . . 0.0 111.328 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -147.2 169.37 19.48 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.2 2.2 . . . . 0.0 107.319 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.91 -177.99 47.49 Favored Glycine 0 CA--C 1.523 0.576 0 O-C-N 121.544 -0.722 . . . . 0.0 112.258 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -142.45 50.71 1.48 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.67 2.388 . . . . 0.0 108.629 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.43 163.53 17.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 119.902 -1.748 . . . . 0.0 109.164 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -160.86 -104.45 0.19 Allowed Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.09 -15.99 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 124.409 0.711 . . . . 0.0 111.144 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.83 174.61 12.03 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.874 2.47 . . . . 0.0 107.343 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.6 tp -98.91 88.54 4.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -79.58 -52.64 7.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.694 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.77 158.53 39.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.532 0.682 . . . . 0.0 111.982 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -148.6 147.09 28.59 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 130.447 3.499 . . . . 0.0 106.576 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -144.18 -173.21 15.4 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.83 156.18 35.75 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.758 1.279 . . . . 0.0 110.624 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -128.68 109.84 11.68 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.65 99.14 8.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.07 101.02 3.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.6 t -130.44 102.71 6.28 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 122.676 1.227 . . . . 0.0 108.059 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 t -163.36 164.55 24.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.46 1.904 . . . . 0.0 107.02 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.1 65.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.6 p -72.38 159.09 86.31 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 -169.27 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.983 2.456 . . . . 0.0 110.246 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.9 t -52.56 149.92 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.157 1.383 . . . . 0.0 109.274 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.6 p -73.38 146.36 86.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -69.01 -166.03 0.15 Allowed 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.702 3.601 . . . . 0.0 115.183 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.21 178.5 1.88 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.896 2.078 . . . . 0.0 110.59 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -74.74 131.09 40.56 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -111.92 147.9 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.633 1.973 . . . . 0.0 106.855 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 48.2 mt -112.32 167.76 10.17 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.166 1.386 . . . . 0.0 107.84 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -73.51 107.33 5.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.8 171.56 10.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.667 0.787 . . . . 0.0 109.339 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.49 148.05 30.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 159.8 -112.44 0.52 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 125.006 1.289 . . . . 0.0 110.897 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -115.67 163.51 12.29 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.882 1.706 . . . . 0.0 110.453 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.13 -5.61 40.31 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.13 1.372 . . . . 0.0 112.474 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.506 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 44.7 tt0 -112.98 144.0 43.32 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.417 1.487 . . . . 0.0 109.752 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.56 171.52 12.87 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 123.795 0.712 . . . . 0.0 113.167 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.4 m -82.07 116.96 21.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.847 0.859 . . . . 0.0 108.901 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.06 126.27 29.19 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -134.13 127.07 31.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.011 0.924 . . . . 0.0 111.746 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -98.18 155.63 17.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.985 1.714 . . . . 0.0 108.681 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -150.81 100.19 2.79 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.55 160.36 5.02 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.617 0.607 . . . . 0.0 114.617 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.54 143.71 51.53 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -104.77 178.33 4.59 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.162 1.385 . . . . 0.0 111.317 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -53.05 -45.1 67.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 126.078 1.751 . . . . 0.0 112.361 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 174.74 -176.33 46.97 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 128.874 3.13 . . . . 0.0 106.157 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.67 141.26 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -121.86 -19.8 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -144.28 158.54 43.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.95 145.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -128.94 156.05 44.36 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 t -136.29 123.35 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.87 57.67 0.58 Allowed Glycine 0 C--N 1.341 0.833 0 C-N-CA 124.394 0.997 . . . . 0.0 114.834 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.471 ' CD ' ' H ' ' A' ' 182' ' ' GLN . 3.2 pm0 -68.21 159.93 30.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.964 0.905 . . . . 0.0 110.024 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.28 -140.07 3.83 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.542 1.544 . . . . 0.0 110.477 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -82.15 -37.13 26.66 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.192 0.997 . . . . 0.0 110.89 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.55 -31.45 11.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.725 2.01 . . . . 0.0 113.759 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.16 -158.48 29.52 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 119.749 1.158 . . . . 0.0 110.975 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mm -64.37 105.94 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.1 m -95.13 -23.46 17.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.998 0.919 . . . . 0.0 111.472 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.35 157.69 38.97 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.808 1.643 . . . . 0.0 109.3 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 30.9 m -138.57 156.53 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.592 1.957 . . . . 0.0 106.545 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.417 ' HE2' ' CG ' ' A' ' 214' ' ' PHE . 59.8 pttt -174.13 134.0 0.43 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 128.78 2.832 . . . . 0.0 105.842 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -125.95 162.22 25.73 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.092 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -103.09 152.35 21.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.778 1.231 . . . . 0.0 109.585 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -164.03 163.9 23.2 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.532 1.133 . . . . 0.0 109.682 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.24 145.72 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.071 1.748 . . . . 0.0 106.978 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -140.56 97.19 3.16 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 65.34 -143.57 46.16 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.65 5.7 10.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.844 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.94 168.5 9.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.738 1.215 . . . . 0.0 110.709 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.75 142.79 49.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.821 1.648 . . . . 0.0 107.186 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.4 mm -131.81 102.41 5.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.26 105.23 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 139.31 170.5 11.9 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 121.751 0.64 . . . . 0.0 114.516 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.43 45.23 0.02 OUTLIER Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.684 2.087 . . . . 0.0 109.28 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.62 100.61 3.38 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.665 1.186 . . . . 0.0 109.87 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -116.84 -24.45 7.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.639 1.176 . . . . 0.0 112.122 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -91.8 -179.24 41.93 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -96.96 91.55 0.97 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.248 1.024 . . . . 0.0 109.161 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.36 156.63 58.36 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 CA-C-N 121.367 1.524 . . . . 0.0 109.324 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 71.2 p -98.91 173.48 6.83 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.62 -10.55 59.6 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.086 -1.009 . . . . 0.0 111.441 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.0 tt -53.37 -39.35 64.13 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.907 1.283 . . . . 0.0 109.623 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.59 175.28 29.73 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.665 1.603 . . . . 0.0 111.149 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CG ' ' HE2' ' A' ' 191' ' ' LYS . 53.4 m-85 -102.34 138.41 39.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.355 1.062 . . . . 0.0 109.628 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.88 164.17 13.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.977 2.511 . . . . 0.0 106.326 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.13 157.37 44.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 121.542 1.974 . . . . 0.0 115.684 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -142.55 143.63 32.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.633 1.173 . . . . 0.0 110.045 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 124.2 43.75 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 108.762 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.96 117.5 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.059 0 C-N-CA 126.604 1.962 . . . . 0.0 106.304 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -93.98 106.36 18.34 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.574 1.079 . . . . 0.0 109.999 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -38.66 -61.42 0.89 Allowed Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.6 -19.31 28.25 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.192 1.819 . . . . 0.0 116.301 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.5 t -106.93 -12.92 15.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 121.576 1.989 . . . . 0.0 114.769 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.33 160.18 15.81 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.285 1.834 . . . . 0.0 107.229 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -152.48 106.87 3.16 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 119.935 -1.728 . . . . 0.0 109.894 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.93 70.48 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 t -68.12 -16.95 64.22 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.546 -1.346 . . . . 0.0 112.739 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -157.94 167.51 29.74 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.862 1.665 . . . . 0.0 107.914 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.9 p -136.55 159.54 37.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.424 ' OE2' ' HE3' ' A' ' 250' ' ' LYS . 31.4 mt-10 -131.51 172.92 11.65 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.41 1.484 . . . . 0.0 108.388 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.52 179.8 42.8 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 13.3 m -157.19 150.52 23.96 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 155.47 48.61 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -153.02 164.4 38.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.892 0.853 . . . . 0.0 108.964 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -70.07 148.36 48.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.053 2.141 . . . . 0.0 112.907 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 40.7 mt -90.16 151.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -108.8 76.8 1.03 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 149.22 -15.85 1.14 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-O 117.944 -1.476 . . . . 0.0 115.483 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 m -132.44 148.49 52.41 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.734 1.267 . . . . 0.0 108.293 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.62 86.23 7.32 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.844 1.258 . . . . 0.0 109.235 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 178.28 -169.92 41.84 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 0.0 110.065 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 45.0 mt -125.65 156.44 39.25 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 126.99 2.116 . . . . 0.0 105.393 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.8 tt -134.52 167.46 25.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.958 1.303 . . . . 0.0 107.761 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.9 mm -99.05 93.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.67 1.188 . . . . 0.0 111.708 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -87.31 -21.77 25.54 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.267 -0.896 . . . . 0.0 113.323 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.9 tmm? -137.72 144.63 41.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 109.632 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -143.31 149.89 38.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.245 0.93 . . . . 0.0 109.624 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.547 ' H ' HD23 ' A' ' 247' ' ' LEU . 73.4 mtt180 -148.33 159.67 43.77 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 125.917 1.687 . . . . 0.0 109.226 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -138.7 116.0 11.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.424 ' HE3' ' OE2' ' A' ' 230' ' ' GLU . 85.2 mttt -73.77 149.79 41.51 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 22.0 p -145.37 165.39 28.62 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.255 0.48 . . . . 0.0 110.493 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -99.99 133.78 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.32 2.248 . . . . 0.0 105.362 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.6 tptp 58.2 -19.0 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.946 2.098 . . . . 0.0 115.498 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.98 171.61 9.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.4 2.28 . . . . 0.0 108.797 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.3 p -141.52 99.88 3.66 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.0 p -82.92 172.46 12.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.031 1.332 . . . . 0.0 111.197 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -120.62 157.82 53.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.015 1.326 . . . . 0.0 111.067 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.214 2.61 . . . . 0.0 107.521 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -81.35 92.21 6.37 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.1 174.19 17.5 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.572 1.558 . . . . 0.0 111.224 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 92.2 mt -95.95 146.57 24.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.522 1.129 . . . . 0.0 109.087 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -71.72 146.72 47.99 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 0.0 110.586 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.9 -179.99 7.17 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.134 1.374 . . . . 0.0 109.986 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 37.73 -96.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.968 2.223 . . . . 0.0 116.082 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 96.2 m -146.29 129.1 16.28 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.873 0.869 . . . . 0.0 110.407 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.34 147.98 35.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -142.01 161.19 38.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.88 154.74 38.84 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.982 -1.074 . . . . 0.0 109.86 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.99 151.97 47.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -158.91 173.96 15.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.991 2.516 . . . . 0.0 107.064 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -144.93 164.09 32.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 107.146 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.34 -18.16 57.67 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 175.84 63.97 0.06 OUTLIER Glycine 0 C--N 1.336 0.54 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -152.24 175.49 12.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.218 1.807 . . . . 0.0 106.753 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -115.46 152.24 33.29 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 125.396 1.478 . . . . 0.0 107.29 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.2 mt -86.61 119.87 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.4 m -147.22 69.39 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.467 0.707 . . . . 0.0 110.569 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.73 -178.79 18.4 Favored Glycine 0 N--CA 1.467 0.722 0 O-C-N 120.198 -1.564 . . . . 0.0 114.316 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.89 160.97 40.44 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.69 1.196 . . . . 0.0 110.758 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -157.69 132.61 8.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -175.43 -152.74 9.62 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.506 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 16.1 ptmt -143.8 147.46 34.17 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.2 156.18 21.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.128 1.371 . . . . 0.0 108.195 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 20.3 t -127.35 -90.66 0.52 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -79.2 -58.17 3.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 20.2 mt -110.75 165.89 11.46 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.999 1.719 . . . . 0.0 111.832 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 49.5 tp -73.01 106.39 4.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 109.545 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -96.12 -45.94 6.67 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.2 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.4 ' HB3' ' H ' ' A' ' 282' ' ' LYS . 11.4 tt0 -122.05 137.68 54.72 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.068 0.849 . . . . 0.0 112.151 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -138.1 149.8 46.27 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.511 1.124 . . . . 0.0 109.945 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -169.16 154.98 24.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 106.855 -2.498 . . . . 0.0 106.855 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.32 151.47 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 118.343 1.072 . . . . 0.0 112.504 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.85 154.02 20.87 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.36 141.24 47.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 123.516 0.726 . . . . 0.0 111.371 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 83.2 mmm -144.73 144.45 24.58 Favored Pre-proline 0 N--CA 1.465 0.278 0 C-N-CA 126.924 2.09 . . . . 0.0 107.399 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.96 159.39 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.627 1.26 . . . . 0.0 110.357 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.42 172.19 6.37 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.088 0.955 . . . . 0.0 110.362 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 14.5 t -119.35 -17.23 8.86 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.682 0.793 . . . . 0.0 111.07 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 . . . . . 0 C--O 1.247 0.933 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 178.622 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.005 0.431 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -130.96 154.04 48.56 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.393 2.277 . . . . 0.0 110.3 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt -129.95 139.12 51.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.904 1.682 . . . . 0.0 107.602 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.4 t -124.83 110.07 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 103.981 -2.599 . . . . 0.0 103.981 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.92 165.63 17.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.983 0.897 . . . . 0.0 110.843 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.84 163.41 12.75 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.307 1.443 . . . . 0.0 107.542 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.07 154.46 25.33 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.99 -153.04 24.75 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.83 -2.508 . . . . 0.0 106.83 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.11 121.71 14.84 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 122.477 1.043 . . . . 0.0 115.087 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.85 -8.36 57.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.812 0.845 . . . . 0.0 111.859 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.96 -19.12 60.83 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.906 -0.941 . . . . 0.0 114.636 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.11 159.95 20.72 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.386 1.593 . . . . 0.0 113.345 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.68 157.37 27.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.205 1.402 . . . . 0.0 108.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -69.9 119.46 14.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.322 0.649 . . . . 0.0 109.458 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -86.48 -70.28 0.62 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 17.52 2.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.643 1.177 . . . . 0.0 113.709 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.45 134.91 55.45 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.04 -1.038 . . . . 0.0 109.686 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.62 79.38 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 106.534 -2.626 . . . . 0.0 106.534 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.72 8.03 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.755 1.222 . . . . 0.0 111.465 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -125.24 -18.15 5.47 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.887 -1.133 . . . . 0.0 113.545 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 47.31 36.57 4.88 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.748 2.019 . . . . 0.0 111.435 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.3 4.26 29.84 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 118.011 1.964 . . . . 0.0 118.011 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.0 124.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 120.839 2.319 . . . . 0.0 110.793 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -104.26 -71.18 0.74 Allowed 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.839 1.256 . . . . 0.0 110.569 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -111.13 151.63 27.92 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.485 1.114 . . . . 0.0 109.251 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.47 141.92 43.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -123.7 120.42 32.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.33 102.79 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.42 129.46 9.82 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -74.3 168.03 20.45 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.118 0.961 . . . . 0.0 109.139 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -155.37 163.92 31.77 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -57.42 -40.78 79.06 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.291 1.436 . . . . 0.0 111.034 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.3 3.22 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.074 2.949 . . . . 0.0 113.613 -177.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.35 -171.23 13.67 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 119.491 1.041 . . . . 0.0 112.208 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.73 106.13 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.27 -22.23 5.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.184 0.994 . . . . 0.0 113.501 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 42.4 p -117.96 131.33 56.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.201 1.0 . . . . 0.0 109.784 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.88 154.45 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 O-C-N 121.271 -0.893 . . . . 0.0 111.159 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -146.47 150.82 36.33 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.9 109.88 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.68 117.68 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.14 171.61 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.289 . . . . 0.0 108.498 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.12 109.3 5.28 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.753 -1.217 . . . . 0.0 109.03 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -116.3 165.51 13.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.306 1.442 . . . . 0.0 108.654 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 43.74 44.5 5.58 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 123.027 1.394 . . . . 0.0 110.79 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m 49.37 33.04 4.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.982 2.913 . . . . 0.0 114.448 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.79 165.26 27.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.425 1.89 . . . . 0.0 109.975 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.41 127.04 31.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.923 2.089 . . . . 0.0 109.48 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 t -135.44 116.75 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.359 1.064 . . . . 0.0 108.79 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.03 159.36 30.95 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.91 0.884 . . . . 0.0 112.205 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.23 -17.72 4.38 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-O 117.352 -1.804 . . . . 0.0 115.805 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.59 154.19 2.96 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-N 120.428 2.114 . . . . 0.0 114.033 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -74.66 105.5 5.78 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.392 -1.064 . . . . 0.0 113.485 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -93.1 176.48 6.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.784 2.834 . . . . 0.0 109.613 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.67 -163.14 54.69 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.49 100.36 11.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 37' ' ' SER 0.297 0.0 OUTLIER -61.75 150.03 38.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.435 -178.541 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.9 p -123.53 157.76 32.89 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.324 1.049 . . . . 0.0 108.837 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 tp -90.74 -38.83 12.78 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.778 0.831 . . . . 0.0 112.009 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 mp -101.46 32.73 3.2 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.978 1.311 . . . . 0.0 112.687 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -154.6 108.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -162.82 146.06 10.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.828 1.651 . . . . 0.0 107.294 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.1 162.04 41.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.322 2.649 . . . . 0.0 108.249 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.0 m -144.7 96.04 2.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -86.39 116.23 24.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.32 133.64 34.53 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.469 1.107 . . . . 0.0 108.814 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.62 107.25 22.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . 8.8 t70 -58.81 160.58 5.63 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.898 1.279 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.66 -40.38 76.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.764 -0.585 . . . . 0.0 111.84 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -94.38 -19.32 20.73 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.469 0.577 . . . . 0.0 112.32 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.454 ' CB ' ' HB3' ' A' ' 68' ' ' ASP . 37.5 t0 -81.03 140.22 35.28 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -135.58 154.55 51.31 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.479 0.712 . . . . 0.0 110.803 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.69 133.64 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.52 -24.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 123.791 0.836 . . . . 0.0 111.1 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.19 156.72 42.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -139.87 146.26 25.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -131.95 115.26 15.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.33 123.95 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.447 HG21 ' H ' ' A' ' 111' ' ' THR . 29.3 m -99.42 138.04 37.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.182 1.793 . . . . 0.0 107.22 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -152.79 155.69 37.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -160.44 169.32 23.29 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -128.21 160.09 33.16 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.396 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -123.85 152.1 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.814 0.846 . . . . 0.0 108.753 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -58.33 113.34 1.91 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.997 0.919 . . . . 0.0 108.615 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.85 3.9 42.44 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.468 -1.184 . . . . 0.0 113.113 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -134.17 84.58 2.13 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.41 24.66 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 130.548 3.539 . . . . 0.0 113.19 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.3 t -149.8 108.47 3.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.181 -1.575 . . . . 0.0 108.533 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -57.56 157.27 7.14 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.023 1.729 . . . . 0.0 109.482 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -139.39 147.11 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.702 1.601 . . . . 0.0 108.524 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.8 mm -70.37 113.19 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.2 p -80.47 -34.19 36.05 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.736 -0.602 . . . . 0.0 109.745 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 p -165.45 164.32 19.55 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.881 1.672 . . . . 0.0 109.712 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.8 tt -141.45 154.41 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.87 142.9 29.24 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -115.3 156.7 24.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.85 -1.166 . . . . 0.0 107.85 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.461 HD22 HG22 ' A' ' 103' ' ' THR . 7.7 m120 -137.25 114.06 10.47 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -104.42 164.99 11.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.311 0.577 . . . . 0.0 110.632 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -59.44 -36.26 75.59 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -28.85 66.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 118.983 0.81 . . . . 0.0 111.816 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.69 5.67 47.76 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -72.85 88.49 1.34 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.461 HG22 HD22 ' A' ' 97' ' ' ASN . 1.1 p -84.76 109.22 17.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 p -71.26 161.76 76.52 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 125.174 1.389 . . . . 0.0 110.18 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.84 165.34 19.92 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 123.034 2.49 . . . . 0.0 110.285 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.44 119.27 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.087 2.525 . . . . 0.0 108.486 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -81.75 77.55 8.58 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.72 -155.8 25.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.563 1.078 . . . . 0.0 111.188 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.0 tp -88.15 119.17 28.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.372 1.469 . . . . 0.0 109.636 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.35 152.14 45.33 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.447 ' H ' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -153.59 168.98 24.37 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.966 -1.084 . . . . 0.0 109.928 -179.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -73.22 -47.48 43.05 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 120.96 -1.087 . . . . 0.0 109.496 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.97 109.15 1.69 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.355 1.074 . . . . 0.0 109.249 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.09 166.49 21.29 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.182 1.393 . . . . 0.0 108.685 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -144.78 164.97 29.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.34 149.14 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.5 141.13 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.947 1.299 . . . . 0.0 108.807 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -157.56 164.47 37.28 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.047 1.339 . . . . 0.0 110.978 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.91 170.87 15.72 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 108.168 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.19 -56.24 12.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.048 -1.032 . . . . 0.0 109.893 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -117.95 -14.08 10.03 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.26 -63.96 0.29 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.47 -143.01 18.0 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -163.38 137.2 5.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.4 tt -69.42 137.51 52.77 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.35 -34.02 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.269 0.941 . . . . 0.0 111.976 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.71 172.95 42.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -125.39 153.46 43.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.582 1.153 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 159.82 42.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 124.469 1.108 . . . . 0.0 108.055 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.08 137.96 2.89 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -61.46 135.73 57.78 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.625 1.97 . . . . 0.0 110.145 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -153.23 164.93 37.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.191 1.396 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -166.72 -107.42 0.2 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 107.236 -2.346 . . . . 0.0 107.236 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.95 -26.59 66.03 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.026 0.913 . . . . 0.0 111.328 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.62 172.03 13.25 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.3 1.84 . . . . 0.0 107.615 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 38.7 tp -84.89 100.15 11.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -81.61 -39.89 23.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.87 146.25 31.04 Favored 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 124.478 1.111 . . . . 0.0 108.81 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.7 tp -155.76 100.11 2.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.335 0.516 . . . . 0.0 112.317 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.99 178.55 16.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.801 2.143 . . . . 0.0 109.293 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.4 163.55 39.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.565 1.682 . . . . 0.0 110.201 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -127.82 143.27 51.13 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.686 1.232 . . . . 0.0 109.534 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -110.42 105.09 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.702 2.001 . . . . 0.0 106.202 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.62 101.02 3.61 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.301 0.955 . . . . 0.0 110.848 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.1 t -121.46 105.87 10.89 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.32 87.9 1.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 107.436 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.7 m -150.74 114.19 4.9 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.192 0.997 . . . . 0.0 108.908 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.82 148.16 35.13 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 119.414 1.006 . . . . 0.0 111.743 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.77 -177.59 3.2 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.3 3.333 . . . . 0.0 109.163 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.55 149.75 17.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.188 0.995 . . . . 0.0 109.685 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -137.75 160.64 64.07 Favored Pre-proline 0 C--O 1.239 0.534 0 C-N-CA 125.734 1.614 . . . . 0.0 109.225 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -76.65 -179.06 4.98 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.034 2.49 . . . . 0.0 107.75 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.01 152.89 44.69 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 121.319 -0.863 . . . . 0.0 110.11 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 133.59 52.48 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -114.31 121.53 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.391 0.677 . . . . 0.0 111.575 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.49 -169.65 1.52 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.7 t -136.33 115.05 12.03 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 120.463 -1.398 . . . . 0.0 108.19 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.41 -171.18 2.33 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.968 0.907 . . . . 0.0 109.861 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.19 152.46 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.82 -72.78 0.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 123.963 0.792 . . . . 0.0 111.295 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.46 143.07 6.0 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 282' ' ' LYS . 10.0 p-10 -90.19 48.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.811 1.644 . . . . 0.0 111.739 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.64 152.12 26.76 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.45 1.5 . . . . 0.0 107.819 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.04 166.88 12.61 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.52 1.534 . . . . 0.0 114.264 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.2 m -65.56 129.32 39.33 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.355 1.062 . . . . 0.0 109.225 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.6 109.46 11.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -95.05 7.15 47.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.474 1.11 . . . . 0.0 112.443 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.99 132.34 51.68 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.816 -0.552 . . . . 0.0 112.331 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.82 -9.59 17.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.863 1.665 . . . . 0.0 111.601 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.45 -156.44 51.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.905 -1.122 . . . . 0.0 111.457 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -109.48 164.41 12.53 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.588 1.555 . . . . 0.0 110.606 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -147.79 -170.29 3.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.822 2.049 . . . . 0.0 110.45 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.04 -45.92 89.52 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.644 -0.66 . . . . 0.0 110.8 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.05 40.63 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.46 HG22 ' CZ ' ' A' ' 194' ' ' TYR . 9.3 t -123.6 156.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.024 1.33 . . . . 0.0 108.964 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -116.49 -55.69 2.36 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -150.93 165.11 34.69 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.61 1.096 . . . . 0.0 111.301 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.6 t -125.65 149.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 127.095 2.158 . . . . 0.0 108.128 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -137.93 120.92 16.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.7 t -98.14 138.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -118.75 83.47 0.35 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 187' ' ' ILE . 6.3 pt20 -74.08 -171.44 1.13 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.311 1.053 . . . . 0.0 111.583 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.99 45.41 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -62.31 -37.31 85.06 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.81 0.844 . . . . 0.0 111.283 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 -15.58 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.544 3.137 . . . . 0.0 113.166 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 122.42 -175.66 16.43 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.483 1.992 . . . . 0.0 108.405 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 182' ' ' GLN . 19.5 mt -69.39 106.14 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 120.941 -1.329 . . . . 0.0 109.381 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 m -98.35 -24.66 15.11 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.636 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.39 47.78 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 122.395 1.093 . . . . 0.0 113.21 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 4.1 m -147.45 144.55 19.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.37 1.868 . . . . 0.0 106.605 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 56.0 pttt -161.61 170.01 20.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.713 1.205 . . . . 0.0 110.435 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -153.94 175.22 13.63 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.787 0.803 . . . . 0.0 113.087 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.8 114.28 17.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.319 -2.845 . . . . 0.0 103.319 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.46 ' CZ ' HG22 ' A' ' 175' ' ' VAL . 7.2 m-85 -129.98 148.37 51.83 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.765 1.626 . . . . 0.0 108.562 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -112.07 155.55 23.66 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.741 0.781 . . . . 0.0 110.244 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -137.21 86.25 2.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.01 1.324 . . . . 0.0 109.161 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.05 -79.39 0.88 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -123.49 -35.39 2.94 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.103 1.361 . . . . 0.0 110.246 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.95 148.61 48.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 122.195 0.997 . . . . 0.0 109.439 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.22 135.64 54.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.8 mm -120.07 116.27 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.03 109.9 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 127.847 2.459 . . . . 0.0 104.827 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.22 1.29 2.28 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-O 117.644 -1.642 . . . . 0.0 116.01 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -73.83 82.75 0.72 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-N 119.687 1.744 . . . . 0.0 108.942 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -112.66 135.02 53.88 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 128.586 2.755 . . . . 0.0 106.778 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -128.97 -43.55 1.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.76 153.1 39.87 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.98 112.51 8.3 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 126.29 1.836 . . . . 0.0 112.222 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.6 171.2 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.919 1.746 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.0 p -129.66 177.26 7.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.348 1.059 . . . . 0.0 108.413 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 69.1 mt -66.52 -10.43 44.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.308 -0.87 . . . . 0.0 111.321 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.79 -22.31 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.71 1.204 . . . . 0.0 109.988 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 86.32 -139.94 17.11 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.464 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 46.3 m-85 -143.58 158.79 43.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.667 1.187 . . . . 0.0 109.193 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -110.28 164.63 12.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.995 2.918 . . . . 0.0 106.422 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.61 139.89 44.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.961 0.8 . . . . 0.0 110.906 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -142.55 123.89 14.73 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.65 0.38 . . . . 0.0 111.035 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.07 130.78 34.55 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.442 1.097 . . . . 0.0 109.392 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.6 mt -127.69 124.58 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -80.23 88.57 5.48 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -52.97 -53.51 54.32 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.631 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.3 -0.71 10.0 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.2 1.933 . . . . 0.0 115.074 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.7 m -125.68 -29.45 3.15 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.504 1.956 . . . . 0.0 116.22 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.74 159.91 24.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.568 1.076 . . . . 0.0 109.504 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.55 124.76 36.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.85 101.31 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -69.09 -36.73 77.89 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.471 ' HB3' ' HD3' ' A' ' 250' ' ' LYS . . . -157.13 170.45 22.48 Favored 'General case' 0 C--N 1.343 0.294 0 O-C-N 120.703 -1.248 . . . . 0.0 112.132 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.53 151.06 10.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -132.44 171.59 13.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.402 1.881 . . . . 0.0 106.119 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 143.4 -175.79 23.22 Favored Glycine 0 N--CA 1.465 0.628 0 O-C-N 119.906 -1.746 . . . . 0.0 112.761 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -140.0 146.42 39.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.155 0.982 . . . . 0.0 110.598 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -128.2 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -156.08 170.82 21.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.793 0.837 . . . . 0.0 110.165 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -75.8 148.18 38.63 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 127.073 2.149 . . . . 0.0 110.886 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.0 pt -102.48 157.61 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 109.325 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -79.01 169.78 17.68 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.27 -41.41 1.57 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 120.863 -1.148 . . . . 0.0 114.873 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.3 m -141.28 160.37 40.26 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.597 1.698 . . . . 0.0 108.198 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -78.79 18.44 0.6 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.91 41.4 Favored Glycine 0 C--N 1.338 0.674 0 O-C-N 120.758 -1.213 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.92 157.08 30.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.371 1.469 . . . . 0.0 108.238 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.3 tt -150.54 168.52 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 40.4 mm -105.74 103.41 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 101.219 -3.622 . . . . 0.0 101.219 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -82.16 -17.43 46.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.595 1.089 . . . . 0.0 112.048 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -150.74 136.02 17.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.19 141.34 45.85 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.8 mtt85 -135.99 158.4 44.51 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.169 0.987 . . . . 0.0 108.576 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -133.92 119.1 18.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 228' ' ' ALA . 36.8 mtpt -68.13 135.55 52.31 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.5 p -128.11 165.4 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.602 1.161 . . . . 0.0 109.941 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -129.87 145.38 51.6 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.6 tptp 72.95 -26.42 0.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.301 1.44 . . . . 0.0 111.589 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -124.06 173.48 8.25 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 120.014 1.279 . . . . 0.0 109.729 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.3 m -117.64 144.17 45.45 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.317 1.447 . . . . 0.0 107.419 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.5 p -121.67 153.87 37.59 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.418 1.087 . . . . 0.0 109.639 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -97.84 159.07 31.79 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.529 1.131 . . . . 0.0 111.418 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.67 115.44 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.366 2.71 . . . . 0.0 107.9 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.78 93.07 7.88 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.35 -179.13 16.98 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.252 0.929 . . . . 0.0 112.582 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.93 111.18 22.71 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.206 1.002 . . . . 0.0 108.369 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.79 107.93 0.92 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.809 0.844 . . . . 0.0 108.853 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.62 156.72 18.57 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.708 2.003 . . . . 0.0 107.345 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.06 -177.54 50.81 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.954 -0.459 . . . . 0.0 111.954 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.87 111.04 1.15 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.651 1.18 . . . . 0.0 111.773 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.4 146.03 28.68 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.802 0.441 . . . . 0.0 110.49 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.32 160.01 41.3 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.284 1.434 . . . . 0.0 110.872 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -146.88 127.53 14.23 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.94 101.32 11.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.69 1.132 . . . . 0.0 110.825 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -123.07 153.39 39.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.452 1.101 . . . . 0.0 110.648 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.73 150.26 36.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.54 1.536 . . . . 0.0 108.143 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -99.02 142.39 30.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.816 1.246 . . . . 0.0 109.894 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 68.25 8.73 55.8 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 123.847 0.736 . . . . 0.0 114.792 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -134.22 175.38 9.55 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.19 1.396 . . . . 0.0 110.467 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 162.21 33.41 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.757 1.623 . . . . 0.0 108.417 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 52.6 mt -95.12 140.91 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.63 -0.35 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 178.43 -167.68 38.35 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.75 166.84 19.05 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.461 1.105 . . . . 0.0 110.983 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -159.08 163.69 36.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.195 1.398 . . . . 0.0 107.964 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.06 -161.99 29.06 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 162' ' ' ASP . 30.4 mtmm -126.97 136.82 52.78 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -158.13 96.84 1.48 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.424 1.489 . . . . 0.0 107.474 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.9 m -69.04 -23.85 64.11 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -165.46 -60.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.8 mt -84.24 147.91 27.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.18 2.592 . . . . 0.0 106.066 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.44 80.22 1.42 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.032 . . . . 0.0 112.089 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -64.53 -40.47 95.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -141.55 129.92 22.43 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.67 1.123 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -119.6 106.95 12.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.252 1.421 . . . . 0.0 107.772 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -132.2 -179.73 16.48 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.2 170.27 10.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 121.582 -0.952 . . . . 0.0 111.158 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.11 156.3 25.48 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.37 160.74 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.524 0.73 . . . . 0.0 109.048 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmt -138.46 144.49 42.79 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.64 149.27 79.17 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.867 1.711 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 2.7 pp -106.09 173.34 6.35 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.939 0.896 . . . . 0.0 112.083 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 18.6 m -143.41 52.85 1.34 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.335 1.854 . . . . 0.0 108.286 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 C--O 1.248 0.982 0 C-N-CA 125.374 1.47 . . . . 0.0 109.289 -179.641 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -69.98 110.93 5.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.192 1.397 . . . . 0.0 112.071 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -147.26 139.71 24.7 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.427 1.891 . . . . 0.0 107.057 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 t -132.28 118.43 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -64.48 137.91 58.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.365 0.666 . . . . 0.0 109.893 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.56 -58.46 8.38 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.708 1.603 . . . . 0.0 109.649 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.93 -23.22 24.1 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.302 1.43 . . . . 0.0 113.12 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.38 173.84 24.0 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.126 0.963 . . . . 0.0 111.581 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.68 174.27 54.81 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 122.56 1.089 . . . . 0.0 113.837 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.74 9.03 15.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.58 1.552 . . . . 0.0 113.126 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.41 174.73 44.35 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.32 -124.36 31.63 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.76 158.91 43.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.728 1.611 . . . . 0.0 109.489 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.9 p -101.69 102.86 13.59 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 116.58 22.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 103.968 -2.605 . . . . 0.0 103.968 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.08 118.61 12.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -133.87 -64.55 0.7 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.703 0.801 . . . . 0.0 110.85 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.82 -76.6 0.4 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-O 118.611 -1.105 . . . . 0.0 113.015 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.87 -16.9 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -71.98 -176.49 1.74 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 120.417 1.462 . . . . 0.0 110.382 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 60.27 56.2 3.33 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.287 1.435 . . . . 0.0 110.792 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.46 102.91 0.73 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 107.376 -2.289 . . . . 0.0 107.376 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.2 157.63 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.476 1.91 . . . . 0.0 112.442 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -131.59 -23.33 2.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.335 1.454 . . . . 0.0 112.908 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -153.19 155.56 36.9 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.99 148.48 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -132.96 144.82 50.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.98 148.81 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.847 2.059 . . . . 0.0 106.431 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 62' ' ' PHE . . . -137.39 -112.16 1.1 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.19 148.28 32.24 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.372 1.086 . . . . 0.0 108.688 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.64 -20.79 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 127.189 2.328 . . . . 0.0 112.912 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -56.13 -40.28 73.54 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.348 2.259 . . . . 0.0 110.237 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.47 7.63 31.07 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.128 3.371 . . . . 0.0 109.514 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.71 159.77 23.79 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 126.371 1.939 . . . . 0.0 109.655 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.58 96.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.3 m -89.78 -21.7 22.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.1 p -127.37 127.19 43.79 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 120.489 1.495 . . . . 0.0 110.83 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 136' ' ' LEU . 4.3 mp -135.76 137.24 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 122.891 1.329 . . . . 0.0 109.561 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -148.38 138.72 22.65 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 123.652 0.781 . . . . 0.0 109.368 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 t -95.51 123.42 47.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -115.99 165.72 12.8 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.83 0.852 . . . . 0.0 108.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.24 108.69 3.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.263 54.9 pttt -117.15 116.18 26.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.457 1.503 . . . . 0.0 110.129 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 47.5 27.28 0.94 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.594 1.958 . . . . 0.0 113.548 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -162.76 -159.34 0.55 Allowed 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.309 -1.494 . . . . 0.0 108.829 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -83.46 165.24 19.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.31 116.48 17.96 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -134.19 109.03 12.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -70.38 162.16 29.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.971 0.908 . . . . 0.0 109.699 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 2.36 9.35 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.611 1.577 . . . . 0.0 112.21 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.37 163.95 27.41 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 119.237 1.518 . . . . 0.0 112.199 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -70.94 147.64 48.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.906 2.082 . . . . 0.0 110.805 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -130.4 104.35 7.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.956 2.103 . . . . 0.0 106.011 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.18 -156.26 26.72 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.18 102.76 7.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.866 1.266 . . . . 0.0 108.457 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -103.29 162.7 12.78 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.9 m -155.6 150.59 26.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.8 tp -72.12 -8.42 54.58 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.69 -4.94 7.17 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.25 15.12 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 CA-C-N 119.625 1.102 . . . . 0.0 114.049 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 4.1 t80 -75.37 128.58 35.71 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.931 1.366 . . . . 0.0 110.145 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -132.49 164.12 27.29 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.226 2.61 . . . . 0.0 111.072 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 m -132.97 138.79 46.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.696 1.599 . . . . 0.0 108.046 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -121.2 109.6 15.16 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.159 1.783 . . . . 0.0 106.364 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -89.75 165.1 14.38 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.699 1.2 . . . . 0.0 109.042 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 p -111.04 152.86 12.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.202 0.525 . . . . 0.0 110.366 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.18 164.9 12.13 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.822 1.249 . . . . 0.0 110.512 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.78 22.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.579 0.752 . . . . 0.0 110.986 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -105.59 0.71 26.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.16 140.1 52.45 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -134.2 151.9 51.55 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.94 1.296 . . . . 0.0 108.95 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.0 mm -82.67 142.82 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.906 1.282 . . . . 0.0 108.075 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.0 m -136.81 -19.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.18 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.12 146.46 28.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -145.59 96.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -65.26 138.3 58.13 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.19 150.13 26.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.599 HG21 ' H ' ' A' ' 111' ' ' THR . 18.4 m -126.06 140.27 52.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.593 1.957 . . . . 0.0 106.754 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -151.8 149.62 29.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -158.82 168.55 26.53 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.829 1.195 . . . . 0.0 111.362 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -103.14 154.9 18.82 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.551 1.54 . . . . 0.0 110.581 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.93 146.46 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -75.68 76.4 2.66 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.06 14.89 0.1 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 127.583 2.516 . . . . 0.0 111.919 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -123.98 111.42 15.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.143 1.377 . . . . 0.0 109.078 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.54 -3.28 8.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.473 1.509 . . . . 0.0 111.42 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -153.37 137.39 16.35 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.716 1.606 . . . . 0.0 109.353 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.71 152.35 45.63 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 102.357 -3.201 . . . . 0.0 102.357 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 pt -131.06 154.72 41.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.19 0.996 . . . . 0.0 109.209 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.16 119.99 22.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.8 p -95.63 -31.1 13.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 118.062 -0.97 . . . . 0.0 112.159 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.5 p -157.43 164.05 37.89 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.823 1.647 . . . . 0.0 110.613 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.91 147.57 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.778 1.631 . . . . 0.0 107.525 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 105.82 4.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.994 0.918 . . . . 0.0 109.387 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.42 148.61 48.15 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.588 -0.695 . . . . 0.0 109.885 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -136.48 114.32 11.25 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.0 p -84.97 158.75 20.42 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.59 -30.41 70.69 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -57.53 -46.84 83.37 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.409 1.083 . . . . 0.0 109.087 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.01 -14.62 3.79 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.847 1.213 . . . . 0.0 112.06 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -68.24 145.07 54.62 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 107.97 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.1 p -133.77 148.05 51.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.251 1.42 . . . . 0.0 108.979 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.2 p -85.43 162.46 48.25 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.34 165.3 32.9 Favored 'Trans proline' 0 CA--C 1.551 1.37 0 N-CA-C 107.285 -1.852 . . . . 0.0 107.285 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.98 105.49 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 N-CA-C 105.738 -2.447 . . . . 0.0 105.738 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.04 81.2 5.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.18 -177.51 18.89 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.301 1.429 . . . . 0.0 111.716 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -84.0 111.5 19.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.697 1.199 . . . . 0.0 112.75 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.436 ' OE2' ' HE3' ' A' ' 114' ' ' LYS . 14.6 mt-10 -65.84 140.54 58.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.599 ' H ' HG21 ' A' ' 79' ' ' THR . 0.6 OUTLIER -128.39 177.14 7.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.775 1.63 . . . . 0.0 109.543 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.91 -48.86 77.15 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -72.91 122.62 21.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.436 ' HE3' ' OE2' ' A' ' 110' ' ' GLU . 12.9 ptmm? 176.34 163.64 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.454 1.902 . . . . 0.0 108.586 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CE2' HD22 ' A' ' 117' ' ' LEU . 5.4 p90 -157.99 167.9 28.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.484 0.713 . . . . 0.0 110.56 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 p -115.59 149.54 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.856 1.662 . . . . 0.0 107.044 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -150.82 136.09 17.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.577 1.951 . . . . 0.0 107.116 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 162.93 34.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.098 0.559 . . . . 0.0 110.064 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -76.69 74.03 3.36 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.693 1.997 . . . . 0.0 109.055 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -54.72 -24.3 21.58 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.452 -2.03 . . . . 0.0 115.147 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -93.66 -7.44 43.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.506 1.122 . . . . 0.0 113.103 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.92 -5.0 75.85 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.501 1.524 . . . . 0.0 115.982 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.14 124.12 9.92 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.029 1.914 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.56 161.83 7.16 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.15 0.58 . . . . 0.0 110.398 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 148.06 43.66 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.343 0.657 . . . . 0.0 109.646 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.82 -35.46 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.054 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.39 -147.46 7.94 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.61 161.04 43.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.148 1.379 . . . . 0.0 108.722 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -122.07 149.55 43.38 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.487 1.115 . . . . 0.0 108.555 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.51 129.74 5.04 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.28 1.895 . . . . 0.0 109.047 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -93.73 -178.17 4.6 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 122.905 1.336 . . . . 0.0 107.916 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.26 164.4 27.81 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.469 1.907 . . . . 0.0 107.026 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.64 -103.16 0.3 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 104.313 -3.515 . . . . 0.0 104.313 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -72.83 -25.75 61.24 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.524 0.662 . . . . 0.0 110.426 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.36 -175.14 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.997 3.319 . . . . 0.0 107.684 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 38' ' ' ILE . 46.9 tp -95.51 129.51 42.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 126.54 1.936 . . . . 0.0 108.47 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.24 -46.37 4.84 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.947 0.499 . . . . 0.0 111.68 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -137.76 153.09 49.75 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.359 1.063 . . . . 0.0 109.028 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.4 tp -161.83 91.51 0.82 Allowed 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -113.86 172.76 14.54 Favored Glycine 0 C--O 1.229 -0.214 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.33 156.59 48.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -124.48 160.38 28.4 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -141.98 131.58 23.97 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 103.541 -2.762 . . . . 0.0 103.541 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.76 165.67 28.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.636 1.107 . . . . 0.0 112.993 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -134.26 167.75 20.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.875 2.07 . . . . 0.0 106.772 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.08 177.87 0.55 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.97 1.308 . . . . 0.0 110.656 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 t -135.92 171.94 13.74 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.166 0.986 . . . . 0.0 108.616 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.6 p -72.34 155.34 91.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 121.931 -0.481 . . . . 0.0 112.208 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.89 174.3 12.13 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.368 3.379 . . . . 0.0 112.116 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.09 144.56 11.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -73.63 152.22 89.41 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.94 -174.21 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.34 2.693 . . . . 0.0 111.755 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.05 168.91 12.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.845 0.858 . . . . 0.0 110.001 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.08 131.06 39.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -93.59 114.4 26.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.62 -172.33 3.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.216 1.008 . . . . 0.0 109.751 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.6 m -77.59 155.44 31.5 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.825 -1.172 . . . . 0.0 109.544 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.54 157.3 36.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.708 1.603 . . . . 0.0 109.941 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -127.66 167.3 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 126.251 1.82 . . . . 0.0 107.472 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.8 -113.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -126.67 164.46 20.23 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.662 ' C ' ' HE3' ' A' ' 282' ' ' LYS . 9.1 p30 -105.92 6.65 31.61 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.641 1.577 . . . . 0.0 111.031 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.48 122.92 43.99 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 135.23 177.04 14.67 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.729 2.585 . . . . 0.0 111.894 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.0 m -102.82 153.58 20.04 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.028 1.414 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -72.49 154.67 40.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.643 1.177 . . . . 0.0 112.422 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -142.55 38.63 1.52 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.248 1.419 . . . . 0.0 109.089 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.3 104.63 0.08 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.082 2.553 . . . . 0.0 112.945 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.43 -40.82 16.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 128.863 2.865 . . . . 0.0 114.11 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.63 -95.83 1.37 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.28 169.69 10.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.37 1.468 . . . . 0.0 109.334 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -135.25 -169.19 2.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.422 2.289 . . . . 0.0 106.271 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.01 -33.14 71.59 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.584 0.707 . . . . 0.0 111.067 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 221' ' ' TYR . . . -179.59 -151.07 9.51 Favored Glycine 0 CA--C 1.534 1.266 1 C-N-CA 131.501 4.381 . . . . 0.0 107.935 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.8 m -135.07 155.54 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.516 1.926 . . . . 0.0 106.146 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -124.55 -53.78 1.68 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.259 0.936 . . . . 0.0 113.229 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.467 ' HE3' ' CZ ' ' A' ' 179' ' ' TYR . 29.5 ttpt -146.35 136.38 23.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.132 -1.605 . . . . 0.0 109.342 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 51.9 t -90.28 146.57 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.467 ' CZ ' ' HE3' ' A' ' 177' ' ' LYS . 45.2 m-85 -141.09 109.81 6.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.134 1.374 . . . . 0.0 108.333 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 t -95.76 138.58 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.86 92.29 0.56 Allowed Glycine 0 C--N 1.339 0.696 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.76 160.88 29.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.251 1.024 . . . . 0.0 109.251 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.4 -170.41 12.04 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 125.414 1.483 . . . . 0.0 109.664 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -46.4 23.28 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.92 1.288 . . . . 0.0 112.182 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 -4.13 54.69 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.715 1.606 . . . . 0.0 114.236 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.12 -154.05 25.73 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 106.938 -2.465 . . . . 0.0 106.938 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 39.5 mm -75.08 133.78 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 119.171 1.485 . . . . 0.0 108.225 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 73.6 m -115.39 -22.41 9.36 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.461 1.104 . . . . 0.0 113.683 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.3 169.15 20.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 122.732 1.254 . . . . 0.0 110.31 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.53 149.48 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -160.16 175.72 12.59 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.824 1.649 . . . . 0.0 107.09 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -162.69 174.77 12.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -120.23 149.31 42.47 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -153.8 167.87 28.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.033 1.333 . . . . 0.0 108.293 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.87 164.89 13.74 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 119.962 -1.711 . . . . 0.0 108.622 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -140.24 93.33 2.62 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 64.03 -118.98 14.33 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 106.366 -2.694 . . . . 0.0 106.366 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -90.17 1.93 55.89 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.861 1.265 . . . . 0.0 113.5 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -102.59 157.33 17.01 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.906 1.23 . . . . 0.0 111.187 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -113.68 125.57 54.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 11.5 mm -120.64 143.82 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.187 1.395 . . . . 0.0 110.773 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.9 t -116.89 136.76 52.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.78 158.21 42.61 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -96.58 107.04 3.45 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -39.0 113.4 0.31 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.968 2.107 . . . . 0.0 112.252 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -93.39 29.42 1.96 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.693 0.797 . . . . 0.0 111.049 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.88 21.14 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 121.207 -0.933 . . . . 0.0 112.842 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -91.2 111.22 47.53 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.02 -0.99 . . . . 0.0 108.767 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.74 157.55 51.84 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.983 1.788 . . . . 0.0 109.462 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.6 p -133.95 166.36 22.88 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 25.6 tp -67.52 -12.83 61.26 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 112.169 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.7 tt -61.68 -32.5 72.7 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.157 0.983 . . . . 0.0 109.771 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.64 -154.2 16.79 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -139.93 142.53 36.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.701 1.601 . . . . 0.0 107.887 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -97.32 110.77 23.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -105.69 134.39 48.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.541 0.736 . . . . 0.0 109.531 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -141.37 111.85 6.97 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.177 0.591 . . . . 0.0 110.527 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.32 131.12 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 110.414 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 57.0 mt -128.21 126.37 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.8 130.65 43.43 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.862 -0.524 . . . . 0.0 109.81 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.461 ' CE1' ' HA3' ' A' ' 174' ' ' GLY . 15.2 t80 -65.06 -63.54 3.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.25 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 221' ' ' TYR . 21.3 Cg_endo -85.96 -29.76 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 CA-C-N 121.249 1.482 . . . . 0.0 114.277 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.6 t -77.32 -26.36 52.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.102 1.319 . . . . 0.0 112.829 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -126.09 172.98 9.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.304 1.041 . . . . 0.0 108.464 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -157.2 117.3 3.48 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.92 -1.113 . . . . 0.0 111.489 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.7 mt -68.22 113.44 4.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.74 -26.71 16.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.386 0.674 . . . . 0.0 111.933 -178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -162.34 169.61 20.27 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.756 1.222 . . . . 0.0 108.846 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.8 145.82 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -132.61 178.42 6.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.607 2.363 . . . . 0.0 109.141 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 166.72 -178.57 41.03 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.6 p -139.98 136.1 33.42 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 117.731 0.765 . . . . 0.0 109.241 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -131.12 156.24 45.6 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.8 0.84 . . . . 0.0 113.157 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.02 162.03 40.75 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.657 -0.652 . . . . 0.0 110.545 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.48 136.12 39.37 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.173 1.389 . . . . 0.0 110.486 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 73.4 mt -72.85 109.71 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -48.3 121.37 4.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.881 0.872 . . . . 0.0 110.647 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.05 -12.94 22.0 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.492 1.52 . . . . 0.0 110.484 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.2 p -141.38 165.27 27.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.696 1.598 . . . . 0.0 109.501 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -88.7 -14.32 37.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.404 0.681 . . . . 0.0 110.306 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -68.47 146.32 45.43 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.16 159.45 24.86 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.418 1.487 . . . . 0.0 113.21 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 16.9 tt -136.96 152.2 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 127.207 2.203 . . . . 0.0 107.972 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 2.8 mt -97.68 134.15 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.8 t -121.31 -8.25 9.21 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -146.6 141.16 26.65 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.347 0.659 . . . . 0.0 109.383 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.75 155.56 43.82 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.238 1.815 . . . . 0.0 108.697 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 34.3 mtt180 -144.89 154.62 42.82 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.877 1.671 . . . . 0.0 107.518 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.71 153.61 46.3 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -120.67 114.66 22.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 18.7 p -133.68 165.9 23.86 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.065 2.946 . . . . 0.0 107.209 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -112.79 160.26 18.15 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 66.15 -16.49 0.12 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.877 1.671 . . . . 0.0 112.996 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 174.2 11.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.772 2.429 . . . . 0.0 108.788 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.3 p -143.65 107.99 4.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.64 -10.72 3.85 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 70.12 165.88 0.13 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.29 1.836 . . . . 0.0 112.187 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 98.5 Cg_endo -78.14 137.9 15.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.932 2.422 . . . . 0.0 109.69 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -108.32 93.13 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.566 1.947 . . . . 0.0 105.763 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.58 177.7 16.85 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.057 0.837 . . . . 0.0 112.797 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.67 113.69 20.52 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.343 1.057 . . . . 0.0 110.243 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -63.21 108.49 1.29 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.354 1.061 . . . . 0.0 109.289 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.15 149.3 19.21 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.301 1.441 . . . . 0.0 109.056 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.56 -175.0 48.95 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 121.649 0.583 . . . . 0.0 112.905 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 25.0 m -66.7 127.53 32.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.508 1.523 . . . . 0.0 108.584 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -86.04 147.56 26.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.778 0.431 . . . . 0.0 110.0 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -136.55 163.7 29.92 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.499 1.12 . . . . 0.0 110.749 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -145.58 147.6 32.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.764 2.425 . . . . 0.0 107.281 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.3 mt -142.01 141.77 32.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.524 1.129 . . . . 0.0 108.528 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -164.65 179.32 6.69 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.303 1.841 . . . . 0.0 110.163 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -144.05 152.95 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.711 2.404 . . . . 0.0 104.892 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -86.52 71.45 10.42 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 120.398 -1.439 . . . . 0.0 112.636 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 134.56 -59.28 0.67 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 123.556 0.598 . . . . 0.0 113.65 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -55.49 155.68 5.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.81 0.844 . . . . 0.0 111.681 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 164.07 12.17 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 108.89 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.78 129.93 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.1 8.4 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.271 1.029 . . . . 0.0 111.617 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 175.11 -179.97 46.05 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -113.73 -179.07 3.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . 0.404 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 15.6 p80 -165.68 158.98 15.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.376 0.989 . . . . 0.0 111.745 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.49 -107.48 0.44 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.662 ' HE3' ' C ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -160.74 165.37 30.54 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.481 1.112 . . . . 0.0 110.23 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.23 147.05 37.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.686 1.594 . . . . 0.0 107.12 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 19.5 t -174.26 70.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 59.73 -7.67 0.06 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 129.481 3.112 . . . . 0.0 114.651 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 72.1 mt -136.43 167.73 20.79 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 127.603 2.361 . . . . 0.0 110.232 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.1 76.19 0.99 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.793 1.637 . . . . 0.0 109.479 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -76.54 -59.56 2.72 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.091 0.956 . . . . 0.0 110.584 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -110.15 152.81 25.58 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.616 1.167 . . . . 0.0 111.596 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -159.33 145.93 16.66 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 123.027 0.531 . . . . 0.0 110.057 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -162.8 -175.91 34.32 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.902 2.191 . . . . 0.0 108.33 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.17 130.44 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 118.633 1.216 . . . . 0.0 113.718 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -73.98 155.59 38.46 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.9 m -130.75 149.64 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 58.2 mmm -151.29 153.65 32.81 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 127.656 2.383 . . . . 0.0 106.354 178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.65 165.92 30.38 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.841 1.694 . . . . 0.0 111.556 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.6 173.26 11.85 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.251 2.22 . . . . 0.0 107.781 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 9.3 t -162.02 172.93 15.14 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 22.5 p30 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.741 1.216 . . . . 0.0 109.708 179.177 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -70.02 144.92 52.09 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 119.268 0.94 . . . . 0.0 111.441 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -149.56 132.48 16.13 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.012 1.325 . . . . 0.0 107.855 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.05 145.51 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.91 143.52 44.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.8 1.64 . . . . 0.0 108.977 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.38 174.89 4.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 109.331 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.6 44.78 0.54 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-O 119.173 -0.793 . . . . 0.0 112.376 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.72 -178.72 26.89 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.03 0.915 . . . . 0.0 111.222 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 161.69 2.19 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.779 1.657 . . . . 0.0 115.042 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.16 3.21 40.9 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.723 1.609 . . . . 0.0 113.549 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.26 -4.87 45.95 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.413 1.006 . . . . 0.0 115.109 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.14 158.19 18.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.46 157.52 28.92 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.235 0.517 . . . . 0.0 110.212 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -47.27 130.11 12.97 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.446 1.099 . . . . 0.0 110.67 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -130.59 121.5 25.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -161.38 141.83 10.91 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -130.32 -20.85 2.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.204 0.911 . . . . 0.0 113.406 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.51 37.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.361 1.457 . . . . 0.0 114.465 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.541 HG22 ' H ' ' A' ' 20' ' ' HIS . 9.4 p -137.36 -171.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 125.428 1.491 . . . . 0.0 108.065 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.541 ' H ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -149.34 162.29 40.36 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 178.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.73 -57.99 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 117.775 -1.107 . . . . 0.0 111.917 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.52 56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.126 1.33 . . . . 0.0 112.725 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.77 90.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.902 1.681 . . . . 0.0 109.428 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -62.8 -39.51 94.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.743 1.617 . . . . 0.0 112.127 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HE3' HG21 ' A' ' 41' ' ' VAL . 36.8 mtmt -145.18 162.23 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.63 1.172 . . . . 0.0 108.15 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.49 115.43 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -113.13 132.9 55.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.52 144.36 27.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 62' ' ' PHE . . . -152.45 140.09 7.46 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.73 143.62 26.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.322 1.849 . . . . 0.0 108.777 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.33 178.8 16.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 127.584 2.516 . . . . 0.0 108.58 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.81 -26.64 68.43 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -6.41 59.42 Favored 'General case' 0 CA--C 1.543 0.691 1 C-N-CA 131.8 4.04 . . . . 0.0 111.78 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.54 -160.35 15.02 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.04 110.45 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.6 m -140.0 0.37 1.75 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -123.45 118.41 27.38 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -144.72 155.3 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.891 0.877 . . . . 0.0 110.424 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.21 147.11 20.66 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.596 0.758 . . . . 0.0 109.567 177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.26 158.56 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 125.424 1.49 . . . . 0.0 108.968 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 25' ' ' LYS . 4.8 t -112.79 135.39 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.92 104.65 13.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -101.67 110.85 22.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm -78.06 166.0 23.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.0 -9.69 23.66 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.414 -1.429 . . . . 0.0 113.82 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -119.75 -17.85 8.46 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.92 149.66 26.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.709 1.595 . . . . 0.0 109.299 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -115.75 135.97 53.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.165 1.386 . . . . 0.0 110.705 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.9 t -142.64 123.07 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 0.0 110.014 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -81.85 124.28 29.55 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.79 -3.27 87.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.64 174.05 49.77 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 118.956 1.378 . . . . 0.0 110.296 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -82.09 152.73 26.43 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.006 -0.702 . . . . 0.0 110.488 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -134.24 154.15 51.44 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.361 1.064 . . . . 0.0 108.338 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.77 -160.48 31.32 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -96.95 105.52 17.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -53.9 121.5 8.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.438 0.695 . . . . 0.0 110.772 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -138.98 95.92 3.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 122.776 1.274 . . . . 0.0 108.326 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.26 3.12 13.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.593 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -16.85 7.09 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.489 2.316 . . . . 0.0 112.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.54 80.37 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.434 ' HA ' ' HA2' ' A' ' 29' ' ' GLY . 12.4 p90 -119.37 159.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.87 164.01 28.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.496 2.319 . . . . 0.0 112.763 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -132.96 95.46 3.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.54 124.87 41.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.45 135.48 44.01 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.434 0.694 . . . . 0.0 109.863 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.2 t -81.51 109.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.46 130.35 42.61 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 102.721 -3.066 . . . . 0.0 102.721 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.79 67.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 120.221 1.373 . . . . 0.0 111.427 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.3 -8.23 59.47 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.723 1.609 . . . . 0.0 111.265 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -107.34 151.85 24.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.322 -0.861 . . . . 0.0 110.135 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -134.79 139.96 45.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.636 0.774 . . . . 0.0 108.988 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mt -78.49 118.35 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.36 -26.57 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.362 0.665 . . . . 0.0 111.524 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.78 152.92 38.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.898 0.879 . . . . 0.0 110.288 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.11 152.89 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' HB2' ' HB ' ' A' ' 95' ' ' THR . 46.2 mt-30 -135.17 127.57 30.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 128.383 2.673 . . . . 0.0 106.691 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.61 116.33 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 119.368 0.985 . . . . 0.0 109.816 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.8 p -87.44 152.0 22.59 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.999 1.272 . . . . 0.0 107.612 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -150.34 142.64 24.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.53 160.27 28.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.42 131.8 35.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.9 m -102.55 175.11 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 122.062 0.934 . . . . 0.0 113.0 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -60.44 119.55 8.21 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.434 1.094 . . . . 0.0 109.082 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 3.44 65.12 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-O 118.239 -1.311 . . . . 0.0 113.794 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -122.31 158.49 29.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.722 1.261 . . . . 0.0 110.979 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -107.31 -48.96 3.35 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -78.94 145.17 34.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.59 0.709 . . . . 0.0 110.57 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.99 155.83 39.9 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.2 pt -139.72 159.86 27.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 mt -65.49 125.5 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.6 p -100.79 -28.27 12.89 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.402 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -157.83 165.53 35.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.302 1.41 . . . . 0.0 109.401 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.6 mt -143.69 145.96 21.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.607 1.963 . . . . 0.0 106.623 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 77' ' ' GLN . 57.8 m -150.61 118.5 6.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -98.36 157.0 16.47 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -133.17 129.95 38.51 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 72.2 p -101.17 154.75 18.48 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.323 0.249 . . . . 0.0 110.838 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -73.2 -28.98 62.49 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 9.2 mmpt? -49.26 -44.56 43.88 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 125.095 1.358 . . . . 0.0 109.354 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.5 -6.18 3.87 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.847 -0.974 . . . . 0.0 114.402 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.256 0.3 OUTLIER -103.2 157.07 17.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.911 1.355 . . . . 0.0 111.559 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.6 p -133.11 147.9 52.14 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.043 1.737 . . . . 0.0 107.916 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.74 158.73 56.27 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.31 167.7 26.2 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 121.652 1.568 . . . . 0.0 108.096 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.4 109.91 1.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.847 2.364 . . . . 0.0 110.247 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -79.09 62.03 3.39 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.51 1.524 . . . . 0.0 108.442 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.54 177.77 15.41 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.891 1.71 . . . . 0.0 110.561 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -72.9 110.03 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 113.631 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -61.28 126.56 27.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.6 m -122.79 171.6 9.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.539 0.735 . . . . 0.0 110.916 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -61.85 -58.72 6.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.66 1.184 . . . . 0.0 109.628 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -67.01 129.57 40.34 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -160.79 169.95 21.69 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 123.029 0.532 . . . . 0.0 111.097 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 117' ' ' LEU . 60.8 t80 -122.15 138.8 54.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.637 2.775 . . . . 0.0 106.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.65 132.59 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 115' ' ' PHE . 2.5 pt? -153.06 151.99 30.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.857 0.863 . . . . 0.0 108.906 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 156.33 20.17 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.195 0.998 . . . . 0.0 109.559 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.02 165.22 12.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.002 0.921 . . . . 0.0 108.57 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -138.22 -75.46 0.39 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -127.85 13.51 6.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.574 1.15 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.25 -17.13 38.04 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-O 117.331 -1.816 . . . . 0.0 116.569 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.19 -157.83 27.39 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.953 1.876 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -137.01 166.34 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.88 128.86 37.84 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.65 -59.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.304 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.7 176.57 17.61 Favored Glycine 0 N--CA 1.465 0.617 0 CA-C-N 119.429 1.013 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -125.3 163.58 22.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.955 1.702 . . . . 0.0 112.321 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -167.79 171.07 10.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.548 1.539 . . . . 0.0 109.466 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.64 -119.66 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -154.73 110.92 3.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 129.641 3.176 . . . . 0.0 103.821 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.02 164.84 18.55 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.558 1.143 . . . . 0.0 108.371 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 173.79 -131.13 1.97 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 105.895 -2.882 . . . . 0.0 105.895 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.96 -17.47 25.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.886 1.675 . . . . 0.0 114.484 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.87 19.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.324 1.05 . . . . 0.0 110.433 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 tp -86.83 87.01 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -86.57 -32.56 20.6 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.5 162.45 40.11 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.336 -0.852 . . . . 0.0 112.999 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.0 tp -161.93 106.08 1.22 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.317 -0.239 . . . . 0.0 110.987 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.01 166.22 13.55 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.316 2.389 . . . . 0.0 107.135 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -140.24 161.75 36.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.133 0.967 . . . . 0.0 109.165 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -101.04 146.13 27.83 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.82 99.82 4.28 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.27 160.4 40.19 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.033 0.933 . . . . 0.0 109.413 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -134.2 143.94 48.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.873 0.869 . . . . 0.0 109.534 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 p -123.9 0.59 8.6 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.988 1.715 . . . . 0.0 110.893 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.0 p -92.91 11.68 26.44 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.6 -1.312 . . . . 0.0 113.02 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.9 p -125.51 152.37 71.6 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 119.826 1.194 . . . . 0.0 113.284 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -81.46 -165.67 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.562 3.508 . . . . 0.0 110.119 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.1 p -75.12 166.2 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.828 0.851 . . . . 0.0 109.434 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.7 p -99.79 153.32 37.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.618 1.167 . . . . 0.0 109.041 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.65 -161.28 0.15 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 124.375 3.383 . . . . 0.0 109.579 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.01 172.36 6.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.554 1.141 . . . . 0.0 110.351 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -74.97 138.34 42.21 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -106.27 110.93 23.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.17 1.388 . . . . 0.0 111.848 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.7 mt -69.0 173.78 5.12 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.258 1.423 . . . . 0.0 108.535 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.6 t -98.23 103.9 15.89 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -82.77 170.88 14.56 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 tt -164.07 160.23 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.725 1.61 . . . . 0.0 106.82 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.68 -20.46 1.3 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.81 -23.6 0.41 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 118.56 1.18 . . . . 0.0 114.004 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.445 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 3.7 m-20 60.14 10.96 2.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.301 1.44 . . . . 0.0 114.027 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -96.2 150.64 20.31 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.821 -1.174 . . . . 0.0 109.075 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 -179.19 18.97 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.025 1.298 . . . . 0.0 110.699 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 65.7 m -75.26 124.22 26.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -86.09 131.53 34.24 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.777 0.831 . . . . 0.0 110.322 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.448 ' HE1' ' HB3' ' A' ' 283' ' ' ALA . 54.6 p-90 -158.89 130.35 6.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.925 0.89 . . . . 0.0 110.028 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.18 135.18 39.51 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -123.44 60.09 1.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.718 2.007 . . . . 0.0 107.269 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -24.68 -82.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.646 0 C-N-CA 129.666 3.507 . . . . 0.0 115.071 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -170.86 162.94 7.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.682 0.793 . . . . 0.0 112.915 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.07 -165.86 1.57 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.648 2.379 . . . . 0.0 108.684 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.83 -45.16 79.12 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.895 -1.128 . . . . 0.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.21 164.26 32.88 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.785 0.707 . . . . 0.0 112.207 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -74.83 157.5 6.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 125.08 1.352 . . . . 0.0 111.3 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -133.49 -65.17 0.69 Allowed 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 124.411 1.084 . . . . 0.0 109.479 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -140.64 156.2 46.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.493 0.588 . . . . 0.0 110.197 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.66 147.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.315 1.846 . . . . 0.0 107.315 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -138.99 163.46 32.33 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.826 1.251 . . . . 0.0 108.515 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.1 t -141.88 123.63 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -100.97 77.09 0.4 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.5 -175.78 0.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.805 0.812 . . . . 0.0 112.151 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.83 -172.53 38.57 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.47 -28.67 69.45 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 128.632 2.773 . . . . 0.0 114.901 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -115.76 -31.67 5.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.6 2.76 . . . . 0.0 112.398 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.8 -167.88 36.01 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.21 114.37 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 38.2 m -103.79 -25.24 13.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.883 1.673 . . . . 0.0 112.005 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -134.21 154.51 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.024 0.93 . . . . 0.0 109.02 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.74 155.34 27.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.418 1.087 . . . . 0.0 109.002 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -175.43 152.56 1.38 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 111.061 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -141.99 162.32 35.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.541 1.536 . . . . 0.0 108.217 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.37 151.22 37.45 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.517 1.127 . . . . 0.0 108.516 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -163.83 154.22 15.39 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.646 0.736 . . . . 0.0 111.052 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -110.27 123.75 50.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -139.78 145.15 37.85 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.34 35.86 61.73 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 68.97 -12.68 0.38 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 130.243 3.417 . . . . 0.0 114.421 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.52 154.75 19.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.756 1.622 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -93.78 130.69 39.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.781 0.832 . . . . 0.0 108.863 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.1 mt -119.25 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 37.2 t -122.54 121.45 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 176.96 -110.97 0.32 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 67.03 -4.63 3.16 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 127.143 2.306 . . . . 0.0 116.469 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.58 124.92 25.39 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.163 1.982 . . . . 0.0 108.678 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -146.22 16.9 1.36 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.435 1.894 . . . . 0.0 111.803 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.45 151.34 23.61 Favored Glycine 0 C--N 1.335 0.501 0 O-C-N 119.099 -2.251 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 285' ' ' GLU . 45.8 pttt -35.43 98.94 0.16 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.682 1.593 . . . . 0.0 114.009 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.37 114.26 2.79 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.243 1.962 . . . . 0.0 107.977 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.0 p -78.32 145.33 35.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.059 0.944 . . . . 0.0 110.329 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 51.5 mt -69.46 -7.1 34.96 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.429 -0.795 . . . . 0.0 110.202 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -27.8 69.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.86 2.064 . . . . 0.0 108.622 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 107.93 -161.95 13.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -141.99 129.06 20.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -79.41 161.93 25.83 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -144.19 157.21 44.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.003 0.43 . . . . 0.0 111.964 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.52 115.75 8.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.38 116.17 31.71 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.9 mm -127.55 107.57 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -67.71 103.79 1.49 Allowed 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 123.92 0.762 . . . . 0.0 110.909 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -36.5 -56.07 1.36 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.211 2.204 . . . . 0.0 115.957 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.7 -16.96 11.35 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 115.017 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.9 m -101.24 -10.59 20.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.484 1.493 . . . . 0.0 113.288 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.532 ' HG2' ' H ' ' A' ' 225' ' ' TYR . 23.8 tt0 -139.99 -168.82 2.6 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.532 ' H ' ' HG2' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -168.27 140.7 2.96 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.35 115.45 49.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 127.372 2.269 . . . . 0.0 106.208 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 32.5 m -94.14 -72.02 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.281 0.491 . . . . 0.0 111.658 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -107.82 170.5 7.95 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.551 1.14 . . . . 0.0 113.981 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.3 p -132.68 144.97 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.81 1.644 . . . . 0.0 107.91 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -133.07 169.82 16.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.711 1.604 . . . . 0.0 107.428 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.87 -175.26 45.77 Favored Glycine 0 N--CA 1.447 -0.625 0 O-C-N 120.248 -1.532 . . . . 0.0 109.599 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.32 136.27 22.23 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.07 146.47 38.99 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.348 1.059 . . . . 0.0 109.339 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -136.97 166.13 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.688 0.756 . . . . 0.0 112.172 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -72.87 141.22 47.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.926 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.1 157.93 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.763 2.025 . . . . 0.0 109.1 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -107.43 106.34 16.7 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 160.25 -49.13 0.38 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.441 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 49.9 m -135.46 173.92 11.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.196 0.998 . . . . 0.0 111.965 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -81.86 -12.2 58.58 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.159 0.584 . . . . 0.0 112.314 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -91.54 120.22 5.95 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.39 172.52 9.3 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.532 1.933 . . . . 0.0 107.061 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.7 tt -125.82 134.49 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.734 1.152 . . . . 0.0 111.441 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.4 mt -79.43 122.88 35.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 t -118.06 -6.67 10.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.983 0.513 . . . . 0.0 111.828 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -143.37 147.29 34.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -138.95 149.13 44.41 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.033 1.733 . . . . 0.0 110.255 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.41 ' H ' HD23 ' A' ' 247' ' ' LEU . 18.8 mtt180 -149.4 153.83 37.96 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.05 1.74 . . . . 0.0 106.613 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.43 138.47 38.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -89.27 114.31 25.67 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.27 0.941 . . . . 0.0 109.492 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.8 p -97.85 165.42 11.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.7 2.0 . . . . 0.0 110.659 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -119.28 134.75 55.04 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? 75.79 -50.92 0.63 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 127.749 2.42 . . . . 0.0 107.659 -177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -82.67 155.91 24.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.853 2.061 . . . . 0.0 108.262 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 59.4 m -118.83 114.52 22.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.3 p -68.88 168.22 14.0 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 111.802 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.45 154.17 42.42 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.021 1.328 . . . . 0.0 109.442 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.45 109.17 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.874 2.383 . . . . 0.0 108.234 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.54 92.34 5.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.42 -172.01 14.41 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.495 1.045 . . . . 0.0 111.495 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.98 133.94 52.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.42 -1.047 . . . . 0.0 110.516 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.2 108.33 3.12 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -147.56 125.91 12.33 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 97.81 -157.77 20.73 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.41 0.45 . . . . 0.0 112.095 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.3 m -77.21 117.52 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.722 1.209 . . . . 0.0 110.474 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.92 129.58 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -136.52 151.24 49.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.46 155.42 50.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.355 1.062 . . . . 0.0 108.58 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp -141.37 130.79 23.76 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.803 0.841 . . . . 0.0 109.017 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.47 166.29 10.26 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.069 1.348 . . . . 0.0 109.369 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -134.78 134.0 40.45 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.74 128.27 35.06 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.864 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.21 26.62 70.1 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -135.96 162.62 32.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.505 1.653 . . . . 0.0 111.097 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -121.62 162.49 20.59 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.211 1.404 . . . . 0.0 110.165 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 25.4 mt -79.63 145.64 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.1 m -145.49 -12.64 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.25 34.34 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 120.674 1.579 . . . . 0.0 111.136 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -144.85 157.06 44.29 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.112 1.765 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -149.64 149.29 30.42 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 128.489 2.716 . . . . 0.0 104.783 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.55 -135.99 6.45 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 11.5 mptt -140.63 157.54 45.3 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.448 ' HB3' ' HE1' ' A' ' 167' ' ' TRP . . . -129.87 149.37 51.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.3 p -159.75 -178.01 6.77 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.212 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.44 ' O ' ' HE2' ' A' ' 208' ' ' LYS . 5.7 mm-40 -67.83 -0.19 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.785 1.234 . . . . 0.0 111.671 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 22.6 mt -140.77 135.81 31.88 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 129.316 3.047 . . . . 0.0 103.148 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 57.0 tp -85.74 95.62 9.45 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -88.89 -70.41 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.277 0.361 . . . . 0.0 111.722 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -106.13 111.68 24.41 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.563 1.145 . . . . 0.0 111.995 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -116.98 160.74 20.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.52 40.24 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.73 141.01 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 117.818 0.809 . . . . 0.0 108.943 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -84.24 155.63 22.39 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.1 m -125.12 158.49 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.861 0.864 . . . . 0.0 109.816 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 28.2 mtt -157.44 145.71 14.27 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 127.871 2.468 . . . . 0.0 105.491 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.54 155.91 62.39 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.182 -1.507 . . . . 0.0 108.182 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.84 150.47 49.12 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 13.0 t -159.66 143.42 14.56 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.337 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -70.5 119.59 14.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.251 0.548 . . . . 0.0 110.738 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -148.53 140.6 23.97 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -130.3 93.35 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.823 0.738 . . . . 0.0 109.03 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.34 146.46 19.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.477 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.67 150.98 47.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.093 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.12 9.67 69.99 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.604 -1.109 . . . . 0.0 114.7 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.28 179.88 43.78 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.305 1.552 . . . . 0.0 111.473 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.37 -31.34 63.53 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.63 12.85 9.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.47 2.308 . . . . 0.0 113.448 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.04 -28.22 12.16 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.749 2.119 . . . . 0.0 116.352 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.71 -81.33 0.58 Allowed Glycine 0 C--N 1.342 0.863 0 CA-C-N 120.15 1.975 . . . . 0.0 110.924 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 131' ' ' ARG . . . -145.67 158.89 43.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.986 0.915 . . . . 0.0 109.885 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.29 97.88 6.0 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.894 1.278 . . . . 0.0 111.414 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.501 ' CD1' ' HG3' ' A' ' 131' ' ' ARG . 0.0 OUTLIER -67.38 0.6 2.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.538 1.535 . . . . 0.0 113.001 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.65 109.79 2.13 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.12 -0.987 . . . . 0.0 111.103 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.05 165.36 17.62 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.983 1.313 . . . . 0.0 109.434 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -85.55 -3.46 86.43 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.376 -1.235 . . . . 0.0 113.443 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.4 m -118.24 155.13 20.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 119.368 1.584 . . . . 0.0 109.839 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -74.85 164.02 27.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -138.81 -93.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.71 165.92 20.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 119.117 0.871 . . . . 0.0 111.875 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 t -143.11 96.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.62 1.568 . . . . 0.0 107.42 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.407 ' HD2' ' HB2' ' A' ' 43' ' ' ALA . 7.9 tpm_? -85.59 -50.56 7.13 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.805 1.242 . . . . 0.0 110.836 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -141.19 164.48 30.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.37 96.97 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.1 126.1 34.56 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 t -141.89 136.85 30.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.38 162.71 30.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -106.86 141.19 38.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.239 2.216 . . . . 0.0 111.259 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.39 -156.68 9.72 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 106.039 -2.824 . . . . 0.0 106.039 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -96.06 -9.4 30.96 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.705 -1.467 . . . . 0.0 109.629 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.82 2.71 38.59 Favored 'General case' 0 CA--C 1.542 0.64 1 C-N-CA 134.132 4.973 . . . . 0.0 112.707 -178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.71 -139.4 14.49 Favored Glycine 0 C--N 1.339 0.736 0 O-C-N 121.146 -0.971 . . . . 0.0 111.642 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.5 t -77.42 96.45 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -105.43 2.74 28.91 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.47 124.91 23.43 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 122.138 2.245 . . . . 0.0 107.919 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 169.37 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -159.14 152.83 22.97 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.745 -1.222 . . . . 0.0 113.568 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -122.58 107.6 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.037 1.335 . . . . 0.0 109.585 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.9 t -128.42 114.88 35.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -101.93 122.97 45.05 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.781 0.719 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . . . -77.81 125.64 29.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -113.98 145.32 41.7 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.16 -35.58 59.93 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 t -80.71 -65.08 1.06 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.207 0.458 . . . . 0.0 110.203 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -150.96 140.91 21.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.341 1.056 . . . . 0.0 108.359 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.63 135.58 46.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.202 1.801 . . . . 0.0 109.665 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.74 146.56 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 126.144 1.778 . . . . 0.0 106.984 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 156.89 21.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.711 1.204 . . . . 0.0 109.657 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.62 35.36 3.33 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.234 1.873 . . . . 0.0 111.384 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.07 -154.36 47.09 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.012 0.906 . . . . 0.0 111.628 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -139.3 152.8 47.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -128.81 166.11 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.1 0.96 . . . . 0.0 109.002 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' A' ' 56' ' ' LYS . . . 85.71 -157.96 31.73 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -126.66 105.56 8.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.722 1.209 . . . . 0.0 113.358 -178.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 1.5 ttmp? -62.41 128.73 37.43 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -131.14 155.17 47.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.6 pt? -75.56 -9.88 58.96 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -0.19 2.66 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.604 1.562 . . . . 0.0 113.089 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.08 130.87 2.39 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 125.888 1.709 . . . . 0.0 108.903 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.523 ' CZ ' ' HE3' ' A' ' 57' ' ' LYS . 63.7 t80 -163.58 132.32 3.85 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.321 2.648 . . . . 0.0 105.781 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 163.67 32.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 125.79 1.636 . . . . 0.0 111.817 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -134.2 96.85 3.7 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.681 1.193 . . . . 0.0 110.926 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -86.61 138.43 31.69 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -119.94 119.21 32.81 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.243 1.017 . . . . 0.0 109.602 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.1 t -71.24 123.67 25.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.046 0.938 . . . . 0.0 109.403 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.42 159.88 31.73 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.51 1.524 . . . . 0.0 110.742 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.85 -28.51 25.99 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.5 1.57 55.71 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.469 2.308 . . . . 0.0 114.254 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -127.21 155.98 42.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.721 1.146 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -135.08 137.12 42.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 124.49 1.116 . . . . 0.0 108.884 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.2 mt -73.96 102.55 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -75.24 -34.77 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 113.965 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.06 43.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.827 0.739 . . . . 0.0 109.482 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -146.29 146.29 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -131.49 137.69 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.1 t -141.49 139.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.0 p -115.8 154.49 29.55 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -154.3 168.63 25.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.86 1.264 . . . . 0.0 108.9 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -161.07 168.51 24.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -115.88 159.02 22.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.848 2.059 . . . . 0.0 109.063 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.1 m -127.25 135.62 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -59.29 107.82 0.61 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.24 3.66 7.99 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 118.041 -1.421 . . . . 0.0 113.35 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.23 142.17 47.26 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 119.817 1.808 . . . . 0.0 108.203 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.71 16.2 12.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.879 2.071 . . . . 0.0 111.517 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 p -136.35 172.72 12.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.348 1.459 . . . . 0.0 111.469 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.84 158.4 30.36 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.811 1.644 . . . . 0.0 106.897 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 pt -131.68 150.51 34.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.736 1.614 . . . . 0.0 107.397 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.9 mm -76.89 122.76 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.292 1.037 . . . . 0.0 110.348 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 p -88.8 -29.67 19.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.71 0.804 . . . . 0.0 112.274 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -164.55 161.61 21.23 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.94 1.296 . . . . 0.0 109.793 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 mt -136.35 136.71 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 m -135.81 132.66 36.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -114.74 158.88 21.23 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.522 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -140.75 144.72 35.67 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.522 2.329 . . . . 0.0 105.227 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -134.2 166.39 22.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.0 -41.04 95.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 10.3 mmpt? -58.33 -12.09 3.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.455 1.102 . . . . 0.0 112.275 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.0 18.61 62.76 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 125.194 1.378 . . . . 0.0 111.954 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -89.15 97.01 10.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 p -85.46 105.81 16.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.24 157.11 83.35 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.53 164.17 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 0.0 111.331 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 111.82 3.1 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.063 2.509 . . . . 0.0 107.02 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -75.52 74.79 2.56 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.365 0.666 . . . . 0.0 109.566 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 142.36 -141.17 10.54 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.228 1.395 . . . . 0.0 110.519 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.9 tp -108.5 132.5 53.75 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 125.544 1.538 . . . . 0.0 109.619 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 116.86 18.8 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 m -114.67 164.6 13.82 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -61.26 -51.9 66.98 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.814 1.246 . . . . 0.0 110.174 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -72.29 115.77 11.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -157.9 168.27 27.64 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.358 -0.839 . . . . 0.0 110.872 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -142.37 167.18 22.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.607 1.563 . . . . 0.0 107.887 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.65 149.8 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -142.95 157.32 44.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.344 0.52 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.42 160.04 15.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.719 1.608 . . . . 0.0 111.51 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -81.28 177.12 9.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.796 1.639 . . . . 0.0 107.898 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.08 -46.31 2.32 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.111 -0.993 . . . . 0.0 112.519 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -109.52 19.25 19.48 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.41 -4.93 85.23 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.001 1.286 . . . . 0.0 114.244 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 118.32 13.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -53.53 164.18 0.54 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 126.243 1.817 . . . . 0.0 113.752 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.28 111.27 1.68 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.9 t -61.75 -50.72 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.68 -178.78 48.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.08 -2.408 . . . . 0.0 107.08 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -102.49 172.32 6.94 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 169.14 20.89 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.48 126.69 1.73 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.501 ' HG3' ' CD1' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -99.74 179.3 4.58 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 123.208 1.48 . . . . 0.0 109.075 -179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.23 152.85 39.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 129.663 3.185 . . . . 0.0 105.519 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.52 -87.09 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 104.214 -3.555 . . . . 0.0 104.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -95.12 -27.48 15.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.186 0.493 . . . . 0.0 111.142 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -134.59 160.73 37.17 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 43.4 tp -77.45 93.67 4.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.597 0.713 . . . . 0.0 110.284 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -81.76 -37.12 27.71 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.306 1.042 . . . . 0.0 112.681 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.58 152.02 39.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.813 1.188 . . . . 0.0 109.853 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.4 tp -161.77 141.89 10.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.256 1.422 . . . . 0.0 108.296 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 175.89 -179.73 46.85 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.55 167.43 28.59 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.654 1.182 . . . . 0.0 109.069 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -136.39 168.44 19.45 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.815 1.293 . . . . 0.0 111.169 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -133.04 97.37 3.99 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 103.151 -2.907 . . . . 0.0 103.151 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.58 4.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 t -108.83 166.68 10.63 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 m 66.99 39.13 3.33 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.809 0.814 . . . . 0.0 110.596 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.0 p -89.87 3.44 52.98 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.573 -1.329 . . . . 0.0 110.488 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 40.8 p -102.75 144.93 29.61 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 127.07 2.148 . . . . 0.0 114.697 -177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.47 109.72 2.7 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.573 2.182 . . . . 0.0 106.801 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.4 t -147.86 122.94 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -137.43 152.41 73.09 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.879 -0.582 . . . . 0.0 111.357 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.33 -169.29 0.63 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.96 3.107 . . . . 0.0 109.857 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.88 -179.04 4.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.92 0.867 . . . . 0.0 110.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 126.52 31.13 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.149 -0.969 . . . . 0.0 112.816 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -87.82 147.88 24.94 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.992 2.117 . . . . 0.0 109.882 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.66 162.47 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.5 t -72.63 135.49 45.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -135.37 169.43 17.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.387 1.875 . . . . 0.0 109.976 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.8 tt -141.6 154.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.25 1.82 . . . . 0.0 108.883 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.8 -85.2 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.68 47.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 126.668 2.08 . . . . 0.0 108.271 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 2.9 p30 -111.19 10.15 21.84 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -83.45 150.06 26.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.35 -179.56 22.94 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.721 1.146 . . . . 0.0 115.805 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.4 m -96.3 119.39 34.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.197 1.799 . . . . 0.0 109.136 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.6 153.65 40.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.438 0.563 . . . . 0.0 110.295 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -142.46 131.2 22.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 122.33 1.062 . . . . 0.0 111.0 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.32 139.91 32.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.806 1.643 . . . . 0.0 108.512 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.16 124.66 19.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -90.78 177.68 41.99 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.386 1.47 . . . . 0.0 111.05 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.36 149.69 27.58 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -131.96 -175.31 3.69 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.216 1.007 . . . . 0.0 110.896 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.07 -32.21 54.01 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.934 1.694 . . . . 0.0 113.327 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.32 -158.64 31.36 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.512 2.006 . . . . 0.0 108.158 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.39 139.47 50.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.688 1.195 . . . . 0.0 108.622 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.89 -68.89 0.9 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.145 0.578 . . . . 0.0 110.233 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 193' ' ' GLU . 49.8 mtpt -119.03 157.65 27.37 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.399 0.545 . . . . 0.0 110.749 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 37.8 t -132.83 143.73 38.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 127.303 2.241 . . . . 0.0 107.775 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -143.39 145.41 32.63 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.722 1.209 . . . . 0.0 108.041 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.4 t -139.39 151.3 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.381 1.072 . . . . 0.0 109.605 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.74 144.37 16.24 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -123.36 -170.05 2.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.359 1.464 . . . . 0.0 110.571 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 172.85 -175.83 45.78 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 126.002 1.763 . . . . 0.0 110.127 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.26 -17.92 2.07 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.428 3.091 . . . . 0.0 118.219 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -117.78 -9.91 10.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 118.912 0.778 . . . . 0.0 112.259 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 137.7 -146.69 18.58 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 38.4 mm -63.86 153.4 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.588 1.194 . . . . 0.0 108.393 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 83.3 p -134.81 -23.84 1.54 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.76 151.93 34.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.692 1.133 . . . . 0.0 111.718 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.3 m -149.51 124.22 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 123.543 0.737 . . . . 0.0 109.471 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -149.81 161.28 42.57 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -151.3 172.91 15.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.013 0.925 . . . . 0.0 108.511 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 177' ' ' LYS . 25.2 mp0 -130.88 147.03 52.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.837 0.827 . . . . 0.0 109.767 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -146.47 168.42 21.22 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.811 2.044 . . . . 0.0 109.979 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -112.3 161.83 16.19 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.0 1.72 . . . . 0.0 108.764 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -134.35 83.77 2.06 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.692 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.63 -66.58 1.34 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.398 1.475 . . . . 0.0 111.477 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -135.07 -45.59 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.365 1.866 . . . . 0.0 108.555 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -60.9 164.43 4.88 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.872 1.32 . . . . 0.0 111.333 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.34 149.78 44.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.625 1.57 . . . . 0.0 107.414 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -140.43 143.9 28.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.53 147.73 13.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -71.79 146.49 40.17 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.46 10.66 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 105.334 -3.106 . . . . 0.0 105.334 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 133.57 49.31 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 118.616 1.208 . . . . 0.0 108.863 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -106.41 -15.25 14.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.559 0.744 . . . . 0.0 110.486 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -102.48 -177.62 27.3 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.827 1.68 . . . . 0.0 113.232 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -107.93 83.52 1.76 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 128.531 2.733 . . . . 0.0 106.323 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.4 148.97 18.88 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.75 . . . . 0.0 111.553 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 66.7 p -87.06 -179.26 6.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.45 -1.06 25.23 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 120.151 -1.593 . . . . 0.0 112.771 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -32.27 32.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.23 0.923 . . . . 0.0 113.239 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.56 -157.11 18.81 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -147.42 119.94 8.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -66.94 154.76 40.27 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -139.75 142.74 36.77 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -143.04 142.98 31.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.495 1.518 . . . . 0.0 107.486 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -133.14 95.85 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.76 129.52 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.97 1.308 . . . . 0.0 111.395 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.78 89.79 2.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.403 1.081 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -45.46 -47.74 35.99 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 126.598 1.959 . . . . 0.0 112.626 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.89 -7.03 15.4 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 122.048 1.767 . . . . 0.0 114.682 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.7 t -109.93 -13.15 14.48 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 120.814 1.643 . . . . 0.0 113.402 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 171.66 13.17 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 119.344 0.975 . . . . 0.0 111.328 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -145.66 90.63 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.62 101.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 7.3 p -87.19 -26.47 23.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.441 1.097 . . . . 0.0 112.46 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.52 171.02 20.63 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.156 0.889 . . . . 0.0 112.24 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.86 159.26 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.16 176.35 5.88 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 127.717 2.407 . . . . 0.0 107.543 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.97 41.86 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.7 m -153.18 141.3 20.41 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.11 153.79 48.06 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.761 0.825 . . . . 0.0 110.432 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . 0.326 0.3 OUTLIER -156.17 172.01 19.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -74.78 139.94 43.66 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.409 1.483 . . . . 0.0 110.953 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.25 157.54 34.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 127.221 2.208 . . . . 0.0 110.041 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -84.93 178.37 7.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.32 -69.7 1.52 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 71.1 p -95.48 -178.21 4.34 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.715 0.769 . . . . 0.0 111.427 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.58 14.19 24.73 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.613 1.565 . . . . 0.0 111.435 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -128.27 163.49 21.81 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.249 1.404 . . . . 0.0 113.099 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.82 173.28 11.35 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.978 1.711 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.75 146.07 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.872 0.869 . . . . 0.0 109.403 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.3 mm -76.12 133.78 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.0 t -112.36 -21.82 11.19 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.4 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -152.27 152.7 32.48 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 140.42 34.23 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.821 2.048 . . . . 0.0 109.013 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -145.23 153.42 41.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 106.339 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -115.45 128.69 56.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -80.47 114.39 19.33 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -119.66 165.16 14.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.365 1.079 . . . . 0.0 109.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -102.93 133.51 47.91 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 2.7 mptt 65.95 -46.39 0.4 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.501 2.32 . . . . 0.0 111.188 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -92.11 165.5 13.13 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 129.283 3.033 . . . . 0.0 109.408 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 73.7 m -150.76 118.83 6.27 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 83.9 p -66.85 165.03 16.08 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.095 0.474 . . . . 0.0 110.613 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -67.84 153.96 94.33 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.84 97.77 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.439 2.093 . . . . 0.0 106.731 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -76.14 92.47 3.23 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 111.28 178.24 20.33 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.952 1.263 . . . . 0.0 111.534 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.75 123.44 49.0 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 124.09 0.956 . . . . 0.0 110.035 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.11 107.23 5.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -157.05 45.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.219 1.008 . . . . 0.0 109.357 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -167.87 -164.92 24.39 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 121.405 -0.81 . . . . 0.0 111.115 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 15.2 m -66.7 104.6 1.34 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.27 146.98 36.54 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.578 -0.701 . . . . 0.0 110.788 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -141.4 170.42 15.75 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.924 0.868 . . . . 0.0 112.763 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -140.99 152.83 45.24 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.542 2.337 . . . . 0.0 106.891 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 79.6 mt -138.64 104.22 5.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -140.05 150.82 44.83 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.255 0.622 . . . . 0.0 110.461 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -144.8 130.75 19.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -67.71 138.72 56.49 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.63 -11.23 3.38 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.483 1.516 . . . . 0.0 115.818 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -99.21 159.75 14.76 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 120.111 1.956 . . . . 0.0 112.197 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -119.95 147.6 44.55 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.823 1.649 . . . . 0.0 107.543 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 87.9 mt -80.69 141.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.16 -29.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -161.46 -178.07 35.08 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.001 1.286 . . . . 0.0 110.559 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -113.37 -179.04 3.53 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.878 1.671 . . . . 0.0 111.22 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -153.35 179.36 8.84 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.822 2.049 . . . . 0.0 105.549 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 126.98 -151.73 18.38 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 162' ' ' ASP . 0.9 OUTLIER -151.54 149.53 29.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -108.11 154.6 21.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.936 1.295 . . . . 0.0 108.513 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 t -151.92 -63.03 0.17 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -149.18 -31.36 0.23 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.387 1.075 . . . . 0.0 112.542 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 79.6 mt -134.4 -112.81 0.21 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.948 1.249 . . . . 0.0 109.259 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.78 77.43 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 120.175 1.352 . . . . 0.0 108.628 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -60.58 -62.24 2.0 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 0.0 113.322 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -132.38 140.76 48.62 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.866 0.757 . . . . 0.0 109.702 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -140.99 151.32 44.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.566 1.547 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.88 165.83 37.76 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.0 m -113.52 157.02 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.788 1.294 . . . . 0.0 113.719 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.97 136.44 38.95 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.59 141.95 38.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -133.21 129.41 20.84 Favored Pre-proline 0 N--CA 1.468 0.454 0 C-N-CA 125.044 1.338 . . . . 0.0 108.425 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.95 86.53 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.857 3.038 . . . . 0.0 110.059 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 20.7 mt -96.46 9.41 41.43 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 35.4 m -78.93 159.04 27.9 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 . . . . . 0 C--O 1.247 0.94 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -70.33 152.57 44.0 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.738 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -140.99 140.66 34.39 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 130.442 3.497 . . . . 0.0 107.1 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 82.5 t -127.94 130.9 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -65.61 169.89 5.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.333 1.053 . . . . 0.0 113.836 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.37 106.55 6.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.44 134.08 13.29 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 105.67 -2.972 . . . . 0.0 105.67 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.25 -151.42 20.08 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.77 168.89 42.89 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 122.779 1.21 . . . . 0.0 114.444 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.74 -18.39 23.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.457 1.103 . . . . 0.0 111.839 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.53 169.33 41.23 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.577 0.608 . . . . 0.0 113.005 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.91 168.49 44.46 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.134 1.35 . . . . 0.0 112.462 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.74 156.06 21.59 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 84.0 2.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.199 1.4 . . . . 0.0 110.264 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -90.04 135.58 33.56 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.38 151.95 28.49 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 128.295 2.638 . . . . 0.0 105.41 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.78 153.0 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.28 -4.35 16.03 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 115.392 0.917 . . . . 0.0 115.392 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 m -65.76 158.71 4.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.773 1.286 . . . . 0.0 110.122 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -67.98 -44.54 76.43 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -172.6 -165.89 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.66 2.784 . . . . 0.0 105.913 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.69 27.68 0.86 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.07 1.319 . . . . 0.0 112.896 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.11 142.71 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 119.397 1.598 . . . . 0.0 109.36 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -132.29 -33.33 1.3 Allowed 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.265 0.626 . . . . 0.0 112.29 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -135.89 160.67 37.88 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 118.453 0.569 . . . . 0.0 110.735 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.29 90.35 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -87.63 110.45 20.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -132.92 147.58 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 172.37 22.45 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -135.12 157.27 47.35 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.835 0.854 . . . . 0.0 112.568 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -125.83 -153.28 8.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.389 -2.684 . . . . 0.0 106.389 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -95.86 -7.34 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.96 -1.318 . . . . 0.0 110.373 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.38 -7.23 26.48 Favored 'General case' 0 N--CA 1.446 -0.645 1 C-N-CA 133.705 4.802 . . . . 0.0 112.427 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.77 -151.91 18.07 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.78 131.69 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -148.09 13.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.758 -1.214 . . . . 0.0 113.297 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 p -131.7 125.42 32.01 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.5 mt -140.52 119.39 11.19 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -128.03 145.36 51.01 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 107.714 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.2 t -129.08 131.51 67.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.313 1.045 . . . . 0.0 110.407 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.59 132.51 44.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 102.184 -3.265 . . . . 0.0 102.184 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -103.07 152.63 21.15 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 109.834 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.26 115.87 30.92 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -114.16 166.73 11.33 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 122.357 1.075 . . . . 0.0 111.16 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.53 -5.65 25.64 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.406 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.2 m -104.91 -67.01 0.93 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 119.583 -1.948 . . . . 0.0 110.803 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -156.35 165.6 35.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.664 1.185 . . . . 0.0 107.831 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.52 141.88 42.94 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.6 t -145.79 138.44 20.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.61 136.45 57.01 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.152 0.981 . . . . 0.0 108.438 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.73 -65.88 1.84 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.333 -2.707 . . . . 0.0 106.333 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.15 171.81 20.17 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.09 146.3 23.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.483 0.659 . . . . 0.0 111.02 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -123.92 83.73 2.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 100.554 -3.869 . . . . 0.0 100.554 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.28 26.29 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -126.61 112.44 15.5 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -52.98 111.96 0.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.147 0.975 . . . . 0.0 110.082 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 p -81.61 108.36 15.11 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 127.756 2.422 . . . . 0.0 109.842 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.77 -24.02 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.569 -0.707 . . . . 0.0 112.672 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.28 8.77 43.89 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.271 1.029 . . . . 0.0 113.548 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -175.44 121.9 0.84 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 119.951 1.25 . . . . 0.0 110.658 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.85 121.38 2.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.623 2.369 . . . . 0.0 105.026 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -128.4 164.45 22.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 57.4 m -121.87 131.22 53.92 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.865 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -137.47 110.27 7.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -95.52 124.66 39.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.98 1.312 . . . . 0.0 108.922 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.84 116.25 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.56 143.57 56.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -41.63 75.41 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.626 -0.671 . . . . 0.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.34 -7.4 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.677 1.191 . . . . 0.0 112.638 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.11 151.33 21.53 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.969 1.708 . . . . 0.0 108.23 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -130.89 143.15 50.52 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.9 mt -68.57 137.64 24.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.2 m -107.18 -46.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 123.144 0.578 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 165.32 31.07 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.215 1.406 . . . . 0.0 108.635 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.07 108.82 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -91.91 137.68 32.17 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 104.929 -2.249 . . . . 0.0 104.929 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.5 t -136.36 144.16 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.523 HG21 ' H ' ' A' ' 111' ' ' THR . 75.6 m -118.61 140.46 49.88 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -153.69 167.17 30.49 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.218 1.807 . . . . 0.0 106.308 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -161.18 168.54 24.03 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.53 0.605 . . . . 0.0 109.842 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -108.5 148.72 29.84 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.375 1.07 . . . . 0.0 111.313 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.48 131.13 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -60.24 -0.25 0.22 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.817 1.647 . . . . 0.0 115.201 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.36 7.66 34.77 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 126.18 1.847 . . . . 0.0 113.35 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -138.42 144.07 40.02 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 120.365 2.083 . . . . 0.0 109.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.59 -2.29 28.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.281 1.832 . . . . 0.0 111.664 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 t -155.02 150.38 27.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.83 -1.169 . . . . 0.0 110.137 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.52 163.87 27.24 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.2 pt -139.39 151.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.973 1.309 . . . . 0.0 109.246 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.16 118.92 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.429 ' OG1' HG22 ' A' ' 79' ' ' THR . 23.4 p -89.53 -32.76 17.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.584 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.5 p -162.84 166.22 24.36 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.557 1.071 . . . . 0.0 112.863 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.6 mt -135.72 151.58 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.066 1.347 . . . . 0.0 107.681 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 71.3 m -141.25 101.74 4.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.392 1.877 . . . . 0.0 107.009 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -81.82 121.8 26.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.752 1.221 . . . . 0.0 108.914 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -106.13 128.24 53.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.414 1.486 . . . . 0.0 109.067 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 59.9 p -99.9 169.06 9.48 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.642 1.177 . . . . 0.0 111.204 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -76.92 -39.93 49.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -68.75 -26.2 65.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 116.432 -1.747 . . . . 0.0 115.348 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.52 -12.58 7.01 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-N 121.068 1.758 . . . . 0.0 114.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -70.49 137.4 50.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.0 m -135.06 128.66 32.69 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.5 p -74.31 158.66 85.11 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-N 117.914 0.325 . . . . 0.0 110.917 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.93 164.53 35.37 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 107.128 -1.912 . . . . 0.0 107.128 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.81 83.5 1.77 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.783 2.322 . . . . 0.0 108.663 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -57.16 115.52 2.71 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.05 -126.45 6.89 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.2 tp -139.4 131.73 28.39 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.87 1.268 . . . . 0.0 107.916 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -68.19 154.26 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.523 ' H ' HG21 ' A' ' 79' ' ' THR . 0.2 OUTLIER -151.34 175.56 12.11 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.432 -1.417 . . . . 0.0 111.784 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.41 ' H ' HG22 ' A' ' 111' ' ' THR . 5.3 tt0 -58.38 -64.52 0.89 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.915 1.686 . . . . 0.0 111.527 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.95 163.52 27.8 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.948 0.88 . . . . 0.0 110.927 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 110' ' ' GLU . 0.1 OUTLIER 176.11 168.82 0.43 Allowed 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 126.156 1.783 . . . . 0.0 109.047 -179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.48 160.96 42.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.663 1.585 . . . . 0.0 107.565 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.06 137.17 26.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.22 137.09 50.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.14 138.03 0.72 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.379 2.672 . . . . 0.0 107.865 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -64.31 140.28 58.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -57.75 -28.06 63.59 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.383 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.99 2.96 55.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.081 1.309 . . . . 0.0 111.641 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.7 87.24 0.75 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.526 1.057 . . . . 0.0 111.153 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.57 144.35 15.92 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.42 145.69 28.84 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.3 tt -75.86 107.66 8.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 m -86.62 -23.57 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.531 0.605 . . . . 0.0 110.135 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.24 -179.68 43.27 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -144.47 175.71 9.92 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.333 1.053 . . . . 0.0 110.265 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.53 167.95 28.24 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.373 2.269 . . . . 0.0 106.565 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 118.48 0.52 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.309 1.413 . . . . 0.0 114.398 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -60.1 120.87 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.13 164.88 31.68 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.601 1.56 . . . . 0.0 109.131 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.77 -112.59 0.26 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.97 -21.89 66.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.971 0.385 . . . . 0.0 111.004 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.65 173.31 13.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.025 2.13 . . . . 0.0 108.998 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 50.5 tp -89.94 98.64 11.89 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -82.55 -42.91 17.74 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.68 34.0 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.245 0.929 . . . . 0.0 112.53 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.45 153.64 36.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.068 0.947 . . . . 0.0 111.086 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.46 -178.15 29.41 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.309 1.433 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.6 156.4 40.37 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.351 1.06 . . . . 0.0 110.505 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -109.66 114.52 28.2 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -107.94 131.75 54.21 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.671 0.788 . . . . 0.0 111.055 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.7 162.93 36.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.795 0.838 . . . . 0.0 112.264 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 t -136.23 166.23 23.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.213 1.405 . . . . 0.0 109.677 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -138.32 173.22 11.84 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.964 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 174.83 11.17 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 108.445 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 24.8 p -140.27 151.08 63.53 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.905 1.282 . . . . 0.0 110.69 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.2 173.59 14.13 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.958 2.438 . . . . 0.0 112.577 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.4 t -58.97 131.78 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 p -74.82 158.38 84.72 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.84 -157.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.14 1 C-N-CA 125.825 4.35 . . . . 0.0 112.915 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.12 168.29 12.4 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.827 2.451 . . . . 0.0 113.727 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -75.85 127.25 32.61 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -95.21 135.38 36.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 50.9 mt -89.87 178.43 6.23 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.3 m -100.1 101.71 12.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.41 173.55 7.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.575 0.702 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.5 tt -144.4 172.03 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.346 1.858 . . . . 0.0 106.76 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 153.36 -111.75 0.5 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -146.74 -1.61 0.6 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 125.325 1.25 . . . . 0.0 114.68 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.589 ' HA ' ' CE ' ' A' ' 282' ' ' LYS 0.388 55.0 m-20 46.68 15.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.66 -29.3 59.03 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 116.601 2.074 . . . . 0.0 116.601 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.29 -168.2 38.74 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.0 t -82.14 112.33 19.07 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.34 1.456 . . . . 0.0 109.462 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.95 35.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -135.82 107.31 6.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 110.177 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 280' ' ' HIS . 12.4 p-10 -97.9 104.68 16.73 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.84 -1.85 15.68 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.01 -83.96 1.15 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.174 1.369 . . . . 0.0 113.108 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.59 170.43 8.14 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.583 2.353 . . . . 0.0 110.65 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -138.6 144.64 39.86 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.151 0.98 . . . . 0.0 109.738 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.65 -10.71 59.34 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.238 1.015 . . . . 0.0 112.665 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.05 153.36 22.04 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.287 1.422 . . . . 0.0 109.964 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.06 156.46 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.899 1.68 . . . . 0.0 108.062 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -124.71 -58.31 1.5 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.616 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -158.76 162.03 37.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 120.277 1.398 . . . . 0.0 112.602 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.59 144.4 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.404 1.882 . . . . 0.0 107.077 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -139.23 144.67 38.57 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.88 1.272 . . . . 0.0 107.88 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 8.9 t -132.27 126.85 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -121.3 83.01 0.35 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -86.15 172.95 10.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.396 1.093 . . . . 0.0 111.286 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.26 -168.6 11.8 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 128.573 2.987 . . . . 0.0 106.981 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -66.49 -36.64 83.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.07 -32.24 61.45 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.53 0.732 . . . . 0.0 112.169 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.0 -154.21 25.35 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.6 mm -64.82 124.51 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.8 m -108.96 -25.48 10.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.683 1.128 . . . . 0.0 112.485 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -140.99 141.53 34.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.174 0.989 . . . . 0.0 110.774 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.47 130.41 72.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -152.47 144.68 23.91 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -144.19 168.76 19.27 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.283 1.033 . . . . 0.0 109.821 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -133.53 129.39 37.04 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -131.28 168.97 16.63 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.763 1.625 . . . . 0.0 110.22 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -124.47 99.25 6.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -117.28 138.7 51.57 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.983 2.113 . . . . 0.0 105.768 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.31 29.27 45.64 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 119.222 -0.765 . . . . 0.0 112.174 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.78 -7.72 0.45 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.475 2.71 . . . . 0.0 114.593 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -88.02 158.66 18.56 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 123.554 1.645 . . . . 0.0 114.752 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -86.6 99.95 12.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.177 1.791 . . . . 0.0 106.937 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.5 143.92 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.27 129.93 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.138 1.375 . . . . 0.0 108.162 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.54 -34.3 28.88 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 75.51 174.49 35.67 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 125.911 1.72 . . . . 0.0 111.113 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -62.84 100.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.005 1.322 . . . . 0.0 108.184 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -73.99 -50.4 20.06 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -93.19 165.27 27.7 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.529 1.061 . . . . 0.0 112.297 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -62.81 108.2 1.58 Allowed Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 126.176 1.791 . . . . 0.0 110.876 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.79 178.55 6.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 N-CA-C 107.713 -1.687 . . . . 0.0 107.713 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 212' ' ' LEU . 1.2 t -147.56 176.15 10.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -14.54 11.76 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.462 ' H ' HG23 ' A' ' 210' ' ' THR . 9.8 tt -65.61 -28.86 69.43 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.883 0.873 . . . . 0.0 110.329 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.89 -137.65 13.51 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -153.28 156.21 38.0 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.306 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -114.52 154.1 28.85 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -136.62 148.69 47.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.474 0.579 . . . . 0.0 111.676 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -143.06 112.54 6.82 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -83.36 109.91 17.69 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.5 mt -110.51 102.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.6 99.26 5.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -45.04 -41.55 13.61 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.46 -26.42 29.02 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 CA-C-N 123.592 2.319 . . . . 0.0 112.887 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 98.6 p -107.79 -16.12 14.4 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 120.97 1.714 . . . . 0.0 114.278 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.53 117.72 29.15 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.301 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.52 92.9 4.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.14 1.776 . . . . 0.0 111.374 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.46 106.17 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 101.6 -3.481 . . . . 0.0 101.6 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 22.4 m -77.86 -38.89 45.04 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.139 0.576 . . . . 0.0 110.436 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.67 36.69 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.952 0.901 . . . . 0.0 110.652 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.9 p -117.2 143.64 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.453 ' CG ' ' HE3' ' A' ' 250' ' ' LYS . 9.5 mm-40 -128.72 166.49 18.86 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.603 1.961 . . . . 0.0 109.094 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 172.08 166.84 31.34 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 75.7 p -128.81 132.66 47.86 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.24 147.62 43.89 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -155.77 171.3 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.951 0.901 . . . . 0.0 110.997 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.92 148.1 42.52 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.63 1.572 . . . . 0.0 110.747 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 236' ' ' ILE . 1.9 mp -96.22 135.59 29.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -75.75 85.63 2.75 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 139.63 -6.04 2.92 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.109 1.338 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 t -123.76 170.55 10.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.61 1.705 . . . . 0.0 108.905 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -116.92 52.62 0.94 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.972 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -167.72 -174.91 37.12 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.07 1.319 . . . . 0.0 110.299 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.59 157.92 23.43 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.381 1.072 . . . . 0.0 109.666 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.7 tt -130.87 135.93 59.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 124.985 1.314 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.05 104.34 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.066 -2.939 . . . . 0.0 103.066 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.284 5.5 t -86.22 -19.17 30.39 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -147.24 149.73 33.46 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.269 -0.895 . . . . 0.0 110.129 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 249' ' ' PHE . 0.2 OUTLIER -136.78 143.61 43.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.307 2.243 . . . . 0.0 108.565 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -147.42 161.81 40.29 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.046 1.738 . . . . 0.0 107.645 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.426 ' CZ ' HD12 ' A' ' 247' ' ' LEU . 71.4 m-85 -131.42 118.79 20.73 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 230' ' ' GLU . 73.6 mttt -69.79 113.14 6.75 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 100.325 -3.954 . . . . 0.0 100.325 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 152.31 23.11 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.162 2.185 . . . . 0.0 107.942 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 154.9 23.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 57.29 -7.72 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -157.55 174.66 15.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 131.208 3.803 . . . . 0.0 106.875 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.8 m -138.24 124.31 20.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.1 175.96 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 122.669 1.223 . . . . 0.0 111.84 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -79.31 158.34 74.27 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.734 2.014 . . . . 0.0 111.94 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.66 90.35 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.924 2.416 . . . . 0.0 106.859 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -73.69 91.97 1.94 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 115.24 -179.91 18.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.623 1.106 . . . . 0.0 113.784 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.17 111.02 22.03 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.63 1.172 . . . . 0.0 109.889 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.57 107.73 1.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -168.36 141.49 3.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.303 2.241 . . . . 0.0 107.284 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 103.74 -177.13 24.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 55.3 m -72.15 122.61 21.29 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.216 -0.579 . . . . 0.0 109.79 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.68 122.08 22.67 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -124.95 120.28 31.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 118.45 0.568 . . . . 0.0 111.465 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -100.47 144.02 29.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.873 0.869 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 82.6 mt -122.47 103.53 8.78 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -133.95 171.35 14.31 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.681 1.992 . . . . 0.0 108.999 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -143.5 167.87 21.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.748 0.819 . . . . 0.0 110.741 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -69.98 7.48 0.93 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.113 1.765 . . . . 0.0 114.102 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 142.36 65.18 0.03 OUTLIER Glycine 0 C--N 1.335 0.472 0 O-C-N 121.298 -0.876 . . . . 0.0 111.583 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -147.74 153.83 39.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.231 1.412 . . . . 0.0 107.84 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -109.68 154.72 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.348 1.459 . . . . 0.0 107.34 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.24 153.36 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 49.8 t -132.01 -80.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -113.15 -151.83 11.0 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 118.913 0.778 . . . . 0.0 111.743 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CE1' ' HA3' ' A' ' 281' ' ' GLY . 4.7 t80 -138.77 147.78 43.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.808 1.243 . . . . 0.0 110.086 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.6 p80 -133.73 92.19 2.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 279' ' ' PHE . . . -155.21 -138.88 2.66 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.589 ' CE ' ' HA ' ' A' ' 162' ' ' ASP 0.289 0.3 OUTLIER -156.4 162.37 40.04 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.082 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.95 50.72 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 121.519 0.676 . . . . 0.0 111.382 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 12.3 t -156.66 -167.4 2.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.696 1.998 . . . . 0.0 107.395 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -62.57 -19.43 63.68 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.076 2.15 . . . . 0.0 112.342 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 24.3 mt -139.23 150.05 45.07 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 128.987 2.915 . . . . 0.0 105.294 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 24.8 tp -85.12 86.62 7.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.007 0.821 . . . . 0.0 111.266 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -78.72 -40.15 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.637 1.175 . . . . 0.0 110.895 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -128.43 130.62 47.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 120.079 1.308 . . . . 0.0 110.037 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.53 148.53 29.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -171.39 -164.67 27.43 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.13 137.47 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.461 0.704 . . . . 0.0 112.478 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 155.56 28.32 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 147.63 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 118.542 0.61 . . . . 0.0 111.641 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 80.2 mtp -139.72 149.09 58.25 Favored Pre-proline 0 N--CA 1.465 0.307 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.74 118.05 5.45 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.686 2.257 . . . . 0.0 108.889 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.36 173.86 10.34 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.322 0.649 . . . . 0.0 111.042 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.7 m -125.08 -0.77 7.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.985 1.714 . . . . 0.0 111.417 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.937 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -70.78 129.93 40.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -149.31 138.53 21.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 80.6 t -133.96 124.16 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.79 164.7 20.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.117 0.96 . . . . 0.0 110.185 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 138' ' ' ALA . . . -69.09 105.61 2.51 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.329 1.452 . . . . 0.0 109.651 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.65 47.53 2.47 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.13 1.824 . . . . 0.0 114.571 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.18 -156.91 9.17 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.466 1.507 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 89' ' ' ASP . . . -80.98 160.06 42.35 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.233 1.016 . . . . 0.0 114.053 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.14 5.42 41.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.333 1.453 . . . . 0.0 112.61 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.34 59.94 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.94 166.18 14.03 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 119.906 1.853 . . . . 0.0 111.771 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 131' ' ' ARG . . . -78.73 156.69 28.77 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 123.735 0.814 . . . . 0.0 110.895 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.5 m -66.19 127.68 33.12 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.683 0.793 . . . . 0.0 111.583 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -134.36 161.4 35.09 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 160.09 149.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 129.599 3.16 . . . . 0.0 107.544 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -142.3 119.71 11.62 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.591 0.756 . . . . 0.0 109.346 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -39.56 -48.78 3.09 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 127.62 2.533 . . . . 0.0 117.829 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.73 146.17 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.447 1.624 . . . . 0.0 111.1 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -78.35 137.58 38.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.52 1.528 . . . . 0.0 112.236 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.31 -15.1 31.84 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.99 158.36 12.58 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.6 2.048 . . . . 0.0 110.711 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.9 t -145.38 139.84 22.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.5 mmt-85 -114.88 -60.97 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.086 1.754 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -126.36 162.85 24.57 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.761 1.225 . . . . 0.0 110.216 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.94 131.95 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -125.11 123.16 39.11 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.18 117.64 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.09 119.19 6.18 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.534 0.519 . . . . 0.0 112.268 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -69.98 172.58 7.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.05 1.74 . . . . 0.0 109.53 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.17 175.95 34.49 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 129.463 3.411 . . . . 0.0 104.821 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -68.06 -31.24 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -26.65 50.08 Favored 'General case' 0 N--CA 1.45 -0.447 1 C-N-CA 132.731 4.413 . . . . 0.0 113.327 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.97 -164.6 24.44 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -62.77 106.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.612 1.206 . . . . 0.0 108.217 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 m -97.16 -34.67 11.04 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.415 1.486 . . . . 0.0 114.455 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 t -119.34 153.26 35.39 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.534 1.133 . . . . 0.0 110.46 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.62 142.2 28.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.789 1.636 . . . . 0.0 109.088 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -158.44 151.62 22.8 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.59 1.956 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.85 158.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.134 1.374 . . . . 0.0 108.93 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.48 124.89 73.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -91.56 167.81 11.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.477 1.111 . . . . 0.0 110.01 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.14 111.39 19.41 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.731 1.212 . . . . 0.0 108.202 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -113.67 109.18 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 126.494 1.918 . . . . 0.0 108.066 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 64.0 1.01 1.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.143 1.777 . . . . 0.0 114.128 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.5 m 118.6 -11.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 1 C-N-CA 133.252 4.621 . . . . 0.0 110.498 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.3 144.72 28.69 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.119 0.967 . . . . 0.0 109.077 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.7 137.04 36.93 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.3 t -129.04 121.86 55.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.806 0.73 . . . . 0.0 110.074 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.98 161.84 20.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.623 2.369 . . . . 0.0 106.83 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.54 25.25 0.05 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.175 2.321 . . . . 0.0 112.384 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -165.33 91.91 0.1 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 121.838 2.819 . . . . 0.0 116.995 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -111.04 114.67 28.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -118.49 175.7 5.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.707 1.603 . . . . 0.0 112.061 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.4 -169.91 22.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 98.66 6.36 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -57.21 133.66 55.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.77 1.228 . . . . 0.0 110.856 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -129.06 124.07 33.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.384 . . . . 0.0 109.231 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tt -65.32 -21.52 66.72 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.13 -0.981 . . . . 0.0 112.851 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.54 38.3 3.79 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.508 1.523 . . . . 0.0 108.849 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.54 100.46 0.27 Allowed Glycine 0 C--N 1.337 0.588 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.044 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.94 151.24 12.19 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.625 1.57 . . . . 0.0 109.673 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -151.14 160.58 43.78 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 130.164 3.386 . . . . 0.0 106.342 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.4 m -135.87 98.56 3.93 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.364 0.666 . . . . 0.0 111.465 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -95.73 108.92 21.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.56 101.79 13.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.683 1.593 . . . . 0.0 108.208 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.1 t -76.96 141.39 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -95.12 150.79 19.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.247 -0.908 . . . . 0.0 112.157 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.4 -5.27 13.85 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.266 1.426 . . . . 0.0 111.949 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.53 -5.96 14.48 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.647 2.379 . . . . 0.0 111.345 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -116.08 150.99 36.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.855 1.262 . . . . 0.0 113.622 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.531 ' CG ' ' HE3' ' A' ' 124' ' ' LYS . 62.1 m-85 -135.56 132.94 37.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 127.589 2.356 . . . . 0.0 108.288 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.8 mt -71.65 113.2 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.0 m -93.9 -21.3 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 121.449 -0.782 . . . . 0.0 112.742 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.56 156.5 42.51 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.86 140.84 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.54 127.63 25.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.9 147.22 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.452 HG22 ' HB3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -109.63 138.24 46.28 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 129.674 3.19 . . . . 0.0 108.613 -178.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -154.57 166.14 34.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.68 0.792 . . . . 0.0 110.543 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.452 ' OD1' ' HE3' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -161.65 169.23 21.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.666 0.786 . . . . 0.0 110.968 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.7 158.44 20.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.512 2.325 . . . . 0.0 109.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.47 154.73 40.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.421 1.089 . . . . 0.0 108.634 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -63.89 144.08 57.35 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.37 11.96 71.03 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.839 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -142.74 142.75 32.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.891 1.276 . . . . 0.0 108.925 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.37 16.5 23.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.414 2.286 . . . . 0.0 107.701 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -115.6 179.34 4.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.681 2.392 . . . . 0.0 109.802 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.479 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 4.6 m-20 -135.15 149.34 49.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 102.896 -3.001 . . . . 0.0 102.896 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 pt -129.48 143.32 41.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.653 1.181 . . . . 0.0 108.764 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.7 mm -75.99 129.2 37.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.0 p -100.23 -38.96 8.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.599 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.3 169.46 18.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.91 1.284 . . . . 0.0 110.368 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.3 mm -132.24 144.83 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.171 1.388 . . . . 0.0 108.613 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 87.6 m -150.27 139.71 21.45 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.124 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -123.39 158.12 31.84 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.72 121.89 34.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.1 p -80.1 159.25 26.17 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.156 0.503 . . . . 0.0 111.166 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.65 -33.39 73.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -21.27 66.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.301 1.44 . . . . 0.0 112.84 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.34 -10.0 30.96 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.245 1.402 . . . . 0.0 113.658 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 12.1 tptt -78.51 159.31 28.26 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.039 2.135 . . . . 0.0 108.259 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.8 p -134.79 156.42 48.9 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.995 1.318 . . . . 0.0 111.648 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.45 157.37 35.55 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.01 165.64 31.57 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 121.854 1.703 . . . . 0.0 109.52 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.87 83.76 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.81 3.006 . . . . 0.0 107.701 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -56.92 101.66 0.07 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.984 1.314 . . . . 0.0 107.698 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.41 -143.65 14.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.8 tp -108.63 121.73 45.62 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.74 153.55 43.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 112' ' ' GLN . 1.4 m -150.75 -179.59 7.39 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.073 -1.642 . . . . 0.0 111.074 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.55 ' H ' HG22 ' A' ' 111' ' ' THR . 41.1 tt0 -73.7 -58.68 3.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.036 -1.04 . . . . 0.0 111.246 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HE3' ' OD1' ' A' ' 81' ' ' ASP . 22.6 mttt -70.19 166.48 19.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.923 1.238 . . . . 0.0 110.223 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.452 ' HB3' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER 175.69 167.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.237 2.215 . . . . 0.0 108.915 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -146.9 164.25 33.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.587 1.555 . . . . 0.0 107.83 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.04 142.39 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.57 135.33 34.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.984 1.313 . . . . 0.0 108.608 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -143.84 163.73 32.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 126.276 1.83 . . . . 0.0 108.784 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -118.5 175.45 5.71 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.679 1.992 . . . . 0.0 105.921 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -63.41 166.87 5.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -67.68 -9.06 40.19 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.585 -1.322 . . . . 0.0 113.795 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.78 -9.51 71.37 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.325 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.69 159.03 20.93 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.806 1.803 . . . . 0.0 113.764 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.531 ' HE3' ' CG ' ' A' ' 72' ' ' TYR . 14.3 mmtm -128.23 166.94 17.59 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.317 2.647 . . . . 0.0 107.441 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.21 147.48 27.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.044 -2.576 . . . . 0.0 104.044 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.16 -61.4 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 125.625 1.57 . . . . 0.0 107.588 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.67 31.07 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -133.25 157.43 45.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.932 1.293 . . . . 0.0 108.277 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -128.07 158.45 37.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.66 100.09 0.18 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 13' ' ' ALA . 54.6 mtt180 -65.19 91.74 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -114.0 165.8 12.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 128.069 2.548 . . . . 0.0 113.663 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -157.3 -121.17 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 106.07 -2.812 . . . . 0.0 106.07 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -66.25 -18.23 65.23 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.16 169.76 19.32 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 125.557 1.543 . . . . 0.0 108.164 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.74 84.26 7.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -69.39 -45.68 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 110.738 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 6' ' ' ALA . . . -146.41 144.28 29.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.099 0.959 . . . . 0.0 111.872 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 30.8 tp -140.72 144.91 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -154.38 -178.63 28.96 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.12 38.41 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.227 1.014 . . . . 0.0 108.281 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.68 113.85 24.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.829 0.852 . . . . 0.0 108.927 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -106.35 100.96 10.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.769 0.828 . . . . 0.0 111.801 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -121.56 130.17 53.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -105.19 166.52 10.35 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.751 1.221 . . . . 0.0 109.27 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.6 m -73.5 108.16 6.2 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.2 p -71.79 173.85 7.67 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.145 0.978 . . . . 0.0 110.354 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.5 p -71.59 140.65 84.5 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.631 -0.668 . . . . 0.0 109.484 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.49 176.96 9.42 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.146 2.564 . . . . 0.0 109.185 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.72 145.14 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.478 1.111 . . . . 0.0 110.583 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.1 p -74.81 158.56 84.54 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 124.047 0.939 . . . . 0.0 110.411 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -80.49 178.22 7.29 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.031 1.821 . . . . 0.0 110.351 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.33 164.72 24.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.047 -0.978 . . . . 0.0 109.139 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 119.24 37.74 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.567 ' HE2' ' CE1' ' A' ' 293' ' ' HIS . 10.4 ptpt -88.19 123.66 33.05 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.0 mt -75.56 -166.81 0.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.312 1.045 . . . . 0.0 109.86 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.2 m -113.96 128.48 56.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -108.58 165.31 11.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.484 1.514 . . . . 0.0 107.653 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.05 -176.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.207 1.003 . . . . 0.0 110.883 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.21 -108.58 3.7 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.754 1.169 . . . . 0.0 111.559 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -176.0 136.9 3.46 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.06 53.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.808 2.443 . . . . 0.0 110.186 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.462 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 81.3 mm-40 -117.4 92.91 3.98 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.663 1.185 . . . . 0.0 110.692 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.79 -177.35 31.33 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.494 1.045 . . . . 0.0 112.278 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.41 113.56 3.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.786 1.634 . . . . 0.0 110.127 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.17 145.2 56.08 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.114 0.966 . . . . 0.0 110.825 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 35.8 p-90 -138.51 61.56 1.58 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.04 104.66 6.67 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.68 99.4 10.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.263 2.625 . . . . 0.0 108.627 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -59.32 177.9 2.29 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 127.762 2.601 . . . . 0.0 112.441 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.23 25.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -118.44 -178.8 3.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.552 1.141 . . . . 0.0 109.257 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.07 -13.2 4.3 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.044 1.738 . . . . 0.0 114.198 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 136.32 -167.85 24.3 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 119.312 0.96 . . . . 0.0 112.291 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.6 m -128.44 156.8 40.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 127.824 2.45 . . . . 0.0 108.504 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -127.35 -52.08 1.39 Allowed 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.918 0.887 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.51 149.69 50.7 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.682 1.193 . . . . 0.0 108.306 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -126.1 139.73 50.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -127.05 112.74 15.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.594 1.157 . . . . 0.0 111.062 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.8 t -100.72 124.96 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.78 1.632 . . . . 0.0 107.623 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -115.78 139.59 15.51 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -138.29 -177.12 4.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.266 1.031 . . . . 0.0 112.019 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.64 -174.07 25.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 128.69 3.043 . . . . 0.0 106.846 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.97 -29.27 70.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.855 0.328 . . . . 0.0 110.854 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -72.36 -31.91 66.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.033 2.533 . . . . 0.0 113.01 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 136.88 -152.83 21.47 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mm -64.98 107.32 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.974 1.31 . . . . 0.0 109.007 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.0 p -101.79 -20.24 15.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.777 0.831 . . . . 0.0 112.564 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.06 160.72 42.11 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.084 1.311 . . . . 0.0 112.185 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 m -156.13 148.3 11.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.07 170.16 10.59 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.803 2.041 . . . . 0.0 107.011 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -160.29 164.49 32.56 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 109.894 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -102.53 123.21 45.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 148.19 23.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.647 1.979 . . . . 0.0 106.185 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.74 130.93 46.06 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -105.01 104.95 14.78 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.9 1.28 . . . . 0.0 108.019 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 71.31 -84.58 0.42 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.62 -18.29 2.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.341 2.257 . . . . 0.0 111.072 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.84 162.04 29.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.941 1.297 . . . . 0.0 109.572 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -112.21 145.5 39.79 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.679 0.792 . . . . 0.0 109.972 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.7 101.59 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.4 t -67.45 133.07 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.3 -169.8 42.6 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -100.1 -153.99 27.41 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.09 141.41 51.99 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 101.92 -3.363 . . . . 0.0 101.92 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -115.03 -80.22 0.59 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.44 1.018 . . . . 0.0 110.54 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.37 -179.11 50.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -99.81 103.69 23.5 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 120.931 2.365 . . . . 0.0 111.333 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.06 160.71 48.8 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 120.928 1.086 . . . . 0.0 109.367 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 25.2 p -102.81 178.11 4.66 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 27.2 tp -65.73 -13.57 59.58 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.795 -0.566 . . . . 0.0 111.509 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.65 -33.87 56.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.692 1.597 . . . . 0.0 110.645 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 110.83 -157.74 14.79 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 123.237 0.446 . . . . 0.0 112.387 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -133.93 170.74 15.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.159 2.184 . . . . 0.0 109.069 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.61 149.69 52.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 129.153 2.981 . . . . 0.0 104.765 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -133.49 149.12 51.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.954 0.797 . . . . 0.0 112.542 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -142.0 124.46 15.74 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -78.66 121.05 24.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.03 1.332 . . . . 0.0 109.682 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.76 124.71 63.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 128.127 2.571 . . . . 0.0 105.721 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.22 94.3 5.29 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -60.36 -33.6 15.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.525 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.76 13.94 1.57 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 CA-C-N 123.762 2.379 . . . . 0.0 111.198 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.31 -53.82 1.03 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.089 1.356 . . . . 0.0 109.878 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.86 177.75 4.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.461 1.504 . . . . 0.0 110.27 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -151.83 115.3 4.8 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 121.814 -0.553 . . . . 0.0 111.208 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.75 101.69 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.7 t -86.32 -19.5 29.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.995 1.318 . . . . 0.0 110.266 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -155.33 156.05 34.77 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.529 1.059 . . . . 0.0 110.833 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.7 144.48 32.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -132.08 173.27 11.4 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.647 1.979 . . . . 0.0 106.843 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 171.82 177.47 41.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 65.6 p -136.92 145.1 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -126.09 131.37 52.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.477 0.711 . . . . 0.0 111.554 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -138.41 170.77 15.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.136 1.375 . . . . 0.0 110.851 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 235' ' ' LYS . 2.6 mppt? -76.01 142.99 41.73 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.875 1.27 . . . . 0.0 111.882 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 20.2 pt -80.43 135.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.2 88.53 0.43 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.127 0.571 . . . . 0.0 110.808 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 151.95 -17.76 0.83 Allowed Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.296 -1.28 . . . . 0.0 112.76 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.2 m -140.27 179.16 6.81 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.554 1.177 . . . . 0.0 110.783 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.22 -30.09 24.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.177 2.591 . . . . 0.0 109.517 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -55.4 152.7 14.73 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 127.349 2.404 . . . . 0.0 112.976 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 66.3 mt -111.43 152.95 26.79 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.607 1.963 . . . . 0.0 109.222 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -143.73 160.38 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.246 1.418 . . . . 0.0 107.482 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.63 105.89 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -41.96 80.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.64 1.176 . . . . 0.0 111.582 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -147.89 159.48 43.81 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.912 0.485 . . . . 0.0 111.769 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 62.7 mt -135.13 147.11 49.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.287 1.835 . . . . 0.0 110.802 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -137.85 128.41 26.61 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.456 2.303 . . . . 0.0 107.749 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -111.38 113.61 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -81.71 113.83 19.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.2 p -109.99 165.84 11.41 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 126.623 1.969 . . . . 0.0 110.316 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -112.37 155.1 24.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 62.94 -16.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -135.18 172.27 13.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.619 1.568 . . . . 0.0 108.398 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.04 155.36 31.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.618 1.167 . . . . 0.0 108.005 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 12.6 p -123.01 178.27 5.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.421 1.889 . . . . 0.0 110.046 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -133.0 159.25 73.45 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 125.064 1.346 . . . . 0.0 109.73 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.61 108.24 2.65 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 109.01 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -79.24 92.94 5.17 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 118.01 179.78 17.2 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.687 1.137 . . . . 0.0 110.655 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 53.7 tp -82.96 111.97 19.31 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -68.47 106.95 2.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -171.23 146.51 2.37 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.838 2.455 . . . . 0.0 107.393 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 105.58 -176.69 22.46 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 18.1 m -67.77 122.97 19.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.7 144.2 43.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.138 -0.351 . . . . 0.0 110.317 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -138.65 144.34 39.64 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.5 1.12 . . . . 0.0 109.139 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.64 155.91 47.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.74 121.14 17.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -169.66 133.32 1.27 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.425 1.89 . . . . 0.0 109.829 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -146.0 129.21 16.67 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.0 1.32 . . . . 0.0 110.449 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 30.33 52.61 0.12 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.115 2.966 . . . . 0.0 112.721 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 53.25 13.04 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-O 117.264 -1.853 . . . . 0.0 115.706 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.41 151.71 3.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.239 1.816 . . . . 0.0 111.228 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -95.28 132.61 40.1 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.15 1.78 . . . . 0.0 109.294 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.19 121.68 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.71 34.15 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.882 0.873 . . . . 0.0 111.069 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 166.86 174.25 35.93 Favored Glycine 0 C--N 1.334 0.436 0 O-C-N 120.663 -1.273 . . . . 0.0 111.918 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 292' ' ' VAL . 48.8 m-85 -129.98 158.81 38.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.235 1.814 . . . . 0.0 108.509 -178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . 0.409 ' CE1' ' HA3' ' A' ' 291' ' ' GLY . 7.8 p-80 -149.26 165.74 31.01 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 112.23 -160.05 13.38 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.462 ' HE2' ' C ' ' A' ' 163' ' ' GLU . 0.0 OUTLIER -129.23 164.58 23.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.928 0.87 . . . . 0.0 110.743 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -127.96 149.52 50.3 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 m -152.37 -155.14 0.58 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 101.668 -3.456 . . . . 0.0 101.668 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -55.31 -36.45 66.21 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.008 -1.058 . . . . 0.0 110.285 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 51.5 mt -127.14 164.44 21.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.128 1.371 . . . . 0.0 110.18 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.72 77.4 9.79 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -60.92 -39.39 89.2 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -128.16 144.88 51.15 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -156.23 110.64 2.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 280' ' ' HIS . . . -137.26 174.45 21.72 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 279' ' ' PHE . 8.9 m -128.45 174.93 11.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.03 0.932 . . . . 0.0 112.578 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . 0.567 ' CE1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER -118.16 128.13 54.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.9 2.48 . . . . 0.0 106.458 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.4 m -115.83 147.52 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.75 1.22 . . . . 0.0 109.996 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 81.2 mtp -141.97 144.15 31.07 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 126.331 1.852 . . . . 0.0 107.652 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.89 153.64 53.11 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.049 2.499 . . . . 0.0 112.433 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.95 82.54 3.0 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.579 1.152 . . . . 0.0 110.261 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.9 m -63.58 -16.52 61.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.056 1.343 . . . . 0.0 109.948 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 127.821 2.448 . . . . 0.0 109.899 -179.331 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -135.67 97.01 3.55 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.945 1.702 . . . . 0.0 110.278 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.04 130.43 34.62 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.35 128.11 60.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 104.2 -2.519 . . . . 0.0 104.2 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -72.7 155.54 39.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.693 0.679 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.44 101.62 13.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.366 1.466 . . . . 0.0 110.042 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.32 153.5 52.94 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.81 177.85 38.32 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 88' ' ' SER . . . -72.53 -50.44 15.35 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.527 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 125.64 0.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 129.639 3.176 . . . . 0.0 118.312 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.67 -4.05 1.88 Allowed Glycine 0 CA--C 1.539 1.535 0 N-CA-C 120.706 3.042 . . . . 0.0 120.706 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 137' ' ' TYR . . . -107.5 -174.01 22.37 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 121.336 2.568 . . . . 0.0 113.899 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.81 159.83 15.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.147 2.579 . . . . 0.0 112.991 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -3.66 109.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 1 C-N-CA 132.862 4.465 . . . . 0.0 117.531 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.489 ' HB3' ' H ' ' A' ' 130' ' ' GLY . 2.6 m0 -56.93 144.0 35.49 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 128.91 2.884 . . . . 0.0 108.353 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 p30 59.1 9.38 1.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -50.67 129.32 22.48 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.385 0.993 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.42 30.88 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -42.13 128.49 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.482 1.913 . . . . 0.0 111.698 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -164.92 169.02 16.99 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 127.143 2.177 . . . . 0.0 106.509 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -142.29 52.78 1.45 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.498 1.142 . . . . 0.0 112.51 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.48 22.68 3.5 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.023 1.297 . . . . 0.0 112.426 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -60.27 146.48 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.712 1.756 . . . . 0.0 111.735 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.06 -28.81 0.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -146.15 159.03 43.86 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -142.68 115.29 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -88.28 144.52 26.38 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 t -141.56 148.08 21.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.496 1.119 . . . . 0.0 108.377 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -141.63 119.95 1.57 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -79.94 126.09 30.57 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.504 1.122 . . . . 0.0 108.72 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.03 -175.82 20.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -64.5 -36.8 85.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.11 17.22 0.25 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 131.126 3.77 . . . . 0.0 112.476 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.67 -136.79 18.45 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.48 95.68 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 p -109.41 -10.54 14.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 118.446 -0.788 . . . . 0.0 113.02 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 p -138.21 128.08 25.39 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.619 1.1 . . . . 0.0 109.015 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.98 154.24 23.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.114 1.366 . . . . 0.0 109.078 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.418 HD21 ' CD ' ' A' ' 50' ' ' GLU . 54.2 t30 -155.63 99.18 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.859 0.463 . . . . 0.0 110.747 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 p -77.97 145.04 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -127.73 134.57 65.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -115.77 169.95 8.83 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.459 1.123 . . . . 0.0 111.508 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.14 134.63 50.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 127.916 2.486 . . . . 0.0 106.61 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -115.88 150.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.55 -39.45 87.97 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 122.204 0.202 . . . . 0.0 110.555 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 t -71.41 -70.89 0.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -149.45 139.91 22.43 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.545 1.138 . . . . 0.0 109.351 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.37 141.05 48.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.473 1.509 . . . . 0.0 108.351 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.5 147.32 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 108.33 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' CD ' HD21 ' A' ' 39' ' ' ASN . 36.3 tt0 -101.1 138.05 38.64 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.06 -68.06 1.64 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.72 144.09 3.93 Favored Glycine 0 N--CA 1.444 -0.806 0 O-C-N 121.595 -0.944 . . . . 0.0 112.465 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.95 133.71 43.07 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.757 1.623 . . . . 0.0 107.687 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -119.65 169.7 9.85 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.913 1.285 . . . . 0.0 110.252 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.38 -151.73 20.81 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -121.36 106.1 11.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -63.41 163.16 11.21 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.195 0.522 . . . . 0.0 111.392 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -138.79 162.7 34.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.044 0.938 . . . . 0.0 108.579 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.9 tp -89.34 -33.22 16.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.841 1.256 . . . . 0.0 112.174 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.9 mt -100.77 12.14 38.12 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.74 106.21 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -160.63 126.27 3.92 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.255 1.422 . . . . 0.0 108.239 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -148.77 163.59 36.92 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.866 1.666 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.2 m -141.14 133.4 28.09 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -128.25 131.24 48.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -113.55 146.67 39.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.153 0.981 . . . . 0.0 108.515 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.3 t -109.8 117.35 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.42 156.4 39.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.27 -12.11 59.65 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.499 -0.75 . . . . 0.0 111.812 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -104.79 -7.79 19.22 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.465 1.506 . . . . 0.0 111.394 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -119.64 136.58 54.33 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.87 147.51 50.45 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.288 0.566 . . . . 0.0 110.739 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.6 mt -78.23 131.2 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.96 -21.41 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 122.691 0.396 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.59 152.62 38.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.935 1.294 . . . . 0.0 108.062 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.5 t -146.42 142.38 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -110.23 115.23 29.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -108.18 125.34 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.2 p -116.43 139.54 50.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -154.78 163.65 39.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.382 1.073 . . . . 0.0 108.6 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.03 168.89 23.59 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.44 0.564 . . . . 0.0 110.113 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -99.55 155.55 17.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.321 1.848 . . . . 0.0 112.008 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.7 137.5 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -78.56 72.26 5.08 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.49 18.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.494 1.521 . . . . 0.0 113.008 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.98 149.68 52.22 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.7 -16.02 61.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.037 0.935 . . . . 0.0 112.554 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 2.2 p -161.28 172.0 17.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.462 ' H ' ' HA3' ' A' ' 9' ' ' GLY . 1.0 OUTLIER -76.47 151.91 36.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 177.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.0 pt -134.64 152.27 33.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 124.594 1.158 . . . . 0.0 109.453 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.2 mm -68.35 112.05 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.422 1.089 . . . . 0.0 108.163 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -81.31 -40.61 23.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.866 1.266 . . . . 0.0 111.217 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 t -157.84 173.92 16.06 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.57 1.948 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.54 155.34 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 109.63 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.1 m -148.92 122.38 9.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.301 1.44 . . . . 0.0 108.761 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -92.74 138.22 31.68 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.564 1.145 . . . . 0.0 108.73 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -123.12 115.56 22.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.006 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.6 p -91.34 168.06 11.84 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 121.546 -0.721 . . . . 0.0 110.409 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -70.88 -30.1 66.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.29 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -69.79 -6.25 30.91 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.21 66.46 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -82.08 126.6 32.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.5 m -127.66 149.8 50.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 31.6 p -99.1 161.58 24.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.006 0.923 . . . . 0.0 110.465 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -76.49 166.25 27.69 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.729 1.619 . . . . 0.0 109.778 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.6 108.53 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.067 2.511 . . . . 0.0 109.089 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -80.31 73.82 7.16 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 135.73 -176.15 20.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.9 tp -78.05 112.86 15.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 110.62 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 154.01 19.88 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -144.24 176.4 9.37 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 119.916 -1.74 . . . . 0.0 112.719 -177.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.489 ' H ' HG22 ' A' ' 111' ' ' THR . 12.3 tt0 -70.36 -56.93 5.49 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -66.07 150.6 48.46 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 pttt 172.73 173.42 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 126.461 1.904 . . . . 0.0 109.321 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -146.91 164.82 31.67 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.617 1.967 . . . . 0.0 107.338 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 p -141.48 139.06 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -136.36 122.67 20.58 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.41 160.77 42.19 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.389 1.475 . . . . 0.0 109.456 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -85.27 176.77 8.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.068 0.849 . . . . 0.0 109.34 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -128.03 -49.48 1.34 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.315 1.446 . . . . 0.0 109.207 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -68.52 -3.05 10.22 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.072 1.749 . . . . 0.0 113.97 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.28 47.55 5.43 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 120.617 1.553 . . . . 0.0 111.275 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -85.73 -165.14 40.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.23 1.395 . . . . 0.0 111.657 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -131.24 151.71 51.22 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.436 1.895 . . . . 0.0 107.281 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.7 tp -71.34 154.06 41.88 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.53 -47.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 118.762 0.71 . . . . 0.0 112.548 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -167.29 168.39 40.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 120.091 1.314 . . . . 0.0 111.022 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -114.49 169.94 8.68 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.967 1.307 . . . . 0.0 110.216 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -164.84 170.88 14.87 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.241 2.616 . . . . 0.0 106.678 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 15' ' ' TRP . . . 128.65 129.4 3.18 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 126.145 1.831 . . . . 0.0 110.027 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.61 122.36 1.94 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.179 0.99 . . . . 0.0 112.651 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.0 166.06 25.03 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.847 2.459 . . . . 0.0 109.628 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 168.29 -119.14 0.82 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -68.5 -6.3 24.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.08 175.1 13.36 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 128.782 2.833 . . . . 0.0 106.656 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.67 95.06 5.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CD1' ' HA3' ' A' ' 12' ' ' GLY . 14.2 m-85 -83.22 -30.44 27.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.845 1.658 . . . . 0.0 113.112 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.16 42.47 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.023 0.929 . . . . 0.0 108.772 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 65.3 tp -154.66 134.56 12.96 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.43 179.12 37.04 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 125.67 1.605 . . . . 0.0 109.127 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.05 171.89 17.7 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.478 0.639 . . . . 0.0 111.395 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -115.7 150.67 36.43 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.592 1.157 . . . . 0.0 108.522 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -125.01 111.53 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.27 141.48 43.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.75 0.786 . . . . 0.0 109.587 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 t -133.49 166.0 23.57 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.495 1.918 . . . . 0.0 107.596 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.41 177.42 11.38 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.805 1.642 . . . . 0.0 106.89 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 t -158.48 59.11 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.5 p -138.05 156.27 74.11 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.441 1.496 . . . . 0.0 110.016 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.69 169.22 22.73 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.021 2.481 . . . . 0.0 110.179 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.49 118.44 26.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 152' ' ' PRO . 75.1 p -130.24 160.69 64.39 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 123.559 0.744 . . . . 0.0 110.245 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 151' ' ' THR . 92.5 Cg_endo -74.11 -167.66 0.41 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.405 2.737 . . . . 0.0 108.914 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -176.64 0.81 Allowed 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.103 -0.998 . . . . 0.0 112.261 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -74.09 129.72 38.4 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.096 -1.002 . . . . 0.0 110.098 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.416 ' HE3' ' ND1' ' A' ' 280' ' ' HIS . 77.9 tttt -98.95 106.47 18.73 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.002 1.321 . . . . 0.0 108.045 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.0 mt -74.88 173.9 9.99 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.0 t -76.08 163.66 26.9 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 120.838 -1.164 . . . . 0.0 109.062 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -144.41 138.19 27.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 tp -118.47 138.35 49.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 127.227 2.211 . . . . 0.0 107.321 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.57 -31.2 0.57 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 154.54 -169.55 32.84 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -136.19 6.69 3.09 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.082 1.753 . . . . 0.0 109.3 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -113.97 146.99 39.34 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.157 1.383 . . . . 0.0 109.82 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.56 175.36 14.04 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.955 1.264 . . . . 0.0 110.43 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.9 m -65.35 123.34 19.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 115.58 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.165 0.986 . . . . 0.0 110.038 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.845 ' HE1' ' HB2' ' A' ' 283' ' ' ALA . 7.8 m0 -78.22 125.08 28.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -96.41 114.45 26.13 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 126.288 1.835 . . . . 0.0 108.142 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.53 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 128.523 2.729 . . . . 0.0 115.012 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 64.28 -162.08 37.05 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -169.79 143.17 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.304 1.842 . . . . 0.0 107.866 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.28 -178.74 4.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.28 -34.0 66.03 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.423 1.011 . . . . 0.0 110.328 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.0 -163.7 33.38 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 124.563 1.078 . . . . 0.0 110.418 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.56 157.18 18.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.403 2.281 . . . . 0.0 108.22 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -120.37 -46.41 2.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.786 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.403 ' HE2' ' OE1' ' A' ' 193' ' ' GLU . 26.1 ttpt -137.19 145.24 43.46 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 145.73 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -126.68 157.72 38.3 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.619 1.168 . . . . 0.0 109.582 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.6 t -138.88 129.5 33.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.65 111.84 2.03 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.22 177.45 4.68 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.478 0.711 . . . . 0.0 110.794 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -160.08 -168.06 21.52 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 127.486 2.47 . . . . 0.0 107.994 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -75.17 -20.0 59.56 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 122.142 -0.622 . . . . 0.0 111.259 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.92 -31.57 35.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 130.869 3.668 . . . . 0.0 112.691 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 139.36 -132.48 5.67 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mm -88.03 105.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.87 -23.46 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 113.18 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.86 150.02 32.29 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.285 0.948 . . . . 0.0 111.717 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.32 133.6 46.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 123.947 0.899 . . . . 0.0 108.596 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 15.0 pttp -156.42 170.99 21.05 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.547 1.539 . . . . 0.0 107.308 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -167.73 174.77 7.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.333 1.453 . . . . 0.0 108.367 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.403 ' OE1' ' HE2' ' A' ' 177' ' ' LYS . 21.7 mt-10 -100.65 137.06 39.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -97.79 167.82 10.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.148 0.499 . . . . 0.0 110.771 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -121.01 116.78 25.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.021 1.728 . . . . 0.0 108.138 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -140.54 114.11 8.75 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 40.51 57.86 2.64 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.289 0.947 . . . . 0.0 113.974 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 65.79 -3.35 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.008 2.523 . . . . 0.0 117.165 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -74.66 170.2 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.349 0.977 . . . . 0.0 108.532 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -136.51 104.44 5.57 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.78 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 119.172 0.896 . . . . 0.0 113.018 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.01 129.33 36.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 124.831 1.252 . . . . 0.0 108.743 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -66.15 -179.36 9.64 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.718 1.627 . . . . 0.0 111.353 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.71 151.7 21.96 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 121.71 0.617 . . . . 0.0 113.294 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -77.39 102.8 6.98 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.219 1.408 . . . . 0.0 107.617 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -78.85 -64.35 1.2 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.65 1.18 . . . . 0.0 109.828 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.74 170.86 53.56 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.659 1.124 . . . . 0.0 111.622 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -80.66 113.32 38.93 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.581 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.82 169.86 20.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.33 1.353 . . . . 0.0 110.748 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.4 p -126.79 173.93 9.17 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.488 1.115 . . . . 0.0 108.49 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.39 -6.33 42.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.512 -0.742 . . . . 0.0 112.494 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.7 -1.44 6.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.332 1.053 . . . . 0.0 111.069 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.48 -160.91 54.15 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.585 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 35.8 m-85 -135.8 163.08 31.02 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.98 1.312 . . . . 0.0 108.5 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -124.47 157.44 35.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.42 148.88 52.42 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.494 1.118 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -141.51 116.33 9.78 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.14 138.42 34.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.412 1.085 . . . . 0.0 109.049 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.6 mm -128.2 130.24 69.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.18 90.23 0.88 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -39.1 -50.99 4.31 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.19 -19.11 8.24 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 121.365 1.523 . . . . 0.0 114.388 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.0 m -106.52 -10.87 16.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.88 147.3 31.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.909 1.284 . . . . 0.0 107.643 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.37 126.3 11.21 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.565 HD12 ' H ' ' A' ' 226' ' ' ILE . 4.5 mp -57.09 112.75 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.248 1.819 . . . . 0.0 108.056 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 21.6 p -84.8 -24.74 28.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 0.0 111.142 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.534 ' HB3' ' HD3' ' A' ' 250' ' ' LYS . . . -172.29 171.13 4.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.942 2.097 . . . . 0.0 109.207 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.5 104.98 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -83.75 171.03 13.57 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.886 -1.134 . . . . 0.0 109.033 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 170.18 177.03 40.16 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.1 p -142.16 147.08 36.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.53 162.39 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.852 0.861 . . . . 0.0 109.415 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -146.9 156.46 43.1 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -71.78 138.83 48.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.963 1.705 . . . . 0.0 113.175 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 81.5 mt -81.24 97.57 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -47.26 147.04 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.569 1.548 . . . . 0.0 112.089 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.85 -12.6 52.46 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 62.9 p -141.13 -174.15 3.93 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.654 1.981 . . . . 0.0 107.68 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -133.69 91.65 2.87 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -158.91 173.44 35.82 Favored Glycine 0 CA--C 1.53 0.994 1 C-N-CA 131.185 4.231 . . . . 0.0 104.154 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.18 166.01 31.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 119.602 1.701 . . . . 0.0 111.781 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 7.6 tt -141.65 144.58 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.176 1.39 . . . . 0.0 109.239 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 37.4 mt -75.45 132.82 32.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.255 5.4 t -116.78 -12.16 10.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.615 0.766 . . . . 0.0 112.027 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -146.63 144.01 29.21 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.602 1.161 . . . . 0.0 108.775 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.95 127.15 13.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.735 0.698 . . . . 0.0 111.206 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -130.55 154.61 47.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.451 1.5 . . . . 0.0 109.408 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -118.54 126.62 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.534 ' HD3' ' HB3' ' A' ' 228' ' ' ALA . 44.0 mtpt -71.97 114.87 10.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 p -109.69 165.76 11.43 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 127.476 2.31 . . . . 0.0 109.231 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -119.83 134.13 55.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 80.7 mttt 59.33 7.17 0.87 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -144.23 152.07 40.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.994 2.118 . . . . 0.0 106.074 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 61.3 m -143.95 118.48 9.73 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 11.7 p -78.16 177.83 8.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.92 1.688 . . . . 0.0 111.793 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -73.51 154.36 89.75 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 123.889 0.875 . . . . 0.0 110.015 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.15 96.96 1.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 109.207 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -78.5 114.26 17.26 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.74 -163.03 22.38 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.9 pp -127.63 122.69 33.74 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.74 108.35 2.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.738 1.615 . . . . 0.0 109.964 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.65 176.9 9.19 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.188 0.995 . . . . 0.0 111.633 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 72.58 -98.74 0.86 Allowed Glycine 0 CA--C 1.52 0.393 0 C-N-CA 126.311 1.91 . . . . 0.0 112.425 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 95.9 m -145.36 122.01 11.14 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.214 1.405 . . . . 0.0 107.612 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.64 145.07 33.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.101 0.56 . . . . 0.0 109.965 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -132.43 158.59 41.62 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 122.534 1.159 . . . . 0.0 110.519 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.92 146.24 26.15 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 53.5 mt -141.87 108.77 5.42 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.861 1.664 . . . . 0.0 108.478 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 228' ' ' ALA . 10.2 pttp -157.8 163.92 37.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.679 1.581 . . . . 0.0 111.496 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.87 157.46 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.3 1.44 . . . . 0.0 107.85 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -75.1 140.88 43.75 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.738 0.815 . . . . 0.0 110.013 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 63.38 5.36 11.26 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 117.389 -1.784 . . . . 0.0 116.741 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -112.1 153.7 26.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.197 1.998 . . . . 0.0 112.003 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -115.52 164.19 14.67 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.272 2.229 . . . . 0.0 107.692 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 6.2 mt -93.08 134.18 31.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.89 -0.38 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.167 0.987 . . . . 0.0 113.554 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -143.98 157.19 27.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -131.33 124.29 30.1 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.495 1.918 . . . . 0.0 109.92 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . 0.416 ' ND1' ' HE3' ' A' ' 155' ' ' LYS . 15.0 p80 -127.27 179.51 5.41 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.03 1.332 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 120.2 -127.37 7.05 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -161.25 151.35 17.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.906 1.282 . . . . 0.0 111.818 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.845 ' HB2' ' HE1' ' A' ' 167' ' ' TRP . . . -113.06 146.8 38.5 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.397 1.479 . . . . 0.0 108.113 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -155.75 -160.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.431 1.892 . . . . 0.0 106.064 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -38.06 88.43 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.36 162.95 20.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.41 1.484 . . . . 0.0 108.884 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.33 95.68 1.76 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.455 0.702 . . . . 0.0 109.855 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -83.56 -84.01 0.14 Allowed 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -88.55 165.6 14.73 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -167.85 99.89 0.47 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.43 1.892 . . . . 0.0 107.435 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -129.35 169.73 20.54 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 121.694 -0.629 . . . . 0.0 111.745 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.1 m -136.06 173.36 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 122.118 0.961 . . . . 0.0 112.776 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.15 124.97 42.94 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 103.998 -2.594 . . . . 0.0 103.998 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 28.8 m -108.93 137.63 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.492 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.24 139.47 34.6 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 123.978 0.911 . . . . 0.0 109.606 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.43 137.09 35.56 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.493 2.795 . . . . 0.0 110.738 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.16 -12.38 61.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.202 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.75 15.13 12.66 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.342 0.973 . . . . 0.0 112.956 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--O 1.245 0.865 0 C-N-CA 127.783 2.433 . . . . 0.0 111.545 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.14 149.19 48.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.15 1.38 . . . . 0.0 110.986 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HD3' ' CD1' ' A' ' 142' ' ' TYR . 71.6 mmtt -137.81 139.77 40.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 128.339 2.656 . . . . 0.0 107.62 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.487 ' CG1' ' H ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -121.4 148.14 24.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.073 0.949 . . . . 0.0 111.267 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.11 131.3 46.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.4 87.87 1.56 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.09 116.16 5.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.39 -170.5 30.99 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.35 177.73 33.74 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 122.834 1.241 . . . . 0.0 115.87 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.09 0.5 55.15 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.844 1.658 . . . . 0.0 114.49 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 175.04 54.85 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.254 0.933 . . . . 0.0 110.817 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -175.06 50.51 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.57 1.081 . . . . 0.0 114.696 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.56 157.2 27.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.155 1.382 . . . . 0.0 110.36 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -77.1 88.17 3.59 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 128.023 2.529 . . . . 0.0 114.942 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -106.17 92.46 4.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.82 149.65 23.72 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.795 1.638 . . . . 0.0 108.797 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 31.21 58.55 0.27 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 127.753 2.421 . . . . 0.0 110.873 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -90.02 -161.37 37.39 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.535 2.017 . . . . 0.0 116.091 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -126.95 10.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 128.232 2.613 . . . . 0.0 112.244 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -104.54 80.24 1.65 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.64 40.08 2.84 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.881 1.272 . . . . 0.0 111.727 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.68 51.33 0.85 Allowed Glycine 0 C--N 1.339 0.715 0 CA-C-O 118.654 -1.081 . . . . 0.0 115.553 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.96 154.08 7.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 119.793 1.796 . . . . 0.0 110.629 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -128.77 -41.53 1.48 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.532 1.133 . . . . 0.0 110.696 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -133.48 171.72 13.69 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.449 1.5 . . . . 0.0 108.174 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -140.25 130.22 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -131.11 144.03 51.09 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.3 t -148.31 147.56 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 127.862 2.465 . . . . 0.0 105.69 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.13 133.15 3.47 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 107.119 -2.392 . . . . 0.0 107.119 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -75.85 176.8 7.47 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.066 0.936 . . . . 0.0 108.934 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.82 -160.42 10.5 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -77.06 -31.53 56.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.836 0.35 . . . . 0.0 110.227 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -91.4 -27.34 18.38 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.653 3.181 . . . . 0.0 115.182 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.75 -140.7 11.46 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -75.63 96.34 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.28 -7.29 21.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.449 1.1 . . . . 0.0 113.647 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -129.86 143.72 50.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.96 1.255 . . . . 0.0 112.377 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -159.02 130.53 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.039 0.936 . . . . 0.0 109.705 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -117.85 151.43 37.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.819 1.648 . . . . 0.0 109.809 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.12 140.96 45.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 125.062 1.345 . . . . 0.0 110.263 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -127.47 98.77 4.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 104.119 -2.549 . . . . 0.0 104.119 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -81.3 105.68 12.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.99 120.44 27.39 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -115.16 157.39 23.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.749 -0.594 . . . . 0.0 110.879 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.44 6.56 4.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.59 1.956 . . . . 0.0 108.609 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -121.58 -69.55 0.83 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.432 2.293 . . . . 0.0 108.742 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -154.96 135.05 13.05 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.84 150.27 39.31 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.906 1.282 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.2 t -138.39 122.9 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.992 0.917 . . . . 0.0 111.37 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -85.21 99.66 11.24 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.91 -21.63 45.46 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.569 -1.128 . . . . 0.0 113.936 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.01 142.29 12.06 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.021 1.296 . . . . 0.0 111.766 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -74.08 130.23 39.4 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.612 1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -116.4 175.7 5.44 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.236 0.541 . . . . 0.0 109.949 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -134.78 12.41 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 105.653 -2.979 . . . . 0.0 105.653 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -126.77 99.24 5.68 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.24 144.97 56.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.06 142.87 30.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 122.776 1.274 . . . . 0.0 110.516 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.6 pp -89.23 -4.65 58.12 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.592 -1.317 . . . . 0.0 110.447 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.49 -16.71 62.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.499 1.12 . . . . 0.0 111.455 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.3 117.83 0.42 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -163.14 135.44 5.29 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 128.997 2.919 . . . . 0.0 105.734 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -132.18 160.12 37.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.8 m -116.3 118.61 33.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.566 1.946 . . . . 0.0 108.905 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.13 109.13 13.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.8 160.91 20.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 109.747 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.72 106.12 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.95 156.92 23.07 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 121.509 -0.744 . . . . 0.0 109.617 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.68 -26.69 27.58 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.414 -0.804 . . . . 0.0 110.311 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.62 -34.98 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.108 1.763 . . . . 0.0 112.393 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -92.86 164.51 13.3 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.986 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.67 -178.72 5.25 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.127 1.771 . . . . 0.0 109.812 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.9 139.11 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.6 m -115.62 -36.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.074 0.95 . . . . 0.0 112.864 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.72 165.76 29.52 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.975 0.91 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -147.7 101.77 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -85.65 94.28 9.04 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -98.2 153.55 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.686 1.994 . . . . 0.0 108.134 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.491 HG21 ' N ' ' A' ' 111' ' ' THR . 7.3 m -139.02 148.47 43.44 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.357 1.063 . . . . 0.0 109.069 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.05 155.42 36.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.121 1.368 . . . . 0.0 108.515 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.84 168.49 22.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.109 0.963 . . . . 0.0 110.144 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -109.51 119.38 39.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.35 1.06 . . . . 0.0 109.213 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.7 m -90.08 151.29 3.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -60.89 -6.61 1.89 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 113.32 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -98.29 -0.65 58.24 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 117.54 -1.7 . . . . 0.0 112.703 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -133.43 158.59 42.67 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.89 1.845 . . . . 0.0 111.051 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -85.29 -19.51 31.45 Favored 'General case' 0 C--N 1.323 -0.547 1 C-N-CA 131.81 4.044 . . . . 0.0 111.586 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.4 t -129.6 164.92 22.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.389 1.876 . . . . 0.0 110.691 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.47 156.14 27.97 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.4 pt -141.0 154.6 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.418 1.887 . . . . 0.0 108.673 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.8 mm -73.27 129.55 36.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -103.31 -41.29 6.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 113.275 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.5 t -146.58 161.23 40.96 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.746 1.219 . . . . 0.0 109.503 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.3 mt -148.06 122.96 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.554 1.541 . . . . 0.0 108.314 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -125.07 107.07 10.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.418 1.087 . . . . 0.0 108.869 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -84.95 149.15 25.82 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.848 0.833 . . . . 0.0 110.383 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -130.75 113.35 14.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -84.25 164.3 19.14 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.396 0.678 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -71.13 -38.23 72.29 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.61 -35.92 82.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.217 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 128.25 3.68 5.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 118.565 -1.13 . . . . 0.0 114.87 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -76.71 95.86 4.09 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -86.64 103.5 15.18 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 p -71.72 155.89 91.8 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.42 166.18 30.55 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 121.939 1.759 . . . . 0.0 110.907 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.24 112.74 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.789 2.993 . . . . 0.0 107.232 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -78.07 67.67 3.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.088 1.355 . . . . 0.0 107.369 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.41 -179.74 17.78 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 124.717 1.151 . . . . 0.0 111.143 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.6 tp -80.07 119.09 22.41 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.68 1.592 . . . . 0.0 111.556 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 157.87 23.1 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.491 ' N ' HG21 ' A' ' 79' ' ' THR . 0.2 OUTLIER -148.18 172.49 14.23 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.777 -1.202 . . . . 0.0 109.771 -178.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -69.34 -49.29 57.01 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -66.72 138.48 57.43 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.1 pttt 169.54 171.36 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.864 2.466 . . . . 0.0 109.79 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -138.4 156.35 47.67 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.384 1.873 . . . . 0.0 107.153 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.6 149.39 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 123.829 0.851 . . . . 0.0 109.844 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.91 142.97 16.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 0.0 109.66 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.25 156.52 30.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.675 0.79 . . . . 0.0 110.077 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.73 175.94 9.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.626 1.97 . . . . 0.0 113.262 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -127.99 -46.87 1.38 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.423 -0.798 . . . . 0.0 112.965 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -127.39 13.45 7.09 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.83 0.852 . . . . 0.0 112.554 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.9 -84.31 0.32 Allowed Glycine 0 C--O 1.227 -0.321 0 N-CA-C 107.508 -2.237 . . . . 0.0 107.508 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.36 76.07 0.11 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 125.855 1.693 . . . . 0.0 112.281 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.21 123.84 12.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.853 0.861 . . . . 0.0 111.197 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.73 115.98 6.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.44 -9.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.194 1.397 . . . . 0.0 112.757 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.65 -91.0 0.3 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 119.295 0.952 . . . . 0.0 114.617 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 78.38 152.2 0.12 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 128.425 2.69 . . . . 0.0 109.811 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -157.75 170.07 23.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.958 2.103 . . . . 0.0 106.172 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.31 101.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 O-C-N 121.533 -0.729 . . . . 0.0 112.737 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -51.57 123.16 9.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.48 164.42 38.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.274 0.63 . . . . 0.0 109.375 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.22 -110.41 0.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -67.38 -12.36 60.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.207 0.503 . . . . 0.0 112.215 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.67 174.48 12.53 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 127.839 2.456 . . . . 0.0 107.528 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -102.04 89.43 3.62 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.219 1.008 . . . . 0.0 108.485 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.4 -38.81 49.0 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.01 167.0 26.07 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 120.016 1.28 . . . . 0.0 112.283 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.93 171.24 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.85 2.06 . . . . 0.0 108.782 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 169.78 169.91 33.58 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.882 1.706 . . . . 0.0 110.106 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' H ' ' CG1' ' A' ' 4' ' ' VAL . . . -153.16 167.69 28.45 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.688 1.595 . . . . 0.0 112.296 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.4 ' CD1' ' HD3' ' A' ' 3' ' ' LYS . 6.9 m-85 -129.77 163.2 26.72 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.257 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -144.4 135.87 25.62 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.16 105.19 5.92 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.957 1.303 . . . . 0.0 112.217 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.3 t -135.07 143.9 46.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.392 1.077 . . . . 0.0 108.477 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 t -162.83 -54.2 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.017 0.927 . . . . 0.0 108.929 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.3 p -148.46 93.17 2.11 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.72 145.71 35.09 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 119.062 0.846 . . . . 0.0 111.113 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -78.67 170.01 18.84 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 125.079 3.852 . . . . 0.0 111.258 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 87.6 t -135.47 108.61 9.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.0 p -137.42 160.78 64.09 Favored Pre-proline 0 C--O 1.242 0.682 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -84.0 4.56 6.88 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.438 3.425 . . . . 0.0 119.408 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.27 153.53 33.78 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 125.976 1.71 . . . . 0.0 112.565 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -75.67 122.23 23.67 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.59 0.756 . . . . 0.0 109.286 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -90.3 146.42 24.22 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.4 mt -101.08 -86.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 t -167.33 171.25 10.8 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.659 1.984 . . . . 0.0 109.07 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -152.73 177.2 10.95 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 126.24 1.816 . . . . 0.0 107.634 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.6 tt -138.34 -25.33 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -23.89 -92.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.757 0 C-N-CA 129.913 3.625 . . . . 0.0 117.667 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.77 41.46 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 126.029 1.776 . . . . 0.0 108.782 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.415 ' C ' ' HE2' ' A' ' 282' ' ' LYS . 1.3 m-20 -114.96 5.71 15.12 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 114.303 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -82.98 122.33 28.15 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.28 1.4 . . . . 0.0 111.529 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.73 -168.52 13.62 Favored Glycine 0 N--CA 1.465 0.57 0 O-C-N 120.663 -1.273 . . . . 0.0 112.707 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.7 m -106.78 124.7 49.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 117.767 0.783 . . . . 0.0 111.121 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.71 153.84 27.62 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.189 1.396 . . . . 0.0 110.703 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -138.32 120.7 15.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.32 1.048 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.66 132.72 33.8 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.41 -0.807 . . . . 0.0 109.074 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.38 91.19 1.8 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.93 -72.75 0.52 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.699 -0.626 . . . . 0.0 114.157 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.12 170.65 20.78 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.221 1.408 . . . . 0.0 110.154 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.6 -179.7 3.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.659 1.184 . . . . 0.0 108.268 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.88 -23.69 55.63 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.678 -1.264 . . . . 0.0 112.297 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 170.79 168.58 32.74 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 128.72 3.057 . . . . 0.0 107.508 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.472 ' H ' ' HB2' ' A' ' 221' ' ' TYR . 1.8 t -122.72 156.28 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.365 1.866 . . . . 0.0 110.145 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -121.53 -34.01 3.52 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -159.79 151.91 20.69 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.092 1.315 . . . . 0.0 110.926 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.6 t -106.25 142.36 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -137.48 160.18 39.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.824 2.45 . . . . 0.0 109.6 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.86 138.83 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -132.51 80.1 0.34 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.739 1.638 . . . . 0.0 109.206 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 15.3 pm0 -85.59 162.48 18.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 111.018 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.3 -158.79 10.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 127.263 2.363 . . . . 0.0 109.056 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -82.85 -22.44 34.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.599 0.76 . . . . 0.0 111.358 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.88 -31.79 9.61 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.416 0.686 . . . . 0.0 112.548 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 165.82 -153.23 23.06 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.42 153.33 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.596 1.198 . . . . 0.0 109.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.1 t -134.22 -33.14 1.02 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.894 1.278 . . . . 0.0 109.625 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.05 164.17 35.4 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.91 0.862 . . . . 0.0 111.708 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 22.7 m -134.13 149.48 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -154.85 155.19 33.94 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 108.996 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.34 173.1 12.06 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.211 0.914 . . . . 0.0 113.028 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.32 141.77 48.11 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 129.296 3.038 . . . . 0.0 104.127 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -149.0 167.93 24.48 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.807 1.243 . . . . 0.0 109.578 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -135.98 96.44 3.41 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -88.8 125.48 34.92 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.25 31.17 56.36 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 76.26 -9.1 1.52 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.253 3.421 . . . . 0.0 114.852 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -76.47 133.14 39.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 120.835 1.652 . . . . 0.0 109.484 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -64.15 124.39 21.52 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.26 1.024 . . . . 0.0 109.197 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.6 mm -136.65 103.65 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.001 1.32 . . . . 0.0 108.415 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.96 127.43 39.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -79.09 -11.91 84.62 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.318 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.71 -172.12 52.99 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -89.35 154.36 20.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.845 0.858 . . . . 0.0 110.002 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -119.27 1.21 11.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.168 0.987 . . . . 0.0 109.651 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.94 173.64 27.05 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 120.304 -1.497 . . . . 0.0 111.182 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -68.68 114.07 20.02 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.18 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.92 167.22 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.344 2.029 . . . . 0.0 110.265 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.0 p -118.25 148.33 42.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.521 1.128 . . . . 0.0 109.481 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.77 -24.83 67.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.331 0.653 . . . . 0.0 110.521 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 10.5 tt -51.65 -34.39 37.83 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 126.336 1.854 . . . . 0.0 111.495 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 114.0 -164.5 12.06 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -140.11 161.2 38.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.65 153.31 38.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.49 152.39 44.14 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.78 0.832 . . . . 0.0 110.75 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -142.06 140.54 32.6 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.997 -0.439 . . . . 0.0 110.956 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -65.15 97.82 0.27 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.164 2.186 . . . . 0.0 112.524 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 31.1 mm -128.94 102.82 8.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -100.44 125.89 46.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.015 1.28 . . . . 0.0 109.839 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.472 ' HB2' ' H ' ' A' ' 175' ' ' VAL . 80.0 t80 -55.49 -51.43 80.08 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.124 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.06 0.47 5.83 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.392 2.061 . . . . 0.0 114.604 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.3 m -128.54 -62.47 1.03 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-N 120.684 1.583 . . . . 0.0 112.997 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -81.26 168.13 18.81 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 110.697 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.17 101.33 3.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.9 mp -35.73 -52.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 128.871 2.868 . . . . 0.0 111.816 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . 0.254 16.6 p 48.92 1.2 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 129.607 3.163 . . . . 0.0 118.932 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -173.84 169.88 4.04 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.538 1.535 . . . . 0.0 107.584 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.71 134.14 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -118.34 165.95 13.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.465 1.906 . . . . 0.0 107.617 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.07 174.31 46.37 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 29.2 p -135.44 147.35 48.93 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.754 1.277 . . . . 0.0 110.928 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -136.79 146.55 45.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -142.87 155.49 44.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.825 2.05 . . . . 0.0 108.225 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -87.55 148.55 24.84 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.596 0.758 . . . . 0.0 111.34 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.24 122.86 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.101 0.961 . . . . 0.0 108.468 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -55.89 152.3 10.21 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.268 0.556 . . . . 0.0 111.748 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 76.21 -9.39 20.02 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.245 0.926 . . . . 0.0 113.848 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -127.46 -176.03 3.63 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.383 1.873 . . . . 0.0 108.468 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.06 74.55 1.46 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.303 1.041 . . . . 0.0 110.594 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -172.08 -168.15 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.159 2.314 . . . . 0.0 109.106 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.93 162.11 36.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.786 1.293 . . . . 0.0 111.361 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.5 tt -139.85 102.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.891 2.076 . . . . 0.0 108.755 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 244' ' ' ILE . 4.9 mp -50.6 126.25 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 121.267 -0.895 . . . . 0.0 109.536 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -106.35 -36.24 6.89 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -122.29 144.55 48.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.462 1.028 . . . . 0.0 108.699 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.28 147.14 49.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.854 1.261 . . . . 0.0 108.264 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -136.01 93.71 2.96 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -71.9 149.46 45.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -133.59 154.04 51.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.544 1.537 . . . . 0.0 107.606 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.2 t -161.94 168.11 23.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.654 1.182 . . . . 0.0 111.67 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -105.67 147.05 28.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 79.86 -52.48 0.39 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 129.663 3.185 . . . . 0.0 110.815 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -84.89 169.68 13.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.27 1.428 . . . . 0.0 109.424 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 m -128.35 99.7 5.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.238 1.015 . . . . 0.0 109.616 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.2 p -84.62 174.63 9.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.867 1.267 . . . . 0.0 112.441 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . -141.62 170.36 9.36 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 128.153 2.581 . . . . 0.0 109.653 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 82.4 Cg_endo -70.96 160.5 49.15 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.793 2.329 . . . . 0.0 111.724 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -131.2 94.65 3.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.651 1.98 . . . . 0.0 106.457 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.51 14.27 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.381 1.467 . . . . 0.0 110.295 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.11 141.81 36.01 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.398 1.079 . . . . 0.0 109.31 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -68.53 108.36 3.28 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.737 0.699 . . . . 0.0 110.303 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.69 21.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.297 1.839 . . . . 0.0 106.519 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 85.37 173.16 49.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.685 0.66 . . . . 0.0 112.744 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.86 134.13 56.75 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.624 1.97 . . . . 0.0 109.398 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -90.81 144.13 26.02 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -133.96 159.34 41.04 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.015 1.326 . . . . 0.0 108.905 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -144.38 154.3 42.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.096 1.358 . . . . 0.0 107.858 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.7 mp -137.47 131.98 32.68 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -165.03 137.97 4.57 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.78 1.232 . . . . 0.0 108.553 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.58 96.51 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -60.56 164.49 4.48 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.113 0.959 . . . . 0.0 111.782 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.79 -2.06 42.87 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 121.266 -0.896 . . . . 0.0 113.318 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -138.22 167.07 22.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.262 3.025 . . . . 0.0 107.181 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 152.8 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.498 -0.751 . . . . 0.0 109.29 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 92.3 mt -74.41 135.05 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.1 -4.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -170.99 -173.48 38.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 120.521 1.51 . . . . 0.0 111.048 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -140.62 164.66 29.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 118.341 1.07 . . . . 0.0 110.204 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -132.65 157.86 43.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.18 -163.57 27.74 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.415 ' HE2' ' C ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -131.03 158.31 40.66 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.669 1.188 . . . . 0.0 109.173 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -137.1 113.91 10.43 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.678 0.791 . . . . 0.0 110.291 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 m -149.82 86.46 1.45 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 58.74 -10.54 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.272 2.229 . . . . 0.0 116.772 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 36.7 mt -143.37 -172.21 3.65 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.778 2.031 . . . . 0.0 109.56 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.63 88.48 2.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.78 1.232 . . . . 0.0 112.423 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.78 -84.74 0.14 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.628 0.728 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -85.65 128.97 34.93 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 120.894 -1.129 . . . . 0.0 109.163 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -149.41 100.05 2.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.127 0.971 . . . . 0.0 108.604 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -120.19 152.18 17.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.4 m -104.28 135.2 43.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 118.951 1.375 . . . . 0.0 111.729 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -89.74 139.01 30.99 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.54 153.69 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 37.0 mmm -147.53 157.21 45.13 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.37 156.89 57.52 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.391 1.394 . . . . 0.0 111.609 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 pp -126.9 158.89 35.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.904 1.682 . . . . 0.0 107.619 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 13.1 t -163.66 179.52 7.12 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.431 1.492 . . . . 0.0 106.998 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 104.011 -2.589 . . . . 0.0 104.011 178.873 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -132.28 101.81 5.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.538 -1.351 . . . . 0.0 109.058 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -139.57 138.49 36.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 117' ' ' LEU . 2.3 t -126.39 84.99 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -56.46 140.21 46.65 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.268 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -73.42 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 O-C-N 125.139 1.524 . . . . 0.0 112.087 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.26 -14.86 23.1 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.046 -1.419 . . . . 0.0 112.672 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.38 -169.59 35.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.07 113.4 1.21 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 112.881 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -6.02 34.76 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.64 -151.19 2.42 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 128.244 2.831 . . . . 0.0 112.153 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.52 -170.79 41.91 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 112.093 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.77 33.16 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.5 p -69.77 69.39 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -84.09 24.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.993 1.717 . . . . 0.0 109.647 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.38 126.46 27.56 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.146 1.779 . . . . 0.0 107.032 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -70.15 -179.0 1.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.44 0.696 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -120.52 4.78 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.962 1.744 . . . . 0.0 110.185 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.3 22.76 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 127.739 2.416 . . . . 0.0 110.059 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 151.49 30.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.33 1.452 . . . . 0.0 109.658 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.49 96.15 9.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 101.675 -3.454 . . . . 0.0 101.675 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.61 76.43 0.34 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.276 0.465 . . . . 0.0 113.387 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 t -136.61 118.7 20.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -94.58 -60.96 1.59 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -149.66 158.09 43.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.82 116.28 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.464 ' CE1' HG23 ' A' ' 64' ' ' THR . 12.1 m-70 -118.66 125.94 50.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.38 142.42 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 123.995 0.918 . . . . 0.0 109.251 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.97 164.08 25.26 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 124.606 1.098 . . . . 0.0 110.42 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -75.22 -148.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.162 1.385 . . . . 0.0 111.146 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.26 -163.58 35.6 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 106.599 -2.6 . . . . 0.0 106.599 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -95.35 -32.45 12.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.859 1.314 . . . . 0.0 107.54 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -81.67 -6.34 58.93 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 134.389 5.076 . . . . 0.0 113.24 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.3 -156.36 15.64 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.64 121.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 96.1 p -132.8 -58.61 0.91 Allowed 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.7 p -72.96 119.41 17.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 119.11 0.868 . . . . 0.0 109.634 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 tt -135.26 142.42 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.297 1.039 . . . . 0.0 108.959 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.97 129.72 21.64 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.617 1.967 . . . . 0.0 106.034 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.46 151.54 24.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.2 t -127.48 118.39 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -107.76 105.13 14.82 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.525 1.53 . . . . 0.0 110.488 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . . . -98.58 134.74 41.1 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 117.951 0.341 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -114.48 163.82 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.58 21.96 0.26 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.834 1.302 . . . . 0.0 111.095 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.9 p -128.8 -68.55 0.74 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 128.083 2.553 . . . . 0.0 109.875 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -148.08 133.91 19.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.288 1.435 . . . . 0.0 109.379 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 15.6 t0 -78.32 152.29 32.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.354 1.462 . . . . 0.0 109.687 178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -132.76 108.67 13.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.973 0.892 . . . . 0.0 109.131 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -88.28 98.41 11.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.86 -22.09 76.87 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.46 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.09 -172.72 40.26 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.42 123.98 28.03 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.548 -0.971 . . . . 0.0 110.864 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.07 160.93 29.3 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 12.73 -86.99 0.0 OUTLIER Glycine 0 CA--C 1.533 1.183 0 C-N-CA 128.417 2.913 . . . . 0.0 115.798 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -69.44 103.78 2.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.74 163.4 21.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.825 1.25 . . . . 0.0 112.432 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.81 10.22 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.712 2.405 . . . . 0.0 112.907 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.13 -13.51 18.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.84 1.256 . . . . 0.0 112.127 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.309 3.2 pp 49.0 -11.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.027 4.131 . . . . 0.0 117.593 -179.19 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.81 61.76 3.04 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -132.24 160.83 35.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.736 1.615 . . . . 0.0 110.814 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.81 164.42 12.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 127.891 2.476 . . . . 0.0 109.298 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.464 HG23 ' CE1' ' A' ' 27' ' ' HIS . 23.5 m -136.03 95.58 3.24 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.578 0.751 . . . . 0.0 109.446 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -95.04 109.56 21.58 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.47 143.08 27.1 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.731 0.812 . . . . 0.0 110.675 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 68.5 t -103.87 156.57 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -149.21 164.14 35.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.913 1.685 . . . . 0.0 107.833 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.67 -9.78 59.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.672 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.69 -9.33 19.22 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.833 1.653 . . . . 0.0 111.462 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 135.76 52.12 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -135.88 149.35 48.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.894 0.878 . . . . 0.0 109.208 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.7 126.64 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.49 -25.81 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.753 -0.642 . . . . 0.0 110.25 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.89 149.18 30.82 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.438 1.017 . . . . 0.0 110.642 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.467 ' O ' HD21 ' A' ' 117' ' ' LEU . 19.0 m -129.22 75.81 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -66.07 134.22 52.38 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -139.67 153.05 23.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.1 p -133.35 142.04 48.22 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 113' ' ' LYS . 44.8 p90 -149.84 156.35 41.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.08 169.48 20.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -126.86 157.74 38.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.723 0.773 . . . . 0.0 110.702 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.99 166.0 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 125.429 1.492 . . . . 0.0 108.62 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -68.42 150.1 48.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.73 20.15 58.59 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.061 -0.855 . . . . 0.0 113.372 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -131.04 166.52 20.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.621 1.569 . . . . 0.0 107.363 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -122.52 -11.98 8.22 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.955 1.702 . . . . 0.0 112.359 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.9 p -145.47 145.8 31.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.768 1.627 . . . . 0.0 109.667 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.72 159.48 33.44 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -135.7 156.91 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 123.715 0.806 . . . . 0.0 109.781 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 mt -73.73 139.62 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-O 121.565 0.698 . . . . 0.0 112.057 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -108.38 -30.96 8.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.587 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.4 t -165.83 166.4 17.69 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.53 1.532 . . . . 0.0 110.624 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.0 mt -145.23 146.28 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 128.12 2.568 . . . . 0.0 105.677 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 m -150.14 101.53 3.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -86.72 148.53 25.39 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.312 -0.867 . . . . 0.0 109.479 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -133.31 121.11 21.92 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.0 p -100.5 159.03 15.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.653 1.115 . . . . 0.0 111.576 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.34 -32.89 74.43 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.714 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -56.19 -10.76 0.93 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.818 2.847 . . . . 0.0 113.042 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.51 30.56 8.5 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 119.238 0.926 . . . . 0.0 111.856 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.81 148.42 42.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.609 1.204 . . . . 0.0 110.093 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 114.64 12.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 58.8 p -73.47 160.75 81.63 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.15 165.59 32.29 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 N-CA-C 107.694 -1.695 . . . . 0.0 107.694 176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.09 109.59 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.022 -1.953 . . . . 0.0 107.022 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -73.38 66.08 0.92 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.294 1.437 . . . . 0.0 110.031 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.78 -129.35 3.5 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.5 tp -139.41 136.17 34.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.673 1.589 . . . . 0.0 109.833 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.62 158.8 11.77 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.44 1.096 . . . . 0.0 110.901 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -156.35 173.52 16.75 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.563 -1.335 . . . . 0.0 111.343 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.485 ' H ' HG22 ' A' ' 111' ' ' THR . 4.8 tt0 -64.74 -58.08 7.22 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.143 1.377 . . . . 0.0 109.254 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 80' ' ' TYR . 16.3 mmtm -70.54 105.93 3.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.48 166.42 33.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 120.604 -1.31 . . . . 0.0 109.021 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 117' ' ' LEU . 15.6 p90 -156.72 166.85 32.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.313 0.578 . . . . 0.0 109.73 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.98 145.84 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 115' ' ' PHE . 1.1 pt? -149.74 136.51 19.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 127.706 2.403 . . . . 0.0 106.354 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 134.44 7.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.49 161.16 21.34 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -142.65 -69.05 0.35 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.605 1.162 . . . . 0.0 111.064 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -127.84 15.37 6.92 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.492 1.517 . . . . 0.0 110.41 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.34 -85.66 1.64 Allowed Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 125.602 1.572 . . . . 0.0 111.011 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -148.97 166.41 29.36 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 -177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.6 140.6 41.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.503 HD11 ' CB ' ' A' ' 141' ' ' ALA . 20.1 tp -54.91 112.66 1.09 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.68 -54.98 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.348 0.976 . . . . 0.0 111.283 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 178.43 -105.28 0.2 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -167.66 176.4 6.44 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.292 1.046 . . . . 0.0 111.526 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -148.84 151.84 35.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.48 -26.42 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.049 -1.072 . . . . 0.0 114.548 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 62.23 69.95 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.535 2.334 . . . . 0.0 113.852 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.99 112.16 20.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.55 -120.46 4.27 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 103.414 -3.875 . . . . 0.0 103.414 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -75.34 -10.22 59.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.259 0.624 . . . . 0.0 112.23 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.42 173.86 11.63 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.222 2.609 . . . . 0.0 107.691 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 40.8 tp -99.51 98.24 9.15 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.684 0.794 . . . . 0.0 109.245 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -76.13 -66.65 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 112.087 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.47 172.79 12.51 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.88 1.218 . . . . 0.0 109.626 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.8 tp -162.73 134.01 5.01 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.86 176.88 44.16 Favored Glycine 0 CA--C 1.523 0.531 0 N-CA-C 106.47 -2.652 . . . . 0.0 106.47 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' HD11 ' A' ' 125' ' ' LEU . . . -153.02 176.96 11.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.975 1.388 . . . . 0.0 109.055 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -147.81 161.73 40.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.684 0.754 . . . . 0.0 109.447 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.1 125.31 12.96 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.111 2.565 . . . . 0.0 104.398 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.79 151.89 43.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.722 0.692 . . . . 0.0 111.858 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.4 t -134.93 144.47 47.48 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.185 0.994 . . . . 0.0 110.508 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.6 p -111.95 170.66 7.99 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.68 1.592 . . . . 0.0 107.178 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.26 172.88 15.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.913 1.285 . . . . 0.0 109.089 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.2 p -130.41 141.45 41.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.008 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 142.76 23.52 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.959 2.439 . . . . 0.0 109.935 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t -144.6 143.43 22.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 p -136.8 159.58 69.69 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.176 0.991 . . . . 0.0 111.318 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -88.86 -179.15 2.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 123.893 3.062 . . . . 0.0 113.673 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.66 178.09 7.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.97 1.308 . . . . 0.0 109.345 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.1 133.87 55.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.195 0.998 . . . . 0.0 110.773 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -113.64 143.43 44.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.408 1.483 . . . . 0.0 108.658 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.48 -89.92 0.13 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.3 t -146.55 160.4 42.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.112 1.765 . . . . 0.0 107.889 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -170.38 136.61 1.36 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.099 2.159 . . . . 0.0 105.371 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.0 tt -97.99 128.45 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.2 107.59 0.62 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.34 -179.03 6.22 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 112.431 -1.885 . . . . 0.0 109.832 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.19 11.94 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 128.659 2.783 . . . . 0.0 115.319 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.485 ' O ' ' HE2' ' A' ' 282' ' ' LYS . 11.8 mt-10 -130.99 156.35 45.26 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 120.207 1.367 . . . . 0.0 114.265 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 96.91 159.53 31.55 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 125.253 1.406 . . . . 0.0 112.768 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 m -102.53 134.43 45.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -70.51 138.86 51.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.815 0.446 . . . . 0.0 110.122 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -128.63 123.94 34.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -85.78 105.66 16.46 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -92.14 -117.94 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 124.405 1.066 . . . . 0.0 108.707 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 132.13 168.16 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 121.35 1.886 . . . . 0.0 111.763 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.87 157.86 37.11 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.098 -0.648 . . . . 0.0 109.254 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -135.31 176.34 8.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.691 1.196 . . . . 0.0 110.621 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.24 -12.24 60.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.739 1.215 . . . . 0.0 113.767 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.21 171.73 22.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 125.525 1.536 . . . . 0.0 110.315 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.1 m -125.89 107.8 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -63.04 -51.1 68.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 110.629 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -149.19 169.69 20.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.753 1.16 . . . . 0.0 112.751 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 86.1 t -122.46 143.95 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.656 1.583 . . . . 0.0 109.208 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -137.79 157.39 46.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.768 1.627 . . . . 0.0 108.342 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.0 t -141.36 146.22 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.77 83.64 0.32 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -71.16 160.51 32.73 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.655 0.741 . . . . 0.0 110.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -141.34 -163.28 9.49 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 128.152 2.787 . . . . 0.0 109.029 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -89.62 -14.36 35.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.902 -1.352 . . . . 0.0 111.565 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -94.21 -29.1 15.28 Favored 'General case' 0 C--N 1.327 -0.379 1 C-N-CA 132.404 4.282 . . . . 0.0 112.917 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 144.45 -136.78 6.9 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 104.97 -3.252 . . . . 0.0 104.97 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.94 104.6 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 104.13 -2.545 . . . . 0.0 104.13 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.23 -26.17 28.9 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.496 0.719 . . . . 0.0 112.215 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.98 146.07 35.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.608 0.763 . . . . 0.0 110.842 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.79 145.07 28.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -148.75 154.73 39.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -139.85 175.45 9.57 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -123.55 120.87 34.12 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.351 0.66 . . . . 0.0 109.555 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -94.85 165.7 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.397 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -144.82 130.38 18.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.109 -0.948 . . . . 0.0 108.556 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.85 151.99 43.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.714 1.143 . . . . 0.0 109.111 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.72 -103.53 0.24 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.601 1.096 . . . . 0.0 111.708 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -136.12 7.89 3.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.266 2.226 . . . . 0.0 110.936 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -109.24 177.93 4.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.011 1.324 . . . . 0.0 107.851 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -133.7 142.29 47.93 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.866 1.266 . . . . 0.0 108.761 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 201' ' ' ILE . 1.8 mp -111.74 99.73 9.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 119.649 1.113 . . . . 0.0 109.351 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 84.5 t -96.68 103.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 164.46 175.28 35.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.158 2.313 . . . . 0.0 107.698 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 134.1 23.95 0.66 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-N 118.327 1.063 . . . . 0.0 113.771 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.92 126.07 27.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.429 1.614 . . . . 0.0 108.123 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -127.68 -6.88 5.67 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.227 2.611 . . . . 0.0 113.363 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.45 159.29 25.73 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -66.29 116.56 34.87 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.801 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.86 134.89 52.59 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.652 2.234 . . . . 0.0 110.077 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.9 p -83.22 161.11 21.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.215 1.006 . . . . 0.0 109.821 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.76 -23.11 65.19 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.468 -0.77 . . . . 0.0 111.096 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.5 tt -64.88 -30.82 71.84 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.963 1.305 . . . . 0.0 111.247 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.95 -146.47 16.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -138.67 163.95 30.78 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.523 1.129 . . . . 0.0 109.538 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -115.03 154.25 29.19 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.365 3.066 . . . . 0.0 105.304 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.5 148.17 28.38 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.61 0.764 . . . . 0.0 110.388 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -142.65 137.19 29.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.251 0.62 . . . . 0.0 109.332 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.13 120.75 33.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.607 0.718 . . . . 0.0 111.028 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.5 mt -127.47 129.35 70.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -89.65 106.73 18.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 119.443 1.02 . . . . 0.0 111.353 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -37.84 -55.82 2.04 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.34 1.59 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 123.02 2.114 . . . . 0.0 113.638 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 31.0 t -108.99 -46.69 3.56 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.737 -1.227 . . . . 0.0 109.522 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.83 160.49 14.55 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.435 1.112 . . . . 0.0 112.643 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -139.93 112.41 7.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.767 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.05 84.58 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.34 57.93 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.655 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -152.75 157.31 40.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.863 0.865 . . . . 0.0 109.752 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.7 146.13 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.603 1.561 . . . . 0.0 106.959 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.75 152.81 39.04 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -161.91 43.42 0.38 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.336 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.0 p -23.41 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 129.429 3.092 . . . . 0.0 109.381 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -122.31 155.37 36.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -144.86 165.79 27.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.617 -0.677 . . . . 0.0 110.275 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -74.51 137.34 42.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.864 1.666 . . . . 0.0 111.49 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.9 mt -80.4 108.17 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -47.11 125.15 7.32 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.03 1.332 . . . . 0.0 112.023 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 106.02 -19.18 38.47 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.329 -1.262 . . . . 0.0 112.829 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 45.1 m -136.16 178.23 7.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.284 1.434 . . . . 0.0 108.77 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.91 7.78 43.44 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.789 0.804 . . . . 0.0 110.595 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -73.8 164.31 54.76 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 162.89 34.32 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.203 1.401 . . . . 0.0 110.023 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.5 tt -151.72 148.16 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.7 mt -74.47 142.82 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.302 1.7 t -119.82 -23.68 6.38 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.944 0.793 . . . . 0.0 111.96 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -146.49 126.31 13.52 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 120.176 1.353 . . . . 0.0 108.048 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 34.8 mt -108.8 150.02 28.23 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.096 1.358 . . . . 0.0 111.101 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -147.46 139.06 23.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -125.92 113.35 17.08 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 154.01 42.33 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.748 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.1 p -144.74 168.3 20.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.238 1.415 . . . . 0.0 108.699 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -123.66 141.0 52.44 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt 72.08 -45.96 0.63 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.164 1.786 . . . . 0.0 110.533 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.54 168.35 17.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.406 1.883 . . . . 0.0 107.629 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 88.2 m -130.5 99.52 5.02 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.359 1.464 . . . . 0.0 107.954 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 38.6 p -67.14 128.9 38.11 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.336 1.055 . . . . 0.0 113.497 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.21 84.41 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.65 157.41 21.64 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.527 2.151 . . . . 0.0 108.676 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -133.37 104.36 6.4 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 101.51 -169.54 20.5 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-N 119.086 0.857 . . . . 0.0 111.49 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.4 mt -116.51 124.26 49.47 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.306 1.042 . . . . 0.0 110.461 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.91 109.19 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.152 2.181 . . . . 0.0 110.777 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.69 162.5 26.93 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 108.458 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 82.28 -165.95 45.48 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 122.251 0.917 . . . . 0.0 112.899 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 26.8 m -73.66 108.47 6.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.958 2.103 . . . . 0.0 108.26 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -74.88 138.89 42.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.91 120.77 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.501 0.667 . . . . 0.0 111.81 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -103.06 124.01 47.72 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.55 110.29 22.44 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -152.06 163.37 39.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.434 1.094 . . . . 0.0 109.934 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -144.71 137.71 26.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 129.37 41.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.393 0.616 . . . . 0.0 111.138 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.21 -1.57 33.11 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 116.973 1.549 . . . . 0.0 116.973 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.43 161.23 13.74 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.331 2.065 . . . . 0.0 113.546 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -107.81 159.64 16.34 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.889 2.475 . . . . 0.0 107.722 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 54.7 mt -99.74 107.69 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.5 m -145.22 90.68 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.485 1.514 . . . . 0.0 109.449 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.73 159.11 9.1 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 126.046 1.784 . . . . 0.0 111.485 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -131.85 164.35 26.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.626 2.371 . . . . 0.0 108.546 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -161.88 103.13 1.16 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -150.38 -179.94 26.6 Favored Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.173 -0.954 . . . . 0.0 114.205 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 163' ' ' GLU . 21.8 ptmt -140.19 117.26 11.16 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.112 -2.922 . . . . 0.0 103.112 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.28 154.62 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 63.3 m -149.46 -72.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.95 -36.35 13.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.587 0.755 . . . . 0.0 110.755 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 15.6 mt -130.33 141.92 50.56 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.056 1.342 . . . . 0.0 107.881 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.57 85.09 2.63 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.888 0.875 . . . . 0.0 110.695 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -76.19 -82.38 0.08 Allowed 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.131 0.572 . . . . 0.0 111.531 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 282' ' ' LYS . 33.5 tt0 -83.3 126.05 32.27 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.616 -0.677 . . . . 0.0 110.785 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -128.06 100.96 6.08 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -122.55 153.75 16.91 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.97 161.78 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.915 1.286 . . . . 0.0 110.008 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.79 160.51 15.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 109.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.97 158.89 23.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 110.514 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 53.0 mmm -156.81 138.91 10.22 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 126.081 1.752 . . . . 0.0 107.023 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.84 123.05 8.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 N-CA-C 105.58 -2.508 . . . . 0.0 105.58 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.5 pp -73.85 167.78 20.75 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.2 0.524 . . . . 0.0 112.029 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 10.8 p -89.9 129.91 36.19 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.894 1.278 . . . . 0.0 107.762 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 117.063 -1.446 . . . . 0.0 108.161 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.27 154.75 50.8 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 130.826 3.651 . . . . 0.0 108.582 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HE2' ' CE1' ' A' ' 142' ' ' TYR . 4.9 tmtt? -38.88 113.73 0.33 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.663 2.785 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.26 146.05 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -95.82 167.82 11.02 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.42 94.44 3.65 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.65 7.78 4.85 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.489 1.518 . . . . 0.0 115.417 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -170.14 27.74 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 118.74 1.27 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.438 ' H ' ' HB2' ' A' ' 89' ' ' ASP . . . -65.52 -28.9 74.08 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.029 1.776 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.13 42.27 30.87 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.452 1.501 . . . . 0.0 110.314 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.31 15.66 1.41 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.424 1.488 . . . . 0.0 112.883 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 174.64 22.42 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.358 1.932 . . . . 0.0 110.63 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 160.79 26.52 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.184 2.194 . . . . 0.0 112.237 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.73 138.39 6.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.686 0.795 . . . . 0.0 110.973 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -155.91 106.67 2.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -148.27 70.89 1.15 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.049 1.339 . . . . 0.0 110.758 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -34.53 127.76 0.46 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 127.345 2.258 . . . . 0.0 113.515 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.03 147.83 48.54 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.471 -1.851 . . . . 0.0 108.471 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.8 p -46.9 -40.76 5.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.893 1.677 . . . . 0.0 113.993 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -82.49 58.15 4.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -72.96 -37.54 67.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.158 1.383 . . . . 0.0 111.847 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.27 48.39 10.78 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 m -58.73 139.35 18.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.289 1.044 . . . . 0.0 112.116 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.36 -58.37 2.04 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.328 1.851 . . . . 0.0 110.128 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -136.66 163.83 29.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 122.03 -0.419 . . . . 0.0 110.527 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -143.28 96.61 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.092 1.757 . . . . 0.0 106.879 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.82 136.28 33.03 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.33 148.25 19.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.539 1.936 . . . . 0.0 106.686 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.69 -115.1 2.01 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 119.483 1.038 . . . . 0.0 111.814 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.21 174.06 1.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.695 0.798 . . . . 0.0 110.759 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.59 -25.59 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.747 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -60.72 -28.31 68.56 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.681 1.741 . . . . 0.0 112.468 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.24 1.06 25.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.978 2.511 . . . . 0.0 110.288 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.91 161.14 23.79 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 128.164 2.792 . . . . 0.0 108.996 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.2 t -84.65 95.66 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.5 p -80.32 -63.99 1.29 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 110.076 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 p -61.1 113.47 2.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.865 1.266 . . . . 0.0 111.162 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.2 mm -134.58 137.3 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 125.379 1.472 . . . . 0.0 107.386 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.96 111.3 5.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.1 p -124.37 150.19 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.41 122.61 59.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -110.2 104.6 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.12 110.35 18.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.596 0.236 . . . . 0.0 110.905 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -79.09 152.97 30.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.29 -38.87 74.64 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.5 m -63.71 -59.83 4.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -155.34 157.3 36.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.223 2.209 . . . . 0.0 106.364 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.23 156.39 39.19 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.96 108.66 2.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.44 138.53 33.89 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 109.369 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.36 -3.09 25.99 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.913 2.197 . . . . 0.0 112.124 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -166.43 21.29 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.431 1.116 . . . . 0.0 114.545 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -105.52 149.26 26.39 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.459 1.904 . . . . 0.0 107.812 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -129.73 155.87 45.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.286 1.434 . . . . 0.0 107.39 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.1 179.61 37.26 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -126.94 116.99 21.64 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.236 -1.155 . . . . 0.0 113.547 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -92.43 164.39 13.5 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 126.174 1.79 . . . . 0.0 110.204 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.2 p -142.9 168.0 20.73 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.0 tp -63.95 -17.66 63.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 71.3 mt -78.98 -9.84 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.954 1.702 . . . . 0.0 112.982 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.55 101.19 0.16 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 120.478 1.49 . . . . 0.0 109.405 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -159.8 131.66 6.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.201 2.2 . . . . 0.0 105.752 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -143.28 162.39 35.79 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 127.302 2.241 . . . . 0.0 107.568 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.9 m -139.63 95.24 2.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -89.74 138.36 31.55 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -130.57 136.9 49.37 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.49 138.24 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.743 1.617 . . . . 0.0 109.607 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 5.8 t0 -82.25 171.08 14.67 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.16 -26.5 65.79 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.995 -1.066 . . . . 0.0 112.587 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -124.4 19.45 8.89 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.326 1.45 . . . . 0.0 112.579 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -98.0 136.44 38.26 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.7 158.12 37.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.16 1.784 . . . . 0.0 109.175 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.0 mt -96.42 121.08 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.175 0.99 . . . . 0.0 109.22 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.3 m -118.38 -18.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.609 0.64 . . . . 0.0 111.952 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.19 141.11 25.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 t -135.54 142.39 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -125.64 118.48 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.78 138.4 54.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 111' ' ' THR . 17.0 m -117.02 137.31 52.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -140.27 148.97 42.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.013 0.525 . . . . 0.0 109.717 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -147.29 150.55 35.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -144.86 158.21 43.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 127.204 2.202 . . . . 0.0 109.273 177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.62 169.48 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.327 1.851 . . . . 0.0 108.304 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -67.16 1.61 1.98 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.552 1.541 . . . . 0.0 113.21 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -116.47 17.31 14.11 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 126.904 2.192 . . . . 0.0 112.895 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -134.38 156.69 48.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.155 1.477 . . . . 0.0 110.281 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -117.25 5.36 12.65 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.341 1.856 . . . . 0.0 112.3 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.408 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 53.2 p -134.11 173.52 11.5 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.678 2.791 . . . . 0.0 110.108 179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 9' ' ' GLY . 7.2 m-20 -119.19 146.27 45.32 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -126.23 140.04 49.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.35 104.32 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.7 p -73.94 -31.13 62.9 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.299 -0.857 . . . . 0.0 111.816 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 57.9 m -150.21 154.35 37.82 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.652 1.581 . . . . 0.0 109.853 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 pt -139.57 148.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 128.441 2.696 . . . . 0.0 106.24 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.63 145.37 25.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -127.45 152.83 47.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -132.45 113.98 13.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 103.554 -2.758 . . . . 0.0 103.554 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.2 p -80.5 161.69 24.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.418 0.553 . . . . 0.0 112.019 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.75 -25.09 66.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.506 1.122 . . . . 0.0 111.29 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -68.62 -15.56 63.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.47 1.908 . . . . 0.0 109.721 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 6.5 61.46 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 127.693 2.568 . . . . 0.0 111.464 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt -73.12 99.13 2.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.532 1.166 . . . . 0.0 111.359 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.12 134.95 33.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.1 p -107.67 162.2 20.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 C-N-CA 124.763 1.225 . . . . 0.0 110.976 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -72.13 162.16 42.55 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.906 1.738 . . . . 0.0 109.498 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 109.73 2.73 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.615 2.21 . . . . 0.0 108.36 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -72.24 79.61 0.98 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 109.488 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.99 -137.2 5.41 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 121.395 -0.816 . . . . 0.0 111.611 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.99 111.13 13.72 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.597 1.959 . . . . 0.0 108.089 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.1 144.8 50.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.557 ' H ' HG21 ' A' ' 79' ' ' THR . 7.4 m -133.71 163.9 28.41 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.345 1.858 . . . . 0.0 107.055 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -63.87 -35.87 82.07 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.616 -0.678 . . . . 0.0 109.407 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -73.45 97.53 2.57 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.51 1.924 . . . . 0.0 108.947 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -150.98 170.18 19.96 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.258 1.023 . . . . 0.0 109.019 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -151.64 167.21 28.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -118.69 141.02 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -145.61 94.02 2.44 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 169.48 23.11 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.11 2.164 . . . . 0.0 108.42 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -116.56 150.25 38.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.473 1.909 . . . . 0.0 109.086 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -67.13 -61.02 2.13 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.189 0.904 . . . . 0.0 111.688 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -68.39 -15.55 63.6 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 118.077 -0.963 . . . . 0.0 112.522 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.99 -53.02 0.8 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.546 -1.697 . . . . 0.0 112.571 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 38.82 91.26 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 C-N-CA 127.21 2.338 . . . . 0.0 114.055 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -52.5 120.7 5.9 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.658 1.729 . . . . 0.0 109.888 -178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.83 144.38 38.92 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 127.173 2.189 . . . . 0.0 110.147 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.46 -31.16 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.677 0.791 . . . . 0.0 110.084 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 176.73 150.89 8.54 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -121.95 84.6 2.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 123.468 1.604 . . . . 0.0 107.642 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.36 151.68 36.12 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 111.759 -2.473 . . . . 0.0 110.554 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.93 78.78 0.16 Allowed Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.809 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -49.33 107.11 0.13 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.045 1.738 . . . . 0.0 109.034 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.5 165.07 18.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.712 2.405 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.54 -86.65 0.2 Allowed Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 105.186 -3.166 . . . . 0.0 105.186 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -93.9 -27.59 16.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.35 166.29 25.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.832 2.453 . . . . 0.0 108.548 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.6 tp -78.81 99.05 6.54 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -82.95 -55.64 4.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 123.556 0.742 . . . . 0.0 112.945 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.81 161.27 21.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.949 0.9 . . . . 0.0 109.852 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 tp -148.43 163.39 37.28 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.717 1.607 . . . . 0.0 108.672 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.57 -179.51 40.39 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -154.72 151.99 29.38 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.449 ' CE1' ' HE2' ' A' ' 3' ' ' LYS . 8.5 m-85 -114.84 146.33 41.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.486 -178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -143.11 156.39 44.79 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.77 147.44 32.93 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.779 0.832 . . . . 0.0 111.469 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.8 t -133.67 163.46 29.4 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.662 1.185 . . . . 0.0 111.863 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m -66.56 -46.79 74.9 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.349 1.859 . . . . 0.0 111.323 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.13 93.22 0.05 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.579 1.552 . . . . 0.0 111.55 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.9 p -154.41 162.29 27.33 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 126.147 1.779 . . . . 0.0 108.199 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.81 -166.21 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.723 2.949 . . . . 0.0 107.745 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.1 p -54.13 142.5 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 p -135.46 163.06 53.5 Favored Pre-proline 0 C--O 1.244 0.795 0 C-N-CA 123.813 0.845 . . . . 0.0 109.466 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.42 -171.32 0.7 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.234 2.623 . . . . 0.0 112.492 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.56 -176.47 0.79 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.513 2.325 . . . . 0.0 112.385 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -73.97 122.92 23.35 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -99.79 118.93 37.32 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.825 1.65 . . . . 0.0 106.931 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.35 -176.68 4.83 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.675 0.671 . . . . 0.0 111.751 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.5 m -121.52 85.74 2.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.893 1.277 . . . . 0.0 113.426 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -80.25 -175.84 5.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.278 1.031 . . . . 0.0 109.13 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.1 tt -123.87 165.17 20.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 127.005 2.122 . . . . 0.0 107.248 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 177.75 -83.04 0.07 OUTLIER Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.832 0.742 . . . . 0.0 114.187 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.44 -24.77 0.02 OUTLIER Glycine 0 N--CA 1.469 0.848 0 CA-C-N 117.403 0.601 . . . . 0.0 112.779 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 282' ' ' LYS . 0.3 OUTLIER 61.43 21.35 11.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -83.59 -47.85 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -64.23 174.54 12.79 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 122.57 1.095 . . . . 0.0 113.765 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.7 m -81.44 134.53 35.55 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.219 -0.577 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.56 124.31 22.88 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.535 0.734 . . . . 0.0 110.505 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -127.05 126.9 43.86 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 122.241 1.02 . . . . 0.0 109.362 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -98.2 156.52 16.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 127.624 2.369 . . . . 0.0 107.278 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.28 -53.48 2.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.776 1.63 . . . . 0.0 110.074 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.8 -105.7 1.85 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -165.62 166.88 17.77 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.645 1.978 . . . . 0.0 108.378 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -121.33 154.3 36.59 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.159 0.584 . . . . 0.0 110.317 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -27.74 61.61 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.116 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 166.12 140.55 2.91 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.747 2.594 . . . . 0.0 106.754 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 1.8 m -91.85 157.14 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.511 1.124 . . . . 0.0 110.634 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -123.71 -21.88 5.09 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.843 1.657 . . . . 0.0 111.086 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -166.11 159.85 15.73 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.625 0.77 . . . . 0.0 110.426 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.74 147.55 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 126.982 2.113 . . . . 0.0 107.694 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -139.4 113.28 8.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.151 1.381 . . . . 0.0 108.322 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.19 133.81 66.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -135.86 144.53 16.37 Favored Glycine 0 C--O 1.238 0.397 0 CA-C-O 122.029 0.794 . . . . 0.0 111.815 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -126.72 171.89 10.8 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 125.285 1.434 . . . . 0.0 107.43 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.16 -171.44 12.4 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -63.43 -6.81 5.38 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.638 1.175 . . . . 0.0 113.484 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -120.04 -4.96 10.05 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.756 1.622 . . . . 0.0 112.859 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 125.14 -162.08 19.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.596 1.089 . . . . 0.0 111.626 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.1 mm -55.6 126.64 13.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 m -134.27 -19.73 1.92 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.62 138.18 16.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 121.174 1.806 . . . . 0.0 111.551 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 18.1 m -141.05 146.85 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 119.146 0.884 . . . . 0.0 109.761 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -160.45 167.23 27.71 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.794 1.637 . . . . 0.0 107.459 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -138.32 172.4 12.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.592 1.157 . . . . 0.0 108.11 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -126.75 124.3 39.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -132.06 167.99 18.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.458 0.572 . . . . 0.0 111.31 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -116.6 91.46 3.59 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -112.96 136.32 52.77 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 127.771 2.428 . . . . 0.0 106.14 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.16 20.32 34.95 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.947 0.784 . . . . 0.0 113.093 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 66.93 4.73 3.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.638 2.375 . . . . 0.0 113.723 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -91.25 -157.33 0.49 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.495 1.518 . . . . 0.0 111.055 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -125.4 73.43 1.32 Allowed 'General case' 0 C--N 1.339 0.142 0 O-C-N 120.694 -1.254 . . . . 0.0 110.924 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.2 mt -84.87 143.77 11.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.0 145.05 31.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -73.57 156.54 51.03 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.35 159.06 46.38 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -78.18 94.41 4.74 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -63.14 -22.04 66.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.381 1.072 . . . . 0.0 113.228 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.56 -179.07 16.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 125.925 1.726 . . . . 0.0 112.19 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.57 117.49 68.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.567 1.547 . . . . 0.0 109.523 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.8 175.16 6.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.407 2.071 . . . . 0.0 110.196 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -139.95 162.08 36.06 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.744 -1.222 . . . . 0.0 110.546 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 71.1 mt -65.38 -15.28 62.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.886 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -4.24 22.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.709 2.404 . . . . 0.0 111.062 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 67.46 -157.63 51.67 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.328 -0.857 . . . . 0.0 111.394 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -128.89 172.67 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.551 1.54 . . . . 0.0 110.482 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.77 147.08 47.85 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 129.568 3.147 . . . . 0.0 102.827 177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.25 147.36 51.96 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -142.94 143.98 32.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.783 1.233 . . . . 0.0 109.278 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.18 136.4 52.99 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 55.4 mt -128.13 103.29 9.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.861 1.664 . . . . 0.0 109.238 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.64 98.48 0.52 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -55.57 -40.17 82.57 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.49 -29.79 44.42 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 CA-C-N 123.187 2.174 . . . . 0.0 112.891 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -89.94 -30.07 18.08 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-O 116.423 -1.751 . . . . 0.0 113.233 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 225' ' ' TYR . 10.9 tp10 -162.01 175.92 11.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 121.622 2.01 . . . . 0.0 111.157 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.439 ' H ' ' CD ' ' A' ' 224' ' ' GLU . 2.6 p90 -153.17 -156.16 0.67 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.537 1.135 . . . . 0.0 109.311 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 92.6 mt -116.77 102.5 13.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 101.885 -3.376 . . . . 0.0 101.885 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.1 p -81.84 -20.64 38.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.392 0.677 . . . . 0.0 112.018 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.26 167.5 25.84 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.516 1.526 . . . . 0.0 108.284 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.43 159.08 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.073 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -132.58 172.0 13.08 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 126.922 2.089 . . . . 0.0 107.591 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.81 171.62 31.28 Favored Glycine 0 CA--C 1.518 0.275 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.483 HG21 ' HG2' ' A' ' 262' ' ' GLU . 3.1 p -140.8 146.41 37.6 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -122.14 145.23 48.38 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.132 0.573 . . . . 0.0 110.301 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -135.61 161.07 36.55 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 110.325 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.52 148.91 38.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.795 1.638 . . . . 0.0 109.873 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.3 pt -115.9 142.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -87.73 99.24 11.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.56 -22.97 1.51 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.873 0.749 . . . . 0.0 113.85 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 m -141.78 155.52 45.6 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.67 -16.92 62.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.848 0.749 . . . . 0.0 112.615 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -72.02 -173.7 20.56 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.915 1.721 . . . . 0.0 115.689 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.6 mt -119.07 173.52 6.86 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.082 2.153 . . . . 0.0 110.055 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.3 tt -139.13 130.72 35.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.843 1.657 . . . . 0.0 108.008 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.9 mt -90.44 76.81 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.1 t -70.41 -8.43 50.73 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.025 1.33 . . . . 0.0 112.539 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -141.79 137.21 31.37 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.855 0.752 . . . . 0.0 111.868 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 60.2 mt -142.79 137.74 29.92 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.724 1.61 . . . . 0.0 109.121 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -139.63 139.42 36.71 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.63 113.04 25.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.3 mtpt -65.95 115.27 5.85 Favored 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 7.5 m -133.6 162.17 32.64 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.071 0.949 . . . . 0.0 109.23 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.16 161.67 26.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.948 2.499 . . . . 0.0 105.074 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 33.5 tptt 75.47 -28.03 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.968 1.707 . . . . 0.0 112.808 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -138.84 167.95 20.88 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.812 1.245 . . . . 0.0 111.25 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 14.4 t -121.96 142.92 49.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.934 2.093 . . . . 0.0 106.005 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 p -133.13 149.29 52.1 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.951 0.901 . . . . 0.0 109.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -66.93 159.9 73.13 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.679 0.792 . . . . 0.0 111.819 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.83 100.03 1.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 N-CA-C 105.51 -2.535 . . . . 0.0 105.51 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -72.97 99.23 2.66 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.72 179.75 17.77 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 34.2 tp -110.04 114.46 27.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 126.543 1.937 . . . . 0.0 107.966 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.483 ' HG2' HG21 ' A' ' 232' ' ' THR . 0.9 OUTLIER -59.68 115.84 3.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.165 0.986 . . . . 0.0 110.136 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.42 24.77 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.873 0.844 . . . . 0.0 111.68 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.68 -93.27 1.25 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 125.799 1.666 . . . . 0.0 113.629 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 6.4 m -149.9 127.47 11.58 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.391 1.076 . . . . 0.0 109.207 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.76 147.69 30.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.423 0.63 . . . . 0.0 109.881 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -142.24 168.28 20.12 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.527 1.531 . . . . 0.0 108.072 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -151.87 156.2 39.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.31 1.444 . . . . 0.0 109.181 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.7 mt -139.95 138.28 35.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -160.53 160.57 32.07 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 108.968 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -144.16 148.18 34.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 121.85 30.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.845 1.258 . . . . 0.0 109.455 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 87.78 -75.23 2.11 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -47.14 144.88 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.316 1.846 . . . . 0.0 111.486 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -117.65 161.07 20.25 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 83.4 mt -79.13 150.47 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 5.6 t -137.46 -55.59 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.8 -176.67 14.81 Favored Glycine 0 C--O 1.239 0.445 0 CA-C-O 122.994 1.33 . . . . 0.0 113.947 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 171.52 9.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.436 2.695 . . . . 0.0 111.271 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -165.31 162.69 19.85 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.016 1.726 . . . . 0.0 106.714 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.21 -136.11 5.28 Favored Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -156.69 131.03 8.63 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.33 137.67 24.55 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 67.8 m -152.16 -29.99 0.16 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.541 1.536 . . . . 0.0 112.225 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -139.23 -57.88 0.59 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.423 1.889 . . . . 0.0 111.753 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.78 165.82 22.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.139 1.375 . . . . 0.0 108.232 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.94 92.05 8.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.569 -0.707 . . . . 0.0 110.088 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.85 -48.24 7.14 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.013 0.925 . . . . 0.0 112.865 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -112.61 141.25 46.6 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.258 1.023 . . . . 0.0 110.438 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -145.92 99.59 3.28 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -113.32 157.57 14.86 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.963 1.268 . . . . 0.0 110.109 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.85 174.85 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 118.217 1.009 . . . . 0.0 113.13 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -127.97 125.93 40.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.345 2.658 . . . . 0.0 104.787 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -110.22 139.98 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.4 mtm -132.44 144.12 51.7 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.4 140.44 27.25 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.995 -1.963 . . . . 0.0 106.995 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -63.78 -74.51 0.1 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 31.0 m -72.88 123.09 22.72 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.702 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -137.94 141.63 40.55 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.934 1.294 . . . . 0.0 113.032 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -149.9 97.97 2.66 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.5 131.46 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.149 1.341 . . . . 0.0 108.978 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -82.21 163.8 21.65 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.652 0.781 . . . . 0.0 112.226 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.97 169.83 17.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.843 1.257 . . . . 0.0 110.683 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.54 87.37 0.1 Allowed Glycine 0 C--O 1.225 -0.433 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.99 -167.96 20.41 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 126.585 2.041 . . . . 0.0 108.665 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.45 177.74 2.47 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 115.679 1.031 . . . . 0.0 115.679 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.43 2.99 12.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.414 1.486 . . . . 0.0 114.903 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.99 -2.31 38.03 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.245 -1.309 . . . . 0.0 116.191 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.4 172.78 14.81 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 121.041 2.421 . . . . 0.0 113.882 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.97 157.57 25.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.783 0.833 . . . . 0.0 109.339 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 p -71.68 84.19 0.88 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.318 0.647 . . . . 0.0 112.698 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -93.98 149.65 21.05 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.23 -10.06 0.66 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.799 1.24 . . . . 0.0 111.779 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -54.27 131.76 42.28 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.558 1.943 . . . . 0.0 110.805 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.22 162.12 29.68 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.75 1.643 . . . . 0.0 110.241 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.73 -178.65 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.32 1.048 . . . . 0.0 111.105 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -94.19 -66.14 0.94 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -169.09 176.05 5.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.732 2.413 . . . . 0.0 106.311 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.7 28.29 6.35 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.455 1.979 . . . . 0.0 113.04 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.52 140.84 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.971 1.386 . . . . 0.0 109.511 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.75 -62.94 1.21 Allowed 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.893 0.877 . . . . 0.0 111.993 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -145.62 164.54 31.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.197 0.999 . . . . 0.0 109.909 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 t -141.71 150.36 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 127.043 2.137 . . . . 0.0 106.337 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -136.8 134.91 37.52 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.3 m -143.77 147.16 20.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 62' ' ' PHE . . . 135.26 124.92 2.47 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.25 -4.71 10.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.179 1.792 . . . . 0.0 111.168 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.4 -73.09 0.1 OUTLIER Glycine 0 C--O 1.224 -0.522 0 C-N-CA 129.386 3.374 . . . . 0.0 114.535 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -56.56 -47.84 78.63 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.065 0.946 . . . . 0.0 110.755 -178.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.9 1.52 56.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.432 1.493 . . . . 0.0 110.34 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.86 -117.47 5.13 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 121.162 -0.962 . . . . 0.0 110.909 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 t -112.2 96.76 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.941 1.296 . . . . 0.0 111.532 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -127.12 -29.21 2.79 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.9 t -68.27 159.02 32.11 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.119 0.872 . . . . 0.0 110.344 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.75 154.37 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.503 1.521 . . . . 0.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -153.09 123.03 6.92 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.927 1.291 . . . . 0.0 107.735 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.35 100.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 123.966 0.906 . . . . 0.0 108.558 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -104.79 134.29 46.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -127.32 154.63 44.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 109.735 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -95.27 109.94 22.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -114.67 130.01 56.75 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 57.16 17.94 3.84 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.845 1.202 . . . . 0.0 112.65 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . 0.325 86.0 p 71.3 23.97 3.88 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.71 2.404 . . . . 0.0 111.285 -176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.95 160.49 19.49 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 129.113 2.965 . . . . 0.0 104.871 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -105.23 118.03 35.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 m -118.67 124.55 73.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.272 1.029 . . . . 0.0 110.503 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -122.76 161.58 23.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.282 1.833 . . . . 0.0 109.752 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.77 -21.97 2.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.211 1.386 . . . . 0.0 110.05 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.0 167.72 12.52 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 128.036 2.732 . . . . 0.0 109.942 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -73.95 159.46 32.73 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.603 1.161 . . . . 0.0 109.951 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -125.49 143.69 50.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.06 -143.79 16.89 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 107.188 -2.365 . . . . 0.0 107.188 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.13 115.73 18.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.785 2.834 . . . . 0.0 108.654 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 151.99 24.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.214 1.37 . . . . 0.0 110.163 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -147.72 156.1 42.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 tp -77.89 -10.43 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.86 -0.525 . . . . 0.0 111.502 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.12 -5.47 27.24 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.57 96.43 0.1 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.492 ' HA ' ' HA3' ' A' ' 29' ' ' GLY . 12.3 p90 -154.19 161.83 41.59 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.712 1.205 . . . . 0.0 109.66 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.66 163.61 33.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 127.197 2.199 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.7 m -131.82 140.81 49.26 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.004 2.121 . . . . 0.0 107.205 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -133.07 140.75 47.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.004 1.322 . . . . 0.0 109.295 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.5 136.24 54.97 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.175 1.79 . . . . 0.0 111.478 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.48 125.8 71.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.94 164.68 26.32 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.572 -0.705 . . . . 0.0 111.634 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.74 -11.13 15.59 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.476 1.511 . . . . 0.0 113.172 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -127.5 10.0 6.65 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.788 1.635 . . . . 0.0 110.885 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -97.79 152.44 19.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.151 0.887 . . . . 0.0 111.786 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -134.53 134.14 41.09 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.61 105.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.91 -55.24 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.213 1.005 . . . . 0.0 108.822 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.6 168.7 22.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.236 1.015 . . . . 0.0 109.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.78 151.37 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -135.17 136.0 41.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -142.59 135.89 27.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.1 p -116.27 156.54 26.43 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -153.55 158.64 41.55 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.486 1.039 . . . . 0.0 112.516 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -162.49 168.89 21.25 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.96 0.886 . . . . 0.0 112.14 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -125.3 141.27 52.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.479 2.712 . . . . 0.0 106.646 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -123.56 159.09 28.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.997 0.919 . . . . 0.0 111.375 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.28 129.19 40.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.29 2.91 51.06 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 111.557 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -138.62 127.65 23.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.028 1.731 . . . . 0.0 106.766 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.57 -11.18 49.46 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.3 p -80.07 -175.5 5.04 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.916 2.486 . . . . 0.0 109.9 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.83 134.91 17.99 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 102.139 -3.282 . . . . 0.0 102.139 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.4 pt -132.73 171.73 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 123.827 0.851 . . . . 0.0 111.729 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.8 mm -73.93 134.06 30.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.3 p -104.73 -30.42 9.93 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.335 0.654 . . . . 0.0 110.172 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.7 t -156.42 160.44 39.61 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.325 0.966 . . . . 0.0 110.214 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.6 mt -142.58 147.62 20.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 126.667 1.987 . . . . 0.0 107.351 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.2 m -150.66 137.18 18.8 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -122.68 115.5 22.19 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.292 1.437 . . . . 0.0 107.747 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.12 135.11 33.41 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.4 p -110.23 159.39 17.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.658 1.117 . . . . 0.0 110.809 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -77.29 -25.88 51.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 5.3 mmpt? -63.56 -11.23 22.82 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.467 1.907 . . . . 0.0 114.491 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.52 31.26 33.99 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 120.862 1.665 . . . . 0.0 110.526 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -128.95 93.59 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.561 1.144 . . . . 0.0 108.397 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -85.74 136.28 33.41 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.82 150.3 75.27 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.92 166.73 28.69 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.615 1.543 . . . . 0.0 108.426 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.32 99.81 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.733 2.288 . . . . 0.0 108.265 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -67.32 85.43 0.16 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.488 1.515 . . . . 0.0 110.173 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.23 -123.75 3.52 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 126.07 1.795 . . . . 0.0 108.867 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 68.2 tp -139.51 120.92 15.02 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.417 1.487 . . . . 0.0 107.719 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.68 151.4 21.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.03 169.56 19.66 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.735 -1.228 . . . . 0.0 110.52 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.15 -61.23 2.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.543 1.137 . . . . 0.0 111.605 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.74 127.64 32.77 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -174.5 173.14 2.98 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.179 0.992 . . . . 0.0 111.1 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.34 167.52 25.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.057 0.943 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.11 150.63 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.725 1.61 . . . . 0.0 108.388 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.21 154.65 42.62 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 109.067 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.85 156.81 1.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.272 2.229 . . . . 0.0 110.02 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 143' ' ' PHE . 31.1 t0 -117.67 175.61 5.56 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.009 2.523 . . . . 0.0 109.238 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -64.89 176.96 1.05 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.703 2.001 . . . . 0.0 110.482 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -68.18 -17.79 64.43 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.942 0.897 . . . . 0.0 112.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -117.44 43.02 1.71 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -133.19 154.36 21.17 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -137.61 149.55 46.72 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.881 0.872 . . . . 0.0 109.892 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.18 133.54 49.05 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.61 -71.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -139.54 166.34 25.59 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 118.268 0.486 . . . . 0.0 112.022 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -125.0 120.06 30.49 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.415 1.886 . . . . 0.0 107.303 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 148.85 25.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.21 96.13 0.18 Allowed Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.31 65.4 1.2 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 109.553 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.01 165.53 12.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 127.526 2.331 . . . . 0.0 108.448 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.22 -102.56 0.51 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 103.215 -3.954 . . . . 0.0 103.215 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -86.75 -9.88 54.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.605 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 170.66 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.337 2.255 . . . . 0.0 108.786 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.452 HD11 HD23 ' A' ' 139' ' ' LEU . 12.9 tp -82.18 93.86 7.16 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.797 2.039 . . . . 0.0 110.772 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.68 -39.8 11.64 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -148.28 148.91 30.98 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.325 -0.86 . . . . 0.0 110.087 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.501 ' CD1' ' H ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -134.84 -169.51 2.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.743 2.417 . . . . 0.0 108.827 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.501 ' H ' ' CD1' ' A' ' 139' ' ' LEU . . . 144.63 172.27 15.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 127.439 2.447 . . . . 0.0 109.469 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -153.56 166.28 33.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 120.031 1.915 . . . . 0.0 111.176 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -136.98 168.96 18.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.216 1.007 . . . . 0.0 110.88 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.431 ' CG ' ' HB2' ' A' ' 119' ' ' ASP . 7.8 m-85 -134.43 97.22 3.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 102.958 -2.979 . . . . 0.0 102.958 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -147.4 117.71 7.38 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.746 -1.121 . . . . 0.0 113.041 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.14 124.05 29.87 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.947 1.249 . . . . 0.0 109.14 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.0 p 51.34 18.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 129.125 2.97 . . . . 0.0 114.007 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.9 t -65.29 -26.76 68.21 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.875 1.67 . . . . 0.0 114.025 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 16.1 p -148.35 144.0 18.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 125.969 1.707 . . . . 0.0 111.002 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -92.97 -163.98 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.501 3.467 . . . . 0.0 109.85 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.23 108.12 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 121.535 -0.728 . . . . 0.0 111.87 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.13 163.95 42.47 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 125.959 1.703 . . . . 0.0 110.433 177.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.18 1.86 8.26 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.965 3.11 . . . . 0.0 114.579 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -87.92 174.46 8.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 130.8 3.64 . . . . 0.0 109.061 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -94.99 126.18 40.16 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HA ' ' CE1' ' A' ' 293' ' ' HIS . 4.3 pttp -85.86 141.31 29.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.851 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.53 157.39 18.07 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.5 m -75.77 126.88 31.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.852 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.23 178.8 0.24 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.088 1.355 . . . . 0.0 112.161 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.421 HG22 ' H ' ' A' ' 160' ' ' GLY . 8.2 mt -128.68 170.68 17.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.555 1.942 . . . . 0.0 107.259 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.421 ' H ' HG22 ' A' ' 159' ' ' ILE . . . -34.53 111.12 0.07 OUTLIER Glycine 0 CA--C 1.493 -1.282 0 C-N-CA 125.859 1.695 . . . . 0.0 113.335 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 164.36 121.66 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 O-C-N 125.471 1.336 . . . . 0.0 113.209 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -146.67 3.43 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -119.76 111.77 18.42 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 110.168 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.56 162.64 10.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.857 1.218 . . . . 0.0 111.633 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.1 t -81.56 141.31 33.88 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -92.83 141.77 28.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -141.63 17.89 2.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.707 1.603 . . . . 0.0 110.87 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -43.12 127.08 4.21 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.221 2.208 . . . . 0.0 111.746 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.38 -7.83 58.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 77.62 -98.58 1.42 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 104.302 -3.519 . . . . 0.0 104.302 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -160.99 159.79 29.89 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.338 1.855 . . . . 0.0 107.425 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -131.56 179.54 5.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.832 2.053 . . . . 0.0 107.31 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.98 -44.09 97.86 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.303 -0.873 . . . . 0.0 110.275 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.7 160.58 30.8 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-O 122.177 0.876 . . . . 0.0 111.662 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.8 156.36 10.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 127.614 2.365 . . . . 0.0 105.342 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -138.42 -41.09 0.51 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.935 0.789 . . . . 0.0 112.911 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -133.65 140.91 47.36 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.339 -0.85 . . . . 0.0 110.871 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.53 120.11 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.02 112.66 24.63 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.62 128.28 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -120.83 97.9 0.65 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.529 1.538 . . . . 0.0 110.355 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -89.85 177.39 6.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 123.075 1.417 . . . . 0.0 111.798 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -131.25 -165.84 11.55 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 129.731 3.539 . . . . 0.0 106.924 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -79.8 -46.99 15.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.011 -0.699 . . . . 0.0 111.843 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.77 -31.87 25.7 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.079 1.351 . . . . 0.0 113.017 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.2 25.01 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.33 149.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.926 0.89 . . . . 0.0 109.657 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 p -132.29 -40.59 1.01 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.93 0.892 . . . . 0.0 110.228 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.0 165.07 20.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.746 1.218 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -153.05 124.61 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.02 90.34 0.68 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.862 0.756 . . . . 0.0 110.76 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -92.93 174.34 7.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.23 0.612 . . . . 0.0 110.505 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.13 140.96 47.46 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.17 168.31 20.11 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.742 1.617 . . . . 0.0 110.867 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -112.41 155.84 23.52 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.403 1.081 . . . . 0.0 110.478 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -139.83 115.31 9.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 69.56 -89.45 0.29 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -147.48 24.28 1.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.898 1.679 . . . . 0.0 109.773 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -126.17 142.24 51.61 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 111.279 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -77.35 141.01 40.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.619 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 32.3 mm -121.88 132.07 71.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 53.4 t -126.46 135.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.256 1.022 . . . . 0.0 108.749 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.01 -131.34 3.29 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 82.94 -8.78 61.99 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 126.373 1.94 . . . . 0.0 113.592 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 125.44 23.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.789 1.295 . . . . 0.0 107.823 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -136.92 -50.23 0.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.305 0.642 . . . . 0.0 109.495 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.41 -179.44 50.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 124.869 1.223 . . . . 0.0 113.595 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.28 105.44 4.11 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 126.649 1.979 . . . . 0.0 108.886 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.63 177.51 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 121.825 1.683 . . . . 0.0 108.008 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -121.77 150.86 41.25 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.2 -12.66 42.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.947 -0.549 . . . . 0.0 112.257 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.9 tt -51.85 -34.4 40.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.039 2.536 . . . . 0.0 110.788 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.27 -155.89 15.93 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -143.53 128.34 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.19 151.06 25.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -135.36 152.56 51.55 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 118.538 0.608 . . . . 0.0 112.428 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -142.24 127.03 18.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.96 115.9 31.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mm -127.67 105.05 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -51.18 117.21 2.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -46.27 -63.66 1.24 Allowed Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.708 2.003 . . . . 0.0 113.519 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.98 -32.43 5.42 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 CA-C-N 122.231 1.832 . . . . 0.0 115.822 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 m -77.59 -19.69 55.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.16 170.24 16.22 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.409 1.004 . . . . 0.0 109.889 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -149.78 108.33 3.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.649 1.179 . . . . 0.0 108.072 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.507 HG22 HD12 ' A' ' 276' ' ' ILE . 4.2 mp -65.03 108.29 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -31.46 19.9 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -151.2 168.23 25.36 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.176 1.353 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.05 149.81 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.943 1.297 . . . . 0.0 108.239 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -132.37 177.2 7.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 130.042 3.337 . . . . 0.0 106.421 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 151.68 -176.27 30.13 Favored Glycine 0 CA--C 1.524 0.635 0 O-C-N 120.683 -1.261 . . . . 0.0 110.94 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.7 p -147.21 155.31 41.98 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.556 1.142 . . . . 0.0 108.231 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.56 165.12 26.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.434 1.494 . . . . 0.0 108.344 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.74 168.04 25.58 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.556 0.693 . . . . 0.0 111.177 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -69.06 149.1 49.11 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.963 2.105 . . . . 0.0 108.826 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -133.0 155.36 41.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.749 1.619 . . . . 0.0 109.394 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.08 88.48 2.74 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 167.48 -25.7 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 15.7 m -132.52 170.67 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.102 0.953 . . . . 0.0 110.419 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -108.82 86.8 2.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 161.61 -146.19 11.84 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.661 1.6 . . . . 0.0 109.844 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.97 156.05 47.53 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.4 1.48 . . . . 0.0 108.492 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.9 tt -113.23 149.18 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.29 1.436 . . . . 0.0 109.011 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 17.0 mm -77.37 137.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -129.63 -35.13 1.72 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.013 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.5 ttt -126.55 146.65 50.06 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 119.044 0.838 . . . . 0.0 110.836 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -140.0 147.83 41.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.428 1.491 . . . . 0.0 109.301 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -149.21 154.92 39.84 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -141.72 122.4 14.28 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -65.15 152.12 44.38 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.0 p -143.15 154.46 43.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -100.4 158.99 15.5 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 51.7 tptt 67.84 -34.37 0.24 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.507 1.923 . . . . 0.0 113.794 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -141.33 174.17 10.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.697 1.999 . . . . 0.0 109.448 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.5 p -114.44 162.71 16.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.085 1.354 . . . . 0.0 110.009 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 3.6 p -98.99 177.56 5.21 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.231 1.413 . . . . 0.0 110.646 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -113.22 157.28 41.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.372 1.469 . . . . 0.0 109.206 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.19 99.14 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.853 2.369 . . . . 0.0 108.402 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -82.84 92.51 7.28 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 126.24 -164.77 19.69 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.942 1.258 . . . . 0.0 111.051 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 46.7 tp -118.88 130.09 55.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.186 1.394 . . . . 0.0 109.542 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -70.99 120.71 16.96 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.2 -178.8 7.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.239 1.416 . . . . 0.0 109.392 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 49.34 -103.59 0.08 OUTLIER Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.253 1.882 . . . . 0.0 113.417 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 16.8 m -147.98 145.42 28.54 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.701 1.201 . . . . 0.0 108.692 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -81.97 152.66 26.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -141.34 151.03 43.22 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.537 1.535 . . . . 0.0 109.557 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.91 155.44 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.335 1.054 . . . . 0.0 110.962 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 42.9 mt -143.4 119.28 10.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.65 1.18 . . . . 0.0 109.354 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -139.31 170.99 14.93 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.237 0.615 . . . . 0.0 111.795 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.93 170.79 15.47 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.927 2.491 . . . . 0.0 107.638 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -120.7 125.2 47.05 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 78.07 17.71 77.86 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.527 1.061 . . . . 0.0 115.097 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -135.18 175.63 9.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.049 1.424 . . . . 0.0 111.924 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.01 161.94 36.66 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.486 1.514 . . . . 0.0 109.742 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 226' ' ' ILE . 91.4 mt -74.24 144.02 12.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.9 2.33 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.182 0.993 . . . . 0.0 112.565 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.0 179.03 26.39 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 120.898 -1.126 . . . . 0.0 112.401 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -113.22 160.52 18.2 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.661 2.385 . . . . 0.0 108.344 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . 0.502 ' CD2' ' HD1' ' A' ' 293' ' ' HIS . 12.1 p80 -151.67 106.54 3.26 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -160.48 -147.41 4.92 Favored Glycine 0 C--O 1.237 0.29 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -153.12 126.04 8.4 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -153.68 134.58 13.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.164 0.986 . . . . 0.0 109.2 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.7 t -133.9 -68.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -95.51 -32.86 12.66 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.172 0.989 . . . . 0.0 111.75 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.4 mp -135.9 175.14 9.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 108.895 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.55 99.92 6.55 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.888 1.275 . . . . 0.0 109.431 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -106.35 -65.65 1.06 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -67.37 115.85 7.47 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.981 0.512 . . . . 0.0 109.688 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.11 160.8 39.12 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.696 0.798 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 161.43 -167.32 36.24 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 12.5 m -152.3 153.5 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.499 1.119 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . 0.502 ' HD1' ' CD2' ' A' ' 280' ' ' HIS . 0.1 OUTLIER -94.19 167.76 11.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.07 143.99 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 66.1 mtp -139.46 140.88 26.85 Favored Pre-proline 0 N--CA 1.466 0.359 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.61 139.51 76.08 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 110.067 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.14 -20.62 66.11 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 22.1 m -147.27 166.63 26.47 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.244 0.767 0 C-N-CA 124.861 1.265 . . . . 0.0 108.168 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 122.235 1.017 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -135.7 154.15 51.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 130.931 3.693 . . . . 0.0 106.178 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HD3' ' CD2' ' A' ' 142' ' ' TYR . 29.7 ttpt -41.84 106.6 0.06 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.067 1.747 . . . . 0.0 111.363 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.22 146.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.67 144.32 14.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.919 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.22 151.28 31.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.89 13.77 17.05 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.739 -0.601 . . . . 0.0 112.175 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.27 102.9 0.21 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 126.508 2.004 . . . . 0.0 112.557 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 88' ' ' SER . . . -126.93 -19.33 2.0 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 116.907 1.523 . . . . 0.0 116.907 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 137' ' ' TYR . . . -78.55 -13.93 59.59 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.676 1.59 . . . . 0.0 109.966 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.74 43.19 19.06 Favored Glycine 0 N--CA 1.416 -2.658 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.251 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 -107.5 0.16 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.6 159.23 43.44 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.628 1.171 . . . . 0.0 110.628 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 p -93.52 129.95 39.56 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.574 -1.328 . . . . 0.0 108.481 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 t90 -93.25 -13.43 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.479 0.712 . . . . 0.0 109.857 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -65.01 103.48 0.74 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.044 0.937 . . . . 0.0 110.179 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.71 -54.53 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -17.09 59.79 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.431 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.85 -17.47 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.46 1.63 . . . . 0.0 112.779 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -173.11 131.31 0.49 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.699 2.8 . . . . 0.0 104.325 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -144.11 73.15 1.37 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.86 128.54 6.72 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.648 1.594 . . . . 0.0 109.541 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.26 150.57 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.58 1.152 . . . . 0.0 108.8 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -126.23 -45.38 1.69 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -143.16 161.88 37.05 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.207 1.403 . . . . 0.0 107.314 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.43 151.17 22.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -131.65 139.83 49.2 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.7 t -150.58 144.32 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.83 146.47 9.41 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -58.46 146.52 34.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 110.303 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.37 -116.33 2.71 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.99 1.281 . . . . 0.0 110.712 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -87.21 -49.15 7.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.766 0.783 . . . . 0.0 111.941 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -126.42 -26.02 3.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.376 1.071 . . . . 0.0 110.259 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.27 176.35 27.13 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.497 1.523 . . . . 0.0 111.183 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.2 m -58.44 96.49 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 126.437 1.895 . . . . 0.0 111.612 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 t -87.42 -50.7 6.38 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.295 1.038 . . . . 0.0 111.371 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 p -66.81 119.96 12.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.706 1.139 . . . . 0.0 109.44 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -132.64 158.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 108.064 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -166.5 141.86 4.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.937 1.295 . . . . 0.0 108.467 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.1 95.92 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.726 1.211 . . . . 0.0 108.37 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.63 130.27 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -100.81 131.98 46.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.74 109.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -114.87 115.89 27.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.33 34.76 24.33 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.967 0.907 . . . . 0.0 108.743 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 t 72.54 -1.23 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.198 2.199 . . . . 0.0 112.481 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.08 144.56 28.16 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.838 1.199 . . . . 0.0 109.655 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.97 126.51 34.17 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.76 109.14 14.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -111.62 162.2 15.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.566 1.547 . . . . 0.0 111.954 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 131.6 57.43 0.09 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.83 -1.6 0.19 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.881 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.515 ' OE2' ' HE2' ' A' ' 57' ' ' LYS . 1.7 tt0 -73.51 112.16 9.33 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.512 1.656 . . . . 0.0 106.816 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -137.18 167.18 22.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.527 1.531 . . . . 0.0 107.286 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.5 -179.01 20.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -82.86 98.08 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.046 -1.267 . . . . 0.0 109.165 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HE2' ' OE2' ' A' ' 53' ' ' GLU . 0.7 OUTLIER -83.53 163.1 20.65 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.4 p -132.08 172.76 11.98 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.595 1.158 . . . . 0.0 109.844 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 tp -89.79 -47.28 8.01 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.287 1.035 . . . . 0.0 111.689 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.01 75.21 1.02 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.93 -34.76 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -81.18 128.5 33.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.811 1.245 . . . . 0.0 111.125 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -143.69 163.83 32.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.337 1.855 . . . . 0.0 107.563 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.2 m -126.85 146.27 50.34 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.6 1.16 . . . . 0.0 108.654 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -129.04 140.94 51.4 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 126.057 1.743 . . . . 0.0 106.905 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -129.1 146.94 50.93 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.405 1.082 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -79.36 157.82 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.97 168.04 13.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.743 1.61 . . . . 0.0 112.087 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.51 -27.15 25.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.478 1.511 . . . . 0.0 110.483 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -121.02 5.96 10.36 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.924 0.784 . . . . 0.0 112.84 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -116.64 156.17 27.51 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -134.77 -176.78 4.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.38 136.17 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.9 m -113.89 -36.0 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.734 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.32 160.39 43.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.257 0.935 . . . . 0.0 110.206 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -146.05 110.03 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -80.73 134.46 35.83 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.5 t -132.43 122.95 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 124.464 1.106 . . . . 0.0 108.32 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.41 ' OG1' ' HE3' ' A' ' 114' ' ' LYS . 30.4 m -118.31 145.26 45.22 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.965 1.706 . . . . 0.0 106.477 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -149.93 168.11 24.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.536 1.134 . . . . 0.0 111.212 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -161.18 158.82 28.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.333 1.053 . . . . 0.0 108.946 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -144.86 135.1 24.12 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.489 1.116 . . . . 0.0 108.646 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -72.33 154.19 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.785 0.721 . . . . 0.0 109.975 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -61.67 -14.62 32.82 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -103.49 -7.89 41.71 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 118.403 -1.221 . . . . 0.0 113.762 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -135.27 105.53 6.33 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.207 1.503 . . . . 0.0 107.584 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -58.65 -24.61 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.913 1.685 . . . . 0.0 115.18 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . 46.1 p -72.8 122.31 21.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.932 1.293 . . . . 0.0 109.178 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.93 164.17 16.7 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 126.331 1.853 . . . . 0.0 109.173 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.4 pt -142.75 149.9 18.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.07 -1.019 . . . . 0.0 108.38 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.0 128.1 32.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 p -95.81 -39.19 9.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.994 -1.479 . . . . 0.0 108.268 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.9 m -160.1 152.34 20.65 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.9 1.682 . . . . 0.0 111.108 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.4 mm -132.95 139.03 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.0 m -130.17 112.58 13.53 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -82.03 155.43 25.15 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.959 0.904 . . . . 0.0 109.783 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.75 113.73 7.24 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 106.927 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 p -90.43 170.6 10.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.638 0.654 . . . . 0.0 111.182 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -60.81 -36.25 78.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.99 -6.67 56.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.24 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 15.8 39.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.227 -1.319 . . . . 0.0 111.28 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -71.72 101.76 2.64 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -93.44 140.11 29.95 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.4 p -92.7 160.95 33.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.02 160.55 49.24 Favored 'Trans proline' 0 CA--C 1.551 1.354 0 N-CA-C 105.41 -2.573 . . . . 0.0 105.41 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.64 89.0 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.753 2.302 . . . . 0.0 107.529 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -58.83 104.23 0.22 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.633 0.773 . . . . 0.0 109.125 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.78 -145.04 16.56 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.4 111.9 12.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.395 1.478 . . . . 0.0 108.154 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -46.81 139.46 5.39 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.227 1.811 . . . . 0.0 113.948 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 178.45 7.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.254 1.422 . . . . 0.0 110.654 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.33 -53.17 5.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.035 1.734 . . . . 0.0 114.066 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -65.15 108.08 1.75 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.689 1.131 . . . . 0.0 108.863 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.41 ' HE3' ' OG1' ' A' ' 79' ' ' THR . 6.1 ptmt -152.91 168.76 24.72 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 123.099 0.56 . . . . 0.0 111.318 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.31 166.99 31.84 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 106.994 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.46 122.06 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 117' ' ' LEU . 1.5 pt? -100.42 133.62 44.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.0 167.89 28.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.869 0.868 . . . . 0.0 111.282 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.65 168.07 10.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.694 1.197 . . . . 0.0 107.938 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -161.38 -27.26 0.05 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.365 2.666 . . . . 0.0 109.648 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -75.79 -5.47 46.02 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.581 2.752 . . . . 0.0 111.838 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 99.67 9.98 48.3 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.605 1.098 . . . . 0.0 113.153 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.01 85.98 0.89 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 124.951 1.263 . . . . 0.0 110.569 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -59.65 142.46 52.9 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.4 tt -69.45 128.19 35.66 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.1 t -93.07 -50.54 12.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.54 -151.22 6.71 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.087 1.327 . . . . 0.0 109.804 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -138.57 169.22 18.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.165 1.483 . . . . 0.0 113.16 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -138.6 166.41 24.39 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.602 1.961 . . . . 0.0 106.941 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.14 125.58 2.97 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.7 -178.44 4.39 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 121.351 -1.088 . . . . 0.0 108.926 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -125.9 158.79 34.26 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.391 2.276 . . . . 0.0 105.993 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -116.56 -83.83 1.04 Allowed Glycine 0 CA--C 1.51 -0.271 0 N-CA-C 105.556 -3.018 . . . . 0.0 105.556 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -107.77 -14.21 14.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.573 0.749 . . . . 0.0 110.506 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -155.43 174.2 15.58 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.883 2.473 . . . . 0.0 107.604 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.5 tp -75.77 131.88 40.09 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.23 0.612 . . . . 0.0 109.48 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-85 -138.45 -55.67 0.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.478 1.911 . . . . 0.0 109.47 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -107.3 108.13 19.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.4 tp -130.78 142.05 50.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.11 -178.18 35.78 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 127.11 2.29 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -155.04 137.48 15.01 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.767 1.283 . . . . 0.0 110.38 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' CD2' ' HD3' ' A' ' 3' ' ' LYS . 41.7 m-85 -81.42 141.43 33.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.878 1.271 . . . . 0.0 107.835 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -137.04 127.3 26.36 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -144.8 124.49 13.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.636 0.653 . . . . 0.0 110.565 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 t -133.4 103.44 5.95 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.4 t -170.5 171.18 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 127.423 2.289 . . . . 0.0 106.837 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.5 m -140.76 73.81 1.44 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 p -134.48 163.07 53.82 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.142 1.777 . . . . 0.0 111.797 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.51 -159.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.988 2.459 . . . . 0.0 106.709 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.28 124.84 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.8 p -74.91 154.15 86.88 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 112.347 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.24 -173.32 1.55 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.733 2.955 . . . . 0.0 112.129 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.46 -174.1 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.687 1.995 . . . . 0.0 112.053 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.6 tppt? -73.96 107.79 6.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -83.56 119.61 24.93 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.249 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 14.4 mt -78.41 -94.24 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 t -155.51 166.1 34.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.921 1.288 . . . . 0.0 109.826 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -147.27 -178.18 6.08 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 130.148 3.379 . . . . 0.0 107.706 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.46 141.86 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.31 1.414 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.12 -105.64 3.22 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 106.43 -2.668 . . . . 0.0 106.43 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.75 64.5 4.15 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.415 1.007 . . . . 0.0 111.172 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.444 ' H ' ' HB3' ' A' ' 288' ' ' HIS . 0.7 OUTLIER -76.01 57.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.224 2.21 . . . . 0.0 114.368 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 53.19 20.53 1.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.549 1.94 . . . . 0.0 114.912 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 168.94 33.0 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 2.8 m -65.43 116.77 7.07 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.844 1.657 . . . . 0.0 109.264 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -66.75 154.63 40.24 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.676 0.79 . . . . 0.0 110.44 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -138.39 120.67 15.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.29 104.95 17.01 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -107.66 93.06 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.558 1.143 . . . . 0.0 108.198 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -63.35 162.7 32.44 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.61 155.03 34.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 117.611 0.705 . . . . 0.0 110.393 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -112.99 167.61 10.38 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.431 1.11 . . . . 0.0 112.057 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 -15.76 57.61 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.189 2.196 . . . . 0.0 110.282 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 165.94 149.51 5.94 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.582 2.039 . . . . 0.0 108.063 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.99 129.56 44.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.44 -53.78 6.56 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -158.81 143.55 15.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.67 0.668 . . . . 0.0 110.086 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.96 148.36 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.95 158.01 44.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.983 1.313 . . . . 0.0 107.621 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.0 t -143.57 142.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.13 82.13 0.35 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 124.788 1.185 . . . . 0.0 112.683 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -70.89 177.26 3.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.908 1.283 . . . . 0.0 110.339 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -149.85 -174.24 20.98 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -63.7 -25.09 68.05 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -122.71 -21.07 5.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.266 1.427 . . . . 0.0 113.833 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 172.3 -178.78 44.28 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 119.53 1.059 . . . . 0.0 111.723 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.5 mm -59.13 115.84 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.476 1.11 . . . . 0.0 109.676 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 55.5 m -93.83 -35.67 12.61 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.415 0.686 . . . . 0.0 111.923 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -143.65 166.81 23.81 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.6 150.92 30.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.788 1.635 . . . . 0.0 107.015 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.606 ' HE2' ' CE2' ' A' ' 214' ' ' PHE . 0.1 OUTLIER 179.82 150.59 0.36 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.435 3.494 . . . . 0.0 106.594 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -153.78 152.22 30.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.561 1.073 . . . . 0.0 108.131 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -94.42 132.41 39.09 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -138.24 169.03 18.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.253 1.021 . . . . 0.0 111.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -119.8 139.13 52.81 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.075 1.35 . . . . 0.0 109.533 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -140.2 76.16 1.54 Allowed 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.69 -128.03 46.47 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.99 10.39 0.55 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.156 1.382 . . . . 0.0 114.066 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.37 140.69 52.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.447 1.476 . . . . 0.0 109.247 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.07 89.35 2.85 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 40.9 mm -70.09 109.29 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.612 1.165 . . . . 0.0 108.82 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.0 t -125.44 94.89 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 126.193 1.797 . . . . 0.0 106.241 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 125.6 176.4 14.52 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.438 1.494 . . . . 0.0 113.64 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.91 75.27 1.0 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.275 1.893 . . . . 0.0 110.281 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.87 155.92 29.13 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.625 -0.926 . . . . 0.0 112.33 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -111.6 -80.12 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.64 162.0 50.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -53.56 116.49 9.93 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.66 1.184 . . . . 0.0 113.567 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.49 144.06 71.67 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.731 1.621 . . . . 0.0 108.339 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.94 135.3 42.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.488 1.115 . . . . 0.0 110.667 -179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.53 -11.09 60.55 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.094 0.558 . . . . 0.0 111.525 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.67 -31.28 69.41 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.209 1.404 . . . . 0.0 109.783 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.39 -171.43 14.63 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.606 ' CE2' ' HE2' ' A' ' 191' ' ' LYS . 13.3 m-85 -136.05 158.81 43.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -111.4 148.06 33.86 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.37 144.35 49.54 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.526 0.516 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 256' ' ' SER . 31.5 t80 -142.88 142.96 31.87 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.68 0.792 . . . . 0.0 110.959 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -92.32 124.68 36.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.409 1.484 . . . . 0.0 108.871 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.0 mt -125.67 112.07 29.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.175 0.99 . . . . 0.0 108.749 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.06 88.48 7.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -62.63 -29.55 4.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 115.778 -2.058 . . . . 0.0 113.644 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.12 -45.01 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 123.902 2.429 . . . . 0.0 110.88 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 m -67.03 -54.0 25.86 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.997 1.319 . . . . 0.0 111.865 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -94.71 -167.66 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.599 1.96 . . . . 0.0 110.631 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -164.11 142.14 7.18 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.508 1.123 . . . . 0.0 108.976 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 32.7 mm -93.48 104.18 15.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.3 p -72.92 -59.76 2.55 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.096 0.959 . . . . 0.0 110.33 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.41 171.72 13.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.647 1.979 . . . . 0.0 111.529 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.78 148.84 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.39 1.876 . . . . 0.0 106.865 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -133.59 160.85 36.27 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.497 1.119 . . . . 0.0 109.997 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -178.78 167.37 37.69 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 124.671 1.129 . . . . 0.0 110.998 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 34.5 p -133.39 127.19 32.91 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -119.76 146.19 45.88 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -142.61 166.91 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -76.94 136.3 38.79 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.758 1.223 . . . . 0.0 112.824 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.66 156.55 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 127.426 2.29 . . . . 0.0 108.252 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -103.5 163.75 12.09 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.78 1.232 . . . . 0.0 111.16 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.11 -15.94 56.88 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.246 1.403 . . . . 0.0 110.347 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 7.7 t -141.45 -174.38 4.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 128.248 2.619 . . . . 0.0 106.618 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -130.92 101.82 5.79 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 126.557 1.943 . . . . 0.0 106.856 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 174.32 -173.37 45.98 Favored Glycine 0 N--CA 1.447 -0.622 0 O-C-N 123.645 0.591 . . . . 0.0 112.451 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.82 141.37 52.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.083 1.353 . . . . 0.0 109.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 10.3 tt -123.72 134.17 67.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.6 1.16 . . . . 0.0 108.773 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 33.4 mt -79.06 98.72 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -76.0 -26.5 56.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.023 0.529 . . . . 0.0 111.766 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -140.99 152.37 44.87 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.083 0.856 . . . . 0.0 110.815 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.4 154.65 51.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.468 1.907 . . . . 0.0 109.965 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 21.3 mtt180 -145.05 152.52 40.24 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.992 2.117 . . . . 0.0 105.688 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -118.07 142.53 47.31 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -95.61 115.42 27.4 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 71.2 p -130.49 166.49 20.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.391 1.476 . . . . 0.0 108.776 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -123.54 160.09 27.75 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.993 1.717 . . . . 0.0 106.552 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 69.35 -27.6 0.16 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.114 2.566 . . . . 0.0 112.191 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -150.88 174.83 12.65 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 127.23 2.212 . . . . 0.0 110.229 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.77 161.02 32.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.579 1.952 . . . . 0.0 106.914 178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.412 ' HB3' ' CE2' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -115.29 -10.99 12.0 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 73.15 162.66 0.15 Allowed Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 126.908 2.083 . . . . 0.0 109.522 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 95.5 Cg_endo -76.28 149.0 31.14 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.438 2.092 . . . . 0.0 110.551 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.17 95.72 4.86 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 125.43 -176.99 17.15 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.275 1.416 . . . . 0.0 110.789 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 63.6 tp -88.18 126.83 35.34 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.353 1.061 . . . . 0.0 110.165 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -73.12 107.17 5.31 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -160.22 154.79 23.91 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.665 1.586 . . . . 0.0 107.987 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 88.1 -174.82 44.27 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 29.9 m -77.33 138.47 39.36 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -92.14 142.81 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.317 0.508 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -138.74 147.88 43.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.767 0.827 . . . . 0.0 111.344 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.31 144.29 34.52 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.23 1.412 . . . . 0.0 109.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 mt -134.22 137.3 44.27 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -150.04 178.27 9.1 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.174 1.789 . . . . 0.0 108.905 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 164.83 29.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.22 1.01 . . . . 0.0 108.566 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -69.84 5.37 1.55 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.302 1.841 . . . . 0.0 114.354 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 166.45 -34.69 0.23 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.389 -1.444 . . . . 0.0 113.324 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -57.01 149.98 17.88 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.768 0.784 . . . . 0.0 109.331 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 157.47 16.85 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.623 -0.673 . . . . 0.0 110.041 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 96.6 mt -95.91 104.2 15.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.45 38.81 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.989 1.316 . . . . 0.0 108.548 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.44 168.03 36.57 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 121.166 -0.959 . . . . 0.0 114.477 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.11 171.23 14.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 129.335 3.054 . . . . 0.0 109.946 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -159.48 146.64 16.87 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.812 1.245 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -179.55 -163.64 30.68 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 121.217 -0.927 . . . . 0.0 113.423 -179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -146.68 138.97 24.88 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.822 1.649 . . . . 0.0 107.765 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -131.86 154.39 49.23 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.184 1.793 . . . . 0.0 110.055 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.3 m -166.39 -46.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.951 1.3 . . . . 0.0 108.691 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.13 -17.63 1.36 Allowed 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -171.4 2.01 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.496 1.919 . . . . 0.0 106.617 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 13.3 tp -83.21 85.58 7.18 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.444 ' HB3' ' H ' ' A' ' 162' ' ' ASP . 87.6 m-70 -60.44 -34.79 74.49 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.264 0.483 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -161.47 163.33 30.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.642 0.734 . . . . 0.0 110.245 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -159.52 135.45 8.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -143.13 -157.71 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 128.538 2.97 . . . . 0.0 108.715 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.73 171.59 13.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-O 122.281 1.039 . . . . 0.0 112.139 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.76 150.16 51.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.874 2.869 . . . . 0.0 105.354 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.25 137.79 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.324 0.65 . . . . 0.0 110.741 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 16.2 mmt -125.38 148.24 60.47 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.431 1.492 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.82 152.62 37.22 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.631 1.554 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 3.4 mp -68.44 159.81 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 6.4 m -158.69 146.36 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 13.8 t30 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 123.824 0.85 . . . . 0.0 109.336 -179.543 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -130.07 97.73 4.54 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.78 1.632 . . . . 0.0 112.727 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -81.15 130.54 35.07 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 102.633 -3.099 . . . . 0.0 102.633 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 36.7 t -123.51 103.87 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.687 0.795 . . . . 0.0 110.02 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -55.85 142.7 34.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.49 1.116 . . . . 0.0 110.987 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.63 179.97 1.95 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.857 1.263 . . . . 0.0 110.161 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.22 143.81 14.48 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.126 -1.99 . . . . 0.0 108.126 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 144.77 -134.13 5.48 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.98 -148.97 18.66 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 118.0 0.9 . . . . 0.0 111.816 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.11 8.32 1.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.389 1.076 . . . . 0.0 112.168 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.93 -11.51 18.1 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 117.089 1.595 . . . . 0.0 117.089 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.45 169.21 12.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.648 2.224 . . . . 0.0 113.766 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.55 151.7 32.32 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.6 97.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.923 0.783 . . . . 0.0 112.736 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -103.56 55.05 0.74 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.11 18.61 19.82 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.198 1.399 . . . . 0.0 111.981 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -151.64 119.31 6.1 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.665 0.786 . . . . 0.0 110.602 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.12 26.7 50.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.865 1.697 . . . . 0.0 115.352 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.23 -37.17 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 119.574 1.687 . . . . 0.0 114.045 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -148.03 162.58 39.08 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.398 1.079 . . . . 0.0 110.375 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -107.35 -34.12 7.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.956 2.502 . . . . 0.0 111.806 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.98 83.49 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.8 m -63.2 158.64 3.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 117.853 0.827 . . . . 0.0 109.207 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 10.5 mmm180 -136.09 -35.7 0.76 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -147.14 157.51 43.63 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 124.784 1.234 . . . . 0.0 107.691 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.8 t -137.0 105.24 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -88.02 140.61 29.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.82 143.17 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.9 152.54 21.5 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.813 0.733 . . . . 0.0 111.335 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.8 tm0? -70.2 120.04 15.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.216 1.406 . . . . 0.0 112.611 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.68 -122.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 130.575 3.94 . . . . 0.0 107.876 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -95.23 -48.35 5.95 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 118.163 0.982 . . . . 0.0 112.256 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.65 -26.88 12.14 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 129.109 2.963 . . . . 0.0 114.676 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.42 -158.05 16.7 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 118.897 0.771 . . . . 0.0 111.381 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 m -72.7 96.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 118.61 1.205 . . . . 0.0 108.846 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -106.63 -45.09 4.31 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -71.02 148.31 47.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 120.291 1.405 . . . . 0.0 112.117 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.9 159.68 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 126.431 1.892 . . . . 0.0 108.091 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.05 152.35 46.15 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.882 2.473 . . . . 0.0 107.458 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -126.52 132.06 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.658 0.783 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 t -128.6 142.96 42.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -132.76 141.38 48.5 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.347 0.659 . . . . 0.0 109.362 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' HB2' ' CG ' ' A' ' 24' ' ' ARG . . . -114.25 120.41 40.35 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 125.086 1.354 . . . . 0.0 108.751 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -113.46 161.99 16.66 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.9 -41.92 92.71 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.2 t -68.81 -69.39 0.33 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.491 -1.243 . . . . 0.0 110.574 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -145.31 165.84 27.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 120.239 1.381 . . . . 0.0 113.677 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -78.49 149.55 33.13 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.777 2.031 . . . . 0.0 105.804 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 p -147.71 145.73 18.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 122.754 1.264 . . . . 0.0 109.277 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -105.97 162.13 13.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.375 1.47 . . . . 0.0 108.688 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -129.63 -15.08 2.02 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 0.0 112.09 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.78 167.03 36.22 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 118.7 1.25 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -103.62 106.39 16.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.32 82.23 2.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.85 -174.61 31.95 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 128.7 3.048 . . . . 0.0 105.676 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -126.78 141.05 51.94 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 118.286 1.043 . . . . 0.0 111.908 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -130.56 148.84 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.397 2.279 . . . . 0.0 105.149 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.5 m -133.85 -48.0 0.8 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.2 tp -70.05 -9.99 57.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.149 0.886 . . . . 0.0 110.494 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.4 mt 66.33 11.48 7.98 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 127.209 2.203 . . . . 0.0 112.175 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.34 86.33 1.36 Allowed Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 106.975 -2.45 . . . . 0.0 106.975 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -131.46 144.68 51.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.505 1.922 . . . . 0.0 108.555 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -142.78 164.69 29.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.041 1.736 . . . . 0.0 110.465 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -124.88 121.22 33.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.356 1.062 . . . . 0.0 113.55 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -87.35 141.83 28.34 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.95 141.21 50.89 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.518 1.127 . . . . 0.0 109.69 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.64 117.44 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.507 1.123 . . . . 0.0 111.538 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -62.1 156.56 21.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.781 1.633 . . . . 0.0 108.591 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.33 68.21 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.353 -0.842 . . . . 0.0 110.81 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -117.87 25.33 10.45 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -97.37 143.06 28.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.19 1.396 . . . . 0.0 111.845 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -133.94 139.74 46.32 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.356 2.663 . . . . 0.0 110.593 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.19 134.19 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.711 1.604 . . . . 0.0 112.332 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.0 -34.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.948 -1.095 . . . . 0.0 112.1 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.63 144.35 28.34 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.432 1.015 . . . . 0.0 108.64 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.57 92.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -79.34 120.91 24.45 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.506 HG13 ' CE1' ' A' ' 115' ' ' PHE . 0.2 OUTLIER -151.77 132.61 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.531 HG21 ' HA ' ' A' ' 110' ' ' GLU . 4.1 t -110.55 153.72 24.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.979 1.711 . . . . 0.0 109.227 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -154.12 147.33 24.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.841 1.656 . . . . 0.0 109.392 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.2 169.33 22.46 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 118.821 0.737 . . . . 0.0 111.155 177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -83.07 136.16 34.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.967 1.307 . . . . 0.0 109.756 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.22 130.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -61.78 114.84 3.55 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.3 41.99 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.324 -1.265 . . . . 0.0 113.113 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -130.49 161.47 31.38 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.192 1.496 . . . . 0.0 109.754 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -96.35 -26.48 15.35 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.768 1.227 . . . . 0.0 110.062 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 p -72.59 166.86 21.9 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.48 1.133 . . . . 0.0 109.022 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.52 135.21 42.2 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.46 166.89 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.354 1.062 . . . . 0.0 112.647 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 138' ' ' ALA . 2.9 mp -74.63 144.03 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.077 1.751 . . . . 0.0 107.445 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -108.61 -29.05 8.94 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.085 0.954 . . . . 0.0 110.849 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.0 t -166.36 164.09 17.46 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.948 1.699 . . . . 0.0 108.933 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.1 tt -157.12 154.87 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 124.999 1.319 . . . . 0.0 110.73 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 m -150.84 157.28 42.73 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.478 1.511 . . . . 0.0 107.235 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -129.86 135.33 48.26 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -121.33 114.05 20.78 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.6 p -81.07 161.19 24.27 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -31.12 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -58.8 -43.07 90.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 111.345 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.97 -7.4 3.8 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.814 0.721 . . . . 0.0 114.383 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.19 132.4 36.52 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.9 m -133.7 156.37 48.06 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 p -121.24 162.34 36.21 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 125.007 1.323 . . . . 0.0 111.386 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.28 167.06 23.65 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.885 2.39 . . . . 0.0 110.483 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.12 112.65 3.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.663 2.909 . . . . 0.0 106.618 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -79.19 81.52 5.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 138.69 -138.13 9.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.372 0.987 . . . . 0.0 110.702 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -129.9 121.36 26.5 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.514 1.526 . . . . 0.0 108.334 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.531 ' HA ' HG21 ' A' ' 79' ' ' THR . 10.1 mm-40 -60.53 156.11 17.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.05 0.54 . . . . 0.0 110.485 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -152.7 -174.5 4.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.692 1.234 . . . . 0.0 112.683 -178.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.418 ' H ' HG22 ' A' ' 111' ' ' THR . 14.1 tt0 -67.47 -64.72 0.8 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 127.219 2.208 . . . . 0.0 112.257 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -70.98 101.83 2.27 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 125.432 1.493 . . . . 0.0 108.633 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -147.8 153.48 39.24 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 121.657 -0.652 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CE1' HG13 ' A' ' 78' ' ' VAL . 28.2 p90 -125.52 158.94 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.686 1.594 . . . . 0.0 109.857 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.9 t -140.46 104.67 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 139.45 53.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.69 150.69 1.76 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.944 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 143' ' ' PHE . 25.3 t0 -120.97 176.2 5.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.559 1.144 . . . . 0.0 110.49 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -65.27 175.8 1.56 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.153 2.181 . . . . 0.0 108.092 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -68.38 2.43 2.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.315 1.446 . . . . 0.0 111.743 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.45 3.92 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.08 2.276 . . . . 0.0 111.159 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.52 165.49 31.46 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 118.248 1.024 . . . . 0.0 111.059 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -161.9 164.69 28.42 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.62 1.968 . . . . 0.0 107.569 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.3 158.77 11.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.965 0.888 . . . . 0.0 110.991 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 16.4 t -134.87 -25.29 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 128.509 2.724 . . . . 0.0 110.722 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 164.38 -176.27 40.31 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -121.08 170.59 9.39 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.62 0.724 . . . . 0.0 109.236 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -156.41 170.13 23.01 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 126.825 2.05 . . . . 0.0 107.181 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.67 -146.42 14.96 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -159.47 135.68 8.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 127.734 2.414 . . . . 0.0 106.009 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -154.52 164.86 38.05 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 128.097 2.559 . . . . 0.0 105.298 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.36 -111.91 0.26 Allowed Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 106.616 -2.594 . . . . 0.0 106.616 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -65.06 -17.83 64.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.525 0.73 . . . . 0.0 110.46 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.9 175.47 12.44 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 126.749 2.02 . . . . 0.0 108.524 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HG ' HD13 ' A' ' 91' ' ' ILE . 26.1 tp -84.8 121.48 27.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.281 1.832 . . . . 0.0 107.341 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -117.16 -31.25 5.4 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 91' ' ' ILE . . . -168.74 161.72 11.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.845 1.657 . . . . 0.0 110.353 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.3 tt -157.68 149.14 21.7 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.016 1.326 . . . . 0.0 108.807 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.85 168.17 37.57 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -137.85 134.53 35.23 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.43 169.23 10.21 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.272 1.429 . . . . 0.0 109.563 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 119' ' ' ASP . 66.1 m-85 -131.17 112.11 12.54 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -136.16 138.96 42.5 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.177 0.991 . . . . 0.0 111.517 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -135.55 102.8 5.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 t -160.95 155.77 23.85 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.866 1.267 . . . . 0.0 108.858 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.2 m -139.28 -98.14 0.16 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 22.1 p -144.52 157.14 56.33 Favored Pre-proline 0 C--N 1.318 -0.789 0 C-N-CA 125.849 1.66 . . . . 0.0 111.602 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.52 154.17 72.22 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.33 134.3 28.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.3 p -113.54 140.54 24.66 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.173 0.442 . . . . 0.0 110.037 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.64 4.21 3.71 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.543 2.829 . . . . 0.0 116.668 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.39 150.97 38.65 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 129.959 3.304 . . . . 0.0 110.933 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -80.12 125.28 29.62 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -111.28 146.79 36.39 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.778 0.717 . . . . 0.0 111.792 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.78 170.84 13.73 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.5 t -87.78 118.86 27.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.271 1.028 . . . . 0.0 110.757 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -85.62 170.0 12.97 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.199 0.999 . . . . 0.0 111.422 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 94.9 mt -138.71 154.76 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 129.898 3.279 . . . . 0.0 105.256 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.56 -96.05 0.16 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 119.593 1.088 . . . . 0.0 110.773 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.77 153.61 24.37 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.08 8.79 30.94 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.965 1.306 . . . . 0.0 114.192 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -122.29 106.33 11.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 120.965 -1.084 . . . . 0.0 110.938 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 172.43 158.11 15.86 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.1 m -66.51 119.1 11.1 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.146 0.978 . . . . 0.0 108.43 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -73.57 130.94 41.11 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -123.17 125.91 46.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -97.61 153.83 17.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.127 0.971 . . . . 0.0 110.745 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.01 135.14 19.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 102.893 -3.003 . . . . 0.0 102.893 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -99.48 169.74 22.71 Favored Glycine 0 CA--C 1.529 0.969 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.48 146.62 50.15 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -114.75 151.37 33.86 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.97 -15.08 54.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.12 2.568 . . . . 0.0 112.179 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 177.13 177.5 46.1 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 123.793 0.711 . . . . 0.0 111.91 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.88 156.46 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.543 1.937 . . . . 0.0 107.046 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -138.38 -54.1 0.62 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.862 0.865 . . . . 0.0 109.118 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' A' ' 179' ' ' TYR . 2.3 tppt? -151.23 142.46 23.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.12 0.873 . . . . 0.0 111.57 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.9 t -93.71 132.75 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 177' ' ' LYS . 13.3 m-85 -136.33 108.49 7.24 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.34 131.79 47.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.44 67.27 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.164 1.364 . . . . 0.0 111.562 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.488 ' CD ' ' H ' ' A' ' 182' ' ' GLN . 2.8 pm0 -70.01 160.94 31.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.182 1.393 . . . . 0.0 109.376 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.01 177.85 35.41 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -51.6 -45.63 63.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.788 0.835 . . . . 0.0 112.721 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -86.17 -3.09 58.89 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.323 1.049 . . . . 0.0 113.511 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 123.5 -176.31 16.72 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.982 0.81 . . . . 0.0 113.662 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.0 mm -63.26 112.38 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.8 m -109.29 -30.91 7.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.256 0.622 . . . . 0.0 110.242 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.701 1.201 . . . . 0.0 108.891 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.88 137.0 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 127.025 2.13 . . . . 0.0 107.283 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.17 155.68 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.27 131.17 27.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.1 140.67 29.25 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -153.19 169.55 22.72 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.964 1.306 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -127.76 127.08 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.412 -2.069 . . . . 0.0 105.412 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -139.95 138.53 35.63 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.19 31.37 49.34 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 71.65 -14.18 0.51 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.417 2.687 . . . . 0.0 112.794 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.44 136.19 49.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.829 1.252 . . . . 0.0 110.424 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -89.5 80.07 6.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 109.697 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.65 144.89 14.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 126.405 1.882 . . . . 0.0 109.694 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.06 129.04 74.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.71 143.3 18.71 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.48 1.038 . . . . 0.0 112.462 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -74.63 160.35 52.9 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -92.54 83.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -62.08 -25.57 67.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.211 1.805 . . . . 0.0 112.003 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.41 176.42 25.34 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.645 1.111 . . . . 0.0 111.088 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.62 138.33 80.46 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.5 179.59 2.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.408 2.738 . . . . 0.0 110.408 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 70.1 p -135.61 172.69 12.65 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 109.96 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.69 -26.01 28.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.755 0.822 . . . . 0.0 110.576 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 212' ' ' LEU . 2.3 tt -63.65 -21.67 66.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.298 1.839 . . . . 0.0 112.461 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.21 171.33 46.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.59 151.3 21.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.23 0.612 . . . . 0.0 112.309 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -111.93 133.75 53.93 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 103.343 -2.836 . . . . 0.0 103.343 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -118.41 146.78 44.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -142.47 143.53 32.63 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.666 1.187 . . . . 0.0 109.222 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -112.33 130.12 56.06 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.5 mm -127.26 107.82 17.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 125.726 1.61 . . . . 0.0 107.452 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 93.95 2.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -56.5 -34.91 29.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.94 -26.88 10.63 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 123.964 2.451 . . . . 0.0 113.264 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.4 m -106.91 -0.78 22.95 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.665 1.575 . . . . 0.0 114.798 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.8 156.8 42.43 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 120.337 1.426 . . . . 0.0 108.425 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -133.61 161.55 34.34 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.861 -1.149 . . . . 0.0 112.073 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.2 mm -92.7 97.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 102.614 -3.106 . . . . 0.0 102.614 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 3.2 m -64.4 -40.27 95.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -164.63 170.86 15.17 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.618 1.167 . . . . 0.0 109.368 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.16 144.51 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.246 -3.242 . . . . 0.0 102.246 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.416 ' HG3' ' HE3' ' A' ' 250' ' ' LYS . 0.8 OUTLIER -132.02 173.13 11.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -179.295 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 155.03 -170.82 33.26 Favored Glycine 0 CA--C 1.508 -0.354 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.8 p -144.8 154.94 43.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -131.55 145.91 51.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -121.88 145.5 48.03 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.878 0.846 . . . . 0.0 111.368 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -70.35 148.26 48.65 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.876 1.27 . . . . 0.0 109.486 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.5 pt -114.53 155.75 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 127.269 2.228 . . . . 0.0 106.724 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -103.59 150.33 24.06 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.86 0.362 . . . . 0.0 111.107 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 85.62 -3.34 87.29 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.657 1.599 . . . . 0.0 111.47 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.8 p -142.23 170.73 15.16 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.606 2.763 . . . . 0.0 107.742 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -108.04 8.5 28.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.672 1.189 . . . . 0.0 110.715 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -80.97 -172.04 45.57 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 122.746 1.192 . . . . 0.0 113.545 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.6 mt -137.78 157.45 46.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.895 2.478 . . . . 0.0 108.6 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 18.5 tt -123.53 135.41 63.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.9 mm -94.41 77.11 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.9 t -83.1 -12.59 56.93 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 122.075 -0.391 . . . . 0.0 112.037 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -137.47 134.64 36.02 Favored 'General case' 0 C--N 1.341 0.228 0 O-C-N 121.796 -0.565 . . . . 0.0 112.451 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 14.6 tp -139.78 152.35 46.51 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.516 1.126 . . . . 0.0 109.51 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -141.32 161.61 37.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.528 1.931 . . . . 0.0 108.352 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -131.03 121.45 25.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.996 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.416 ' HE3' ' HG3' ' A' ' 230' ' ' GLU . 69.8 mttt -80.08 115.28 19.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 15.4 p -125.17 165.03 18.99 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.066 1.746 . . . . 0.0 108.154 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.25 160.97 25.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? 63.31 -26.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.511 1.925 . . . . 0.0 115.636 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -132.25 124.4 28.85 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.933 2.093 . . . . 0.0 108.216 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 16.0 m -78.19 113.14 15.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.695 1.598 . . . . 0.0 107.735 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 8.1 p -84.37 162.86 19.87 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.271 0.557 . . . . 0.0 109.622 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -109.79 152.19 42.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.144 1.778 . . . . 0.0 108.334 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.07 130.97 13.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.251 1.968 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -102.38 92.26 4.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.68 169.3 14.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.48 1.514 . . . . 0.0 110.724 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 94.0 mt -95.26 146.62 24.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.93 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.39 124.34 25.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -144.83 106.34 4.24 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 89.75 -164.95 31.78 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 122.978 1.321 . . . . 0.0 115.23 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 43.2 m -64.26 132.81 51.37 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.366 1.466 . . . . 0.0 109.992 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -85.67 145.64 27.21 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -126.93 137.2 53.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.795 0.807 . . . . 0.0 112.52 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -124.29 140.76 52.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 72.7 mt -144.86 114.92 7.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -143.6 172.43 12.81 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.541 1.136 . . . . 0.0 110.009 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -144.41 153.85 42.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -101.74 140.09 36.5 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.358 1.063 . . . . 0.0 109.004 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 72.55 21.37 79.56 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -143.47 166.65 24.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.601 1.56 . . . . 0.0 109.251 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 298' ' ' THR . 34.0 pttt -129.92 174.21 9.97 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.982 2.113 . . . . 0.0 106.754 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 26.8 mt -109.01 154.31 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.24 24.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.416 1.086 . . . . 0.0 113.322 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.54 -155.05 23.95 Favored Glycine 0 N--CA 1.465 0.632 0 O-C-N 120.429 -1.419 . . . . 0.0 111.693 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.23 174.1 10.99 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.297 1.839 . . . . 0.0 111.159 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -155.66 163.27 40.13 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.715 2.406 . . . . 0.0 107.974 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.64 -169.99 36.48 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 120.78 1.627 . . . . 0.0 114.78 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 130.33 18.54 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.975 1.31 . . . . 0.0 108.488 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.95 154.49 17.68 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.303 1.841 . . . . 0.0 108.355 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.0 t -125.65 -52.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.972 0.909 . . . . 0.0 109.738 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.17 -31.05 5.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.245 1.418 . . . . 0.0 113.304 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 46.3 mt -138.87 159.16 42.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.88 92.92 1.29 Allowed 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.782 -0.573 . . . . 0.0 111.491 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -76.56 -78.33 0.12 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -101.0 148.61 24.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.906 1.23 . . . . 0.0 113.025 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -141.18 128.03 20.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.236 1.414 . . . . 0.0 107.216 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -144.14 176.1 23.59 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.07 176.06 5.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.251 1.02 . . . . 0.0 110.6 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -122.03 150.49 42.03 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.345 1.858 . . . . 0.0 107.172 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 31.3 m -123.06 139.4 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 44.2 mtt -139.77 147.27 50.84 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.49 68.98 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.132 3.221 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.1 mt 65.66 -8.56 0.29 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.478 2.711 . . . . 0.0 113.601 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.464 ' O ' ' HE2' ' A' ' 275' ' ' LYS . 4.0 p -80.94 -173.88 4.51 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.068 2.547 . . . . 0.0 110.881 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--O 1.246 0.894 0 C-N-CA 126.509 1.924 . . . . 0.0 108.868 -179.772 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -70.22 90.0 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.838 0.827 . . . . 0.0 109.213 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -144.93 138.91 27.22 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.732 2.013 . . . . 0.0 106.196 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.25 146.28 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -106.89 168.12 9.41 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB1' ' HB1' ' A' ' 138' ' ' ALA . . . -68.27 -70.88 0.24 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.993 1.317 . . . . 0.0 111.629 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 51.87 66.05 2.82 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.275 1.417 . . . . 0.0 114.911 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 138' ' ' ALA . . . -141.39 21.75 2.57 Favored Glycine 0 C--O 1.215 -1.055 0 CA-C-N 118.056 0.928 . . . . 0.0 113.767 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.26 171.04 19.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 127.05 2.262 . . . . 0.0 109.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.44 -0.25 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.414 1.086 . . . . 0.0 113.245 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.58 178.54 38.22 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.84 -175.46 27.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.136 0.874 . . . . 0.0 113.057 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.67 144.42 43.95 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.584 1.153 . . . . 0.0 108.113 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 p -65.74 95.49 0.24 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.711 1.205 . . . . 0.0 112.265 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -97.2 -79.28 0.46 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 63.63 19.77 11.88 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.55 1.14 . . . . 0.0 110.911 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.08 141.44 58.77 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.745 1.618 . . . . 0.0 109.174 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.02 106.38 0.74 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 106.999 -2.44 . . . . 0.0 106.999 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.9 t -134.72 95.5 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 118.667 1.234 . . . . 0.0 108.231 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.9 p80 30.3 47.21 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.74 2.816 . . . . 0.0 117.303 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -108.34 -38.83 5.62 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.5 165.58 33.06 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.168 1.366 . . . . 0.0 111.211 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.98 144.7 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.385 -1.068 . . . . 0.0 111.986 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -46.8 5.07 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.203 1.801 . . . . 0.0 112.881 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -138.02 163.73 30.83 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.12 144.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -136.35 141.53 43.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.93 142.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.24 114.94 1.64 Allowed Glycine 0 C--N 1.333 0.374 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -66.44 141.84 57.78 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.39 -171.76 14.58 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -72.31 -48.19 44.06 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.561 0.744 . . . . 0.0 111.679 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.47 -10.51 34.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.131 1.772 . . . . 0.0 114.001 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.6 32.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -74.25 139.3 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -133.94 10.57 3.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.5 p -161.21 147.0 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.281 0.946 . . . . 0.0 111.673 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 155.4 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.042 1.737 . . . . 0.0 108.813 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.19 135.43 11.16 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.08 161.02 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.564 1.945 . . . . 0.0 111.13 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.2 t -121.87 139.95 47.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -107.94 170.41 8.01 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.872 0.76 . . . . 0.0 109.652 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.66 51.91 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.834 0.854 . . . . 0.0 109.978 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -116.96 166.34 12.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.498 1.119 . . . . 0.0 108.522 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -70.13 -3.2 15.6 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.07 -1.019 . . . . 0.0 109.746 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -108.86 -83.86 0.55 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.311 3.044 . . . . 0.0 110.641 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -133.89 159.24 41.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.975 1.71 . . . . 0.0 110.372 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.05 145.12 34.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.47 1.508 . . . . 0.0 110.295 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -144.86 146.09 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.044 0.938 . . . . 0.0 110.352 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -114.78 151.65 33.42 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.634 1.974 . . . . 0.0 109.302 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.92 -67.73 0.92 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.712 1.625 . . . . 0.0 109.905 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.7 174.88 27.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.179 1.371 . . . . 0.0 112.026 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.87 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.083 0.942 . . . . 0.0 109.761 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -125.04 133.11 53.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.47 -153.08 21.17 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.301 -2.72 . . . . 0.0 106.301 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -128.2 114.62 17.21 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.103 0.951 . . . . 0.0 112.97 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.17 134.66 49.55 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -81.28 155.62 25.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.368 1.067 . . . . 0.0 108.954 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.16 -32.8 74.67 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.575 -0.703 . . . . 0.0 111.161 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.32 26.93 7.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 110.701 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.86 96.2 0.17 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -163.05 146.05 10.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 128.954 2.902 . . . . 0.0 104.823 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -142.29 164.84 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.403 1.481 . . . . 0.0 108.856 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -144.48 103.11 3.92 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -108.11 140.87 40.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.056 1.743 . . . . 0.0 106.993 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -126.69 143.5 51.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 111.007 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.9 t -95.93 111.25 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 156.01 38.68 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 109.406 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.75 -27.16 61.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.172 -0.955 . . . . 0.0 111.67 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -106.94 13.56 27.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.555 1.942 . . . . 0.0 113.511 -177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.25 136.58 35.1 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.972 0.806 . . . . 0.0 110.332 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.452 ' CG ' ' HE2' ' A' ' 124' ' ' LYS . 12.0 m-85 -128.66 162.24 27.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.689 0.796 . . . . 0.0 110.424 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mt -75.3 150.43 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.93 -30.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 125.821 1.648 . . . . 0.0 109.146 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.97 157.44 43.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.164 0.893 . . . . 0.0 108.99 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.0 t -139.35 139.57 38.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -128.2 116.81 20.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.54 134.64 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.8 p -113.98 157.22 22.74 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -151.03 158.69 44.43 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.429 -0.794 . . . . 0.0 109.648 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -160.39 168.72 24.59 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.864 1.265 . . . . 0.0 108.67 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 94.36 3.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -66.3 138.22 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.837 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -61.25 114.3 3.09 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.05 -5.22 5.7 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.852 1.215 . . . . 0.0 111.935 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -134.5 158.14 44.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.161 1.384 . . . . 0.0 107.785 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.44 22.11 15.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.342 1.857 . . . . 0.0 108.759 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.6 p -137.95 129.24 27.67 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 120.937 -1.102 . . . . 0.0 112.578 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.17 148.76 50.44 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.324 2.25 . . . . 0.0 105.131 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 pt -143.93 158.46 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.1 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.3 mm -83.22 103.24 10.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.587 0.755 . . . . 0.0 109.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 p -66.89 -41.04 87.87 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.466 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.9 p -156.68 165.77 35.3 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.541 1.519 . . . . 0.0 111.75 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.77 151.69 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.043 0.537 . . . . 0.0 111.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.7 m -149.44 154.17 38.43 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.708 2.003 . . . . 0.0 108.687 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -125.04 154.59 41.08 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.738 2.015 . . . . 0.0 107.383 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -132.22 118.24 19.27 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.9 p -99.01 159.87 14.66 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.666 0.746 . . . . 0.0 112.896 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.87 -32.74 73.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.349 1.859 . . . . 0.0 113.357 -178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -67.8 -11.37 58.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.008 178.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.03 49.81 3.22 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -127.69 139.69 52.55 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.4 p -134.76 147.53 50.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.662 0.385 . . . . 0.0 110.522 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 161.02 32.21 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 123.419 0.687 . . . . 0.0 110.673 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.33 166.6 24.15 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 122.269 1.979 . . . . 0.0 108.516 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.75 106.18 1.79 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.42 2.08 . . . . 0.0 107.502 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -75.47 85.99 2.58 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 137.1 -137.18 8.8 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.801 1.191 . . . . 0.0 110.379 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 59.2 tp -112.55 125.43 54.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.461 1.505 . . . . 0.0 108.985 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -64.34 143.12 58.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 m -146.07 147.34 31.49 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -52.72 -49.52 65.21 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.922 2.089 . . . . 0.0 110.216 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -68.3 108.25 3.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.862 1.665 . . . . 0.0 107.259 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -152.1 160.08 43.51 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.505 1.122 . . . . 0.0 108.983 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -143.08 167.72 21.43 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.449 0.7 . . . . 0.0 112.042 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.25 143.08 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.268 1.427 . . . . 0.0 107.837 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -137.85 1.95 2.34 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 145.01 41.99 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.824 0.85 . . . . 0.0 113.169 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.49 149.81 34.95 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.95 -35.65 64.47 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.834 -1.166 . . . . 0.0 111.866 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -69.48 -22.52 63.61 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.311 1.044 . . . . 0.0 112.508 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.67 -68.92 0.42 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 105.313 -3.115 . . . . 0.0 105.313 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.39 79.26 1.44 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 124.814 1.197 . . . . 0.0 112.348 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 72' ' ' TYR . 39.5 ttmt -63.87 127.79 32.95 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 tp -77.7 88.77 3.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.69 -49.58 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -151.32 -174.14 21.88 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -152.56 -178.03 6.6 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.757 1.223 . . . . 0.0 108.545 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.97 148.81 30.21 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.25 110.59 0.37 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -79.22 54.38 1.65 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.756 1.623 . . . . 0.0 108.712 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.69 120.11 26.76 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -97.61 -108.72 2.67 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.48 -29.08 70.41 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.721 1.208 . . . . 0.0 112.353 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 169.02 20.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.115 1.766 . . . . 0.0 109.138 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.7 tp -86.71 101.06 12.94 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -87.73 -71.52 0.57 Allowed 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HB1' ' HB1' ' A' ' 6' ' ' ALA . . . -107.18 150.08 27.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.865 0.866 . . . . 0.0 110.777 -178.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -141.57 110.65 6.26 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 125.392 1.477 . . . . 0.0 108.786 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -121.32 170.65 14.73 Favored Glycine 0 C--O 1.238 0.37 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -151.96 165.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.13 0.572 . . . . 0.0 111.015 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -123.13 131.07 53.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.64 99.81 6.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.796 2.039 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.38 103.54 3.84 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -134.95 102.79 5.34 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.442 1.019 . . . . 0.0 113.505 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.6 p -157.07 143.55 18.18 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.119 1.767 . . . . 0.0 107.536 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.2 m -133.07 13.53 4.27 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.171 1.788 . . . . 0.0 109.98 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.442 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 12.5 p -134.69 161.42 63.79 Favored Pre-proline 0 C--O 1.241 0.638 0 O-C-N 120.546 -1.346 . . . . 0.0 107.922 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.37 151.37 42.77 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 105.973 -2.357 . . . . 0.0 105.973 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 89.3 t -66.83 124.34 21.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 23.3 p -128.69 156.72 77.04 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.872 1.269 . . . . 0.0 110.193 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.99 -6.05 13.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.085 1.857 . . . . 0.0 116.509 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.435 ' HA ' ' SD ' ' A' ' 295' ' ' MET . . . -119.13 156.68 29.34 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 129.408 3.083 . . . . 0.0 109.363 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -101.33 136.59 40.93 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.089 0.555 . . . . 0.0 112.463 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HE3' ' HB ' ' A' ' 148' ' ' THR . 6.2 pttt -114.45 146.92 40.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.804 1.642 . . . . 0.0 108.607 177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 69.8 mt -116.35 171.38 7.87 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.319 1.848 . . . . 0.0 106.86 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 m -75.24 170.64 15.65 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.207 -0.933 . . . . 0.0 108.872 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.14 165.82 26.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.271 1.029 . . . . 0.0 108.643 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.6 mt -117.4 151.06 19.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.62 -67.22 0.45 Allowed Glycine 0 C--N 1.333 0.382 0 CA-C-O 119.341 -0.7 . . . . 0.0 111.357 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 174.39 -160.61 30.19 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.888 1.232 . . . . 0.0 110.106 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -140.6 27.78 2.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.225 1.41 . . . . 0.0 111.184 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -125.5 141.62 51.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.19 1.796 . . . . 0.0 108.647 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 124.71 167.1 12.57 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.817 2.151 . . . . 0.0 111.154 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 97.4 m -71.97 122.7 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.144 0.978 . . . . 0.0 111.484 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.11 117.23 20.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -131.54 35.87 3.8 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.227 0.611 . . . . 0.0 111.33 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.44 145.07 0.64 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.124 1.369 . . . . 0.0 114.363 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -123.62 111.41 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 128.096 2.558 . . . . 0.0 108.79 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -69.77 168.56 46.52 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.06 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.15 120.18 12.22 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -100.85 -172.16 2.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.588 0.755 . . . . 0.0 109.72 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -4.95 17.25 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.588 0.755 . . . . 0.0 111.341 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 142.78 161.11 8.65 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.822 2.153 . . . . 0.0 110.829 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.45 157.57 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.361 1.864 . . . . 0.0 108.68 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -131.54 -70.77 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -133.29 153.42 51.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.434 0.561 . . . . 0.0 112.461 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.0 t -120.29 141.18 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.738 2.015 . . . . 0.0 106.18 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -127.88 128.04 44.48 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.68 116.25 51.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.89 95.52 1.82 Allowed Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -60.86 169.91 1.72 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.67 -174.11 13.81 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.33 -23.02 61.09 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.59 -0.805 . . . . 0.0 111.456 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -131.34 -19.28 2.79 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 179.18 -172.74 44.85 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 126.973 2.225 . . . . 0.0 107.689 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.4 mm -63.94 124.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 120.101 1.95 . . . . 0.0 111.824 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.7 m -118.57 -20.42 8.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.669 1.188 . . . . 0.0 112.685 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.77 156.63 47.76 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 119.568 -1.958 . . . . 0.0 111.301 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.02 151.01 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -162.68 165.48 25.64 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 127.77 2.428 . . . . 0.0 106.504 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -144.06 174.56 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.789 1.236 . . . . 0.0 110.305 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -129.63 113.0 14.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -102.66 155.58 18.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -128.37 138.31 52.3 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -129.2 96.23 4.26 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 70.29 -95.93 0.53 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -120.74 -7.09 9.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.423 1.489 . . . . 0.0 110.212 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -77.69 153.89 32.63 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.86 100.23 5.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.32 106.92 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.62 131.75 34.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -91.42 176.38 40.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.426 1.012 . . . . 0.0 111.374 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.96 172.44 14.5 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.354 1.454 . . . . 0.0 111.946 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.01 104.13 16.69 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -77.59 -34.38 53.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.096 0.959 . . . . 0.0 112.335 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -108.24 -178.46 21.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 124.774 1.178 . . . . 0.0 113.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -72.8 105.2 1.37 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.565 1.546 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.48 168.69 20.45 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 121.813 1.675 . . . . 0.0 109.47 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 9.6 t -137.22 161.13 37.03 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.657 0.783 . . . . 0.0 109.181 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.76 -15.5 63.53 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.561 0.744 . . . . 0.0 110.399 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -19.91 65.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.252 1.021 . . . . 0.0 109.876 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 97.06 -153.11 20.23 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -139.95 141.23 36.46 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.74 1.616 . . . . 0.0 107.552 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -85.18 151.58 23.99 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -134.92 144.38 47.44 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 118.938 0.79 . . . . 0.0 111.996 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -142.42 113.01 7.3 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.785 0.834 . . . . 0.0 109.29 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -73.34 141.16 47.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 15.5 mt -116.15 114.3 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.908 0.776 . . . . 0.0 109.268 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.82 148.71 27.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.919 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.72 24.67 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.6 2.36 . . . . 0.0 116.536 -178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.91 -27.82 9.86 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.371 2.048 . . . . 0.0 114.144 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 21.2 t -128.81 -66.42 0.83 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.81 172.4 13.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.589 1.556 . . . . 0.0 108.451 178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -165.94 171.4 12.66 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.809 1.244 . . . . 0.0 108.186 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 60.4 mt -87.24 152.03 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.2 p -140.43 -5.12 1.24 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -166.58 170.79 12.36 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.836 1.255 . . . . 0.0 107.768 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.18 141.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -132.86 151.61 52.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 129.32 3.048 . . . . 0.0 108.482 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.02 179.53 44.39 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 266' ' ' ALA . 25.5 p -137.15 142.87 42.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.642 1.221 . . . . 0.0 110.463 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.52 145.29 48.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.722 0.809 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -147.67 163.94 35.07 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 122.056 -0.403 . . . . 0.0 110.739 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.42 141.15 52.15 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.492 1.117 . . . . 0.0 113.794 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.73 155.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -111.03 141.89 43.92 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.94 -7.24 82.61 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.545 -0.722 . . . . 0.0 111.827 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 60.4 p -140.65 -172.11 3.38 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.858 2.063 . . . . 0.0 107.643 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.42 72.0 1.49 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.904 1.282 . . . . 0.0 108.706 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -163.17 178.54 38.79 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.873 1.225 . . . . 0.0 111.383 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.3 mt -108.44 159.61 16.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 110.58 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 15.0 tt -135.85 138.49 47.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.232 1.413 . . . . 0.0 109.305 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 25.0 mm -76.54 96.57 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 6.0 t -76.24 -16.86 59.73 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.677 -0.639 . . . . 0.0 112.313 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -156.79 138.61 14.28 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.622 1.169 . . . . 0.0 107.986 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 24.3 tp -135.49 123.91 23.39 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -109.58 172.48 6.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.984 0.914 . . . . 0.0 108.576 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -136.68 145.71 45.07 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -115.88 121.36 42.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 124.425 1.09 . . . . 0.0 109.027 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 p -138.66 168.14 20.45 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 127.344 2.258 . . . . 0.0 107.277 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.23 156.02 19.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.8 mttm 60.76 -17.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -98.97 175.3 5.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.33 1.452 . . . . 0.0 112.555 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -131.42 99.82 4.95 Favored 'General case' 0 C--N 1.334 -0.069 0 C-N-CA 126.11 1.764 . . . . 0.0 108.186 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 17.1 p -80.18 160.18 25.74 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.083 0.553 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -94.53 155.85 39.14 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.827 0.851 . . . . 0.0 111.528 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.22 88.98 0.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.072 2.514 . . . . 0.0 107.877 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -77.09 92.52 3.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.87 172.86 34.55 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.146 1.355 . . . . 0.0 111.797 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -97.84 122.97 41.58 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.552 1.541 . . . . 0.0 109.232 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -71.82 108.34 5.07 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.345 2.258 . . . . 0.0 110.139 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.78 168.32 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.973 1.309 . . . . 0.0 110.103 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 91.84 -98.43 2.42 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 98.8 m -145.08 118.85 9.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 232' ' ' THR . . . -87.71 136.03 33.12 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -126.27 166.03 17.87 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.06 0.944 . . . . 0.0 109.565 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.45 151.88 35.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.458 0.703 . . . . 0.0 109.816 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.5 mt -139.42 120.49 14.63 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.789 1.636 . . . . 0.0 107.563 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.37 152.27 18.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.166 0.894 . . . . 0.0 110.92 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.49 157.23 44.04 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.587 1.555 . . . . 0.0 108.756 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -80.15 143.25 34.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 65.15 28.65 73.8 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 116.838 1.495 . . . . 0.0 116.838 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -142.49 152.73 42.99 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 121.08 2.44 . . . . 0.0 110.757 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.94 165.01 17.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.875 2.07 . . . . 0.0 107.563 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.8 mt -92.15 150.93 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.68 -10.55 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 177.81 -179.97 48.14 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.833 1.197 . . . . 0.0 110.84 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -112.91 135.71 53.38 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.79 1.636 . . . . 0.0 108.204 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.71 137.37 52.44 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.47 -150.49 22.2 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.06 128.85 10.17 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.16 46.34 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 109.55 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 36.5 m -140.29 -67.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.442 1.097 . . . . 0.0 111.631 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -121.86 -64.48 1.21 Allowed 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 119.001 0.819 . . . . 0.0 110.748 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.4 113.74 27.5 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 23.3 tp -50.31 92.14 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.75 -73.84 0.31 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.525 1.13 . . . . 0.0 111.939 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -104.85 114.36 28.52 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.843 0.747 . . . . 0.0 112.346 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -117.87 156.77 27.84 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.655 1.582 . . . . 0.0 107.005 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -172.1 -179.66 43.16 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 23.5 m -138.81 146.5 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 118.58 1.19 . . . . 0.0 111.529 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.02 160.26 24.6 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 118.411 0.55 . . . . 0.0 110.885 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.435 ' SD ' ' HA ' ' A' ' 153' ' ' ALA . 83.8 mmm -146.02 142.9 18.29 Favored Pre-proline 0 N--CA 1.464 0.262 0 C-N-CA 124.589 1.156 . . . . 0.0 110.784 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.59 105.77 2.09 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.824 2.349 . . . . 0.0 109.461 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 17.9 mt -118.23 81.94 1.76 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.1 t -72.7 170.52 14.39 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.29 0.567 . . . . 0.0 111.626 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 116.802 -1.57 . . . . 0.0 107.402 178.892 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.57 154.75 41.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.588 2.355 . . . . 0.0 110.317 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -149.05 100.94 3.11 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.223 -0.923 . . . . 0.0 112.788 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -82.37 142.53 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.33 159.7 16.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.683 0.793 . . . . 0.0 110.027 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.51 105.38 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.288 1.435 . . . . 0.0 112.512 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.09 83.23 1.09 Allowed Glycine 0 C--N 1.334 0.466 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.02 -160.71 19.01 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 126.909 2.195 . . . . 0.0 107.657 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.86 150.23 39.66 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.53 -21.02 53.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.244 1.022 . . . . 0.0 113.582 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.86 164.02 39.9 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.96 0.79 . . . . 0.0 114.59 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.37 164.85 34.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.189 1.376 . . . . 0.0 113.98 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.79 141.73 29.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.209 1.403 . . . . 0.0 107.236 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.9 123.12 22.03 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -127.33 85.7 2.4 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.883 1.673 . . . . 0.0 107.034 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -140.94 147.0 38.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.647 2.379 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -160.63 174.22 14.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.41 1.484 . . . . 0.0 108.534 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.11 -111.86 2.09 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 104.149 -3.58 . . . . 0.0 104.149 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.8 t 52.37 31.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 117.777 0.789 . . . . 0.0 112.951 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -64.21 110.68 2.29 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.318 -1.489 . . . . 0.0 110.136 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -118.28 -63.6 1.39 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 124.928 1.291 . . . . 0.0 109.943 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.81 164.88 31.41 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -117.82 155.79 19.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 109.64 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -54.93 1.24 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.323 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -145.8 168.39 20.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 118.759 0.708 . . . . 0.0 110.622 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.144 2.578 . . . . 0.0 104.777 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -138.9 122.32 17.2 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 m -143.77 139.6 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.87 131.23 3.89 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -67.16 -168.53 0.07 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.212 1.405 . . . . 0.0 110.519 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 169.67 -177.32 43.23 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.88 -32.69 73.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.427 1.091 . . . . 0.0 111.507 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -105.63 8.29 33.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.259 1.824 . . . . 0.0 114.036 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.72 -168.41 12.93 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.258 -0.901 . . . . 0.0 112.836 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.36 95.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.4 p -101.94 -9.24 20.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.9 p -87.8 147.53 25.11 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 120.362 1.437 . . . . 0.0 109.524 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.1 pt -145.01 158.55 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.44 1.096 . . . . 0.0 108.8 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -153.91 151.31 29.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.285 1.834 . . . . 0.0 107.266 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.73 119.86 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -128.97 121.27 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -103.55 158.64 16.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 48' ' ' ASP . . . -156.26 109.66 2.69 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -111.84 154.03 25.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -33.27 62.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.64 0.776 . . . . 0.0 112.611 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.525 1.53 . . . . 0.0 111.735 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -156.02 120.06 4.48 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 120.401 1.455 . . . . 0.0 107.679 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 43' ' ' ALA 0.395 0.5 OUTLIER -116.83 165.46 13.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -179.279 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.78 145.98 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.536 1.534 . . . . 0.0 111.801 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.3 139.09 37.94 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.95 -1.094 . . . . 0.0 109.377 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.35 -73.49 0.97 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 123.57 0.605 . . . . 0.0 111.788 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.33 171.15 17.67 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.725 1.631 . . . . 0.0 110.033 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -101.52 142.63 32.61 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.136 -0.626 . . . . 0.0 110.591 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -129.63 173.99 10.1 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.611 1.964 . . . . 0.0 109.682 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.97 -155.97 37.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -112.79 125.58 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.89 160.26 14.63 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 p -132.34 114.53 14.5 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.365 1.866 . . . . 0.0 108.221 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.46 -36.5 80.57 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.262 -1.524 . . . . 0.0 107.988 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -72.44 -1.88 17.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.223 2.209 . . . . 0.0 115.554 179.272 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.97 -8.87 0.23 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 120.291 1.405 . . . . 0.0 115.846 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.99 125.04 28.07 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.084 1.442 . . . . 0.0 110.88 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.01 142.01 50.76 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.486 1.915 . . . . 0.0 106.273 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 34.6 m -104.15 143.61 32.68 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.042 0.937 . . . . 0.0 108.735 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -134.68 125.1 26.4 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.883 0.873 . . . . 0.0 109.629 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -99.39 143.57 29.49 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.618 1.567 . . . . 0.0 109.142 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.69 147.52 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.631 1.173 . . . . 0.0 109.089 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -109.91 172.62 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.936 1.294 . . . . 0.0 113.35 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.65 -38.52 19.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.473 1.509 . . . . 0.0 110.332 178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -83.19 21.05 1.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.328 1.451 . . . . 0.0 109.742 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -147.8 136.76 22.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.205 1.002 . . . . 0.0 110.998 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -136.08 150.07 48.99 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.8 mt -79.88 147.49 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.32 -28.95 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.765 0.826 . . . . 0.0 110.836 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.36 155.64 41.51 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.182 0.901 . . . . 0.0 108.888 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.99 95.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.67 113.66 20.5 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.69 147.91 15.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 113' ' ' LYS . 39.1 m -131.74 138.73 48.74 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -150.28 167.11 27.94 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 129.136 2.974 . . . . 0.0 104.619 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.03 165.7 29.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -120.82 105.73 11.0 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.981 0.912 . . . . 0.0 109.277 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.85 144.76 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.05 108.15 1.17 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 126.91 3.61 6.32 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 117.874 -1.515 . . . . 0.0 113.403 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -131.56 118.87 20.7 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 120.119 1.96 . . . . 0.0 108.142 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.33 1.85 2.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.559 2.744 . . . . 0.0 114.138 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.7 t -147.97 135.53 20.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.625 -1.297 . . . . 0.0 109.04 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.16 158.33 33.39 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.92 141.11 43.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.189 1.796 . . . . 0.0 107.962 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 138' ' ' ALA . 44.1 mm -64.29 125.68 21.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.987 0.915 . . . . 0.0 110.054 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 p -104.42 -32.54 8.97 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.28 1.032 . . . . 0.0 109.24 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -161.05 165.6 29.48 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 120.015 1.279 . . . . 0.0 112.689 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pt -144.76 137.44 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 126.402 1.881 . . . . 0.0 109.928 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.7 m -132.21 114.61 14.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.197 1.799 . . . . 0.0 107.952 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -96.82 121.8 39.07 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -100.79 127.62 47.16 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.8 p -97.48 164.51 12.41 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.151 0.887 . . . . 0.0 111.756 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.94 -41.2 82.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.378 1.071 . . . . 0.0 108.934 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -68.47 -22.8 64.54 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.22 1.408 . . . . 0.0 114.608 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.56 -7.6 22.39 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 119.809 1.186 . . . . 0.0 114.186 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -74.26 147.05 42.75 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.49 127.11 30.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.9 p -80.98 149.33 66.55 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.68 158.86 48.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.138 1.892 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.47 83.46 1.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.053 2.502 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -55.89 109.31 0.56 Allowed 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.59 -134.88 10.55 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.3 tp -139.87 138.16 35.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.537 1.135 . . . . 0.0 109.927 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.42 164.83 20.13 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.2 OUTLIER -149.8 -167.14 2.74 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.742 -1.849 . . . . 0.0 111.609 -179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 111' ' ' THR . 16.9 tt0 -73.25 -59.18 2.83 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.543 1.137 . . . . 0.0 109.509 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.41 ' O ' HG23 ' A' ' 79' ' ' THR . 50.3 mttp -68.73 178.24 2.2 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 165.03 162.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.353 3.061 . . . . 0.0 108.471 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.51 149.79 17.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.344 1.058 . . . . 0.0 108.198 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 p -140.05 148.14 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -143.31 145.87 33.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.175 2.19 . . . . 0.0 106.512 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 174.68 12.54 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.632 1.173 . . . . 0.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 143' ' ' PHE . 5.8 p30 -110.1 147.93 32.7 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.596 1.158 . . . . 0.0 109.0 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -143.26 -84.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -100.42 -10.81 20.77 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.717 0.69 . . . . 0.0 110.198 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.18 -49.04 49.3 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.248 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.05 -133.25 2.91 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 119.267 1.533 . . . . 0.0 112.187 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -132.81 153.61 51.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.934 0.893 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.6 106.92 10.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.01 3.25 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.456 0.702 . . . . 0.0 111.556 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 177.38 178.22 46.86 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.923 0.773 . . . . 0.0 111.749 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.74 177.02 8.45 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 126.74 2.016 . . . . 0.0 109.735 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -146.41 148.82 32.7 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.07 92.45 0.17 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 118.254 0.479 . . . . 0.0 112.388 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -60.32 121.26 11.56 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -152.8 164.82 37.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.388 0.994 . . . . 0.0 110.595 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.56 -95.72 0.13 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -75.73 -23.94 56.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.047 0.424 . . . . 0.0 110.201 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.4 -179.69 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 127.23 2.212 . . . . 0.0 106.366 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.54 153.45 33.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.846 1.658 . . . . 0.0 108.487 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -143.93 -56.34 0.38 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.509 0.595 . . . . 0.0 112.007 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 91' ' ' ILE . . . -135.24 155.71 50.2 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.986 0.812 . . . . 0.0 112.592 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.11 113.21 9.24 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.21 2.204 . . . . 0.0 107.346 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.92 174.81 15.48 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 123.814 0.721 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.01 158.85 43.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 121.537 -0.978 . . . . 0.0 108.728 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -122.77 151.81 41.26 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 119' ' ' ASP . 45.4 m-85 -137.72 99.81 4.02 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.015 0.926 . . . . 0.0 109.421 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.16 148.66 45.11 Favored 'General case' 0 C--N 1.334 -0.068 0 O-C-N 121.605 -0.684 . . . . 0.0 110.678 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -135.98 131.5 35.13 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 m -153.6 148.15 26.18 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.1 t -145.34 151.88 39.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 p -150.77 145.11 17.92 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.209 1.804 . . . . 0.0 108.799 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.03 112.57 3.57 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.242 2.628 . . . . 0.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 86.5 t -135.37 155.51 37.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.2 p -128.85 160.1 65.01 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.015 0.926 . . . . 0.0 112.286 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.97 174.25 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.367 2.711 . . . . 0.0 112.181 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.3 -178.39 7.02 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.769 1.628 . . . . 0.0 108.736 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -114.65 129.38 56.67 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.152 -0.968 . . . . 0.0 109.567 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -103.97 106.78 17.4 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.88 161.54 23.74 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.4 t -84.86 111.94 20.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.94 159.77 29.71 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.721 0.408 . . . . 0.0 110.113 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 42.2 mt -125.21 161.24 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.009 2.924 . . . . 0.0 105.949 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 128.94 -72.12 0.48 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.857 1.208 . . . . 0.0 113.317 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.81 -4.89 0.03 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.515 -1.158 . . . . 0.0 115.217 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . 0.264 0.7 OUTLIER 53.61 -3.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 129.156 2.982 . . . . 0.0 117.476 179.281 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -109.76 164.9 12.13 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.839 1.655 . . . . 0.0 112.769 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.51 -175.23 16.0 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 126.341 1.924 . . . . 0.0 114.195 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.37 104.22 4.3 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.033 1.733 . . . . 0.0 109.525 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.85 154.76 29.55 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.254 0.622 . . . . 0.0 110.265 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -146.57 28.29 1.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.99 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -42.71 110.42 0.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.912 1.685 . . . . 0.0 110.235 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.38 -11.37 60.45 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.3 -85.75 1.57 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.37 147.57 5.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -109.6 155.48 21.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.352 1.061 . . . . 0.0 109.548 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -76.42 -11.02 59.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.926 -1.033 . . . . 0.0 112.901 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.05 -179.94 44.07 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.21 155.21 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.18 1.392 . . . . 0.0 108.596 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -138.48 -74.13 0.39 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.788 1.235 . . . . 0.0 107.873 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -150.87 165.94 32.09 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.03 139.41 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -118.48 156.89 28.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.58 131.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -109.84 83.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.68 -165.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 110.682 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.02 -168.71 37.93 Favored Glycine 0 N--CA 1.447 -0.608 0 O-C-N 120.183 -1.573 . . . . 0.0 112.064 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.09 -45.58 11.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.23 1.412 . . . . 0.0 109.618 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.78 -15.53 51.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.528 0.731 . . . . 0.0 111.479 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.06 -154.39 24.44 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 27.7 mm -58.36 150.81 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 118.559 1.179 . . . . 0.0 108.855 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.4 t -127.65 -38.36 1.9 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.199 1.399 . . . . 0.0 112.822 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -136.7 161.58 35.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.137 0.881 . . . . 0.0 110.027 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.91 127.85 25.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 44.7 pttt -161.67 160.53 28.77 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.296 1.439 . . . . 0.0 109.49 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.48 169.13 24.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.428 0.558 . . . . 0.0 109.834 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -100.03 148.27 24.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.465 ' CZ ' HG21 ' A' ' 201' ' ' ILE . 1.2 p90 -151.67 165.84 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.5 92.58 2.59 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -89.2 99.44 12.43 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 72.36 -79.98 0.64 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.73 0.696 . . . . 0.0 111.662 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -141.33 -0.18 1.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.597 1.959 . . . . 0.0 111.135 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.4 102.05 7.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -77.67 67.06 3.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.295 1.438 . . . . 0.0 108.251 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.465 HG21 ' CZ ' ' A' ' 194' ' ' TYR . 36.9 mm -72.13 122.69 25.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.189 0.995 . . . . 0.0 113.429 -178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 29.0 t -127.65 150.37 33.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 127.109 2.164 . . . . 0.0 105.93 176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.44 -108.98 2.77 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.862 -0.966 . . . . 0.0 111.548 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 72.38 12.47 76.83 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 116.014 1.165 . . . . 0.0 116.014 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -58.81 116.44 3.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.839 2.32 . . . . 0.0 110.409 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -117.64 2.78 12.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.671 1.588 . . . . 0.0 113.993 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -147.01 162.41 28.57 Favored Glycine 0 C--N 1.335 0.482 0 O-C-N 120.069 -1.645 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -47.07 106.37 0.58 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.744 1.617 . . . . 0.0 110.929 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.53 135.57 26.63 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.985 2.457 . . . . 0.0 109.327 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.61 131.66 35.2 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 29.3 tp -56.51 -26.4 54.42 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 pp -55.52 -30.06 60.01 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.197 1.399 . . . . 0.0 112.186 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.72 -166.01 13.91 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.019 1.295 . . . . 0.0 110.488 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 23.5 m-85 -128.88 168.13 16.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.549 1.54 . . . . 0.0 108.232 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -117.75 171.6 7.93 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 126.882 2.073 . . . . 0.0 106.787 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.86 158.59 44.32 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.451 0.7 . . . . 0.0 112.771 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -142.74 129.67 20.63 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.943 1.697 . . . . 0.0 108.311 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.19 109.54 21.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 107.707 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mt -103.85 104.45 16.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -88.96 92.61 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.774 1.63 . . . . 0.0 107.556 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -57.16 -35.29 33.7 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -35.27 10.01 Favored 'Trans proline' 0 C--N 1.353 0.772 0 CA-C-N 123.609 2.325 . . . . 0.0 110.093 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.7 m -75.91 -77.09 0.14 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.591 1.557 . . . . 0.0 112.021 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.18 124.71 28.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.052 2.541 . . . . 0.0 112.476 -176.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -95.47 83.31 3.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.463 HD13 ' H ' ' A' ' 226' ' ' ILE . 0.0 OUTLIER -45.98 128.19 2.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 109.824 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.1 m -124.42 -22.96 4.55 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -161.81 171.26 18.08 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.347 1.43 . . . . 0.0 113.46 -178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 1.8 p -139.1 158.19 28.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.73 172.18 12.89 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.39 1.476 . . . . 0.0 109.322 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -172.68 171.24 44.23 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.2 p -141.33 137.81 32.66 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.498 ' CD1' HD13 ' A' ' 242' ' ' LEU . 5.2 p90 -135.96 160.8 37.48 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.898 0.749 . . . . 0.0 112.14 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -145.87 168.94 19.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.153 0.981 . . . . 0.0 108.985 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -75.05 147.9 40.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.902 1.281 . . . . 0.0 110.075 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.8 mt -92.98 112.46 26.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -74.36 104.41 5.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 119.02 -0.52 14.81 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.436 1.017 . . . . 0.0 112.811 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 5.5 t -141.19 -174.28 3.97 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.11 80.24 1.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 172.66 -176.99 45.44 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 233' ' ' TYR . 22.1 mt -108.66 157.61 18.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 11.1 tt -126.78 137.2 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 125.974 1.709 . . . . 0.0 109.135 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 26.6 mm -81.32 130.2 36.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.277 10.3 t -112.04 -50.35 2.92 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.021 -0.99 . . . . 0.0 112.622 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -128.77 150.61 50.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.149 1.341 . . . . 0.0 109.619 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.4 mt -130.53 150.32 51.79 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.373 1.469 . . . . 0.0 110.441 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -142.97 147.64 35.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.646 1.579 . . . . 0.0 107.62 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -122.75 113.19 18.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -71.14 136.15 48.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 20.6 p -142.18 165.18 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.35 1.86 . . . . 0.0 106.383 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 148.15 31.69 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 -29.42 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 128.465 2.706 . . . . 0.0 115.157 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -81.22 174.42 11.56 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.386 2.674 . . . . 0.0 108.295 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 55.4 m -144.31 152.29 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 45.3 p -146.09 174.46 11.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.612 0.765 . . . . 0.0 112.257 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -103.98 158.66 31.44 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.872 1.669 . . . . 0.0 110.576 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.05 115.09 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.224 2.616 . . . . 0.0 106.401 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -83.94 92.38 7.81 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 116.71 -176.99 16.57 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.229 1.395 . . . . 0.0 111.59 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.05 116.67 26.39 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.108 0.963 . . . . 0.0 110.066 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.78 108.86 3.59 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.419 1.088 . . . . 0.0 109.219 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -155.17 -177.31 6.44 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.287 1.035 . . . . 0.0 110.965 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 64.15 -103.47 0.73 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 126.261 1.886 . . . . 0.0 114.657 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 91.1 m -146.92 128.62 15.2 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.008 1.323 . . . . 0.0 107.444 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -89.92 144.41 25.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.751 0.82 . . . . 0.0 111.431 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -129.48 165.94 20.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.592 1.157 . . . . 0.0 110.039 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -143.84 146.58 33.15 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.232 1.813 . . . . 0.0 107.092 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 73.0 mt -132.0 102.01 5.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.699 1.6 . . . . 0.0 107.239 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -127.11 163.7 23.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.146 0.978 . . . . 0.0 109.061 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -143.75 167.44 22.28 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.365 1.466 . . . . 0.0 107.627 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -97.04 117.59 31.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.593 1.157 . . . . 0.0 113.559 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 64.74 21.73 67.54 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.148 -0.97 . . . . 0.0 114.623 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -107.06 164.59 12.02 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.126 1.37 . . . . 0.0 111.606 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -127.98 151.16 49.47 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.682 2.793 . . . . 0.0 105.01 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 68.7 mt -82.49 145.12 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.38 -5.37 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.778 0.831 . . . . 0.0 112.842 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 170.89 -164.17 37.3 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 119.626 1.103 . . . . 0.0 110.684 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -128.35 156.01 43.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.888 2.875 . . . . 0.0 107.238 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -147.83 113.27 5.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -178.52 -171.56 41.95 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 154.28 46.12 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 113.55 -1.325 . . . . 0.0 107.838 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -145.3 152.48 39.98 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.991 -1.459 . . . . 0.0 107.858 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.6 t -163.95 113.55 1.24 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 59.82 11.47 2.53 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.07 2.548 . . . . 0.0 114.447 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 167.1 -179.88 0.02 OUTLIER 'General case' 0 C--O 1.237 0.415 0 C-N-CA 129.433 3.093 . . . . 0.0 106.865 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 51.9 tp -87.95 102.97 15.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.441 0.696 . . . . 0.0 110.172 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -82.88 -43.42 16.59 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.237 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -133.71 142.16 47.86 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.795 1.18 . . . . 0.0 112.799 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.83 149.64 35.76 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 176.5 -158.89 25.46 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.4 m -147.89 138.66 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.98 0.912 . . . . 0.0 111.661 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.96 136.92 37.38 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.12 149.23 24.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.32 0.581 . . . . 0.0 111.233 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 29.7 mmm -142.47 141.61 21.26 Favored Pre-proline 0 C--O 1.234 0.277 0 C-N-CA 126.988 2.115 . . . . 0.0 107.414 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.18 146.98 71.88 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.368 2.045 . . . . 0.0 108.878 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.7 mp -71.57 153.75 41.92 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 22.1 m -133.66 99.63 4.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 24.4 t30 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 126.071 1.749 . . . . 0.0 108.842 179.334 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -70.47 109.68 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.394 1.078 . . . . 0.0 111.911 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -149.74 139.48 21.76 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 130.614 3.566 . . . . 0.0 105.166 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.36 129.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 118.931 0.787 . . . . 0.0 112.388 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.34 138.69 47.47 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.37 -62.52 1.7 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.027 0.531 . . . . 0.0 109.692 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.33 69.76 0.84 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 126.241 1.876 . . . . 0.0 109.534 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.75 -166.11 12.07 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.733 1.635 . . . . 0.0 110.075 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.29 17.63 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.433 1.116 . . . . 0.0 113.403 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.12 -1.13 4.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.303 1.841 . . . . 0.0 112.548 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.75 42.38 3.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 120.698 -1.251 . . . . 0.0 112.734 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.64 -154.68 6.66 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 127.095 2.283 . . . . 0.0 111.561 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.96 142.2 51.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -72.29 121.9 20.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 112.579 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -124.27 58.42 1.2 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -89.91 18.68 5.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.855 2.462 . . . . 0.0 112.277 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -148.09 160.22 43.11 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.012 -1.055 . . . . 0.0 110.913 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.98 145.27 4.73 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.274 1.893 . . . . 0.0 108.772 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.25 152.84 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.235 0.614 . . . . 0.0 109.568 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -63.54 -39.11 93.57 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t0 64.94 9.12 5.14 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 128.387 2.675 . . . . 0.0 113.891 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 63.65 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 123.515 0.579 . . . . 0.0 112.544 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -59.55 141.87 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 111.759 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 13.2 mmm180 -117.91 -32.48 4.77 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -150.49 160.63 43.64 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.36 121.1 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.558 ' CD2' HD22 ' A' ' 39' ' ' ASN . 1.2 m-70 -98.38 140.96 31.88 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 118.768 0.713 . . . . 0.0 109.557 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 t -143.2 145.84 22.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.643 -2.355 . . . . 0.0 104.643 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.04 141.83 8.59 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.05 146.78 35.08 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.548 1.139 . . . . 0.0 109.722 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.14 165.68 28.56 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 125.992 1.758 . . . . 0.0 109.459 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -55.72 -34.67 65.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.922 1.289 . . . . 0.0 112.327 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -94.84 -7.92 38.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 129.465 3.106 . . . . 0.0 113.788 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.65 -164.35 20.26 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.87 95.49 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 m -112.61 2.45 16.19 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.5 p -107.18 108.93 20.61 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.67 132.65 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 109.702 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.558 HD22 ' CD2' ' A' ' 27' ' ' HIS . 24.4 t30 -150.23 147.39 27.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.652 1.581 . . . . 0.0 108.562 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.0 117.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.9 t -68.22 148.23 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -128.41 126.31 40.34 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 120.275 1.398 . . . . 0.0 111.933 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' HB2' ' CG ' ' A' ' 24' ' ' ARG . . . -86.29 139.62 30.84 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -112.5 165.56 12.12 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.56 -23.48 67.4 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 122.093 -0.379 . . . . 0.0 111.234 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -104.67 -39.38 6.38 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.561 1.144 . . . . 0.0 113.608 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -154.81 158.22 39.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 120.043 1.292 . . . . 0.0 113.509 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 125.73 30.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.42 145.32 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.535 1.16 . . . . 0.0 112.361 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.5 153.3 39.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.057 2.143 . . . . 0.0 106.183 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.72 61.06 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 127.939 2.685 . . . . 0.0 107.703 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.6 14.51 4.18 Favored Glycine 0 N--CA 1.472 1.035 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.28 116.56 8.19 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.06 1.43 . . . . 0.0 111.404 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -126.59 82.12 2.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.26 -144.92 5.77 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.93 111.23 13.87 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.92 119.79 6.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.1 p -70.53 153.57 42.78 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.262 1.825 . . . . 0.0 111.291 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.18 -33.55 16.99 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.803 1.241 . . . . 0.0 109.781 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.2 mt -71.34 -14.43 62.19 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 123.66 0.6 . . . . 0.0 109.469 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.82 161.16 33.19 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-O 124.637 2.243 . . . . 0.0 109.659 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -123.89 157.61 33.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 110.529 -2.835 . . . . 0.0 109.334 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -121.78 165.19 16.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 127.767 2.427 . . . . 0.0 107.633 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -128.13 125.92 40.11 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.543 -0.723 . . . . 0.0 110.123 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -87.12 119.58 27.49 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.987 1.715 . . . . 0.0 107.414 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.07 141.99 35.33 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.878 0.847 . . . . 0.0 109.871 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 84.1 t -114.75 112.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.875 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.63 172.16 14.1 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.53 -59.0 2.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -74.73 -22.28 58.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -81.36 146.78 30.16 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.02 152.8 51.3 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 123.868 0.867 . . . . 0.0 110.617 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.2 mt -80.78 114.44 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.8 m -93.67 -31.04 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.687 0.795 . . . . 0.0 112.012 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.2 166.77 26.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.652 1.181 . . . . 0.0 108.502 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.46 117.23 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -95.14 126.16 40.28 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.9 t -135.8 146.26 29.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.81 0.844 . . . . 0.0 109.869 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 p -120.74 152.51 38.2 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -154.2 168.72 25.59 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.106 0.962 . . . . 0.0 108.517 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.19 168.96 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -129.2 108.41 10.32 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.793 2.037 . . . . 0.0 108.458 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.54 147.65 12.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.861 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -62.21 149.6 41.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.26 6.35 88.83 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.929 -0.928 . . . . 0.0 112.642 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -139.58 164.44 29.9 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.028 2.131 . . . . 0.0 106.704 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -125.02 0.71 7.94 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.418 1.087 . . . . 0.0 111.295 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.1 t -98.48 157.66 16.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -109.48 153.27 24.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.7 pt -131.7 141.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 125.75 1.62 . . . . 0.0 107.802 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.42 128.53 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.8 p -104.7 -27.19 11.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.839 -1.077 . . . . 0.0 111.8 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.0 t -154.67 159.62 40.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.158 1.344 . . . . 0.0 109.022 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.5 mm -141.6 141.71 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 128.023 2.529 . . . . 0.0 106.368 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -151.12 108.51 3.61 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.383 1.473 . . . . 0.0 107.565 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -77.88 150.22 34.16 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -123.84 114.06 19.36 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.1 p -82.84 162.26 21.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.982 1.313 . . . . 0.0 111.409 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.2 -30.71 70.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -17.37 59.41 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 121.238 -0.914 . . . . 0.0 112.777 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.19 2.98 60.43 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 119.3 0.954 . . . . 0.0 111.132 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -79.36 89.45 4.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.12 147.46 26.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.089 0.555 . . . . 0.0 109.904 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.8 p -84.86 161.91 51.59 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 124.055 0.942 . . . . 0.0 110.647 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.92 164.66 34.92 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 N-CA-C 108.586 -1.352 . . . . 0.0 108.586 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.05 109.61 2.92 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 N-CA-C 106.466 -2.167 . . . . 0.0 106.466 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -66.71 9.41 0.18 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -169.55 -170.12 33.66 Favored Glycine 0 N--CA 1.442 -0.9 0 O-C-N 120.76 -1.213 . . . . 0.0 111.427 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.0 tp -77.3 106.03 8.78 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.617 0.767 . . . . 0.0 111.11 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -60.65 109.53 1.06 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 m -100.44 166.34 10.99 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.547 0.739 . . . . 0.0 110.281 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.39 -52.86 61.93 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.624 0.77 . . . . 0.0 110.725 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -62.9 117.01 5.79 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -157.57 159.65 37.33 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -139.57 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.269 1.828 . . . . 0.0 110.556 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.82 114.29 3.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.812 1.245 . . . . 0.0 108.237 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.17 128.57 36.38 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 138.97 9.3 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.5 175.35 9.31 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.321 1.049 . . . . 0.0 110.855 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -106.96 -25.93 11.42 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.588 1.155 . . . . 0.0 110.967 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -119.98 33.63 5.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.571 1.548 . . . . 0.0 111.387 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.84 31.63 81.56 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 174.63 2.65 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.001 1.762 . . . . 0.0 114.853 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm -125.68 137.0 53.83 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.601 1.16 . . . . 0.0 109.506 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.39 151.54 43.78 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.742 0.817 . . . . 0.0 109.3 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.58 -62.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -156.09 164.5 32.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.1 160.43 14.34 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.941 0.896 . . . . 0.0 111.283 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -144.59 149.3 35.56 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.859 2.064 . . . . 0.0 107.04 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.83 172.51 24.43 Favored Glycine 0 C--O 1.229 -0.217 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -142.25 37.62 1.55 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.297 1.439 . . . . 0.0 107.412 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.02 111.8 20.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.645 1.178 . . . . 0.0 110.206 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.69 -101.34 0.32 Allowed Glycine 0 CA--C 1.519 0.305 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -76.37 -31.65 58.16 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 119.516 -0.278 . . . . 0.0 110.536 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.6 169.17 17.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.381 1.472 . . . . 0.0 110.745 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.1 tp -75.91 88.44 2.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.715 1.206 . . . . 0.0 113.264 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -90.38 -32.77 16.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.03 139.73 19.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.165 0.986 . . . . 0.0 109.28 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.6 tp -158.85 113.1 2.44 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.182 1.393 . . . . 0.0 108.379 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -140.25 -175.94 14.78 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.436 1.493 . . . . 0.0 111.298 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -146.6 159.51 43.34 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.43 1.115 . . . . 0.0 111.261 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -99.39 154.99 17.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.384 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -129.51 118.37 21.97 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.807 1.243 . . . . 0.0 108.81 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.6 131.18 18.83 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.905 1.682 . . . . 0.0 108.661 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.5 t -133.91 160.18 38.45 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.586 1.154 . . . . 0.0 109.264 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.8 m -64.46 100.9 0.39 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.2 t -77.12 -7.98 56.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 29.6 p -104.97 161.62 22.2 Favored Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 126.221 1.809 . . . . 0.0 113.932 -178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.97 171.97 17.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.413 2.075 . . . . 0.0 109.703 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.2 p -123.08 125.16 71.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 47.4 p -137.13 164.52 41.53 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.028 1.331 . . . . 0.0 110.85 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.34 6.51 5.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.391 2.727 . . . . 0.0 114.606 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.54 -173.91 0.64 Allowed 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 130.369 3.468 . . . . 0.0 112.236 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.78 122.09 28.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -106.0 147.56 28.71 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 67.9 mt -125.09 122.51 37.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.97 2.108 . . . . 0.0 107.161 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.1 t -69.15 108.39 3.59 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 127.143 2.177 . . . . 0.0 107.081 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.03 -178.58 2.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.078 0.951 . . . . 0.0 111.228 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.447 HD12 ' CE2' ' A' ' 233' ' ' TYR . 17.5 pt -108.15 156.13 8.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.054 1.342 . . . . 0.0 108.389 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.31 -109.88 0.49 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -156.39 -162.6 11.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.989 1.757 . . . . 0.0 109.629 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -121.65 13.6 10.85 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.853 1.261 . . . . 0.0 111.383 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -107.65 120.77 43.14 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 112.163 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.36 -172.84 36.86 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.867 1.699 . . . . 0.0 109.506 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.9 m -96.3 146.21 24.92 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -103.08 138.37 40.01 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.582 -0.699 . . . . 0.0 110.973 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -155.74 58.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -71.33 104.22 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.02 -24.65 21.16 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.864 -0.522 . . . . 0.0 112.049 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.0 -118.71 4.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -135.42 135.66 40.78 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.353 1.577 . . . . 0.0 110.006 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -91.4 170.6 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -42.62 64.78 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 124.798 1.239 . . . . 0.0 113.195 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.58 134.01 3.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.18 156.82 4.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 126.065 1.746 . . . . 0.0 107.685 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -127.03 -64.1 1.02 Allowed 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -126.3 155.31 42.17 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.512 0.597 . . . . 0.0 111.756 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -121.56 146.11 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.588 1.955 . . . . 0.0 107.255 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -137.07 146.44 45.17 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.599 0.76 . . . . 0.0 109.197 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.2 132.41 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.22 65.82 0.56 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 124.42 1.009 . . . . 0.0 112.404 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.3 pm0 -78.72 176.51 9.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.375 1.07 . . . . 0.0 109.981 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -162.53 -167.61 23.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.3 mm100 -69.75 -20.35 63.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.683 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -115.6 -16.81 11.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.275 0.943 . . . . 0.0 113.516 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.89 30.76 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.193 0.906 . . . . 0.0 112.925 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -71.77 111.91 6.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.1 0.96 . . . . 0.0 108.946 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -96.02 -37.1 10.78 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 118.95 -0.547 . . . . 0.0 110.905 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.18 155.58 47.96 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 122.56 1.171 . . . . 0.0 111.777 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.8 t -144.51 148.16 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 103.597 -2.742 . . . . 0.0 103.597 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -168.3 142.17 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.407 1.883 . . . . 0.0 106.764 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -139.14 155.36 47.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -108.84 130.1 55.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -140.98 168.41 19.85 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.986 0.914 . . . . 0.0 111.741 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -147.39 133.84 19.71 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.76 1.224 . . . . 0.0 110.966 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -140.05 147.21 40.0 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.74 -100.13 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 124.657 1.122 . . . . 0.0 112.715 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -133.36 12.82 4.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.84 1.656 . . . . 0.0 110.881 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -127.48 110.66 12.97 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.302 1.041 . . . . 0.0 112.019 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -77.47 152.47 34.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.318 1.847 . . . . 0.0 107.302 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 25.0 mm -132.88 129.63 58.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.119 0.968 . . . . 0.0 109.534 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.22 141.5 45.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 118.34 -135.46 11.6 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.85 23.65 66.31 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.971 0.385 . . . . 0.0 112.542 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -78.75 78.98 5.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -84.7 21.49 1.52 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.582 1.153 . . . . 0.0 112.534 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.95 156.18 26.89 Favored Glycine 0 N--CA 1.45 -0.368 0 O-C-N 119.809 -1.807 . . . . 0.0 108.889 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -71.3 129.76 88.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.56 155.1 71.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.53 2.153 . . . . 0.0 109.084 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.5 p -98.76 173.03 7.08 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.953 0.901 . . . . 0.0 109.587 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 40.1 tp -75.08 -18.57 60.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.7 tt -68.3 -34.73 76.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.161 1.385 . . . . 0.0 108.746 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 101.78 -132.38 10.95 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -142.33 -179.67 6.41 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.904 1.681 . . . . 0.0 109.061 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.42 158.03 43.97 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 131.414 3.885 . . . . 0.0 104.711 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -143.96 147.78 34.41 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.687 1.131 . . . . 0.0 113.77 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.48 143.48 32.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.741 1.217 . . . . 0.0 109.402 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -119.74 113.86 21.28 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.681 1.192 . . . . 0.0 107.807 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.3 mm -128.04 103.17 9.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -75.58 115.74 15.56 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -56.67 -32.0 11.87 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.06 8.46 1.06 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 124.015 2.47 . . . . 0.0 113.569 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.7 m -145.45 -68.12 0.29 Allowed 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.975 -1.078 . . . . 0.0 110.034 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -84.78 151.84 24.08 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 119.123 0.874 . . . . 0.0 110.095 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -143.58 168.13 20.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.636 1.684 . . . . 0.0 115.177 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 36.3 mm -109.05 124.98 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 127.742 2.417 . . . . 0.0 105.263 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 10.3 t -115.84 -15.38 11.28 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.708 1.14 . . . . 0.0 113.139 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -154.02 170.34 21.35 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.829 1.251 . . . . 0.0 107.913 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.91 125.2 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.64 170.08 8.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 157.52 -178.73 33.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 27.6 p -137.18 153.73 50.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.447 ' CE2' HD12 ' A' ' 159' ' ' ILE . 35.7 p90 -131.26 144.33 51.22 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.49 165.23 23.11 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.747 0.419 . . . . 0.0 110.12 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -95.44 148.22 22.71 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.124 1.37 . . . . 0.0 113.174 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 236' ' ' ILE . 1.5 mp -99.87 138.95 22.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -75.34 152.13 38.17 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.407 -0.808 . . . . 0.0 109.169 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.21 1.51 89.51 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.299 0.952 . . . . 0.0 112.979 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 59.3 m -140.79 179.54 6.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.493 1.517 . . . . 0.0 109.794 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -125.39 66.41 1.15 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -162.88 -177.82 36.2 Favored Glycine 0 CA--C 1.523 0.559 0 O-C-N 121.548 -0.72 . . . . 0.0 112.395 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.77 167.23 22.58 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.056 1.742 . . . . 0.0 112.13 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 20.0 tt -141.67 158.62 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.066 2.147 . . . . 0.0 109.338 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 44.4 mm -72.52 126.98 34.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.2 m -107.61 -31.11 8.23 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.773 0.829 . . . . 0.0 111.712 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.7 tmm? -144.65 154.65 43.02 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -140.74 130.44 24.24 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.941 1.697 . . . . 0.0 109.553 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -129.31 109.35 11.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 124.963 1.305 . . . . 0.0 107.759 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -76.64 139.81 40.73 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -121.95 114.13 20.57 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.2 p -112.19 165.32 12.26 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.138 2.575 . . . . 0.0 109.714 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -100.74 150.97 22.22 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? 65.21 -35.11 0.19 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.415 2.286 . . . . 0.0 114.298 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -120.08 174.2 6.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.575 1.95 . . . . 0.0 110.113 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 13.0 t -125.77 148.51 49.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.7 m -115.09 -0.34 13.36 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 258' ' ' PRO . . . 74.8 163.81 0.14 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.513 2.325 . . . . 0.0 113.537 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 257' ' ' ALA . 56.5 Cg_endo -86.53 150.15 8.88 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.672 2.915 . . . . 0.0 109.674 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.94 112.13 13.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.79 176.53 26.93 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.802 1.192 . . . . 0.0 110.776 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.5 tt -97.56 118.57 34.37 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.606 1.163 . . . . 0.0 108.397 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -59.1 109.72 0.9 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.743 1.217 . . . . 0.0 110.261 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -149.5 150.93 33.08 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.065 1.746 . . . . 0.0 106.821 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 84.11 -169.54 46.16 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 67.3 m -76.55 139.81 40.87 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.0 1.32 . . . . 0.0 108.406 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -94.91 137.5 33.89 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.317 1.047 . . . . 0.0 109.945 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -130.61 148.3 52.39 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.247 1.019 . . . . 0.0 108.752 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -150.9 103.67 3.09 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 122.062 -0.399 . . . . 0.0 110.296 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.89 140.85 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.79 165.05 32.62 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.31 0.504 . . . . 0.0 112.289 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -146.28 167.48 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -132.23 137.27 47.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 71.7 17.78 76.86 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 118.818 0.736 . . . . 0.0 112.588 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -143.44 172.24 13.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.316 1.847 . . . . 0.0 109.175 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.461 ' HE3' ' CG1' ' A' ' 277' ' ' VAL . 0.1 OUTLIER -141.42 160.69 39.61 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.035 0.934 . . . . 0.0 109.916 177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 38.6 mt -81.93 134.99 25.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.461 ' CG1' ' HE3' ' A' ' 275' ' ' LYS . 28.0 m -141.52 1.11 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -155.61 173.47 33.71 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 120.174 1.352 . . . . 0.0 113.385 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 290' ' ' PHE . 3.0 t80 -145.79 134.04 21.72 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 127.557 2.343 . . . . 0.0 107.842 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -141.54 147.39 37.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.154 2.582 . . . . 0.0 104.228 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.48 -144.62 12.71 Favored Glycine 0 C--N 1.331 0.294 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 149.2 29.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 122.052 0.929 . . . . 0.0 110.819 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -155.64 154.4 31.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.341 1.857 . . . . 0.0 106.797 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.2 t -146.38 -106.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.79 -1.929 . . . . 0.0 105.79 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.73 -23.1 60.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 119.943 1.247 . . . . 0.0 109.236 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.99 159.86 41.86 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 129.029 2.932 . . . . 0.0 108.79 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 27.3 tp -78.89 131.03 36.26 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -119.34 -32.21 4.43 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.561 -1.209 . . . . 0.0 113.001 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -140.05 125.39 18.92 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.59 1.541 . . . . 0.0 107.051 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.431 ' HA ' ' CE1' ' A' ' 279' ' ' PHE . 15.8 t80 -122.11 97.69 5.6 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -97.86 98.51 2.09 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.4 m -79.78 130.43 36.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -90.37 153.97 20.03 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.324 0.65 . . . . 0.0 109.81 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 18.1 m -126.43 138.11 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.1 0.96 . . . . 0.0 109.735 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 73.4 mtp -143.56 152.05 55.61 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.151 1.38 . . . . 0.0 107.667 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.24 152.98 79.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.436 2.091 . . . . 0.0 113.721 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 7.4 mt -75.3 111.45 10.58 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 24.4 p -74.37 177.3 6.0 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.03 0.932 . . . . 0.0 110.713 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.206 2.202 . . . . 0.0 105.895 178.787 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.536 0.207 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' H ' ' HB2' ' A' ' 144' ' ' ALA . 16.2 mm-40 -136.19 151.82 50.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.09 1.756 . . . . 0.0 108.399 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -140.05 138.66 35.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.78 136.48 44.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.36 140.76 55.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.239 0.542 . . . . 0.0 110.763 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 164.82 19.26 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.157 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.23 145.96 18.01 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 127.62 -175.51 18.25 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 126.202 1.858 . . . . 0.0 110.829 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.55 -163.88 7.29 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.757 1.646 . . . . 0.0 113.865 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.0 0.22 43.43 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.172 1.389 . . . . 0.0 112.287 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.86 165.61 54.78 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.05 152.48 20.04 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.318 0.961 . . . . 0.0 111.941 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.5 114.51 6.16 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.491 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m 97.32 59.3 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 129.794 3.238 . . . . 0.0 118.284 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.429 ' CE3' ' CB ' ' A' ' 129' ' ' HIS . 30.9 p-90 -62.55 -14.96 48.04 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 125.592 1.557 . . . . 0.0 113.817 175.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.87 112.96 10.49 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.8 -37.42 71.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.002 0.521 . . . . 0.0 111.762 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.67 25.36 72.87 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 115.222 0.849 . . . . 0.0 115.222 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.71 -175.57 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 109.46 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -83.03 -173.62 4.82 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.573 -1.329 . . . . 0.0 108.178 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -93.11 99.07 11.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 103.02 -2.956 . . . . 0.0 103.02 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.52 28.29 1.2 Allowed Glycine 0 C--O 1.228 -0.281 0 CA-C-O 118.142 -1.366 . . . . 0.0 114.395 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.62 128.03 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 120.116 1.958 . . . . 0.0 108.452 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -114.65 -56.75 2.35 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.891 1.276 . . . . 0.0 110.31 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -138.87 169.48 17.71 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.744 2.418 . . . . 0.0 106.897 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.03 142.65 25.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -127.76 107.93 10.3 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.4 m -115.97 134.89 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.87 142.59 14.03 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -93.21 161.23 14.5 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.525 1.13 . . . . 0.0 110.009 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -171.79 -167.99 32.71 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 125.587 1.565 . . . . 0.0 109.291 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.02 -38.63 83.26 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.096 0.558 . . . . 0.0 111.222 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.86 11.72 2.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.221 1.408 . . . . 0.0 111.335 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.5 -136.37 15.37 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.82 106.96 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.43 -14.38 14.87 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 -176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 87.0 p -131.16 139.03 49.7 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.152 1.342 . . . . 0.0 109.61 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 mm -142.88 140.66 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 126.328 1.851 . . . . 0.0 106.263 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -154.74 140.19 17.79 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 126.594 1.958 . . . . 0.0 105.886 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.54 156.17 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.32 144.04 23.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -116.73 105.22 12.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.59 125.21 27.47 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.906 -1.122 . . . . 0.0 108.284 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -114.77 160.57 19.26 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.39 -8.78 14.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.038 1.335 . . . . 0.0 111.606 178.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.6 t -101.56 -68.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.955 1.702 . . . . 0.0 106.863 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -154.57 165.8 35.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.245 1.018 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.59 139.2 43.51 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.29 145.89 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -112.06 153.63 26.6 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.735 -1.228 . . . . 0.0 111.031 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 -123.75 2.03 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.18 176.6 35.96 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -75.13 142.04 43.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -123.21 65.1 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.268 2.227 . . . . 0.0 105.702 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.7 -164.01 37.59 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.56 123.26 43.5 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.76 143.26 51.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 p -106.9 -177.65 3.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.862 0.839 . . . . 0.0 111.86 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.2 tp -89.59 -39.59 13.16 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.059 0.944 . . . . 0.0 108.811 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -54.34 -38.56 66.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.988 2.115 . . . . 0.0 112.786 -178.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.06 163.37 27.68 Favored Glycine 0 N--CA 1.426 -1.977 0 CA-C-O 124.102 1.946 . . . . 0.0 108.427 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -109.63 162.94 13.94 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 110.966 -2.617 . . . . 0.0 108.854 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.62 164.23 13.94 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.078 1.751 . . . . 0.0 110.512 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.6 m -119.38 99.28 6.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.099 0.959 . . . . 0.0 113.53 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -87.72 140.63 29.32 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.06 130.71 52.83 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.649 1.579 . . . . 0.0 111.992 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.8 t -115.18 110.07 30.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 124.858 1.263 . . . . 0.0 108.276 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -69.84 173.18 6.59 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.054 1.341 . . . . 0.0 109.734 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.3 87.55 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.858 -1.151 . . . . 0.0 111.311 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -101.95 7.65 41.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.349 1.459 . . . . 0.0 112.883 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.64 135.6 38.34 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -134.84 125.67 27.29 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mt -75.25 121.65 27.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.2 m -109.28 -19.17 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.82 147.18 29.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.01 113.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.26 130.56 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.46 144.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.824 1.25 . . . . 0.0 107.697 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -128.19 137.15 51.93 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -146.34 148.15 32.08 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.48 169.36 21.98 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.73 0.695 . . . . 0.0 110.185 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.31 148.05 33.78 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.906 1.282 . . . . 0.0 110.546 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.4 161.16 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.821 1.248 . . . . 0.0 108.792 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -61.83 129.11 39.41 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.414 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.15 -10.43 70.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.158 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.46 77.3 1.76 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.295 -2.484 . . . . 0.0 104.295 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.4 -9.49 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.345 2.258 . . . . 0.0 113.336 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.54 127.32 37.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.02 1.328 . . . . 0.0 109.207 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.04 114.14 4.98 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.3 pt -110.08 151.8 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.349 0.977 . . . . 0.0 110.412 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.3 mm -66.12 109.16 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 108.084 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.7 p -80.1 -28.55 39.02 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.682 -0.636 . . . . 0.0 110.967 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 t -170.51 174.0 5.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.39 1.476 . . . . 0.0 109.476 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.68 144.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 126.617 1.967 . . . . 0.0 107.28 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.5 m -138.38 104.06 5.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.236 1.414 . . . . 0.0 107.612 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -78.81 150.5 32.31 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.871 -1.143 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -137.48 120.51 16.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -109.25 164.6 12.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.866 0.841 . . . . 0.0 112.895 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -63.68 -25.39 68.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.198 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -79.56 -5.5 55.07 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.531 -0.731 . . . . 0.0 110.727 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.77 2.68 62.83 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.833 1.206 . . . . 0.0 111.307 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -67.06 135.27 53.41 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.84 109.87 10.42 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.8 p -75.96 156.68 84.16 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.68 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.84 165.14 33.6 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 N-CA-C 106.814 -2.033 . . . . 0.0 106.814 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.71 108.5 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.069 2.512 . . . . 0.0 107.393 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -79.83 71.42 6.5 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.49 -130.87 3.46 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 63.3 tp -139.78 105.9 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.732 2.013 . . . . 0.0 106.649 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.431 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 1.5 mt-10 -59.52 148.56 32.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 112' ' ' GLN . 0.9 OUTLIER -127.66 178.82 5.87 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 109.328 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.413 ' H ' HG22 ' A' ' 111' ' ' THR . 21.7 tt0 -62.06 -54.88 35.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.59 130.76 48.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 1.1 ptpm? -160.18 166.47 29.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 120.924 0.392 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -150.43 160.4 43.78 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 126.89 2.076 . . . . 0.0 107.01 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -142.68 118.83 5.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -105.82 140.06 39.43 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.616 0.766 . . . . 0.0 110.01 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 172.51 17.28 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 126.988 2.115 . . . . 0.0 108.875 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.05 175.81 7.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.913 1.685 . . . . 0.0 111.243 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -145.75 -15.39 0.48 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.081 0.553 . . . . 0.0 111.982 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.61 1.48 6.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.307 1.443 . . . . 0.0 110.871 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.01 108.48 0.99 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -167.39 162.96 36.75 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -110.23 159.08 17.71 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.083 1.353 . . . . 0.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.0 tt -72.86 130.13 39.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.6 m -131.15 -14.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.93 178.37 47.43 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -135.69 171.71 14.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.758 1.223 . . . . 0.0 112.442 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.429 ' CB ' ' CE3' ' A' ' 15' ' ' TRP . 10.7 p80 -164.37 168.65 18.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.953 1.301 . . . . 0.0 109.986 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.92 -82.33 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 170.93 86.33 0.0 OUTLIER 'General case' 0 C--N 1.349 0.566 0 C-N-CA 129.359 3.064 . . . . 0.0 108.136 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -137.16 164.59 28.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.8 -99.45 0.12 Allowed Glycine 0 C--O 1.227 -0.341 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.42 -0.19 40.43 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.706 0.802 . . . . 0.0 113.154 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.54 166.51 26.93 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 126.19 1.796 . . . . 0.0 106.587 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.7 tp -94.49 81.89 3.97 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -79.41 -64.75 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.584 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.45 131.18 35.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.451 0.7 . . . . 0.0 110.697 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 tp -155.38 173.64 16.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.554 0.692 . . . . 0.0 111.059 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.78 161.61 34.38 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 127.482 2.468 . . . . 0.0 107.902 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.56 159.56 35.96 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.357 1.063 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -121.91 159.01 27.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.515 0.726 . . . . 0.0 111.237 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -135.87 97.23 3.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.465 ' HB2' ' H ' ' A' ' 2' ' ' GLN . . . -147.14 160.72 42.1 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 127.005 2.122 . . . . 0.0 111.205 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -134.95 148.34 50.0 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.964 1.306 . . . . 0.0 107.663 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.3 t -153.82 -176.98 6.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.434 1.094 . . . . 0.0 108.412 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 m -87.76 -135.02 0.09 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.036 2.135 . . . . 0.0 106.357 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.48 144.53 28.46 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 120.431 -1.418 . . . . 0.0 111.51 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.53 145.11 23.16 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.701 2.267 . . . . 0.0 107.923 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 23.3 t -145.88 158.31 12.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 64.9 p -136.76 144.94 48.91 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 124.327 1.051 . . . . 0.0 108.683 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -82.31 174.79 9.61 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.933 2.422 . . . . 0.0 109.627 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.93 169.24 17.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.011 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -98.38 147.53 24.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.329 0.651 . . . . 0.0 109.445 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -113.58 146.0 40.38 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 104.081 -2.562 . . . . 0.0 104.081 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 59.9 mt -111.06 -176.4 2.95 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.137 0.975 . . . . 0.0 109.768 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 122.9 48.67 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.842 1.257 . . . . 0.0 110.515 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -78.57 177.61 8.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.252 1.421 . . . . 0.0 111.604 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.8 tt -128.46 160.9 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 125.7 1.6 . . . . 0.0 108.096 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.77 -102.26 0.14 Allowed Glycine 0 C--N 1.336 0.583 0 C-N-CA 125.771 1.653 . . . . 0.0 111.289 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.65 -117.44 11.56 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 65.65 -25.82 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 128.875 2.87 . . . . 0.0 114.481 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -132.25 148.0 52.43 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.043 1.737 . . . . 0.0 108.88 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 122.08 176.17 15.05 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 128.212 2.815 . . . . 0.0 107.363 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.0 m -80.8 142.04 34.12 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.71 110.14 14.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -155.87 130.79 9.22 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 120.034 1.288 . . . . 0.0 113.355 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.4 148.75 23.38 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.73 -27.85 17.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.321 1.448 . . . . 0.0 109.255 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 83.24 -147.55 24.64 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.95 138.86 18.06 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.427 ' CD1' ' CE2' ' A' ' 194' ' ' TYR . 69.1 m-85 -111.76 179.85 3.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.97 0.508 . . . . 0.0 111.849 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -53.96 -36.5 62.92 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.952 0.882 . . . . 0.0 110.361 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.24 -177.31 44.22 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 127.929 2.68 . . . . 0.0 107.504 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 20.9 m -121.94 157.79 25.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 125.989 1.716 . . . . 0.0 108.033 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.04 -50.64 2.14 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 118.529 0.604 . . . . 0.0 109.591 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -140.93 140.23 34.44 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 118.791 0.723 . . . . 0.0 109.736 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.53 142.1 14.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -133.95 152.7 51.95 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.507 0.723 . . . . 0.0 109.181 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.71 144.8 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -140.42 134.54 6.54 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -141.2 174.43 10.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.921 0.867 . . . . 0.0 112.093 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -140.62 -172.85 13.13 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 128.591 2.996 . . . . 0.0 106.41 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -65.56 -23.75 66.93 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.044 -0.68 . . . . 0.0 110.661 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -17.58 60.65 Favored 'General case' 0 N--CA 1.451 -0.38 1 C-N-CA 132.083 4.153 . . . . 0.0 112.8 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 115.82 -163.04 12.37 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 18.8 mm -62.38 124.12 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.09 -19.09 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.752 1.221 . . . . 0.0 113.908 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -137.26 150.04 47.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.458 1.026 . . . . 0.0 111.846 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.63 142.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -164.48 168.56 18.25 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.959 2.504 . . . . 0.0 106.565 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.14 175.5 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.34 128.77 38.39 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.427 ' CE2' ' CD1' ' A' ' 172' ' ' TYR . 20.0 p90 -153.26 168.32 26.4 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.991 0.917 . . . . 0.0 110.236 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -115.91 149.32 38.9 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.615 1.566 . . . . 0.0 109.567 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -125.93 123.87 39.53 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 60.83 -98.83 0.17 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -129.36 18.29 5.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.033 1.333 . . . . 0.0 112.293 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -130.51 125.09 33.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.977 0.911 . . . . 0.0 111.281 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -75.76 153.43 37.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.464 1.106 . . . . 0.0 108.582 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 194' ' ' TYR . 12.7 mt -127.03 136.59 60.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.684 1.594 . . . . 0.0 107.147 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.7 t -125.21 128.66 72.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 149.07 -120.98 1.23 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 74.12 -10.26 8.08 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.025 1.774 . . . . 0.0 113.799 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.53 132.34 48.35 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.241 1.52 . . . . 0.0 109.786 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -154.93 -40.85 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.578 0.751 . . . . 0.0 112.258 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.99 151.11 36.68 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 107.314 -2.315 . . . . 0.0 107.314 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -37.79 99.59 0.19 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 127.529 2.331 . . . . 0.0 114.775 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.29 151.55 54.52 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.9 m -122.97 152.64 40.68 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.01 -11.56 40.43 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.854 -0.529 . . . . 0.0 111.172 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.77 -24.97 67.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.29 1.836 . . . . 0.0 109.497 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.21 -156.77 17.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -139.52 152.97 47.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 106.21 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -106.19 154.16 21.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.63 157.07 44.37 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.899 0.48 . . . . 0.0 112.134 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -142.58 139.94 31.54 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.235 1.014 . . . . 0.0 110.606 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.65 125.98 32.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 12.8 mm -127.77 110.59 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.94 89.18 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -36.16 -52.69 1.65 Allowed Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.89 -14.39 15.47 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.32 2.013 . . . . 0.0 114.515 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -93.66 -40.71 10.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.663 1.574 . . . . 0.0 109.404 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -92.19 172.25 8.54 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 107.418 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -146.42 -20.32 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.797 -1.189 . . . . 0.0 112.325 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.3 mp 49.88 88.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 127.922 2.489 . . . . 0.0 109.036 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.0 p -90.13 -4.46 57.29 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.76 163.13 34.89 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.207 1.003 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.0 p -146.16 153.28 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.267 1.427 . . . . 0.0 107.49 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -133.4 178.22 7.09 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.196 1.798 . . . . 0.0 109.776 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 167.49 -179.54 40.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 262' ' ' GLU . 18.6 p -141.08 141.13 34.28 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -134.87 153.26 52.12 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 122.951 0.5 . . . . 0.0 111.751 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.439 ' OD1' ' HE2' ' A' ' 235' ' ' LYS . 2.6 t0 -136.29 170.91 15.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.202 1.001 . . . . 0.0 109.558 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.439 ' HE2' ' OD1' ' A' ' 234' ' ' ASP . 0.0 OUTLIER -88.55 147.98 24.33 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.88 1.272 . . . . 0.0 112.732 -178.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.62 117.47 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -63.01 145.09 56.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 79.29 1.5 86.0 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 119.283 -0.731 . . . . 0.0 112.729 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.9 m -138.17 -177.5 4.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.995 2.118 . . . . 0.0 108.511 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -136.8 87.74 2.31 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -169.54 -176.25 39.26 Favored Glycine 0 CA--C 1.52 0.389 0 O-C-N 121.022 -1.049 . . . . 0.0 111.012 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -126.69 149.66 49.43 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.081 0.952 . . . . 0.0 111.276 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 14.7 tt -134.18 130.5 54.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.962 1.705 . . . . 0.0 106.792 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.31 128.72 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.4 t -111.84 -18.79 12.62 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.723 1.209 . . . . 0.0 111.827 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -144.61 154.52 42.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.905 0.482 . . . . 0.0 110.423 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.36 143.17 30.83 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.272 1.829 . . . . 0.0 109.195 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -142.79 153.78 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -128.54 113.48 15.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -77.89 113.71 16.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 p -98.24 164.76 12.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.924 2.089 . . . . 0.0 108.559 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -112.65 147.26 37.11 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 57.86 11.34 1.36 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -155.5 147.64 23.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.074 1.749 . . . . 0.0 106.934 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.5 p -113.14 100.24 8.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.438 1.495 . . . . 0.0 108.619 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 5.5 p -65.38 161.55 19.51 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.365 2.266 . . . . 0.0 114.441 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -105.2 163.1 17.84 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 127.186 2.195 . . . . 0.0 111.067 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.39 159.28 29.33 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.831 2.354 . . . . 0.0 110.415 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -137.3 110.91 8.05 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.96 -167.01 15.81 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 118.731 0.696 . . . . 0.0 112.417 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.48 110.6 23.0 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.906 1.283 . . . . 0.0 109.581 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 232' ' ' THR . 48.2 tt0 -66.02 108.75 2.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.425 1.49 . . . . 0.0 110.866 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.9 28.64 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.058 1.343 . . . . 0.0 109.529 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 78.88 -164.81 50.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 122.548 1.082 . . . . 0.0 114.236 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 59.7 m -64.54 108.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.199 2.2 . . . . 0.0 109.095 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -77.75 142.31 38.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -141.45 170.95 14.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 122.391 1.091 . . . . 0.0 111.234 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.43 155.47 39.61 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.427 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 85.1 mt -131.95 154.78 48.93 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -170.45 173.07 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.567 1.147 . . . . 0.0 107.911 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -139.47 165.94 25.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -43.77 71.48 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.845 0.748 . . . . 0.0 111.13 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -161.03 72.23 0.22 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-O 118.995 -0.892 . . . . 0.0 111.835 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -151.05 158.03 43.57 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.325 1.063 . . . . 0.0 109.742 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -88.82 177.11 6.79 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.025 1.73 . . . . 0.0 108.717 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 37.8 mt -125.0 111.33 27.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.997 1.319 . . . . 0.0 108.608 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.27 93.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.255 2.222 . . . . 0.0 108.967 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.77 6.19 Favored Glycine 0 N--CA 1.468 0.771 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -120.6 135.65 55.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.224 1.809 . . . . 0.0 111.347 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -133.04 136.73 46.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 161.51 -159.93 31.76 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.926 -1.109 . . . . 0.0 112.64 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -137.21 127.4 26.22 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -162.21 154.68 19.5 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.94 1.296 . . . . 0.0 109.278 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 37.0 t -147.04 -98.49 0.09 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -79.71 -21.26 44.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.247 1.019 . . . . 0.0 111.456 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 1.3 mp -136.21 153.11 51.33 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 20.6 tp -94.13 83.77 4.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.616 0.766 . . . . 0.0 111.225 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -78.94 -22.11 46.22 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.425 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -136.44 152.62 50.78 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 119.876 1.216 . . . . 0.0 113.12 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -162.69 134.9 5.43 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -158.82 169.67 35.18 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 135.15 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.852 0.826 . . . . 0.0 111.565 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -74.78 145.11 43.21 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.63 136.02 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.522 0.677 . . . . 0.0 110.548 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 70.3 mtp -138.62 137.06 19.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 129.372 3.069 . . . . 0.0 106.287 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.36 165.81 30.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.948 1.765 . . . . 0.0 109.589 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.55 -55.37 15.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.68 175.54 5.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.867 0.867 . . . . 0.0 111.388 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 126.733 2.013 . . . . 0.0 108.197 178.091 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -68.58 134.31 49.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -142.15 102.88 4.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.201 0.6 . . . . 0.0 109.886 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t -75.52 143.29 13.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -97.23 134.62 40.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.524 1.53 . . . . 0.0 111.587 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.29 167.63 19.05 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.762 1.225 . . . . 0.0 111.687 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.3 163.51 30.66 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.568 2.032 . . . . 0.0 108.562 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.08 -109.08 0.41 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 107.053 -2.419 . . . . 0.0 107.053 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.3 -171.43 15.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 125.318 1.437 . . . . 0.0 109.628 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.34 91.72 2.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.482 0.713 . . . . 0.0 110.253 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.59 18.77 3.01 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.167 1.365 . . . . 0.0 112.231 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.88 -177.73 16.5 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 118.724 1.262 . . . . 0.0 113.054 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.99 158.43 27.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.752 1.263 . . . . 0.0 111.616 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 p -63.29 131.96 50.05 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -134.41 -19.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.212 1.005 . . . . 0.0 110.64 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.85 100.71 7.3 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -117.5 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.46 1.504 . . . . 0.0 107.727 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -149.23 -163.2 10.83 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 125.058 1.313 . . . . 0.0 109.918 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.48 156.91 20.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.641 0.776 . . . . 0.0 109.822 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -137.63 -34.7 0.68 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.67 1.188 . . . . 0.0 109.454 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.3 p30 58.61 8.9 0.97 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.016 2.527 . . . . 0.0 114.756 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -81.69 5.68 68.6 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.514 1.53 . . . . 0.0 114.105 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.4 m -62.45 155.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.677 1.738 . . . . 0.0 108.978 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.0 ttt-85 -130.86 -32.58 1.64 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -138.9 167.95 20.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.225 1.01 . . . . 0.0 109.555 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -139.46 85.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -87.83 135.29 33.46 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -149.88 148.62 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 127.473 2.309 . . . . 0.0 106.861 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.44 -157.87 10.65 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -134.08 164.2 27.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.732 0.766 . . . . 0.0 110.005 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.25 37.46 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 129.059 3.218 . . . . 0.0 105.97 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -91.68 -32.66 15.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.168 0.484 . . . . 0.0 110.131 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -101.11 -23.61 14.44 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 130.989 3.715 . . . . 0.0 114.094 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.56 -165.78 38.33 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 120.639 1.563 . . . . 0.0 112.97 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.71 96.07 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 107.956 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -75.54 -21.55 57.83 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.3 p -128.44 139.62 52.25 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.926 1.694 . . . . 0.0 113.728 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -145.28 154.01 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 107.975 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -140.4 137.99 34.43 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -144.89 159.07 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 119.489 1.041 . . . . 0.0 112.206 -178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.01 135.84 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -124.85 104.64 8.73 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.21 110.86 17.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.87 1.268 . . . . 0.0 108.852 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -116.74 139.55 50.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 61.54 -161.29 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.914 1.286 . . . . 0.0 109.176 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -73.07 24.78 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.246 1.418 . . . . 0.0 112.131 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -141.03 165.42 27.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.468 1.907 . . . . 0.0 111.34 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -107.84 140.25 41.21 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.8 t -136.81 133.73 48.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -66.95 129.02 38.54 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.45 -60.2 4.86 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.24 167.73 14.21 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -118.99 85.71 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.504 1.922 . . . . 0.0 107.561 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -83.83 170.41 14.14 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 121.871 0.843 . . . . 0.0 109.637 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.78 -166.12 42.79 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.479 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -111.33 102.72 11.09 Favored 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 124.801 1.241 . . . . 0.0 109.063 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -61.04 134.05 56.68 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 p -134.31 111.86 10.56 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.152 1.381 . . . . 0.0 109.566 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -8.24 13.37 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.1 mt -76.08 -4.82 43.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.435 0.694 . . . . 0.0 111.692 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.89 110.46 0.28 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -155.68 143.15 19.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 129.064 2.946 . . . . 0.0 106.267 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.4 164.14 30.65 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.528 1.931 . . . . 0.0 110.876 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 54.3 m -128.03 128.5 45.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.774 1.63 . . . . 0.0 108.665 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -137.18 136.11 37.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -123.65 142.07 51.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.889 0.876 . . . . 0.0 109.144 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.4 t -98.34 110.5 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.73 161.36 30.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 109.137 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.97 -27.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -28.66 28.05 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -112.03 146.95 37.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -132.98 157.07 46.09 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.441 0.696 . . . . 0.0 109.783 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.29 138.89 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.34 -20.77 5.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.261 1.424 . . . . 0.0 111.851 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.0 156.31 42.51 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.349 -0.845 . . . . 0.0 109.346 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.71 100.27 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -86.31 122.49 30.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 101.353 -3.573 . . . . 0.0 101.353 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 115' ' ' PHE . 2.3 p -139.09 153.91 25.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 110' ' ' GLU . 9.8 t -136.52 151.91 49.94 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.048 1.739 . . . . 0.0 107.108 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.29 166.28 33.66 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.444 1.098 . . . . 0.0 110.409 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -161.19 169.17 22.79 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.769 1.168 . . . . 0.0 111.507 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -115.07 151.45 34.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.844 2.058 . . . . 0.0 110.71 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.34 126.91 74.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -54.28 121.9 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.967 0.907 . . . . 0.0 108.745 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 -3.19 26.91 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.532 1.063 . . . . 0.0 112.183 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -132.13 144.82 50.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.369 1.467 . . . . 0.0 107.617 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.89 -21.5 23.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.22 0.608 . . . . 0.0 109.516 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -67.59 -177.65 0.78 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.373 1.559 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -149.39 151.59 34.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.52 144.73 28.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.34 0.656 . . . . 0.0 109.846 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.35 122.34 20.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -89.71 -28.99 19.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.041 0.936 . . . . 0.0 111.249 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.3 t -163.11 160.87 24.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.448 1.476 . . . . 0.0 110.644 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.82 129.11 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 126.56 1.944 . . . . 0.0 108.55 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -135.49 101.45 4.81 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.115 1.366 . . . . 0.0 109.083 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -80.85 154.45 27.1 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 120.591 -1.318 . . . . 0.0 108.624 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.55 125.39 27.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.7 p -93.69 167.16 11.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.148 0.975 . . . . 0.0 111.668 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -65.94 -21.97 66.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.226 1.01 . . . . 0.0 109.698 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -7.07 52.74 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.295 1.038 . . . . 0.0 111.686 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.6 -4.08 75.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 125.534 1.54 . . . . 0.0 111.587 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -79.35 149.59 31.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 118.492 1.146 . . . . 0.0 108.404 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.7 p -134.3 135.73 43.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.68 163.39 61.26 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.18 162.3 42.09 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.39 101.68 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.35 2.7 . . . . 0.0 108.546 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -73.45 78.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 145.48 -135.3 5.89 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 61.6 tp -139.43 127.91 22.95 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 127.06 2.144 . . . . 0.0 107.386 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.741 ' HA ' HG21 ' A' ' 79' ' ' THR . 1.1 tt0 -69.47 155.5 40.36 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.217 0.917 . . . . 0.0 110.917 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -142.45 164.51 29.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.068 0.947 . . . . 0.0 108.909 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -60.98 -40.89 95.2 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -70.43 112.14 6.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -155.17 160.23 40.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.197 -0.94 . . . . 0.0 111.327 -178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.424 ' CD1' HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -155.92 165.81 35.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.607 0.763 . . . . 0.0 112.133 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.53 150.26 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.977 1.711 . . . . 0.0 106.454 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 mt -111.7 4.47 18.56 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -47.09 117.99 1.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.466 1.106 . . . . 0.0 112.975 -178.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -73.32 175.91 6.46 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.004 1.722 . . . . 0.0 108.298 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -121.67 -11.41 8.64 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.015 -1.053 . . . . 0.0 112.684 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -78.57 -5.97 54.24 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.43 24.63 25.79 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 119.318 -0.712 . . . . 0.0 112.082 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.25 175.4 11.39 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.584 1.564 . . . . 0.0 112.86 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -132.45 152.84 51.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.82 141.11 58.4 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -129.45 -33.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -173.54 -169.5 35.96 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 120.601 -1.312 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 0.4 OUTLIER -134.14 172.74 12.43 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.614 1.566 . . . . 0.0 111.205 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.7 p-80 -164.99 149.39 9.02 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 127.955 2.502 . . . . 0.0 105.862 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.14 115.86 0.41 Allowed Glycine 0 C--O 1.221 -0.718 0 C-N-CA 119.616 -1.278 . . . . 0.0 116.001 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -48.97 110.96 0.41 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.533 1.533 . . . . 0.0 107.664 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.38 165.22 25.66 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.878 1.671 . . . . 0.0 108.53 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -168.93 -97.77 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -81.89 -8.19 59.66 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.16 24.5 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 126.648 1.979 . . . . 0.0 108.545 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.78 93.98 9.65 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.17 -72.99 0.27 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.992 0.917 . . . . 0.0 111.092 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.2 143.8 38.14 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.296 1.039 . . . . 0.0 109.953 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 64.7 tp -134.67 115.49 13.85 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.291 1.037 . . . . 0.0 109.641 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -130.87 174.31 19.9 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.158 1.361 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . . . -150.4 175.43 11.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.617 0.767 . . . . 0.0 110.473 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -117.15 133.54 55.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -126.56 99.32 5.76 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 128.017 2.527 . . . . 0.0 108.581 -178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.6 162.68 36.93 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.544 1.138 . . . . 0.0 108.666 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . 0.257 1.8 t -134.56 166.39 23.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.876 -0.515 . . . . 0.0 110.994 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 9.23 3.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.158 2.183 . . . . 0.0 109.839 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.0 p -64.37 89.1 0.06 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 126.24 1.816 . . . . 0.0 110.776 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 29.0 p -147.57 154.42 44.7 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.271 1.428 . . . . 0.0 107.511 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.95 162.74 38.5 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.14 1.893 . . . . 0.0 110.868 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.17 124.86 29.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.351 1.06 . . . . 0.0 108.185 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.0 p -136.67 157.29 75.34 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.323 0.649 . . . . 0.0 111.156 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.52 -173.07 1.65 Allowed 'Trans proline' 0 CA--C 1.538 0.712 1 C-N-CA 125.445 4.096 . . . . 0.0 112.714 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.43 -179.5 1.35 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.561 1.545 . . . . 0.0 112.231 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -145.76 151.51 38.09 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.484 1.513 . . . . 0.0 108.729 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -112.18 133.66 54.18 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.227 2.211 . . . . 0.0 106.642 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.99 -173.94 3.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.24 1.016 . . . . 0.0 109.332 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 128.46 44.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -121.19 -179.87 4.18 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.885 1.274 . . . . 0.0 109.59 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.92 146.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 124.639 1.176 . . . . 0.0 107.904 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.85 -94.31 0.11 Allowed Glycine 0 C--O 1.228 -0.273 0 C-N-CA 124.979 1.276 . . . . 0.0 110.414 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.57 -157.44 19.19 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.451 ' CA ' ' HE2' ' A' ' 282' ' ' LYS . 6.7 p-10 -116.83 -4.68 11.57 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.867 1.667 . . . . 0.0 111.47 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -75.37 112.27 11.5 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.137 2.175 . . . . 0.0 111.669 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 131.58 161.94 10.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 124.807 1.194 . . . . 0.0 111.729 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 7.2 m -81.76 142.39 32.67 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.63 138.05 56.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -125.7 32.36 5.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.16 104.77 3.17 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -83.79 -50.27 8.28 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.689 0.795 . . . . 0.0 111.455 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 145.66 -123.32 1.85 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.25 160.94 43.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.878 2.071 . . . . 0.0 107.865 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.93 163.66 19.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.196 0.998 . . . . 0.0 109.826 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.27 -32.4 72.54 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.57 102.97 0.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 O-C-N 121.512 -0.743 . . . . 0.0 111.299 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.5 m -71.25 152.29 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -40.95 5.29 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -140.71 153.17 45.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.674 1.124 . . . . 0.0 108.402 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.24 143.54 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -126.65 164.18 21.83 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.416 0.687 . . . . 0.0 112.551 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 259' ' ' PHE . 3.6 t -131.51 128.02 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.47 89.4 0.38 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.928 1.728 . . . . 0.0 111.626 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -74.8 -177.9 3.46 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.893 1.33 . . . . 0.0 112.916 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -159.08 177.13 35.77 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 128.488 2.947 . . . . 0.0 107.603 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -62.53 -45.83 91.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.261 0.625 . . . . 0.0 111.333 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.81 -32.54 57.69 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.336 1.455 . . . . 0.0 110.294 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.55 -168.09 32.64 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-O 121.996 0.776 . . . . 0.0 111.321 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.76 119.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.9 m -108.22 -29.08 9.1 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.94 164.52 25.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.595 0.758 . . . . 0.0 109.766 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.53 141.7 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HE2' ' CD2' ' A' ' 214' ' ' PHE . 58.8 pttt -161.39 159.08 27.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.091 0.957 . . . . 0.0 110.256 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -146.84 174.35 11.56 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 108.11 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.95 147.34 33.63 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.343 1.857 . . . . 0.0 108.035 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 196' ' ' LYS . 7.7 t80 -147.45 153.52 39.68 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -128.09 92.21 3.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.531 2.332 . . . . 0.0 105.803 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 19.4 ptmt -89.19 139.72 30.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 49.85 46.4 40.18 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.457 1.027 . . . . 0.0 112.15 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . 60.67 3.88 0.67 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.277 1.831 . . . . 0.0 115.562 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.17 -158.53 0.41 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.307 1.443 . . . . 0.0 107.312 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -136.73 139.0 41.57 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.376 1.444 . . . . 0.0 110.635 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.8 mt -125.5 122.91 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.806 1.642 . . . . 0.0 107.22 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 27.8 t -112.41 134.86 53.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.98 -119.37 3.28 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.49 5.69 66.81 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.242 1.401 . . . . 0.0 114.002 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.36 118.78 11.89 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.472 1.509 . . . . 0.0 111.34 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -123.14 13.16 9.65 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 0.0 111.344 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -146.53 -178.53 21.98 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.744 1.64 . . . . 0.0 109.229 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -106.16 102.8 41.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 118.065 0.932 . . . . 0.0 110.945 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -78.18 -175.36 2.67 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.671 2.247 . . . . 0.0 108.427 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 65.1 p -116.18 174.18 6.19 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.498 -0.751 . . . . 0.0 110.273 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.52 -9.39 34.29 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.804 -0.617 . . . . 0.0 112.308 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.74 -27.71 68.14 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.965 0.802 . . . . 0.0 110.371 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 105.23 -155.51 17.0 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.442 ' CD2' ' HE2' ' A' ' 191' ' ' LYS . 41.6 m-85 -134.1 172.18 13.19 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.435 1.494 . . . . 0.0 109.563 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.67 160.8 31.32 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 128.49 2.716 . . . . 0.0 105.686 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -137.59 153.61 49.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.307 0.643 . . . . 0.0 111.709 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 256' ' ' SER . 27.7 t80 -142.66 143.05 32.18 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.06 0.944 . . . . 0.0 110.228 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -78.52 115.3 18.13 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.761 1.625 . . . . 0.0 109.536 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.8 mm -128.36 104.25 11.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -105.75 88.15 2.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -55.29 -33.46 17.63 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 117.083 -1.436 . . . . 0.0 114.695 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.4 -3.26 12.08 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 CA-C-N 123.585 2.316 . . . . 0.0 111.991 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 20.3 m -132.44 -8.18 3.29 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.117 1.767 . . . . 0.0 113.31 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -140.47 159.94 41.09 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.525 1.93 . . . . 0.0 110.542 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -144.25 119.93 10.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.422 1.089 . . . . 0.0 109.136 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.58 HG22 HD12 ' A' ' 276' ' ' ILE . 89.3 mt -81.88 94.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -24.16 45.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.966 0.803 . . . . 0.0 111.22 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -146.72 167.8 22.93 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.167 0.987 . . . . 0.0 111.362 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.74 150.45 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.906 1.682 . . . . 0.0 106.481 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.444 ' OE1' ' HE3' ' A' ' 250' ' ' LYS . 36.6 mt-10 -132.87 160.44 36.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.398 1.079 . . . . 0.0 108.247 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -177.82 164.74 33.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.6 p -130.9 148.96 52.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -142.34 146.83 35.42 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.548 0.739 . . . . 0.0 109.863 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -130.57 155.2 46.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.396 0.678 . . . . 0.0 109.718 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -69.55 147.11 51.22 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.139 0.976 . . . . 0.0 112.358 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 88.0 mt -88.99 115.9 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -52.64 133.54 36.29 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.278 0.561 . . . . 0.0 110.522 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 87.63 1.58 82.99 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.389 -1.228 . . . . 0.0 113.086 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.8 t -140.81 169.89 16.78 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.389 1.595 . . . . 0.0 109.391 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.51 -12.17 38.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.533 1.533 . . . . 0.0 108.183 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -74.08 175.65 47.82 Favored Glycine 0 C--N 1.345 1.062 0 C-N-CA 127.195 2.331 . . . . 0.0 112.16 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 242' ' ' LEU . 0.0 OUTLIER -149.02 169.67 20.1 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 111.883 -178.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 5.8 tp -136.25 143.74 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.688 1.595 . . . . 0.0 108.467 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -91.38 105.9 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 104.146 -2.539 . . . . 0.0 104.146 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.329 1.0 OUTLIER -104.11 -3.81 24.0 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.606 0.639 . . . . 0.0 112.165 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -149.52 143.55 25.71 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.036 -1.04 . . . . 0.0 111.568 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 39.9 mt -137.49 154.79 49.82 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.999 1.72 . . . . 0.0 111.031 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 27.6 mtt85 -142.48 170.84 14.96 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.494 2.317 . . . . 0.0 109.003 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -148.21 113.76 5.65 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.674 1.19 . . . . 0.0 109.406 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.444 ' HE3' ' OE1' ' A' ' 230' ' ' GLU . 67.1 mttt -77.05 114.47 15.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 5.2 p -109.9 165.84 11.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 127.059 2.144 . . . . 0.0 108.272 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -116.95 140.37 49.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 63.17 -8.29 0.14 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.306 1.442 . . . . 0.0 113.739 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -117.07 169.01 9.75 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.735 2.014 . . . . 0.0 107.852 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.0 m -130.98 108.16 9.6 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 123.622 0.769 . . . . 0.0 110.875 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . 0.403 ' HA ' ' CE1' ' A' ' 217' ' ' PHE . 4.5 p -79.82 -178.13 6.27 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.825 1.25 . . . . 0.0 109.411 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -138.93 158.87 69.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.12 0.968 . . . . 0.0 110.034 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.97 101.92 1.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.057 2.504 . . . . 0.0 109.357 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 180' ' ' VAL . 91.7 m-85 -79.48 95.45 5.81 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 122.12 -169.64 14.88 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -112.7 122.32 47.31 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.129 0.972 . . . . 0.0 109.099 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -60.42 113.26 2.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.864 1.666 . . . . 0.0 110.509 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -154.99 149.0 25.78 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.347 1.459 . . . . 0.0 109.267 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . 74.89 -165.15 54.72 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 121.869 0.705 . . . . 0.0 114.171 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' THR . . . . . . . . . . . . . 21.8 m -62.97 137.97 58.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.523 1.929 . . . . 0.0 109.338 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -108.59 121.71 45.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.54 43.21 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.56 0.744 . . . . 0.0 111.179 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -130.97 130.45 43.42 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.602 1.961 . . . . 0.0 107.302 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.8 mt -119.22 129.74 55.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -149.38 171.35 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 107.975 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -138.4 147.09 42.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.17 -4.67 30.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.295 1.438 . . . . 0.0 114.851 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -167.72 -19.32 0.02 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -92.57 168.1 11.48 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.854 1.827 . . . . 0.0 110.698 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.49 162.75 13.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.717 2.007 . . . . 0.0 110.387 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.58 HD12 HG22 ' A' ' 226' ' ' ILE . 21.6 mt -88.64 112.57 24.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.507 1.123 . . . . 0.0 108.892 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.37 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.26 153.12 8.93 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 125.383 1.468 . . . . 0.0 111.946 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -121.86 160.21 25.19 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.909 2.084 . . . . 0.0 108.779 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -159.29 176.89 11.62 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.615 0.766 . . . . 0.0 110.262 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 119.12 -111.29 2.05 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 126.549 2.023 . . . . 0.0 108.665 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.451 ' HE2' ' CA ' ' A' ' 162' ' ' ASP . 10.1 mtmp? -146.26 153.55 40.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.854 . . . . 0.0 112.498 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.92 131.22 34.9 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.132 1.773 . . . . 0.0 107.064 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.8 p -171.6 75.29 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 67.33 -70.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.873 2.469 . . . . 0.0 110.356 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 70.2 mt -81.33 172.56 13.43 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.217 2.207 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 21.7 tp -94.51 64.35 3.06 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.206 1.402 . . . . 0.0 109.688 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -61.4 -17.62 54.98 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -153.55 165.87 34.53 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -160.5 122.81 3.23 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -155.81 163.61 31.84 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 7.1 m -133.84 152.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.014 0.907 . . . . 0.0 113.116 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -85.25 167.71 15.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.969 1.708 . . . . 0.0 111.156 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.0 m -124.95 148.3 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.936 1.694 . . . . 0.0 109.092 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 92.1 mmm -152.99 149.07 21.05 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.634 1.973 . . . . 0.0 107.729 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.76 157.95 54.24 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.813 1.676 . . . . 0.0 110.037 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.41 29.51 1.26 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.341 1.056 . . . . 0.0 108.565 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 1.3 m -141.28 164.35 30.47 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.254 2.222 . . . . 0.0 105.585 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 C--O 1.247 0.936 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 179.215 . . . . . . . . 0 0 . 1 stop_ save_